PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, HK; Liu, ZP; Meyer-Franke, A; Brodbeck, J; Miranda, RD; McGuire, JG; Pleiss, MA; Ji, ZS; Balestra, ME; Walker, DW; Xu, Q; Jeong, DE; Budamagunta, MS; Voss, JC; Freedman, SB; Weisgraber, KH; Huang, YD; Mahley, RW				Chen, Hung-Kai; Liu, Zhaoping; Meyer-Franke, Anke; Brodbeck, Jens; Miranda, Rene D.; McGuire, James G.; Pleiss, Michael A.; Ji, Zhong-Sheng; Balestra, Maureen E.; Walker, David W.; Xu, Qin; Jeong, Dah-eun; Budamagunta, Madhu S.; Voss, John C.; Freedman, Stephen B.; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.			Small Molecule Structure Correctors Abolish Detrimental Effects of Apolipoprotein E4 in Cultured Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMER-DISEASE; SITE SPECIFIC CHAPERONE; ALPHA-GALACTOSIDASE-A; E TYPE-4 ALLELE; MUTANT P53; DOMAIN INTERACTION; FABRY-DISEASE; NEURITE OUTGROWTH; TRANSGENIC MICE; PHARMACOLOGICAL CHAPERONE	Apolipoprotein E4 (apoE4), the major genetic risk factor for late onset Alzheimer disease, assumes a pathological conformation, intramolecular domain interaction. ApoE4 domain interaction mediates the detrimental effects of apoE4, including decreased mitochondrial cytochrome c oxidase subunit 1 levels, reduced mitochondrial motility, and reduced neurite outgrowth in vitro. Mutant apoE4 (apoE4-R61T) lacks domain interaction, behaves like apoE3, and does not cause detrimental effects. To identify small molecules that inhibit domain interaction (i.e. structure correctors) and reverse the apoE4 detrimental effects, we established a high throughput cell-based FRET primary assay that determines apoE4 domain interaction and secondary cell- and function-based assays. Screening a ChemBridge library with the FRET assay identified CB9032258 (a phthalazinone derivative), which inhibits domain interaction in neuronal cells. In secondary functional assays, CB9032258 restored mitochondrial cytochrome c oxidase subunit 1 levels and rescued impairments of mitochondrial motility and neurite outgrowth in apoE4-expressing neuronal cells. These benefits were apoE4-specific and dose-dependent. Modifying CB9032258 yielded well defined structure-activity relationships and more active compounds with enhanced potencies in the FRET assay (IC50 of 23 and 116 nM, respectively). These compounds efficiently restored functional activities of apoE4-expressing cells in secondary assays. An EPR binding assay showed that the apoE4 structure correction resulted from direct interaction of a phthalazinone. With these data, a six-feature pharmacophore model was constructed for future drug design. Our results serve as a proof of concept that pharmacological intervention with apoE4 structure correctors negates apoE4 detrimental effects in neuronal cells and could be further developed as an Alzheimer disease therapeutic.	[Xu, Qin; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Chen, Hung-Kai; Liu, Zhaoping; Meyer-Franke, Anke; Brodbeck, Jens; Miranda, Rene D.; McGuire, James G.; Pleiss, Michael A.; Ji, Zhong-Sheng; Balestra, Maureen E.; Walker, David W.; Xu, Qin; Jeong, Dah-eun; Freedman, Stephen B.; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Gladstone Ctr Translat Res, San Francisco, CA 94158 USA; [Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Mahley, Robert W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weisgraber, Karl H.; Mahley, Robert W.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biol Chem, Sch Med, Davis, CA 95616 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Mahley, RW (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	rmahley@gladstone.ucsf.edu	Budamagunta, Madhu S/C-4628-2011; Brodbeck, Jens/AAB-9275-2020; liu, zhao/GXV-6141-2022	Voss, John/0000-0001-9279-209X; Chen, Hung-Kai/0000-0002-2169-4924	National Institutes of Health [P01 AG022074]; Merck Research Laboratories; NATIONAL INSTITUTE ON AGING [R01AG029246, P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant P01 AG022074. This work was also supported by Merck Research Laboratories.	[Anonymous], 2009, MOL THER, V17, P1309; Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Benjamin ER, 2009, J INHERIT METAB DIS, V32, P424, DOI 10.1007/s10545-009-1077-0; Bien-Ly N, 2011, P NATL ACAD SCI USA, V108, P4236, DOI 10.1073/pnas.1018381108; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Buttini M, 1999, J NEUROSCI, V19, P4867; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Clayton T, 2007, CURR MED CHEM, V14, P2755, DOI 10.2174/092986707782360097; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Fan JQ, 2003, METHOD ENZYMOL, V363, P412; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fossa P, 2001, QUANT STRUCT-ACT REL, V20, P17, DOI 10.1002/1521-3838(200105)20:1<17::AID-QSAR17>3.3.CO;2-O; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Guner O, 2004, CURR MED CHEM, V11, P2991, DOI 10.2174/0929867043364036; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Hughes D, 2010, J INHERIT METAB DIS, V33, pS148; Irizarry MC, 2000, ACTA NEUROPATHOL, V100, P451, DOI 10.1007/s004010000263; Ishii S, 2004, BBA-MOL BASIS DIS, V1690, P250, DOI 10.1016/j.bbadis.2004.07.001; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; Lambert JMR, 2010, ONCOGENE, V29, P1329, DOI 10.1038/onc.2009.425; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lee JY, 2007, B KOR CHEM SOC, V28, P379; LEMANSKY P, 1987, J BIOL CHEM, V262, P2062; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Li Y, 2002, CURR PHARM DESIGN, V8, P99, DOI 10.2174/1381612023396546; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martin Y., 2007, COMPR MED CHEM 2, V4, P119; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nicolotti O, 2004, CURR TOP MED CHEM, V4, P335, DOI 10.2174/1568026043451384; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Singh N, 2008, J MOL GRAPH MODEL, V27, P131, DOI 10.1016/j.jmgm.2008.03.007; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	83	94	97	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5253	5266		10.1074/jbc.M111.276162	http://dx.doi.org/10.1074/jbc.M111.276162			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22158868	hybrid, Green Published			2022-12-25	WOS:000300638000008
J	Krastanova, I; Sannino, V; Amenitsch, H; Gileadi, O; Pisani, FM; Onesti, S				Krastanova, Ivet; Sannino, Vincenzo; Amenitsch, Heinz; Gileadi, Opher; Pisani, Francesca M.; Onesti, Silvia			Structural and Functional Insights into the DNA Replication Factor Cdc45 Reveal an Evolutionary Relationship to the DHH Family of Phosphoesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; S-PHASE; GINS COMPLEX; STRUCTURE PREDICTION; RECJ EXONUCLEASE; MCM2-7 HELICASE; HIGH-THROUGHPUT; PROTEIN; ASSOCIATION; INITIATION	Cdc45 is an essential protein conserved in all eukaryotes and is involved both in the initiation of DNA replication and the progression of the replication fork. With GINS, Cdc45 is an essential cofactor of the Mcm2-7 replicative helicase complex. Despite its importance, no detailed information is available on either the structure or the biochemistry of the protein. Intriguingly, whereas homologues of both GINS and Mcm proteins have been described in Archaea, no counterpart for Cdc45 is known. Herein we report a bioinformatic analysis that shows a weak but significant relationship among eukaryotic Cdc45 proteins and a large family of phosphoesterases that has been described as the DHH family, including inorganic pyrophosphatases and RecJ ssDNA exonucleases. These enzymes catalyze the hydrolysis of phosphodiester bonds via a mechanism involving two Mn2+ ions. Only a subset of the amino acids that coordinates Mn2+ is conserved in Cdc45. We report biochemical and structural data on the recombinant human Cdc45 protein, consistent with the proposed DHH family affiliation. Like the RecJ exonucleases, the human Cdc45 protein is able to bind single-stranded, but not double-stranded DNA. Small angle x-ray scattering data are consistent with a model compatible with the crystallographic structure of the RecJ/DHH family members.	[Sannino, Vincenzo; Pisani, Francesca M.] CNR, Ist Biochim Prot, I-80131 Naples, Italy; [Krastanova, Ivet; Onesti, Silvia] Sincrotrone Trieste, Struct Biol Lab, I-34149 Trieste, Italy; [Amenitsch, Heinz] Austrian Acad Sci, Inst Biophys & Nanosyst Res, A-8042 Graz, Austria; [Gileadi, Opher] Struct Genom Consortium, Oxford OX3 7DQ, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Elettra Sincrotrone Trieste; Austrian Academy of Sciences; University of Oxford	Pisani, FM (corresponding author), CNR, Ist Biochim Prot, I-80131 Naples, Italy.	fm.pisani@ibp.cnr.it; silvia.onesti@elettra.trieste.it	Gileadi, Opher/F-1105-2013; Pisani, Francesca M./AAX-4025-2020	Gileadi, Opher/0000-0001-6886-898X; Onesti, Silvia/0000-0002-0612-7948; Amenitsch, Heinz/0000-0002-0788-1336; Sannino, Vincenzo/0000-0002-3570-7810	Friuli Venezia Giulia; Associazione Italiana per la Ricerca sul Cancro [IG10646, IG9087]	Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The work was supported by a Friuli Venezia Giulia grant (DAGEAST to I. K.) and by the Associazione Italiana per la Ricerca sul Cancro (Grant IG10646 to S. O. and Grant IG9087 to F. M. P.).	Amenitsch H, 1997, J APPL CRYSTALLOGR, V30, P872, DOI 10.1107/S0021889897001593; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Costa A, 2009, CRIT REV BIOCHEM MOL, V44, P326, DOI 10.1080/10409230903186012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabrichniy IP, 2004, BIOCHEMISTRY-US, V43, P14403, DOI 10.1021/bi0484973; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Motz M, 2002, J BIOL CHEM, V277, P16179, DOI 10.1074/jbc.M107793200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Owens JC, 1997, P NATL ACAD SCI USA, V94, P12521, DOI 10.1073/pnas.94.23.12521; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Rajman LA, 2000, J BACTERIOL, V182, P607, DOI 10.1128/JB.182.3.607-612.2000; Sakakibara N, 2009, MOL MICROBIOL, V72, P286, DOI 10.1111/j.1365-2958.2009.06663.x; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Uchiyama M, 2001, MOL GENET GENOMICS, V265, P1039, DOI 10.1007/s004380100499; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	41	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4121	4128		10.1074/jbc.M111.285395	http://dx.doi.org/10.1074/jbc.M111.285395			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147708	Green Published, hybrid			2022-12-25	WOS:000300410900045
J	Lee, J; Kim, HR; Quinley, C; Kim, J; Gonzalez-Navajas, J; Xavier, R; Raz, E				Lee, Jongdae; Kim, Hye Ri; Quinley, Christine; Kim, Joanna; Gonzalez-Navajas, Jose; Xavier, Ramnik; Raz, Eyal			Autophagy Suppresses Interleukin-1 beta (IL-1 beta) Signaling by Activation of p62 Degradation via Lysosomal and Proteasomal Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; NF-KAPPA-B; CROHNS-DISEASE; IMPAIRED AUTOPHAGY; GENE ATG16L1; ASSOCIATION; P62/SQSTM1; CULLIN3; CELLS; KEAP1	ATG16L1 is an essential component of the autophagasome. The T300A allele of ATG16L1 is associated with the increased susceptibility to Crohn disease. In this study, we identified a novel function of ATG16L1, which suppresses signaling of the pro-inflammatory cytokine IL-1 beta. Deletion of ATG16L1 in mouse embryonic fibroblasts significantly amplifies IL-1 beta signal transduction cascades. This amplification is due to elevated p62 levels in ATG16L1-deficient cells. We found that ATG16L1 regulates p62 levels via both autolysosomal and proteasomal pathways. For proteasomal degradation, we found that Cullin-3 (Cul-3) is a E3 ubiquitin ligase of p62 and that ATG16L1 is essential for neddylation of Cul-3, a step required for Cul-3 activation. Taken together our data indicate that loss-of-function of ATG16L1 results in a hyper-responsiveness to the IL-1 beta signaling because of the increased p62 level.	[Lee, Jongdae; Kim, Hye Ri; Quinley, Christine; Kim, Joanna; Gonzalez-Navajas, Jose; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Xavier, Ramnik] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Xavier, Ramnik] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lee, J (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	j142lee@ucsd.edu; eraz@ucsd.edu	González-Navajas, Jose Manuel/AAB-1575-2019	González-Navajas, Jose Manuel/0000-0002-1591-939X; Lee, Jongdae/0000-0002-6270-4658	National Institutes of Health [A1068685, A1095623, DK35108, DK080506]; CCFA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095623, R01AI068685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, P30DK043351, P01DK035108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants A1068685, A1095623, DK35108, and DK080506, and a grant from CCFA.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Liu J, 2010, BIOPHYS J, V99, P736, DOI 10.1016/j.bpj.2010.05.021; Mistry H, 2004, MECH DEVELOP, V121, P1495, DOI 10.1016/j.mod.2004.07.007; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542	25	77	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4033	4040		10.1074/jbc.M111.280065	http://dx.doi.org/10.1074/jbc.M111.280065			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167182	Green Published, hybrid			2022-12-25	WOS:000300410900037
J	Ohashi, Y; Iijima, H; Yamaotsu, N; Yamazaki, K; Sato, S; Okamura, M; Sugimoto, K; Dan, S; Hirono, S; Yamori, T				Ohashi, Yoshimi; Iijima, Hiroshi; Yamaotsu, Noriyuki; Yamazaki, Kanami; Sato, Shigeo; Okamura, Mutsumi; Sugimoto, Kenji; Dan, Shingo; Hirono, Shuichi; Yamori, Takao			AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ITERATIVE PARTIAL EQUALIZATION; NUCLEOTIDE EXCHANGE FACTORS; SMALL-MOLECULE INHIBITORS; ANTICANCER DRUG SCREEN; TUMOR-CELL-LINES; BREFELDIN-A; ORBITAL ELECTRONEGATIVITY; CONFORMATIONAL ENERGIES; ENDOPLASMIC-RETICULUM; 3-KINASE INHIBITOR	ADP-ribosylation factor1(Arf1) plays a major role in mediating vesicular transport. Brefeldin A (BFA), a known inhibitor of the Arf1-guanine nucleotide exchange factor (GEF) interaction, is highly cytotoxic. Therefore, interaction of Arf1 with ArfGEF is an attractive target for cancer treatment. However, BFA and its derivatives have not progressed beyond the pre-clinical stage of drug development because of their poor bioavailability. Here, we aimed to identify novel inhibitors of the Arf1-ArfGEF interaction that display potent antitumor activity in vivo but with a chemical structure distinct from that of BFA. We exploited a panel of 39 cell lines (termed JFCR39) coupled with a drug sensitivity data base and COMPARE algorithm, resulting in the identification of a possible novel Arf1-ArfGEF inhibitor AMF-26, which differed structurally from BFA. By using a pulldown assay with GGA3-conjugated beads, we demonstrated that AMF-26 inhibited Arf1 activation. Subsequently, AMF-26 induced Golgi disruption, apoptosis, and cell growth inhibition. Computer modeling/molecular dynamics (MD) simulation suggested that AMF-26 bound to the contact surface of the Arf1-Sec7 domain where BFA bound. AMF-26 affected membrane traffic, including the cis-Golgi and trans-Golgi networks, and the endosomal systems. Furthermore, using AMF-26 and its derivatives, we demonstrated that there was a significant correlation between cell growth inhibition and Golgi disruption. In addition, orally administrated AMF-26(83 mg/kg of body weight; 5 days) induced complete regression of human breast cancer BSY-1 xenografts in vivo, suggesting that AMF-26 is a novel anticancer drug candidate that inhibits the Golgi system, targeting Arf1 activation.	[Ohashi, Yoshimi; Yamazaki, Kanami; Okamura, Mutsumi; Dan, Shingo; Yamori, Takao] Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Sato, Shigeo] Japanese Fdn Canc Res, Div Expt Chemotherapy, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Iijima, Hiroshi; Yamaotsu, Noriyuki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Tokyo 1088641, Japan; [Sugimoto, Kenji] Osaka Prefecture Univ, Div Appl Biochem, Lab Appl Mol Biol, Grad Sch Agr & Biol Sci, Osaka 5998531, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Kitasato University; Osaka Metropolitan University	Yamori, T (corresponding author), Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Tokyo 1358550, Japan.	yamori@jfcr.or.jp	Yamaotsu, Noriyuki/AAW-2545-2020	Yamaotsu, Noriyuki/0000-0002-4302-1085	Japan Society for the Promotion of Science [22240092]; Ministry of Education, Culture, Sports, Science and Technology [11177101]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research (A) 22240092 from the Japan Society for the Promotion of Science (to T. Y.) and Grant-in-aid for Scientific Research on Priority Areas 11177101 from the Ministry of Education, Culture, Sports, Science and Technology (to T. Y.).	Anadu NO, 2006, J MED CHEM, V49, P3897, DOI 10.1021/jm0602817; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; BRUNING A, 1992, J BIOL CHEM, V267, P7726; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Case D, 2006, AMBER 9; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dan S, 2002, CANCER RES, V62, P1139; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Frisch M., 2016, GAUSSIAN 16 REVISION; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Iwase K, 1999, J COMPUT AID MOL DES, V13, P499, DOI 10.1023/A:1008011422113; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Lauria A, 2010, CURR MED CHEM, V17, P3142, DOI 10.2174/092986710792232021; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MARSILI M, 1980, CROAT CHEM ACTA, V53, P601; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; MORRE DJ, 1985, EUR J CELL BIOL, V37, P107; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Naasani I, 1999, CANCER RES, V59, P4004; Nakayama K, 2003, CELL STRUCT FUNCT, V28, P431, DOI 10.1247/csf.28.431; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Pan HL, 2008, J BIOL CHEM, V283, P31087, DOI 10.1074/jbc.M806592200; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; PURCELL WP, 1967, J CHEM ENG DATA, V12, P235, DOI 10.1021/je60033a020; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sakaushi S, 2007, BIOSCI BIOTECH BIOCH, V71, P571, DOI 10.1271/bbb.60434; Sausville E A, 1996, Cancer J Sci Am, V2, P52; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; THYBERG J, 1989, J SUBMICR CYTOL PATH, V21, P259; Tsujishita H, 1997, J COMPUT AID MOL DES, V11, P305, DOI 10.1023/A:1007964913898; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watari K, 2012, INT J CANCER, V131, P310, DOI 10.1002/ijc.26356; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yamori T, 2003, CANCER CHEMOTH PHARM, V52, pS74, DOI 10.1007/s00280-003-0649-1; Yamori T, 1999, CANCER RES, V59, P4042; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200	64	48	51	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3885	3897		10.1074/jbc.M111.316125	http://dx.doi.org/10.1074/jbc.M111.316125			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158626	Green Published, hybrid			2022-12-25	WOS:000300410900025
J	Armon, L; Eisenbach, M				Armon, Leah; Eisenbach, Michael			Behavioral Mechanism during Human Sperm Chemotaxis: Involvement of Hyperactivation	PLOS ONE			English	Article							HUMAN-SPERMATOZOA; POSTNATAL-DEVELOPMENT; BACTERIAL CHEMOTAXIS; INTRACELLULAR CA2+; FOLLICULAR FACTORS; MALE-FERTILITY; MOUSE TESTIS; MOTILITY; PROGESTERONE; CHANNEL	When mammalian spermatozoa become capacitated they acquire, among other activities, chemotactic responsiveness and the ability to exhibit occasional events of hyperactivated motility-a vigorous motility type with large amplitudes of head displacement. Although a number of roles have been proposed for this type of motility, its function is still obscure. Here we provide evidence suggesting that hyperactivation is part of the chemotactic response. By analyzing tracks of spermatozoa swimming in a spatial chemoattractant gradient we demonstrate that, in such a gradient, the level of hyperactivation events is significantly lower than in proper controls. This suggests that upon sensing an increase in the chemoattractant concentration capacitated cells repress their hyperactivation events and thus maintain their course of swimming toward the chemoattractant. Furthermore, in response to a temporal concentration jump achieved by photorelease of the chemoattractant progesterone from its caged form, the responsive cells exhibited a delayed turn, often accompanied by hyperactivation events or an even more intense response in the form of flagellar arrest. This study suggests that the function of hyperactivation is to cause a rather sharp turn during the chemotactic response of capacitated cells so as to assist them to reorient according to the chemoattractant gradient. On the basis of these results a model for the behavior of spermatozoa responding to a spatial chemoattractant gradient is proposed.	[Armon, Leah; Eisenbach, Michael] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Armon, L (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.eisenbach@weizmann.ac.il		Eisenbach, Michael/0000-0001-9048-4720				Avidan N, 2003, EUR J HUM GENET, V11, P497, DOI 10.1038/sj.ejhg.5200991; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; BURKMAN LJ, 1984, ARCH ANDROLOGY, V13, P153, DOI 10.3109/01485018408987514; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; COHENDAYAG A, 1994, BIOL REPROD, V50, P786, DOI 10.1095/biolreprod50.4.786; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; Davis RO, 1995, REPROD FERT DEVELOP, V7, P857, DOI 10.1071/RD9950857; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Eisenbach M, 1999, DEV GENET, V25, P87, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;87::AID-DVG2&gt;3.0.CO;2-4; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Gakamsky A, 2008, INT J DEV BIOL, V52, P481, DOI 10.1387/ijdb.072520ag; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; Hardy DM, 2002, FERTILIZATION, P3; HAUSER R, 1992, INT J ANDROL, V15, P498, DOI 10.1111/j.1365-2605.1992.tb01143.x; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; HUNTER RHF, 1994, MOL REPROD DEV, V39, P176, DOI 10.1002/mrd.1080390209; Jaiswal BS, 2002, FERTILIZATION, P57, DOI DOI 10.1016/B978-012311629-1/50005-X; JANSEN RPS, 1980, AM J OBSTET GYNECOL, V136, P292, DOI 10.1016/0002-9378(80)90853-4; KHAN S, 1993, BIOPHYS J, V65, P2368, DOI 10.1016/S0006-3495(93)81317-1; Kilic F, 2009, J AM CHEM SOC, V131, P4027, DOI 10.1021/ja808334f; Li HG, 2007, MOL HUM REPROD, V13, P299, DOI 10.1093/molehr/gam009; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Marquez B, 2004, BIOL REPROD, V70, P1626, DOI 10.1095/biolreprod.103.026476; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; Mortimer ST, 1997, HUM REPROD UPDATE, V3, P403, DOI 10.1093/humupd/3.5.403; Mortimer ST, 1996, HUM REPROD, V11, P1049; MUJICA A, 1994, MOL REPROD DEV, V38, P285, DOI 10.1002/mrd.1080380309; Nikpoor P, 2004, HUM REPROD, V19, P124, DOI 10.1093/humrep/deh043; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; PACEY AA, 1995, HUM REPROD, V10, P2603, DOI 10.1093/oxfordjournals.humrep.a135754; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; RALT D, 1994, BIOL REPROD, V50, P774, DOI 10.1095/biolreprod50.4.774; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; ROBERTSON L, 1988, BIOL REPROD, V39, P797, DOI 10.1095/biolreprod39.4.797; STAUSS CR, 1995, BIOL REPROD, V53, P1280, DOI 10.1095/biolreprod53.6.1280; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Suarez SS, 2003, REPROD DOMEST ANIM, V38, P119, DOI 10.1046/j.1439-0531.2003.00397.x; SUAREZ SS, 1992, BIOL REPROD, V46, P686, DOI 10.1095/biolreprod46.4.686; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; UHLER ML, 1992, FERTIL STERIL, V58, P1191; *WHO, 1993, WHO LAB MAN EX HUM S; YONISHROUACH E, 1990, J IMMUNOL METHODS, V135, P147, DOI 10.1016/0022-1759(90)90267-Y	49	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28359	10.1371/journal.pone.0028359	http://dx.doi.org/10.1371/journal.pone.0028359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163296	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900032
J	Campan, M; Moffitt, M; Houshdaran, S; Shen, H; Widschwendter, M; Daxenbichler, G; Long, T; Marth, C; Laird-Offringa, IA; Press, MF; Dubeau, L; Siegmund, KD; Wu, AH; Groshen, S; Chandavarkar, U; Roman, LD; Berchuck, A; Pearce, CL; Laird, PW				Campan, Mihaela; Moffitt, Melissa; Houshdaran, Sahar; Shen, Hui; Widschwendter, Martin; Daxenbichler, Guenter; Long, Tiffany; Marth, Christian; Laird-Offringa, Ite A.; Press, Michael F.; Dubeau, Louis; Siegmund, Kimberly D.; Wu, Anna H.; Groshen, Susan; Chandavarkar, Uma; Roman, Lynda D.; Berchuck, Andrew; Pearce, Celeste L.; Laird, Peter W.			Genome-Scale Screen for DNA Methylation-Based Detection Markers for Ovarian Cancer	PLOS ONE			English	Article							BIOMARKERS; SERUM; CELL; EPIDEMIOLOGY; PREDICTION; MANAGEMENT; CARCINOMA; SPECIMENS; DIAGNOSIS	Background: The identification of sensitive biomarkers for the detection of ovarian cancer is of high clinical relevance for early detection and/or monitoring of disease recurrence. We developed a systematic multi-step biomarker discovery and verification strategy to identify candidate DNA methylation markers for the blood-based detection of ovarian cancer. Methodology/Principal Findings: We used the Illumina Infinium platform to analyze the DNA methylation status of 27,578 CpG sites in 41 ovarian tumors. We employed a marker selection strategy that emphasized sensitivity by requiring consistency of methylation across tumors, while achieving specificity by excluding markers with methylation in control leukocyte or serum DNA. Our verification strategy involved testing the ability of identified markers to monitor disease burden in serially collected serum samples from ovarian cancer patients who had undergone surgical tumor resection compared to CA-125 levels. We identified one marker, IFFO1 promoter methylation (IFFO1-M), that is frequently methylated in ovarian tumors and that is rarely detected in the blood of normal controls. When tested in 127 serially collected sera from ovarian cancer patients, IFFO1-M showed post-resection kinetics significantly correlated with serum CA-125 measurements in six out of 16 patients. Conclusions/Significance: We implemented an effective marker screening and verification strategy, leading to the identification of IFFO1-M as a blood-based candidate marker for sensitive detection of ovarian cancer. Serum levels of IFFO1-M displayed post-resection kinetics consistent with a reflection of disease burden. We anticipate that IFFO1-M and other candidate markers emerging from this marker development pipeline may provide disease detection capabilities that complement existing biomarkers.	[Campan, Mihaela; Long, Tiffany; Laird-Offringa, Ite A.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Moffitt, Melissa; Chandavarkar, Uma; Roman, Lynda D.] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles, CA 90033 USA; [Houshdaran, Sahar; Laird-Offringa, Ite A.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Widschwendter, Martin] UCL, Dept Gynecol Oncol, Elizabeth Garrett Anderson Inst Womens Hlth, London, England; [Daxenbichler, Guenter; Marth, Christian] Innsbruck Med Univ, Dept Obstet & Gynecol, Innsbruck, Austria; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27710 USA; [Siegmund, Kimberly D.; Wu, Anna H.; Groshen, Susan; Pearce, Celeste L.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Shen, Hui; Laird, Peter W.] Univ So Calif, Epigenome Ctr, Los Angeles, CA 90033 USA; [Press, Michael F.; Dubeau, Louis] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of London; University College London; Medical University of Innsbruck; Duke University; University of Southern California; University of Southern California; University of Southern California	Campan, M (corresponding author), Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA.	plaird@usc.edu	Offringa, Ite/R-4101-2019; Laird, Peter W/G-8683-2012; Shen, Hui/AAO-4387-2020	Laird, Peter W/0000-0001-9117-3641; Shen, Hui/0000-0001-9767-4084; moffitt, melissa/0000-0002-1270-0034; Widschwendter, Martin/0000-0002-7778-8380	Ovarian Cancer Research Fund [PPD/USC.06]; National Institutes of Health and National Cancer Institute [R01-CA096958]; NATIONAL CANCER INSTITUTE [R01CA096958] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; National Institutes of Health and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ovarian Cancer Research Fund, grant PPD/USC.06, and National Institutes of Health and National Cancer Institute, grant R01-CA096958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2010, JNCI-J NATL CANCER I, V102, P26, DOI 10.1093/jnci/djp438; [Anonymous], 2011, CANC GENOME ATLAS DA; Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Board RE, 2007, BIOMARK INSIGHTS, V2, P307; Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; de Caceres Inmaculada Ibanez, 2004, Cancer Research, V64, P6476, DOI 10.1158/0008-5472.CAN-04-1529; Diamandis EP, 2004, J NATL CANCER I, V96, P353, DOI 10.1093/jnci/djh056; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Houshdaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009359; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LEON SA, 1977, CANCER RES, V37, P646; Melnikov A, 2009, J MOL DIAGN, V11, P60, DOI 10.2353/jmoldx.2009.080072; Memarzadeh S, 2001, J REPROD MED, V46, P621; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schwartz Peter E, 2002, Cancer Treat Res, V107, P99; Sepulveda Antonia R, 2009, J Mol Diagn, V11, P266, DOI 10.2353/jmoldx.2009.080125; Su HY, 2009, INT J CANCER, V124, P387, DOI 10.1002/ijc.23957; Vineis P, 2007, CANCER EPIDEM BIOMAR, V16, P1954, DOI 10.1158/1055-9965.EPI-07-0457; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	35	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28141	10.1371/journal.pone.0028141	http://dx.doi.org/10.1371/journal.pone.0028141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163280	Green Submitted, Green Published, gold			2022-12-25	WOS:000298161900015
J	Starmans, MHW; Fung, G; Steck, H; Wouters, BG; Lambin, P				Starmans, Maud H. W.; Fung, Glenn; Steck, Harald; Wouters, Bradly G.; Lambin, Philippe			A Simple but Highly Effective Approach to Evaluate the Prognostic Performance of Gene Expression Signatures	PLOS ONE			English	Article							CELL-LUNG-CANCER; BREAST-CANCER; PATIENT SURVIVAL; DNA MICROARRAYS; CHEMOTHERAPY; PREDICTORS; HYPOXIA	Background: Highly parallel analysis of gene expression has recently been used to identify gene sets or 'signatures' to improve patient diagnosis and risk stratification. Once a signature is generated, traditional statistical testing is used to evaluate its prognostic performance. However, due to the dimensionality of microarrays, this can lead to false interpretation of these signatures. Principal Findings: A method was developed to test batches of a user-specified number of randomly chosen signatures in patient microarray datasets. The percentage of random generated signatures yielding prognostic value was assessed using ROC analysis by calculating the area under the curve (AUC) in six public available cancer patient microarray datasets. We found that a signature consisting of randomly selected genes has an average 10% chance of reaching significance when assessed in a single dataset, but can range from 1% to similar to 40% depending on the dataset in question. Increasing the number of validation datasets markedly reduces this number. Conclusions: We have shown that the use of an arbitrary cut-off value for evaluation of signature significance is not suitable for this type of research, but should be defined for each dataset separately. Our method can be used to establish and evaluate signature performance of any derived gene signature in a dataset by comparing its performance to thousands of randomly generated signatures. It will be of most interest for cases where few data are available and testing in multiple datasets is limited.	[Starmans, Maud H. W.; Wouters, Bradly G.; Lambin, Philippe] Maastricht Univ, Dept Radiat Oncol Maastro, GROW Sch Oncol & Dev Biol, Med Ctr, Maastricht, Netherlands; [Fung, Glenn; Steck, Harald] Siemens Med Solut, Dept CAD & Knowledge Solut, Malvern, PA USA; [Wouters, Bradly G.] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON, Canada	Maastricht University; Siemens AG; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Starmans, MHW (corresponding author), Maastricht Univ, Dept Radiat Oncol Maastro, GROW Sch Oncol & Dev Biol, Med Ctr, Maastricht, Netherlands.	maud.starmans@maastrichtuniversity.nl	Wouters, Bradly/T-1525-2017	Wouters, Bradly/0000-0002-8187-592X; Lambin, Philippe/0000-0001-7961-0191	Siemens Oncology Care Systems (OCS); CTMM	Siemens Oncology Care Systems (OCS); CTMM	The authors acknowledge financial support from Siemens Oncology Care Systems (OCS) and the CTMM framework (AIRFORCE project). G. Fung and H. Steck are employed by Siemens Medical Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Siemens OCS and Siemens Medical Solutions are separate divisions.	Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Boulesteix AL, 2009, BRIEF BIOINFORM, V10, P556, DOI 10.1093/bib/bbp034; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Bryant CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011712; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; FISHEL I, 2007, BIOINFORMATICS; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sanchez-Palencia A, 2010, INT J CANC; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xu WW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-465; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325; Zien A, 2003, J COMPUT BIOL, V10, P653, DOI 10.1089/10665270360688246	29	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28320	10.1371/journal.pone.0028320	http://dx.doi.org/10.1371/journal.pone.0028320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163293	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900028
J	Vilela, ML; Azevedo, CG; Carvalho, BM; Rangel, EF				Vilela, Mauricio Luiz; Azevedo, Carina Graser; Carvalho, Bruno M.; Rangel, Elizabeth F.			Phlebotomine Fauna (Diptera: Psychodidae) and Putative Vectors of Leishmaniases in Impacted Area by Hydroelectric Plant, State of Tocantins, Brazil	PLOS ONE			English	Article							AMERICAN CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; SPECIES ABUNDANCE; CLIMATE	Background: Although leishmaniases are regarded as serious public health issues in the State of Tocantins, as consequence of the impact of environmental changes, small advances in taxonomic and ecological studies of Phlebotominae fauna are taking place in this state. The present study aimed to improve the knowledge about the sand flies, as well as about the aspects of the bioecology of leishmaniases vectors from Porto Nacional, a city that was directly impacted by the construction of Luis Eduardo Magalhaes Hydroelectric Plant (HEP - Lajeado). Methodology/Principal Findings: Sand flies were collected monthly using CDC light traps and Shannon traps for a period of 40 consecutive months, at different monitoring stations, where 7162 specimens were collected and 48 species were detected. Among the species found, 22 are first records in the state and seven are considered important vectors of leishmaniases. Lutzomyia longipalpis, the vector of American Visceral Leishmaniasis (AVL) showed higher frequency in urban compared to rural areas, and Nyssomyia whitmani, the vector of American Cutaneous Leishmaniasis (ACL), predominated in rural areas. The frequency and habits of sand fly vectors are discussed considering environmental characteristics and climatic factors. Conclusions/Significance: The construction of dams requires a great amount of labor, therefore attracting people from elsewhere. Increased migration, without adequate structure, leads to bad living conditions in new and unplanned settlements. It also leads to deforestation associated with environmental impacts, which can facilitate the spread of leishmaniases. This study discusses the importance of Lu. longipalpis and Ny. whitmani on the transmission cycles of leishmaniases in Porto Nacional and the record of Bi. flaviscutellata in periurban area of the city.	[Vilela, Mauricio Luiz; Carvalho, Bruno M.; Rangel, Elizabeth F.] Inst Oswaldo Cruz FIOCRUZ, Lab Transmissores Leishmanioses, Rio De Janeiro, Brazil; [Azevedo, Carina Graser] Secretaria Sau Estado Tocantins, Palmas, Tocantins, Brazil	Fundacao Oswaldo Cruz	Vilela, ML (corresponding author), Inst Oswaldo Cruz FIOCRUZ, Lab Transmissores Leishmanioses, Rio De Janeiro, Brazil.	mvilela@ioc.fiocruz.br	Carvalho, Bruno/G-9558-2013; Rangel, Elizabeth F/F-8355-2013	Carvalho, Bruno/0000-0002-0009-5770; Rangel, Elizabeth/0000-0002-9584-1202	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [025/2006, 014/2008]; Oswaldo Cruz Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation	The study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq/MS-SCTIE-DECIT no 025/2006; MCT/CNPq no 014/2008) (www.cnpq.br) and Oswaldo Cruz Foundation (www.fiocruz.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Filho J D, 2001, Rev Soc Bras Med Trop, V34, P323, DOI 10.1590/S0037-86822001000400003; Andrade JD, 2004, MEM I OSWALDO CRUZ, V99, P609, DOI 10.1590/S0074-02762004000600013; Barretto Mauro Pereira, 1946, REV BRASIL BIOL, V6, P427; Bigeli JG, 2010, AN 14 REUN PESQ APL, P148; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2007, MAN VIGL LEISHM TEG, P179; Brasil Ministerio da Saude . Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2006, MAN VIG CONTR LEISHM; Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004; Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176; da Costa SM, 2007, MEM I OSWALDO CRUZ, V102, P149, DOI 10.1590/S0074-02762007005000016; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 1995, B DIR MALARIOL SAN A, V35, P133; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Governo do Estado de Tocantins, 2010, INF ENT EP LEISHM; LAINSON R, 1994, MEM I OSWALDO CRUZ, V89, P435, DOI 10.1590/S0074-02761994000300027; Loiola CF, 2007, MEM I OSWALDO CRUZ, V102, P581, DOI 10.1590/S0074-02762007005000050; Lustosa ED, 1986, NOTA PREVIA I REV PA, V15, P7; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; MARTINS A V, 1975, Revista Brasileira de Biologia, V35, P515; MARTINS A. V., 1964, REV BRASIL BIOL, V24, P321; MARTINS A. VIANNA, 1962, REV BRAS IL MALARIOL DOENCAS TROP, V14, P379; Rangel EF, 2010, WORKSH GEN BIOL MOL, P25; Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025; Rangel EF, 2009, MEM I OSWALDO CRUZ, V104, P937, DOI 10.1590/S0074-02762009000700001; Rede Grupo, 2003, US HIDR LUIS ED MAG; ROBERTS DR, 1979, ENVIRON ENTOMOL, V8, P1007, DOI 10.1093/ee/8.6.1007; RODRIGUES W. C., 2005, DIVES DIVERSIDADE ES; SUDIA WILLIAM D., 1962, MOSQUITO NEWS, V22, P126; Vilela ML, 2008, 6 INT S PHLEB SANDFL; WHO, 2010, WHO TECH REP SER, V949, P1	30	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27721	10.1371/journal.pone.0027721	http://dx.doi.org/10.1371/journal.pone.0027721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163271	Green Submitted, Green Published, gold			2022-12-25	WOS:000298161900007
J	Brites, P; Ferreira, AS; da Silva, TF; Sousa, VF; Malheiro, AR; Duran, M; Waterham, HR; Baes, M; Wanders, RJA				Brites, Pedro; Ferreira, Ana Sofia; da Silva, Tiago Ferreira; Sousa, Vera F.; Malheiro, Ana R.; Duran, Marinus; Waterham, Hans R.; Baes, Myriam; Wanders, Ronald J. A.			Alkyl-Glycerol Rescues Plasmalogen Levels and Pathology of Ether-Phospholipid Deficient Mice	PLOS ONE			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; ACID ALPHA-OXIDATION; PHYTANIC ACID; PEROXISOMAL DISORDERS; ZELLWEGER-SYNDROME; HARDERIAN-GLAND; PTS2 RECEPTOR; FATTY-ACIDS; DIHYDROXYACETONEPHOSPHATE SYNTHASE; BIOLOGICAL-MEMBRANES	A deficiency of plasmalogens, caused by impaired peroxisomal metabolism affects normal development and multiple organs in adulthood. Treatment options aimed at restoring plasmalogen levels may be relevant for the therapy of peroxisomal and non-peroxisomal disorders. In this study we determined the in vivo efficacy of an alkyl glycerol (AG), namely, 1-O-octadecyl-rac-glycerol, as a therapeutic agent for defects in plasmalogen synthesis. To achieve this, Pex7 knockout mice, a mouse model for Rhizomelic Chondrodysplasia Punctata type 1 characterized by the absence of plasmalogens, and WT mice were fed a control diet or a diet containing 2% alkyl-glycerol. Plasmalogen levels were measured in target organs and the biochemical data were correlated with the histological analysis of affected organs. Plasmalogen levels in all peripheral tissues of Pex7 KO mice fed the AG diet for 2 months normalized to the levels of AG fed WT mice. In nervous tissues of Pex7 KO mice fed the AG-diet, plasmalogen levels were significantly increased compared to control fed KO mice. Histological analysis of target organs revealed that the AG-diet was able to stop the progression of the pathology in testis, adipose tissue and the Harderian gland. Interestingly, the latter tissues are characterized by the presence of lipid droplets which were absent or reduced in size and number when ether-phospholipids are lacking, but which can be restored with the AAG treatment. Furthermore, nerve conduction in peripheral nerves was improved. When given prior to the occurrence of major pathological changes, the AG-diet prevented or ameliorated the pathology observed in Pex7 KO mice depending on the degree of plasmalogen restoration. This study provides evidence of the beneficial effects of treating a plasmalogen deficiency with alkyl-glycerol.	[Brites, Pedro; da Silva, Tiago Ferreira; Sousa, Vera F.; Malheiro, Ana R.] IBMC, Nerve Regenerat Grp, Oporto, Portugal; [Brites, Pedro; Ferreira, Ana Sofia; Duran, Marinus; Waterham, Hans R.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [da Silva, Tiago Ferreira; Sousa, Vera F.] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Baes, Myriam] Katholieke Univ Leuven, Lab Cell Metab, Dept Pharmaceut Sci, Louvain, Belgium	Universidade do Porto; University of Amsterdam; Academic Medical Center Amsterdam; Universidade do Porto; KU Leuven	Brites, P (corresponding author), IBMC, Nerve Regenerat Grp, Oporto, Portugal.	pedro.brites@ibmc.up.pt	Brites, Pedro/K-4231-2013; Silva, Tiago JCF/I-6961-2015; Ferreira, Ana Sofia/F-7899-2014; Malheiro, Ana/L-1174-2014	Brites, Pedro/0000-0003-1754-1543; Silva, Tiago JCF/0000-0002-0732-8741; Malheiro, Ana/0000-0002-9093-5875; Ferreira, Ana Sofia/0000-0003-3805-8278; Sousa Figueiredo, Vera/0000-0001-7945-0116; Baes, Myriam/0000-0002-2525-2269	Association Europeenne contre les Leucodystrophies [ELA 2008-009C4B, 2010-042c5]; FundaCao para a Cioncia e Tecnologia [PTDS/SAU-ORG/112406/2009]	Association Europeenne contre les Leucodystrophies; FundaCao para a Cioncia e Tecnologia	This research was supported by grants from the Association Europeenne contre les Leucodystrophies (ELA 2008-009C4B and 2010-042c5) and by PTDS/SAU-ORG/112406/2009 from FundaCao para a Cioncia e Tecnologia under the programs FEDER and COMPETE. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2008, BRIT J NUTR, V99, P653, DOI 10.1017/S000711450782407X; BALFE A, 1990, PEDIATR RES, V27, P304, DOI 10.1203/00006450-199003000-00023; Beams-Mengerink AM, 2006, NEUROLOGY, V66, P798, DOI 10.1212/01.wnl.0000205594.34647.d0; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; Braverman N, 2010, MOL GENET METAB, V99, P408, DOI 10.1016/j.ymgme.2009.12.005; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Brites P, 2003, HUM MOL GENET, V12, P2255, DOI 10.1093/hmg/ddg236; Brites P, 2009, BRAIN, V132, P482, DOI 10.1093/brain/awn295; Brookhyser KM, 1999, PRENATAL DIAG, V19, P383, DOI 10.1002/(SICI)1097-0223(199904)19:4<383::AID-PD544>3.0.CO;2-S; Dacremont G, 1995, J INHERIT METAB DIS, V18, P84, DOI 10.1007/BF00711431; DAS AK, 1988, FEBS LETT, V227, P187, DOI 10.1016/0014-5793(88)80895-0; DAS AK, 1992, LIPIDS, V27, P401, DOI 10.1007/BF02536379; de Vet ECJM, 1998, J BIOL CHEM, V273, P10296, DOI 10.1074/jbc.273.17.10296; de Vet ECJM, 2000, CELL BIOCHEM BIOPHYS, V32, P117, DOI 10.1385/CBB:32:1-3:117; Dragonas C, 2009, CLIN CHEM LAB MED, V47, P894, DOI 10.1515/CCLM.2009.205; Ferdinandusse S, 2008, P NATL ACAD SCI USA, V105, P17712, DOI 10.1073/pnas.0806066105; Gaposchkin DP, 1999, J LIPID RES, V40, P495; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grandl M, 2006, CYTOM PART A, V69A, P189, DOI 10.1002/cyto.a.20232; Gressens P, 2000, ANN NEUROL, V48, P336, DOI 10.1002/1531-8249(200009)48:3<336::AID-ANA8>3.0.CO;2-Q; HEIKOOP JC, 1990, J CLIN INVEST, V86, P126, DOI 10.1172/JCI114674; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; HOEFLER S, 1988, PRENATAL DIAG, V8, P571, DOI 10.1002/pd.1970080804; HORIE S, 1989, BIOCHEM J, V262, P677, DOI 10.1042/bj2620677; KAUFMAN S, 1990, BIOCHIM BIOPHYS ACTA, V1040, P19, DOI 10.1016/0167-4838(90)90141-2; Khan M, 2008, J NEUROCHEM, V106, P1766, DOI 10.1111/j.1471-4159.2008.05513.x; KREMSER K, 1989, J CLIN CHEM CLIN BIO, V27, P315; Lankalapalli RS, 2009, ORG LETT, V11, P2784, DOI 10.1021/ol9009078; Lee TC, 1998, BBA-LIPID LIPID MET, V1394, P129, DOI 10.1016/S0005-2760(98)00107-6; Lessig J, 2009, CURR MED CHEM, V16, P2021; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Motley AM, 2002, AM J HUM GENET, V70, P612, DOI 10.1086/338998; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Ofman R, 1998, HUM MOL GENET, V7, P847, DOI 10.1093/hmg/7.5.847; PALTAUF F, 1994, CHEM PHYS LIPIDS, V74, P101, DOI 10.1016/0009-3084(94)90054-X; PALTAUF F, 1988, FASEB J, V2, pA1740; PAYNE AP, 1994, J ANAT, V185, P1; POULOS A, 1988, J PEDIATR-US, V113, P685, DOI 10.1016/S0022-3476(88)80378-0; Powers JM, 1999, ACTA NEUROPATHOL, V98, P129, DOI 10.1007/s004010051060; Pugliese PT, 1998, J ALTERN COMPLEM MED, V4, P87, DOI 10.1089/acm.1998.4.1-87; Purdue PE, 1999, NEUROCHEM RES, V24, P581, DOI 10.1023/A:1023957110171; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; RADOMINSKAPYREK A, 1979, BIOCHIM BIOPHYS ACTA, V574, P248, DOI 10.1016/0005-2760(79)90006-7; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Rosenberger TA, 2002, J LIPID RES, V43, P59; Sakai S, 2008, BRAIN DEV-JPN, V30, P68, DOI 10.1016/j.braindev.2007.06.002; SCHRAKAMP G, 1988, J LIPID RES, V29, P325; SCHUTGENS RBH, 1993, CLIN CHEM, V39, P1632; Snyder F, 1988, Prog Clin Biol Res, V282, P57; STURK A, 1987, BLOOD, V70, P460; Styger R, 2002, BBA-MOL CELL BIOL L, V1585, P39, DOI 10.1016/S1388-1981(02)00320-7; van den Bosch H, 1988, Prog Clin Biol Res, V282, P139; Van Overloop H, 2007, BIOL CHEM, V388, P315, DOI 10.1515/BC.2007.035; VANDENBOSCH H, 1993, BIOCHIMIE, V75, P183, DOI 10.1016/0300-9084(93)90076-5; Verhoeven NM, 2001, PROG LIPID RES, V40, P453, DOI 10.1016/S0163-7827(01)00011-X; Wanders RJA, 2003, BBA-MOL CELL BIOL L, V1631, P119, DOI 10.1016/S1388-1981(03)00003-9; Wanders RJA, 2001, J NEUROPATH EXP NEUR, V60, P1021, DOI 10.1093/jnen/60.11.1021; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang HJ, 2010, MOL BIOL CELL, V21, P1991, DOI 10.1091/mbc.E09-05-0364; White AL, 2003, AM J MED GENET A, V118A, P332, DOI 10.1002/ajmg.a.20009; Wierzbicki AS, 2007, BIOCHEM SOC T, V35, P881, DOI 10.1042/BST0350881; WILSON GN, 1986, AM J MED GENET, V24, P69, DOI 10.1002/ajmg.1320240109	64	75	75	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28539	10.1371/journal.pone.0028539	http://dx.doi.org/10.1371/journal.pone.0028539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163031	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500031
J	Du, QS; Meng, JZ; Wang, CH; Long, SY; Huang, RB				Du, Qi-Shi; Meng, Jian-Zong; Wang, Cheng-Hua; Long, Si-Yu; Huang, Ri-Bo			Structural Position Correlation Analysis (SPCA) for Protein Family	PLOS ONE			English	Article							PDZ DOMAIN; CRYSTAL-STRUCTURE; DETERMINANTS; RECOGNITION; ACTIVATION; INFLUENZA; CATALYSIS; PATHWAYS; MODULES; SYSTEM	Background: The proteins in a family, which perform the similar biological functions, may have very different amino acid composition, but they must share the similar 3D structures, and keep a stable central region. In the conservative structure region similar biological functions are performed by two or three catalytic residues with the collaboration of several functional residues at key positions. Communication signals are conducted in a position network, adjusting the biological functions in the protein family. Methodology: A computational approach, namely structural position correlation analysis (SPCA), is developed to analyze the correlation relationship between structural segments (or positions). The basic hypothesis of SPCA is that in a protein family the structural conservation is more important than the sequence conservation, and the local structural changes may contain information of biology functional evolution. A standard protein P((0)) is defined in a protein family, which consists of the most-frequent amino acids and takes the average structure of the protein family. The foundational variables of SPCA is the structural position displacements between the standard protein P((0)) and individual proteins P(i) of the family. The structural positions are organized as segments, which are the stable units in structural displacements of the protein family. The biological function differences of protein members are determined by the position structural displacements of individual protein Pi to the standard protein P((0)). Correlation analysis is used to analyze the communication network among segments. Conclusions: The structural position correlation analysis (SPCA) is able to find the correlation relationship among the structural segments (or positions) in a protein family, which cannot be detected by the amino acid sequence and frequency-based methods. The functional communication network among the structural segments (or positions) in protein family, revealed by SPCA approach, well illustrate the distantly allosteric interactions, and contains valuable information for protein engineering study.	[Du, Qi-Shi; Wang, Cheng-Hua; Long, Si-Yu; Huang, Ri-Bo] Guangxi Acad Sci, State Key Lab Nonfood Biomass Energy & Enzyme Tec, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi; Meng, Jian-Zong; Huang, Ri-Bo] Guangxi Univ, Life Sci & Biotechnol Coll, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Wang, Cheng-Hua; Huang, Ri-Bo] Nanjing Univ Technol, Nanjing, Jiangsu, Peoples R China	Guangxi University; Nanjing Tech University	Du, QS (corresponding author), Guangxi Acad Sci, State Key Lab Nonfood Biomass Energy & Enzyme Tec, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China.	qishi_du@yahoo.com.cn			National Program on Key Basic Research Project (973 Program) of China [2009CB724703]; National Science Foundation of China (NSFC) [30970562]	National Program on Key Basic Research Project (973 Program) of China(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Program on Key Basic Research Project (973 Program) of China under the project 2009CB724703, and by the National Science Foundation of China (NSFC) under the project 30970562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Coleman SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008715; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Du QS, 2007, BIOCHEM BIOPH RES CO, V362, P525, DOI 10.1016/j.bbrc.2007.08.025; Du QS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013207; Du QS, 2010, CHEM PHYS LETT, V485, P191, DOI 10.1016/j.cplett.2009.12.037; Dunn CJ, 1999, DRUGS, V58, P761, DOI 10.2165/00003495-199958040-00016; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; Kidd BA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000484; Kurakin A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000953; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Ponting CP, 1997, PROTEIN SCI, V6, P464; Prakash O, 2010, APPL BIOCHEM BIOTECH, V160, P2401, DOI 10.1007/s12010-009-8735-4; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Thomas MC, 2006, ELEMENTS INFORM THEO; Velthuis AJWT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000189; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28206	10.1371/journal.pone.0028206	http://dx.doi.org/10.1371/journal.pone.0028206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163002	gold, Green Published, Green Submitted			2022-12-25	WOS:000298172800019
J	Heine, M; Nollau, P; Masslo, C; Nielsen, P; Freund, B; Bruns, OT; Reimer, R; Hohenberg, H; Peldschus, K; Ittrich, H; Schumacher, U				Heine, Markus; Nollau, Peter; Masslo, Christoph; Nielsen, Peter; Freund, Barbara; Bruns, Oliver T.; Reimer, Rudolph; Hohenberg, Heinrich; Peldschus, Kersten; Ittrich, Harald; Schumacher, Udo			Investigations on the Usefulness of CEACAMs as Potential Imaging Targets for Molecular Imaging Purposes	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL-ANTIBODIES; PROGNOSTIC INDICATOR; METASTASIS FORMATION; MALIGNANT-MELANOMA; C-CAM; CANCER; EXPRESSION; CARCINOMA	Members of the carcinoembryonic antigen cell adhesion molecules (CEACAMs) family are the prototype of tumour markers. Classically they are used as serum markers, however, CEACAMs could serve as targets for molecular imaging as well. In order to test the anti CEACAM monoclonal antibody T84.1 for imaging purposes, CEACAM expression was analysed using this antibody. Twelve human cancer cell lines from different entities were screened for their CEACAM expression using qPCR, Western Blot and FACS analysis. In addition, CEACAM expression was analyzed in primary tumour xenografts of these cells. Nine of 12 tumour cell lines expressed CEACAM mRNA and protein when grown in vitro. Pancreatic and colon cancer cell lines showed the highest expression levels with good correlation of mRNA and protein level. However, when grown in vivo, the CEACAM expression was generally downregulated except for the melanoma cell lines. As the CEACAM expression showed pronounced expression in FemX-1 primary tumours, this model system was used for further experiments. As the accessibility of the antibody after i.v. application is critical for its use in molecular imaging, the binding of the T84.1 monoclonal antibody was assessed after i.v. injection into SCID mice harbouring a FemX-1 primary tumour. When applied i.v., the CEACAM specific T84.1 antibody bound to tumour cells in the vicinity of blood vessels. This binding pattern was particularly pronounced in the periphery of the tumour xenograft, however, some antibody binding was also observed in the central areas of the tumour around blood vessels. Still, a general penetration of the tumour by i.v. application of the anti CEACAM antibody could not be achieved despite homogenous CEACAM expression of all melanoma cells when analysed in tissue sections. This lack of penetration is probably due to the increased interstitial fluid pressure in tumours caused by the absence of functional lymphatic vessels.	[Heine, Markus; Schumacher, Udo] Univ Hosp Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Nollau, Peter; Masslo, Christoph] Univ Hosp Hamburg Eppendorf, Dept Clin Chem, Ctr Clin Pathol, Hamburg, Germany; [Nielsen, Peter; Freund, Barbara] Univ Hosp Hamburg Eppendorf, Inst Biochem & Mol Biol Mol Cell Biol 2, Hamburg, Germany; [Bruns, Oliver T.; Reimer, Rudolph; Hohenberg, Heinrich] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany; [Peldschus, Kersten; Ittrich, Harald] Univ Hosp Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heine, M (corresponding author), Univ Hosp Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany.	ma.heine@uke.uni-hamburg.de	Bruns, Oliver T/D-6735-2015	Bruns, Oliver T/0000-0002-5738-0126; Masslo, Christoph/0000-0002-8595-9637	Bundesministerium fur Bildung und Forschung (TOMCAT) [01EZ0824]	Bundesministerium fur Bildung und Forschung (TOMCAT)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (TOMCAT, grant number 01EZ0824). http://www.bmbf.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; BURAGGI GL, 1991, NUCL MED BIOL, V18, P45, DOI 10.1016/0883-2897(91)90045-M; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; EDLUND M, 1993, EUR J BIOCHEM, V213, P1109, DOI 10.1111/j.1432-1033.1993.tb17860.x; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; FODSTAD O, 1988, CANCER RES, V48, P4382; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; JAIN RK, 1988, CANCER RES, V48, P7022; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; JAQUES G, 1988, CANCER, V62, P125, DOI 10.1002/1097-0142(19880701)62:1<125::AID-CNCR2820620122>3.0.CO;2-X; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kohler S, 2010, BRIT J CANCER, V102, P602, DOI 10.1038/sj.bjc.6605492; Kokkonen N, 2007, INT J CANCER, V121, P2443, DOI 10.1002/ijc.22965; KREUZER F, 1982, EXPERIENTIA, V38, P1415, DOI 10.1007/BF01955753; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; Lange A, 2011, LUNG CANCER, V74, P178, DOI 10.1016/j.lungcan.2011.03.017; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Lucka L, 2005, GLYCOBIOLOGY, V15, P87, DOI 10.1093/glycob/cwh139; Luo WP, 1999, CANCER GENE THER, V6, P313, DOI 10.1038/sj.cgt.7700055; Marcus CD, 2009, CRIT REV ONCOL HEMAT, V72, P217, DOI 10.1016/j.critrevonc.2008.07.012; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; PARK JG, 1990, CANCER RES, V50, P2773; Planque C, 2009, MOL CELL PROTEOMICS, V8, P2746, DOI 10.1074/mcp.M900134-MCP200; Riethdorf L, 1997, J HISTOCHEM CYTOCHEM, V45, P957, DOI 10.1177/002215549704500705; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schumacher U, 1997, HISTOCHEM J, V29, P677, DOI 10.1023/A:1026404832394; Schumacher U, 1990, LECTINS; SHARKEY RM, 1990, CANCER RES, V50, P2823; Singer BB, 2000, CANCER RES, V60, P1236; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEWARD AM, 1974, CANCER-AM CANCER SOC, V33, P1246, DOI 10.1002/1097-0142(197405)33:5<1246::AID-CNCR2820330509>3.0.CO;2-O; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Thies A, 2001, J PATHOL, V195, P537, DOI 10.1002/path.988; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; WANEBO HJ, 1978, NEW ENGL J MED, V299, P448, DOI 10.1056/NEJM197808312990904; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	44	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28030	10.1371/journal.pone.0028030	http://dx.doi.org/10.1371/journal.pone.0028030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162753	Green Submitted, gold, Green Published			2022-12-25	WOS:000298172800011
J	Ito, K; Chadani, Y; Nakamori, K; Chiba, S; Akiyama, Y; Abo, T				Ito, Koreaki; Chadani, Yuhei; Nakamori, Kenta; Chiba, Shinobu; Akiyama, Yoshinori; Abo, Tatsuhiko			Nascentome Analysis Uncovers Futile Protein Synthesis in Escherichia coli	PLOS ONE			English	Article							PEPTIDYL-TRANSFER-RNA; TRANSFER-MESSENGER RNA; RIBOSOME-RESCUE FACTOR; PROLYL-TRANSFER-RNA; CHEMICAL REACTIVITY; TRANS-TRANSLATION; ESTER BOND; AMINO-ACID; A-SITE; SECM	Although co-translational biological processes attract much attention, no general and easy method has been available to detect cellular nascent polypeptide chains, which we propose to call collectively a "nascentome.'' We developed a method to selectively detect polypeptide portions of cellular polypeptidyl-tRNAs and used it to study the generality of the quality control reactions that rescue dead-end translation complexes. To detect nascent polypeptides, having their growing ends covalently attached to a tRNA, cellular extracts are separated by SDS-PAGE in two dimensions, first with the peptidyl-tRNA ester bonds preserved and subsequently after their in-gel cleavage. Pulse-labeled nascent polypeptides of Escherichia coli form a characteristic line below the main diagonal line, because each of them had contained a tRNA of nearly uniform size in the first-dimension electrophoresis but not in the second-dimension. The detection of nascent polypeptides, separately from any translation-completed polypeptides or degradation products thereof, allows us to follow their fates to gain deeper insights into protein biogenesis and quality control pathways. It was revealed that polypeptidyl-tRNAs were significantly stabilized in E. coli upon dysfunction of the tmRNA-ArfA ribosome-rescuing system, whose function had only been studied previously using model constructs. Our results suggest that E. coli cells are intrinsically producing aberrant translation products, which are normally eliminated by the ribosome-rescuing mechanisms.	[Ito, Koreaki; Nakamori, Kenta; Chiba, Shinobu] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan; [Chadani, Yuhei; Abo, Tatsuhiko] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Akiyama, Yoshinori] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan	Kyoto Sangyo University; Okayama University; Kyoto University	Ito, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan.	kito@cc.kyoto-su.ac.jp	ABO, Tatsuhiko/B-1496-2011	Chiba, Shinobu/0000-0003-3485-3477	MEXT (Ministry of Education, Culture, Sports, Science & Technology in Japan) [20247020]; JSPS (Japan Society for the Promotion of Science) [22020035, 22770125]; Grants-in-Aid for Scientific Research [20247020, 22770125] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science & Technology in Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT (Ministry of Education, Culture, Sports, Science & Technology in Japan) Grant-in-Aid for Scientific Research on Priority Areas (20247020), JSPS (Japan Society for the Promotion of Science) Grant-in-Aids for Scientific Research (A) (22020035) and JSPS Grant-in-Aid for Young Scientists (B) (22770125). Website: http://www.jsps.go.jp/english/e-grants/grants01.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONAVENTURA C, 1994, ANAL BIOCHEM, V222, P44, DOI 10.1006/abio.1994.1451; BRESLER S, 1968, BIOCHIM BIOPHYS ACTA, V155, P465, DOI 10.1016/0005-2787(68)90192-5; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chadani Y, 2011, GENES GENET SYST, V86, P151; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Clement SL, 2006, NAT STRUCT MOL BIOL, V13, P299, DOI 10.1038/nsmb0406-299; Fu J, 2010, EMBO J, V29, P3819, DOI 10.1038/emboj.2010.255; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Hachmann JP, 2005, ANAL BIOCHEM, V342, P237, DOI 10.1016/j.ab.2005.04.015; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; HENTZEN D, 1972, BIOCHIM BIOPHYS ACTA, V281, P228, DOI 10.1016/0005-2787(72)90174-8; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; MENNINGER JR, 1976, J BIOL CHEM, V251, P3392; MENNINGER JR, 1978, J BIOL CHEM, V253, P6808; Miller J.H., 1972, EXPT MOL GENETICS; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Murakami A, 2004, P NATL ACAD SCI USA, V101, P12330, DOI 10.1073/pnas.0404907101; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2005, GENE DEV, V19, P436, DOI 10.1101/gad.1259505; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Pradhan P, 2009, J MOL BIOL, V385, P831, DOI 10.1016/j.jmb.2008.11.027; RYCHLIK I, 1970, EUR J BIOCHEM, V16, P136, DOI 10.1111/j.1432-1033.1970.tb01064.x; SCHUBER F, 1974, BIOCHIMIE, V56, P391, DOI 10.1016/S0300-9084(74)80147-1; SCHUBER F, 1974, BIOCHIMIE, V56, P397, DOI 10.1016/S0300-9084(74)80148-3; SCHUBER F, 1974, BIOCHIMIE, V56, P383, DOI 10.1016/S0300-9084(74)80146-X; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Weis F, 2010, EMBO J, V29, P3810, DOI 10.1038/emboj.2010.252; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	54	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28413	10.1371/journal.pone.0028413	http://dx.doi.org/10.1371/journal.pone.0028413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162769	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800035
J	Seidel, HS; Kimble, J				Seidel, Hannah S.; Kimble, Judith			The Oogenic Germline Starvation Response in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; EGG SIZE; PLASTICITY; PATHWAY; GROWTH	Many animals alter their reproductive strategies in response to environmental stress. Here we have investigated how L4 hermaphrodites of Caenorhabditis elegans respond to starvation. To induce starvation, we removed food at 2 h intervals from very early-to very late-stage L4 animals. The starved L4s molted into adulthood, initiated oogenesis, and began producing embryos; however, all three processes were severely delayed, and embryo viability was reduced. Most animals died via 'bagging,' because egg-laying was inhibited, and embryos hatched in utero, consuming their parent hermaphrodites from within. Some animals, however, avoided bagging and survived long term. Long-term survival did not rely on embryonic arrest but instead upon the failure of some animals to produce viable progeny during starvation. Regardless of the bagging fate, starved animals showed two major changes in germline morphology: All oogenic germlines were dramatically reduced in size, and these germlines formed only a single oocyte at a time, separated from the remainder of the germline by a tight constriction. Both changes in germline morphology were reversible: Upon re-feeding, the shrunken germlines regenerated, and multiple oocytes formed concurrently. The capacity for germline regeneration upon re-feeding was not limited to the small subset of animals that normally survive starvation: When bagging was prevented ectopically by par-2 RNAi, virtually all germlines still regenerated. In addition, germline shrinkage strongly correlated with oogenesis, suggesting that during starvation, germline shrinkage may provide material for oocyte production. Finally, germline shrinkage and regeneration did not depend upon crowding. Our study confirms previous findings that starvation uncouples germ cell proliferation from germline stem cell maintenance. Our study also suggests that when nutrients are limited, hermaphrodites scavenge material from their germlines to reproduce. We discuss our findings in light of the recently proposed state of dormancy, termed Adult Reproductive Diapause.	[Seidel, Hannah S.; Kimble, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Kimble, Judith] Howard Hughes Med Inst, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute	Seidel, HS (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	hsseidel@wisc.edu; jekimble@wisc.edu			National Institutes of Health [R01 GM069454]; NIH National Center for Research Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JK is supported by National Institutes of Health grant R01 GM069454. JK is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains, Jadwiga Forster for media preparation, and two reviewers for helpful comments on the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chen JJ, 2004, J NEMATOL, V36, P107; Chen JJ, 2003, NEMATOLOGY, V5, P641, DOI 10.1163/156854103322683355; Daniels SA, 2000, GENETICS, V156, P123; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Fox CW, 1999, EVOLUTION, V53, P552, DOI [10.2307/2640791, 10.1111/j.1558-5646.1999.tb03790.x]; Hong Y, 1998, DEVELOPMENT, V125, P3585; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Nadarajan S, 2009, DEVELOPMENT, V136, P2223, DOI 10.1242/dev.034603; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; Schafer William R, 2005, WormBook, P1; Stiernagle Theresa, 2006, WormBook, P1; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Waggoner LF, 2000, GENETICS, V154, P1181	21	74	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28074	10.1371/journal.pone.0028074	http://dx.doi.org/10.1371/journal.pone.0028074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164230	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400031
J	Isaakidis, P; Cox, HS; Varghese, B; Montaldo, C; Da Silva, E; Mansoor, H; Ladomirska, J; Sotgiu, G; Migliori, GB; Pontali, E; Saranchuk, P; Rodrigues, C; Reid, T				Isaakidis, Petros; Cox, Helen S.; Varghese, Bhanumati; Montaldo, Chiara; Da Silva, Esdras; Mansoor, Homa; Ladomirska, Joanna; Sotgiu, Giovanni; Migliori, Giovanni B.; Pontali, Emanuele; Saranchuk, Peter; Rodrigues, Camilla; Reid, Tony			Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMMUNITY-BASED TREATMENT; MDR-TB TREATMENT; METAANALYSIS; MORTALITY; CAMBODIA; CHILDREN; THERAPY; PROGRAM; AFRICA	Background: India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of treatment for MDR-TB is extremely limited, particularly for HIV-infected individuals. Medecins Sans Frontieres (MSF) has been treating HIV-infected MDR-TB patients in Mumbai since May 2007. This is the first report of treatment outcomes among HIV-infected MDR-TB patients in India. Methods: HIV-infected patients with suspected MDR-TB were referred to the MSF-clinic by public Antiretroviral Therapy (ART) Centers or by a network of community non-governmental organizations. Patients were initiated on either empiric or individualized second-line TB-treatment as per WHO recommendations. MDR-TB treatment was given on an ambulatory basis and under directly observed therapy using a decentralized network of providers. Patients not already receiving ART were started on treatment within two months of initiating MDR-TB treatment. Results: Between May 2007 and May 2011, 71 HIV-infected patients were suspected to have MDR-TB, and 58 were initiated on treatment. MDR-TB was confirmed in 45 (78%), of which 18 (40%) were resistant to ofloxacin. Final treatment outcomes were available for 23 patients; 11 (48%) were successfully treated, 4 (17%) died, 6 (26%) defaulted, and 2 (9%) failed treatment. Overall, among 58 patients on treatment, 13 (22%) were successfully treated, 13 (22%) died, 7 (12%) defaulted, two (3%) failed treatment, and 23 (40%) were alive and still on treatment at the end of the observation period. Twenty-six patients (45%) experienced moderate to severe adverse events, requiring modification of the regimen in 12 (20%). Overall, 20 (28%) of the 71 patients with MDR-TB died, including 7 not initiated on treatment. Conclusions: Despite high fluoroquinolone resistance and extensive prior second-line treatment, encouraging results are being achieved in an ambulatory MDR-T-program in a slum setting in India. Rapid scale-up of both ART and second-line treatment for MDR-TB is needed to ensure survival of co-infected patients and mitigate this growing epidemic.	[Isaakidis, Petros; Varghese, Bhanumati; Montaldo, Chiara; Da Silva, Esdras; Mansoor, Homa; Ladomirska, Joanna] Med San Frontieres, Bombay, Maharashtra, India; [Cox, Helen S.; Saranchuk, Peter] Med San Frontieres, Cape Town, South Africa; [Cox, Helen S.] Monash Univ, Melbourne, Vic 3004, Australia; [Sotgiu, Giovanni] Univ Sassari, Hyg & Prevent Med Inst, I-07100 Sassari, Italy; [Migliori, Giovanni B.] World Hlth Org Collaborating Ctr TB & Lung Dis, S Maugeri Fdn, Tradate, Italy; [Pontali, Emanuele] Galliera Hosp, Dept Infect Dis, Genoa, Italy; [Rodrigues, Camilla] PD Hinduja Natl Hosp & Med Res Ctr Hinduja, Bombay, Maharashtra, India; [Reid, Tony] Med San Frontieres, Operat Res Unit, Brussels, Belgium	Monash University; University of Sassari; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; Ente Ospedaliero Ospedali Galliera; University of Genoa	Isaakidis, P (corresponding author), Med San Frontieres, Bombay, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org	Sotgiu, Giovanni/N-1032-2017; Migliori, Giovanni Battista/AAB-8589-2020; Montaldo, Chiara/AAE-3265-2020	Sotgiu, Giovanni/0000-0002-1600-4474; Migliori, Giovanni Battista/0000-0002-2597-574X; Isaakidis, Petros/0000-0002-7881-1554; Pontali, Emanuele/0000-0002-1085-0442; Cox, Helen/0000-0002-6538-7192	M�decins Sans Fronti�res [OCG_pilot_00_Montaldo] Funding Source: researchfish	M�decins Sans Fronti�res		Agrawal D, 2009, INT J TUBERC LUNG D, V13, P79; [Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2010, ROADM ROLL OUT XPERT; Bhargava A, 2011, HYPOTHESIS, V9, pe7; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brust J, 2010, PLOS ONE, V6; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Deivanayagam C N, 2002, Indian J Chest Dis Allied Sci, V44, P237; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Isaakidis P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-11; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Joseph P, 2011, INDIAN J MED RES, V133, P529; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Mahadev B, 2004, INDIAN J TUBERC, V52, P5; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2009, MAN MDR TB FIELD GUI	35	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28066	10.1371/journal.pone.0028066	http://dx.doi.org/10.1371/journal.pone.0028066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145022	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900005
J	Kashima, H; Hayashi, N				Kashima, Hideaki; Hayashi, Naoyuki			Basic Taste Stimuli Elicit Unique Responses in Facial Skin Blood Flow	PLOS ONE			English	Article							NERVOUS-SYSTEM RESPONSES; CAPSAICIN RECEPTOR; INCREASE; HUMANS	Facial expression changes characteristically with the emotions induced by basic tastes in humans. We tested the hypothesis that the five basic tastes also elicit unique responses in facial skin blood flow. Facial skin blood flow was measured using laser speckle flowgraphy in 16 healthy subjects before and during the application of basic taste stimuli in the oral cavity for 20 s. The skin blood flow in the eyelid increased in response to sweet and umami taste stimuli, while that in the nose decreased in response to a bitter stimulus. There was a significant correlation between the subjective hedonic scores accompanying these taste stimuli and the above changes in skin blood flow. These results demonstrate that sweet, umami, and bitter tastes induce unique changes in facial skin blood flow that reflect subjective hedonic scores.	[Kashima, Hideaki; Hayashi, Naoyuki] Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka 812, Japan; [Hayashi, Naoyuki] Kyushu Univ, Inst Hlth Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kashima, H (corresponding author), Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka 812, Japan.	naohayashi@ihs.kyushu-u.ac.jp	Hayashi, Naoyuki/AAK-5097-2021; Hayashi, Naoyuki/C-1457-2015	Hayashi, Naoyuki/0000-0002-9814-3530	Yazuya Co. Ltd.	Yazuya Co. Ltd.	This work was supported by a grant from Yazuya Co. Ltd. to N.H. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2010, NEUROSCIENCE, V165, P1476, DOI 10.1016/j.neuroscience.2009.11.051; BERGERSEN TK, 1993, ACTA PHYSIOL SCAND, V147, P195, DOI 10.1111/j.1748-1716.1993.tb09489.x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Darwin C., 1899, EXPRESSION EMOTIONS; Drummond PD, 1997, PSYCHOPHYSIOLOGY, V34, P163, DOI 10.1111/j.1469-8986.1997.tb02127.x; DRUMMOND PD, 1995, J AUTONOM NERV SYST, V52, P117, DOI 10.1016/0165-1838(94)00151-9; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; GALEF BG, 1978, J COMP PHYSIOL PSYCH, V92, P907, DOI 10.1037/h0077531; Horio T, 2000, CHEM SENSES, V25, P149, DOI 10.1093/chemse/25.2.149; Jones D, 2007, NATURE, V447, P768, DOI 10.1038/447768a; KARITA K, 1992, J AUTONOM NERV SYST, V39, P229, DOI 10.1016/0165-1838(92)90016-A; Kemppainen P, 2001, PAIN, V91, P331, DOI 10.1016/S0304-3959(00)00462-0; KEMPPAINEN P, 1994, BRAIN RES BULL, V33, P655, DOI 10.1016/0361-9230(94)90229-1; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; LEE TS, 1954, J PHYSIOL-LONDON, V124, P528, DOI 10.1113/jphysiol.1954.sp005126; Leterme A, 2008, PHYSIOL BEHAV, V93, P994, DOI 10.1016/j.physbeh.2008.01.005; Nakayama K, 2005, PHYSIOL BEHAV, V84, P783, DOI 10.1016/j.physbeh.2005.03.009; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Robin O, 2003, PHYSIOL BEHAV, V78, P385, DOI 10.1016/S0031-9384(02)00981-2; Rolls ET, 2009, AM J CLIN NUTR, V90, p804S, DOI 10.3945/ajcn.2009.27462R; Rousmans S, 2000, CHEM SENSES, V25, P709, DOI 10.1093/chemse/25.6.709; Someya N, 2008, AM J PHYSIOL-REG I, V295, pR1921, DOI 10.1152/ajpregu.90493.2008; Steiner JE, 1987, BASIC TASTE, P97; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voncken MJ, 2009, BIOL PSYCHOL, V81, P86, DOI 10.1016/j.biopsycho.2009.02.004; YAMAGUCHI S, 1984, AGR BIOL CHEM TOKYO, V48, P1077, DOI 10.1080/00021369.1984.10866271	26	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28236	10.1371/journal.pone.0028236	http://dx.doi.org/10.1371/journal.pone.0028236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145032	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168900015
J	Patel, N; Masaratana, P; Diaz-Castro, J; Latunde-Dada, GO; Qureshi, A; Lockyer, P; Jacob, M; Arno, M; Matak, P; Mitry, RR; Hughes, RD; Dhawan, A; Patterson, C; Simpson, RJ; Mckie, AT				Patel, Neeta; Masaratana, Patarabutr; Diaz-Castro, Javier; Latunde-Dada, Gladys O.; Qureshi, Aakafa; Lockyer, Pamela; Jacob, Molly; Arno, Matthew; Matak, Pavle; Mitry, Ragai R.; Hughes, Robin D.; Dhawan, Anil; Patterson, Cam; Simpson, Robert J.; McKie, Andrew T.			BMPER Protein Is a Negative Regulator of Hepcidin and Is Up-regulated in Hypotransferrinemic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE HEPCIDIN; GENE-EXPRESSION; IRON; ANEMIA; CROSSVEINLESS-2; TRANSFERRIN; FERROPORTIN; INHIBITOR	The BMP/SMAD4 pathway has major effects on liver hepcidin levels. Bone morphogenetic protein-binding endothelial cell precursor-derived regulator (Bmper), a known regulator of BMP signaling, was found to be overexpressed at the mRNA and protein levels in liver of genetically hypotransferrinemic mice (Trfhpx/hpx). Soluble BMPER peptide inhibited BMP2- and BMP6-dependent hepcidin promoter activity in both HepG2 and HuH7 cells. These effects correlated with reduced cellular levels of pSMAD1/5/8. Addition of BMPER peptide to primary human hepatocytes abolished the BMP2-dependent increase in hepcidin mRNA, whereas injection of Bmper peptide into mice resulted in reduced liver hepcidin and increased serum iron levels. Thus Bmper may play an important role in suppressing hepcidin production in hypotransferrinemic mice.	[Patel, Neeta; Masaratana, Patarabutr; Latunde-Dada, Gladys O.; Qureshi, Aakafa; Simpson, Robert J.; McKie, Andrew T.] Kings Coll London, Diabet & Nutr Sci Div, Sch Med, London WC2R 2LS, England; [Masaratana, Patarabutr] Siriraj Hosp, Dept Biochem, Fac Med, Bangkok 10700, Thailand; [Diaz-Castro, Javier] Univ Granada, Dept Physiol, Granada 10871, Spain; [Lockyer, Pamela; Patterson, Cam] Univ N Carolina, Div Cardiol, Chapel Hill, NC 27599 USA; [Jacob, Molly] Christian Med Coll & Hosp, Dept Biochem, Vellore 632002, Tamil Nadu, India; [Arno, Matthew] Kings Coll London, Genom Ctr, London WC2R 2LS, England; [Matak, Pavle] Univ Paris 05, Inst Cochin, F-75014 Paris, France; [Mitry, Ragai R.; Hughes, Robin D.; Dhawan, Anil] Kings Coll Hosp London, Hepatocyte Biol & Transplantat Grp, London SE5 9RS, England	University of London; King's College London; Mahidol University; University of Granada; University of North Carolina; University of North Carolina Chapel Hill; Christian Medical College & Hospital (CMCH) Vellore; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; King's College Hospital NHS Foundation Trust; King's College Hospital	Mckie, AT (corresponding author), Kings Coll London, Div Diabet & Nutr, London SE1 9NH, England.	andrew.t.mckie@kcl.ac.uk	Dhawan, Anil/B-6730-2009; Díaz-Castro, Javier/AAX-6697-2021; Diaz-Castro, Javier/H-2985-2015; Simpson, Robert J/A-8776-2013	Díaz-Castro, Javier/0000-0003-3659-1757; Diaz-Castro, Javier/0000-0003-3659-1757; Simpson, Robert J/0000-0002-2196-5368; Dhawan, Anil/0000-0002-4942-0845; , Patarabutr/0000-0001-7228-7176	Kings College Graduate School Bursary; Anandamahidol Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Kings College Graduate School Bursary; Anandamahidol Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Kings College Graduate School Bursary (to N. P.) and by the Anandamahidol Foundation (to P. M.).	Ambrosio AL, 2008, DEV CELL, V15, P248, DOI 10.1016/j.devcel.2008.06.013; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; Bier E, 2008, DEV CELL, V15, P176, DOI 10.1016/j.devcel.2008.07.012; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Conley CA, 2000, DEVELOPMENT, V127, P3947; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Latunde-Dada GO, 2006, BBA-MOL BASIS DIS, V1762, P414, DOI 10.1016/j.bbadis.2005.12.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mitry RR, 2003, CELL TRANSPLANT, V12, P69, DOI 10.3727/000000003783985197; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Moser M, 2007, J MOL CELL CARDIOL, V43, P243, DOI 10.1016/j.yjmcc.2007.05.008; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nemeth E, 2006, HAEMATOLOGICA, V91, P727; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Raja KB, 1999, BLOOD, V94, P3185, DOI 10.1182/blood.V94.9.3185.421a20_3185_3192; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	32	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4099	4106		10.1074/jbc.M111.310789	http://dx.doi.org/10.1074/jbc.M111.310789			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22144676	hybrid, Green Published			2022-12-25	WOS:000300410900043
J	Birkenstock, T; Liebeke, M; Winstel, V; Krismer, B; Gekeler, C; Niemiec, MJ; Bisswanger, H; Lalk, M; Peschel, A				Birkenstock, Timo; Liebeke, Manuel; Winstel, Volker; Krismer, Bernhard; Gekeler, Cordula; Niemiec, Maria J.; Bisswanger, Hans; Lalk, Michael; Peschel, Andreas			Exometabolome Analysis Identifies Pyruvate Dehydrogenase as a Target for the Antibiotic Triphenylbismuthdichloride in Multiresistant Bacterial Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; MULTIENZYME COMPLEX; NMR METABOLOMICS; INACTIVATION; GROWTH; GENES; RESISTANCE; FLUOROPYRUVATE	The desperate need for new therapeutics against notoriously antibiotic-resistant bacteria has led to a quest for novel antibacterial target structures and compounds. Moreover, defining targets and modes of action of new antimicrobial compounds remains a major challenge with standard technologies. Here we characterize the antibacterial properties of triphenylbismuthdichloride (TPBC), which has recently been successfully used against device-associated infections. We demonstrate that TPBC has potent antimicrobial activity against many bacterial pathogens. Using an exometabolome profiling approach, a unique TPBC-mediated change in the metabolites of Staphylococcus aureus was identified, indicating that TPBC blocks bacterial pyruvate catabolism. Enzymatic studies showed that TPBC is a highly efficient, uncompetitive inhibitor of the bacterial pyruvate dehydrogenase complex. Our study demonstrates that metabolomics approaches can offer new avenues for studying the modes of action of antimicrobial compounds, and it indicates that inhibition of the bacterial pyruvate dehydrogenase complex may represent a promising strategy for combating multidrug-resistant bacteria.	[Birkenstock, Timo; Winstel, Volker; Krismer, Bernhard; Gekeler, Cordula; Niemiec, Maria J.; Peschel, Andreas] Univ Tubingen, Cellular & Mol Microbiol Div, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Bisswanger, Hans] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Liebeke, Manuel; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ernst Moritz Arndt Universitat Greifswald	Lalk, M (corresponding author), Friedrich Ludwig Jahn Str 17, D-17487 Greifswald, Germany.	lalk@uni-greifswald.de; andreas.peschel@med.uni-tuebingen.de	Krismer, Bernhard/O-3741-2019; Liebeke, Manuel/F-3559-2012; Lalk, Michael/C-1618-2010; Krismer, Bernhard/V-1380-2017	Krismer, Bernhard/0000-0002-9505-8285; Liebeke, Manuel/0000-0002-2339-1409; Lalk, Michael/0000-0002-9230-0267; Winstel, Volker/0000-0002-3248-2572; Niemiec, Maria Joanna/0000-0001-5667-6032; Gekeler, Cordula/0000-0001-9041-6672	German Ministry of Education and Research; Gambro Inc. (ABBA-Tech); German Science Foundation [TRR34, SFB766]; IZKF of the Medical Faculty, University of Tubingen; Alfried Krupp von Bohlen Halbach-Stiftung	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Gambro Inc. (ABBA-Tech); German Science Foundation(German Research Foundation (DFG)); IZKF of the Medical Faculty, University of Tubingen; Alfried Krupp von Bohlen Halbach-Stiftung	This work was supported by grants from the German Ministry of Education and Research with Gambro Inc. (ABBA-Tech), the German Science Foundation (TRR34, SFB766), and the IZKF Program of the Medical Faculty, University of Tubingen (to A. P.).; Recipient of a fellowship from the Alfried Krupp von Bohlen Halbach-Stiftung: "A Functional Genomics Approach in Infection Biology." Present address: Biomolecular Medicine, Dept. of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom.	ADLER LA, 1988, J BACTERIOL, V170, P5337, DOI 10.1128/jb.170.11.5337-5343.1988; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bandow JE, 2003, ANTIMICROB AGENTS CH, V47, P948, DOI 10.1128/AAC.47.3.948-955.2003; BARTON DHR, 1985, J CHEM SOC PERK T 1, P2667, DOI 10.1039/p19850002667; Bathe OF, 2011, CANCER EPIDEM BIOMAR, V20, P140, DOI 10.1158/1055-9965.EPI-10-0712; BISSWANGER H, 1981, J BIOL CHEM, V256, P815; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; BROWN JP, 1976, BIOCHEM J, V155, P419, DOI 10.1042/bj1550419; Bundy JG, 2005, FEMS MICROBIOL LETT, V242, P127, DOI 10.1016/j.femsle.2004.10.048; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Cook P. F., 2007, ENZYME KINETICS MECH; DANSON MJ, 1976, BIOCHEM J, V159, P677, DOI 10.1042/bj1590677; de Kok A, 1998, BBA-PROTEIN STRUCT M, V1385, P353, DOI 10.1016/S0167-4838(98)00079-X; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FLOURNOY DS, 1989, BIOCHEMISTRY-US, V28, P9594, DOI 10.1021/bi00451a007; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Halouska S, 2007, J PROTEOME RES, V6, P4608, DOI 10.1021/pr0704332; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Herbert M, 2003, INT J MED MICROBIOL, V293, P145, DOI 10.1078/1438-4221-00261; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Jang HJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-411; Leebrick J. R., 1966, United States Patent, Patent No. [3,239,411, 323941118]; Lentino JR, 2008, EUR J CLIN MICROBIOL, V27, P3, DOI 10.1007/s10096-007-0389-y; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; Liebeke M, 2010, ANAL BIOCHEM, V401, P312, DOI 10.1016/j.ab.2009.04.030; Liebeke M, 2009, APPL MICROBIOL BIOT, V83, P161, DOI 10.1007/s00253-009-1965-0; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; MAGER J, 1954, NATURE, V173, P126, DOI 10.1038/173126a0; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Nakano MM, 1997, J BACTERIOL, V179, P6749, DOI 10.1128/jb.179.21.6749-6755.1997; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Projan SJ, 2007, CURR OPIN MICROBIOL, V10, P441, DOI 10.1016/j.mib.2007.08.007; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sadykov MR, 2010, J BIOL CHEM, V285, P36616, DOI 10.1074/jbc.M110.152843; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Schindler R, 2010, NEPHROL DIAL TRANSPL, V25, P2651, DOI 10.1093/ndt/gfq052; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schnell A, 2007, INT J ARTIF ORGANS, V30, P746; SCHWARTZ ER, 1968, BIOCHEM BIOPH RES CO, V31, P495, DOI 10.1016/0006-291X(68)90504-4; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Sun HZ, 2004, MET IONS BIOL SYST, V41, P333; URBAN P, 1988, EUR J BIOCHEM, V173, P155, DOI 10.1111/j.1432-1033.1988.tb13979.x; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Weidenmaier C, 2003, CURR DRUG TARGETS, V4, P643, DOI 10.2174/1389450033490731; White AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011814	53	47	49	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2887	2895		10.1074/jbc.M111.288894	http://dx.doi.org/10.1074/jbc.M111.288894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22144679	hybrid, Green Published			2022-12-25	WOS:000300292300060
J	Hijazi, K; Wang, YF; Scala, C; Jeffs, S; Longstaff, C; Stieh, D; Haggarty, B; Vanham, G; Schols, D; Balzarini, J; Jones, IM; Hoxie, J; Shattock, R; Kelly, CG				Hijazi, Karolin; Wang, Yufei; Scala, Carlo; Jeffs, Simon; Longstaff, Colin; Stieh, Daniel; Haggarty, Beth; Vanham, Guido; Schols, Dominique; Balzarini, Jan; Jones, Ian M.; Hoxie, James; Shattock, Robin; Kelly, Charles G.			DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; IMMATURE DENDRITIC CELLS; C-TYPE LECTIN; LANGERHANS CELLS; T-CELLS; BINDING-SITE; TYPE-1 GP120; IN-VITRO; CARBOHYDRATE-RECOGNITION	Mannose-binding C-type lectin receptors, expressed on Langerhans cells and subepithelial dendritic cells (DCs) of cervicovaginal tissues, play an important role in HIV-1 capture and subsequent dissemination to lymph nodes. DC-SIGN has been implicated in both productive infection of DCs and the DC-mediated trans infection of CD4(+) T cells that occurs in the absence of replication. However, the molecular events that underlie this efficient transmission have not been fully defined. In this study, we have examined the effect of the extracellular domains of DC-SIGN and Langerin on the stability of the interaction of the HIV-1 envelope glycoprotein with CD4 and also on replication in permissive cells. Surface plasmon resonance analysis showed that DC-SIGN increases the binding affinity of trimeric gp140 envelope glycoproteins to CD4. In contrast, Langerin had no effect on the stability of the gp140: CD4 complex. In vitro infection experiments to compare DC-SIGN enhancement of CD4-dependent and CD4-independent strains demonstrated significantly lower enhancement of the CD4-independent strain. In addition DC-SIGN increased the relative rate of infection of the CD4-dependent strain but had no effect on the CD4-independent strain. DC-SIGN binding to the HIV envelope protein effectively increases exposure of the CD4 binding site, which in turn contributes to enhancement of infection.	[Hijazi, Karolin; Wang, Yufei; Scala, Carlo; Kelly, Charles G.] Guys Hosp, Kings Coll London, Inst Dent, London SE1 9RT, England; [Jeffs, Simon] Univ London Imperial Coll Sci Technol & Med, Jefferiss Trust Res Labs, Wright Fleming Inst, Div Med,Fac Med, London, England; [Longstaff, Colin] Natl Inst Biol Stand & Controls, Biotherapeut Sect, Potters Bar, Herts, England; [Stieh, Daniel; Shattock, Robin] Univ London, Ctr Infect, Dept Cellular & Mol Med, London, England; [Haggarty, Beth; Hoxie, James] Univ Penn, Penn Ctr AIDS Res, Philadelphia, PA 19104 USA; [Vanham, Guido] Inst Trop Med, Virol Unit, Div Microbiol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Vanham, Guido] Free Univ Brussels, Fac Med & Pharm, Brussels, Belgium; [Schols, Dominique; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Balzarini, Jan] Univ Reading, Sch Biol Sci, Reading, Berks, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; National Institute for Biological Standards & Control; University of London; University of Pennsylvania; Institute of Tropical Medicine (ITM); University of Antwerp; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; University of Reading	Hijazi, K (corresponding author), Univ Aberdeen Dent Sch & Hosp, Coll Life Sci & Med, Foresterhill, Aberdeen, Scotland.	charles.kelly@kcl.ac.uk	Longstaff, Colin/D-2413-2013; Jones, Ian/AAF-4986-2019; Schols, Dominique/S-9057-2017; Schols, Dominique/AAC-1309-2021	Longstaff, Colin/0000-0001-7608-208X; Jones, Ian/0000-0002-7738-2516; Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850; Hijazi, Karolin/0000-0002-8589-2129	European Commission [LSHP-CT-2003-503558, LSHP-CT-2006-037611, 242135]; Fondation Dormeur; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; Centers of Excellence [PF-10/18]; Fonds voor Wetenschappelijk Onderzoek [G-485-08, G-0125-06 N]; Medical Research Council [G0200000] Funding Source: researchfish; MRC [G0200000] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation Dormeur; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; Centers of Excellence; Fonds voor Wetenschappelijk Onderzoek(FWO); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the European Commission LSHP-CT-2003-503558, LSHP-CT-2006-037611, 242135 (7th Framework Programme) and supported by an equipment grant from the Fondation Dormeur. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. JB and DS were supported by the Centers of Excellence (PF-10/18) and Fonds voor Wetenschappelijk Onderzoek (G-485-08) and GV by Fonds voor Wetenschappelijk Onderzoek (G-0125-06 N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astoul CH, 2000, BIOCHEM BIOPH RES CO, V274, P455, DOI 10.1006/bbrc.2000.3166; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Dunfee RL, 2007, VIROLOGY, V367, P222, DOI 10.1016/j.virol.2007.05.029; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hoffman TL, 1999, P NATL ACAD SCI USA, V96, P6359, DOI 10.1073/pnas.96.11.6359; HOLLA A, 2011, PROTEIN ENG DES SEL; Hong PWP, 2007, J VIROL, V81, P8325, DOI 10.1128/JVI.01765-06; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; Jeffs SA, 2007, MED ANIMAL CELL CULT, P59; Kawamura T, 2005, J DERMATOL SCI, V40, P147, DOI 10.1016/j.jdermsci.2005.08.009; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Kong L, 2010, J MOL BIOL, V403, P131, DOI 10.1016/j.jmb.2010.08.033; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LaBranche CC, 1999, J VIROL, V73, P10310, DOI 10.1128/JVI.73.12.10310-10319.1999; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Lekkerkerker AN, 2004, VIROLOGY, V329, P465, DOI 10.1016/j.virol.2004.08.028; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Moog C, 1997, AIDS RES HUM RETROV, V13, P19, DOI 10.1089/aid.1997.13.19; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; POPOVIC M, 1984, SCIENCE, V226, P459, DOI 10.1126/science.6093248; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Van Herrewege Y, 2002, AIDS RES HUM RETROV, V18, P1091, DOI 10.1089/088922202320567833; VANDAMME EJM, 1988, PHYSIOL PLANTARUM, V73, P52, DOI 10.1111/j.1399-3054.1988.tb09192.x; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; Zhang WT, 2001, BIOCHEMISTRY-US, V40, P1662, DOI 10.1021/bi001397m; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	71	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28307	10.1371/journal.pone.0028307	http://dx.doi.org/10.1371/journal.pone.0028307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163292	Green Submitted, gold, Green Published			2022-12-25	WOS:000298161900027
J	Stanley, JA; Radford, CA; Jeffs, AG				Stanley, Jenni A.; Radford, Craig A.; Jeffs, Andrew G.			Behavioural Response Thresholds in New Zealand Crab Megalopae to Ambient Underwater Sound	PLOS ONE			English	Article							ENDOGENOUS SWIMMING RHYTHMS; JUVENILE BLUE CRABS; CALLINECTES-SAPIDUS; OLFACTORY ABILITIES; DECAPOD CRUSTACEANS; FISH LARVAE; REEF FISHES; HEARING; ORIENTATION; SENSITIVITY	A small number of studies have demonstrated that settlement stage decapod crustaceans are able to detect and exhibit swimming, settlement and metamorphosis responses to ambient underwater sound emanating from coastal reefs. However, the intensity of the acoustic cue required to initiate the settlement and metamorphosis response, and therefore the potential range over which this acoustic cue may operate, is not known. The current study determined the behavioural response thresholds of four species of New Zealand brachyuran crab megalopae by exposing them to different intensity levels of broadcast reef sound recorded from their preferred settlement habitat and from an unfavourable settlement habitat. Megalopae of the rocky-reef crab, Leptograpsus variegatus, exhibited the lowest behavioural response threshold (highest sensitivity), with a significant reduction in time to metamorphosis (TTM) when exposed to underwater reef sound with an intensity of 90 dB re 1 mu Pa and greater (100, 126 and 135 dB re 1 mu Pa). Megalopae of the mud crab, Austrohelice crassa, which settle in soft sediment habitats, exhibited no response to any of the underwater reef sound levels. All reef associated species exposed to sound levels from an unfavourable settlement habitat showed no significant change in TTM, even at intensities that were similar to their preferred reef sound for which reductions in TTM were observed. These results indicated that megalopae were able to discern and respond selectively to habitat-specific acoustic cues. The settlement and metamorphosis behavioural response thresholds to levels of underwater reef sound determined in the current study of four species of crabs, enables preliminary estimation of the spatial range at which an acoustic settlement cue may be operating, from 5 m to 40 km depending on the species. Overall, these results indicate that underwater sound is likely to play a major role in influencing the spatial patterns of settlement of coastal crab species.	[Stanley, Jenni A.; Radford, Craig A.; Jeffs, Andrew G.] Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand	University of Auckland	Stanley, JA (corresponding author), Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand.	ja.stanley@auckland.ac.nz	Jeffs, Andrew G/D-9474-2012	Radford, Craig/0000-0001-7949-9497; Jeffs, Andrew/0000-0002-8504-1949	Glenn Family Foundation; Stanley Wishart Low Memorial Scholarship	Glenn Family Foundation; Stanley Wishart Low Memorial Scholarship	Thanks to the Glenn Family Foundation, as well as the Stanley Wishart Low Memorial Scholarship for financial support for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; BREITHAUPT T, 1990, ADV LIF SCI, P114; BREITHAUPT T, 1988, NATURWISSENSCHAFTEN, V75, P310, DOI 10.1007/BF00367325; CRONIN TW, 1986, AM ZOOL, V26, P403; Egner SA, 2005, MAR ECOL PROG SER, V285, P213, DOI 10.3354/meps285213; FAO, 2009, GLOB CAPT PROD 1950; Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x; Forward RB, 2005, J EXP MAR BIOL ECOL, V316, P91, DOI 10.1016/j.jembe.2004.10.005; Forward RB, 2004, J EXP MAR BIOL ECOL, V299, P63, DOI 10.1016/j.jembe.2003.09.002; Forward RB, 2001, AM ZOOL, V41, P1108, DOI 10.1668/0003-1569(2001)041[1108:CFMOBC]2.0.CO;2; Forward RB, 2000, J EXP MAR BIOL ECOL, V245, P277, DOI 10.1016/S0022-0981(99)00169-0; Hadfield MG, 2001, AM ZOOL, V41, P1123, DOI 10.1668/0003-1569(2001)041[1123:MCAMAC]2.0.CO;2; Hickford MJH, 1999, MAR ECOL PROG SER, V186, P293, DOI 10.3354/meps186293; Higgs Dennis M., 2002, Bioacoustics, V12, P180; Higgs DM, 2004, J EXP BIOL, V207, P155, DOI 10.1242/jeb.00735; Horodysky AZ, 2008, J EXP BIOL, V211, P1504, DOI 10.1242/jeb.016196; Houser DS, 2006, J ACOUST SOC AM, V120, P1713, DOI 10.1121/1.2229286; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Lovell JM, 2005, COMP BIOCHEM PHYS A, V140, P89, DOI 10.1016/j.cbpb.2004.11.003; Mann David A., 2006, P107; McLay CL, 1988, LAB B U AUCKLAND NZ, V22; Meekan MG, 2001, MAR BIOL, V139, P373; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Montgomery JC, 2001, FISH FISH, V2, P261, DOI 10.1046/j.1467-2960.2001.00053.x; Mulsow J, 2010, J ACOUST SOC AM, V127, P2692, DOI 10.1121/1.3327662; Popper AN, 2001, J COMP PHYSIOL A, V187, P83, DOI 10.1007/s003590100184; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Radford CA, 2007, B MAR SCI, V80, P369; Radford CA, 2011, MAR ECOL PROG SER, V438, P167, DOI 10.3354/meps09312; Rittschof D, 1998, BIOFOULING, V12, P31, DOI 10.1080/08927019809378344; Shanks AL, 2001, IDENTIFICATION GUIDE; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Stanley JA, 2011, AMBIENT UNDERWATER S; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Tolimieri Nicholas, 2002, Bioacoustics, V12, P214; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Valero J, 1999, J SHELLFISH RES, V18, P663; Wear R. G., 1985, NZ OCEANOGRAPHIC I M, V92; Wright KJ, 2008, J FISH BIOL, V72, P2543, DOI 10.1111/j.1095-8649.2008.01864.x; Wright KJ, 2007, MAR BIOL, V150, P1049, DOI 10.1007/s00227-006-0515-x; Wright KJ, 2010, CORAL REEFS, V29, P235, DOI 10.1007/s00338-009-0572-y; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z; Zar J.R., 1999, BIOSTAT ANAL	46	42	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28572	10.1371/journal.pone.0028572	http://dx.doi.org/10.1371/journal.pone.0028572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163314	Green Submitted, Green Published, gold			2022-12-25	WOS:000298161900050
J	Zhao, J; Wang, CX; Bedair, M; Welti, R; Sumner, LW; Baxter, I; Wang, XM				Zhao, Jian; Wang, Cunxi; Bedair, Mohamed; Welti, Ruth; Sumner, Lloyd W.; Baxter, Ivan; Wang, Xuemin			Suppression of Phospholipase D gamma s Confers Increased Aluminum Resistance in Arabidopsis thaliana	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; LIPID-COMPOSITION; MEMBRANE-LIPIDS; MALATE TRANSPORTER; GENE-EXPRESSION; D-ALPHA; TOLERANCE; STRESS; PLANTS; INHIBITION	Aluminum (Al) toxicity is the major stress in acidic soil that comprises about 50% of the world's arable land. The complex molecular mechanisms of Al toxicity have yet to be fully determined. As a barrier to Al entrance, plant cell membranes play essential roles in plant interaction with Al, and lipid composition and membrane integrity change significantly under Al stress. Here, we show that phospholipase D gamma s (PLD gamma s) are induced by Al stress and contribute to Al-induced membrane lipid alterations. RNAi suppression of PLD gamma resulted in a decrease in both PLD gamma 1 and PLD gamma 2 expression and an increase in Al resistance. Genetic disruption of PLD gamma 1 also led to an increased tolerance to Al while knockout of PLD gamma 2 did not. Both RNAi-suppressed and pld gamma 1-1 mutants displayed better root growth than wild-type under Al stress conditions, and PLD gamma 1-deficient plants had less accumulation of callose, less oxidative damage, and less lipid peroxidation compared to wild-type plants. Most phospholipids and glycolipids were altered in response to Al treatment of wild-type plants, whereas fewer changes in lipids occurred in response to Al stress in PLD gamma mutant lines. Our results suggest that PLD gamma s play a role in membrane lipid modulation under Al stress and that high activities of PLD gamma s negatively modulate plant tolerance to Al.	[Zhao, Jian; Wang, Cunxi; Wang, Xuemin] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Welti, Ruth] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Zhao, Jian; Bedair, Mohamed; Sumner, Lloyd W.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Baxter, Ivan] ARS, USDA, Plant Genet Res Unit, St Louis, MO USA; [Baxter, Ivan; Wang, Xuemin] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Wang, Xuemin] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Kansas State University; Kansas State University; Noble Research Institute; United States Department of Agriculture (USDA); Donald Danforth Plant Science Center; University of Missouri System; University of Missouri Saint Louis	Zhao, J (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.	wangxue@umsl.edu	Sumner, Lloyd W/A-3270-2013; Wang, Xuemin/M-2853-2013; Zhao, Jian/Q-8591-2019; Baxter, Ivan R/A-1052-2009; Zhao, Jian/M-4237-2014	Sumner, Lloyd W/0000-0002-4086-663X; Zhao, Jian/0000-0002-4416-7334; Baxter, Ivan R/0000-0001-6680-1722; Zhao, Jian/0000-0002-4416-7334; wang, xuemin/0000-0002-6251-6745; Bedair, Mohamed/0000-0002-2667-5845; Welti, Ruth/0000-0003-4373-2538	National Science Foundation [IOS 0818740, CMB 0922879, EPS 0236913, MCB 0920663, DBI 0521587]; USDA [2007-35318-18393]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20RR16475]; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0920663] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by grants from National Science Foundation (IOS 0818740; CMB 0922879) and USDA (2007-35318-18393). Equipment acquisition and method development at the Kansas Lipidomics Research Center were funded by National Science Foundation (EPS 0236913, MCB 0920663, DBI 0521587), Kansas Technology Enterprise Corporation, K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health (P20RR16475), and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Chaffai R, 2005, PHYTOCHEMISTRY, V66, P1903, DOI 10.1016/j.phytochem.2005.06.028; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; da Silva ALS, 2006, J PLANT PHYSIOL, V163, P26, DOI 10.1016/j.jplph.2005.03.009; Degenhardt J, 1998, PLANT PHYSIOL, V117, P19, DOI 10.1104/pp.117.1.19; Delhaize E, 1999, J BIOL CHEM, V274, P7082, DOI 10.1074/jbc.274.11.7082; Ezaki B, 2004, PLANT PHYSIOL, V134, P1672, DOI 10.1104/pp.103.037135; Ezaki B, 2001, PLANT PHYSIOL, V127, P918, DOI 10.1104/pp.010399; EZAKI B, 2000, PLANT PHYSIOL, V122, P657; Fan L, 1999, PLANT PHYSIOL, V119, P1371, DOI 10.1104/pp.119.4.1371; Gunse B, 1997, PLANT PHYSIOL, V113, P595, DOI 10.1104/pp.113.2.595; Hernandez LE, 1997, J EXP BOT, V48, P1375, DOI 10.1093/jxb/48.7.1375; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; HONG YY, 2008, MOL PLANT, V1, P262, DOI DOI 10.1093/mp/ssm025; Jones DL, 2006, PLANT CELL ENVIRON, V29, P1309, DOI 10.1111/j.1365-3040.2006.01509.x; JONES DL, 1995, PLANT CELL, V7, P1913, DOI 10.1105/tpc.7.11.1913; Kobayashi Y, 2007, PLANT PHYSIOL, V145, P843, DOI 10.1104/pp.107.102335; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Larsen PB, 1998, PLANT PHYSIOL, V117, P9, DOI 10.1104/pp.117.1.9; Li L, 1999, FEBS LETT, V458, P419, DOI 10.1016/S0014-5793(99)01196-5; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Martinez-Estevez M, 2003, J PLANT PHYSIOL, V160, P1297, DOI 10.1078/0176-1617-01168; Meriga B., 2010, ACAD J PLANT SCI, V3, P53; Milla MAR, 2002, PLANT PHYSIOL, V130, P1706, DOI 10.1104/pp.009969; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Novotna Z, 2003, FEBS LETT, V554, P50, DOI 10.1016/S0014-5793(03)01093-7; Ouariti O, 1997, PHYTOCHEMISTRY, V45, P1343, DOI 10.1016/S0031-9422(97)00159-3; Peixoto Paulo Henrique Pereira, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P137; Pejchar P, 2008, CELL BIOL INT, V32, P554, DOI 10.1016/j.cellbi.2007.11.008; Pineros MA, 2005, PLANT PHYSIOL, V137, P231, DOI 10.1104/pp.104.047357; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Qin CB, 2006, BBA-MOL CELL BIOL L, V1761, P1450, DOI 10.1016/j.bbalip.2006.09.017; Qin WS, 1997, J BIOL CHEM, V272, P28267, DOI 10.1074/jbc.272.45.28267; Quartacci MF, 2000, PHYSIOL PLANTARUM, V108, P87, DOI 10.1034/j.1399-3054.2000.108001087.x; Quartacci MF, 2001, J EXP BOT, V52, P77, DOI 10.1093/jexbot/52.354.77; Quintal-Tun F, 2007, J INORG BIOCHEM, V101, P362, DOI 10.1016/j.jinorgbio.2006.10.010; Ramos-Diaz A, 2007, PLANTA, V225, P393, DOI 10.1007/s00425-006-0348-3; Rounds MA, 2008, CURR BIOL, V18, P1495, DOI 10.1016/j.cub.2008.08.050; Ryan PR, 2007, PLANT PHYSIOL, V144, P1968, DOI 10.1104/pp.107.100446; Ryan PR, 2009, PLANT PHYSIOL, V149, P340, DOI 10.1104/pp.108.129155; Sarin S, 1997, BIOL TRACE ELEM RES, V59, P133, DOI 10.1007/BF02783238; Shen H, 2005, PLANT PHYSIOL, V138, P287, DOI 10.1104/pp.104.058065; VIERSTRA R, 1978, BIOCHEM BIOPH RES CO, V84, P138, DOI 10.1016/0006-291X(78)90274-7; Wang XM, 2000, PROG LIPID RES, V39, P109, DOI 10.1016/S0163-7827(00)00002-3; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Yamaguchi M, 2005, PLANT CELL PHYSIOL, V46, P812, DOI 10.1093/pcp/pci083; Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.010417; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Zhang GC, 1997, PHYSIOL PLANTARUM, V99, P302, DOI 10.1034/j.1399-3054.1997.990213.x; Zhang GC, 1996, PHYSIOL PLANTARUM, V96, P683, DOI 10.1111/j.1399-3054.1996.tb00243.x; Zhao J, 2005, BIOTECHNOL BIOENG, V90, P621, DOI 10.1002/bit.20465; ZHAO XJ, 1987, PLANT PHYSIOL, V83, P159, DOI 10.1104/pp.83.1.159; [No title captured]; [No title captured]	57	31	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28086	10.1371/journal.pone.0028086	http://dx.doi.org/10.1371/journal.pone.0028086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163277	Green Published, gold			2022-12-25	WOS:000298161900012
J	Koscianska, E; Starega-Roslan, J; Krzyzosiak, WJ				Koscianska, Edyta; Starega-Roslan, Julia; Krzyzosiak, Wlodzimierz J.			The Role of Dicer Protein Partners in the Processing of MicroRNA Precursors	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; PASSENGER-STRAND; NUCLEAR EXPORT; RNA; EXPRESSION; TRBP; BIOGENESIS; MIRNAS; SIRNA; PACT	One of the cellular functions of the ribonuclease Dicer is to process microRNA precursors (pre-miRNAs) into mature microRNAs (miRNAs). Human Dicer performs this function in cooperation with its protein partners, AGO2, PACT and TRBP. The exact role of these accessory proteins in Dicer activity is still poorly understood. In this study, we used the northern blotting technique to investigate pre-miRNA cleavage efficiency and specificity after depletion of AGO2, PACT and TRBP by RNAi. The results showed that the inhibition of either Dicer protein partner substantially affected not only miRNA levels but also pre-miRNA levels, and it had a rather minor effect on the specificity of Dicer cleavage. The analysis of the Dicer cleavage products generated in vitro revealed the presence of a cleavage intermediate when pre-miRNA was processed by recombinant Dicer alone. This intermediate was not observed during pre-miRNA cleavage by endogenous Dicer. We demonstrate that AGO2, PACT and TRBP were required for the efficient functioning of Dicer in cells, and we suggest that one of the roles of these proteins is to assure better synchronization of cleavages triggered by two RNase III domains of Dicer.	[Koscianska, Edyta; Starega-Roslan, Julia; Krzyzosiak, Wlodzimierz J.] Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Koscianska, E (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, Poznan, Poland.	wlodkrzy@ibch.poznan.pl		Koscianska, Edyta/0000-0002-1665-2500	European Regional Development Fund within the Innovative Economy Programme [POIG.01.03.01-30-098/08]; Polish Ministry of Science and Higher Education [N N301 523038]	European Regional Development Fund within the Innovative Economy Programme; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the European Regional Development Fund within the Innovative Economy Programme (POIG.01.03.01-30-098/08) and by the Polish Ministry of Science and Higher Education (N N301 523038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Flores-Jasso CF, 2009, ACTA PHARMACOL SIN, V30, P1177, DOI 10.1038/aps.2009.108; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Koscianska E, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-14; Koscianska E, 2011, THESCIENTIFICWORLDJO, V11, P102, DOI 10.1100/tsw.2011.11; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Lund E, 2006, COLD SPRING HARB SYM, V71, P59, DOI 10.1101/sqb.2006.71.050; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sakurai K, 2011, NUCLEIC ACIDS RES, V39, P1510, DOI 10.1093/nar/gkq846; Shin YW, 2006, ARCH PHARM RES, V29, P685, DOI 10.1007/BF02968253; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	40	87	93	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28548	10.1371/journal.pone.0028548	http://dx.doi.org/10.1371/journal.pone.0028548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163034	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500033
J	Helbing, CC; Wagner, MJ; Pettem, K; Johnston, J; Heimeier, RA; Veldhoen, N; Jirik, FR; Shi, YB; Browder, LW				Helbing, Caren C.; Wagner, Mary J.; Pettem, Katherine; Johnston, Jill; Heimeier, Rachel A.; Veldhoen, Nik; Jirik, Frank R.; Shi, Yun-Bo; Browder, Leon W.			Modulation of Thyroid Hormone-Dependent Gene Expression in Xenopus laevis by INhibitor of Growth (ING) Proteins	PLOS ONE			English	Article							PHD FINGER; BREAST-CANCER; PLANT HOMEODOMAIN; TUMOR-SUPPRESSOR; AXIS DISRUPTION; HISTONE H3; METAMORPHOSIS; RECEPTOR; FAMILY; CHROMATIN	Background: INhibitor of Growth (ING) proteins belong to a large family of plant homeodomain finger-containing proteins important in epigenetic regulation and carcinogenesis. We have previously shown that ING1 and ING2 expression is regulated by thyroid hormone (TH) during metamorphosis of the Xenopus laevis tadpole. The present study investigates the possibility that ING proteins modulate TH action. Methodology/Principal Findings: Tadpoles expressing a Xenopus ING2 transgene (Trans(ING2)) were significantly smaller than tadpoles not expressing the transgene (Trans(GFP)). When exposed to 10 nM 3,5,3'-triiodothyronine (T(3)), premetamorphic Trans(ING2) tadpoles exhibited a greater reduction in tail, head, and brain areas, and a protrusion of the lower jaw than T(3)-treated Trans(GFP) tadpoles. Quantitative real time polymerase chain reaction (QPCR) demonstrated elevated TH receptor beta (TR beta) and TH/bZIP transcript levels in Trans(ING2) tadpole tails compared to Trans(GFP) tadpoles while TR alpha mRNAs were unaffected. In contrast, no difference in TR alpha, TR beta or insulin-like growth factor (IGF2) mRNA abundance was observed in the brain between Trans(ING2) and Trans(GFP) tadpoles. All of these transcripts, except for TR alpha mRNA in the brain, were inducible by the hormone in both tissues. Oocyte transcription assays indicated that ING proteins enhanced TR-dependent, T(3)-induced TR beta gene promoter activity. Examination of endogenous T(3)-responsive promoters (TR beta and TH/bZIP) in the tail by chromatin immunoprecipitation assays showed that ING proteins were recruited to TRE-containing regions in T(3)-dependent and independent ways, respectively. Moreover, ING and TR proteins coimmunoprecipitated from tail protein homogenates derived from metamorphic climax animals. Conclusions/Significance: We show for the first time that ING proteins modulate TH-dependent responses, thus revealing a novel role for ING proteins in hormone signaling. This has important implications for understanding hormone influenced disease states and suggests that the induction of ING proteins may facilitate TR function during metamorphosis in a tissue-specific manner.	[Helbing, Caren C.; Wagner, Mary J.; Pettem, Katherine; Veldhoen, Nik] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Johnston, Jill; Jirik, Frank R.; Browder, Leon W.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Heimeier, Rachel A.; Shi, Yun-Bo] NICHHD, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, Program Cell Regulat & Metab,NIH, Bethesda, MD 20892 USA; [Jirik, Frank R.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada	University of Victoria; University of Calgary; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Calgary	Helbing, CC (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	chelbing@uvic.ca		Helbing, Caren/0000-0002-8861-1070; Shi, Yun-Bo/0000-0002-6330-0639	Natural Sciences and Engineering Research Council (NSERC); National Institute of Child Health and Human Development, NIH; NSERC-PGSM; Michael Smith Foundation for Health Research (MSFHR); PGSD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSERC-PGSM(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); PGSD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by Natural Sciences and Engineering Research Council (NSERC) Discovery grants to CCH and LWB, and also in part by the Intramural Research Program of the National Institute of Child Health and Human Development, NIH (YBS). MJW was recipient of NSERC-PGSM and PGSD scholarships and a Michael Smith Foundation for Health Research (MSFHR) trainee award. CCH is a past MSFHR scholar and recipient of a NSERC University Faculty Award; and FRJ held a Canada Tier I Research Chair Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOUZNI G, 1990, NUCLEIC ACIDS RES, V18, P5767, DOI 10.1093/nar/18.19.5767; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Boland D, 2000, HYBRIDOMA, V19, P161, DOI 10.1089/02724570050031202; Bua DJ, 2009, CURR DRUG TARGETS, V10, P418, DOI 10.2174/138945009788185112; Buchholz DR, 2005, J BIOL CHEM, V280, P41222, DOI 10.1074/jbc.M509593200; Champagne KS, 2009, CURR DRUG TARGETS, V10, P432, DOI 10.2174/138945009788185040; Cordera F, 2006, SEMIN ONCOL, V33, P631, DOI 10.1053/j.seminoncol.2006.08.020; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; ELICEIRI BP, 1994, J BIOL CHEM, V269, P24459; Ellerhorst JA, 2003, ONCOL REP, V10, P1317; Garske AL, 2010, NAT CHEM BIOL, V6, P283, DOI [10.1038/NCHEMBIO.319, 10.1038/nchembio.319]; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Gunduz M, 2009, CURR DRUG TARGETS, V10, P465, DOI 10.2174/138945009788185086; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helbing CC, 2007, AQUAT TOXICOL, V82, P227, DOI 10.1016/j.aquatox.2007.02.013; Helbing CC, 2007, AQUAT TOXICOL, V82, P215, DOI 10.1016/j.aquatox.2007.02.014; Helbing CC, 1997, CANCER RES, V57, P1255; Kataoka H, 2003, CANCER RES, V63, P5785; Kichina JV, 2006, ONCOGENE, V25, P857, DOI 10.1038/sj.onc.1209118; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Maher Stacey K, 2009, Curr Drug Targets, V10, P392; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Menendez C, 2009, CURR DRUG TARGETS, V10, P406, DOI 10.2174/138945009788185077; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pena PV, 2009, MAGN RESON CHEM, V47, P352, DOI 10.1002/mrc.2390; Rotondi M, J CLIN ENDOCRINOL ME, V96, P344; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Shah S, 2009, CURR DRUG TARGETS, V10, P385, DOI 10.2174/138945009788185103; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y.B., 2000, AMPHIBIAN METAMORPHO; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Sparrow D B, 2000, Nucleic Acids Res, V28, pE12, DOI 10.1093/nar/28.4.e12; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Toyama T, 2003, J STEROID BIOCHEM, V87, P57, DOI 10.1016/S0960-0760(03)00388-1; Turken O, 2003, BREAST CANCER RES, V5, pR110, DOI 10.1186/bcr609; Unoki M, 2009, CURR DRUG TARGETS, V10, P442, DOI 10.2174/138945009788185059; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Veldhoen N, 2002, DEV DYNAM, V225, P457, DOI 10.1002/dvdy.10175; Wagner MJ, 2008, BBA-GENE REGUL MECH, V1779, P152, DOI 10.1016/j.bbagrm.2007.12.002; Wagner MJ, 2005, GEN COMP ENDOCR, V144, P38, DOI 10.1016/j.ygcen.2005.04.008; Wagner MJ, 2001, J BIOL CHEM, V276, P47013, DOI 10.1074/jbc.M106965200; Walzak AA, 2008, EXP CELL RES, V314, P273, DOI 10.1016/j.yexcr.2007.07.029; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030	52	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28658	10.1371/journal.pone.0028658	http://dx.doi.org/10.1371/journal.pone.0028658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163049	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800054
J	Kerzel, D; Schonhammer, J; Burra, N; Born, S; Souto, D				Kerzel, Dirk; Schoenhammer, Josef; Burra, Nicolas; Born, Sabine; Souto, David			Saliency Changes Appearance	PLOS ONE			English	Article							VISUAL-SEARCH; ELECTROPHYSIOLOGICAL EVIDENCE; ATTENTIONAL CAPTURE; TOP-DOWN; COLOR; CONTRAST; TARGET; MAP; DIMENSIONS; CONTINGENT	Numerous studies have suggested that the deployment of attention is linked to saliency. In contrast, very little is known about how salient objects are perceived. To probe the perception of salient elements, observers compared two horizontally aligned stimuli in an array of eight elements. One of them was salient because of its orientation or direction of motion. We observed that the perceived luminance contrast or color saturation of the salient element increased: the salient stimulus looked even more salient. We explored the possibility that changes in appearance were caused by attention. We chose an event-related potential indexing attentional selection, the N2pc, to answer this question. The absence of an N2pc to the salient object provides preliminary evidence against involuntary attentional capture by the salient element. We suggest that signals from a master saliency map flow back into individual feature maps. These signals boost the perceived feature contrast of salient objects, even on perceptual dimensions different from the one that initially defined saliency.	[Kerzel, Dirk; Schoenhammer, Josef; Burra, Nicolas; Born, Sabine; Souto, David] Univ Geneva, Fac Psychol & Sci Educ, Psychol Sect, Geneva, Switzerland	University of Geneva	Kerzel, D (corresponding author), Univ Geneva, Fac Psychol & Sci Educ, Psychol Sect, Geneva, Switzerland.	dirk.kerzel@unige.ch	Souto, David/D-2014-2012	Souto, David/0000-0002-2423-9468; Born, Sabine/0000-0002-2017-2147	Swiss National Foundation [PDFM1-129459, 100014-135374]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	Funding was provided by the Swiss National Foundation PDFM1-129459 and 100014-135374 (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Donk M, 2008, PSYCHOL SCI, V19, P733, DOI 10.1111/j.1467-9280.2008.02149.x; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Eimer M, 2008, J COGNITIVE NEUROSCI, V20, P1423, DOI 10.1162/jocn.2008.20099; Eimer M, 2010, ACTA PSYCHOL, V135, P100, DOI 10.1016/j.actpsy.2010.04.010; Engmann S, 2009, ATTEN PERCEPT PSYCHO, V71, P1337, DOI 10.3758/APP.71.6.1337; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Fuller S, 2006, VISION RES, V46, P4032, DOI 10.1016/j.visres.2006.07.014; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kastner S, 1999, VISUAL NEUROSCI, V16, P587, DOI 10.1017/S095252389916317X; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Koene AR, 2007, J VISION, V7, DOI 10.1167/7.7.6; Krummenacher J, 2002, J EXP PSYCHOL HUMAN, V28, P1303, DOI 10.1037//0096-1523.28.6.1303; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Lien MC, 2008, J EXP PSYCHOL HUMAN, V34, P509, DOI 10.1037/0096-1523.34.3.509; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Muller HJ, 2003, J EXP PSYCHOL HUMAN, V29, P1021, DOI 10.1037/0096-1523.29.5.1021; Nothdurft HC, 2000, VISION RES, V40, P1183, DOI 10.1016/S0042-6989(00)00031-6; Poirier FJAM, 2008, J VISION, V8, DOI 10.1167/8.15.14; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Sawaki R, 2010, ATTEN PERCEPT PSYCHO, V72, P1455, DOI 10.3758/APP.72.6.1455; Schade U, 2011, VISION RES, V51, P1, DOI 10.1016/j.visres.2010.09.010; Soltani A, 2010, J NEUROSCI, V30, P12831, DOI 10.1523/JNEUROSCI.1517-10.2010; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Tollner T, 2011, CEREB CORTEX; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TSO DY, 1988, J NEUROSCI, V8, P1712; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Turatto M, 2004, EXP BRAIN RES, V158, P141, DOI 10.1007/s00221-004-1884-3; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wykowska A, 2010, J COGNITIVE NEUROSCI, V22, P640, DOI 10.1162/jocn.2009.21222	42	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28292	10.1371/journal.pone.0028292	http://dx.doi.org/10.1371/journal.pone.0028292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863NX	22162760	Green Published, gold, Green Submitted			2022-12-25	WOS:000298172800022
J	Yang, CY; Zhang, L; Wang, LL; Zhang, HA; Qiu, LM; Siva, VS; Song, LS				Yang, Chuanyan; Zhang, Lei; Wang, Lingling; Zhang, Huan; Qiu, Limei; Siva, Vinu S.; Song, Linsheng			The Gln32Lys Polymorphism in HSP22 of Zhikong Scallop Chlamys farreri Is Associated with Heat Tolerance	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; SHOCK-PROTEIN HSP22; DROSOPHILA-MELANOGASTER; HEAT-SHOCK-PROTEIN-90 GENE; ARGOPECTEN-IRRADIANS; MOLECULAR CHAPERONES; TERMINAL DOMAIN; STRESS-RESPONSE; EXPRESSION; CELLS	Background: Heat shock protein 22 is a member of small heat shock proteins with molecular chaperone activity. Though their multiple functions have been well characterized, there is no report about the association between the polymorphisms of HSP22 and heat tolerance. Methodology: Three single nucleotide polymorphisms were identified in HSP22 from scallop Chlamys farreri (CfHSP22), and the +94 C-A locus was found to be nonsynonymous. Three genotypes at locus +94, A/A, A/C and C/C, were revealed by using Bi-PASA PCR analysis, and their frequencies were 19.5%, 27.6% and 52.9% in the heat resistant stock, while 9.3%, 17.4% and 73.3% in the heat susceptible stock, respectively. The frequency differences of the three genotypes were significant (P<0.05) between the two stocks. After incubating at 30 degrees C for 84 h, the cumulative mortality of scallops with +94 C/C genotype and +94 A/C genotypes was 95% and 90%, respectively, which was significantly higher (P<0.01) than that of scallops with +94 A/A genotype (70%). The molecular chaperone activity of two His-tagged fusion proteins, rCfHSP22Q with +94 C/C genotype and rCfHSP22K with +94 A/A genotype were analyzed by testing the ability of protecting citrate synthase (CS) against thermal inactivation in vitro. After incubated with rCfHSP22Q or rCfHSP22K at 38 degrees C for 1 h, the activity of CS lost 50% and 45%, and then recovered to 89% and 95% of the original activity following 1 h restoration at 22 degrees C, respectively, indicating that the mutation from Gln to Lys at this site might have an impact on molecular chaperone activities of CfHSP22. Conclusions: These results implied that the polymorphism at locus +94 of CfHSP22 was associated with heat tolerance of scallop, and the +94 A/A genotype could be a potential marker available in future selection of Zhikong scallop with heat tolerance.	[Yang, Chuanyan; Zhang, Lei; Wang, Lingling; Zhang, Huan; Qiu, Limei; Siva, Vinu S.; Song, Linsheng] Chinese 7 Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China; [Yang, Chuanyan; Zhang, Lei; Siva, Vinu S.] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, CY (corresponding author), Chinese 7 Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China [2010CB126404]; Chinese Academy of Sciences [KZCX2-EW-QN201]; National Science Foundation of China [30925028]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research Program of China (no. 2010CB126404), a grant from the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KZCX2-EW-QN201 to HZ), and a grant (No. 30925028 to LS) from National Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2003, HEREDITY, V90, P195, DOI 10.1038/sj.hdy.6800220; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Dahlgaard J, 1998, FUNCT ECOL, V12, P786, DOI 10.1046/j.1365-2435.1998.00246.x; Depre C, 2006, CIRC RES, V98, P280, DOI 10.1161/01.RES.0000201284.45482.e8; Eifert C, 2005, BBA-PROTEINS PROTEOM, V1748, P146, DOI 10.1016/j.bbapap.2004.12.015; Elicker KS, 2007, GENE, V403, P60, DOI 10.1016/j.gene.2007.08.003; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Frydenberg J, 2010, CELL STRESS CHAPERON, V15, P271, DOI 10.1007/s12192-009-0140-y; Gallagher G, 2003, CYTOKINE HDB; Gao Q, 2008, FISH SHELLFISH IMMUN, V24, P379, DOI 10.1016/j.fsi.2007.08.008; Gao Q, 2007, COMP BIOCHEM PHYS B, V147, P704, DOI 10.1016/j.cbpb.2007.04.010; Gober MD, 2003, J BIOL CHEM, V278, P37600, DOI 10.1074/jbc.M303834200; Gottler LM, 2008, BIOCHEMISTRY-US, V47, P9243, DOI 10.1021/bi801045n; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hong SW, 2003, PLANT PHYSIOL, V132, P757, DOI 10.1104/pp.102.017145; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Jackson TR, 1998, HEREDITY, V80, P143, DOI 10.1046/j.1365-2540.1998.00289.x; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Jolly C, 1999, GENE EXPRESSION, V7, P261; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kim MV, 2006, ARCH BIOCHEM BIOPHYS, V454, P32, DOI 10.1016/j.abb.2006.07.014; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lee GJ, 1995, METHOD CELL BIOL, V50, P325, DOI 10.1016/S0091-679X(08)61040-7; Lee JH, 1996, MOL GEN GENET, V252, P11, DOI 10.1007/BF02173200; Li L, 2009, FISH SHELLFISH IMMUN, V27, P136, DOI 10.1016/j.fsi.2008.12.005; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu ZH, 2007, APPL MICROBIOL BIOT, V77, P901, DOI 10.1007/s00253-007-1226-z; Lund AA, 1998, PLANT PHYSIOL, V116, P1097, DOI 10.1104/pp.116.3.1097; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; McColl G, 1996, GENETICS, V143, P1615; MERCK KB, 1993, MOL BIOL REP, V18, P209, DOI 10.1007/BF01674432; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; Salerno JC, 2003, PROTEIN ENG, V16, P847, DOI 10.1093/protein/gzg102; Shemetov AA, 2008, J NEUROSCI RES, V86, P264, DOI 10.1002/jnr.21441; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh R, 2006, CELL STRESS CHAPERON, V11, P208, DOI 10.1379/CSC-184R.1; Smith CC, 2000, J BIOL CHEM, V275, P25690, DOI 10.1074/jbc.M002140200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song LS, 2006, FISH SHELLFISH IMMUN, V21, P335, DOI 10.1016/j.fsi.2005.12.011; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Verschuure P, 2003, EUR J CELL BIOL, V82, P523, DOI 10.1078/0171-9335-00337; [吴龙涛 Wu Longtao], 2003, [高技术通讯, High Technology Letters], V13, P75; Yang H. S., 1999, CHINA MAR SCI, V1, P44; Zhang L, 2010, MOL BIOL REP, V37, P1763, DOI 10.1007/s11033-009-9603-6; Zhang L, 2010, AQUAC RES, V41, P257, DOI 10.1111/j.1365-2109.2009.02328.x	50	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28564	10.1371/journal.pone.0028564	http://dx.doi.org/10.1371/journal.pone.0028564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162777	Green Submitted, gold, Green Published			2022-12-25	WOS:000298172800048
J	Chatterjee, S; Kumar, D				Chatterjee, Samrat; Kumar, Dhiraj			Unraveling the Design Principle for Motif Organization in Signaling Networks	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FEEDBACK LOOPS; COMPLEX NETWORKS; OSCILLATIONS; THRESHOLD; DECISIONS; SPACE; CELLS; TIME; RAS	Cellular signaling networks display complex architecture. Defining the design principle of this architecture is crucial for our understanding of various biological processes. Using a mathematical model for three-node feed-forward loops, we identify that the organization of motifs in specific manner within the network serves as an important regulator of signal processing. Further, incorporating a systemic stochastic perturbation to the model we could propose a possible design principle, for higher-order organization of motifs into larger networks in order to achieve specific biological output. The design principle was then verified in a large, complex human cancer signaling network. Further analysis permitted us to classify signaling nodes of the network into robust and vulnerable nodes as a result of higher order motif organization. We show that distribution of these nodes within the network at strategic locations then provides for the range of features displayed by the signaling network.	[Chatterjee, Samrat; Kumar, Dhiraj] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chatterjee, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India.	dhiraj@icgeb.res.in			Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by the IYBA grant from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; Chaudhri VK, 2009, J BIOL CHEM; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Eungdamrong NJ, 2007, BIOPHYS J, V92, P808, DOI 10.1529/biophysj.106.093104; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Justman QA, 2009, SCIENCE, V324, P509, DOI 10.1126/science.1169498; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kumar D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100197; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Martinez LA, 1999, ONCOGENE, V18, P397, DOI 10.1038/sj.onc.1202300; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Williams JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.70; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28606	10.1371/journal.pone.0028606	http://dx.doi.org/10.1371/journal.pone.0028606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164309	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400111
J	Finsen, AV; Lunde, IG; Sjaastad, I; Ostli, EK; Lyngra, M; Jarstadmarken, HO; Hasic, A; Nygard, S; Wilcox-Adelman, SA; Goetinck, PF; Lyberg, T; Skrbic, B; Florholmen, G; Tonnessen, T; Louch, WE; Djurovic, S; Carlson, CR; Christensen, G				Finsen, Alexandra V.; Lunde, Ida G.; Sjaastad, Ivar; Ostli, Even K.; Lyngra, Marianne; Jarstadmarken, Hilde O.; Hasic, Almira; Nygard, Stale; Wilcox-Adelman, Sarah A.; Goetinck, Paul F.; Lyberg, Torstein; Skrbic, Biljana; Florholmen, Geir; Tonnessen, Theis; Louch, William E.; Djurovic, Srdjan; Carlson, Cathrine R.; Christensen, Geir			Syndecan-4 Is Essential for Development of Concentric Myocardial Hypertrophy via Stretch-Induced Activation of the Calcineurin-NFAT Pathway	PLOS ONE			English	Article							INDUCED CARDIAC-HYPERTROPHY; GLYCOGEN-SYNTHASE KINASE-3; PHOSPHATASE-ACTIVITY; PRESSURE-OVERLOAD; AUTOINHIBITORY DOMAIN; FOCAL ADHESIONS; HEART-FAILURE; PROTEIN; MECHANISMS; INHIBITION	Sustained pressure overload leads to compensatory myocardial hypertrophy and subsequent heart failure, a leading cause of morbidity and mortality. Further unraveling of the cellular processes involved is essential for development of new treatment strategies. We have investigated the hypothesis that the transmembrane Z-disc proteoglycan syndecan-4, a co-receptor for integrins, connecting extracellular matrix proteins to the cytoskeleton, is an important signal transducer in cardiomyocytes during development of concentric myocardial hypertrophy following pressure overload. Echocardiographic, histochemical and cardiomyocyte size measurements showed that syndecan-4(-/-) mice did not develop concentric myocardial hypertrophy as found in wild-type mice, but rather left ventricular dilatation and dysfunction following pressure overload. Protein and gene expression analyses revealed diminished activation of the central, pro-hypertrophic calcineurin-nuclear factor of activated T-cell (NFAT) signaling pathway. Cardiomyocytes from syndecan-4(-/-)-NFAT-luciferase reporter mice subjected to cyclic mechanical stretch, a hypertrophic stimulus, showed minimal activation of NFAT (1.6-fold) compared to 5.8-fold increase in NFAT-luciferase control cardiomyocytes. Accordingly, overexpression of syndecan-4 or introducing a cell-permeable membrane-targeted syndecan-4 polypeptide (gain of function) activated NFATc4 in vitro. Pull-down experiments demonstrated a direct intracellular syndecan-4-calcineurin interaction. This interaction and activation of NFAT were increased by dephosphorylation of serine 179 (pS179) in syndecan-4. During pressure overload, phosphorylation of syndecan-4 was decreased, and association between syndecan-4, calcineurin and its co-activator calmodulin increased. Moreover, calcineurin dephosphorylated pS179, indicating that calcineurin regulates its own binding and activation. Finally, patients with hypertrophic myocardium due to aortic stenosis had increased syndecan-4 levels with decreased pS179 which was associated with increased NFAT activation. In conclusion, our data show that syndecan-4 is essential for compensatory hypertrophy in the pressure overloaded heart. Specifically, syndecan-4 regulates stretch-induced activation of the calcineurin-NFAT pathway in cardiomyocytes. Thus, our data suggest that manipulation of syndecan-4 may provide an option for therapeutic modulation of calcineurin-NFAT signaling.	[Finsen, Alexandra V.; Lunde, Ida G.; Sjaastad, Ivar; Lyngra, Marianne; Jarstadmarken, Hilde O.; Hasic, Almira; Nygard, Stale; Skrbic, Biljana; Florholmen, Geir; Louch, William E.; Carlson, Cathrine R.; Christensen, Geir] Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway; [Finsen, Alexandra V.; Lunde, Ida G.; Sjaastad, Ivar; Lyngra, Marianne; Jarstadmarken, Hilde O.; Hasic, Almira; Nygard, Stale; Skrbic, Biljana; Florholmen, Geir; Tonnessen, Theis; Louch, William E.; Carlson, Cathrine R.; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Finsen, Alexandra V.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Finsen, Alexandra V.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Ostli, Even K.; Djurovic, Srdjan] Oslo Univ Hosp Ulleval, Dept Med Genet, Oslo, Norway; [Sjaastad, Ivar] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway; [Nygard, Stale] Univ Oslo, Dept Math, Oslo, Norway; [Nygard, Stale] Oslo Univ Hosp, Bioinformat Core Facil, Oslo, Norway; [Wilcox-Adelman, Sarah A.] Boston Biomed Res Inst, Watertown, MA USA; [Goetinck, Paul F.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Lyberg, Torstein] Oslo Univ Hosp Ulleval, Clin Res Ctr, Oslo, Norway; [Skrbic, Biljana; Tonnessen, Theis] Oslo Univ Hosp Ulleval, Dept Cardiothorac Surg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Boston Biomedical Research Institute; Harvard University; Massachusetts General Hospital; University of Oslo; University of Oslo	Finsen, AV (corresponding author), Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway.	a.v.finsen@medisin.uio.no	Nygård, Ståle/AGU-4330-2022; Nygård, Ståle/H-2148-2012; Lunde, Ida Gjervold/ABN-5567-2022	Nygard, Stale/0000-0002-5263-4748; Lunde, Ida Gjervold/0000-0001-9502-6841; Djurovic, Srdjan/0000-0002-8140-8061	Norwegian Research Council; South-Eastern Regional Health Authority; University of Oslo, Rakel; Otto Kr. Bruun's Fund; Joh. H. Andresens Medical Fund; Ella and Kristian Nyrrod Fund; American Heart Association [0250523N]; National Institutes of Health [HD-37490]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037490] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Regional Health Authority; University of Oslo, Rakel; Otto Kr. Bruun's Fund; Joh. H. Andresens Medical Fund; Ella and Kristian Nyrrod Fund; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was funded by the Norwegian Research Council, the South-Eastern Regional Health Authority, Anders Jahre's Fund for the Promotion of Science, Molecular Life Sciences at the University of Oslo, Rakel and Otto Kr. Bruun's Fund, Joh. H. Andresens Medical Fund, Ella and Kristian Nyrrod Fund, the American Heart Association; AHA Grant 0250523N and National Institutes of Health; NICHD Grant HD-37490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bellin RM, 2009, P NATL ACAD SCI USA, V106, P22102, DOI 10.1073/pnas.0902639106; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Diedrichs H, 2007, J INT MED RES, V35, P803, DOI 10.1177/147323000703500609; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Echtermeyer F, 2011, CARDIOVASC RES, V92, P123, DOI 10.1093/cvr/cvr149; Finsen AV, 2004, PHYSIOL GENOMICS, V16, P301, DOI 10.1152/physiolgenomics.00144.2002; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; LETOHA T, 2010, BIOCH BIOPHYS ACTA; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; PARSONS JN, 1994, J BIOL CHEM, V269, P19610; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Ross RS, 2004, CARDIOVASC RES, V63, P381, DOI 10.1016/j.cardiores.2004.04.027; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sagoo JK, 1996, BIOCHEM J, V320, P879, DOI 10.1042/bj3200879; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Sharp WW, 1997, AM J PHYSIOL-HEART C, V273, pH546, DOI 10.1152/ajpheart.1997.273.2.H546; Simons M, 2001, CELL SIGNAL, V13, P855, DOI 10.1016/S0898-6568(01)00190-5; Stilli D, 2006, EXP PHYSIOL, V91, P571, DOI 10.1113/expphysiol.2005.032607; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; VanWinkle WB, 2002, ANAT RECORD, V268, P38, DOI 10.1002/ar.10130; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; YAMAZAKI T, 1995, J CLIN INVEST, V96, P438, DOI 10.1172/JCI118054; Zobel C, 2007, CARDIOLOGY, V107, P281, DOI 10.1159/000099063; Zou YZ, 2002, ENDOCR J, V49, P1, DOI 10.1507/endocrj.49.1	53	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28302	10.1371/journal.pone.0028302	http://dx.doi.org/10.1371/journal.pone.0028302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164265	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400066
J	Jonsson, ME; Woodin, BR; Stegeman, JJ; Brunstrom, B				Jonsson, Maria E.; Woodin, Bruce R.; Stegeman, John J.; Brunstrom, Bjorn			Cytochrome P450 1 Genes in Birds: Evolutionary Relationships and Transcription Profiles in Chicken and Japanese Quail Embryos	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; WHITE LEGHORN CHICKEN; PHEASANT PHASIANUS-COLCHICUS; GALLUS-DOMESTICUS EMBRYOS; ZEBRAFISH DANIO-RERIO; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; COMMON PHEASANT; OVO EXPOSURE; PCR DATA; POLYCHLORINATED-BIPHENYLS	Background: Cytochrome P450 1 (CYP1) genes are biomarkers for aryl hydrocarbon receptor (AHR) agonists and may be involved in some of their toxic effects. CYP1s other than the CYP1As are poorly studied in birds. Here we characterize avian CYP1B and CYP1C genes and the expression of the identified CYP1 genes and AHR1, comparing basal and induced levels in chicken and quail embryos. Methodology/Principal Findings: We cloned cDNAs of chicken CYP1C1 and quail CYP1B1 and AHR1. CYP1Cs occur in several bird genomes, but we found no CYP1C gene in quail. The CYP1C genomic region is highly conserved among vertebrates. This region also shares some synteny with the CYP1B region, consistent with CYP1B and CYP1C genes deriving from duplication of a common ancestor gene. Real-time RT-PCR analyses revealed similar tissue distribution patterns for CYP1A4, CYP1A5, CYP1B1, and AHR1 mRNA in chicken and quail embryos, with the highest basal expression of the CYP1As in liver, and of CYP1B1 in eye, brain, and heart. Chicken CYP1C1 mRNA levels were appreciable in eye and heart but relatively low in other organs. Basal transcript levels of the CYP1As were higher in quail than in chicken, while CYP1B1 levels were similar in the two species. 3,3',4,5,5'-Pentachlorobiphenyl induced all CYP1s in chicken; in quail a 1000-fold higher dose induced the CYP1As, but not CYP1B1. Conclusions/Significance: The apparent absence of CYP1C1 in quail, and weak expression and induction of CYP1C1 in chicken suggest that CYP1Cs have diminishing roles in tetrapods; similar tissue expression suggests that such roles may be met by CYP1B1. Tissue distribution of CYP1B and CYP1C transcripts in birds resembles that previously found in zebrafish, suggesting that these genes serve similar functions in diverse vertebrates. Determining CYP1 catalytic functions in different species should indicate the evolving roles of these duplicated genes in physiological and toxicological processes.	[Jonsson, Maria E.; Brunstrom, Bjorn] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Jonsson, Maria E.; Woodin, Bruce R.; Stegeman, John J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Uppsala University; Woods Hole Oceanographic Institution	Jonsson, ME (corresponding author), Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden.	maria.jonsson@ebc.uu.se			Carl Tryggers Stiftelse; Swedish Research Council Formas; United States National Institutes of Health (National Institute of Environmental Health Sciences) [R01ES015912, P42ES007381]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015912, P42ES007381] Funding Source: NIH RePORTER	Carl Tryggers Stiftelse; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); United States National Institutes of Health (National Institute of Environmental Health Sciences); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding to MEJ and BB was from the Carl Tryggers Stiftelse and The Swedish Research Council Formas. Funding for BRW and JJS was from the United States National Institutes of Health (National Institute of Environmental Health Sciences), grants R01ES015912 and P42ES007381 to JJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beedanagari SR, 2010, MOL PHARMACOL, V78, P608, DOI 10.1124/mol.110.064899; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BRUNSTROM B, 1988, POULTRY SCI, V67, P52, DOI 10.3382/ps.0670052; BRUNSTROM B, 1983, TOXICOLOGY, V27, P103, DOI 10.1016/0300-483X(83)90015-X; Brunstrom B, 1998, COMP BIOCHEM PHYS C, V121, P213, DOI 10.1016/S0742-8413(98)10042-7; BRUNSTROM B, 1988, ARCH TOXICOL, V62, P263, DOI 10.1007/BF00332485; BRUNSTROM B, 1988, COMP BIOCHEM PHYS C, V91, P507, DOI 10.1016/0742-8413(88)90069-2; Chambers D, 2007, DEVELOPMENT, V134, P1369, DOI 10.1242/dev.02815; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Choudhary D, 2006, DRUG METAB REV, V38, P337, DOI 10.1080/03602530600570149; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Choudhary D, 2004, DRUG METAB DISPOS, V32, P840, DOI 10.1124/dmd.32.8.840; Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7; Choudhary D, 2007, DRUG METAB DISPOS, V35, P987, DOI 10.1124/dmd.106.014282; Cohen-Barnhouse AM, 2011, ENVIRON TOXICOL CHEM, V30, P1659, DOI 10.1002/etc.551; Cohen-Barnhouse AM, 2011, TOXICOL SCI, V119, P93, DOI 10.1093/toxsci/kfq289; Dey A, 1999, BIOCHEM PHARMACOL, V58, P525, DOI 10.1016/S0006-2952(99)00110-0; Gao K, 2011, COMP BIOCHEM PHYS C, V154, P42, DOI 10.1016/j.cbpc.2011.02.005; Gilday D, 1998, TOXICOL APPL PHARM, V150, P106, DOI 10.1006/taap.1997.8360; Gilday D, 1996, J BIOL CHEM, V271, P33054, DOI 10.1074/jbc.271.51.33054; Godard CAJ, 2005, BIOCHEM BIOPH RES CO, V331, P1016, DOI 10.1016/j.bbrc.2005.03.231; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; Goldstone JV, 2009, ARCH BIOCHEM BIOPHYS, V482, P7, DOI 10.1016/j.abb.2008.12.002; Goldstone JV, 2007, MOL BIOL EVOL, V24, P2619, DOI 10.1093/molbev/msm200; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hahn ME, 2006, J EXP ZOOL PART A, V305A, P693, DOI 10.1002/jez.a.323; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a; Jonsson ME, 2007, TOXICOL SCI, V100, P180, DOI 10.1093/toxsci/kfm207; Jonsson ME, 2007, TOXICOL APPL PHARM, V221, P29, DOI 10.1016/j.taap.2007.02.017; Jonsson ME, 2010, AQUAT TOXICOL, V98, P311, DOI 10.1016/j.aquatox.2010.03.003; Jonsson ME, 2011, TOXICOL APPL PHARM; Jung RE, 1997, ENVIRON TOXICOL CHEM, V16, P230, DOI 10.1002/etc.5620160219; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; Kawai YK, 2010, MAMM GENOME, V21, P320, DOI 10.1007/s00335-010-9263-9; Lavine JA, 2005, TOXICOL SCI, V88, P60, DOI 10.1093/toxsci/kfi228; Lee JS, 2009, TOXICOL APPL PHARM, V234, P1, DOI 10.1016/j.taap.2008.09.007; Lewis DFV, 2003, CHEM-BIOL INTERACT, V145, P281, DOI 10.1016/S0009-2797(03)00021-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matthews Jason, 2006, Nucl Recept Signal, V4, pe016; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; POLAND A, 1994, MOL PHARMACOL, V46, P915; Powell DC, 1996, ARCH ENVIRON CON TOX, V31, P404, DOI 10.1007/BF00212680; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimada T, 2003, TOXICOL APPL PHARM, V187, P1, DOI 10.1016/S0041-008X(02)00035-2; Uno Y, 2011, BIOCHEM PHARMACOL, V81, P442, DOI 10.1016/j.bcp.2010.11.003; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Yang YF, 2010, ENVIRON TOXICOL CHEM, V29, P1490, DOI 10.1002/etc.171; Yasui T, 2007, TOXICOL SCI, V99, P101, DOI 10.1093/toxsci/kfm139; Zanette J, 2009, AQUAT TOXICOL, V93, P234, DOI 10.1016/j.aquatox.2009.05.008; ZeRuth G, 2007, CHEM-BIOL INTERACT, V170, P100, DOI 10.1016/j.cbi.2007.07.003; Zeruth G, 2005, ZEBRAFISH, V2, P197, DOI 10.1089/zeb.2005.2.197; Zhou SF, 2009, CURR MED CHEM, V16, P3480, DOI 10.2174/092986709789057635	63	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28257	10.1371/journal.pone.0028257	http://dx.doi.org/10.1371/journal.pone.0028257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164255	Green Published, gold			2022-12-25	WOS:000298171400056
J	Lin, HN; Notredame, C; Chang, JM; Sung, TY; Hsu, WL				Lin, Hsin-Nan; Notredame, Cedric; Chang, Jia-Ming; Sung, Ting-Yi; Hsu, Wen-Lian			Improving the Alignment Quality of Consistency Based Aligners with an Evaluation Function Using Synonymous Protein Words	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; STRUCTURE PREDICTION; TWILIGHT ZONE; CONSTRUCTION; GENERATION; PROFILES; ACCURACY; MATRICES; SATCHMO; FOLD	Most sequence alignment tools can successfully align protein sequences with higher levels of sequence identity. The accuracy of corresponding structure alignment, however, decreases rapidly when considering distantly related sequences (<20% identity). In this range of identity, alignments optimized so as to maximize sequence similarity are often inaccurate from a structural point of view. Over the last two decades, most multiple protein aligners have been optimized for their capacity to reproduce structure-based alignments while using sequence information. Methods currently available differ essentially in the similarity measurement between aligned residues using substitution matrices, Fourier transform, sophisticated profile-profile functions, or consistency-based approaches, more recently. In this paper, we present a flexible similarity measure for residue pairs to improve the quality of protein sequence alignment. Our approach, called SymAlign, relies on the identification of conserved words found across a sizeable fraction of the considered dataset, and supported by evolutionary analysis. These words are then used to define a position specific substitution matrix that better reflects the biological significance of local similarity. The experiment results show that the SymAlign scoring scheme can be incorporated within T-Coffee to improve sequence alignment accuracy. We also demonstrate that SymAlign is less sensitive to the presence of structurally non-similar proteins. In the analysis of the relationship between sequence identity and structure similarity, SymAlign can better differentiate structurally similar proteins from non-similar proteins. We show that protein sequence alignments can be significantly improved using a similarity estimation based on weighted n-grams. In our analysis of the alignments thus produced, sequence conservation becomes a better indicator of structural similarity. SymAlign also provides alignment visualization that can display sub-optimal alignments on dot-matrices. The visualization makes it easy to identify well-supported alternative alignments that may not have been identified by dynamic programming. SymAlign is available at http://bio-cluster.iis.sinica.edu.tw/SymAlign/.	[Lin, Hsin-Nan; Sung, Ting-Yi; Hsu, Wen-Lian] Acad Sinica, Inst Informat Sci, Bioinformat Lab, Taipei, Taiwan; [Notredame, Cedric; Chang, Jia-Ming] UPF, CRG, Barcelona, Spain	Academia Sinica - Taiwan; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Lin, HN (corresponding author), Acad Sinica, Inst Informat Sci, Bioinformat Lab, Taipei, Taiwan.	tsung@iis.sinica.edu.tw; hsu@iis.sinica.edu.tw	Sung, Ting-Yi/AAQ-5413-2021; Lin, Hsin-Nan/AFI-7411-2022; Hsu, Wen-Lian/ABB-2851-2020; Lin, Hsin-Nan/AFL-1244-2022; Chang, Jia-Ming/A-5642-2008; notredame, cedric/G-3868-2010	Sung, Ting-Yi/0000-0002-6028-0409; Lin, Hsin-Nan/0000-0001-7225-7161; Hsu, Wen-Lian/0000-0001-7061-3513; Chang, Jia-Ming/0000-0002-6711-1739; notredame, cedric/0000-0003-1461-0988	Academia Sinica [AS95ASIA03]; National Science Council [NSC97-2627-P-001-004]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by the thematic program of Academia Sinica (AS95ASIA03) and the National Science Council (NSC97-2627-P-001-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armougom F, 2006, BIOINFORMATICS, V22, pE35, DOI 10.1093/bioinformatics/btl218; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2004, BIOINFORMATICS, V20, P1301, DOI 10.1093/bioinformatics/bth090; Edgar RC, 2004, BIOINFORMATICS, V20, P1309, DOI 10.1093/bioinformatics/bth091; Edgar RC, 2003, BIOINFORMATICS, V19, P1404, DOI 10.1093/bioinformatics/btg158; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; Edgar RC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-396; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Hagopian R, 2010, NUCLEIC ACIDS RES, V38, pW29, DOI 10.1093/nar/gkq298; Hara T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-235; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOGEWEG P, 1984, J MOL EVOL, V20, P175, DOI 10.1007/BF02257378; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin HN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S4; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2003, BIOINFORMATICS, V19, pi215, DOI 10.1093/bioinformatics/btg1029; Panchenko AR, 2003, NUCLEIC ACIDS RES, V31, P683, DOI 10.1093/nar/gkg154; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pei JM, 2006, NUCLEIC ACIDS RES, V34, P4364, DOI 10.1093/nar/gkl514; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rychlewski L, 1998, FOLD DES, V3, P229, DOI 10.1016/S1359-0278(98)00034-0; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Skolnick J, 2001, PROTEINS, V42, P319; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sternberg MJE, 1999, CURR OPIN STRUC BIOL, V9, P368, DOI 10.1016/S0959-440X(99)80050-5; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zhou HY, 2005, BIOINFORMATICS, V21, P3615, DOI 10.1093/bioinformatics/bti582	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27872	10.1371/journal.pone.0027872	http://dx.doi.org/10.1371/journal.pone.0027872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22163274	gold, Green Published			2022-12-25	WOS:000298171400017
J	Mishra, RR; Chaudhary, JK; Bajaj, GD; Rath, PC				Mishra, Rasmi Rekha; Chaudhary, Jitendra Kumar; Bajaj, Gagan Deep; Rath, Pramod C.			A Novel Human TPIP Splice-Variant (TPIP-C2) mRNA, Expressed in Human and Mouse Tissues, Strongly Inhibits Cell Growth in HeLa Cells	PLOS ONE			English	Article							PTEN TUMOR-SUPPRESSOR; TYROSINE-PHOSPHATASE; MEMBRANE-BINDING; C2 DOMAIN; GENE; BREAST; P53; PHOSPHORYLATION; STABILIZATION; ASSOCIATION	Alternative splicing of mRNAs is known to involve a major regulation of gene expression at RNA level in mammalian cells. The PTEN (Phosphatase and TENsin homologue deleted from the human chromosome 10), TPTE (Transmembrane Phosphatase with TEnsin homology) and TPIP (TPTE and PTEN homologous Inositol lipid Phosphatase) belong to a family of dual-specific lipid and protein phosphatases. PTEN is a well characterized tumor suppressor, which plays crucial role in cell survival, cell cycle regulation, cell proliferation as well as adhesion, motility and migration of cells. The C2-domain of PTEN is essential for PTEN-functions. We have isolated a novel 1019 bp human TPIP cDNA (TPIP-C2) from a human testis cDNA library. In silico analysis of the cDNA revealed that it is produced from the TPIP-locus on the human chromosome 13 by alternative RNA-splicing. It has a unique 59-Alu sequence, a LINE sequence followed by a 582 bp Open Reading Frame (ORF) encoding a 193 aa polypeptide with a partial phosphatase domain and a C2-domain. TPIP-C2 mRNA is expressed in human testis and in mouse tissues. Mouse testis and brain showed higher levels of TPIP-C2 mRNA in comparison to the heart, liver and kidney under normal physiological conditions. TPIP-C2 mRNAs from human and mouse testes show extensive sequence identity. Over-expression of TPIP-C2 cDNA in HeLa cells strongly (up to 85%) inhibited cell growth/proliferation and caused apoptosis in a caspase 3-dependent manner. These findings suggest for the first time that a TPIP splice-variant mRNA with a partial phosphatase domain and a C2-domain is expressed in cells and tissues of human and murine origins under normal physiological conditions. Inhibition of cell growth/proliferation and induction of apoptosis by overexpression of TPIP-C2 mRNA in HeLa cells suggest that it may be involved in negative regulation of cell growth/proliferation.	[Mishra, Rasmi Rekha; Chaudhary, Jitendra Kumar; Bajaj, Gagan Deep; Rath, Pramod C.] Jawaharlal Nehru Univ, Sch Life Sci, Mol Biol Lab, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Mishra, RR (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Mol Biol Lab, New Delhi 110067, India.	pcrath@mail.jnu.ac.in	RATH, PRAMOD/AAP-5565-2020	CHAUDHARY, JITENDRA/0000-0001-8499-9656	Capacity Buildup; UGC-Research Network Resource Centre; Government of India; Council of Scientific and Industrial Research (CSIR); UGC	Capacity Buildup; UGC-Research Network Resource Centre; Government of India; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India)	This work is supported by the Capacity Buildup, UGC-Research Network Resource Centre and DST-Purse grants of the Government of India to JNU/SLS and PCR. RRM and GDB were supported by fellowships (JRF and SRF) from the Council of Scientific and Industrial Research (CSIR) and UGC respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, HUM MOL GENET, V15, P777, DOI 10.1093/hmg/ddi492; Babich V, 1999, GENE, V239, P341, DOI 10.1016/S0378-1119(99)00391-1; Bajaj GD, 2002, THESIS J NEHRU U NEW; Cabarcas Stephanie, 2010, Online J Biol Sci, V10, P114; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen HM, 1999, HUM GENET, V105, P399, DOI 10.1007/s004390051122; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Dey I, 2005, BIOCHEM BIOPH RES CO, V327, P276, DOI 10.1016/j.bbrc.2004.12.015; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Georgescu MM, 2000, CANCER RES, V60, P7033; Gildea JJ, 2004, ONCOGENE, V23, P6788, DOI 10.1038/sj.onc.1207599; Guipponi H, 2000, HUM GENET, V107, P127, DOI 10.1007/s004390000343; Gustafson S, 2007, SEMIN ONCOL, V34, P428, DOI 10.1053/j.seminoncol.2007.07.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lehman JA, 2011, J BIOL CHEM, V286, P36631, DOI 10.1074/jbc.M110.217620; Leslie NR, 2005, BIOCHEM SOC T, V33, P1507, DOI 10.1042/BST0331507; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Mehenni H, 2005, HUM MOL GENET, V14, P2209, DOI 10.1093/hmg/ddi225; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sambrook J, 2001, MOL CLONING LAB MANU; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Wu Y, 2001, J BIOL CHEM, V276, P21745, DOI 10.1074/jbc.M101480200; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891; Zhou MX, 2003, CANCER RES, V63, P6357	44	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28433	10.1371/journal.pone.0028433	http://dx.doi.org/10.1371/journal.pone.0028433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164291	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400092
J	Poeppl, W; Herkner, H; Burgmann, H; Pustelnik, T; Mooseder, G; Popow-Kraupp, T; Redlberger-Fritz, M				Poeppl, Wolfgang; Herkner, Harald; Burgmann, Heinz; Pustelnik, Tom; Mooseder, Gerhard; Popow-Kraupp, Theresia; Redlberger-Fritz, Monika			Performance of the QuickVue Influenza A plus B Rapid Test for Pandemic H1N1 (2009) Virus Infection in Adults	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; A/H1N1; SENSITIVITY; OUTBREAK	To investigate the diagnostic accuracy of the QuickVue (R) Influenza A+B rapid test we conducted a prospective observational study in which this rapid test was compared with a real-time reverse transcription polymerase chain reaction (RT-PCR) for pandemic influenza A H1N1 (2009) infection in Austrian adults. The sensitivity, specificity, and positive and negative predictive values of the QuickVue test compared with the RT-PCR were 26% (95% CI 18-35), 98% (95% CI 92-100), 94% (95% CI 80-99) and 50% (95% CI 42-58), respectively. The prevalence of pandemic H1N1 (2009) virus infection among the 209 patients included in the study was 57%. Our data suggest that a positive QuickVue test provides considerable information for the diagnosis of pandemic influenza A H1N1 (2009) virus infection in young adults but that a negative QuickVue test result should, if relevant for patient management or public health measures, be verified using PCR.	[Poeppl, Wolfgang; Burgmann, Heinz] Med Univ Vienna, Dept Infect Dis & Trop Med, Vienna, Austria; [Herkner, Harald] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Poeppl, Wolfgang; Pustelnik, Tom; Mooseder, Gerhard] Mil Hosp Vienna, Dept Dermatol & Trop Med, Vienna, Austria; [Popow-Kraupp, Theresia; Redlberger-Fritz, Monika] Med Univ Vienna, Dept Virol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Poeppl, W (corresponding author), Med Univ Vienna, Dept Infect Dis & Trop Med, Vienna, Austria.	wolfgang.poeppl@meduniwien.ac.at	Burgmann, Heinz/N-2409-2013	Burgmann, Heinz/0000-0002-2114-0999; Redlberger-Fritz, Monika/0000-0001-6265-557X; Herkner, Harald/0000-0003-1329-6149				Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1029; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Drexler JF, 2009, EMERG INFECT DIS, V15, P1662, DOI 10.3201/eid1510.091186; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gordon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010364; Gordon SM, 2009, CLEV CLIN J MED, V76, P577, DOI 10.3949/ccjm.76a.05009; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; Louie JK, 2010, EMERG INFECT DIS, V16, P824, DOI [10.3201/eid1605.091794, 10.3201/eid1605.091797]; Redlberger-Fritz M, 2009, RUCKBLICK ERSTE WELL; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Suntarattiwong P, 2010, PEDIATR INFECT DIS J, V29, P366, DOI 10.1097/INF.0b013e3181c6f05c; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Watcharananan S, 2010, J INFECTION, V60, P86, DOI 10.1016/j.jinf.2009.10.049	19	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28089	10.1371/journal.pone.0028089	http://dx.doi.org/10.1371/journal.pone.0028089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145023	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168900006
J	Guil, F; Fernandez-Olalla, M; Moreno-Opo, R; Mosqueda, I; Gomez, ME; Aranda, A; Arredondo, A; Guzman, J; Oria, J; Gonzalez, LM; Margalida, A				Guil, Francisco; Fernandez-Olalla, Mariana; Moreno-Opo, Ruben; Mosqueda, Ignacio; Elena Gomez, Maria; Aranda, Antonio; Arredondo, Angel; Guzman, Jose; Oria, Javier; Mariano Gonzalez, Luis; Margalida, Antoni			Minimising Mortality in Endangered Raptors Due to Power Lines: The Importance of Spatial Aggregation to Optimize the Application of Mitigation Measures	PLOS ONE			English	Article							EAGLE AQUILA-ADALBERTI; MARKED POINT-PROCESSES; OWL BUBO-BUBO; HEMORRHAGIC-DISEASE; RABBIT-POPULATIONS; MOSAIC LANDSCAPE; BONELLIS EAGLE; ELECTROCUTION; SPAIN; AREAS	Electrocution by power lines is one of the main causes of non-natural mortality in birds of prey. In an area in central Spain, we surveyed 6304 pylons from 333 power lines to determine electrocution rates, environmental and design factors that may influence electrocution and the efficacy of mitigation measures used to minimise electrocution cases. A total of 952 electrocuted raptors, representing 14 different species, were observed. Electrocuted raptors were concentrated in certain areas and the environmental factors associated with increased electrocution events were: greater numbers of prey animals; greater vegetation cover; and shorter distance to roads. The structural elements associated with electrocutions were shorter strings of insulators, one or more phases over the crossarm, cross-shaped design and pylon function. Of the 952 carcasses found, 148 were eagles, including golden eagle (Aquila chrysaetos), Spanish imperial eagle (Aquila adalberti) and Bonelli's eagle (Aquila fasciata). Electrocuted eagles were clustered in smaller areas than other electrocuted raptors. The factors associated with increased eagle electrocution events were: pylons function, shorter strings of insulators, higher slopes surrounding the pylon, and more numerous potential prey animals. Pylons with increased string of insulators had lower raptor electrocution rates than unimproved pylons, although this technique was unsuccessful for eagles. Pylons with cable insulation showed higher electrocution rates than unimproved pylons, both for raptors and eagles, despite this is the most widely used and recommended mitigation measure in several countries. To optimize the application of mitigation measures, our results recommend the substitution of pin-type insulators to suspended ones and elongating the strings of insulators.	[Guil, Francisco; Moreno-Opo, Ruben; Arredondo, Angel; Guzman, Jose; Oria, Javier] CBD Habitat Fdn, Madrid, Spain; [Guil, Francisco] Tragsatec, Gerencia Biodiversidad, Madrid, Spain; [Guil, Francisco; Fernandez-Olalla, Mariana] Univ Politecn Madrid, ETS Ingn Montes, Madrid, Spain; [Mosqueda, Ignacio; Elena Gomez, Maria; Aranda, Antonio] Direcc Gen Montes & Espacios Nat, Toledo, Spain; [Mariano Gonzalez, Luis] Spanish Minist Environm & Rural & Marine Affairs, Direcc Gen Medio Nat & Polit Forestal, Serv Especies Amenazadas, Madrid, Spain; [Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain	Universidad Politecnica de Madrid; Fundacion para la Conservacion del Quebranthuesos (FCQ)	Guil, F (corresponding author), CBD Habitat Fdn, Madrid, Spain.	francisco.guilcelada@gmail.com	Margalida, Antoni/A-2723-2011; Margalida, Antoni/AAG-5337-2020; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212	Obra Social Caja Madrid	Obra Social Caja Madrid	This study has been developed within the framework of LIFE+07/NAT/E/000743 "Conservacion de especies prioritarias del monte mediterraneo en Castilla-La Mancha'', coordinated by the Organismo Autonomo Espacios Naturales de Castilla-La Mancha and participated in by the Fundacion CBD-Habitat and LIFE03/NAT/E/00050" Conservacion del Aguila imperial, Buitre negro y Ciguena negra'', developed by the CBD-Habitat Foundation with the cooperation of the Junta de Castilla-La Mancha and the Spanish Ministry of the Environment. This project is part of the regional recovery plan of Castilla-La Mancha and the National Preservation Strategy for the Spanish imperial eagle. Obra Social Caja Madrid also provided financial and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avian Power Line Interaction Committee, 2006, SUGG PRACT AV PROT P; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Beisbart C, 2002, LECT NOTES PHYS, V600, P358; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; BirdLife International, 2004, BIRDS EUR POP EST TR; Burnham KP, 2002, MULTIMODEL INFERENCE; Cadahia L, 2010, EUR J WILDLIFE RES, V56, P923, DOI 10.1007/s10344-010-0391-z; Crawley M. J., 2007, R BOOK ATRIUM SO GAT; Del Moral J.C., 2018, AGUILA PERDICERA ESP, DOI [10.31170/0066, DOI 10.31170/0066]; Del Moral J.C., 2009, AGUILA REAL ESPANA P; Delibes-Mateos M, 2008, BIODIVERS CONSERV, V17, P559, DOI 10.1007/s10531-007-9272-5; Dwyer JF, 2007, J RAPTOR RES, V41, P259, DOI 10.3356/0892-1016(2007)41[259:PREIAU]2.0.CO;2; Ferguson-Lees J, 2001, RAPTORS WORLD; Fernandez N, 2005, LANDSCAPE ECOL, V20, P897, DOI 10.1007/s10980-004-3976-7; FERRER M, 1991, J FIELD ORNITHOL, V62, P181; Gonzalez LM, 2008, BIRD CONSERV INT, V18, P242, DOI 10.1017/S0959270908000245; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Gonzalez LM, 2006, BIRD STUDY, V53, P285, DOI 10.1080/00063650609461444; Guzman Jose, 1998, Ardeola, V45, P161; Haas D., 2005, PROTECTING BIRDS POW; Hager SB, 2009, J RAPTOR RES, V43, P210, DOI 10.3356/JRR-08-63.1; Harness RE, 2001, WILDLIFE SOC B, V29, P612; Janss GFE, 1999, WILDLIFE SOC B, V27, P263; Janss GFE, 2000, BIOL CONSERV, V95, P353, DOI 10.1016/S0006-3207(00)00021-5; Janss GFE, 2001, BIRD CONSERV INT, V11, P3, DOI 10.1017/S0959270901001022; Jenness J, 2004, NEAREST FEATURES EXT; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; Lehman RN, 2010, J WILDLIFE MANAGE, V74, P459, DOI 10.2193/2008-332; LIFE Unit, 2010, LIFE PROJ DAT; Lopez-Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017196; Madrono A., 2004, LIBRO ROJO AVES ESPA; Manosa S, 2001, BIODIVERS CONSERV, V10, P1997, DOI 10.1023/A:1013129709701; Marti R., 2003, ATLAS AVES REPRODUCT; MMA, 2001, ESTR NAC CONS AG IMP; Mojica EK, 2009, J RAPTOR RES, V43, P57, DOI 10.3356/JRR-07-60.1; Moleon M, 2007, ARDEOLA, V54, P319; Montes F, 2008, CAN J FOREST RES, V38, P1924, DOI 10.1139/X08-002; NEGRO JJ, 1995, IBIS, V137, P423, DOI 10.1111/j.1474-919X.1995.tb08045.x; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Palomino D, 2007, BIOL CONSERV, V140, P100, DOI 10.1016/j.biocon.2007.07.029; Palomino D, 2007, LANDSCAPE URBAN PLAN, V83, P268, DOI 10.1016/j.landurbplan.2007.04.011; Penteriani V, 2005, OIKOS, V108, P523, DOI 10.1111/j.0030-1299.2005.13514.x; PENTTINEN A, 1992, FOREST SCI, V38, P806; Ponce C, 2010, ANIM CONSERV, V13, P603, DOI 10.1111/j.1469-1795.2010.00387.x; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Rubolini D, 2001, BIRD CONSERV INT, V11, P319, DOI 10.1017/S0959270901000363; Schaub M, 2010, BIOL CONSERV, V143, P1911, DOI 10.1016/j.biocon.2010.04.047; Sergio F, 2004, J APPL ECOL, V41, P836, DOI 10.1111/j.0021-8901.2004.00946.x; Soutullo A, 2008, BIOL CONSERV, V141, P1013, DOI 10.1016/j.biocon.2008.01.011; STOYAN D, 1994, FRACTAL RANDOM SHAPE; Tinto A, 2010, J WILDLIFE MANAGE, V74, P1852, DOI 10.2193/2009-521; Villafuerte R, 1995, MAMMALIA, V59, P651, DOI 10.1515/mamm.1995.59.4.651; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Williams RD, 1989, W RAPT MAN S WORKSH, P173	54	52	55	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28212	10.1371/journal.pone.0028212	http://dx.doi.org/10.1371/journal.pone.0028212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140549	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400038
J	Hauk, P; Barbosa, AS; Ho, PL; Farah, CS				Hauk, Pricila; Barbosa, Angela Silva; Ho, Paulo Lee; Farah, Chuck Shaker			Calcium Binding to Leptospira Outer Membrane Antigen LipL32 Is Not Necessary for Its Interaction with Plasma Fibronectin, Collagen Type IV, and Plasminogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; PATHOGENIC LEPTOSPIRA; SURFACE PROTEIN; INTERROGANS; IDENTIFICATION; LIPOPROTEIN; DYE; EXPRESSION; ADHERENCE; LAMININ	LipL32 is the most abundant outer membrane protein from pathogenic Leptospira and has been shown to bind extracellular matrix (ECM) proteins as well as Ca2+. Recent crystal structures have been obtained for the protein in the apo-and Ca2+-bound forms. In this work, we produced three LipL32 mutants (D163-168A, Q67A, and S247A) and evaluated their ability to interact with Ca2+ and with ECM glycoproteins and human plasminogen. The D163-168A mutant modifies aspartate residues involved in Ca2+ binding, whereas the other two modify residues in a cavity on the other side of the protein structure. Loss of calcium binding in the D163-D168A mutant was confirmed using intrinsic tryptophan fluorescence, circular dichroism, and thermal denaturation whereas the Q67A and S247A mutants presented the same Ca2+ affinity as the wild-type protein. We then evaluated if Ca2+ binding to LipL32 would be crucial for its interaction with collagen type IV and plasma proteins fibronectin and plasminogen. Surprisingly, the wild-type protein and all three mutants, including the D163-168A variant, bound to these ECM proteins with very similar affinities, both in the presence and absence of Ca2+ ions. In conclusion, calcium binding to LipL32 may be important to stabilize the protein, but is not necessary to mediate interaction with host extracellular matrix proteins.	[Barbosa, Angela Silva] Inst Butantan, Bacteriol Lab, BR-05503900 Sao Paulo, Brazil; [Hauk, Pricila; Farah, Chuck Shaker] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil; [Ho, Paulo Lee] Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Instituto Butantan	Barbosa, AS (corresponding author), Inst Butantan, Bacteriol Lab, BR-05503900 Sao Paulo, Brazil.	angelabarbosa@butantan.gov.br; chsfarah@iq.usp.br	Farah, Chuck Shaker/G-5565-2012; 4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Barbosa, Angela S/I-3518-2013; Hauk, Pricila/AAS-9424-2021; Hauk, Pricila/C-8559-2013; Ho, Paulo/P-8267-2015	Farah, Chuck Shaker/0000-0003-3110-6302; Barbosa, Angela S/0000-0002-6458-9489; Hauk, Pricila/0000-0002-4761-1920; Ho, Paulo/0000-0003-3652-241X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao Butantan; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), the Fundacao Butantan, and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bers D., 1994, METHODS CELL BIOL; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; Breiner DD, 2009, INFECT IMMUN, V77, P5528, DOI 10.1128/IAI.00546-09; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; CADAY CG, 1985, J BIOL CHEM, V260, P5985; Cameron CE, 2003, INFECT IMMUN, V71, P2525, DOI 10.1128/IAI.71.5.2525-2533.2003; Candela M, 2007, J BACTERIOL, V189, P5929, DOI 10.1128/JB.00159-07; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Dabo SM, 2006, MICROB PATHOGENESIS, V41, P10, DOI 10.1016/j.micpath.2006.04.003; DUNCANSON GO, 1990, CLIN CHEM, V36, P756; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Hauk P, 2011, BRAZ J MED BIOL RES, V44, P297, DOI 10.1590/S0100-879X2011007500025; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; KLOTZ SA, 1993, MICROB PATHOGENESIS, V14, P133, DOI 10.1006/mpat.1993.1014; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; LOWRANCE JH, 1988, INFECT IMMUN, V56, P2279, DOI 10.1128/IAI.56.9.2279-2285.1988; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Seixas FK, 2007, VACCINE, V26, P88, DOI 10.1016/j.vaccine.2007.10.052; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; WANG LP, 1994, INVEST OPHTH VIS SCI, V35, P2421; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62	40	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4826	4834		10.1074/jbc.M111.277210	http://dx.doi.org/10.1074/jbc.M111.277210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22147698	hybrid, Green Published			2022-12-25	WOS:000300608500044
J	Li, HB; Panina, S; Kaur, A; Ruano, MJ; Sanchez-Gonzalez, P; la Cour, JM; Stephan, A; Olesen, UH; Berchtold, MW; Villalobo, A				Li, Hongbing; Panina, Svetlana; Kaur, Amandeep; Ruano, Maria J.; Sanchez-Gonzalez, Pablo; la Cour, Jonas M.; Stephan, Alexander; Olesen, Uffe H.; Berchtold, Martin W.; Villalobo, Antonio			Regulation of the Ligand-dependent Activation of the Epidermal Growth Factor Receptor by Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; EGF-RECEPTOR; JUXTAMEMBRANE REGION; PLASMA-MEMBRANE; BINDING SITE; CALCIUM; CELLS; PHOSPHORYLATION; MECHANISM; PROTEIN	Calmodulin (CaM) is the major component of calcium signaling pathways mediating the action of various effectors. Transient increases in the intracellular calcium level triggered by a variety of stimuli lead to the formation of Ca2+/CaM complexes, which interact with and activate target proteins. In the present study the role of Ca2+/CaM in the regulation of the ligand-dependent activation of the epidermal growth factor receptor (EGFR) has been examined in living cells. We show that addition of different cell permeable CaM antagonists to cultured cells or loading cells with a Ca2+ chelator inhibited ligand-dependent EGFR auto(trans) phosphorylation. This occurred also in the presence of inhibitors of protein kinase C, CaM-dependent protein kinase II and calcineurin, which are known Ca2+-and/or Ca2+/CaM-dependent EGFR regulators, pointing to a direct effect of Ca2+/CaM on the receptor. Furthermore, we demonstrate that down-regulation of CaM in conditional CaM knock out cells stably transfected with the human EGFR decreased its ligand-dependent phosphorylation. Substitution of six basic amino acid residues within the CaM-binding domain (CaM-BD) of the EGFR by alanine resulted in a decreased phosphorylation of the receptor and of its downstream substrate phospholipase C gamma 1. These results support the hypothesis that CaCa2+/CaM reg-ulates the EGFR activity by directly interacting with the CaM-BD of the receptor located at its cytosolic juxtamembrane region.	[Li, Hongbing; Kaur, Amandeep; Ruano, Maria J.; Sanchez-Gonzalez, Pablo; Villalobo, Antonio] CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; [Li, Hongbing; Kaur, Amandeep; Ruano, Maria J.; Sanchez-Gonzalez, Pablo; Villalobo, Antonio] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Panina, Svetlana] Novo Nordisk AS, Dept Monocyte Biol, DK-2760 Malov, Denmark; [la Cour, Jonas M.; Stephan, Alexander; Olesen, Uffe H.; Berchtold, Martin W.] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Novo Nordisk; University of Copenhagen	Villalobo, A (corresponding author), CSIC, Inst Invest Biomed, Arturo Duperier 4, E-28029 Madrid, Spain.	hongbing.li@sickkids.ca; mruanor@mapa.es; antonio.villalobo@iib.uam.es	Villalobo, Antonio/O-9621-2019; Berchtold, Martin/L-1695-2014; Villalobo, Antonio/K-2902-2017; la Cour, Jonas/M-5088-2016	Villalobo, Antonio/0000-0002-4200-374X; Berchtold, Martin/0000-0001-8995-9047; Sanhez, Pablo/0000-0002-2844-6843; Olesen, Uffe Hogh/0000-0002-4578-684X; la Cour, Jonas/0000-0002-1588-0608	Ministerio de Ciencia e Innovacion [SAF2008-00986, SAF2011-23494]; European Commission [ITN 289033]; Danish Research Council; Lundbeck Foundation; AP Moller Fonden; Dagmar Marshall Fonden; Willumsen Fonden; Danielsen Fonden; Wedell Wedellsborg Fonden; Junta de Ampliacion de Estudios, CSIC, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Research Council(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); AP Moller Fonden; Dagmar Marshall Fonden; Willumsen Fonden; Danielsen Fonden; Wedell Wedellsborg Fonden; Junta de Ampliacion de Estudios, CSIC, Spain	This work was financed by grants (to A. V.) from the Ministerio de Ciencia e Innovacion (SAF2008-00986 and SAF2011-23494) and the European Commission (contract ITN 289033); Grant from the Danish Research Council (to M. W. B.), the Lundbeck Foundation, AP Moller Fonden, Dagmar Marshall Fonden, Willumsen Fonden, Danielsen Fonden, and Wedell Wedellsborg Fonden.; Supported by a predoctoral fellowship from the Junta de Ampliacion de Estudios, CSIC, Spain.	Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Aifa S, 2005, EXP CELL RES, V302, P108, DOI 10.1016/j.yexcr.2004.08.032; Aifa S, 2002, CELL SIGNAL, V14, P1005, DOI 10.1016/S0898-6568(02)00034-7; Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BENGURIA A, 1994, EUR J BIOCHEM, V224, P909, DOI 10.1111/j.1432-1033.1994.00909.x; Benguria A, 1995, ANN NY ACAD SCI, V766, P472, DOI 10.1111/j.1749-6632.1995.tb26698.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; Dagher R, 2011, BBA-MOL CELL RES, V1813, P1059, DOI 10.1016/j.bbamcr.2010.11.004; EMERY AEH, 1967, BIOCHEM J, V105, P599, DOI 10.1042/bj1050599; Hackl H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013013; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Kroll T, 2002, J CANCER RES CLIN, V128, P125, DOI 10.1007/s00432-001-0308-z; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; Lee YJ, 2008, AM J PHYSIOL-RENAL, V294, pF534, DOI 10.1152/ajprenal.00408.2007; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Li HB, 2004, FEBS LETT, V559, P175, DOI 10.1016/S0014-5793(04)00067-5; Li HB, 2002, BIOCHEM J, V362, P499, DOI 10.1042/bj3620499; MARTIN BL, 1993, BIOCHEM BIOPH RES CO, V194, P150, DOI 10.1006/bbrc.1993.1797; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; MARTINNIETO J, 2002, RRD BIOCHEM 1, V3, P41; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k; PALLEN CJ, 1985, BIOCHEMISTRY-US, V24, P4727, DOI 10.1021/bi00339a003; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Poppleton HM, 2000, ARCH BIOCHEM BIOPHYS, V383, P309, DOI 10.1006/abbi.2000.2095; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; SANJOSE E, 1992, J BIOL CHEM, V267, P15237; Sato T, 2006, BIOCHEMISTRY-US, V45, P12704, DOI 10.1021/bi061264m; Schmalzigaug R, 2001, IMMUNOLOGY, V103, P332, DOI 10.1046/j.1365-2567.2001.01259.x; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; TOJYO Y, 1990, BIOCHEM PHARMACOL, V39, P1775; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Villalobo A., 2000, CALCIUM MOL BASIS CA, P45; WANG H, 1991, BIOCHEMISTRY-US, V30, P3019, DOI 10.1021/bi00226a006; White CD, 2011, BBA-MOL CELL RES, V1813, P1074, DOI 10.1016/j.bbamcr.2010.12.016; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; YAMANE K, 1992, BIOCHEM BIOPH RES CO, V184, P1301, DOI 10.1016/S0006-291X(05)80024-5; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang L, 2007, MOL CELL BIOCHEM, V305, P19, DOI 10.1007/s11010-007-9523-5; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	55	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3273	3281		10.1074/jbc.M111.317529	http://dx.doi.org/10.1074/jbc.M111.317529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157759	Green Published, hybrid			2022-12-25	WOS:000300295100033
J	Katyal, S; Glubrecht, DD; Li, L; Gao, ZH; Godbout, R				Katyal, Sachin; Glubrecht, Darryl D.; Li, Lei; Gao, Zhihua; Godbout, Roseline			Disabled-1 Alternative Splicing in Human Fetal Retina and Neural Tumors	PLOS ONE			English	Article							AII AMACRINE CELLS; APOE RECEPTOR 2; TYROSINE PHOSPHORYLATION; BRAIN-DEVELOPMENT; REELIN PATHWAY; RETINOBLASTOMA CELLS; NEURONAL MIGRATION; VLDL RECEPTOR; CHICK RETINA; MOUSE	Background: The Reelin-Dab1 signaling pathway plays a critical role in the positioning of migrating neurons, dendrite formation and lamination in the developing central nervous system. We have previously identified two alternatively spliced forms of Dab1 in the developing chick retina: an early form, Dab1-E, expressed in retinal progenitor cells, and a late form, Dab1 or Dab1-L, expressed in amacrine and ganglion cells. Compared to Dab1-L, Dab1-E lacks two exons that encode two Src family kinase (SFK) phosphorylation sites. Principal Findings: Both Dab1-L and Dab1-E-like transcripts were identified in human fetal retina. Expression of human Dab1-L in primary chick retinal cultures resulted in Reelin-mediated induction of SFK phosphorylation and formation of neurite-like processes. In contrast, human Dab1-E-expressing cells retained an undifferentiated morphology. The human Dab1 gene is located within a common fragile site, and it has been postulated that it may function as a tumor suppressor. Analysis of Dab1 splice forms in retinoblastoma and neuroblastoma tumor cells revealed relative enrichment of Dab1-L-like (includes exons 7 and 8) and Dab1-E-like (excludes exons 7 and 8) transcripts in retinoblastoma and neuroblastoma, respectively. Treatment of retinoblastoma cell line RB522A with Reelin resulted in increased tyrosine phosphorylation of Dab1. As Nova2 has previously been implicated in the exclusion of exons 9B and 9C in Dab1, we examined the expression of this splicing factor in neuroblastoma and retinoblastoma cell lines. Nova2 was only detected in neuroblastoma cells, suggesting a correlation between Nova2 expression and increased levels of Dab1-E-like splice forms in neuroblastoma. Conclusions: These results indicate that alternative splicing of Dab1 is conserved in avian and mammalian species, with Dab1-L driving SFK phosphorylation in both species. Dab1-E-and Dab-L-like isoforms are also expressed in childhood neural tumors, with preferential enrichment of Dab1-L-like and Dab1-E-like isoforms in retinoblastoma and neuroblastoma, respectively.	[Katyal, Sachin; Glubrecht, Darryl D.; Li, Lei; Gao, Zhihua; Godbout, Roseline] Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada	University of Alberta	Katyal, S (corresponding author), Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB, Canada.	rgodbout@ualberta.ca	Godbout, Roseline/I-4639-2016	Godbout, Roseline/0000-0002-4779-9265; Katyal, Sachin/0000-0002-7790-4054	Canadian Institutes of Health Research; Alberta Cancer Foundation; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by the Canadian Institutes of Health Research. S.K. was supported by the Dr. Cyril Kay Graduate Studentship Award from the Alberta Cancer Foundation. Z.G. was supported by a studentship from the Alberta Heritage Foundation for Medical Research. L.L. was supported by a fellowship from the Alberta Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Ballif BA, 2003, MOL BRAIN RES, V117, P152, DOI 10.1016/S0169-328X(03)00295-X; Bar I, 2003, J BIOL CHEM, V278, P5802, DOI 10.1074/jbc.M207178200; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; BOGENMANN E, 1983, J NATL CANCER I, V70, P95; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Costagli A, 2006, DEV GENES EVOL, V216, P291, DOI 10.1007/s00427-005-0052-5; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; GALLIE BL, 1982, CANCER RES, V42, P301; Gallie BL, 1999, CANCER RES, V59, p1731S; Gao ZH, 2011, CELL SIGNAL, V23, P555, DOI 10.1016/j.cellsig.2010.11.007; Gao ZH, 2010, MOL CELL BIOL, V30, P4339, DOI 10.1128/MCB.00545-10; Glubrecht DD, 2009, J NEUROCHEM, V111, P250, DOI 10.1111/j.1471-4159.2009.06322.x; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Kam R, 2004, NEUROPATH APPL NEURO, V30, P225, DOI 10.1046/j.0305-1846.2004.00526.x; Katyal S, 2004, EMBO J, V23, P1878, DOI 10.1038/sj.emboj.7600185; Katyal S, 2007, J MOL BIOL, V368, P349, DOI 10.1016/j.jmb.2007.01.068; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Lee EJ, 2004, J COMP NEUROL, V470, P372, DOI 10.1002/cne.20010; Li XD, 2010, GENE CHROMOSOME CANC, V49, P819, DOI 10.1002/gcc.20790; Long HA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-17; McAvoy S, 2008, GENE CHROMOSOME CANC, V47, P165, DOI 10.1002/gcc.20519; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; SQUIRE JA, 1995, ONCOGENE, V10, P1417; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28579	10.1371/journal.pone.0028579	http://dx.doi.org/10.1371/journal.pone.0028579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163036	Green Published, gold			2022-12-25	WOS:000298173500035
J	Mankus, C; Rich, C; Minns, M; Trinkaus-Randall, V				Mankus, Courtney; Rich, Celeste; Minns, Martin; Trinkaus-Randall, Vickery			Corneal Epithelium Expresses a Variant of P2X(7) Receptor in Health and Disease	PLOS ONE			English	Article							P2X7 RECEPTOR; PORE FORMATION; CELL-DEATH; CASPASE-1 ACTIVATION; P2Y RECEPTORS; CANCER-CELLS; C-TERMINUS; ATP; CHANNEL; APOPTOSIS	Improper wound repair of the corneal epithelium can alter refraction of light resulting in impaired vision. We have shown that ATP is released after injury, activates purinergic receptor signaling pathways and plays a major role in wound closure. In many cells or tissues, ATP activates P2X(7) receptors leading to cation fluxes and cytotoxicity. The corneal epithelium is an excellent model to study the expression of both the full-length P2X(7) form (defined as the canonical receptor) and its truncated forms. When Ca2+ mobilization is induced by BzATP, a P2X(7) agonist, it is attenuated in the presence of extracellular Mg2+ or Zn2+, negligible in the absence of extracellular Ca2+, and inhibited by the competitive P2X7 receptor inhibitor, A438079. BzATP enhanced phosphorylation of ERK. Together these responses indicate the presence of a canonical or full-length P2X(7) receptor. In addition BzATP enhanced epithelial cell migration, and transfection with siRNA to the P2X(7) receptor reduced cell migration. Furthermore, sustained activation did not induce dye uptake indicating the presence of truncated or variant forms that lack the ability to form large pores. Reverse transcription-polymerase chain reaction and Northern blot analysis revealed a P2X(7) splice variant. Western blots identified a full-length and truncated form, and the expression pattern changed as cultures progressed from monolayer to stratified. Cross-linking gels demonstrated the presence of homo- and heterotrimers. We examined epithelium from age matched diabetic and non-diabetic corneas patients and detected a 4-fold increase in P2X(7) mRNA from diabetic corneal epithelium compared to non-diabetic controls and an increased trend in expression of P2X(7)variant mRNA. Taken together, these data indicate that corneal epithelial cells express full-length and truncated forms of P2X(7), which ultimately allows P2X(7) to function as a multifaceted receptor that can mediate cell proliferation and migration or cell death.	[Mankus, Courtney; Rich, Celeste; Minns, Martin; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Mankus, Courtney] ECI Biotech Worcester, Worcester, MA USA	Boston University; Boston University	Mankus, C (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	vickery@bu.edu		Trinkaus-Randall, Vickery/0000-0002-8573-9108; Minns, Martin/0000-0002-9793-5819	National Institutes of Health [EY06000, EY013431]; Massachusetts Lions Eye Research; New England Corneal Transplant Fund; NATIONAL EYE INSTITUTE [R01EY013431, R01EY006000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research; New England Corneal Transplant Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health EY06000, EY013431, Massachusetts Lions Eye Research, and New England Corneal Transplant Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 1998, JPN J PHARMACOL, V78, P113, DOI 10.1254/jjp.78.113; Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; Boucher I, 2011, AM J PATHOL, V178, P1092, DOI 10.1016/j.ajpath.2010.11.060; Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Chen YG, 2011, J IMMUNOL, V186, P4278, DOI 10.4049/jimmunol.1003733; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Feng YH, 2006, NUCLEOS NUCLEOT NUCL, V25, P1271, DOI 10.1080/15257770600890921; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Georgiou JG, 2005, J INVEST DERMATOL, V125, P482, DOI 10.1111/j.0022-202X.2005.23835.x; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Hayashi T, 2003, RECENT PROG HORM RES, V58, P131, DOI 10.1210/rp.58.1.131; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258; Klepeis VE, 2001, J CELL SCI, V114, P4185; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Mayo C, 2008, INVEST OPHTH VIS SCI, V49, P4384, DOI 10.1167/iovs.08-1688; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Ralevic V, 1998, PHARMACOL REV, V50, P413; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Saghizadeh M, 2010, INVEST OPHTH VIS SCI, V51, P1970, DOI 10.1167/iovs.09-4569; Solini A, 1999, J CELL SCI, V112, P297; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Sugiyama T, 2005, AM J PHYSIOL-CELL PH, V288, pC568, DOI 10.1152/ajpcell.00380.2004; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wang CM, 2003, CELL SIGNAL, V15, P1129, DOI 10.1016/S0898-6568(03)00112-8; Wang QF, 2004, AM J PHYSIOL-CELL PH, V287, pC1349, DOI 10.1152/ajpcell.00256.2004; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Wiley JS, 1998, AM J PHYSIOL-CELL PH, V275, pC1224, DOI 10.1152/ajpcell.1998.275.5.C1224; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Zhang XL, 2005, INVEST OPHTH VIS SCI, V46, P2183, DOI 10.1167/iovs.05-0052; ZIESKE JD, 1989, J CELL BIOL, V109, P571, DOI 10.1083/jcb.109.2.571	53	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28541	10.1371/journal.pone.0028541	http://dx.doi.org/10.1371/journal.pone.0028541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163032	Green Published, gold			2022-12-25	WOS:000298173500032
J	Lu, HL; Tanguy, S; Rispe, C; Gauthier, JP; Walsh, T; Gordon, K; Edwards, O; Tagu, D; Chang, CC; Jaubert-Possamai, S				Lu, Hsiao-ling; Tanguy, Sylvie; Rispe, Claude; Gauthier, Jean-Pierre; Walsh, Tom; Gordon, Karl; Edwards, Owain; Tagu, Denis; Chang, Chun-che; Jaubert-Possamai, Stephanie			Expansion of Genes Encoding piRNA-Associated Argonaute Proteins in the Pea Aphid: Diversification of Expression Profiles in Different Plastic Morphs	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM HEMIPTERA; PIWI; RNA; CELL; PATHWAY; RECOGNITION; BIOGENESIS; SEQUENCE; MEIOSIS	Piwi-interacting RNAs (piRNAs) are known to regulate transposon activity in germ cells of several animal models that propagate sexually. However, the role of piRNAs during asexual reproduction remains almost unknown. Aphids that can alternate sexual and asexual reproduction cycles in response to seasonal changes of photoperiod provide a unique opportunity to study piRNAs and the piRNA pathway in both reproductive modes. Taking advantage of the recently sequenced genome of the pea aphid Acyrthosiphon pisum, we found an unusually large lineage-specific expansion of genes encoding the Piwi sub-clade of Argonaute proteins. In situ hybridisation showed differential expressions between the duplicated piwi copies: while Api-piwi2 and Api-piwi6 are "specialised" in germ cells their most closely related copy, respectively Api-piwi5 and Api-piwi3, are expressed in the somatic cells. The differential expression was also identified in duplicated ago3: Api-ago3a in germ cells and Api-ago3b in somatic cells. Moreover, analyses of expression profiles of the expanded piwi and ago3 genes by semi-quantitative RT-PCR showed that expressions varied according to the reproductive types. These specific expression patterns suggest that expanded aphid piwi and ago3 genes have distinct roles in asexual and sexual reproduction.	[Lu, Hsiao-ling; Chang, Chun-che] Natl Taiwan Univ, Dept Entomol, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Tanguy, Sylvie; Rispe, Claude; Gauthier, Jean-Pierre; Tagu, Denis; Jaubert-Possamai, Stephanie] Univ Rennes 1, INRA, UMR Unite Mixte Rech Biol Organismes & Populat Ap, Le Rheu, France; [Walsh, Tom; Gordon, Karl] CSIRO Commonwealth Sci & Ind Res Org Ecosyst Sci, Canberra, ACT, Australia; [Edwards, Owain] CSIRO Ecosyst Sci, Wembley, WA, Australia; [Lu, Hsiao-ling; Chang, Chun-che] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chang, Chun-che] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan	National Taiwan University; INRAE; Universite de Rennes; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Taiwan University; National Taiwan University	Lu, HL (corresponding author), Natl Taiwan Univ, Dept Entomol, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan.	chunche@ntu.edu.tw; Stephanie.Jaubert@rennes.inra.fr	Walsh, Thomas K/C-1263-2009; Edwards, Owain Rhys/B-9707-2008; Gordon, Karl H J/A-1976-2008	Walsh, Thomas K/0000-0001-8425-0135; Edwards, Owain Rhys/0000-0003-3861-7906; Gordon, Karl H J/0000-0002-4371-0454; Chang, Chun-che/0000-0002-3586-1607; Rispe, Claude/0000-0002-9489-5719; Tagu, Denis/0000-0002-6320-8648	National Science Council [97-2313-B-002-035-MY3]; Bureau of Animal and Plant Health Inspection and Quarantine (BAPHIQ) of the Agricultural Council [97-1.1.1-B1(6), 98-1.1.1-B1(2), 100-9.2.1-B1(6)]	National Science Council(Ministry of Science and Technology, Taiwan); Bureau of Animal and Plant Health Inspection and Quarantine (BAPHIQ) of the Agricultural Council	This work was supported by the National Science Council (97-2313-B-002-035-MY3, web site: http://web1.nsc.gov.tw/mp.aspx?mp = 7) and the Bureau of Animal and Plant Health Inspection and Quarantine (BAPHIQ) of the Agricultural Council (97-1.1.1-B1(6); 98-1.1.1-B1(2); 100-9.2.1-B1(6)), web site: http://www.baphiq.gov.tw/mp.asp?mp = 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUNING J, 1985, J MORPHOL, V186, P209, DOI 10.1002/jmor.1051860206; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; Chang CC, 2008, ARCH INSECT BIOCHEM, V68, P186, DOI 10.1002/arch.20243; Chang CC, 2007, DEV GENES EVOL, V217, P275, DOI 10.1007/s00427-007-0142-7; Couvillion MT, 2010, GENE DEV, V24, P2742, DOI 10.1101/gad.1996210; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang TY, 2010, INSECT MOL BIOL, V19, P75, DOI 10.1111/j.1365-2583.2009.00940.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Le Trionnaire G, 2007, INSECT BIOCHEM MOLEC, V37, P1094, DOI 10.1016/j.ibmb.2007.06.008; Le Trionnaire G, 2008, BIOL CELL, V100, P441, DOI 10.1042/BC20070135; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowotny M, 2009, CURR OPIN STRUC BIOL, V19, P286, DOI 10.1016/j.sbi.2009.04.006; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schurko AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-78; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Simon JC, 2011, J HERED, DOI [10.1093/jhered/esr1020, DOI 10.1093/JHERED/ESR1020]; Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; The International Aphid Genomics Consortium, 2010, PLoS Biology, V8, P1, DOI 10.1371/journal.pbio.1000313; Wilczynska A, 2009, RNA, V15, P337, DOI 10.1261/rna.1422509; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhao J, 2010, TOHOKU J EXP MED, V222, P63, DOI 10.1620/tjem.222.63	47	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28051	10.1371/journal.pone.0028051	http://dx.doi.org/10.1371/journal.pone.0028051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162754	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800012
J	Hutson, CL; Carroll, DS; Gallardo-Romero, N; Weiss, S; Clemmons, C; Hughes, CM; Salzer, JS; Olson, VA; Abel, J; Karem, KL; Damon, IK				Hutson, Christina L.; Carroll, Darin S.; Gallardo-Romero, Nadia; Weiss, Sonja; Clemmons, Cody; Hughes, Christine M.; Salzer, Johanna S.; Olson, Victoria A.; Abel, Jason; Karem, Kevin L.; Damon, Inger K.			Monkeypox Disease Transmission in an Experimental Setting: Prairie Dog Animal Model	PLOS ONE			English	Article							VIRUS; CONGO	Monkeypox virus (MPXV) is considered the most significant human public health threat in the genus Orthopoxvirus since the eradication of variola virus (the causative agent of smallpox). MPXV is a zoonotic agent endemic to forested areas of Central and Western Africa. In 2003, MPXV caused an outbreak in the United States due to the importation of infected African rodents, and subsequent sequential infection of North American prairie dogs (Cynomys ludovicianus) and humans. In previous studies, the prairie dog MPXV model has successfully shown to be very useful for understanding MPXV since the model emulates key characteristics of human monkeypox disease. In humans, percutaneous exposure to animals has been documented but the primary method of human-to-human MPXV transmission is postulated to be by respiratory route. Only a few animal model studies of MPXV transmission have been reported. Herein, we show that MPXV infected prairie dogs are able to transmit the virus to naive animals through multiple transmission routes. All secondarily exposed animals were infected with MPXV during the course of the study. Notably, animals secondarily exposed appeared to manifest more severe disease; however, the disease course was very similar to those of experimentally challenged animals including inappetence leading to weight loss, development of lesions, production of orthopoxvirus antibodies and shedding of similar levels or in some instances higher levels of MPXV from the oral cavity. Disease was transmitted via exposure to contaminated bedding, co-housing, or respiratory secretions/nasal mucous (we could not definitively say that transmission occurred via respiratory route exclusively). Future use of the model will allow us to evaluate infection control measures, vaccines and antiviral strategies to decrease disease transmission.	[Hutson, Christina L.; Carroll, Darin S.; Gallardo-Romero, Nadia; Weiss, Sonja; Clemmons, Cody; Hughes, Christine M.; Salzer, Johanna S.; Olson, Victoria A.; Abel, Jason; Karem, Kevin L.; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA; [Salzer, Johanna S.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University	Hutson, CL (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA.	CHutson1@cdc.gov						BREMAN JG, 1980, B WORLD HEALTH ORGAN, V58, P165; BREMAN JG, 1977, AM J TROP MED HYG, V26, P273, DOI 10.4269/ajtmh.1977.26.273; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P561; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; FOSTER SO, 1972, B WORLD HEALTH ORGAN, V46, P569; HEBERLING RL, 1971, J INFECT DIS, V124, P33, DOI 10.1093/infdis/124.1.33; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2010, VIRUSES-BASEL, V2, P2763, DOI 10.3390/v2122763; Hutson CL, 2010, VIROLOGY, V402, P72, DOI 10.1016/j.virol.2010.03.012; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Shchelkunov SN, 2005, ORTHOPOXVIRUSES PATH, P303; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106	19	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28295	10.1371/journal.pone.0028295	http://dx.doi.org/10.1371/journal.pone.0028295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164263	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400064
J	Jin, KT; Li, GL; Cui, BB; Zhang, J; Lan, HR; Han, N; Xie, BJ; Cao, FL; He, KF; Wang, HH; Xu, ZZ; Teng, LS; Zhu, TM				Jin, Ketao; Li, Guangliang; Cui, Binbin; Zhang, Jing; Lan, Huanrong; Han, Na; Xie, Bojian; Cao, Feilin; He, Kuifeng; Wang, Haohao; Xu, Zhenzhen; Teng, Lisong; Zhu, Tieming			Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases	PLOS ONE			English	Article							PRIMARY COLORECTAL-CANCER; IN-SITU HYBRIDIZATION; CORRESPONDING METASTASES; ENDOTHELIAL SPROUTS; NODE METASTASIS; BREAST-CANCER; BLOOD-VESSELS; HER-2 STATUS; EGFR; HETEROGENEITY	The lack of appropriate tumor models of primary tumors and corresponding metastases that can reliably predict for response to anticancer agents remains a major deficiency in the clinical practice of cancer therapy. It was the aim of our study to establish patient-derived tumor tissue (PDTT) xenograft models of colon carcinoma with lymphatic and hepatic metastases useful for testing of novel molecularly targeted agents. PDTT of primary colon carcinoma, lymphatic and hepatic metastases were used to create xenograft models. Hematoxylin and eosin staining, immunohistochemical staining, genome-wide gene expression analysis, pyrosequencing, qRT-PCR, and western blotting were used to determine the biological stability of the xenografts during serial transplantation compared with the original tumor tissues. Early passages of the PDTT xenograft models of primary colon carcinoma, lymphatic and hepatic metastases revealed a high degree of similarity with the original clinical tumor samples with regard to histology, immunohistochemistry, genes expression, and mutation status as well as mRNA expression. After we have ascertained that these xenografts models retained similar histopathological features and molecular signatures as the original tumors, drug sensitivities of the xenografts to a novel VEGF targeted agent, FP3 was evaluated. In this study, PDTT xenograft models of colon carcinoma with lymphatic and hepatic metastasis have been successfully established. They provide appropriate models for testing of novel molecularly targeted agents.	[Jin, Ketao; Li, Guangliang; Zhang, Jing; He, Kuifeng; Wang, Haohao; Xu, Zhenzhen; Teng, Lisong] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Ketao; Lan, Huanrong; Zhu, Tieming] Wenzhou Med Coll, Affiliated Zhuji Hosp, Dept Surg, Zhuji, Zhejiang, Peoples R China; [Cui, Binbin; Xie, Bojian; Cao, Feilin] Wenzhou Med Coll, Taizhou Hosp, Dept Surg Oncol, Taizhou, Zhejiang, Peoples R China; [Han, Na] Zhejiang Univ Tradit & Chinese Med, Zhejiang Prov Canc Hosp, Ctr Canc Chemotherapy, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Zhejiang Cancer Hospital; Zhejiang Chinese Medical University	Teng, LS (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China.; Zhu, TM (corresponding author), Wenzhou Med Coll, Affiliated Zhuji Hosp, Dept Surg, Zhuji, Zhejiang, Peoples R China.	jinketao2001@zju.edu.cn; doctm@163.com	Li, Guangliang/B-6715-2011		State Key Basic Research and Development Program of China (973 Program) [2009CB521704]; National High-tech Research AMP; Development Program of China (863 Program) [2006AA02A245]; National Natural Science Foundation of China [81000894]; Zhejiang Provincial Science and Technology Project [2009C13021]	State Key Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); National High-tech Research AMP; Development Program of China (863 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Science and Technology Project	This work was supported by the State Key Basic Research and Development Program of China (973 Program, Grant No. 2009CB521704), National High-tech Research & Development Program of China (863 Program, Grant No. 2006AA02A245), National Natural Science Foundation of China (Grant No. 81000894) and Zhejiang Provincial Science and Technology Project (Grant No. 2009C13021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakanat A, 2008, CANCER-AM CANCER SOC, V112, P2352, DOI 10.1002/cncr.23456; Baffert F, 2004, CIRC RES, V94, P984, DOI 10.1161/01.RES.0000125295.43813.1F; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Bozzetti C, 2003, CANCER CYTOPATHOL, V99, P310, DOI 10.1002/cncr.11731; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Gancberg D, 2002, ANN ONCOL, V13, P1036, DOI 10.1093/annonc/mdf252; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gong Y, 2005, CANCER-AM CANCER SOC, V103, P1763, DOI 10.1002/cncr.20987; Huang JZ, 2003, P NATL ACAD SCI USA, V100, P7785, DOI 10.1073/pnas.1432908100; Huynh H, 2002, CELL GROWTH DIFFER, V13, P115; JIN K, 2011, CLIN TRANSL IN PRESS; Jin KT, 2011, HEPATO-GASTROENTEROL, V58, P1814, DOI 10.5754/hge11136; Jin KT, 2011, PERS MED, V8, P175, DOI [10.2217/pme.10.81, 10.2217/PME.10.81]; Jin KT, 2010, PERS MED, V7, P597, DOI [10.2217/pme.10.48, 10.2217/PME.10.48]; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Li ZQ, 2011, HEPATO-GASTROENTEROL, V58, P411; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Molinari F, 2009, BRIT J CANCER, V100, P1087, DOI 10.1038/sj.bjc.6604848; Monaco SE, 2010, HUM PATHOL, V41, P94, DOI 10.1016/j.humpath.2009.06.019; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Perez-Soler R, 2000, CLIN CANCER RES, V6, P4932; Regitnig P, 2004, J PATHOL, V203, P918, DOI 10.1002/path.1592; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Sasatomi E, 2002, CANCER RES, V62, P2681; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Scartozzi M, 2007, BRIT J CANCER, V97, P92, DOI 10.1038/sj.bjc.6603847; Scartozzi M, 2004, J CLIN ONCOL, V22, P4772, DOI 10.1200/JCO.2004.00.117; Schneider S, 2005, J AM COLL SURGEONS, V200, P336, DOI 10.1016/j.jamcollsurg.2004.10.035; Tanner M, 2001, CANCER RES, V61, P5345; Tapia C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1676; Teng LS, 2010, J CHIN MED ASSOC, V73, P281, DOI 10.1016/S1726-4901(10)70062-9; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Zhang M, 2008, MOL VIS, V14, P37; Zhang M, 2011, OPHTHALMOLOGY, V118, P672, DOI 10.1016/j.ophtha.2010.08.008; Zhang M, 2009, PHARM RES-DORDR, V26, P204, DOI 10.1007/s11095-008-9718-9	43	30	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28384	10.1371/journal.pone.0028384	http://dx.doi.org/10.1371/journal.pone.0028384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164281	Green Published, gold			2022-12-25	WOS:000298171400082
J	Wong, LC; Schedl, P				Wong, Li Chin; Schedl, Paul			Cup Blocks the Precocious Activation of the Orb Autoregulatory Loop	PLOS ONE			English	Article							OSKAR MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; BINDING-PROTEIN; TRANSLATIONAL REPRESSION; DROSOPHILA OOGENESIS; OOCYTE; BRUNO; CPEB; GENE; RECRUITMENT	Translational regulation of localized mRNAs is essential for patterning and axes determination in many organisms. In the Drosophila ovary, the germline-specific Orb protein mediates the translational activation of a variety of mRNAs localized in the oocyte. One of the Orb target mRNAs is orb itself, and this autoregulatory activity ensures that Orb proteins specifically accumulate in the developing oocyte. Orb is an RNA-binding protein and is a member of the cytoplasmic polyadenylation element binding (CPEB) protein family. We report here that Cup forms a complex in vivo with Orb. We also show that cup negatively regulates orb and is required to block the precocious activation of the orb positive autoregulatory loop. In cup mutant ovaries, high levels of Orb accumulate in the nurse cells, leading to what appears to be a failure in oocyte specification as a number of oocyte markers inappropriately accumulate in nurse cells. In addition, while orb mRNA is mislocalized and destabilized, a longer poly(A) tail is maintained than in wild type ovaries. Analysis of Orb phosphoisoforms reveals that loss of cup leads to the accumulation of hyperphosphorylated Orb, suggesting that an important function of cup in orb-dependent mRNA localization pathways is to impede Orb activation.	[Wong, Li Chin; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Wong, LC (corresponding author), NYU, Sch Med, Smilow Neurosci Program, New York, NY USA.	lichin.wong@nyumc.org			National Institutes of Health [GM56937, GM043432]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056937, R01GM043432, R56GM043432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was initially supported by grant number GM56937 from National Institutes of Health until it was terminated in 2009. Subsequent support came from National Institutes of Health grant number GM043432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit P, 2008, DEVELOPMENT, V135, P1969, DOI 10.1242/dev.021444; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Castagnetti S, 2003, DEVELOPMENT, V130, P835, DOI 10.1242/dev.00309; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chang JS, 2001, DEVELOPMENT, V128, P3169; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Dickson KS, 2001, J BIOL CHEM, V276, P41810, DOI 10.1074/jbc.M103030200; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Huynh JR, 2000, DEVELOPMENT, V127, P2785; Igreja C, 2011, GENE DEV, V25, P1955, DOI 10.1101/gad.17136311; KARPEN GH, 1992, GENETICS, V132, P737; Keyes LN, 1997, DEVELOPMENT, V124, P1419; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1992, DEVELOPMENT, V115, P75; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Snee MJ, 2009, DEV DYNAM, V238, P918, DOI 10.1002/dvdy.21914; Tan LH, 2001, DEVELOPMENT, V128, P1159; Van Buskirk C, 2000, DEVELOPMENT, V127, P4753; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Wong LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024355; Zappavigna V, 2004, P NATL ACAD SCI USA, V101, P14800, DOI 10.1073/pnas.0406451101	31	14	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28261	10.1371/journal.pone.0028261	http://dx.doi.org/10.1371/journal.pone.0028261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164257	Green Published, gold			2022-12-25	WOS:000298171400058
J	Auger, C; Lemire, J; Cecchini, D; Bignucolo, A; Appanna, VD				Auger, Christopher; Lemire, Joseph; Cecchini, Dominic; Bignucolo, Adam; Appanna, Vasu D.			The Metabolic Reprogramming Evoked by Nitrosative Stress Triggers the Anaerobic Utilization of Citrate in Pseudomonas fluorescens	PLOS ONE			English	Article							NITRIC-OXIDE; OXIDATIVE STRESS; ISOCITRATE DEHYDROGENASE; GENE-CLUSTER; TCA CYCLE; TOXICITY; PEROXYNITRITE; ALUMINUM; PYRUVATE; HEPATOCYTES	Nitrosative stress is an ongoing challenge that most organisms have to contend with. When nitric oxide (NO) that may be generated either exogenously or endogenously encounters reactive oxygen species (ROS), it produces a set of toxic moieties referred to as reactive nitrogen species (RNS). As these RNS can severely damage essential biomolecules, numerous organisms have evolved elaborate detoxification strategies to nullify RNS. However, the contribution of cellular metabolism in fending off nitrosative stress is poorly understood. Using a variety of functional proteomic and metabolomic analyses, we have identified how the soil microbe Pseudomonas fluorescens reprogrammed its metabolic networks to survive in an environment enriched by sodium nitroprusside (SNP), a generator of nitrosative stress. To combat the RNS-induced ineffective aconitase (ACN) and tricarboxylic acid (TCA) cycle, the microbe invoked the participation of citrate lyase (CL), phosphoenolpyruvate carboxylase (PEPC) and pyruvate phosphate dikinase (PPDK) to convert citrate, the sole source of carbon into pyruvate and ATP. These enzymes were not evident in the control conditions. This metabolic shift was coupled to the concomitant increase in the activities of such classical RNS detoxifiers as nitrate reductase (NR), nitrite reductase (NIR) and S-nitrosoglutathione reductase (GSNOR). Hence, metabolism may hold the clues to the survival of organisms subjected to nitrosative stress and may provide therapeutic cues against RNS-resistant microbes.	[Auger, Christopher; Lemire, Joseph; Cecchini, Dominic; Bignucolo, Adam; Appanna, Vasu D.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada	Laurentian University	Auger, C (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.	vappanna@laurentian.ca	Auger, Christopher/AAF-5757-2019	Appanna, Vasu/0000-0002-0138-5665	Laurentian University; Ontario graduate scholarship; Alexander Graham Bell Canada doctoral fellowship	Laurentian University; Ontario graduate scholarship(Ontario Graduate Scholarship); Alexander Graham Bell Canada doctoral fellowship	This work was funded by Laurentian University. C. Auger is supported by a doctoral Ontario graduate scholarship and J. Lemire is a recipient of the Alexander Graham Bell Canada doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Blancato VS, 2008, J BACTERIOL, V190, P7419, DOI 10.1128/JB.01704-07; Borisov VB, 2009, J INORG BIOCHEM, V103, P1185, DOI 10.1016/j.jinorgbio.2009.06.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buch A, 2010, BIORESOURCE TECHNOL, V101, P679, DOI 10.1016/j.biortech.2009.08.075; Chenier D, 2008, APPL ENVIRON MICROB, V74, P3977, DOI 10.1128/AEM.02702-07; Das UN, 2006, NUTRITION, V22, P965, DOI 10.1016/j.nut.2006.05.009; Denayer S, 2006, FEMS MICROBIOL LETT, V264, P59, DOI 10.1111/j.1574-6968.2006.00435.x; Durzan DJ, 2002, BIOTECHNOL GENET ENG, V19, P293, DOI 10.1080/02648725.2002.10648032; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Frenzel J, 2005, GLIA, V52, P276, DOI 10.1002/glia.20244; Gebicka L, 2009, J INORG BIOCHEM, V103, P1375, DOI 10.1016/j.jinorgbio.2009.07.011; GIBSON A, 1992, BRIT J PHARMACOL, V107, P715, DOI 10.1111/j.1476-5381.1992.tb14512.x; Heinzelmann S, 2010, BIOL CHEM, V391, P675, DOI 10.1515/BC.2010.068; Kanao T, 2001, EUR J BIOCHEM, V268, P1670, DOI 10.1046/j.1432-1033.2001.02034.x; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Lemire J, 2008, J APPL TOXICOL, V28, P175, DOI 10.1002/jat.1263; Mailloux RJ, 2007, TOXICOL IN VITRO, V21, P16, DOI 10.1016/j.tiv.2006.07.013; Mailloux RJ, 2006, J BIOCHEM MOL TOXIC, V20, P198, DOI 10.1002/jbt.20137; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Mailloux RJ, 2009, BIOCHIMIE, V91, P408, DOI 10.1016/j.biochi.2008.10.014; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Middaugh J, 2005, J BIOL CHEM, V280, P3159, DOI 10.1074/jbc.M411979200; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Pelletier AM, 2010, AM J PHYSIOL-GASTR L, V298, pG896, DOI 10.1152/ajpgi.00259.2009; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Pun PBL, 2010, MITOCHONDRION, V10, P83, DOI 10.1016/j.mito.2009.12.142; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider K, 2002, J BACTERIOL, V184, P2439, DOI 10.1128/JB.184.9.2439-2446.2002; Singh R, 2005, J BIOCHEM BIOPH METH, V64, P189, DOI 10.1016/j.jbbm.2005.07.005; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Tortora V, 2007, FREE RADICAL BIO MED, V42, P1075, DOI 10.1016/j.freeradbiomed.2007.01.007; van Wonderen JH, 2008, J BIOL CHEM, V283, P9587, DOI 10.1074/jbc.M709090200; Varela-Gomez M, 2004, J BIOL CHEM, V279, P54124, DOI 10.1074/jbc.M401697200; Varma SD, 2007, MOL CELL BIOCHEM, V298, P199, DOI 10.1007/s11010-006-9352-y	35	36	36	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28469	10.1371/journal.pone.0028469	http://dx.doi.org/10.1371/journal.pone.0028469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145048	Green Published, gold			2022-12-25	WOS:000298168900031
J	Denison, FC; Smith, LB; Muckett, PJ; O'Hara, L; Carling, D; Woods, A				Denison, Fiona C.; Smith, Lee B.; Muckett, Phillip J.; O'Hara, Laura; Carling, David; Woods, Angela			LKB1 Is an Essential Regulator of Spermatozoa Release during Spermiation in the Mammalian Testis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; TUMOR-SUPPRESSOR LKB1; ECTOPLASMIC SPECIALIZATION; SEMINIFEROUS EPITHELIUM; JUNCTION DYNAMICS; SPLICE VARIANT; MALE-FERTILITY; SPERMATOGENESIS; SUBSTRATE	LKB1 acts as a master upstream protein kinase regulating a number of kinases involved in diverse cellular functions. Recent studies have suggested a role for LKB1 in male fertility. Male mice with reduced total LKB1 expression, including the complete absence of the major splice variant in testis (LKB1(S)), are completely infertile. We sought to further characterise these mice and determine the mechanism underlying this infertility. This involved expression studies of LKB1 in developing germ cells, morphological analysis of mature spermatozoa and histological studies of both the testis and epididymis using light microscopy and transmission electron microscopy. We conclude that a defect in the release of mature spermatids from the seminiferous epithelium (spermiation) during spermatozoan development is a major cause of the infertility phenotype. We also present evidence that this is due, at least in part, to defects in the breakdown of the junctions, known as ectoplasmic specialisations, between the sertoli cells of the testis epithelium and the heads of the maturing spermatids. Overall this study uncovers a critical role for LKB1 in spermiation, a highly regulated, but poorly understood process vital for male fertility.	[Denison, Fiona C.; Muckett, Phillip J.; Carling, David; Woods, Angela] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England; [Smith, Lee B.; O'Hara, Laura] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	Imperial College London; University of Edinburgh	Denison, FC (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England.	angela.woods@csc.mrc.ac.uk	Carling, David/F-1943-2014; Smith, Lee B/J-4861-2013	Carling, David/0000-0002-2316-1830; O'Hara, Laura/0000-0001-7790-9261; Smith, Lee/0000-0002-4103-3074	UK Medical Research Council; BBSRC-CASE; Unilever Discover; Medical Research Council [G1100354, MC_U120027537, G1002033] Funding Source: researchfish; MRC [G1002033, G1100354] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC-CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever Discover(Unilever); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the UK Medical Research Council. FCD was the recipient of a BBSRC-CASE PhD studentship with Unilever Discover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Beardsley A, 2003, BIOL REPROD, V68, P1299, DOI 10.1095/biolreprod.102.009811; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Galardo MN, 2007, J MOL ENDOCRINOL, V39, P279, DOI 10.1677/JME-07-0054; Guttman JA, 2000, J CELL SCI, V113, P2167; Guttman JA, 2004, BIOL REPROD, V71, P548, DOI 10.1095/biolreprod.104.028803; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Lefebvre DL, 2005, BBA-GEN SUBJECTS, V1724, P71, DOI 10.1016/j.bbagen.2005.03.015; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; MOORE HDM, 1987, GAMETE RES, V17, P245, DOI 10.1002/mrd.1120170308; O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Riera MF, 2009, AM J PHYSIOL-ENDOC M, V297, pE907, DOI 10.1152/ajpendo.00235.2009; Russell L. D., 1990, HISTOLOGICAL HISTOPA; RUSSELL LD, 1993, SERTOLI CELL, P269; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siu MKY, 2003, ENDOCRINOLOGY, V144, P2141, DOI 10.1210/en.2002-221035; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Wong CH, 2005, ENDOCRINOLOGY, V146, P1192, DOI 10.1210/en.2004-1275; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zhang JY, 2005, ENDOCRINOLOGY, V146, P1268, DOI 10.1210/en.2004-1194; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	51	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28306	10.1371/journal.pone.0028306	http://dx.doi.org/10.1371/journal.pone.0028306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145035	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900018
J	McFarlane, R; Becker, N; Field, H				McFarlane, Rosemary; Becker, Niels; Field, Hume			Investigation of the Climatic and Environmental Context of Hendra Virus Spillover Events 1994-2010	PLOS ONE			English	Article							SUSCEPTIBILITY; SEASONALITY; INFECTION; LANDSCAPE; DYNAMICS; DRIVEN; BATS	Hendra virus is a recently emerged bat-borne zoonotic agent with high lethality in horses and humans in Australia. This is a rare disease and the determinants of bat to horse transmission, including the factors that bring these hosts together at critical times, are poorly understood. In this cross-disciplinary study climatic and vegetation primary productivity variables are compared for the dispersed and heterogenic 1994-2010 outbreak sites. The significant occurrence of spillover events within the dry season (p = 0.013, 95% CI (0.57-0.98)) suggests seasonal forcing of transmission across species, or seasonal forcing of virus excretion by the reservoir host. We explore the evidence for both. Preliminary investigations of the spatial determinants of Hendra disease locations are also presented. We find that postal areas in the Australian state of Queensland in which pteropid fruit bat (flying fox) roosts occur are approximately forty times more likely (OR = 40.5, (95% CI (5.16, 317.52)) to be the location of Hendra spillover events. This appears to be independent of density of horses at these locations. We consider issues of scale of host resource use, land use change and limitations of existing data that challenge analysis and limit further conclusive outcomes. This investigation of a broad range of potential climatic and environmental influences provides a good base for future investigations. Further understanding of cross-species Hendra virus transmission requires better understanding of flying fox resource use in the urban-rural landscape.	[McFarlane, Rosemary; Becker, Niels] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Field, Hume] Biosecur Queensland DEEDI, Queensland Ctr Emerging Infect Dis, Brisbane, Qld, Australia	Australian National University	McFarlane, R (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	romcfarlane@gmail.com		McFarlane, Rosemary/0000-0001-8859-3776	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases	Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was funded by the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases (http://www.abcrc.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Berry S, 2010, GREEN CARBON: THE ROLE OF NATURAL FORESTS IN CARBON STORAGE, PT 2: BIOMASS CARBON STOCKS IN THE GREAT WESTERN WOODLANDS, P1; BiosecurityQueensland, 2011, GUID VET HANDL POT H; Daszak P, 2006, DIS ECOLOGY COMMUNIT; *DEP ENV WAT RES, 2007, AUSTR NAT VEG SUMM A; Donohue RJ, 2008, REMOTE SENS ENVIRON, V112, P2938, DOI 10.1016/j.rse.2008.02.008; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Field H., 2005, ECOLOGY HENDRA VIRUS; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K., 1996, Communicable Diseases Intelligence, V20, P476; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Kausrud KL, 2007, P ROY SOC B-BIOL SCI, V274, P1963, DOI 10.1098/rspb.2007.0568; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Langlois JP, 2001, LANDSCAPE ECOL, V16, P255, DOI 10.1023/A:1011148316537; Lee PF, 2004, J BIOGEOGR, V31, P307, DOI 10.1046/j.0305-0270.2003.00988.x; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Pinzon JE, 2004, AM J TROP MED HYG, V71, P664, DOI 10.4269/ajtmh.2004.71.664; Plowright R, 2008, FRONT ECOL ENV, V6; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Relman DA, 2008, CLIMATE ECOLOGY INFE, P104; Sergeant E.S.G., 2018, EPITOOLS EPIDEMIOLOG; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; Tucker C, 2002, EBOLA OUTBREAKS PHOT, V68; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364	35	32	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28374	10.1371/journal.pone.0028374	http://dx.doi.org/10.1371/journal.pone.0028374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145039	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000298168900022
J	Pilotte, J; Dupont-Versteegden, EE; Vanderklish, PW				Pilotte, Julie; Dupont-Versteegden, Esther E.; Vanderklish, Peter W.			Widespread Regulation of miRNA Biogenesis at the Dicer Step by the Cold-Inducible RNA-Binding Protein, RBM3	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MICRORNA BIOGENESIS; LET-7 MICRORNA; POSTTRANSCRIPTIONAL REGULATION; THERAPEUTIC HYPOTHERMIA; MESSENGER-RNA; HNRNP A1; EXPRESSION; GENES; CELLS	MicroRNAs (miRNAs) play critical roles in diverse cellular events through their effects on translation. Emerging data suggest that modulation of miRNA biogenesis at post-transcriptional steps by RNA-binding proteins is a key point of regulatory control over the expression of some miRNAs and the cellular processes they influence. However, the extent and conditions under which the miRNA pathway is amenable to regulation at posttranscriptional steps are poorly understood. Here we show that RBM3, a cold-inducible, developmentally regulated RNA-binding protein and putative protooncogene, is an essential regulator of miRNA biogenesis. Utilizing miRNA array, Northern blot, and PCR methods, we observed that over 60% of miRNAs detectable in a neuronal cell line were significantly downregulated by knockdown of RBM3. Conversely, for select miRNAs assayed by Northern blot, induction of RBM3 by overexpression or mild hypothermia increased their levels. Changes in miRNA expression were accompanied by changes in the levels of their similar to 70 nt precursors, whereas primary transcript levels were unaffected. Mechanistic studies revealed that knockdown of RBM3 does not reduce Dicer activity or impede transport of pre-miRNAs into the cytoplasm. Rather, we find that RBM3 binds directly to similar to 70 nt pre-miRNA intermediates and promotes / de-represses their ability as larger ribonucleoproteins (pre-miRNPs) to associate with active Dicer complexes. Our findings suggest that the processing of a majority of pre-miRNPs by Dicer is subject to an intrinsic inhibitory influence that is overcome by RBM3 expression. RBM3 may thus orchestrate changes in miRNA expression during hypothermia and other cellular stresses, and in the euthermic contexts of early development, differentiation, and oncogenesis where RBM3 expression is highly elevated. Additionally, our data suggest that temperature-dependent changes in miRNA expression mediated by RBM3 may contribute to the therapeutic effects of hypothermia, and are an important variable to consider in in vitro studies of translation-dependent cellular events.	[Pilotte, Julie; Vanderklish, Peter W.] Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; [Dupont-Versteegden, Esther E.] Univ Kentucky, Dept Rehabil Sci, Coll Hlth Sci, Lexington, KY USA	Scripps Research Institute; University of Kentucky	Pilotte, J (corresponding author), Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA.	pvanderk@scripps.edu			NINDS [R01NS066053]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066053] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from NINDS (R01NS066053) to P. W. V. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dietrich WD, 2009, CRIT CARE MED, V37, pS238, DOI 10.1097/CCM.0b013e3181aa5d85; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Ferry AL, 2011, J CELL PHYS IN PRESS, DOI 0.1152/ajpcell.00098.2011; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Nodin B, 2011, TRANSL ONCOL, V4, P212; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pilotte J, 2009, BRAIN RES, V1258, P12, DOI 10.1016/j.brainres.2008.12.050; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Smyth GK, 2003, METHODS SELECTING CA, P265; Sureban SM, 2008, ONCOGENE, V27, P4544, DOI 10.1038/onc.2008.97; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YH, 2001, PROC SPIE, V4266, P141, DOI 10.1117/12.427982; Zeng Y, 2009, J CELL BIOCHEM, V107, P179, DOI 10.1002/jcb.22114	53	60	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28446	10.1371/journal.pone.0028446	http://dx.doi.org/10.1371/journal.pone.0028446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145045	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168900028
J	Chowda-Reddy, RV; Sun, HY; Hill, JH; Poysa, V; Wang, AM				Chowda-Reddy, R. V.; Sun, Haiyue; Hill, John H.; Poysa, Vaino; Wang, Aiming			Simultaneous Mutations in Multi-Viral Proteins Are Required for Soybean mosaic virus to Gain Virulence on Soybean Genotypes Carrying Different R Genes	PLOS ONE			English	Article							SILENCING SUPPRESSION ACTIVITY; HELPER COMPONENT PROTEINASE; LONG-DISTANCE MOVEMENT; RESISTANCE GENE; P3 PROTEIN; ELICITOR FUNCTION; CI PROTEIN; CELL-DEATH; POTYVIRUS; GENOME	Background: Genetic resistance is the most effective and sustainable approach to the control of plant pathogens that are a major constraint to agriculture worldwide. In soybean, three dominant R genes, i.e., Rsv1, Rsv3 and Rsv4, have been identified and deployed against Soybean mosaic virus (SMV) with strain-specificities. Molecular identification of virulent determinants of SMV on these resistance genes will provide essential information for the proper utilization of these resistance genes to protect soybean against SMV, and advance knowledge of virus-host interactions in general. Methodology/Principal Findings: To study the gain and loss of SMV virulence on all the three resistance loci, SMV strains G7 and two G2 isolates L and LRB were used as parental viruses. SMV chimeras and mutants were created by partial genome swapping and point mutagenesis and then assessed for virulence on soybean cultivars PI96983 (Rsv1), L-29 (Rsv3), V94-5152 (Rsv4) and Williams 82 (rsv). It was found that P3 played an essential role in virulence determination on all three resistance loci and CI was required for virulence on Rsv1- and Rsv3-genotype soybeans. In addition, essential mutations in HC-Pro were also required for the gain of virulence on Rsv1-genotype soybean. To our best knowledge, this is the first report that CI and P3 are involved in virulence on Rsv1- and Rsv3-mediated resistance, respectively. Conclusions/Significance: Multiple viral proteins, i.e., HC-Pro, P3 and CI, are involved in virulence on the three resistance loci and simultaneous mutations at essential positions of different viral proteins are required for an avirulent SMV strain to gain virulence on all three resistance loci. The likelihood of such mutations occurring naturally and concurrently on multiple viral proteins is low. Thus, incorporation of all three resistance genes in a soybean cultivar through gene pyramiding may provide durable resistance to SMV.	[Chowda-Reddy, R. V.; Sun, Haiyue; Wang, Aiming] Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON, Canada; [Chowda-Reddy, R. V.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Hill, John H.] Iowa State Univ, Dept Plant Pathol, Ames, IA USA; [Poysa, Vaino] Agr & Agri Food Canada, Greenhouse & Proc Crops Res Ctr, Harrow, ON, Canada	Agriculture & Agri Food Canada; Western University (University of Western Ontario); Iowa State University; Agriculture & Agri Food Canada	Chowda-Reddy, RV (corresponding author), Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON, Canada.	Aiming.Wang@AGR.GC.CA			AAFC Canadian Crop Genomics Initiative; Grain Farmers of Ontario; Natural Sciences and Engineering Research Council of Canada	AAFC Canadian Crop Genomics Initiative(Agriculture & Agri Food Canada); Grain Farmers of Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by AAFC Canadian Crop Genomics Initiative, a research grant from Grain Farmers of Ontario, and a discover grant from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Razzak A, 2009, MOL PLANT PATHOL, V10, P109, DOI 10.1111/j.1364-3703.2008.00513.x; Agudelo-Romero P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002397; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Blanc S, 1997, VIROLOGY, V231, P141, DOI 10.1006/viro.1997.8521; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; BUSS GR, 1999, P WORLD SOYB RES C C; Carrington JC, 1998, PLANT J, V14, P393, DOI 10.1046/j.1365-313X.1998.00120.x; CHO EK, 1979, PHYTOPATHOLOGY, V69, P467, DOI 10.1094/Phyto-69-467; Choi BK, 2005, VIRUS RES, V112, P42, DOI 10.1016/j.virusres.2005.03.020; Chowda-Reddy RV, 2011, MOL PLANT MICROBE IN, V24, P37, DOI 10.1094/MPMI-07-10-0158; Chu MH, 1997, MOL PLANT MICROBE IN, V10, P472, DOI 10.1094/MPMI.1997.10.4.472; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Cui XY, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P335; Cui XY, 2010, VIROLOGY, V397, P56, DOI 10.1016/j.virol.2009.11.015; CULVER JN, 1991, ANNU REV PHYTOPATHOL, V29, P193, DOI 10.1146/annurev.py.29.090191.001205; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Dodds PN, 2010, SCIENCE, V330, P1486, DOI 10.1126/science.1200245; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Eggenberger AL, 2008, MOL PLANT MICROBE IN, V21, P931, DOI 10.1094/MPMI-21-7-0931; GACIAARENAL F, 2003, INT MICROBIOL, V6, P225; Gagarinova AG, 2008, VIRUS RES, V138, P50, DOI 10.1016/j.virusres.2008.08.010; Gore MA, 2002, GENOME, V45, P592, DOI 10.1139/G02-009; Gunduz I, 2004, PHYTOPATHOLOGY, V94, P687, DOI 10.1094/PHYTO.2004.94.7.687; Gunduz I, 2002, CROP SCI, V42, P90, DOI 10.2135/cropsci2002.0090; Hajimorad MR, 2008, MOL PLANT MICROBE IN, V21, P937, DOI 10.1094/MPMI-21-7-0937; Hajimorad MR, 2011, J VIROL, V85, P2557, DOI 10.1128/JVI.01935-10; Hajimorad MR, 2006, VIROLOGY, V345, P156, DOI 10.1016/j.virol.2005.09.055; Hajimorad MR, 2005, J VIROL, V79, P1215, DOI 10.1128/JVI.79.2.1215-1222.2005; Hajimorad MR, 2003, VIROLOGY, V314, P497, DOI 10.1016/S0042-6822(03)00456-2; Hajimorad MR, 2001, MOL PLANT MICROBE IN, V14, P587, DOI 10.1094/MPMI.2001.14.5.587; Hayes AJ, 2000, CROP SCI, V40, P1434, DOI 10.2135/cropsci2000.4051434x; Hjulsager CK, 2006, VIROLOGY, V355, P52, DOI 10.1016/j.virol.2006.07.016; Janzac B, 2009, MOL PLANT PATHOL, V10, P599, DOI [10.1111/j.1364-3703.2009.00554.x, 10.1111/J.1364-3703.2009.00554.X]; Jenner CE, 2003, MOL PLANT MICROBE IN, V16, P777, DOI 10.1094/MPMI.2003.16.9.777; Jenner CE, 2002, VIROLOGY, V300, P50, DOI 10.1006/viro.2002.1519; Jenner CE, 2000, MOL PLANT MICROBE IN, V13, P1102, DOI 10.1094/MPMI.2000.13.10.1102; Jeong SC, 2002, CROP SCI, V42, P265, DOI 10.2135/cropsci2002.0265; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kasschau KD, 2001, VIROLOGY, V285, P71, DOI 10.1006/viro.2001.0901; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kekarainen T, 2002, GENOME RES, V12, P584, DOI 10.1101/gr.220702; Kim BM, 2010, MOL PLANT MICROBE IN, V23, P144, DOI 10.1094/MPMI-23-2-0144; Kim YH, 2003, PLANT DIS, V87, P1372, DOI 10.1094/PDIS.2003.87.11.1372; KLEIN PG, 1994, VIROLOGY, V204, P759, DOI 10.1006/viro.1994.1591; Liao L, 2002, J HERED, V93, P447, DOI 10.1093/jhered/93.6.447; Malpica JM, 2002, GENETICS, V162, P1505; Maroof MAS, 2010, PLANT GENOME-US, V3, P14, DOI 10.3835/plantgenome2009.07.0020; Merits A, 1999, VIROLOGY, V263, P15, DOI 10.1006/viro.1999.9926; Montarry J, 2011, MOL PLANT PATHOL, V12, P911, DOI [10.1111/J.1364-3703.2011.00724.X, 10.1111/j.1364-3703.2011.00724.x]; Moury B, 2011, MOL PLANT MICROBE IN, V24, P787, DOI 10.1094/MPMI-10-10-0246; Saenz P, 2002, J VIROL, V76, P1922, DOI 10.1128/JVI.76.4.1922-1931.2002; Seo JK, 2011, ARCH VIROL, V156, P135, DOI 10.1007/s00705-010-0829-3; Seo JK, 2009, VIROLOGY, V393, P91, DOI 10.1016/j.virol.2009.07.007; Seo JK, 2009, MOL PLANT MICROBE IN, V22, P1151, DOI 10.1094/MPMI-22-9-1151; Shiboleth YM, 2007, J VIROL, V81, P13135, DOI 10.1128/JVI.01031-07; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Torres-Barcelo C, 2008, GENETICS, V180, P1039, DOI 10.1534/genetics.108.091363; Tromas N, 2010, GENETICS, V185, P983, DOI 10.1534/genetics.110.115915; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Wei TY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000962; Wen RH, 2011, MOL PLANT PATHOL, V12, P799, DOI [10.1111/J.1364-3703.2011.00714.X, 10.1111/j.1364-3703.2011.00714.x]; Yambao MLM, 2008, ARCH VIROL, V153, P105, DOI 10.1007/s00705-007-1073-3; Zhang CQ, 2009, VIROLOGY, V391, P240, DOI 10.1016/j.virol.2009.06.020; Zheng C, 2005, CROP SCI, V45, P2503, DOI 10.2135/cropsci2005.0114	65	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28342	10.1371/journal.pone.0028342	http://dx.doi.org/10.1371/journal.pone.0028342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140577	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100065
J	Diotel, N; Servili, A; Gueguen, MM; Mironov, S; Pellegrini, E; Vaillant, C; Zhu, Y; Kah, O; Anglade, I				Diotel, Nicolas; Servili, Arianna; Gueguen, Marie-Madeleine; Mironov, Svetlana; Pellegrini, Elisabeth; Vaillant, Colette; Zhu, Yong; Kah, Olivier; Anglade, Isabelle			Nuclear Progesterone Receptors Are Up-Regulated by Estrogens in Neurons and Radial Glial Progenitors in the Brain of Zebrafish	PLOS ONE			English	Article							STEROID-HORMONE RECEPTORS; DEVELOPING PURKINJE-CELL; SYNTHESIZED DE-NOVO; NEURAL STEM-CELLS; ADULT MALE-MICE; CEREBRAL-CORTEX; VENTRICULAR ZONE; NEWBORN NEURONS; NERVOUS-SYSTEM; MESSENGER-RNA	In rodents, there is increasing evidence that nuclear progesterone receptors are transiently expressed in many regions of the developing brain, notably outside the hypothalamus. This suggests that progesterone and/or its metabolites could be involved in functions not related to reproduction, particularly in neurodevelopment. In this context, the adult fish brain is of particular interest, as it exhibits constant growth and high neurogenic activity that is supported by radial glia progenitors. However, although synthesis of neuroprogestagens has been documented recently in the brain of zebrafish, information on the presence of progesterone receptors is very limited. In zebrafish, a single nuclear progesterone receptor (pgr) has been cloned and characterized. Here, we demonstrate that this pgr is widely distributed in all regions of the zebrafish brain. Interestingly, we show that Pgr is strongly expressed in radial glial cells and more weakly in neurons. Finally, we present evidence, based on quantitative PCR and immunohistochemistry, that nuclear progesterone receptor mRNA and proteins are upregulated by estrogens in the brain of adult zebrafish. These data document for the first time the finding that radial glial cells are preferential targets for peripheral progestagens and/or neuroprogestagens. Given the crucial roles of radial glial cells in adult neurogenesis, the potential effects of progestagens on their activity and the fate of daughter cells require thorough investigation.	[Diotel, Nicolas; Servili, Arianna; Gueguen, Marie-Madeleine; Mironov, Svetlana; Pellegrini, Elisabeth; Vaillant, Colette; Kah, Olivier; Anglade, Isabelle] Univ Rennes 1, CNRS, UMR 6026, IFR140, Rennes, France; [Zhu, Yong] E Carolina Univ, Dept Biol, Greenville, NC USA	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; University of North Carolina; East Carolina University	Diotel, N (corresponding author), Univ Rennes 1, CNRS, UMR 6026, IFR140, Rennes, France.	olivier.kah@univ-rennes1.fr	Vaillant-Capitaine, Colette CVC/K-1734-2015; Pellegrini, Elisabeth/K-1705-2015; GUEGUEN, marie madeleine/K-1731-2015; Diotel, Nicolas/Y-1126-2019; kah, olivier/K-7624-2012	Pellegrini, Elisabeth/0000-0003-4821-0966; Diotel, Nicolas/0000-0003-2032-518X; Servili, Arianna/0000-0002-6813-7500; Zhu, Yong/0000-0003-0374-485X	ANR [CES 2008-011]; Post-Grenelle de l'Environnement NEMO;  [222719]	ANR(French National Research Agency (ANR)); Post-Grenelle de l'Environnement NEMO; 	The study was funded by the European project no 222719 (LIFECYCLE to OK), the ANR NEED (CES 2008-011), the Post-Grenelle de l'Environnement NEMO to OK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; BARHA CK, 2011, EXP NEUROL; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Chen SX, 2010, BIOL REPROD, V82, P171, DOI 10.1095/biolreprod.109.077644; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Costa MR, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00026; Costa MR, 2010, BRAIN RES REV, V63, P47, DOI 10.1016/j.brainresrev.2010.01.002; DIOTEL N, 2011, EUR J NEUROSCI; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; DULKA JG, 1993, BRAIN BEHAV EVOLUT, V42, P265, DOI 10.1159/000114166; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; GRONEMEYER H, 1987, EMBO J, V6, P3985, DOI 10.1002/j.1460-2075.1987.tb02741.x; Hanna RN, 2010, BIOL REPROD, V82, P112, DOI 10.1095/biolreprod.109.078527; Hawkins MB, 2005, P ROY SOC B-BIOL SCI, V272, P633, DOI 10.1098/rspb.2004.3008; JIANG R, 2011, J NEUROTRAUMA; Jung-Testas I, 1998, J STEROID BIOCHEM, V65, P243, DOI 10.1016/S0960-0760(97)00191-X; Jung-Testas I, 1999, J STEROID BIOCHEM, V69, P97, DOI 10.1016/S0960-0760(98)00149-6; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kudwa AE, 2009, PHYSIOL BEHAV, V97, P146, DOI 10.1016/j.physbeh.2009.02.023; Kudwa AE, 2004, ENDOCRINOLOGY, V145, P4500, DOI 10.1210/en.2003-1708; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Labombarda F, 2010, NEUROSCIENCE, V166, P94, DOI 10.1016/j.neuroscience.2009.12.012; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Le Page Y, 2010, EUR J NEUROSCI, V32, P2105, DOI 10.1111/j.1460-9568.2010.07519.x; Liu LF, 2010, ENDOCRINOLOGY, V151, P5782, DOI 10.1210/en.2010-0005; Lonstein JS, 2004, J NEUROENDOCRINOL, V16, P534, DOI 10.1111/j.1365-2826.2004.01198.x; Lopez V, 2009, J COMP NEUROL, V512, P124, DOI 10.1002/cne.21883; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; McCarthy MM, 2009, NEUROSCIENTIST, V15, P599, DOI 10.1177/1073858409340924; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Menuet A, 2003, J COMP NEUROL, V462, P180, DOI 10.1002/cne.10726; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Micevych P, 2008, MOL CELL ENDOCRINOL, V290, P44, DOI 10.1016/j.mce.2008.04.016; Micevych P, 2010, NEUROENDOCRINOLOGY, V91, P211, DOI 10.1159/000289568; Micevych PE, 2007, ENDOCRINOLOGY, V148, P782, DOI 10.1210/en.2006-0774; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Mouriec K, 2008, BRAIN RES BULL, V75, P274, DOI 10.1016/j.brainresbull.2007.10.030; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pluchino N, 2009, MATURITAS, V62, P349, DOI 10.1016/j.maturitas.2008.11.023; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; RAKIC P, 1978, POSTGRAD MED J, V54, P25; ROTHENAIGNER I, 2011, DEVELOPMENT; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sakamoto H, 2002, NEUROSCI LETT, V322, P111, DOI 10.1016/S0304-3940(02)00077-0; Sakamoto H, 2001, J COMP NEUROL, V439, P291, DOI 10.1002/cne.1351; Sakamoto H, 2001, J NEUROSCI, V21, P6221, DOI 10.1523/JNEUROSCI.21-16-06221.2001; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHMECHEL DE, 1979, NATURE, V277, P303, DOI 10.1038/277303a0; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; STACEY NE, 1989, GEN COMP ENDOCR, V75, P62, DOI 10.1016/0016-6480(89)90008-7; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tsutsui K, 1999, INT J MOL MED, V4, P49; Tsutsui K, 1999, COMP BIOCHEM PHYS C, V124, P121, DOI 10.1016/S0742-8413(99)00065-1; Vicent GP, 2008, J STEROID BIOCHEM, V109, P344, DOI 10.1016/j.jsbmb.2008.03.015; Vicent GP, 2006, ANN NY ACAD SCI, V1089, P59, DOI 10.1196/annals.1386.025; Wagner CK, 2001, J NEUROBIOL, V47, P176, DOI 10.1002/neu.1025; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Zhang Z, 2010, NEUROPHARMACOLOGY, V58, P930, DOI 10.1016/j.neuropharm.2010.01.002; Zhang Z, 2010, HIPPOCAMPUS, V20, P402, DOI 10.1002/hipo.20642; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	79	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28375	10.1371/journal.pone.0028375	http://dx.doi.org/10.1371/journal.pone.0028375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140581	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100067
J	Hernandez, JG; Sunden, F; Connolly, J; Svanborg, C; Wullt, B				Hernandez, Jenny Gronberg; Sunden, Fredrik; Connolly, John; Svanborg, Catharina; Wullt, Bjorn			Genetic Control of the Variable Innate Immune Response to Asymptomatic Bacteriuria	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; GRAM-NEGATIVE INFECTION; ACUTE PYELONEPHRITIS; ESCHERICHIA-COLI; INTERLEUKIN-6 RESPONSE; CHILDREN; SUSCEPTIBILITY; CYSTITIS; CHILDHOOD; RECEPTORS	The severity of urinary tract infection (UTI) reflects the quality and magnitude of the host response. While strong local and systemic innate immune activation occurs in patients with acute pyelonephritis, the response to asymptomatic bacteriuria (ABU) is low. The immune response repertoire in ABU has not been characterized, due to the inherent problem to distinguish bacterial differences from host-determined variation. In this study, we investigated the host response to ABU and genetic variants affecting innate immune signaling and UTI susceptibility. Patients were subjected to therapeutic urinary tract inoculation with E. coli 83972 to ensure that they were exposed to the same E. coli strain. The innate immune response repertoire was characterized in urine samples, collected from each patient before and after inoculation with bacteria or PBS, if during the placebo arm of the study. Long-term E. coli 83972 ABU was established in 23 participants, who were followed for up to twelve months and the innate immune response was quantified in 233 urine samples. Neutrophil numbers increased in all but two patients and in an extended urine cytokine/chemokine analysis (31 proteins), the chemoattractants IL-8 and GRO-alpha, RANTES, Eotaxin-1 and MCP-1, the T cell chemoattractant and antibacterial peptide IP-10, inflammatory regulators IL-1-alpha and sIL-1RA and the T lymphocyte/dendritic cell product sIL-2R alpha were detected and variably increased, compared to sterile samples. IL-6, which is associated with symptomatic UTI, remained low and numerous specific immune mediators were not detected. The patients were also genotyped for UTI-associated IRF3 and TLR4 promoter polymorphisms. Patients with ABU associated TLR4 polymorphisms had low neutrophil numbers, IL-6, IP-10, MCP-1 and sIL-2R alpha concentrations. Patients with the ABU-associated IRF3 genotype had lower neutrophils, IL-6 and MCP-1 responses than the remaining group. The results suggest that the host-specific, low immune response to ABU mainly includes innate immune mediators and that host genetics directly influence the magnitude of this response.	[Hernandez, Jenny Gronberg; Svanborg, Catharina; Wullt, Bjorn] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Sunden, Fredrik] Skane Univ Hosp, Dept Urol, Malmo, Sweden; [Connolly, John] ASTAR, Inst Biomed Sci, Singapore Immunol Network SIgN, Singapore, Singapore	Lund University; Lund University; Skane University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Hernandez, JG (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	catharina.svanborg@med.lu.se			Swedish Medical Research Council [2010 3070]; Crafoord Foundation; Wallenberg Foundation; Lundberg Foundation; Osterlund Foundation; Royal Physiographic Society; Foundation of Gosta Jonsson; Foundation of Hillevi Fries; Foundation of Per-Olof Strom; Foundation of Greta Ekholm, Lund, Sweden; Coloplast, Copenhagen, Denmark; Riksforbundet for Trafik och Polioskadade; Swedish Strategic Programme Against Antibiotic Resistance (STRAMA); Region Skane's FoU	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoord Foundation; Wallenberg Foundation(European Commission); Lundberg Foundation(European Commission); Osterlund Foundation; Royal Physiographic Society; Foundation of Gosta Jonsson; Foundation of Hillevi Fries; Foundation of Per-Olof Strom; Foundation of Greta Ekholm, Lund, Sweden; Coloplast, Copenhagen, Denmark; Riksforbundet for Trafik och Polioskadade; Swedish Strategic Programme Against Antibiotic Resistance (STRAMA); Region Skane's FoU	The studies were supported by grants from the Swedish Medical Research Council (2010 3070), the Crafoord, Wallenberg and Lundberg Foundations, the Osterlund Foundation and the Royal Physiographic Society. Furthermore, the inoculation study was supported by the Foundations of Gosta Jonsson, Hillevi Fries, Per-Olof Strom and Greta Ekholm, Lund, Sweden; Coloplast, Copenhagen, Denmark; Riksforbundet for Trafik och Polioskadade; the Swedish Strategic Programme Against Antibiotic Resistance (STRAMA) and by Region Skane's FoU grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGACE WW, 1993, J CLIN INVEST, V92, P780, DOI 10.1172/JCI116650; Akahoshi M, 2008, LUPUS, V17, P568, DOI 10.1177/0961203308089340; Benson M, 1996, J INFECT DIS, V174, P1080, DOI 10.1093/infdis/174.5.1080; BENSON M, 1994, PEDIATR INFECT DIS J, V13, P612, DOI 10.1097/00006454-199407000-00006; Candela JV, 1998, UROL RES, V26, P175, DOI 10.1007/s002400050043; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Ciszek M, 2006, TRANSPLANTATION, V81, P1653, DOI 10.1097/01.tp.0000226072.20185.f8; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Davidoff R, 1997, J UROLOGY, V157, P1980, DOI 10.1016/S0022-5347(01)64914-0; DEMAN P, 1991, J INFECT DIS, V163, P331, DOI 10.1093/infdis/163.2.331; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; EDEN CS, 1976, LANCET, V2, P490; Fischer H, 2006, EUR J IMMUNOL, V36, P267, DOI 10.1002/eji.200535149; Fischer H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001109; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hansson S, 1997, INFECT DIS CLIN N AM, V11, P499, DOI 10.1016/S0891-5520(05)70370-6; HANSSON S, 1990, J UROLOGY, V143, P330, DOI 10.1016/S0022-5347(17)39950-0; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008300; HEDGES S, 1992, J INFECT DIS, V166, P653, DOI 10.1093/infdis/166.3.653; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; HOPP TP, 1986, IMMUNOL RES, V5, P271, DOI 10.1007/BF02935500; Jennette JC, 2007, HEPTINSTALLS PATHOLO; Klemm P, 2006, INFECT IMMUN, V74, P781, DOI 10.1128/IAI.74.1.781-785.2006; KO YC, 1993, INFECT IMMUN, V61, P1307, DOI 10.1128/IAI.61.4.1307-1314.1993; Kunin CM, 1997, URINARY TRACT INFECT; LINDBERG U, 1975, ACTA PAEDIATR SCAND, V64, P425, DOI 10.1111/j.1651-2227.1975.tb03859.x; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Nanda N, 2009, BIOMARK INSIGHTS, V4, P111; Olszyna DP, 2000, J INFECT DIS, V182, P1731, DOI 10.1086/317603; Otto G, 2005, KIDNEY INT, V68, P62, DOI 10.1111/j.1523-1755.2005.00381.x; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; PLOS K, 1995, J INFECT DIS, V171, P625, DOI 10.1093/infdis/171.3.625; Ragnarsdottir B, 2008, EUR J CLIN INVEST, V38, P12, DOI 10.1111/j.1365-2362.2008.02004.x; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; Ragnarsdottir B, 2011, NAT REV UROL, V8, P449, DOI 10.1038/nrurol.2011.100; Ragnarsdottir B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010734; Rodhe N, 2009, SCAND J PRIM HEALTH, V27, P74, DOI 10.1080/02813430902757634; Rozsai B, 2006, PEDIATR DIABETES, V7, P153, DOI 10.1111/j.1399-543X.2006.00161.x; RUBIN LA, 1985, J IMMUNOL, V135, P3172; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Silver SA, 2009, CAN J INFECT DIS MED, V20, P107, DOI 10.1155/2009/702545; Sunden F, 2010, J UROLOGY, V184, P179, DOI 10.1016/j.juro.2010.03.024; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Tullus K, 1996, ACTA PAEDIATR, V85, P158, DOI 10.1111/j.1651-2227.1996.tb13984.x; Zdziarski J, 2008, INFECT IMMUN, V76, P695, DOI 10.1128/IAI.01215-07	46	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28289	10.1371/journal.pone.0028289	http://dx.doi.org/10.1371/journal.pone.0028289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140570	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400042
J	Dirkx, E; Schwenk, RW; Coumans, WA; Hoebers, N; Angin, Y; Viollet, B; Bonen, A; van Eys, GJJM; Glatz, JFC; Luiken, JJFP				Dirkx, Ellen; Schwenk, Robert W.; Coumans, Will A.; Hoebers, Nicole; Angin, Yeliz; Viollet, Benoit; Bonen, Arend; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.			Protein Kinase D1 Is Essential for Contraction-induced Glucose Uptake but Is Not Involved in Fatty Acid Uptake into Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSIVE FUNCTIONS; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; CARDIAC MYOCYTES; OXIDATIVE STRESS; INSULIN; AMPK; ACTIVATION; TRANSPORT; ROS	Increased contraction enhances substrate uptake into cardiomyocytes via translocation of the glucose transporter GLUT4 and the long chain fatty acid (LCFA) transporter CD36 from intracellular stores to the sarcolemma. Additionally, contraction activates the signaling enzymes AMP-activated protein kinase (AMPK) and protein kinase D1 (PKD1). Although AMPK has been implicated in contraction-induced GLUT4 and CD36 translocation in cardiomyocytes, the precise role of PKD1 in these processes is not known. To study this, we triggered contractions in cardiomyocytes by electric field stimulation (EFS). First, the role of PKD1 in GLUT4 and CD36 translocation was defined. In PKD1 siRNA-treated cardiomyocytes as well as cardiomyocytes from PKD1 knock-out mice, EFS-induced translocation of GLUT4, but not CD36, was abolished. In AMPK siRNA-treated cardiomyocytes and cardiomyocytes from AMPK alpha 2 knock-out mice, both GLUT4 and CD36 translocation were abrogated. Hence, unlike AMPK, PKD1 is selectively involved in glucose uptake. Second, we analyzed upstream factors in PKD1 activation. Cardiomyocyte contractions enhanced reactive oxygen species (ROS) production. Using ROS scavengers, we found that PKD1 signaling and glucose uptake are more sensitive to changes in intracellular ROS than AMPK signaling or LCFA uptake. Furthermore, silencing of death-activated protein kinase (DAPK) abrogated EFS-induced GLUT4 but not CD36 translocation. Finally, possible links between PKD1 and AMPK signaling were investigated. PKD1 silencing did not affect AMPK activation. Reciprocally, AMPK silencing did not alter PKD1 activation. In conclusion, we present a novel contraction-induced ROS-DAPK-PKD1 pathway in cardiomyocytes. This pathway is activated separately from AMPK and mediates GLUT4 translocation/glucose uptake, but not CD36 translocation/LCFA uptake.	[Dirkx, Ellen; Schwenk, Robert W.; Coumans, Will A.; Hoebers, Nicole; Angin, Yeliz; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Dirkx, Ellen; Schwenk, Robert W.; Coumans, Will A.; Hoebers, Nicole; Angin, Yeliz; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Viollet, Benoit] Univ Paris 05, Inst Cochin, INSERM, CNRS,U1016,UMR 8104, F-75014 Paris, France; [Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Coll Biol Sci, Guelph, ON N1G 2W1, Canada	Maastricht University; Maastricht University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Guelph	Luiken, JJFP (corresponding author), POB 616, NL-6200 MD Maastricht, Netherlands.	j.luiken@maastrichtuniversity.nl	Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	Transnational University Limburg; European Community [LSHM-CT-2004-005272]	Transnational University Limburg; European Community(European Commission)	This work was supported by the Transnational University Limburg and European Community Integrated Project LSHM-CT-2004-005272 (Exgenesis).	De Giusti VC, 2009, J MOL CELL CARDIOL, V47, P716, DOI 10.1016/j.yjmcc.2009.07.023; Eisenberg-Lerner A, 2007, CELL DEATH DIFFER, V14, P1908, DOI 10.1038/sj.cdd.4402212; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Ghanekar Y, 2005, NAT CELL BIOL, V7, P851, DOI 10.1038/ncb0905-851; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Habets DDJ, 2009, BBA-MOL CELL BIOL L, V1791, P212, DOI 10.1016/j.bbalip.2008.12.009; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Heinzel FR, 2006, CARDIOVASC RES, V71, P374, DOI 10.1016/j.cardiores.2006.05.014; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lefort N, 2008, AM J PHYSIOL-ENDOC M, V295, pE1447, DOI 10.1152/ajpendo.90362.2008; Levy-Strumpf N, 1998, ONCOGENE, V17, P3331, DOI 10.1038/sj.onc.1202588; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 2008, CELL SIGNAL, V20, P543, DOI 10.1016/j.cellsig.2007.11.007; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Merry TL, 2010, AM J PHYSIOL-ENDOC M, V298, pE577, DOI 10.1152/ajpendo.00239.2009; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Ng MHL, 2002, APOPTOSIS, V7, P261, DOI 10.1023/A:1015364104672; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Smith MA, 2006, RESP PHYSIOL NEUROBI, V151, P229, DOI 10.1016/j.resp.2005.12.011; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	29	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5871	5881		10.1074/jbc.M111.281881	http://dx.doi.org/10.1074/jbc.M111.281881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22158620	Green Published, hybrid			2022-12-25	WOS:000300638000061
J	Jeziorska, DM; Koentges, G; Vance, KW				Jeziorska, Danuta M.; Koentges, Georgy; Vance, Keith W.			Novel cis-Regulatory Modules Control Expression of the Hairy and Enhancer of Split-1 (HES1) Transcription Factor in Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTIN PROMOTER; NOTCH PATHWAY; GENE HES1; FACTOR-I; CHROMOSOME CONFORMATION; NEURAL PROGENITORS; ORGAN SIZE; WRPW MOTIF; M-CAT; ACTIVATION	The expression profile of a gene is controlled by DNA sequences called cis-regulatory modules (CRMs). CRMs can function over large genomic distances and can be located many kilobases away from their target promoters. hes1 is a key developmental gene that is overexpressed in certain cancers and is a primary target of NOTCH signaling. Despite this, analysis of hes1 transcriptional control has been limited solely to its promoter. Here, we identify seven conserved DNA sequence blocks, representing the hes1 promoter and six novel CRMs, within 57 kb upstream of the mouse hes1 gene. We identify 12 binding sites for the RBP-J kappa NOTCH effector and a single M-CAT motif within these regions. We validate RBP-J kappa and TEAD family occupancy in cells in culture and test the response of each of these CRMs to active NOTCH. We show that two regions, CRM5 and CRM7, function as enhancers, and four can repress transcription. A pair of RBP-J kappa motifs arranged in a tail-tail configuration in CRM5 and the M-CAT motif in CRM7 are necessary for enhancer function. Furthermore, these enhancers are occupied by transcriptional co-activators and loop onto the hes1 promoter within the endogenous hes1 locus. This work demonstrates the power of combining computational genomics and experimental methodologies to identify novel CRMs and characterize their function.	[Vance, Keith W.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Jeziorska, Danuta M.; Koentges, Georgy; Vance, Keith W.] Univ Warwick, Sch Life Sci, Lab Genom Syst Anal, Coventry CV4 7AL, W Midlands, England	University of Oxford; University of Warwick	Vance, KW (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, S Parks Rd, Oxford OX1 3QX, England.	keith.vance@dpag.ox.ac.uk	Vance, Keith/AAK-5410-2021	Vance, Keith/0000-0002-3411-8213	Wellcome Trust [WT 066790/E/02/Z, 066745/Z/01/Z]; Human Frontier Science Program [RGP0029/2007-C]; Warwick University; MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); Warwick University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Grants WT 066790/E/02/Z and 066745/Z/01/Z, Human Frontier Science Program Grant RGP0029/2007-C (to G. K.), and a Warwick University Senior Research Fellowship (to K. W. V.).	Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Azakie A, 2005, AM J PHYSIOL-CELL PH, V289, pC1522, DOI 10.1152/ajpcell.00126.2005; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cave JW, 2005, CURR BIOL, V15, P94, DOI 10.1016/j.cub.2004.12.070; Cuevas IC, 2005, CANCER RES, V65, P5070, DOI 10.1158/0008-5472.CAN-05-0240; Curry CL, 2006, LAB INVEST, V86, P842, DOI 10.1038/labinvest.3700442; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Granier C, 2011, DEV BIOL, V349, P350, DOI 10.1016/j.ydbio.2010.10.036; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hopfer O, 2005, BRIT J CANCER, V93, P709, DOI 10.1038/sj.bjc.6602719; Hucl T, 2007, CANCER RES, V67, P9055, DOI 10.1158/0008-5472.CAN-07-0474; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Issack PS, 1998, CELL GROWTH DIFFER, V9, P827; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Morel V, 2000, GENE DEV, V14, P377; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Sanalkumar R, 2010, J NEUROCHEM, V113, P807, DOI 10.1111/j.1471-4159.2010.06574.x; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Swartz EA, 1998, AM J PHYSIOL-CELL PH, V275, pC608, DOI 10.1152/ajpcell.1998.275.2.C608; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	61	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5687	5697		10.1074/jbc.M111.286484	http://dx.doi.org/10.1074/jbc.M111.286484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22167192	Green Published, hybrid			2022-12-25	WOS:000300638000045
J	Ray, RM; Viar, MJ; Johnson, LR				Ray, Ramesh M.; Viar, Mary Jane; Johnson, Leonard R.			Amino Acids Regulate Expression of Antizyme-1 to Modulate Ornithine Decarboxylase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						f	INTESTINAL EPITHELIAL-CELLS; MESSENGER-RNA; PROTEIN-SYNTHESIS; GENE-EXPRESSION; TRANSLATION INITIATION; POLYAMINE DEPLETION; NEOPLASTIC GROWTH; RAG GTPASES; IEC-6 CELLS; INDUCTION	In a glucose-salt solution (Earle's balanced salt solution), asparagine (Asn) stimulates ornithine decarboxylase (ODC) activity in a dose-dependent manner, and the addition of epidermal growth factor (EGF) potentiates the effect of Asn. However, EGF alone fails to activate ODC. Thus, the mechanism by which Asn activates ODC is important for understanding the regulation of ODC activity. Asn reduced antizyme-1 (AZ1) mRNA and protein. Among the amino acids tested, Asn and glutamine (Gln) effectively inhibited AZ1 expression, suggesting a differential role for amino acids in the regulation of ODC activity. Asn decreased the putrescine-induced AZ1 translation. The absence of amino acids increased the binding of eukaryotic initiation factor 4E-binding protein (4EBP1) to 5'-mRNA cap and thereby inhibited global protein synthesis. Asn failed to prevent the binding of 4EBP1 to mRNA, and the bound 4EBP1 was unphosphorylated, suggesting the involvement of the mammalian target of rapamycin (mTOR) in the regulation of AZ1 synthesis. Rapamycin treatment (4 h) failed to alter the expression of AZ1. However, extending the treatment (24 h) allowed expression in the presence of amino acids, indicating that AZ1 is expressed when TORC1 signaling is decreased. This suggests the involvement of cap-independent translation. However, transient inhibition of mTORC2 by PP242 completely abolished the phosphorylation of 4EBP1 and decreased basal as well as putrescine-induced AZ1 expression. Asn decreased the phosphorylation of mTOR-Ser(2448) and AKT-Ser(473), suggesting the inhibition of mTORC2. In the absence of amino acids, mTORC1 is inhibited, whereas mTORC2 is activated, leading to the inhibition of global protein synthesis and increased AZ1 synthesis via a cap-independent mechanism.	[Ray, Ramesh M.; Viar, Mary Jane; Johnson, Leonard R.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Ray, RM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave,Nash Bldg, Memphis, TN 38163 USA.	rray3@uthsc.edu			National Institutes of Health; NIDDK [DK-16505, DK-052784, ARRA-USPHS-GR-DK052784-13S1]; Thomas A. Gerwin endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016505, R37DK016505, R01DK052784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Thomas A. Gerwin endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants DK-16505 and DK-052784 and Grant ARRA-USPHS-GR-DK052784-13S1. This work was also supported by the Thomas A. Gerwin endowment.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canellakis E S, 1979, Curr Top Cell Regul, V15, P155; CHEN KY, 1977, P NATL ACAD SCI USA, V74, P3791, DOI 10.1073/pnas.74.9.3791; CHEN ZP, 1992, J BIOL CHEM, V267, P6946; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Christian BE, 2010, BIOCHEM BIOPH RES CO, V391, P942, DOI 10.1016/j.bbrc.2009.11.169; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; ELIAS S, 1995, EUR J BIOCHEM, V229, P276, DOI 10.1111/j.1432-1033.1995.0276l.x; FAUSTO N, 1971, BIOCHIM BIOPHYS ACTA, V238, P116, DOI 10.1016/0005-2787(71)90015-3; Feith DJ, 2001, CANCER RES, V61, P6073; Fong LYY, 2003, CANCER RES, V63, P3945; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; GAZZOLA GC, 1972, BIOCHIM BIOPHYS ACTA, V266, P407, DOI 10.1016/0005-2736(72)90097-1; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Hayashi S., 1989, ORNITHINE DECARBOXYL, P35; HAYASHI SI, 1995, BIOCHEM J, V306, P1; HELLER JS, 1976, P NATL ACAD SCI USA, V73, P1858, DOI 10.1073/pnas.73.6.1858; HOLTTA E, 1993, J CELL BIOL, V122, P903, DOI 10.1083/jcb.122.4.903; HOLTTA E, 1988, J BIOL CHEM, V263, P4500; HOVIS JG, 1986, J BIOL CHEM, V261, P380; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 1998, RNA, V4, P1230, DOI 10.1017/S1355838298980864; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KITANI T, 1984, J BIOL CHEM, V259, P36; KONTULA KK, 1984, P NATL ACAD SCI-BIOL, V81, P731, DOI 10.1073/pnas.81.3.731; Kumar V, 2000, J BIOL CHEM, V275, P10779, DOI 10.1074/jbc.275.15.10779; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Lin Y, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-15; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MATSUFUJI S, 1990, J BIOCHEM-TOKYO, V108, P365, DOI 10.1093/oxfordjournals.jbchem.a123207; MAUDSLEY DV, 1976, AM J PHYSIOL, V231, P1557, DOI 10.1152/ajplegacy.1976.231.5.1557; MCCORMACK SA, 1993, AM J PHYSIOL, V264, pG367, DOI 10.1152/ajpgi.1993.264.2.G367; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; MINAMI H, 1985, J BIOCHEM-TOKYO, V98, P133, DOI 10.1093/oxfordjournals.jbchem.a135251; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; MOSHIER JA, 1993, CANCER RES, V53, P2618; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nakajo T, 2005, BIOCHEM BIOPH RES CO, V326, P174, DOI 10.1016/j.bbrc.2004.11.015; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nilsson J, 1997, EUR J BIOCHEM, V250, P223, DOI 10.1111/j.1432-1033.1997.0223a.x; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2003, BIOCHEM SOC T, V31, P356, DOI 10.1042/BST0310356; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Pham FH, 2000, CIRC RES, V86, P1252, DOI 10.1161/01.RES.86.12.1252; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Ray RM, 1999, AM J PHYSIOL-GASTR L, V276, pG773, DOI 10.1152/ajpgi.1999.276.3.G773; Ray RM, 2000, AM J PHYSIOL-CELL PH, V278, pC480, DOI 10.1152/ajpcell.2000.278.3.C480; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; RICHMAN RA, 1971, P SOC EXP BIOL MED, V138, P880; RINEHART CA, 1985, J CELL PHYSIOL, V123, P435, DOI 10.1002/jcp.1041230321; RINEHART CA, 1985, P NATL ACAD SCI USA, V82, P4365, DOI 10.1073/pnas.82.13.4365; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shantz LM, 1998, CANCER RES, V58, P2748; Shantz LM, 1996, CANCER RES, V56, P3265; Shantz LM, 1996, CANCER RES, V56, P5136; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; VICEPSMADORE D, 1982, BIOCHIM BIOPHYS ACTA, V717, P305, DOI 10.1016/0304-4165(82)90184-2; WANG JY, 1993, AM J PHYSIOL, V265, pG331, DOI 10.1152/ajpgi.1993.265.2.G331; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2003, MOL CELL BIOL, V23, P1546, DOI 10.1128/MCB.23.5.1546-1557.2003; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006	73	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3674	3690		10.1074/jbc.M111.232561	http://dx.doi.org/10.1074/jbc.M111.232561			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157018	hybrid, Green Published			2022-12-25	WOS:000300410900006
J	Sabotic, J; Bleuler-Martinez, S; Renko, M; Caglic, PA; Kallert, S; Strukelj, B; Turk, D; Aebi, M; Kos, J; Kunzler, M				Sabotic, Jerica; Bleuler-Martinez, Silvia; Renko, Miha; Caglic, Petra Avanzo; Kallert, Sandra; Strukelj, Borut; Turk, Dusan; Aebi, Markus; Kos, Janko; Kuenzler, Markus			Structural Basis of Trypsin Inhibition and Entomotoxicity of Cospin, Serine Protease Inhibitor Involved in Defense of Coprinopsis cinerea Fruiting Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSHROOM CLITOCYBE-NEBULARIS; PROTEINASE-INHIBITOR; COPRINUS-CINEREUS; INTRAMOLECULAR CHAPERONE; CAENORHABDITIS-ELEGANS; PARTIAL-PURIFICATION; CRYSTAL-STRUCTURE; HIGHER FUNGI; ENZYMES; BASIDIOMYCETE	Cospin (PIC1) from Coprinopsis cinerea is a serine protease inhibitor with biochemical properties similar to those of the previously characterized fungal serine protease inhibitors, cnispin from Clitocybe nebularis and LeSPI from Lentinus edodes, classified in the family I66 of the MEROPS protease inhibitor classification. In particular, it exhibits a highly specific inhibitory profile as a very strong inhibitor of trypsin with K-i in the picomolar range. Determination of the crystal structure revealed that the protein has a beta-trefoil fold. Site-directed mutagenesis and mass spectrometry results have confirmed Arg-27 as the reactive binding site for trypsin inhibition. The loop containing Arg-27 is positioned between the beta 2 and beta 3 strands, distinguishing cospin from other beta-trefoil-fold serine protease inhibitors in which beta 4-beta 5 or beta 5-beta 6 loops are involved in protease inhibition. Biotoxicity assays of cospin on various model organisms revealed a strong and specific entomotoxic activity against Drosophila melanogaster. The inhibitory inactive R27N mutant was not entomotoxic, associating toxicity with inhibitory activity. Along with the abundance of cospin in fruiting bodies of C. cinerea and the lack of trypsin-like proteases in the C. cinerea genome, these results suggest that cospin and its homologs are effectors of a fungal defense mechanism against fungivorous insects that function by specific inhibition of serine proteases in the insect gut.	[Sabotic, Jerica; Caglic, Petra Avanzo; Strukelj, Borut; Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia; [Renko, Miha; Turk, Dusan] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia; [Turk, Dusan] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Bleuler-Martinez, Silvia; Kallert, Sandra; Aebi, Markus; Kuenzler, Markus] Swiss Fed Inst Technol, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sabotic, J (corresponding author), Jozef Stefan Inst, Dept Biotechnol, Jamova 39, Ljubljana, Slovenia.	Jerica.Sabotic@ijs.si	Sabotič, Jerica/AAJ-5050-2021	Sabotič, Jerica/0000-0002-2404-0192; Kunzler, Markus/0000-0003-1275-0629; Turk, Dusan/0000-0003-0205-6609	Swiss National Science Foundation [31003A-130671]; ETH Zurich; Slovenian Research Agency [P4-0127, P1-0048, PR-02266]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Swiss National Science Foundation Grant 31003A-130671 (to M. K., M. O. Hengartner and M. A.), by ETH Zurich, and by Slovenian Research Agency Grants P4-0127 (to J. K.) and P1-0048 and PR-02266 (to D. T.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Avanzo P, 2009, MICROBIOL-SGM, V155, P3971, DOI 10.1099/mic.0.032805-0; Bertossa RC, 2004, FUNGAL GENET BIOL, V41, P1120, DOI 10.1016/j.fgb.2004.09.001; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BLUMBERG S, 1970, EUR J BIOCHEM, V15, P97, DOI 10.1111/j.1432-1033.1970.tb00981.x; Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721; Brzin J, 2000, J BIOL CHEM, V275, P20104, DOI 10.1074/jbc.M001392200; Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; DOHMAE N, 1995, BIOSCI BIOTECH BIOCH, V59, P2074, DOI 10.1271/bbb.59.2074; Dubovenko AG, 2010, FUNGAL BIOL-UK, V114, P151, DOI 10.1016/j.funbio.2009.11.004; Goldstein IJ, 2007, COMPREHENSIVE GLYCOS, V3, P601; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; Gzogyan LA, 2005, APPL BIOCHEM MICRO+, V41, P538, DOI 10.1007/s10438-005-0097-2; HABIB, 2007, BIOTECH MOL BIOL REV, V2, P68; Hansen D, 2007, BIOCHEM BIOPH RES CO, V360, P735, DOI 10.1016/j.bbrc.2007.06.144; Haq SK, 2004, ARCH BIOCHEM BIOPHYS, V431, P145, DOI 10.1016/j.abb.2004.07.022; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Hu G, 2004, J EVOLUTION BIOL, V17, P1204, DOI 10.1111/j.1420-9101.2004.00786.x; Kojima S, 2005, FEBS LETT, V579, P4430, DOI 10.1016/j.febslet.2005.06.083; Krivosheina N. P., 2008, ENTOMOLOGICAL REV, V88, P778, DOI DOI 10.1134/S0013873808070038; Kudryavtseva OA, 2008, MICROBIOLOGY+, V77, P643, DOI 10.1134/S0026261708060015; Kunzler M, 2010, METHOD ENZYMOL, V480, P141, DOI 10.1016/S0076-6879(10)80007-2; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lawrence PK, 2002, ELECTRON J BIOTECHN, V5, DOI 10.2225/vol5-issue1-fulltext-3; Miyatake H, 2006, ACTA CRYSTALLOGR D, V62, P280, DOI 10.1107/S0907444905041909; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Murdock LL, 2002, J AGR FOOD CHEM, V50, P6605, DOI 10.1021/jf020192c; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura M, 2011, MYCOSCIENCE, V52, P234, DOI 10.1007/s10267-010-0089-9; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Odani S, 1999, EUR J BIOCHEM, V262, P915, DOI 10.1046/j.1432-1327.1999.00463.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pohleven J, 2009, BBA-GEN SUBJECTS, V1790, P173, DOI 10.1016/j.bbagen.2008.11.006; Ravichandran S, 1999, ACTA CRYSTALLOGR D, V55, P1814, DOI 10.1107/S0907444999009877; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; RAY C, 1992, MOL BIOCHEM PARASIT, V51, P239, DOI 10.1016/0166-6851(92)90074-T; Renko M, 2010, J BIOL CHEM, V285, P308, DOI 10.1074/jbc.M109.043331; Rouge P., 2007, COMPREHENSIVE GLYCOS, V3, P563; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sabotic J, 2007, J BIOTECHNOL, V128, P297, DOI 10.1016/j.jbiotec.2006.10.006; Sabotic J, 2006, BIOL CHEM, V387, P1559, DOI 10.1515/BC.2006.194; Sabotic J, 2009, FEBS J, V276, P4334, DOI 10.1111/j.1742-4658.2009.07138.x; Sasakawa H, 2002, J MOL BIOL, V317, P159, DOI 10.1006/jmbi.2002.5412; Serrano-Luna JD, 2006, CAN J MICROBIOL, V52, P16, DOI 10.1139/W05-114; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; SWAMY S, 1984, J GEN MICROBIOL, V130, P3219; Tcherepanova I, 2000, J BIOL CHEM, V275, P26359, DOI 10.1074/jbc.M000956200; Terra, 2005, COMPREHENSIVE MOL IN, P171, DOI [10.1016/B0-44-451924-6/00053-3, DOI 10.1016/B0-44-451924-6/00053-3]; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; TURK D, 1992, WEITERENTWICKLUNG PR; Vetter J, 2000, EUR FOOD RES TECHNOL, V211, P346, DOI 10.1007/s002170000180; WEINER MP, 1994, PCR METH APPL, V4, pS131; Zuchowski J, 2009, BIOCHEMISTRY-MOSCOW+, V74, P226, DOI 10.1134/S0006297909020151; Zuchowski J, 2006, CURR MICROBIOL, V53, P259, DOI 10.1007/s00284-005-0386-2	58	37	38	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3898	3907		10.1074/jbc.M111.285304	http://dx.doi.org/10.1074/jbc.M111.285304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167196	Green Published, hybrid			2022-12-25	WOS:000300410900026
J	Warfel, NA; Newton, AC				Warfel, Noel A.; Newton, Alexandra C.			Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase (PHLPP): A New Player in Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							KINASE; AKT; ACTIVATION; FEEDBACK; PTEN; IDENTIFICATION; DEFICIENT; MECHANISM; ISOFORM; SCOP	Precise balance between phosphorylation, catalyzed by protein kinases, and dephosphorylation, catalyzed by protein phosphatases, is essential for cellular homeostasis. Deregulation of this balance leads to pathophysiological states that drive diseases such as cancer, heart disease, and diabetes. The recent discovery of the PHLPP (pleckstrin homology domain leucinerich repeat protein phosphatase) family of Ser/Thr phosphatases adds a new player to the cast of phosphate-controlling enzymes in cell signaling. PHLPP isozymes catalyze the dephosphorylation of a conserved regulatory motif, the hydrophobic motif, on the AGC kinases Akt, PKC, and S6 kinase, as well as an inhibitory site on the kinase Mst1, to inhibit cellular proliferation and induce apoptosis. The frequent deletion of PHLPP in cancer, coupled with the development of prostate tumors in mice lacking PHLPP1, identifies PHLPP as a novel tumor suppressor. This minireview discusses the structure, function, and regulation of PHLPP, with particular focus on its role in disease.	[Warfel, Noel A.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Warfel, Noel A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu		Warfel, Noel/0000-0001-6410-9011	National Institutes of Health [GM067946]; Department of Defense from the United States Army Medical Research Acquisition Activity [BC093021]; University of California through National Institutes of Health from NIGMS [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067946, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense from the United States Army Medical Research Acquisition Activity; University of California through National Institutes of Health from NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067946 (to A.C.N.). This work was also supported by Department of Defense Breast Cancer Research Program Award BC093021 from the United States Army Medical Research Acquisition Activity (to N.A.W.).; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant T32 GM007752 from NIGMS.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Andreozzi F, 2011, DIABETOLOGIA, V54, P1879, DOI 10.1007/s00125-011-2116-6; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brognard J, 2009, J BIOL CHEM, V284, P15215, DOI 10.1074/jbc.M901468200; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Sierecki E, 2010, J MED CHEM, V53, P6899, DOI 10.1021/jm100331d; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Warfel NA, 2011, J BIOL CHEM, V286, P19777, DOI 10.1074/jbc.M111.237081	44	55	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3610	3616		10.1074/jbc.R111.318675	http://dx.doi.org/10.1074/jbc.R111.318675			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22144674	hybrid, Green Published			2022-12-25	WOS:000300410900001
J	Santhekadur, PK; Gredler, R; Chen, D; Siddiq, A; Shen, XN; Das, SK; Emdad, L; Fisher, PB; Sarkar, D				Santhekadur, Prasanna K.; Gredler, Rachel; Chen, Dong; Siddiq, Ayesha; Shen, Xue-Ning; Das, Swadesh K.; Emdad, Luni; Fisher, Paul B.; Sarkar, Devanand			Late SV40 Factor (LSF) Enhances Angiogenesis by Transcriptionally Up-regulating Matrix Metalloproteinase-9 (MMP-9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; IV COLLAGENASE; MATRIX METALLOPROTEINASES; TUMOR ANGIOGENESIS; CELLS; METASTASIS; EXPRESSION; INVASION; CARCINOGENESIS; ADENOCARCINOMA	The transcription factor late SV40 factor (LSF) is overexpressed in human hepatocellular carcinoma (HCC) fostering a highly aggressive and metastatic phenotype. Angiogenesis is an essential component of cancer aggression and metastasis and HCC is a highly aggressive and angiogenic cancer. In the present studies, we analyzed the molecular mechanism of LSF-induced angiogenesis in HCC. Employing human umbilical vein endothelial cells (HUVEC) differentiation assay and chicken chorioallantoic membrane (CAM) assay we document that stable LSF overexpression augments and stable dominant negative inhibition of LSF (LSFdn) abrogates angiogenesis by human HCC cells. A quest for LSF-regulated factors contributing to angiogenesis, by chromatin immunoprecipitation-on-chip (ChIP-on-chip) assay, identified matrix metalloproteinase-9 (MMP-9) as a direct target of LSF. MMP-9 expression and enzymatic activity were higher in LSF-overexpressing cells and lower in LSFdn-expressing cells. Deletion mutation analysis identified the LSF-responsive regions in the MMP-9 promoter and ChIP assay confirmed LSF binding to the MMP-9 promoter. Inhibition of MMP-9 significantly abrogated LSF-induced angiogenesis as well as in vivo tumorigenesis, thus reinforcing the role of MMP-9 in facilitating LSF function. The present findings identify a novel target of LSF contributing to its oncogenic properties.	[Santhekadur, Prasanna K.; Gredler, Rachel; Siddiq, Ayesha; Shen, Xue-Ning; Das, Swadesh K.; Emdad, Luni; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23298 USA; [Chen, Dong; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Pathol, Sch Med, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Inst Mol Med, Sch Med, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, 1220 E Broad St,POB 980035, Richmond, VA 23298 USA.	dsarkar@vcu.edu	Santhekadur, Prasanna/O-7006-2019; chen, dong/A-6889-2012	Santhekadur, Prasanna/0000-0003-3338-375X; chen, dong/0000-0001-6661-9410	NCI, National Institutes of Health [R01 CA138540, R01 CA134721]; Dana Foundation; James S. McDonnell Foundation; Samuel Waxman Cancer Research Foundation (SWCRF); NATIONAL CANCER INSTITUTE [R01CA138540, R01CA134721] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Foundation; James S. McDonnell Foundation; Samuel Waxman Cancer Research Foundation (SWCRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants R01 CA138540 (to D. S.) and R01 CA134721 (to P. B. F.). This work study was also supported in part by grants from the Dana Foundation, the James S. McDonnell Foundation, and the Samuel Waxman Cancer Research Foundation (SWCRF).	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Arii S, 1996, HEPATOLOGY, V24, P316; Bausch D, 2011, ANGIOGENESIS, V14, P235, DOI 10.1007/s10456-011-9207-3; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bruni-Cardoso A, 2010, MOL CANCER RES, V8, P459, DOI 10.1158/1541-7786.MCR-09-0445; Chantrain CF, 2006, EUR J CANCER, V42, P310, DOI 10.1016/j.ejca.2005.11.010; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Emdad L, 2010, MOL CANCER THER, V9, P79, DOI 10.1158/1535-7163.MCT-09-0752; Harper J, 2006, EXP SUPPL, V96, P223; Hayasaka A, 1996, HEPATOLOGY, V24, P1058; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; LENGYEL E, 1995, CANCER RES, V55, P963; LEVY AT, 1991, CANCER RES, V51, P439; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; NAKAJIMA M, 1993, CANCER RES, V53, P5802; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; Parekh V, 2004, MOL CELL BIOL, V24, P7113, DOI 10.1128/MCB.24.16.7113-7129.2004; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; WATANABE H, 1993, J CELL SCI, V104, P991; Yoo BK, 2011, J HEPATOL, V55, P1317, DOI 10.1016/j.jhep.2011.02.036; Yoo BK, 2010, P NATL ACAD SCI USA, V107, P8357, DOI 10.1073/pnas.1000374107; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106	32	29	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3425	3432		10.1074/jbc.M111.298976	http://dx.doi.org/10.1074/jbc.M111.298976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167195	hybrid, Green Published			2022-12-25	WOS:000300295100047
J	Duran-Pinedo, AE; Paster, B; Teles, R; Frias-Lopez, J				Duran-Pinedo, Ana E.; Paster, Bruce; Teles, Ricardo; Frias-Lopez, Jorge			Correlation Network Analysis Applied to Complex Biofilm Communities	PLOS ONE			English	Article							GENE-COEXPRESSION NETWORK; MICROBIAL COMMUNITIES; BACTERIAL DIVERSITY; SUBGINGIVAL PLAQUE; ANALYSIS REVEALS; IDENTIFICATION; TRANSCRIPTOME; ORGANIZATION; MODULARITY; FRAMEWORK	The complexity of the human microbiome makes it difficult to reveal organizational principles of the community and even more challenging to generate testable hypotheses. It has been suggested that in the gut microbiome species such as Bacteroides thetaiotaomicron are keystone in maintaining the stability and functional adaptability of the microbial community. In this study, we investigate the interspecies associations in a complex microbial biofilm applying systems biology principles. Using correlation network analysis we identified bacterial modules that represent important microbial associations within the oral community. We used dental plaque as a model community because of its high diversity and the well known species-species interactions that are common in the oral biofilm. We analyzed samples from healthy individuals as well as from patients with periodontitis, a polymicrobial disease. Using results obtained by checkerboard hybridization on cultivable bacteria we identified modules that correlated well with microbial complexes previously described. Furthermore, we extended our analysis using the Human Oral Microbe Identification Microarray (HOMIM), which includes a large number of bacterial species, among them uncultivated organisms present in the mouth. Two distinct microbial communities appeared in healthy individuals while there was one major type in disease. Bacterial modules in all communities did not overlap, indicating that bacteria were able to effectively re-associate with new partners depending on the environmental conditions. We then identified hubs that could act as keystone species in the bacterial modules. Based on those results we then cultured a not-yet-cultivated microorganism, Tannerella sp.OT286 (clone BU063). After two rounds of enrichment by a selected helper (Prevotella oris OT311) we obtained colonies of Tannerella sp.OT286 growing on blood agar plates. This system-level approach would open the possibility of manipulating microbial communities in a targeted fashion as well as associating certain bacterial modules to clinical traits (e. g.: obesity, Crohn's disease, periodontal disease, etc).	[Duran-Pinedo, Ana E.; Paster, Bruce; Teles, Ricardo; Frias-Lopez, Jorge] Forsyth Inst, Cambridge, MA 02142 USA; [Paster, Bruce; Teles, Ricardo; Frias-Lopez, Jorge] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Duran-Pinedo, AE (corresponding author), Forsyth Inst, Cambridge, MA 02142 USA.	jfrias@forsyth.org	Paster, Bruce J/AAP-8559-2021	Frias-Lopez, Jorge/0000-0002-2097-3171; Duran-Pinedo, Ana/0000-0001-5648-6597				Allen E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-62; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Chung HC, 2010, ISME J, V4, P817, DOI 10.1038/ismej.2009.157; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Frias J, 2001, INFECT IMMUN, V69, P3431, DOI 10.1128/IAI.69.5.3431-3434.2001; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Haffajee AD, 2008, ORAL MICROBIOL IMMUN, V23, P148, DOI 10.1111/j.1399-302X.2007.00403.x; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Haffajee AD, 2005, PERIODONTOL 2000, V38, P9, DOI 10.1111/j.1600-0757.2005.00112.x; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan F, 2009, PHILOS T R SOC B, V364, P1733, DOI 10.1098/rstb.2008.0335; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kinniment SL, 1996, MICROBIOL-SGM, V142, P631, DOI 10.1099/13500872-142-3-631; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sissons CH, 2007, CARIES RES, V41, P413, DOI 10.1159/000104801; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Steele JA, 2011, ISME J; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P722, DOI 10.1034/j.1600-051x.2000.027010722.x; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11; Zuger J, 2007, MICROBIOL-SGM, V153, P3809, DOI 10.1099/mic.0.2007/010926-0	49	81	86	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28438	10.1371/journal.pone.0028438	http://dx.doi.org/10.1371/journal.pone.0028438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163302	gold, Green Published, Green Submitted			2022-12-25	WOS:000298161900039
J	Lenz, G; Doron-Faigenboim, A; Ron, EZ; Tuller, T; Gophna, U				Lenz, Gal; Doron-Faigenboim, Adi; Ron, Eliora Z.; Tuller, Tamir; Gophna, Uri			Sequence Features of E. coli mRNAs Affect Their Degradation	PLOS ONE			English	Article							CODON USAGE BIAS; ESCHERICHIA-COLI; GENE-EXPRESSION; STRESS-RESPONSE; DECAY; TRANSLATION; STABILITY; PROTEINS; BACTERIA; BINDING	Degradation of mRNA in bacteria is a regulatory mechanism, providing an efficient way to fine-tune protein abundance in response to environmental changes. While the mechanisms responsible for initiation and subsequent propagation of mRNA degradation are well studied, the mRNA features that affect its stability are yet to be elucidated. We calculated three properties for each mRNA in the E. coli transcriptome: G+C content, tRNA adaptation index (tAI) and folding energy. Each of these properties were then correlated with the experimental transcript half life measured for each transcript and detected significant correlations. A sliding window analysis identified the regions that displayed the maximal signal. The correlation between transcript half life and both G+C content and folding energy was strongest at the 59 termini of the mRNAs. Partial correlations showed that each of the parameters contributes separately to mRNA half life. Notably, mRNAs of recently-acquired genes in the E. coli genome, which have a distinct nucleotide composition, tend to be highly stable. This high stability may aid the evolutionary fixation of horizontally acquired genes.	[Lenz, Gal; Doron-Faigenboim, Adi; Ron, Eliora Z.; Gophna, Uri] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [Tuller, Tamir] Tel Aviv Univ, Iby & Aladar Fleischman Fac Engn, Ramat Aviv, Israel	Tel Aviv University; Tel Aviv University	Lenz, G (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel.	urigo@post.tau.ac.il	Gophna, Uri/AAS-8376-2020	Gophna, Uri/0000-0001-5129-5652; Tuller, Tamir/0000-0003-4194-7068				Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Braun F, 1998, EMBO J, V17, P4790, DOI 10.1093/emboj/17.16.4790; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; El-Sharoud Walid M., 2007, Science Progress, V90, P15, DOI 10.3184/003685007780440549; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; GROSS G, 1990, J BIOL CHEM, V265, P17627; Gu W, PLOS COMPUT BIOL, V6, pe100; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Jia MW, 2005, FEBS LETT, V579, P5333, DOI 10.1016/j.febslet.2005.08.059; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nierlich DP, 1996, PROG NUCLEIC ACID RE, V52, P153, DOI 10.1016/S0079-6603(08)60967-8; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Phadtare S, 2009, J MOL MICROB BIOTECH, V17, P110, DOI 10.1159/000226587; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shenhar Y, 2009, ENVIRON MICROBIOL, V11, P2989, DOI 10.1111/j.1462-2920.2009.01993.x; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tuller T, CELL, V141, P344; Tuller T, P NATL ACAD SCI US, V107, P3645; Tuller T, GENOME BIOL IN PRESS; Vytvytska O, 2000, GENE DEV, V14, P1109	31	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28544	10.1371/journal.pone.0028544	http://dx.doi.org/10.1371/journal.pone.0028544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163312	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900048
J	O'Bryant, SE; Xiao, GH; Barber, R; Huebinger, R; Wilhelmsen, K; Edwards, M; Graff-Radford, N; Doody, R; Diaz-Arrastia, R				O'Bryant, Sid E.; Xiao, Guanghua; Barber, Robert; Huebinger, Ryan; Wilhelmsen, Kirk; Edwards, Melissa; Graff-Radford, Neill; Doody, Rachelle; Diaz-Arrastia, Ramon		Texas Alzheimer's Res Care; Alzheimer's Dis Neuroimaging	A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI	PLOS ONE			English	Article							ACID-BINDING PROTEIN; CEREBROSPINAL-FLUID; BIOMARKERS; DIAGNOSIS; DEMENTIA; MARKER; ALGORITHM; BDNF; MCI	Context: There is no rapid and cost effective tool that can be implemented as a front-line screening tool for Alzheimer's disease (AD) at the population level. Objective: To generate and cross-validate a blood-based screener for AD that yields acceptable accuracy across both serum and plasma. Design, Setting, Participants: Analysis of serum biomarker proteins were conducted on 197 Alzheimer's disease (AD) participants and 199 control participants from the Texas Alzheimer's Research Consortium (TARC) with further analysis conducted on plasma proteins from 112 AD and 52 control participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI). The full algorithm was derived from a biomarker risk score, clinical lab (glucose, triglycerides, total cholesterol, homocysteine), and demographic (age, gender, education, APOE*E4 status) data. Major Outcome Measures: Alzheimer's disease. Results: 11 proteins met our criteria and were utilized for the biomarker risk score. The random forest (RF) biomarker risk score from the TARC serum samples (training set) yielded adequate accuracy in the ADNI plasma sample (training set) (AUC = 0.70, sensitivity (SN) = 0.54 and specificity (SP) = 0.78), which was below that obtained from ADNI cerebral spinal fluid (CSF) analyses (t-tau/A beta ratio AUC = 0.92). However, the full algorithm yielded excellent accuracy (AUC = 0.88, SN = 0.75, and SP = 0.91). The likelihood ratio of having AD based on a positive test finding (LR+) = 7.03 (SE = 1.17; 95% CI = 4.49-14.47), the likelihood ratio of not having AD based on the algorithm (LR-) = 3.55 (SE = 1.15; 2.22-5.71), and the odds ratio of AD were calculated in the ADNI cohort (OR) = 28.70 (1.55; 95% CI = 11.86-69.47). Conclusions: It is possible to create a blood-based screening algorithm that works across both serum and plasma that provides a comparable screening accuracy to that obtained from CSF analyses.	[O'Bryant, Sid E.] Texas Tech Univ, Hlth Sci Ctr, Dept Neurol, F Marie Hall Inst Rural & Community Hlth,Garrison, Lubbock, TX 79430 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Barber, Robert] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA; [Huebinger, Ryan] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Wilhelmsen, Kirk] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Edwards, Melissa] Texas Tech Univ, Dept Psychol, Lubbock, TX 79430 USA; [Graff-Radford, Neill] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Doody, Rachelle] Baylor Coll Med, Dept Neurol, Alzheimers Dis & Memory Disorders Ctr, Houston, TX 77030 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA	Texas Tech University System; Texas Tech University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Texas Tech University System; Texas Tech University; Mayo Clinic; Baylor College of Medicine; Uniformed Services University of the Health Sciences - USA	O'Bryant, SE (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Neurol, F Marie Hall Inst Rural & Community Hlth,Garrison, Lubbock, TX 79430 USA.	Sid.Obryant@ttuhsc.edu		O'Bryant, Sid/0000-0003-0582-5266; Ballantyne, Christie/0000-0002-6432-1730; Diaz-Arrastia, Ramon/0000-0001-6051-3594	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders; NIH, NIA [P30AG12300]; Cynthia and George Mitchell Foundation; CH Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Abbott; AstraZeneca AB; Bayer Schering Pharma AG; Bristol-Myers Squibb; Eisai Global Clinical Development; Elan Corporation; Genentech; GE Healthcare; GlaxoSmithKline; Innogenetics; Johnson and Johnson; Eli Lilly and Co.; Medpace, Inc.; Merck and Co., Inc.; Novartis AG; Pfizer Inc; F. Hoffman-La Roche; Schering-Plough; Synarc, Inc.; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; U.S. Food and Drug Administration; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [K01AG030514, P30AG010129, U19AG010483, U01AG024904, P30AG012300] Funding Source: NIH RePORTER	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders; NIH, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cynthia and George Mitchell Foundation(General Electric); CH Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Abbott(Abbott Laboratories); AstraZeneca AB(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai Global Clinical Development(Eisai Co Ltd); Elan Corporation; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); GlaxoSmithKline(GlaxoSmithKline); Innogenetics; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Eli Lilly and Co.(Eli Lilly); Medpace, Inc.; Merck and Co., Inc.(Merck & Company); Novartis AG; Pfizer Inc(Pfizer); F. Hoffman-La Roche; Schering-Plough(Merck & CompanySchering Plough Corporation); Synarc, Inc.; Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; U.S. Food and Drug Administration; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was made possible by the Texas Alzheimer's Research Consortium funded by the state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders. Investigators at the UTSW acknowledge NIH, NIA grant P30AG12300. The investigations at Baylor's Alzheimer's Disease and Memory Disorders Center were supported by the Cynthia and George Mitchell Foundation. Investigators at Texas Tech University Health Sciences Center were supported by The CH Foundation. ADNI. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest: In the TARC, a patent has been submitted on this blood-based screener. There are no other products in development or marketed products to declare. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. ADNI has received funding from the following commercial sources: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. ADNI data is freely available to any interested scientists.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F; [Anonymous], 1998, Neurobiol Aging, V19, P109; [Anonymous], 1998, NEUROBIOL AGING, V19, P285; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, MANUAL SETTING USING; Brys M, 2009, J ALZHEIMERS DIS, V16, P351, DOI 10.3233/JAD-2009-0968; Buerger K, 2009, BIOL PSYCHIAT, V65, P979, DOI 10.1016/j.biopsych.2009.01.032; Cui YF, 2011, PANCREATOLOGY, V11, P279, DOI 10.1159/000329188; Doody R, CLIN DRUG I IN PRESS; Ewers M, 2010, EXP GERONTOL, V45, P75, DOI 10.1016/j.exger.2009.09.005; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Galimberti D, 2006, NEUROBIOL AGING, V27, P1763, DOI 10.1016/j.neurobiolaging.2005.10.007; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gustafson DR, 2010, J NEUROL SCI, V299, P30, DOI 10.1016/j.jns.2010.08.036; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Luis CA, 2009, AGING NEUROPSYCHOL C, V16, P203, DOI 10.1080/13825580802411766; Mayeux R, 2003, NEUROLOGY, V61, P1185, DOI 10.1212/01.WNL.0000091890.32140.8F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; O'Bryant S, ARCH NEUROL IN PRESS; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; O'Bryant SE, 2011, DEMENT GERIATR COGN, V32, P55, DOI 10.1159/000330750; O'Bryant SE, 2011, DEMENT GERIATR COGN, V31, P31, DOI 10.1159/000321980; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; O'Bryant SE, 2010, J GERIATR PSYCH NEUR, V23, P49, DOI 10.1177/0891988709351832; O'Bryant SE, 2009, J ALZHEIMERS DIS, V17, P337, DOI 10.3233/JAD-2009-1051; Osborne J.W., 2010, PRACT ASSESS RES EVA, V15, P1, DOI [10.7275/qbpc-gk17, DOI 10.7275/QBPC-GK17]; R Core Team, 2021, R LANG ENV STAT COMP; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Schneider P, 2009, CNS NEUROSCI THER, V15, P358, DOI 10.1111/j.1755-5949.2009.00104.x; Soares HD, 2009, IDENTIFYING EARLY MA, P56; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Steinacker P, 2004, NEUROSCI LETT, V370, P36, DOI 10.1016/j.neulet.2004.07.061; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Teunissen CE, 2011, EUR J NEUROL, V18, P865, DOI 10.1111/j.1468-1331.2010.03273.x; Thal LJ, 2006, ALZ DIS ASSOC DIS, V20, P6, DOI 10.1097/01.wad.0000191420.61260.a8; Une K, 2011, EUR J NEUROL, V18, P1006, DOI 10.1111/j.1468-1331.2010.03194.x; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Zellner M, 2009, ACTA NEUROPATHOL, V118, P181, DOI 10.1007/s00401-009-0502-7; Zhang D, 2011, NEUROIMAGE; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011	48	105	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28092	10.1371/journal.pone.0028092	http://dx.doi.org/10.1371/journal.pone.0028092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163278	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900013
J	Andrews, N; Waight, PA; Borrow, R; Ladhani, S; George, RC; Slack, MPE; Miller, E				Andrews, Nick; Waight, Pauline A.; Borrow, Ray; Ladhani, Shamez; George, Robert C.; Slack, Mary P. E.; Miller, Elizabeth			Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INFANTS; DISEASE; IMMUNOGENICITY; SCHEDULE; EFFICACY; CHILDREN	Background: The 7-valent pneumococcal conjugate vaccine (PCV-7) was introduced in the United Kingdom in 2006 with a 2,3 and 13month schedule, and has led to large decreases in invasive pneumococcal disease (IPD) caused by the vaccine serotypes in both vaccinated and unvaccinated cohorts. We estimated the effectiveness of PCV-7 against IPD. Methods and Findings: We used enhanced surveillance data, collated at the Health Protection Agency, on vaccine type (n = 153) and non vaccine type (n = 919) IPD cases eligible for PCV-7. The indirect cohort method, a case-control type design which uses non vaccine type cases as controls, was used to estimate effectiveness of various numbers of doses as well as for each vaccine serotype. Possible bias with this design, caused by differential serotype replacement in vaccinated and unvaccinated individuals, was estimated after deriving formulae to quantify the bias. The results showed good effectiveness, increasing from 56% (95% confidence interval (CI): -7-82) for a single dose given under one year of age to 93% (95% CI: 7098) for two doses under one year of age plus a booster dose in the second year of life. Serotype specific estimates indicated higher effectiveness against serotypes 4, 14 and 18C and lower effectiveness against 6B. Under the assumption of complete serotype replacement by non vaccine serotypes in carriage, we estimated that effectiveness estimates may be overestimated by about 2 to 5%. Conclusions: This study shows high effectiveness of PCV-7 under the reduced schedule used in the UK. This finding agrees with the large reductions seen in vaccine type IPD in recent years in England and Wales. The formulae derived to assess the bias of the indirect cohort method for PCV-7 can also be used when using the design for other vaccines that affect carriage such as the recently introduced 13 valent pneumococcal conjugate vaccine.	[Andrews, Nick] Hlth Protect Agcy, Stat Modelling & Econ Dept, Hlth Protect Serv, London, England; [Waight, Pauline A.; Ladhani, Shamez; Miller, Elizabeth] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, Hlth Protect Serv, London, England; [Borrow, Ray] Hlth Protect Agcy, Microbiol Serv Div, Vaccine Evaluat Unit, Manchester, Lancs, England; [George, Robert C.; Slack, Mary P. E.] Hlth Protect Agcy, Microbiol Serv Div, Resp & Syst Infect Lab, London, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Health Protection Agency	Andrews, N (corresponding author), Hlth Protect Agcy, Stat Modelling & Econ Dept, Hlth Protect Serv, London, England.	nick.andrews@hpa.org.uk		Ladhani, Shamez/0000-0002-0856-2476	Health Protection Agency; Pfizer; GlaxoSmithKline; Sanofi Pasteur; Merck	Health Protection Agency; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur; Merck(Merck & Company)	Funding was provided by the Health Protection Agency. The funder had no role in study design, data collection and analysis or preparation of the manuscript. The funder approved the submission of the manuscript.; RB has performed contract research on behalf of the Health Protection Agency that was funded by Pfizer, GlaxoSmithKline, Sanofi Pasteur, and Merck. MS has received assistance to attend scientific meetings from Pfizer and GlaxoSmithKline and research funding from Pfizer and GlaxoSmithKline. RG has received support for conference attendance from Pfizer and GlaxoSmithKline, and his laboratory has received research funding from Pfizer and GlaxoSmithKline. SL has received assistance to attend scientific meetings from Pfizer and GlaxoSmithKline. This declaration does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. None of the funding from Pfizer, GlaxoSmithKline, Sanofi Pasteur, or Merck was used specifically for this study.	[Anonymous], 2006, IMMUNISATION INFECT; [Anonymous], 2005, NHS MAT STAT 2005 06; Barricarte A, 2007, CLIN INFECT DIS, V44, P1436, DOI 10.1086/516779; BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Deceuninck G, 2010, PEDIATR INFECT DIS J, V29, P546, DOI 10.1097/INF.0b013e3181cffa2a; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Goldblatt D, 2010, PEDIATR INFECT DIS J, V29, P401, DOI 10.1097/INF.0b013e3181c67f04; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Lucero MG, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004977.PUB2; Mahon BE, 2006, VACCINE, V24, P2514, DOI 10.1016/j.vaccine.2005.12.025; Messina AF, 2007, PEDIATR INFECT DIS J, V26, P461, DOI 10.1097/INF.0b013e31805cdbeb; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Pilishvili T, 2010, PEDIATRICS, V126, pE9, DOI 10.1542/peds.2009-2150; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Ruckinger S, 2010, VACCINE, V28, P5012, DOI 10.1016/j.vaccine.2010.05.021; Salisbury DS, CHANGES CHILDHOOD PN; Sheppard CL, 2011, J MED MICROBIOL, V60, P49, DOI 10.1099/jmm.0.023150-0; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; Weinberger DM, 2011, LANCET IN PRESS; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2	22	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28435	10.1371/journal.pone.0028435	http://dx.doi.org/10.1371/journal.pone.0028435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164292	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400093
J	Castaldo, E; Sabato, D; Lauro, D; Sesti, G; Marini, MA				Castaldo, Ersilia; Sabato, Donata; Lauro, Davide; Sesti, Giorgio; Marini, Maria Adelaide			Hypoglycemia Assessed by Continuous Glucose Monitoring Is Associated with Preclinical Atherosclerosis in Individuals with Impaired Glucose Tolerance	PLOS ONE			English	Article							CAROTID-ARTERY INTIMA; CARDIOVASCULAR OUTCOMES; MEDIA THICKNESS; TYPE-2; MORTALITY; RISK; HYPERGLYCEMIA; HEALTHY; EVENTS; SYSTEM	Hypoglycemia is associated with increased risk of cardiovascular adverse clinical outcomes. There is evidence that impaired glucose tolerance (IGT) is associated with cardiovascular morbidity and mortality. Whether IGT individuals have asymptomatic hypoglycemia under real-life conditions that are related to early atherosclerosis is unknown. To this aim, we measured episodes of hypoglycemia during continuous interstitial glucose monitoring (CGM) and evaluated their relationship with early manifestation of vascular atherosclerosis in glucose tolerant and intolerant individuals. An oral glucose tolerance test (OGTT) was performed in 79 non-diabetic subjects. Each individual underwent continuous glucose monitoring for 72 h. Cardiovascular risk factors and ultrasound measurement of carotid intima-media thickness (IMT) were evaluated. IGT individuals had a worse cardiovascular risk profile, including higher IMT, and spent significantly more time in hypoglycemia than glucose-tolerant individuals. IMT was significantly correlated with systolic (r = 0.22; P = 0.05) and diastolic blood pressure (r = 0.28; P = 0.01), total (r = 0.26; P = 0.02) and LDL cholesterol (r = 0.27; P = 0.01), 2-h glucose (r = 0.39; P<0.0001), insulin sensitivity (r = 20.26; P = 0.03), and minutes spent in hypoglycemia (r = 0.45; P<0.0001). In univariate analyses adjusted for gender, minutes spent in hypoglycemia were significantly correlated with age (r = 0.26; P = 0.01), waist circumference (r = 0.33; P = 0.003), 2-h glucose (r = 0.58; P<0.0001), and 2-h insulin (r = 0.27; P = 0.02). In a stepwise multivariate regression analysis, the variables significantly associated with IMT were minutes spent in hypoglycemia (r(2) = 0.252; P<0.0001), and ISI index (r(2) = 0.089; P = 0.004), accounting for 34.1% of the variation. Episodes of hypoglycemia may be considered as a new potential cardiovascular risk factor for IGT individuals.	[Castaldo, Ersilia; Sabato, Donata; Lauro, Davide; Marini, Maria Adelaide] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	University of Rome Tor Vergata; Magna Graecia University of Catanzaro	Castaldo, E (corresponding author), Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy.	sesti@unicz.it	Sesti, Giorgio/B-1509-2012; Lauro, Davide/K-4683-2018	Sesti, Giorgio/0000-0002-1618-7688; Lauro, Davide/0000-0002-8597-4415				Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Cardellini M, 2007, AM J PHYSIOL-ENDOC M, V292, pE347, DOI 10.1152/ajpendo.00291.2006; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Derosa G, 2009, DIABETES TECHNOL THE, V11, P159, DOI 10.1089/dia.2008.0101; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; HILSTED J, 1984, DIABETOLOGIA, V26, P328; Johnston SS, 2011, DIABETES CARE, V34, P1164, DOI 10.2337/dc10-1915; Joy NG, 2010, DIABETES CARE, V33, P1529, DOI 10.2337/dc09-0354; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sachedina N, 2003, DIABETIC MED, V20, P1012, DOI 10.1046/j.1464-5491.2003.01037.x; Saydah SH, 2001, DIABETES CARE, V24, P1397, DOI 10.2337/diacare.24.8.1397; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	25	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28312	10.1371/journal.pone.0028312	http://dx.doi.org/10.1371/journal.pone.0028312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164268	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400069
J	Jung, IH; Jung, DE; Park, YN; Song, SY; Park, SW				Jung, In Hye; Jung, Dawoon E.; Park, Young Nyun; Song, Si Young; Park, Seung Woo			Aberrant Hedgehog Ligands Induce Progressive Pancreatic Fibrosis by Paracrine Activation of Myofibroblasts and Ductular Cells in Transgenic Zebrafish	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SONIC HEDGEHOG; SIGNALING PATHWAY; INDIAN HEDGEHOG; GENE-EXPRESSION; STELLATE CELLS; TGF-BETA; CANCER; PROMOTES; GLI1	Hedgehog (Hh) signaling is frequently up-regulated in fibrogenic pancreatic diseases including chronic pancreatitis and pancreatic cancer. Although recent series suggest exclusive paracrine activation of stromal cells by Hh ligands from epithelial components, debates still exist on how Hh signaling works in pathologic conditions. To explore how Hh signaling affects the pancreas, we investigated transgenic phenotypes in zebrafish that over-express either Indian Hh or Sonic Hh along with green fluorescence protein (GFP) to enable real-time observation, or GFP alone as control, at the ptf1a domain. Transgenic embryos and zebrafish were serially followed for transgenic phenotypes, and investigated using quantitative reverse transcription-polymerase chain reaction (qRT-PCR), in situ hybridization, and immunohistochemistry. Overexpression of Ihh or Shh reveals virtually identical phenotypes. Hh induces morphologic changes in a developing pancreas without derangement in acinar differentiation. In older zebrafish, Hh induces progressive pancreatic fibrosis intermingled with proliferating ductular structures, which is accompanied by the destruction of the acinar structures. Both myofibroblasts and ductular are activated and proliferated by paracrine Hh signaling, showing restricted expression of Hh downstream components including Patched1 (Ptc1), Smoothened (Smo), and Gli1/2 in those Hh-responsive cells. Hh ligands induce matrix metalloproteinases (MMPs), especially MMP9 in all Hh-responsive cells, and transform growth factor-beta 1 (TGF beta 1) only in ductular cells. Aberrant Hh over-expression, however, does not induce pancreatic tumors. On treatment with inhibitors, embryonic phenotypes are reversed by either cyclopamine or Hedgehog Primary Inhibitor-4 (HPI-4). Pancreatic fibrosis is only prevented by HPI-4. Our study provides strong evidence of Hh signaling which induces pancreatic fibrosis through paracrine activation of Hh-responsive cells in vivo. Induction of MMPs and TGF beta 1 by Hh signaling expands on the current understanding of how Hh signaling affects fibrosis and tumorigenesis. These transgenic models will be a valuable platform in exploring the mechanism of fibrogenic pancreatic diseases which are induced by Hh signaling activation.	[Jung, In Hye] Yonsei Univ, Coll Med, Inst Gastroenterol, Postgrad Sch,Natl Core Res Ctr Nanomed Technol, Seoul, South Korea; [Jung, Dawoon E.] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Pathol, Seoul, South Korea; [Song, Si Young; Park, Seung Woo] Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, IH (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Postgrad Sch,Natl Core Res Ctr Nanomed Technol, Seoul, South Korea.	swoopark@yuhs.ac	Lee, In Sook/J-9324-2013; Song, SY/E-2891-2012	Park, Young Nyun/0000-0003-0357-7967; Song, Si Young/0000-0002-1417-4314; Park, Seung Woo/0000-0001-8230-964X	National Research Foundation [72010-0025]; National R&D Program for Cancer [0720390]; National Research Foundation; National Core Research Center for Nanomedical Technology [R15-2004-024-00000-0]; Yonsei University College of Medicine [6-2010-0041]	National Research Foundation; National R&D Program for Cancer; National Research Foundation; National Core Research Center for Nanomedical Technology; Yonsei University College of Medicine(General Electric)	National Research Foundation, Mid-career Researcher Program 72010-0025, National R&D Program for Cancer Control Grant 0720390, National Research Foundation, National Core Research Center for Nanomedical Technology R15-2004-024-00000-0, and an Institutional Grant of Yonsei University College of Medicine 6-2010-0041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Cheng PY, 2008, DEVELOPMENT, V135, P941, DOI 10.1242/dev.010595; Davison JM, 2008, METHOD ENZYMOL, V438, P391, DOI 10.1016/S0076-6879(07)38027-0; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Deshpande G, 2001, CELL, V106, P759, DOI 10.1016/S0092-8674(01)00488-3; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Du SJ, 2001, DIFFERENTIATION, V67, P84, DOI 10.1046/j.1432-0436.2001.067003084.x; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hao LT, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-24; Haramis APG, 2006, EMBO REP, V7, P444, DOI 10.1038/sj.embor.7400638; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kayed H, 2004, INT J CANCER, V110, P668, DOI 10.1002/ijc.20194; Kayed H, 2003, J ENDOCRINOL, V178, P467, DOI 10.1677/joe.0.1780467; Kolpak A, 2005, J NEUROSCI, V25, P3432, DOI 10.1523/JNEUROSCI.4938-04.2005; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Li M, 2008, J BIOL CHEM, V283, P36257, DOI 10.1074/jbc.M806786200; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lin N, 2008, BIOCHEM BIOPH RES CO, V372, P260, DOI 10.1016/j.bbrc.2008.05.029; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Pisharath Harshan, 2009, V546, P133, DOI 10.1007/978-1-60327-977-2_9; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Shinozaki S, 2008, J CELL PHYSIOL, V216, P38, DOI 10.1002/jcp.21372; Sicklick JK, 2005, LAB INVEST, V85, P1368, DOI 10.1038/labinvest.3700349; Stewart GA, 2003, J PATHOL, V199, P488, DOI 10.1002/path.1295; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Wijgerde M, 2005, ENDOCRINOLOGY, V146, P3558, DOI 10.1210/en.2005-0311; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	54	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27941	10.1371/journal.pone.0027941	http://dx.doi.org/10.1371/journal.pone.0027941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164219	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400020
J	Krishna, S; Ray, A; Dubey, SK; Larrouy-Maumus, G; Chalut, C; Castanier, R; Noguera, A; Gilleron, M; Puzo, G; Vercellone, A; Nampoothiri, KM; Nigou, J				Krishna, Shyam; Ray, Aurelie; Dubey, Shiv K.; Larrouy-Maumus, Gerald; Chalut, Christian; Castanier, Romain; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Vercellone, Alain; Nampoothiri, K. Madhavan; Nigou, Jerome			Lipoglycans Contribute to Innate Immune Detection of Mycobacteria	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; STAPHYLOCOCCUS-AUREUS; LIPOTEICHOIC ACID; TUBERCULOSIS; BIOSYNTHESIS; TLR2; LIPOPROTEINS; LIPOARABINOMANNAN; RECOGNITION; BINDING	Innate immune recognition is based on the detection, by pattern recognition receptors (PRRs), of molecular structures that are unique to microorganisms. Lipoglycans are macromolecules specific to the cell envelope of mycobacteria and related genera. They have been described to be ligands, as purified molecules, of several PRRs, including the C-type lectins Mannose Receptor and DC-SIGN, as well as TLR2. However, whether they are really sensed by these receptors in the context of a bacterium infection remains unclear. To address this question, we used the model organism Mycobacterium smegmatis to generate mutants altered for the production of lipoglycans. Since their biosynthesis cannot be fully abrogated, we manipulated the biosynthesis pathway of GDP-Mannose to obtain some strains with either augmented (similar to 1.7 fold) or reduced (similar to 2 fold) production of lipoglycans. Interestingly, infection experiments demonstrated a direct correlation between the amount of lipoglycans in the bacterial cell envelope on one hand and the magnitude of innate immune signaling in TLR2 reporter cells, monocyte/macrophage THP-1 cell line and human dendritic cells, as revealed by NF-kappa B activation and IL-8 production, on the other hand. These data establish that lipoglycans are bona fide Microbe-Associated Molecular Patterns contributing to innate immune detection of mycobacteria, via TLR2 among other PRRs.	[Krishna, Shyam; Ray, Aurelie; Dubey, Shiv K.; Larrouy-Maumus, Gerald; Chalut, Christian; Castanier, Romain; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Vercellone, Alain; Nigou, Jerome] CNRS, IPBS, Toulouse, France; [Krishna, Shyam; Ray, Aurelie; Dubey, Shiv K.; Larrouy-Maumus, Gerald; Chalut, Christian; Castanier, Romain; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Vercellone, Alain; Nigou, Jerome] Univ Toulouse, UPS, IPBS, Toulouse, France; [Krishna, Shyam; Nampoothiri, K. Madhavan] CSIR, Natl Inst Interdisciplinary Sci & Technol, Div Biotechnol, Thiruvananthapuram, Kerala, India	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Krishna, S (corresponding author), INRS, Quebec City, PQ, Canada.	madhavan85@hotmail.com; jerome.nigou@ipbs.fr	Nigou, Jérôme/D-6802-2019; Nampoothiri, K.Madhavan/J-4727-2017	Nigou, Jérôme/0000-0002-6233-2487; Dubey, Shiv/0000-0001-5841-2807; Larrouy-Maumus, Gerald/0000-0001-6614-8698; Chalut, Christian/0000-0002-4849-1369; GILLERON, Martine/0000-0002-2581-3302; Nampoothiri, K.Madhavan/0000-0003-4151-0974	Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA) [3403-1]; CEFIPRA; Embassy of France in India to perform research at IPBS; French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale (FRM)	Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)(Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)); CEFIPRA; Embassy of France in India to perform research at IPBS; French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA) grant 3403-1. S. K. and S. K. D. are CEFIPRA-sponsored PhD student and post-doc respectively. S. K. was awarded a "Sandwich PhD" scholarship of the Embassy of France in India to perform research at IPBS (Toulouse). A. R. is a recipient of PhD fellowships from the French Ministere de l'Enseignement Superieur et de la Recherche and from Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Beutler B, 2003, IMMUNITY, V19, P155, DOI 10.1016/S1074-7613(03)00212-7; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026316; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; GRACY RW, 1968, J BIOL CHEM, V243, P3161; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Keiser TL, 2011, INFECT IMMUN, V79, P4668, DOI 10.1128/IAI.05635-11; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; McCarthy TR, 2005, MOL MICROBIOL, V58, P774, DOI 10.1111/j.1365-2958.2005.04862.x; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; MUNCHPETERSEN A, 1962, METHOD ENZYMOL, V5, P171, DOI 10.1016/S0076-6879(62)05203-9; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nigou J, 2000, J MOL BIOL, V299, P1353, DOI 10.1006/jmbi.2000.3821; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Patterson JH, 2003, BIOCHEM J, V372, P77, DOI 10.1042/BJ20021700; PINDAR DF, 1975, BIOCHEM J, V152, P617, DOI 10.1042/bj1520617; Pitarque S, 2008, TUBERCULOSIS, V88, P560, DOI 10.1016/j.tube.2008.04.002; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rezwan M, 2007, MICROBIOL-SGM, V153, P652, DOI 10.1099/mic.0.2006/000216-0; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sutcliffe L, 2005, TUBERCULOSIS, V85, P205, DOI 10.1016/j.tube.2004.12.002; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	45	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28476	10.1371/journal.pone.0028476	http://dx.doi.org/10.1371/journal.pone.0028476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164297	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400098
J	Bansal, S; Srivastava, A; Mukherjee, G; Pandey, R; Verma, AK; Mishra, P; Kundu, B				Bansal, Saurabh; Srivastava, Ankit; Mukherjee, Goutam; Pandey, Ramendra; Verma, Anita Kamra; Mishra, Prashant; Kundu, Bishwajit			Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: structural insights on their mechanism of action	FASEB JOURNAL			English	Article						Pyroccocus furiosus; leukemia; stability; MD simulation; catalytic triad	ESCHERICHIA-COLI-ASPARAGINASE; CAROTOVORA L-ASPARAGINASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ENGINEERING RESISTANCE; CONFORMATIONAL-CHANGES; THERMAL-STABILITY; PROTEIN; PURIFICATION; EXPRESSION	Thermophilic L-asparaginases display high stability and activity at elevated temperatures. However, they are of limited use in leukemia therapy because of their low substrate affinity and reduced activity under physiological conditions. In an attempt to combine stability with activity at physiological conditions, 3 active-site mutants of Pyrococcus furiosus L-asparaginase (PfA) were developed. The mutants, specifically K274E, showed improved enzymatic properties at physiological conditions as compared to the wild type. All variants were thermodynamically stable and resistant to proteolytic digestion. None of the enzymes displayed glutaminase activity, a highly desirable therapeutic property. All variants showed higher and significant killing of human cell lines HL60, MCF7, and K562 as compared to the Escherichia coli L-asparaginase. Our study revealed that increased substrate accessibility through the active site loop plays a major role in determining activity. A new mechanistic insight has been proposed based on molecular dynamics simulated structures, where dynamic flipping of a critical Tyr residue is responsible for the activity of thermophilic L-asparaginases. Our study not only resulted in development of PfA mutants with combination of desirable properties but also gave a mechanistic insight about their activity.-Bansal, S., Srivastava, A., Mukherjee, G., Pandey, R., Verma, A. K., Mishra, P., Kundu, B. Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: structural insights on their mechanism of action. FASEB J. 26, 1161-1171 (2012). www.fasebj.org	[Bansal, Saurabh; Mishra, Prashant] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Srivastava, Ankit; Kundu, Bishwajit] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi, India; [Mukherjee, Goutam] Indian Inst Technol Delhi, Supercomp Facil Bioinformat & Computat Biol, New Delhi, India; [Pandey, Ramendra; Verma, Anita Kamra] Univ Delhi, Kirorimal Coll, Dept Zool, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Delhi	Kundu, B (corresponding author), Indian Inst Technol, Sch Biol Sci, Hauz Khas, New Delhi 110016, India.	bkundu@bioschool.iitd.ac.in	Bansal, Saurabh/I-8051-2019; Mukherjee, Goutam/B-6478-2017; Verma, Anita Kamra/GNW-5479-2022; Pandey, Ramendra pati/AAE-6970-2021; Bansal, Saurabh/S-9094-2016; verma, Anita/AAU-2760-2021; Mishra, Prashant/R-4701-2019	Bansal, Saurabh/0000-0002-0574-4063; Mukherjee, Goutam/0000-0002-4620-2770; Verma, Anita Kamra/0000-0001-6341-5930; Bansal, Saurabh/0000-0002-0574-4063; Pandey, Ramendrapati/0000-0002-5196-6468; Mukherjee, Babul/0000-0003-2422-1601; Kundu, Bishwajit/0000-0002-5786-3144	Indian Institute of Technology Delhi; Council of Scientific and Industrial Research, Government of India; supercomputing facility of the Indian Institute of Technology Delhi	Indian Institute of Technology Delhi; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); supercomputing facility of the Indian Institute of Technology Delhi	S. B. acknowledges the Indian Institute of Technology Delhi and the Council of Scientific and Industrial Research, Government of India, for providing financial and infrastructural support. The authors are thankful for the support of the supercomputing facility of the Indian Institute of Technology Delhi. The authors also thank Dr. P. Guptasarma, Dr. K. K. Pandey, and Ms. Rachana for helping at different phases of the work.	AMMON HL, 1988, J BIOL CHEM, V263, P150; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avramis VI, 2006, INT J NANOMED, V1, P241; Balcao VM, 2001, BIOTECHNOL PROGR, V17, P537, DOI 10.1021/bp000163r; Bansal S, 2010, BIOCHEMISTRY-MOSCOW+, V75, P375, DOI 10.1134/S0006297910030144; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case D, 2006, AMBER 9; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; CURRAN MP, 1985, ARCH BIOCHEM BIOPHYS, V241, P571, DOI 10.1016/0003-9861(85)90582-X; CURTHOYS NP, 1974, J BIOL CHEM, V249, P3261; DAVIDSON L, 1977, J BACTERIOL, V129, P1379, DOI 10.1128/JB.129.3.1379-1386.1977; de Champdore Marcella, 2006, Reviews in Environmental Science and Bio/Technology, V5, P233, DOI 10.1007/s11157-006-0009-9; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; DUNLOP PC, 1975, J BACTERIOL, V122, P1017, DOI 10.1128/JB.122.3.1017-1024.1975; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Graham ML, 2003, ADV DRUG DELIVER REV, V55, P1293, DOI 10.1016/S0169-409X(03)00110-8; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Guo L, 2000, BIOCHEM BIOPH RES CO, V276, P197, DOI 10.1006/bbrc.2000.3434; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keating M J, 1993, Leuk Lymphoma, V10 Suppl, P153, DOI 10.3109/10428199309149129; Khushoo A, 2004, PROTEIN EXPRES PURIF, V38, P29, DOI 10.1016/j.pep.2004.07.009; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kotzia GA, 2005, J BIOTECHNOL, V119, P309, DOI 10.1016/j.jbiotec.2005.04.016; Kotzia GA, 2007, BIOCHEM J, V404, P337, DOI 10.1042/BJ20061708; Kotzia GA, 2007, J BIOTECHNOL, V127, P657, DOI 10.1016/j.jbiotec.2006.07.037; Kotzia GA, 2009, FEBS J, V276, P1750, DOI 10.1111/j.1742-4658.2009.06910.x; Kukurova K, 2009, MOL NUTR FOOD RES, V53, P1532, DOI 10.1002/mnfr.200800600; Kwon YM, 2009, J CONTROL RELEASE, V139, P182, DOI 10.1016/j.jconrel.2009.06.027; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li LZ, 2007, ENZYME MICROB TECH, V41, P523, DOI 10.1016/j.enzmictec.2007.04.004; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; Mishra A, 2006, APPL BIOCHEM BIOTECH, V135, P33, DOI 10.1385/ABAB:135:1:33; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; NEWSTED WJ, 1995, ENZYME MICROB TECH, V17, P757, DOI 10.1016/0141-0229(95)91162-R; Oettgen H F, 1970, Recent Results Cancer Res, V33, P219; Offman MN, 2011, BLOOD, V117, P1614, DOI 10.1182/blood-2010-07-298422; Oza VP, 2009, J INTEGR PLANT BIOL, V51, P201, DOI 10.1111/j.1744-7909.2008.00779.x; Palm GJ, 1996, FEBS LETT, V390, P211, DOI 10.1016/0014-5793(96)00660-6; Papageorgiou AC, 2008, FEBS J, V275, P4306, DOI 10.1111/j.1742-4658.2008.06574.x; Pedreschi F, 2008, FOOD CHEM, V109, P386, DOI 10.1016/j.foodchem.2007.12.057; Polizzi KM, 2007, CURR OPIN CHEM BIOL, V11, P220, DOI 10.1016/j.cbpa.2007.01.685; Pritsa AA, 2001, MOL CELL BIOCHEM, V216, P93, DOI 10.1023/A:1011066129771; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanches M, 2007, CURR CHEM BIOL, V1, P75, DOI DOI 10.2174/2212796810701010075; Soares AL, 2002, INT J PHARMACEUT, V237, P163, DOI 10.1016/S0378-5173(02)00046-7; Stecher A L, 1999, Pharm Acta Helv, V74, P1, DOI 10.1016/S0031-6865(99)00009-6; TOLLERSRUD OK, 1989, BIOCHEM J, V260, P101, DOI 10.1042/bj2600101; van den Berg H, 2011, LEUKEMIA LYMPHOMA, V52, P168, DOI 10.3109/10428194.2010.537796; Vemparala S, 2011, BBA-PROTEINS PROTEOM, V1814, P630, DOI 10.1016/j.bbapap.2011.03.012; Verma N, 2007, CRIT REV BIOTECHNOL, V27, P45, DOI 10.1080/07388550601173926; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Xiao GS, 1996, BBA-PROTEIN STRUCT M, V1294, P1; Yao M, 2005, ACTA CRYSTALLOGR D, V61, P294, DOI 10.1107/S0907444904032950; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; ZHOU HM, 1993, BIOCHEM J, V291, P103, DOI 10.1042/bj2910103	64	47	52	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1161	1171		10.1096/fj.11-191254	http://dx.doi.org/10.1096/fj.11-191254			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22166247				2022-12-25	WOS:000300949300019
J	Gortat, A; San-Roman, MJ; Vannier, C; Schmidt, AA				Gortat, Anna; San-Roman, Mabel Jouve; Vannier, Christian; Schmidt, Anne A.			Single Point Mutation in Bin/Amphiphysin/Rvs (BAR) Sequence of Endophilin Impairs Dimerization, Membrane Shaping, and Src Homology 3 Domain-mediated Partnership	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; CENTRAL-NERVOUS-SYSTEM; SH3 DOMAIN; AMPHIPATHIC HELICES; CONTAINING PROTEINS; STRUCTURAL BASIS; CURVATURE; SYNAPTOJANIN; AMPHIPHYSIN; MECHANISM	Bin/Amphiphysin/Rvs ( BAR) domain-containing proteins are essential players in the dynamics of intracellular compartments. The BAR domain is an evolutionarily conserved dimeric module characterized by a crescent-shaped structure whose intrinsic curvature, flexibility, and ability to assemble into highly ordered oligomers contribute to inducing the curvature of target membranes. Endophilins, diverging into A and B subgroups, are BAR and SH3 domain-containing proteins. They exert activities in membrane dynamic processes such as endocytosis, autophagy, mitochondrial dynamics, and permeabilization during apoptosis. Here, we report on the involvement of the third alpha-helix of the endophilin A BAR sequence in dimerization and identify leucine 215 as a key residue within a network of hydrophobic interactions stabilizing the entire BAR dimer interface. With the combination of N-terminal truncation retaining the high dimerization capacity of the third alpha-helices of endophilin A and leucine 215 substitution by aspartate (L215D), we demonstrate the essential role of BAR sequence-mediated dimerization on SH3 domain partnership. In comparison with wild type, full-length endophilin A2 heterodimers with one protomer bearing the L215D substitution exhibit very significant changes in membrane binding and shaping activities as well as a dramatic decrease of SH3 domain partnership. This suggests that subtle changes in the conformation and/or rigidity of the BAR domain impact both the control of membrane curvature and downstream binding to effectors. Finally, we show that expression, in mammalian cells, of endophilin A2 bearing the L215D substitution impairs the endocytic recycling of transferrin receptors.	[Gortat, Anna; San-Roman, Mabel Jouve; Vannier, Christian; Schmidt, Anne A.] Univ Paris Diderot, CNRS, UMR7592, Inst Jacques Monod, F-75205 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Schmidt, AA (corresponding author), Univ Paris Diderot, CNRS, UMR7592, Inst Jacques Monod, Batiment Buffon,15 Rue Helene Brion, F-75205 Paris, France.	schmidt.anne@ijm.univ-paris-diderot.fr		Schmidt, Anne/0000-0002-8326-0937; Jouve San Roman, Mabel Juana/0000-0002-3115-4681	CNRS; French Ministry of Research [ACI BCMS 2004 2 421]; Charities Association pour la Recherche sur le Cancer; La Ligue Nationale Contre le Cancer, Comite de Paris	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Charities Association pour la Recherche sur le Cancer; La Ligue Nationale Contre le Cancer, Comite de Paris	This work was supported in part by CNRS, by Grant ACI BCMS 2004 2 421 from the French Ministry of Research, and by grants from the Charities Association pour la Recherche sur le Cancer and La Ligue Nationale Contre le Cancer, Comite de Paris.	Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Childress C, 2006, BIOCHEM J, V394, P693, DOI 10.1042/BJ20050576; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Loll PJ, 2008, ACTA CRYSTALLOGR F, V64, P243, DOI 10.1107/S1744309108007574; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rikhy R, 2002, J NEUROSCI, V22, P7478; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Ross JA, 2011, BIOPHYS J, V100, P729, DOI 10.1016/j.bpj.2010.12.3717; Rostovtseva TK, 2009, J BIOL CHEM, V284, P34390, DOI 10.1074/jbc.M109.021873; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Schmidt A, 1998, METHODS, V16, P160, DOI 10.1006/meth.1998.0663; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503	48	18	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4232	4247		10.1074/jbc.M111.325837	http://dx.doi.org/10.1074/jbc.M111.325837			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167186	hybrid, Green Published			2022-12-25	WOS:000300410900056
J	Patel, AG; Flatten, KS; Schneider, PA; Dai, NT; McDonald, JS; Poirier, GG; Kaufmann, SH				Patel, Anand G.; Flatten, Karen S.; Schneider, Paula A.; Dai, Nga T.; McDonald, Jennifer S.; Poirier, Guy G.; Kaufmann, Scott H.			Enhanced Killing of Cancer Cells by Poly(ADP-ribose) Polymerase Inhibitors and Topoisomerase I Inhibitors Reflects Poisoning of Both Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSE POLYMERASE; SINGLE-STRAND BREAK; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; REPLICATION FORKS; LEUKEMIA-CELLS; PARP INHIBITOR; POSTTRANSLATIONAL MODIFICATION; TRANSDOMINANT INHIBITION	Poly(ADP-ribose) polymerase-1 (PARP1) plays critical roles in the regulation of DNA repair. Accordingly, small molecule inhibitors of PARP are being developed as agents that could modulate the activity of genotoxic chemotherapy, such as topoisomerase I poisons. In this study we evaluated the ability of the PARP inhibitor veliparib to enhance the cytotoxicity of the topoisomerase I poisons topotecan and camptothecin (CPT). Veliparib increased the cell cycle and cytotoxic effects of topotecan in multiple cell line models. Importantly, this sensitization occurred at veliparib concentrations far below those required to substantially inhibit poly(ADP-ribose) polymer synthesis and at least an order of magnitude lower than those involved in selective killing of homologous recombination-deficient cells. Further studies demonstrated that veliparib enhanced the effects of CPT in wild-type mouse embryonic fibroblasts (MEFs) but not Parp1(-/-) MEFs, confirming that PARP1 is the critical target for this sensitization. Importantly, parental and Parp1(-/-) MEFs had indistinguishable CPT sensitivities, ruling out models in which PARP1 catalytic activity plays a role in protecting cells from topoisomerase I poisons. To the contrary, cells were sensitized to CPT in a veliparib-independent manner upon transfection with PARP1 E988K, which lacks catalytic activity, or the isolated PARP1 DNA binding domain. These results are consistent with a model in which small molecule inhibitors convert PARP1 into a protein that potentiates the effects of topoisomerase I poisons by binding to damaged DNA and preventing its normal repair.	[Patel, Anand G.; Flatten, Karen S.; Schneider, Paula A.; Dai, Nga T.; McDonald, Jennifer S.; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Patel, Anand G.; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Poirier, Guy G.] Univ Laval, Med Ctr, Quebec City, PQ G1V 4G2, Canada	Mayo Clinic; Mayo Clinic; Laval University	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-212,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.Scott@mayo.edu	Patel, Anand/G-9877-2018	Patel, Anand/0000-0002-1438-8275; Poirier, Guy/0000-0002-4869-1424; Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [T32 GM072474, P50 CA136393, R01 CA73709]; Mayo Foundation for Research and Education; NATIONAL CANCER INSTITUTE [R01CA073709, P50CA136393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation for Research and Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant T32 GM072474 and a pre-doctoral fellowship from the Mayo Foundation for Research and Education.; This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA136393 and R01 CA73709.	Adjei AA, 1998, CLIN CANCER RES, V4, P683; Affar EB, 1999, BBA-GEN SUBJECTS, V1428, P137, DOI 10.1016/S0304-4165(99)00054-9; Aggarwal M, 2011, P NATL ACAD SCI USA, V108, P1525, DOI 10.1073/pnas.1006423108; Alexander B. M., 2011, J NEUROONCO IN PRESS; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Barrows LR, 1998, MUTAT RES-DNA REPAIR, V408, P103, DOI 10.1016/S0921-8777(98)00022-6; Bauer PI, 2000, INT J MOL MED, V5, P533; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Calabrese CR, 2003, CLIN CANCER RES, V9, P2711; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHAMPOUX JJ, 1976, P NATL ACAD SCI USA, V73, P3488, DOI 10.1073/pnas.73.10.3488; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; COVEY JM, 1989, CANCER RES, V49, P5016; Delaney CA, 2000, CLIN CANCER RES, V6, P2860; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Desnoyers S, 1996, EXP CELL RES, V227, P146, DOI 10.1006/excr.1996.0259; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Erlichman C, 2001, CANCER RES, V61, P739; FAKAN S, 1988, EXP CELL RES, V179, P517, DOI 10.1016/0014-4827(88)90289-3; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Galvez-Peralta M, 2008, MOL PHARMACOL, V74, P724, DOI 10.1124/mol.108.047787; Goldwasser F, 1996, CANCER RES, V56, P4430; Haince J. F., 2001, CURRENT PROTOCOLS CE; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2005, TRENDS MOL MED, V11, P456, DOI 10.1016/j.molmed.2005.08.003; Hans MA, 1999, ONCOGENE, V18, P7010, DOI 10.1038/sj.onc.1203178; HECK MMS, 1988, P NATL ACAD SCI USA, V85, P1086, DOI 10.1073/pnas.85.4.1086; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; KASID UN, 1989, J BIOL CHEM, V264, P18687; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Kaufmann SH, 1997, BLOOD, V89, P2098, DOI 10.1182/blood.V89.6.2098; Kaufmann SH, 2001, ANAL BIOCHEM, V296, P283, DOI 10.1006/abio.2001.5313; KAUFMANN SH, 1989, J BIOL CHEM, V264, P13946; Koch SSC, 2002, J MED CHEM, V45, P4961, DOI 10.1021/jm02059n; KOHN KW, 1976, BIOCHEMISTRY-US, V15, P4629, DOI 10.1021/bi00666a013; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kummar S, 2009, J CLIN ONCOL, V27, P2705, DOI 10.1200/JCO.2008.19.7681; Kupper JH, 1996, CANCER RES, V56, P2715; KUPPER JH, 1995, MOL CELL BIOL, V15, P3154; LAMARRE D, 1988, BIOCHIM BIOPHYS ACTA, V950, P147, DOI 10.1016/0167-4781(88)90007-3; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Li XF, 2011, DRUG METAB DISPOS, V39, P1161, DOI 10.1124/dmd.110.037820; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Liu XS, 2009, MOL CANCER RES, V7, P1686, DOI 10.1158/1541-7786.MCR-09-0299; Marple T, 2006, MUTAT RES-FUND MOL M, V602, P110, DOI 10.1016/j.mrfmmm.2006.08.005; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Meng XW, 2011, J BIOL CHEM, V286, P35823, DOI 10.1074/jbc.M111.240432; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; MULLER MT, 1985, BIOCHIM BIOPHYS ACTA, V824, P263, DOI 10.1016/0167-4781(85)90057-0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Park SY, 2005, CANCER RES, V65, P3894, DOI 10.1158/0008-5472.CAN-04-4014; Park SY, 2002, CANCER RES, V62, P459; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; PIKE BL, 1970, J CELL PHYSIOL, V76, P77, DOI 10.1002/jcp.1040760111; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; POTMESIL M, 1988, CANCER RES, V48, P3537; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; RYAN AJ, 1991, NUCLEIC ACIDS RES, V19, P3295, DOI 10.1093/nar/19.12.3295; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SCHREIBER V, 1995, P NATL ACAD SCI USA, V92, P4753, DOI 10.1073/pnas.92.11.4753; Segovis CM, 2009, J IMMUNOL, V182, P6933, DOI 10.4049/jimmunol.0803840; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNAPKA RM, 1986, MOL CELL BIOL, V6, P4221, DOI 10.1128/MCB.6.12.4221; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Tikhe JG, 2004, J MED CHEM, V47, P5467, DOI 10.1021/jm030513r; von Kobbe C, 2004, NUCLEIC ACIDS RES, V32, P4003, DOI 10.1093/nar/gkh721; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; White AW, 2000, J MED CHEM, V43, P4084, DOI 10.1021/jm000950v; Yang SX, 2009, CANCER BIOL THER, V8, P2004, DOI 10.4161/cbt.8.21.9917; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304	99	78	79	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4198	4210		10.1074/jbc.M111.296475	http://dx.doi.org/10.1074/jbc.M111.296475			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158865	Green Published, hybrid			2022-12-25	WOS:000300410900053
J	Perugino, G; Vettone, A; Illiano, G; Valenti, A; Ferrara, MC; Rossi, M; Ciaramella, M				Perugino, Giuseppe; Vettone, Antonella; Illiano, Giuseppina; Valenti, Anna; Ferrara, Maria C.; Rossi, Mose; Ciaramella, Maria			Activity and Regulation of Archaeal DNA Alkyltransferase CONSERVED PROTEIN INVOLVED IN REPAIR OF DNA ALKYLATION DAMAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; FUSION PROTEINS; REVERSE GYRASE; BINDING; DEGRADATION	Agents that form methylation adducts in DNA are highly mutagenic and carcinogenic, and organisms have evolved specialized cellular pathways devoted to their repair, including DNA alkyltransferases. These are proteins conserved in eucarya, bacteria and archaea, acting by a unique reaction mechanism, which leads to direct repair of DNA alkylation damage and irreversible protein alkylation. The alkylated form of DNA alkyltransferases is inactive, and in eukaryotes, it is rapidly directed to degradation. We report here in vitro and in vivo studies on the DNA alkyltransferase from the thermophilic archaeon Sulfolobus solfataricus (SsOGT). The development of a novel, simple, and sensitive fluorescence-based assay allowed a careful characterization of the SsOGT biochemical and DNA binding activities. In addition, transcriptional and post-translational regulation of SsOGT by DNA damage was studied. We show that although the gene transcription is induced by alkylating agent treatment, the protein is degraded in vivo by an alkylation-dependent mechanism. These experiments suggest a striking conservation, from archaea to humans, of this important pathway safeguarding genome stability.	[Perugino, Giuseppe; Vettone, Antonella; Illiano, Giuseppina; Valenti, Anna; Ferrara, Maria C.; Rossi, Mose; Ciaramella, Maria] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Ciaramella, M (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.	m.ciaramella@ibp.cnr.it	Perugino, Giuseppe/P-8147-2016; Ciaramella, Maria/O-1152-2015	Ciaramella, Maria/0000-0003-1583-1694; Perugino, Giuseppe/0000-0003-3266-4744; Valenti, Anna/0000-0002-5278-3524	Merit Grant [RBNE08YFN3]; Ministero degli Affari Esteri [L. 401/1990]	Merit Grant; Ministero degli Affari Esteri(Ministry of Foreign Affairs and International Cooperation (Italy))	This work was partially supported by Merit Grant RBNE08YFN3 and Ministero degli Affari Esteri (Grant L. 401/1990).	Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Fang QM, 2005, BIOCHEMISTRY-US, V44, P15396, DOI 10.1021/bi051460d; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Ishiguro K, 2008, ANAL BIOCHEM, V383, P44, DOI 10.1016/j.ab.2008.08.009; Ishiguro K, 2010, BIOCHEM PHARMACOL, V80, P1317, DOI 10.1016/j.bcp.2010.07.022; Kanugula S, 2003, BIOCHEM J, V375, P449, DOI 10.1042/BJ20030809; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Keppler A, 2004, METHODS, V32, P437, DOI 10.1016/j.ymeth.2003.10.007; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Leatherbarrow R. J., 2004, GRAFIT VERSION 5 0; Leclere MM, 1998, MOL GEN GENET, V258, P69, DOI 10.1007/s004380050708; Lim A, 1996, EMBO J, V15, P4050, DOI 10.1002/j.1460-2075.1996.tb00778.x; Makarova KS, 2010, ARCHAEA, V2010, DOI 10.1155/2010/710303; Margison GP, 2003, CARCINOGENESIS, V24, P625, DOI 10.1093/carcin/bgg005; Maupin-Furlow JA, 2006, CURR TOP DEV BIOL, V75, P125, DOI 10.1016/S0070-2153(06)75005-0; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Nishikori S, 2004, J BIOCHEM, V136, P503, DOI 10.1093/jb/mvh149; Pegg AE, 2011, CHEM RES TOXICOL, V24, P618, DOI 10.1021/tx200031q; Rabik CA, 2006, CANCER TREAT REV, V32, P261, DOI 10.1016/j.ctrv.2006.03.004; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Roberts A, 2006, MAGN RESON CHEM, V44, pS71, DOI 10.1002/mrc.1823; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Tintore M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/632041; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Valenti A, 2009, NUCLEIC ACIDS RES, V37, P4287, DOI 10.1093/nar/gkp386; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580	32	30	30	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4222	4231		10.1074/jbc.M111.308320	http://dx.doi.org/10.1074/jbc.M111.308320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167184	hybrid, Green Published			2022-12-25	WOS:000300410900055
J	Jamison, DK; Driver, JW; Diehl, MR				Jamison, D. Kenneth; Driver, Jonathan W.; Diehl, Michael R.			Cooperative Responses of Multiple Kinesins to Variable and Constant Loads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUG-OF-WAR; CARGO TRANSPORT; BIDIRECTIONAL TRANSPORT; MICROTUBULE MOTORS; PROCESSIVITY; MECHANISM; PROTEINS	Microtubule-dependent transport is most often driven by collections of kinesins and dyneins that function in either a concerted fashion or antagonistically. Several lines of evidence suggest that cargo transport may not be influenced appreciably by the combined action of multiple kinesins. Yet, as in previous optical trapping experiments, the forces imposed on cargos will vary spatially and temporally in cells depending on a number of local environmental factors, and the influence of these conditions has been largely overlooked. Here, we characterize the dynamics of structurally defined complexes containing multiple kinesins under the controlled loads of an optical force clamp. While demonstrating that there are generic kinetic barriers that restrict the ability of multiple kinesins to cooperate productively, the spatial and temporal properties of applied loads is found to play an important role in the collective dynamics of multiple motor systems. We propose this dependence has implications for intracellular transport processes, especially for bidirectional transport.	[Jamison, D. Kenneth; Driver, Jonathan W.; Diehl, Michael R.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Diehl, Michael R.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University; Rice University	Diehl, MR (corresponding author), Rice Univ, Dept Chem, 6100 Main St,MS 142, Houston, TX 77005 USA.	diehl@rice.edu			National Institutes of Health [1R01GM094489-01, F31GM089062]; National Science Foundation [MCB-0643832]; Welch Foundation [C-1559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM089062, R01GM094489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM094489-01 and F31GM089062 and by the National Science Foundation (MCB-0643832) and the Welch Foundation (C-1559).	Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; Beeg J, 2008, BIOPHYS J, V94, P532, DOI 10.1529/biophysj.106.097881; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Driver JW, 2010, PHYS CHEM CHEM PHYS, V12, P10398, DOI 10.1039/c0cp00117a; Fisher ME, 2005, P NATL ACAD SCI USA, V102, P16209, DOI 10.1073/pnas.0507802102; Gennerich A, 2006, PHYS BIOL, V3, P45, DOI 10.1088/1478-3975/3/1/005; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Holzbaur ELF, 2010, CURR OPIN CELL BIOL, V22, P4, DOI 10.1016/j.ceb.2009.12.014; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Muller MJI, 2010, BIOPHYS J, V98, P2610, DOI 10.1016/j.bpj.2010.02.037; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Schweller RM, 2008, BIOCONJUGATE CHEM, V19, P2304, DOI 10.1021/bc8003606; Shtridelman Y, 2008, CELL BIOCHEM BIOPHYS, V52, P19, DOI 10.1007/s12013-008-9021-8; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045	25	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3357	3365		10.1074/jbc.M111.296582	http://dx.doi.org/10.1074/jbc.M111.296582			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158622	Green Published, hybrid			2022-12-25	WOS:000300295100041
J	Kurihara, Y; Kanki, T; Aoki, Y; Hirota, Y; Saigusa, T; Uchiumi, T; Kang, DC				Kurihara, Yusuke; Kanki, Tomotake; Aoki, Yoshimasa; Hirota, Yuko; Saigusa, Tetsu; Uchiumi, Takeshi; Kang, Dongchon			Mitophagy Plays an Essential Role in Reducing Mitochondrial Production of Reactive Oxygen Species and Mutation of Mitochondrial DNA by Maintaining Mitochondrial Quantity and Quality in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKIN-DEFICIENT MICE; SACCHAROMYCES-CEREVISIAE; AUTOPHAGY; MECHANISM; ATG32; INDUCTION; MUTANTS; PROTEIN; NEURONS	In mammalian cells, the autophagy-dependent degradation of mitochondria (mitophagy) is thought to maintain mitochondrial quality by eliminating damaged mitochondria. However, the physiological importance of mitophagy has not been clarified in yeast. Here, we investigated the physiological role of mitophagy in yeast using mitophagy-deficient atg32- or atg11-knock-out cells. When wild-type yeast cells in respiratory growth encounter nitrogen starvation, mitophagy is initiated, excess mitochondria are degraded, and reactive oxygen species (ROS) production from mitochondria is suppressed; as a result, the mitochondria escape oxidative damage. On the other hand, in nitrogen-starved mitophagy-deficient yeast, excess mitochondria are not degraded and the undegraded mitochondria spontaneously age and produce surplus ROS. The surplus ROS damage the mitochondria themselves and the damaged mitochondria produce more ROS in a vicious circle, ultimately leading to mitochondrial DNA deletion and the so-called "petitemutant" phenotype. Cells strictly regulate mitochondrial quantity and quality because mitochondria produce both necessary energy and harmful ROS. Mitophagy contributes to this process by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production.	[Kurihara, Yusuke; Kanki, Tomotake; Aoki, Yoshimasa; Hirota, Yuko; Saigusa, Tetsu; Uchiumi, Takeshi; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 8128582, Japan	Kyushu University	Kanki, T (corresponding author), 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan.	kanki@cclm.med.kyushu-u.ac.jp	Kanki, Tomotake/H-7250-2012	Kanki, Tomotake/0000-0001-9646-5379	Ministry of Education, Culture, Sports, Science and Technology of Japan [23689032, 22020028, 22249018]; Takeda Science Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kyushu University; Grants-in-Aid for Scientific Research [23689032] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 23689032 (to T. K.), 22020028 (to T. K.), and 22249018 (to D. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Takeda Science Foundation (to T. K.), the Naito Foundation (to T. K.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T. K.), the Kowa Life Science Foundation (to T. K.), and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (to T. K.).	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2011, ANTIOXID REDOX SIGN, V14, P1989, DOI 10.1089/ars.2010.3762; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Noda T, 2008, METHOD ENZYMOL, V451, P27, DOI 10.1016/S0076-6879(08)03202-3; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	30	187	195	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3265	3272		10.1074/jbc.M111.280156	http://dx.doi.org/10.1074/jbc.M111.280156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157017	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000300295100032
J	Mburu, YK; Egloff, AM; Walker, WH; Wang, L; Seethala, RR; van Waes, C; Ferris, RL				Mburu, Yvonne K.; Egloff, Ann Marie; Walker, William H.; Wang, Lin; Seethala, Raja R.; van Waes, Carter; Ferris, Robert L.			Chemokine Receptor 7 (CCR7) Gene Expression Is Regulated by NF-kappa B and Activator Protein 1 (AP1) in Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; PROLIFERATION; TRANSCRIPTION; PATHWAYS; APOPTOSIS; CYTOKINES; BIOLOGY; LINES; IL-8; AP-1	The chemokine receptor CCR7 is a seven-transmembrane domain G-protein-coupled receptor that facilitates leukocyte migration to regional lymph nodes. Aberrant CCR7 expression in a number of human malignancies has been linked to prosurvival, -invasive, and -metastatic pathways. We demonstrate here that up-regulation of CCR7 in squamous cell carcinoma of the head and neck (SCCHN) patient tumors correlates with lower survival because of metastatic disease. Because of this important oncogenic phenotype, we investigated the mechanisms that regulate CCR7 expression in these tumors. Interestingly, the inflammatory transcription factor NF-kappa B has been associated with a more aggressive SCCHN phenotype. Immunohistochemical staining of a SCCHN tumor cohort (n = 47) strongly linked NF-kappa B staining and CCR7 expression in SCCHN. Thus, we investigated whether NF-kappa B contributes to metastatic disease by promoting CCR7 expression in SCCHN tumor cells. Wecharacterized four novel, potential NF-kappa B binding sites in the 1000-bp promoter region upstream of the CCR7 gene, using luciferase, ChIP, and EMSA. However, NF-kappa B inhibition only resulted in partial reduction in CCR7 expression, prompting consideration of other co-regulators of CCR7. Indeed, cooperation between NF-kappa B and AP1 transcription factors, which are often co-activated, is crucial to the regulation of CCR7 mRNA expression in metastatic SCCHN cells. Thus, our findings support an important biological role for inflammatory NF-kappa B and AP1 in the regulation of CCR7 expression in metastatic SCCHN. As such, CCR7, NF-kappa B, and AP1 could be potentially useful therapeutic targets in controlling the progression and metastasis of SCCHN tumors.	[Ferris, Robert L.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Mburu, Yvonne K.; Ferris, Robert L.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Egloff, Ann Marie; Ferris, Robert L.] Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Walker, William H.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Wang, Lin; Seethala, Raja R.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [van Waes, Carter] Natl Inst Deafness & Other Commun Disorders, Head & Neck Surg Branch, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Ferris, RL (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Wing,Rm 2-26B,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	ferrisrl@upmc.edu		Ferris, Robert/0000-0001-6605-2071	National Institutes of Health [1R01 CA115902]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 CA115902 (to R. L. F.).	Bancroft CC, 2001, CLIN CANCER RES, V7, P435; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Egloff AM, 2009, CLIN CANCER RES, V15, P6529, DOI 10.1158/1078-0432.CCR-09-0862; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; HEO DS, 1989, CANCER RES, V49, P5167; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Hopken UE, 2002, BLOOD, V99, P1109, DOI 10.1182/blood.V99.4.1109; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim JW, 2005, CLIN CANCER RES, V11, P7901, DOI 10.1158/1078-0432.CCR-05-1346; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Mburu YK, 2011, CARCINOGENESIS, V32, P168, DOI 10.1093/carcin/bgq236; Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807; Nakayama T, 2008, ONCOGENE, V27, P3221, DOI 10.1038/sj.onc.1210984; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Wang J, 2004, CANCER RES, V64, P1861, DOI 10.1158/0008-5472.CAN-03-2968; Wang J, 2008, JNCI-J NATL CANCER I, V100, P502, DOI 10.1093/jnci/djn059; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Wolf JS, 2001, CLIN CANCER RES, V7, P1812	28	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3581	3590		10.1074/jbc.M111.294876	http://dx.doi.org/10.1074/jbc.M111.294876			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158872	hybrid, Green Published			2022-12-25	WOS:000300295100062
J	Nadtochiy, SM; Zhu, QY; Urciuoli, W; Rafikov, R; Black, SM; Brookes, PS				Nadtochiy, Sergiy M.; Zhu, Qiuyu; Urciuoli, William; Rafikov, Ruslan; Black, Stephen M.; Brookes, Paul S.			Nitroalkenes Confer Acute Cardioprotection via Adenine Nucleotide Translocase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA-REPERFUSION INJURY; NITRATED FATTY-ACIDS; NITRIC-OXIDE; ADP/ATP CARRIER; REACTIVE OXYGEN; CYCLOPHILIN-D; CARDIAC MITOCHONDRIA; N-ETHYLMALEIMIDE; OXIDATIVE STRESS	Electrophilic nitrated lipids (nitroalkenes) are emerging as an important class of protective cardiovascular signaling molecules. Although species such as nitro-linoleate (LNO2) and nitro-oleate can confer acute protection against cardiac ischemic injury, their mechanism of action is unclear. Mild uncoupling of mitochondria is known to be cardioprotective, and adenine nucleotide translocase 1 (ANT1) is a key mediator of mitochondrial uncoupling. ANT1 also contains redox-sensitive cysteines that may be targets for modification by nitroalkenes. Therefore, in this study we tested the hypothesis that nitroalkenes directly modify ANT1 and that nitroalkene-mediated cardioprotection requires ANT1. Using biotin-tagged LNO2 infused into intact perfused hearts, we obtained mass spectrometric (MALDI-TOF-TOF) evidence for direct modification (nitroalkylation) of ANT1 on cysteine 57. Furthermore, in a cell model of ischemia-reperfusion injury, siRNA knockdown of ANT1 inhibited the cardioprotective effect of LNO2. Although the molecular mechanism linking ANT1-Cys(57) nitroalkylation and uncoupling is not yet known, these data suggest that ANT1-mediated uncoupling may be a mechanism for nitroalkene-induced cardioprotection.	[Nadtochiy, Sergiy M.; Urciuoli, William; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Zhu, Qiuyu] Univ Rochester, Med Ctr, Aab Cardiovas Res Inst, Rochester, NY 14642 USA; [Rafikov, Ruslan; Black, Stephen M.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	University of Rochester; University of Rochester; University System of Georgia; Augusta University	Brookes, PS (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, Box 604,601 Elmwood Ave, Rochester, NY 14642 USA.	paul_brookes@urmc.rochester.edu	Rafikov, Ruslan/AAG-9352-2019; Zhu, Qiuyu/M-7578-2017	Zhu, Qiuyu/0000-0003-2751-7985; Brookes, Paul/0000-0002-8639-8413; Rafikov, Ruslan/0000-0001-5950-4076	National Institutes of Health [HL071158, HL101902, HL067841, 5T32HL06699]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101902, R01HL067841, R01HL071158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071158 (to P. S. B.) and HL101902 and HL067841 (to S. M. B.).; Supported in part by National Institutes of Health Training Grant 5T32HL06699.	Al-Khalifa A, 2007, AM J PHYSIOL-REG I, V292, pR1198, DOI 10.1152/ajpregu.00661.2006; Baines CP, 2009, J MOL CELL CARDIOL, V46, P969, DOI 10.1016/j.yjmcc.2009.01.016; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker PRS, 2009, FREE RADICAL BIO MED, V46, P989, DOI 10.1016/j.freeradbiomed.2008.11.021; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Bosetti F, 2004, FEBS LETT, V563, P161, DOI 10.1016/S0014-5793(04)00294-7; BOULAY F, 1984, BIOCHEMISTRY-US, V23, P4807, DOI 10.1021/bi00315a042; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Brookes PS, 2002, FREE RADICAL BIO MED, V33, P755, DOI 10.1016/S0891-5849(02)00901-2; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Chavez JD, 2011, J PROTEOMICS, V74, P2417, DOI 10.1016/j.jprot.2011.03.031; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Di Lisa F, 2009, J MOL CELL CARDIOL, V46, P775, DOI 10.1016/j.yjmcc.2009.03.006; Dong Y, 2010, J CARDIOVASC PHARM T, V15, P220, DOI 10.1177/1074248410370327; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; GIRONCALLE J, 1994, ARCH BIOCHEM BIOPHYS, V315, P1, DOI 10.1006/abbi.1994.1463; Groeger AL, 2010, MOL INTERV, V10, P39, DOI 10.1124/mi.10.1.7; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Koenitzer JR, 2010, ANN NY ACAD SCI, V1203, P45, DOI 10.1111/j.1749-6632.2010.05559.x; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Landar A, 2006, BIOCHEM J, V394, P185, DOI 10.1042/BJ20051259; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; LEPRAN I, 1992, J CARDIOVASC PHARM, V19, P40, DOI 10.1097/00005344-199201000-00006; Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3; Lim DG, 2002, P NATL ACAD SCI USA, V99, P15941, DOI 10.1073/pnas.232409599; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Muscari C, 2006, CELL BIOCHEM FUNCT, V24, P511, DOI 10.1002/cbf.1294; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Petrovski G, 2011, ANTIOXID REDOX SIGN, V14, P2191, DOI 10.1089/ars.2010.3486; Quarrie R, 2011, J SURG RES, V165, P5, DOI 10.1016/j.jss.2010.09.018; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Vyssokikh MY, 2001, BIOCHEM J, V358, P349, DOI 10.1042/0264-6021:3580349; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Wong HL, 2008, CHEM RES TOXICOL, V21, P796, DOI 10.1021/tx700433m; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287	64	37	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3573	3580		10.1074/jbc.M111.298406	http://dx.doi.org/10.1074/jbc.M111.298406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158628	Green Published, hybrid			2022-12-25	WOS:000300295100061
J	Otero, M; Plumb, DA; Tsuchimochi, K; Dragomir, CL; Hashimoto, K; Peng, HB; Olivotto, E; Bevilacqua, M; Tan, LJ; Yang, ZY; Zhan, YM; Oettgen, P; Li, YF; Marcu, KB; Goldring, MB				Otero, Miguel; Plumb, Darren A.; Tsuchimochi, Kaneyuki; Dragomir, Cecilia L.; Hashimoto, Ko; Peng, Haibing; Olivotto, Eleonora; Bevilacqua, Michael; Tan, Lujian; Yang, Zhiyong; Zhan, Yumei; Oettgen, Peter; Li, Yefu; Marcu, Kenneth B.; Goldring, Mary B.			E74-like Factor 3 (ELF3) Impacts on Matrix Metalloproteinase 13 (MMP13) Transcriptional Control in Articular Chondrocytes under Proinflammatory Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OSTEOARTHRITIC CHONDROCYTES; FACTOR-KAPPA-B; MESSENGER-RNA EXPRESSION; MAMMARY EPITHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; BINDING-PROTEIN-BETA; GENE-EXPRESSION; HUMAN COLLAGENASE-3; FACTOR ESE-1; II COLLAGEN	Matrix metalloproteinase (MMP)-13 has a pivotal, rate-limiting function in cartilage remodeling and degradation due to its specificity for cleaving type II collagen. The proximal MMP13 promoter contains evolutionarily conserved E26 transformation-specific sequence binding sites that are closely flanked by AP-1 and Runx2 binding motifs, and interplay among these and other factors has been implicated in regulation by stress and inflammatory signals. Here we report that ELF3 directly controls MMP13 promoter activity by targeting an E26 transformation-specific sequence binding site at position -78 bp and by cooperating with AP-1. In addition, ELF3 binding to the proximal MMP13 promoter is enhanced by IL-1 beta stimulation in chondrocytes, and the IL-1 beta-induced MMP13 expression is inhibited in primary human chondrocytes by siRNA-ELF3 knockdown and in chondrocytes from Elf3(-/-) mice. Further, we found that MEK/ERK signaling enhances ELF3-driven MMP13 transactivation and is required for IL-1 beta-induced ELF3 binding to the MMP13 promoter, as assessed by chromatin immunoprecipitation. Finally, we show that enhanced levels of ELF3 co-localize with MMP13 protein and activity in human osteoarthritic cartilage. These studies define a novel role for ELF3 as a procatabolic factor that may contribute to cartilage remodeling and degradation by regulating MMP13 gene transcription.	[Otero, Miguel; Plumb, Darren A.; Tsuchimochi, Kaneyuki; Dragomir, Cecilia L.; Hashimoto, Ko; Bevilacqua, Michael; Goldring, Mary B.] Hosp Special Surg, Lab Cartilage Biol, Div Res, Weill Cornell Med Coll, New York, NY 10021 USA; [Peng, Haibing; Tan, Lujian; Zhan, Yumei; Oettgen, Peter] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Peng, Haibing; Tan, Lujian; Zhan, Yumei; Oettgen, Peter] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Olivotto, Eleonora; Marcu, Kenneth B.] Ist Ortoped Rizzoli, Ctr Ric Codivilla Putti, SC Lab Immunoreumatol & Rigeneraz Tissutale, I-40136 Bologna, Italy; [Yang, Zhiyong] Pfizer Biotherapeut Res, Inflammat & Remodeling Res Unit, Cambridge, MA 02140 USA; [Li, Yefu] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Marcu, Kenneth B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; IRCCS Istituto Ortopedico Rizzoli; Pfizer; Harvard University; Harvard School of Dental Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goldring, MB (corresponding author), Hosp Special Surg, Lab Cartilage Biol, Div Res, Weill Cornell Med Coll, Caspary Res Bldg,5th Floor,535 E 70th St, New York, NY 10021 USA.	goldringm@hss.edu	Oettgen, Peter/AAF-5026-2021; Olivotto, Eleonora/AAE-5763-2020; Olivotto, Eleonora/C-6938-2019	Olivotto, Eleonora/0000-0002-6726-3177; Hashimoto, Ko/0000-0002-9644-054X	National Institutes of Health [R01-AG022021, R21-AR054887, RC4 AR060546]; Arthritis Foundation; Osteoarthritis Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR054887, RC4AR060546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Osteoarthritis Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG022021, R21-AR054887, and RC4 AR060546 (to M. B. G.). This work was also supported by an Arthritis Foundation postdoctoral fellowship (to M. O.) and an Osteoarthritis Research Society international scholarship (to E. O.).	Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Benderdour M, 2002, J RHEUMATOL, V29, P1262; Benderdour M, 2002, BIOCHEM BIOPH RES CO, V291, P1151, DOI 10.1006/bbrc.2002.6580; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Brown C, 2004, J BIOL CHEM, V279, P12794, DOI 10.1074/jbc.M308593200; Cabral A, 2003, J BIOL CHEM, V278, P17792, DOI 10.1074/jbc.M300508200; Diaz-Sanjuan T, 2009, J HEPATOL, V50, P128, DOI 10.1016/j.jhep.2008.07.034; Eckel KL, 2003, DNA CELL BIOL, V22, P79, DOI 10.1089/104454903321515896; Fan ZY, 2006, ARTHRITIS RHEUM-US, V54, P2471, DOI 10.1002/art.21961; Freemont AJ, 1997, ANN RHEUM DIS, V56, P542, DOI 10.1136/ard.56.9.542; Geng Y, 1996, J CLIN INVEST, V98, P2425, DOI 10.1172/JCI119056; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grall F, 2003, ARTHRITIS RHEUM, V48, P1249, DOI 10.1002/art.10942; Grall FT, 2005, FEBS J, V272, P1676, DOI 10.1111/j.1742-4658.2005.04592.x; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Iwai S, 2008, ORAL DIS, V14, P144, DOI 10.1111/j.1601-0825.2007.01360.x; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Kopp JL, 2007, J BIOL CHEM, V282, P3027, DOI 10.1074/jbc.M609907200; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lee SH, 2008, MOL CANCER THER, V7, P3739, DOI 10.1158/1535-7163.MCT-08-0548; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Lo YYC, 1998, J CELL BIOCHEM, V69, P19, DOI 10.1002/(SICI)1097-4644(19980401)69:1<19::AID-JCB3>3.0.CO;2-Y; Manavathi B, 2007, J BIOL CHEM, V282, P19820, DOI 10.1074/jbc.M702309200; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Muddasani P, 2007, J BIOL CHEM, V282, P31409, DOI 10.1074/jbc.M706508200; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nagarajan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004179; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Neve R, 1998, FASEB J, V12, P1541, DOI 10.1096/fasebj.12.14.1541; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Nieminen R, 2005, MEDIAT INFLAMM, P249, DOI 10.1155/MI.2005.249; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Okazaki K, 2002, J BIOL CHEM, V277, P31526, DOI 10.1074/jbc.M202815200; Pei Y, 2006, OSTEOARTHR CARTILAGE, V14, P749, DOI 10.1016/j.joca.2006.01.017; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Reddy SPM, 2003, J BIOL CHEM, V278, P21378, DOI 10.1074/jbc.M212258200; Rogerson FM, 2010, ARTHRITIS RHEUM-US, V62, P3365, DOI 10.1002/art.27661; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Tardif G, 2001, J RHEUMATOL, V28, P1631; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	69	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3559	3572		10.1074/jbc.M111.265744	http://dx.doi.org/10.1074/jbc.M111.265744			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158614	Green Published, hybrid			2022-12-25	WOS:000300295100060
J	Pelaez, R; Fernandez-Garcia, P; Herrero, P; Moreno, F				Pelaez, Rafael; Fernandez-Garcia, Paula; Herrero, Pilar; Moreno, Fernando			Nuclear Import of the Yeast Hexokinase 2 Protein Requires alpha/beta-Importin-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LOCALIZATION SIGNALS; NUCLEOCYTOPLASMIC TRANSPORT; REPRESSOR; KINASE; EXPORT; MIG1; PHOSPHORYLATION; GENES; HXT1	Hexokinase 2 (Hxk2) from Saccharomyces cerevisiae was one of the first metabolic enzymes described as a multifunctional protein. Hxk2 has a double subcellular localization and role, it functions as a glycolytic enzyme in the cytoplasm and as a regulator of gene transcription of several Mig1-regulated genes in the nucleus. However, the mechanism by which Hxk2 enters in the nucleus was unknown until now. Here, we report that the Hxk2 protein is an import substrate of the carriers alpha-importin (Kap60 in yeast) and beta-importin (Kap95 in yeast). We also show that the Hxk2 nuclear import and the binding of Hxk2 with Kap60 are glucose-dependent and involve one lysine-rich nuclear localization sequence (NLS), located between lysine 6 and lysine 12. Moreover, Kap95 facilitates the recognition of the Hxk2 NLS1 motif by Kap60 and both importins are essential for Hxk2 nuclear import. It is also demonstrated that Hxk2 nuclear import and its binding to Kap95 and Kap60 depend on the Gsp1-GTP/GDP protein levels. Thus, our study uncovers Hxk2 as a new cargo for the alpha/beta-importin pathway of S. cerevisiae.	[Pelaez, Rafael; Fernandez-Garcia, Paula; Herrero, Pilar; Moreno, Fernando] Univ Oviedo, Dept Biochem & Mol Biol, Oviedo 33006, Spain	University of Oviedo	Moreno, F (corresponding author), Campus El Cristo, Oviedo 33006, Spain.	fmoreno@uniovi.es	Fernández-García, Paula/M-5227-2019; Peláez, Rafael/R-9458-2019; Fernández García, Paula/L-8101-2014	Fernández-García, Paula/0000-0002-8128-7028; Peláez, Rafael/0000-0002-4047-6017; 	Ministerio de Ciencia e Innovacion (Spain) [BFU2007-66063-C02-02, BFU2010-19628-C02-01]; FICYT Foundation (Principado de Asturias); MICINN (Spain) [BFU2007-66063-C02-02]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FICYT Foundation (Principado de Asturias); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants BFU2007-66063-C02-02 and BFU2010-19628-C02-01 from the Ministerio de Ciencia e Innovacion (Spain).; Supported by a Severo Ochoa fellowship from the FICYT Foundation (Principado de Asturias). Present address: Centro de Investigacion Medica Aplicada (CIMA), Universidad de Navarra, 31008 Pamplona, Spain.; Supported by Formacion de Personal Investigador fellowship Grant BFU2007-66063-C02-02 from the MICINN (Spain).	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Belinchon MM, 2007, FEMS YEAST RES, V7, P40, DOI 10.1111/j.1567-1364.2006.00136.x; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; GASCON S, 1968, J BIOL CHEM, V243, P1567; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leslie DM, 2006, METHODS, V39, P291, DOI 10.1016/j.ymeth.2006.07.013; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Polizotto RS, 2001, J CELL BIOL, V154, P951, DOI 10.1083/jcb.200104078; Quan XX, 2007, BBA-MOL CELL RES, V1773, P1052, DOI 10.1016/j.bbamcr.2007.04.014; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Randez-Gil F, 1998, FEBS LETT, V425, P475, DOI 10.1016/S0014-5793(98)00289-0; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Taberner FJ, 2009, CELL CYCLE, V8, P3010; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	31	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3518	3529		10.1074/jbc.M111.317230	http://dx.doi.org/10.1074/jbc.M111.317230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157003	Green Published, hybrid			2022-12-25	WOS:000300295100056
J	Tidhar, R; Ben-Dor, S; Wang, E; Kelly, S; Merrill, AH; Futerman, AH				Tidhar, Rotem; Ben-Dor, Shifra; Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Acyl Chain Specificity of Ceramide Synthases Is Determined within a Region of 150 Residues in the Tram-Lag-CLN8 (TLC) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; LONGEVITY ASSURANCE GENES; HIGH-THROUGHPUT; FAMILY-MEMBERS; PREDICTION; LAG1; SPHINGOLIPIDS; ACCURACY; YEAST; CLASSIFICATION	In mammals, ceramides are synthesized by a family of six ceramide synthases (CerS), transmembrane proteins located in the endoplasmic reticulum, where each use fatty acyl-CoAs of defined chain length for ceramide synthesis. Little is known about the molecular features of the CerS that determine acyl-CoA selectivity. We now explore CerS structure-function relationships by constructing chimeric proteins combining sequences from CerS2, which uses C22-CoA for ceramide synthesis, and CerS5, which uses C16-CoA. CerS2 and -5 are 41% identical and 63% similar. Chimeras containing approximately half of CerS5 (from the N terminus) and half of CerS2 (from the C terminus) were catalytically inactive. However, the first 158 residues of CerS5 could be replaced with the equivalent region of CerS2 without affecting specificity of CerS5 toward C16-CoA; likewise, the putative sixth transmembrane domain (at the C terminus) of CerS5 could be replaced with the corresponding sequence of CerS2 without affecting CerS5 specificity. Remarkably, a chimeric CerS5/2 protein containing the first 158 residues and the last 83 residues of CerS2 displayed specificity toward C16-CoA, and a chimeric CerS2/5 protein containing the first 150 residues and the last 79 residues of CerS5 displayed specificity toward C22-CoA, demonstrating that a minimal region of 150 residues is sufficient for retaining CerS specificity.	[Tidhar, Rotem; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Ben-Dor, Shifra] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019	BEN-DOR, SHIFRA/0000-0001-9604-1939; Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217, and by the Israel Science Foundation (1404/07) and the Minerva Foundation.	Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Drummond AJ, 2010, GENEIOUS V5 3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Goldfinger M, 2009, J IMMUNOL, V182, P7038, DOI 10.4049/jimmunol.0802990; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Pasquier C, 1999, PROTEIN ENG, V12, P631, DOI 10.1093/protein/12.8.631; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Rost B, 1996, METHOD ENZYMOL, V266, P525; Shabi Uri, 2010, Syst Synth Biol, V4, P227, DOI 10.1007/s11693-010-9059-y; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sullards M C, 2001, Sci STKE, V2001, ppl1; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	45	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3197	3206		10.1074/jbc.M111.280271	http://dx.doi.org/10.1074/jbc.M111.280271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22144673	Green Published, hybrid			2022-12-25	WOS:000300295100025
J	Zhang, PX; Takeuchi, K; Csaki, LS; Reue, K				Zhang, Peixiang; Takeuchi, Kazuharu; Csaki, Lauren S.; Reue, Karen			Lipin-1 Phosphatidic Phosphatase Activity Modulates Phosphatidate Levels to Promote Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Gene Expression during Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; C/EBP-DELTA; ACID; LIPODYSTROPHY; OBESITY; ALPHA; PROTEIN; ROLES; PHOSPHORYLATION; TRANSCRIPTION	Adipose tissue plays a key role in metabolic homeostasis. Disruption of the Lpin1 gene encoding lipin-1 causes impaired adipose tissue development and function in rodents. Lipin-1 functions as a phosphatidate phosphatase (PAP) enzyme in the glycerol 3-phosphate pathway for triglyceride storage and as a transcriptional coactivator/corepressor for metabolic nuclear receptors. Previous studies established that lipin-1 is required at an early step in adipocyte differentiation for induction of the adipogenic gene transcription program, including the key regulator peroxisome proliferator-activated receptor gamma (PPAR gamma). Here, we investigate the requirement of lipin-1 PAP versus coactivator function in the establishment of Pparg expression during adipocyte differentiation. We demonstrate that PAP activity supplied by lipin-1, lipin-2, or lipin-3, but not lipin-1 coactivator activity, can rescue Pparg gene expression and lipogenesis during adipogenesis in lipin-1-deficient preadipocytes. In adipose tissue from lipin-1-deficient mice, there is an accumulation of phosphatidate species containing a range of medium chain fatty acids and an activation of the MAPK/extracellular signal-related kinase (ERK) signaling pathway. Phosphatidate inhibits differentiation of cultured adipocytes, and this can be rescued by the expression of lipin-1 PAP activity or by inhibition of ERK signaling. These results emphasize the importance of lipid intermediates as choreographers of gene regulation during adipogenesis, and the results highlight a specific role for lipins as determinants of levels of a phosphatidic acid pool that influences Pparg expression.	[Zhang, Peixiang; Takeuchi, Kazuharu; Csaki, Lauren S.; Reue, Karen] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Reue, K (corresponding author), Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Gonda 6506A,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	reuek@ucla.edu			National Institutes of Health [P01 HL90553, P01 HL28481, T32 HG002536, P20RR16475]; National Science Foundation [EPS 0236913, MCB 0455318, 0920663, DBI 0521587]; Kansas Technology Enterprise Corp.; K-IDeA Networks of Biomedical Research Excellence; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL090553] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; Direct For Biological Sciences [0920663] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corp.; K-IDeA Networks of Biomedical Research Excellence; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL90553 and P01 HL28481 (to K.R.) and T32 HG002536 (to L.C.).; The lipidomic analyses by mass spectrometry were performed at the Kansas Lipidomics Research Center Analytical Laboratory. Instrument acquisition and methods development at the Kansas Lipidomics Research Center were supported by National Science Foundation Grants EPS 0236913, MCB 0455318 and 0920663, and DBI 0521587, the Kansas Technology Enterprise Corp., National Institutes of Health Grant P20RR16475, K-IDeA Networks of Biomedical Research Excellence, and Kansas State University.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; FRANCKHAUSER S, 1995, BIOCHEM J, V305, P65, DOI 10.1042/bj3050065; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Patwardhan GA, 2011, PROG LIPID RES, V50, P104, DOI 10.1016/j.plipres.2010.10.003; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, DRUG NEWS PERSPECT, V18, P5, DOI 10.1358/dnp.2005.18.1.877165; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Reue K, 2006, CURR OPIN CLIN NUTR, V9, P436, DOI 10.1097/01.mco.0000232904.82038.db; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Simha V, 2009, CURR OPIN LIPIDOL, V20, P300, DOI 10.1097/MOL.0b013e32832d4a33; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stapleton CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018932; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Vernochet C, 2009, FEBS J, V276, P5729, DOI 10.1111/j.1742-4658.2009.07302.x; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Zalesin KC, 2011, MED CLIN N AM, V95, P919, DOI 10.1016/j.mcna.2011.06.005; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	64	58	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3485	3494		10.1074/jbc.M111.296681	http://dx.doi.org/10.1074/jbc.M111.296681			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157014	Green Published, hybrid			2022-12-25	WOS:000300295100053
J	Fischer, A; Sambashivan, S; Brunger, AT; Montal, M				Fischer, Audrey; Sambashivan, Shilpa; Brunger, Axel T.; Montal, Mauricio			Beltless Translocation Domain of Botulinum Neurotoxin A Embodies a Minimum Ion-conductive Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-ANALYSIS; RECEPTOR-BINDING; ANTHRAX TOXIN; HEAVY-CHAIN; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; PROTEIN-RECEPTOR; MEMBRANE-FUSION; PORE FORMATION; LIGHT-CHAIN	Botulinum neurotoxin, the causative agent of the paralytic disease botulism, is an endopeptidase composed of a catalytic domain (or light chain (LC)) and a heavy chain (HC) encompassing the translocation domain (TD) and receptor-binding domain. Upon receptor-mediated endocytosis, the LC and TD are proposed to undergo conformational changes in the acidic endocytic environment resulting in the formation of an LC protein-conducting TD channel. The mechanism of channel formation and the conformational changes in the toxin upon acidification are important but less well understood aspects of botulinum neurotoxin intoxication. Here, we have identified a minimum channel-forming truncation of the TD, the "beltless" TD, that forms transmembrane channels with ion conduction properties similar to those of the full-length TD. At variance with the holotoxin and the HC, channel formation for both the TD and the beltless TD occurs independent of a transmembrane pH gradient. Furthermore, acidification in solution induces moderate secondary structure changes. The subtle nature of the conformational changes evoked by acidification on the TD suggests that, in the context of the holotoxin, larger structural rearrangements and LC unfolding occur preceding or concurrent to channel formation. This notion is consistent with the hypothesis that although each domain of the holotoxin functions individually, each domain serves as a chaperone for the others.	[Fischer, Audrey; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Sambashivan, Shilpa; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of California System; University of California San Diego; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Montal, M (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	mmontal@ucsd.edu	Pacific-Southwest, RCE/B-6155-2009	Brunger, Axel/0000-0001-5121-2036	Howard Hughes Medical Institute; National Institutes of Health [MH63105, GM49711, AI065359]; Genentech Foundation; Stanford University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105, R01MH063105] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech Foundation(Roche HoldingGenentech); Stanford University(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Howard Hughes Medical Institute. This work was also supported, in whole or in part, by National Institutes of Health Grants MH63105 (to A. T. B.), GM49711, and AI065359 (to M. M).; Supported by the Genentech Foundation postdoctoral fellowship, Stanford University. Present address: Dept. of Neurosciences, Amgen Inc., South San Francisco, CA 94080.	Agarwal R, 2009, NAT STRUCT MOL BIOL, V16, P789, DOI 10.1038/nsmb.1626; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Carpaneto A, 1999, EXP BRAIN RES, V124, P193, DOI 10.1007/s002210050614; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Fanucchi S, 2008, BIOCHEMISTRY-US, V47, P11674, DOI 10.1021/bi801147r; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Galloux M, 2008, J BIOL CHEM, V283, P27668, DOI 10.1074/jbc.M802557200; Haug G, 2003, BIOCHEMISTRY-US, V42, P15284, DOI 10.1021/bi0354278; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krieger E., 2011, YASARA; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lai B, 2010, J MEMBRANE BIOL, V236, P191, DOI 10.1007/s00232-010-9292-z; Lascola CD, 1998, J NEUROSCI, V18, P1679; LEBEDA FJ, 1995, TOXICON, V33, P559, DOI 10.1016/0041-0101(94)00192-B; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTAL MS, 1992, FEBS LETT, V313, P12, DOI 10.1016/0014-5793(92)81173-J; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Mushrush DJ, 2011, J BIOL CHEM, V286, P27011, DOI 10.1074/jbc.M111.256982; OBLATTMONTAL M, 1995, PROTEIN SCI, V4, P1490, DOI 10.1002/pro.5560040806; Pirazzini M, 2011, CELL MICROBIOL, V13, P1731, DOI 10.1111/j.1462-5822.2011.01654.x; Ren JH, 1999, SCIENCE, V284, P955, DOI 10.1126/science.284.5416.955; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schmitt J, 2010, BIOCHEMISTRY-US, V49, P5200, DOI 10.1021/bi100412v; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	45	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1657	1661		10.1074/jbc.C111.319400	http://dx.doi.org/10.1074/jbc.C111.319400			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22158863	Green Published, hybrid			2022-12-25	WOS:000299321000008
J	Rabenold, D; Pearson, OM				Rabenold, Diana; Pearson, Osbjorn M.			Abrasive, Silica Phytoliths and the Evolution of Thick Molar Enamel in Primates, with Implications for the Diet of Paranthropus boisei	PLOS ONE			English	Article							UNDERGROUND-STORAGE ORGANS; DENTAL MICROWEAR; EARLY HOMINID; AUSTRALOPITHECUS-ANAMENSIS; MECHANICAL-PROPERTIES; ISOTOPIC EVIDENCE; TOOTH WEAR; AYE-AYES; ECOLOGY; PAPIO	Background: Primates-including fossil species of apes and hominins-show variation in their degree of molar enamel thickness, a trait long thought to reflect a diet of hard or tough foods. The early hominins demonstrated molar enamel thickness of moderate to extreme degrees, which suggested to most researchers that they ate hard foods obtained on or near the ground, such as nuts, seeds, tubers, and roots. We propose an alternative hypothesis-that the amount of phytoliths in foods correlates with the evolution of thick molar enamel in primates, although this effect is constrained by a species' degree of folivory. Methodology/Principal Findings: From a combination of dietary data and evidence for the levels of phytoliths in plant families in the literature, we calculated the percentage of plant foods rich in phytoliths in the diets of twelve extant primates with wide variation in their molar enamel thickness. Additional dietary data from the literature provided the percentage of each primate's diet made up of plants and of leaves. A statistical analysis of these variables showed that the amount of abrasive silica phytoliths in the diets of our sample primates correlated positively with the thickness of their molar enamel, constrained by the amount of leaves in their diet (R-2 = 0.875; p<.0006). Conclusions/Significance: The need to resist abrasion from phytoliths appears to be a key selective force behind the evolution of thick molar enamel in primates. The extreme molar enamel thickness of the teeth of the East African hominin Paranthropus boisei, long thought to suggest a diet comprising predominantly hard objects, instead appears to indicate a diet with plants high in abrasive silica phytoliths.	[Rabenold, Diana; Pearson, Osbjorn M.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of New Mexico	Rabenold, D (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	drabenol@unm.edu		Pearson, Osbjorn/0000-0002-1814-7663				ANDREWS P, 1991, PHILOS T R SOC B, V334, P199, DOI 10.1098/rstb.1991.0109; Andrews P., 1976, HUMAN ORIGINS L LEAK, P279; ANDRIAMASIMANANA M, 1994, FOLIA PRIMATOL, V62, P37, DOI 10.1159/000156761; [Anonymous], 2003, MET MAT CONV HARDN V; BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; Bamford MK, 2006, QUATERN INT, V148, P95, DOI 10.1016/j.quaint.2005.11.027; Bentley-Condit VK, 2009, AM J PRIMATOL, V71, P432, DOI 10.1002/ajp.20670; Bowes G, 2002, FUNCT PLANT BIOL, V29, P379, DOI 10.1071/PP01219; BOYDE A, 1984, ANAT EMBRYOL, V170, P57, DOI 10.1007/BF00319458; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; CHALMERS NR, 1968, FOLIA PRIMATOL, V8, P247, DOI 10.1159/000155157; Ciochon RL, 1990, PALEOANTHROPOLOGY AN, P47; Conklin-Brittain Nancy Lou, 2002, P61; Constantino P, 2007, EVOL ANTHROPOL, V16, P49, DOI 10.1002/evan.20130; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; DOUGALL H. W., 1964, EAST AFRICAN WILDLIFE J, V2, P86; Dumont Elizabeth R, 2011, Proc Biol Sci, V278, P3654, DOI 10.1098/rspb.2011.0528; Eck GG, 1987, FAUNES PLIO PLEISTOC, P18; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; ERICKSON CJ, 1994, FOLIA PRIMATOL, V62, P125, DOI 10.1159/000156769; Fashing PJ, 2001, INT J PRIMATOL, V22, P579, DOI 10.1023/A:1010737601922; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; FOX CL, 1994, J ARCHAEOL SCI, V21, P29, DOI 10.1006/jasc.1994.1005; Gantt DG, 1977, ENAMEL PRIMATE TEETH; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Grine F.E., 1988, P3; Grine FE, 2004, S AFR J SCI, V100, P389; Grine FE, 2006, S AFR J SCI, V102, P301; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Gugel IL, 2001, AM J PHYS ANTHROPOL, V114, P124, DOI 10.1002/1096-8644(200102)114:2&lt;124::AID-AJPA1012&gt;3.0.CO;2-S; HATLEY T, 1980, HUM ECOL, V8, P371, DOI 10.1007/BF01561000; Hummel J, 2011, P ROY SOC B-BIOL SCI, V278, P1742, DOI 10.1098/rspb.2010.1939; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; JOLLY CJ, 1970, MAN, V5, P5, DOI 10.2307/2798801; JONES L. H. P., 1967, Advances in agronomy. Vol. 19., P107, DOI 10.1016/S0065-2113(08)60734-8; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; KELLEY J, 1990, FOLIA PRIMATOL, V55, P73, DOI 10.1159/000156502; King SJ, 2005, P NATL ACAD SCI USA, V102, P16579, DOI 10.1073/pnas.0508377102; Kojola I, 1998, OECOLOGIA, V117, P26, DOI 10.1007/s004420050627; Kuroda Suehisa, 1996, P71, DOI 10.1017/CBO9780511752414.008; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lalueza C, 1996, AM J PHYS ANTHROPOL, V101, P101; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Lanning FC, 1965, ADV FRONTIERS PLANT, V12, P55; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Lucas PW, 2009, AM J PHYS ANTHROPOL, V140, P643, DOI 10.1002/ajpa.21026; LUCAS PW, 1995, FOLIA PRIMATOL, V64, P30, DOI 10.1159/000156829; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Martin, 1983, RELATIONSHIPS LATER; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Mau M, 2009, AM J PRIMATOL, V71, P663, DOI 10.1002/ajp.20701; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P528, DOI 10.2307/1940401; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Metcalfe C. R., 1950, Anatomy of the Dicotyledons: leaves, stem, and wood, in relation to taxonomy, with notes on economic uses.; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Milton K., 1978, P535; Nystrom P, 2004, AM J PHYS ANTHROPOL, V125, P279, DOI 10.1002/ajpa.10274; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak AJ, 2006, ANAT REC PART A, V288A, P263, DOI 10.1002/ar.a.20307; Olejniczak AJ, 2008, J HUM EVOL, V54, P187, DOI 10.1016/j.jhevol.2007.09.014; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Peters C. R., 1992, EDIBLE WILD PLANTS S; Peters CR, 2005, J HUM EVOL, V48, P219, DOI 10.1016/j.jhevol.2004.11.003; PETERS CR, 1981, CURR ANTHROPOL, V22, P127, DOI 10.1086/202631; Peters CR, 1999, AFRICAN PLANTS BIODI, P483; Piperno D. R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; PIPERNO DR, 1989, REV PALAEOBOT PALYNO, V61, P147, DOI 10.1016/0034-6667(89)90067-5; PIPERNO DR, 1985, REV PALAEOBOT PALYNO, V45, P185, DOI 10.1016/0034-6667(85)90002-8; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; RICHARDS.RC, 1968, WEAR, V11, P245, DOI 10.1016/0043-1648(68)90175-0; ROSENBERGER AL, 1976, AM J PHYS ANTHROPOL, V45, P281, DOI 10.1002/ajpa.1330450214; Samsonov GV, 1968, HDB PHYSICOCHEMICAL; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schwartz GT, 2000, AM J PHYS ANTHROPOL, V111, P221, DOI 10.1002/(SICI)1096-8644(200002)111:2<221::AID-AJPA8>3.0.CO;2-G; Shellis RP, 1998, J HUM EVOL, V35, P507, DOI 10.1006/jhev.1998.0238; Shipman P., 1988, P343; Shumway CA., 1999, FORGOTTEN WATERS FRE; SKOGLAND T, 1988, OIKOS, V51, P238, DOI 10.2307/3565648; Smith C. C., 1977, P97; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2005, J HUM EVOL, V48, P301, DOI 10.1016/j.jhevol.2004.11.008; Sponheimer M, 2009, AM J PHYS ANTHROPOL, V140, P661, DOI 10.1002/ajpa.21111; STERLING EJ, 1994, FOLIA PRIMATOL, V62, P115, DOI 10.1159/000156768; STERLING EJ, 1994, FOLIA PRIMATOL, V62, P142, DOI 10.1159/000156771; Stromberg CAE, 2006, PALEOBIOLOGY, V32, P236, DOI 10.1666/0094-8373(2006)32[236:EOHIET]2.0.CO;2; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; Teaford MF, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P433; TEAFORD MF, 1993, THEROPITHECUS, P331, DOI 10.1017/CBO9780511565540.013; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Terborgh J, 5 NEW WORLD PRIMATES; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2012, J HUM EVOL, V63, P429, DOI 10.1016/j.jhevol.2011.04.006; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; UNGAR PS, 1995, INT J PRIMATOL, V16, P221, DOI 10.1007/BF02735479; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Wahungu GM, 1998, AFR J ECOL, V36, P159, DOI 10.1046/j.1365-2028.1998.00120.x; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732; WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006	115	67	71	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28379	10.1371/journal.pone.0028379	http://dx.doi.org/10.1371/journal.pone.0028379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163299	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900035
J	Herder, C; Peeters, W; Illig, T; Baumert, J; de Kleijn, DPV; Moll, FL; Poschen, U; Klopp, N; Muller-Nurasyid, M; Roden, M; Preuss, M; Karakas, M; Meisinger, C; Thorand, B; Pasterkamp, G; Koenig, W				Herder, Christian; Peeters, Wouter; Illig, Thomas; Baumert, Jens; de Kleijn, Dominique P. V.; Moll, Frans L.; Poschen, Ulrike; Klopp, Norman; Mueller-Nurasyid, Martina; Roden, Michael; Preuss, Michael; Karakas, Mahir; Meisinger, Christa; Thorand, Barbara; Pasterkamp, Gerard; Koenig, Wolfgang		CARDioGRAM Consortium	RANTES/CCL5 and Risk for Coronary Events: Results from the MONICA/KORA Augsburg Case-Cohort, Athero-Express and CARDIoGRAM Studies	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; INHIBITORY FACTOR MIF; HEART-DISEASE; ATHEROSCLEROTIC PLAQUES; ARTERY-DISEASE; ADIPOSE-TISSUE; SERUM CONCENTRATIONS; GENE POLYMORPHISMS; CARDIAC MORTALITY; EUROPEAN-SOCIETY	Background: The chemokine RANTES (regulated on activation, normal T-cell expressed and secreted)/CCL5 is involved in the pathogenesis of cardiovascular disease in mice, whereas less is known in humans. We hypothesised that its relevance for atherosclerosis should be reflected by associations between CCL5 gene variants, RANTES serum concentrations and protein levels in atherosclerotic plaques and risk for coronary events. Methods and Findings: We conducted a case-cohort study within the population-based MONICA/KORA Augsburg studies. Baseline RANTES serum levels were measured in 363 individuals with incident coronary events and 1,908 non-cases (mean follow-up: 10.2 +/- 4.8 years). Cox proportional hazard models adjusting for age, sex, body mass index, metabolic factors and lifestyle factors revealed no significant association between RANTES and incident coronary events (HR [95% CI] for increasing RANTES tertiles 1.0, 1.03 [0.75-1.42] and 1.11 [0.81-1.54]). None of six CCL5 single nucleotide polymorphisms and no common haplotype showed significant associations with coronary events. Also in the CARDIoGRAM study (>22,000 cases, >60,000 controls), none of these CCL5 SNPs was significantly associated with coronary artery disease. In the prospective Athero-Express biobank study, RANTES plaque levels were measured in 606 atherosclerotic lesions from patients who underwent carotid endarterectomy. RANTES content in atherosclerotic plaques was positively associated with macrophage infiltration and inversely associated with plaque calcification. However, there was no significant association between RANTES content in plaques and risk for coronary events (mean follow-up 2.8 +/- 0.8 years). Conclusions: High RANTES plaque levels were associated with an unstable plaque phenotype. However, the absence of associations between (i) RANTES serum levels, (ii) CCL5 genotypes and (iii) RANTES content in carotid plaques and either coronary artery disease or incident coronary events in our cohorts suggests that RANTES may not be a novel coronary risk biomarker. However, the potential relevance of RANTES levels in platelet-poor plasma needs to be investigated in further studies.	[Herder, Christian; Poschen, Ulrike; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Peeters, Wouter; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Illig, Thomas; Klopp, Norman] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Baumert, Jens; Meisinger, Christa; Thorand, Barbara] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany; [de Kleijn, Dominique P. V.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Expt Cardiol Lab, Utrecht, Netherlands; [de Kleijn, Dominique P. V.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Mueller-Nurasyid, Martina] Univ Munich, Dept Med 1, Univ Hosp Grosshadern, Munich, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina] German Res Ctr Environm Hlth, Inst Genet Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, D-40225 Dusseldorf, Germany; [Preuss, Michael] Univ Lubeck, Inst Med Biometr & Stat, Lubeck, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Utrecht University; Utrecht University Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; University of Lubeck; Ulm University	Herder, C (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany.	thorand@helmholtz-muenchen.de	Peters, Annette/A-6117-2011; Müller-Nurasyid, Martina/I-8735-2018; Roden, Michael/AAD-3843-2019; Meisinger, Christine/B-5358-2014; Thorand, Barbara/B-5349-2014; Willenborg, Christina/D-2668-2012; Meitinger, Thomas/O-1318-2015; Gudnason, Vilmundur/K-6885-2015; Schnabel, Renate B/F-6527-2014; König, Inke R/A-4544-2009; Erdmann, Jeanette/P-7513-2014; Erdmann, Jeanette/A-4417-2009; Dehghan, Abbas/B-9896-2008; Ziegler, Andreas/G-4246-2012; Smith, Albert Vernon/K-5150-2015	Peters, Annette/0000-0001-6645-0985; Müller-Nurasyid, Martina/0000-0003-3793-5910; Thorand, Barbara/0000-0002-8416-6440; Willenborg, Christina/0000-0001-5217-6882; Gudnason, Vilmundur/0000-0001-5696-0084; König, Inke R/0000-0003-0504-6465; Erdmann, Jeanette/0000-0002-4486-6231; Dehghan, Abbas/0000-0001-6403-016X; Aherrahrou, Zouhair/0000-0002-1241-8733; Ramachandran, Vasan/0000-0001-7357-5970; ELOSUA, ROBERTO/0000-0001-8235-0095; Koenig, Wolfgang/0000-0002-2064-9603; Wild, Philipp/0000-0003-4413-9752; Melander, Olle/0000-0002-2581-484X; Voight, Benjamin/0000-0002-6205-9994; Ziegler, Andreas/0000-0002-8386-5397; Zeller, Tanja/0000-0003-3379-2641; Stewart, Alexandre/0000-0003-2673-9164; Glazer, Nicole/0000-0002-6397-609X; Smith, Albert Vernon/0000-0003-1942-5845; Preuss, Michael/0000-0001-5266-8465; Van Duijn, Cornelia/0000-0002-2374-9204; Meitinger, Thomas/0000-0002-8838-8403; Pilz, Stefan/0000-0002-7959-1311; Reilly, Muredach/0000-0002-3035-9386; Hall, Alistair/0000-0003-0306-7887; Meisinger, Christa/0000-0002-9026-6544; Kleber, Marcus/0000-0003-0663-7275	German Research Foundation [TH-784/2-1, TH-784/2-2]; German Diabetes Center (Dusseldorf, Germany); Federal Ministry of Health (Berlin, Germany); Federal Ministry of Education, Science, Research and Technology (National Genome Research Net-2, cardiovascular, Berlin, Germany) [01GS0423]; Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; University of Ulm; Helmholtz Zentrum Munchen; Federal Ministry of Education and Research, Berlin, Germany; University Medical Center Utrecht; CARDIoGRAM Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087647] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Diabetes Center (Dusseldorf, Germany); Federal Ministry of Health (Berlin, Germany); Federal Ministry of Education, Science, Research and Technology (National Genome Research Net-2, cardiovascular, Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany(Helmholtz Association); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; University of Ulm; Helmholtz Zentrum Munchen(Helmholtz Association); Federal Ministry of Education and Research, Berlin, Germany(Federal Ministry of Education & Research (BMBF)); University Medical Center Utrecht; CARDIoGRAM Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The MONICA/KORA Augsburg case-cohort study was supported by research grants from the German Research Foundation (TH-784/2-1, TH-784/2-2) and by additional funds provided by the German Diabetes Center (Dusseldorf, Germany); the Federal Ministry of Health (Berlin, Germany); the Federal Ministry of Education, Science, Research and Technology (National Genome Research Net-2, cardiovascular, 01GS0423; Berlin, Germany); the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany (formerly GSF National Research Center for Environment and Health; funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria); and the University of Ulm. The MONICA/KORA Augsburg cohort study was financed by the Helmholtz Zentrum Munchen and supported by grants from the Federal Ministry of Education and Research, Berlin, Germany. The Athero-Express study was partially funded by the University Medical Center Utrecht. For the complete list of funders of the CARDIoGRAM Consortium and their support information, please refer to our supplementary file entitled "Text S2. Funding information and competing interests of the CARDIoGRAM Consortium". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM R, 1993, J IMMUNOL, V150, P3442; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Appay V, 1999, J BIOL CHEM, V274, P27505, DOI 10.1074/jbc.274.39.27505; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Aukrust P, 2007, THROMB HAEMOSTASIS, V97, P748, DOI 10.1160/TH07-01-0029; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Berg KK, 2009, SCAND J IMMUNOL, V69, P36, DOI 10.1111/j.1365-3083.2008.02187.x; Boger CA, 2005, ATHEROSCLEROSIS, V183, P121, DOI 10.1016/j.atherosclerosis.2005.03.006; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Breland UM, 2010, CARDIOVASC RES, V86, P265, DOI 10.1093/cvr/cvq044; Cavusoglu E, 2007, ARTERIOSCL THROM VAS, V27, P929, DOI 10.1161/01.ATV.0000258789.21585.76; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Correia LCL, 2010, CLIN CHIM ACTA, V411, P540, DOI 10.1016/j.cca.2010.01.011; de Kleijn DPV, 2010, ARTERIOSCL THROM VAS, V30, P612, DOI 10.1161/ATVBAHA.109.194944; Ding ZQ, 2000, J LEUKOCYTE BIOL, V67, P825, DOI 10.1002/jlb.67.6.825; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2005, DIABETES, V54, pS11, DOI 10.2337/diabetes.54.suppl_2.S11; Herder C, 2008, ATHEROSCLEROSIS, V200, P380, DOI 10.1016/j.atherosclerosis.2007.12.025; Herder C, 2008, EUR J ENDOCRINOL, V158, pR1, DOI 10.1530/EJE-07-0686; Herder C, 2006, ARTERIOSCL THROM VAS, V26, P2147, DOI 10.1161/01.ATV.0000235691.84430.86; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; Montecucco F, 2010, STROKE, V41, P1394, DOI 10.1161/STROKEAHA.110.578369; Oran PE, 2010, CLIN CHEM, V56, P1432, DOI 10.1373/clinchem.2010.147884; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Peeters W, 2009, ARTERIOSCL THROM VAS, V29, P128, DOI 10.1161/ATVBAHA.108.173658; Peeters W, 2011, EUR HEART J, V32, P2314, DOI 10.1093/eurheartj/ehq517; Peeters W, 2011, EUR HEART J, V32, P1758, DOI 10.1093/eurheartj/ehq387; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Simeoni E, 2004, EUR HEART J, V25, P1438, DOI 10.1016/j.ehj.2004.05.005; Skurk T, 2009, HORM METAB RES, V41, P183, DOI 10.1055/s-0028-1093345; Szalai C, 2001, ATHEROSCLEROSIS, V158, P233, DOI 10.1016/S0021-9150(01)00423-3; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Virani SS, 2011, EUR HEART J, V32, P459, DOI 10.1093/eurheartj/ehq367; Vogiatzi K, 2009, THROMB RES, V124, P84, DOI 10.1016/j.thromres.2008.12.043; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	58	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e25734	10.1371/journal.pone.0025734	http://dx.doi.org/10.1371/journal.pone.0025734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162987	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500001
J	Schiffers, K; Teal, LR; Travis, JMJ; Solan, M				Schiffers, Katja; Teal, Lorna Rachel; Travis, Justin Mark John; Solan, Martin			An Open Source Simulation Model for Soil and Sediment Bioturbation	PLOS ONE			English	Article							LATTICE-AUTOMATON MODEL; PARTICLE-TRANSPORT; ECOSYSTEM PROCESSES; TRACER DYNAMICS; REWORKING; QUANTIFICATION; BIODIVERSITY; RATES; MASSACHUSETTS; IRRIGATION	Bioturbation is one of the most widespread forms of ecological engineering and has significant implications for the structure and functioning of ecosystems, yet our understanding of the processes involved in biotic mixing remains incomplete. One reason is that, despite their value and utility, most mathematical models currently applied to bioturbation data tend to neglect aspects of the natural complexity of bioturbation in favour of mathematical simplicity. At the same time, the abstract nature of these approaches limits the application of such models to a limited range of users. Here, we contend that a movement towards process-based modelling can improve both the representation of the mechanistic basis of bioturbation and the intuitiveness of modelling approaches. In support of this initiative, we present an open source modelling framework that explicitly simulates particle displacement and a worked example to facilitate application and further development. The framework combines the advantages of rule-based lattice models with the application of parameterisable probability density functions to generate mixing on the lattice. Model parameters can be fitted by experimental data and describe particle displacement at the spatial and temporal scales at which bioturbation data is routinely collected. By using the same model structure across species, but generating species-specific parameters, a generic understanding of species-specific bioturbation behaviour can be achieved. An application to a case study and comparison with a commonly used model attest the predictive power of the approach.	[Schiffers, Katja; Travis, Justin Mark John] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Teal, Lorna Rachel; Solan, Martin] Univ Aberdeen, Oceanlab, Newburgh, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Schiffers, K (corresponding author), Univ Grenoble 1, CNRS, LECA Lab Ecol Alpine, Unites Mixtes Rech,UMR 5553, Grenoble, France.	katja.schiffers@gmail.com	Teal, Lorna R/C-8972-2009; Solan, Martin/E-9338-2012; Travis, Justin/B-8571-2014	Solan, Martin/0000-0001-9924-5574; Travis, Justin/0000-0002-5785-4272	University of Aberdeen; CEFAS (Centre for Environment, Fisheries and Aquaculture Science); Lowestoft [DP204]; German Academic Exchange Service (DAAD)	University of Aberdeen; CEFAS (Centre for Environment, Fisheries and Aquaculture Science); Lowestoft; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by University of Aberdeen 6th century scholarship (awarded to LRT), CEFAS (Centre for Environment, Fisheries and Aquaculture Science), Lowestoft (DP204) and the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behzadi B, 2005, CHEM ENG SCI, V60, P6607, DOI 10.1016/j.ces.2005.05.041; BELISLE CJP, 1992, J APPL PROBAB, V29, P885, DOI 10.2307/3214721; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Berg P, 2001, AQUAT MICROB ECOL, V26, P81, DOI 10.3354/ame026081; Berner R.A., 1980, EARLY DIAGENESIS THE; Bertics VJ, 2010, ENVIRON MICROBIOL, V12, P3022, DOI 10.1111/j.1462-2920.2010.02279.x; Blair NE, 1996, LIMNOL OCEANOGR, V41, P1208, DOI 10.4319/lo.1996.41.6.1208; BOUDREAU BP, 1987, AM J SCI, V287, P693, DOI 10.2475/ajs.287.7.693; BOUDREAU BP, 1986, AM J SCI, V286, P161, DOI 10.2475/ajs.286.3.161; Boudreau BP, 2001, J MAR RES, V59, P749, DOI 10.1357/002224001762674926; BOUDREAU BP, 1989, GEOCHIM COSMOCHIM AC, V53, P1857, DOI 10.1016/0016-7037(89)90306-2; Broyden C.G., 1970, IMA J APPL MATH, V6, P222, DOI [10.1093/imamat/6.3.222, DOI 10.1093/IMAMAT/6.3.222]; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Burnham K. P., 1998, MODEL SELECTION INFE; Choi J, 2002, COMPUT GEOSCI-UK, V28, P213, DOI 10.1016/S0098-3004(01)00064-4; Crank J, 1975, MATH DIFFUSION, P424; Darwin C., 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; Fernandes S, 2006, MAR CHEM, V102, P148, DOI 10.1016/j.marchem.2005.12.002; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Fornes WL, 1999, J MAR RES, V57, P335, DOI 10.1357/002224099321618245; Forster S, 2003, J MAR RES, V61, P335, DOI 10.1357/002224003322201223; Francois F, 2002, MAR ECOL PROG SER, V229, P127, DOI 10.3354/meps229127; Francois F, 1997, ACTA BIOTHEOR, V45, P295, DOI 10.1023/A:1000636109604; Gerino M, 1998, ESTUAR COAST SHELF S, V46, P531, DOI 10.1006/ecss.1997.0298; GERINO M, 1994, OCEANOL ACTA, V17, P547; Gilbert F, 2003, J EXP MAR BIOL ECOL, V285, P251, DOI 10.1016/S0022-0981(02)00531-2; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; GOLDBERG ED, 1962, GEOCHIM COSMOCHIM AC, V26, P417, DOI 10.1016/0016-7037(62)90112-6; GOLDFARB D, 1970, MATH COMPUT, V24, P23, DOI 10.2307/2004873; Green MA, 2002, DEEP-SEA RES PT II, V49, P4627, DOI 10.1016/S0967-0645(02)00132-7; GUINASSO NL, 1975, J GEOPHYS RES-OC ATM, V80, P3032, DOI 10.1029/JC080i021p03032; Hilborn Ray, 1997, V28; Hollertz K, 2001, MAR BIOL, V139, P951; Jamieson AJ, 2011, MAR BIOL, V158, P2695, DOI 10.1007/s00227-011-1767-7; MAHAUT ML, 1987, OCEANOL ACTA, V10, P323; Maire O, 2008, AQUAT BIOL, V2, P219, DOI 10.3354/ab00053; Maire O, 2006, MAR ECOL PROG SER, V319, P135, DOI 10.3354/meps319135; McCraith BJ, 2003, J MAR RES, V61, P359, DOI 10.1357/002224003322201232; McDonald CP, 2010, ECOL MODEL, V221, P428, DOI 10.1016/j.ecolmodel.2009.10.021; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; Mermillod-Blondin F, 2003, J EXP MAR BIOL ECOL, V287, P193, DOI 10.1016/S0022-0981(02)00548-8; Meysman FJR, 2008, GEOCHIM COSMOCHIM AC, V72, P3460, DOI 10.1016/j.gca.2008.04.023; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Meysman FJR, 2010, J MAR RES, V68, P881, DOI 10.1357/002224010796673885; Meysman FJR, 2003, J MAR RES, V61, P391, DOI 10.1357/002224003322201241; Mugnai C, 2003, HYDROBIOLOGIA, V494, P245, DOI 10.1023/A:1025430719520; Palomar NE, 2005, J ETHOL, V23, P173, DOI 10.1007/s10164-005-0149-3; R Core Team, 2022, R LANG ENV STAT COMP; Raffaelli D, 2005, MAR ECOL PROG SER, V304, P283; Rands SA, 2006, BEHAV ECOL SOCIOBIOL, V60, P572, DOI 10.1007/s00265-006-0202-4; Reed DC, 2007, J MAR RES, V65, P813, DOI 10.1357/002224007784219039; Reed DC, 2006, GEOCHIM COSMOCHIM AC, V70, P5855, DOI 10.1016/j.gca.2006.03.026; RHOADS DC, 1971, MAR BIOL, V11, P255, DOI 10.1007/BF00401273; Rosenberg R, 2008, MAR ECOL PROG SER, V363, P171, DOI 10.3354/meps07463; Sandnes J, 2000, MAR ECOL PROG SER, V197, P169, DOI 10.3354/meps197169; SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840; Shull DH, 2001, J MAR RES, V59, P453, DOI 10.1357/002224001762842271; Soetaert K, 1996, J MAR RES, V54, P1207, DOI 10.1357/0022240963213808; Solan M, 2004, MAR ECOL PROG SER, V271, P1, DOI 10.3354/meps271001; Solan M, 2002, MAR ECOL PROG SER, V228, P179, DOI 10.3354/meps228179; Solan M, 2008, AQUAT BIOL, V2, P289, DOI 10.3354/ab00058; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Teal LR, 2008, AQUAT BIOL, V2, P207, DOI 10.3354/ab00052; Vabo R, 2008, ECOL MODEL, V214, P125, DOI 10.1016/j.ecolmodel.2008.01.026; Vikebo F, 2007, MAR ECOL PROG SER, V347, P207, DOI 10.3354/meps06979; WHEATCROFT RA, 1994, J MAR RES, V52, P1129, DOI 10.1357/0022240943076803; WHEATCROFT RA, 1990, J MAR RES, V48, P177, DOI 10.1357/002224090784984560; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005	69	38	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28028	10.1371/journal.pone.0028028	http://dx.doi.org/10.1371/journal.pone.0028028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162997	Green Published, Green Accepted, gold			2022-12-25	WOS:000298172800010
J	Hempel, F; Lau, J; Klingl, A; Maier, UG				Hempel, Franziska; Lau, Julia; Klingl, Andreas; Maier, Uwe G.			Algae as Protein Factories: Expression of a Human Antibody and the Respective Antigen in the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							B SURFACE-ANTIGEN; HUMAN MONOCLONAL-ANTIBODY; NICOTIANA-TABACUM PLANTS; TRANSGENIC PLANTS; PHARMACEUTICAL PROTEINS; MICROALGAL BIOFUELS; CELLS; BIOREACTORS; YEAST; BIOPHARMACEUTICALS	Microalgae are thought to offer great potential as expression system for various industrial, therapeutic and diagnostic recombinant proteins as they combine high growth rates with all benefits of eukaryotic expression systems. Moreover, microalgae exhibit a phototrophic lifestyle like land plants, hence protein expression is fuelled by photosynthesis, which is CO(2)-neutral and involves only low production costs. So far, however, research on algal bioreactors for recombinant protein expression is very rare calling for further investigations in this highly promising field. In this study, we present data on the expression of a monoclonal human IgG antibody against the Hepatitis B surface protein and the respective antigen in the diatom Phaeodactylum tricornutum. Antibodies are fully-assembled and functional and accumulate to 8.7% of total soluble protein, which complies with 21 mg antibody per gram algal dry weight. The Hepatitis B surface protein is functional as well and is recognized by algae-produced and commercial antibodies.	[Hempel, Franziska; Klingl, Andreas; Maier, Uwe G.] LOEWE Res Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany; [Lau, Julia; Maier, Uwe G.] Univ Marburg, Cell Biol Lab, Marburg, Germany	Philipps University Marburg	Hempel, F (corresponding author), LOEWE Res Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany.	franziska.hempel@synmikro.uni-marburg.de	Klingl, Andreas/K-6675-2014	Klingl, Andreas/0000-0001-8414-8317	LOEWE program of the State of Hessen (Germany)	LOEWE program of the State of Hessen (Germany)	This work was supported by the LOEWE program of the State of Hessen (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; BIEMANS R, 1992, DNA CELL BIOL, V11, P621, DOI 10.1089/dna.1992.11.621; Bozarth A, 2009, APPL MICROBIOL BIOT, V82, P195, DOI 10.1007/s00253-008-1804-8; Bruss V, 1996, INTERVIROLOGY, V39, P23, DOI 10.1159/000150471; Chadd HE, 2001, CURR OPIN BIOTECH, V12, P188, DOI 10.1016/S0958-1669(00)00198-1; Chiba Y, 2007, CURR OPIN CHEM BIOL, V11, P670, DOI 10.1016/j.cbpa.2007.08.037; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Chu L, 2001, CURR OPIN BIOTECH, V12, P180, DOI 10.1016/S0958-1669(00)00197-X; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; De Muynck B, 2009, TRANSGENIC RES, V18, P467, DOI 10.1007/s11248-008-9240-1; Decker EL, 2008, BIOPROC BIOSYST ENG, V31, P3, DOI 10.1007/s00449-007-0151-y; Dogan B, 2000, BIOTECHNOL PROGR, V16, P435, DOI 10.1021/bp0000454; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fischer R, 2000, TRANSGENIC RES, V9, P279, DOI 10.1023/A:1008975123362; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; FUJISAWA Y, 1983, NUCLEIC ACIDS RES, V11, P3581, DOI 10.1093/nar/11.11.3581; GODDIJN OJM, 1995, TRENDS BIOTECHNOL, V13, P379, DOI 10.1016/S0167-7799(00)88985-4; Guan ZJ, 2010, VACCINE, V28, P7351, DOI 10.1016/j.vaccine.2010.08.100; Hempel F, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-81; Hempel F, 2009, MOL BIOL EVOL, V26, P1781, DOI 10.1093/molbev/msp079; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Komarnytsky S, 2006, PLANT PHYSIOL, V141, P1185, DOI 10.1104/pp.105.074419; Kumar GBS, 2005, PLANTA, V222, P484, DOI 10.1007/s00425-005-1556-y; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Maeda F, 1999, J MED VIROL, V58, P338, DOI 10.1002/(SICI)1096-9071(199908)58:4<338::AID-JMV4>3.0.CO;2-5; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; Mayfield SP, 2005, VACCINE, V23, P1828, DOI 10.1016/j.vaccine.2004.11.013; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; Milich DR, 1997, J VIRAL HEPATITIS, V4, P25, DOI 10.1111/j.1365-2893.1997.tb00177.x; Morweiser M, 2010, APPL MICROBIOL BIOT, V87, P1291, DOI 10.1007/s00253-010-2697-x; PATZER EJ, 1986, J VIROL, V58, P884, DOI 10.1128/JVI.58.3.884-892.1986; Potvin G, 2010, BIOTECHNOL ADV, V28, P910, DOI 10.1016/j.biotechadv.2010.08.006; Raja R, 2008, CRIT REV MICROBIOL, V34, P77, DOI [10.1080/10408410802086783, 10.1080/10408410802086783 ]; Ramirez N, 2003, BIOTECHNOL APPL BIOC, V38, P223, DOI 10.1042/BA20030028; Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153; Sharp JM, 2001, BIOTECHNOL PROGR, V17, P979, DOI 10.1021/bp010104t; Sojikul P, 2003, P NATL ACAD SCI USA, V100, P2209, DOI 10.1073/pnas.0438037100; Stephens E, 2010, NAT BIOTECHNOL, V28, P126, DOI 10.1038/nbt0210-126; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; Ugwu CU, 2008, BIORESOURCE TECHNOL, V99, P4021, DOI 10.1016/j.biortech.2007.01.046; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Verma R, 1998, J IMMUNOL METHODS, V216, P165, DOI 10.1016/S0022-1759(98)00077-5; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Yano A, 2004, J MED VIROL, V73, P208, DOI 10.1002/jmv.20077	51	106	110	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28424	10.1371/journal.pone.0028424	http://dx.doi.org/10.1371/journal.pone.0028424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164289	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400090
J	Itoh, H; Tatematsu, M; Watanabe, A; Iwano, K; Funami, K; Seya, T; Matsumoto, M				Itoh, Hiroki; Tatematsu, Megumi; Watanabe, Ayako; Iwano, Katsunori; Funami, Kenji; Seya, Tsukasa; Matsumoto, Misako			UNC93B1 Physically Associates with Human TLR8 and Regulates TLR8-Mediated Signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEIN; DENDRITIC CELLS; STRANDED-RNA; RECOGNITION; EXPRESSION; ACTIVATION; RESPONSES; SYSTEM	Toll-like receptors (TLRs) 3, 7, 8, and 9 are localized to intracellular compartments where they encounter foreign or self nucleic acids and activate innate and adaptive immune responses. The endoplasmic reticulum (ER)-resident membrane protein, UNC93B1, is essential for intracellular trafficking and endolysosomal targeting of TLR7 and TLR9. TLR8 is phylogenetically and structurally related to TLR7 and TLR9, but little is known about its localization or function. In this study, we demonstrate that TLR8 localized to the early endosome and the ER but not to the late endosome or lysosome in human monocytes and HeLa transfectants. UNC93B1 physically associated with human TLR8, similar to TLRs 3, 7, and 9, and played a critical role in TLR8-mediated signaling. Localization analyses of TLR8 tail-truncated mutants revealed that the transmembrane domain and the Toll/interleukin-1 receptor domain were required for proper targeting of TLR8 to the early endosome. Hence, although UNC93B1 participates in intracellular trafficking and signaling for all nucleotide-sensing TLRs, the mode of regulation of TLR localization differs for each TLR.	[Itoh, Hiroki; Tatematsu, Megumi; Watanabe, Ayako; Iwano, Katsunori; Funami, Kenji; Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan	Hokkaido University	Itoh, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	matumoto@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Funami, Kenji/A-4284-2012; Seya, Tsukasa/A-4336-2012		Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Akiyama Life Science Foundation; Grants-in-Aid for Scientific Research [23590558] Funding Source: KAKEN	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Akiyama Life Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, and Culture, the Ministry of Health, Labor, and Welfare of Japan, and by the Akiyama Life Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhu J, 2009, MOL IMMUNOL, V46, P884, DOI 10.1016/j.molimm.2008.09.020	34	52	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28500	10.1371/journal.pone.0028500	http://dx.doi.org/10.1371/journal.pone.0028500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164301	gold, Green Published			2022-12-25	WOS:000298171400102
J	Rankovic, V; Landgraf, P; Kanyshkova, T; Ehling, P; Meuth, SG; Kreutz, MR; Budde, T; Munsch, T				Rankovic, Vladan; Landgraf, Peter; Kanyshkova, Tatyana; Ehling, Petra; Meuth, Sven G.; Kreutz, Michael R.; Budde, Thomas; Munsch, Thomas			Modulation of Calcium-Dependent Inactivation of L-Type Ca2+ Channels via beta-Adrenergic Signaling in Thalamocortical Relay Neurons	PLOS ONE			English	Article							CARDIAC CA(V)1.2 CHANNELS; PROTEIN PHOSPHATASE 2A; CA2+-DEPENDENT INACTIVATION; ION CHANNELS; PHOSPHORYLATION; VOLTAGE; CALCINEURIN; KINASE; CELLS; CURRENTS	Neuronal high-voltage-activated (HVA) Ca2+ channels are rapidly inactivated by a mechanism that is termed Ca2+-dependent inactivation (CDI). In this study we have shown that b-adrenergic receptor (bAR) stimulation inhibits CDI in rat thalamocortical (TC) relay neurons. This effect can be blocked by inhibition of cAMP-dependent protein kinase (PKA) with a cell-permeable inhibitor (myristoylated protein kinase inhibitor-(14-22)-amide) or A-kinase anchor protein (AKAP) St-Ht31 inhibitory peptide, suggesting a critical role of these molecules downstream of the receptor. Moreover, inhibition of protein phosphatases (PP) with okadaic acid revealed the involvement of phosphorylation events in modulation of CDI after bAR stimulation. Double fluorescence immunocytochemistry and pull down experiments further support the idea that modulation of CDI in TC neurons via bAR stimulation requires a protein complex consisting of CaV1.2, PKA and proteins from the AKAP family. All together our data suggest that AKAPs mediate targeting of PKA to L-type Ca2+ channels allowing their phosphorylation and thereby modulation of CDI.	[Rankovic, Vladan; Munsch, Thomas] Univ Magdeburg, Inst Physiol, D-39106 Magdeburg, Germany; [Landgraf, Peter; Kreutz, Michael R.] Leibniz Inst Neurobiol, PG Neuroplast, Magdeburg, Germany; [Kanyshkova, Tatyana; Ehling, Petra; Budde, Thomas] Inst Physiol 1, Munster, Germany; [Ehling, Petra; Meuth, Sven G.] Inst Neuropathophysiol, Munster, Germany; [Ehling, Petra; Meuth, Sven G.] Neurol Clin, Dept Inflammatory Disorders Nervous Syst & Neuroo, Munster, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Rankovic, V (corresponding author), Univ Magdeburg, Inst Physiol, D-39106 Magdeburg, Germany.	vladan.rankovic@lin-magdeburg.de	Meuth, Sven G/HHM-8941-2022; Rankovic, Vladan/S-4353-2019	Meuth, Sven G/0000-0003-2571-3501; Rankovic, Vladan/0000-0003-0285-5232	Deutsche Forschungsgemeinschaft [GRK 1167-P1, BU 1019/8-1, DFG Kr1879/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GRK 1167-P1 to TM; BU 1019/8-1 to TB; DFG Kr1879/3-1 to MK). VR was a fellow of the GRK 1167, Magdeburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Biella Gerardo, 2001, Thalamus & Related Systems, V1, P157, DOI 10.1017/S1472928801000152; Branchaw JL, 1997, J NEUROSCI, V17, P5772; Broicher T, 2007, MOL CELL NEUROSCI, V36, P132, DOI 10.1016/j.mcn.2007.05.013; Budde T, 2005, J NEUROSCI, V25, P9871, DOI 10.1523/JNEUROSCI.2590-05.2005; Budde T, 2000, NEURON, V26, P483, DOI 10.1016/S0896-6273(00)81180-0; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Budde T, 1998, EUR J NEUROSCI, V10, P586, DOI 10.1046/j.1460-9568.1998.00067.x; Burley JR, 2000, EUR J NEUROSCI, V12, P2881, DOI 10.1046/j.1460-9568.2000.00178.x; Catterall WA, 1997, ADV SEC MESS PHOSPH, V31, P159; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; KALMAN D, 1988, J GEN PHYSIOL, V92, P531, DOI 10.1085/jgp.92.4.531; KAWAI M, 1993, FEBS LETT, V316, P107, DOI 10.1016/0014-5793(93)81196-7; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Lukyanetz EA, 1998, J PHYSIOL-LONDON, V510, P371, DOI 10.1111/j.1469-7793.1998.371bk.x; Marshall MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175257; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Meuth S, 2002, EUR J NEUROSCI, V15, P1603, DOI 10.1046/j.1460-9568.2002.01999.x; Meuth SG, 2005, PFLUG ARCH EUR J PHY, V450, P111, DOI 10.1007/s00424-004-1377-z; Meuth Sven, 2001, Thalamus & Related Systems, V1, P31, DOI 10.1017/S1472928801000061; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; PAPE HC, 1994, J PHYSIOL-LONDON, V478, P403, DOI 10.1113/jphysiol.1994.sp020261; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rankovic V, 2010, EUR J NEUROSCI, V31, P439, DOI 10.1111/j.1460-9568.2010.07081.x; Rossie S, 1999, ADV SEC MESS PHOSPH, V33, P23; Schuhmann K, 1997, J GEN PHYSIOL, V110, P503, DOI 10.1085/jgp.110.5.503; SCULPTOREANU A, 1993, P NATL ACAD SCI USA, V90, P10135, DOI 10.1073/pnas.90.21.10135; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Steriade M, 1997, THALAMUS RELATED SYS; Victor RG, 1997, J MEMBRANE BIOL, V156, P53, DOI 10.1007/s002329900187; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; Xu H, 2010, BIOCHEMISTRY-US, V49, P10298, DOI 10.1021/bi101018c; You YD, 1995, BIOPHYS J, V69, P1838, DOI 10.1016/S0006-3495(95)80054-8; Zeilhofer HU, 2000, NEUROSCIENCE, V95, P235	55	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27474	10.1371/journal.pone.0027474	http://dx.doi.org/10.1371/journal.pone.0027474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164209	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400009
J	Samanta, S; Dutta, D; Ghoshal, A; Mukhopadhyay, S; Saha, B; Sundar, S; Jarmalavicius, S; Forgber, M; Mandal, C; Walden, P; Mandal, C				Samanta, Sajal; Dutta, Devawati; Ghoshal, Angana; Mukhopadhyay, Sumi; Saha, Bibhuti; Sundar, Shyam; Jarmalavicius, Saulius; Forgber, Michael; Mandal, Chhabinath; Walden, Peter; Mandal, Chitra			Glycosylation of Erythrocyte Spectrin and Its Modification in Visceral Leishmaniasis	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; SIALIC ACIDS; COMPLEMENT PATHWAY; IDENTIFICATION; MEMBRANE; BINDING; ASSAY; SIALOGLYCANS; ACHATININ(H); ACTIVATION	Using a lectin, Achatinin-H, having preferential specificity for glycoproteins with terminal 9-O-acetyl sialic acid derivatives linked in alpha 2-6 linkages to subterminal N-acetylgalactosamine, eight distinct disease-associated 9-O-acetylated sialoglycoproteins was purified from erythrocytes of visceral leishmaniaisis (VL) patients (RBCVL). Analyses of tryptic fragments by mass spectrometry led to the identification of two high-molecular weight 9-O-acetylated sialoglycoproteins as human erythrocytic alpha- and beta-spectrin. Total spectrin purified from erythrocytes of VL patients (spectrin(VL)) was reactive with Achatinin-H. Interestingly, along with two high molecular weight bands corresponding to alpha- and beta-spectrin another low molecular weight 60 kDa band was observed. Total spectrin was also purified from normal human erythrocytes (spectrin(N)) and insignificant binding with Achatinin-H was demonstrated. Additionally, this 60 kDa fragment was totally absent in spectrin(N). Although the presence of both N- and O-glycosylations was found both in spectrin(N) and spectrin(VL), enhanced sialylation was predominantly induced in spectrin(VL). Sialic acids accounted for approximately 1.25 kDa mass of the 60 kDa polypeptide. The demonstration of a few identified sialylated tryptic fragments of alpha- and beta-spectrin(VL) confirmed the presence of terminal sialic acids. Molecular modelling studies of spectrin suggest that a sugar moiety can fit into the potential glycosylation sites. Interestingly, highly sialylated spectrin(VL) showed decreased binding with spectrin-depleted inside-out membrane vesicles of normal erythrocytes compared to spectrin(N) suggesting functional abnormality. Taken together this is the first report of glycosylated eythrocytic spectrin in normal erythrocytes and its enhanced sialylation in RBCVL. The enhanced sialylation of this cytoskeleton protein is possibly related to the fragmentation of spectrin(VL) as evidenced by the presence of an additional 60 kDa fragment, absent in spectrin(N) which possibly affects the biology of RBCVL linked to both severe distortion of erythrocyte development and impairment of erythrocyte membrane integrity and may provide an explanation for their sensitivity to hemolysis and anemia in VL patients.	[Samanta, Sajal; Dutta, Devawati; Ghoshal, Angana; Mukhopadhyay, Sumi; Mandal, Chitra] Indian Inst Chem Biol, Council Sci & Ind Research, Canc & Cell Biol Div, Kolkata, India; [Saha, Bibhuti] Sch Trop Med, Dept Trop Med, Kolkata, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India; [Jarmalavicius, Saulius; Forgber, Michael; Walden, Peter] Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol, D-10099 Berlin, Germany; [Mandal, Chhabinath] Indian Inst Chem Biol, Council Sci & Ind Research, Natl Inst Pharmaceut Educ & Res, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Calcutta School of Tropical Medicine (CSTM); Banaras Hindu University (BHU); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); National Institute of Pharmaceutical Education & Research (NIPER)	Samanta, S (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Research, Canc & Cell Biol Div, Kolkata, India.	chitra_mandal@yahoo.com		, NIPERKolkata/0000-0003-4906-3988	Council of Scientific and Industrial Research-Indian Institute of Chemical Biology; Indian Council of Medical Research, New Delhi [GAP266]; Department of Science and Technology, Government of India [P90807]; Tropical Medical Research Centre [P50AI074321]; Volkswagen Foundation, Germany; German Research Council (DFG); ProFit programme; European Union/Berlin and the Federal Ministry for Research and Education of Germany; Department of Biotechnology [GAP235]	Council of Scientific and Industrial Research-Indian Institute of Chemical Biology; Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Tropical Medical Research Centre; Volkswagen Foundation, Germany(Volkswagen); German Research Council (DFG)(German Research Foundation (DFG)); ProFit programme; European Union/Berlin and the Federal Ministry for Research and Education of Germany; Department of Biotechnology	This work received financial support from the Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, Department of Biotechnology (GAP235)(dbtindia.nic.in/index.asp), Indian Council of Medical Research (GAP266)(www.icmr.nic.in/), New Delhi, J. C. Bose Fellowship, Department of Science and Technology (P90807)(www.dst.gov.in/), Government of India, Tropical Medical Research Centre Grant number P50AI074321, the Volkswagen Foundation, Germany, German Research Council (DFG), the ProFit programme, European Union/Berlin and the Federal Ministry for Research and Education of Germany (www.bmbf.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansar W, 2009, GLYCOCONJUGATE J, V26, P1151, DOI 10.1007/s10719-009-9236-y; Bandyopadhyay S, 2004, J INFECT DIS, V190, P2010, DOI 10.1086/425519; Bandyopadhyay S, 2004, DIAGN MICR INFEC DIS, V50, P15, DOI 10.1016/j.diagmicrobio.2004.04.014; Bandyopadhyay SMN, 2008, ADV EXP MED BIOL, V625, P87; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bossi D, 1996, MOL ASPECTS MED, V17, P171, DOI 10.1016/0098-2997(96)88346-4; Bulai T, 2003, BIOCHIMIE, V85, P241, DOI 10.1016/S0300-9084(03)00059-2; Bulai T, 2002, BIOCHIMIE, V84, P655, DOI 10.1016/S0300-9084(02)01436-0; Chatterjee M, 1998, GLYCOCONJUGATE J, V15, P1141, DOI 10.1023/A:1006963806318; Chatterjee M, 2003, GLYCOBIOLOGY, V13, P351, DOI 10.1093/glycob/cwg027; Chava AK, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P71; Chava AK, 2003, GLYCOCONJUGATE J, V20, P199, DOI 10.1023/B:GLYC.0000024251.30100.08; Chava AK, 2004, J INFECT DIS, V189, P1257, DOI 10.1086/382752; Chava AK, 2004, BIOL CHEM, V385, P59, DOI 10.1515/BC.2004.008; Chava AK, 2002, J IMMUNOL METHODS, V270, P1, DOI 10.1016/S0022-1759(02)00216-8; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; Demine R, 2004, RAPID COMMUN MASS SP, V18, P907, DOI 10.1002/rcm.1420; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Domingues CC, 2008, BRAZ J MED BIOL RES, V41, P758, DOI 10.1590/S0100-879X2008000900003; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Ghosh S, 2007, GLYCOCONJUGATE J, V24, P17, DOI 10.1007/s10719-006-9007-y; Ghoshal A, 2009, PARASITOLOGY, V136, P159, DOI 10.1017/S0031182008005180; Ghoshal A, 2008, MINI-REV MED CHEM, V8, P358, DOI 10.2174/138955708783955980; Ghoshal A, 2010, GLYCOBIOLOGY, V20, P553, DOI 10.1093/glycob/cwp207; Ghoshal A, 2009, CLIN VACCINE IMMUNOL, V16, P889, DOI 10.1128/CVI.00453-08; Ghoshal A, 2009, GLYCOCONJUGATE J, V26, P675, DOI 10.1007/s10719-008-9223-8; Grossin N, 2009, BIORHEOLOGY, V46, P63, DOI 10.3233/BIR-2009-0519; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LINDBERG G, 1991, BRIT MED J, V302, P143, DOI 10.1136/bmj.302.6769.143; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Mandal C, MODELYN MOL MODELLIN; Mukhopadhyay S, 2006, INDIAN J MED RES, V123, P203; Nigam PK, 2006, INDIAN J CLIN BIOCHE, V21, P54, DOI 10.1007/BF02913067; Patterson ST, 2009, J BIOL CHEM, V284, P14547, DOI 10.1074/jbc.M809076200; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Raval GN, 2003, ORAL DIS, V9, P119, DOI 10.1034/j.1601-0825.2003.01795.x; Resmi H, 2001, CLIN EXP MED, V1, P187, DOI 10.1007/s102380100002; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; SCHWARTZ RS, 1991, DIABETES, V40, P701, DOI 10.2337/diabetes.40.6.701; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEN GT, 1995, CARBOHYD RES, V268, P115, DOI 10.1016/0008-6215(94)00311-3; Sharma V, 1998, AM J TROP MED HYG, V58, P551, DOI 10.4269/ajtmh.1998.58.551; Sharma V, 2000, GLYCOCONJUGATE J, V17, P887, DOI 10.1023/A:1010925414222; Spencer K, 2002, PRENATAL DIAG, V22, P656, DOI 10.1002/pd.351; Starodubtseva MN, 2008, B EXP BIOL MED+, V145, P99, DOI 10.1007/s10517-008-0036-3; Stehling P, 1998, GLYCOCONJUGATE J, V15, P339, DOI 10.1023/A:1006965600322; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; WARREN L, 1959, J BIOL CHEM, V234, P1971; World Health Organization, 2010, TECH REP SER, V949, P186; ZAIL SS, 1984, J CLIN INVEST, V74, P753, DOI 10.1172/JCI111491	54	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28169	10.1371/journal.pone.0028169	http://dx.doi.org/10.1371/journal.pone.0028169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164239	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400040
J	Yoshida, Y; Iigusa, H; Wang, NY; Hasunuma, K				Yoshida, Yusuke; Iigusa, Hideo; Wang, Niyan; Hasunuma, Kohji			Cross-Talk between the Cellular Redox State and the Circadian System in Neurospora	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTOR; WHITE COLLAR-1; DNA-BINDING; RHYTHMS; CLOCK; CRASSA; TRANSCRIPTION; FREQUENCY; OXYGEN; EXPRESSION	The circadian system is composed of a number of feedback loops, and multiple feedback loops in the form of oscillators help to maintain stable rhythms. The filamentous fungus Neurospora crassa exhibits a circadian rhythm during asexual spore formation (conidiation banding) and has a major feedback loop that includes the FREQUENCY (FRQ)/WHITE COLLAR (WC) -1 and -2 oscillator (FWO). A mutation in superoxide dismutase (sod)-1, an antioxidant gene, causes a robust and stable circadian rhythm compared with that of wild-type (Wt). However, the mechanisms underlying the functions of reactive oxygen species (ROS) remain unknown. Here, we show that cellular ROS concentrations change in a circadian manner (ROS oscillation), and the amplitudes of ROS oscillation increase with each cycle and then become steady (ROS homeostasis). The ROS oscillation and homeostasis are produced by the ROS-destroying catalases (CATs) and ROS-generating NADPH oxidase (NOX). cat-1 is also induced by illumination, and it reduces ROS levels. Although ROS oscillation persists in the absence of frq, wc-1 or wc-2, its homeostasis is altered. Furthermore, genetic and biochemical evidence reveals that ROS concentration regulates the transcriptional function of WCC and a higher ROS concentration enhances conidiation banding. These findings suggest that the circadian system engages in cross-talk with the cellular redox state via ROS-regulatory factors.	[Yoshida, Yusuke; Iigusa, Hideo; Wang, Niyan; Hasunuma, Kohji] Yokohama City Univ, Grad Sch Integrated Sci, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 232, Japan	Yokohama City University	Yoshida, Y (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 232, Japan.	yyoshida@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21790227]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid (No. 21790227) for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Bai ZH, 2001, BIOTECHNOL BIOENG, V75, P204, DOI 10.1002/bit.1180; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brody S, 2010, FUNGAL GENET BIOL, V47, P159, DOI 10.1016/j.fgb.2009.09.006; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Christensen MK, 2004, J BIOL RHYTHM, V19, P280, DOI 10.1177/0748730404265532; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Paula RM, 2007, COLD SPRING HARB SYM, V72, P345, DOI 10.1101/sqb.2007.72.002; Dunlap JC, 2008, GENETICS, V178, P1, DOI 10.1534/genetics.104.86496; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Granshaw T, 2003, J BIOL RHYTHM, V18, P287, DOI 10.1177/0748730403255934; HARDING RW, 1981, PLANT PHYSIOL, V68, P745, DOI 10.1104/pp.68.3.745; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; Iigusa H, 2005, FEBS LETT, V579, P4012, DOI 10.1016/j.febslet.2005.06.014; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Jalil JE, 2005, HYPERTENSION, V46, P1362, DOI 10.1161/01.HYP.0000188980.57312.63; Krishnan N, 2008, BIOCHEM BIOPH RES CO, V374, P299, DOI 10.1016/j.bbrc.2008.07.011; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; Lakin-Thomas PL, 2000, P NATL ACAD SCI USA, V97, P256, DOI 10.1073/pnas.97.1.256; LALORAYA MM, 1994, BIOCHEM MOL BIOL INT, V33, P543; Lamb JS, 2009, J MOL BIOL, V393, P909, DOI 10.1016/j.jmb.2009.08.045; Lee B, 2009, FEBS LETT, V583, P3291, DOI 10.1016/j.febslet.2009.09.026; Lledias F, 1999, FREE RADICAL BIO MED, V26, P1396, DOI 10.1016/S0891-5849(98)00341-4; MASKIEWICZ R, 1979, J AM CHEM SOC, V101, P5347, DOI 10.1021/ja00512a040; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Michan S, 2003, EUKARYOT CELL, V2, P798, DOI 10.1128/EC.2.4.798-808.2003; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SARGENT ML, 1969, J BACTERIOL, V97, P861, DOI 10.1128/JB.97.2.861-866.1969; Schliebs W, 2006, EUKARYOT CELL, V5, P1490, DOI 10.1128/EC.00113-06; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Taylor BL, 2007, MOL MICROBIOL, V65, P1415, DOI 10.1111/j.1365-2958.2007.05889.x; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; Wang NY, 2007, MOL GENET GENOMICS, V277, P13, DOI 10.1007/s00438-006-0170-4; Yamashita K, 2007, GENES GENET SYST, V82, P301, DOI 10.1266/ggs.82.301; Yoshida Y, 2004, J BIOL CHEM, V279, P6986, DOI 10.1074/jbc.M310060200; Yoshida Y, 2008, MOL GENET GENOMICS, V279, P193, DOI 10.1007/s00438-007-0308-z; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	50	39	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28227	10.1371/journal.pone.0028227	http://dx.doi.org/10.1371/journal.pone.0028227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164247	Green Submitted, gold, Green Published			2022-12-25	WOS:000298171400048
J	Azarias, G; Chatton, JY				Azarias, Guillaume; Chatton, Jean-Yves			Selective Ion Changes during Spontaneous Mitochondrial Transients in Intact Astrocytes	PLOS ONE			English	Article							CA2+; OSCILLATIONS; DYSFUNCTION; SUPEROXIDE; TRANSPORT; PH	The bioenergetic status of cells is tightly regulated by the activity of cytosolic enzymes and mitochondrial ATP production. To adapt their metabolism to cellular energy needs, mitochondria have been shown to exhibit changes in their ionic composition as the result of changes in cytosolic ion concentrations. Individual mitochondria also exhibit spontaneous changes in their electrical potential without altering those of neighboring mitochondria. We recently reported that individual mitochondria of intact astrocytes exhibit spontaneous transient increases in their Na+ concentration. Here, we investigated whether the concentration of other ionic species were involved during mitochondrial transients. By combining fluorescence imaging methods, we performed a multiparameter study of spontaneous mitochondrial transients in intact resting astrocytes. We show that mitochondria exhibit coincident changes in their Na+ concentration, electrical potential, matrix pH and mitochondrial reactive oxygen species production during a mitochondrial transient without involving detectable changes in their Ca2+ concentration. Using widefield and total internal reflection fluorescence imaging, we found evidence for localized transient decreases in the free Mg2+ concentration accompanying mitochondrial Na+ spikes that could indicate an associated local and transient enrichment in the ATP concentration. Therefore, we propose a sequential model for mitochondrial transients involving a localized ATP microdomain that triggers a Na+-mediated mitochondrial depolarization, transiently enhancing the activity of the mitochondrial respiratory chain. Our work provides a model describing ionic changes that could support a bidirectional cytosol-to-mitochondria ionic communication.	[Azarias, Guillaume; Chatton, Jean-Yves] Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland; [Chatton, Jean-Yves] Univ Lausanne, Cellular Imaging Facil, Lausanne, Switzerland	University of Lausanne; University of Lausanne	Azarias, G (corresponding author), Karolinska Inst, Astrid Lindgren Childrens Hosp, Stockholm, Sweden.	jean-yves.chatton@unil.ch	Azarias, Guillaume/A-6877-2008	Azarias, Guillaume/0000-0001-5627-7349; Chatton, Jean-Yves/0000-0002-8911-0315	Swiss National Science Foundation [3100A0-119827, 31003A-135720]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants #3100A0-119827 and 31003A-135720 from the Swiss National Science Foundation to JY Chatton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarias G, 2008, GLIA, V56, P342, DOI 10.1002/glia.20619; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Chatton JY, 2000, EUR J NEUROSCI, V12, P3843, DOI 10.1046/j.1460-9568.2000.00269.x; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hattori T, 2005, BIOPHYS J, V88, P2340, DOI 10.1529/biophysj.104.041483; Inoue M, 2002, J PHYSIOL-LONDON, V539, P145, DOI 10.1113/jphysiol.2001.012936; Jacobson J, 2002, J CELL SCI, V115, P1175; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Magistretti PJ, 2005, J NEURAL TRANSM, V112, P77, DOI 10.1007/s00702-004-0171-6; Marchaland J, 2008, J NEUROSCI, V28, P9122, DOI 10.1523/JNEUROSCI.0040-08.2008; Muller FL, 2009, FREE RADICAL BIO MED, V47, P1779, DOI 10.1016/j.freeradbiomed.2009.09.019; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Schwarzlander M, 2011, BIOCHEM J, V437, P381, DOI 10.1042/BJ20110883; SORG O, 1992, J NEUROSCI, V12, P4923; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Yaniv Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021985	32	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28505	10.1371/journal.pone.0028505	http://dx.doi.org/10.1371/journal.pone.0028505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145050	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900033
J	Glyakina, AV; Bogatyreva, NS; Galzitskaya, OV				Glyakina, Anna V.; Bogatyreva, Natalya S.; Galzitskaya, Oxana V.			Accessible Surfaces of Beta Proteins Increase with Increasing Protein Molecular Mass More Rapidly than Those of Other Proteins	PLOS ONE			English	Article							GLOBULAR-PROTEINS; DIMENSIONS; INTERIOR; AREA	Here we present a systematic analysis of accessible surface areas and hydrogen bonds of 2554 globular proteins from four structural classes (all-alpha, all-beta, alpha/beta and alpha+beta proteins) that is aimed to learn in which structural class the accessible surface area increases with increasing protein molecular mass more rapidly than in other classes, and what structural peculiarities are responsible for this effect. The beta structural class of proteins was found to be the leader, with the following possible explanations of this fact. First, in beta structural proteins, the fraction of residues not included in the regular secondary structure is the largest, and second, the accessible surface area of packaged elements of the beta-structure increases more rapidly with increasing molecular mass in comparison with the alpha-structure. Moreover, in the beta structure, the probability of formation of backbone hydrogen bonds is higher than that in the alpha helix for all residues of alpha+beta proteins (the average probability is 0.73 +/- 0.01 for the beta-structure and 0.60 +/- 0.01 for the alpha-structure without proline) and alpha/beta proteins, except for asparagine, aspartic acid, glycine, threonine, and serine (0.70 +/- 0.01 for the beta-structure and 0.60 +/- 0.01 for the alpha-structure without the proline residue). There is a linear relationship between the number of hydrogen bonds and the number of amino acid residues in the protein (Number of hydrogen bonds=0.678: number of residues=3.350).	[Glyakina, Anna V.; Bogatyreva, Natalya S.; Galzitskaya, Oxana V.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia; [Glyakina, Anna V.] Russian Acad Sci, Inst Math Problems Biol, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences	Glyakina, AV (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia.	ogalzit@vega.protres.ru	Glyakina, Anna/O-2759-2013; GALZITSKAYA, OXANA V/L-2664-2015; Bogatyreva, Natalya S/B-9598-2017	Glyakina, Anna/0000-0002-6352-2880; Bogatyreva, Natalya/0000-0002-1719-1136	Russian Foundation for Basic Research [01200959110, 11-04-00763]; Russian Science Support Foundation; Federal Agency for Science and Innovation [02.740.11.0295]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Support Foundation(Russian Science Foundation (RSF)); Federal Agency for Science and Innovation(Federal Agency for Science & Innovations (FASI))	This work was supported by the programs "Molecular and Cellular Biology" (01200959110) and "Fundamental Sciences to Medicine", by the Russian Foundation for Basic Research (11-04-00763), by the Russian Science Support Foundation, and by a grant from the Federal Agency for Science and Innovation (#02.740.11.0295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007361; Bogatyreva N S, 2008, Mol Biol (Mosk), V42, P1048; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; FEDOROV BA, 1993, J CHEM PHYS, V99, P4076, DOI 10.1063/1.466104; FUSHMAN D, 1990, J BIOMOL STRUCT DYN, V7, P1333, DOI 10.1080/07391102.1990.10508569; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Morita H, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.020901; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; PFEIFER P, 1983, J CHEM PHYS, V79, P3558, DOI 10.1063/1.446210; Pfeifer P., 1989, FRACTAL APPROACH HET; Raschke TM, 2001, P NATL ACAD SCI USA, V98, P5965, DOI 10.1073/pnas.111158498; Serdyuk LN, 1997, BIOFIZIKA+, V42, P1197; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Tejera E, 2009, PHYSICA A, V388, P4600, DOI 10.1016/j.physa.2009.07.015; Timchenko AA, 1997, PROTEINS, V28, P194	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28464	10.1371/journal.pone.0028464	http://dx.doi.org/10.1371/journal.pone.0028464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145047	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900030
J	Humphries, AT; La Peyre, MK; Decossas, GA				Humphries, Austin T.; La Peyre, Megan K.; Decossas, Gary A.			The Effect of Structural Complexity, Prey Density, and "Predator-Free Space" on Prey Survivorship at Created Oyster Reef Mesocosms	PLOS ONE			English	Article							DRUM SCIAENOPS-OCELLATUS; HABITAT COMPLEXITY; GALVESTON BAY; FISH; SIZE; FOOD; FRAGMENTATION; COLONIZATION; COMPETITION; VEGETATION	Interactions between predators and their prey are influenced by the habitat they occupy. Using created oyster (Crassostrea virginica) reef mesocosms, we conducted a series of laboratory experiments that created structure and manipulated complexity as well as prey density and "predator-free space" to examine the relationship between structural complexity and prey survivorship. Specifically, volume and spatial arrangement of oysters as well as prey density were manipulated, and the survivorship of prey (grass shrimp, Palaemonetes pugio) in the presence of a predator (wild red drum, Sciaenops ocellatus) was quantified. We found that the presence of structure increased prey survivorship, and that increasing complexity of this structure further increased survivorship, but only to a point. This agrees with the theory that structural complexity may influence predator-prey dynamics, but that a threshold exists with diminishing returns. These results held true even when prey density was scaled to structural complexity, or the amount of "predator-free space" was manipulated within our created reef mesocosms. The presence of structure and its complexity (oyster shell volume) were more important in facilitating prey survivorship than perceived refugia or density-dependent prey effects. A more accurate indicator of refugia might require "predator-free space" measures that also account for the available area within the structure itself (i.e., volume) and not just on the surface of a structure. Creating experiments that better mimic natural conditions and test a wider range of "predator-free space" are suggested to better understand the role of structural complexity in oyster reefs and other complex habitats.	[Humphries, Austin T.; La Peyre, Megan K.] Louisiana State Univ, US Geol Survey, Louisiana Fish & Wildlife Cooperat Res Unit, Sch Renewable Nat Resources,AgCtr, Baton Rouge, LA 70803 USA; [Humphries, Austin T.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Louisiana State University System; Louisiana State University; United States Department of the Interior; United States Geological Survey; Rhodes University	Humphries, AT (corresponding author), Louisiana State Univ, US Geol Survey, Louisiana Fish & Wildlife Cooperat Res Unit, Sch Renewable Nat Resources,AgCtr, Baton Rouge, LA 70803 USA.	austin.humphries@gmail.com			Louisiana Department of Wildlife and Fisheries; Louisiana Sea Grant	Louisiana Department of Wildlife and Fisheries; Louisiana Sea Grant	The authors thank the Louisiana Department of Wildlife and Fisheries (http://www.wlf.louisiana.gov) for financial support, and Louisiana Sea Grant for funding through a grant to GD under the Undergraduate Research Opportunities Program (http://www.laseagrant.org/urop/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomew A, 2000, MAR ECOL PROG SER, V206, P45, DOI 10.3354/meps206045; Bartholomew A, 2002, ESTUARIES, V25, P1045, DOI 10.1007/BF02691351; Beck MW, 1998, MAR ECOL PROG SER, V169, P165, DOI 10.3354/meps169165; Bell S, 1991, HABITAT STRUCTURE PH, P3; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; BOOTHBY RN, 1971, T AM FISH SOC, V100, P290, DOI 10.1577/1548-8659(1971)100<290:FHLRAC>2.0.CO;2; Breitburg D, 1999, OYSTER REEF HABITAT, P238; Canion CR, 2009, MAR ECOL PROG SER, V393, P37, DOI 10.3354/meps08272; COEN LD, 1981, ECOLOGY, V62, P1484, DOI 10.2307/1941505; Coen LD, 2000, ECOL ENG, V15, P323, DOI 10.1016/S0925-8574(00)00084-7; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Dibble ED, 1996, J FRESHWATER ECOL, V11, P311, DOI 10.1080/02705060.1996.9664453; Downes BJ, 1998, ECOL MONOGR, V68, P237, DOI 10.1890/0012-9615(1998)068[0237:HSAROL]2.0.CO;2; Eggleston DB, 1999, J EXP MAR BIOL ECOL, V236, P107, DOI 10.1016/S0022-0981(98)00192-0; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Graham S, 1998, BIOL BULL, V195, P241, DOI 10.2307/1542860; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; Harding JM, 2001, J SHELLFISH RES, V20, P951; Harding JM, 1999, B MAR SCI, V65, P289; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HECK KL, 1981, J EXP MAR BIOL ECOL, V53, P125, DOI 10.1016/0022-0981(81)90014-9; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Hovel KA, 2001, ECOLOGY, V82, P1814; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Humphries AT, J EXPT MARI IN PRESS; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; Leight AK, 2005, INTEGR COMP BIOL, V45, P143, DOI 10.1093/icb/45.1.143; Liao IC, 2003, FISHERIES SCI, V69, P317, DOI 10.1046/j.1444-2906.2003.00623.x; Manatunge J, 2000, ENVIRON BIOL FISH, V58, P425, DOI 10.1023/A:1007691425268; Mattila J, 2008, MAR ECOL PROG SER, V361, P15, DOI 10.3354/meps07392; McCoy E.D., 1991, P3; Minello TJ, 1998, AM FISH S S, V22, P43; NELSON WG, 1979, J EXP MAR BIOL ECOL, V38, P225, DOI 10.1016/0022-0981(79)90069-8; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pattillo ME, 1997, DISTRIBUTION ABUNDAN, VII; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Rilov G, 2007, MAR ECOL PROG SER, V329, P225, DOI 10.3354/meps329225; ROZAS LP, 1988, OECOLOGIA, V77, P101, DOI 10.1007/BF00380932; RUSSO AR, 1987, MAR ECOL PROG SER, V36, P101, DOI 10.3354/meps036101; Scharf FS, 2000, ESTUARIES, V23, P128, DOI 10.2307/1353230; Schmid PE, 2000, ADV ECOL RES, V30, P339; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; STONER AW, 1985, J EXP MAR BIOL ECOL, V94, P19, DOI 10.1016/0022-0981(85)90048-6; Stunz GW, 2010, MAR ECOL PROG SER, V406, P147, DOI 10.3354/meps08556; Stunz GW, 2001, J EXP MAR BIOL ECOL, V260, P13, DOI 10.1016/S0022-0981(01)00248-9; UNDERWOOD R, 1982, BEHAVIOUR, V79, P81, DOI 10.1163/156853982X00193; vandeKoppel J, 1996, ECOLOGY, V77, P736, DOI 10.2307/2265498; Warfe DM, 2008, OIKOS, V117, P1764, DOI 10.1111/j.1600-0706.2008.16836.x; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; WILCOVE DS, 1985, ECOLOGY, V66, P1211, DOI 10.2307/1939174; Zimmerman R. J, 1989, OYSTER REEF HABITAT	56	50	50	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28339	10.1371/journal.pone.0028339	http://dx.doi.org/10.1371/journal.pone.0028339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145037	gold, Green Submitted, Green Published			2022-12-25	WOS:000298168900020
J	Boudjeltia, KZ; Faraut, B; Esposito, MJ; Stenuit, P; Dyzma, M; Van Antwerpen, P; Brohee, D; Vanhamme, L; Moguilevsky, N; Vanhaeverbeek, M; Kerkhofs, M				Boudjeltia, Karim Zouaoui; Faraut, Brice; Esposito, Maria Jose; Stenuit, Patricia; Dyzma, Michal; Van Antwerpen, Pierre; Brohee, Dany; Vanhamme, Luc; Moguilevsky, Nicole; Vanhaeverbeek, Michel; Kerkhofs, Myriam			Temporal Dissociation between Myeloperoxidase (MPO)-Modified LDL and MPO Elevations during Chronic Sleep Restriction and Recovery in Healthy Young Men	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GROWTH-FACTOR-I; INFLAMMATORY MARKERS; CARDIOVASCULAR RISK; DURATION; CATECHOLAMINE; DEPRIVATION; INCREASES; DISEASE; IMPACT	Objectives: Many studies have evaluated the ways in which sleep disturbances may influence inflammation and the possible links of this effect to cardiovascular risk. Our objective was to investigate the effects of chronic sleep restriction and recovery on several blood cardiovascular biomarkers. Methods and Results: Nine healthy male non-smokers, aged 22-29 years, were admitted to the Sleep Laboratory for 11 days and nights under continuous electroencephalogram polysomnography. The study consisted of three baseline nights of 8 hours sleep (from 11 pm to 7 am), five sleep-restricted nights, during which sleep was allowed only between 1 am and 6 am, and three recovery nights of 8 hours sleep (11 pm to 7 am). Myeloperoxidase-modified low-density lipoprotein levels increased during the sleep-restricted period indicating an oxidative stress. A significant increase in the quantity of slow-wave sleep was measured during the first recovery night. After this first recovery night, insulin-like growth factor-1 levels increased and myeloperoxidase concentration peaked. Conclusions: We observed for the first time that sleep restriction and the recovery process are associated with differential changes in blood biomarkers of cardiovascular disease.	[Boudjeltia, Karim Zouaoui; Faraut, Brice; Esposito, Maria Jose; Dyzma, Michal; Brohee, Dany; Vanhaeverbeek, Michel; Kerkhofs, Myriam] Univ Libre Brussels, Expt Med Lab, Ctr Hosp,Univ Charleroi, Andre Vesale Hosp, Montignies le Tilleul, Belgium; [Faraut, Brice; Esposito, Maria Jose; Stenuit, Patricia; Dyzma, Michal; Kerkhofs, Myriam] Univ Libre Brussels, Sleep Lab, Ctr Hosp,Univ Charleroi, Andre Vesale Hosp, Montignies le Tilleul, Belgium; [Van Antwerpen, Pierre] Univ Libre Brussels, Lab Pharmaceut Chem, Brussels, Belgium; [Vanhamme, Luc] Univ Libre Brussels, Mol Parasitol Lab, Inst Mol Biol & Med, Gosselies, Belgium; [Moguilevsky, Nicole] Univ Namur, Namur, Belgium	Universite Libre de Bruxelles; University of Namur	Boudjeltia, KZ (corresponding author), Univ Libre Brussels, Expt Med Lab, Ctr Hosp,Univ Charleroi, Andre Vesale Hosp, Montignies le Tilleul, Belgium.	mykerkho@ulb.ac.be		Van Antwerpen, Pierre/0000-0002-4934-8863	European Union [MCRTN-CT-2004-512362]; ISPPC-CHU de Charleroi; Institut de Pathologie et de Genetique (Gosselies) Belgium	European Union(European Commission); ISPPC-CHU de Charleroi; Institut de Pathologie et de Genetique (Gosselies) Belgium	This work was supported by European Union Grant MCRTN-CT-2004-512362, Scientific Research Fund of the ISPPC-CHU de Charleroi and Institut de Pathologie et de Genetique (Gosselies) Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus S, 2004, FREE RADICAL BIO MED, V37, P902, DOI 10.1016/j.freeradbiomed.2004.06.003; BJERKNES R, 1995, J CLIN ENDOCR METAB, V80, P1948, DOI 10.1210/jc.80.6.1948; Bleeke T, 2004, CIRC RES, V94, P37, DOI 10.1161/01.RES.0000109412.80157.7D; Boudjeltia KZ, 2008, VASC HEALTH RISK MAN, V4, P1467; Boudjeltia KZ, 2004, BIOCHEM BIOPH RES CO, V325, P434, DOI 10.1016/j.bbrc.2004.10.049; Calay D, 2010, ANTIOXID REDOX SIGN, V13, P1491, DOI 10.1089/ars.2009.2971; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Faraut B, 2011, SLEEP MED REV   0809; Faraut B, 2011, BRAIN BEHAV IMMUN, V25, P16, DOI 10.1016/j.bbi.2010.08.001; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Haack M, 2002, PSYCHONEUROENDOCRINO, V27, P921, DOI 10.1016/S0306-4530(02)00006-9; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Heemskerk VH, 1999, CYTOKINE GROWTH F R, V10, P5, DOI 10.1016/S1359-6101(98)00022-7; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; Irwin M, 1999, J CLIN ENDOCR METAB, V84, P1979, DOI 10.1210/jc.84.6.1979; Irwin MR, 2010, BRAIN BEHAV IMMUN, V24, P54, DOI 10.1016/j.bbi.2009.06.001; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Kerkhofs M, 2007, MATURITAS, V56, P212, DOI 10.1016/j.maturitas.2006.07.007; King CR, 2008, JAMA-J AM MED ASSOC, V300, P2859, DOI 10.1001/jama.2008.867; Lange T, 2011, BRAIN BEHAV IMMUN, V25, P14, DOI 10.1016/j.bbi.2010.08.008; Larsson A, 2008, CLIN BIOCHEM, V41, P859, DOI 10.1016/j.clinbiochem.2008.02.018; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; Miller MA, 2009, SLEEP, V32, P857; Moguilevsky N, 2004, BIOCHEM BIOPH RES CO, V323, P1223, DOI 10.1016/j.bbrc.2004.08.220; National Sleep Foundation, 2009, 2009 SLEEP AM POLL; OLIVARES R, 1993, AM J EPIDEMIOL, V137, P49, DOI 10.1093/oxfordjournals.aje.a116601; OSCARSSON J, 1995, CLIN ENDOCRINOL, V42, P673, DOI 10.1111/j.1365-2265.1995.tb02699.x; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Spiegel K, 2000, AM J PHYSIOL-REG I, V279, pR8746; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; Tsimikas S, 2008, AM J CARDIOL, V101, p34D, DOI 10.1016/j.amjcard.2008.02.006; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; van Leeuwen WMA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/108641; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Veldhuis JD, 1996, SLEEP, V19, pS221, DOI 10.1093/sleep/19.suppl_10.S221; ZALOKAR JB, 1981, NEW ENGL J MED, V304, P465, DOI 10.1056/NEJM198102193040806	40	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28230	10.1371/journal.pone.0028230	http://dx.doi.org/10.1371/journal.pone.0028230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140557	Green Submitted, gold, Green Published			2022-12-25	WOS:000298168100055
J	Sun, HF; Lin, CH; Smith, ME				Sun, Huifang; Lin, Chia-Hui; Smith, Michael E.			Growth Hormone Promotes Hair Cell Regeneration in the Zebrafish (Danio rerio) Inner Ear following Acoustic Trauma	PLOS ONE			English	Article							LATERAL-LINE; NEURAL RETINA; HEARING; GH; PROLIFERATION; MECHANISMS; MACROPHAGE; SURVIVAL; COCHLEA; REPLACEMENT	Background: Previous microarray analysis showed that growth hormone (GH) was significantly upregulated following acoustic trauma in the zebrafish (Danio rerio) ear suggesting that GH may play an important role in the process of auditory hair cell regeneration. Our objective was to examine the effects of exogenous and endogenous GH on zebrafish inner ear epithelia following acoustic trauma. Methodology/Principal Findings: We induced auditory hair cell damage by exposing zebrafish to acoustic overstimulation. Fish were then injected intraperitoneally with either carp GH or buffer, and placed in a recovery tank for either one or two days. Phalloidin-, bromodeoxyuridine (BrdU)-, and TUNEL-labeling were used to examine hair cell densities, cell proliferation, and apoptosis, respectively. Two days post-trauma, saccular hair cell densities in GH-treated fish were similar to that of baseline controls, whereas buffer-injected fish showed significantly reduced densities of hair cell bundles. Cell proliferation was greater and apoptosis reduced in the saccules, lagenae, and utricles of GH-treated fish one day following trauma compared to controls. Fluorescent in situ hybridization (FISH) was used to examine the localization of GH mRNA in the zebrafish ear. At one day post-trauma, GH mRNA expression appeared to be localized perinuclearly around erythrocytes in the blood vessels of the inner ear epithelia. In order to examine the effects of endogenous GH on the process of cell proliferation in the ear, a GH antagonist was injected into zebrafish immediately following acoustic trauma, resulting in significantly decreased cell proliferation one day post-trauma in all three zebrafish inner ear end organs. Conclusions/Significance: Our results show that exogenous GH promotes post-trauma auditory hair cell regeneration in the zebrafish ear through stimulating proliferation and suppressing apoptosis, and that endogenous GH signals are present in the zebrafish ear during the process of auditory hair cell regeneration.	[Sun, Huifang; Lin, Chia-Hui; Smith, Michael E.] Western Kentucky Univ, Dept Biol & Biotechnol Ctr, Bowling Green, KY 42101 USA	Western Kentucky University	Sun, HF (corresponding author), Western Kentucky Univ, Dept Biol & Biotechnol Ctr, Bowling Green, KY 42101 USA.	michael.smith1@wku.edu	Smith, Michael/AAM-8542-2020	Smith, Michael/0000-0002-2174-9825	National Institutes of Health [P20RR16481]; WKU; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WKU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by National Institutes of Health grant P20RR16481 and a WKU faculty summer scholarship to MES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2011, CURR OPIN ENDOCRINOL, V18, P3, DOI 10.1097/MED.0b013e328341f873; Avallone B, 2003, HEARING RES, V178, P79, DOI 10.1016/S0378-5955(03)00040-6; Beisel K, 2008, CELL TISSUE RES, V333, P373, DOI 10.1007/s00441-008-0639-z; Bhave SA, 1998, J COMP NEUROL, V398, P241, DOI 10.1002/(SICI)1096-9861(19980824)398:2<241::AID-CNE6>3.0.CO;2-0; Bidlingmaier Martin, 2010, Handb Exp Pharmacol, P187, DOI 10.1007/978-3-540-79088-4_8; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Brignull HR, 2009, BRAIN RES, V1277, P12, DOI 10.1016/j.brainres.2009.02.028; Brunet-Dunand SE, 2009, ENDOCRINOLOGY, V150, P1341, DOI 10.1210/en.2008-0608; Cacciafesta V, 2001, EUR J ORTHODONT, V23, P733, DOI 10.1093/ejo/23.6.733; CalduchGiner JA, 1997, CELL TISSUE RES, V287, P535, DOI 10.1007/s004410050777; CASANUEVA FF, 1992, ENDOCRIN METAB CLIN, V21, P483, DOI 10.1016/S0889-8529(18)30199-3; CHARDIN S, 1995, SCIENCE, V267, P707, DOI 10.1126/science.7839151; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; ELLIS AE, 1977, J FISH BIOL, V11, P453, DOI 10.1111/j.1095-8649.1977.tb04140.x; Fettiplace R, 2006, SPR HDB AUD, V27, P154; GILPIN DA, 1994, ANN SURG, V220, P19, DOI 10.1097/00000658-199407000-00004; GOLDE DW, 1977, SCIENCE, V196, P1112, DOI 10.1126/science.870971; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Harvey S, 2010, ENDOCRINE, V38, P335, DOI 10.1007/s12020-010-9403-8; Harvey S, 2006, NEUROREPORT, V17, P1715, DOI 10.1097/01.wnr.0000239952.22578.90; HERDON DN, 1996, HORM RES S1, V45, P29; Hernandez PP, 2007, DEV NEUROBIOL, V67, P637, DOI 10.1002/dneu.20386; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; ISAKSSON OGP, 1982, SCIENCE, V216, P1237, DOI 10.1126/science.7079756; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jones JE, 1996, J NEUROSCI, V16, P649; JONES JE, 1993, J NEUROSCI, V13, P1022; Jongkamonwiwat N, 2010, CURR DRUG TARGETS, V11, P888, DOI 10.2174/138945010791320836; Jung GW, 1998, J UROLOGY, V160, P1899, DOI 10.1016/S0022-5347(01)62440-6; KANJE M, 1988, BRAIN RES, V475, P254, DOI 10.1016/0006-8993(88)90613-0; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; Lefebvre PP, 2000, ACTA OTO-LARYNGOL, V120, P142; LOMBARTE A, 1993, HEARING RES, V64, P166, DOI 10.1016/0378-5955(93)90002-I; LOWENSTEIN O, 1971, P253; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Matsuda T, 1998, JPEN-PARENTER ENTER, V22, P368, DOI 10.1177/0148607198022006368; Matsui JI, 2005, J REHABIL RES DEV, V42, P187, DOI 10.1682/JRRD.2005.01.0008; McCullar JS, 2010, J NEUROSCI, V30, P478, DOI 10.1523/JNEUROSCI.5154-09.2010; O'Halloran EK, 2004, J COMP NEUROL, V475, P340, DOI 10.1002/cne.20162; Okada S, 2001, TRENDS MOL MED, V7, P126, DOI 10.1016/S1471-4914(01)01933-5; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pandey V, 2008, ENDOCRINOLOGY, V149, P3909, DOI 10.1210/en.2008-0286; Pennisi PA, 2004, ENDOCRINOLOGY, V145, P4748, DOI 10.1210/en.2004-0655; PLATT C, 1993, HEARING RES, V65, P133, DOI 10.1016/0378-5955(93)90208-I; Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007; RENDER CL, 1995, J ENDOCRINOL, V147, P413, DOI 10.1677/joe.0.1470413; Rivolta MN, 2010, DRUG DISCOV TODAY, V15, P283, DOI 10.1016/j.drudis.2010.02.006; ROBERSON DW, 1994, AM J OTOL, V15, P28; Rotwein P, 2010, PEDIATR NEPHROL, V25, P651, DOI 10.1007/s00467-009-1258-y; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Sanders EJ, 2008, GEN COMP ENDOCR, V156, P613, DOI 10.1016/j.ygcen.2008.02.005; Sanders EJ, 2006, EXP EYE RES, V83, P1205, DOI 10.1016/j.exer.2006.06.009; Sanders EJ, 2009, GEN COMP ENDOCR, V163, P63, DOI 10.1016/j.ygcen.2009.01.005; Scheepens A, 2005, HORM RES, V64, P66, DOI 10.1159/000089320; Schuck JB, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-88; Schuck JB, 2009, HEARING RES, V253, P67, DOI 10.1016/j.heares.2009.03.008; SMITH CG, 1952, PROG FISH CULT, V14, P169; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Smith ME, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-19; TANNER JM, 1972, NATURE, V237, P433, DOI 10.1038/237433a0; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Tresguerres JAF, 1999, J ENDOCRINOL, V160, P217, DOI 10.1677/joe.0.1600217; ULLMAN M, 1989, ACTA PHYSIOL SCAND, V135, P537, DOI 10.1111/j.1748-1716.1989.tb08613.x; van den Eijnden MJ, 2007, MOL ENDOCRINOL, V21, P2832, DOI 10.1210/me.2007-0092; Warchol ME, 1997, J NEUROBIOL, V33, P724, DOI 10.1002/(SICI)1097-4695(19971120)33:6<724::AID-NEU2>3.0.CO;2-B; WEIGENT DA, 1988, FASEB J, V2, P2812, DOI 10.1096/fasebj.2.12.3044906; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	75	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28372	10.1371/journal.pone.0028372	http://dx.doi.org/10.1371/journal.pone.0028372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140580	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168100066
J	Yang, JR; Huang, YP; Chang, FY; Hsu, LC; Lin, YC; Su, CH; Chen, PJ; Wu, HS; Liu, MT				Yang, Ji-Rong; Huang, Yuan-Pin; Chang, Feng-Yee; Hsu, Li-Ching; Lin, Yu-Cheng; Su, Chun-Hui; Chen, Pei-Jer; Wu, Ho-Sheng; Liu, Ming-Tsan			New Variants and Age Shift to High Fatality Groups Contribute to Severe Successive Waves in the 2009 Influenza Pandemic in Taiwan	PLOS ONE			English	Article							H1N1 VIRUS-INFECTION; A H1N1; HOSPITALIZED-PATIENTS; UNITED-STATES; VIRULENCE	Past influenza pandemics have been characterized by the signature feature of multiple waves. However, the reasons for multiple waves in a pandemic are not understood. Successive waves in the 2009 influenza pandemic, with a sharp increase in hospitalized and fatal cases, occurred in Taiwan during the winter of 2010. In this study, we sought to discover possible contributors to the multiple waves in this influenza pandemic. We conducted a large-scale analysis of 4703 isolates in an unbiased manner to monitor the emergence, dominance and replacement of various variants. Based on the data from influenza surveillance and epidemic curves of each variant clade, we defined virologically and temporally distinct waves of the 2009 pandemic in Taiwan from May 2009 to April 2011 as waves 1 and 2, an interwave period and wave 3. Except for wave 3, each wave was dominated by one distinct variant. In wave 3, three variants emerged and co-circulated, and formed distinct phylogenetic clades, based on the hemagglutinin (HA) genes and other segments. The severity of influenza was represented as the case fatality ratio (CFR) in the hospitalized cases. The CFRs in waves 1 and 2, the interwave period and wave 3 were 6.4%, 5.1%, 15.2% and 9.8%, respectively. The results highlight the association of virus evolution and variable influenza severity. Further analysis revealed that the major affected groups were shifted in the waves to older individuals, who had higher age-specific CFRs. The successive pandemic waves create challenges for the strategic preparedness of health authorities and make the pandemic uncertain and variable. Our findings indicate that the emergence of new variants and age shift to high fatality groups might contribute potentially to the occurrence of successive severe pandemic waves and offer insights into the adjustment of national responses to mitigate influenza pandemics.	[Yang, Ji-Rong; Huang, Yuan-Pin; Chang, Feng-Yee; Hsu, Li-Ching; Lin, Yu-Cheng; Su, Chun-Hui; Wu, Ho-Sheng; Liu, Ming-Tsan] Ctr Dis Control, Taipei, Taiwan; [Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Taiwan University; Taipei Medical University	Yang, JR (corresponding author), Ctr Dis Control, Taipei, Taiwan.	wuhs@cdc.gov.tw; mtliu@cdc.gov.tw		Chen, Pei-Jer/0000-0001-8316-3785	National Science Council [98-0324-01-F-20, 99-0324-01-F-12]; Centers for Disease Control, Department of Health, Taiwan [DOH99-DC-2027, DOH100-DC-2019, DOH100-DC-2022]	National Science Council(Ministry of Science and Technology, Taiwan); Centers for Disease Control, Department of Health, Taiwan	This study was supported by grants from the National Science Council (National Research Program for Genome Medicine 98-0324-01-F-20 and 99-0324-01-F-12) and the Centers for Disease Control, Department of Health, Taiwan (DOH99-DC-2027, DOH100-DC-2019 and DOH100-DC-2022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDARANAYAKE D, 2011, EURO SURVEILL, V16; Barr IG, 2010, EUROSURVEILLANCE, V15, P6; Brandsaeter BJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-75; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Christman MC, 2011, INFECT GENET EVOL, V11, P803, DOI 10.1016/j.meegid.2011.02.021; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Ellis J, 2011, EURO SURVEILL, V16, P19760; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Keramarou M, 2011, EURO SURVEILL, V16; Kilander A, 2010, EURO SURVEILL, V15; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mak G, 2011, EURO SURVEILL, V16; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Nelson M, 2009, PLOS CURR INFLUENZA, P1; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishiura H, 2010, LANCET INFECT DIS, V10, P443, DOI 10.1016/S1473-3099(10)70120-1; POEPPL W, 2011, INFECTION; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Song MS, 2011, J VIROL, V85, P6275, DOI 10.1128/JVI.02125-10; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Truelove SA, 2011, J INFECT DIS, V203, P828, DOI 10.1093/infdis/jiq117; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WILKING H, 2010, EURO SURVEILL, V15; Yang JR, 2010, ANTIVIR RES, V88, P256, DOI 10.1016/j.antiviral.2010.09.014; Yang JR, 2009, J CLIN MICROBIOL, V47, P3714, DOI 10.1128/JCM.01646-09	38	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28288	10.1371/journal.pone.0028288	http://dx.doi.org/10.1371/journal.pone.0028288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140569	Green Submitted, Green Published, gold			2022-12-25	WOS:000298168100061
J	Yoshida, Y; Ninomiya, K; Hamada, H; Noda, M				Yoshida, Y.; Ninomiya, K.; Hamada, H.; Noda, M.			Involvement of the SKP2-p27(KIP1) pathway in suppression of cancer cell proliferation by RECK	ONCOGENE			English	Article						RECK; cell cycle; extracellular matrix; SKP2; p27; collagen	GENE-EXPRESSION SIGNATURE; REGULATOR RECK; IN-VIVO; PROTEIN; SKP2; INHIBITOR; P27; METALLOPROTEINASE; CLASSIFICATION; ACCUMULATION	The membrane-anchored matrix metalloproteinase-regulator RECK is often downregulated in cancers; in some cases, a significant correlation between the level of residual RECK in resected tumors and patient survival has been noted. Furthermore, restoration of RECK expression in certain cancer-derived cell lines results in reduced tumorigenicity. Here we report that acute RECK expression in colon carcinoma cells results in cell cycle-arrest accompanied by downregulation of a ubiquitin ligase component, S-phase kinase-associated protein 2 (SKP2), and upregulation of its substrate, p27(KIP1). Our data indicate that RECK-induced growth suppression is at least partially dependent on p27, and that RECK and type I collagen share similar effects on the SKP2-p27 pathway. Importantly, in patients with lung, colorectal and bladder cancers, the RECK/SKP2 ratio is high in normal tissues and lower in the cancer tissues. These findings reveal a novel molecular pathway linking cell-cycle progression to RECK downregulation, extracellular matrix degradation and SKP2 upregulation, and suggest that treatment regimens that induce RECK expression could be promising cancer therapies. Oncogene (2012) 31, 4128-4138; doi:10.1038/onc.2011.570; published online 12 December 2011	[Yoshida, Y.; Ninomiya, K.; Noda, M.] Kyoto Univ, Dept Mol Oncol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Yoshida, Y.; Ninomiya, K.; Noda, M.] Kyoto Univ, Global COE Program, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Hamada, H.] Tokyo Univ Pharm & Life Sci, Dept Life Sci, Lab Oncol, Tokyo, Japan	Kyoto University; Kyoto University; Tokyo University of Pharmacy & Life Sciences	Noda, M (corresponding author), Kyoto Univ, Dept Mol Oncol, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	mnoda@virus.kyoto-u.ac.jp			JSPS; MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Chiaki Takahashi for the RECK cDNA, Mako Yamamoto for R1B2-6 cells, Hitoshi Kitayama and Tomoko Matsuzaki for discussions, David Alexander for critical reading of the manuscript, Hai-Ou Gu and Aiko Nishimoto for technical assistance and Aki Miyazaki for secretarial assistance. This work was supported by JSPS Grant-in-Aid for Creative Scientific Research and MEXT Grant-in-Aid on Priority Areas.	Bond M, 2008, CARDIOVASC RES, V80, P290, DOI 10.1093/cvr/cvn188; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chandana EPS, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-84; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Freshney R.I., 1987, CULTURE ANIMAL CELLS, P117; Fu Y, 2007, J CELL BIOCHEM, V102, P704, DOI 10.1002/jcb.21323; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hatta M, 2009, CELL SIGNAL, V21, P1885, DOI 10.1016/j.cellsig.2009.08.005; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kondo S, 2007, J CELL SCI, V120, P849, DOI 10.1242/jcs.03388; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Murai R, 2010, ONCOTARGET, V1, P252; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; NODA M, 1989, P NATL ACAD SCI USA, V86, P162, DOI 10.1073/pnas.86.1.162; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Omura A, 2009, J BIOL CHEM, V284, P3461, DOI 10.1074/jbc.M806212200; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sasahara RM, 1999, BIOCHEM BIOPH RES CO, V264, P668, DOI 10.1006/bbrc.1999.1552; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Yoshida Y, 1997, BIOCHEM BIOPH RES CO, V230, P426, DOI 10.1006/bbrc.1996.5975; Zhang H, 2003, HEPATOLOGY, V38, P305, DOI 10.1053/jhep.2003.50345; Zhu L, 2010, CELL RES, V20, P605, DOI 10.1038/cr.2010.71	40	26	27	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	37					4128	4138		10.1038/onc.2011.570	http://dx.doi.org/10.1038/onc.2011.570			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NR	22158033				2022-12-25	WOS:000308688900005
J	Huang, Z; Cheng, Y; Chiu, PM; Cheung, FMF; Nicholls, JM; Kwong, DLW; Lee, AWM; Zabarovsky, ER; Stanbridge, EJ; Lung, HL; Lung, ML				Huang, Z.; Cheng, Y.; Chiu, P. M.; Cheung, F. M. F.; Nicholls, J. M.; Kwong, D. L-W; Lee, A. W. M.; Zabarovsky, E. R.; Stanbridge, E. J.; Lung, H. L.; Lung, M. L.			Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties	ONCOGENE			English	Article						Alpha B-crystallin; nasopharyngeal carcinoma; E-cadherin; beta-catenin	EPSTEIN-BARR-VIRUS; NASOPHARYNGEAL EPITHELIAL-CELLS; LYMPH-NODE METASTASIS; DOWN-REGULATION; MESENCHYMAL TRANSITIONS; MOLECULAR-MECHANISMS; DECREASED EXPRESSION; GENE-EXPRESSION; BETA-CATENIN; CARCINOMA	Alpha B-crystallin (CRYAB) maps within the nasopharyngeal carcinoma (NPC) tumor-suppressive critical region 11q22-23 and its downregulation is significantly associated with the progression of NPC. However, little is known about the functional impact of CRYAB on NPC progression. In this study we evaluated the NPC tumor-suppressive and progression-associated functions of CRYAB. Activation of CRYAB suppressed NPC tumor formation in nude mice. Overexpression of CRYAB affected NPC progression-associated phenotypes such as loss of cell adhesion, invasion, interaction with the tumor microenvironment, invasive protrusion formation in three dimensional Matrigel culture, as well as expression of epithelial-mesenchymal transition-associated markers. CRYAB mediates this ability to suppress cancer progression by inhibition of E-cadherin cytoplasmic internalization and maintenance of beta-catenin in the membrane that subsequently reduces the levels of expression of critical downstream targets such as cyclin-D1 and c-myc. Both ectopically expressed and recombinant CRYAB proteins were associated with endogenous E-cadherin and beta-catenin, and, thus, the cadherin/catenin adherens junction. The CRYAB alpha-crystallin core domain is responsible for the interaction of CRYAB with both E-cadherin and beta-catenin. Taken together, these results indicate that CRYAB functions to suppress NPC progression by associating with the cadherin/catenin adherens junction and modulating the beta-catenin function. Oncogene (2012) 31, 3709-3720; doi:10.1038/onc.2011.529; published online 12 December 2011	[Huang, Z.; Cheng, Y.; Chiu, P. M.; Kwong, D. L-W; Lung, H. L.; Lung, M. L.] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Cheung, F. M. F.] Pamela Youde Nethersole Eastern Hosp, Dept Clin Pathol, Hong Kong, Peoples R China; [Nicholls, J. M.] Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China; [Lee, A. W. M.] Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Hong Kong, Peoples R China; [Huang, Z.; Cheng, Y.; Chiu, P. M.; Kwong, D. L-W; Lung, H. L.; Lung, M. L.] Univ Hong Kong, Ctr Canc Res, Hong Kong, Peoples R China; Karolinska Inst, Dept Microbiol,Tumor & Cell Biol, Stockholm, Sweden; [Zabarovsky, E. R.] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Zabarovsky, E. R.] Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Struct & Funct Genom, Moscow, Russia; [Stanbridge, E. J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of California System; University of California Irvine	Lung, HL (corresponding author), Univ Hong Kong, Dept Clin Oncol, Room L2-23,2-F Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	hllung2@hku.hk; mlilung@hku.hk	Lung, Maria Li/C-4495-2009; Nicholls, John Malcolm/C-4375-2009; /E-9853-2010	Lung, Maria Li/0000-0003-2559-3626; Nicholls, John Malcolm/0000-0001-7217-7444; /0000-0002-2472-1879	Research Grants Council; University Grants Council of Hong Kong Special Administrative Region, People's Republic of China [AoE/M-06/08]; University of Hong Kong Seed Funding Programme for Basic Research; Swedish Cancer Society; Swedish Research Council; Swedish Institute; Karolinska Institute	Research Grants Council(Hong Kong Research Grants Council); University Grants Council of Hong Kong Special Administrative Region, People's Republic of China; University of Hong Kong Seed Funding Programme for Basic Research(University of Hong Kong); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute; Karolinska Institute(Karolinska Institutet)	We thank Patrick Vicart for the pcDNA3-CRYAB construct. We acknowledge the funding support from the Research Grants Council grants, and the University Grants Council of Hong Kong Special Administrative Region, People's Republic of China, for AoE/M-06/08 to MLL; The University of Hong Kong Seed Funding Programme for Basic Research to HLL; and the Swedish Cancer Society, the Swedish Research Council, the Swedish Institute and Karolinska Institute to ERZ. We acknowledge the Area of Excellence Hong Kong NPC Research Tissue Bank for the NPC specimens and tissue blocks.	Cheng Y, 2000, GENE CHROMOSOME CANC, V28, P82, DOI 10.1002/(SICI)1098-2264(200005)28:1<82::AID-GCC10>3.0.CO;2-8; Chetty R, 2008, ADV ANAT PATHOL, V15, P234, DOI 10.1097/PAP.0b013e31817bf566; Cheung AKL, 2009, P NATL ACAD SCI USA, V106, P14478, DOI 10.1073/pnas.0900198106; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hui ABY, 1996, CANCER RES, V56, P3225; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leung ACC, 2008, INT J CANCER, V122, P587, DOI 10.1002/ijc.23144; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Li JF, 2004, ONCOGENE, V23, P5941, DOI 10.1038/sj.onc.1207789; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin JC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-105; Lo AKF, 2003, LAB INVEST, V83, P697, DOI 10.1097/01.LAB.0000067480.44925.10; Lo KW, 2000, CANCER RES, V60, P3348; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lung HL, 2005, ONCOGENE, V24, P6525, DOI 10.1038/sj.onc.1208812; Lung HL, 2008, INT J CANCER, V122, P1288, DOI 10.1002/ijc.23259; Lung HL, 2006, CANCER RES, V66, P9385, DOI 10.1158/0008-5472.CAN-06-0590; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; Maddala R, 2005, EXP CELL RES, V306, P203, DOI 10.1016/j.yexcr.2005.01.026; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; Solares CA, 2010, OTOLARYNG HEAD NECK, V142, pS15, DOI 10.1016/j.otohns.2009.12.001; Stronach EA, 2003, CANCER RES, V63, P8648; Takashi M, 1998, UROL RES, V26, P395, DOI 10.1007/s002400050075; Thedieck C, 2008, J MOL BIOL, V378, P145, DOI 10.1016/j.jmb.2008.02.008; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Wong VCL, 2011, BRIT J CANCER, V104, P841, DOI 10.1038/bjc.2011.25; Wong VCL, 2012, INT J CANCER, V130, P83, DOI 10.1002/ijc.25970; Zhang JJ, 2010, CELL CYCLE, V9, P4848, DOI 10.4161/cc.9.24.14136; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509; Zheng Z, 1999, HUM PATHOL, V30, P458, DOI 10.1016/S0046-8177(99)90123-5	43	48	49	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	32					3709	3720		10.1038/onc.2011.529	http://dx.doi.org/10.1038/onc.2011.529			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	990TF	22158051				2022-12-25	WOS:000307653800005
J	Macia, A; Gallel, P; Vaquero, M; Gou-Fabregas, M; Santacana, M; Maliszewska, A; Robledo, M; Gardiner, JR; Basson, MA; Matias-Guiu, X; Encinas, M				Macia, A.; Gallel, P.; Vaquero, M.; Gou-Fabregas, M.; Santacana, M.; Maliszewska, A.; Robledo, M.; Gardiner, J. R.; Basson, M. A.; Matias-Guiu, X.; Encinas, M.			Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma	ONCOGENE			English	Article						sprouty; medullary thyroid carcinoma; mouse models	RET PROTOONCOGENE; CELLULAR SENESCENCE; KINASE INHIBITOR; GDNF FAMILY; C-CELL; EXPRESSION; GROWTH; MICE; MORPHOGENESIS; PROTEINS	Medullary thyroid carcinoma (MTC) is a malignancy derived from the calcitonin-producing C-cells of the thyroid gland. Oncogenic mutations of the Ret protooncogene are found in all heritable forms of MTC and roughly one half of the sporadic cases. However, several lines of evidence argue for the existence of additional genetic lesions necessary for the development of MTC. Sprouty (Spry) family of genes is composed of four members in mammals (Spry1-4). Some Spry family members have been proposed as candidate tumor-suppressor genes in a variety of cancerous pathologies. In this work, we show that targeted deletion of Spry1 causes C-cell hyperplasia, a precancerous lesion preceding MTC, in young adult mice. Expression of Spry1 restrains proliferation of the MTC-derived cell line, TT. Finally, we found that the Spry1 promoter is frequently methylated in MTC and that Spry1 expression is consequently decreased. These findings identify Spry1 as a candidate tumor- suppressor gene in MTC. Oncogene (2012) 31, 3961-3972; doi:10.1038/onc.2011.556; published online 12 December 2011	[Macia, A.; Vaquero, M.; Gou-Fabregas, M.; Encinas, M.] Univ Lleida, Inst Recerca Biomed Lleida, Dept Expt Med, Lleida, Spain; [Gallel, P.; Santacana, M.; Matias-Guiu, X.] Univ Lleida, Inst Recerca Biomed Lleida, Dept Pathol & Mol Genet, Lleida, Spain; [Maliszewska, A.; Robledo, M.] Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain; [Maliszewska, A.; Robledo, M.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Gardiner, J. R.; Basson, M. A.] Kings Coll London, Dept Craniofacial Dev, London WC2R 2LS, England	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of London; King's College London	Encinas, M (corresponding author), Hosp Arnau Vilanova, Lab Invest UdL HUAV, Dept Med Expt, Rovira Roure 80, Lleida 25198, Spain.	mario.encinas@mex.udl.cat	Armengol, Anna Macià/V-2631-2017; Basson, M. Albert/C-5565-2009; Gou-Fabregas, Myriam/K-1899-2016; Robledo, Mercedes/O-2230-2013; matias-guiu, xavier/C-3039-2009; Encinas, Mario/B-5600-2009	Armengol, Anna Macià/0000-0001-6038-178X; Gou-Fabregas, Myriam/0000-0002-5329-7640; Robledo, Mercedes/0000-0001-6256-5902; matias-guiu, xavier/0000-0002-7201-6605; Encinas, Mario/0000-0003-3509-7431; Basson, M. Albert/0000-0001-9834-7528; Santacana, Maria/0000-0003-1975-2598; Vaquero Susagna, Marta/0000-0002-3856-6769	Ministerio de Educacion y Ciencia [BFU2007-67619, BFU2010-17628]; Fundacio La Marato de TV3; Suport als Grups de Recerca from Generalitat de Catalunya [2009 SGR 740]; programa de intensificacion de la investigacion, Instituto Carlos III; Fondo de Investigaciones Sanitarias [PI080883]; Fundacion Mutua Madrilena [AP2775/2008]; Medical Research Council [G0601104]; Tumor Banc Platform of RTICC [RD09/0076/00059]; Universitat de Lleida; Fundacio Alicia Cuello de Merigo;  [2009SGR794];  [RD06/0020/1034]; MRC [G0601104] Funding Source: UKRI	Ministerio de Educacion y Ciencia(Spanish Government); Fundacio La Marato de TV3; Suport als Grups de Recerca from Generalitat de Catalunya; programa de intensificacion de la investigacion, Instituto Carlos III; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tumor Banc Platform of RTICC; Universitat de Lleida; Fundacio Alicia Cuello de Merigo; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Esteban J Rozen for his initial contribution to the development of this work. We also thank Ana Velasco and Carme Guerris for technical assistance. This work was supported by grants from Ministerio de Educacion y Ciencia (BFU2007-67619 and BFU2010-17628) and Fundacio La Marato de TV3, and funding from Suport als Grups de Recerca (2009 SGR 740) from Generalitat de Catalunya to ME; grants 2009SGR794,RD06/0020/1034 and programa de intensificacion de la investigacion, Instituto Carlos III to XM-G; grants from Fondo de Investigaciones Sanitarias (PI080883) and Fundacion Mutua Madrilena (AP2775/2008) to MR; and from the Medical Research Council (G0601104) to MAB Tumor samples were obtained with the support of Xarxa catalana de Bancs de Tumors, the Tumor Banc Platform of RTICC and RD09/0076/00059. AM is supported by a predoctoral fellowship from Universitat de Lleida and was supported by a fellowship from a Fundacio Alicia Cuello de Merigo. MV was recipient of a 'beca d'introduccio a la recerca fellowship from Universitat de Lleida.	Acton DS, 2000, ONCOGENE, V19, P3121, DOI 10.1038/sj.onc.1203648; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Akeno-Stuart N, 2007, CANCER RES, V67, P6956, DOI 10.1158/0008-5472.CAN-06-4605; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Asai N, 2006, PATHOL INT, V56, P164, DOI 10.1111/j.1440-1827.2006.01942.x; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Cerrato A, 2009, J MOL ENDOCRINOL, V43, P143, DOI 10.1677/JME-09-0024; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Darimipourain M, 2011, PROSTATE CANCER P D, V14, P279, DOI 10.1038/pcan.2011.33; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Encinas M, 2008, CELL DEATH DIFFER, V15, P1510, DOI 10.1038/cdd.2008.76; Eritja N, 2010, AM J PATHOL, V176, P2722, DOI 10.2353/ajpath.2010.090974; Fagman H, 2010, MOL CELL ENDOCRINOL, V323, P35, DOI 10.1016/j.mce.2009.12.008; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; Gagel RF, 2003, WILLIAMS TXB ENDOCRI, P1717; Gallel P, 2008, HUM PATHOL, V39, P994, DOI 10.1016/j.humpath.2007.11.015; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Ishida M, 2007, CANCER SCI, V98, P815, DOI 10.1111/j.1349-7006.2007.00457.x; Kawai K, 2000, CANCER RES, V60, P5254; Kwabi-Addo B, 2004, CANCER RES, V64, P4728, DOI 10.1158/0008-5472.CAN-03-3759; Kwabi-Addo B, 2009, EPIGENETICS, V4, P54, DOI 10.4161/epi.4.1.7400; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Llobet D, 2008, ONCOGENE, V27, P2513, DOI 10.1038/sj.onc.1210924; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matias-Guiu X, 2004, PATHOLOGY GENETICS T, V8, P86; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Michiels FM, 1997, P NATL ACAD SCI USA, V94, P3330, DOI 10.1073/pnas.94.7.3330; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Reynolds L, 2001, ONCOGENE, V20, P3986, DOI 10.1038/sj.onc.1204434; Rozen EJ, 2009, J AM SOC NEPHROL, V20, P255, DOI 10.1681/ASN.2008030267; Santarpia L, 2009, J INTERN MED, V266, P99, DOI 10.1111/j.1365-2796.2009.02112.x; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Smith-Hicks CL, 2000, EMBO J, V19, P612, DOI 10.1093/emboj/19.4.612; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Velasco A, 2011, HUM PATHOL, V42, P185, DOI 10.1016/j.humpath.2010.08.001; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013; Ye L, 2008, J CLIN ENDOCR METAB, V93, P4367, DOI 10.1210/jc.2008-0912; Yin L, 2007, INT J CANCER, V121, P292, DOI 10.1002/ijc.22378; Zaremba A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-192; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	55	32	33	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	35					3961	3972		10.1038/onc.2011.556	http://dx.doi.org/10.1038/onc.2011.556			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	999VJ	22158037	Bronze, Green Accepted			2022-12-25	WOS:000308342800005
J	Feng, Y; Mckee, K; Tran, K; O'Dell, S; Schmidt, SD; Phogat, A; Forsell, MN; Hedestam, GBK; Mascola, JR; Wyatt, RT				Feng, Yu; Mckee, Krisha; Tran, Karen; O'Dell, Sijy; Schmidt, Stephen D.; Phogat, Adhuna; Forsell, Mattias N.; Hedestam, Gunilla B. Karlsson; Mascola, John R.; Wyatt, Richard T.			Biochemically Defined HIV-1 Envelope Glycoprotein Variant Immunogens Display Differential Binding and Neutralizing Specificities to the CD4-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-CELL RESPONSES; SUBTYPE-C; ANTIBODY-SPECIFICITIES; MONOCLONAL-ANTIBODIES; OLIGOMERIC STRUCTURE; GP120 GLYCOPROTEINS; IMMUNE-RESPONSES; ENV CLONES; RECEPTOR	HIV-1 gp120 binds the primary receptor CD4. Recently, a plethora of broadly neutralizing antibodies to the gp120 CD4-binding site (CD4bs) validated this region as a target for immunogen design. Here, we asked if modified HIV-1 envelope glycoproteins (Env) designed to increase CD4 recognition might improve recognition by CD4bs neutralizing antibodies and more efficiently elicit such reactivities. We also asked if CD4bs stabilization, coupled with altering the Env format (monomer to trimer or cross-clade), might better elicit neutralizing antibodies by focusing the immune response on the functionally conserved CD4bs. We produced monomeric and trimeric Envs stabilized by mutations within the gp120 CD4bs cavity (pocket-filling; PF2) or by appending heterologous trimerization motifs to soluble Env ectodomains (gp120/gp140). Recombinant glycoproteins were purified to relative homogeneity, and ligand binding properties were analyzed by ELISA, surface plasmon resonance, and isothermal titration microcalorimetry. In some formats, the PF2 substitutions increased CD4 affinity, and importantly, PF2-containing proteins were better recognized by the broadly neutralizing CD4bs mAbs, VRC01 and VRC-PG04. Based on this analysis, we immunized selected Env variants into rabbits using heterologous or homologous regimens. Analysis of the sera revealed that homologous inoculation of the PF2-containing, variable region-deleted YU2 gp120 trimers (Delta V123/PF2-GCN4) more rapidly elicited CD4bs-directed neutralizing antibodies compared with other regimens, whereas homologous trimers elicited increased neutralization potency, mapping predominantly to the gp120 third major variable region (V3). These results suggest that some engineered Env proteins may more efficiently direct responses toward the conserved CD4bs and be valuable to elicit antibodies of greater neutralizing capacity.	[Feng, Yu; Tran, Karen; Wyatt, Richard T.] Scripps Res Inst, Dept Immunol & Microbial Sci, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Mckee, Krisha; O'Dell, Sijy; Schmidt, Stephen D.; Phogat, Adhuna; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Forsell, Mattias N.] Karolinska Inst, Dept Med, Translat Immunol Unit, SE-17177 Stockholm, Sweden	International AIDS Vaccine Initiative; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet; Karolinska Institutet	Wyatt, RT (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA USA.	wyatt@scripps.edu	Feng, Yu/A-3396-2012; Hedestam, Gunilla Karlsson/AAN-9616-2021; Forsell, Mattias/L-9618-2016; Schmidt, Stephen/B-5398-2012; Mascola, John/AAI-7193-2021; Schmidt, Stephen/AAC-6967-2019	Forsell, Mattias/0000-0001-6904-742X; 	National Institutes of Health NIAID; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation; Swedish Research Council	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported, in whole or in part, by National Institutes of Health NIAID intramural research program. This work was also supported by the International AIDS Vaccine Initiative, the Bill and Melinda Gates Foundation, and the Swedish Research Council.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Barnett SW, 1997, VACCINE, V15, P869, DOI 10.1016/S0264-410X(96)00264-2; Belshe RB, 1998, AIDS, V12, P2407, DOI 10.1097/00002030-199818000-00009; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Ching L, 2010, J VIROL, V84, P9932, DOI 10.1128/JVI.00868-10; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Douagi I, 2010, J VIROL, V84, P1683, DOI 10.1128/JVI.01896-09; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; MCDOUGAL JS, 1986, SCIENCE, V231, P382, DOI 10.1126/science.3001934; Morner A, 2009, J VIROL, V83, P540, DOI 10.1128/JVI.01102-08; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; PINTER A, 1989, J VIROL, V63, P2674, DOI 10.1128/JVI.63.6.2674-2679.1989; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; WEISS CD, 1990, J VIROL, V64, P5674, DOI 10.1128/JVI.64.11.5674-5677.1990; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zhang CWH, 2001, J BIOL CHEM, V276, P39577, DOI 10.1074/jbc.M107147200; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	70	49	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5673	5686		10.1074/jbc.M111.317776	http://dx.doi.org/10.1074/jbc.M111.317776			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22167180	Green Published, hybrid			2022-12-25	WOS:000300638000044
J	Cho, CC; Su, LH; Huang, YC; Pan, YJ; Sun, CH				Cho, Chao-Cheng; Su, Li-Hsin; Huang, Yu-Chang; Pan, Yu-Jiao; Sun, Chin-Hung			Regulation of a Myb Transcription Factor by Cyclin-dependent Kinase 2 in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRRITABLE-BOWEL-SYNDROME; WALL PROTEIN GENES; CELL-CYCLE; CYST WALL; C-MYB; B-MYB; ACTIVATION; EXPRESSION; ENCYSTATION; DNA	The protozoan Giardia lamblia parasitizes the human small intestine to cause diseases. It undergoes differentiation into infectious cysts by responding to intestinal stimulation. How the activated signal transduction pathways relate to encystation stimulation remain largely unknown. During encystation, genes encoding cyst wall proteins (CWPs) are coordinately up-regulated by a Myb2 transcription factor. Because cell differentiation is linked to cell cycle regulation, we tried to understand the role of cell cycle regulators, cyclin-dependent kinases (Cdks), in encystation. We found that the recombinant Myb2 was phosphorylated by Cdk-associated complexes and the levels of phosphorylation increased significantly during encystation. We have identified a putative cdk gene (cdk2) by searching the Giardia genome database. Cdk2 was found to localize in the cytoplasm with higher expression during encystation. Interestingly, overexpression of Cdk2 resulted in a significant increase of the levels of cwp gene expression and cyst formation. In addition, the Cdk2-associated complexes can phosphorylate Myb2 and the levels of phosphorylation increased significantly during encystation. Mutations of important catalytic residues of Cdk2 resulted in a significant decrease of kinase activity and ability of inducing cyst formation. Addition of a Cdk inhibitor, purvalanol A, significantly decreased the Cdk2 kinase activity and the levels of cwp gene expression and cyst formation. Our results suggest that the Cdk2 pathway may be involved in phosphorylation of Myb2, leading to activation of the Myb2 function and up-regulation of cwp genes during encystation. The results provide insights into the use of Cdk inhibitory drugs in disruption of Giardia differentiation into cysts.	[Cho, Chao-Cheng; Su, Li-Hsin; Huang, Yu-Chang; Pan, Yu-Jiao; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, NSC 100-2325-B-002039]; National Health Research Institutes in Taiwan [NHRI-EX98-9510NC, NHRI-EX99-9510NC]; Department of Medical Research in the National Taiwan University Hospital; National Taiwan University	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Department of Medical Research in the National Taiwan University Hospital; National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grants NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, and NSC 100-2325-B-002039, National Health Research Institutes Grants NHRI-EX98-9510NC and NHRI-EX99-9510NC in Taiwan, the Department of Medical Research in the National Taiwan University Hospital, and the Aim for the Top University Program of the National Taiwan University.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Ansieau S, 1997, J MOL MED-JMM, V75, P815, DOI 10.1007/s001090050170; Araki S, 2004, J BIOL CHEM, V279, P32979, DOI 10.1074/jbc.M403171200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Banerjee S, 2006, FEMS MICROBIOL LETT, V256, P75, DOI 10.1111/j.1574-6968.2006.00105.x; Bennett JD, 1996, ONCOGENE, V13, P1073; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Carranza PG, 2010, MICROBES INFECT, V12, P71, DOI 10.1016/j.micinf.2009.09.008; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chiappetta A, 2011, ANN BOT-LONDON, V107, P1223, DOI 10.1093/aob/mcq127; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; Chuang S. F., 2012, PLOS ONE IN PRESS; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; Doonan JH, 2009, MOL BIOTECHNOL, V42, P14, DOI 10.1007/s12033-008-9126-8; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Ellis J, 2004, MOL MICROBIOL, V53, P1487, DOI 10.1111/j.1365-2958.2004.04218.x; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Ghosh E, 2009, DRUG DES DEV THER, V3, P103; Gomes FC, 2010, MOL BIOCHEM PARASIT, V171, P89, DOI 10.1016/j.molbiopara.2010.03.002; Gourguechon S, 2011, EUKARYOT CELL, V10, P142, DOI 10.1128/EC.00190-10; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Guo ZH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-69; Hanevik K., 2009, BMC GASTROENTEROL, V21, P9; HAYLES J, 1986, EMBO J, V5, P3373, DOI 10.1002/j.1460-2075.1986.tb04653.x; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; Ito M, 2001, PLANT CELL, V13, P1891, DOI 10.1105/tpc.13.8.1891; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jirage D, 2010, MOL BIOCHEM PARASIT, V172, P9, DOI 10.1016/j.molbiopara.2010.03.009; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; KU DH, 1993, J BIOL CHEM, V268, P2255; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Lauwaet T, 2007, CURR OPIN MICROBIOL, V10, P554, DOI 10.1016/j.mib.2007.09.011; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Martin-Castellanos C, 1997, TRENDS CELL BIOL, V7, P95, DOI 10.1016/S0962-8924(96)10055-6; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morch K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-206; Morf L, 2010, EUKARYOT CELL, V9, P1566, DOI 10.1128/EC.00100-10; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morken MH, 2009, SCAND J GASTROENTERO, V44, P308, DOI 10.1080/00365520802588091; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Muller-Tidow C, 2001, BLOOD, V97, P2091, DOI 10.1182/blood.V97.7.2091; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ondarza R. N., 2007, Infectious Disorders - Drug Targets, V7, P266, DOI 10.2174/187152607782110059; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Poxleitner MK, 2008, EUKARYOT CELL, V7, P569, DOI 10.1128/EC.00415-07; Reiner DS, 2008, INT J PARASITOL, V38, P935, DOI 10.1016/j.ijpara.2007.12.005; Robertson LJ, 2010, TRENDS PARASITOL, V26, P75, DOI 10.1016/j.pt.2009.11.010; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Santori MI, 2002, MOL BIOCHEM PARASIT, V121, P225, DOI 10.1016/S0166-6851(02)00039-7; Saraiya AA, 2011, RNA, V17, P2152, DOI 10.1261/rna.028118.111; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Stark D, 2007, INT J PARASITOL, V37, P11, DOI 10.1016/j.ijpara.2006.09.009; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Su LH, 2011, J BIOL CHEM, V286, P34101, DOI 10.1074/jbc.M111.280206; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 2005, MOL BIOCHEM PARASIT, V142, P1, DOI 10.1016/j.molbiopara.2005.03.003; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Svard SG, 2003, FEMS MICROBIOL LETT, V218, P3, DOI 10.1016/S0378-1097(02)01107-2; TRAVALI S, 1991, ONCOGENE, V6, P887; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zhang H, 2002, BBA-MOL CELL RES, V1591, P119, DOI 10.1016/S0167-4889(02)00258-6; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7	91	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3733	3750		10.1074/jbc.M111.298893	http://dx.doi.org/10.1074/jbc.M111.298893			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167200	Green Published, hybrid			2022-12-25	WOS:000300410900011
J	Storch, U; Forst, AL; Philipp, M; Gudermann, T; Schnitzler, MMY				Storch, Ursula; Forst, Anna-Lena; Philipp, Maximilian; Gudermann, Thomas; Mederos y Schnitzler, Michael			Transient Receptor Potential Channel 1 (TRPC1) Reduces Calcium Permeability in Heteromeric Channel Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CATION CHANNEL; SIRNA DESIGN; RAT-BRAIN; LOCALIZATION; PROTEIN; PROLIFERATION; ACTIVATION; EXPRESSION; ISOFORM	Specific biological roles of the classical transient receptor potential channel 1 (TRPC1) are still largely elusive. To investigate the function of TRPC1 proteins in cell physiology, we studied heterologously expressed TRPC1 channels and found that recombinant TRPC1 subunits do not form functional homomeric channels. Instead, by electrophysiological analysis TRPC1 was shown to form functional heteromeric, receptor-operated channel complexes with TRPC3, -4, -5, -6, and -7 indicating that TRPC1 proteins can co-assemble with all members of the TRPC subfamily. In all TRPC1-containing heteromers, TRPC1 subunits significantly decreased calcium permeation. The exchange of select amino acids in the putative pore-forming region of TRPC1 further reduced calcium permeability, suggesting that TRPC1 subunits contribute to the channel pore. In immortalized immature gonadotropin-releasing hormone neurons endogenously expressing TRPC1, -2, -5, and -6, down-regulation of TRPC1 resulted in increased calcium permeability and elevated basal cytosolic calcium concentrations. We did not observe any involvement of TRPC1 in storeoperated cation influx. Notably, TRPC1 suppressed the migration of gonadotropin-releasing hormone neurons without affecting cell proliferation. Conversely, in TRPC1 knockdown neurons, specific migratory properties like distance covered, locomotion speed, and directionality were increased. These findings suggest a novel regulatory mechanism relying on the expression of TRPC1 and the subsequent formation of heteromeric TRPC channel complexes with reduced calcium permeability, thereby fine-tuning neuronal migration.	[Storch, Ursula; Forst, Anna-Lena; Gudermann, Thomas; Mederos y Schnitzler, Michael] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany; [Philipp, Maximilian] Univ Marburg, Inst Pharmacol & Toxicol, D-35032 Marburg, Germany	University of Munich; Philipps University Marburg	Gudermann, T (corresponding author), Univ Munich, Walther Straub Inst Pharmacol & Toxicol, Goethestr 33, D-80336 Munich, Germany.	thomas.gudermann@lrz.uni-muenchen.de	Forst, Anna-Lena/K-1909-2015					Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Berbey C, 2009, J BIOL CHEM, V284, P36387, DOI 10.1074/jbc.M109.073221; Bollimuntha S, 2011, ADV EXP MED BIOL, V704, P573, DOI 10.1007/978-94-007-0265-3_31; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cui Kai, 2007, P55; Dalmazzo S, 2008, BRAIN RES, V1230, P27, DOI 10.1016/j.brainres.2008.07.019; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Fabian A, 2008, PFLUG ARCH EUR J PHY, V457, P475, DOI 10.1007/s00424-008-0515-4; Fabian A, 2011, PFLUG ARCH EUR J PHY, V461, P295, DOI 10.1007/s00424-010-0901-6; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rychkov G., 2007, V179, P23; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Selvaraj S, 2010, CNS NEUROL DISORD-DR, V9, P94, DOI 10.2174/187152710790966650; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Uehara K, 2005, HISTOCHEM CELL BIOL, V123, P347, DOI 10.1007/s00418-004-0741-6; Varga-Szabo D, 2008, PFLUG ARCH EUR J PHY, V457, P377, DOI 10.1007/s00424-008-0531-4; Wang WC, 1999, AM J PHYSIOL-CELL PH, V276, pC969, DOI 10.1152/ajpcell.1999.276.4.C969; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yiu SM, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bth498; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zaninetti R, 2008, MOL ENDOCRINOL, V22, P729, DOI 10.1210/me.2007-0277	43	111	112	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3530	3540		10.1074/jbc.M111.283218	http://dx.doi.org/10.1074/jbc.M111.283218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157757	hybrid, Green Published			2022-12-25	WOS:000300295100057
J	Takahashi, K; Makita, N; Manaka, K; Hisano, M; Akioka, Y; Miura, K; Takubo, N; Iida, A; Ueda, N; Hashimoto, M; Fujita, T; Igarashi, T; Sekine, T; Iiri, T				Takahashi, Kazuhiro; Makita, Noriko; Manaka, Katsunori; Hisano, Masataka; Akioka, Yuko; Miura, Kenichiro; Takubo, Noriyuki; Iida, Atsuko; Ueda, Norishi; Hashimoto, Makiko; Fujita, Toshiro; Igarashi, Takashi; Sekine, Takashi; Iiri, Taroh			V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED-RECEPTORS; INAPPROPRIATE ANTIDIURESIS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-MECHANISMS; AVPR2 MUTATIONS; TYPE-2 RECEPTOR; MUTANT; ACTIVATION; G(S-ALPHA); FAMILIES	Inactivating mutations of the V2 vasopressin receptor (V2R) cause cross-linked congenital nephrogenic diabetes insipidus (NDI), resulting in renal resistance to the antidiuretic hormone AVP. In two families showing partial NDI, characterized by an apparently normal response to diagnostic tests and an increase in the basal ADH levels suggesting AVP resistance, we have identified two V2R mutations, Ser-333del and Y128S. Both mutant V2Rs, when expressed in COS-7 cells, show partial defects in vasopressin-stimulated cAMP accumulation and intracellular localization. The inhibition of internalization does not rescue their localization. In contrast, the non-peptide V2R antagonists OPC41061 and OPC31260 partially rescue the membrane localization and basal function of these V2R mutants, whereas they inhibit the basal activity of the wild-type V2R. These results indicate that a partial loss of function of Ser-333del and Y128S mutant V2Rs results from defective membrane trafficking. These findings further indicate that V2R antagonists can act as protean agonists, serving as pharmacological chaperones for inactivating V2R mutants and also as inverse agonists of wild-type receptors. We speculate that this protean agonism could underlie the possible dual beneficial effects of the V2R antagonist: improvement of hyponatremia with heart failure or polycystic kidney disease and potential rescue of NDI.	[Takahashi, Kazuhiro; Miura, Kenichiro; Igarashi, Takashi; Sekine, Takashi] Univ Tokyo, Dept Pediat, Tokyo 1138655, Japan; [Makita, Noriko; Manaka, Katsunori; Hashimoto, Makiko; Fujita, Toshiro; Iiri, Taroh] Univ Tokyo, Dept Endocrinol & Nephrol, Tokyo 1138655, Japan; [Hisano, Masataka] Chiba Childrens Hosp, Dept Pediat Nephrol, Chiba 2660007, Japan; [Akioka, Yuko] Tokyo Womans Med Univ, Dept Pediat Nephrol, Tokyo 1628666, Japan; [Takubo, Noriyuki] Kitasato Univ, Dept Pediat, Sch Med, Kanagawa 2520375, Japan; [Iida, Atsuko] Tokyo Womans Med Univ, Dept Pediat, Med Ctr E, Tokyo 1168567, Japan; [Ueda, Norishi] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi 4660065, Japan; [Sekine, Takashi] Toho Univ, Dept Pediat, Ohashi Hosp, Med Ctr, Tokyo 1538515, Japan	University of Tokyo; University of Tokyo; Chiba Children's Hospital; Tokyo Women's Medical University; Kitasato University; Tokyo Women's Medical University; Nagoya University; Toho University	Makita, N (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	norimaki-tky@umin.ac.jp; tsekine@med.toho-u.ac.jp; tiiri-tky@umin.ac.jp	Makita, Noriko/GQY-8175-2022		Ministry of Education, Science, Sports, and Culture, Japan; Grants-in-Aid for Scientific Research [22591008, 23591586] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan.	Ala Y, 1998, J AM SOC NEPHROL, V9, P1861; Arthus MF, 2000, J AM SOC NEPHROL, V11, P1044, DOI 10.1681/ASN.V1161044; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; BICHET DG, 1993, J CLIN INVEST, V92, P1262, DOI 10.1172/JCI116698; BICHET DG, 1994, AM J HUM GENET, V55, P278; Boson L, 2006, GENET TEST, V10, P157, DOI 10.1089/gte.2006.10.157; Carroll P, 2006, GENET MED, V8, P443, DOI 10.1097/01.gim.0000223554.46981.7a; Chen CH, 2002, J HUM GENET, V47, P66, DOI 10.1007/s100380200002; Faerch M, 2008, CLIN ENDOCRINOL, V68, P395, DOI 10.1111/j.1365-2265.2007.03054.x; Faerch M, 2009, AM J PHYSIOL-RENAL, V297, pF1518, DOI 10.1152/ajprenal.00331.2009; Farmakis D, 2009, HEART FAIL REV, V14, P59, DOI 10.1007/s10741-008-9109-7; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Inaba S, 2001, J CLIN ENDOCR METAB, V86, P381, DOI 10.1210/jc.86.1.381; Irazabal MV, 2011, KIDNEY INT, V80, P295, DOI 10.1038/ki.2011.119; Jean-Alphonse F, 2009, J AM SOC NEPHROL, V20, P2190, DOI 10.1681/ASN.2008121289; Kalenga K, 2002, AM J KIDNEY DIS, V39, P737, DOI 10.1053/ajkd.2002.31993; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Macion-Dazard R, 2006, J PHARMACOL EXP THER, V316, P564, DOI 10.1124/jpet.105.095554; Makita N, 2008, CALCIUM SENSING RECE, DOI [10.1038/mp.a004000.01, DOI 10.1038/MP.A004000.01]; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Neubig RR, 2007, MOL PHARMACOL, V71, P1200, DOI 10.1124/mol.107.034926; Pasel K, 2000, J CLIN ENDOCR METAB, V85, P1703, DOI 10.1210/jc.85.4.1703; Robben JH, 2007, AM J PHYSIOL-RENAL, V292, pF253, DOI 10.1152/ajprenal.00247.2006; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Rochdi MD, 2010, MOL PHARMACOL, V77, P836, DOI 10.1124/mol.109.061804; Sadeghi H, 1997, MOL ENDOCRINOL, V11, P1806, DOI 10.1210/me.11.12.1806; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Shoji Y, 1998, HUM MUTAT, pS278; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Suzuki J, 2001, J CLIN INVEST, V107, P363, DOI 10.1172/JCI10254; Tao YX, 2006, PHARMACOL THERAPEUT, V111, P949, DOI 10.1016/j.pharmthera.2006.02.008; Tenenbaum J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008383; Torres VE, 2011, AM J KIDNEY DIS, V57, P692, DOI 10.1053/j.ajkd.2010.11.029; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Zmily HD, 2011, INT J NEPHROL RENOV, V4, P57, DOI 10.2147/IJNRD.S7032	50	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2099	2106		10.1074/jbc.M111.268797	http://dx.doi.org/10.1074/jbc.M111.268797			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22144672	Green Published, hybrid			2022-12-25	WOS:000299321000050
J	Connolly, KL; Braden, AK; Holder, RC; Reid, SD				Connolly, Kristie L.; Braden, Amy K.; Holder, Robert C.; Reid, Sean D.			Srv Mediated Dispersal of Streptococcal Biofilms Through SpeB Is Observed in CovRS plus Strains	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; SHOCK-LIKE SYNDROME; SEROTYPE M3 STRAIN; RESPONSE REGULATOR; VIRULENCE FACTOR; IN-VIVO; UNITED-STATES; PYOGENES; IDENTIFICATION; EXPRESSION	Group A Streptococcus (GAS) is a human specific pathogen capable of causing both mild infections and severe invasive disease. We and others have shown that GAS is able to form biofilms during infection. That is to say, they form a three-dimensional, surface attached structure consisting of bacteria and a multi-component extracellular matrix. The mechanisms involved in regulation and dispersal of these GAS structures are still unclear. Recently we have reported that in the absence of the transcriptional regulator Srv in the MGAS5005 background, the cysteine protease SpeB is constitutively produced, leading to increased tissue damage and decreased biofilm formation during a subcutaneous infection in a mouse model. This was interesting because MGAS5005 has a naturally occurring mutation that inactivates the sensor kinase domain of the two component regulatory system CovRS. Others have previously shown that strains lacking covS are associated with decreased SpeB production due to CovR repression of speB expression. Thus, our results suggest the inactivation of srv can bypass CovR repression and lead to constitutive SpeB production. We hypothesized that Srv control of SpeB production may be a mechanism to regulate biofilm dispersal and provide a mechanism by which mild infection can transition to severe disease through biofilm dispersal. The question remained however, is this mechanism conserved among GAS strains or restricted to the unique genetic makeup of MGAS5005. Here we show that Srv mediated control of SpeB and biofilm dispersal is conserved in the invasive clinical isolates RGAS053 (serotype M1) and MGAS315 (serotype M3), both of which have covS intact. This work provides additional evidence that Srv regulated control of SpeB may mediate biofilm formation and dispersal in diverse strain backgrounds.	[Connolly, Kristie L.; Holder, Robert C.; Reid, Sean D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA; [Braden, Amy K.] Wake Forest Univ, Bowman Gray Sch Med, Program Mol Genet, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Connolly, KL (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA.	sreid@wfubmc.edu		Connolly, Kristie/0000-0002-7516-4427	National Institutes of Health [R01AI063453]; American Heart Association [11GRNT7980017]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R01AI063453 from the National Institutes of Health and American Heart Association Grant in Aid 11GRNT7980017 to S.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2003, J DERMATOL SCI, V32, P193, DOI 10.1016/S0923-1811(03)00096-3; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Banks DJ, 2003, INFECT IMMUN, V71, P7079, DOI 10.1128/IAI.71.12.7079-7086.2003; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chaussee MS, 1997, INFECT IMMUN, V65, P1956, DOI 10.1128/IAI.65.5.1956-1959.1997; Chiang-Ni C, 2008, J FORMOS MED ASSOC, V107, P677, DOI 10.1016/S0929-6646(08)60112-6; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Churchward G, 2009, MICROBIOL-SGM, V155, P566, DOI 10.1099/mic.0.024620-0; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Connolly KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018984; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; Doern CD, 2008, MICROBIOL-SGM, V154, P1998, DOI 10.1099/mic.0.2007/013466-0; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Gao JX, 2005, J BIOL CHEM, V280, P38948, DOI 10.1074/jbc.M506121200; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HOGE CW, 1993, JAMA-J AM MED ASSOC, V269, P384, DOI 10.1001/jama.269.3.384; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lukomski S, 1999, INFECT IMMUN, V67, P1779; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; MUSSER JM, 1993, J INFECT DIS, V167, P337, DOI 10.1093/infdis/167.2.337; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; Reid SD, 2004, INFECT IMMUN, V72, P1799, DOI 10.1128/IAI.72.3.1799-1803.2004; Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003; Reid SD, 2006, FEMS IMMUNOL MED MIC, V48, P283, DOI 10.1111/j.1574-695X.2006.00150.x; Richter SS, 2005, CLIN INFECT DIS, V41, P599, DOI 10.1086/432473; Roberts AL, 2010, INFECT IMMUN; Roberts Amity L, 2010, BMC Res Notes, V3, P281, DOI 10.1186/1756-0500-3-281; Roberts SA, 2007, J BACTERIOL, V189, P1459, DOI 10.1128/JB.01026-06; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tamura F, 2004, INFECT IMMUN, V72, P4836, DOI 10.1128/IAI.72.8.4836-4847.2004; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28640	10.1371/journal.pone.0028640	http://dx.doi.org/10.1371/journal.pone.0028640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163320	Green Submitted, Green Published, gold			2022-12-25	WOS:000298161900056
J	Garzon, J; Rodriguez-Munoz, M; Vicente-Sanchez, A; Garcia-Lopez, MA; Martinez-Murillo, R; Fischer, T; Sanchez-Blazquez, P				Garzon, Javier; Rodriguez-Munoz, Maria; Vicente-Sanchez, Ana; Angeles Garcia-Lopez, Maria; Martinez-Murillo, Ricardo; Fischer, Thierry; Sanchez-Blazquez, Pilar			SUMO-SIM Interactions Regulate the Activity of RGSZ2 Proteins	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; MU-OPIOID-RECEPTORS; ESCHERICHIA-COLI; C-TERMINUS; SUMOYLATION; ASSOCIATION; DOMAIN; PHOSPHORYLATION; NUCLEAR; COMPLEX	The RGSZ2 gene, a regulator of G protein signaling, has been implicated in cognition, Alzheimer's disease, panic disorder, schizophrenia and several human cancers. This 210 amino acid protein is a GTPase accelerating protein (GAP) on G alpha i/o/z subunits, binds to the N terminal of neural nitric oxide synthase (nNOS) negatively regulating the production of nitric oxide, and binds to the histidine triad nucleotide-binding protein 1 at the C terminus of different G protein-coupled receptors (GPCRs). We now describe a novel regulatory mechanism of RGS GAP function through the covalent incorporation of Small Ubiquitin-like MOdifiers (SUMO) into RGSZ2 RGS box (RH) and the SUMO non covalent binding with SUMO-interacting motifs (SIM): one upstream of the RH and a second within this region. The covalent attachment of SUMO does not affect RGSZ2 binding to GPCR-activated G alpha GTP subunits but abolishes its GAP activity. By contrast, non-covalent binding of SUMO with RH SIM impedes RGSZ2 from interacting with G alpha GTP subunits. Binding of SUMO to the RGSZ2 SIM that lies outside the RH does not affect G alpha GTP binding or GAP activity, but it could lead to regulatory interactions with sumoylated proteins. Thus, sumoylation and SUMO-SIM interactions constitute a new regulatory mechanism of RGS GAP function and therefore of GPCR cell signaling as well.	[Garzon, Javier; Vicente-Sanchez, Ana; Martinez-Murillo, Ricardo; Sanchez-Blazquez, Pilar] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Garzon, Javier; Rodriguez-Munoz, Maria; Vicente-Sanchez, Ana; Sanchez-Blazquez, Pilar] ISCIII, CIBER Mental Hlth, Madrid, Spain; [Angeles Garcia-Lopez, Maria; Fischer, Thierry] CSIC, Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC)	Garzon, J (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	psb@cajal.csic.es	Martinez-Murillo, Ricardo/K-7596-2014; García-López, Maria Angeles/AAB-5755-2019	Martinez-Murillo, Ricardo/0000-0003-3657-3890; García-López, Maria Angeles/0000-0002-1417-9385; Sanchez Blazquez, Pilar/0000-0002-7211-4504; Fischer, Thierry/0000-0002-9542-322X; Rodriguez-Munoz, Maria/0000-0001-6611-8050; Garzon, Javier/0000-0002-0053-258X	Fondo Investigacion Sanitaria [PS090332, PI080417, MIRG-CT-2006-026702]	Fondo Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the following grants: Fondo Investigacion Sanitaria PS090332 (JG), Fondo Investigacion Sanitaria PI080417 (PSB), MIRG-CT-2006-026702 (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajit SK, 2007, CELL SIGNAL, V19, P723, DOI 10.1016/j.cellsig.2006.09.008; Bailey D, 2002, J GEN VIROL, V83, P2951, DOI 10.1099/0022-1317-83-12-2951; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Garzon J, 1997, EUR J NEUROSCI, V9, P1194, DOI 10.1111/j.1460-9568.1997.tb01474.x; Garzon J, 2005, NEUROPSYCHOPHARMACOL, V30, P1632, DOI 10.1038/sj.npp.1300726; Garzon J, 2005, NEUROPHARMACOLOGY, V48, P853, DOI 10.1016/j.neuropharm.2005.01.004; Garzon J, 2000, METHOD ENZYMOL, V314, P3; Garzon J, 2011, ANTIOXID REDOX SIGN, V15, P873, DOI 10.1089/ars.2010.3767; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; Guey LT, 2010, EUR UROL, V57, P283, DOI 10.1016/j.eururo.2009.08.001; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; James MA, 2009, CANCER RES, V69, P2108, DOI 10.1158/0008-5472.CAN-08-3495; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Krumins AM, 2002, METHOD ENZYMOL, V344, P673; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Martemyanov KA, 2004, METHOD ENZYMOL, V390, P196; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; MARTINEZMURILLO R, 1989, NEUROSCI LETT, V96, P121, DOI 10.1016/0304-3940(89)90044-X; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; Nixon AB, 2002, J BIOL CHEM, V277, P18127, DOI 10.1074/jbc.M201065200; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Rodriguez-Munoz M, 2008, CELL SIGNAL, V20, P1855, DOI 10.1016/j.cellsig.2008.06.015; Rodriguez-Munoz M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-19; Rodriguez-Munoz M, 2007, NEUROPSYCHOPHARMACOL, V32, P842, DOI 10.1038/sj.npp.1301184; Rodriguez-Munoz M, 2011, ANTIOXID REDOX SIGN, V14, P2413, DOI 10.1089/ars.2010.3511; Rodriguez-Munoz M, 2011, CELL MOL LIFE SCI, V68, P2933, DOI 10.1007/s00018-010-0598-x; Scheschonka A, 2007, TRENDS NEUROSCI, V30, P85, DOI 10.1016/j.tins.2007.01.003; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stemmle LN, 2006, MOL PHARMACOL, V70, P1461, DOI 10.1124/mol.106.023705; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Takahashi Y, 2008, CELL CYCLE, V7, P1738, DOI 10.4161/cc.7.12.6156; Tang W, 2006, J NEURAL TRANSM, V113, P1537, DOI 10.1007/s00702-005-0419-9; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Tu YP, 1999, J BIOL CHEM, V274, P38260, DOI 10.1074/jbc.274.53.38260; Tu YP, 2003, J BIOL CHEM, V278, P52273, DOI 10.1074/jbc.M309626200; Wang J, 1997, J BIOL CHEM, V272, P5732, DOI 10.1074/jbc.272.9.5732; Wang J, 1998, J BIOL CHEM, V273, P26014, DOI 10.1074/jbc.273.40.26014; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335	61	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28557	10.1371/journal.pone.0028557	http://dx.doi.org/10.1371/journal.pone.0028557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163035	gold, Green Published			2022-12-25	WOS:000298173500034
J	Nestor, CE; Monckton, DG				Nestor, Colm E.; Monckton, Darren G.			Correlation of Inter-Locus Polyglutamine Toxicity with CAG center dot CTG Triplet Repeat Expandability and Flanking Genomic DNA GC Content	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-17; SECONDARY STRUCTURE ASSIGNMENT; DOMINANT CEREBELLAR-ATAXIA; MYOTONIC-DYSTROPHY; TRANSGENIC MICE; HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; SOMATIC INSTABILITY; LATE-ONSET; GENETIC INSTABILITY	Dynamic expansions of toxic polyglutamine (polyQ)-encoding CAG repeats in ubiquitously expressed, but otherwise unrelated, genes cause a number of late-onset progressive neurodegenerative disorders, including Huntington disease and the spinocerebellar ataxias. As polyQ toxicity in these disorders increases with repeat length, the intergenerational expansion of unstable CAG repeats leads to anticipation, an earlier age-at-onset in successive generations. Crucially, disease associated alleles are also somatically unstable and continue to expand throughout the lifetime of the individual. Interestingly, the inherited polyQ length mediating a specific age-at-onset of symptoms varies markedly between disorders. It is widely assumed that these inter-locus differences in polyQ toxicity are mediated by protein context effects. Previously, we demonstrated that the tendency of expanded CAG center dot CTG repeats to undergo further intergenerational expansion (their 'expandability') also differs between disorders and these effects are strongly correlated with the GC content of the genomic flanking DNA. Here we show that the inter-locus toxicity of the expanded polyQ tracts of these disorders also correlates with both the expandability of the underlying CAG repeat and the GC content of the genomic DNA flanking sequences. Inter-locus polyQ toxicity does not correlate with properties of the mRNA or protein sequences, with polyQ location within the gene or protein, or steady state transcript levels in the brain. These data suggest that the observed inter-locus differences in polyQ toxicity are not mediated solely by protein context effects, but that genomic context is also important, an effect that may be mediated by modifying the rate at which somatic expansion of the DNA delivers proteins to their cytotoxic state.	[Nestor, Colm E.; Monckton, Darren G.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Nestor, Colm E.] Univ Edinburgh, Breakthrough Breast Canc Res Unit, Edinburgh, Midlothian, Scotland; [Nestor, Colm E.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Edinburgh; University of Edinburgh	Nestor, CE (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	cnestor@hgu.mrc.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was carried out as a PhD and was funded by the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ramahi I, 2006, J BIOL CHEM; ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; Benton CS, 1998, NEUROLOGY, V51, P1081, DOI 10.1212/WNL.51.4.1081; Brock GJR, 1999, HUM MOL GENET, V8, P1061, DOI 10.1093/hmg/8.6.1061; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Charles P, 2007, NEUROLOGY, V69, P1970, DOI 10.1212/01.wnl.0000269323.21969.db; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Cleary JD, 2003, CYTOGENET GENOME RES, V100, P25, DOI 10.1159/000072837; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Dion V, 2008, HUM MOL GENET, V17, P1306, DOI 10.1093/hmg/ddn019; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Edelmann W, 2000, CANCER RES, V60, P803; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Foiry L, 2006, HUM GENET, V119, P520, DOI 10.1007/s00439-006-0164-7; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frontali M, 2001, BRAIN RES BULL, V56, P227, DOI 10.1016/S0361-9230(01)00574-3; Frontali M, 1999, PHILOS T ROY SOC B, V354, P1089, DOI 10.1098/rstb.1999.0464; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gao R, 2008, EUR J HUM GENET, V16, P215, DOI 10.1038/sj.ejhg.5201954; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Geschwind DH, 1997, AM J HUM GENET, V60, P842; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Gomes-Pereira M, 2006, MUTAT RES-FUND MOL M, V598, P15, DOI 10.1016/j.mrfmmm.2006.01.011; Gouw LG, 1998, HUM MOL GENET, V7, P525, DOI 10.1093/hmg/7.3.525; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hubert Jr L, 2011, HUMAN MOL GENETICS; Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0; Jayaraman M, 2009, PROTEIN ENG DES SEL, V22, P469, DOI 10.1093/protein/gzp023; Kaplan S, 2007, PLOS COMPUT BIOL, V3, P2291, DOI 10.1371/journal.pcbi.0030235; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Kartsaki E, 2006, INT J MOL MED, V17, P335; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Kratter IH, 2010, NEURON, V67, P897, DOI 10.1016/j.neuron.2010.09.012; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; Libby RT, 2003, HUM MOL GENET, V12, P41, DOI 10.1093/hmg/ddg006; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Maciel P, 1997, AM J HUM GENET, V60, P993; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Matsuyama Z, 1999, J MED GENET, V36, P546; Menon RP, 2006, CELL MOL LIFE SCI; Monckton DG, 1999, HUM MOL GENET, V8, P2473, DOI 10.1093/hmg/8.13.2473; Monckton DG, 1997, NAT GENET, V15, P193, DOI 10.1038/ng0297-193; Oz G, 2011, CEREBELLUM, V10, P208, DOI 10.1007/s12311-010-0213-6; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; QUAN F, 1995, HUM MOL GENET, V4, P2411, DOI 10.1093/hmg/4.12.2411; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rasmussen A, 2007, ANN NEUROL, V61, P607, DOI 10.1002/ana.21139; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Robertson AL, 2010, CURR MED CHEM; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Squitieri F, 2006, MECH AGEING DEV, V127, P208, DOI 10.1016/j.mad.2005.09.012; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; Tome S, 2011, HUM MOL GENET, V20, P2131, DOI 10.1093/hmg/ddr099; Tomiuk J, 2007, EUR J HUM GENET, V15, P81, DOI 10.1038/sj.ejhg.5201721; TZAGOURNISSAKIS M, 1995, HUM MOL GENET, V4, P2239, DOI 10.1093/hmg/4.12.2239; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Veitch NJ, 2007, DNA REPAIR, V6, P789, DOI 10.1016/j.dnarep.2007.01.002; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; WONG LJC, 1995, AM J HUM GENET, V56, P114; Zuhlke C, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-27	82	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28260	10.1371/journal.pone.0028260	http://dx.doi.org/10.1371/journal.pone.0028260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163004	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000298173500013
J	O'Mahony, E; Buckley, JF; Bolton, D; Whyte, P; Fanning, S				O'Mahony, Emer; Buckley, James F.; Bolton, Declan; Whyte, Paul; Fanning, Seamus			Molecular Epidemiology of Campylobacter Isolates from Poultry Production Units in Southern Ireland	PLOS ONE			English	Article							MATERNAL ANTIBODIES; BROILER HOUSES; JEJUNI; SPP.; FLOCKS; DIFFERENTIATION; IDENTIFICATION; CONTAMINATION; COLONIZATION; TRANSMISSION	This study aimed to identify the sources and routes of transmission of Campylobacter in intensively reared poultry farms in the Republic of Ireland. Breeder flocks and their corresponding broilers housed in three growing facilities were screened for the presence of Campylobacter species from November 2006 through September 2007. All breeder flocks tested positive for Campylobacter species (with C. jejuni and C. coli being identified). Similarly, all broiler flocks also tested positive for Campylobacter by the end of the rearing period. Faecal and environmental samples were analyzed at regular intervals throughout the rearing period of each broiler flock. Campylobacter was not detected in the disinfected house, or in one-day old broiler chicks. Campylobacter jejuni was isolated from environmental samples including air, water puddles, adjacent broiler flocks and soil. A representative subset of isolates from each farm was selected for further characterization using flaA-SVR sub-typing and multi-locus sequence typing (MLST) to determine if same-species isolates from different sources were indistinguishable or not. Results obtained suggest that no evidence of vertical transmission existed and that adequate cleaning/disinfection of broiler houses contributed to the prevention of carryover and cross-contamination. Nonetheless, the environment appears to be a potential source of Campylobacter. The population structure of Campylobacter isolates from broiler farms in Southern Ireland was diverse and weakly clonal.	[O'Mahony, Emer; Whyte, Paul; Fanning, Seamus] Univ Coll Dublin, UCD Ctr Food Safety, Sch Publ Hlth Physiotherapy & Populat Sci, UCD Vet Sci Ctr, Dublin 2, Ireland; [O'Mahony, Emer; Buckley, James F.] Cork Cty Council, Vet Food Safety Lab, Inniscarra, County Cork, Ireland; [Bolton, Declan] Teagasc Food Res Ctr, Food Safety Dept, Dublin, Ireland	University College Dublin; Teagasc	O'Mahony, E (corresponding author), Univ Coll Dublin, UCD Ctr Food Safety, Sch Publ Hlth Physiotherapy & Populat Sci, UCD Vet Sci Ctr, Dublin 2, Ireland.	sfanning@ucd.ie	Bolton, Declan/ABE-6797-2020	Fanning, Seamus/0000-0002-1922-8836	Safefood [04-RESR-04]	Safefood	This work was funded by Safefood (04-RESR-04). www.safefood.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACMSF, 2005, 2 ACMSF; Allen VM, 2008, J FOOD PROTECT, V71, P264, DOI 10.4315/0362-028X-71.2.264; [Anonymous], 2010, EFSA J, V8, P1437, DOI DOI 10.2903/J.EFSA.2010.1437; Buhr RJ, 2005, AVIAN DIS, V49, P577, DOI 10.1637/7337-020205R.1; Buhr RJ, 2002, AVIAN DIS, V46, P919, DOI 10.1637/0005-2086(2002)046[0919:ROCFSO]2.0.CO;2; Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006; Cawthraw SA, 2010, AVIAN DIS, V54, P86, DOI 10.1637/9004-072709-Reg.1; Cogan TA, 2006, GUT; Cox NA, 2002, AVIAN DIS, V46, P717, DOI 10.1637/0005-2086(2002)046[0717:IOCSFS]2.0.CO;2; Cox NA, 2002, AVIAN DIS, V46, P535, DOI 10.1637/0005-2086(2002)046[0535:IOANSO]2.0.CO;2; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1503; European Food Safety Authority, 2011, EFSA Journal, V9, P2090; Hald B, 2001, LETT APPL MICROBIOL, V32, P253, DOI 10.1046/j.1472-765X.2001.00896.x; Hansson I, 2007, J FOOD PROTECT, V70, P2008, DOI 10.4315/0362-028X-70.9.2008; Hofshagen M, 2005, J FOOD PROTECT, V68, P2220, DOI 10.4315/0362-028X-68.10.2220; HPSC, 2010, INF DIS NOT IR 2004; Hue O, 2010, FOOD MICROBIOL, V27, P992, DOI 10.1016/j.fm.2010.06.004; JacobsReitsma WF, 1997, VET QUART, V19, P113, DOI 10.1080/01652176.1997.9694753; JACOBSREITSMA WF, 1995, AVIAN DIS, V39, P355, DOI 10.2307/1591879; Lynch OA, 2010, J MICROBIOL METHODS; Meinersmann RJ, 2005, APPL ENVIRON MICROB, V71, P6368, DOI 10.1128/AEM.71.10.6368-6374.2005; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Nesbit EG, 2001, AM J VET RES, V62, P190, DOI 10.2460/ajvr.2001.62.190; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Patriarchi A, 2011, FOODBORNE PATHOG DIS, V8, P99, DOI 10.1089/fpd.2010.0637; Pearson AD, 1996, APPL ENVIRON MICROB, V62, P4614, DOI 10.1128/AEM.62.12.4614-4620.1996; Petersen L, 2001, APPL ENVIRON MICROB, V67, P2739, DOI 10.1128/AEM.67.6.2739-2745.2001; Petersen L, 2001, APPL ENVIRON MICROB, V67, P3115, DOI 10.1128/AEM.67.7.3115-3121.2001; Rosethorn H, 2009, EMPLOYER BRAND: KEEPING FAITH WITH THE DEAL, P1; Sahin O, 2003, J APPL MICROBIOL, V95, P1070, DOI 10.1046/j.1365-2672.2003.02083.x; Sahin O, 2003, APPL ENVIRON MICROB, V69, P5372, DOI 10.1128/AEM.69.9.5372-5379.2003; Sears A, 2011, EMERG INFECT DIS JUN; Stern NJ, 2003, EPIDEMIOL INFECT, V130, P23, DOI 10.1017/S0950268802007914; Stern NJ, 2001, J FOOD PROTECT, V64, P1705, DOI 10.4315/0362-028X-64.11.1705; Wang GH, 2002, J CLIN MICROBIOL, V40, P4744, DOI 10.1128/JCM.40.12.4744-4747.2002	36	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28490	10.1371/journal.pone.0028490	http://dx.doi.org/10.1371/journal.pone.0028490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163024	gold, Green Submitted, Green Published			2022-12-25	WOS:000298173500026
J	Galuska, D; Pirkmajer, S; Barres, R; Ekberg, K; Wahren, J; Chibalin, AV				Galuska, Dana; Pirkmajer, Sergej; Barres, Romain; Ekberg, Karin; Wahren, John; Chibalin, Alexander V.			C-Peptide Increases Na,K-ATPase Expression via PKC- and MAP Kinase-Dependent Activation of Transcription Factor ZEB in Human Renal Tubular Cells	PLOS ONE			English	Article							NA+-K+-ATPASE; DIABETIC-RATS; INSULIN; MUSCLE; NERVE; ALPHA; ISOFORM; GLUCOSE; PHOSPHORYLATION; AMELIORATION	Background: Replacement of proinsulin C-peptide in type 1 diabetes ameliorates nerve and kidney dysfunction, conditions which are associated with a decrease in Na,K-ATPase activity. We determined the molecular mechanism by which long term exposure to C-peptide stimulates Na,K-ATPase expression and activity in primary human renal tubular cells (HRTC) in control and hyperglycemic conditions. Methodology/Principal Findings: HRTC were cultured from the outer cortex obtained from patients undergoing elective nephrectomy. Ouabain-sensitive rubidium (Rb-86(+)) uptake and Na,K-ATPase activity were determined. Abundance of Na,K-ATPase was determined by Western blotting in intact cells or isolated basolateral membranes (BLM). DNA binding activity was determined by electrical mobility shift assay (EMSA). Culturing of HRTCs for 5 days with 1 nM, but not 10 nM of human C-peptide leads to increase in Na,K-ATPase alpha(1)-subunit protein expression, accompanied with increase in Rb-86(+) uptake, both in normal- and hyperglycemic conditions. Na,K-ATPase alpha(1)-subunit expression and Na,K-ATPase activity were reduced in BLM isolated from cells cultured in presence of high glucose. Exposure to 1 nM, but not 10 nM of C-peptide increased PKC epsilon phosphorylation as well as phosphorylation and abundance of nuclear ERK1/2 regardless of glucose concentration. Exposure to 1 nM of C-peptide increased DNA binding activity of transcription factor ZEB (AREB6), concomitant with Na,K-ATPase a1-subunit mRNA expression. Effects of 1 nM C-peptide on Na,K-ATPase alpha(1)-subunit expression and/or ZEB DNA binding activity in HRTC were abolished by incubation with PKC or MEK1/2 inhibitors and ZEB siRNA silencing. Conclusions/Significance: Despite activation of ERK1/2 and PKC by hyperglycemia, a distinct pool of PKCs and ERK1/2 is involved in regulation of Na,K-ATPase expression and activity by C-peptide. Most likely C-peptide stimulates sodium pump expression via activation of ZEB, a transcription factor that has not been previously implicated in C-peptide-mediated signaling. Importantly, only physiological concentrations of C-peptide elicit this effect.	[Galuska, Dana] Karolinska Inst, Dept Physiol & Pharmacol, Sect Integrat Physiol, Stockholm, Sweden; [Pirkmajer, Sergej; Barres, Romain; Ekberg, Karin; Wahren, John; Chibalin, Alexander V.] Karolinska Inst, Dept Mol Med & Surg, Sect Integrat Physiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Galuska, D (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Integrat Physiol, Stockholm, Sweden.	Alexander.Chibalin@ki.se	BARRES, Romain/N-2501-2016	BARRES, Romain/0000-0002-0158-519X; Chibalin, Alexander/0000-0002-6339-6271; Pirkmajer, Sergej/0000-0003-1459-6936	Swedish Research Council [K2010-55X-14191-3]; Novo-Nordisk Foundation; Swedish Society of Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo-Nordisk Foundation(Novo Nordisk Foundation); Swedish Society of Medicine	This work was supported by grants from the Swedish Research Council (www.vr.se; contract # K2010-55X-14191-3), the Novo-Nordisk Foundation, and the Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2004, AM J PHYSIOL-CELL PH, V286, pC1410, DOI 10.1152/ajpcell.00444.2003; Chibalin Alexander V, 2007, Pathophysiology, V14, P153; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 2001, ENDOCRINOLOGY, V142, P3474, DOI 10.1210/en.142.8.3474; CRAVEN PA, 1989, J CLIN INVEST, V83, P1667, DOI 10.1172/JCI114066; Crider JY, 1997, J OCUL PHARMACOL TH, V13, P337, DOI 10.1089/jop.1997.13.337; Ekberg K, 2003, DIABETES, V52, P536, DOI 10.2337/diabetes.52.2.536; Ekberg K, 2007, DIABETES CARE, V30, P71, DOI 10.2337/dc06-1274; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; FINK DJ, 1994, J NEUROCHEM, V63, P1782; Galuska D, 2009, AM J PHYSIOL-ENDOC M, V297, pE38, DOI 10.1152/ajpendo.90990.2008; GREENE DA, 1984, AM J PHYSIOL, V247, pE534, DOI 10.1152/ajpendo.1984.247.4.E534; Grunberger G, 2001, DIABETOLOGIA, V44, P1247, DOI 10.1007/s001250100632; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; INOGUCHI T, 1992, P NATL ACAD SCI USA, V89, P11059, DOI 10.1073/pnas.89.22.11059; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Johansson BL, 2000, DIABETIC MED, V17, P181, DOI 10.1046/j.1464-5491.2000.00274.x; KJELDSEN K, 1987, DIABETES, V36, P842, DOI 10.2337/diabetes.36.7.842; Kowluru RA, 1998, DIABETES, V47, P464, DOI 10.2337/diabetes.47.3.464; Li ZG, 2003, DIABETES-METAB RES, V19, P375, DOI 10.1002/dmrr.389; Li Zhen-guo, 2002, Int J Exp Diabetes Res, V3, P241, DOI 10.1080/15604280214936; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Nordquist L, 2010, DIABETES-METAB RES, V26, P193, DOI 10.1002/dmrr.1071; Ohtomo Y, 1996, DIABETOLOGIA, V39, P199, DOI 10.1007/BF00403963; PEREZ GO, 1977, ARCH INTERN MED, V137, P1018, DOI 10.1001/archinte.137.8.1018; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Samnegard B, 2001, KIDNEY INT, V60, P1258, DOI 10.1046/j.1523-1755.2001.00964.x; SCHMIDT TA, 1994, J APPL PHYSIOL, V76, P2140, DOI 10.1152/jappl.1994.76.5.2140; SHIBA T, 1993, AM J PHYSIOL, V265, pE783, DOI 10.1152/ajpendo.1993.265.5.E783; Sima AAF, 2001, DIABETOLOGIA, V44, P889, DOI 10.1007/s001250100570; Sugimoto K, 2000, DIABETES-METAB RES, V16, P408; Thompson CB, 1996, J BIOL CHEM, V271, P32653, DOI 10.1074/jbc.271.51.32653; Tsimaratos M, 2003, DIABETOLOGIA, V46, P124, DOI 10.1007/s00125-002-0996-1; Upadhyay D, 2003, FEBS LETT, V545, P173, DOI 10.1016/S0014-5793(03)00527-1; WATANABE Y, 1993, J BIOCHEM-TOKYO, V114, P849, DOI 10.1093/oxfordjournals.jbchem.a124267; Zhong Z, 2005, DIABETOLOGIA, V48, P187, DOI 10.1007/s00125-004-1602-5; Zhong Z, 2004, CELL MOL LIFE SCI, V61, P2782, DOI 10.1007/s00018-004-4258-x	37	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28294	10.1371/journal.pone.0028294	http://dx.doi.org/10.1371/journal.pone.0028294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162761	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800023
J	Kuchibhatla, A; Bhattacharya, A; Panda, D				Kuchibhatla, Anuradha; Bhattacharya, Anusri; Panda, Dulal			ZipA Binds to FtsZ with High Affinity and Enhances the Stability of FtsZ Protofilaments	PLOS ONE			English	Article							BACTERIAL-CELL-DIVISION; ESCHERICHIA-COLI; ASSEMBLY DYNAMICS; PROTEIN FTSZ; SEPTAL RING; INHIBITORS; SCATTERING; RESONANCE; TURNOVER; POLYMERS	A bacterial membrane protein ZipA that tethers FtsZ to the membrane is known to promote FtsZ assembly. In this study, the binding of ZipA to FtsZ was monitored using fluorescence spectroscopy. ZipA was found to bind to FtsZ with high affinities at three different (6.0, 6.8 and 8.0) pHs, albeit the binding affinity decreased with increasing pH. Further, thick bundles of FtsZ protofilaments were observed in the presence of ZipA under the pH conditions used in this study indicating that ZipA can promote FtsZ assembly and stabilize FtsZ polymers under unfavorable conditions. Bis-ANS, a hydrophobic probe, decreased the interaction of FtsZ and ZipA indicating that the interaction between FtsZ and ZipA is hydrophobic in nature. ZipA prevented the dilution induced disassembly of FtsZ polymers suggesting that it stabilizes FtsZ protofilaments. Fluorescein isothiocyanate-labeled ZipA was found to be uniformly distributed along the length of the FtsZ protofilaments indicating that ZipA stabilizes FtsZ protofilaments by cross-linking them.	[Kuchibhatla, Anuradha; Bhattacharya, Anusri; Panda, Dulal] Indian Inst Technol, Wadhwani Res Ctr, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kuchibhatla, A (corresponding author), Indian Inst Technol, Wadhwani Res Ctr, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in			Board of Research in Nuclear Sciences, Government of India	Board of Research in Nuclear Sciences, Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	This work was supported by a grant from the Board of Research in Nuclear Sciences, Government of India. http://www.barc.ernet.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 2002, J MOL BIOL, V318, P219, DOI 10.1016/S0022-2836(02)00024-4; Beuria TK, 2006, INT J BIOL MACROMOL, V40, P30, DOI 10.1016/j.ijbiomac.2006.05.006; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Jennings LD, 2004, BIOORGAN MED CHEM, V12, P5115, DOI 10.1016/j.bmc.2004.07.031; Jennings LD, 2004, BIOORG MED CHEM LETT, V14, P1427, DOI 10.1016/j.bmcl.2004.01.028; Kapoor S, 2009, EXPERT OPIN THER TAR, V13, P1037, DOI 10.1517/14728220903173257; Kenny CH, 2003, ANAL BIOCHEM, V323, P224, DOI 10.1016/j.ab.2003.08.033; Kuchibhatla A, 2011, INT J BIOL MACROMOL, V49, P737, DOI 10.1016/j.ijbiomac.2011.07.008; Kuchibhatla A, 2011, INDIAN J CHEM A, V50, P491; Kuchibhatla A, 2009, LANGMUIR, V25, P3775, DOI 10.1021/la8036605; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Santra MK, 2007, PROTEINS, V67, P177, DOI 10.1002/prot.21178; Santra MK, 2004, J BIOL CHEM, V279, P25959, DOI 10.1074/jbc.M312473200; SHI L, 1994, BIOCHEMISTRY-US, V33, P7536, DOI 10.1021/bi00190a006; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Sutherland AG, 2003, ORG BIOMOL CHEM, V1, P4138, DOI 10.1039/b312016c; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x	33	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28262	10.1371/journal.pone.0028262	http://dx.doi.org/10.1371/journal.pone.0028262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164258	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400059
J	Lawing, AM; Polly, PD				Lawing, A. Michelle; Polly, P. David			Pleistocene Climate, Phylogeny, and Climate Envelope Models: An Integrative Approach to Better Understand Species' Response to Climate Change	PLOS ONE			English	Article							WESTERN RATTLESNAKE; CROTALUS-VIRIDIS; VIPERIDAE; EVOLUTION; RANGE; BIOGEOGRAPHY; ECOLOGY; RECONSTRUCTION; DISTRIBUTIONS; CONSTRAINTS	Mean annual temperature reported by the Intergovernmental Panel on Climate Change increases at least 1.1 degrees C to 6.4 degrees C over the next 90 years. In context, a change in climate of 6 degrees C is approximately the difference between the mean annual temperature of the Last Glacial Maximum (LGM) and our current warm interglacial. Species have been responding to changing climate throughout Earth's history and their previous biological responses can inform our expectations for future climate change. Here we synthesize geological evidence in the form of stable oxygen isotopes, general circulation paleoclimate models, species' evolutionary relatedness, and species' geographic distributions. We use the stable oxygen isotope record to develop a series of temporally high-resolution paleoclimate reconstructions spanning the Middle Pleistocene to Recent, which we use to map ancestral climatic envelope reconstructions for North American rattlesnakes. A simple linear interpolation between current climate and a general circulation paleoclimate model of the LGM using stable oxygen isotope ratios provides good estimates of paleoclimate at other time periods. We use geologically informed rates of change derived from these reconstructions to predict magnitudes and rates of change in species' suitable habitat over the next century. Our approach to modeling the past suitable habitat of species is general and can be adopted by others. We use multiple lines of evidence of past climate (isotopes and climate models), phylogenetic topology (to correct the models for long-term changes in the suitable habitat of a species), and the fossil record, however sparse, to cross check the models. Our models indicate the annual rate of displacement in a clade of rattlesnakes over the next century will be 2 to 3 orders of magnitude greater (430-2,420 m/yr) than it has been on average for the past 320 ky (2.3 m/yr).	[Lawing, A. Michelle; Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Lawing, A. Michelle] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lawing, AM (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	alawing@indiana.edu	Polly, P. David/ABC-6597-2020; Lawing, Michelle/F-7453-2019	Polly, P. David/0000-0001-7338-8526; Lawing, Michelle/0000-0003-4041-6177	National Science Foundation [EAR-0843935]; CEA; CNRS; MOTIF; Programme National d'Etude de la Dynamique du Climat; Directorate For Geosciences [0843935] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); MOTIF; Programme National d'Etude de la Dynamique du Climat; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation Research Grant EAR-0843935. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S.C. Brassell, A.K. Bormet, C. Casola, E.S. Gercke, R.M. Green, C.C. Johnson, E.P. Martins, J.M. Meik, L.C. Moyle, K.D. Nold, J.-Y. Peterschmitt, and L.M. Pratt for assistance, advice and thoughtful discussion. J.M. Meik kindly provided an insightful review of this manuscript, as well as two anonymous reviewers. We acknowledge the Paleobiology Database (paleodb.org) and the Laboratoire des Sciences du Climat et de l'Environnement (pmip2.lsce.ipsl.fr/) for collecting and archiving data. The PMIP2 Data Archive is supported by CEA, CNRS, MOTIF, and the Programme National d'Etude de la Dynamique du Climat.	Ashton KG, 2001, MOL PHYLOGENET EVOL, V21, P176, DOI 10.1006/mpev.2001.1013; AUSTIN MP, 1984, VEGETATIO, V55, P11, DOI 10.1007/BF00039976; Bennett KD, 1997, BIOL RESPONSE EVOLUT, P154; Bennett SH, 1995, ECOLOGY STATUS E DIA; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Campbell J. A., 2004, VENOMOUS REPTILES W; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Clark AM, 2003, J HERPETOL, V37, P145, DOI 10.1670/0022-1511(2003)037[0145:POTTRC]2.0.CO;2; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hardy CR, 2005, SYST BIOL, V54, P299, DOI 10.1080/10635150590923317; Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344; Heikinheimo H, 2007, J BIOGEOGR, V34, P1053, DOI 10.1111/j.1365-2699.2006.01664.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Holman JA, 2000, FOSSIL SNAKES N AM; Holt RD, 2003, EVOL ECOL RES, V5, P159; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Lawton JL, 2000, CONCLUDING REMARKS R, P401; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Means DB, 1986, SPECIAL CONCERN E DI; Meik JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-35; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Murphy Robert W., 2002, P69; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Polly P. David, 2008, P167, DOI 10.1007/978-1-4020-6997-0_9; Polly PD, 2010, CARNIVORAN EVOLUTION; Polly PD, 2004, SIMULATION MORPHOLOG, p7A; Pook CE, 2000, MOL PHYLOGENET EVOL, V15, P269, DOI 10.1006/mpev.1999.0756; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; Solomon S, 2007, INT PAN CLIM CHANG C; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P19715, DOI 10.1073/pnas.0902956106; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	64	63	63	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28554	10.1371/journal.pone.0028554	http://dx.doi.org/10.1371/journal.pone.0028554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164305	Green Published, gold			2022-12-25	WOS:000298171400107
J	Marion, ZH; Hay, ME				Marion, Zachary H.; Hay, Mark E.			Chemical Defense of the Eastern Newt (Notophthalmus viridescens): Variation in Efficiency against Different Consumers and in Different Habitats	PLOS ONE			English	Article							RED-SPOTTED NEWT; EXPERIMENTAL COMMUNITIES; SALAMANDER PREDATION; TARICHA-GRANULOSA; GARTER SNAKES; POISON FROGS; TETRODOTOXIN; PREY; SKIN; PALATABILITY	Amphibian secondary metabolites are well known chemically, but their ecological functions are poorly understood-even for well-studied species. For example, the eastern newt (Notophthalmus viridescens) is a well known secretor of tetrodotoxin (TTX), with this compound hypothesized to facilitate this salamander's coexistence with a variety of aquatic consumers across the eastern United States. However, this assumption of chemical defense is primarily based on observational data with low replication against only a few predator types. Therefore, we tested the hypothesis that N. viridescens is chemically defended against co-occurring fishes, invertebrates, and amphibian generalist predators and that this defense confers high survivorship when newts are transplanted into both fish-containing and fishless habitats. We found that adult eastern newts were unpalatable to predatory fishes (Micropterus salmoides, Lepomis macrochirus) and a crayfish (Procambarus clarkii), but were readily consumed by bullfrogs (Lithobates catesbeianus). The eggs and neonate larvae were also unpalatable to fish (L. macrochirus). Bioassay-guided fractionation confirmed that deterrence is chemical and that ecologically relevant concentrations of TTX would deter feeding. Despite predatory fishes rejecting eastern newts in laboratory assays, field experiments demonstrated that tethered newts suffered high rates of predation in fish-containing ponds. We suggest that this may be due to predation by amphibians (frogs) and reptiles (turtles) that co-occur with fishes rather than from fishes directly. Fishes suppress invertebrate consumers that prey on bullfrog larvae, leading to higher bullfrog densities in fish containing ponds and thus considerable consumption of newts due to bullfrog tolerance of newt chemical defenses. Amphibian chemical defenses, and consumer responses to them, may be more complex and indirect than previously appreciated.	[Marion, Zachary H.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Marion, Zachary H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	University System of Georgia; Georgia Institute of Technology; University of Tennessee System; University of Tennessee Knoxville	Marion, ZH (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Marion, Zachary/I-9102-2016; Hay, Mark/D-9752-2011	Marion, Zachary/0000-0002-7351-1819; Hay, Mark/0000-0002-6130-9349	National Science Foundation [DGE 0114400]; FOGARTY INTERNATIONAL CENTER [U19TW007401] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship Program award (DGE 0114400), http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 12759, and the Teasley Endowment to the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CK, 2011, AM MIDL NAT, V166, P211, DOI 10.1674/0003-0031-166.1.211; Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2010, R LANG ENV STAT COMP; Bates D., 2010, IME4 LINEAR MIXED EF; Benard MF, 2003, ECOLOGY, V84, P68, DOI 10.1890/0012-9658(2003)084[0068:AIDCCO]2.0.CO;2; BRANDON RA, 1979, HERPETOLOGICA, V35, P289; BRODIE ED, 1990, EVOLUTION, V44, P651, DOI 10.1111/j.1558-5646.1990.tb05945.x; BRODIE ED, 1968, AM MIDL NAT, V80, P276, DOI 10.2307/2423618; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Clark VC, 2005, P NATL ACAD SCI USA, V102, P11617, DOI 10.1073/pnas.0503502102; Conant R., 1991, FIELD GUIDE REPTILES; DALY JW, 1995, P NATL ACAD SCI USA, V92, P9, DOI 10.1073/pnas.92.1.9; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; DALY JW, 1987, TOXICON, V25, P1023, DOI 10.1016/0041-0101(87)90265-0; DUFFY JE, 2001, MARINE COMMUNITY ECO, P131; Eisner T, 2000, P NATL ACAD SCI USA, V97, P11313, DOI 10.1073/pnas.190335397; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Etnier DA, 1993, FISHES TENNESSEE, Vxiv, P681; Fay MP, 2010, R J, V2, P53; Fordyce JA, 2005, J CHEM ECOL, V31, P2835, DOI 10.1007/s10886-005-8397-9; FOX J, 2010, CAR COMPANION APPL R; Gamradt SC, 1997, CONSERV BIOL, V11, P793, DOI 10.1046/j.1523-1739.1997.96230.x; GATES JE, 1982, J HERPETOL, V16, P7, DOI 10.2307/1563901; Glendinning JI, 2007, BIOL BULL-US, V213, P252, DOI 10.2307/25066643; Gunzburger MS, 2005, J HERPETOL, V39, P547, DOI 10.1670/1-05A.1; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Hanifin CT, 2004, TOXICON, V43, P243, DOI 10.1016/j.toxicon.2003.11.025; Hanifin CT, 2003, J CHEM ECOL, V29, P1729, DOI 10.1023/A:1024885824823; Hay M. E, 1998, METHODS CHEM ECOLOGY, P39; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hecnar SJ, 1997, BIOL CONSERV, V79, P123, DOI 10.1016/S0006-3207(96)00113-9; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HURLBERT S H, 1970, Journal of Herpetology, V4, P47, DOI 10.2307/1562702; KRUSE KC, 1977, T AM FISH SOC, V106, P248, DOI 10.1577/1548-8659(1977)106<248:APDILO>2.0.CO;2; Kuchta SR, 2008, EVOLUTION, V62, P984, DOI 10.1111/j.1558-5646.2008.00338.x; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; LEVENSON CH, 1979, TOXICON, V17, P184, DOI 10.1016/0041-0101(79)90301-5; LICHT L E, 1968, Herpetologica, V24, P93; Lindquist N, 1996, ECOL MONOGR, V66, P431, DOI 10.2307/2963489; Lodge DM, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:NCTNAF>2.0.CO;2; MORIN PJ, 1981, SCIENCE, V212, P1284, DOI 10.1126/science.212.4500.1284; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; MORIN PJ, 1983, ECOLOGY, V64, P1430, DOI 10.2307/1937497; MOSHER HS, 1964, SCIENCE, V144, P1100, DOI 10.1126/science.144.3622.1100; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Myers CW, 1978, DANGEROUSLY TOXIC NE; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; ORIANS GH, 1974, AM NAT, V108, P581, DOI 10.1086/282937; Page LM, 1991, FIELD GUIDE FRESHWAT; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Parker JD, 2006, J CHEM ECOL, V32, P815, DOI 10.1007/s10886-006-9038-7; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Petranka, 1998, SALAMANDERS US CANAD; Post DM, 2008, ECOLOGY, V89, P2019, DOI 10.1890/07-1216.1; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Rosenthal GA., 1992, HERBIVORES THEIR INT; SARGEANT AB, 1975, AM MIDL NAT, V94, P108, DOI 10.2307/2424542; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Smith GR, 1999, FRESHWATER BIOL, V41, P829, DOI 10.1046/j.1365-2427.1999.00445.x; Stachowicz JJ, 2001, MARINE CHEM ECOLOGY; Stoks R, 2003, ECOLOGY, V84, P1576, DOI 10.1890/0012-9658(2003)084[1576:PALHSL]2.0.CO;2; Szuroczki D, 2011, HERPETOLOGICA, V67, P213, DOI 10.1655/HERPETOLOGICA-D-10-00059.1; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; Vonesh JR, 2009, OIKOS, V118, P1219, DOI 10.1111/j.1600-0706.2009.17369.x; WAKELY JANE FAIL, 1966, TOXICON, V3, P195, DOI 10.1016/0041-0101(66)90021-3; WEBSTER DA, 1960, COPEIA, P74; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; WILBUR HM, 1983, ECOLOGY, V64, P1423, DOI 10.2307/1937496; Williams BL, 2010, CHEMOECOLOGY, V20, P285, DOI 10.1007/s00049-010-0057-z; Williams BL, 2003, HERPETOLOGICA, V59, P155, DOI 10.1655/0018-0831(2003)059[0155:CODTAP]2.0.CO;2; YOTSU M, 1990, TOXICON, V28, P238, DOI 10.1016/0041-0101(90)90419-8; Yotsu-Yamashita M, 2003, TOXICON, V41, P893, DOI 10.1016/S0041-0101(03)00068-0; Yotsu-Yamashita M, 2001, TOXICON, V39, P1261, DOI 10.1016/S0041-0101(00)00263-4; ZARET TM, 1980, PREDATION FRESHWATER; [No title captured]; [No title captured]	81	8	8	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27581	10.1371/journal.pone.0027581	http://dx.doi.org/10.1371/journal.pone.0027581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164212	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400012
J	Romeo, S; Zeni, L; Sarti, M; Sannino, A; Scarfi, MR; Vernier, PT; Zeni, O				Romeo, Stefania; Zeni, Luigi; Sarti, Maurizio; Sannino, Anna; Scarfi, Maria Rosaria; Vernier, P. Thomas; Zeni, Olga			DNA Electrophoretic Migration Patterns Change after Exposure of Jurkat Cells to a Single Intense Nanosecond Electric Pulse	PLOS ONE			English	Article							DAMAGE; APOPTOSIS; FIELDS	Intense nanosecond pulsed electric fields (nsPEFs) interact with cellular membranes and intracellular structures. Investigating how cells respond to nanosecond pulses is essential for a) development of biomedical applications of nsPEFs, including cancer therapy, and b) better understanding of the mechanisms underlying such bioelectrical effects. In this work, we explored relatively mild exposure conditions to provide insight into weak, reversible effects, laying a foundation for a better understanding of the interaction mechanisms and kinetics underlying nsPEF bio-effects. In particular, we report changes in the nucleus of Jurkat cells (human lymphoblastoid T cells) exposed to single pulses of 60 ns duration and 1.0, 1.5 and 2.5 MV/m amplitudes, which do not affect cell growth and viability. A dose-dependent reduction in alkaline comet-assayed DNA migration is observed immediately after nsPEF exposure, accompanied by permeabilization of the plasma membrane (YO-PRO-1 uptake). Comet assay profiles return to normal within 60 minutes after pulse delivery at the highest pulse amplitude tested, indicating that our exposure protocol affects the nucleus, modifying DNA electrophoretic migration patterns.	[Romeo, Stefania; Zeni, Luigi; Sarti, Maurizio; Sannino, Anna; Scarfi, Maria Rosaria] CNR, Inst Electromagnet Sensing Environm, I-80125 Naples, Italy; [Romeo, Stefania; Zeni, Luigi] Univ Naples 2, Dept Informat Engn, Aversa, Italy; [Sannino, Anna] Univ Salerno, Dept Pharmaceut Sci, Fisciano, Italy; [Vernier, P. Thomas; Zeni, Olga] Univ So Calif, Viterbi Sch Engn, Ming Hsieh Dept Elect Engn, Los Angeles, CA USA	Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Rilevamento Elettromagnetico Dell'Ambiente (IREA-CNR); Universita della Campania Vanvitelli; University of Salerno; University of Southern California	Romeo, S (corresponding author), CNR, Inst Electromagnet Sensing Environm, I-80125 Naples, Italy.	zeni.o@irea.cnr.it	Zeni, Luigi/AAC-5044-2022; Zeni, Olga/ABH-5688-2020; Sarti, Maurizio/AAL-7105-2021; Romeo, Stefania/I-6664-2019; Vernier, P. Thomas/D-7926-2016	Zeni, Luigi/0000-0001-8356-7480; Zeni, Olga/0000-0002-2432-2384; Sarti, Maurizio/0000-0002-5063-4154; Romeo, Stefania/0000-0002-9849-3637; Vernier, P. Thomas/0000-0003-2335-1500				Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; Buescher ES, 2003, IEEE T DIELECT EL IN, V10, P788, DOI 10.1109/TDEI.2003.1237328; Chen NY, 2004, BIOCHEM BIOPH RES CO, V317, P421, DOI 10.1016/j.bbrc.2004.03.063; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Collins AR, 2001, ACTA BIOCHIM POL, V48, P611; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Joshi R. P., 2010, Critical Reviews in Biomedical Engineering, V38, P255, DOI 10.1615/CritRevBiomedEng.v38.i3.20; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; Lovell DP, 2008, MUTAGENESIS, V23, P171, DOI 10.1093/mutage/gen015; MATZKE AJM, 1991, BIOELECTROCH BIOENER, V25, P357, DOI 10.1016/0302-4598(91)80002-K; Merk O, 1999, ENVIRON MOL MUTAGEN, V33, P167, DOI 10.1002/(SICI)1098-2280(1999)33:2<167::AID-EM9>3.0.CO;2-D; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Palumbo R, 2008, RADIAT RES, V170, P327, DOI 10.1667/RR1098.1; PORSCHKE D, 1984, BIOPHYS CHEM, V20, P225, DOI 10.1016/0301-4622(84)87027-1; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Tekle E, 2005, BIOPHYS J, V89, P274, DOI 10.1529/biophysj.104.054494; Tice RR, 1997, MUTAT RES-REV MUTAT, V386, P315, DOI 10.1016/S1383-5742(97)00004-5; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; White JA, 2011, EUR BIOPHYS J BIOPHY, V40, P947, DOI 10.1007/s00249-011-0710-7; Zeni O, 2010, METHODS MOL BIOL, V625, P109, DOI 10.1007/978-1-60761-579-8_10	32	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28419	10.1371/journal.pone.0028419	http://dx.doi.org/10.1371/journal.pone.0028419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164287	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400088
J	Bang, G; Prieur, E; Roussilhon, C; Druilhe, P				Bang, Gilles; Prieur, Eric; Roussilhon, Christian; Druilhe, Pierre			Pre-Clinical Assessment of Novel Multivalent MSP3 Malaria Vaccine Constructs	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-3; BLOOD-STAGE ANTIGENS; PLASMODIUM-FALCIPARUM; INTERFERON-GAMMA; SEASONAL MALARIA; BURKINA-FASO; B-CELL; ANTIBODIES; IDENTIFICATION; TRANSMISSION	Background: MSP3 has been shown to induce protection against malaria in African children. The characterization of a family of Plasmodium falciparum merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneously expressed on the merozoite surface and targeted by a cross-reactive network of protective antibodies, is intriguing and offers new perspectives for the development of subunit vaccines against malaria. Methods: Eight recombinant polyproteins containing carefully selected regions of this family covalently linked in different combinations were all efficiently produced in Escherichia coli. The polyproteins consisted of one monovalent, one bivalent, one trivalent, two tetravalents, one hexavalent construct, and two tetravalents incorporating coiled-coil repeats regions from LSA3 and p27 vaccine candidates. Results: All eight polyproteins induced a strong and homogeneous antibody response in mice of three distinct genotypes, with a dominance of cytophilic IgG subclasses, lasting up to six months after the last immunization. Vaccine-induced antibodies exerted a strong monocyte-mediated in vitro inhibition of P. falciparum growth. Naturally acquired antibodies from individuals living in an endemic area of Senegal recognized the polyproteins with a reactivity mainly constituted of cytophilic IgG subclasses. Conclusions: Combination of genetically conserved and antigenically related MSP3 proteins provides promising subunit vaccine constructs, with improved features as compared to the first generation construct employed in clinical trials (MSP3-LSP). These multivalent MSP3 vaccine constructs expand the epitope display of MSP3 family proteins, and lead to the efficient induction of a wider range of antibody subclasses, even in genetically different mice. These findings are promising for future immunization of genetically diverse human populations.	[Bang, Gilles] Inst Pasteur, Malaria Vaccine Dev Lab, Paris, France; Vac4all Initiat, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bang, G (corresponding author), Inst Pasteur, Malaria Vaccine Dev Lab, Paris, France.	druilhe@vac4all.org			Ministry of Research	Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This study received support from the VIH-PAL+ program from the Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Daher LJ, 2010, INFECT IMMUN, V78, P477, DOI 10.1128/IAI.00941-08; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; Demanga CG, 2010, INFECT IMMUN, V78, P486, DOI 10.1128/IAI.01359-08; DRUILHE P, 1987, INFECT IMMUN, V55, P888, DOI 10.1128/IAI.55.4.888-891.1987; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Druilhe Pierre, 2002, Methods Mol Med, V72, P457, DOI 10.1385/1-59259-271-6:457; Duah NO, 2010, PARASITE IMMUNOL, V32, P125, DOI 10.1111/j.1365-3024.2009.01165.x; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Huber W, 1997, MOL BIOCHEM PARASIT, V87, P231, DOI 10.1016/S0166-6851(97)00067-4; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Jouin H, 2004, CYTOM PART A, V57A, P34, DOI 10.1002/cyto.a.10110; Lusingu JPA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-163; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Martin RM, 1997, IMMUNOGENETICS, V46, P167, DOI 10.1007/s002510050258; McColl DJ, 1997, MOL BIOCHEM PARASIT, V90, P21, DOI 10.1016/S0166-6851(97)00130-8; MORGADO MG, 1989, EMBO J, V8, P3245, DOI 10.1002/j.1460-2075.1989.tb08484.x; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; OEUVRAY C, 1994, BLOOD, V84, P1594; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; SEPPALA I, 1981, SCAND J IMMUNOL, V14, P335, DOI 10.1111/j.1365-3083.1981.tb00573.x; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1988, P NATL ACAD SCI USA, V85, P6107, DOI 10.1073/pnas.85.16.6107; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Zwetyenga J, 1999, T ROY SOC TROP MED H, V93, P375, DOI 10.1016/S0035-9203(99)90122-0	36	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28165	10.1371/journal.pone.0028165	http://dx.doi.org/10.1371/journal.pone.0028165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145028	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168900011
J	Rehberg, M; Krombach, F; Pohl, U; Dietzel, S				Rehberg, Markus; Krombach, Fritz; Pohl, Ulrich; Dietzel, Steffen			Label-Free 3D Visualization of Cellular and Tissue Structures in Intact Muscle with Second and Third Harmonic Generation Microscopy	PLOS ONE			English	Article							ACTIN-MYOSIN INTERACTIONS; 2ND-HARMONIC GENERATION; 3RD-HARMONIC GENERATION; IN-VIVO; RESONANCE ENHANCEMENT; FLUORESCENCE; PROTEIN; DNA; VASODILATION; ARRANGEMENTS	Second and Third Harmonic Generation (SHG and THG) microscopy is based on optical effects which are induced by specific inherent physical properties of a specimen. As a multi-photon laser scanning approach which is not based on fluorescence it combines the advantages of a label-free technique with restriction of signal generation to the focal plane, thus allowing high resolution 3D reconstruction of image volumes without out-of-focus background several hundred micrometers deep into the tissue. While in mammalian soft tissues SHG is mostly restricted to collagen fibers and striated muscle myosin, THG is induced at a large variety of structures, since it is generated at interfaces such as refraction index changes within the focal volume of the excitation laser. Besides, colorants such as hemoglobin can cause resonance enhancement, leading to intense THG signals. We applied SHG and THG microscopy to murine (Mus musculus) muscles, an established model system for physiological research, to investigate their potential for label-free tissue imaging. In addition to collagen fibers and muscle fiber substructure, THG allowed us to visualize blood vessel walls and erythrocytes as well as white blood cells adhering to vessel walls, residing in or moving through the extravascular tissue. Moreover peripheral nerve fibers could be clearly identified. Structure down to the nuclear chromatin distribution was visualized in 3D and with more detail than obtainable by bright field microscopy. To our knowledge, most of these objects have not been visualized previously by THG or any label-free 3D approach. THG allows label-free microscopy with inherent optical sectioning and therefore may offer similar improvements compared to bright field microscopy as does confocal laser scanning microscopy compared to conventional fluorescence microscopy.	[Rehberg, Markus; Krombach, Fritz; Pohl, Ulrich; Dietzel, Steffen] Univ Munich, Walter Brendel Zentrum Expt Med, Munich, Germany	University of Munich	Rehberg, M (corresponding author), Univ Munich, Walter Brendel Zentrum Expt Med, Munich, Germany.	dietzel@lmu.de		Rehberg, Markus/0000-0001-7314-6332; Dietzel, Steffen/0000-0001-5725-3242	BioImaging Network of the Ludwig-Maximilians-Universitat Munchen; Excellence Initiative of the Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Friedrich-Baur-Stiftung	BioImaging Network of the Ludwig-Maximilians-Universitat Munchen; Excellence Initiative of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Friedrich-Baur-Stiftung	This study was supported by the BioImaging Network of the Ludwig-Maximilians-Universitat Munchen (www.bin.lmu.de) and the Excellence Initiative of the Deutsche Forschungsgemeinschaft (www.dfg.de) and the Bundesministerium fur Bildung und Forschung (www.bmbf.de). MR received support by the Friedrich-Baur-Stiftung (www.baur-stiftung.de). UP is a member of the Munich Heart Alliance. The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbulut O, 2006, NAT METHODS, V3, P331, DOI 10.1038/nmeth0506-331; Agbulut O, 2007, J BIOL CHEM, V282, P10465, DOI 10.1074/jbc.M610418200; Amos B, 2011, COMPREHENSIVE BIOPHYSICS, VOL 2: BIOPHYSICAL TECHNIQUES FOR CHARACTERIZATION OF CELLS, P3, DOI 10.1016/B978-0-12-374920-8.00203-4; ANDERS A, 1981, CHEM PHYS LETT, V81, P270, DOI 10.1016/0009-2614(81)80250-3; Aviles-Espinosa R, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3477535; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Belisle JM, 2008, BIOPHYS J, V94, pL26, DOI 10.1529/biophysj.107.125443; Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14; Both M, 2004, J BIOMED OPT, V9, P882, DOI 10.1117/1.1783354; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Campagnola PJ, 2008, HDB BIOMEDICAL NONLI, P377; Chang CF, 2010, J BIOPHOTONICS, V3, P678, DOI 10.1002/jbio.201000045; Chang CF, 2010, OPT EXPRESS, V18, P7397, DOI 10.1364/OE.18.007397; Chen SY, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363369; Cheng P.C., 2006, HDB BIOL CONFOCAL MI, P162, DOI DOI 10.1007/978-0-387-45524-2_8; Cheng P-C, 2006, HDB BIOL CONFOCAL MI, P703, DOI DOI 10.1007/978-0-387-45524-2_40; Chu SW, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3080722; Chu SW, 2004, BIOPHYS J, V86, P3914, DOI 10.1529/biophysj.103.034595; Clay GO, 2006, J OPT SOC AM B, V23, P932, DOI 10.1364/JOSAB.23.000932; Cox G, 2004, MICROSC RES TECHNIQ, V63, P18, DOI 10.1002/jemt.10423; Cox Guy, 2006, V319, P15; de Wit C, 2000, CIRC RES, V86, P649, DOI 10.1161/01.RES.86.6.649; Dombeck DA, 2003, P NATL ACAD SCI USA, V100, P7081, DOI 10.1073/pnas.0731953100; Farrar MJ, 2011, BIOPHYS J, V100, P1362, DOI 10.1016/j.bpj.2011.01.031; FERGUSON M, 1992, CHROMOSOMA, V101, P557, DOI 10.1007/BF00660315; Friedl Peter, 2007, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0415s34; GORCZYNSKI RJ, 1978, AM J PHYSIOL, V235, pH505, DOI 10.1152/ajpheart.1978.235.5.H505; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Kao FJ, 2004, MICROSC RES TECHNIQ, V63, P175, DOI 10.1002/jemt.20026; Khandoga AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004693; Lee WJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3469848; Legare F, 2007, BIOPHYS J, V93, P1312, DOI 10.1529/biophysj.106.100586; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Mak GWY, 2007, ANAL BIOCHEM, V362, P296, DOI 10.1016/j.ab.2006.12.017; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Mempel TR, 2003, J VASC RES, V40, P435, DOI 10.1159/000073902; Mertz J, 2001, OPT COMMUN, V196, P325, DOI 10.1016/S0030-4018(01)01403-1; Millard AC, 1999, APPL OPTICS, V38, P7393, DOI 10.1364/AO.38.007393; Moreaux L, 2001, BIOPHYS J, V80, P1568, DOI 10.1016/S0006-3495(01)76129-2; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; Rehberg M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3374337; Schaller RD, 2000, ANAL CHEM, V72, P5361, DOI 10.1021/ac000699r; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Tai Shih-Peng, 2005, Opt Express, V13, P8231, DOI 10.1364/OPEX.13.008231; Tai SP, 2006, OPT EXPRESS, V14, P6178, DOI 10.1364/OE.14.006178; Vaya I, 2010, J AM CHEM SOC, V132, P11834, DOI 10.1021/ja102800r; WEIMER R, 1992, HUM GENET, V88, P673, DOI 10.1007/BF02265296; Witte S, 2011, P NATL ACAD SCI USA, V108, P5970, DOI 10.1073/pnas.1018743108; Yu CH, 2008, OPT LETT, V33, P387, DOI 10.1364/OL.33.000387; Yu CH, 2007, OPT EXPRESS, V15, P11167, DOI 10.1364/OE.15.011167; Zhao H, 2009, CYTOM PART A, V75A, P510, DOI 10.1002/cyto.a.20727; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	55	66	67	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28237	10.1371/journal.pone.0028237	http://dx.doi.org/10.1371/journal.pone.0028237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140560	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163400041
J	Huang, W; Fridman, Y; Bonfil, RD; Ustach, CV; Conley-LaComb, MK; Wiesner, C; Saliganan, A; Cher, ML; Kim, HRC				Huang, W.; Fridman, Y.; Bonfil, R. D.; Ustach, C. V.; Conley-LaComb, M. K.; Wiesner, C.; Saliganan, A.; Cher, M. L.; Kim, H-R C.			A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth	ONCOGENE			English	Article						prostate cancer; bone responses; osteoclastic differentiation; PDGF-D	PROSTATE-CANCER; PLASMINOGEN-ACTIVATOR; PDGF-D; BONE; RANKL; METALLOPROTEINASE; THERAPY	Although increasing evidence suggests a critical role for platelet-derived growth factor (PDGF) receptor beta (beta-PDGFR) signaling in prostate cancer (PCa) progression, the precise roles of beta-PDGFR and PDGF isoform-specific cell signaling have not been delineated. Recently, we identified the PDGF-D isoform as a ligand for beta-PDGFR in PCa and showed that PDGF-D is activated by serine protease-mediated proteolytic removal of the CUB domain in a two-step process, yielding first a hemidimer (HD) and then a growth factor domain dimer. Herein, we demonstrate that the expression of PDGF-D in human PCa LNCaP cells leads to enhanced bone tumor growth and bone responses in immunodeficient mice. Histopathological analyses of bone tumors generated by PDGF-D-expressing LNCaP cells (LNCaP-PDGF-D) revealed osteolytic and osteoblastic responses similar to those observed in human PCa bone metastases. Importantly, we discovered a novel function of PDGF-D in the regulation of osteoclast differentiation, independent of the RANKL/RANK signaling axis. Although both PDGF-B and -D were able to activate beta-PDGFR, only PDGF-D was able to induce osteoclastic differentiation in vitro, and upregulate the expression and nuclear translocation of nuclear factor of activated T cells 1, a master transcription factor for osteoclastogenesis. Taken together, these results reveal a new function of PDGF-D as a regulator of osteoclastic differentiation, an activity critical for the establishment of skeletal metastatic deposit in PCa patients.	[Huang, W.; Fridman, Y.; Bonfil, R. D.; Ustach, C. V.; Conley-LaComb, M. K.; Cher, M. L.; Kim, H-R C.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA; [Bonfil, R. D.; Wiesner, C.; Saliganan, A.; Cher, M. L.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Urol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Kim, HRC (corresponding author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol, 540 E Canfield, Detroit, MI 48201 USA.	hrckim@med.wayne.edu	Huang, Wei/O-2346-2013	Bonfil, R. Daniel/0000-0002-1605-8317	NIH/NCI [CA64139, CA123362, R01CA137280]; Ruth L. Kirschstein National Research Service Award [T32-CA009531]; NATIONAL CANCER INSTITUTE [T32CA009531, R01CA137280, R01CA123362, R01CA064139, R29CA064139] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI RO1 grants CA64139 and CA123362 (to H-RCK), R01CA137280 (to MLC) as well as the Ruth L. Kirschstein National Research Service Award T32-CA009531 (to MKC-L). We thank Dr. C-J Kim for his help with IHC analysis.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Blair JM, 2006, NAT CLIN PRACT ONCOL, V3, P41, DOI 10.1038/ncponc0381; Bonfil RD, 2007, AM J PATHOL, V170, P2100, DOI 10.2353/ajpath.2007.060720; Breccia M, 2009, LEUKEMIA RES, V33, P871, DOI 10.1016/j.leukres.2009.01.040; Buijs JT, 2009, CANCER LETT, V273, P177, DOI 10.1016/j.canlet.2008.05.044; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chott A, 1999, AM J PATHOL, V155, P1271, DOI 10.1016/S0002-9440(10)65229-7; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Ehnman M, 2009, ONCOGENE, V28, P534, DOI 10.1038/onc.2008.410; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Godwin SL, 1997, J BIOL CHEM, V272, P11307; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Guilhot F, 2004, ONCOLOGIST, V9, P271, DOI 10.1634/theoncologist.9-3-271; Himeno M, 2002, J BONE MINER RES, V17, P1297, DOI 10.1359/jbmr.2002.17.7.1297; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kubota K, 2003, PROTEOMICS, V3, P616, DOI 10.1002/pmic.200300410; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Mathew P, 2007, CLIN CANCER RES, V13, P5816, DOI 10.1158/1078-0432.CCR-07-1269; Mehrotra M, 2004, J CELL BIOCHEM, V93, P741, DOI 10.1002/jcb.20138; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Ng SSW, 2004, CLIN CANCER RES, V10, P4192, DOI 10.1158/1078-0432.CCR-03-0700; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Robbins JR, 1999, DEV BIOL, V212, P255, DOI 10.1006/dbio.1999.9373; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; Ustach CV, 2004, CANCER RES, V64, P1722, DOI 10.1158/0008-5472.CAN-03-3047; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; van der Poel HG, 2004, EUR UROL, V45, P1, DOI 10.1016/j.eururo.2003.08.011; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	37	23	26	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	42					4527	4535		10.1038/onc.2011.573	http://dx.doi.org/10.1038/onc.2011.573			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	022SH	22158043	Green Published, hybrid			2022-12-25	WOS:000309982100004
J	Lee, HJ; Mariappan, MM; Feliers, D; Cavaglieri, RC; Sataranatarajan, K; Abboud, HE; Choudhury, GG; Kasinath, BS				Lee, Hak Joo; Mariappan, Meenalakshmi M.; Feliers, Denis; Cavaglieri, Rita C.; Sataranatarajan, Kavithalakshmi; Abboud, Hanna E.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.			Hydrogen Sulfide Inhibits High Glucose-induced Matrix Protein Synthesis by Activating AMP-activated Protein Kinase in Renal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CYSTATHIONINE-GAMMA-LYASE; DIABETIC-NEPHROPATHY; MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; SULFANE SULFUR; KNOCKOUT MICE; HYPERTROPHY; GROWTH; RAT	Hydrogen sulfide, a signaling gas, affects several cell functions. We hypothesized that hydrogen sulfide modulates high glucose (30 mM) stimulation of matrix protein synthesis in glomerular epithelial cells. High glucose stimulation of global protein synthesis, cellular hypertrophy, and matrix laminin and type IV collagen content was inhibited by sodium hydrosulfide (NaHS), an H2S donor. High glucose activation of mammalian target of rapamycin (mTOR) complex 1 (mTORC1), shown by phosphorylation of p70S6 kinase and 4E-BP1, was inhibited by NaHS. High glucose stimulated mTORC1 to promote key events in the initiation and elongation phases of mRNA translation: binding of eIF4A to eIF4G, reduction in PDCD4 expression and inhibition of its binding to eIF4A, eEF2 kinase phosphorylation, and dephosphorylation of eEF2; these events were inhibited by NaHS. The role of AMP-activated protein kinase (AMPK), an inhibitor of protein synthesis, was examined. NaHS dose-dependently stimulated AMPK phosphorylation and restored AMPK phosphorylation reduced by high glucose. Compound C, an AMPK inhibitor, abolished NaHS modulation of high glucose effect on events in mRNA translation as well as global and matrix protein synthesis. NaHS induction of AMPK phosphorylation was inhibited by siRNA for calmodulin kinase kinase beta, but not LKB1, upstream kinases for AMPK; STO-609, a calmodulin kinase kinase beta inhibitor, had the same effect. Renal cortical content of cystathionine beta-synthase and cystathionine gamma-lyase, hydrogen sulfide-generating enzymes, was significantly reduced in mice with type 1 diabetes or type 2 diabetes, coinciding with renal hypertrophy and matrix accumulation. Hydrogen sulfide is a newly identified modulator of protein synthesis in the kidney, and reduction in its generation may contribute to kidney injury in diabetes.	[Lee, Hak Joo; Mariappan, Meenalakshmi M.; Feliers, Denis; Cavaglieri, Rita C.; Sataranatarajan, Kavithalakshmi; Abboud, Hanna E.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Lee, Hak Joo; Mariappan, Meenalakshmi M.; Sataranatarajan, Kavithalakshmi; Abboud, Hanna E.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Kasinath, BS (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	kasinath@uthscsa.edu		Feliers, Denis/0000-0003-1952-1386	National Institutes of Health [DK077295, RC2AG036613, DK050190]; Veterans Affairs Medical Research Service; Juvenile Diabetes Research Foundation [1-2010-141, 1-2008-185]; Veterans Affairs Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077295, R01DK050190, R29DK050190, R01DK078971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Medical Research Service(US Department of Veterans Affairs); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs Research Career Scientist Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077295 and RC2AG036613 (to B. S. K.) and DK050190 (to G. G. C.). This work was also supported by a grant from the Veterans Affairs Medical Research Service (to B. S. K. and G. G. C.) and Juvenile Diabetes Research Foundation Grants 1-2010-141 (to D. F.) and 1-2008-185 (to G. G. C.).; Recipient of a Veterans Affairs Research Career Scientist Award.	Abe K, 1996, J NEUROSCI, V16, P1066; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carrera AC, 2004, J CELL SCI, V117, P4615, DOI 10.1242/jcs.01311; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2011, CELL SIGNAL, V23, P1311, DOI 10.1016/j.cellsig.2011.03.012; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Givvimani S, 2011, J APPL PHYSIOL, V110, P1093, DOI 10.1152/japplphysiol.01064.2010; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Kasinath B. S., 2003, CONT DIABETES DIABET, P97; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee MJ, 2010, CELL SIGNAL, V22, P65, DOI 10.1016/j.cellsig.2009.09.011; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2011, AM J PHYSIOL-RENAL, V300, pF219, DOI 10.1152/ajprenal.00207.2010; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Miner JH, 2011, PEDIATR NEPHROL, V26, P1413, DOI 10.1007/s00467-011-1785-1; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Perna AF, 2009, NEPHROL DIAL TRANSPL, V24, P3756, DOI 10.1093/ndt/gfp378; Predmore Benjamin L, 2011, Expert Rev Clin Pharmacol, V4, P83, DOI 10.1586/ecp.10.56; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Scotland RS, 2005, CIRCULATION, V111, P796, DOI 10.1161/01.CIR.0000155238.70797.4E; Sen U, 2010, AM J NEPHROL, V31, P442, DOI 10.1159/000296717; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Senthil D, 2003, KIDNEY INT, V64, P468, DOI 10.1046/j.1523-1755.2003.00135.x; Shi YX, 2007, AM J PHYSIOL-HEART C, V293, pH2093, DOI 10.1152/ajpheart.00088.2007; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sivarajah A, 2006, SHOCK, V26, P154, DOI 10.1097/01.shk.0000225722.56681.64; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Wolf G, 2005, KIDNEY INT, V68, P1583, DOI 10.1111/j.1523-1755.2005.00570.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248; Zhu YZ, 2007, J APPL PHYSIOL, V102, P261, DOI 10.1152/japplphysiol.00096.2006; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	92	100	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4451	4461		10.1074/jbc.M111.278325	http://dx.doi.org/10.1074/jbc.M111.278325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158625	hybrid, Green Published			2022-12-25	WOS:000300608500009
J	Sun, Y; Liou, B; Xu, YH; Quinn, B; Zhang, WJ; Hamler, R; Setchell, KDR; Grabowski, GA				Sun, Ying; Liou, Benjamin; Xu, You-Hai; Quinn, Brian; Zhang, Wujuan; Hamler, Rick; Setchell, Kenneth D. R.; Grabowski, Gregory A.			Ex Vivo and in Vivo Effects of Isofagomine on Acid beta-Glucosidase Variants and Substrate Levels in Gaucher Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONES INCREASE; POINT MUTATIONS; MOUSE MODELS; FIBROBLASTS; EXPRESSION; PHENOTYPE; TRANSPORT; STRATEGY	Isofagomine (IFG) is an acid beta-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone. The effect of IFG on GCase function was investigated in GCase mutant fibroblasts and mouse models. IFG inhibits GCase with K-i similar to 30 nM for wild-type and mutant enzymes (N370S and V394L). Fibroblasts treated with IFG at mu M concentrations showed enhancement of WT and mutant GCase activities and protein levels. Administration of IFG (30 mg/kg/day) to the mice homozygous for GCase mutations (V394L, D409H, or D409V) led to increased GCase activity in visceral tissues and brain extracts. IFG effects on GCase stability and substrate levels were evaluated in a mouse model (hG/4L/PS-NA) that has doxycycline-controlled human WT GCase (hGCase) expression driven by a liver-specific promoter and is also homozygous for the IFG-responsive V394L GCase. Both human and mouse GCase activity and protein levels were increased in IFG-treated mice. The liver-secreted hGCase in serum was stabilized, and its effect on the lung and spleen involvement was enhanced by IFG treatment. In 8-week IFG-treated mice, the accumulated glucosylceramide and glucosylsphingosine were reduced by 75 and 33%, respectively. Decreases of storage cells were correlated with >50% reductions in substrate levels. These results indicate that IFG stabilizes GCase in tissues and serum and can reduce visceral substrates in vivo.	[Sun, Ying; Liou, Benjamin; Xu, You-Hai; Quinn, Brian; Grabowski, Gregory A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Sun, Ying; Xu, You-Hai; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Hamler, Rick] Amicus Therapeut Inc, Cranbury, NJ 08512 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Grabowski, GA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave,MLC 4006, Cincinnati, OH 45229 USA.	greg.grabowski@cchmc.org			National Institutes of Health [HD 059823, DK 36729, NS 36681]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD059823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD 059823, DK 36729, and NS 36681 (to G. A. G.).	Bulow A, 2000, J AM CHEM SOC, V122, P8567, DOI 10.1021/ja001762x; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Dreyfus H, 1997, ANAL BIOCHEM, V249, P67, DOI 10.1006/abio.1997.2143; EYAL N, 1990, GENE, V96, P277, DOI 10.1016/0378-1119(90)90264-R; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; GRABOWSKI GA, 2010, ONLINE METABOLIC MOL, pCH146; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Ishii S, 2009, J PHARMACOL EXP THER, V328, P723, DOI 10.1124/jpet.108.149054; Khanna R, 2010, FEBS J, V277, P1618, DOI 10.1111/j.1742-4658.2010.07588.x; Kolodny E H, 1982, Prog Clin Biol Res, V95, P33; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; PasmanikChor M, 1996, BIOCHEM MOL MED, V59, P125, DOI 10.1006/bmme.1996.0077; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2006, J LIPID RES, V47, P2161, DOI 10.1194/jlr.M600239-JLR200; Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019037; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TSUJI A, 1988, J BIOCHEM-TOKYO, V104, P276, DOI 10.1093/oxfordjournals.jbchem.a122457; VACCARO AM, 1985, EUR J BIOCHEM, V146, P315, DOI 10.1111/j.1432-1033.1985.tb08655.x; VOLK BW, 1967, J NEUROPATH EXP NEUR, V26, P176; Wei RR, 2011, J BIOL CHEM, V286, P299, DOI 10.1074/jbc.M110.150433; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 1996, PEDIATR RES, V39, P313, DOI 10.1203/00006450-199602000-00021; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x	33	74	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4275	4287		10.1074/jbc.M111.280016	http://dx.doi.org/10.1074/jbc.M111.280016			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167193	Green Published, hybrid			2022-12-25	WOS:000300410900059
J	Bayro, MJ; Daviso, E; Belenky, M; Griffin, RG; Herzfeld, J				Bayro, Marvin J.; Daviso, Eugenio; Belenky, Marina; Griffin, Robert G.; Herzfeld, Judith			An Amyloid Organelle, Solid-state NMR Evidence for Cross-beta Assembly of Gas Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; PROTEIN; FIBRILS; HYDROPHOBIN; DISEASE; GVPA	Functional amyloids have been identified in a wide range of organisms, taking on a variety of biological roles and being controlled by remarkable mechanisms of directed assembly. Here, we report that amyloid fibrils constitute the ribs of the buoyancy organelles of Anabaena flos-aquae. The walls of these gas-filled vesicles are known to comprise a single protein, GvpA, arranged in a low pitch helix. However, the tertiary and quaternary structures have been elusive. Using solid-state NMR correlation spectroscopy we find detailed evidence for an extended cross-beta structure. This amyloid assembly helps to account for the strength and amphiphilic properties of the vesicle wall. Buoyancy organelles thus dramatically extend the scope of known functional amyloids.	[Daviso, Eugenio; Belenky, Marina; Herzfeld, Judith] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Bayro, Marvin J.; Griffin, Robert G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bayro, Marvin J.; Daviso, Eugenio; Griffin, Robert G.] MIT, Francis Bitter Magnet Lab, Cambridge, MA 02139 USA	Brandeis University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Herzfeld, J (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02454 USA.	herzfeld@brandeis.edu	Bayro, Marvin/Q-4643-2016	Bayro, Marvin/0000-0003-1482-9381	National Institutes of Health [EB001035, EB003151, EB002026]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001035, P41EB002026, R01EB003151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants EB001035, EB003151, and EB002026.	Bayro MJ, 2010, BIOCHEMISTRY-US, V49, P7474, DOI 10.1021/bi100864t; Bayro MJ, 2009, ANGEW CHEM INT EDIT, V48, P5708, DOI 10.1002/anie.200901520; Belenky M, 2004, BIOPHYS J, V86, P499, DOI 10.1016/S0006-3495(04)74128-4; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; BLAUROCK AE, 1976, J MOL BIOL, V105, P183, DOI 10.1016/0022-2836(76)90106-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; De Paepe G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3036928; de Vocht ML, 2000, J BIOL CHEM, V275, P28428, DOI 10.1074/jbc.M000691200; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; JOST M, 1970, CAN J MICROBIOL, V16, P159, DOI 10.1139/m70-028; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; McMaster TJ, 1996, BIOPHYS J, V70, P2432, DOI 10.1016/S0006-3495(96)79813-2; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Offner S, 1998, MICROBIOL-UK, V144, P1331, DOI 10.1099/00221287-144-5-1331; Otzen D, 2008, CELL MOL LIFE SCI, V65, P910, DOI 10.1007/s00018-007-7404-4; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Sivertsen AC, 2010, BIOPHYS J, V99, P1932, DOI 10.1016/j.bpj.2010.06.041; Sivertsen AC, 2009, J MOL BIOL, V387, P1032, DOI 10.1016/j.jmb.2009.02.015; Smith AM, 2010, MACROMOL CHEM PHYS, V211, P127, DOI 10.1002/macp.200900420; Strunk T, 2011, MOL MICROBIOL, V81, P56, DOI 10.1111/j.1365-2958.2011.07669.x; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994	36	30	31	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3479	3484		10.1074/jbc.M111.313049	http://dx.doi.org/10.1074/jbc.M111.313049			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22147705	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000300295100052
J	Kogai, T; Liu, YY; Mody, K; Shamsian, DV; Brent, GA				Kogai, Takahiko; Liu, Yan-Yun; Mody, Kaizeen; Shamsian, Deborah V.; Brent, Gregory A.			Regulation of Sodium Iodide Symporter Gene Expression by Rac1/p38 beta Mitogen-activated Protein Kinase Signaling Pathway in MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-STIMULATING HORMONE; SODIUM/IODIDE SYMPORTER; RETINOIC ACID; SELECTIVE ACTIVATION; RADIOIODIDE UPTAKE; NIS; RADIOVIROTHERAPY; TRANSPORTER; INHIBITION; PROSTATE	Activation of p38 MAPK is a key pathway for cell proliferation and differentiation in breast cancer and thyroid cells. The sodium/iodide symporter (NIS) concentrates iodide in the thyroid and lactating breast. All-trans-retinoic acid (tRA) markedly induces NIS activity in some breast cancer cell lines and promotes uptake of beta-emitting radioiodide I-131 sufficient for targeted cytotoxicity. To identify a signal transduction pathway that selectively stimulates NIS expression, we investigated regulation by the Rac1-p38 signaling pathway in MCF-7 breast cancer cells and compared it with regulation in FRTL-5 rat thyroid cells. Loss of function experiments with pharmacologic inhibitors and small interfering RNA, as well as RT-PCR analysis of p38 isoforms, demonstrated the requirement of Rac1, MAPK kinase 3B, and p38 beta for the full expression of NIS in MCF-7 cells. In contrast, p38 alpha was critical for NIS expression in FRTL-5 cells. Treatment with tRA or overexpression of Rac1 induced the phosphorylation of p38 isoforms, including p38 beta. A dominant negative mutant of Rac1 abolished tRA-induced phosphorylation in MCF-7 cells. Overexpression of p38 beta or Rac1 significantly enhanced (1.9- and 3.9-fold, respectively), the tRA-stimulated NIS expression in MCF-7 cells. This study demonstrates differential regulation of NIS by distinct p38 isoforms in breast cancer cells and thyroid cells. Targeting isoform-selective activation of p38 may enhance NIS induction, resulting in higher efficacy of I-131 concentration and treatment of breast cancer.	[Kogai, Takahiko; Brent, Gregory A.] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kogai, T (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Bldg 114,Rm 229,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	tkogai@ucla.edu; gbrent@ucla.edu			National Institutes of Health [RO1 CA089364]; Veterans Affairs Merit Review Funds; NATIONAL CANCER INSTITUTE [R01CA089364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Funds(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA089364 (to G. A. B.). This work was also supported by Veterans Affairs Merit Review Funds.	Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Barros LF, 1997, J PHYSIOL-LONDON, V504, P517, DOI 10.1111/j.1469-7793.1997.517bd.x; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Boelaert K, 2003, LANCET, V361, P796, DOI 10.1016/S0140-6736(03)12720-1; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Ju HS, 2002, J PHARMACOL EXP THER, V301, P15, DOI 10.1124/jpet.301.1.15; Klutz K, 2011, HUM GENE THER, V22, P1403, DOI 10.1089/hum.2010.158; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Kogai T, 1997, ENDOCRINOLOGY, V138, P2227, DOI 10.1210/en.138.6.2227; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; Kogai T, 2005, ENDOCRINOLOGY, V146, P3059, DOI 10.1210/en.2004-1334; Kogai T, 2004, CANCER RES, V64, P415, DOI 10.1158/0008-5472.CAN-03-2285; Kogai T, 2003, BREAST CANCER RES TR, V78, P119, DOI 10.1023/A:1022179717847; Kogai T, 2008, J ENDOCRINOL, V199, P243, DOI [10.1677/JOE-08-0333, 10.1677/JOE-08-0333e]; Kogai T, 2008, J CLIN ENDOCR METAB, V93, P1884, DOI 10.1210/jc.2007-1627; Munoz L, 2010, EUR J PHARMACOL, V635, P212, DOI 10.1016/j.ejphar.2010.02.037; Ohashi E, 2009, CANCER RES, V69, P3443, DOI 10.1158/0008-5472.CAN-08-3234; Penheiter AR, 2010, AM J ROENTGENOL, V195, P341, DOI 10.2214/AJR.09.3672; Pomerance M, 2003, MOL ENDOCRINOL, V17, P2283, DOI 10.1210/me.2002-0400; Pomerance M, 2000, J BIOL CHEM, V275, P40539, DOI 10.1074/jbc.M002097200; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Riesco-Eizaguirre G, 2011, J CLIN ENDOCR METAB, V96, pE1435, DOI 10.1210/jc.2010-2373; Schmutzler C, 1997, BIOCHEM BIOPH RES CO, V240, P832, DOI 10.1006/bbrc.1997.7715; Tanosaki S, 2003, BREAST CANCER RES TR, V79, P335, DOI 10.1023/A:1024064424855; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Trujillo MA, 2010, GENE THER, V17, P1325, DOI 10.1038/gt.2010.63; Unterholzner S, 2006, J CLIN ENDOCR METAB, V91, P69, DOI 10.1210/jc.2005-0779; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Wapnir IL, 2003, J CLIN ENDOCR METAB, V88, P1880, DOI 10.1210/jc.2002-021544; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Welcsh PL, 2000, NATURE, V406, P688, DOI 10.1038/35021173	37	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3292	3300		10.1074/jbc.M111.315523	http://dx.doi.org/10.1074/jbc.M111.315523			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157753	Green Published, hybrid			2022-12-25	WOS:000300295100035
J	Zuo, XP; Sheng, JP; Lau, HT; McDonald, CM; Andrade, M; Cullen, DE; Bell, FT; Iacovino, M; Kyba, M; Xu, GL; Li, XJ				Zuo, Xiaopan; Sheng, Jipo; Lau, Ho-Tak; McDonald, Carol M.; Andrade, Monica; Cullen, Dana E.; Bell, Fong T.; Iacovino, Michelina; Kyba, Michael; Xu, Guoliang; Li, Xiajun			Zinc Finger Protein ZFP57 Requires Its Co-factor to Recruit DNA Methyltransferases and Maintains DNA Methylation Imprint in Embryonic Stem Cells via Its Transcriptional Repression Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; RNAI SCREEN; EFFECT GENE; INSIGHTS; HETEROCHROMATIN; COREPRESSOR; PATTERNS; DNMT3L; PHD; RECONSTITUTION	Previously, we discovered that ZFP57 is a maternal-zygotic effect gene, and it maintains DNA methylation genomic imprint at multiple imprinted regions in mouse embryos. Despite these findings, it remains elusive how DNA methyltransferases are targeted to the imprinting control regions to initiate and maintain DNA methylation imprint. To gain insights into these essential processes in genomic imprinting, we examined how ZFP57 maintains genomic DNA methylation imprint in mouse embryonic stem (ES) cells. Here we demonstrate that the loss of ZFP57 in mouse ES cells led to a complete loss of genomic DNA methylation imprint at multiple imprinted regions, similar to its role in mouse embryos. However, reintroduction of ZFP57 into Zfp57-null ES cells did not result in reacquisition of DNA methylation imprint, suggesting that the memory for genomic imprinting had been lost or altered in Zfp57-null ES cells in culture. Interestingly, ZFP57 and DNA methyltransferases could form complexes in the presence of KAP1/TRIM28/TIF1 beta when co-expressed in COS cells. We also found that the wildtype exogenous ZFP57 but not the mutant ZFP57 lacking the KRAB box that interacts with its co-factor KAP1/TRIM28/TIF1 beta could substitute for the endogenous ZFP57 in maintaining the DNA methylation imprint in ES cells. These results suggest that ZFP57 may recruit DNA methyltransferases to its target regions to maintain DNA methylation imprint, and this interaction is likely facilitated by KAP1/TRIM28/TIF1 beta.	[Zuo, Xiaopan; Sheng, Jipo; Lau, Ho-Tak; McDonald, Carol M.; Andrade, Monica; Cullen, Dana E.; Bell, Fong T.; Li, Xiajun] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Iacovino, Michelina; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Iacovino, Michelina; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Xu, Guoliang] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, XJ (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	Xiajun.li@mssm.edu	zuo, xiaopan/B-7991-2013	iacovino, michelina/0000-0002-1076-3146; Kyba, Michael/0000-0002-5579-7534	National Institutes of Health [GM093335]; March of Dimes Basil O'Connor Starter Research Award; New York State NYSTEM [C026434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor Starter Research Award; New York State NYSTEM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM093335 (to X. L.). This work was also supported in part by the March of Dimes Basil O'Connor Starter Research Award (to X. L.) and New York State NYSTEM Contract C026434 (to X. L.).	Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Ben-Porath I, 2000, CURR OPIN GENET DEV, V10, P550, DOI 10.1016/S0959-437X(00)00126-X; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Borowczyk E, 2009, P NATL ACAD SCI USA, V106, P20806, DOI 10.1073/pnas.0905668106; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hata K, 2002, DEVELOPMENT, V129, P1983; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jones MJ, 2011, MOL CELL BIOL, V31, P2827, DOI 10.1128/MCB.01435-10; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Li XJ, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-37; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li XJ, 2010, MOL HUM REPROD, V16, P695, DOI 10.1093/molehr/gaq028; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; Matsuda E, 2001, J BIOL CHEM, V276, P14222, DOI 10.1074/jbc.M010663200; Murakami K, 2011, DEVELOPMENT, V138, P197, DOI 10.1242/dev.056606; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Peng J, 2008, TRENDS BIOCHEM SCI, V33, P191, DOI 10.1016/j.tibs.2008.02.003; Reik W, 2004, COLD SPRING HARB SYM, V69, P29, DOI 10.1101/sqb.2004.69.29; Renfree MB, 2009, ANNU REV GENOM HUM G, V10, P241, DOI 10.1146/annurev-genom-082908-150026; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schumacher A, 2004, NUCLEIC ACIDS RES, V32, P1566, DOI 10.1093/nar/gkh322; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Tucker KL, 1996, P NATL ACAD SCI USA, V93, P12920, DOI 10.1073/pnas.93.23.12920; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416	60	123	128	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2107	2118		10.1074/jbc.M111.322644	http://dx.doi.org/10.1074/jbc.M111.322644			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22144682	Green Published, hybrid			2022-12-25	WOS:000299321000051
J	Marks, DS; Colwell, LJ; Sheridan, R; Hopf, TA; Pagnani, A; Zecchina, R; Sander, C				Marks, Debora S.; Colwell, Lucy J.; Sheridan, Robert; Hopf, Thomas A.; Pagnani, Andrea; Zecchina, Riccardo; Sander, Chris			Protein 3D Structure Computed from Evolutionary Sequence Variation	PLOS ONE			English	Article							ALL-ATOM REFINEMENT; STRUCTURE PREDICTION; RESIDUE CONTACTS; INFORMATION; RESOLUTION; NETWORKS; CONFORMATION; BOTTLENECKS; PROGRESS; DYNAMICS	The evolutionary trajectory of a protein through sequence space is constrained by its function. Collections of sequence homologs record the outcomes of millions of evolutionary experiments in which the protein evolves according to these constraints. Deciphering the evolutionary record held in these sequences and exploiting it for predictive and engineering purposes presents a formidable challenge. The potential benefit of solving this challenge is amplified by the advent of inexpensive high-throughput genomic sequencing. In this paper we ask whether we can infer evolutionary constraints from a set of sequence homologs of a protein. The challenge is to distinguish true co-evolution couplings from the noisy set of observed correlations. We address this challenge using a maximum entropy model of the protein sequence, constrained by the statistics of the multiple sequence alignment, to infer residue pair couplings. Surprisingly, we find that the strength of these inferred couplings is an excellent predictor of residue-residue proximity in folded structures. Indeed, the top-scoring residue couplings are sufficiently accurate and well-distributed to define the 3D protein fold with remarkable accuracy. We quantify this observation by computing, from sequence alone, all-atom 3D structures of fifteen test proteins from different fold classes, ranging in size from 50 to 260 residues., including a G-protein coupled receptor. These blinded inferences are de novo, i.e., they do not use homology modeling or sequence-similar fragments from known structures. The co-evolution signals provide sufficient information to determine accurate 3D protein structure to 2.7-4.8 A Ca-RMSD error relative to the observed structure, over at least two-thirds of the protein (method called EVfold, details at http://EVfold.org). This discovery provides insight into essential interactions constraining protein evolution and will facilitate a comprehensive survey of the universe of protein structures, new strategies in protein and drug design, and the identification of functional genetic variants in normal and disease genomes.	[Marks, Debora S.; Hopf, Thomas A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Colwell, Lucy J.] MRC Lab Mol Biol, Cambridge, England; [Sheridan, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Pagnani, Andrea; Zecchina, Riccardo] Human Genet Fdn, Turin, Italy; [Zecchina, Riccardo] Politecn Torino, Turin, Italy	Harvard University; Harvard Medical School; MRC Laboratory Molecular Biology; Memorial Sloan Kettering Cancer Center; Polytechnic University of Turin	Marks, DS (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	foldingproteins@cbio.mskcc.org	Pagnani, Andrea/J-2363-2015	Pagnani, Andrea/0000-0002-6509-0807; ZECCHINA, Riccardo/0000-0002-1221-5207	Dana Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center [NIH U54-CA143798]; Engineering and Physical Sciences Research Council [EP/H028064/1]; German National Academic Foundation; European Community [267915]; EPSRC [EP/H028064/1] Funding Source: UKRI; MRC [MC_U105161047] Funding Source: UKRI; Medical Research Council [MC_U105161047] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	Dana Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); German National Academic Foundation; European Community(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CS and RS have support from the Dana Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center (NIH U54-CA143798). LC is supported by an Engineering and Physical Sciences Research Council fellowship (EP/H028064/1). TH has support from the German National Academic Foundation. RZ has support from European Community grant 267915. No other financial support was received for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1988, PROTEIN ENG, V2, P193, DOI 10.1093/protein/2.3.193; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Bradley P, 2003, PROTEINS, V53, P457, DOI 10.1002/prot.10552; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; CHOTHIA C, 1973, J MOL BIOL, V75, P295, DOI 10.1016/0022-2836(73)90022-3; Cozzetto D, 2005, FEBS J, V272, P881, DOI 10.1111/j.1742-4658.2005.04549.x; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; DeBartolo J, 2009, P NATL ACAD SCI USA, V106, P3734, DOI 10.1073/pnas.0811363106; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Duan Y, 1998, P NATL ACAD SCI USA, V95, P9897, DOI 10.1073/pnas.95.17.9897; Duarte JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-283; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Giraud BG, 1999, PHYS REV E, V59, P4983, DOI 10.1103/PhysRevE.59.4983; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HAVEL TF, 1983, J THEOR BIOL, V104, P359, DOI 10.1016/0022-5193(83)90112-1; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Joost P, 2002, GENOME BIOL, V3; Kamat AP, 2007, PROTEINS, V66, P869, DOI 10.1002/prot.21241; Kappen HJ, 1998, NEURAL COMPUT, V10, P1137, DOI 10.1162/089976698300017386; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kolesov G, 2007, NUCLEIC ACIDS RES, V35, pW425, DOI 10.1093/nar/gkm312; Kryshtafovych A, 2005, PROTEINS, V61, P225, DOI 10.1002/prot.20740; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; Liu LC, 1999, MONOGRAPH SERIES I M, P236; Locasale JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006522; Mezard M, 2009, J PHYSIOL-PARIS, V103, P107, DOI 10.1016/j.jphysparis.2009.05.013; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Miyano M, 2001, Tanpakushitsu Kakusan Koso, V46, P687; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Morea V, 1997, BIOPHYS CHEM, V68, P9, DOI 10.1016/S0301-4622(96)02266-1; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589; Nair Rajesh, 2009, Journal of Structural and Functional Genomics, V10, P181, DOI 10.1007/s10969-008-9055-6; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ortiz AR, 1998, P NATL ACAD SCI USA, V95, P1020, DOI 10.1073/pnas.95.3.1020; Ortiz AR, 1999, PROTEINS, P177; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313; Qiu J, 2008, PROTEINS, V71, P1175, DOI 10.1002/prot.21809; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Ravikumar P, 2010, ANN STAT, V38, P1287, DOI 10.1214/09-AOS691; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Roudi Y, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.022.2009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sathyapriya R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000584; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schrodinger L., 2020, PYMOL; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Sessak V, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/5/055001; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; Simons KT, 1999, PROTEINS, P171; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skolnick J, 1997, J MOL BIOL, V265, P217, DOI 10.1006/jmbi.1996.0720; Taylor WR, 2007, COMPUT BIOL CHEM, V31, P151, DOI 10.1016/j.compbiolchem.2007.03.002; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wu S, 2008, BIOINFORMATICS, V24, P924, DOI 10.1093/bioinformatics/btn069; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Yang JS, 2007, STRUCTURE, V15, P53, DOI 10.1016/j.str.2006.11.010; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang Y, 2005, PROTEINS, V61, P91, DOI 10.1002/prot.20724; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	80	683	697	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28766	10.1371/journal.pone.0028766	http://dx.doi.org/10.1371/journal.pone.0028766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163331	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900067
J	Takeda, A; Takada, S; Nakamura, M; Suzuki, M; Tamano, H; Ando, M; Oku, N				Takeda, Atsushi; Takada, Shunsuke; Nakamura, Masatoshi; Suzuki, Miki; Tamano, Haruna; Ando, Masaki; Oku, Naoto			Transient Increase in Zn2+ in Hippocampal CA1 Pyramidal Neurons Causes Reversible Memory Deficit	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; OBJECT-RECOGNITION; CHELATABLE ZINC; MODULATION; CLIOQUINOL; CHANNELS; AMYGDALA; ACCUMULATION; IMPAIRMENT	The translocation of synaptic Zn2+ to the cytosolic compartment has been studied to understand Zn2+ neurotoxicity in neurological diseases. However, it is unknown whether the moderate increase in Zn2+ in the cytosolic compartment affects memory processing in the hippocampus. In the present study, the moderate increase in cytosolic Zn2+ in the hippocampus was induced with clioquinol (CQ), a zinc ionophore. Zn2+ delivery by Zn-CQ transiently attenuated CA1 long-term potentiation (LTP) in hippocampal slices prepared 2 h after i.p. injection of Zn-CQ into rats, when intracellular Zn2+ levels was transiently increased in the CA1 pyramidal cell layer, followed by object recognition memory deficit. Object recognition memory was transiently impaired 30 min after injection of ZnCl2 into the CA1, but not after injection into the dentate gyrus that did not significantly increase intracellular Zn2+ in the granule cell layer of the dentate gyrus. Object recognition memory deficit may be linked to the preferential increase in Zn2+ and/or the preferential vulnerability to Zn2+ in CA1 pyramidal neurons. In the case of the cytosolic increase in endogenous Zn2+ in the CA1 induced by 100 mM KCl, furthermore, object recognition memory was also transiently impaired, while ameliorated by co-injection of CaEDTA to block the increase in cytosolic Zn2+. The present study indicates that the transient increase in cytosolic Zn2+ in CA1 pyramidal neurons reversibly impairs object recognition memory.	[Takeda, Atsushi; Takada, Shunsuke; Nakamura, Masatoshi; Suzuki, Miki; Tamano, Haruna; Ando, Masaki; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, Shizuoka 4228526, Japan	University of Shizuoka	Takeda, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, Global COE-21, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172	Global COE	Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The source of funding is Global COE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aggleton JP, 2005, Q J EXP PSYCHOL-B, V58, P218, DOI 10.1080/02724990444000131; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Ando M, 2010, NEUROCHEM INT, V57, P608, DOI 10.1016/j.neuint.2010.07.010; Bareggi SR, 2009, BRAIN RES, V1280, P195, DOI 10.1016/j.brainres.2009.05.031; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Dias CP, 2007, NEUROSCIENCE, V146, P1719, DOI 10.1016/j.neuroscience.2007.03.018; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; Howland JG, 2008, PROG BRAIN RES, V169, P145, DOI 10.1016/S0079-6123(07)00008-8; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Krezel A, 2008, J BIOL INORG CHEM, V13, P401, DOI 10.1007/s00775-007-0330-y; Krezel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P188, DOI 10.1016/j.abb.2007.02.017; Lee JY, 2000, J NEUROSCI, V20; Lengyel I, 2000, J NEUROCHEM, V75, P594, DOI 10.1046/j.1471-4159.2000.0750594.x; Liu J, 1999, J NEUROSCI, V19, P8292; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; MURRAY EA, 1984, J NEUROSCI, V4, P2565; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Qian J, 2011, J NEUROSCI, V31, P97, DOI 10.1523/JNEUROSCI.5162-10.2011; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Sekler I, 2002, J COMP NEUROL, V447, P201, DOI 10.1002/cne.10224; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Takeda A, 2003, J NEUROSCI RES, V72, P537, DOI 10.1002/jnr.10600; Takeda A, 2010, NEUROSCIENCE, V171, P443, DOI 10.1016/j.neuroscience.2010.09.017; Takeda A, 2009, NEUROSCIENCE, V158, P585, DOI 10.1016/j.neuroscience.2008.10.009; Takeda A., 2011, INT J ALZHEIMERS DIS, V2011; Takeda A, 2008, J NEUROSCI RES, V86, P2906, DOI 10.1002/jnr.21732; Takeda A, 2007, J NEUROSCI RES, V85, P3666, DOI 10.1002/jnr.21449; Takeda A, 2007, J NEUROSCI RES, V85, P1310, DOI 10.1002/jnr.21233; Takeda A, 2006, J NEUROCHEM, V99, P670, DOI 10.1111/j.1471-4159.2006.04092.x; Takeda A, 2011, MOL NEUROBIOL, V44, P166, DOI 10.1007/s12035-010-8158-9; Takeda A, 2010, BRAIN RES, V1354, P188, DOI 10.1016/j.brainres.2010.07.039; Takeda A, 2010, BRAIN RES, V1323, P59, DOI 10.1016/j.brainres.2010.01.085; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Takeda A, 2009, NEUROTOXICOLOGY, V30, P712, DOI 10.1016/j.neuro.2009.05.009; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; ZOLAMORGAN S, 1982, SCIENCE, V218, P1337, DOI 10.1126/science.6890713	55	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28615	10.1371/journal.pone.0028615	http://dx.doi.org/10.1371/journal.pone.0028615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163318	gold, Green Submitted, Green Published			2022-12-25	WOS:000298161900054
J	Althen, H; Grimm, S; Escera, C				Althen, Heike; Grimm, Sabine; Escera, Carles			Fast Detection of Unexpected Sound Intensity Decrements as Revealed by Human Evoked Potentials	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; AUDITORY BRAIN-STEM; MISMATCH NEGATIVITY; MIDDLE-LATENCY; INFERIOR COLLICULUS; ANESTHETIZED RAT; CORTICAL-NEURONS; SENSORY MEMORY; RESPONSES; CORTEX	The detection of deviant sounds is a crucial function of the auditory system and is reflected by the automatically elicited mismatch negativity (MMN), an auditory evoked potential at 100 to 250 ms from stimulus onset. It has recently been shown that rarely occurring frequency and location deviants in an oddball paradigm trigger a more negative response than standard sounds at very early latencies in the middle latency response of the human auditory evoked potential. This fast and early ability of the auditory system is corroborated by the finding of neurons in the animal auditory cortex and subcortical structures, which restore their adapted responsiveness to standard sounds, when a rare change in a sound feature occurs. In this study, we investigated whether the detection of intensity deviants is also reflected at shorter latencies than those of the MMN. Auditory evoked potentials in response to click sounds were analyzed regarding the auditory brain stem response, the middle latency response (MLR) and the MMN. Rare stimuli with a lower intensity level than standard stimuli elicited (in addition to an MMN) a more negative potential in the MLR at the transition from the Na to the Pa component at circa 24 ms from stimulus onset. This finding, together with the studies about frequency and location changes, suggests that the early automatic detection of deviant sounds in an oddball paradigm is a general property of the auditory system.	[Althen, Heike; Grimm, Sabine; Escera, Carles] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain; [Althen, Heike; Grimm, Sabine; Escera, Carles] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Cognit Neurosci Res Grp, Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona	Althen, H (corresponding author), Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain.	cescera@ub.edu	Althen, Heike/E-2435-2016; Escera, Carles/A-8658-2010; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Grimm, Sabine/AAO-1547-2021	Escera, Carles/0000-0001-8203-2951; Grimm, Sabine/0000-0002-9071-5944	Consolider-Ingenio [CDS2007-00012]; Spanish Ministry of Science and Innovation [PSI2009-08063]; Bial Foundation (Portugal) [37/10]; Catalan Government [SGR2009-11]; ICREA	Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Bial Foundation (Portugal)(Bial Foundation); Catalan Government; ICREA(ICREA)	This work was supported by the program Consolider-Ingenio 2010 (CDS2007-00012), the National Program for Fundamental Research (PSI2009-08063) from the Spanish Ministry of Science and Innovation, the Bial Foundation (Portugal, grant #37/10), a grant from the Catalan Government (SGR2009-11), and an ICREA Academia Distinguished Professorship awarded to C. E. URLs: http://www.ingenio2010.es/contenido.asp?menu1=&menu2=&menu2=&menu3=&menu3=&dir=./02_instrumentos/02_Caracteristicas/01_CONSOLIDER&id=En. http://www.micinn.es/portal/site/MICINN/menuitem.00d7c011ca2a3753222b7d1001432ea0/?vgnextoid=33881f4368aef110VgnVCM1000001034e20aRCRD&lang_choosen=en. http://www.bial.com/en/bial_foundation.11.html. http://www.gencat.cat/index_eng.htm. http://www.icrea.cat/web/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Borgmann C, 2001, HEARING RES, V158, P57, DOI 10.1016/S0378-5955(01)00292-1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUCHWALD JS, 1981, BRAIN RES, V205, P91, DOI 10.1016/0006-8993(81)90722-8; BUTLER RA, 1968, J ACOUST SOC AM, V44, P945, DOI 10.1121/1.1911233; CSEPE V, 1995, EAR HEARING, V16, P91, DOI 10.1097/00003446-199502000-00007; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; ELBERLING C, 1987, J ACOUST SOC AM, V81, P115, DOI 10.1121/1.395019; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Grimm S, BIOL PSYCHO IN PRESS; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; HECOX K, 1974, ARCH OTOLARYNGOL, V99, P30; Jacobsen T, 2003, AUDIOL NEURO-OTOL, V8, P338, DOI 10.1159/000073518; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; Malmierca MS, 2011, AUDITORY CORTEX, P189, DOI 10.1007/978-1-4419-0074-6_9; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malmierca MS, 2005, NEUROSCIENCE, V136, P883, DOI 10.1016/j.neuroscience.2005.04.040; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; MCFADDEN D, 1975, J ACOUST SOC AM, V57, P702, DOI 10.1121/1.380496; Naatanen R, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P125; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1989, NEUROSCI LETT, V98, P217, DOI 10.1016/0304-3940(89)90513-2; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; PAAVILAINEN P, 1993, BIOL PSYCHOL, V35, P139, DOI 10.1016/0301-0511(93)90010-6; Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Picton TW, 2011, HUMAN AUDITORY EVOKE, P213; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Sabri M, 2001, COGNITIVE BRAIN RES, V12, P171, DOI 10.1016/S0926-6410(01)00026-X; Schroger E, 2007, J PSYCHOPHYSIOL, V21, P138, DOI 10.1027/0269-8803.21.34.138; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Sonnadara RR, 2006, BRAIN RES, V1076, P187, DOI 10.1016/j.brainres.2005.12.093; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Verhey JL, 2002, J ACOUST SOC AM, V111, P1349, DOI 10.1121/1.1451065; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; WOODS DL, 1987, ELECTROEN CLIN NEURO, V68, P132, DOI 10.1016/0168-5597(87)90040-2; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yvert B, 2005, NEUROIMAGE, V28, P140, DOI 10.1016/j.neuroimage.2005.05.056; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411	47	51	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28522	10.1371/journal.pone.0028522	http://dx.doi.org/10.1371/journal.pone.0028522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163029	gold, Green Published			2022-12-25	WOS:000298173500029
J	Catala-Rabasa, A; Ndagire, D; Sabio, JM; Fedetz, M; Matesanz, F; Alcina, A				Catala-Rabasa, Antonio; Ndagire, Dorothy; Sabio, Jose Mario; Fedetz, Maria; Matesanz, Fuencisla; Alcina, Antonio			High ACSL5 Transcript Levels Associate with Systemic Lupus Erythematosus and Apoptosis in Jurkat T Lymphocytes and Peripheral Blood Cells	PLOS ONE			English	Article							ACYL-COA SYNTHETASE-5; IMPAIRED EXPRESSION; DISEASE-ACTIVITY; ACID; CARDIOLIPIN; CYTOKINE; GENES; DEATH; MICE	Background: Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease in which increased apoptosis and decreased apoptotic cells removal has been described as most relevant in the pathogenesis. Long-chain acyl-coenzyme A synthetases (ACSLs) have been involved in the immunological dysfunction of mouse models of lupus-like autoimmunity and apoptosis in different in vitro cell systems. The aim of this work was to assess among the ACSL isoforms the involvement of ACSL2, ACSL4 and ACSL5 in SLE pathogenesis. Findings: With this end, we determined the ACSL2, ACSL4 and ACSL5 transcript levels in peripheral blood mononuclear cells (PBMCs) of 45 SLE patients and 49 healthy controls by quantitative real time-PCR (q-PCR). We found that patients with SLE had higher ACSL5 transcript levels than healthy controls [median (range), healthy controls = 16.5 (12.3-18.0) vs. SLE = 26.5 (17.8-41.7), P = 3.9x10 E-5] but no differences were found for ACSL2 and ACSL4. In in vitro experiments, ACSL5 mRNA expression was greatly increased when inducing apoptosis in Jurkat T cells and PBMCs by Phorbol-Myristate-Acetate plus Ionomycin (PMA+Io). On the other hand, short interference RNA (siRNA)-mediated silencing of ACSL5 decreased induced apoptosis in Jurkat T cells up to the control levels as well as decreased mRNA expression of FAS, FASLG and TNF. Conclusions: These findings indicate that ACSL5 may play a role in the apoptosis that takes place in SLE. Our results point to ACSL5 as a potential novel functional marker of pathogenesis and a possible therapeutic target in SLE.	[Catala-Rabasa, Antonio; Ndagire, Dorothy; Fedetz, Maria; Matesanz, Fuencisla; Alcina, Antonio] IPBLN CSIC, Dept Cell Biol & Immunol, Granada, Spain; [Sabio, Jose Mario] Hosp Univ Virgen Nieves, Med Interna Serv, Unidad Enfermedades Autoinmunes Sistem, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Virgen de las Nieves	Catala-Rabasa, A (corresponding author), IPBLN CSIC, Dept Cell Biol & Immunol, Granada, Spain.	jmsabio@gmail.com; lindo@ipb.csic.es; pulgoso@ipb.csic.es	Alcina, Antonio/T-1893-2017; Matesanz, Fuencisla/F-3715-2016	Alcina, Antonio/0000-0001-7294-0948; Matesanz, Fuencisla/0000-0002-9429-1819	Ministerio de Ciencia e Innovacion-Fondos Feder [PN-SAF2009-11491]; Junta de Andalucia [P07-CVI-02551]; Fondo de Investigacion Sanitaria [FIS PI081636, CP10/00526]	Ministerio de Ciencia e Innovacion-Fondos Feder(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	Financial support for the study was provided by the Ministerio de Ciencia e Innovacion-Fondos Feder (PN-SAF2009-11491) and Junta de Andalucia (P07-CVI-02551) to A. Alcina and Fondo de Investigacion Sanitaria (FIS PI081636, CP10/00526) to F. Matesanz. M. Fedetz and D. Ndagire are holders of a fellowship from Fundacion Espanola de Esclerosis Multiple (FEDEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P141, DOI 10.1016/0925-4439(93)90103-8; Avramescu C, 2010, ROM J MORPHOL EMBRYO, V51, P633; BENNETT S, 1992, J IMMUNOL METHODS, V146, P229, DOI 10.1016/0022-1759(92)90232-I; Borba EF, 2006, CLIN DEV IMMUNOL, V13, P203, DOI 10.1080/17402520600876945; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dhir V, 2009, LUPUS, V18, P785, DOI 10.1177/0961203309103152; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Gassler N, 2005, J PATHOL, V207, P295, DOI 10.1002/path.1831; Gassler N, 2004, J PATHOL, V202, P188, DOI 10.1002/path.1504; Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iversen Nina, 2005, Genet Vaccines Ther, V3, P2, DOI 10.1186/1479-0556-3-2; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Kurien BT, 2003, LIFE SCI, V73, P1655, DOI 10.1016/S0024-3205(03)00475-2; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Liphaus BL, 2010, CLINICS, V65, P327, DOI 10.1590/S1807-59322010000300014; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashima T, 2009, ONCOGENE, V28, P9, DOI 10.1038/onc.2008.355; Mevorach D, 2003, CLIN REV ALLERG IMMU, V25, P49, DOI 10.1385/CRIAI:25:1:49; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; Obermuller N, 2006, INT J COLORECTAL DIS, V21, P130, DOI 10.1007/s00384-004-0738-6; Otaki N, 2010, J BIOL CHEM, V285, P33834, DOI 10.1074/jbc.M110.165175; Posadas-Romero C, 2004, ARTHRITIS RHEUM-US, V50, P160, DOI 10.1002/art.11472; Reinartz A, 2010, BBA-MOL CELL BIOL L, V1801, P1025, DOI 10.1016/j.bbalip.2010.04.010; Shah D, 2010, IMMUNOL LETT, V129, P7, DOI 10.1016/j.imlet.2010.01.005; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Sweeney B, 2005, PEDIATR SURG INT, V21, P335, DOI 10.1007/s00383-005-1385-x; Tait JF, 2008, J NUCL MED, V49, P1573, DOI 10.2967/jnumed.108.052803; TOMITAYAMAGUCHI M, 1990, J EXP MED, V171, P787, DOI 10.1084/jem.171.3.787; Vermes I, 1997, ACTA HAEMATOL-BASEL, V98, P8; Yahata T, 1999, EUR J IMMUNOL, V29, P727, DOI 10.1002/(SICI)1521-4141(199903)29:03<727::AID-IMMU727>3.0.CO;2-0	37	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28591	10.1371/journal.pone.0028591	http://dx.doi.org/10.1371/journal.pone.0028591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163040	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500038
J	Chang, CP; Yang, MC; Lei, HY				Chang, Chih-Peng; Yang, Ming-Chen; Lei, Huan-Yao			Concanavalin A/IFN-Gamma Triggers Autophagy-Related Necrotic Hepatocyte Death through IRGM1-Mediated Lysosomal Membrane Disruption	PLOS ONE			English	Article							CELL-DEATH; IFN-GAMMA; INTERFERON-GAMMA; APOPTOSIS; MACROPHAGES; MECHANISMS; HEPATITIS; NECROSIS; TUBERCULOSIS; ACTIVATION	Interferon-gamma (IFN-gamma), a potent Th1 cytokine with multiple biological functions, can induce autophagy to enhance the clearance of the invading microorganism or cause cell death. We have reported that Concanavalin A (Con A) can cause autophagic cell death in hepatocytes and induce both T cell-dependent and -independent acute hepatitis in immunocompetent and immunodeficient mice, respectively. Although IFN-gamma is known to enhance liver injury in Con A-induced hepatitis, its role in autophagy-related hepatocyte death is not clear. In this study we report that IFN-gamma can enhance Con A-induced autophagic flux and cell death in hepatoma cell lines. A necrotic cell death with increased lysosomal membrane permeabilization (LMP) is observed in Con A-treated hepatoma cells in the presence of IFN-gamma. Cathepsin B and L were released from lysosomes to cause cell death. Furthermore, IFN-gamma induces immunity related GTPase family M member 1(IRGM1) translocation to lysosomes and prolongs its activity in Con A-treated hepatoma cells. Knockdown of IRGM1 inhibits the IFN-gamma/Con A-induced LMP change and cell death. Furthermore, IFN-gamma(-/-) mice are resistant to Con A-induced autophagy-associated necrotic hepatocyte death. We conclude that IFN-gamma enhances Con A-induced autophagic flux and causes an IRGM1-dependent lysosome-mediated necrotic cell death in hepatocytes.	[Chang, Chih-Peng; Lei, Huan-Yao] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Yang, Ming-Chen; Lei, Huan-Yao] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chang, Chih-Peng; Lei, Huan-Yao] Natl Cheng Kung Univ, Coll Med, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chang, CP (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan.	hylei@mail.ncku.edu.tw		Chang, Chih-Peng/0000-0002-0061-3478	National Science Council, Taiwan [NSC-98-2320-B-006-031-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC-98-2320-B-006-031-MY2 from the National Science Council, Taiwan (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chang CP, 2008, INT J IMMUNOPATH PH, V21, P817, DOI 10.1177/039463200802100406; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Giammarioli AM, 2009, FEBS J, V276, P5920, DOI 10.1111/j.1742-4658.2009.07271.x; GILLES PN, 1992, HEPATOLOGY, V16, P655, DOI 10.1002/hep.1840160308; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; Khalkhali-Ellis Z, 2008, J CELL BIOCHEM, V105, P208, DOI 10.1002/jcb.21814; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Krysko DV, 2008, CELL DEATH DIFFER, V15, P29, DOI 10.1038/sj.cdd.4402271; Lei HY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-10; Li JH, 2005, J IMMUNOL, V175, P1858, DOI 10.4049/jimmunol.175.3.1858; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; Petrovski G, 2007, AUTOPHAGY, V3, P509; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Tateishi K, 2006, INT J CANCER, V118, P2237, DOI 10.1002/ijc.21658; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhao YO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008648	35	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28323	10.1371/journal.pone.0028323	http://dx.doi.org/10.1371/journal.pone.0028323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163006	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800025
J	Gomes, CM; Kohlsdorf, T				Gomes, Camilla M.; Kohlsdorf, Tiana			Evolution of Sexual Dimorphism in the Digit Ratio 2D:4D-Relationships with Body Size and Microhabitat Use in Iguanian Lizards	PLOS ONE			English	Article							EVO-DEVO; LENGTH RATIOS; ANOLIS-CAROLINENSIS; HINDLIMB KINEMATICS; ACCELERATION CAPACITY; LOCOMOTOR PERFORMANCE; TROPIDURINAE LIZARDS; INDUCED PLASTICITY; FINGER LENGTH; GREEN ANOLES	The ratio between lengths of digit II and IV (digit ratio 2D:4D) is a morphological feature that likely affects tetrapod locomotor performances in different microhabitats. Modifications of this trait may be triggered by changes in steroids concentrations during embryo development, which might reflect direct selection acting on digit ratio or be solely a consequence of hormonal differences related for example to body size. Here we apply both conventional and phylogenetic analyses on morphological data from 25 lizard species of 3 families of Iguania (Iguanidae, Polychrotidae, and Tropiduridae), in order to verify whether selective pressures related to locomotion in different microhabitats could override the prenatal developmental cues imposed on the digit ratio 2D:4D by differences in body size between males and females. Data suggest that this trait evolved in association with ecological divergence in the species studied, despite the clear effect of body size on the digit ratio 2D:4D. The ecological associations of size-corrected digit ratios were restricted to one sex, and females of species that often use perches exhibited small digit ratios in the front limbs, which translated into larger sexual dimorphism indexes of arboreal species. The results, together with the subsequent discussion, provide outlines for further investigation about possible developmental mechanisms related to the evolution of adaptive changes in digit lengths that may have occurred during the evolution of ecological divergence in squamates.	[Gomes, Camilla M.; Kohlsdorf, Tiana] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Gomes, CM (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil.	tiana@usp.br	Kohlsdorf, Tiana/C-3463-2012	Kohlsdorf, Tiana/0000-0002-3873-2042	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) [2005/60140-4]; Pro-Reitoria de Pesquisa from University of Sao Paulo, Brazil	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pro-Reitoria de Pesquisa from University of Sao Paulo, Brazil	This study was financed by a FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil) grant to TK (2005/60140-4) and an undergraduate fellowship to CMG (Pro-Reitoria de Pesquisa from University of Sao Paulo, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts P, 2000, NETH J ZOOL, V50, P261, DOI 10.1163/156854200505865; Bininda-Emonds ORP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-182; Brakefield PM, 2003, ZOOLOGY, V106, P283, DOI 10.1078/0944-2006-00124; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Brown WM, 2002, ANAT RECORD, V267, P231, DOI 10.1002/ar.10108; Buck JJ, 2003, HUM REPROD, V18, P976, DOI 10.1093/humrep/deg198; Burley NT, 2004, P ROY SOC B-BIOL SCI, V271, P239, DOI 10.1098/rspb.2003.2562; CAROTHERS JH, 1986, EVOLUTION, V40, P871, DOI 10.1111/j.1558-5646.1986.tb00550.x; Carrano MT, 1997, ZOOL J LINN SOC-LOND, V121, P77; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chang JL, 2006, CAN J ZOOL, V84, P1489, DOI 10.1139/Z06-144; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Collar DC, 2006, EVOLUTION, V60, P2575; COLLI GR, 1992, J HERPETOL, V26, P66, DOI 10.2307/1565023; Conrad JL, 2007, J PALEONTOL, V81, P1365, DOI 10.1666/06-005R.1; Corl A, 2010, EVOLUTION, V64, P79, DOI 10.1111/j.1558-5646.2009.00791.x; Eising CM, 2003, GEN COMP ENDOCR, V132, P241, DOI 10.1016/S0016-6480(03)00090-X; EMERSON SB, 1980, BIOL J LINN SOC, V13, P199, DOI 10.1111/j.1095-8312.1980.tb00082.x; EMERSON SB, 1990, EVOLUTION, V44, P1931, DOI 10.1111/j.1558-5646.1990.tb04300.x; Felsenstein J, 2004, INFERRING PHYLOGENIE, P644; Forstmeier W, 2005, P R SOC B, V272, P2641, DOI 10.1098/rspb.2005.3264; Freeman PW, 2000, EVOL ECOL RES, V2, P317; Frost DR, 2001, MOL PHYLOGENET EVOL, V21, P352, DOI 10.1006/mpev.2001.1015; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Garland T, 1999, SYST BIOL, V48, P547, DOI 10.1080/106351599260139; Gartner GEA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P43, DOI 10.1086/648509; GEBO DL, 1988, FOLIA PRIMATOL, V50, P3, DOI 10.1159/000156332; Goodman CS, 2000, P NATL ACAD SCI USA, V97, P4424, DOI 10.1073/pnas.97.9.4424; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Grizante MB, 2010, J EVOLUTION BIOL, V23, P98, DOI 10.1111/j.1420-9101.2009.01868.x; Hall BK, 2003, INT J DEV BIOL, V47, P491; Herrel A, 2002, BIOL J LINN SOC, V77, P149, DOI 10.1046/j.1095-8312.2002.00101.x; Higham TE, 2004, J EXP BIOL, V207, P233, DOI 10.1242/jeb.00763; Higham TE, 2001, J EXP BIOL, V204, P4141; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HORNBRUCH A, 1991, DEVELOPMENT, V111, P725; Irschick DJ, 2005, BIOL J LINN SOC, V85, P211, DOI 10.1111/j.1095-8312.2005.00486.x; Irschick Duncan J., 1996, Contributions to Herpetology, V12, P291; Jayne BC, 1999, J EXP BIOL, V202, P143; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Kohlsdorf T, 2008, J EVOLUTION BIOL, V21, P781, DOI 10.1111/j.1420-9101.2008.01516.x; Kohlsdorf T, 2004, J EXP BIOL, V207, P1183, DOI 10.1242/jeb.00870; Kohlsdorf T, 2001, J MORPHOL, V248, P151, DOI 10.1002/jmor.1026; Kohlsdorf T, 2007, BIOL J LINN SOC, V91, P393, DOI 10.1111/j.1095-8312.2007.00804.x; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Lannoo J.M., 1987, FIELDIANA ZOOL, V38, P1, DOI DOI 10.5962/BHL.TITLE.2932; Laurila A, 2002, OECOLOGIA, V132, P524, DOI 10.1007/s00442-002-0984-7; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Leoni B, 2005, ANAT REC PART A, V286A, P955, DOI 10.1002/ar.a.20226; Lilley T, 2010, PHYSIOL BEHAV, V99, P433, DOI 10.1016/j.physbeh.2009.11.015; Liou NS, 2008, HIST NATURAL DUAS ES; LOSOS JB, 1989, J EXP BIOL, V145, P23; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; Lovern MB, 2003, J EXP ZOOL PART A, V295A, P206, DOI 10.1002/jez.a.10225; Lovern MB, 2003, GEN COMP ENDOCR, V134, P109, DOI 10.1016/S0016-6480(03)00240-5; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; MacFadden BJ, 1997, PALEOBIOLOGY, V23, P77, DOI 10.1017/S0094837300016651; Macrini TE, 2003, J HERPETOL, V37, P52, DOI 10.1670/0022-1511(2003)037[0052:EDITCB]2.0.CO;2; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2006, ANN HUM BIOL, V33, P480, DOI 10.1080/03014460600802551; Manning JT, 2003, MED HYPOTHESES, V60, P340, DOI 10.1016/S0306-9877(02)00400-0; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT., 2002, DIGIT RATIO POINTER; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; McFadden D, 2005, HORM BEHAV, V47, P99, DOI 10.1016/j.yhbeh.2004.08.013; Melville J, 2000, BIOL J LINN SOC, V70, P667; Miller-Butterworth CM, 2003, NATURE, V424, P187, DOI 10.1038/nature01742; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Murray DL, 2002, J ZOOL, V256, P289, DOI 10.1017/S095283690200033X; O'Meara BC, 2006, EVOLUTION, V60, P922; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; PETERSON JA, 1984, J ZOOL, V202, P1; Poe S, 2004, HERPETOL MONOGR, V18, P37, DOI 10.1655/0733-1347(2004)018[0037:POA]2.0.CO;2; Pough F. H., 1998, HERPETOLOGY; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Raff RA, 2000, NAT REV GENET, V1, P74, DOI 10.1038/35049594; Relyea RA, 2005, ECOLOGY, V86, P1723, DOI 10.1890/04-1920; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Ribas SC, 2004, REV CHIL HIST NAT, V77, P599; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, ANAT REC PART A, V288A, P491, DOI 10.1002/ar.a.20323; Saino N, 2007, NATURWISSENSCHAFTEN, V94, P207, DOI 10.1007/s00114-006-0188-9; Spezzano LC, 2004, J EXP BIOL, V207, P2115, DOI 10.1242/jeb.00995; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; TICKLE C, 1994, ANNU REV CELL BIOL, V10, P121; Toro E, 2004, AM NAT, V163, P844, DOI 10.1086/386347; Tulli MJ, 2009, ZOOLOGY, V112, P379, DOI 10.1016/j.zool.2009.02.001; van Sluys M., 1992, Revista Brasileira de Biologia, V52, P181; Vanhooydonck B, 2006, J EXP BIOL, V209, P4515, DOI 10.1242/jeb.02511; Vanhooydonck B, 2006, EVOLUTION, V60, P2137, DOI 10.1111/j.0014-3820.2006.tb01851.x; VANZOLINI P E, 1979, Papeis Avulsos de Zoologia (Sao Paulo), V32, P243; Vidal N, 2004, P ROY SOC B-BIOL SCI, V271, pS226, DOI 10.1098/rsbl.2003.0151; Vitt LJ, 1997, P NATL ACAD SCI USA, V94, P3828, DOI 10.1073/pnas.94.8.3828; Wiens JJ, 2000, SYST BIOL, V49, P143, DOI 10.1080/10635150050207447; Zaaf A, 2001, ZOOMORPHOLOGY, V121, P45, DOI 10.1007/s004350100044; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x	105	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28465	10.1371/journal.pone.0028465	http://dx.doi.org/10.1371/journal.pone.0028465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162772	gold, Green Published, Green Submitted			2022-12-25	WOS:000298172800039
J	Kobayashi, T; Washiyama, K; Ikeda, K				Kobayashi, Toru; Washiyama, Kazuo; Ikeda, Kazutaka			Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Different Classes of Antidepressants	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; HERG POTASSIUM CHANNELS; IN-VIVO; FUNCTIONAL EXPRESSION; GIRK CHANNELS; TRICYCLIC ANTIDEPRESSANTS; BRAIN PHARMACOKINETICS; RELATIVE TOXICITY; MESSENGER-RNAS; FLUOXETINE	Various antidepressants are commonly used for the treatment of depression and several other neuropsychiatric disorders. In addition to their primary effects on serotonergic or noradrenergic neurotransmitter systems, antidepressants have been shown to interact with several receptors and ion channels. However, the molecular mechanisms that underlie the effects of antidepressants have not yet been sufficiently clarified. G protein-activated inwardly rectifying K+ (GIRK, Kir3) channels play an important role in regulating neuronal excitability and heart rate, and GIRK channel modulation has been suggested to have therapeutic potential for several neuropsychiatric disorders and cardiac arrhythmias. In the present study, we investigated the effects of various classes of antidepressants on GIRK channels using the Xenopus oocyte expression assay. In oocytes injected with mRNA for GIRK1/GIRK2 or GIRK1/GIRK4 subunits, extracellular application of sertraline, duloxetine, and amoxapine effectively reduced GIRK currents, whereas nefazodone, venlafaxine, mianserin, and mirtazapine weakly inhibited GIRK currents even at toxic levels. The inhibitory effects were concentration-dependent, with various degrees of potency and effectiveness. Furthermore, the effects of sertraline were voltage-independent and time-independent during each voltage pulse, whereas the effects of duloxetine were voltage-dependent with weaker inhibition with negative membrane potentials and time-dependent with a gradual decrease in each voltage pulse. However, Kir2.1 channels were insensitive to all of the drugs. Moreover, the GIRK currents induced by ethanol were inhibited by sertraline but not by intracellularly applied sertraline. The present results suggest that GIRK channel inhibition may reveal a novel characteristic of the commonly used antidepressants, particularly sertraline, and contributes to some of the therapeutic effects and adverse effects.	[Kobayashi, Toru; Washiyama, Kazuo] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Project Programs, Niigata, Japan; [Kobayashi, Toru; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Res Project Addict Subst, Tokyo 113, Japan	Niigata University; Tokyo Metropolitan Institute of Medical Science	Kobayashi, T (corresponding author), Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Project Programs, Niigata, Japan.	torukoba@bri.niigata-u.ac.jp	Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278	Ministry of Education, Culture, Sports Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by research grants from the Ministry of Education, Culture, Sports Science and Technology of Japan and the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado C, 2008, J NEUROCHEM, V105, P497, DOI 10.1111/j.1471-4159.2007.05153.x; ALTAMURA AC, 1987, PROG NEURO-PSYCHOPH, V11, P23, DOI 10.1016/0278-5846(87)90028-5; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P447; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Blednov YA, 2001, J PHARMACOL EXP THER, V298, P521; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; Bymaster FP, 2005, CURR PHARM DESIGN, V11, P1475, DOI 10.2174/1381612053764805; Bymaster FP, 2001, NEUROPSYCHOPHARMACOL, V25, P871, DOI 10.1016/S0893-133X(01)00298-6; Choi BH, 2001, NEUROPHARMACOLOGY, V41, P443, DOI 10.1016/S0028-3908(01)00088-0; Cruz HG, 2008, J NEUROSCI, V28, P4069, DOI 10.1523/JNEUROSCI.0267-08.2008; Cuellar-Quintero JL, 2001, NEUROREPORT, V12, P2195, DOI 10.1097/00001756-200107200-00030; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Deak F, 2000, NEUROPHARMACOLOGY, V39, P1029, DOI 10.1016/S0028-3908(99)00206-3; Dreixler JC, 2000, EUR J PHARMACOL, V401, P1, DOI 10.1016/S0014-2999(00)00401-5; FAN P, 1994, BRIT J PHARMACOL, V112, P741, DOI 10.1111/j.1476-5381.1994.tb13140.x; FROMMER DA, 1987, JAMA-J AM MED ASSOC, V257, P521, DOI 10.1001/jama.257.4.521; Goeringer KE, 2000, J FORENSIC SCI, V45, P633; Gray AM, 2002, EUR NEUROPSYCHOPHARM, V12, P245, DOI 10.1016/S0924-977X(02)00028-7; GULLEY JM, 1995, ALCOHOL, V12, P177, DOI 10.1016/0741-8329(94)00079-S; Harada Yoshimitsu, 2006, Folia Pharmacologica Japonica, V128, P417, DOI 10.1254/fpj.128.417; Hashimoto N, 2006, PHARMACOL RES, V54, P136, DOI 10.1016/j.phrs.2006.03.021; He YL, 2010, J PHARMACOL EXP THER, V332, P437, DOI 10.1124/jpet.109.159160; Henry ME, 2005, NEUROPSYCHOPHARMACOL, V30, P1576, DOI 10.1038/sj.npp.1300749; Henry ME, 2000, AM J PSYCHIAT, V157, P1506, DOI 10.1176/appi.ajp.157.9.1506; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hill KG, 2003, PSYCHOPHARMACOLOGY, V169, P108, DOI 10.1007/s00213-003-1472-4; Holzbach R, 1998, BIOL PSYCHIAT, V44, P925, DOI 10.1016/S0006-3223(98)00081-X; Ikeda K, 2003, METH MOLEC MED, V84, P53; Inanobe A, 1999, J NEUROSCI, V19, P1006; Isbister GK, 2004, J TOXICOL-CLIN TOXIC, V42, P277, DOI 10.1081/CLT-120037428; Karschin C, 1996, J NEUROSCI, V16, P3559; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kent J, 2000, LANCET, V355, P2000; Kobayashi T, 2004, NEUROPSYCHOPHARMACOL, V29, P1841, DOI 10.1038/sj.npp.1300484; Kobayashi T, 2000, BRIT J PHARMACOL, V129, P1716, DOI 10.1038/sj.bjp.0703224; Kobayashi T, 2003, BRIT J PHARMACOL, V138, P1119, DOI 10.1038/sj.bjp.0705172; Kobayashi T, 2002, BRIT J PHARMACOL, V135, P313, DOI 10.1038/sj.bjp.0704475; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Kobayashi T, 2006, J PHARMACOL SCI, V102, P278, DOI 10.1254/jphs.FP0060708; Kobayashi T, 2006, CURR PHARM DESIGN, V12, P4513, DOI 10.2174/138161206779010468; Kobayashi T, 2010, NEUROPSYCHOPHARMACOL, V35, P1560, DOI 10.1038/npp.2010.27; KOVOOR A, 1995, J BIOL CHEM, V270, P589, DOI 10.1074/jbc.270.2.589; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuzhikandathil EV, 2002, MOL PHARMACOL, V62, P119, DOI 10.1124/mol.62.1.119; Lee K, 1997, BRIT J PHARMACOL, V121, P1810, DOI 10.1038/sj.bjp.0701333; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Levine B, 1996, J ANAL TOXICOL, V20, P502, DOI 10.1093/jat/20.6.502; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Liao YJ, 1996, J NEUROSCI, V16, P7137; LITOVITZ TL, 1983, JAMA-J AM MED ASSOC, V250, P1069, DOI 10.1001/jama.250.8.1069; Lobo ED, 2008, CLIN PHARMACOKINET, V47, P191, DOI 10.2165/00003088-200847030-00005; Lott RS, 2003, ADV PHARMACOL, V1, P228; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Maertens C, 1999, BRIT J PHARMACOL, V126, P508, DOI 10.1038/sj.bjp.0702314; Maertens C, 2002, N-S ARCH PHARMACOL, V366, P158, DOI 10.1007/s00210-002-0567-5; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Montgomery SA, 2005, INT J CLIN PRACT, V59, P1435, DOI 10.1111/j.1368-5031.2005.00731.x; Morgan AD, 2003, NEUROPSYCHOPHARMACOL, V28, P932, DOI 10.1038/sj.npp.1300100; Musshoff F, 2004, FORENSIC SCI INT, V142, P161, DOI 10.1016/j.forsciint.2004.02.017; Nacca A, 1996, BRIT J PHARMACOL, V125, P1617; Nakazawa K, 1999, NEUROSCI LETT, V264, P93, DOI 10.1016/S0304-3940(99)00183-4; Ni YG, 1997, P NATL ACAD SCI USA, V94, P2036, DOI 10.1073/pnas.94.5.2036; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; OGATA N, 1989, BRAIN RES, V476, P140, DOI 10.1016/0006-8993(89)91546-1; Pabon A, 2000, J BIOL CHEM, V275, P30677, DOI 10.1074/jbc.M005338200; Pancrazio JJ, 1998, J PHARMACOL EXP THER, V284, P208; Pettinati HM, 2000, ALCOHOL CLIN EXP RES, V24, P1041, DOI 10.1111/j.1530-0277.2000.tb04648.x; Reimann F, 1999, CURR OPIN CELL BIOL, V11, P503, DOI 10.1016/S0955-0674(99)80073-8; Sanchez C, 1997, PSYCHOPHARMACOLOGY, V129, P197, DOI 10.1007/s002130050181; Schatzberg AF, 2000, J CLIN PSYCHIAT, V61, P9; Scherer D, 2008, N-S ARCH PHARMACOL, V378, P73, DOI 10.1007/s00210-008-0289-4; SEDGWICK P, 1982, J ANAL TOXICOL, V6, P82, DOI 10.1093/jat/6.2.82; SERNAGOR E, 1989, NEURON, V2, P1221, DOI 10.1016/0896-6273(89)90306-1; Shytle RD, 2002, MOL PSYCHIATR, V7, P525, DOI 10.1038/sj.mp.4001035; SIGEL E, 1990, J MEMBRANE BIOL, V117, P201, DOI 10.1007/BF01868451; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; TAYLOR RL, 1982, J ANAL TOXICOL, V6, P309, DOI 10.1093/jat/6.6.309; Terstappen GC, 2001, NEUROPHARMACOLOGY, V40, P772, DOI 10.1016/S0028-3908(01)00007-7; Teschemacher AG, 1999, BRIT J PHARMACOL, V128, P479, DOI 10.1038/sj.bjp.0702800; TREMAINE LM, 1989, DRUG METAB DISPOS, V17, P542; Uhr M, 2003, BIOL PSYCHIAT, V54, P840, DOI 10.1016/S0006-3223(03)00074-X; Vey EL, 2010, J FORENSIC LEG MED, V17, P175, DOI 10.1016/j.jflm.2010.02.002; WELZEN M, 2004, TIAFT REFERENCE BLOO; Whyte IM, 2003, QJM-INT J MED, V96, P369, DOI 10.1093/qjmed/hcg062	90	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28208	10.1371/journal.pone.0028208	http://dx.doi.org/10.1371/journal.pone.0028208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164246	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400047
J	Liu, S; Schwarzinger, M; Carrat, F; Goldhaber-Fiebert, JD				Liu, Shan; Schwarzinger, Michael; Carrat, Fabrice; Goldhaber-Fiebert, Jeremy D.			Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients	PLOS ONE			English	Article							HEALTH-STATE UTILITIES; QUALITY-OF-LIFE; LIVER FIBROSIS; BIOCHEMICAL MARKERS; VIRUS-INFECTION; UNITED-STATES; BLOOD-TESTS; BIOPSY; FIBROTEST; POPULATION	Background and Aims: Chronic hepatitis C (HCV) is a liver disease affecting over 3 million Americans. Liver biopsy is the gold standard for assessing liver fibrosis and is used as a benchmark for initiating treatment, though it is expensive and carries risks of complications. FibroTest is a non-invasive biomarker assay for fibrosis, proposed as a screening alternative to biopsy. Methods: We assessed the cost-effectiveness of FibroTest and liver biopsy used alone or sequentially for six strategies followed by treatment of eligible U. S. patients: FibroTest only; FibroTest with liver biopsy for ambiguous results; FibroTest followed by biopsy to rule in; or to rule out significant fibrosis; biopsy only (recommended practice); and treatment without screening. We developed a Markov model of chronic HCV that tracks fibrosis progression. Outcomes were expressed as expected lifetime costs (2009 USD), quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICER). Results: Treatment of chronic HCV without fibrosis screening is preferred for both men and women. For genotype 1 patients treated with pegylated interferon and ribavirin, the ICERs are $ 5,400/QALY (men) and $ 6,300/QALY (women) compared to FibroTest only; the ICERs increase to $ 27,200/QALY (men) and $ 30,000/QALY (women) with the addition of telaprevir. For genotypes 2 and 3, treatment is more effective and less costly than all alternatives. In clinical settings where testing is required prior to treatment, FibroTest only is more effective and less costly than liver biopsy. These results are robust to multi-way and probabilistic sensitivity analyses. Conclusions: Early treatment of chronic HCV is superior to the other fibrosis screening strategies. In clinical settings where testing is required, FibroTest screening is a cost-effective alternative to liver biopsy.	[Liu, Shan] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Schwarzinger, Michael] Paris Diderot Univ, INSERM, Equipe ATIP, AVENIR,UMR S 738, Paris, France; [Carrat, Fabrice] Univ Paris 06, INSERM, UMR S 707, Paris, France; [Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Dept Med, Ctr Hlth Policy, Stanford, CA 94305 USA; [Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Stanford University	Liu, S (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	shanliu@stanford.edu	Carrat, Fabrice/AAU-8480-2020; Schwarzinger, Michael/F-7367-2011; Liu, Sheng/K-2815-2013	Carrat, Fabrice/0000-0002-8672-7918; Schwarzinger, Michael/0000-0002-0573-6856; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	U.S. National Institutes of Health National Institute on Aging [K01 AG037593-01A1]; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Ms. Liu was supported by a Stanford Graduate Fellowship. Dr. Goldhaber- Fiebert was supported in part by a U.S. National Institutes of Health National Institute on Aging Career Development Award (K01 AG037593-01A1: PI; Goldhaber-Fiebert). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHFS Drug Information, BETHESDA MD AMERICAN; Andriulli A, 2004, J VIRAL HEPATITIS, V11, P536, DOI 10.1111/j.1365-2893.2004.00519.x; Arias E:, 2007, NATL VITAL STAT REPO; Armstrong EP, 2004, CURR MED RES OPIN, V20, P671, DOI 10.1185/030079904125003485; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bedossa P, 2009, J HEPATOL, V50, P1, DOI 10.1016/j.jhep.2008.10.014; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Boursier J, 2009, EUR J GASTROEN HEPAT, V21, P28, DOI 10.1097/MEG.0b013e32830cebd7; Cales P, 2008, LIVER INT, V28, P1352, DOI 10.1111/j.1478-3231.2008.01789.x; Carlson JJ, 2009, J GASTROEN HEPATOL, V24, P786, DOI 10.1111/j.1440-1746.2009.05778.x; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Federal Supply Schedule, 2011, FEDERAL SUPPLY SCHED; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; GOLD MR, 1996, COST EFFECTIVENESS H, V23; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Halfon P, 2006, AM J GASTROENTEROL, V101, P547, DOI 10.1111/j.1572-0241.2006.00411.x; Halfon P, 2007, J HEPATOL, V46, P395, DOI 10.1016/j.jhep.2006.09.020; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Jacobson IM, N ENGL J MED, V364, P2405; Levinson DR., 2005, MED DRUG PRICE COMPA; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; MITRA D, 2010, VALUE HLTH; Narasimhan G, 2006, J VIRAL HEPATITIS, V13, P783, DOI 10.1111/j.1365-2893.2006.00763.x; NIH, 2002, JUN 10 12, V19, P1; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Pollack A, 2011, 2 DRUG WINS APPROVAL; Poret AW, 2002, DIS MANAG, V5, P95; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Poynard T, 2000, CAN J GASTROENTEROL, V14, P543, DOI 10.1155/2000/107982; Poynard T, 2004, COMP HEPATOLOGY; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Practice of FibroTest for hepatitis C, PRACT FIBR TEST HEPA; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Rossi E, 2003, CLIN CHEM, V49, P450, DOI 10.1373/49.3.450; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sherman KE, 2004, ARCH INTERN MED, V164, P2377, DOI 10.1001/archinte.164.21.2377; Siddiqui FA, 2008, HEPATOL INT, V2, P376, DOI 10.1007/s12072-008-9086-x; Sporea I, 2008, WORLD J GASTROENTERO, V14, P3396, DOI 10.3748/wjg.14.3396; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Tan JA, 2008, HEPATOLOGY, V48, P1387, DOI 10.1002/hep.22509; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thomson Corporation, 2009, RED BOOK PHARM FUND; United States Department of Labor, BUR LAB STAT CONS PR; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 1998, JAMA-J AM MED ASSOC, V280, P2088, DOI 10.1001/jama.280.24.2088	55	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e26783	10.1371/journal.pone.0026783	http://dx.doi.org/10.1371/journal.pone.0026783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164204	gold, Green Submitted, Green Published			2022-12-25	WOS:000298171400004
J	Munneke, J; Heslenfeld, DJ; Usrey, WM; Theeuwes, J; Mangun, GR				Munneke, Jaap; Heslenfeld, Dirk J.; Usrey, W. Martin; Theeuwes, Jan; Mangun, George R.			Preparatory Effects of Distractor Suppression: Evidence from Visual Cortex	PLOS ONE			English	Article							SPATIAL SELECTIVE ATTENTION; EXTRASTRIATE CORTEX; NEURAL MECHANISMS; FUNCTIONAL MRI; INHIBITORY SURROUNDS; SIGNAL ENHANCEMENT; DIRECTED ATTENTION; BRAIN ACTIVITY; FIELD; FMRI	Spatial selective attention is the mechanism that facilitates the selection of relevant information over irrelevant information in the visual field. The current study investigated whether foreknowledge of the presence or absence of distractors surrounding an impending target stimulus results in preparatory changes in visual cortex. We cued the location of the target and the presence or absence of distractors surrounding the target while changes in blood oxygen level dependent (BOLD) signals were measured. In line with prior work, we found that top-down spatial attention resulted in an increased contralateral BOLD response, evoked by the cue throughout early visual cortex (areas V1, V2 and V3). In addition, cues indicating distractor presence evoked a substantial increase in the magnitude of the BOLD signal in visual area V3, but not in V2 or V1. This study shows that prior knowledge concerning the presence of a distractor results in enhanced attentional modulation of visual cortex, in visual areas where neuronal receptive fields are large enough to encompass both targets and distractors. We interpret these findings as evidence that top-down attentional control processes include active preparatory suppression mechanisms for irrelevant, distracting information in the visual scene.	[Munneke, Jaap; Heslenfeld, Dirk J.; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Usrey, W. Martin] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Usrey, W. Martin; Mangun, George R.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Usrey, W. Martin] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Mangun, George R.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Mangun, George R.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	Vrije Universiteit Amsterdam; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Munneke, J (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	JA.Munneke@psy.vu.nl	Theeuwes, Jan/B-6862-2008; Theeuwes, Jan/ABF-3771-2020	Theeuwes, Jan/0000-0002-5849-7721; Munneke, Jaap/0000-0002-3117-6186	National Institutes of Health [MH057714, EY013588]; National Science Foundation [BCS0727115]; NATIONAL EYE INSTITUTE [R01EY013588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants MH057714 to George R. Mangun and EY013588 to W. Martin Usrey, and by National Science Foundation grant BCS0727115 to George R. Mangun and W. Martin Usrey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2003, J EXP PSYCHOL HUMAN, V29, P52, DOI 10.1037/0096-1523.29.1.52; Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Bahcall DO, 1999, VISION RES, V39, P71, DOI 10.1016/S0042-6989(98)00090-X; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BURKHALTER A, 1986, J NEUROSCI, V6, P2327; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Couperus JW, 2010, BRAIN RES, V1359, P155, DOI 10.1016/j.brainres.2010.08.076; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Downing C. J., 1985, ATTENTION PERFORM, P171; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopf JM, 2006, J NEUROSCI, V26, P3532, DOI 10.1523/JNEUROSCI.4510-05.2006; Hopf JM, 2006, P NATL ACAD SCI USA, V103, P1053, DOI 10.1073/pnas.0507746103; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Mounts JRW, 2000, PERCEPT PSYCHOPHYS, V62, P1485, DOI 10.3758/BF03212148; Mounts JRW, 2000, PERCEPT PSYCHOPHYS, V62, P969, DOI 10.3758/BF03212082; Muller NG, 2005, VISION RES, V45, P1129, DOI 10.1016/j.visres.2004.11.003; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Munneke J, 2008, ACTA PSYCHOL, V129, P101, DOI 10.1016/j.actpsy.2008.05.004; Munneke J, 2008, BRAIN RES, V1222, P184, DOI 10.1016/j.brainres.2008.05.039; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Ruff CC, 2006, J COGNITIVE NEUROSCI, V18, P522, DOI 10.1162/jocn.2006.18.4.522; Serences JT, 2004, J NEUROPHYSIOL, V92, P3538, DOI 10.1152/jn.00435.2004; SHIU LP, 1994, J EXP PSYCHOL HUMAN, V20, P1037, DOI 10.1037/0096-1523.20.5.1037; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; van der Heijden AHC., 1992, SELECTIVE ATTENTION; Vandenberghe R, 1997, J NEUROSCI, V17, P3739; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638	46	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27700	10.1371/journal.pone.0027700	http://dx.doi.org/10.1371/journal.pone.0027700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164213	Green Submitted, gold, Green Published			2022-12-25	WOS:000298171400013
J	Jendrysik, MA; Vasilevsky, S; Yi, L; Wood, A; Zhu, NN; Zhao, YG; Koontz, SM; Jackson, SH				Jendrysik, Meghan A.; Vasilevsky, Sam; Yi, Liang; Wood, Adam; Zhu, Nannan; Zhao, Yongge; Koontz, Sherry M.; Jackson, Sharon H.			NADPH Oxidase-2 Derived ROS Dictates Murine DC Cytokine-Mediated Cell Fate Decisions during CD4 T Helper-Cell Commitment	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NEGATIVE FEEDBACK-REGULATION; MATURE DENDRITIC CELLS; IL-12 PRODUCTION; INNATE IMMUNITY; P38 MAPK; INTERLEUKIN-12; DIFFERENTIATION; MACROPHAGES; MATURATION	NADPH oxidase-2 (Nox2)/gp91(phox) and p47(phox) deficient mice are prone to hyper-inflammatory responses suggesting a paradoxical role for Nox2-derived reactive oxygen species (ROS) as anti-inflammatory mediators. The molecular basis for this mode of control remains unclear. Here we demonstrate that IFN gamma/LPS matured p47(phox-/-)-ROS deficient mouse dendritic cells (DC) secrete more IL-12p70 than similarly treated wild type DC, and in an in vitro co-culture model IFN gamma/LPS matured p47phox(-/-) DC bias more ovalbumin-specific CD4(+) T lymphocytes toward a Th1 phenotype than wild type (WT) DC through a ROS-dependent mechanism linking IL-12p70 expression to regulation of p38-MAPK activation. The Nox2-dependent ROS production in DC negatively regulates proinflammatory IL-12 expression in DC by constraining p38-MAPK activity. Increasing endogenous H(2)O(2) attenuates p38-MAPK activity in IFN gamma/LPS stimulated WT and p47(phox-/-) DC, which suggests that endogenous Nox 2-derived ROS functions as a secondary messenger in the activated p38-MAPK signaling pathway during IL-12 expression. These findings indicate that ROS, generated endogenously by innate and adaptive immune cells, can function as important secondary messengers that can regulate cytokine production and immune cell cross-talk to control during the inflammatory response.	[Jendrysik, Meghan A.] NIAID, Mol Def Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Vasilevsky, Sam; Yi, Liang; Wood, Adam; Zhu, Nannan; Koontz, Sherry M.; Jackson, Sharon H.] NIAID, Monocyte Trafficking Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Zhao, Yongge] NIAID, Clin Immunol Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jendrysik, MA (corresponding author), NIAID, Mol Def Sect, Lab Host Def, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sjackson@niaid.nih.gov			Division of Intramural Research of the National Institutes of Health/National Institute of Allergy and Infectious Diseases; National Institutes of Health/National Center on Minority Health and Health Disparities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000792] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of Intramural Research of the National Institutes of Health/National Institute of Allergy and Infectious Diseases. This study was also partially supported by the National Institutes of Health/National Center on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aksoy E, 2002, EUR J IMMUNOL, V32, P3040, DOI 10.1002/1521-4141(200211)32:11<3040::AID-IMMU3040>3.0.CO;2-M; Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bentley R, 1966, METHODS ENZYMOLOGY, V9, P86; Bentley R, 1963, ENZYMES, P567; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; CLARK RA, 1989, NEW ENGL J MED, V321, P647, DOI 10.1056/NEJM198909073211005; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Donaldson M, 2009, CELL DEATH DIFFER, V16, P125, DOI 10.1038/cdd.2008.129; Ebner S, 2001, J IMMUNOL, V166, P633, DOI 10.4049/jimmunol.166.1.633; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Elsen S, 2004, J CELL SCI, V117, P2215, DOI 10.1242/jcs.01085; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kikuchi K, 2003, IMMUNOL LETT, V89, P149, DOI 10.1016/S0165-2478(03)00134-2; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Richter C, 2009, J IMMUNOL, V182, P4183, DOI 10.4049/jimmunol.0800795; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; ROOS D, 1994, IMMUNOL REV, V138, P121, DOI 10.1111/j.1600-065X.1994.tb00850.x; Rosenzweig SD, 2008, J CLIN IMMUNOL, V28, pS67, DOI 10.1007/s10875-007-9160-5; Schappi MG, 2008, SEMIN IMMUNOPATHOL, V30, P255, DOI 10.1007/s00281-008-0119-2; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; Vasilevsky S, 2008, J IMMUNOL, V181, P1787, DOI 10.4049/jimmunol.181.3.1787; Viola A, 2006, TRENDS IMMUNOL, V27, P421, DOI 10.1016/j.it.2006.07.004; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; WOLF SF, 1991, J IMMUNOL, V146, P3074; Zhang JS, 2000, CELL IMMUNOL, V204, P38, DOI 10.1006/cimm.2000.1690	44	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28198	10.1371/journal.pone.0028198	http://dx.doi.org/10.1371/journal.pone.0028198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145029	Green Submitted, Green Published, gold			2022-12-25	WOS:000298168900012
J	Hu, YF; Shen, Y; Silva, NCE; Zhou, DX				Hu, Yongfeng; Shen, Yuan; Conde e Silva, Natalia; Zhou, Dao-Xiu			The Role of Histone Methylation and H2A.Z Occupancy during Rapid Activation of Ethylene Responsive Genes	PLOS ONE			English	Article							ARABIDOPSIS; TRIMETHYLATION; EXPRESSION; H3; REPRESSION; INDUCTION; LYSINE-4; RICE; LHP1	Ethylene signaling pathway leads to rapid gene activation by two hierarchies of transcription factors with EIN3/EIL proteins as primary ones and ERF proteins as secondary ones. The role of chromatin modifications during the rapid gene activation is not known. In this work we studied trimethylated histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3), two opposite histone methylation marks for gene activity, during the induction course of three ethylene-responsive genes (ERF1, AtERF14 and ChiB). We found that the three genes displayed different histone modification profiles before induction. After induction, H3K4me3 was increased in the 59 region and the gene body of ERF1, while H3K27me3 was decreased in the promoter of AtERF14. But the modification changes were later than the gene activation. Analysis of other rapidly inducible ERF genes confirmed the observation. In addition, histone H2A.Z occupancy on the three genes and the association of the H3K27me3-binding protein LHP1 with AtERF14 and ChiB were not affected by the inductive signal. However, the mutation of genes encoding H2A.Z and LHP1 attenuated and enhanced respectively the induction of target genes and altered H3K4me3. These results indicate that the induction of ethylene-responsive genes does not require immediate modulation of H3K4me3 and H3K27me3 and dissociation of LHP1 and H2A.Z from the targets, and suggest that the chromatin structure of the genes before induction is committed for transcriptional activation and that H3K4me3 is not required for ethylene-responsive gene activation, but may serve as a mark for gene activity.	[Hu, Yongfeng; Shen, Yuan; Conde e Silva, Natalia; Zhou, Dao-Xiu] Univ Paris 11, Inst Biol Plantes, Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	Hu, YF (corresponding author), Univ Paris 11, Inst Biol Plantes, Orsay, France.	dao-xiu.zhou@u-psud.fr		Zhou, Dao-Xiu/0000-0002-1540-0598; Conde e Silva, Natalia/0000-0003-2435-9184	French Agence Nationale de la Recherche	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant from the French Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Buzas DM, 2010, PLANT J; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; Finnegan EJ, 2011, PLANT J, V65, P382, DOI 10.1111/j.1365-313X.2010.04428.x; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Huang LM, 2007, PLANT PHYSIOL, V144, P1508, DOI 10.1104/pp.107.099473; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Kim DH, 2010, PLANT PHYSIOL, V154, P949, DOI 10.1104/pp.110.161083; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Latrasse D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016592; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; March-Diaz R, 2008, PLANT J, V53, P475, DOI 10.1111/j.1365-313X.2007.03361.x; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Smith AP, 2010, PLANT PHYSIOL, V152, P217, DOI 10.1104/pp.109.145532; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62	27	18	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28224	10.1371/journal.pone.0028224	http://dx.doi.org/10.1371/journal.pone.0028224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140554	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163400039
J	Keklikoglou, I; Koerner, C; Schmidt, C; Zhang, JD; Heckmann, D; Shavinskaya, A; Allgayer, H; Guckel, B; Fehm, T; Schneeweiss, A; Sahin, O; Wiemann, S; Tschulena, U				Keklikoglou, I.; Koerner, C.; Schmidt, C.; Zhang, J. D.; Heckmann, D.; Shavinskaya, A.; Allgayer, H.; Gueckel, B.; Fehm, T.; Schneeweiss, A.; Sahin, Oe; Wiemann, S.; Tschulena, U.			MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappa B and TGF-beta signaling pathways	ONCOGENE			English	Article						NF-kappaB; TGF-beta; miR-373; miR-520c; breast cancer; ER-negative	EMBRYONIC STEM-CELLS; GROWTH-FACTOR; BONE METASTASIS; UP-REGULATION; INVASION; EXPRESSION; ACTIVATION; MICRORNAS; PROLIFERATION; ANGIOGENESIS	MicroRNAs (miRNAs) as modulators of gene expression have been described to display both tumor-promoting and tumor-suppressive functions. Although their role has been studied in different tumor types, little is known about how they regulate nuclear factor kappa B (NF-kappa B) signaling in breast cancer. Here, we performed an unbiased whole genome miRNA (miRome) screen to identify novel modulators of NF-kappa B pathway in breast cancer. The screen identified 13 miRNA families whose members induced consistent effects on NF-kappa B activity. Among those, the miR-520/373 family inhibited NF-kappa B signaling through direct targeting of RELA and thus strongly reduced expression and secretion of the pro-inflammatory cytokines interleukin (IL)-6 and IL-8. With a combination of in vitro and in vivo approaches, we propose a metastasis-suppressive role of miR-520/373 family. miR-520c and miR-373 abrogated both in vitro cell invasion and in vivo intravasation of highly invasive MDA-MB-231 cells. However, knockdown of RELA did not affect their metastatic ability. mRNA profiling of MDA-MB-231 cells on overexpression of miR-520/373 members revealed a strong downregulation of transforming growth factor-beta (TGF-beta) signaling. Mechanistically, the metastasis-suppressive role of miR-520/373 can be attributed to direct suppression of TGFBR2, as the silencing of TGFBR2 phenocopied the effects of miR-520/373 overexpression on suppression of Smad-dependent expression of the metastasis-promoting genes parathyroid hormone-related protein, plasminogen activator inhibitor-1 and angiopoietin-like 4 as well as tumor cell invasion, in vitro and in vivo. A negative correlation between miR-520c and TGFBR2 expression was observed in estrogen receptor negative (ER-) breast cancer patients but not in the ER positive (ER+) subtype. Remarkably, decreased expression of miR-520c correlated with lymph node metastasis specifically in ER- tumors. Taken together, our findings reveal that miR-520/373 family has a tumor-suppressive role in ER- breast cancer by acting as a link between the NF-kappa B and TGF-beta pathways and may thus contribute to the interplay of tumor progression, metastasis and inflammation. Oncogene (2012) 31, 4150-4163; doi:10.1038/onc.2011.571; published online 12 December 2011	[Keklikoglou, I.; Koerner, C.; Schmidt, C.; Zhang, J. D.; Sahin, Oe; Wiemann, S.; Tschulena, U.] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Heckmann, D.; Shavinskaya, A.; Allgayer, H.] German Canc Res Ctr, Clin Cooperat Unit Mol Oncol Solid Tumors, D-69120 Heidelberg, Germany; [Gueckel, B.; Fehm, T.] Univ Tubingen, Womens Hosp, Dept Gynecol & Obstet, Tubingen, Germany; [Schneeweiss, A.] Univ Heidelberg Hosp, Dept Gynecol & Obstet, Natl Ctr Tumor Dis, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Keklikoglou, I (corresponding author), German Canc Res Ctr, Div Mol Genome Anal, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	i.keklikoglou@dkfz-heidelberg.de; s.wiemann@dkfz-heidelberg.de	Sahin, Özgür/F-4403-2014; Wiemann, Stefan/E-4424-2013; Schneeweiss, Andreas/HHS-4098-2022	Sahin, Özgür/0000-0002-8033-7089; Wiemann, Stefan/0000-0003-4683-3174; Keklikoglou, Ioanna/0000-0003-1219-6912; Koerner, Cindy/0000-0003-1150-9462; Fehm, Tanja/0000-0002-4926-0108; Schmidt, Christian/0000-0002-9605-5959	National Genome Research Network of the German Federal Ministry of Education and Research (BMBF) [01GS0816, 01GS0864]; DKFZ International PhD Program	National Genome Research Network of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DKFZ International PhD Program	We thank Dr Wolfgang Koestler for critical reading of the paper and discussion. We also thank Professor Dr George Mosialos for kindly providing us with the 3xKBL vector, Jennifer Lee for providing us with the pcDNA3.1-TGFBR2 vector, Johanna Sonntag, Dr Frank Goetschel and Dr Ulrike Korf for providing us with antibodies. We thank Serafeim Perdikis for data analysis and Aoife Ward, Angelika Worner, Ute Ernst, Heike Wilhelm, Ewald Munstermann for excellent technical assistance. This work was supported by the National Genome Research Network (Contracts No. 01GS0816 and 01GS0864) of the German Federal Ministry of Education and Research (BMBF). CK and JDZ were supported by the DKFZ International PhD Program.	Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas DK, 2003, CANCER RES, V63, P290; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen YP, 2010, ADV APPL MATH MECH, V2, P56, DOI 10.4208/aamm.09-m0931; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang S, 2000, CANCER RES, V60, P5334; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Laurent LC, 2008, J CELL MOL MED, V12, P2181, DOI 10.1111/j.1582-4934.2008.00513.x; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Leek RD, 1996, CANCER RES, V56, P4625; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Sorlie Therese, 2007, Methods Mol Biol, V360, P91; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; van der Horst EH, 2004, BIOTECHNIQUES, V37, P940, DOI 10.2144/04376ST02; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu N., 2011, FEBS J; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013; Zijlstra A, 2002, CANCER RES, V62, P7083	58	214	223	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	37					4150	4163		10.1038/onc.2011.571	http://dx.doi.org/10.1038/onc.2011.571			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NR	22158050	hybrid			2022-12-25	WOS:000308688900007
J	Shprung, T; Peleg, A; Rosenfeld, Y; Trieu-Cuot, P; Shai, Y				Shprung, Tal; Peleg, Adi; Rosenfeld, Yosef; Trieu-Cuot, Patrick; Shai, Yechiel			Effect of PhoP-PhoQ Activation by Broad Repertoire of Antimicrobial Peptides on Bacterial Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT REGULATORY SYSTEM; ENTERICA SEROVAR TYPHIMURIUM; OUTER-MEMBRANE; SEQUENCE ALTERATION; VIRULENCE GENE; POLYMYXIN-B; SALMONELLA; SENSOR; REGULON; PROTEIN	Pathogenic bacteria can resist their microenvironment by changing the expression of virulence genes. In Salmonella typhimurium, some of these genes are controlled by the two-component system PhoP-PhoQ. Studies have shown that activation of the system by cationic antimicrobial peptides (AMPs) results, among other changes, in outer membrane remodeling. However, it is not fully clear what characteristics of AMPs are required to activate the PhoP-PhoQ system and whether activation can induce resistance to the various AMPs. For that purpose, we investigated the ability of a broad repertoire of AMPs to traverse the inner membrane, to activate the PhoP-PhoQ system, and to induce bacterial resistance. The AMPs differ in length, composition, and net positive charge, and the tested bacteria include two wild-type (WT) Salmonella strains and their corresponding PhoP-PhoQ knock-out mutants. A lacZ-reporting system was adapted to follow PhoP-PhoQ activation. The data revealed that: (i) a good correlation exists among the extent of the positive charge, hydrophobicity, and amphipathicity of an AMP and its potency to activate PhoP-PhoQ; (ii) a + 1 charged peptide containing histidines was highly potent, suggesting the existence of an additional mechanism independent of the peptide charge; (iii) the WT bacteria are more resistant to AMPs that are potent activators of PhoP-PhoQ; (iv) only a subset of AMPs, independent of their potency to activate the system, is more toxic to the mutated bacteria compared with the WT strains; and (v) short term exposure of WT bacteria to these AMPs does not enhance resistance. Overall, this study advances our understanding of the molecular mechanism by which AMPs activate PhoP-PhoQ and induce bacterial resistance. It also reveals that some AMPs can overcome such a resistance mechanism.	[Shprung, Tal; Peleg, Adi; Rosenfeld, Yosef; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Trieu-Cuot, Patrick] CNRS, Inst Pasteur, Unite Biol Bacteries Pathogenes Gram positif, URA 2172, F-75724 Paris, France	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Yechiel.Shai@weizmann.ac.il		TRIEU-CUOT, Patrick/0000-0002-2768-9587	German-Israel Foundation for Scientific Research and Development (GIF); Weizmann-Pasteur Joint Research Program	German-Israel Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); Weizmann-Pasteur Joint Research Program	This work was supported in part by the German-Israel Foundation for Scientific Research and Development (GIF) and by the Weizmann-Pasteur Joint Research Program.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Baker SJ, 1997, MICROB PATHOGENESIS, V22, P165, DOI 10.1006/mpat.1996.0099; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Bishop JL, 2006, TRENDS MOL MED, V12, P3, DOI 10.1016/j.molmed.2005.11.001; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Choi E, 2009, J BACTERIOL, V191, P7174, DOI 10.1128/JB.00958-09; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Kindrachuk J, 2007, ANTIMICROB AGENTS CH, V51, P4374, DOI 10.1128/AAC.00854-07; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Macfarlane ELA, 2000, MICROBIOL-SGM, V146, P2543, DOI 10.1099/00221287-146-10-2543; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Matson JS, 2010, J BACTERIOL, V192, P2044, DOI 10.1128/JB.00023-10; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Miller JH., 1972, EXPT MOL GENETICS; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Papo N, 2004, BIOCHEMISTRY-US, V43, P6393, DOI 10.1021/bi049944h; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Schurek KN, 2009, ANTIMICROB AGENTS CH, V53, P4345, DOI 10.1128/AAC.01267-08; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; VESCOVI EG, 1994, RES MICROBIOL, V145, P473, DOI 10.1016/0923-2508(94)90096-5; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Vescovi EG, 1997, J BIOL CHEM, V272, P1440, DOI 10.1074/jbc.272.3.1440; Yu JL, 2011, J PROTEOME RES, V10, P2992, DOI 10.1021/pr101177g	42	28	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4544	4551		10.1074/jbc.M111.278523	http://dx.doi.org/10.1074/jbc.M111.278523			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158870	hybrid, Green Published			2022-12-25	WOS:000300608500017
J	Guangqi, E; Cao, Y; Bhattacharya, S; Dutta, S; Wang, EF; Mukhopadhyay, D				Guangqi, E.; Cao, Ying; Bhattacharya, Santanu; Dutta, Shamit; Wang, Enfeng; Mukhopadhyay, Debabrata			Endogenous Vascular Endothelial Growth Factor-A (VEGF-A) Maintains Endothelial Cell Homeostasis by Regulating VEGF Receptor-2 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PERMEABILITY FACTOR; SIGNAL-TRANSDUCTION; AUTOCRINE VEGF; TYROSINE PHOSPHORYLATION; TUMOR ANGIOGENESIS; GENE-EXPRESSION; CADHERIN; KDR/FLK-1; CANCER	Vascular endothelial growth factor A (VEGF-A) is one of the most important factors controlling angiogenesis. Although the functions of exogenous VEGF-A have been widely studied, the roles of endogenous VEGF-A remain unclear. Here we focused on the mechanistic functions of endogenous VEGF-A in endothelial cells. We found that it is complexed with VEGF receptor 2 (VEGFR-2) and maintains a basal expression level for VEGFR-2 and its downstream signaling activation. Endogenous VEGF-A also controls expression of key endothelial specific genes including VEGFR-2, Tie-2, and vascular endothelial cadherin. Of importance, endogenous VEGF-A differs from exogenous VEGF-A by regulating VEGFR-2 transcription through mediation of FoxC2 binding to the FOX: ETS motif, and the complex formed by endogenous VEGF-A with VEGFR-2 is localized within the EEA1 (early endosome antigen 1) endosomal compartment. Taken together, our results emphasize the importance of endogenous VEGF-A in endothelial cells by regulating key vascular proteins and maintaining the endothelial homeostasis.	[Guangqi, E.; Cao, Ying; Bhattacharya, Santanu; Dutta, Shamit; Wang, Enfeng; Mukhopadhyay, Debabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Mukhopadhyay, D (corresponding author), Guggenheim 1321C,200 1st St SW, Rochester, MN 55905 USA.	mukhopadhyay.debabrata@mayo.edu	Bhattacharya, Santanu/N-6531-2019; Bhattacharya, Santanu/GRS-4780-2022	Bhattacharya, Santanu/0000-0001-9040-8971; 	National Institutes of Health [HL070567, CA78383, CA150190]; NATIONAL CANCER INSTITUTE [R01CA078383, R01CA150190, R29CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070567, CA78383, and CA150190. This work was also supported by a generous gift from Bruce and Martha Atwater.	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dvorak HF, 2006, EXP CELL RES, V312, P522, DOI 10.1016/j.yexcr.2005.11.026; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Herve MAJ, 2006, J ENDOCRINOL, V188, P91, DOI 10.1677/joe.1.06184; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Meissner M, 2009, CANCER RES, V69, P1976, DOI 10.1158/0008-5472.CAN-08-3150; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Mukhopadhyay D, 2004, MOL CELL BIOCHEM, V264, P51, DOI 10.1023/B:MCBI.0000044374.85095.df; Nagy JA, 2002, COLD SPRING HARB SYM, V67, P227, DOI 10.1101/sqb.2002.67.227; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Rabascio C, 2004, CANCER RES, V64, P4373, DOI 10.1158/0008-5472.CAN-04-0265; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shen BQ, 1998, J BIOL CHEM, V273, P29979, DOI 10.1074/jbc.273.45.29979; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Wang DF, 2000, J BIOL CHEM, V275, P15905, DOI 10.1074/jbc.M001847200; Ward NL, 2002, SEMIN CELL DEV BIOL, V13, P19, DOI 10.1006/scdb.2001.0288; Watanabe Y, 1997, ONCOGENE, V14, P2025, DOI 10.1038/sj.onc.1201033; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Yang SY, 2001, ARTERIOSCL THROM VAS, V21, P1934, DOI 10.1161/hq1201.099432; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200	59	30	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3029	3041		10.1074/jbc.M111.293985	http://dx.doi.org/10.1074/jbc.M111.293985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167188	hybrid, Green Published			2022-12-25	WOS:000300295100010
J	Jurado, S; Conlan, LA; Baker, EK; Ng, JL; Tenis, N; Hoch, NC; Gleeson, K; Smeets, M; Izon, D; Heierhorst, J				Jurado, Sabine; Conlan, Lindus A.; Baker, Emma K.; Ng, Jane-Lee; Tenis, Nora; Hoch, Nicolas C.; Gleeson, Kimberly; Smeets, Monique; Izon, David; Heierhorst, Joerg			ATM Substrate Chk2-interacting Zn2+ Finger (ASCIZ) Is a Bi-functional Transcriptional Activator and Feedback Sensor in the Regulation of Dynein Light Chain (DYNLL1) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE PROTEIN ASCIZ; DNA-DAMAGE; INTERACTING PROTEIN; INTERMEDIATE CHAIN; CELL-DEATH; BINDS; AUTOREGULATION; ACCUMULATION; DROSOPHILA; NETWORKS	The highly conserved DYNLL1 (LC8) protein was originally discovered as a light chain of the dynein motor complex, but is increasingly emerging as a sequence-specific regulator of protein dimerization with hundreds of targets and wide-ranging cellular functions. Despite its important roles, DYNLL1's own regulation remains poorly understood. Here we identify ASCIZ (ATMIN/ZNF822), an essential Zn2+ finger protein with dual roles in the DNA base damage response and as a developmental transcription factor, as a conserved regulator of Dynll1 gene expression. DYNLL1 levels are reduced by similar to 10-fold in the absence of ASCIZ in human, mouse and chicken cells. ASCIZ binds directly to the Dynll1 promoter and regulates its activity in a Zn2+ finger-dependent manner. DYNLL1 protein in turn interacts with ten binding sites in the ASCIZ transcription activation domain, and high DYNLL1 levels inhibit the transcriptional activity of ASCIZ. In addition, DYNLL1 was also required for DNA damage-induced ASCIZ focus formation. The dual ability of ASCIZ to activate Dynll1 gene expression and to sense free DYNLL1 protein levels enables a simple dynamic feedback loop to adjust DYNLL1 levels to cellular needs. The ASCIZ-DYNLL1 feedback loop represents a novel mechanism for auto-regulation of gene expression, where the gene product directly inhibits the transcriptional activator while bound at its own promoter.	[Jurado, Sabine; Conlan, Lindus A.; Baker, Emma K.; Ng, Jane-Lee; Tenis, Nora; Hoch, Nicolas C.; Gleeson, Kimberly; Smeets, Monique; Izon, David; Heierhorst, Joerg] Univ Melbourne, St Vincents Inst Med Res, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Jurado, Sabine; Ng, Jane-Lee; Hoch, Nicolas C.; Heierhorst, Joerg] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia	St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Heierhorst, J (corresponding author), Univ Melbourne, St Vincents Inst Med Res, St Vincents Hosp, 9 Princes St, Fitzroy, Vic 3065, Australia.	jheierhorst@svi.edu.au	Hoch, Nicolas/J-5288-2012	Hoch, Nicolas/0000-0002-7610-1305; Heierhorst, Jorg/0000-0003-2789-9514	National Health and Medical Research Council (NHMRC) of Australia; Cooperative Research Centre Cancer Therapeutics; Victorian Government	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre Cancer Therapeutics(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Victorian Government	This work was supported by grants and a Senior Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (to J. H.), a PhD scholarship from the Cooperative Research Centre Cancer Therapeutics (to S. J.), and in part by the Victorian Government's Operational Infrastructure Support Program.	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Batlevi Y, 2010, P NATL ACAD SCI USA, V107, P742, DOI 10.1073/pnas.0907967107; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Dick T, 1996, MOL CELL BIOL, V16, P1966; Dorsett M, 2009, MOL CELL BIOL, V29, P6128, DOI 10.1128/MCB.00815-09; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Heierhorst J, 2011, CELL CYCLE, V10, P1222, DOI 10.4161/cc.10.8.15336; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jurado S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001170; Kanu N, 2010, J BIOL CHEM, V285, P38534, DOI 10.1074/jbc.M110.145896; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; King SM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.147pe51; Liu XY, 2011, CANCER CELL, V19, P569, DOI 10.1016/j.ccr.2011.05.002; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Loizou JI, 2011, CANCER CELL, V19, P587, DOI 10.1016/j.ccr.2011.03.022; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McNees CJ, 2005, EMBO J, V24, P2447, DOI 10.1038/sj.emboj.7600704; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Oka H, 2008, BIOCHEM BIOPH RES CO, V371, P225, DOI 10.1016/j.bbrc.2008.04.052; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Perdomo J, 2002, EUR J BIOCHEM, V269, P5885, DOI 10.1046/j.1432-1033.2002.03313.x; Pike BL, 2004, MOL CELL BIOL, V24, P2779, DOI 10.1128/MCB.24.7.2779-2788.2004; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rapali P, 2011, BIOCHEM BIOPH RES CO, V414, P493, DOI 10.1016/j.bbrc.2011.09.093; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Rayala SK, 2005, EMBO REP, V6, P538, DOI 10.1038/sj.embor.7400417; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104	32	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3156	3164		10.1074/jbc.M111.306019	http://dx.doi.org/10.1074/jbc.M111.306019			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167198	Green Published, hybrid			2022-12-25	WOS:000300295100021
J	Gabunia, K; Ellison, SP; Singh, H; Datta, P; Kelemen, SE; Rizzo, V; Autieri, MV				Gabunia, Khatuna; Ellison, Stephen P.; Singh, Harrinder; Datta, Prasun; Kelemen, Sheri E.; Rizzo, Victor; Autieri, Michael V.			Interleukin-19 (IL-19) Induces Heme Oxygenase-1 (HO-1) Expression and Decreases Reactive Oxygen Species in Human Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROTIC LESION FORMATION; ENDOTHELIAL-CELLS; TNF-ALPHA; INDUCED APOPTOSIS; OXIDATIVE STRESS; GENE; CYTOKINES; GROWTH; PROGRESSION; ACTIVATION	Heme oxygenase-1 (HO-1) has potent anti-inflammatory activity and recognized vascular protective effects. We have recently described the expression and vascular protective effects of an anti-inflammatory interleukin (IL-19), in vascular smooth muscle cells (VSMC) and injured arteries. The objective of this study was to link the anti-inflammatory effects of IL-19 with HO-1 expression in resident vascular cells. IL-19 induced HO-1 mRNA and protein in cultured human VSMC, as assayed by quantitative RT-PCR, immunoblot, and ELISA. IL-19 does not induce HO-1 mRNA or protein in human endothelial cells. IL-19 activates STAT3 in VSMC, and IL-19-induced HO-1 expression is significantly reduced by transfection of VSMC with STAT3 siRNA or mutation of the consensus STAT binding site in the HO-1 promoter. IL-19 treatment can significantly reduce ROS-induced apoptosis, as assayed by Annexin V flow cytometry. IL-19 significantly reduced ROS concentrations in cultured VSMC. The IL-19-induced reduction in ROS concentration is attenuated when HO-1 is reduced by siRNA, indicating that the IL-19-driven decrease in ROS is mediated by HO-1 expression. IL-19 reduces vascular ROS in vivo in mice treated with TNF alpha. This points to IL-19 as a potential therapeutic for vascular inflammatory diseases and a link for two previously unassociated protective processes: Th2 cytokine-induced anti-inflammation and ROS reduction.	[Autieri, Michael V.] Temple Univ, Sch Med, Dept Physiol, IBC Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Gabunia, Khatuna; Ellison, Stephen P.; Singh, Harrinder; Kelemen, Sheri E.; Rizzo, Victor; Autieri, Michael V.] Temple Univ, Sch Med, Independence Blue Cross Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Singh, Harrinder; Rizzo, Victor] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Datta, Prasun] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Autieri, MV (corresponding author), Temple Univ, Sch Med, Dept Physiol, IBC Cardiovasc Res Ctr, Room 1050,MERB,3500 N Broad St, Philadelphia, PA 19140 USA.	mautieri@temple.edu		Datta, Prasun/0000-0001-5133-253X; Singh, Harinder/0000-0002-0160-1575	NHLBI, National Institutes of Health [HL090885]; American Heart Association [11POST7530001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090885] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grant HL090885 from the NHLBI, National Institutes of Health (to M. V. A.) and postdoctoral grant 11POST7530001 from the American Heart Association (to K. G.).	Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; ALAM J, 1994, J BIOL CHEM, V269, P25049; Cheng C, 2009, CIRCULATION, V119, P3017, DOI 10.1161/CIRCULATIONAHA.108.808618; Cuneo AA, 2010, J MOL CELL CARDIOL, V49, P647, DOI 10.1016/j.yjmcc.2010.04.016; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Durante W, 2003, J CELL PHYSIOL, V195, P373, DOI 10.1002/jcp.10274; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Gabunia K, 2011, AM J PHYSIOL-CELL PH, V300, pC896, DOI 10.1152/ajpcell.00439.2010; Gallagher G, 2004, INT IMMUNOPHARMACOL, V4, P615, DOI 10.1016/j.intimp.2004.01.005; Hafer K, 2008, RADIAT RES, V169, P460, DOI 10.1667/RR1212.1; Ishikawa K, 2001, CIRC RES, V88, P506, DOI 10.1161/01.RES.88.5.506; Jain S, 2011, ARTERIOSCL THROM VAS, V31, P167, DOI 10.1161/ATVBAHA.110.214916; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Maranto J, 2008, J NEUROIMMUNE PHARM, V3, P43, DOI 10.1007/s11481-007-9096-9; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Oral HB, 2006, EUR J IMMUNOL, V36, P380, DOI 10.1002/eji.200425523; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Peyton KJ, 2002, BLOOD, V99, P4443, DOI 10.1182/blood.V99.12.4443; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; ROSS, 1999, J MED, V340, P115; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Singer CA, 2004, BIOESSAYS, V26, P646, DOI 10.1002/bies.20041; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Takahashi S, 1999, BBA-GENE STRUCT EXPR, V1447, P231, DOI 10.1016/S0167-4781(99)00156-6; Tian Y, 2008, AM J PATHOL, V173, P901, DOI 10.2353/ajpath.2008.080163; Tulis DA, 2001, CIRCULATION, V104, P2710, DOI 10.1161/hc4701.099585; Volti GL, 2002, BIOCHEM BIOPH RES CO, V296, P1077, DOI 10.1016/S0006-291X(02)02054-5; Wang LJ, 1998, AM J PATHOL, V152, P711; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje	39	41	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2477	2484		10.1074/jbc.M111.312470	http://dx.doi.org/10.1074/jbc.M111.312470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22158875	Green Published, hybrid			2022-12-25	WOS:000300292300022
J	Guo, QX; Li, HM; Gaddam, SSK; Justice, NJ; Robertson, CS; Zheng, H				Guo, Qinxi; Li, Hongmei; Gaddam, Samson S. K.; Justice, Nicholas J.; Robertson, Claudia S.; Zheng, Hui			Amyloid Precursor Protein Revisited NEURON-SPECIFIC EXPRESSION AND HIGHLY STABLE NATURE OF SOLUBLE DERIVATIVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MESSENGER-RNAS; DYSTROPHIC NEURITES; HIPPOCAMPAL-NEURONS; REACTIVE ASTROCYTES; ASTROGLIAL CELLS; SENILE PLAQUES; GLIAL-CELLS; IN-VIVO	APP processing and amyloid-beta production play a central role in Alzheimer disease pathogenesis. APP has been considered a ubiquitously expressed protein. In addition to amyloid-beta, alpha- or beta-secretase-dependent cleavage of APP also generates soluble secreted APP (APPs alpha or APPs beta, respectively). Interestingly, APPs beta has been shown to be subject to further cleavage to create an N-APP fragment that binds to the DR6 death receptor and mediates axon pruning and degeneration under trophic factor withdrawal conditions. By performing APP immunocytochemical staining, we found that, unexpectedly, many antibodies yielded nonspecific staining in APP-null samples. Screening of a series of antibodies allowed us to identify a rabbit monoclonal antibody Y188 that is highly specific for APP and prompted us to re-examine the expression, localization, and stability of endogenous APP and APPs beta in wild-type and in APPs beta knock-in mice, respectively. In contrast to earlier studies, we found that APP is specifically expressed in neurons and that its expression cannot be detected in major types of glial cells under basal or neuroinflammatory conditions. Both APPs alpha and APPs beta are highly stable in the central nervous system (CNS) and do not undergo further cleavage with or without trophic factor support. Our results clarify several key questions with regard to the fundamental properties of APP and offer critical cellular insights into the pathophysiology of APP.	[Guo, Qinxi; Li, Hongmei; Justice, Nicholas J.; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Guo, Qinxi] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Gaddam, Samson S. K.; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, BCM230,1 Baylor Plaza, Houston, TX 77030 USA.	huiz@bcm.edu	Li, Hongmei/L-2595-2013; Guo, Qinxi/J-1473-2014	Li, Hongmei/0000-0002-4952-1734; Guo, Qinxi/0000-0003-4320-6757	National Institutes of Health [P01 NS38660, R01 AG032051, AG033467, NS076117]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076117, P01NS038660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032051, R01AG033467, R01AG020670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 NS38660 (to C. S. R.) and R01 AG032051, AG033467, and NS076117 (to H. Z.).	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; BENOWITZ LI, 1989, EXP NEUROL, V106, P237, DOI 10.1016/0014-4886(89)90156-8; BERKENBOSCH F, 1990, J NEUROSCI RES, V25, P431, DOI 10.1002/jnr.490250321; Bitner BR, 2010, J CEREBR BLOOD F MET, V30, P1105, DOI 10.1038/jcbfm.2010.47; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Chauvet N, 1997, J COMP NEUROL, V377, P550; Clarner T, 2011, J MOL NEUROSCI, V43, P268, DOI 10.1007/s12031-010-9419-9; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; CUMMINGS BJ, 1992, NEUROSCIENCE, V48, P763, DOI 10.1016/0306-4522(92)90265-4; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hsu WC, 2008, J NEURAL TRANSM, V115, P1537, DOI 10.1007/s00702-008-0117-5; HYMAN BT, 1992, J NEUROPATH EXP NEUR, V51, P76, DOI 10.1097/00005072-199201000-00009; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kohler C, 2005, NEUROBIOL DIS, V20, P528, DOI 10.1016/j.nbd.2005.04.009; LeBlanc AC, 1997, J NEUROCHEM, V68, P1183; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Martins RN, 2001, NEUROSCIENCE, V106, P557, DOI 10.1016/S0306-4522(01)00289-5; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Moreno-Flores MT, 1998, J NEUROSCI RES, V52, P661, DOI 10.1002/(SICI)1097-4547(19980615)52:6<661::AID-JNR5>3.0.CO;2-6; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Norstrom EM, 2010, J NEUROSCI, V30, P15677, DOI 10.1523/JNEUROSCI.4464-10.2010; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PALACIOS G, 1995, EUR J NEUROSCI, V7, P501, DOI 10.1111/j.1460-9568.1995.tb00346.x; PALACIOS G, 1992, MOL BRAIN RES, V15, P195, DOI 10.1016/0169-328X(92)90109-O; Palmert M R, 1989, Prog Clin Biol Res, V317, P971; PALMERT MR, 1988, BIOCHEM BIOPH RES CO, V156, P432, DOI 10.1016/S0006-291X(88)80859-3; Pierce JES, 1996, J NEUROSCI, V16, P1083; Shim DJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-42; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; SHOJI M, 1990, BRAIN RES, V512, P164, DOI 10.1016/0006-8993(90)91187-L; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SOLA C, 1993, MOL BRAIN RES, V17, P41, DOI 10.1016/0169-328X(93)90071-V; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tran MD, 2011, NEUROSCI LETT, V492, P155, DOI 10.1016/j.neulet.2011.01.078; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Yasuoka K, 2004, J ANAT, V205, P135, DOI 10.1111/j.0021-8782.2004.00320.x; Young MJ, 1999, BRAIN RES BULL, V50, P27, DOI 10.1016/S0361-9230(99)00084-2; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	49	62	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2437	2445		10.1074/jbc.M111.315051	http://dx.doi.org/10.1074/jbc.M111.315051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22144675	hybrid, Green Published			2022-12-25	WOS:000300292300018
J	Hiremath, S; Knoll, G; Weinstein, MC				Hiremath, Swapnil; Knoll, Greg; Weinstein, Milton C.			Should the Arteriovenous Fistula Be Created before Starting Dialysis?: A Decision Analytic Approach	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INCIDENT HEMODIALYSIS-PATIENTS; VASCULAR ACCESS TYPE; REFER PATIENTS; CATHETER USE; MORTALITY; OUTCOMES; DEATH; RISK; ASSOCIATION	Background: An arteriovenous fistula (AVF) is considered the vascular access of choice, but uncertainty exists about the optimal time for its creation in pre-dialysis patients. The aim of this study was to determine the optimal vascular access referral strategy for stage 4 (glomerular filtration rate <30 ml/min/1.73 m(2)) chronic kidney disease patients using a decision analytic framework. Methods: A Markov model was created to compare two strategies: refer all stage 4 chronic kidney disease patients for an AVF versus wait until the patient starts dialysis. Data from published observational studies were used to estimate the probabilities used in the model. A Markov cohort analysis was used to determine the optimal strategy with life expectancy and quality adjusted life expectancy as the outcomes. Sensitivity analyses, including a probabilistic sensitivity analysis, were performed using Monte Carlo simulation. Results: The wait strategy results in a higher life expectancy (66.6 versus 65.9 months) and quality adjusted life expectancy (38.9 versus 38.5 quality adjusted life months) than immediate AVF creation. It was robust across all the parameters except at higher rates of progression and lower rates of ischemic steal syndrome. Conclusions: Early creation of an AVF, as recommended by most guidelines, may not be the preferred strategy in all pre-dialysis patients. Further research on cost implications and patient preferences for treatment options needs to be done before recommending early AVF creation.	[Hiremath, Swapnil; Knoll, Greg] Ottawa Hosp Res Inst, Div Nephrol, Kidney Res Ctr, Ottawa, ON, Canada; [Hiremath, Swapnil; Knoll, Greg] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Hiremath, Swapnil; Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Harvard University; Harvard T.H. Chan School of Public Health	Hiremath, S (corresponding author), Ottawa Hosp Res Inst, Div Nephrol, Kidney Res Ctr, Ottawa, ON, Canada.	shiremath@toh.on.ca	Hiremath, Swapnil/H-3492-2019	Hiremath, Swapnil/0000-0003-0010-3416; Knoll, Greg/0000-0001-5442-9310				Barlow AD, 2008, J VASC ACCESS, V9, P129, DOI 10.1177/112972980800900209; BECK JR, 1983, MED DECIS MAKING, V3, P3, DOI 10.1177/0272989X8300300102; Besarab A, 2008, J AM SOC NEPHROL, V19, P1629, DOI 10.1681/ASN.2008020172; Besarab Anatole, 2004, Hemodial Int, V8, P199, DOI 10.1111/j.1492-7535.2004.01096.x; Bradbury BD, 2009, AM J KIDNEY DIS, V53, P804, DOI 10.1053/j.ajkd.2008.11.031; Briggs AH, 2004, EUR J GASTROEN HEPAT, V16, P551, DOI 10.1097/00042737-200406000-00007; Canadian Institute For Health Information, 2008, 2007 ANN REP TREATM; Conway B, 2009, NEPHROL DIAL TRANSPL, V24, P1930, DOI 10.1093/ndt/gfn772; Davison SN, 2008, VALUE HLTH; Dhingra RK, 2001, KIDNEY INT, V60, P1443, DOI 10.1046/j.1523-1755.2001.00947.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Graham J, 2008, NEPHROL DIAL TRANSPL, V23, P3585, DOI 10.1093/ndt/gfn317; Group K.W., 2002, AM J KIDNEY DIS, V39, pS46, DOI DOI 10.1053/AJKD.2002.30943; Hawkins N, 2005, MED DECIS MAKING, V25, P511, DOI 10.1177/0272989X05280562; Huijbregts HJT, 2008, CLIN J AM SOC NEPHRO, V3, P714, DOI 10.2215/CJN.02950707; Jindal Kailash, 2006, J Am Soc Nephrol, V17, pS1; JOHANNESSON M, 1994, MED DECIS MAKING, V14, P188, DOI 10.1177/0272989X9401400212; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Keough-Ryan TM, 2008, KIDNEY INT, V74, P356, DOI 10.1038/ki.2008.190; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Luxton G, 2010, NEPHROLOGY, V15, pS2, DOI 10.1111/j.1440-1797.2010.01224.x; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Moist LM, 2008, CLIN J AM SOC NEPHRO, V3, P1726, DOI 10.2215/CJN.01240308; Murad MH, 2008, J VASC SURG, V48, p31S, DOI 10.1016/j.jvs.2008.08.046; Naimark DMJ, 2008, MED DECIS MAKING, V28, P706, DOI 10.1177/0272989X08315241; Ng LJ, 2011, NEPHROL DIAL TRANSPL, V26, P3659, DOI 10.1093/ndt/gfr063; O'Hare AM, 2007, KIDNEY INT, V71, P555, DOI 10.1038/sj.ki.5002078; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2010, SEMIN DIALYSIS, V23, P452, DOI 10.1111/j.1525-139X.2010.00783.x; Pastan S, 2002, KIDNEY INT, V62, P620, DOI 10.1046/j.1523-1755.2002.00460.x; Patel ST, 2003, J VASC SURG, V38, P439, DOI 10.1016/S0741-5214(03)00732-8; Patel UD, 2005, AM J KIDNEY DIS, V46, P406, DOI 10.1053/j.ajkd.2005.05.027; Pisoni RL, 2002, KIDNEY INT, V61, P305, DOI 10.1046/j.1523-1755.2002.00117.x; Polkinghorne KR, 2004, J AM SOC NEPHROL, V15, P477, DOI 10.1097/01.ASN.0000109668.05157.05; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Scheltinga MR, 2009, NEPHROL DIAL TRANSPL; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Vachharajani TJ, 2011, CLIN J AM SOC NEPHRO, V6, P1663, DOI 10.2215/CJN.05830710; Vascular Access 2006 Work Group, 2006, AM J KIDNEY DIS S, V48, pS176, DOI [DOI 10.1053/J.AJKD.2006.04.029, 10.1053/j.ajkd.2006.04.029]; Xi W, 2011, NEPHROL DIAL TRANSPL, V26, P3302, DOI 10.1093/ndt/gfr055; Xue H, 2010, CLIN J AM SOC NEPHRO, V5, P2289, DOI 10.2215/CJN.03210410; Xue JL, 2003, AM J KIDNEY DIS, V42, P1013, DOI 10.1016/j.ajkd.2003.07.004	43	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28453	10.1371/journal.pone.0028453	http://dx.doi.org/10.1371/journal.pone.0028453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163305	gold, Green Published			2022-12-25	WOS:000298161900042
J	Powers-Fletcher, MV; Jambunathan, K; Brewer, JL; Krishnan, K; Feng, XZ; Galande, AK; Askew, DS				Powers-Fletcher, Margaret V.; Jambunathan, Kalyani; Brewer, Jordan L.; Krishnan, Karthik; Feng, Xizhi; Galande, Amit K.; Askew, David S.			Impact of the Lectin Chaperone Calnexin on the Stress Response, Virulence and Proteolytic Secretome of the Fungal Pathogen Aspergillus fumigatus	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; BLAST FUNGUS; GENE; HOMOLOG; THERMOTOLERANCE; TRANSLOCATION; CALRETICULIN	Calnexin is a membrane-bound lectin chaperone in the endoplasmic reticulum (ER) that is part of a quality control system that promotes the accurate folding of glycoproteins entering the secretory pathway. We have previously shown that ER homeostasis is important for virulence of the human fungal pathogen Aspergillus fumigatus, but the contribution of calnexin has not been explored. Here, we determined the extent to which A. fumigatus relies on calnexin for growth under conditions of environmental stress and for virulence. The calnexin gene, clxA, was deleted from A. fumigatus and complemented by reconstitution with the wild type gene. Loss of clxA altered the proteolytic secretome of the fungus, but had no impact on growth rates in either minimal or complex media at 37 degrees C. However, the Delta clxA mutant was growth impaired at temperatures above 42 degrees C and was hypersensitive to acute ER stress caused by the reducing agent dithiothreitol. In contrast to wild type A. fumigatus, Delta clxA hyphae were unable to grow when transferred to starvation medium. In addition, depleting the medium of cations by chelation prevented Delta clxA from sustaining polarized hyphal growth, resulting in blunted hyphae with irregular morphology. Despite these abnormal stress responses, the Delta clxA mutant remained virulent in two immunologically distinct models of invasive aspergillosis. These findings demonstrate that calnexin functions are needed for growth under conditions of thermal, ER and nutrient stress, but are dispensable for surviving the stresses encountered in the host environment.	[Powers-Fletcher, Margaret V.; Brewer, Jordan L.; Krishnan, Karthik; Feng, Xizhi; Askew, David S.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Jambunathan, Kalyani; Galande, Amit K.] SRI Int, Harrisonburg, VA USA	University System of Ohio; University of Cincinnati; SRI International	Powers-Fletcher, MV (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.	David.Askew@uc.edu		Askew, David/0000-0002-6477-2515; Mosur Krishnan, Karthik/0000-0003-4411-4029	National Institutes of Health [R01AI072297]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01AI072297 to DSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima H, 1998, FEBS LETT, V440, P89, DOI 10.1016/S0014-5793(98)01437-9; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; Bhabhra R, 2004, INFECT IMMUN, V72, P4731, DOI 10.1128/IAI.72.8.4731-4740.2004; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Chang YC, 2004, FUNGAL GENET BIOL, V41, P888, DOI 10.1016/j.fgb.2004.06.004; Chen Kuo-Shu, 2007, Journal of Microbiology Immunology and Infection, V40, P462; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Hajjar F, 2007, YEAST, V24, P89, DOI 10.1002/yea.1440; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; JOUBERT A, 2011, MOL MICROBIOL; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Kimura S, 2010, FUNGAL GENET BIOL, V47, P1044, DOI 10.1016/j.fgb.2010.09.003; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Marechal A, 2004, BIOCHEM J, V380, P441, DOI 10.1042/BJ20031546; Moreno MA, 2007, MOL MICROBIOL, V64, P1182, DOI 10.1111/j.1365-2958.2007.05726.x; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; PARLATI F, 1995, EMBO J, V14, P3064, DOI 10.1002/j.1460-2075.1995.tb07309.x; Ramos ER, 2011, ONCOLOGIST, V16, P1049, DOI 10.1634/theoncologist.2010-0290; Richie DL, 2007, EUKARYOT CELL, V6, P2437, DOI 10.1128/EC.00224-07; Richie DL, 2011, VIRULENCE, V2, P12, DOI 10.4161/viru.2.1.13345; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Schrettl M, 2010, PLOS PATHOG, V6, DOI DOI E1001124; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Shahinian S, 1998, GENETICS, V149, P843; Song YT, 2002, FEBS LETT, V512, P213, DOI 10.1016/S0014-5793(02)02258-5; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Wang H, 2003, MOL GENET GENOMICS, V268, P684, DOI 10.1007/s00438-002-0790-2; Watson DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021001; Xu XH, 2004, FEBS LETT, V570, P155, DOI 10.1016/j.febslet.2004.06.039; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988	44	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28865	10.1371/journal.pone.0028865	http://dx.doi.org/10.1371/journal.pone.0028865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163332	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900068
J	Vidovic, S; Horsman, GB; Liao, MM; Dillon, JAR				Vidovic, Sinisa; Horsman, Greg B.; Liao, Mingmin; Dillon, Jo-Anne R.			Influence of Conserved and Hypervariable Genetic Markers on Genotyping Circulating Strains of Neisseria gonorrhoeae	PLOS ONE			English	Article							ISOLATES REQUIRING PROLINE; FIELD GEL-ELECTROPHORESIS; PLASMID CONTENT; RECOMBINATION; DIVERSITY; CLUSTERS; SEROVAR; URACIL; EPIDEMIOLOGY; POPULATION	Presently there is no vaccine against Neisseria gonorrhoeae and therefore accurate information on gonococcal transmission plays a crucial role for interventions designed to limit the spread of infections caused by this microorganism. We evaluated the impact of two different categories of genetic markers, (i) concatenated sequences of 10 housekeeping genes and (ii) hypervariable porB DNA sequences, on the genetic relatedness and subsequently on genotyping analysis of this human pathogen. Eighty gonococcal isolates from Canada, China, the US, Argentina, Venezuela and Chile, collected over different times, were analyzed. Our results show that the choice of genetic marker had a profound effect on the interpretation of genotyping results associated with N. gonorrhoeae. The concatenated sequences of the housekeeping genes preserved the genetic relatedness of closely related isolates, enabling detection of the predominant strains circulating within a community (Saskatchewan, Canada) over an extended period of time. In contrast, a genetic marker based on antigen gene, porB, may lead to a failure to detect these predominant circulating strains. Based on the analysis of the DNA sequences of the 10 housekeeping genes, we identified two major clonal complexes, CC33 and CC22, which comprised STs from China, and Argentina as well as two STs from Canada. Several minor clonal complexes were observed among isolates from Saskatchewan. eBURST analysis suggested that the majority of the tested gonococcal isolates from Saskatchewan, Canada were endemic, with only a couple of genotypes introduced.	[Vidovic, Sinisa; Liao, Mingmin; Dillon, Jo-Anne R.] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Horsman, Greg B.] Saskatchewan Dis Control Lab, Regina, SK, Canada; [Dillon, Jo-Anne R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan	Vidovic, S (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	j.dillon@usask.ca		Vidovic, Sinisa/0000-0001-8264-3859	Saskatchewan Health Research Foundation [9127]	Saskatchewan Health Research Foundation	This work was supported by the Saskatchewan Health Research Foundation (Grant # 9127, the 2007-08 Health Research Team Grant Competition, Research Alliance for the Prevention of Infectious Disease [RAPID]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JS, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-35; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; CAMARENA JJ, 1995, SEX TRANSM DIS, V22, P128, DOI 10.1097/00007435-199503000-00009; CATLIN BW, 1973, J INFECT DIS, V128, P178, DOI 10.1093/infdis/128.2.178; DILLON JR, 1987, GENITOURIN MED, V63, P160; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fudyk TC, 1999, J BACTERIOL, V181, P5591, DOI 10.1128/JB.181.18.5591-5599.1999; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; HENDRY AT, 1979, CAN J MICROBIOL, V25, P512, DOI 10.1139/m79-075; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KNAPP JS, 1984, J INFECT DIS, V150, P44, DOI 10.1093/infdis/150.1.44; LI H, 1995, J MED MICROBIOL, V43, P208, DOI 10.1099/00222615-43-3-208; Liao MM, 2008, J ANTIMICROB CHEMOTH, V61, P478, DOI 10.1093/jac/dkm544; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; MEE BJ, 1993, J GEN MICROBIOL, V139, P2613, DOI 10.1099/00221287-139-11-2613; NEI M, 1986, MOL BIOL EVOL, V3, P418; NG LK, 1993, J CLIN MICROBIOL, V31, P1555, DOI 10.1128/JCM.31.6.1555-1561.1993; NG LK, 1995, J CLIN MICROBIOL, V33, P1039, DOI 10.1128/JCM.33.4.1039-1041.1995; OROURKE M, 1995, MOL MICROBIOL, V17, P865, DOI 10.1111/j.1365-2958.1995.mmi_17050865.x; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PICARD FJ, 1989, CAN J MICROBIOL, V35, P1069, DOI 10.1139/m89-179; Poh CL, 1996, J CLIN MICROBIOL, V34, P292, DOI 10.1128/JCM.34.2.292-295.1996; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rozen S, 2000, Methods Mol Biol, V132, P365; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SMITH JM, 1992, J MOL EVOL, V34, P126; Sneath P.H.A., 1973, NUMERICAL TAXONOMY F; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; Unemo M, 2011, CLIN MICROBIOL REV, V24, P447, DOI 10.1128/CMR.00040-10; Viscidi RP, 2003, J CLIN MICROBIOL, V41, P197, DOI 10.1128/JCM.41.1.197-204.2003; Viscidi RP, 2000, J CLIN MICROBIOL, V38, P4430, DOI 10.1128/JCM.38.12.4430-4438.2000; Wang IN, 1999, GENETICS, V151, P15; WEST SEH, 1989, CLIN MICROBIOL REV, V2, pS92, DOI 10.1128/CMR.2.Suppl.S92-103.1989; World Health Organization collaborating centre for STD and HIV Sydney Australia, 2001, ANT RES NEISS GON; XIA MS, 1995, J INFECT DIS, V171, P455, DOI 10.1093/infdis/171.2.455	44	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28259	10.1371/journal.pone.0028259	http://dx.doi.org/10.1371/journal.pone.0028259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163288	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900023
J	De Vos, D; Bruggeman, FJ; Westerhoff, HV; Bakker, BM				De Vos, Dirk; Bruggeman, Frank J.; Westerhoff, Hans V.; Bakker, Barbara M.			How Molecular Competition Influences Fluxes in Gene Expression Networks	PLOS ONE			English	Article							METABOLIC CONTROL ANALYSIS; SIGMA-FACTOR COMPETITION; MOIETY-CONSERVED CYCLES; CORE RNA-POLYMERASE; ESCHERICHIA-COLI; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; GROWTH-RATE; TRANSLATION	Often, in living cells different molecular species compete for binding to the same molecular target. Typical examples are the competition of genes for the transcription machinery or the competition of mRNAs for the translation machinery. Here we show that such systems have specific regulatory features and how they can be analysed. We derive a theory for molecular competition in parallel reaction networks. Analytical expressions for the response of network fluxes to changes in the total competitor and common target pools indicate the precise conditions for ultrasensitivity and intuitive rules for competitor strength. The calculations are based on measurable concentrations of the competitor-target complexes. We show that kinetic parameters, which are usually tedious to determine, are not required in the calculations. Given their simplicity, the obtained equations are easily applied to networks of any dimension. The new theory is illustrated for competing sigma factors in bacterial transcription and for a genome-wide network of yeast mRNAs competing for ribosomes. We conclude that molecular competition can drastically influence the network fluxes and lead to negative response coefficients and ultrasensitivity. Competitors that bind a large fraction of the target, like bacterial sigma(70), tend to influence competing pathways strongly. The less a competitor is saturated by the target, the more sensitive it is to changes in the concentration of the target, as well as to other competitors. As a consequence, most of the mRNAs in yeast turn out to respond ultrasensitively to changes in ribosome concentration. Finally, applying the theory to a genome-wide dataset we observe that high and low response mRNAs exhibit distinct Gene Ontology profiles.	[De Vos, Dirk; Bruggeman, Frank J.; Westerhoff, Hans V.; Bakker, Barbara M.] Vrije Univ Amsterdam, Netherlands Inst Syst Biol, Dept Mol Cell Biol, Amsterdam, Netherlands; [De Vos, Dirk; Westerhoff, Hans V.; Bakker, Barbara M.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Bruggeman, Frank J.] Ctr Math & Comp Sci, Regulatory Networks Grp, Netherlands Inst Syst Biol, Amsterdam, Netherlands; [Westerhoff, Hans V.] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Bakker, Barbara M.] Univ Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Univ Med Ctr Groningen, Groningen, Netherlands	Vrije Universiteit Amsterdam; University of Manchester; University of Groningen	De Vos, D (corresponding author), Univ Antwerp, B-2020 Antwerp, Belgium.	b.m.bakker@med.umcg.nl	Westerhoff, Hans V/I-5762-2012; Bruggeman, Frank/AAS-8371-2020; Bruggeman, Frank/C-4356-2015	Westerhoff, Hans V/0000-0002-0443-6114; Bruggeman, Frank/0000-0002-0255-4766; Bruggeman, Frank/0000-0002-0255-4766; Bakker, Barbara/0000-0001-6274-3633	Netherlands Genomics Initiative, through the Kluyver Centre for Genomics of Industrial Fermentation; IOP Genomics; EU; SysMO; Netherlands Centre for Systems Biology (NCSB); Rosalind Franklin Fellowship; BBSRC [BB/C008219/1, BBE0037291]; NISB; Biotechnology and Biological Sciences Research Council [BB/C008219/1] Funding Source: researchfish	Netherlands Genomics Initiative, through the Kluyver Centre for Genomics of Industrial Fermentation; IOP Genomics; EU(European Commission); SysMO; Netherlands Centre for Systems Biology (NCSB); Rosalind Franklin Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NISB; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Netherlands Genomics Initiative, through the Kluyver Centre for Genomics of Industrial Fermentation. The work of BMB and HVW is further funded by IOP Genomics, EU-FP7, SysMO, the Netherlands Centre for Systems Biology (NCSB), and a Rosalind Franklin Fellowship to BMB and grants from the BBSRC (in particular BB/C008219/1 and BBE0037291) to HVW. FJB is funded by NISB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Fell D., 1997, UNDERSTANDING CONTRO; GOLDBETER A, 1982, Q REV BIOPHYS, V15, P555, DOI 10.1017/S0033583500003449; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; HEINRICH R, 1980, J THEOR BIOL, V86, P279, DOI 10.1016/0022-5193(80)90008-9; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; HELMANN JD, 1991, MOL MICROBIOL, V5, P2875, DOI 10.1111/j.1365-2958.1991.tb01847.x; HOFMEYR JHS, 1986, EUR J BIOCHEM, V155, P631, DOI 10.1111/j.1432-1033.1986.tb09534.x; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KAWAKAMI K, 1979, MOL GEN GENET, V174, P107, DOI 10.1007/BF00268348; KAZAZIAN HH, 1968, J BIOL CHEM, V243, P6446; KHOLODENKO BN, 1994, EUR J BIOCHEM, V225, P179, DOI 10.1111/j.1432-1033.1994.00179.x; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; KJELDGAARD NO, 1963, J MOL BIOL, V6, P341, DOI 10.1016/S0022-2836(63)80093-5; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; Krogfelt KA, 2000, INFECT IMMUN, V68, P2518, DOI 10.1128/IAI.68.5.2518-2524.2000; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; Liu XY, 1996, MOL MICROBIOL, V21, P613, DOI 10.1111/j.1365-2958.1996.tb02569.x; Lovmar M, 2006, BIOCHIMIE, V88, P951, DOI 10.1016/j.biochi.2006.04.019; Maaloe O., 1979, BIOL REGUL DEV, P487; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Makinoshima H, 2003, J BACTERIOL, V185, P1338, DOI 10.1128/JB.185.4.1338-1345.2003; MALIK S, 1987, NUCLEIC ACIDS RES, V15, P8521, DOI 10.1093/nar/15.20.8521; Mehra A, 2006, BIOPHYS J, V90, P1136, DOI 10.1529/biophysj.105.062521; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; ROSE JK, 1977, P NATL ACAD SCI USA, V74, P3672, DOI 10.1073/pnas.74.9.3672; SAURO HM, 1994, BIOSYSTEMS, V33, P55, DOI 10.1016/0303-2647(94)90061-2; Schwabe A, 2011, METHOD ENZYMOL, V500, P597, DOI 10.1016/B978-0-12-385118-5.00028-1; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	55	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28494	10.1371/journal.pone.0028494	http://dx.doi.org/10.1371/journal.pone.0028494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163025	gold, Green Published			2022-12-25	WOS:000298172800041
J	Fernandes, N; Case, RJ; Longford, SR; Seyedsayamdost, MR; Steinberg, PD; Kjelleberg, S; Thomas, T				Fernandes, Neil; Case, Rebecca J.; Longford, Sharon R.; Seyedsayamdost, Mohammad R.; Steinberg, Peter D.; Kjelleberg, Staffan; Thomas, Torsten			Genomes and Virulence Factors of Novel Bacterial Pathogens Causing Bleaching Disease in the Marine Red Alga Delisea pulchra	PLOS ONE			English	Article							BLACK BAND DISEASE; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; H-NS; PHAEOBACTER-GALLAECIENSIS; SECONDARY METABOLITES; ENVIRONMENTAL SIGNALS; ERWINIA-CHRYSANTHEMI; ALPHA-PROTEOBACTERIA; ROSEOBACTER LINEAGE	Nautella sp. R11, a member of the marine Roseobacter clade, causes a bleaching disease in the temperate-marine red macroalga, Delisea pulchra. To begin to elucidate the molecular mechanisms underpinning the ability of Nautella sp. R11 to colonize, invade and induce bleaching of D. pulchra, we sequenced and analyzed its genome. The genome encodes several factors such as adhesion mechanisms, systems for the transport of algal metabolites, enzymes that confer resistance to oxidative stress, cytolysins, and global regulatory mechanisms that may allow for the switch of Nautella sp. R11 to a pathogenic lifestyle. Many virulence effectors common in phytopathogenic bacteria are also found in the R11 genome, such as the plant hormone indole acetic acid, cellulose fibrils, succinoglycan and nodulation protein L. Comparative genomics with non-pathogenic Roseobacter strains and a newly identified pathogen, Phaeobacter sp. LSS9, revealed a patchy distribution of putative virulence factors in all genomes, but also led to the identification of a quorum sensing (QS) dependent transcriptional regulator that was unique to pathogenic Roseobacter strains. This observation supports the model that a combination of virulence factors and QS-dependent regulatory mechanisms enables indigenous members of the host alga's epiphytic microbial community to switch to a pathogenic lifestyle, especially under environmental conditions when innate host defence mechanisms are compromised.	[Fernandes, Neil; Longford, Sharon R.; Steinberg, Peter D.; Kjelleberg, Staffan; Thomas, Torsten] Univ New S Wales, CMB, Sydney, NSW, Australia; [Fernandes, Neil; Kjelleberg, Staffan; Thomas, Torsten] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Case, Rebecca J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Longford, Sharon R.; Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Seyedsayamdost, Mohammad R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kjelleberg, Staffan] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore	University of New South Wales Sydney; University of New South Wales Sydney; Harvard University; Harvard Medical School; University of New South Wales Sydney; Harvard University; Harvard Medical School; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Fernandes, N (corresponding author), Univ New S Wales, CMB, Sydney, NSW, Australia.	thomas@unsw.edu.au	Kjelleberg, Staffan/AAB-4641-2020; Seyedsayamdost, Mohammad/AHD-0859-2022; Kjelleberg, Staffan/C-9229-2015; Case, Rebecca/A-2624-2014	Kjelleberg, Staffan/0000-0003-4271-6413; Seyedsayamdost, Mohammad/0000-0003-2707-4854; Kjelleberg, Staffan/0000-0003-4271-6413; Case, Rebecca/0000-0003-2417-2969; Steinberg, Peter/0000-0002-1781-0726; Thomas, Torsten/0000-0001-9557-3001	Australian Research Council; Betty and Gordon Moore Foundation; Centre for Marine Bio-Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM098299, K99GM098299] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); Centre for Marine Bio-Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Australian Research Council, the Betty and Gordon Moore Foundation and the Centre for Marine Bio-Innovation supported this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Abramovitch RB, 2004, CURR OPIN PLANT BIOL, V7, P356, DOI 10.1016/j.pbi.2004.05.002; ALVAREZ ME, 1998, BIOPHYS J, V92, P773; Amaro AM, 2005, J EUKARYOT MICROBIOL, V52, P191, DOI 10.1111/j.1550-7408.2005.00031.x; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Antunez-Lamas M, 2009, MICROBIOL-SGM, V155, P434, DOI 10.1099/mic.0.022244-0; Ashen JB, 2000, APPL ENVIRON MICROB, V66, P3024, DOI 10.1128/AEM.66.7.3024-3030.2000; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Bartsev AV, 2004, PLANT PHYSIOL, V134, P871, DOI 10.1104/pp.103.031740; BEATTIE GA, 1995, ANNU REV PHYTOPATHOL, V33, P145, DOI 10.1146/annurev.py.33.090195.001045; Becker PT, 2009, J INVERTEBR PATHOL, V100, P127, DOI 10.1016/j.jip.2008.11.002; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Boyd KG, 1999, BIOFOULING, V14, P227, DOI 10.1080/08927019909378414; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cai W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024701; Calva E, 2006, MICROB ECOL, V51, P166, DOI 10.1007/s00248-005-0087-1; Campbell AH, 2011, GLOBAL CHAN IN PRESS; Case R, THESIS U NEW S WALES; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; Case RJ, 2011, ENVIRON MICROBIOL, V13, P529, DOI 10.1111/j.1462-2920.2010.02356.x; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cohen BA, 2002, PHYTOPATHOLOGY, V92, P590, DOI 10.1094/PHYTO.2002.92.6.590; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Cotter PA, 2000, ANNU REV MICROBIOL, V54, P519, DOI 10.1146/annurev.micro.54.1.519; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; de Nys R, 2006, MAR MOL BIOTECHNOL, V42, P55; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DENYS R, 1995, BIOFOULING, V8, P259, DOI 10.1080/08927019509378279; Ferluga S, 2009, J BACTERIOL, V191, P890, DOI 10.1128/JB.01507-08; Forman S, 2003, INFECT IMMUN, V71, P2253, DOI 10.1128/IAI.71.4.2253-2257.2003; Geider K, 2001, ACTA HORT ISHS, V590, P457; Gledhill M, 2007, MAR CHEM, V103, P393, DOI 10.1016/j.marchem.2006.10.008; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Imai I, 2006, AFR J MAR SCI, V28, P319, DOI 10.2989/18142320609504170; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; LITTLER MM, 1995, SCIENCE, V267, P1356, DOI 10.1126/science.267.5202.1356; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Longford S, 2007, THESIS U NEW S WALES; Maloy AP, 2007, AQUACULTURE, V269, P71, DOI 10.1016/j.aquaculture.2007.04.008; Marie C, 2003, MOL PLANT MICROBE IN, V16, P743, DOI 10.1094/MPMI.2003.16.9.743; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martens T, 2006, INT J SYST EVOL MICR, V56, P1293, DOI 10.1099/ijs.0.63724-0; MATTHYSSE AG, 1983, J BACTERIOL, V154, P906, DOI 10.1128/JB.154.2.906-915.1983; Maximilien R, 1998, AQUAT MICROB ECOL, V15, P233, DOI 10.3354/ame015233; Mithofer A, 2002, TRENDS PLANT SCI, V7, P440, DOI 10.1016/S1360-1385(02)02336-1; Mole BM, 2007, TRENDS MICROBIOL, V15, P363, DOI 10.1016/j.tim.2007.06.005; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Nasser W, 2001, MOL PLANT MICROBE IN, V14, P10, DOI 10.1094/MPMI.2001.14.1.10; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Parker CT, 2009, CELL MICROBIOL, V11, P363, DOI 10.1111/j.1462-5822.2008.01272.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Quest B, 2004, EUR J BIOCHEM, V271, P1117, DOI 10.1111/j.1432-1033.2004.04015.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Rao D, 2006, APPL ENVIRON MICROB, V72, P5547, DOI 10.1128/AEM.00449-06; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI 10.1038/NCHEM.1002; SMIT G, 1987, J BACTERIOL, V169, P4294, DOI 10.1128/jb.169.9.4294-4301.1987; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Soto MJ, 2006, MICROBIOL-SGM, V152, P3167, DOI 10.1099/mic.0.29112-0; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; TANCREDE C, 1992, EUR J CLIN MICROBIOL, V11, P1012, DOI 10.1007/BF01967791; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; Vandecandelaere I, 2009, INT J SYST EVOL MICR, V59, P811, DOI 10.1099/ijs.0.002683-0; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Waldminghaus T, 2005, BIOL CHEM, V386, P1279, DOI 10.1515/BC.2005.145; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; White-Ziegler CA, 2009, J BACTERIOL, V191, P1106, DOI 10.1128/JB.00599-08; Williams P, 2000, PHILOS T R SOC B, V355, P667, DOI 10.1098/rstb.2000.0607; YAMADA T, 1993, ANNU REV PHYTOPATHOL, V31, P253, DOI 10.1146/annurev.py.31.090193.001345; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	120	75	75	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27387	10.1371/journal.pone.0027387	http://dx.doi.org/10.1371/journal.pone.0027387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162749	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000298172800004
J	Robinson, KL; Tohidi-Esfahani, D; Lo, N; Simpson, SJ; Sword, GA				Robinson, Katie L.; Tohidi-Esfahani, Donya; Lo, Nathan; Simpson, Stephen J.; Sword, Gregory A.			Evidence for Widespread Genomic Methylation in the Migratory Locust, Locusta migratoria (Orthoptera: Acrididae)	PLOS ONE			English	Article							EGG POD FOAM; DNA METHYLATION; PHASE POLYPHENISM; GENE-EXPRESSION; INSECTICIDE RESISTANCE; CPG METHYLATION; SYSTEM; METHYLTRANSFERASE; CONSERVATION; EVOLUTION	The importance of DNA methylation in mammalian and plant systems is well established. In recent years there has been renewed interest in DNA methylation in insects. Accumulating evidence, both from mammals and insects, points towards an emerging role for DNA methylation in the regulation of phenotypic plasticity. The migratory locust (Locusta migratoria) is a model organism for the study of phenotypic plasticity. Despite this, there is little information available about the degree to which the genome is methylated in this species and genes encoding methylation machinery have not been previously identified. We therefore undertook an initial investigation to establish the presence of a functional DNA methylation system in L. migratoria. We found that the migratory locust possesses genes that putatively encode methylation machinery (DNA methyltransferases and a methyl-binding domain protein) and exhibits genomic methylation, some of which appears to be localised to repetitive regions of the genome. We have also identified a distinct group of genes within the L. migratoria genome that appear to have been historically methylated and show some possible functional differentiation. These results will facilitate more detailed research into the functional significance of DNA methylation in locusts.	[Robinson, Katie L.; Tohidi-Esfahani, Donya; Lo, Nathan; Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Tohidi-Esfahani, Donya] Australian Natl Univ, Coll Med Biol & Environm, Canberra, ACT, Australia; [Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of Sydney; Australian National University; Texas A&M University System; Texas A&M University College Station	Robinson, KL (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	katie.robinson@sydney.edu.au	Tohidi-Esfahani, Donya/M-7491-2019; Lo, Nathan/E-6115-2010	Lo, Nathan/0000-0003-2176-2840; Simpson, Stephen J./0000-0003-0256-7687; Sword, Gregory/0000-0003-2094-2436; Tohidi-Esfahani, Donya/0000-0003-3682-7272; Robinson, Katie/0000-0003-0757-910X	Australian Research Council; University of Sydney	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	This work was supported by an Australian Research Council Discovery Project grant to GAS, SJS and NL (http://www.arc.gov.au/ncgp/dp/dp_default.htm) and a University of Sydney Postgraduate Award to KLR (http://sydney.edu.au/scholarships/research/postgraduate_awards.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RLP, 1990, BIOCHEM J, V265, P309, DOI 10.1042/bj2650309; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ben Hamouda A, 2009, J INSECT PHYSIOL, V55, P617, DOI 10.1016/j.jinsphys.2009.03.008; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1485, DOI 10.1093/nar/8.7.1485; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Boerjan B, 2011, GEN COMP ENDOCR, V173, P120, DOI 10.1016/j.ygcen.2011.05.003; Bongiorni S, 2003, GENETICA, V117, P271, DOI 10.1023/A:1022964700446; BRADFIELD JY, 1985, DNA-J MOLEC CELL BIO, V4, P357, DOI 10.1089/dna.1985.4.357; BROWN SJ, 1990, INSECT BIOCHEM, V20, P185, DOI 10.1016/0020-1790(90)90011-I; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Clissold FJ, 2010, P ROY SOC B-BIOL SCI, V277, P1751, DOI 10.1098/rspb.2009.2045; Drummond A, 2010, GENEIOUS V5 1; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; FIELD LM, 1989, FEBS LETT, V243, P323, DOI 10.1016/0014-5793(89)80154-1; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Food and Agriculture Organization of the United Nations, 2010, MIGR LOC; GAGE LP, 1974, CHROMOSOMA, V45, P27; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gray LJ, 2009, BIOL LETTERS, V5, P306, DOI 10.1098/rsbl.2008.0764; Gregory TR, 2002, GENETICA, V115, P131, DOI 10.1023/A:1016032400147; Guo W, 2010, J INSECT PHYSIOL, V56, P943, DOI 10.1016/j.jinsphys.2010.05.007; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hick CA, 1996, INSECT BIOCHEM MOLEC, V26, P41, DOI 10.1016/0965-1748(95)00059-3; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsu DW, 1999, P NATL ACAD SCI USA, V96, P9751, DOI 10.1073/pnas.96.17.9751; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Kirkness EF, 2011, P NATL ACAD SCI USA, V108, P6335, DOI 10.1073/pnas.1103909108; Krauss V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007223; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lockett GA, 2010, NEUROREPORT, V21, P812, DOI 10.1097/WNR.0b013e32833ce5be; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Mandrioli M, 2003, GENETICA, V119, P187, DOI 10.1023/A:1026016021415; Marhold J, 2004, INSECT MOL BIOL, V13, P117, DOI 10.1111/j.0962-1075.2004.00466.x; McCaffery AR, 1998, J EXP BIOL, V201, P347; OTT J, 1979, HUM GENET, V51, P79, DOI 10.1007/BF00278296; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROESSINGH P, 1993, P ROY SOC B-BIOL SCI, V252, P43, DOI 10.1098/rspb.1993.0044; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; SARKAR S, 1992, GENOME, V35, P163, DOI 10.1139/g92-026; Simpson S. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P147; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2002, J EXP BIOL, V205, P121; Song Hojun, 2005, Journal of Orthoptera Research, V14, P235, DOI 10.1665/1082-6467(2005)14[235:PPOTEO]2.0.CO;2; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Sword GA, 2010, J INSECT PHYSIOL, V56, P949, DOI 10.1016/j.jinsphys.2010.05.005; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka S, 2010, J INSECT PHYSIOL, V56, P911, DOI 10.1016/j.jinsphys.2010.05.013; Tweedie S, 1999, NAT GENET, V23, P389, DOI 10.1038/70490; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Uvarov B. P., 1966, GRASSHOPPERS LOCUSTS, V1; Walsh TK, 2010, INSECT MOL BIOL, V19, P215, DOI 10.1111/j.1365-2583.2009.00974.x; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Wang Y, 2009, J MOL EVOL, V68, P700, DOI 10.1007/s00239-009-9244-3; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WILMORE PJ, 1975, CHROMOSOMA, V51, P337, DOI 10.1007/BF00326320; WYATT GR, 1951, BIOCHEM J, V48, P584, DOI 10.1042/bj0480584; Xiang H, 2010, NAT BIOTECHNOL, V28, P756, DOI 10.1038/nbt0710-756d; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	74	26	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28167	10.1371/journal.pone.0028167	http://dx.doi.org/10.1371/journal.pone.0028167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163001	Green Published, gold, Green Submitted			2022-12-25	WOS:000298172800017
J	Feligioni, M; Brambilla, E; Camassa, A; Sclip, A; Arnaboldi, A; Morelli, F; Antoniou, X; Borsello, T				Feligioni, Marco; Brambilla, Elisa; Camassa, Agata; Sclip, Alessandra; Arnaboldi, Andrea; Morelli, Federica; Antoniou, Xanthi; Borsello, Tiziana			Crosstalk between JNK and SUMO Signaling Pathways: deSUMOylation Is Protective against H2O2-Induced Cell Injury	PLOS ONE			English	Article							N-TERMINAL KINASE; OXIDATIVE STRESS; C-JUN; CEREBRAL-ISCHEMIA; PROTEIN SUMOYLATION; ACTIVATION; DEATH; ANTIOXIDANTS; CONJUGATION; OXIDANTS	Background: Oxidative stress is a key feature in the pathogenesis of several neurological disorders. Following oxidative stress stimuli a wide range of pathways are activated and contribute to cellular death. The mechanism that couples c-Jun N-terminal kinase (JNK) signaling, a key pathway in stress conditions, to the small ubiquitin-related modifier (SUMO), an emerging protein in the field, is largely unknown. Methodology/ Principal Findings: With this study we investigated if SUMOylation participates in the regulation of JNK activation as well as cellular death in a model of H2O2 induced-oxidative stress. Our data show that H2O2 modulates JNK activation and induces cellular death in neuroblastoma SH-SY5Y cells. Inhibition of JNK's action with the D-JNKI1 peptide rescued cells from death. Following H2O2, SUMO-1 over-expression increased phosphorylation of JNK and exacerbated cell death, although only in conditions of mild oxidative stress. Furthermore inhibition of SUMOylation, following transfection with SENP1, interfered with JNK activation and rescued cells from H2O2 induced death. Importantly, in our model, direct interaction between these proteins can occur. Conclusions/Significance: Taken together our results show that SUMOylation may significantly contribute to modulation of JNK activation and contribute to cell death in oxidative stress conditions.	[Feligioni, Marco; Brambilla, Elisa; Camassa, Agata; Sclip, Alessandra; Arnaboldi, Andrea; Morelli, Federica; Antoniou, Xanthi; Borsello, Tiziana] Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Feligioni, M (corresponding author), Mario Negri Inst Pharmacol Res, Dept Neurosci, Via Eritrea 62, Milan, Italy.	tiziana.borsello@marionegri.it	Brambilla, Elisabeth MP/L-8796-2013; Borsello, Tiziana/ABG-7759-2020; Feligioni, Marco/F-8649-2012; Stefanadis, Christodoulos/ABH-2232-2020; Borsello, Tiziana/J-8232-2016	Stefanadis, Christodoulos/0000-0001-5974-6454; Borsello, Tiziana/0000-0002-9729-7642	San Paolo [2008-2437]; Marie Curie Industry-Academia Partnerships and Pathways (IAPP) CPADS (Cell permeable peptides as drug delivery system); CARIPLO (Cassa di risparmio delle provincie Lombarde) Foundation [2009-2425]	San Paolo; Marie Curie Industry-Academia Partnerships and Pathways (IAPP) CPADS (Cell permeable peptides as drug delivery system); CARIPLO (Cassa di risparmio delle provincie Lombarde) Foundation(Fondazione Cariplo)	This study was supported by San Paolo 2008-2437, the Marie Curie Industry-Academia Partnerships and Pathways (IAPP) CPADS (Cell permeable peptides as drug delivery system) and CARIPLO (Cassa di risparmio delle provincie Lombarde) Foundation 2009-2425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer J, 2006, BRIT J HAEMATOL, V132, P108, DOI 10.1111/j.1365-2141.2005.05834.x; Bagatini MD, 2011, HEART VESSELS, V26, P55, DOI 10.1007/s00380-010-0029-9; Behl C, 1999, INT J VITAM NUTR RES, V69, P213, DOI 10.1024/0300-9831.69.3.213; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; de Diego-Otero Y, 2009, NEUROPSYCHOPHARMACOL, V34, P1011, DOI 10.1038/npp.2008.152; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golbidi S, 2011, CURR DIABETES REV, V7, P106, DOI 10.2174/157339911794940729; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Lee YS, 2005, EMBO REP, V6, P949, DOI 10.1038/sj.embor.7400511; Leitao BB, 2011, FASEB J; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Navascues J, 2007, CHROMOSOMA, V116, P441, DOI 10.1007/s00412-007-0107-7; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Repici M, 2009, NEUROSCIENCE, V159, P94, DOI 10.1016/j.neuroscience.2008.11.049; Ryan CM, 2010, BIOCHEM BIOPH RES CO, V391, P1136, DOI 10.1016/j.bbrc.2009.12.040; Vogiatzi G, 2009, HELL J CARDIOL, V50, P402; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	35	45	48	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28185	10.1371/journal.pone.0028185	http://dx.doi.org/10.1371/journal.pone.0028185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164242	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400043
J	Tadesse, T; Demissie, M; Berhane, Y; Kebede, Y; Abebe, M				Tadesse, Takele; Demissie, Meaza; Berhane, Yemane; Kebede, Yigzaw; Abebe, Markos			Two-Thirds of Smear-Positive Tuberculosis Cases in the Community Were Undiagnosed in Northwest Ethiopia: Population Based Cross-Sectional Study	PLOS ONE			English	Article							PREVALENCE	Background: Tuberculosis (TB) case detection rate remains low in Ethiopia. One of the underlying reasons is the emphasis on passive case finding strategy which may seriously underestimate the burden of the disease. Estimating the prevalence of smear-positive pulmonary TB through active case finding at population level can help assessing the degree to which passive case detection is successful. Methods and findings: This is population based cross-sectional study. The study population was all individuals aged >= 14 years. Interviews using a uniform questionnaire were done initially to identify individuals with chronic cough (>= 15 days) and the two sputum (spot and morning) samples were gathered for standard smear microscopy. A total of 23,590 individuals aged >= 14 years were interviewed and 984 had a chronic cough for >= 15 days. Of 831 individuals who provided two sputum samples for acid fast bacilli (AFB), 41 had positive smears. A total of 22 smear-positive TB cases detected through passive case finding were on anti-TB treatment. The prevalence of new smear-positive TB was 174 per 100,000 in persons aged >= 14 years (95% CI: 121-227). The ratio of active to passive case finding was 2:1. Higher rates of smear-positivity were observed among females [AOR: 3.28, 95% CI (1.54-6.77)], and in the age group >= 45 years [AOR: 2.26, 95% CI (1.12-4.59). Conclusions: The study revealed that about two-thirds of patients with active TB remain undiagnosed and thus untreated. This may indicate the need for strengthening case detection at the community level. Furthermore, the high burden of TB among females and in the age group >= 45 years warrants appropriate measures to control the disease.	[Tadesse, Takele; Kebede, Yigzaw] Univ Gondar, Sch Publ Hlth, Gondar, Ethiopia; [Demissie, Meaza; Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Abebe, Markos] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	University of Gondar; Addis Continental Institute of Public Health	Tadesse, T (corresponding author), Univ Gondar, Sch Publ Hlth, Gondar, Ethiopia.	takele_tadesse@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	University of Gondar; Armeaur Hansen Research Institute; World Health Organization	University of Gondar; Armeaur Hansen Research Institute; World Health Organization(World Health Organization)	Financial support was obtained from the University of Gondar, Armeaur Hansen Research Institute and the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Statistical Authority, 2007, POP HOUS CENS ETH RE; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Ditah IC, 2008, THORAX, V63, P440, DOI 10.1136/thx.2006.073916; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Federal Ministry of Health, 2010, ANN HLTH SERV REP; Federal Ministry of Health Ethiopia, 2008, TUB LEPR TB HIV PREV; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Horie T, 2007, INT J TUBERC LUNG D, V11, P562; Jianming W, 2008, BMC PUBLIC HEALTH, V8, P1; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P7; Ministry of Health, 2007, SINGL POINT HIV PREV; Murray E, 2005, INT J TUBERC LUNG D, V13, P767; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Norval PY, 2004, INT J TUBERC LUNG D, V8, P299; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Sebhatu M, 2007, B WORLD HEALTH ORGAN, V85, P593, DOI 10.2471/BLT.06.038604; Shargie B, 2009, B WORLD HEALTH ORGAN, V84, P112; Shargie EB, 2006, INT J TUBERC LUNG D, V10, P87; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Tadesse T, 2011, EJHBS IN PRESS; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Thomas N, 2005, MALAWI MED J, V17, P33; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; van der Werf MJ, 2007, TROP MED INT HEALTH, V12, P475, DOI 10.1111/j.1365-3156.2006.01799.x; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; WHO, 2009, STOP TB PARTN WHO GL; World Health Organization, 2010, TUB PREV SURV HDB; World Health Organization, 2010, WHOHTMTB20107; World Health Organization (WHO), 2009, WHOHTMTB2009426; Yimer S, 2009, INT J TUBERC LUNG D, V13, P1399; Zaman K, 2006, EPIDEMIOL INFECT, V134, P1052, DOI 10.1017/S0950268806006108	35	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28258	10.1371/journal.pone.0028258	http://dx.doi.org/10.1371/journal.pone.0028258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164256	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400057
J	Tanadini, LG; Schmidt, BR				Tanadini, Lorenzo G.; Schmidt, Benedikt R.			Population Size Influences Amphibian Detection Probability: Implications for Biodiversity Monitoring Programs	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; SPECIES DETECTION PROBABILITY; BIOLOGICAL DIVERSITY; COUNT DATA; MODELS; ABUNDANCE; SCALE; DISTRIBUTIONS; FLUCTUATIONS; EXTINCTION	Monitoring is an integral part of species conservation. Monitoring programs must take imperfect detection of species into account in order to be reliable. Theory suggests that detection probability may be determined by population size but this relationship has not yet been assessed empirically. Population size is particularly important because it may induce heterogeneity in detection probability and thereby cause bias in estimates of biodiversity. We used a site occupancy model to analyse data from a volunteer-based amphibian monitoring program to assess how well different variables explain variation in detection probability. An index to population size best explained detection probabilities for four out of six species (to avoid circular reasoning, we used the count of individuals at a previous site visit as an index to current population size). The relationship between the population index and detection probability was positive. Commonly used weather variables best explained detection probabilities for two out of six species. Estimates of site occupancy probabilities differed depending on whether the population index was or was not used to model detection probability. The relationship between the population index and detectability has implications for the design of monitoring and species conservation. Most importantly, because many small populations are likely to be overlooked, monitoring programs should be designed in such a way that small populations are not overlooked. The results also imply that methods cannot be standardized in such a way that detection probabilities are constant. As we have shown here, one can easily account for variation in population size in the analysis of data from long-term monitoring programs by using counts of individuals from surveys at the same site in previous years. Accounting for variation in population size is important because it can affect the results of long-term monitoring programs and ultimately the conservation of imperiled species.	[Tanadini, Lorenzo G.; Schmidt, Benedikt R.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmidt, Benedikt R.] KARCH, Neuchatel, Switzerland	University of Zurich	Tanadini, LG (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	benedikt.schmidt@ieu.uzh.ch	Tanadini, Lorenzo/E-7290-2015; Schmidt, Benedikt R./B-8491-2008	Tanadini, Lorenzo/0000-0003-4337-0637; Schmidt, Benedikt R./0000-0002-4023-1001	MAVA Fondation pour la nature	MAVA Fondation pour la nature	BRS was supported by the "MAVA Fondation pour la nature.'' The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpizar-Jara R, 2004, OECOLOGIA, V141, P652, DOI 10.1007/s00442-004-1641-0; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; BLANKENHORN HJ, 1972, OECOLOGIA, V9, P223, DOI 10.1007/BF00345233; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Dorazio RM, 2007, ECOLOGY, V88, P2773, DOI 10.1890/07-0006.1; Fletcher D.J., 1994, STAT ECOLOGY ENV MON, P105; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2004, BASIC APPL ECOL, V5, P65, DOI 10.1078/1439-1791-00194; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kropfli M, 2010, AMPHIBIA-REPTILIA, V31, P403, DOI 10.1163/156853810791769374; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marsh DM, 2001, BIOL CONSERV, V101, P327, DOI 10.1016/S0006-3207(01)00076-3; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; Mcclintock BT, 2010, J WILDLIFE MANAGE, V74, P1882, DOI 10.2193/2009-321; Meier C., 1999, MITT AARGAUER NAT GE, V35, P41; Meyer A, 2009, SCHLANGENSPUREN KROT; Meyer AH, 1998, P ROY SOC B-BIOL SCI, V265, P523, DOI 10.1098/rspb.1998.0326; Nichols J. D., 2008, J ECOLOGICAL ENV STA, V3, P201; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Pellet J, 2005, BIOL CONSERV, V123, P27, DOI 10.1016/j.biocon.2004.10.005; Pellet J, 2008, J INSECT CONSERV, V12, P155, DOI 10.1007/s10841-007-9075-8; Pellet J, 2006, OECOLOGIA, V149, P65, DOI 10.1007/s00442-006-0432-1; Peterson James T., 2004, P173; Pollock Kenneth H., 2004, P43; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; PRESTON FW, 1979, ECOLOGY, V60, P451, DOI 10.2307/1936061; Royle JA, 2006, J AGR BIOL ENVIR ST, V11, P249, DOI 10.1198/108571106X129153; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Salvidio S, 2009, BIOL CONSERV, V142, P455, DOI 10.1016/j.biocon.2008.10.035; SANDLAND RL, 1981, BIOMETRIKA, V68, P531, DOI 10.1093/biomet/68.2.531; Schmidt BR, 2005, J WILDLIFE MANAGE, V69, P884, DOI 10.2193/0022-541X(2005)069[0884:RIOPPA]2.0.CO;2; Schmidt BR, 2005, AQUAT CONSERV, V15, P681, DOI 10.1002/aqc.740; Schmidt BR, 2004, HERPETOL J, V14, P167; Sewell D, 2010, BIOL CONSERV, V143, P2102, DOI 10.1016/j.biocon.2010.05.019; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vences Miguel, 2007, Zeitschrift fuer Feldherpetologie, V14, P153; Weber D, 2004, GLOBAL ECOL BIOGEOGR, V13, P97, DOI 10.1111/j.1466-882X.2004.00078.x; Weir LA, 2005, J HERPETOL, V39, P627; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	46	53	55	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28244	10.1371/journal.pone.0028244	http://dx.doi.org/10.1371/journal.pone.0028244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164250	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000298171400051
J	Braun, G; Nemcsics, B; Enyedi, P; Czirjak, G				Braun, Gabriella; Nemcsics, Balazs; Enyedi, Peter; Czirjak, Gabor			TRESK Background K+ Channel Is Inhibited by PAR-1/MARK Microtubule Affinity-Regulating Kinases in Xenopus Oocytes	PLOS ONE			English	Article							ROOT GANGLION NEURONS; POTASSIUM CHANNELS; NEURITE OUTGROWTH; SENSORY NEURONS; ION CHANNELS; POLARITY; PHOSPHORYLATION; ESTABLISHMENT; LOCALIZATION; BINDING	TRESK (TWIK-related spinal cord K+ channel, KCNK18) is a major background K+ channel of sensory neurons. Dominant-negative mutation of TRESK is linked to familial migraine. This important two-pore domain K+ channel is uniquely activated by calcineurin. The calcium/calmodulin-dependent protein phosphatase directly binds to the channel and activates TRESK current several-fold in Xenopus oocytes and HEK293 cells. We have recently shown that the kinase, which is responsible for the basal inhibition of the K+ current, is sensitive to the adaptor protein 14-3-3. Therefore we have examined the effect of the 14-3-3-inhibited PAR-1/MARK, microtubule-associated-protein/microtubule affinity-regulating kinase on TRESK in the Xenopus oocyte expression system. MARK1, MARK2 and MARK3 accelerated the return of TRESK current to the resting state after the calcium-dependent activation. Several other serine-threonine kinase types, generally involved in the modulation of other ion channels, failed to influence TRESK current recovery. MARK2 phosphorylated the primary determinant of regulation, the cluster of three adjacent serine residues (S274, 276 and 279) in the intracellular loop of mouse TRESK. In contrast, serine 264, the 14-3-3-binding site of TRESK, was not phosphorylated by the kinase. Thus MARK2 selectively inhibits TRESK activity via the S274/276/279 cluster, but does not affect the direct recruitment of 14-3-3 to the channel. TRESK is the first example of an ion channel phosphorylated by the dynamically membrane-localized MARK kinases, also known as general determinants of cellular polarity. These results raise the possibility that microtubule dynamics is coupled to the regulation of excitability in the neurons, which express TRESK background potassium channel.	[Braun, Gabriella; Nemcsics, Balazs; Enyedi, Peter; Czirjak, Gabor] Semmelweis Univ, Dept Physiol, Budapest, Hungary	Semmelweis University	Braun, G (corresponding author), Semmelweis Univ, Dept Physiol, Budapest, Hungary.	czirjak@eok.sote.hu	Braun, Gabriella/D-7494-2015	Braun, Gabriella/0000-0002-1762-7622; Czirjak, Gabor/0000-0002-5485-2327	Hungarian National Research Fund (OTKA) [K75239]; Hungarian Academy of Sciences	Hungarian National Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian National Research Fund (OTKA K75239). Gabor Czirjak was supported by the Janos Bolyai fellowship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Chae YJ, 2010, ANESTHESIOLOGY, V113, P1326, DOI 10.1097/ALN.0b013e3181f90ca5; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Czirjak G, 2010, J BIOL CHEM, V285, P14549, DOI 10.1074/jbc.M110.102020; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gerhold KA, 2009, ANN NY ACAD SCI, V1170, P184, DOI 10.1111/j.1749-6632.2009.03895.x; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Huang Dong-Yue, 2008, Neurosci Bull, V24, P166, DOI 10.1007/s12264-008-0225-0; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Mathie A, 2010, J PHARM PHARMACOL, V62, P1089, DOI 10.1111/j.2042-7158.2010.01131.x; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Sapir T, 2008, J NEUROSCI, V28, P13008, DOI 10.1523/JNEUROSCI.2363-08.2008; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Smith HS, 2009, PAIN PHYSICIAN, V12, pE309; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062	42	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28119	10.1371/journal.pone.0028119	http://dx.doi.org/10.1371/journal.pone.0028119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145024	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168900007
J	Collins, SL; Herve, R; Keevil, CW; Blaydes, JP; Webb, JS				Collins, Samuel L.; Herve, Rodolphe; Keevil, C. W.; Blaydes, Jeremy P.; Webb, Jeremy S.			Down-Regulation of DNA Mismatch Repair Enhances Initiation and Growth of Neuroblastoma and Brain Tumour Multicellular Spheroids	PLOS ONE			English	Article							CANCER STEM-CELLS; GENETIC INSTABILITY; MUTATOR PHENOTYPE; ALKYLATING-AGENTS; COLON-CANCER; EXPRESSION; RESISTANCE; HYPOXIA; CULTURE; MODEL	Multicellular tumour spheroid (MCTS) cultures are excellent model systems for simulating the development and microenvironmental conditions of in vivo tumour growth. Many documented cell lines can generate differentiated MCTS when cultured in suspension or in a non-adhesive environment. While physiological and biochemical properties of MCTS have been extensively characterized, insight into the events and conditions responsible for initiation of these structures is lacking. MCTS are formed by only a small subpopulation of cells during surface-associated growth but the processes responsible for this differentiation are poorly understood and have not been previously studied experimentally. Analysis of gene expression within spheroids has provided clues but to date it is not known if the observed differences are a cause or consequence of MCTS growth. One mechanism linked to tumourigenesis in a number of cancers is genetic instability arising from impaired DNA mismatch repair (MMR). This study aimed to determine the role of MMR in MCTS initiation and development. Using surface-associated N2a and CHLA-02-ATRT culture systems we have investigated the impact of impaired MMR on MCTS growth. Analysis of the DNA MMR genes MLH1 and PMS2 revealed both to be significantly down-regulated at the mRNA level compared with non-spheroid-forming cells. By using small interfering RNA (siRNA) against these genes we show that silencing of MLH1 and PMS2 enhances both MCTS initiation and subsequent expansion. This effect was prolonged over several passages following siRNA transfection. Down-regulation of DNA MMR can contribute to tumour initiation and progression in N2a and CHLA-02-ATRT MCTS models. Studies of surface-associated MCTS differentiation may have broader applications in studying events in the initiation of cancer foci.	[Collins, Samuel L.; Herve, Rodolphe; Webb, Jeremy S.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Keevil, C. W.] Univ Southampton, Environm Hlth Care Unit, Southampton, Hants, England; [Blaydes, Jeremy P.] Univ Southampton, Fac Med, Southampton Canc Res UK Ctr, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton; University of Southampton	Collins, SL (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	J.S.Webb@soton.ac.uk	Blaydes, Jeremy/AAC-6939-2019	Blaydes, Jeremy/0000-0001-8525-0209; Webb, Jeremy/0000-0003-2068-8589; Collins, Samuel/0000-0003-4721-0040; Keevil, Charles/0000-0003-1917-7706	charitable organisation in the UK; Gerald Kerkut Trust; Biotechnology and Biological Sciences Research Council (BBSRC); Gerald Kerkut Charitable Trust; BBSRC [BB/C520655/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520655/1] Funding Source: researchfish	charitable organisation in the UK; Gerald Kerkut Trust; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gerald Kerkut Charitable Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a charitable organisation in the UK, the Gerald Kerkut Trust (http://www.soton.ac.uk/similar to gktrust/). This work was also partially supported by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship awarded to JSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Gerald Kerkut Charitable Trust for continued support throughout this project.	Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Cahill DP, 1999, TRENDS BIOCHEM SCI, V24, pM57, DOI 10.1016/S0968-0004(99)01466-8; Condat CA, 2006, PHYSICA A, V371, P76, DOI 10.1016/j.physa.2006.04.082; Coquelle A, 1998, MOL CELL, V2, P259, DOI 10.1016/S1097-2765(00)80137-9; DARLING JL, 1983, CELL BIOL INT REP, V7, P23, DOI 10.1016/0309-1651(83)90101-7; Davis TW, 1998, CANCER RES, V58, P767; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; DUNHAM LJ, 1953, JNCI-J NATL CANCER I, V13, P1299; EVANS SM, 1986, INT J RADIAT ONCOL, V12, P969, DOI 10.1016/0360-3016(86)90393-7; Fink D, 1998, CLIN CANCER RES, V4, P1; Francia G, 2005, MOL CANCER THER, V4, P1484, DOI 10.1158/1535-7163.MCT-04-0214; Francia G, 2004, MOL CELL BIOL, V24, P6837, DOI 10.1128/mcb.24.15.6837-6849.2004; Genc M, 2004, J CANCER RES CLIN, V130, P45, DOI 10.1007/s00432-003-0506-y; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Jiricny J, 2000, NAT GENET, V24, P6, DOI 10.1038/71698; Kerbel R S, 1990, Adv Cancer Res, V55, P87, DOI 10.1016/S0065-230X(08)60469-8; KERR DJ, 1987, CANCER CHEMOTH PHARM, V19, P1, DOI 10.1007/BF00296245; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Kumar HR, 2008, PEDIATR SURG INT, V24, P1229, DOI 10.1007/s00383-008-2245-2; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunz-Schughart LA, 1999, CELL BIOL INT, V23, P157, DOI 10.1006/cbir.1999.0384; Lagasse E, 2008, GENE THER, V15, P136, DOI 10.1038/sj.gt.3303068; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Loeb LA, 2001, CANCER RES, V61, P3230; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; LUK CK, 1986, BRIT J CANCER, V54, P25, DOI 10.1038/bjc.1986.148; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Matheson EC, 2003, CARCINOGENESIS, V24, P31, DOI 10.1093/carcin/24.1.31; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Mueller J, 2009, CANCER RES, V69, P7053, DOI 10.1158/0008-5472.CAN-09-0358; Nicolaides NC, 1998, MOL CELL BIOL, V18, P1635, DOI 10.1128/MCB.18.3.1635; Papp-Szabo E, 2005, INT J CANCER, V116, P679, DOI 10.1002/ijc.21088; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Pors K, 2005, CURR TOP MED CHEM, V5, P1133, DOI 10.2174/156802605774370883; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds TY, 1996, CANCER RES, V56, P5754; RONEN S, 1989, MAGNET RESON MED, V12, P274, DOI 10.1002/mrm.1910120217; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Spillane JB, 2007, ANZ J SURG, V77, P464, DOI 10.1111/j.1445-2197.2007.04096.x; Surtees JA, 2004, CYTOGENET GENOME RES, V107, P146, DOI 10.1159/000080593; SUTHERLAND R, 1981, CANCER RES, V41, P2980; SUTHERLAND RM, 1977, JNCI-J NATL CANCER I, V58, P1849, DOI 10.1093/jnci/58.6.1849; SUTHERLAND RM, 1971, JNCI-J NATL CANCER I, V46, P113; Takagi A, 2007, ANTICANCER RES, V27, P45; Wu LY, 2008, BIOMED MICRODEVICES, V10, P197, DOI 10.1007/s10544-007-9125-8; Wu XZ, 2008, ANN SURG ONCOL, V15, P407, DOI 10.1245/s10434-007-9695-y; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Zhang M, 2006, CURR OPIN GENET DEV, V16, P60, DOI 10.1016/j.gde.2005.12.008	56	6	7	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28123	10.1371/journal.pone.0028123	http://dx.doi.org/10.1371/journal.pone.0028123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145025	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000298168900008
J	Nasonkin, IO; Ward, RD; Bavers, DL; Beuschlein, F; Mortensen, AH; Keegan, CE; Hammer, GD; Camper, SA				Nasonkin, Igor O.; Ward, Robert D.; Bavers, David L.; Beuschlein, Felix; Mortensen, Amanda H.; Keegan, Catherine E.; Hammer, Gary D.; Camper, Sally A.			Aged PROP1 Deficient Dwarf Mice Maintain ACTH Production	PLOS ONE			English	Article							PITUITARY-HORMONE DEFICIENCY; 2-BASE PAIR DELETION; GROWTH-HORMONE; ANTERIOR-PITUITARY; PIT-1 GENE; X-ZONE; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; CELL-PROLIFERATION; BINDING PROTEIN; TRANSGENIC MICE	Humans with PROP1 mutations have multiple pituitary hormone deficiencies (MPHD) that typically advance from growth insufficiency diagnosed in infancy to include more severe growth hormone (GH) deficiency and progressive reduction in other anterior pituitary hormones, eventually including adrenocorticotropic hormone (ACTH) deficiency and hypocortisolism. Congenital deficiencies of GH, prolactin, and thyroid stimulating hormone have been reported in the Prop1(null) (Prop1(-/-)) and the Ames dwarf (Prop1(df/df)) mouse models, but corticotroph and pituitary adrenal axis function have not been thoroughly investigated. Here we report that the C57BL6 background sensitizes mutants to a wasting phenotype that causes approximately one third to die precipitously between weaning and adulthood, while remaining homozygotes live with no signs of illness. The wasting phenotype is associated with severe hypoglycemia. Circulating ACTH and corticosterone levels are elevated in juvenile and aged Prop1 mutants, indicating activation of the pituitary-adrenal axis. Despite this, young adult Prop1 deficient mice are capable of responding to restraint stress with further elevation of ACTH and corticosterone. Low blood glucose, an expected side effect of GH deficiency, is likely responsible for the elevated corticosterone level. These studies suggest that the mouse model differs from the human patients who display progressive hormone loss and hypocortisolism.	[Nasonkin, Igor O.; Mortensen, Amanda H.; Camper, Sally A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ward, Robert D.; Keegan, Catherine E.; Hammer, Gary D.; Camper, Sally A.] Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Bavers, David L.; Beuschlein, Felix; Hammer, Gary D.; Camper, Sally A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Beuschlein, Felix] Univ Clin Munich, Endocrine Res Unit, Munich, Germany; [Keegan, Catherine E.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Munich; University of Michigan System; University of Michigan	Nasonkin, IO (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	scamper@umich.edu		Beuschlein, Felix/0000-0001-7826-3984; Camper, Sally/0000-0001-8556-3379	National Institutes of Health (NIH) [NIH R37HD30428, R01HD34283, T32 GM 07544, T32 HD 07048, T32 GM07863, T32 GM07315]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030428, R01HD034283] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD030428, T32HD007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007315, T32GM007544] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grants and fellowships: NIH R37HD30428, R01HD34283 (SAC), T32 GM 07544 and T32 HD 07048 (ION), T32 GM07863 and T32 GM07315 (RDW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2000, J CLIN ENDOCR METAB, V85, P4556, DOI 10.1210/jc.85.12.4556; Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040; Babu PS, 2002, ENDOCRINOLOGY, V143, P665, DOI 10.1210/en.143.2.665; Beuschlein F, 2003, MOL CELL BIOL, V23, P3951, DOI 10.1128/MCB.23.11.3951-3964.2003; BLACK SM, 1993, ENDOCRINOLOGY, V132, P539, DOI 10.1210/en.132.2.539; BORG KE, 1995, P SOC EXP BIOL MED, V210, P126; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P5256, DOI 10.1210/jc.2004-0661; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; BUCKWALTER MS, 1991, GENOMICS, V10, P515, DOI 10.1016/0888-7543(91)90430-M; Burrows HL, 1998, J CLIN INVEST, V101, P1439, DOI 10.1172/JCI1963; Chrousos GP, 1998, ANN NY ACAD SCI, V851, P311, DOI 10.1111/j.1749-6632.1998.tb09006.x; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cogan JD, 1998, J CLIN ENDOCR METAB, V83, P3346, DOI 10.1210/jc.83.9.3346; Coll AP, 2004, ENDOCRINOLOGY, V145, P4721, DOI 10.1210/en.2004-0491; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Coulter C. L., 2002, Archives of Physiology and Biochemistry, V110, P99, DOI 10.1076/apab.110.1.99.894; Fluck C, 1998, J CLIN ENDOCR METAB, V83, P3727, DOI 10.1210/jc.83.10.3727; GAGE PJ, 1995, ENDOCRINOLOGY, V136, P1161, DOI 10.1210/en.136.3.1161; Gage PJ, 1996, MOL ENDOCRINOL, V10, P1570, DOI 10.1210/me.10.12.1570; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Ghayee HK, 2011, J CLIN ENDOCR METAB, V96, pE243, DOI 10.1210/jc.2010-1222; GOTOH H, 1988, ENDOCRINOLOGY, V123, P1923, DOI 10.1210/endo-123-4-1923; Hershkovitz L, 2007, ENDOCRINOLOGY, V148, P976, DOI 10.1210/en.2006-1100; HOLMES PV, 1971, J ANAT, V108, P159; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; JOB JC, 1989, HORM RES, V31, P149, DOI 10.1159/000181106; Karolyi IJ, 1999, P NATL ACAD SCI USA, V96, P11595, DOI 10.1073/pnas.96.20.11595; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Laron Z, 2004, J CLIN ENDOCR METAB, V89, P1031, DOI 10.1210/jc.2003-031033; Lindsay JR, 2006, J ENDOCRINOL INVEST, V29, P983, DOI 10.1007/BF03349211; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; MARKOWSKA A, 1993, CELL TISSUE RES, V272, P439, DOI 10.1007/BF00318550; Mendonca BB, 1999, J CLIN ENDOCR METAB, V84, P942, DOI 10.1210/jc.84.3.942; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; OHTA K, 1992, BIOCHEM BIOPH RES CO, V189, P851, DOI 10.1016/0006-291X(92)92281-2; Parks JS, 1999, J CLIN ENDOCR METAB, V84, P4362, DOI 10.1210/jc.84.12.4362; Pernasetti F, 2000, J CLIN ENDOCR METAB, V85, P390, DOI 10.1210/jc.85.1.390; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Piekorz RP, 2005, MOL ENDOCRINOL, V19, P431, DOI 10.1210/me.2004-0302; Procter AM, 1998, HUM GENET, V103, P255, DOI 10.1007/s004390050815; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Riepe FG, 2001, J CLIN ENDOCR METAB, V86, P4353, DOI 10.1210/jc.86.9.4353; ROUX M, 1982, CELL TISSUE RES, V223, P415, DOI 10.1007/BF01258498; SADEGHIN.A, 1974, J PEDIATR-US, V84, P79, DOI 10.1016/S0022-3476(74)80557-3; Scheys JO, 2011, ENDOCRINOLOGY, V152, P3430, DOI 10.1210/en.2010-0986; SHIRE JGM, 1973, ACTA PATH MICRO IM A, VA 81, P225; Sobrier ML, 2006, J CLIN ENDOCR METAB, V91, P4528, DOI 10.1210/jc.2006-0426; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Stratakis CA, 2004, REV ENDOCR METAB DIS, V5, P53, DOI 10.1023/B:REMD.0000016124.44064.8f; Taback SP, 1996, J CLIN ENDOCR METAB, V81, P1693, DOI 10.1210/jc.81.5.1693; TANG KC, 1993, ENDOCRINOLOGY, V132, P2518, DOI 10.1210/en.132.6.2518; VIMPANI GV, 1977, BMJ-BRIT MED J, V2, P427, DOI 10.1136/bmj.2.6084.427; Wang XJ, 1998, ENDOCRINOLOGY, V139, P3903, DOI 10.1210/en.139.9.3903; Ward RD, 2005, MOL ENDOCRINOL, V19, P698, DOI 10.1210/me.2004-0341; Ward RD, 2006, MOL ENDOCRINOL, V20, P1378, DOI 10.1210/me.2005-0409; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	59	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28355	10.1371/journal.pone.0028355	http://dx.doi.org/10.1371/journal.pone.0028355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145038	Green Submitted, Green Published, gold			2022-12-25	WOS:000298168900021
J	Chen, LH; Kuo, WH; Tsai, MH; Chen, PC; Hsiao, CHK; Chuang, EY; Chang, LY; Hsieh, FJ; Lai, LC; Chang, KJ				Chen, Lee H.; Kuo, Wen-Hung; Tsai, Mong-Hsun; Chen, Pei-Chun; Hsiao, Chuhsing K.; Chuang, Eric Y.; Chang, Li-Yun; Hsieh, Fon-Jou; Lai, Liang-Chuan; Chang, King-Jen			Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in Taiwan	PLOS ONE			English	Article							MOLECULAR PORTRAITS; EXPRESSION; SUBTYPES; RECEPTOR; CARCINOMAS; PATTERNS; SURVIVAL; TUMORS; CELLS	Discrepancies in the prognosis of triple negative breast cancer exist between Caucasian and Asian populations. Yet, the gene signature of triple negative breast cancer specifically for Asians has not become available. Therefore, the purpose of this study is to construct a prediction model for recurrence of triple negative breast cancer in Taiwanese patients. Whole genome expression profiling of breast cancers from 185 patients in Taiwan from 1995 to 2008 was performed, and the results were compared to the previously published literature to detect differences between Asian and Western patients. Pathway analysis and Cox proportional hazard models were applied to construct a prediction model for the recurrence of triple negative breast cancer. Hierarchical cluster analysis showed that triple negative breast cancers from different races were in separate sub-clusters but grouped in a bigger cluster. Two pathways, cAMP-mediated signaling and ephrin receptor signaling, were significantly associated with the recurrence of triple negative breast cancer. After using stepwise model selection from the combination of the initial filtered genes, we developed a prediction model based on the genes SLC22A23, PRKAG3, DPEP3, MORC2, GRB7, and FAM43A. The model had 91.7% accuracy, 81.8% sensitivity, and 94.6% specificity under leave-one-out support vector regression. In this study, we identified pathways related to triple negative breast cancer and developed a model to predict its recurrence. These results could be used for assisting with clinical prognosis and warrant further investigation into the possibility of targeted therapy of triple negative breast cancer in Taiwanese patients.	[Chen, Lee H.; Tsai, Mong-Hsun; Hsiao, Chuhsing K.; Chuang, Eric Y.; Lai, Liang-Chuan] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Chen, Pei-Chun] Providence Univ, Dept Stat & Bioinformat Sci, Taichung, Taiwan; [Hsiao, Chuhsing K.] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chang, Li-Yun; Hsieh, Fon-Jou] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan; [Chang, King-Jen] Cheng Ching Gen Hosp, Dept Surg, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Providence University - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chen, LH (corresponding author), Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan.	llai@ntu.edu.tw; kingjen@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; TSAI, MONG-HSUN/0000-0001-8777-5818; Chang, King jen/0000-0001-9811-3422; KUO, WEN-HUNG/0000-0002-9881-4605; hsiao, chuhsing kate/0000-0003-4905-8484	National Science Council, Taiwan [97-2314-B-002-154-MY3]; Center of Genomic Medicine, National Taiwan University	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Center of Genomic Medicine, National Taiwan University(National Taiwan University)	Financial support provided by the National Science Council, Taiwan (Grant No. 97-2314-B-002-154-MY3) and the Center of Genomic Medicine, National Taiwan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of Health Promotion DoH ROC Taiwan, 2010, CANC REG ANN REP 200; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Deblois G, 2009, CANCER RES, V69, P6149, DOI 10.1158/0008-5472.CAN-09-1251; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Kurebayashi J, 2007, BREAST, V16, pS72, DOI 10.1016/j.breast.2007.07.017; Lin C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-192; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Marsh S, 2001, Clin Colorectal Cancer, V1, P175, DOI 10.3816/CCC.2001.n.018; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Peppercorn J, 2008, CANCER INVEST, V26, P1, DOI 10.1080/07357900701784238; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Saif MW, 2008, CUTAN OCUL TOXICOL, V27, P311, DOI 10.1080/15569520802355774; Sato K, 2008, BIOSCI BIOTECH BIOCH, V72, P2589, DOI 10.1271/bbb.80279; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12	32	19	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28222	10.1371/journal.pone.0028222	http://dx.doi.org/10.1371/journal.pone.0028222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140552	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300040
J	Goda, K; Ito, H; Kondo, T; Oyama, T				Goda, Kazuhito; Ito, Hiroshi; Kondo, Takao; Oyama, Tokitaka			Fluorescence Correlation Spectroscopy to Monitor Kai Protein-based Circadian Oscillations in Real Time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONNATURAL AMINO-ACIDS; IN-VITRO; PHOSPHORYLATION RHYTHM; CYANOBACTERIA; CLOCK; ENTRAINMENT; PROTEOMICS; COMPLEXES; DYNAMICS; POSITION	Dynamic protein-protein interactions play an essential role in cellular regulatory systems. The cyanobacterial circadian clock is an oscillatory system that can be reconstituted in vitro by mixing ATP and three clock proteins: KaiA, KaiB, and KaiC. Association and dissociation of KaiB from KaiC-containing complexes are critical to circadian phosphorylation and dephosphorylation of KaiC. We developed an automated and noninvasive method to monitor dynamic complex formation in real time using confocal fluorescence correlation spectroscopy (FCS) and uniformly labeled KaiB as a probe. A nanomolar concentration of the labeled KaiB for FCS measurement did not interfere with the oscillatory system but behaved similarly to the wild-type one during the measurement period (>5 days). The fluorescent probe was stable against repeated laser exposure. As an application, we show that this detection system allowed analysis of the dynamics of both long term circadian oscillations and short term responses to temperature changes (similar to 10 min) in the same sample. This suggested that a phase shift of the clock with a high temperature pulse occurred just after the stimulus through dissociation of KaiB from the KaiC complex. This monitoring method should improve our understanding of the mechanisms underlying this cellular circadian oscillator and provide a means to assess dynamic protein interactions in biological systems characterized by rates similar to those observed with the Kai proteins.	[Goda, Kazuhito] Olympus Corp, Med Technol Res & Dev Div, Adv Anal Technol Res & Dev Dept, Tokyo 1920904, Japan; [Ito, Hiroshi; Kondo, Takao; Oyama, Tokitaka] Nagarjuna Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Kondo, Takao; Oyama, Tokitaka] Japan Sci & Technol Corp, Nagoya, Aichi 4648602, Japan	Olympus Corporation; Japan Science & Technology Agency (JST)	Oyama, T (corresponding author), Kyoto Univ, Dept Bot, Grad Sch Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	oyama@cosmos.bot.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15GS0308]; Japan Society for the Promotion of Science [17370088, 21010517]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant 15GS0308 to T. K. and T. O.), the Japan Society for the Promotion of Science (Grant 17370088 to T. O. and Grant 21010517 to H. I.), and Takeda Science Foundation (to T. O.).	Abe R, 2010, J BIOSCI BIOENG, V110, P32, DOI 10.1016/j.jbiosc.2010.01.003; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Hohsaka T, 2002, CURR OPIN CHEM BIOL, V6, P809, DOI 10.1016/S1367-5931(02)00376-9; Hori K., 2003, Current Pharmaceutical Biotechnology, V4, P477, DOI 10.2174/1389201033377391; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Johnson C. H., 2004, BIOL TIMEKEEPING, P67; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murayama Y, 2011, EMBO J, V30, P68, DOI 10.1038/emboj.2010.298; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nakata H, 2009, ANAL BIOCHEM, V390, P121, DOI 10.1016/j.ab.2009.03.049; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Piehler J, 2005, CURR OPIN STRUC BIOL, V15, P4, DOI 10.1016/j.sbi.2005.01.008; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Schmid JA, 2005, CHEMBIOCHEM, V6, P1149, DOI 10.1002/cbic.200500029; Stoevesandt O, 2005, NAT METHODS, V2, P833, DOI 10.1038/NMETH802; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017; Yoshida T, 2009, P NATL ACAD SCI USA, V106, P1648, DOI 10.1073/pnas.0806741106	29	9	9	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3241	3248		10.1074/jbc.M111.265777	http://dx.doi.org/10.1074/jbc.M111.265777			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157012	Green Published, hybrid			2022-12-25	WOS:000300295100029
J	Norscia, I; Palagi, E				Norscia, Ivan; Palagi, Elisabetta			Yawn Contagion and Empathy in Homo sapiens	PLOS ONE			English	Article							SEX-DIFFERENCES; INFANTS; BRAIN; RECOGNITION; CHIMPANZEES; EXPRESSION; ALTRUISM; CHILDREN; BEHAVIOR; MOTHERS	The ability to share others' emotions, or empathy, is crucial for complex social interactions. Clinical, psychological, and neurobiological clues suggest a link between yawn contagion and empathy in humans (Homo sapiens). However, no behavioral evidence has been provided so far. We tested the effect of different variables (e.g., country of origin, sex, yawn characteristics) on yawn contagion by running mixed models applied to observational data collected over 1 year on adult (> 16 years old) human subjects. Only social bonding predicted the occurrence, frequency, and latency of yawn contagion. As with other measures of empathy, the rate of contagion was greatest in response to kin, then friends, then acquaintances, and lastly strangers. Related individuals (r >= 0.25) showed the greatest contagion, in terms of both occurrence of yawning and frequency of yawns. Strangers and acquaintances showed a longer delay in the yawn response (latency) compared to friends and kin. This outcome suggests that the neuronal activation magnitude related to yawn contagion can differ as a function of subject familiarity. In conclusion, our results demonstrate that yawn contagion is primarily driven by the emotional closeness between individuals and not by other variables, such as gender and nationality.	[Norscia, Ivan; Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy; [Palagi, Elisabetta] ISTC CNR, Unita Primatol Cognit, Rome, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Norscia, I (corresponding author), Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy.	betta.palagi@museo.unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Arnott SR, 2009, COGN AFFECT BEHAV NE, V9, P335, DOI 10.3758/CABN.9.3.335; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal FBM, 2010, TRENDS COGN SCI, V14, P201, DOI 10.1016/j.tics.2010.03.003; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Ferrari PF, 2009, CURR BIOL, V19, P1768, DOI 10.1016/j.cub.2009.08.055; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; GIGANTI F, 2009, CURR PSYCHOL LETT, V25, P1; Giganti F, 2011, J ETHOL, V29, P215, DOI 10.1007/s10164-010-0242-0; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; Harrison F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018338; Helt MS, 2010, CHILD DEV, V81, P1620, DOI 10.1111/j.1467-8624.2010.01495.x; KAPLAN HB, 1960, J NERV MENT DIS, V131, P128, DOI 10.1097/00005053-196008000-00006; Kaufman AB, 2009, ANIM BEHAV, V78, P1487, DOI 10.1016/j.anbehav.2009.09.014; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Meno P, 2003, CURR PSYCHOL LETT, V11, P1; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Minagawa-Kawai Y, 2009, CEREB CORTEX, V19, P284, DOI 10.1093/cercor/bhn081; Moore JE, 1942, J GEN PSYCHOL, V27, P289, DOI 10.1080/00221309.1942.10544414; Nahab FB, 2009, HUM BRAIN MAPP, V30, P1744, DOI 10.1002/hbm.20638; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Paukner A, 2006, BIOL LETTERS, V2, P36, DOI 10.1098/rsbl.2005.0411; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Provine Robert R., 1996, P179, DOI 10.1016/B978-012273965-1/50010-8; Provine RR, 2005, AM SCI, V93, P532, DOI 10.1511/2005.56.980; PROVINE RR, 1989, B PSYCHONOMIC SOC, V27, P211, DOI 10.3758/BF03334587; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schurmann M, 2005, NEUROIMAGE, V24, P1260, DOI 10.1016/j.neuroimage.2004.10.022; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Stenberg RJ, 2009, COGNITIVE PSYCHOL; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; WIGGERS M, 1985, DEV PSYCHOL, V21, P338, DOI 10.1037/0012-1649.21.2.338; Yoon JMD, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2010.02.011; [No title captured]	46	101	102	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28472	10.1371/journal.pone.0028472	http://dx.doi.org/10.1371/journal.pone.0028472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KK	22163307	Green Submitted, Green Published, gold			2022-12-25	WOS:000298161900044
J	Rodrigues, CR; Cabrini, M; Lenicov, FR; Sabatte, J; Ceballos, A; Jancic, C; Raiden, S; Ostrowski, M; Silberstein, C; Geffner, J				Rodriguez Rodrigues, Christian; Cabrini, Mercedes; Remes Lenicov, Federico; Sabatte, Juan; Ceballos, Ana; Jancic, Carolina; Raiden, Silvina; Ostrowski, Matias; Silberstein, Claudia; Geffner, Jorge			Epithelial Cells Activate Plasmacytoid Dendritic Cells Improving Their Anti-HIV Activity	PLOS ONE			English	Article							VIRAL-INFECTION; NUCLEIC-ACIDS; CUTTING EDGE; T-CELLS; RECEPTORS; INNATE; VIRUS; TRANSMISSION; REPLICATION; COMPLEXES	Plasmacytoid dendritic cells (pDCs) play a major role in anti-viral immunity by virtue of their ability to produce high amounts of type I interferons (IFNs) and a variety of inflammatory cytokines and chemokines in response to viral infections. Since recent studies have established that pDCs accumulate at the site of virus entry in the mucosa, here we analyzed whether epithelial cells were able to modulate the function of pDCs. We found that the epithelial cell lines HT-29 and Caco-2, as well as a primary culture of human renal tubular epithelial cells (HRTEC), induced the phenotypic maturation of pDCs stimulating the production of inflammatory cytokines. By contrast, epithelial cells did not induce any change in the phenotype of conventional or myeloid DCs (cDCs) while significantly stimulated the production of the anti-inflammatory cytokine IL-10. Activation of pDCs by epithelial cells was prevented by Bafilomycin A1, an inhibitor of endosomal acidification as well as by the addition of RNase to the culture medium, suggesting the participation of endosomal TLRs. Interestingly, the cross-talk between both cell populations was shown to be associated to an increased expression of TLR7 and TLR9 by pDCs and the production of LL37 by epithelial cells, an antimicrobial peptide able to bind and transport extracellular nucleic acids into the endosomal compartments. Interestingly, epithelium-activated pDCs impaired the establishment of a productive HIV infection in two susceptible target cells through the stimulation of the production of type I IFNs, highlighting the anti-viral efficiency of this novel activation pathway.	[Rodriguez Rodrigues, Christian; Cabrini, Mercedes; Remes Lenicov, Federico; Sabatte, Juan; Ceballos, Ana; Ostrowski, Matias; Geffner, Jorge] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, RA-1053 Buenos Aires, DF, Argentina; [Jancic, Carolina; Raiden, Silvina; Geffner, Jorge] Acad Nacl Med Buenos Aires, IIHEMA, Buenos Aires, DF, Argentina; [Silberstein, Claudia] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina	University of Buenos Aires; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; University of Buenos Aires	Rodrigues, CR (corresponding author), Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, RA-1053 Buenos Aires, DF, Argentina.	larageffner@yahoo.com.ar	Remes Lenicov, Federico/J-2694-2012	Remes Lenicov, Federico/0000-0003-4108-6341; Rodriguez Rodrigues, Christian/0000-0001-8720-2083; Ostrowski, Matias/0000-0002-3982-1338	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Buenos Aires University School of Medicine; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Buenos Aires University School of Medicine(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This study was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, the Buenos Aires University School of Medicine, and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelot F, 2009, HAEMATOL-HEMATOL J, V94, P1502, DOI 10.3324/haematol.2009.010934; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bave U, 2000, J IMMUNOL, V165, P3519, DOI 10.4049/jimmunol.165.6.3519; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Charles J, 2010, EUR J DERMATOL, V20, P16, DOI 10.1684/ejd.2010.0816; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; CHULUYAN HE, 1993, J CLIN INVEST, V92, P2768, DOI 10.1172/JCI116895; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Groot F, 2006, BLOOD, V108, P1957, DOI 10.1182/blood-2006-03-010918; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gutzmer R, 2006, J INVEST DERMATOL, V126, P2422, DOI 10.1038/sj.jid.5700416; Hartmann E, 2006, CLIN VACCINE IMMUNOL, V13, P1278, DOI 10.1128/CVI.00172-06; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Iliev ID, 2007, J EXP MED, V204, P2253, DOI 10.1084/jem.20062535; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Kim JM, 2006, SCAND J IMMUNOL, V63, P453, DOI 10.1111/j.1365-3083.2006.001756.x; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Liu YJ, 2000, BLOOD, V95, P2482, DOI 10.1182/blood.V95.8.2482.008a38_2482_2483; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Russo C, 2011, BLOOD, V117, P5683, DOI 10.1182/blood-2010-12-328138; Sabatte J, 2007, J VIROL, V81, P13723, DOI 10.1128/JVI.01079-07; Sabatte J, 2007, CYTOKINE GROWTH F R, V18, P5, DOI 10.1016/j.cytogfr.2007.01.002; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schmitz H, 2002, AIDS, V16, P983, DOI 10.1097/00002030-200205030-00004; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; Silberstein C, 2008, PEDIATR NEPHROL, V23, P1981, DOI 10.1007/s00467-008-0896-9; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Sonnier DI, 2010, J GASTROINTEST SURG, V14, P1592, DOI 10.1007/s11605-010-1321-9; SOZZANI S, TRENDS IMMUNOL; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Vodros D, 2001, VIROLOGY, V291, P1, DOI 10.1006/viro.2001.1163; Wang HW, 2006, J IMMUNOL, V177, P6263, DOI 10.4049/jimmunol.177.9.6263; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411	49	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28709	10.1371/journal.pone.0028709	http://dx.doi.org/10.1371/journal.pone.0028709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163327	gold, Green Published, Green Submitted			2022-12-25	WOS:000298161900063
J	Galinanes, GL; Braz, BY; Murer, MG				Galinanes, Gregorio L.; Braz, Barbara Y.; Gustavo Murer, Mario			Origin and Properties of Striatal Local Field Potential Responses to Cortical Stimulation: Temporal Regulation by Fast Inhibitory Connections	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; TERM SYNAPTIC PLASTICITY; PROJECTION NEURONS; DOPAMINERGIC MODULATION; EVOKED-POTENTIALS; BASAL GANGLIA; SPINY NEURONS; RAT; CORTEX; OSCILLATIONS	Evoked striatal field potentials are seldom used to study corticostriatal communication in vivo because little is known about their origin and significance. Here we show that striatal field responses evoked by stimulating the prelimbic cortex in mice are reduced by more than 90% after infusing the AMPA receptor antagonist CNQX close to the recording electrode. Moreover, the amplitude of local field responses and dPSPs recorded in striatal medium spiny neurons increase in parallel with increasing stimulating current intensity. Finally, the evoked striatal fields show several of the basic known properties of corticostriatal transmission, including paired pulse facilitation and topographical organization. As a case study, we characterized the effect of local GABA(A) receptor blockade on striatal field and multiunitary action potential responses to prelimbic cortex stimulation. Striatal activity was recorded through a 24 channel silicon probe at about 600 mm from a microdialysis probe. Intrastriatal administration of the GABA(A) receptor antagonist bicuculline increased by 65 +/- 7% the duration of the evoked field responses. Moreover, the associated action potential responses were markedly enhanced during bicuculline infusion. Bicuculline enhancement took place at all the striatal sites that showed a response to cortical stimulation before drug infusion, but sites showing no field response before bicuculline remained unresponsive during GABAA receptor blockade. Thus, the data demonstrate that fast inhibitory connections exert a marked temporal regulation of input-output transformations within spatially delimited striatal networks responding to a cortical input. Overall, we propose that evoked striatal fields may be a useful tool to study corticostriatal synaptic connectivity in relation to behavior.	[Galinanes, Gregorio L.; Braz, Barbara Y.; Gustavo Murer, Mario] Univ Buenos Aires, Dept Physiol & Biophys, Sch Med, Neural Circuit Physiol Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina	University of Buenos Aires	Galinanes, GL (corresponding author), Univ Buenos Aires, Dept Physiol & Biophys, Sch Med, Neural Circuit Physiol Lab,Syst Neurosci Grp, Buenos Aires, DF, Argentina.	neurofis@fmed.uba.ar		Galinanes, Gregorio/0000-0002-9338-4175	Secretaria de Ciencia; Tecnologia e Innovacion Productiva; Fondo para la Investigacion Cientifica y Tecnologica [PICT 2007 05-1000, PICT 2008 05-2205]; Universidad de Buenos Aires [UBACYT M050]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 0077]	Secretaria de Ciencia; Tecnologia e Innovacion Productiva; Fondo para la Investigacion Cientifica y Tecnologica; Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the following Argentine institutions: Secretaria de Ciencia, Tecnologia e Innovacion Productiva, Fondo para la Investigacion Cientifica y Tecnologica (PICT 2007 05-1000 and PICT 2008 05-2205), Universidad de Buenos Aires (UBACYT M050), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 0077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian G, 2002, J NEUROPHYSIOL, V87, P157, DOI 10.1152/jn.00115.2001; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Choi SK, 1997, J NEUROSCI, V17, P8613; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; CORDINGLEY GE, 1986, BRIT J PHARMACOL, V88, P847, DOI 10.1111/j.1476-5381.1986.tb16258.x; Courtemanche R, 2003, J NEUROSCI, V23, P11741; Czubayko U, 2002, P NATL ACAD SCI USA, V99, P15764, DOI 10.1073/pnas.242428599; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Galinanes GL, 2009, J NEUROSCI, V29, P2496, DOI 10.1523/JNEUROSCI.4421-08.2009; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gruber AJ, 2009, J NEUROPHYSIOL, V101, P1876, DOI 10.1152/jn.91002.2008; Guzman JN, 2003, J NEUROSCI, V23, P8931; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hamann M, 2007, BRAIN RES, V1150, P190, DOI 10.1016/j.brainres.2007.02.074; Humphries MD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001011; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; Kasanetz F, 2006, J PHYSIOL-LONDON, V577, P97, DOI 10.1113/jphysiol.2006.113050; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; LOVINGER DM, 1993, J NEUROPHYSIOL, V69, P1236, DOI 10.1152/jn.1993.69.4.1236; Magill PJ, 2004, J NEUROPHYSIOL, V92, P700, DOI 10.1152/jn.00134.2004; Mahon S, 2004, TRENDS NEUROSCI, V27, P460, DOI 10.1016/j.tins.2004.06.010; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; MAREN S, 1995, J NEUROSCI, V15, P7548; MISGELD U, 1979, EXP BRAIN RES, V34, P575; Ou XR, 1997, SYNAPSE, V27, P57, DOI 10.1002/(SICI)1098-2396(199709)27:1<57::AID-SYN6>3.0.CO;2-C; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; PENNARTZ CMA, 1990, VISION RES, V30, P1223, DOI 10.1016/0042-6989(90)90177-M; PENNARTZ CMA, 1990, BRAIN RES, V529, P30, DOI 10.1016/0006-8993(90)90808-O; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Plenz D, 1998, J NEUROSCI, V18, P266; Pomata PE, 2008, J NEUROSCI, V28, P13384, DOI 10.1523/JNEUROSCI.4343-08.2008; Ponzi A, 2010, J NEUROSCI, V30, P5894, DOI 10.1523/JNEUROSCI.5540-09.2010; RYAN LJ, 1986, BRAIN RES BULL, V17, P751, DOI 10.1016/0361-9230(86)90086-9; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Sharott A, 2009, J NEUROSCI, V29, P4571, DOI 10.1523/JNEUROSCI.5097-08.2009; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stoetzner CR, 2010, NEUROSCIENCE, V165, P1013, DOI 10.1016/j.neuroscience.2009.11.031; Tecuapetla F, 2007, P NATL ACAD SCI USA, V104, P10258, DOI 10.1073/pnas.0703813104; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; West AR, 2002, J PHARMACOL EXP THER, V301, P867, DOI 10.1124/jpet.301.3.867; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	53	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28473	10.1371/journal.pone.0028473	http://dx.doi.org/10.1371/journal.pone.0028473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163020	Green Submitted, Green Published, gold			2022-12-25	WOS:000298173500023
J	Rodhouse, TJ; Irvine, KM; Vierling, KT; Vierling, LA				Rodhouse, Thomas J.; Irvine, Kathryn M.; Vierling, Kerri T.; Vierling, Lee A.			Estimating Temporal Trend in the Presence of Spatial Complexity: A Bayesian Hierarchical Model for a Wetland Plant Population Undergoing Restoration	PLOS ONE			English	Article							AUTOCORRELATION; CAMASSIA; ECOLOGY	Monitoring programs that evaluate restoration and inform adaptive management are important for addressing environmental degradation. These efforts may be well served by spatially explicit hierarchical approaches to modeling because of unavoidable spatial structure inherited from past land use patterns and other factors. We developed Bayesian hierarchical models to estimate trends from annual density counts observed in a spatially structured wetland forb (Camassia quamash [camas]) population following the cessation of grazing and mowing on the study area, and in a separate reference population of camas. The restoration site was bisected by roads and drainage ditches, resulting in distinct subpopulations ("zones") with different land use histories. We modeled this spatial structure by fitting zone-specific intercepts and slopes. We allowed spatial covariance parameters in the model to vary by zone, as in stratified kriging, accommodating anisotropy and improving computation and biological interpretation. Trend estimates provided evidence of a positive effect of passive restoration, and the strength of evidence was influenced by the amount of spatial structure in the model. Allowing trends to vary among zones and accounting for topographic heterogeneity increased precision of trend estimates. Accounting for spatial autocorrelation shifted parameter coefficients in ways that varied among zones depending on strength of statistical shrinkage, autocorrelation and topographic heterogeneity-a phenomenon not widely described. Spatially explicit estimates of trend from hierarchical models will generally be more useful to land managers than pooled regional estimates and provide more realistic assessments of uncertainty. The ability to grapple with historical contingency is an appealing benefit of this approach.	[Rodhouse, Thomas J.; Vierling, Kerri T.] Univ Idaho, Dept Fish & Wildlife, Moscow, ID 83843 USA; [Irvine, Kathryn M.] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA; [Vierling, Lee A.] Univ Idaho, Geospatial Lab Environm Dynam, Moscow, ID 83843 USA	Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho	Rodhouse, TJ (corresponding author), Univ Idaho, Dept Fish & Wildlife, Moscow, ID 83843 USA.	Tom_Rodhouse@nps.gov	Vierling, Kerri/N-6653-2016; Vierling, Lee/E-6428-2010	Vierling, Lee/0000-0001-5344-1983; Rodhouse, Thomas/0000-0001-5953-9113	National Park Service Upper Columbia Basin Network;  [NIH/NCRR P20RR16448];  [P20RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454, P20RR016448] Funding Source: NIH RePORTER	National Park Service Upper Columbia Basin Network; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the National Park Service Upper Columbia Basin Network. Additional material support was provided by Nez Perce National Historical Park and Big Hole National Battlefield. Access to the University of Idaho Institute for Bioinformatics and Evolutionary Studies (IBEST) Unix computing core was made possible by grant NIH/NCRR P20RR16448 and P20RR016454 provided to IBEST (but not to the authors). Staff members of the National Park Service funding organizations provided input into the study design and data collection procedures, but did not influence analysis, decision to publish, or participate in manuscript preparation.	Alpargu G, 2003, J STAT COMPUT SIM, V73, P165, DOI 10.1080/00949650215866; Banerjee S., 2004, HIERARCHICAL MODELIN; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; Cressie N. A. C., 1993, STAT SPATIAL DATA WI; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Dahl T., 1990, WETLANDS LOSSES US 1; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gelman A., 2007, DATA ANAL USING REGR; Gould Frank W., 1942, AMER MIDLAND NAT, V28, P712, DOI 10.2307/2420901; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; Irvine KM, 2011, ENVIRON ECOL STAT, V18, P447, DOI 10.1007/s10651-010-0146-8; Irvine KM, 2007, J AGR BIOL ENVIR ST, V12, P1; Isaaks E.H., 1989, APPL GEOSTATISTICS; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Larkin Daniel, 2006, P142; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Palmer M. A., 2006, FDN RESTORATION ECOL, P1; Pendergrass KL, 1999, ECOL APPL, V9, P1420, DOI 10.1890/1051-0761(1999)009[1420:TROPBI]2.0.CO;2; Piepho HP, 2002, J AGRIC BIOL ENVIR S, V7, P350, DOI 10.1198/108571102366; Rodhouse T.J., 2007, NPSUCBNNRR2007011; STEIN A, 1988, GEODERMA, V43, P163, DOI 10.1016/0016-7061(88)90041-9; Storm L., 2006, ECOLOGICAL RESTORATI, V24, P256, DOI DOI 10.3368/ER.24.4.256; Taft OW, 2003, WETLANDS, V23, P51, DOI 10.1672/0277-5212(2003)023[0051:HWIOWV]2.0.CO;2; Thogmartin WE, 2009, RESTOR ECOL, V17, P290, DOI 10.1111/j.1526-100X.2007.00344.x; Tomimatsu H, 2009, MOL ECOL, V18, P3918, DOI 10.1111/j.1365-294X.2009.04341.x; TURNER NJ, 1983, ECOL FOOD NUTR, V13, P199, DOI 10.1080/03670244.1983.9990754; VanLeeuwen D. M., 1996, Journal of Agricultural, Biological, and Environmental Statistics, V1, P435, DOI 10.2307/1400438; Wallerman J, 2002, CAN J FOREST RES, V32, P509, DOI 10.1139/X01-214; Wang FJ, 2003, BIOSTATISTICS, V4, P569, DOI 10.1093/biostatistics/4.4.569; Wikle CK, 2003, INT STAT REV, V71, P181, DOI 10.1111/j.1751-5823.2003.tb00192.x; Williams BK, 2011, J ENVIRON MANAGE, V92, P1346, DOI 10.1016/j.jenvman.2010.10.041	35	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28635	10.1371/journal.pone.0028635	http://dx.doi.org/10.1371/journal.pone.0028635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163047	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500043
J	Kim, S; Nguon, C; Guillard, B; Duong, S; Chy, S; Sum, S; Nhem, S; Bouchier, C; Tichit, M; Christophel, E; Taylor, WRJ; Baird, JK; Menard, D				Kim, Saorin; Nguon, Chea; Guillard, Bertrand; Duong, Socheat; Chy, Sophy; Sum, Sarorn; Nhem, Sina; Bouchier, Christiane; Tichit, Magali; Christophel, Eva; Taylor, Walter R. J.; Baird, John Kevin; Menard, Didier			Performance of the CareStart (TM) G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; DEHYDROGENASE-DEFICIENCY; INTERNATIONAL COMMITTEE; ARTEMISININ RESISTANCE; CAMBODIAN POPULATION; SOUTHEAST-ASIA; MALARIA; 871G-GREATER-THAN-A; STANDARDIZATION; HEMATOLOGY	Development of reliable, easy-to-use, rapid diagnostic tests (RDTs) to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency at point of care is essential to deploying primaquine therapies as part of malaria elimination strategies. We assessed a kit under research and development called CareStart (TM) G6PD deficiency screening test (Access Bio, New Jersey, USA) by comparing its performance to quantitative G6PD enzyme activity using a standardized spectrophotometric method ('gold standard'). Blood samples (n = 903) were collected from Cambodian adults living in Pailin province, western Cambodia. G6PD enzyme activities ranged from 0 to 20.5 U/g Hb (median 12.0 U/g Hg). Based on a normal haemoglobin concentration and wild-type G6PD gene, the normal values of G6PD enzymatic activity for this population was 3.6 to 20.5 U/g Hg (95(th) percentiles from 5.5 to 17.2 U/g Hg). Ninety-seven subjects (10.7%) had <3.6 U/g Hg and were classified as G6PD deficient. Prevalence of deficiency was 15.0% (64/425) among men and 6.9% (33/478) among women. Genotype was analyzed in 66 G6PD-deficient subjects and 63 of these exhibited findings consistent with Viangchang genotype. The sensitivity and specificity of the CareStart (TM) G6PD deficiency screening test was 0.68 and 1.0, respectively. Its detection threshold was <2.7 U/g Hg, well within the range of moderate and severe enzyme deficiencies. Thirteen subjects (1.4%, 12 males and 1 female) with G6PD enzyme activities,2 U/g Hg were falsely classified as "normal" by RDT. This experimental RDT test here evaluated outside of the laboratory for the first time shows real promise, but safe application of it will require lower rates of falsely "normal" results.	[Kim, Saorin; Chy, Sophy; Sum, Sarorn; Nhem, Sina; Menard, Didier] Pasteur Inst Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Nguon, Chea; Duong, Socheat] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Guillard, Bertrand] Pasteur Inst Cambodia, Med Lab, Phnom Penh, Cambodia; [Bouchier, Christiane; Tichit, Magali] Inst Pasteur, Paris, France; [Christophel, Eva] WHO Reg Off Western Pacific, Manila, Philippines; [Taylor, Walter R. J.] Hop Univ Geneve, Serv Med Int & Humanitaire, Geneva, Switzerland; [Baird, John Kevin] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Baird, John Kevin] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; WHO Western Pacific Regional Office; World Health Organization; University of Geneva; Eijkman Institute; University of Oxford	Kim, S (corresponding author), Pasteur Inst Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia.	dmenard@pasteur-kh.org	Menard, Didier/O-3294-2013	Menard, Didier/0000-0003-1357-4495	WHO Regional Office for the Western Pacific; French Ministry of Foreign Affairs; Wellcome Trust	WHO Regional Office for the Western Pacific; French Ministry of Foreign Affairs; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grant from WHO Regional Office for the Western Pacific. Didier Menard is supported by the French Ministry of Foreign Affairs and Kevin Baird by the Wellcome Trust. The CareStart (TM) G6PD deficiency screening test was provided by the manufacturer (Access Bio). Access Bio has developed the second generation of CareStart (TM) G6PD deficiency screening test. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainoon O, 2003, Hum Mutat, V21, P101, DOI 10.1002/humu.9103; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; DERN RJ, 1981, J LAB CLIN MED, V97, P750; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Goueffon S, 1969, Bull Soc Pathol Exot Filiales, V62, P1118; Iwai K, 2001, HUM GENET, V108, P445, DOI 10.1007/s004390100527; Kornberg A, 1955, GLUCOSE 6 PHOSPHATE; LOHR GW, 1957, KLIN WOCHENSCHR, V35, P871, DOI 10.1007/BF01481476; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Monchy D, 2004, Med Trop (Mars), V64, P355; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010; Shekalaghe S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001023; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Tinley KE, 2010, AM J TROP MED HYG, V82, P210, DOI 10.4269/ajtmh.2010.09-0416; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 2010, METH MAN LAB QUAL CO	32	80	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28357	10.1371/journal.pone.0028357	http://dx.doi.org/10.1371/journal.pone.0028357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164279	Green Published, gold			2022-12-25	WOS:000298171400080
J	Winge, MCG; Hoppe, T; Berne, B; Vahlquist, A; Nordenskjold, M; Bradley, M; Torma, H				Winge, Marten C. G.; Hoppe, Torborg; Berne, Berit; Vahlquist, Anders; Nordenskjold, Magnus; Bradley, Maria; Torma, Hans			Filaggrin Genotype Determines Functional and Molecular Alterations in Skin of Patients with Atopic Dermatitis and Ichthyosis Vulgaris	PLOS ONE			English	Article							BARRIER FUNCTION; GENE; EXPRESSION; MUTATIONS; ECZEMA; DIFFERENTIATION; CALCIUM	Background: Several common genetic and environmental disease mechanisms are important for the pathophysiology behind atopic dermatitis (AD). Filaggrin (FLG) loss-of-function is of great significance for barrier impairment in AD and ichthyosis vulgaris (IV), which is commonly associated with AD. The molecular background is, however, complex and various clusters of genes are altered, including inflammatory and epidermal-differentiation genes. Objective: The objective was to study whether the functional and molecular alterations in AD and IV skin depend directly on FLG loss-of-function, and whether FLG genotype determines the type of downstream molecular pathway affected. Methods and Findings: Patients with AD/IV (n = 43) and controls (n = 15) were recruited from two Swedish outpatient clinics and a Swedish AD family material with known FLG genotype. They were clinically examined and their medical history recorded using a standardized questionnaire. Blood samples and punch biopsies were taken and trans-epidermal water loss (TEWL) and skin pH was assessed with standard techniques. In addition to FLG genotyping, the STS gene was analyzed to exclude X-linked recessive ichthyosis (XLI). Microarrays and quantitative real-time PCR were used to compare differences in gene expression depending on FLG genotype. Several different signalling pathways were altered depending on FLG genotype in patients suffering from AD or AD/IV. Disease severity, TEWL and pH follow FLG deficiency in the skin; and the number of altered genes and pathways are correlated to FLG mRNA expression. Conclusions: We emphasize further the role of FLG in skin-barrier integrity and the complex compensatory activation of signalling pathways. This involves inflammation, epidermal differentiation, lipid metabolism, cell signalling and adhesion in response to FLG-dependent skin-barrier dysfunction.	[Winge, Marten C. G.; Bradley, Maria] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med Solna, Dermatol Unit, Stockholm, Sweden; [Winge, Marten C. G.; Nordenskjold, Magnus; Bradley, Maria] Karolinska Inst, Karolinska Univ Hosp Solna, Ctr Mol Med, Stockholm, Sweden; [Hoppe, Torborg; Berne, Berit; Vahlquist, Anders; Torma, Hans] Uppsala Univ, Dept Med Sci Dermatol & Venereol, Uppsala, Sweden; [Winge, Marten C. G.; Nordenskjold, Magnus; Bradley, Maria] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Winge, MCG (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med Solna, Dermatol Unit, Stockholm, Sweden.	marten.winge@ki.se	Törmä, Hans/F-8152-2011	Törmä, Hans/0000-0002-3617-8551; Bradley, Maria/0000-0001-7192-5041; Nordenskjold, Magnus/0000-0002-4974-425X; Winge, Marten/0000-0001-6119-6009	Welander and Finsen foundations; Centre of Allergy Research (CFA); Stockholm County Council; Karolinska Institutet; Uppsala County Council; Uppsala University	Welander and Finsen foundations; Centre of Allergy Research (CFA); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Uppsala County Council; Uppsala University	The study was performed with grants from Welander and Finsen foundations, the Centre of Allergy Research (CFA) and through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet and Uppsala County Council and Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc, 2007, QUAL ASS EX GEN ARR; Akiyama M, 2010, HUM MUTAT, V31, P1090, DOI 10.1002/humu.21326; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Brown SJ, 2009, J INVEST DERMATOL, V129, P543, DOI 10.1038/jid.2008.413; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Ekelund E, 2008, ACTA DERM-VENEREOL, V88, P15, DOI 10.2340/00015555-0383; Elias PM, 2008, J ALLERGY CLIN IMMUN, V121, P1337, DOI 10.1016/j.jaci.2008.01.022; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Elias PM, 2002, J INVEST DERMATOL, V119, P1128, DOI 10.1046/j.1523-1747.2002.19512.x; Gamero AM, 2010, CANCER PREV RES, V3, P495, DOI 10.1158/1940-6207.CAPR-09-0105; Ginger RS, 2005, ARCH DERMATOL RES, V297, P235, DOI 10.1007/s00403-005-0590-8; Gruber R, 2011, AM J PATHOL, V178, P2252, DOI 10.1016/j.ajpath.2011.01.053; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jungersted JM, 2010, ALLERGY, V65, P911, DOI 10.1111/j.1398-9995.2010.02326.x; Kezic S, 2011, ALLERGY, V66, P934, DOI 10.1111/j.1398-9995.2010.02540.x; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Mathay C, 2011, J INVEST DERMATOL, V131, P46, DOI 10.1038/jid.2010.272; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Nardi A, 2009, J STEROID BIOCHEM, V115, P68, DOI 10.1016/j.jsbmb.2009.02.017; Neuber K, 2006, CLIN EXP IMMUNOL, V146, P262, DOI 10.1111/j.1365-2249.2006.03218.x; Novak N, 2011, ALLERGY, V66, P830, DOI 10.1111/j.1398-9995.2011.02571.x; Ohman H, 1998, J INVEST DERMATOL, V111, P674, DOI 10.1046/j.1523-1747.1998.00356.x; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; Posteraro P, 1998, BIOCHEM BIOPH RES CO, V243, P758, DOI 10.1006/bbrc.1998.8180; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Torma H, 2008, J INVEST DERMATOL, V128, P1212, DOI 10.1038/sj.jid.5701170; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Winge MCG, 2011, J DERMATOL SCI, V63, P62, DOI 10.1016/j.jdermsci.2011.03.011; Zhu AJ, 1996, J CELL SCI, V109, P3013	42	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28254	10.1371/journal.pone.0028254	http://dx.doi.org/10.1371/journal.pone.0028254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164253	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400054
J	Zhao, Y; Zhou, YQ; Jiang, HY; Li, XY; Gan, DF; Peng, XJ; Zhu, SW; Cheng, BJ				Zhao, Yang; Zhou, Yuqiong; Jiang, Haiyang; Li, Xiaoyu; Gan, Defang; Peng, Xiaojian; Zhu, Suwen; Cheng, Beijiu			Systematic Analysis of Sequences and Expression Patterns of Drought-Responsive Members of the HD-Zip Gene Family in Maize	PLOS ONE			English	Article							HOMEOBOX GENE; TRANSCRIPTION FACTOR; DEPENDENT EXPRESSION; DRAFT SEQUENCE; WATER-DEFICIT; HOMEODOMAIN; ARABIDOPSIS; PROTEIN; RICE; DOMAINS	Background: Members of the homeodomain-leucine zipper (HD-Zip) gene family encode transcription factors that are unique to plants and have diverse functions in plant growth and development such as various stress responses, organ formation and vascular development. Although systematic characterization of this family has been carried out in Arabidopsis and rice, little is known about HD-Zip genes in maize (Zea mays L.). Methods and Findings: In this study, we described the identification and structural characterization of HD-Zip genes in the maize genome. A complete set of 55 HD-Zip genes (Zmhdz1-55) were identified in the maize genome using Blast search tools and categorized into four classes (HD-Zip I-IV) based on phylogeny. Chromosomal location of these genes revealed that they are distributed unevenly across all 10 chromosomes. Segmental duplication contributed largely to the expansion of the maize HD-ZIP gene family, while tandem duplication was only responsible for the amplification of the HD-Zip II genes. Furthermore, most of the maize HD-Zip I genes were found to contain an overabundance of stress-related cis-elements in their promoter sequences. The expression levels of the 17 HD-Zip I genes under drought stress were also investigated by quantitative real-time PCR (qRT-PCR). All of the 17 maize HD-ZIP I genes were found to be regulated by drought stress, and the duplicated genes within a sister pair exhibited the similar expression patterns, suggesting their conserved functions during the process of evolution. Conclusions: Our results reveal a comprehensive overview of the maize HD-Zip gene family and provide the first step towards the selection of Zmhdz genes for cloning and functional research to uncover their roles in maize growth and development.	[Zhao, Yang; Zhou, Yuqiong; Jiang, Haiyang; Li, Xiaoyu; Gan, Defang; Peng, Xiaojian; Zhu, Suwen; Cheng, Beijiu] Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China	Anhui Agricultural University	Zhao, Y (corresponding author), Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China.	bjchengahau@163.com			National Key Technologies R & D Program of China [2009BADA6B]; Research Fund for the Doctoral Program of Higher Education of China [20103418120001]	National Key Technologies R & D Program of China(National Key Technology R&D Program); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The research work was supported by grants from the National Key Technologies R & D Program of China during the Eleventh Five-Year Plan Period (2009BADA6B) (http://finance.most.gov.cn) and Research Fund for the Doctoral Program of Higher Education of China (20103418120001) (http://finance.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Ciarbelli AR, 2008, PLANT MOL BIOL, V68, P465, DOI 10.1007/s11103-008-9383-8; Cote CL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-273; Depege-Fargeix N, 2011, J EXP BOT, V62, P293, DOI 10.1093/jxb/erq267; Dezar CA, 2005, TRANSGENIC RES, V14, P429, DOI 10.1007/s11248-005-5076-0; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frank W, 1998, PLANT J, V15, P413, DOI 10.1046/j.1365-313X.1998.00222.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Harris JC, 2011, NEW PHYTOL IN PRESS; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ingram GC, 1999, PLANT MOL BIOL, V40, P343, DOI 10.1023/A:1006271332400; Ingram GC, 2000, PLANT J, V22, P401, DOI 10.1046/j.1365-313X.2000.00755.x; Ito M, 2002, PLANT J, V29, P497, DOI 10.1046/j.1365-313x.2002.01234.x; Jain M, 2008, FEBS J, V275, P2845, DOI 10.1111/j.1742-4658.2008.06424.x; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Magnani E, 2011, PLANT CELL, V23, P567, DOI 10.1105/tpc.110.080754; Mayda E, 1999, PLANT J, V20, P591, DOI 10.1046/j.1365-313X.1999.00633.x; Mehan Michael R., 2004, Human Genomics, V1, P335; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Ni YX, 2008, ACTA BIOCH BIOPH SIN, V40, P78, DOI 10.1111/j.1745-7270.2008.00371.x; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qin YF, 2010, PLANT CELL REP, V29, P1147, DOI 10.1007/s00299-010-0901-1; Raes Jeroen, 2003, Journal of Structural and Functional Genomics, V3, P117, DOI 10.1023/A:1022666020026; RUBERTI I, 1991, EMBO J, V10, P1787, DOI 10.1002/j.1460-2075.1991.tb07703.x; Rueda EC, 2005, PLANT CELL PHYSIOL, V46, P1954, DOI 10.1093/pcp/pci210; Sakakibara K, 2001, MOL BIOL EVOL, V18, P491, DOI 10.1093/oxfordjournals.molbev.a003828; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; SCHENA M, 1992, P NATL ACAD SCI USA, V89, P3894, DOI 10.1073/pnas.89.9.3894; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Soderman E, 1999, PLANT MOL BIOL, V40, P1073, DOI 10.1023/A:1006267013170; Steindler C, 1999, DEVELOPMENT, V126, P4235; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Vernoud V, 2009, PLANT J, V59, P883, DOI 10.1111/j.1365-313X.2009.03916.x; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wang Y, 2003, DEV BIOL, V264, P228, DOI 10.1016/j.ydbio.2003.07.017; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7	77	102	131	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28488	10.1371/journal.pone.0028488	http://dx.doi.org/10.1371/journal.pone.0028488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164299	gold, Green Submitted, Green Published			2022-12-25	WOS:000298171400100
J	Fatima, R				Fatima, Roshan			Drosophila Dynein Intermediate Chain Gene, Dic61B, Is Required for Spermatogenesis	PLOS ONE			English	Article							CYTOPLASMIC DYNEIN; Y-CHROMOSOME; LIGHT-CHAIN; SPERM INDIVIDUALIZATION; FERTILITY FACTORS; MESSENGER-RNA; BASE DELETION; IDENTIFICATION; DYNACTIN; PROTEIN	This study reports the identification and characterization of a novel gene, Dic61B, required for male fertility in Drosophila. Complementation mapping of a novel male sterile mutation, ms21, isolated in our lab revealed it to be allelic to CG7051 at 61B1 cytogenetic region, since two piggyBac insertion alleles, CG7051(c05439) and CG7051(f07138) failed to complement. CG7051 putatively encodes a Dynein intermediate chain. All three mutants, ms21, CG7051(c05439) and CG7051(f07138), exhibited absolute recessive male sterility with abnormally coiled sperm axonemes causing faulty sperm individualization as revealed by Phalloidin staining in Don Juan-GFP background. Sequencing of PCR amplicons uncovered two point mutations in ms21 allele and confirmed the piggyBac insertions in CG7051(c05439) and CG7051(f07138) alleles to be in 5'UTR and 4(th) exon of CG7051 respectively, excision of which reverted the male sterility. In situ hybridization to polytene chromosomes demonstrated CG7051 to be a single copy gene. RT-PCR of testis RNA revealed defective splicing of the CG7051 transcripts in mutants. Interestingly, expression of cytoplasmic dynein intermediate chain, alpha, beta, gamma tubulins and alpha-spectrin was normal in mutants while ultra structural studies revealed defects in the assembly of sperm axonemes. Bioinformatics further highlighted the homology of CG7051 to axonemal dynein intermediate chain of various organisms, including DNAI1 of humans, mutations in which lead to male sterility due to immotile sperms. Based on these observations we conclude that CG7051 encodes a novel axonemal dynein intermediate chain essential for male fertility in Drosophila and rename it as Dic61B. This is the first axonemal Dic gene of Drosophila to be characterized at molecular level and shown to be required for spermatogenesis.	Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Fatima, R (corresponding author), Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India.	roshanfatima@rediffmail.com	Fatima, Roshan/AAP-9300-2021	Fatima, Roshan/0000-0002-8926-5026	Indian Council of Medical Research (ICMR), India [2007-01320, 45/5/2007]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR))	RF was awarded Senior Research Fellow (SRF) from the Indian Council of Medical Research (ICMR, www.icmr.nic.in/), India. Grant No: IRIS ID No. 2007-01320 (File No: 45/5/2007). Department of Science and Technology (DST) (www.dst.gov.in/), India is acknowledged for the National Facility of Confocal Microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanksha, 2008, J GENET, V87, P87, DOI 10.1007/s12041-008-0012-8; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; ASAI DJ, 1995, CELL MOTIL CYTOSKEL, V32, P129, DOI 10.1002/cm.970320212; Bonilla E, 2008, MOL HUM REPROD, V14, P137, DOI 10.1093/molehr/gan002; Boylan K, 2000, MOL BIOL CELL, V11, P3791, DOI 10.1091/mbc.11.11.3791; Boylan KLM, 2002, GENETICS, V162, P1211; Bridges CB, 1916, GENETICS, V1, P1; BROSSEAU GE, 1960, GENETICS, V45, P257; Caggese C, 2001, MOL GENET GENOMICS, V265, P436, DOI 10.1007/s004380000431; Carvalho AB, 2000, P NATL ACAD SCI USA, V97, P13239, DOI 10.1073/pnas.230438397; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; DALLAI R, 1993, INT J INSECT MORPHOL, V22, P449, DOI 10.1016/0020-7322(93)90023-T; DiBella LM, 2001, INT REV CYTOL, V210, P227; ElHefnawy T, 1996, MOL CELL ENDOCRINOL, V119, P207; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Fuller Margaret T., 1993, P71; Ghosh-Roy A, 2005, MOL BIOL CELL, V16, P3107, DOI 10.1091/mbc.E05-02-0103; Ghosh-Roy A, 2004, MOL BIOL CELL, V15, P2470, DOI 10.1091/mbc.E03-11-0848; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; GOLDSTEIN LSB, 1982, P NATL ACAD SCI-BIOL, V79, P7405, DOI 10.1073/pnas.79.23.7405; Hackstein JHP, 2000, TRENDS GENET, V16, P565, DOI 10.1016/S0168-9525(00)02140-5; Han BG, 2003, ONCOGENE, V22, P5325, DOI 10.1038/sj.onc.1206783; HARDY RW, 1981, CHROMOSOMA, V83, P593, DOI 10.1007/BF00328522; HAYS TS, 1994, J CELL SCI, V107, P1557; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Hennig W, 1996, INT J DEV BIOL, V40, P167; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KENNISON JA, 1981, GENETICS, V98, P529; KIEFER BI, 1966, GENETICS, V54, P1441; KIEFER BI, 1968, GENETICS, V60, P192; KIEFER BI, 1970, J CELL SCI, V6, P177; Kiger AA, 1999, GENETICS, V153, P799; KLEMENZ R, 1985, EMBO J, V4, P2053, DOI 10.1002/j.1460-2075.1985.tb03891.x; Kondo T, 1998, BLOOD, V92, P1091, DOI 10.1182/blood.V92.4.1091.416a36_1091_1096; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li MG, 2004, MOL BIOL CELL, V15, P3005, DOI 10.1091/mbc.E04-01-0013; Lindsley D.L., 1980, Genetics and Biology of Drosophila, V2d, P225; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Mencarelli C, 2008, INT REV CEL MOL BIO, V268, P95, DOI 10.1016/S1937-6448(08)00804-6; Milisav I, 1998, CELL MOTIL CYTOSKEL, V39, P261, DOI 10.1002/(SICI)1097-0169(1998)39:4<261::AID-CM2>3.0.CO;2-6; MITCHELL DR, 1994, INT REV CYTOL, V155, P141, DOI 10.1016/S0074-7696(08)62098-7; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Nielsen MG, 2002, EVOL DEV, V4, P303, DOI 10.1046/j.1525-142X.2002.02015.x; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Porter ME, 1996, CURR OPIN CELL BIOL, V8, P10, DOI 10.1016/S0955-0674(96)80042-1; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Prasanth KV, 2000, J CELL SCI, V113, P3485; PRITCHARD AE, 1992, J VIROL, V66, P1951, DOI 10.1128/JVI.66.4.1951-1958.1992; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Rajendra TK, 2001, J GENET, V80, P97, DOI 10.1007/BF02728335; RASMUSSON K, 1994, MOL BIOL CELL, V5, P45, DOI 10.1091/mbc.5.1.45; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Santel A, 1998, J CELL SCI, V111, P3299; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Timakov B, 2000, GENETICS, V155, P179; Vibranovski MD, 2008, GENETICS, V179, P2325, DOI 10.1534/genetics.108.086819; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096	72	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e27822	10.1371/journal.pone.0027822	http://dx.doi.org/10.1371/journal.pone.0027822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145020	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168900003
J	Yang, ZJ; Zhang, L; Ma, AH; Liu, LL; Li, JJ; Gu, JR; Liu, YZ				Yang, Zhaojuan; Zhang, Li; Ma, Aihui; Liu, Lanlan; Li, Jinjun; Gu, Jianren; Liu, Yongzhong			Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+Cell Populations	PLOS ONE			English	Article							CANCER STEM-CELLS; MAMMALIAN TARGET; HEPATOCELLULAR-CARCINOMA; EPIGENETIC REGULATION; CELLULAR SENESCENCE; HUMAN GLIOBLASTOMA; COLORECTAL-CANCER; PANCREATIC-CANCER; 1A-DEFICIENT MICE; INITIATING CELLS	The mammalian target of the rapamycin (mTOR) pathway, which drives cell proliferation, is frequently hyperactivated in a variety of malignancies. Therefore, the inhibition of the mTOR pathway has been considered as an appropriate approach for cancer therapy. In this study, we examined the roles of mTOR in the maintenance and differentiation of cancer stem-like cells (CSCs), the conversion of conventional cancer cells to CSCs and continuous tumor growth in vivo. In H-Ras-transformed mouse liver tumor cells, we found that pharmacological inhibition of mTOR with rapamycin greatly increased not only the CD133+ populations both in vitro and in vivo but also the expression of stem cell-like genes. Enhancing mTOR activity by over-expressing Rheb significantly decreased CD133 expression, whereas knockdown of the mTOR yielded an opposite effect. In addition, mTOR inhibition severely blocked the differentiation of CD133+ to CD133-liver tumor cells. Strikingly, single-cell culture experiments revealed that CD133- liver tumor cells were capable of converting to CD133+ cells and the inhibition of mTOR signaling substantially promoted this conversion. In serial implantation of tumor xenografts in nude BALB/c mice, the residual tumor cells that were exposed to rapamycin in vivo displayed higher CD133 expression and had increased secondary tumorigenicity compared with the control group. Moreover, rapamycin treatment also enhanced the level of stem cell-associated genes and CD133 expression in certain human liver tumor cell lines, such as Huh7, PLC/PRC/7 and Hep3B. The mTOR pathway is significantly involved in the generation and the differentiation of tumorigenic liver CSCs. These results may be valuable for the design of more rational strategies to control clinical malignant HCC using mTOR inhibitors.	[Yang, Zhaojuan; Zhang, Li; Ma, Aihui; Liu, Lanlan; Li, Jinjun; Gu, Jianren; Liu, Yongzhong] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Sch Med, Renji Hosp,Shanghai Canc Inst, Shanghai 200030, Peoples R China; [Liu, Lanlan] Jinan Univ, Inst Reprod Immunol, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Jinan University	Yang, ZJ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Sch Med, Renji Hosp,Shanghai Canc Inst, Shanghai 200030, Peoples R China.	liuyzg@yahoo.com			Ministry of Health of China [2008ZX10002-022]	Ministry of Health of China	This work was supported by grants from the Ministry of Health of China (2008ZX10002-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Campbell TB, 2009, BLOOD, V114, P3392, DOI 10.1182/blood-2008-12-195214; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Curtin JC, 2010, ONCOTARGET, V1, P563, DOI 10.18632/oncotarget.191; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Dudkin L, 2001, CLIN CANCER RES, V7, P1758; Easley CA, 2010, CELL REPROGRAM, V12, P263, DOI 10.1089/cell.2010.0011; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Kemper K, 2010, ONCOTARGET, V1, P387, DOI 10.18632/oncotarget.173; Kenerson HL, 2002, CANCER RES, V62, P5645; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rountree CB, 2008, HEPATOLOGY, V47, P1288, DOI 10.1002/hep.22141; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wolpin BM, 2009, J CLIN ONCOL, V27, P193, DOI 10.1200/JCO.2008.18.9514; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Zender L, 2005, COLD SH Q B, V70, P251, DOI 10.1101/sqb.2005.70.059; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	62	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28405	10.1371/journal.pone.0028405	http://dx.doi.org/10.1371/journal.pone.0028405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145042	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168900025
J	Rusiniak, ME; Kunnev, D; Freeland, A; Cady, GK; Pruitt, SC				Rusiniak, M. E.; Kunnev, D.; Freeland, A.; Cady, G. K.; Pruitt, S. C.			Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma	ONCOGENE			English	Article						DNA replication; licensing factor; dormant origins; lymphoblastic lymphoma; Mcm2	ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTORS; HUMAN-CELLS; REPLICATIVE STRESS; T-ALL; MUTATIONS; ORIGINS; CANCER; NOTCH1; CYCLE	Mini-chromosome maintenance (Mcm) proteins are part of the replication- licensing complex that is loaded onto chromatin during the G1-phase of the cell cycle and required for initiation of DNA replication in the subsequent S-phase. Mcm proteins are typically loaded in excess of the number of locations that are used during S-phase. Nonetheless, partial depletion of Mcm proteins leads to cancers and stem cell deficiencies. Mcm2 deficient mice, on a 129Sv genetic background, display a high rate of thymic lymphoblastic lymphoma. Here array comparative genomic hybridization is used to characterize the genetic damage accruing in these tumors. The predominant events are deletions averaging less than 0.5 Mbp, considerably shorter than observed in prior studies using alternative mouse lymphoma models or human tumors. Such deletions facilitate identification of specific genes and pathways responsible for the tumors. Mutations in many genes that have been implicated in human lymphomas are recapitulated in this mouse model. These features, and the fact that the mutation underlying the accelerated genetic damage does not target a specific gene or pathway a priori, are valuable features of this mouse model for identification of tumor suppressor genes. Genes affected in all tumors include Pten, Tcfe2a, Mbd3 and Setd1b. Notch1 and additional genes are affected in subsets of tumors. The high frequency of relatively short deletions is consistent with elevated recombination between nearby stalled replication forks in Mcm2-deficient mice. Oncogene (2012) 31, 4034-4044; doi:10.1038/onc.2011.566; published online 12 December 2011	[Rusiniak, M. E.; Kunnev, D.; Freeland, A.; Cady, G. K.; Pruitt, S. C.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Pruitt, SC (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.	steven.pruitt@roswellpark.org			NIH-NCI; Ellison Medical Foundation; NYSTEM; NCI-CCS; NATIONAL CANCER INSTITUTE [R01CA130995] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); NYSTEM; NCI-CCS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NIH-NCI, the Ellison Medical Foundation and NYSTEM to SCP. Cost of animal maintenance and flow cytometry was supported in part by an NCI-CCS grant to RPCI.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Bai T, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-7; Blow JJ, 2011, TRENDS BIOCHEM SCI, V36, P405, DOI 10.1016/j.tibs.2011.05.002; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Buckler JL, 2008, IMMUNOL REV, V224, P239, DOI 10.1111/j.1600-065X.2008.00650.x; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Collins-Underwood JR, 2010, LEUKEMIA, V24, P1676, DOI 10.1038/leu.2010.177; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jeannet R, 2010, BLOOD, V116, P5443, DOI 10.1182/blood-2010-05-286658; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; LeBrun DP, 2003, FRONT BIOSCI, V8, pS206, DOI 10.2741/1030; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Orr SJ, 2010, ONCOGENE, V29, P3803, DOI 10.1038/onc.2010.138; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Remke M, 2009, BLOOD, V114, P1053, DOI 10.1182/blood-2008-10-186536; Santos J, 2010, CANCER GENET CYTOGEN, V197, P60, DOI 10.1016/j.cancergencyto.2009.10.010; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Williams RT, 2008, COLD SH Q B, V73, P461, DOI 10.1101/sqb.2008.73.039; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124	38	26	26	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	36					4034	4044		10.1038/onc.2011.566	http://dx.doi.org/10.1038/onc.2011.566			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NQ	22158038	Green Accepted			2022-12-25	WOS:000308688800004
J	Dittmann, LM; Danner, A; Gronych, J; Wolter, M; Stuhler, K; Grzendowski, M; Becker, N; Bageritz, J; Goidts, V; Toedt, G; Felsberg, J; Sabel, MC; Barbus, S; Reifenberger, G; Lichter, P; Tews, B				Dittmann, L. M.; Danner, A.; Gronych, J.; Wolter, M.; Stuehler, K.; Grzendowski, M.; Becker, N.; Bageritz, J.; Goidts, V.; Toedt, G.; Felsberg, J.; Sabel, M. C.; Barbus, S.; Reifenberger, G.; Lichter, P.; Tews, B.			Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro	ONCOGENE			English	Article						chemosensitivity; oligodendroglioma; peroxiredoxin 1; promoter methylation; radiosensitivity; temozolomide	GENE-EXPRESSION; PEROXIREDOXIN-II; OXIDATIVE STRESS; CANCER-CELLS; MGMT GENE; 1P; TEMOZOLOMIDE; GRADE; CHEMOTHERAPY; IDENTIFICATION	Deletions of chromosomal arms 1p and 19q are frequent in oligodendroglial tumours and linked to radio- and chemotherapy response as well as longer survival. The molecular mechanisms underlying this clinically important association are as yet unknown. Here, we studied the peroxiredoxin 1 (PRDX1) gene at 1p34.1 for promoter methylation and expression in primary gliomas and investigated its role in radio- and chemosensitivity of glioma cells in vitro. In total, we screened primary glioma tissues from 93 patients for methylation of the 50-CpG island of PRDX1 by sodium bisulfite sequencing. PRDX1 mRNA and protein expression levels were determined in subsets of the tumours by quantitative PCR and western blot analysis, respectively. PRDX1 hypermethylation and reduced expression were frequently detected in oligodendroglial tumours and secondary glioblastomas, but not in primary glioblastomas. In oligodendroglial tumours, both PRDX1 hypermethylation and reduced mRNA expression were significantly associated with 1p/19q-deletion. Stable knockdown of PRDX1 by lentiviral transduction of short-hairpin (sh) RNA constructs significantly increased apoptosis and reduced cell viability of Hs683 glioma cells exposed to ionizing irradiation or temozolomide in vitro. Taken together, our findings indicate that epigenetic silencing of PRDX1 is frequent in 1p/19q-deleted oligodendroglial tumours and likely contributes to radio- and chemosensitivity of these tumours. Oncogene (2012) 31, 3409-3418; doi:10.1038/onc.2011.513; published online 12 December 2011	[Dittmann, L. M.; Danner, A.; Gronych, J.; Becker, N.; Bageritz, J.; Goidts, V.; Toedt, G.; Barbus, S.; Lichter, P.] German Canc Res Ctr, Div Mol Genet, D-6900 Heidelberg, Germany; [Wolter, M.; Felsberg, J.; Reifenberger, G.] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Stuehler, K.; Grzendowski, M.] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany; [Stuehler, K.] Univ Dusseldorf, Biol Med Forschungszentrum, Mol Prote Lab, D-40225 Dusseldorf, Germany; [Sabel, M. C.] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Tews, B.] Univ Zurich, Brain Res Inst, Zurich, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Ruhr University Bochum; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Zurich	Lichter, P (corresponding author), German Canc Res Ctr, Div Mol Genet, Neuenheimer Feld 280, D-69120 Heidelberg, Baden Wuerttemb, Germany.	m.macleod@dkfz.de	Gronych, Jan/G-9954-2013; Reifenberger, Guido/AAE-3599-2019	Bageritz, Josephine/0000-0002-9531-0452	German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network NGFN2 [01GS0460, 01GS0462]; NGFN<SUP>plus</SUP> [01GS0883, 01GS0884, 01GS08186]; Ministry for Innovation, Science, Research and Technology (MIWFT) of Nordrhein Westfalen; Helmholtz international graduate school for cancer research	German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network NGFN2(Federal Ministry of Education & Research (BMBF)); NGFN<SUP>plus</SUP>; Ministry for Innovation, Science, Research and Technology (MIWFT) of Nordrhein Westfalen; Helmholtz international graduate school for cancer research	The study was supported by the German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network NGFN2 (01GS0460 to PL, 01GS0462 to GR), NGFN<SUP>plus</SUP> (01GS0883 to PL, 01GS0884 to GR and MW, 01GS08186 to KS) and the Ministry for Innovation, Science, Research and Technology (MIWFT) of Nordrhein Westfalen (MG). JG and JB were supported by scholarships from the Helmholtz international graduate school for cancer research.	Bae JY, 2007, J CELL BIOCHEM, V101, P1038, DOI 10.1002/jcb.21241; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Belot N, 2001, GLIA, V36, P375, DOI 10.1002/glia.1124; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Brada M, 2003, ANN ONCOL, V14, P1715, DOI 10.1093/annonc/mdg371; Branle F, 2002, CANCER-AM CANCER SOC, V95, P641, DOI 10.1002/cncr.10710; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Camby I, 2000, BRAIN PATHOL, V10, P569; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Felsberg J, 2004, BRAIN PATHOL, V14, P121, DOI 10.1111/j.1750-3639.2004.tb00044.x; Felsberg J, 2010, ACTA NEUROPATHOL, V119, P501, DOI 10.1007/s00401-010-0647-4; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Grzenclowski M, 2010, NEURO-ONCOLOGY, V12, P243, DOI 10.1093/neuonc/nop025; Grzendowski M, 2009, PROTEOMICS, V9, P4985, DOI 10.1002/pmic.200800902; Hattori Fumiyuki, 2007, V44, P357; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Hubstenberger A, 2008, EXP CELL RES, V314, P2870, DOI 10.1016/j.yexcr.2008.06.017; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Korshunov A, 2003, AM J PATHOL, V163, P1721, DOI 10.1016/S0002-9440(10)63530-4; Kouwenhoven MCM, 2006, EUR J CANCER, V42, P2499, DOI 10.1016/j.ejca.2006.05.021; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mollemann M, 2005, INT J CANCER, V113, P379, DOI 10.1002/ijc.20575; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; Riemenschneider MJ, 2009, CURR OPIN NEUROL, V22, P619, DOI 10.1097/WCO.0b013e32833245b0; Tews B, 2007, ONCOGENE, V26, P5010, DOI 10.1038/sj.onc.1210297; Tews B, 2006, INT J CANCER, V119, P792, DOI 10.1002/ijc.21901; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; van den Bent MJ, 2006, ANN ONCOL, V17, pX186, DOI 10.1093/annonc/mdl258; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wang TL, 2005, CANCER RES, V65, P10338, DOI 10.1158/0008-5472.CAN-04-4614; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Zhang B, 2008, BIOCHEM PHARMACOL, V75, P660, DOI 10.1016/j.bcp.2007.09.016	42	34	35	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	29					3409	3418		10.1038/onc.2011.513	http://dx.doi.org/10.1038/onc.2011.513			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	976FN	22158042				2022-12-25	WOS:000306566400002
J	Franco, HL; Rubel, CA; Large, MJ; Wetendorf, M; Fernandez-Valdivia, R; Jeong, JW; Spencer, TE; Behringer, RR; Lydon, JP; DeMayo, FJ				Franco, Heather L.; Rubel, Cory A.; Large, Michael J.; Wetendorf, Margeaux; Fernandez-Valdivia, Rodrigo; Jeong, Jae-Wook; Spencer, Thomas E.; Behringer, Richard R.; Lydon, John P.; DeMayo, Francesco J.			Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function	FASEB JOURNAL			English	Article						embryo implantation; proliferation; adenogenesis	FEMALE REPRODUCTIVE-TRACT; INDIAN HEDGEHOG; PROMOTER ACTIVITY; ESTROGEN; IMPLANTATION; PROLIFERATION; EXPRESSION; UTERUS; DECIDUALIZATION; RESPONSIVENESS	The ovarian steroid progesterone, acting through the progesterone receptor (PR), coordinates endometrial epithelial-stromal cell communication, which is critical for its development and function. PR expression in these cellular compartments is under tight temporal and endocrine control. Although ex vivo studies demonstrated the importance of stromal PR expression, they failed to show a role for epithelial PR in uterine function. Here, the in vivo role of PR in the uterine epithelium is defined using floxed PR (PRf/f) mice crossed to Wnt7a-Cre mice. Progesterone was unable to stimulate the expression of its epithelial target genes, including Ihh, in the Wnt7a-Cre(+)PR(f/-) mice. Analysis was conducted on Ihh to determine whether PR directly regulates epithelial gene transcription. ChIP-on-chip analysis identified PR binding sites in the 5'-flanking region of Ihh. Cotransfection of the proximal Ihh promoter with PR demonstrated that PR directly regulates Ihh transcription. Female Wnt7a-Cre(+)PR(f/-) mice are infertile due to defects in embryo attachment, stromal cell decidualization, and the inability to cease estrogen-induced epithelial cell proliferation. Finally, progesterone was unable to inhibit neonatal endometrial glandular development in Wnt7a-Cre(+)PR(f/-) mice. Thus, epithelial PR is necessary for the regulation of progesterone epithelial target gene expression, as well as uterine function and development.-Franco, H. L., Rubel, C. A., Large, M. J., Wetendorf, M., Fernandez-Valdivia, R., Jeong, J.-W., Spencer, T. E., Behringer, R. R., Lydon, J. P., DeMayo, F. J. Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function. FASEB J. 26, 1218-1227 (2012). www.fasebj.org	[Franco, Heather L.; Rubel, Cory A.; Large, Michael J.; Wetendorf, Margeaux; Lydon, John P.; DeMayo, Francesco J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wetendorf, Margeaux] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Fernandez-Valdivia, Rodrigo] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Michigan State University; Washington State University	DeMayo, FJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	fdemayo@bcm.tmc.edu	Spencer, Thomas/AAD-6434-2020; DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Large, Michael/0000-0002-0170-3918; Marbrey, Margeaux/0000-0002-0473-9422; Spencer, Thomas/0000-0003-2815-766X	U.S. National Institutes of Health (NIH) [R01HD042311, R01HD057873, R01CA77530, HD30284]; Reproductive Biology Training grant [5T32HD07165]; Baylor Research Advocates for Student Scientists; Winter-man Foundation; Houston Livestock Show and Rodeo Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007165, R01HD042311, R01HD030284, R01HD057873] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077530] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reproductive Biology Training grant; Baylor Research Advocates for Student Scientists; Winter-man Foundation; Houston Livestock Show and Rodeo Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Sungnam Cho, Jie Yang, Genpathway, Inc., and Grant Orvis for technical assistance and Janet DeMayo for manuscript preparation. This work was supported by U.S. National Institutes of Health (NIH) grants R01HD042311 (to F.J.D.), R01HD057873 (to J.W.J.), R01CA77530 (to J.P.L), and HD30284 (to R. R. B.), and Reproductive Biology Training grant 5T32HD07165 and a scholarship from Baylor Research Advocates for Student Scientists, supported, in part, by the Winter-man Foundation and the Houston Livestock Show and Rodeo Scholarship Fund (to H.L.F.).	BARTOL FF, 1988, J ANIM SCI, V66, P3000; Chen B, 2005, MOL ENDOCRINOL, V19, P1978, DOI 10.1210/me.2004-0274; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; DAS SK, 1995, MOL ENDOCRINOL, V9, P691, DOI 10.1210/me.9.6.691; Fernandez-Valdivia R, 2010, GENESIS, V48, P106, DOI 10.1002/dvg.20586; FINN CA, 1972, BIOL REPROD, V7, P82, DOI 10.1093/biolreprod/7.1.82; Franco HL, 2008, SEMIN CELL DEV BIOL, V19, P178, DOI 10.1016/j.semcdb.2007.12.001; Franco HL, 2010, BIOL REPROD, V82, P991, DOI 10.1095/biolreprod.109.081513; Franco HL, 2010, BIOL REPROD, V82, P783, DOI 10.1095/biolreprod.109.080259; Gao JG, 2001, MOL CELL ENDOCRINOL, V176, P97, DOI 10.1016/S0303-7207(01)00450-6; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gray CA, 2001, BIOL REPROD, V64, P797, DOI 10.1095/biolreprod64.3.797; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; Ismail PM, 2002, MOL ENDOCRINOL, V16, P2475, DOI 10.1210/me.2002-0169; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jeong JW, 2005, ENDOCRINOLOGY, V146, P3490, DOI 10.1210/en.2005-0016; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Large MJ, 2012, MOL CELL ENDOCRINOL, V358, P155, DOI 10.1016/j.mce.2011.07.027; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Li XT, 2003, J BIOL CHEM, V278, P39261, DOI 10.1074/jbc.R300024200; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; MARTIN L, 1973, J ENDOCRINOL, V57, P549, DOI 10.1677/joe.0.0570549; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Pan HY, 2006, P NATL ACAD SCI USA, V103, P14021, DOI 10.1073/pnas.0601271103; Rubel CA, 2010, SEMIN REPROD MED, V28, P27, DOI 10.1055/s-0029-1242990; Simmen RCM, 1999, ENDOCRINOLOGY, V140, P2517, DOI 10.1210/en.140.6.2517; Simon L, 2009, ENDOCRINOLOGY, V150, P3871, DOI 10.1210/en.2008-1691; Spencer TE, 2004, BIOL REPROD, V71, P2, DOI 10.1095/biolreprod.103.024133; Stewart CA, 2011, BIOL REPROD, V85, P954, DOI 10.1095/biolreprod.111.091470; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takamoto N, 2005, MOL ENDOCRINOL, V19, P2299, DOI 10.1210/me.2005-0019; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Tang MY, 2002, MOL CELL ENDOCRINOL, V192, P45, DOI 10.1016/S0303-7207(02)00111-9; Tong W, 1999, MOL CELL BIOL, V19, P2251; Tseng L, 2003, DNA CELL BIOL, V22, P633, DOI 10.1089/104454903770238102; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Yang ZM, 1996, MOL REPROD DEV, V43, P470	43	104	110	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1218	1227		10.1096/fj.11-193334	http://dx.doi.org/10.1096/fj.11-193334			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22155565	Green Published			2022-12-25	WOS:000300949300024
J	Chandrayan, SK; McTernan, PM; Hopkins, RC; Sun, JS; Jenney, FE; Adams, MWW				Chandrayan, Sanjeev K.; McTernan, Patrick M.; Hopkins, R. Christopher; Sun, Junsong; Jenney, Francis E., Jr.; Adams, Michael W. W.			Engineering Hyperthermophilic Archaeon Pyrococcus furiosus to Overproduce Its Cytoplasmic [NiFe]-Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIFE HYDROGENASE; DESULFOVIBRIO-GIGAS; ESCHERICHIA-COLI; ACTIVE-SITE; MATURATION; METABOLISM; ENZYMES; METALLOENZYME; PURIFICATION; QUANTITATION	The cytoplasmic hydrogenase (SHI) of the hyperthermophilic archaeon Pyrococcus furiosus is an NADP(H)-dependent heterotetrameric enzyme that contains a nickel-iron catalytic site, flavin, and six iron-sulfur clusters. It has potential utility in a range of bioenergy systems in vitro, but a major obstacle in its use is generating sufficient amounts. We have engineered P. furiosus to overproduce SHI utilizing a recently developed genetic system. In the overexpression (OE-SHI) strain, transcription of the four-gene SHI operon was under the control of a strong constitutive promoter, and a Strep-tag II was added to the N terminus of one subunit. OE-SHI and wild-type P. furiosus strains had similar rates of growth and H-2 production on maltose. Strain OE-SHI had a 20-fold higher transcription of the polycistronic hydrogenase mRNA encoding SHI, and the specific activity of the cytoplasmic hydrogenase was similar to 10-fold higher when compared with the wild-type strain, although the expression levels of genes encoding processing and maturation of SHI were the same in both strains. Overexpressed SHI was purified by a single affinity chromatography step using the Strep-tag II, and it and the native form had comparable activities and physical properties. Based on protein yield per gram of cells (wet weight), the OE-SHI strain yields a 100-fold higher amount of hydrogenase when compared with the highest homologous [NiFe]-hydrogenase system previously reported (from Synechocystis). This new P. furiosus system will allow further engineering of SHI and provide hydrogenase for efficient in vitro biohydrogen production.	[Chandrayan, Sanjeev K.; McTernan, Patrick M.; Hopkins, R. Christopher; Sun, Junsong; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Jenney, Francis E., Jr.] Philadelphia Coll Osteopath Med, Suwanee, GA 30024 USA	University System of Georgia; University of Georgia	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	McTernan, Patrick/HGV-0762-2022; CHANDRAYAN, SANJEEV/M-1662-2016	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Adams, Michael/0000-0002-9796-5014; Jenney, Francis/0000-0002-1667-6924	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy [DE-FG05-95ER20175, DE-FG02-05ER15710]	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Grants DE-FG05-95ER20175 and DE-FG02-05ER15710 from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (to M. W. W. A.).	Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; Cammack R., 2001, HYDROGEN FUEL LEARNI, P201; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Gupta R. B., 2009, HYDROGEN FUEL PRODUC, P1; Hopkins RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026569; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jenney FE, 2008, ANN NY ACAD SCI, V1125, P252, DOI 10.1196/annals.1419.013; Kallnik V, 2011, APPL MICROBIOL BIOT, V90, P1285, DOI 10.1007/s00253-011-3187-5; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; Lee HS, 2006, J BACTERIOL, V188, P2115, DOI 10.1128/JB.188.6.2115-2125.2006; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; MA KS, 1994, FEMS MICROBIOL LETT, V122, P245, DOI 10.1016/0378-1097(94)00330-0; Maier T, 1998, ANAL BIOCHEM, V259, P68, DOI 10.1006/abio.1998.2649; Marques MC, 2010, J MOL BIOL, V396, P893, DOI 10.1016/j.jmb.2009.12.013; Mukherjee S, 2005, ANAL BIOCHEM, V347, P49, DOI 10.1016/j.ab.2005.08.028; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Porthun A, 2002, ARCH MICROBIOL, V177, P159, DOI 10.1007/s00203-001-0371-5; Rousset M, 1998, J BACTERIOL, V180, P4982, DOI 10.1128/JB.180.18.4982-4986.1998; Sambrook J, 2001, MOL CLONING LAB MANU, p[38, 51]; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; Verhagen MFJM, 2001, METHOD ENZYMOL, V330, P25; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhang YHP, 2010, CURR OPIN BIOTECH, V21, P663, DOI 10.1016/j.copbio.2010.05.005	43	43	45	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3257	3264		10.1074/jbc.M111.290916	http://dx.doi.org/10.1074/jbc.M111.290916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157005	Green Published, hybrid			2022-12-25	WOS:000300295100031
J	Cullen, TW; Madsen, JA; Ivanov, PL; Brodbelt, JS; Trent, MS				Cullen, Thomas W.; Madsen, James A.; Ivanov, Petko L.; Brodbelt, Jennifer S.; Trent, M. Stephen			Characterization of Unique Modification of Flagellar Rod Protein FlgG by Campylobacter jejuni Lipid A Phosphoethanolamine Transferase, Linking Bacterial Locomotion and Antimicrobial Peptide Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-GONORRHOEAE; IV PILI; SALMONELLA-ENTERICA; HELICOBACTER-PYLORI; MASS-SPECTROMETRY; SEQUENCE ANALYSIS; ESCHERICHIA-COLI; INNER-CORE; LIPOPOLYSACCHARIDE; IDENTIFICATION	Gram-negative bacteria assemble complex surface structures that interface with the surrounding environment and are involved in pathogenesis. Recent work in Campylobacter jejuni identified a gene encoding a novel phosphoethanolamine (pEtN) transferase Cj0256, renamed EptC, that serves a dual role in modifying the flagellar rod protein, FlgG, and the lipid A domain of C. jejuni lipooligosaccharide with a pEtN residue. In this work, we characterize the unique post-translational pEtN modification of FlgG using collision-induced and electron transfer dissociation mass spectrometry, as well as a genetic approach using site-directed mutagenesis to determine the site of modification. Specifically, we show that FlgG is modified with pEtN at a single site (Thr(75)) by EptC and demonstrate enzyme specificity by showing that EptC is unable to modify other amino acids (e. g. serine and tyrosine). Using Campylobacter strains expressing site-directed FlgG mutants, we also show that defects in motility arise directly from the loss of pEtN modification of FlgG. Interestingly, alignments of FlgG from most epsilon proteobacteria reveal a conserved site of modification. Characterization of EptC and its enzymatic targets expands on the increasingly important field of prokaryotic post-translational modification of bacterial surface structures and the unidentified role they may play in pathogenesis.	[Cullen, Thomas W.; Ivanov, Petko L.; Trent, M. Stephen] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Madsen, James A.; Brodbelt, Jennifer S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Trent, M. Stephen] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Trent, MS (corresponding author), 1 Univ Stn,A5000, Austin, TX 78712 USA.	strent@mail.utexas.edu			National Institutes of Health [AI064184, AI76322]; National Science Foundation [CHE-1012622]; Welch Foundation [F-1155]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076322, R01AI076322, R01AI064184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064184 and AI76322 (to M. S. T.).; Supported by National Science Foundation Grant CHE-1012622 and Welch Foundation Grant F-1155.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; ASPINALL GO, 1995, EUR J BIOCHEM, V231, P570, DOI 10.1111/j.1432-1033.1995.0570d.x; Balaban M, 2009, J BACTERIOL, V191, P6602, DOI 10.1128/JB.00884-09; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Chevance FFV, 2007, GENE DEV, V21, P2326, DOI 10.1101/gad.1571607; Coon JJ, 2009, ANAL CHEM, V81, P3208, DOI 10.1021/ac802330b; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; McLuckey SA, 2011, J AM SOC MASS SPECTR, V22, P3, DOI 10.1007/s13361-010-0004-9; Naessan CL, 2008, J BACTERIOL, V190, P387, DOI 10.1128/JB.00765-07; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; SHI WY, 1993, J BACTERIOL, V175, P7711, DOI 10.1128/JB.175.23.7711-7714.1993; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; WASSENAAR TM, 1993, J GEN MICROBIOL, V139, P1171, DOI 10.1099/00221287-139-6-1171; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Yao RJ, 1996, J BACTERIOL, V178, P3335, DOI 10.1128/jb.178.11.3335-3338.1996	37	36	38	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3326	3336		10.1074/jbc.M111.321737	http://dx.doi.org/10.1074/jbc.M111.321737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158617	Green Published, hybrid			2022-12-25	WOS:000300295100038
J	Bounedjah, O; Hamon, L; Savarin, P; Desforges, B; Curmi, PA; Pastre, D				Bounedjah, Ouissame; Hamon, Loic; Savarin, Philippe; Desforges, Benedicte; Curmi, Patrick A.; Pastre, David			Macromolecular Crowding Regulates Assembly of mRNA Stress Granules after Osmotic Stress NEW ROLE FOR COMPATIBLE OSMOLYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION COMMUNICATION; ENHANCER-BINDING PROTEIN; RENAL MEDULLARY CELLS; RAT-KIDNEY; STIMULATES TRANSCRIPTION; BUNDLE FORMATION; GENE-EXPRESSION; HEPATOMA-CELLS; LIPID OLEAMIDE; MDCK CELLS	The massive uptake of compatible osmolytes such as betaine, taurine, and myo-inositol is a protective response shared by all eukaryotes exposed to hypertonic stress. Their accumulation results mostly from the expression of specific transporters triggered by the transcriptional factor NFAT5/TonEBP. This allows the recovery of the cell volume without increasing intracellular ionic strength. In this study we consider the assembly and dissociation of mRNA stress granules (SGs) in hypertonic-stressed cells and the role of compatible osmolytes. In agreement with in vitro results obtained on isolated mRNAs, both macromolecular crowding and a high ionic strength favor the assembly of SGs in normal rat kidney epithelial cells. However, after hours of constant hypertonicity, the slow accumulation in the cytoplasm of compatible osmolytes via specific transporters both reduces macromolecular crowding and ionic strength, thus leading to the progressive dissociation of SGs. In line with this, when cells are exposed to hypertonicity to accumulate a large amount of compatible osmolytes, the formation of SGs is severely impaired, and cells increase their chances of survival to another hypertonic episode. Altogether, these results indicate that the impact of compatible osmolytes on the mRNA-associated machineries and especially that associated with SGs may play an important role in cell resistance and adaption to hyperosmolarity in many tissues like kidney and liver.	[Pastre, David] INSERM, Lab Struct Act Biomol Normales & Pathol, U829, F-91025 Evry, France; Univ Evry Val Essonne, F-91025 Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Pastre, D (corresponding author), INSERM, Lab Struct Act Biomol Normales & Pathol, U829, F-91025 Evry, France.	david.pastre@univ-evry.fr	Pastre, David/B-2958-2014; CURMI, Patrick/G-4036-2013	Pastre, David/0000-0002-3348-9514; hamon, loic/0000-0003-2032-7994; CURMI, Patrick A./0000-0001-5045-8501	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by funds from the INSERM.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARAJAS L, 1994, KIDNEY INT, V46, P621, DOI 10.1038/ki.1994.314; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Boger DL, 1998, P NATL ACAD SCI USA, V95, P4810, DOI 10.1073/pnas.95.9.4810; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Chernov KG, 2009, J BIOL CHEM, V284, P36569, DOI 10.1074/jbc.M109.042879; Davydova EK, 1997, NUCLEIC ACIDS RES, V25, P2911, DOI 10.1093/nar/25.14.2911; de Vries R, 2001, BIOPHYS J, V80, P1186, DOI 10.1016/S0006-3495(01)76095-X; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Desforges B, 2011, AM J PHYSIOL-CELL PH, V301, pC705, DOI 10.1152/ajpcell.00128.2011; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Dmitrieva NI, 2004, P NATL ACAD SCI USA, V101, P2317, DOI 10.1073/pnas.0308463100; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Ferraris JD, 1999, AM J PHYSIOL-CELL PH, V276, pC667, DOI 10.1152/ajpcell.1999.276.3.C667; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hamon L, 2011, BIOPHYS J, V101, P205, DOI 10.1016/j.bpj.2011.05.022; Haussinger D, 1996, BIOCHEM J, V313, P697; Horio M, 2001, NEPHROL DIAL TRANSPL, V16, P483, DOI 10.1093/ndt/16.3.483; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Ko K, 2000, AM J PHYSIOL-CELL PH, V279, pC147, DOI 10.1152/ajpcell.2000.279.1.C147; KWON ED, 1995, AM J PHYSIOL-CELL PH, V268, pC402, DOI 10.1152/ajpcell.1995.268.2.C402; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Liu YF, 2006, P NATL ACAD SCI USA, V103, P10654, DOI 10.1073/pnas.0510381103; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Loyher ML, 2004, NEUROSCIENCE, V124, P89, DOI 10.1016/j.neuroscience.2003.10.025; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; MORIYAMA T, 1989, J BIOL CHEM, V264, P16810; Morley SJ, 2002, J BIOL CHEM, V277, P32855, DOI 10.1074/jbc.C200376200; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; NAKANISHI T, 1989, P NATL ACAD SCI USA, V86, P6002, DOI 10.1073/pnas.86.15.6002; NAKANISHI T, 1989, AM J PHYSIOL, V257, pC964, DOI 10.1152/ajpcell.1989.257.5.C964; NAKANISHI T, 1990, AM J PHYSIOL, V258, pF1061, DOI 10.1152/ajprenal.1990.258.4.F1061; Natalello A, 2009, PROTEINS, V75, P509, DOI 10.1002/prot.22266; Navarro P, 2008, BIOCHEM BIOPH RES CO, V372, P326, DOI 10.1016/j.bbrc.2008.05.067; Neuhofer W, 2010, CURR GENOMICS, V11, P584, DOI 10.2174/138920210793360961; Pastre D, 2007, BIOMACROMOLECULES, V8, P3712, DOI 10.1021/bm700856u; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; PETRONINI PG, 1992, BIOCHEM J, V282, P69, DOI 10.1042/bj2820069; Rodgaard T, 2008, AM J PHYSIOL-CELL PH, V295, pC1528, DOI 10.1152/ajpcell.00081.2008; Roger F, 1999, J BIOL CHEM, V274, P34103, DOI 10.1074/jbc.274.48.34103; SAIKIA TC, 1965, Q J EXP PHYSIOL CMS, V50, P146, DOI 10.1113/expphysiol.1965.sp001777; Schafer C, 2007, AM J PHYSIOL-GASTR L, V292, pG1089, DOI 10.1152/ajpgi.00088.2006; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Strange K, 2004, ADV PHYSIOL EDUC, V28, P155, DOI 10.1152/advan.00034.2004; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; STRANGE K, 1991, AM J PHYSIOL, V260, pC784, DOI 10.1152/ajpcell.1991.260.4.C784; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; WIEGANT FAC, 1993, CELL BIOL TOXICOL, V9, P49, DOI 10.1007/BF00755139; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; YAMAUCHI A, 1993, AM J PHYSIOL, V264, pF20, DOI 10.1152/ajprenal.1993.264.1.F20; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	78	63	64	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2446	2458		10.1074/jbc.M111.292748	http://dx.doi.org/10.1074/jbc.M111.292748			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147700	Green Published, hybrid			2022-12-25	WOS:000300292300019
J	Roff, G; Kvennefors, ECE; Fine, M; Ortiz, J; Davy, JE; Hoegh-Guldberg, O				Roff, George; Kvennefors, E. Charlotte E.; Fine, Maoz; Ortiz, Juan; Davy, Joanne E.; Hoegh-Guldberg, Ove			The Ecology of 'Acroporid White Syndrome', a Coral Disease from the Southern Great Barrier Reef	PLOS ONE			English	Article							BLACK BAND DISEASE; INDO-PACIFIC REEFS; PLAGUE TYPE-II; POPULATION-DYNAMICS; FLORIDA-KEYS; SCLERACTINIAN CORALS; ERODING BAND; HOST-RANGE; RED-SEA; SIZE	Outbreaks of coral disease have increased worldwide over the last few decades. Despite this, remarkably little is known about the ecology of disease in the Indo-Pacific Region. Here we report the spatiotemporal dynamics of a coral disease termed 'Acroporid white syndrome' observed to affect tabular corals of the genus Acropora on the southern Great Barrier Reef. The syndrome is characterised by rapid tissue loss initiating in the basal margins of colonies, and manifests as a distinct lesion boundary between apparently healthy tissue and exposed white skeleton. Surveys of eight sites around Heron Reef in 2004 revealed a mean prevalence of 8.1 +/- 0.9%, affecting the three common species (Acropora cytherea, A. hyacinthus, A. clathrata) and nine other tabular Acropora spp. While all sizes of colonies were affected, white syndrome disproportionately affected larger colonies of tabular Acroporids (> 80 cm). The prevalence of white syndrome was strongly related to the abundance of tabular Acroporids within transects, yet the incidence of the syndrome appears unaffected by proximity to other colonies, suggesting that while white syndrome is density dependant, it does not exhibit a strongly aggregated spatial pattern consistent with previous coral disease outbreaks. Acroporid white syndrome was not transmitted by either direct contact in the field or by mucus in aquaria experiments. Monitoring of affected colonies revealed highly variable rates of tissue loss ranging from 0 to 1146 cm(-2) week(-1), amongst the highest documented for a coral disease. Contrary to previous links between temperature and coral disease, rates of tissue loss in affected colonies increased threefold during the winter months. Given the lack of spatial pattern and non-infectious nature of Acroporid white syndrome, further studies are needed to determine causal factors and longer-term implications of disease outbreaks on the Great Barrier Reef.	[Roff, George; Ortiz, Juan] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Roff, George; Kvennefors, E. Charlotte E.; Ortiz, Juan; Davy, Joanne E.; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Fine, Maoz] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Fine, Maoz] Interuniversity, Inst Marine Sci, Elat, Israel; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland; Bar Ilan University; University of Queensland	Roff, G (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	g.roff@uq.edu.au	Hoegh-Guldberg, Ove/H-6169-2011; Roff, George/ABB-4406-2021; Hoegh-Guldberg, Ove/ABA-5420-2020; Fine, Maoz/S-5582-2019; Kvennefors, Eva Charlotte E/B-9585-2013; Roff, George/C-8766-2015; Ortiz Cuellar, Juan carlos/GQZ-3899-2022	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Roff, George/0000-0002-2823-0575; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Fine, Maoz/0000-0003-4911-4562; Roff, George/0000-0002-2823-0575; 	ARC Centre of Excellence for Coral Reef Studies; Coral Reef Targeted Research Program	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Coral Reef Targeted Research Program	This project was supported by funding from the ARC Centre of Excellence for Coral Reef Studies as well as the Coral Reef Targeted Research Program to OH-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Antonius A., 1988, P293; Antonius A, 1999, CORAL REEFS, V18, P300, DOI 10.1007/s003380050199; ANTONIUS A, 1985, Marine Ecology, V6, P197, DOI 10.1111/j.1439-0485.1985.tb00322.x; Antonius A, 1981, P 4 INT COR REEF S, V2, P7; Antonius A.A., 2001, ATOLL RES BULL, V481, P1, DOI [10.5479/si.00775630.481, DOI 10.5479/SI.00775630.481]; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; BABCOCK RC, 1984, CORAL REEFS, V2, P187; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Borger JL, 2005, CORAL REEFS, V24, P139, DOI 10.1007/s00338-004-0434-6; Bourne DG, 2008, APPL ENVIRON MICROB, V74, P883, DOI 10.1128/AEM.01124-07; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Coles S, 1994, CORAL REEFS, V13, P242, DOI DOI 10.1007/BF00303638; Connell JH, 1973, BIOLOGY GEOLOGY CORA, VII, P205; Croquer A, 2006, DIS AQUAT ORGAN, V69, P75, DOI 10.3354/dao069075; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Fine M, 2006, CORAL REEFS, V25, P577, DOI 10.1007/s00338-006-0143-4; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Haapkyla J, 2010, CORAL REEFS, V29, P1035, DOI 10.1007/s00338-010-0660-z; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Hayes RL, 1998, REV BIOL TROP, V46, P173; Hobbs JPA, 2010, DIS AQUAT ORGAN, V89, P1, DOI 10.3354/dao02181; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1987, AM NAT, V129, P818, DOI 10.1086/284677; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; Jolles AE, 2002, ECOLOGY, V83, P2373, DOI 10.1890/0012-9658(2002)083[2373:DTOAIS]2.0.CO;2; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lirman D, 2000, J EXP MAR BIOL ECOL, V251, P41, DOI 10.1016/S0022-0981(00)00205-7; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MEESTERS EH, 1995, MAR ECOL PROG SER, V121, P203, DOI 10.3354/meps121203; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Muko S, 2001, J ANIM ECOL, V70, P579, DOI 10.1046/j.1365-2656.2001.00513.x; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; Nugues MM, 2009, CORAL REEFS, V28, P507, DOI 10.1007/s00338-009-0468-x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Oren U, 1997, MAR ECOL PROG SER, V146, P101, DOI 10.3354/meps146101; Page CA, 2008, CORAL REEFS, V27, P257, DOI 10.1007/s00338-007-0317-8; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Pandolfi JM, 2002, CORAL REEFS, V21, P13, DOI 10.1007/s00338-001-0204-7; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Richardson LL, 1998, REV BIOL TROP, V46, P187; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Richardson LL, 2002, P 9 INT COR REEF S, V1, P1225; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Rodriguez-Martinez RE, 2001, AQUATIC, V47, P229; Roff G, 2008, CORAL REEFS, V27, P373, DOI 10.1007/s00338-007-0339-2; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Shenkar N, 2005, MAR ECOL PROG SER, V294, P181, DOI 10.3354/meps294181; Sokal R. R., 2012, BIOMETRY; STIMSON J, 1985, ECOLOGY, V66, P40, DOI 10.2307/1941305; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweatman H.H., 2008, 8 AUSTR I MAR SCI; Szmant-Froelich A, 1985, P 5 INT COR REEF C T, V4, P399; Ulstrup KE, 2007, APPL ENVIRON MICROB, V73, P1968, DOI 10.1128/AEM.02292-06; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Veron JEN, 1984, SCLERACTINIA AUSTR V; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wegley L, 2004, MAR ECOL PROG SER, V273, P89, DOI 10.3354/meps273089; Williams GJ, 2008, CORAL REEFS, V27, P207, DOI 10.1007/s00338-007-0314-y; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Winkler R, 2004, MAR ECOL-P S Z N I, V25, P129, DOI 10.1111/j.1439-0485.2004.00020.x	81	25	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e26829	10.1371/journal.pone.0026829	http://dx.doi.org/10.1371/journal.pone.0026829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163267	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900003
J	Vethanayagam, RR; Almyroudis, NG; Grimm, MJ; Lewandowski, DC; Pham, CTN; Blackwell, TS; Petraitiene, R; Petraitis, V; Walsh, TJ; Urban, CF; Segal, BH				Vethanayagam, R. Robert; Almyroudis, Nikolaos G.; Grimm, Melissa J.; Lewandowski, David C.; Pham, Christine T. N.; Blackwell, Timothy S.; Petraitiene, Ruta; Petraitis, Vidmantas; Walsh, Thomas J.; Urban, Constantin F.; Segal, Brahm H.			Role of NADPH Oxidase versus Neutrophil Proteases in Antimicrobial Host Defense	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PAPILLON-LEFEVRE-SYNDROME; P47(PHOX-/-) MOUSE MODEL; PULMONARY ASPERGILLOSIS; INFLAMMATORY RESPONSE; BURKHOLDERIA-CEPACIA; FUNGAL-INFECTIONS; AMPHOTERICIN-B; GENE-TRANSFER; ELASTASE	NADPH oxidase is a crucial enzyme in mediating antimicrobial host defense and in regulating inflammation. Patients with chronic granulomatous disease, an inherited disorder of NADPH oxidase in which phagocytes are defective in generation of reactive oxidant intermediates (ROIs), suffer from life-threatening bacterial and fungal infections. The mechanisms by which NADPH oxidase mediate host defense are unclear. In addition to ROI generation, neutrophil NADPH oxidase activation is linked to the release of sequestered proteases that are posited to be critical effectors of host defense. To definitively determine the contribution of NADPH oxidase versus neutrophil serine proteases, we evaluated susceptibility to fungal and bacterial infection in mice with engineered disruptions of these pathways. NADPH oxidase-deficient mice (p47(phox-/-)) were highly susceptible to pulmonary infection with Aspergillus fumigatus. In contrast, double knockout neutrophil elastase (NE)(-/-) x cathepsin G (CG)(-/-) mice and lysosomal cysteine protease cathepsin C/dipeptidyl peptidase I (DPPI)-deficient mice that are defective in neutrophil serine protease activation demonstrated no impairment in antifungal host defense. In separate studies of systemic Burkholderia cepacia infection, uniform fatality occurred in p47(phox-/-) mice, whereas NE-/- x CG(-/-) mice cleared infection. Together, these results show a critical role for NADPH oxidase in antimicrobial host defense against A. fumigatus and B. cepacia, whereas the proteases we evaluated were dispensable. Our results indicate that NADPH oxidase dependent pathways separate from neutrophil serine protease activation are required for host defense against specific pathogens.	[Vethanayagam, R. Robert; Almyroudis, Nikolaos G.; Grimm, Melissa J.; Lewandowski, David C.; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Almyroudis, Nikolaos G.; Segal, Brahm H.] SUNY Buffalo, Dept Med, Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Pham, Christine T. N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Petraitiene, Ruta; Petraitis, Vidmantas; Walsh, Thomas J.] Weill Cornell Univ, Med Ctr, Transplantat Oncol Infect Dis Program, New York, NY USA; [Urban, Constantin F.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Segal, Brahm H.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Washington University (WUSTL); Vanderbilt University; Cornell University; Umea University; Roswell Park Cancer Institute	Vethanayagam, RR (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	brahm.segal@roswellpark.org	Segal, Brahm/AAW-2706-2020; Urban, Constantin/H-5121-2019	Urban, Constantin/0000-0003-1438-1134	Chronic Granulomatous Disorder Research Trust, NIAID [R01AI079253, R0AI049261]; NCI Cancer Center [CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079253, R01AI049261, R56AI049261] Funding Source: NIH RePORTER	Chronic Granulomatous Disorder Research Trust, NIAID; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Chronic Granulomatous Disorder Research Trust (BHS), NIAID R01AI079253 (BHS) and R0AI049261 (CTNP). This research was supported, in part, by the NCI Cancer Center Support Grant to Roswell Park Cancer Institute (CA016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Akk AM, 2008, J IMMUNOL, V180, P3535, DOI 10.4049/jimmunol.180.5.3535; Almuneef M, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e85; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BAEHNER RL, 1967, SCIENCE, V155, P835, DOI 10.1126/science.155.3764.835; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bignell E, 2005, INFECT IMMUN, V73, P5204, DOI 10.1128/IAI.73.8.5204-5207.2005; Boyle KB, 2011, J IMMUNOL, V186, P2978, DOI 10.4049/jimmunol.1002268; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chang YC, 1998, J CLIN INVEST, V101, P1843, DOI 10.1172/JCI2301; Dalgic B, 2011, EUR J PEDIATR, V170, P803, DOI 10.1007/s00431-010-1368-3; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dennis CG, 2006, ANTIMICROB AGENTS CH, V50, P422, DOI 10.1128/AAC.50.2.422-427.2006; Dinauer MC, 2001, BLOOD, V97, P3738, DOI 10.1182/blood.V97.12.3738; DIXON DM, 1989, INFECT IMMUN, V57, P1452, DOI 10.1128/IAI.57.5.1452-1456.1989; Francesconi A, 2006, J CLIN MICROBIOL, V44, P2475, DOI 10.1128/JCM.02693-05; FRANCIS P, 1994, J INFECT DIS, V169, P356, DOI 10.1093/infdis/169.2.356; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gallin JI, 2003, NEW ENGL J MED, V348, P2416, DOI 10.1056/NEJMoa021931; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hu Y, 2005, ARTHRITIS RHEUM-US, V52, P2553, DOI 10.1002/art.21192; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jann NJ, 2009, J LEUKOCYTE BIOL, V86, P1159, DOI 10.1189/jlb.0209053; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Marcos V, 2011, NAT MED, V17, P899, DOI 10.1038/nm0711-899a; Mardiney M, 1997, BLOOD, V89, P2268, DOI 10.1182/blood.V89.7.2268; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Petraitiene R, 2001, ANTIMICROB AGENTS CH, V45, P857, DOI 10.1128/AAC.45.3.857-869.2001; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Segal BH, 2003, INFECT IMMUN, V71, P205, DOI 10.1128/IAI.71.1.205-210.2003; Segal BH, 1998, MEDICINE, V77, P345, DOI 10.1097/00005792-199809000-00004; Segal BH, 2000, INFECT IMMUN, V68, P2374, DOI 10.1128/IAI.68.4.2374-2378.2000; Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006; Segal BH, 2011, BIOL BLOOD MARROW TR, V17, pS123, DOI 10.1016/j.bbmt.2010.09.008; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; SPEERT DP, 1994, J INFECT DIS, V170, P1524, DOI 10.1093/infdis/170.6.1524; THRASHER AJ, 1994, BBA-MOL BASIS DIS, V1227, P1, DOI 10.1016/0925-4439(94)90100-7; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC; Zaas AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000101; Zarember KA, 2007, J IMMUNOL, V178, P6367, DOI 10.4049/jimmunol.178.10.6367	65	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28149	10.1371/journal.pone.0028149	http://dx.doi.org/10.1371/journal.pone.0028149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163282	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900017
J	Ullah, N; Lee, HY; Naseer, MI; Ullah, I; Suh, JW; Kim, MO				Ullah, Najeeb; Lee, Hae Young; Naseer, Muhammad Imran; Ullah, Ikram; Suh, Joo Won; Kim, Myeong Ok			Nicotinamide Inhibits Alkylating Agent-Induced Apoptotic Neurodegeneration in the Developing Rat Brain	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE-1; HEMATOLOGICAL MALIGNANCIES; ANTICANCER AGENTS; NAD(+) DEPLETION; NERVOUS-SYSTEM; INDUCED INJURY; CYTOCHROME-C	Background: Exposure to the chemotherapeutic alkylating agent thiotepa during brain development leads to neurological complications arising from neurodegeneration and irreversible damage to the developing central nerve system (CNS). Administration of single dose of thiotepa in 7-d postnatal (P7) rat triggers activation of apoptotic cascade and widespread neuronal death. The present study was aimed to elucidate whether nicotinamide may prevent thiotepa-induced neurodegeneration in the developing rat brain. Methodology/Principal Findings: Neuronal cell death induced by thiotepa was associated with the induction of Bax, release of cytochrome-c from mitochondria into the cytosol, activation of caspase-3 and cleavage of poly (ADP-ribose) polymerase (PARP-1). Post-treatment of developing rats with nicotinamide suppressed thiotepa-induced upregulation of Bax, reduced cytochrome-c release into the cytosol and reduced expression of activated caspase-3 and cleavage of PARP-1. Cresyl violet staining showed numerous dead cells in the cortex hippocampus and thalamus; post-treatment with nicotinamide reduced the number of dead cells in these brain regions. Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) and immunohistochemical analysis of caspase-3 show that thiotepa-induced cell death is apoptotic and that it is inhibited by nicotinamide treatment. Conclusion: Nicotinamide (Nic) treatment with thiotepa significantly improved neuronal survival and alleviated neuronal cell death in the developing rat. These data demonstrate that nicotinamide shows promise as a therapeutic and neuroprotective agent for the treatment of neurodegenerative disorders in newborns and infants.	[Ullah, Najeeb; Lee, Hae Young; Naseer, Muhammad Imran; Ullah, Ikram; Kim, Myeong Ok] Gyeongsang Natl Univ, Coll Nat Sci RINS & Appl Life Sci Brain Korea 21, Div Life Sci, Chinju, South Korea; [Suh, Joo Won] Myongji Univ, Div Biosci & Bioinformat, Yongin, Kyonggido, South Korea	Gyeongsang National University; Myongji University	Ullah, N (corresponding author), Gyeongsang Natl Univ, Coll Nat Sci RINS & Appl Life Sci Brain Korea 21, Div Life Sci, Chinju, South Korea.	mokim@gsnu.ac.kr	Naseer, Muhammad Imran/H-9477-2012; Naseer, Muhammad Imran/AAG-4921-2020; Kim, Myeong Ok/AAS-1488-2021; Ullah, Najeeb/AAU-3677-2021	Kim, Myeong Ok/0000-0003-4317-1072; Ullah, Najeeb/0000-0001-7875-6834; Naseer, Muhammad Imran/0000-0002-9343-5825	Rural Development Administration [PJ008075, PJ007361]	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Next Generation Biogreen 21 program (PJ008075) and Agenda PJ007361 of Rural Development Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2002, P NATL ACAD SCI USA, V99, P245, DOI 10.1073/pnas.012460399; Albers J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005228.pub2; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Brown RT, 1999, J DEV BEHAV PEDIATR, V20, P373, DOI 10.1097/00004703-199910000-00013; Burkle A, 2001, CHEMBIOCHEM, V2, P725, DOI 10.1002/1439-7633(20011001)2:10<725::AID-CBIC725>3.0.CO;2-3; Cavaliere R, 2006, CURR NEUROL NEUROSCI, V6, P218, DOI 10.1007/s11910-006-0009-8; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; CHETSANGA CJ, 1979, NUCLEIC ACIDS RES, V6, P3673, DOI 10.1093/nar/6.11.3673; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584; Chong ZZ, 2002, J VASC RES, V39, P131, DOI 10.1159/000057762; Davoodi J, 2010, INT J BIOCHEM CELL B, V42, P958, DOI 10.1016/j.biocel.2010.02.008; Debatin KM, 2002, ONCOGENE, V21, P8786, DOI 10.1038/sj.onc.1206039; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Formigli L, 2000, J CELL PHYSIOL, V182, P41, DOI 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Holcik M, 2000, P NATL ACAD SCI USA, V97, P2286, DOI 10.1073/pnas.040469797; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Ieraci A, 2006, PLOS MED, V3, P547, DOI 10.1371/journal.pmed.0030101; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Klaidman LK, 2001, BBA-GEN SUBJECTS, V1525, P136, DOI 10.1016/S0304-4165(00)00181-1; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Mukherjee SK, 1997, EUR J PHARMACOL, V330, P27, DOI 10.1016/S0014-2999(97)00171-4; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Olney JW, 2003, CURR OPIN PHARMACOL, V3, P101, DOI 10.1016/S1471-4892(02)00002-4; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Reddy Alyssa T, 2003, Curr Neurol Neurosci Rep, V3, P137, DOI 10.1007/s11910-003-0065-2; Rupinder SK, 2007, VASC PHARMACOL, V46, P383, DOI 10.1016/j.vph.2007.01.006; Rzeski W, 2004, ANN NEUROL, V56, P351, DOI 10.1002/ana.20185; Sairanen T, 2009, ACTA NEUROPATHOL, V118, P541, DOI 10.1007/s00401-009-0559-3; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; Solary E, 2000, LEUKEMIA, V14, P1833, DOI 10.1038/sj.leu.2401902; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Uehara N, 2006, EXP EYE RES, V82, P488, DOI 10.1016/j.exer.2005.08.006; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Van Gool SW, 2000, LEUKEMIA, V14, P2076, DOI 10.1038/sj.leu.2401934; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Verstappen CCP, 2003, DRUGS, V63, P1549, DOI 10.2165/00003495-200363150-00003; Wisessmith W, 2009, J PINEAL RES, V46, P433, DOI 10.1111/j.1600-079X.2009.00680.x; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	60	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27093	10.1371/journal.pone.0027093	http://dx.doi.org/10.1371/journal.pone.0027093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164206	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400006
J	Zou, ZY; Wu, LP; Ding, HY; Wang, Y; Zhang, YQ; Chen, XJ; Chen, X; Zhang, CY; Zhang, QP; Zen, K				Zou, Zhenyou; Wu, Linping; Ding, Hanying; Wang, Yang; Zhang, Yaqin; Chen, Xuejiao; Chen, Xi; Zhang, Chen-Yu; Zhang, Qipeng; Zen, Ke			MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; HEPATOCELLULAR-CARCINOMA; OVARIAN-CANCER; APOPTOSIS; P53; INHIBITION; EXPRESSION; RESISTANCE; PROTEIN; CHOLANGIOCARCINOMA	Autophagy is activated in cancer cells during chemotherapy and often contributes to tumor chemotherapy resistance. In this study, we characterized the role of microRNA-30a (miR-30a) in the coordination of cancer cell apoptosis and autophagy, which determines the sensitivity of cancer cells to chemotherapy. First, the autophagy activity in cancer cells increased after cis-dichloro-diamine platinum (cis-DDP) or Taxol treatment, as indicated by the enhanced expression of beclin 1, a key regulator of autophagy, and increased number of LC3-positive autophagosomes. Second, miRNA screening using a TaqMan probe-based quantitative RT-PCR assay identified that miR-30a, a miRNA that targets beclin 1, was significantly reduced in tumor cells by cis-DDP treatment. Forced expression of miR-30a significantly reduced beclin 1 and the autophagy activity of tumor cells induced by cis-DDP. Third, the blockade of tumor cell autophagy activity by miR-30a expression or 3-methyladenine significantly increased tumor cell apoptosis induced by cis-DDP treatment. Finally, an in vivo tumor implantation mouse model clearly showed that elevation of miR-30a in implanted tumor cells by administration of the recombinant lentivirus expressing miR-30a strongly enhanced cis-DDP-induced apoptosis of tumor cells. In conclusion, our results demonstrate for the first time that miR-30a can sensitize tumor cells to cis-DDP via reducing beclin 1-mediated autophagy and that increasing miR-30a level in tumor cells represents a novel approach to enhance the efficacy of chemotherapy during cancer treatment.	[Zou, Zhenyou; Wu, Linping; Ding, Hanying; Wang, Yang; Zhang, Yaqin; Chen, Xuejiao; Chen, Xi; Zhang, Chen-Yu; Zhang, Qipeng; Zen, Ke] Nanjing Univ, Sch Life Sci, JERC MBB, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, JERC MBB, State Key Lab Pharmaceut Biotechnol, Hankou Rd 22, Nanjing 210093, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; promoterzhang@gmail.com; kzen@nju.edu.cn		Ding, Hanying/0000-0002-0155-6057	National Natural Science Foundation of China [30988003, 30871019, 30890044, 30890032, 31071232, 31000323, 31100777, 90608010]; National Basic Research Program of China 973 Program [2011CB504803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30988003, 30871019, 30890044, 30890032, 31071232, 31000323, 31100777, and 90608010 and National Basic Research Program of China 973 Program No. 2011CB504803.	Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Chaney SG, 2004, J INORG BIOCHEM, V98, P1551, DOI 10.1016/j.jinorgbio.2004.04.024; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YS, 2009, PATHOL ONCOL RES, V15, P487, DOI 10.1007/s12253-008-9143-8; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; FAN SJ, 1995, CANCER RES, V55, P1649; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hou XM, 2009, NUCLEIC ACIDS RES, V37, P1400, DOI 10.1093/nar/gkn933; Hou YJ, 2011, LAB INVEST, V91, P1146, DOI 10.1038/labinvest.2011.97; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koivusalo R, 2002, CANCER RES, V62, P7364; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lee AJX, 2012, J PATHOL, V226, P482, DOI 10.1002/path.2998; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li LM, 2011, J IMMUNOL, V186, P2552, DOI 10.4049/jimmunol.1001633; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Miracco C, 2007, INT J ONCOL, V30, P429; Mukhopadhyay P, 2011, ANN NY ACAD SCI, V1215, P109, DOI 10.1111/j.1749-6632.2010.05866.x; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Shen Y, 2008, AUTOPHAGY, V4, P1067, DOI 10.4161/auto.6827; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Sun QM, 2009, AUTOPHAGY, V5, P713, DOI 10.4161/auto.5.5.8524; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tao J, 2011, ONCOL REP, V25, P1721, DOI 10.3892/or.2011.1245; Vollmer CM, 1999, CANCER RES, V59, P4369; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Xiao J, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-35; Zhang Y, 2012, ONCOGENE, V31, P1055, DOI 10.1038/onc.2011.290; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	49	153	165	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4148	4156		10.1074/jbc.M111.307405	http://dx.doi.org/10.1074/jbc.M111.307405			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157765	Green Published, hybrid			2022-12-25	WOS:000300410900048
J	Malicdan, MCV; Noguchi, S; Tokutomi, T; Goto, Y; Nonaka, I; Hayashi, YK; Nishino, I				Malicdan, May Christine V.; Noguchi, Satoru; Tokutomi, Tomoharu; Goto, Yu-ichi; Nonaka, Ikuya; Hayashi, Yukiko K.; Nishino, Ichizo			Peracetylated N-Acetylmannosamine, a Synthetic Sugar Molecule, Efficiently Rescues Muscle Phenotype and Biochemical Defects in Mouse Model of Sialic Acid-deficient Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; RIMMED VACUOLES; DISTAL MYOPATHY; 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; GLYCOLYLNEURAMINIC ACID; ACETYLNEURAMINIC ACID; EXPRESSION; SIALYLATION; MUTATION; ENZYME	Distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy (DMRV/hIBM), characterized by progressive muscle atrophy, weakness, and degeneration, is due to mutations in GNE, a gene encoding a bifunctional enzyme critical in sialic acid biosynthesis. In the DMRV/hIBM mouse model, which exhibits hyposialylation in various tissues in addition to muscle atrophy, weakness, and degeneration, we recently have demonstrated that the myopathic phenotype was prevented by oral administration of N-acetylneuraminic acid, N-acetylmannosamine, and sialyllactose, underscoring the crucial role of hyposialylation in the disease pathomechanism. The choice for the preferred molecule, however, was limited probably by the complex pharmacokinetics of sialic acids and the lack of biomarkers that could clearly show dose response. To address these issues, we screened several synthetic sugar compounds that could increase sialylation more remarkably and allow demonstration of measurable effects in the DMRV/hIBM mice. In this study, we found that tetra-O-acetylated N-acetylmannosamine increased cell sialylation most efficiently, and in vivo evaluation in DMRV/hIBM mice revealed a more dramatic, measurable effect and improvement in muscle phenotype, enabling us to establish analysis of protein biomarkers that can be used for assessing response to treatment. Our results provide a proof of concept in sialic acid-related molecular therapy with synthetic monosaccharides.	[Malicdan, May Christine V.; Noguchi, Satoru; Tokutomi, Tomoharu; Nonaka, Ikuya; Hayashi, Yukiko K.; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Tokutomi, Tomoharu] Natl Def Med Coll, Dept Pathol & Lab Med, Saitama 3598513, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Defense Medical College - Japan	Noguchi, S (corresponding author), Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878502, Japan.	noguchi@ncnp.go.jp	Nishino, Ichizo/G-2676-2010; Malicdan, May Christine/AAK-7422-2021; Malicdan, May Christine/F-2806-2013	Nishino, Ichizo/0000-0001-9452-112X; 	Japanese Health Sciences Foundation; National Institute of Biomedical Innovation; National Center of Neurology and Psychiatry [22-5, 20B-12, 20B-13]; Kato Memorial Trust; Neuromuscular Disease Foundation; Association Francaise contre les Myopathies; United States National Institute of Child Health and Human Development, National Institutes of Health	Japanese Health Sciences Foundation; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Kato Memorial Trust; Neuromuscular Disease Foundation; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); United States National Institute of Child Health and Human Development, National Institutes of Health	This work was supported in part by Research on Psychiatric and Neurological Diseases and Mental Health from the Japanese Health Sciences Foundation; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Intramural Research Grants 22-5, 20B-12, and 20B-13 for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry; and the Kato Memorial Trust for Nambyo Research.; Supported in part by the Neuromuscular Disease Foundation and Association Francaise contre les Myopathies. Present address: Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892.; We thank Fumiko Funato for technical assistance. The monoclonal antibody (H4A3) that recognizes Lamp2, generated by J. T. August and James E. K. Hildreth, was obtained from the Development Studies Hybridoma Bank, developed under the auspices of the United States National Institute of Child Health and Human Development, National Institutes of Health and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA.	ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; ASKANAS V, 2003, MOL GENETIC BASIS NE, P501; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Gagiannis D, 2007, BBA-GEN SUBJECTS, V1770, P297, DOI 10.1016/j.bbagen.2006.09.023; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Hackler R, 2000, CLIN CHEM, V46, P483; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HIGA HH, 1985, J BIOL CHEM, V260, P8838; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; Jacobs CL, 2001, BIOCHEMISTRY-US, V40, P12864, DOI 10.1021/bi010862s; Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901; Kayashima T, 2002, J HUM GENET, V47, P77, DOI 10.1007/s100380200004; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Kim EJ, 2004, J BIOL CHEM, V279, P18342, DOI 10.1074/jbc.M400205200; Kim S, 2000, J CLIN INVEST, V105, P191, DOI 10.1172/JCI7302; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Malicdan MCV, 2008, PHYSIOL GENOMICS, V35, P106, DOI 10.1152/physiolgenomics.90219.2008; Malicdan MCV, 2009, METHOD ENZYMOL, V453, P379, DOI 10.1016/S0076-6879(08)04019-6; Nishino I, 2005, Acta Myol, V24, P80; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; Nonaka Ikuya, 2005, Curr Neurol Neurosci Rep, V5, P61, DOI 10.1007/s11910-005-0025-0; Querfurth HW, 2001, MOL CELL NEUROSCI, V17, P793, DOI 10.1006/mcne.2001.0972; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Tajima Y, 2005, AM J PATHOL, V166, P1121, DOI 10.1016/S0002-9440(10)62332-2; Thompson MW, 2003, ARCH BIOCHEM BIOPHYS, V413, P236, DOI 10.1016/S0003-9861(03)00123-1; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Vattemi G, 2003, EXP NEUROL, V179, P150, DOI 10.1016/S0014-4886(02)00025-0; Viswanathan K, 2003, BIOCHEMISTRY-US, V42, P15215, DOI 10.1021/bi034994s; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; YAMAMOTO H, 1993, J BIOCHEM-TOKYO, V114, P132, DOI 10.1093/oxfordjournals.jbchem.a124128; Yarema KJ, 2001, BIOTECHNIQUES, V31, P384, DOI 10.2144/01312rv02	44	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2689	2705		10.1074/jbc.M111.297051	http://dx.doi.org/10.1074/jbc.M111.297051			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22157763	Green Published, hybrid			2022-12-25	WOS:000300292300041
J	Mir, SA; Chatterjee, A; Mitra, A; Pathak, K; Mahata, SK; Sarkar, S				Mir, Saiful Anam; Chatterjee, Arunachal; Mitra, Arkadeep; Pathak, Kanchan; Mahata, Sushil K.; Sarkar, Sagartirtha			Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; ANGIOTENSIN-II; JAK-STAT; GROWTH-FACTOR; UP-REGULATION; CELL-DEATH; ISCHEMIA/REPERFUSION INJURY; DILATED CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; PRESSURE-OVERLOAD	IL-6 has been shown to play a major role in collagen up-regulation process during cardiac hypertrophy, although the precise mechanism is still not known. In this study we have analyzed the mechanism by which IL-6 modulates cardiac hypertrophy. For the in vitro model, IL-6-treated cultured cardiac fibroblasts were used, whereas the in vivo cardiac hypertrophy model was generated by renal artery ligation in adult male Wistar rats (Rattus norvegicus). During induction of hypertrophy, increased phosphorylation of STAT1, STAT3, MAPK, and ERK proteins was observed both in vitro and in vivo. Treatment of fibroblasts with specific inhibitors for STAT1 (fludarabine, 50 mu M), STAT3 (S31-201, 10 mu M), p38 MAPK (SB203580, 10 mu M), and ERK1/2 (U0126, 10 mu M) resulted in down-regulation of IL-6-induced phosphorylation of specific proteins; however, only S31-201 and SB203580 inhibited collagen biosynthesis. In ligated rats in vivo, only STAT3 inhibitors resulted in significant decrease in collagen synthesis and hypertrophy markers such as atrial natriuretic factor and beta-myosin heavy chain. In addition, decreased heart weight to body weight ratio and improved cardiac function as measured by echocardiography was evident in animals treated with STAT3 inhibitor or siRNA. Compared with IL-6 neutralization, more pronounced down-regulation of collagen synthesis and regression of hypertrophy was observed with STAT3 inhibition, suggesting that STAT3 is the major downstream signaling molecule and a potential therapeutic target for cardiac hypertrophy.	[Mir, Saiful Anam; Chatterjee, Arunachal; Mitra, Arkadeep; Pathak, Kanchan; Sarkar, Sagartirtha] Univ Calcutta, Dept Zool, Kolkata 700019, India; [Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Calcutta; University of California System; University of California San Diego	Sarkar, S (corresponding author), Univ Calcutta, Dept Zool, 35 Ballygunge Circular Rd, Kolkata 700019, India.	sagartirtha.sarkar@gmail.com	Mitra, Arkadeep/J-4163-2019; Chatterjee, Arunachal/AAW-9807-2021; Mahata, Sushil/AAF-8781-2021	Mitra, Arkadeep/0000-0002-9257-0427; 				Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Behr TM, 2001, CIRCULATION, V104, P1292, DOI 10.1161/hc3601.094275; BISHOP JE, 1994, CARDIOVASC RES, V28, P1581, DOI 10.1093/cvr/28.10.1581; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1893, DOI 10.1006/jmcc.2001.1469; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Bueno OF, 2001, CIRC RES, V88, P88, DOI 10.1161/01.RES.88.1.88; Chatterjee A, 2011, J CELL PHYSIOL, V226, P2543, DOI 10.1002/jcp.22599; Chen LM, 2007, EXP PHYSIOL, V92, P409, DOI 10.1113/expphysiol.2006.036590; Cook SA, 1999, J MOL CELL CARDIOL, V31, P1429, DOI 10.1006/jmcc.1999.0979; CRABOS M, 1994, J CLIN INVEST, V93, P2372, DOI 10.1172/JCI117243; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Frias MA, 2007, CARDIOVASC RES, V73, P57, DOI 10.1016/j.cardiores.2006.09.016; Hedayat M, 2010, HEART FAIL REV, V15, P543, DOI 10.1007/s10741-010-9168-4; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hocher B, 2002, J HYPERTENS, V20, P745, DOI 10.1097/00004872-200204000-00034; Jia N., 2010, CARDIOVASC IN PRESS; Kapoun AM, 2004, CIRC RES, V94, P453, DOI 10.1161/01.RES.0000117070.86556.9F; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; Kurdi M, 2007, J CARDIOVASC PHARM, V50, P126, DOI 10.1097/FJC.0b013e318068dd49; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Mascareno E, 2001, CIRCULATION, V104, P325, DOI 10.1161/01.CIR.104.3.325; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Ng DCH, 2001, J BIOL CHEM, V276, P29490, DOI 10.1074/jbc.M100699200; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Pan J, 1999, CIRC RES, V84, P1127, DOI 10.1161/01.RES.84.10.1127; Pathak M, 2001, HYPERTENSION, V37, P833, DOI 10.1161/01.HYP.37.3.833; Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF; Ramires FJA, 1998, J MOL CELL CARDIOL, V30, P475, DOI 10.1006/jmcc.1997.0612; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sano M, 2000, J BIOL CHEM, V275, P29717, DOI 10.1074/jbc.M003128200; Sarkar S, 2004, J BIOL CHEM, V279, P52630, DOI 10.1074/jbc.M402037200; Sarkar S, 2004, AM J PHYSIOL-HEART C, V287, pH107, DOI 10.1152/ajpheart.00763.2003; SEN S, 1974, CIRC RES, V35, P775, DOI 10.1161/01.RES.35.5.775; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sil P, 1997, HYPERTENSION, V30, P209; Sivakumar P, 2008, MOL CELL BIOCHEM, V307, P159, DOI 10.1007/s11010-007-9595-2; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Skoumal R, 2011, J MOL CELL CARDIOL, V50, P634, DOI 10.1016/j.yjmcc.2011.01.001; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Terui K, 2004, BIOCHEM J, V380, P203, DOI 10.1042/BJ20031891; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Tyralla K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015287; Vatner DE, 2000, CIRC RES, V86, P802, DOI 10.1161/01.RES.86.7.802; Wang GY, 2008, SCAND J IMMUNOL, V68, P589, DOI 10.1111/j.1365-3083.2008.02174.x; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Xiao L, 2001, J MOL CELL CARDIOL, V33, P779, DOI 10.1006/jmcc.2001.1348; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Zauberman A, 1999, ONCOGENE, V18, P3886, DOI 10.1038/sj.onc.1202738	58	101	105	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2666	2677		10.1074/jbc.M111.246173	http://dx.doi.org/10.1074/jbc.M111.246173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22157761	hybrid, Green Published			2022-12-25	WOS:000300292300039
J	Marei, HES; Althani, A; Afifi, N; Michetti, F; Pescatori, M; Pallini, R; Casalbore, P; Cenciarelli, C; Schwartz, P; Ahmed, AE				Marei, Hany E. S.; Althani, Asma; Afifi, Nahla; Michetti, Fabrizio; Pescatori, Mario; Pallini, Roberto; Casalbore, Patricia; Cenciarelli, Carlo; Schwartz, Philip; Ahmed, Abd-Elmaksoud			Gene Expression Profiling of Embryonic Human Neural Stem Cells and Dopaminergic Neurons from Adult Human Substantia Nigra	PLOS ONE			English	Article							PROGENITOR CELLS; EFFICIENT GENERATION; TARGETED DISRUPTION; PARKINSONS-DISEASE; IN-VITRO; DIFFERENTIATION; MIDBRAIN; INDUCTION; MOUSE; NEUROGENESIS	Neural stem cells (NSC) with self-renewal and multipotent properties serve as an ideal cell source for transplantation to treat neurodegenerative insults such as Parkinson's disease. We used Agilent's and Illumina Whole Human Genome Oligonucleotide Microarray to compare the genomic profiles of human embryonic NSC at a single time point in culture, and a multicellular tissue from postmortem adult substantia nigra (SN) which are rich in dopaminergic (DA) neurons. We identified 13525 up-regulated genes in both cell types of which 3737 (27.6%) genes were up-regulated in the hENSC, 4116 (30.4%) genes were up-regulated in the human substantia nigra dopaminergic cells, and 5672 (41.93%) were significantly up-regulated in both cell population. Careful analysis of the data that emerged using DAVID has permitted us to distinguish several genes and pathways that are involved in dopaminergic (DA) differentiation, and to identify the crucial signaling pathways that direct the process of differentiation. The set of genes expressed more highly at hENSC is enriched in molecules known or predicted to be involved in the M phase of the mitotic cell cycle. On the other hand, the genes enriched in SN cells include a different set of functional categories, namely synaptic transmission, central nervous system development, structural constituents of the myelin sheath, the internode region of axons, myelination, cell projection, cell somata, ion transport, and the voltage-gated ion channel complex. Our results were also compared with data from various databases, and between different types of arrays, Agilent versus Illumina. This approach has allowed us to confirm the consistency of our obtained results for a large number of genes that delineate the phenotypical differences of embryonic NSCs, and SN cells.	[Marei, Hany E. S.; Ahmed, Abd-Elmaksoud] Mansoura Univ, Dept Cytol & Histol, Fac Vet Med, Mansoura, Egypt; [Althani, Asma; Afifi, Nahla] Qatar Univ, Dept Hlth Sci, Coll Arts & Sci, Doha, Qatar; [Michetti, Fabrizio; Pescatori, Mario] Univ Cattolica Sacro Cuore, Inst Anat & Cell Biol, Rome, Italy; [Pallini, Roberto] Univ Cattolica Sacro Cuore, Inst Neurosurg, Rome, Italy; [Casalbore, Patricia] Natl Res Council Italy, Inst Cell Biol & Neurobiol, Rome, Italy; [Cenciarelli, Carlo] Natl Res Council Italy, Inst Translat Pharmacol, Rome, Italy; [Schwartz, Philip] Childrens Hosp Orange Cty, Res Inst, Orange, CA 92668 USA	Egyptian Knowledge Bank (EKB); Mansoura University; Qatar University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); Childrens Hospital of Orange County	Marei, HES (corresponding author), Mansoura Univ, Dept Cytol & Histol, Fac Vet Med, Mansoura, Egypt.	hany800@yahoo.com	pescatori, mario/H-3986-2012; PALLINI, Roberto/AAA-3747-2019; CENCIARELLI, CARLO/AAC-1603-2019; Marei, Hany E/AAC-7076-2019; Pallini, Roberto/AAA-3760-2019	PALLINI, Roberto/0000-0002-4611-8827; CENCIARELLI, CARLO/0000-0001-7480-4608; Marei, Hany E/0000-0002-0069-4212; 	Science and Technology Development Fund (STDF) [99]; Department of Cytology, Faculty of Veterinary Medicine, Mansoura University, Egypt; NSC [HD059967]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059967] Funding Source: NIH RePORTER	Science and Technology Development Fund (STDF)(Science and Technology Development Fund (STDF)); Department of Cytology, Faculty of Veterinary Medicine, Mansoura University, Egypt; NSC(Ministry of Science and Technology, Taiwan); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Science and Technology Development Fund (STDF, Egypt: ID:99). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to extend their appreciation and recognize to the staff at the Department of Cytology, Faculty of Veterinary Medicine, Mansoura University, Egypt, for their support. We thank Alexander Stover and Dr. David Brick who provide us with an additional three samples of human embryonic NSC (NIH grant HD059967). We thank Dr. Ahmed Abd El-Wahed for assistance with purchasing the Invitrogen's NSC line from Invitrogen's Germany. We also thank the staff at Institute of Virology Georg-August-University-Goettingen Kreuzbergring 57, 37075 Goettingen, Germany, for performing the DNA microarray experiments and data analysis.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003917; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Cai JL, 2004, EXP HEMATOL, V32, P585, DOI 10.1016/j.exphem.2004.03.013; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carvey PM, 2001, EXP NEUROL, V171, P98, DOI 10.1006/exnr.2001.7735; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chung S, 2005, MOL CELL NEUROSCI, V28, P241, DOI 10.1016/j.mcn.2004.09.008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; GIBB WRG, 1992, BRAIN RES, V581, P283, DOI 10.1016/0006-8993(92)90719-P; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hermann A, 2006, J NEUROCHEM, V98, P629, DOI 10.1111/j.1471-4159.2006.03916.x; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kawasoe T, 2000, CANCER RES, V60, P3354; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Liste I, 2004, J NEUROSCI, V24, P10786, DOI 10.1523/JNEUROSCI.3208-04.2004; Lum M, 2009, J NEUROSCI RES, V87, P2201, DOI 10.1002/jnr.22047; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Ohishi K, 2002, INT J HEMATOL, V75, P449, DOI 10.1007/BF02982106; Ota M, 2003, DEV DYNAM, V227, P544, DOI 10.1002/dvdy.10336; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Prakash N, 2007, NEURODEGENER DIS, V4, P333, DOI 10.1159/000101891; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Sato Hiromi, 2005, Curr Drug Discov Technol, V2, P89, DOI 10.2174/1570163054064701; Satoh J, 2010, CELL MOL NEUROBIOL, V30, P415, DOI 10.1007/s10571-009-9466-3; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schein JC, 1998, DEV BIOL, V204, P432, DOI 10.1006/dbio.1998.9076; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Tago K, 2000, GENE DEV, V14, P1741; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wang X, 2004, INT J DEV NEUROSCI, V22, P175, DOI 10.1016/j.ijdevneu.2004.05.008; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; Yang YH, 2001, SPIE BIOS 2001 JAN 2; Yen G, 2001, MOL BRAIN RES, V96, P59, DOI 10.1016/S0169-328X(01)00267-4; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	75	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28420	10.1371/journal.pone.0028420	http://dx.doi.org/10.1371/journal.pone.0028420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163301	Green Published, gold			2022-12-25	WOS:000298161900038
J	Roedig, JV; Rapp, E; Hoper, D; Genzel, Y; Reichl, U				Roedig, Jana Verena; Rapp, Erdmann; Hoeper, Dirk; Genzel, Yvonne; Reichl, Udo			Impact of Host Cell Line Adaptation on Quasispecies Composition and Glycosylation of Influenza A Virus Hemagglutinin	PLOS ONE			English	Article							VACCINE PRODUCTION; RECEPTOR-BINDING; MEMBRANE-FUSION; MDCK CELLS; NUCLEOTIDE-SEQUENCE; ELECTRON-MICROSCOPY; GLYCAN ANALYSIS; RNA VIRUSES; ELEVATED PH; CGE-LIF	The genome of influenza A viruses is constantly changing (genetic drift) resulting in small, gradual changes in viral proteins. Alterations within antibody recognition sites of the viral membrane glycoproteins hemagglutinin (HA) and neuraminidase (NA) result in an antigenetic drift, which requires the seasonal update of human influenza virus vaccines. Generally, virus adaptation is necessary to obtain sufficiently high virus yields in cell culture-derived vaccine manufacturing. In this study detailed HA N-glycosylation pattern analysis was combined with in-depth pyrosequencing analysis of the virus genomic RNA. Forward and backward adaptation from Madin-Darby Canine Kidney (MDCK) cells to African green monkey kidney (Vero) cells was investigated for two closely related influenza A virus PR/8/34 (H1N1) strains: from the National Institute for Biological Standards and Control (NIBSC) or the Robert Koch Institute (RKI). Furthermore, stability of HA N-glycosylation patterns over ten consecutive passages and different harvest time points is demonstrated. Adaptation to Vero cells finally allowed efficient influenza A virus replication in Vero cells. In contrast, during back-adaptation the virus replicated well from the very beginning. HA N-glycosylation patterns were cell line dependent and stabilized fast within one (NIBSC-derived virus) or two (RKI-derived virus) successive passages during adaptation processes. However, during adaptation new virus variants were detected. These variants carried "rescue" mutations on the genomic level within the HA stem region, which result in amino acid substitutions. These substitutions finally allowed sufficient virus replication in the new host system. According to adaptation pressure the composition of the virus populations varied. In Vero cells a selection for "rescue" variants was characteristic. After back-adaptation to MDCK cells some variants persisted at indifferent frequencies, others slowly diminished and even dropped below the detection limit.	[Roedig, Jana Verena; Rapp, Erdmann; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Hoeper, Dirk] Friedrich Loeffler Inst FLI, Greifswald, Germany; [Reichl, Udo] Otto von Guericke Univ, Chair Bioproc Engn, Magdeburg, Germany	Max Planck Society; Friedrich Loeffler Institute; Otto von Guericke University	Roedig, JV (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.	rapp@mpi-magdeburg.mpg.de		Reichl, Udo/0000-0001-6538-1332; Hoper, Dirk/0000-0001-8408-2274; Rapp, Erdmann/0000-0001-6618-2626; Genzel, Yvonne/0000-0002-2652-5943	Max Planck Institute for Dynamics of Complex Technical Systems (MPI-DCTS); Friedrich Loeffler Institute (FLI)	Max Planck Institute for Dynamics of Complex Technical Systems (MPI-DCTS); Friedrich Loeffler Institute (FLI)	The funders, which are solely the authors' home institutions: Max Planck Institute for Dynamics of Complex Technical Systems (MPI-DCTS) and Friedrich Loeffler Institute (FLI), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Bull JJ, 1997, GENETICS, V147, P1497; Chen ZY, 2008, VACCINE, V26, P361, DOI 10.1016/j.vaccine.2007.11.013; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Domingo E, 1998, EMERG INFECT DIS, V4, P521, DOI 10.3201/eid0404.980402; DOMS RW, 1986, J VIROL, V57, P603, DOI 10.1128/JVI.57.2.603-613.1986; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Genzel Y, 2004, VACCINE, V22, P2202, DOI 10.1016/j.vaccine.2003.11.041; Genzel Y, 2010, APPL MICROBIOL BIOT, V88, P461, DOI 10.1007/s00253-010-2742-9; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Heynisch B, 2010, VACCINE, V28, P8210, DOI 10.1016/j.vaccine.2010.07.076; HIRST GK, 1947, J EXP MED, V86, P357, DOI 10.1084/jem.86.5.357; Hoper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019075; Hoper D, 2009, J CLIN MICROBIOL, V47, P674, DOI 10.1128/JCM.01028-08; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Klenk HD, 2002, VIRUS RES, V82, P73; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Leifer I, 2010, J GEN VIROL, V91, P2687, DOI 10.1099/vir.0.023200-0; Lin YP, 1997, VIROLOGY, V233, P402, DOI 10.1006/viro.1997.8626; Opitz L, 2008, J VIROL METHODS, V154, P61, DOI 10.1016/j.jviromet.2008.09.004; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROTT R, 1984, EMBO J, V3, P3329, DOI 10.1002/j.1460-2075.1984.tb02299.x; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Ruhaak LR, 2010, J PROTEOME RES, V9, P6655, DOI 10.1021/pr100802f; RUIGROK RWH, 1986, EMBO J, V5, P41, DOI 10.1002/j.1460-2075.1986.tb04175.x; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Saito T, 2004, J MED VIROL, V74, P336, DOI 10.1002/jmv.20178; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Scholtissek C, 1995, VIRUS GENES, V11, P209, DOI 10.1007/BF01728660; Schulze-Horsel J, 2009, VACCINE, V27, P2712, DOI 10.1016/j.vaccine.2009.02.027; Schwarzer J, 2008, ELECTROPHORESIS, V29, P4203, DOI 10.1002/elps.200800042; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Vester D, 2010, J PROTEOMICS, V73, P1656, DOI 10.1016/j.jprot.2010.04.006; Wagner R, 2002, J GEN VIROL, V83, P601, DOI 10.1099/0022-1317-83-3-601; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; Wiley G., 2009, CURR PROTOC HUM GENE; WINTER G, 1981, NATURE, V292, P72, DOI 10.1038/292072a0; WRIGLEY NG, 1979, BRIT MED BULL, V35, P35, DOI 10.1093/oxfordjournals.bmb.a071539	54	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27989	10.1371/journal.pone.0027989	http://dx.doi.org/10.1371/journal.pone.0027989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163276	Green Published, gold			2022-12-25	WOS:000298161900011
J	Biehl, SC; Dresler, T; Reif, A; Scheuerpflug, P; Deckert, J; Herrmann, MJ				Biehl, Stefanie C.; Dresler, Thomas; Reif, Andreas; Scheuerpflug, Peter; Deckert, Juergen; Herrmann, Martin J.			Dopamine Transporter (DAT1) and Dopamine Receptor D4 (DRD4) Genotypes Differentially Impact on Electrophysiological Correlates of Error Processing	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CATECHOL-O-METHYLTRANSFERASE; MESSENGER-RNA EXPRESSION; PARKINSONS-DISEASE; HEALTHY-VOLUNTEERS; PERSONALITY-TRAIT; ANTISACCADE TASK; NOVELTY SEEKING; ERP COMPONENTS; ADULT PATIENTS	Recent studies as well as theoretical models of error processing assign fundamental importance to the brain's dopaminergic system. Research about how the electrophysiological correlates of error processing-the error-related negativity (ERN) and the error positivity (Pe)-are influenced by variations of common dopaminergic genes, however, is still relatively scarce. In the present study, we therefore investigated whether polymorphisms in the DAT1 gene and in the DRD4 gene, respectively, lead to interindividual differences in these error processing correlates. One hundred sixty participants completed a version of the Eriksen Flanker Task while a 26-channel EEG was recorded. The task was slightly modified in order to increase error rates. During data analysis, participants were split into two groups depending on their DAT1 and their DRD4 genotypes, respectively. ERN and Pe amplitudes after correct responses and after errors as well as difference amplitudes between errors and correct responses were analyzed. We found a differential effect of DAT1 genotype on the Pe difference amplitude but not on the ERN difference amplitude, while the reverse was true for DRD4 genotype. These findings are in line with predictions from theoretical models of dopaminergic transmission in the brain. They furthermore tie results from clinical investigations of disorders impacting on the dopamine system to genetic variations known to be at-risk genotypes.	[Biehl, Stefanie C.; Dresler, Thomas; Reif, Andreas; Deckert, Juergen; Herrmann, Martin J.] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Scheuerpflug, Peter] Univ Wurzburg, Dept Child & Adolescent Psychiat & Psychotherapy, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Biehl, SC (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany.	Biehl_S@klinik.uni-wuerzburg.de	Herrmann, Martin J./C-9904-2009; Biehl, Stefanie/L-2771-2019; herrmann, martin/AAT-9836-2020; Dresler, Thomas/F-8631-2010	Herrmann, Martin J./0000-0001-9970-2122; 	German Research Foundation (DFG) [HE 4531/1-1, RTG 1253/1]; German Research Foundation; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); University of Wuerzburg	This research was supported by the German Research Foundation (DFG; HE 4531/1-1 and RTG 1253/1). This publication was funded by the German Research Foundation and the University of Wuerzburg in the funding programme Open Access Publishing. http://www.dfg.de/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus M, 2010, BIOL PSYCHOL, V85, P19, DOI 10.1016/j.biopsycho.2010.04.007; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Beste C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000086; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; de Bruijn ERA, 2006, BRAIN RES, V1105, P122, DOI 10.1016/j.brainres.2006.01.006; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Dresler T, 2010, NEUROPSYCHOPHARMACOL, V35, P2193, DOI 10.1038/npp.2010.91; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Frank MJ, 2007, COGN AFFECT BEHAV NE, V7, P297, DOI 10.3758/CABN.7.4.297; Franke B, 2010, NEUROPSYCHOPHARMACOL, V35, P656, DOI 10.1038/npp.2009.170; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Garcia JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014162; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hautzinger M, 1994, BECK DEPRESSIONS INV; Herrmann MJ, 2010, WORLD J BIOL PSYCHIA, V11, P457, DOI [10.3109/15622970902977552, 10.1080/15622970902977552]; Herrmann MJ, 2009, PSYCHIAT RES, V169, P144, DOI 10.1016/j.psychres.2008.06.015; Holroyd CB, 2002, NEUROPSYCHOLOGIA, V40, P2116, DOI 10.1016/S0028-3932(02)00052-0; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Huennerkopf R, 2007, NEUROPSYCHOPHARMACOL, V32, P2552, DOI 10.1038/sj.npp.1301383; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Jonkman LM, 2007, BIOL PSYCHOL, V76, P217, DOI 10.1016/j.biopsycho.2007.08.004; Kereszturi E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-18; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Liotti M, 2005, CORTEX, V41, P377, DOI 10.1016/S0010-9452(08)70274-0; MeadorWoodruff JH, 1996, NEUROPSYCHOPHARMACOL, V15, P17, DOI 10.1016/0893-133X(95)00150-C; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miller GM, 2002, MOL PSYCHIATR, V7, P44, DOI 10.1038/sj/mp/4000921; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Okuyama Y, 2000, MOL PSYCHIATR, V5, P64, DOI 10.1038/sj.mp.4000563; Overtoom CCE, 2002, BIOL PSYCHIAT, V51, P668, DOI 10.1016/S0006-3223(01)01290-2; Potts GF, 2006, NEUROSCI LETT, V397, P130, DOI 10.1016/j.neulet.2005.12.003; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Sesack SR, 1998, J NEUROSCI, V18, P2697; Simpson J, 2010, AM J MED GENET B, V153B, P1228, DOI 10.1002/ajmg.b.31084; Thapar A, 2005, HUM MOL GENET, V14, pR275, DOI 10.1093/hmg/ddi263; Ullsperger M, 2010, NEUROSCI BIOBEHAV R, V34, P649, DOI 10.1016/j.neubiorev.2009.06.009; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; van Dyck CH, 2005, J NUCL MED, V46, P745; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Wiersema JR, 2005, J NEURAL TRANSM, V112, P1417, DOI 10.1007/s00702-005-0276-6; Willemssen R, 2008, J NEURAL TRANSM, V115, P461, DOI 10.1007/s00702-007-0842-1; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	57	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28396	10.1371/journal.pone.0028396	http://dx.doi.org/10.1371/journal.pone.0028396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162768	Green Published, gold, Green Submitted			2022-12-25	WOS:000298172800034
J	Cope, EK; Goldstein-Daruech, N; Kofonow, JM; Christensen, L; McDermott, B; Monroy, F; Palmer, JN; Chiu, AG; Shirtliff, ME; Cohen, NA; Leid, JG				Cope, Emily K.; Goldstein-Daruech, Natalia; Kofonow, Jennifer M.; Christensen, Lanette; McDermott, Bridget; Monroy, Fernando; Palmer, James N.; Chiu, Alexander G.; Shirtliff, Mark E.; Cohen, Noam A.; Leid, Jeff G.			Regulation of Virulence Gene Expression Resulting from Streptococcus pneumoniae and Nontypeable Haemophilus influenzae Interactions in Chronic Disease	PLOS ONE			English	Article							IN-VIVO; BIOFILM FORMATION; OTITIS-MEDIA; CHINCHILLA MODEL; BACTERIAL; HOST; INFECTION; COLONIZATION; PATHOGENESIS; PNEUMOLYSIN	Chronic rhinosinusitis (CRS) is a common inflammatory disease of the sinonasal cavity mediated, in part, by polymicrobial communities of bacteria. Recent molecular studies have confirmed the importance of Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) in CRS. Here, we hypothesize that interaction between S. pneumoniae and NTHi mixed-species communities cause a change in bacterial virulence gene expression. We examined CRS as a model human disease to validate these polymicrobial interactions. Clinical strains of S. pneumoniae and NTHi were grown in mono-and co-culture in a standard biofilm assay. Reverse transcriptase real-time PCR (RTqPCR) was used to measure gene expression of key virulence factors. To validate these results, we investigated the presence of the bacterial RNA transcripts in excised human tissue from patients with CRS. Consequences of physical or chemical interactions between microbes were also investigated. Transcription of NTHi type IV pili was only expressed in co-culture in vitro, and expression could be detected ex vivo in diseased tissue. S. pneumoniae pyruvate oxidase was up-regulated in co-culture, while pneumolysin and pneumococcal adherence factor A were down-regulated. These results were confirmed in excised human CRS tissue. Gene expression was differentially regulated by physical contact and secreted factors. Overall, these data suggest that interactions between H. influenzae and S. pneumoniae involve physical and chemical mechanisms that influence virulence gene expression of mixed-species biofilm communities present in chronically diseased human tissue. These results extend previous studies of population-level virulence and provide novel insight into the importance of S. pneumoniae and NTHi in CRS.	[Cope, Emily K.; Christensen, Lanette; McDermott, Bridget; Monroy, Fernando; Leid, Jeff G.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Goldstein-Daruech, Natalia; Kofonow, Jennifer M.; Palmer, James N.; Chiu, Alexander G.; Cohen, Noam A.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Cohen, Noam A.] Univ Penn, Philadelphia Vet Affairs Med Ctr, Surg Serv, Philadelphia, PA 19104 USA; [Shirtliff, Mark E.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	Northern Arizona University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University System of Maryland; University of Maryland Baltimore	Cope, EK (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Emily.Cope@nau.edu	Chiu, Alexander G/J-1230-2014; Shirtliff, Mark E/H-2563-2017; Monroy, Francisco/N-2763-2013	Chiu, Alexander G/0000-0002-7592-6575; Shirtliff, Mark E/0000-0002-8913-3445; Monroy, Francisco/0000-0001-6455-3083; Cohen, Noam/0000-0002-9462-3932	Science Foundation Arizona [GRF 0204-08]; Flight Attendants Medical Research Institute [103019]	Science Foundation Arizona; Flight Attendants Medical Research Institute	This work was supported by Science Foundation Arizona GRF 0204-08 (http://www.sfaz.org) and the Flight Attendants Medical Research Institute, Clinical Innovator Award #103019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeldaim GMK, 2009, DIAGN MICR INFEC DIS, V64, P366, DOI 10.1016/j.diagmicrobio.2009.03.030; Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006; Alverdy J, 2000, ANN SURG, V232, P480, DOI 10.1097/00000658-200010000-00003; Battig P, 2008, J BACTERIOL, V190, P1184, DOI 10.1128/JB.01517-07; Bakaletz LO, 2005, INFECT IMMUN, V73, P1635, DOI 10.1128/IAI.73.3.1635-1643.2005; Bishop JL, 2006, TRENDS MOL MED, V12, P3, DOI 10.1016/j.molmed.2005.11.001; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Chan J, 2001, Ear Nose Throat J, V80, P143; Cheadle WG, 2003, AM J SURG, V186, p15S, DOI 10.1016/j.amjsurg.2003.10.003; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Crook DW, 2006, CLIN INFECT DIS, V42, P460, DOI 10.1086/499248; Ehrlich GD, 2010, FEMS IMMUNOL MED MIC, V59, P269, DOI 10.1111/j.1574-695X.2010.00704.x; Ehrlich GD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-225; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; ELLIS ME, 1984, ARCH DIS CHILD, V59, P848, DOI 10.1136/adc.59.9.848; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Foreman A, 2009, AM J RHINOL ALLERGY, V23, P556, DOI 10.2500/ajra.2009.23.3413; Gupta R, 2009, MICROB PATHOGENESIS, V47, P101, DOI 10.1016/j.micpath.2009.05.003; Hardy Gail G, 2003, Methods Mol Med, V71, P1; Healy DY, 2008, OTOLARYNG HEAD NECK, V138, P641, DOI 10.1016/j.otohns.2008.02.002; Henriques-Normark B, 2010, EXP CELL RES, V316, P1408, DOI 10.1016/j.yexcr.2010.03.003; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hu FZ, 2008, FUTURE MICROBIOL, V3, P31, DOI 10.2217/17460913.3.1.31; Itani KMF, 2003, AM J SURG, V186, p31S, DOI 10.1016/j.amjsurg.2003.10.005; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Jurcisek JA, 2007, MOL MICROBIOL, V65, P1288, DOI 10.1111/j.1365-2958.2007.05864.x; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kennedy BJ, 2000, INFECT IMMUN, V68, P2756, DOI 10.1128/IAI.68.5.2756-2765.2000; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Leid JG, 2009, INFECT IMMUN; LUO GY, 1993, INFECT IMMUN, V61, P830, DOI 10.1128/IAI.61.3.830-835.1993; Mantovani K, 2010, BRAZ J OTORHINOLAR, V76, P548, DOI 10.1590/S1808-86942010000500002; Mason KM, 2003, INFECT IMMUN, V71, P3454, DOI 10.1128/IAI.71.6.3454-3462.2003; Morton DJ, 2007, MICROBES INFECT, V9, P932, DOI 10.1016/j.micinf.2007.03.013; Niederfuhr A, 2009, ARCH OTOLARYNGOL, V135, P131, DOI 10.1001/archoto.2008.531; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Novotny LA, 2009, VACCINE, V28, P279, DOI 10.1016/j.vaccine.2009.08.017; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; PreventionCfDCa, 2007, PNEUM DIS EP PREV VA; Psaltis AJ, 2008, LARYNGOSCOPE, V118, P895, DOI 10.1097/MLG.0b013e31816381d4; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Schleimer Robert P, 2009, Proc Am Thorac Soc, V6, P288, DOI 10.1513/pats.200808-088RM; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; St Geme JW, 2000, VACCINE, V19, pS41, DOI 10.1016/S0264-410X(00)00277-2; Stephenson MF, 2010, J OTOLARYNGOL-HEAD N, V39, P182, DOI 10.2310/7070.2009.090060; Tieu DD, 2009, J ALLERGY CLIN IMMUN, V124, P37, DOI 10.1016/j.jaci.2009.04.045; van der Linden M, 2010, EUR J CLIN MICROBIOL, V29, P749, DOI 10.1007/s10096-010-0945-8; Weimer KED, 2010, J INFECT DIS, V202, P1068, DOI 10.1086/656046; Wu Licheng R, 2005, Surg Infect (Larchmt), V6, P185, DOI 10.1089/sur.2005.6.185	62	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28523	10.1371/journal.pone.0028523	http://dx.doi.org/10.1371/journal.pone.0028523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162775	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800045
J	Hussain, A; Moodley, D; Naidoo, S; Esterhuizen, TM				Hussain, Akthar; Moodley, Dhayendre; Naidoo, Sudhindra; Esterhuizen, Tonya M.			Pregnant Women's Access to PMTCT and ART Services in South Africa and Implications for Universal Antiretroviral Treatment	PLOS ONE			English	Article							PRETERM DELIVERY; INCREASED RISK; THERAPY; HIV; OUTCOMES; BIRTH; PREVENTION; INFECTION; DRUGS; TIME	Objectives: We describe pregnant womens' access to PMTCT and HAART services and associated birth outcomes in South Africa. Methods: Women recuperating in postnatal wards of a referral hospital participated in an evaluation during February-May 2010 during which their maternity records were examined to describe their access to VCT, CD4 Counts, dual ART or HAART during pregnancy. Results: Of the 1609 women who participated in this evaluation, 39% (95%CI36.7-41.5%) tested HIV-positive during their pregnancy. Of the HIV-positive women 2.9% did not have a CD4 count done and an additional 31.3% did not receive their CD4 results. The majority (96.8%) of the HIV-positive women commenced dual ART at their first antenatal visit independent of their CD4 result. During February-May 2010, 48.0% of the women who had a CD4 result were eligible for HAART (CD4<200 cells/mm(3)) and 29.1% of these initiated HAART during pregnancy. Under the current South African PMTCT guidelines 71.1% (95%CI66.4-75.4%) of HIV positive pregnant women could be eligible for HAART (CD4<350 cells/mm(3)). There were significantly more preterm births among HIV-positive women (p = 0.01) and women who received HAART were no more at risk of preterm deliveries (AOR 0.73; 95%CI0.39-1.36; p = 0.2) as compared to women who received dual ART. Nine (2.4%; 95%CI1.1-4.5%) HIV exposed infants were confirmed HIV infected at birth. The in-utero transmission rate was highest among women who required HAART but did not initiate treatment (8.5%) compared to 2.7% and 0.4% among women who received HAART and women who were not eligible for HAART and received PMTCT prophylaxis respectively. Conclusion: In this urban South African community the antenatal HIV prevalence remains high (39%) and timeous access to CD4 results during pregnancy is limited. Under the current South African guidelines, and assuming that access to CD4 results has improved, more than 70% of HIV-positive pregnant women in this community would be requiring HAART.	[Hussain, Akthar] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Family Med, Durban, Kwazulu Natal, South Africa; [Moodley, Dhayendre; Naidoo, Sudhindra] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Womens Hlth & HIV Res Unit, Dept Obstet & Gynaecol, Durban, Kwazulu Natal, South Africa; [Esterhuizen, Tonya M.] Univ KwaZulu Natal, Coll Hlth Sci, Dept Res Eth & Med Law, Programme Biostat, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Hussain, A (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Family Med, Durban, Kwazulu Natal, South Africa.	maleeha@mweb.co.za	Moodley, Dhayendre/U-6802-2019					[Anonymous], SAV MOTH 2005 2007 4; Carter RJ, 2010, J ACQUIR IMMUNE DEFI; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; Horwood C, 2010, TROP MED INT HLTH; Joint United Nations Program on HIV/AIDS (UNAIDS) World Health Organization (WHO), 2010, REP GLOB AIDS EP; Kalish LA, 1997, J INFECT DIS, V175, P712, DOI 10.1093/infdis/175.3.712; Kuhn L, 2010, AIDS, V24, P1374, DOI 10.1097/QAD.0b013e3283394f5b; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Nakakeeto ON, 2009, AIDS, V23, P987, DOI 10.1097/QAD.0b013e32832a17e9; National Department of Health, 2010, POL GUID IMPL PMTCT; National Department of Health, 2008, POL GUID IMPL PMTCT; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Taha TE, 2011, AIDS; Thorne C, 2004, AIDS, V18, P2337, DOI 10.1097/00002030-200411190-00019; Townsend CL, 2010, BJOG-INT J OBSTET GY, V117, P1399, DOI 10.1111/j.1471-0528.2010.02689.x; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; Tuomala RK, 2005, JAIDS-J ACQ IMM DEF, V38, P449, DOI 10.1097/01.qai.0000139398.38236.4d; van der Merwe K, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-42; *WHO, 2009, RAP ADV US ANT DRUGS; Zolfo M, 2010, JAIDS-J ACQ IMM DEF, V55, P287, DOI 10.1097/QAI.0b013e3181eef3da	24	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27907	10.1371/journal.pone.0027907	http://dx.doi.org/10.1371/journal.pone.0027907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162993	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800007
J	van der Veen, S; Abee, T				van der Veen, Stijn; Abee, Tjakko			Generation of Variants in Listeria monocytogenes Continuous-Flow Biofilms Is Dependent on Radical-Induced DNA Damage and RecA-Mediated Repair	PLOS ONE			English	Article							SOS RESPONSE; DISINFECTANT RESISTANCE; INDUCED MUTAGENESIS; EGD-E; OXYGEN; PATHOGENESIS; ENVIRONMENT; COMMUNITIES; SUPEROXIDE; ATTACHMENT	The food-borne pathogen Listeria monocytogenes is a Gram-positive microaerophilic facultative anaerobic rod and the causative agent of the devastating disease listeriosis. L. monocytogenes is able to form biofilms in the food processing environment. Since biofilms are generally hard to eradicate, they can function as a source for food contamination. In several occasions biofilms have been identified as a source for genetic variability, which potentially can result in adaptation of strains to food processing or clinical conditions. However, nothing is known about mutagenesis in L. monocytogenes biofilms and the possible mechanisms involved. In this study, we showed that the generation of genetic variants was specifically induced in continuous-flow biofilms of L. monocytogenes, but not in static biofilms. Using specific dyes and radical inhibitors, we showed that the formation of superoxide and hydroxyl radicals was induced in continuous-flow biofilms, which was accompanied with in an increase in DNA damage. Promoter reporter studies showed that recA, which is an important component in DNA repair and the activator of the SOS response, is activated in continuous-flow biofilms and that activation was dependent on radical-induced DNA damage. Furthermore, continuous-flow biofilm experiments using an in-frame recA deletion mutant verified that RecA is required for induced generation of genetic variants. Therefore, we can conclude that generation of genetic variants in L. monocytogenes continuous-flow biofilms results from radical-induced DNA damage and RecA-mediated mutagenic repair of the damaged DNA.	[van der Veen, Stijn; Abee, Tjakko] TIFN, Wageningen, Netherlands; [van der Veen, Stijn; Abee, Tjakko] Univ Wageningen & Res Ctr, Food Microbiol Lab, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	van der Veen, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	Tjakko.Abee@wur.nl		van der Veen, Stijn/0000-0002-8176-391X				Allegrucci M, 2007, J BACTERIOL, V189, P2030, DOI 10.1128/JB.01369-06; Baharoglu Z, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001165; Banas JA, 2007, APPL ENVIRON MICROB, V73, P357, DOI 10.1128/AEM.02014-06; BOISIVON A, 1990, EUR J CLIN MICROBIOL, V9, P206, DOI 10.1007/BF01963839; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Dalton CB, 1997, NEW ENGL J MED, V336, P100, DOI 10.1056/NEJM199701093360204; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Glaser P, 2001, SCIENCE, V294, P849; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Kalmokoff ML, 2001, J APPL MICROBIOL, V91, P725, DOI 10.1046/j.1365-2672.2001.01419.x; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Krasovec R, 2003, MED HYPOTHESES, V60, P484, DOI 10.1016/S0306-9877(02)00394-8; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li BR, 2010, MICROBES INFECT, V12, P662, DOI 10.1016/j.micinf.2010.04.009; Ligeza A, 1998, BBA-BIOENERGETICS, V1365, P453, DOI 10.1016/S0005-2728(98)00098-X; Lungu B, 2010, FOODBORNE PATHOG DIS, DOI 10.1089=fpd.2010.0718; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mols M, 2010, ENVIRON MICROBIOL, V12, P873, DOI 10.1111/j.1462-2920.2009.02132.x; Mols M, 2009, INT J FOOD MICROBIOL, V135, P303, DOI 10.1016/j.ijfoodmicro.2009.09.002; Morse R, 1999, J CLIN MICROBIOL, V37, P2913, DOI 10.1128/JCM.37.9.2913-2919.1999; Morvan A, 2010, ANTIMICROB AGENTS CH, V54, P2728, DOI 10.1128/AAC.01557-09; Nuryastuti T, 2008, ANTON LEEUW INT J G, V94, P317, DOI 10.1007/s10482-008-9249-8; PRITCHARD TJ, 1995, INT J FOOD MICROBIOL, V26, P375, DOI 10.1016/0168-1605(94)00130-X; Rieu A, 2008, APPL ENVIRON MICROB, V74, P4491, DOI 10.1128/AEM.00255-08; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rodriguez A, 2008, J FOOD PROTECT, V71, P170, DOI 10.4315/0362-028X-71.1.170; Salmelin C, 2002, MUTAT RES-FUND MOL M, V500, P125, DOI 10.1016/S0027-5107(02)00004-0; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Silva IMM, 2003, INT J FOOD MICROBIOL, V81, P241, DOI 10.1016/S0168-1605(02)00223-4; Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334; Tompkin RB, 2002, J FOOD PROTECT, V65, P709, DOI 10.4315/0362-028X-65.4.709; van der Veen S, 2010, CURR OPIN BIOTECH, DOI [10.1016/j.copbio.2010.1011.1012, DOI 10.1016/J.COPBIO.2010.1011.1012]; van der Veen S, 2011, INT J MED MICROBIOL, V301, P334, DOI 10.1016/j.ijmm.2010.11.006; van der Veen S, 2010, MICROBIOL-SGM, V156, P3782, DOI 10.1099/mic.0.043000-0; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P7854, DOI 10.1128/AEM.01519-10; van der Veen S, 2010, MICROBIOL-SGM, V156, P374, DOI 10.1099/mic.0.035196-0; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P1992, DOI 10.1128/AEM.02680-09; Varhimo E, 2007, J BACTERIOL, V189, P5210, DOI 10.1128/JB.00473-07; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Waite RD, 2001, MOL MICROBIOL, V42, P1223, DOI 10.1046/j.1365-2958.2001.02674.x	57	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28590	10.1371/journal.pone.0028590	http://dx.doi.org/10.1371/journal.pone.0028590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163039	gold, Green Published, Green Submitted			2022-12-25	WOS:000298172800050
J	Galan-Moya, EM; de la Cruz-Morcillo, MA; Valero, ML; Callejas-Valera, JL; Melgar-Rojas, P; Losa, JH; Salcedo, M; Fernandez-Aramburo, A; Cajal, SRY; Sanchez-Prieto, R				Galan-Moya, Eva M.; de la Cruz-Morcillo, Miguel A.; Llanos Valero, Maria; Callejas-Valera, Juan L.; Melgar-Rojas, Pedro; Hernadez Losa, Javier; Salcedo, Mayte; Fernandez-Aramburo, Antonio; Ramon y Cajal, Santiago; Sanchez-Prieto, Ricardo			Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL LUNG-CANCER; GENOTOXIC STRESS; DNA-REPAIR; P38-ALPHA; PATHWAY; SENSITIVITY; SURVIVAL; GROWTH; CHEMOTHERAPY	The p38 MAPK signaling pathway has been proposed as a critical mediator of the therapeutic effect of several antitumor agents, including cisplatin. Here, we found that sensitivity to cisplatin, in a system of 7 non-small cell lung carcinoma derived cell lines, correlated with high levels of MKK6 and marked activation of p38 MAPK. However, knockdown of MKK6 modified neither the response to cisplatin nor the activation of p38 MAPK. Deeper studies showed that resistant cell lines also displayed higher basal levels of MKK3. Interestingly, MKK3 knockdown significantly decreased p38 phosphorylation upon cisplatin exposure and consequently reduced the response to the drug. Indeed, cisplatin poorly activated MKK3 in resistant cells, while in sensitive cell lines MKK3 showed the opposite pattern in response to the drug. Our data also demonstrate that the low levels of MKK6 expressed in resistant cell lines are the consequence of high basal activity of p38 MAPK mediated by the elevated levels of MKK3. This finding supports the existence of a regulatory mechanism between both MAPK kinases through their MAPK. Furthermore, our results were also mirrored in head and neck carcinoma derived cell lines, suggesting our observations boast a potential universal characteristic in cancer resistance of cisplatin. Altogether, our work provides evidence that MKK3 is the major determinant of p38 MAPK activation in response to cisplatin and, hence, the resistance associated with this MAPK. Therefore, these data suggest that the balance between both MKK3 and MKK6 could be a novel mechanism which explains the cellular response to cisplatin.	[Galan-Moya, Eva M.; de la Cruz-Morcillo, Miguel A.; Llanos Valero, Maria; Callejas-Valera, Juan L.; Melgar-Rojas, Pedro; Fernandez-Aramburo, Antonio; Sanchez-Prieto, Ricardo] PCYTA UCLM, Ctr Reg Invest Biomed, Lab Oncol Mol, Albacete, Spain; [Hernadez Losa, Javier; Salcedo, Mayte; Ramon y Cajal, Santiago] Fundacio Inst Recerca Hosp Vall Hebron, Dept Pathol, Barcelona, Spain; [Fernandez-Aramburo, Antonio] Serv Oncol CHUA, Albacete, Spain	Hospital Universitari Vall d'Hebron	Galan-Moya, EM (corresponding author), PCYTA UCLM, Ctr Reg Invest Biomed, Lab Oncol Mol, Albacete, Spain.	ricardo.sanchez@uclm.es	Javier, Hernandez Losa/C-1173-2008; Ramon y Cajal, Santiago/H-4955-2016; Salcedo-Allende, M Teresa/N-7091-2014; Sanchez-Prieto, Ricardo/B-6877-2008; Sanchez-Prieto, Ricardo/AAY-4271-2021; Galan-Moya, Eva M/I-2912-2015; Prieto, Ricardo/AAZ-7221-2021; Romo, José A./J-3024-2012	Javier, Hernandez Losa/0000-0003-1526-3201; Ramon y Cajal, Santiago/0000-0002-3867-1390; Salcedo-Allende, M Teresa/0000-0002-4822-5060; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Galan-Moya, Eva M/0000-0001-5758-7592; Romo, José A./0000-0003-2907-580X; de la Cruz-Morcillo, Miguel Angel/0000-0002-6674-1333; Fernandez Aramburo, Antonio/0000-0003-3897-2262	Fundacion Leticia Castillejo Castillo; Ministerio de Ciencia e Inovacion [SAF2009-07329]; RSP Research Institute; European Community	Fundacion Leticia Castillejo Castillo; Ministerio de Ciencia e Inovacion(Spanish Government); RSP Research Institute; European Community(European Commission)	This work was supported by grants from Fundacion Leticia Castillejo Castillo and Ministerio de Ciencia e Inovacion (SAF2009-07329) and the RSP Research Institute, and the work carried out in this laboratory receive support from the European Community through the regional development funding program (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; Ahmad S, 2010, CHEM BIODIVERS, V7, P543, DOI 10.1002/cbdv.200800340; Ambrosino C, 2003, MOL CELL BIOL, V23, P370, DOI 10.1128/MCB.23.1.370-381.2003; Benedetti V, 2008, MOL CANCER THER, V7, P679, DOI 10.1158/1535-7163.MCT-07-0450; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Callejas-Valera JL, 2008, J BIOL CHEM, V283, P13450, DOI 10.1074/jbc.M709230200; Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Chin TM, 2008, CLIN CANCER RES, V14, P6867, DOI 10.1158/1078-0432.CCR-08-0093; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; de la Cruz-Morcillo MA, 2012, ONCOGENE, V31, P1073, DOI 10.1038/onc.2011.321; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Dienstmann R, 2011, ONCOTARGET, V2, P165; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Francescato HDC, 2009, LIFE SCI, V84, P590, DOI 10.1016/j.lfs.2009.02.004; Fukuda K, 2008, LAB INVEST, V88, P398, DOI 10.1038/labinvest.2008.10; Girnun GD, 2008, CLIN CANCER RES, V14, P6478, DOI 10.1158/1078-0432.CCR-08-1128; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Ishida S, 2010, CANCER CELL, V17, P574, DOI 10.1016/j.ccr.2010.04.011; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; Mountzios G, 2010, CRIT REV ONCOL HEMAT, V75, P94, DOI 10.1016/j.critrevonc.2009.10.002; Nijwening JH, 2011, CELL CYCLE, V10, P380, DOI 10.4161/cc.10.3.14642; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Olaussen KA, 2007, CURR OPIN PULM MED, V13, P284, DOI 10.1097/MCP.0b013e32816b5c63; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Pan Q, 2009, EXPERT OPIN PHARMACO, V10, P2291, DOI 10.1517/14656560903136754; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; Pio R, 2004, CANCER RES, V64, P4171, DOI 10.1158/0008-5472.CAN-03-2982; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rosell R, 2006, CURR OPIN PHARMACOL, V6, P323, DOI 10.1016/j.coph.2006.01.011; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wang Y, 2009, REDOX REP, V14, P243, DOI 10.1179/135100009X12525712409896; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Zhang Q, 2007, MOL CANCER THER, V6, P1414, DOI 10.1158/1535-7163.MCT-06-0678; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297; 2010, NEOPLASIA, V12, P527	54	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28406	10.1371/journal.pone.0028406	http://dx.doi.org/10.1371/journal.pone.0028406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164285	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400086
J	Muralla, R; Lloyd, J; Meinke, D				Muralla, Rosanna; Lloyd, Johnny; Meinke, David			Molecular Foundations of Reproductive Lethality in Arabidopsis thaliana	PLOS ONE			English	Article							MALE GAMETOPHYTE DEVELOPMENT; MEDEA POLYCOMB GENE; EMBRYO DEVELOPMENT; SEED DEVELOPMENT; MATURE POLLEN; ENDOSPERM DEVELOPMENT; FEMALE GAMETOPHYTE; PATERNAL GENOME; TUBE GROWTH; IDENTIFICATION	The SeedGenes database (www.seedgenes.org) contains information on more than 400 genes required for embryo development in Arabidopsis. Many of these EMBRYO-DEFECTIVE (EMB) genes encode proteins with an essential function required throughout the life cycle. This raises a fundamental question. Why does elimination of an essential gene in Arabidopsis often result in embryo lethality rather than gametophyte lethality? In other words, how do mutant (emb) gametophytes survive and participate in fertilization when an essential cellular function is disrupted? Furthermore, why do some mutant embryos proceed further in development than others? To address these questions, we first established a curated dataset of genes required for gametophyte development in Arabidopsis based on information extracted from the literature. This provided a basis for comparison with EMB genes obtained from the SeedGenes dataset. We also identified genes that exhibited both embryo and gametophyte defects when disrupted by a loss-of-function mutation. We then evaluated the relationship between mutant phenotype, gene redundancy, mutant allele strength, gene expression pattern, protein function, and intracellular protein localization to determine what factors influence the phenotypes of lethal mutants in Arabidopsis. After removing cases where continued development potentially resulted from gene redundancy or residual function of a weak mutant allele, we identified numerous examples of viable mutant (emb) gametophytes that required further explanation. We propose that the presence of gene products derived from transcription in diploid (heterozygous) sporocytes often enables mutant gametophytes to survive the loss of an essential gene in Arabidopsis. Whether gene disruption results in embryo or gametophyte lethality therefore depends in part on the ability of residual, parental gene products to support gametophyte development. We also highlight here 70 preglobular embryo mutants with a zygotic pattern of inheritance, which provide valuable insights into the maternal-to-zygotic transition in Arabidopsis and the timing of paternal gene activation during embryo development.	[Muralla, Rosanna; Lloyd, Johnny; Meinke, David] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Muralla, R (corresponding author), Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA.	david.meinke@okstate.edu		Lloyd, John/0000-0003-0454-4374	National Science Foundation [DBI-0618166]; Oklahoma Center for the Advancement of Science and Technology	National Science Foundation(National Science Foundation (NSF)); Oklahoma Center for the Advancement of Science and Technology	This research was supported by National Science Foundation grant DBI-0618166 through the Arabidopsis 2010 Program, and by the Oklahoma Center for the Advancement of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Autran D, 2011, CELL, V145, P707, DOI 10.1016/j.cell.2011.04.014; Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Berg M, 2005, PLANT J, V44, P866, DOI 10.1111/j.1365-313X.2005.02580.x; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Boavida LC, 2009, GENETICS, V181, P1369, DOI 10.1534/genetics.108.090852; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brown SDM, 2009, ANNU REV GENET, V43, P305, DOI 10.1146/annurev-genet-102108-134143; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; CASTLE LA, 1993, MOL GEN GENET, V241, P504, DOI 10.1007/BF00279892; Chen CB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-280; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Drews GN, 2011, J EXP BOT, V62, P1593, DOI 10.1093/jxb/erq385; FRANZMANN LH, 1995, PLANT J, V7, P341, DOI 10.1046/j.1365-313X.1995.7020341.x; Ge XC, 2005, EMBO REP, V6, P282, DOI 10.1038/sj.embor.7400357; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grimanelli D, 2005, PLANT CELL, V17, P1061, DOI 10.1105/tpc.104.029819; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Holmes-Davis R, 2005, PROTEOMICS, V5, P4864, DOI 10.1002/pmic.200402011; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Jahnke S, 2009, CURR BIOL, V19, P1677, DOI 10.1016/j.cub.2009.08.053; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lalanne E, 2004, GENETICS, V167, P1975, DOI 10.1534/genetics.104.030270; Liang H, 2009, TRENDS GENET, V25, P441, DOI 10.1016/j.tig.2009.08.001; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Libeau P, 2011, PLANT BIOLOGY, V13, P784, DOI 10.1111/j.1438-8677.2010.00435.x; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; MASCARENHAS JP, 1989, PLANT CELL, V1, P657, DOI 10.1105/tpc.1.7.657; McElver J, 2001, GENETICS, V159, P1751; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Meinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007386; Meinke D, 2009, TRENDS PLANT SCI, V14, P414, DOI 10.1016/j.tplants.2009.06.001; MEINKE DW, 1985, THEOR APPL GENET, V69, P543, DOI 10.1007/BF00251102; MEINKE DW, 1979, DEV BIOL, V72, P50, DOI 10.1016/0012-1606(79)90097-6; Meinke DW, 2003, PLANT PHYSIOL, V131, P409, DOI 10.1104/pp.014134; MEINKE DW, 1982, THEOR APPL GENET, V63, P381, DOI 10.1007/BF00303912; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Msadek T, 2009, J BACTERIOL, V191, P4701, DOI 10.1128/JB.00572-09; MULLER A. J., 1963, BIOL ZENTRALBL, V82, P133; Muralla R, 2008, PLANT PHYSIOL, V146, P60, DOI 10.1104/pp.107.107409; Muralla R, 2007, PLANT PHYSIOL, V144, P890, DOI 10.1104/pp.107.096511; Noir S, 2005, BIOCHEM BIOPH RES CO, V337, P1257, DOI 10.1016/j.bbrc.2005.09.185; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Onodera Y, 2008, GENETICS, V180, P207, DOI 10.1534/genetics.108.090621; Osterman Andrei L., 2008, V416, P459, DOI 10.1007/978-1-59745-321-9_31; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Park D, 2008, GENOMICS, V92, P414, DOI 10.1016/j.ygeno.2008.08.001; Perrimon N, 1996, GENETICS, V144, P1681; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Procissi A, 2001, GENETICS, V158, P1773; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Schmidt A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001155; Sheoran IS, 2006, SEX PLANT REPROD, V19, P185, DOI 10.1007/s00497-006-0035-3; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Tax FE, 2001, PLANT PHYSIOL, V126, P1527, DOI 10.1104/pp.126.4.1527; Teng C, 2008, PLANT PHYSIOL, V146, P1322, DOI 10.1104/pp.107.113506; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Yang HX, 2011, PLANT J, V65, P503, DOI 10.1111/j.1365-313X.2010.04439.x; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zou JJ, 2009, J INTEGR PLANT BIOL, V51, P438, DOI 10.1111/j.1744-7909.2009.00823.x	83	67	69	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28398	10.1371/journal.pone.0028398	http://dx.doi.org/10.1371/journal.pone.0028398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164284	Green Published, gold			2022-12-25	WOS:000298171400085
J	Veiga, RSL; Jansa, J; Frossard, E; van der Heijden, MGA				Veiga, Rita S. L.; Jansa, Jan; Frossard, Emmanuel; van der Heijden, Marcel G. A.			Can Arbuscular Mycorrhizal Fungi Reduce the Growth of Agricultural Weeds?	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PHOSPHORUS UPTAKE; SOIL; DIVERSITY; COLONIZATION; WHEAT; RESPONSES; PRODUCTIVITY; DEPRESSIONS; ACQUISITION	Background: Arbuscular mycorrhizal fungi (AMF) are known for their beneficial effects on plants. However, there is increasing evidence that some ruderal plants, including several agricultural weeds, respond negatively to AMF colonization. Here, we investigated the effect of AMF on the growth of individual weed species and on weed-crop interactions. Methodology/Principal Findings: First, under controlled glasshouse conditions, we screened growth responses of nine weed species and three crops to a widespread AMF, Glomus intraradices. None of the weeds screened showed a significant positive mycorrhizal growth response and four weed species were significantly reduced by the AMF (growth responses between -22 and -35%). In a subsequent experiment, we selected three of the negatively responding weed species Echinochloa crus-galli, Setaria viridis and Solanum nigrum - and analyzed their responses to a combination of three AMF (Glomus intraradices, Glomus mosseae and Glomus claroideum). Finally, we tested whether the presence of a crop (maize) enhanced the suppressive effect of AMF on weeds. We found that the growth of the three selected weed species was also reduced by a combination of AMF and that the presence of maize amplified the negative effect of AMF on the growth of E. crus-galli. Conclusions/Significance: Our results show that AMF can negatively influence the growth of some weed species indicating that AMF have the potential to act as determinants of weed community structure. Furthermore, mycorrhizal weed growth reductions can be amplified in the presence of a crop. Previous studies have shown that AMF provide a number of beneficial ecosystem services. Taken together with our current results, the maintenance and promotion of AMF activity may thereby contribute to sustainable management of agroecosystems. However, in order to further the practical and ecological relevance of our findings, additional experiments should be performed under field conditions.	[Veiga, Rita S. L.; van der Heijden, Marcel G. A.] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Veiga, Rita S. L.; van der Heijden, Marcel G. A.] Univ Utrecht, Fac Sci, Inst Environm Biol, Utrecht, Netherlands; [Jansa, Jan; Frossard, Emmanuel] Swiss Fed Inst Technol, Inst Agr Sci, Lindau, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Veiga, RSL (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	rita.lopesdeveiga@art.admin.ch	Jansa, Jan/H-3161-2014; van der Heijden, Marcel G.A./H-5243-2011; van der Heijden, Marcel/AAY-1593-2021	Jansa, Jan/0000-0002-0331-1774; van der Heijden, Marcel/0000-0001-7040-1924	Swiss Federal Government (Agroscope Reckenholz-Tanikon Research Station ART); Swiss National Science Foundation [315230_ 130764/1]	Swiss Federal Government (Agroscope Reckenholz-Tanikon Research Station ART); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss Federal Government (Agroscope Reckenholz-Tanikon Research Station ART) and a grant from the Swiss National Science Foundation (grant number: 315230_ 130764/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MF, 1989, NEW PHYTOL, V111, P45, DOI 10.1111/j.1469-8137.1989.tb04216.x; [Anonymous], 2009, LANG ENV STAT COMP; [Anonymous], 2006, ACKERFLORA WICHTIGE; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Boyetchko SM, 1996, PHYTOPROTECTION, V77, P41, DOI 10.7202/706099ar; Cameron DD, 2010, PLANT SOIL, V333, P1, DOI 10.1007/s11104-010-0361-y; FRANCIS R, 1994, PLANT SOIL, V159, P11, DOI 10.1007/BF00000091; FRANCIS R, 1995, CAN J BOT, V73, pS1301, DOI 10.1139/b95-391; Gamper HA, 2009, NEW PHYTOL, V182, P495, DOI 10.1111/j.1469-8137.2008.02750.x; Gianinazzi S, 2010, MYCORRHIZA, V20, P519, DOI 10.1007/s00572-010-0333-3; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; Grace EJ, 2009, NEW PHYTOL, V181, P938, DOI 10.1111/j.1469-8137.2008.02720.x; Graham JH, 2000, PLANT SOIL, V220, P207, DOI 10.1023/A:1004709209009; Grundy AC, 2011, WEED RES, V51, P187, DOI 10.1111/j.1365-3180.2010.00831.x; Hebeisen T, 1997, GLOB CHANGE BIOL, V3, P149, DOI 10.1046/j.1365-2486.1997.00073.x; HETRICK BAD, 1992, CAN J BOT, V70, P2032, DOI 10.1139/b92-253; HOLM S, 1979, SCAND J STAT, V6, P65; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; Jansa J, 2005, PLANT SOIL, V276, P163, DOI 10.1007/s11104-005-4274-0; Jansa J, 2003, ECOL APPL, V13, P1164, DOI 10.1890/1051-0761(2003)13[1164:STATCS]2.0.CO;2; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jordan N, 2008, RENEW AGR FOOD SYST, V23, P108, DOI 10.1017/S1742170508002226; Jordan NR, 2000, WEED RES, V40, P397, DOI 10.1046/j.1365-3180.2000.00207.x; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; KOIDE R, 1985, NEW PHYTOL, V99, P449, DOI 10.1111/j.1469-8137.1985.tb03672.x; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Li HY, 2008, NEW PHYTOL, V178, P852, DOI 10.1111/j.1469-8137.2008.02410.x; Li HY, 2006, NEW PHYTOL, V172, P536, DOI 10.1111/j.1469-8137.2006.01846.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Merryweather J, 1998, NEW PHYTOL, V138, P117, DOI 10.1046/j.1469-8137.1998.00888.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Munkvold L, 2004, NEW PHYTOL, V164, P357, DOI 10.1111/j.1469-8137.2004.01169.x; Oehl F, 2004, OECOLOGIA, V138, P574, DOI 10.1007/s00442-003-1458-2; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Plenchette C, 1996, BIOL FERT SOILS, V21, P303, DOI 10.1007/BF00334907; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Pringle A, 2008, NEW PHYTOL, V180, P162, DOI 10.1111/j.1469-8137.2008.02537.x; READ DJ, 1989, P ROY SOC EDINB B, V96, P89, DOI 10.1017/S0269727000010873; Read DJ, 2002, ECOL STU AN, V157, P3; Rinaudo V, 2010, PLANT SOIL, V333, P7, DOI 10.1007/s11104-009-0202-z; Ryan MH, 2002, AUST J AGR RES, V53, P1173, DOI 10.1071/AR02005; SANDERS IR, 1994, FUNCT ECOL, V8, P77, DOI 10.2307/2390114; Scheublin TR, 2007, J ECOL, V95, P631, DOI 10.1111/j.1365-2745.2007.01244.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; TEMPLETON GE, 1979, ANNU REV PHYTOPATHOL, V17, P301, DOI 10.1146/annurev.py.17.090179.001505; van der Heijden MGA, 2006, NEW PHYTOL, V172, P739, DOI 10.1111/j.1469-8137.2006.01862.x; van der Heijden MGA, 2009, J ECOL, V97, P1139, DOI 10.1111/j.1365-2745.2009.01570.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 2002, ECOL STU AN, V157, P243; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Vatovec C, 2005, RENEW AGR FOOD SYST, V20, P181, DOI 10.1079/RAF2005115; Verbruggen E, 2012, PLANT SOIL, V350, P43, DOI 10.1007/s11104-011-0828-5; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; WAPSHERE AJ, 1974, ANN APPL BIOL, V77, P201, DOI 10.1111/j.1744-7348.1974.tb06886.x; WYSE DL, 1994, WEED TECHNOL, V8, P403, DOI 10.1017/S0890037X00039014	64	62	69	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27825	10.1371/journal.pone.0027825	http://dx.doi.org/10.1371/journal.pone.0027825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164216	gold, Green Published			2022-12-25	WOS:000298171400016
J	Williams, M; Vannier, J; Corbari, L; Massabuau, JC				Williams, Mark; Vannier, Jean; Corbari, Laure; Massabuau, Jean-Charles			Oxygen as a Driver of Early Arthropod Micro-Benthos Evolution	PLOS ONE			English	Article							PHYLLOPOD BED COMMUNITY; FUNCTIONAL-MORPHOLOGY; BRADORIID ARTHROPODS; PHOSPHATOCOPID CRUSTACEAN; ORDOVICIAN OSTRACODS; MYODOCOPID OSTRACOD; CIRCULATORY-SYSTEM; TISSUE-OXYGENATION; OLENID TRILOBITES; BURGESS SHALE	Background: We examine the physiological and lifestyle adaptations which facilitated the emergence of ostracods as the numerically dominant Phanerozoic bivalve arthropod micro-benthos. Methodology/Principal Findings: The PO2 of modern normoxic seawater is 21 kPa (air-equilibrated water), a level that would cause cellular damage if found in the tissues of ostracods and much other marine fauna. The PO2 of most aquatic breathers at the cellular level is much lower, between 1 and 3 kPa. Ostracods avoid oxygen toxicity by migrating to waters which are hypoxic, or by developing metabolisms which generate high consumption of O-2. Interrogation of the Cambrian record of bivalve arthropod micro-benthos suggests a strong control on ecosystem evolution exerted by changing seawater O-2 levels. The PO2 of air-equilibrated Cambrian-seawater is predicted to have varied between 10 and 30 kPa. Three groups of marine shelf-dwelling bivalve arthropods adopted different responses to Cambrian seawater O-2. Bradoriida evolved cardiovascular systems that favoured colonization of oxygenated marine waters. Their biodiversity declined during intervals associated with black shale deposition and marine shelf anoxia and their diversity may also have been curtailed by elevated late Cambrian (Furongian) oxygen-levels that increased the PO2 gradient between seawater and bradoriid tissues. Phosphatocopida responded to Cambrian anoxia differently, reaching their peak during widespread seabed dysoxia of the SPICE event. They lacked a cardiovascular system and appear to have been adapted to seawater hypoxia. As latest Cambrian marine shelf waters became well oxygenated, phosphatocopids went extinct. Changing seawater oxygen-levels and the demise of much of the seabed bradoriid micro-benthos favoured a third group of arthropod micro-benthos, the ostracods. These animals adopted lifestyles that made them tolerant of changes in seawater O-2. Ostracods became the numerically dominant arthropod micro-benthos of the Phanerozoic. Conclusions/Significance: Our work has implications from an evolutionary context for understanding how oxygen-level in marine ecosystems drives behaviour.	[Williams, Mark] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Vannier, Jean] Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon Terre Planetes Environm, F-69622 Villeurbanne, France; [Corbari, Laure] Museum Natl Hist Nat, CNRS, UMR 7138, Paris, France; [Massabuau, Jean-Charles] Univ Bordeaux 1, CNRS, EPOC, UMR 5805, Arcachon, France	University of Leicester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Williams, M (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	mri@le.ac.uk	Williams, Mark/B-7590-2009	Williams, Mark/0000-0002-7987-6069; Massabuau, Jean-Charles/0000-0003-1302-1719; Corbari, Laure/0000-0002-3323-6162	Agence Nationale de la Recherche [ANR] [ORECO-BLAN06-3-136294]	Agence Nationale de la Recherche [ANR](French National Research Agency (ANR))	This study was supported by Agence Nationale de la Recherche [ANR] grant ORECO-BLAN06-3-136294 'RALI' The Rise of Animal Life [http://www.agence-nationale-recherche.fr/Intl]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1995, MAR BIOL, V124, P51, DOI 10.1007/BF00349146; Ahlberg P, 2005, ACTA PALAEONTOL POL, V50, P429; Ahlberg P, 2009, LETHAIA, V42, P2, DOI 10.1111/j.1502-3931.2008.00127.x; Alvarez MED, 2008, ACTA PALAEONTOL POL, V53, P647; ANGEL MV, 1993, SYNOPSES BRIT FAUNA, V48, P1; Bennett Carys, 2008, Senckenbergiana Lethaea, V88, P37; Bennett MB, 1997, INT J PARASITOL, V27, P275, DOI 10.1016/S0020-7519(96)00201-9; Berg-Madsen V., 1985, Bulletin of the Geological Society of Denmark, V34, P133; Bottjer D.J., 2000, GSA TODAY, V10, P1; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Caron JB, 2006, PALAIOS, V21, P451, DOI 10.2110/palo.2003.P05-070R; COHEN AC, 1989, J CRUSTACEAN BIOL, V9, P297, DOI 10.2307/1548508; Corbari L, 2005, MAR BIOL, V147, P1377, DOI 10.1007/s00227-005-0040-3; Corbari L, 2005, J EXP BIOL, V208, P661, DOI 10.1242/jeb.01427; Corbari L, 2004, J EXP BIOL, V207, P4415, DOI 10.1242/jeb.01290; Droser ML, 2003, INTEGR COMP BIOL, V43, P178, DOI 10.1093/icb/43.1.178; Fortey R, 2000, P NATL ACAD SCI USA, V97, P6574, DOI 10.1073/pnas.97.12.6574; Gill BC, 2011, NATURE, V469, P80, DOI 10.1038/nature09700; GRUNDEL J, 1981, FREIBERGER FORSCH C, V363, P57; Harvey THP, 2011, J GEOL SOC LONDON, V168, P705, DOI 10.1144/0016-76492010-031; Hinz-Schallreuter I, 1996, ARCH GESCHIEBEKUNDE, V2, P841; Hinz-Schallreuter Ingelore, 1993, Archiv fuer Geschiebekunde, V1, P385; Hinz-Schallreuter Ingelore, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P103; Hinz-Schallreuter Ingelore C.U., 1996, Stereo-Atlas of Ostracod Shells, V23, P85; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Hou XG, 2002, T ROY SOC EDIN-EARTH, V92, P347; Hou XG, 2010, P ROY SOC B-BIOL SCI, V277, P1835, DOI 10.1098/rspb.2009.2194; Hull SL, 1998, J NAT HIST, V32, P501, DOI 10.1080/00222939800770271; Jago J.B., 2006, Palaeoworld, V15, P406, DOI 10.1016/j.palwor.2006.10.014; Salas MJ, 2007, J PALEONTOL, V81, P1384, DOI 10.1666/05-134.1; Loughlin JD, 2011, PALAEOGEOGR PALAEOCL, V297, P239; Maas Andreas, 2003, Fossils and Strata, V49, P1; Massabuau JC, 2003, MECH AGEING DEV, V124, P857, DOI 10.1016/S0047-6374(03)00147-7; Massabuau JC, 2001, RESP PHYSIOL, V128, P249, DOI 10.1016/S0034-5687(01)00305-X; Massabuau JC, 2011, OXIDATIVE S IN PRESS; Melnikova LM, 1997, J MICROPALAEONTOL, V16, P179, DOI 10.1144/jm.16.2.179; MONTAGNA PA, 1995, J EXP MAR BIOL ECOL, V185, P149, DOI 10.1016/0022-0981(94)00138-4; MULLER KJ, 1979, LETHAIA, V12, P1, DOI 10.1111/j.1502-3931.1979.tb01234.x; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Orr PJ, 2003, GEOLOGY, V31, P769, DOI 10.1130/G19193.1; Perrier V, 2011, PALAEONTOLO IN PRESS; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Pour MG, 2011, ALCHERINGA, V35, P517, DOI 10.1080/03115518.2011.538909; Rushton AWA, 2011, SPECIAL REPORT GEOLO, V25, P1; Saltzman MR, 2011, P NATL ACAD SCI USA, V108, P3876, DOI 10.1073/pnas.1011836108; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Shu DG, 1999, LETHAIA, V32, P279; Siveter D.J., 1991, Journal of Micropalaeontology, V10, P151; Siveter DJ, 2007, P ROY SOC B-BIOL SCI, V274, P465, DOI 10.1098/rspb.2006.3756; Siveter David J., 1997, Special Papers in Palaeontology, V57, P1; Siveter DJ, 2010, P ROY SOC B-BIOL SCI, V277, P1539, DOI 10.1098/rspb.2009.2122; Siveter DJ, 2001, SCIENCE, V293, P479, DOI 10.1126/science.1061697; Siveter DJ, 2003, SPEC PAP PALAEONTOL, P9; Siveter DJ, 1996, T ROY SOC EDIN-EARTH, V86, P113, DOI 10.1017/S0263593300006374; Siveter DJ, 2003, SCIENCE, V302, P1749, DOI 10.1126/science.1091376; SIVETER DJ, 1995, J GEOL SOC LONDON, V152, P221, DOI 10.1144/gsjgs.152.2.0221; SOHN IG, 1979, J PALEONTOL, V53, P578; Sylvester-Bradley P. C., 1961, TREATISE INVERTEBR Q, pQ100; Terfelt F, 2008, NORW J GEOL, V88, P73; Tinn O, 2004, PALAEONTOLOGY, V47, P199, DOI 10.1111/j.0031-0239.2004.00369.x; Topper TP, 2011, GONDWANA RES, V19, P310, DOI 10.1016/j.gr.2010.05.012; VANDERKOOI JM, 1991, AM J PHYSIOL, V260, pC1131, DOI 10.1152/ajpcell.1991.260.6.C1131; Vannier J, 2005, PALAIOS, V20, P3, DOI 10.2110/palo.2003.p03-40; VANNIER J, 1993, J CRUSTACEAN BIOL, V13, P51, DOI 10.2307/1549122; Vannier J, 1995, PALAEONTOLOGY, V38, P843; Vannier J, 1997, LETHAIA, V30, P169; Vannier J, 1998, MAR BIOL, V132, P391, DOI 10.1007/s002270050406; Vannier J, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P81; Vannier J, 2010, GEOLOGY, V38, P711, DOI 10.1130/G30829.1; Waloszek Dieter, 2003, P69; Weitschat W., 1983, Stereo-Atlas of Ostracod Shells, V10, P127; Whatley R., 1991, Journal of Micropalaeontology, V10, P181; Williams M, 2006, PALAEOGEOGR PALAEOCL, V230, P299, DOI 10.1016/j.palaeo.2005.07.021; WILLIAMS M, 1994, T ROY SOC EDIN-EARTH, V85, P123, DOI 10.1017/S0263593300003527; Williams M, 2007, PALAEOGEOGR PALAEOCL, V248, P202, DOI 10.1016/j.palaeo.2006.12.004; Williams Mark, 1998, Monograph of the Palaeontographical Society, V152, P1; Williams Mark, 2008, Senckenbergiana Lethaea, V88, P11; Woods MA, 2011, J GEOL SOC LONDON, V168, P851, DOI 10.1144/0016-76492010-111; Wrona R, 2009, POL POLAR RES, V30, P347, DOI 10.4202/ppres.2009.19; Zhang H.Q., 2010, NEUES JB GEOLOGIE PA, V259, P157; Zhang XG, 2007, PALAEONTOGR ABT A, V281, P93, DOI 10.1127/pala/281/2007/93; Zhu Mao-Yan, 2006, Palaeoworld, V15, P217, DOI 10.1016/j.palwor.2006.10.016; Zhuravlev AY, 1996, GEOLOGY, V24, P311, DOI 10.1130/0091-7613(1996)024<0311:AATCOT>2.3.CO;2	84	27	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28183	10.1371/journal.pone.0028183	http://dx.doi.org/10.1371/journal.pone.0028183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164241	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400042
J	Cai, XW; Gaudet, JJ; Mangan, JK; Chen, MJ; De Obaldia, ME; Oo, Z; Ernst, P; Speck, NA				Cai, Xiongwei; Gaudet, Justin J.; Mangan, James K.; Chen, Michael J.; De Obaldia, Maria Elena; Oo, Zaw; Ernst, Patricia; Speck, Nancy A.			Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells	PLOS ONE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; X-RAY-SENSITIVITY; CBF-BETA-SMMHC; BONE-MARROW; STEM/PROGENITOR CELLS; PROGENITOR CELLS; POINT MUTATIONS; SELF-RENEWAL; PROLIFERATION; CYCLE	RUNX1 encodes a DNA binding subunit of the core-binding transcription factors and is frequently mutated in acute leukemia, therapy-related leukemia, myelodysplastic syndrome, and chronic myelomonocytic leukemia. Mutations in RUNX1 are thought to confer upon hematopoietic stem cells (HSCs) a pre-leukemic state, but the fundamental properties of Runx1 deficient pre-leukemic HSCs are not well defined. Here we show that Runx1 deficiency decreases both apoptosis and proliferation, but only minimally impacts the frequency of long term repopulating HSCs (LT-HSCs). It has been variously reported that Runx1 loss increases LT-HSC numbers, decreases LT-HSC numbers, or causes age-related HSC exhaustion. We attempt to resolve these discrepancies by showing that Runx1 deficiency alters the expression of several key HSC markers, and that the number of functional LT-HSCs varies depending on the criteria used to score them. Finally, we identify genes and pathways, including the cell cycle and p53 pathways that are dysregulated in Runx1 deficient HSCs.	[Cai, Xiongwei; Mangan, James K.; Chen, Michael J.; De Obaldia, Maria Elena; Oo, Zaw; Speck, Nancy A.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Cai, Xiongwei; Mangan, James K.; Chen, Michael J.; De Obaldia, Maria Elena; Oo, Zaw; Speck, Nancy A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Gaudet, Justin J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03756 USA; [Ernst, Patricia] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Dartmouth College; Dartmouth College	Cai, XW (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	patricia.ernst@dartmouth.edu; nancyas@exchange.upenn.edu	Cai, Xiongwei/G-3169-2015	Ernst, Patricia/0000-0001-7638-2939; De Obaldia, Maria/0000-0003-2488-3672	Norris Cotton Cancer Center [CA23108]; National Institutes of Health [R01CA149976, T32AR07576]; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [T32CA009615, P30CA023108, R01CA149976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007576] Funding Source: NIH RePORTER	Norris Cotton Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The microarray core was supported in part by the Core Grant of the Norris Cotton Cancer Center (CA23108). This work was supported by National Institutes of Health R01CA149976 and T32AR07576, and funds from the Abramson Family Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bernardin F, 2002, ONCOGENE, V21, P3247, DOI 10.1038/sj.onc.1205447; Bloomfield CD, 1998, CANCER RES, V58, P4173; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Burel SA, 2001, MOL CELL BIOL, V22, P144; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; D'Costa J, 2005, LEUKEMIA, V19, P921, DOI 10.1038/sj.leu.2403755; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ichikawa M, 2008, J IMMUNOL, V180, P4402, DOI 10.4049/jimmunol.180.7.4402; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Kuo MC, 2009, LEUKEMIA, V23, P1426, DOI 10.1038/leu.2009.48; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lou JR, 2000, ONCOGENE, V19, P2695, DOI 10.1038/sj.onc.1203588; Motoda L, 2007, STEM CELLS, V25, P2976, DOI 10.1634/stemcells.2007-0061; Nimmo R, 2005, DEVELOPMENT, V132, P5043, DOI 10.1242/dev.02102; NISHI N, 1995, STEM CELLS, V13, P517, DOI 10.1002/stem.5530130509; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Oliveros JC, 2007, VENNY INTERACTIVE TO; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Robertson AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003770; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Schnittger S, 2011, BLOOD, V117, P2348, DOI 10.1182/blood-2009-11-255976; SINCLAIR WK, 1966, RADIAT RES, V29, P450, DOI 10.2307/3572025; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Strom DK, 2000, J BIOL CHEM, V275, P3438, DOI 10.1074/jbc.275.5.3438; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zharlyganova D, 2008, J RADIAT RES, V49, P549, DOI 10.1269/jrr.08040	68	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28430	10.1371/journal.pone.0028430	http://dx.doi.org/10.1371/journal.pone.0028430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145044	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900027
J	Capparelli, R; Nocerino, N; Medaglia, C; Blaiotta, G; Bonelli, P; Iannelli, D				Capparelli, Rosanna; Nocerino, Nunzia; Medaglia, Chiara; Blaiotta, Giuseppe; Bonelli, Patrizia; Iannelli, Domenico			The Staphylococcus aureus Peptidoglycan Protects Mice against the Pathogen and Eradicates Experimentally Induced Infection	PLOS ONE			English	Article							POLYMORPHISM; IDENTIFICATION; ASSOCIATION; ANTIBODIES; STRAINS; ACID; GENE; PCR	Staphylococcus aureus, in spite of antibiotics, is still a major human pathogen causing a wide range of infections. The present study describes the new vaccine A170PG, a peptidoglycan-based vaccine. In a mouse model of infection, A170PG protects mice against a lethal dose of S. aureus. Protection lasts at least 40 weeks and correlates with increased survival and reduced colonization. Protection extends into drug-resistant (MRSA or VISA) and genetically diverse clinical strains. The vaccine is effective when administered - in a single dose and without adjuvant - by the intramuscular, intravenous or the aerosol routes and induces active as well as passive immunization. Of note, A170PG also displays therapeutic activity, eradicating staphylococci, even when infection is systemic. Sustained antibacterial activity and induction of a strong and rapid anti-inflammatory response are the mechanisms conferring therapeutic efficacy to A170PG.	[Capparelli, Rosanna] Univ Naples Federico II, Fac Biotechnol, Naples, Italy; [Nocerino, Nunzia; Medaglia, Chiara; Blaiotta, Giuseppe; Iannelli, Domenico] Univ Naples Federico II, Fac Agr, Naples, Italy; [Bonelli, Patrizia] Fdn G Pascale, Ist Nazl & Tumori, Naples, Italy	University of Naples Federico II; University of Naples Federico II; IRCCS Fondazione Pascale	Capparelli, R (corresponding author), Univ Naples Federico II, Fac Biotechnol, Naples, Italy.	iannelli@unina.it	Bonelli, Patrizia/AAA-5106-2020; Capparelli, Rosanna/Q-3144-2017	Bonelli, Patrizia/0000-0002-0916-4015; Capparelli, Rosanna/0000-0001-8614-6251; BLAIOTTA, Giuseppe/0000-0002-2174-8259				Blaiotta G, 2004, J APPL MICROBIOL, V97, P719, DOI 10.1111/j.1365-2672.2004.02349.x; Blaiotta G, 2003, SYST APPL MICROBIOL, V26, P423, DOI 10.1078/072320203322497455; Blaiotta G, 2001, J DAIRY RES, V68, P139, DOI 10.1017/S0022029900004672; Blaiotta G, 2006, APPL ENVIRON MICROB, V72, P6117, DOI 10.1128/AEM.00773-06; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Capparelli R, 2009, J INFECT DIS, V201, P52; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gantner BN, 2007, NATURE, V447, P916, DOI 10.1038/447916a; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Goodner K, 1935, J EXP MED, V62, P359, DOI 10.1084/jem.62.3.359; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; KOWALSKI JJ, 1971, INFECT IMMUN, V4, P205, DOI 10.1128/IAI.4.3.205-211.1971; Liu GY, 2009, PEDIATR RES, V65, p71R, DOI 10.1203/PDR.0b013e31819dc44d; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; MARKS MI, 1990, INFECTION, V18, P53, DOI 10.1007/BF01644186; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Moore CE, 2004, CLIN DIAGN LAB IMMUN, V11, P1194, DOI 10.1128/CDLI.11.6.1194-1197.2004; Muller-Ansett M, 2010, PLOS ONE, V5, P1; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; PETERSON PK, 1978, J CLIN INVEST, V61, P597, DOI 10.1172/JCI108971; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Verdier I, 2007, J CLIN MICROBIOL, V45, P725, DOI 10.1128/JCM.01572-06; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; WERGELAND HI, 1989, J CLIN MICROBIOL, V27, P1286, DOI 10.1128/JCM.27.6.1286-1291.1989; WERGELAND HI, 1987, J CLIN MICROBIOL, V25, P540, DOI 10.1128/JCM.25.3.540-545.1987	31	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28377	10.1371/journal.pone.0028377	http://dx.doi.org/10.1371/journal.pone.0028377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145040	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900023
J	Chavada, R; Kok, J; van Hal, S; Chen, SCA				Chavada, Ruchir; Kok, Jen; van Hal, Sebastiaan; Chen, Sharon C-A.			Seeking Clarity within Cloudy Effluents: Differentiating Fungal from Bacterial Peritonitis in Peritoneal Dialysis Patients	PLOS ONE			English	Article							PROPHYLAXIS; EXPERIENCE; RISK	Background: Fungal peritonitis is a serious complication of peritoneal dialysis (PD) therapy with the majority of patients ceasing PD permanently. The aims of this study were to identify risk factors and clinical associations that may discriminate between fungal from bacterial peritonitis. Methods: We retrospectively identified episodes of fungal peritonitis from 2001-2010 in PD patients at Liverpool and Westmead Hospitals (Australia). Fungal peritonitis cases were matched in a 1: 2 ratio with patients with bacterial peritonitis from each institution's dialysis registry, occurring closest in time to the fungal episode. Patient demographic, clinical and outcome data were obtained from the medical records. Results: Thirty-nine episodes of fungal peritonitis (rate of 0.02 episodes per patient-year of dialysis) were matched with 78 episodes of bacterial peritonitis. Candida species were the commonest pathogens (35/39; 90% episodes) with Candida albicans (37%), Candida parapsilosis (32%) and Candida glabrata (13%) the most frequently isolated species. Compared to bacterial peritonitis, fungal peritonitis patients had received PD for significantly longer (1133 vs. 775 catheter-days; p = 0.016), were more likely to have had previous episodes of bacterial peritonitis (51% vs. 10%; p = 0.01), and to have received prior antibacterial therapy (51% vs. 10%; p = 0.01). Patients with fungal peritonitis were less likely to have fever and abdominal pain on presentation, but had higher rates of PD catheter removal (79% vs. 22%; p < 0.005), and permanent transfer to haemodialysis (87% vs. 24%; p < 0.005). Hospital length of stay was significantly longer in patients with fungal peritonitis (26.1 days vs. 12.6 days; p = 0.017), but the all-cause 30-day mortality rate was similar in both groups. Fluconazole was a suitable empiric antifungal agent; with no Candida resistance detected. Conclusion: Prompt recognition of clinical risk factors, initiation of antifungal therapy and removal of PD catheters are key considerations in optimising outcomes.	[Chavada, Ruchir; van Hal, Sebastiaan] Liverpool Hosp, Sydney SW Pathol Serv, Dept Microbiol & Infect Dis, Liverpool, Merseyside, England; [Kok, Jen; Chen, Sharon C-A.] Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia	University of Sydney	Chavada, R (corresponding author), Liverpool Hosp, Sydney SW Pathol Serv, Dept Microbiol & Infect Dis, Liverpool, Merseyside, England.	sharon.chen@swahs.health.nsw.gov.au		van Hal, Sebastiaan/0000-0001-5852-4155				[Anonymous], 2010, 33 AUSTR NZ DIAL TRA; Bren A, 1998, EUR J CLIN MICROBIOL, V17, P839, DOI 10.1007/s100960050203; Chang TI, 2011, PERITON DIALYSIS INT, V31, P60, DOI 10.3747/pdi.2009.00057; Chen Chih-Ming, 2004, Journal of Microbiology Immunology and Infection, V37, P115; CLSI, 2010, M27A3 CLSI; Gandhi B. V., 2005, Journal of Postgraduate Medicine, V51, P30; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Matuszkiewicz-Rowinska J, 2009, PERITON DIALYSIS INT, V29, pS161; Miles R, 2009, KIDNEY INT, V76, P622, DOI 10.1038/ki.2009.202; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; Mujais S, 2006, KIDNEY INT, V70, pS55, DOI 10.1038/sj.ki.5001916; Oygar DD, 2009, RENAL FAILURE, V31, P25, DOI 10.1080/08860220802546446; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prasad N, 2005, PERITON DIALYSIS INT, V25, P207; Ram R, 2008, NEPHRON CLIN PRACT, V110, pC207, DOI 10.1159/000167867; Restrepo C, 2010, PERITON DIALYSIS INT, V30, P619, DOI 10.3747/pdi.2008.00189; Troidle L, 2003, SEMIN DIALYSIS, V16, P428, DOI 10.1046/j.1525-139X.2003.16095.x; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wang AYM, 2000, AM J KIDNEY DIS, V36, P1183, DOI 10.1053/ajkd.2000.19833; Wong PN, 2008, PERITON DIALYSIS INT, V28, P155; Wong PN, 2007, PERITON DIALYSIS INT, V27, P531	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28247	10.1371/journal.pone.0028247	http://dx.doi.org/10.1371/journal.pone.0028247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145033	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168900016
J	Lai, HC; Wu, MJ; Chen, PY; Sheu, TT; Chiu, SP; Lin, MH; Ho, CT; Yen, JH				Lai, Hui-Chi; Wu, Ming-Jiuan; Chen, Pei-Yi; Sheu, Ting-Ting; Chiu, Szu-Ping; Lin, Meng-Han; Ho, Chi-Tang; Yen, Jui-Hung			Neurotrophic Effect of Citrus 5-Hydroxy-3,6,7,8,3 ',4 '-Hexamethoxyflavone: Promotion of Neurite Outgrowth via cAMP/PKA/CREB Pathway in PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; IMPROVES MEMORY IMPAIRMENT; LONG-TERM POTENTIATION; HYDROXYLATED POLYMETHOXYFLAVONES; TRANSCRIPTIONAL REGULATION; PHEOCHROMOCYTOMA CELLS; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; FLAVONOIDS; CREB	5-Hydroxy-3,6,7,8,3',4'-hexamethoxyflavone (5-OH-HxMF), a hydroxylated polymethoxyflavone, is found exclusively in the Citrus genus, particularly in the peels of sweet orange. In this research, we report the first investigation of the neurotrophic effects and mechanism of 5-OH-HxMF in PC12 pheochromocytoma cells. We found that 5-OH-HxMF can effectively induce PC12 neurite outgrowth accompanied with the expression of neuronal differentiation marker protein growth-associated protein-43(GAP-43). 5-OH-HxMF caused the enhancement of cyclic AMP response element binding protein (CREB) phosphorylation, c-fos gene expression and CRE-mediated transcription, which was inhibited by 2-naphthol AS-E phosphate (KG-501), a specific antagonist for the CREB-CBP complex formation. Moreover, 5-OH-HxMF-induced both CRE transcription activity and neurite outgrowth were inhibited by adenylate cyclase and protein kinase A (PKA) inhibitor, but not MEK1/2, protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3K) or calcium/calmodulin-dependent protein kinase (CaMK) inhibitor. Consistently, 5-OH-HxMF treatment increased the intracellular cAMP level and downstream component, PKA activity. We also found that addition of K252a, a TrKA antagonist, significantly inhibited NGF- but not 5-OH-HxMF-induced neurite outgrowth. These results reveal for the first time that 5-OH-HxMF is an effective neurotrophic agent and its effect is mainly through a cAMP/PKA-dependent, but TrKA-independent, signaling pathway coupling with CRE-mediated gene transcription. A PKC-dependent and CREB-independent pathway was also involved in its neurotrophic action.	[Lai, Hui-Chi; Chiu, Szu-Ping; Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Wu, Ming-Jiuan; Lin, Meng-Han] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Chen, Pei-Yi; Yen, Jui-Hung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chen, Pei-Yi] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan; [Sheu, Ting-Ting] Tzu Chi Univ, Inst Microbiol Immunol & Biochem, Hualien, Taiwan; [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08903 USA	Tzu Chi University; Chia Nan University of Pharmacy & Science; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Rutgers State University New Brunswick	Lai, HC (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	imyenjh@mail.tcu.edu.tw		Wu, Ming-Jiuan/0000-0003-3327-828X; Sheu, Ting-Ting/0000-0001-5183-357X	National Science Council, Taiwan, Republic of China [NSC-97-2320-B-320-011-MY3, NSC-99-2320-B-041-005-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by grant NSC-97-2320-B-320-011-MY3 and NSC-99-2320-B-041-005-MY3 from National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rahim M, 2009, BIOCHEMISTRY-US, V48, P7713, DOI 10.1021/bi901088w; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; COSTELLO B, 1990, J NEUROSCI, V10, P1398; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Dworkin S, 2010, EXPERT OPIN THER TAR, V14, P869, DOI 10.1517/14728222.2010.501332; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Katoh S, 1997, BIOCHEM BIOPH RES CO, V241, P347, DOI 10.1006/bbrc.1997.7514; Lai CS, 2007, CARCINOGENESIS, V28, P2581, DOI 10.1093/carcin/bgm231; Lai CS, 2011, MOL NUTR FOOD RES, V55, P278, DOI 10.1002/mnfr.201000224; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Levy YS, 2005, BIODRUGS, V19, P97, DOI 10.2165/00063030-200519020-00003; Li SM, 2007, BIOORGAN MED CHEM, V15, P3381, DOI 10.1016/j.bmc.2007.03.021; Li SM, 2006, J AGR FOOD CHEM, V54, P4176, DOI 10.1021/jf060234n; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Manthey JA, 2001, CURR MED CHEM, V8, P135, DOI 10.2174/0929867013373723; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsuzaki K, 2008, EUR J PHARMACOL, V578, P194, DOI 10.1016/j.ejphar.2007.09.028; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Nagase H, 2005, BIOCHEMISTRY-US, V44, P13683, DOI 10.1021/bi050643x; Nagase H, 2005, BIOCHEM BIOPH RES CO, V337, P1330, DOI 10.1016/j.bbrc.2005.10.001; Nakajima A, 2007, J PHARMACOL SCI, V105, P122, DOI 10.1254/jphs.SC0070155; Onozuka H, 2008, J PHARMACOL EXP THER, V326, P739, DOI 10.1124/jpet.108.140293; Pan MH, 2007, J AGR FOOD CHEM, V55, P5081, DOI 10.1021/jf070068z; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Poduslo JF, 1996, J NEUROCHEM, V67, P734; Pollard SE, 2006, BIOCHEM BIOPH RES CO, V350, P960, DOI 10.1016/j.bbrc.2006.09.131; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Qiu PJ, 2010, MOL NUTR FOOD RES, V54, pS244, DOI 10.1002/mnfr.200900605; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; RiceEvans CA, 1996, BIOCHEM SOC T, V24, P790, DOI 10.1042/bst0240790; SAN ERAJT, 1991, J NEUROSCI RES, V29, P149, DOI 10.1002/jnr.490290203; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Scholzke MN, 2007, J MOL MED, V85, P577, DOI 10.1007/s00109-007-0196-z; Schulte-Herbruggen O, 2008, CURR ALZHEIMER RES, V5, P38; Spedding M, 2008, NOVART FDN SYMP, V289, P222, DOI [DOI 10.1002/9780470751251.CH18, DOI 10.1002/SERIES1767]; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; Spencer JPE, 2009, ARCH BIOCHEM BIOPHYS, V492, P1, DOI 10.1016/j.abb.2009.10.003; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Spencer JPE, 2009, CHEM SOC REV, V38, P1152, DOI 10.1039/b800422f; VANHOOFF COM, 1989, J CELL BIOL, V108, P1115, DOI 10.1083/jcb.108.3.1115; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Yamamoto Y, 2009, BRAIN RES, V1295, P218, DOI 10.1016/j.brainres.2009.07.081; Yen JH, 2011, MOL NUTR FOOD RES, V55, P733, DOI 10.1002/mnfr.201000226; Zhao LX, 2003, J NEUROSCI, V23, P4228	60	41	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28280	10.1371/journal.pone.0028280	http://dx.doi.org/10.1371/journal.pone.0028280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140566	gold, Green Published, Green Submitted			2022-12-25	WOS:000298166300044
J	Lawrence, DP; Kroken, S; Pryor, BM; Arnold, AE				Lawrence, Daniel P.; Kroken, Scott; Pryor, Barry M.; Arnold, A. Elizabeth			Interkingdom Gene Transfer of a Hybrid NPS/PKS from Bacteria to Filamentous Ascomycota	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; POLYKETIDE SYNTHASE GENES; FUNCTIONAL-ANALYSIS; HORIZONTAL TRANSFER; EVOLUTION; REVEALS; VIRULENCE; GENOMES; CLUSTER; FUNGI	Nonribosomal peptides (NRPs) and polyketides (PKs) are ecologically important secondary metabolites produced by bacteria and fungi using multidomain enzymes called nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs), respectively. Previous phylogenetic analyses of fungal NRPSs and PKSs have suggested that a few of these genes were acquired by fungi via horizontal gene transfer (HGT) from bacteria, including a hybrid NPS/PKS found in Cochliobolus heterostrophus (Dothideomycetes, Ascomycota). Here, we identify this hybrid gene in fungi representing two additional classes of Ascomycota (Aspergillus spp., Microsporum canis, Arthroderma spp., and Trichophyton spp., Eurotiomycetes; Chaetomium spp. and Metarhizium spp., Sordariomycetes) and use phylogenetic analyses of the most highly conserved domains from NRPSs (adenylation (A) domain) and PKSs (ketoacyl synthase (KS) domain) to examine the hypothesis that the hybrid NPS7/PKS24 was acquired by fungi from bacteria via HGT relatively early in the evolution of the Pezizomycotina. Our results reveal a unique ancestry of the A domain and KS domain in the hybrid gene relative to known fungal NRPSs and PKSs, provide strong evidence for HGT of the hybrid gene from a putative bacterial donor in the Burkholderiales, and suggest the HGT event occurred early in the evolution of the filamentous Ascomycota.	[Lawrence, Daniel P.; Kroken, Scott; Pryor, Barry M.; Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ 85719 USA	University of Arizona	Lawrence, DP (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85719 USA.				School of Plant Sciences at the University of Arizona; College of Agriculture and Life Sciences at the University of Arizona; National Science Foundation; University of Arizona	School of Plant Sciences at the University of Arizona; College of Agriculture and Life Sciences at the University of Arizona; National Science Foundation(National Science Foundation (NSF)); University of Arizona	This study was supported by the School of Plant Sciences and College of Agriculture and Life Sciences at the University of Arizona, by the National Science Foundation-Integrative Graduate Education Research Traineeship (NSF-IGERT) and by the Graduate Fellowship program in Genomics at the University of Arizona (DPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AHARONOWITZ Y, 1992, ANNU REV MICROBIOL, V46, P461, DOI 10.1146/annurev.mi.46.100192.002333; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Bhatnagar D, 2003, APPL MICROBIOL BIOT, V61, P83, DOI 10.1007/s00253-002-1199-x; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Buades C, 1996, J MOL EVOL, V42, P537, DOI 10.1007/BF02352283; Bushley KE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-26; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Doolittle WE, 1998, TRENDS GENET, V14, P307; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Ginolhac A, 2005, J MOL EVOL, V60, P716, DOI 10.1007/s00239-004-0161-1; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; Katz LA, 2002, INT J SYST EVOL MICR, V52, P1893, DOI 10.1099/00207713-52-5-1893; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; KONO Y, 1979, BIOORG CHEM, V8, P391, DOI 10.1016/0045-2068(79)90064-6; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; LANDAN G, 1990, MOL BIOL EVOL, V7, P399; Lee BN, 2005, EUKARYOT CELL, V4, P545, DOI 10.1128/EC.4.3.545-555.2005; Liras P, 2006, INT MICROBIOL, V9, P9; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; MADDISON DR, 2003, MACCLADE 4 06 ANAL P; PENALVA MA, 1990, P ROY SOC B-BIOL SCI, V241, P164, DOI 10.1098/rspb.1990.0081; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Rogers MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-89; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Schmitt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004437; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; SMITH MW, 1992, TRENDS BIOCHEM SCI, V17, P489, DOI 10.1016/0968-0004(92)90335-7; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; WEBER G, 1994, CURR GENET, V26, P120, DOI 10.1007/BF00313798; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Zaneveld JR, 2008, MICROBIOL-SGM, V154, P1, DOI 10.1099/mic.0.2007/011833-0; Zhang YQ, 2005, MYCOLOGY S, V22, P355	51	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28231	10.1371/journal.pone.0028231	http://dx.doi.org/10.1371/journal.pone.0028231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140558	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300042
J	Kuusisto, HV; Wagstaff, KM; Alvisi, G; Roth, DM; Jans, DA				Kuusisto, Henna V.; Wagstaff, Kylie M.; Alvisi, Gualtiero; Roth, Daniela M.; Jans, David A.			Global enhancement of nuclear localization-dependent nuclear transport in transformed cells	FASEB JOURNAL			English	Article						importins; exportins; neoplastic transformation; isogenic; specific drug delivery	HORMONE-RELATED PROTEIN; GENE-EXPRESSION; IMPORTIN-ALPHA; BREAST-CANCER; DIFFERENTIAL EXPRESSION; MODULAR TRANSPORTERS; OVARIAN-CARCINOMA; TARGETING SIGNAL; CSE1L/CAS GENE; MESSENGER-RNA	Fundamental to eukaryotic cell function, nucleocytoplasmic transport can be regulated at many levels, including through modulation of the importin/exportin (Imp/Exp) nuclear transport machinery itself. Although Imps/Exps are overexpressed in a number of transformed cell lines and patient tumor tissues, the efficiency of nucleocytoplasmic transport in transformed cell types compared with nontransformed cells has not been investigated. Here we use quantitative live cell imaging of 3 isogenic nontransformed/transformed cell pairs to show that nuclear accumulation of nuclear localization signal (NLS)-containing proteins, but not their NLS-mutated derivatives, is increased up to 7-fold in MCF10CA1h human epithelial breast carcinoma cells and in simian virus 40 (SV40)-transformed fibroblasts of human and monkey origin, compared with their nontransformed counterparts. The basis for this appears to be a significantly faster rate of nuclear import in transformed cell types, as revealed by analysis using fluorescence recovery after photobleaching for the human MCF10A/MCF10CA1h cell pair. Nuclear accumulation of NLS/nuclear export signal-containing (shuttling) proteins was also enhanced in transformed cell types, experiments using the nuclear export inhibitor leptomycin B demonstrating that efficient Exp-1-mediated nuclear export was not impaired in transformed compared with nontransformed cells. Enhanced nuclear import and export efficiencies were found to correlate with 2- to 4-fold higher expression of specific Imps/Exps in transformed cells, as indicated by quantitative Western blot analysis, with ectopic expression of Imps able to enhance NLS nuclear accumulation levels up to 5-fold in nontransformed MCF10A cells. The findings indicate that transformed cells possess altered nuclear transport properties, most likely due to the overexpression of Imps/Exps. The findings have important implications for the development of tumor-specific drug nanocarriers in anticancer therapy.-Kuusisto, H. V., Wagstaff, K. M., Alvisi, G., Roth, D. M., Jans, D. A. Global enhancement of nuclear localization-dependent nuclear transport in transformed cells. FASEB J. 26, 1181-1193 (2012). www.fasebj.org	[Kuusisto, Henna V.; Wagstaff, Kylie M.; Alvisi, Gualtiero; Roth, Daniela M.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Clayton, Vic 3800, Australia	Monash University	Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Clayton, Vic 3800, Australia.	david.jans@monash.edu	Alvisi, Gualtiero/F-9915-2012	Wagstaff, Kylie/0000-0003-4791-1410; Alvisi, Gualtiero/0000-0002-8177-3616; Jans, David/0000-0001-5115-4745	National Health and Medical Research Council (Australia) [436614, 384105]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (Australia; grant 436614 and fellowship 384105). The authors thank Cassandra David for skilled technical assistance and Caroline Garrett (Sussex Centre for Genome Damage and Stability, Sussex, UK) and Steven Santner (Karmanos Cancer Institute, Detroit, MI, USA) for the 1BR3/1BR3N and MCF10A/CA1h cell lines, respectively. All microscopic imaging was conducted using microscopes provided by the Monash Micro Imaging facility (Monash University, Clayton, VIC, Australia). The authors declare no conflicts of interest.	Akhlynina TV, 1997, J BIOL CHEM, V272, P20328, DOI 10.1074/jbc.272.33.20328; Alvisi G, 2006, TRAFFIC, V7, P1322, DOI 10.1111/j.1600-0854.2006.00477.x; ARLETT CF, 1988, INT J RADIAT BIOL, V54, P911, DOI 10.1080/09553008814552321; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Behrens P, 2001, ANTICANCER RES, V21, P2413; Brinkmann U, 1996, GENOME RES, V6, P187, DOI 10.1101/gr.6.3.187; Brustmann H, 2004, GYNECOL ONCOL, V92, P268, DOI 10.1016/j.ygyno.2003.10.029; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Chahine MN, 2009, PHARMACOL REV, V61, P358, DOI 10.1124/pr.108.000620; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Dankof A, 2007, VIRCHOWS ARCH, V451, P877, DOI 10.1007/s00428-007-0513-5; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Faggad A, 2009, MODERN PATHOL, V22, P579, DOI 10.1038/modpathol.2009.14; FELDHERR C, 1995, MOL CELL BIOL, V15, P7043; FELDHERR CM, 1992, P NATL ACAD SCI USA, V89, P11002, DOI 10.1073/pnas.89.22.11002; Forwood JK, 2002, BIOCHEMISTRY-US, V41, P9333, DOI 10.1021/bi025548s; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; Hakata Y, 2002, J VIROL, V76, P8079, DOI 10.1128/JVI.76.16.8079-8089.2002; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Hosokawa K, 2008, NEUROSCIENCE, V157, P864, DOI 10.1016/j.neuroscience.2008.09.045; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Jensen JB, 2011, EUR UROL, V59, P841, DOI 10.1016/j.eururo.2011.01.048; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kirschbaum-Slager N, 2005, PHYSIOL GENOMICS, V21, P423, DOI 10.1152/physiolgenomics.00237.2004; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Kuusisto HV, 2008, INT J CANCER, V123, P2965, DOI 10.1002/ijc.23884; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Loveland KL, 2006, BIOL REPROD, V74, P67, DOI 10.1095/biolreprod.105.042341; Mortezavi A., CLIN CANC RES, V17, P1111; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; NAKASHIMA T, 1994, EUR ARCH OTO-RHINO-L, V251, pS87, DOI 10.1007/BF02565228; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Pache JC, 2006, ENDOCRINOLOGY, V147, P990, DOI 10.1210/en.2005-0663; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Poon IKH, 2005, J VIROL, V79, P1339, DOI 10.1128/JVI.79.2.1339-1341.2005; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Rosenkranz AA, 2003, FASEB J, V17, P1121, DOI 10.1096/fj.02-0888fje; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Roth DM, 2011, J BIOL CHEM, V286, P14335, DOI 10.1074/jbc.M110.210302; Sakai M, 2010, ANTICANCER RES, V30, P851; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sato F, 2006, BIOCHEM BIOPH RES CO, V342, P465, DOI 10.1016/j.bbrc.2006.01.177; Smith ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009295; Sobolev AS, 2009, J BUON, V14, pS33; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; SOULE HD, 1990, CANCER RES, V50, P6075; Tachibana T, 1999, FEBS LETT, V442, P235, DOI 10.1016/S0014-5793(98)01664-0; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Truant R, 1999, MOL CELL BIOL, V19, P1210; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2009, EUR J PHARMACOL, V625, P174, DOI 10.1016/j.ejphar.2009.06.069; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wellmann A, 2001, INT J MOL MED, V7, P489; Wu MS, 2005, WORLD J GASTROENTERO, V11, P7405, DOI 10.3748/wjg.v11.i47.7405; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Yasuhara, 2007, NAT CELL BIOL, V9, P479; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yoshitake K, 2011, ANN SURG ONCOL, V18, P2093, DOI 10.1245/s10434-011-1569-7; Young JC, 2011, FASEB J, V25, P3958, DOI 10.1096/fj.10-176941; Zheng M, 2010, OBSTET GYNECOL, V116, P884, DOI 10.1097/AOG.0b013e3181f104ce	81	44	47	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1181	1193		10.1096/fj.11-191585	http://dx.doi.org/10.1096/fj.11-191585			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22155563	Green Submitted			2022-12-25	WOS:000300949300021
J	Namanja, AT; Li, YJ; Su, Y; Wong, S; Lu, JJ; Colson, LT; Wu, CG; Li, SSC; Chen, Y				Namanja, Andrew T.; Li, Yi-Jia; Su, Yang; Wong, Steven; Lu, Jingjun; Colson, Loren T.; Wu, Chenggang; Li, Shawn S. C.; Chen, Yuan			Insights into High Affinity Small Ubiquitin-like Modifier (SUMO) Recognition by SUMO-interacting Motifs (SIMs) Revealed by a Combination of NMR and Peptide Array Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING MOTIF; E3 LIGASE; IN-VIVO; SUMOYLATION; MECHANISM; PROTEINS; ROLES; DYNAMICS; FACTOR-1; DOMAINS	The small ubiquitin-like modifiers (SUMOs) regulate many essential cellular functions. Only one type of SUMO-interacting motif (SIM) has been identified that can extend the beta-sheet of SUMO as either a parallel or an antiparallel strand. The molecular determinants of the bound orientation and paralogue specificity of a SIM are unclear. To address this question, we have conducted structural studies of SUMO1 in complex with a SUMO1-specific SIM that binds to SUMO1 with high affinity without post-translational modifications using nuclear magnetic resonance methods. In addition, the SIM sequence requirements have been investigated by peptide arrays in comparison with another high affinity SIM that binds in the opposing orientation. We found that antiparallel binding SIMs tolerate more diverse sequences, whereas the parallel binding SIMs prefer the more strict sequences consisting of (I/V) DLT that have a preference in high affinity SUMO2 and -3 binding. Comparison of two high affinity SUMO1-binding SIMs that bind in opposing orientations has revealed common SUMO1-specific interactions needed for high affinity binding. This study has significantly advanced our understanding of the molecular determinants underlining SUMO-SIM recognition.	[Namanja, Andrew T.; Li, Yi-Jia; Su, Yang; Wong, Steven; Lu, Jingjun; Colson, Loren T.; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Wu, Chenggang; Li, Shawn S. C.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	City of Hope; Beckman Research Institute of City of Hope; Western University (University of Western Ontario)	Chen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ychen@coh.org		Li, Yi-Jia/0000-0002-8791-8097; Namanja, Andrew/0000-0001-8950-8860	National Institutes of Health [R01GM074748, R01GM086171, F32CA134180]; AMMI; NATIONAL CANCER INSTITUTE [F32CA134180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086171, R01GM074748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMMI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074748 and R01GM086171 (to Y. C.) and F32CA134180 (to Y. L.).; Supported by an AMMI grant.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chang PC, 2010, J BIOL CHEM, V285, P5266, DOI 10.1074/jbc.M109.088088; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Escobar-Cabrera E, 2011, J BIOL CHEM, V286, P19816, DOI 10.1074/jbc.M111.231647; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kovrigin EL, 2006, BIOCHEMISTRY-US, V45, P2636, DOI 10.1021/bi0525066; Li SSC, 2009, METHODS MOL BIOL, V570, P67, DOI 10.1007/978-1-60327-394-7_3; Li YJ, 2010, ONCOGENE, V29, P3509, DOI 10.1038/onc.2010.108; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Truong K, 2011, BIOCHEMISTRY-US, V50, P5757, DOI 10.1021/bi2001856; Ulrich HD, 2009, DNA REPAIR, V8, P429, DOI 10.1016/j.dnarep.2009.01.012; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	33	51	53	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3231	3240		10.1074/jbc.M111.293118	http://dx.doi.org/10.1074/jbc.M111.293118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22147707	Green Published, hybrid			2022-12-25	WOS:000300295100028
J	Osborn-Heaford, HL; Ryan, AJ; Murthy, S; Racila, AM; He, C; Sieren, JC; Spitz, DR; Carter, AB				Osborn-Heaford, Heather L.; Ryan, Alan J.; Murthy, Shubha; Racila, Ana-Monica; He, Chao; Sieren, Jessica C.; Spitz, Douglas R.; Carter, A. Brent			Mitochondrial Rac1 GTPase Import and Electron Transfer from Cytochrome c Are Required for Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASBESTOS INDUCES APOPTOSIS; RHO GTPASES; IN-VIVO; REDOX REGULATION; GENE-EXPRESSION; CELL APOPTOSIS; NADPH OXIDASE; TNF-ALPHA; MACROPHAGES; GENERATION	The generation of reactive oxygen species, particularly H2O2, from alveolar macrophages is causally related to the development of pulmonary fibrosis. Rac1, a small GTPase, is known to increase mitochondrial H2O2 generation in macrophages; however, the mechanism by which this occurs is not known. This study shows that Rac1 is localized in the mitochondria of alveolar macrophages from asbestosis patients, and mitochondrial import requires the C-terminal cysteine of Rac1 (Cys-189), which is post-translationally modified by geranylgeranylation. Furthermore, H2O2 generation mediated by mitochondrial Rac1 requires electron transfer from cytochrome c to a cysteine residue on Rac1 (Cys-178). Asbestos-exposed mice harboring a conditional deletion of Rac1 in macrophages demonstrated decreased oxidative stress and were significantly protected from developing pulmonary fibrosis. These observations demonstrate that mitochondrial import and direct electron transfer from cytochrome c to Rac1 modulates mitochondrial H2O2 production in alveolar macrophages pulmonary fibrosis.	[Osborn-Heaford, Heather L.; Ryan, Alan J.; Murthy, Shubha; Racila, Ana-Monica; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA; [He, Chao; Spitz, Douglas R.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA; [Sieren, Jessica C.] Univ Iowa, Carver Coll Med, Dept Radiol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Human Toxicol Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Free Rad & Radiat Biol Program, C33 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu		Sieren, Jessica/0000-0002-1109-7886; Racila, Ana-Monica/0000-0002-5751-5422; Spitz, Douglas/0000-0002-1254-8765	National Institutes of Health [ES015981, ES014871, CA133114, P30 CA086862, UL1RR024979]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA133114, P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981, R01ES014871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES015981 and ES014871(to A. B. C.), CA133114 (to D. R. S.), P30 CA086862 (to University of Iowa Cancer Center), and UL1RR024979 (to University of Iowa Institute of Clinical and Translational Science). This work was also supported by a Merit Review from the Department of Veterans Affairs (to A. B. C.).	Attfield M. D., 2004, Morbidity and Mortality Weekly Report, V53, P627; BOIVIN D, 1995, AM J PHYSIOL-RENAL, V269, pF180, DOI 10.1152/ajprenal.1995.269.2.F180; Broaddus VC, 1996, J CLIN INVEST, V98, P2050, DOI 10.1172/JCI119010; Chade AR, 2008, J HYPERTENS, V26, P1651, DOI 10.1097/HJH.0b013e328302833a; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Deshpande SS, 2003, ARTERIOSCL THROM VAS, V23, pE1, DOI 10.1161/01.ATV.0000047869.13737.53; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Guidotti TL, 2004, AM J RESP CRIT CARE, V170, P691, DOI 10.1164/rccm.200310-1436ST; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hamilton RF, 1996, AM J PHYSIOL-LUNG C, V271, pL813, DOI 10.1152/ajplung.1996.271.5.L813; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heo JY, 2006, BIOCHEMISTRY-US, V45, P14481, DOI 10.1021/bi0610101; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Kamp DW, 2002, MOL CELL BIOCHEM, V234, P153, DOI 10.1023/A:1015949118495; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kowluru A, 2003, ENDOCR RES, V29, P363, DOI 10.1081/ERC-120025043; Li M, 2008, PROTEIN PEPTIDE LETT, V15, P200; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; MOSSMAN BT, 1989, ENVIRON HEALTH PERSP, V81, P91, DOI 10.2307/3430811; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Namati E, 2006, PHYS MED BIOL, V51, P6061, DOI 10.1088/0031-9155/51/23/008; Ostrau C, 2009, RADIOTHER ONCOL, V92, P492, DOI 10.1016/j.radonc.2009.06.020; Ozaki M, 2000, J BIOL CHEM, V275, P35377, DOI 10.1074/jbc.M005287200; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Senger DL, 2002, CANCER RES, V62, P2131; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Thiesse J, 2010, J APPL PHYSIOL, V109, P1960, DOI 10.1152/japplphysiol.01322.2009; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Ueda S, 1998, J IMMUNOL, V161, P6689; Velaithan R, 2011, BLOOD, V117, P6214, DOI 10.1182/blood-2010-08-301283; Watts KL, 2005, AM J RESP CELL MOL, V32, P290, DOI 10.1165/rcmb.2004-0127OC; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200	48	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3301	3312		10.1074/jbc.M111.308387	http://dx.doi.org/10.1074/jbc.M111.308387			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157762	hybrid, Green Published			2022-12-25	WOS:000300295100036
J	Milczarski, P; Bolibok-Bragoszewska, H; Myskow, B; Stojalowski, S; Heller-Uszynska, K; Goralska, M; Bragoszewski, P; Uszynski, G; Kilian, A; Rakoczy-Trojanowska, M				Milczarski, Pawel; Bolibok-Bragoszewska, Hanna; Myskow, Beata; Stojalowski, Stefan; Heller-Uszynska, Katarzyna; Goralska, Magdalena; Bragoszewski, Piotr; Uszynski, Grzegorz; Kilian, Andrzej; Rakoczy-Trojanowska, Monika			A High Density Consensus Map of Rye (Secale cereale L.) Based on DArT Markers	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; POLYMORPHIC DNA RAPD; GENETIC-MAP; DIVERSITY ARRAYS; LINKAGE MAP; GENOME; MICROSATELLITE; LOCI; SSR; RFLP	Background: Rye (Secale cereale L.) is an economically important crop, exhibiting unique features such as outstanding resistance to biotic and abiotic stresses and high nutrient use efficiency. This species presents a challenge to geneticists and breeders due to its large genome containing a high proportion of repetitive sequences, self incompatibility, severe inbreeding depression and tissue culture recalcitrance. The genomic resources currently available for rye are underdeveloped in comparison with other crops of similar economic importance. The aim of this study was to create a highly saturated, multilocus linkage map of rye via consensus mapping, based on Diversity Arrays Technology (DArT) markers. Methodology/Principal Findings: Recombinant inbred lines (RILs) from 5 populations (564 in total) were genotyped using DArT markers and subjected to linkage analysis using Join Map 4.0 and Multipoint Consensus 2.2 software. A consensus map was constructed using a total of 9703 segregating markers. The average chromosome map length ranged from 199.9 cM (2R) to 251.4 cM (4R) and the average map density was 1.1 cM. The integrated map comprised 4048 loci with the number of markers per chromosome ranging from 454 for 7R to 805 for 4R. In comparison with previously published studies on rye, this represents an eight-fold increase in the number of loci placed on a consensus map and a more than two-fold increase in the number of genetically mapped DArT markers. Conclusions/Significance: Through the careful choice of marker type, mapping populations and the use of software packages implementing powerful algorithms for map order optimization, we produced a valuable resource for rye and triticale genomics and breeding, which provides an excellent starting point for more in-depth studies on rye genome organization.	[Milczarski, Pawel; Myskow, Beata; Stojalowski, Stefan; Goralska, Magdalena] W Pomeranian Univ Technol, Dept Plant Genet Breeding & Biotechnol, Szczecin, Poland; [Bolibok-Bragoszewska, Hanna; Rakoczy-Trojanowska, Monika] Warsaw Univ Life Sci, Dept Plant Genet Breeding & Biotechnol, Warsaw, Poland; [Heller-Uszynska, Katarzyna; Uszynski, Grzegorz; Kilian, Andrzej] Divers Arrays Technol PL, Canberra, ACT, Australia; [Bragoszewski, Piotr] Int Inst Mol & Cell Biol, Lab Mitochondrial Biogenesis, Warsaw, Poland	West Pomeranian University of Technology; Warsaw University of Life Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Milczarski, P (corresponding author), W Pomeranian Univ Technol, Dept Plant Genet Breeding & Biotechnol, Szczecin, Poland.	tapatik@yahoo.com	Brągoszewski, Piotr/ABD-7014-2020; Milczarski, Paweł/M-6657-2016; Stojałowski, Stefan/H-2161-2016; Myśków, Beata/H-2024-2016	Brągoszewski, Piotr/0000-0002-9684-6750; Milczarski, Paweł/0000-0003-2622-8938; Stojałowski, Stefan/0000-0002-2666-9090; Myśków, Beata/0000-0001-5062-9841; Bolibok-Bragoszewska, Hanna/0000-0002-8030-2716; Goralska, Magdalena/0000-0003-0219-6281; Rakoczy-Trojanowska, Monika/0000-0001-6891-0471; Kilian, Andrzej/0000-0002-2730-7462	Ministry of Science and Higher Education [NN 302361833]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work has been financially supported by the Ministry of Science and Higher Education [http://www.nauka.gov.pl/home/] grant NN 302361833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Areshchenkova T, 2002, THEOR APPL GENET, V104, P229, DOI 10.1007/s00122-001-0775-2; Badea A, 2011, THEOR APPL GENET, V122, P1547, DOI 10.1007/s00122-011-1554-3; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; BAUM M, 1991, CHROMOSOMA, V101, P1, DOI 10.1007/BF00360680; Bednarek PT, 2003, J APPL GENET, V44, P21; Bolibok H, 2005, EUPHYTICA, V146, P109, DOI 10.1007/s10681-005-0548-0; Bolibok H, 2007, CELL MOL BIOL LETT, V12, P523, DOI 10.2478/s11658-007-0023-0; Bolibok-Bragoszewska H, 2011, CEREAL RES IN PRESS; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Borner A, 1998, THEOR APPL GENET, V97, P1279, DOI 10.1007/s001220051020; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Ferreira A, 2006, GENET MOL BIOL, V29, P187, DOI 10.1590/S1415-47572006000100033; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Hackauf B, 2009, THEOR APPL GENET, V118, P371, DOI 10.1007/s00122-008-0906-0; Hackauf B, 2002, PLANT BREEDING, V121, P17, DOI 10.1046/j.1439-0523.2002.00649.x; Isidore E, 2003, GENETICS, V165, P2107; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Khlestkina EK, 2004, THEOR APPL GENET, V109, P725, DOI 10.1007/s00122-004-1659-z; Korol A, 2009, PLANT GENET GENOMICS, V7, P163, DOI 10.1007/978-0-387-77489-3_6; Korzun V, 2001, THEOR APPL GENET, V102, P709, DOI 10.1007/s001220051701; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Loarce Y, 1996, THEOR APPL GENET, V93, P1112, DOI 10.1007/BF00230133; LUKASZEWSKI AJ, 1982, THEOR APPL GENET, V62, P145, DOI 10.1007/BF00293347; Lumpkin TA, 2010, MOLECULAR PLANT BREEDING, P113, DOI 10.1079/9781845933920.0113; Ma XF, 2001, THEOR APPL GENET, V102, P517, DOI 10.1007/s001220051676; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Madej L. J., 1996, Vortrage fur Pflanzenzuchtung, P1; Masojc P, 2001, THEOR APPL GENET, V102, P1273, DOI 10.1007/s001220000512; Milczarski P, 2010, IDENTIFICATION COMP; Milczarski P, 2007, J APPL GENET, V48, P11, DOI 10.1007/BF03194653; Myskow B, 2010, J APPL GENET, V51, P283; Myskow Beata, 2001, Journal of Applied Genetics, V42, P1; Myskow B, 2012, MOL BREEDING, V30, P367, DOI 10.1007/s11032-011-9627-1; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; PHILIPP U, 1994, THEOR APPL GENET, V88, P243, DOI 10.1007/BF00225904; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Saal B, 1999, GENOME, V42, P964, DOI 10.1139/gen-42-5-964; Schiantarelli E, 2001, THEOR APPL GENET, V102, P335, DOI 10.1007/s001220051650; SCHLEGEL R, 1987, THEOR APPL GENET, V74, P820, DOI 10.1007/BF00247563; Schlegel R, 2008, GENES MARKERS LINKAG; Senft P, 1996, PLANT BREEDING, V115, P508, DOI 10.1111/j.1439-0523.1996.tb00966.x; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Stojalowski Stefan, 2005, Journal of Applied Genetics, V46, P371; Stojalowski S, 2009, CELL MOL BIOL LETT, V14, P190, DOI 10.2478/s11658-008-0042-5; Stojalowski SA, 2011, J APPL GENET, V52, P313, DOI 10.1007/s13353-011-0049-x; Tenhola-Roininen T, 2011, J APPL GENET, V52, P299, DOI 10.1007/s13353-011-0029-1; Tyrka M, 2011, GENOME, V54, P391, DOI [10.1139/g11-009, 10.1139/G11-009]; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Varshney RK, 2007, THEOR APPL GENET, V114, P1105, DOI 10.1007/s00122-007-0504-6; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206	60	61	65	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28495	10.1371/journal.pone.0028495	http://dx.doi.org/10.1371/journal.pone.0028495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163026	gold, Green Submitted, Green Published			2022-12-25	WOS:000298173500027
J	Anderegg, F; Geblinger, D; Horvath, P; Charnley, M; Textor, M; Addadi, L; Geiger, B				Anderegg, Fabian; Geblinger, Dafna; Horvath, Peter; Charnley, Mirren; Textor, Marcus; Addadi, Lia; Geiger, Benjamin			Substrate Adhesion Regulates Sealing Zone Architecture and Dynamics in Cultured Osteoclasts	PLOS ONE			English	Article							CELL-MATRIX ADHESIONS; EXTRACELLULAR-MATRIX; MECHANOSENSORY FUNCTION; INTEGRIN; PODOSOMES; GROWTH; DIFFERENTIATION; ORGANIZATION; RESORPTION; TURNOVER	The bone-degrading activity of osteoclasts depends on the formation of a cytoskeletal-adhesive super-structure known as the sealing zone (SZ). The SZ is a dynamic structure, consisting of a condensed array of podosomes, the elementary adhesion-mediating structures of osteoclasts, interconnected by F-actin filaments. The molecular composition and structure of the SZ were extensively investigated, yet despite its major importance for bone formation and remodelling, the mechanisms underlying its assembly and dynamics are still poorly understood. Here we determine the relations between matrix adhesiveness and the formation, stability and expansion of the SZ. By growing differentiated osteoclasts on micro-patterned glass substrates, where adhesive areas are separated by non-adhesive PLL-g-PEG barriers, we show that SZ growth and fusion strictly depend on the continuity of substrate adhesiveness, at the micrometer scale. We present a possible model for the role of mechanical forces in SZ formation and reorganization, inspired by the current data.	[Anderegg, Fabian; Charnley, Mirren; Textor, Marcus] Swiss Fed Inst Technol, Lab Surface Sci & Technol, Dept Mat, Zurich, Switzerland; [Geblinger, Dafna; Addadi, Lia] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Anderegg, Fabian; Geblinger, Dafna; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Horvath, Peter] Swiss Fed Inst Technol, Dept Biol, Light Microscopy Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Weizmann Institute of Science; Weizmann Institute of Science; Swiss Federal Institutes of Technology Domain; ETH Zurich	Anderegg, F (corresponding author), Swiss Fed Inst Technol, Lab Surface Sci & Technol, Dept Mat, Zurich, Switzerland.	benny.geiger@weizmann.ac.il	Textor, Marcus/A-6200-2012	Textor, Marcus/0000-0002-0178-1801; Charnley, Mirren/0000-0003-3845-9290	Israel Science Foundation; Swiss Society of Friends of the Weizmann Institute of Science; Eidgenossische Technische Hochshule Zurich [TH-31 06-2]; European Union [FP7/2007-2013, 237946]	Israel Science Foundation(Israel Science Foundation); Swiss Society of Friends of the Weizmann Institute of Science; Eidgenossische Technische Hochshule Zurich; European Union(European Commission)	This study was supported by grants from the Israel Science Foundation and the Swiss Society of Friends of the Weizmann Institute of Science. Additionally, financial support by Eidgenossische Technische Hochshule Zurich (grant No. TH-31 06-2) and the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 237946 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Falconnet D, 2004, ADV FUNCT MATER, V14, P749, DOI 10.1002/adfm.200305182; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Geblinger D, 2011, J ROYAL SOC IN PRESS; Geblinger D, 2010, J CELL SCI, V123, P1503, DOI 10.1242/jcs.060954; Geblinger D, 2009, CHEMBIOCHEM, V10, P158, DOI 10.1002/cbic.200800549; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P751, DOI 10.1007/s00198-006-0298-4; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Jimi E, 1999, J IMMUNOL, V163, P434; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura I, 1996, J BONE MINER RES, V11, P1873; NERMUT MV, 1991, EXP CELL RES, V193, P382, DOI 10.1016/0014-4827(91)90111-7; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Pfaff M, 2001, J CELL SCI, V114, P2775; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; SHIMIZU H, 1989, BONE MINER, V6, P261, DOI 10.1016/0169-6009(89)90033-0; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vaananen HK, 2000, J CELL SCI, V113, P377; VAANANEN HK, 1988, ANN CHIR GYNAECOL FE, V77, P193; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; ZALLONE AZ, 1989, CONNECT TISSUE RES, V20, P143, DOI 10.3109/03008208909023882; ZAMBONINZALLONE A, 1989, EXP CELL RES, V182, P645, DOI 10.1016/0014-4827(89)90266-8; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zimerman B, 2004, IEE Proc Nanobiotechnol, V151, P62, DOI 10.1049/ip-nbt:20040474	60	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28583	10.1371/journal.pone.0028583	http://dx.doi.org/10.1371/journal.pone.0028583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162778	Green Published, gold, Green Submitted			2022-12-25	WOS:000298172800049
J	Beyersdorf, N; Werner, S; Wolf, N; Herrmann, T; Kerkau, T				Beyersdorf, Niklas; Werner, Sandra; Wolf, Nelli; Herrmann, Thomas; Kerkau, Thomas			Characterization of a New Mouse Model for Peripheral T Cell Lymphoma in Humans	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CYTOKINE STORM; RELEASE; DISEASE; MICE	Peripheral T cell lymphomas (PTCLs) are associated with a poor prognosis due to often advanced disease at the time of diagnosis and due to a lack of efficient therapeutic options. Therefore, appropriate animal models of PTCL are vital to improve clinical management of this disease. Here, we describe a monoclonal CD8(+) CD4(-) alpha beta T cell receptor V beta 2(+) CD28(+) T cell lymphoma line, termed T8-28. T8-28 cells were isolated from an un-manipulated adult BALB/c mouse housed under standard pathogen-free conditions. T8-28 cells induced terminal malignancy upon adoptive transfer into syngeneic BALB/c mice. Despite intracellular expression of the cytotoxic T cell differentiation marker granzyme B, T8-28 cells appeared to be defective with respect to cytotoxic activity as read-out in vitro. Among the protocols tested, only addition of interleukin 2 in vitro could partially compensate for the in vivo micro-milieu in promoting growth of the T8-28 lymphoma cells.	[Beyersdorf, Niklas; Werner, Sandra; Wolf, Nelli; Herrmann, Thomas; Kerkau, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany	University of Wurzburg	Beyersdorf, N (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	niklas.beyersdorf@vim.uni-wuerzburg.de	Kerkau, Thomas/ABE-8007-2020; Beyersdorf, Niklas/S-3845-2016; Herrmann, Thomas/J-4943-2012	Beyersdorf, Niklas/0000-0002-9236-5415; Herrmann, Thomas/0000-0002-1093-0194	Wilhelm Sander-Stiftung [2005.133.1, 2005.133.2]; The Deutsche Forschungsgemeinschaft	Wilhelm Sander-Stiftung; The Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Wilhelm Sander-Stiftung (2005.133.1 and 2005.133.2; http://www.sanst.de). The Deutsche Forschungsgemeinschaft (http://www.dfg.de) supported the publication of this article as 'open access'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Aschan J, 2006, BRIT MED BULL, V77-78, P23, DOI 10.1093/bmb/ldl005; Beyersdorf N, 2008, BLOOD, V112, P4328, DOI 10.1182/blood-2008-03-146662; Beyersdorf N, 2009, BLOOD, V114, P4575, DOI 10.1182/blood-2009-04-218248; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Gogishvili T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004643; GOLDMAN M, 1989, LANCET, V2, P802; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; Kolb HJ, 2004, BLOOD, V103, P767, DOI 10.1182/blood-2003-02-0342; Mulloy JC, 2010, J EXP MED, V207, P911, DOI 10.1084/jem.20100608; Pechloff K, 2010, J EXP MED, V207, P1031, DOI 10.1084/jem.20092042; Savage KJ, 2007, BLOOD REV, V21, P201, DOI 10.1016/j.blre.2007.03.001; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; van Hall T, 2000, J IMMUNOL, V165, P869, DOI 10.4049/jimmunol.165.2.869	16	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28546	10.1371/journal.pone.0028546	http://dx.doi.org/10.1371/journal.pone.0028546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163033	gold, Green Published, Green Submitted			2022-12-25	WOS:000298172800046
J	Dubey, R; Chhabra, R; Saini, N				Dubey, Richa; Chhabra, Ravindresh; Saini, Neeru			Small Interfering RNA against Transcription Factor STAT6 Leads to Increased Cholesterol Synthesis in Lung Cancer Cell Lines	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; SIGNAL TRANSDUCER; HODGKIN LYMPHOMA; GENE-EXPRESSION; FORK HEAD; APOPTOSIS; MICE; INTERLEUKIN-4; ACTIVATION; RESPONSES	STAT6 transcription factor has become a potential molecule for therapeutic intervention because it regulates broad range of cellular processes in a large variety of cell types. Although some target genes and interacting partners of STAT6 have been identified, its exact mechanism of action needs to be elucidated. In this study, we sought to further characterize the molecular interactions, networks, and functions of STAT6 by profiling the mRNA expression of STAT6 silenced human lung cells (NCI-H460) using microarrays. Our analysis revealed 273 differentially expressed genes after STAT6 silencing. Analysis of the gene expression data with Ingenuity Pathway Analysis (IPA) software revealed Gene expression, Cell death, Lipid metabolism as the functions associated with highest rated network. Cholesterol biosynthesis was among the most enriched pathways in IPA as well as in PANTHER analysis. These results have been validated by real-time PCR and cholesterol assay using scrambled siRNA as a negative control. Similar findings were also observed with human type II pulmonary alveolar epithelial cells, A549. In the present study we have, for the first time, shown the inverse relationship of STAT6 with the cholesterol biosynthesis in lung cancer cells. The present findings are potentially significant to advance the understanding and design of therapeutics for the pathological conditions where both STAT6 and cholesterol biosynthesis are implicated viz. asthma, atherosclerosis etc.	[Dubey, Richa; Chhabra, Ravindresh; Saini, Neeru] Inst Genom & Integrat Biol CSIR, Funct Genom Unit, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Dubey, R (corresponding author), Inst Genom & Integrat Biol CSIR, Funct Genom Unit, Delhi, India.	nsaini@igib.in	Chhabra, Ravindresh/GSE-1747-2022; Chhabra, Ravindresh/X-5251-2018; Chhabra, Ravindresh/AAM-4994-2021	Chhabra, Ravindresh/0000-0002-2734-7368; 	Department of Biotechnology (DBT) [GAP0047]; DBT [GAP0047]; CSIR (Council of Scientific and Industrial Research)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); CSIR (Council of Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the Department of Biotechnology (DBT) for funding the project titled 'Study of STAT6 transcription factor in apoptosis regulation using RNAi Technology' (GAP0047). RD was financially supported by DBT project GAP0047. RC was supported with CSIR-Senior Research Fellowship (Council of Scientific and Industrial Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Aprahamian T, 2006, J IMMUNOL, V177, P3028, DOI 10.4049/jimmunol.177.5.3028; Bailey DP, 2004, EXP HEMATOL, V32, P52, DOI 10.1016/j.exphem.2003.10.011; Baus D, 2009, LEUKEMIA, V23, P1885, DOI 10.1038/leu.2009.103; Black HES NJ, 1993, USE INTERLEUKIN 4 LO; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Cui X, 2007, ONCOGENE, V26, P4253, DOI 10.1038/sj.onc.1210222; Darcan-Nicolaisen Y, 2009, J IMMUNOL, V182, P7501, DOI 10.4049/jimmunol.0713433; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fessler MB, 2009, J ALLERGY CLIN IMMUN, V124, P967, DOI 10.1016/j.jaci.2009.08.005; Gomez-Ferreria MA, 2003, J MOL BIOL, V329, P631, DOI 10.1016/S0022-2836(03)00524-2; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Iff J, 2009, J PROTEOME RES, V8, P4511, DOI 10.1021/pr9003272; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1998, MOL CELL BIOL, V18, P1996, DOI 10.1128/MCB.18.4.1996; Kato A, 2000, INFLAMM RES, V49, P275, DOI 10.1007/PL00000207; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; King VL, 2002, J LIPID RES, V43, P768; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Li BH, 2008, BIOCHEM BIOPH RES CO, V369, P554, DOI 10.1016/j.bbrc.2008.02.052; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Martin-de-Lara F, 2008, TRANSGENIC RES, V17, P1131, DOI 10.1007/s11248-008-9214-3; Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Ni ZY, 2002, J UROLOGY, V167, P1859, DOI 10.1016/S0022-5347(05)65249-4; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pandey AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009063; Perez-Sanchez C, 2000, J BIOL CHEM, V275, P12909, DOI 10.1074/jbc.275.17.12909; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Yap YL, 2005, NUCLEIC ACIDS RES, V33, P409, DOI 10.1093/nar/gki188; Yu HH, 2010, LUPUS, V19, P1219, DOI 10.1177/0961203310371152; Zhang MS, 2006, CHINESE MED J-PEKING, V119, P801, DOI 10.1097/00029330-200605020-00002; Zhang MS, 2006, CANCER LETT, V243, P38, DOI 10.1016/j.canlet.2005.11.020; Zheng JS, 2003, NUCLEIC ACIDS RES, V31, P1995, DOI 10.1093/nar/gkg287; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	47	16	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28509	10.1371/journal.pone.0028509	http://dx.doi.org/10.1371/journal.pone.0028509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162773	gold, Green Published, Green Submitted			2022-12-25	WOS:000298172800043
J	Sato, Y; Watanabe, N; Fukushima, N; Mita, S; Hirata, T				Sato, Yasufumi; Watanabe, Naoki; Fukushima, Nanae; Mita, Sakura; Hirata, Tatsumi			Actin-Independent Behavior and Membrane Deformation Exhibited by the Four-Transmembrane Protein M6a	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MU-OPIOID RECEPTOR; PROTEOLIPID PROTEIN; GLYCOPROTEIN M6A; LIPID RAFTS; CNS MYELIN; GENE FAMILY; SIGNAL-TRANSDUCTION; NEURITE OUTGROWTH; CELL-MEMBRANE	M6a is a four-transmembrane protein that is abundantly expressed in the nervous system. Previous studies have shown that over-expression of this protein induces various cellular protrusions, such as neurites, filopodia, and dendritic spines. In this detailed characterization of M6a-induced structures, we found their varied and peculiar characteristics. Notably, the M6a-induced protrusions were mostly devoid of actin filaments or microtubules and exhibited free random vibrating motion. Moreover, when an antibody bound to M6a, the membrane-wrapped protrusions were suddenly disrupted, leading to perturbation of the surrounding membrane dynamics involving phosphoinositide signaling. During single-molecule analysis, M6a exhibited cytoskeleton-independent movement and became selectively entrapped along the cell perimeter in an actin-independent manner. These observations highlight the unusual characteristics of M6a, which may have a significant yet unappreciated role in biological systems.	[Sato, Yasufumi; Mita, Sakura; Hirata, Tatsumi] Grad Univ Adv Studies Sokendai, Natl Inst Genet, Div Brain Funct, Mishima, Shizuoka, Japan; [Watanabe, Naoki] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Sendai, Miyagi 980, Japan; [Fukushima, Nanae] Shinshu Univ, Sch Med, Dept Anat, Matsumoto, Nagano 390, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tohoku University; Shinshu University	Sato, Y (corresponding author), Natl Inst Basic Biol, Div Embryol, Okazaki, Aichi 444, Japan.	tathirat@lab.nig.ac.jp	Sato, Yasufumi/AAF-3367-2019		Ministry of Education, Sports, Science and Technology; Japan Science and Technology Agency [20500298, 18500250]; Next Program [LS013]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23657151] Funding Source: KAKEN	Ministry of Education, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Next Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Sports, Science and Technology and the Japan Science and Technology Agency (20500298, 18500250) that were awarded to T.H. This work was also supported by the Next Program grant (LS013) and a grant from Takeda Science Foundation that were awarded to N.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cooper B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003659; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DIAZ RS, 1990, J NEUROCHEM, V55, P1304, DOI 10.1111/j.1471-4159.1990.tb03139.x; Earle WR, 1943, J NATL CANCER I, V4, P165; Fernandez ME, 2010, J NEUROSCI RES, V88, P1298, DOI 10.1002/jnr.22298; Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2; Fjorback AW, 2009, J MOL NEUROSCI, V37, P191, DOI 10.1007/s12031-008-9092-4; Fuchsova B, 2009, J BIOL CHEM, V284, P32075, DOI 10.1074/jbc.M109.012377; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gow A, 1997, J NEUROSCI, V17, P181, DOI 10.1523/JNEUROSCI.17-01-00181.1997; Gow A, 1997, J NEUROSCI RES, V50, P659, DOI 10.1002/(SICI)1097-4547(19971201)50:5<659::AID-JNR3>3.0.CO;2-G; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; INOUYE H, 1991, J NEUROSCI RES, V28, P1, DOI 10.1002/jnr.490280102; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KLEBE RJ, 1969, J CELL BIOL, V43, P69; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Ko M, 2005, J BIOL CHEM, V280, P42759, DOI 10.1074/jbc.M509164200; Kramer-Albers EM, 2006, J NEUROSCI, V26, P11743, DOI 10.1523/JNEUROSCI.3581-06.2006; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; Liang YJ, 2008, CELL RES, V18, P768, DOI 10.1038/cr.2008.71; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Michibata H, 2008, STEM CELLS DEV, V17, P641, DOI 10.1089/scd.2008.0088; Mobius W, 2008, NEURON GLIA BIOL, V4, P111, DOI 10.1017/S1740925X0900009X; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nozumi M, 2003, J CELL SCI, V116, P239, DOI 10.1242/jcs.00233; Palaniyar N, 1998, BBA-BIOMEMBRANES, V1415, P85, DOI 10.1016/S0005-2736(98)00180-1; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; Sato Y, 2011, DEV NEUROBIOL, V71, P733, DOI 10.1002/dneu.20941; Scorticati C, 2011, J NEUROCHEM, DOI [10.1111/j.1471-4159.2011.07252.x, DOI 10.1111/J.1471-4159.2011.07252.X]; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SHEETZ MP, 1989, NATURE, V340, P284, DOI 10.1038/340284a0; SHEETZ MP, 1990, CELL, V61, P231, DOI 10.1016/0092-8674(90)90804-N; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Stecca B, 2000, J NEUROSCI, V20, P4002; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; van Meer G, 2005, EMBO REP, V6, P418, DOI 10.1038/sj.embor.7400410; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; Yamatani H, 2010, DEV NEUROBIOL, V70, P523, DOI 10.1002/dneu.20794; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2; YONEMURA S, 1995, J CELL SCI, V108, P127; Zhao J, 2008, MOL VIS, V14, P1623	65	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e26702	10.1371/journal.pone.0026702	http://dx.doi.org/10.1371/journal.pone.0026702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162747	Green Published, gold, Green Submitted			2022-12-25	WOS:000298172800002
J	Saito, H; Takeuchi, M; Chida, K; Miyajima, A				Saito, Hiroki; Takeuchi, Masaki; Chida, Kazuhiro; Miyajima, Atsushi			Generation of Glucose-Responsive Functional Islets with a Three-Dimensional Structure from Mouse Fetal Pancreatic Cells and iPS Cells In Vitro	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CELLS; KEY ROLE; DIFFERENTIATION; INSULIN; ENDOCRINE; ENDODERM; CLUSTERS; QUANTIFICATION; HEPATOBLASTS	Islets of Langerhans are a pancreatic endocrine compartment consisting of insulin-producing beta cells together with several other hormone-producing cells. While some insulin-producing cells or immature pancreatic cells have been generated in vitro from ES and iPS cells, islets with proper functions and a three-dimensional (3D) structure have never been successfully produced. To test whether islets can be formed in vitro, we first examined the potential of mouse fetal pancreatic cells. We found that E16.5 pancreatic cells, just before forming islets, were able to develop cell aggregates consisting of beta cells surrounded by glucagon-producing alpha cells, a structure similar to murine adult islets. Moreover, the transplantation of these cells improved blood glucose levels in hyperglycemic mice. These results indicate that functional islets are formed in vitro from fetal pancreatic cells at a specific developmental stage. By adopting these culture conditions to the differentiation of mouse iPS cells, we developed a two-step system to generate islets, i.e. immature pancreatic cells were first produced from iPS cells, and then transferred to culture conditions that allowed the formation of islets from fetal pancreatic cells. The islets exhibited distinct 3D structural features similar to adult pancreatic islets and secreted insulin in response to glucose concentrations. Transplantation of the islets improved blood glucose levels in hyperglycemic mice. In conclusion, the two-step culture system allows the generation of functional islets with a 3D structure from iPS cells.	[Saito, Hiroki; Takeuchi, Masaki; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Saito, Hiroki; Chida, Kazuhiro] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Saito, H (corresponding author), Shionogi & Co Ltd, Shionogi Innovat Ctr Drug Discovery, Innovat Drug Discovery Res Labs, Sapporo, Hokkaido, Japan.	hiroki.saito@shionogi.co.jp; miyajima@iam.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Takeda Science Foundation; JST	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); JST(Japan Science & Technology Agency (JST))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Core Research for Evolutional Science and Technology (CREST) project and the project for realization of regenerative medicine from the Japan Science and Technology Agency (JST), and Takeda Science Foundation. H.S. was supported by the project to promote a career path for research personnel of academia and accelerate technology transfer of JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Castaing M, 2005, DEV DYNAM, V234, P339, DOI 10.1002/dvdy.20547; Castaing M, 2001, DIABETOLOGIA, V44, P2066, DOI 10.1007/s001250100012; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Hara A, 2007, DEV DYNAM, V236, P3451, DOI 10.1002/dvdy.21359; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Miralles F, 1998, DEVELOPMENT, V125, P1017; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Paek HJ, 2005, CLONING STEM CELLS, V7, P226, DOI 10.1089/clo.2005.7.226; Paek HJ, 2005, STEM CELLS, V23, P862, DOI 10.1634/stemcells.2004-0288; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; Rajagopal J, 2003, SCIENCE, V299, P363; Sipione S, 2004, DIABETOLOGIA, V47, P499, DOI 10.1007/s00125-004-1349-z; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Suzuki A, 2002, CELL TRANSPLANT, V11, P451; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	32	34	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28209	10.1371/journal.pone.0028209	http://dx.doi.org/10.1371/journal.pone.0028209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145030	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168900013
J	Llorens-Martin, M; Trejo, JL				Llorens-Martin, Maria; Trejo, Jose L.			Mifepristone Prevents Stress-Induced Apoptosis in Newborn Neurons and Increases AMPA Receptor Expression in the Dentate Gyrus of C57/BL6 Mice	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC FACTOR TRANSCRIPTS; GENERATED GRANULE CELLS; GLUCOCORTICOID-RECEPTOR; OXIDATIVE STRESS; PSYCHOSOCIAL STRESS; PROTEIN EXPRESSION; ADRENAL-STEROIDS; MAJOR DEPRESSION; PROGENITOR CELLS	Chronic stress produces sustained elevation of corticosteroid levels, which is why it is considered one of the most potent negative regulators of adult hippocampal neurogenesis (AHN). Several mood disorders are accompanied by elevated glucocorticoid levels and have been linked to alterations in AHN, such as major depression (MD). Nevertheless, the mechanism by which acute stress affects the maturation of neural precursors in the dentate gyrus is poorly understood. We analyzed the survival and differentiation of 1 to 8 week-old cells in the dentate gyrus of female C57/BL6 mice following exposure to an acute stressor (the Porsolt or forced swimming test). Furthermore, we evaluated the effects of the glucocorticoid receptor (GR) antagonist mifepristone on the cell death induced by the Porsolt test. Forced swimming induced selective apoptotic cell death in 1 week-old cells, an effect that was abolished by pretreatment with mifepristone. Independent of its antagonism of GR, mifepristone also induced an increase in the percentage of 1 week-old cells that were AMPA(+). We propose that the induction of AMPA receptor expression in immature cells may mediate the neuroprotective effects of mifepristone, in line with the proposed antidepressant effects of AMPA receptor potentiators.	[Llorens-Martin, Maria; Trejo, Jose L.] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Llorens-Martin, Maria; Trejo, Jose L.] Ctr Investigac Red Enfermedades Neurodegenerat CI, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Llorens-Martin, M (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	mllorens@cbm.uam.es	Trejo, Jose Luis/F-5518-2016; Llorens-Martin, Maria/R-4613-2017	Llorens-Martin, Maria/0000-0001-9129-5198	Ministerio de Educacion y Ciencia [BFU2007-60195/BFI, BFU2010-20396]	Ministerio de Educacion y Ciencia(Spanish Government)	This work was funded by grant BFU2007-60195/BFI and BFU2010-20396 from Ministerio de Educacion y Ciencia to Jose Luis Trejo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2006, J NEUROSCI, V26, P3951, DOI 10.1523/JNEUROSCI.4901-05.2006; Alonso R, 2004, MOL PSYCHIATR, V9, P278, DOI 10.1038/sj.mp.4001464; Ambrogini P, 2006, ARCH ITAL BIOL, V144, P115; Autry AE, 2006, NEUROENDOCRINOLOGY, V83, P371, DOI 10.1159/000096092; Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Behl C, 1997, EUR J NEUROSCI, V9, P912, DOI 10.1111/j.1460-9568.1997.tb01442.x; Belanoff JK, 2002, BIOL PSYCHIAT, V52, P386, DOI 10.1016/S0006-3223(02)01432-4; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Boyer PA, 1998, J MOL NEUROSCI, V10, P219, DOI 10.1007/BF02761776; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; CAMERON HA, 1993, BRAIN RES, V611, P342, DOI 10.1016/0006-8993(93)90524-Q; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DeBattista C, 2006, BIOL PSYCHIAT, V60, P1343, DOI 10.1016/j.biopsych.2006.05.034; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Dhikav V, 2007, MED HYPOTHESES, V68, P1088, DOI 10.1016/j.mehy.2006.09.038; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2005, NEUROBIOL AGING, V26, pS88, DOI 10.1016/j.neurobiolaging.2005.08.018; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Elizalde N, 2010, PSYCHOPHARMACOLOGY, V210, P393, DOI 10.1007/s00213-010-1835-6; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fitzsimons CP, 2009, MINI-REV MED CHEM, V9, P249, DOI 10.2174/138955709787316001; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; GOULD E, 1991, J COMP NEUROL, V313, P479, DOI 10.1002/cne.903130308; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Gould E, 1997, J NEUROSCI, V17, P2492; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Joels M, 2007, PROG BRAIN RES, V163, P355, DOI 10.1016/S0079-6123(07)63021-0; Karasawa J, 2005, BRAIN RES, V1042, P92, DOI 10.1016/j.brainres.2005.02.032; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Korte SM, 1996, EUR J PHARMACOL, V301, P19, DOI 10.1016/0014-2999(96)00064-7; Kronenberg G, 2009, EUR ARCH PSY CLIN N, V259, P499, DOI 10.1007/s00406-009-0036-y; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107; Leverenz JB, 1999, J NEUROSCI, V19, P2356; Li WZ, 2010, EUR J PHARMACOL, V628, P108, DOI 10.1016/j.ejphar.2009.11.045; Li X, 2001, NEUROPHARMACOLOGY, V40, P1028, DOI 10.1016/S0028-3908(00)00194-5; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; Llorens-Martin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012188; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; LOWY MT, 1995, J NEUROCHEM, V65, P268; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; LUINE V, 1994, ANN NY ACAD SCI, V746, P403; Lussier AL, 2009, NEUROSCI LETT, V460, P170, DOI 10.1016/j.neulet.2009.05.050; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; Martinez-Turrillas R, 2007, BIOCHEM BIOPH RES CO, V353, P750, DOI 10.1016/j.bbrc.2006.12.078; Mayer JL, 2006, J NEUROENDOCRINOL, V18, P629, DOI 10.1111/j.1365-2826.2006.01455.x; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MURPHY BEP, 1993, J PSYCHIATR NEUROSCI, V18, P209; Nair A, 2007, NEUROPSYCHOPHARMACOL, V32, P1504, DOI 10.1038/sj.npp.1301276; Nihalani ND, 2007, CURR OPIN INVEST DR, V8, P563; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Overstreet DH, 2004, EUR J PHARMACOL, V497, P49, DOI 10.1016/j.ejphar.2004.06.035; Papp Mariusz, 1993, Polish Journal of Pharmacology, V45, P549; Peeters BWMM, 2008, ANN NY ACAD SCI, V1148, P536, DOI 10.1196/annals.1410.072; Pfaffl MW, 2010, METHODS, V50, P215, DOI 10.1016/j.ymeth.2010.02.005; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Quirarte GL, 2009, LEARN MEMORY, V16, P586, DOI 10.1101/lm.1493609; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sousa N, 2002, REV NEUROSCIENCE, V13, P59; Sousa N, 2008, BRAIN RES REV, V57, P561, DOI 10.1016/j.brainresrev.2007.06.007; Sterner EY, 2010, PROG NEURO-PSYCHOPH, V34, P777, DOI 10.1016/j.pnpbp.2010.03.005; Su XWW, 2009, PSYCHOPHARMACOLOGY, V206, P215, DOI 10.1007/s00213-009-1598-0; Suppiramaniam V, 2001, SYNAPSE, V40, P154, DOI 10.1002/syn.1037; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; Tata DA, 2010, PHYSIOL BEHAV, V99, P186, DOI 10.1016/j.physbeh.2009.09.008; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Thomas RM, 2006, EXP NEUROL, V201, P308, DOI 10.1016/j.expneurol.2006.04.010; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VELDHUIS HD, 1985, EUR J PHARMACOL, V115, P211, DOI 10.1016/0014-2999(85)90693-4; Voss OP, 2007, NEUROPHARMACOLOGY, V52, P590, DOI 10.1016/j.neuropharm.2006.09.001; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; You JM, 2009, CAN J PHYSIOL PHARM, V87, P440, DOI [10.1139/y09-027, 10.1139/Y09-027]; Zarate CA, 2003, ANN NY ACAD SCI, V1003, P273, DOI 10.1196/annals.1300.017; Zarate CA, 2008, EXP NEUROL, V211, P7, DOI 10.1016/j.expneurol.2008.01.011	111	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28376	10.1371/journal.pone.0028376	http://dx.doi.org/10.1371/journal.pone.0028376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140582	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100068
J	Lannergard, J; Cao, S; Norstrom, T; Delgado, A; Gustafson, JE; Hughes, D				Lannergard, Jonas; Cao, Sha; Norstrom, Tobias; Delgado, Alejandro; Gustafson, John E.; Hughes, Diarmaid			Genetic Complexity of Fusidic Acid-Resistant Small Colony Variants (SCV) in Staphylococcus aureus	PLOS ONE			English	Article							HEMB MUTANTS; PHENOTYPE; INFECTIONS; PERSISTENT; MENADIONE; IDENTIFICATION; DETERMINANTS; MUTATIONS; MEND; SITE	FusE mutants are fusidic acid-resistant small colony variants (SCVs) of Staphylococcus aureus that can be selected with aminoglycosides. All FusE SCVs have mutations in rplF, encoding ribosomal protein L6. However, individual FusE mutants including some with the same mutation in rplF display auxotrophy for either hemin or menadione, suggesting that additional mutations are involved. Here we show that FusE SCVs can be divided into three genetic sub-groups and that some carry an additional mutation, in one of the genes required for hemin biosynthesis, or in one of the genes required for menadione biosynthesis. Reversion analysis and genome sequencing support the hypothesis that these combinations of mutations in the rplF, hem, and/or men genes can account for the SCV and auxotrophic phenotypes of FusE mutants.	[Lannergard, Jonas; Norstrom, Tobias] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Cao, Sha; Hughes, Diarmaid] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Delgado, Alejandro; Gustafson, John E.] New Mexico State Univ, Dept Biol, Microbiol Grp, Las Cruces, NM 88003 USA	Uppsala University; Uppsala University; New Mexico State University	Lannergard, J (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	diarmaid.hughes@imbim.uu.se	Lannergård, Jonas/L-6513-2013; Hughes, Diarmaid/A-9487-2014	Hughes, Diarmaid/0000-0002-7456-9182; Lannergard, Jonas/0000-0001-9072-6486	Swedish Science Research Council (VR); European Union; Vinnova [P35553-1]; SSF [(RBa08-0063)-JL]; Carl Trygger Foundation-JEG; National Institutes of Health [SC1GM083882-01, R25 GM07667-30, S06 GM61222-05]; National Center for Research Resources [P20RR016480]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061222, T34GM007667] Funding Source: NIH RePORTER	Swedish Science Research Council (VR)(Swedish Research Council); European Union(European Commission); Vinnova(Vinnova); SSF(Swedish Foundation for Strategic Research); Carl Trygger Foundation-JEG; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DH acknowledges support from the Swedish Science Research Council (VR), the European Union (FP6 and FP7 programmes; projects EAR and PAR), Vinnova (P35553-1), and SSF (RBa08-0063)-JL and SC were each supported by postdoctoral stipends from the Carl Trygger Foundation-JEG and AD acknowledges support from the National Institutes of Health: SC1GM083882-01; R25 GM07667-30 (NMSU-MARC PROGRAM); S06 GM61222-05 (NMSU-MBRS-RISE PROGRAM); and P20RR016480 from the NM-INBRE Program of the National Center for Research Resources-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; BALWIT JM, 1994, J INFECT DIS, V170, P1033, DOI 10.1093/infdis/170.4.1033; Bates DM, 2003, J INFECT DIS, V187, P1654, DOI 10.1086/374642; Besier S, 2007, INT J MED MICROBIOL, V297, P217, DOI 10.1016/j.ijmm.2007.02.003; Chatterjee I, 2008, J BACTERIOL, V190, P834, DOI 10.1128/JB.00912-07; CHOPRA I, 1976, J GEN MICROBIOL, V96, P229, DOI 10.1099/00221287-96-2-229; Chuard C, 1997, J ANTIMICROB CHEMOTH, V39, P603, DOI 10.1093/jac/39.5.603; Clements MO, 1999, J BACTERIOL, V181, P501, DOI 10.1128/JB.181.2.501-507.1999; Jonsson IM, 2003, MICROB PATHOGENESIS, V34, P73, DOI 10.1016/S0882-4010(02)00208-5; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Lannergard J, 2009, ANTIMICROB AGENTS CH, V53, P2059, DOI 10.1128/AAC.00871-08; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; O'Brien FG, 2002, J ANTIMICROB CHEMOTH, V50, P313, DOI 10.1093/jac/dkf153; O'Neill AJ, 2007, ANTIMICROB AGENTS CH, V51, P1737, DOI 10.1128/AAC.01542-06; O'Neill AJ, 2007, J CLIN MICROBIOL, V45, P1505, DOI 10.1128/JCM.01984-06; O'Neill AJ, 2006, MOL MICROBIOL, V59, P664, DOI 10.1111/j.1365-2958.2005.04971.x; PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Schaaff F, 2003, INT J MED MICROBIOL, V293, P427, DOI 10.1078/1438-4221-00282; von Eiff C, 2006, J BACTERIOL, V188, P687, DOI 10.1128/JB.188.2.687-693.2006; von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997	24	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28366	10.1371/journal.pone.0028366	http://dx.doi.org/10.1371/journal.pone.0028366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140579	Green Submitted, gold, Green Published			2022-12-25	WOS:000298166300050
J	Roy, SG; Raikhel, AS				Roy, Saurabh G.; Raikhel, Alexander S.			Nutritional and hormonal regulation of the TOR effector 4E-binding protein (4E-BP) in the mosquito Aedes aegypti	FASEB JOURNAL			English	Article						amino acids; insulin; translation; blood-feeding insect	TRANSLATION INITIATION; JUVENILE-HORMONE; INSULIN; DROSOPHILA; DOWNSTREAM; FOXO; STRESS; TARGET; VITELLOGENIN; TRANSDUCTION	Mosquitoes require blood for egg development, and, as a consequence, they transmit pathogens of devastating diseases. Target of rapamycin (TOR) signaling is a key pathway linking blood feeding and egg development in the mosquito Aedes aegypti. We show that the regulation of the TOR effector translational repressor 4E-BP is finely tuned to the nutritional requirements of the female mosquito, and it occurs at transcriptional and post-translational levels. Immediately after blood feeding, 4E-BP became hyperphosphorylated, suggesting rapid inhibition of its translational repression function. 4E-BP was highly phosphorylated after in vitro incubation of the fat body in the presence of amino acids; this phosphorylation was rapamycin insensitive, in contrast to another TOR target, S6K, phosphorylation of which was rapamycin sensitive. A high level of 4E-BP phosphorylation was also elicited by insulin. Rapamycin and the PI3K inhibitor LY294002 blocked insulin-mediated 4E-BP phosphorylation. RNA-interference depletion of the insulin receptor or Akt resulted in severe reduction of 4E-BP phosphorylation. Phosphorylation and stability of 4E-BP was dependent on its partner eIF4E translation initiation factor. Silencing of 4E-BP resulted in reduction of the life span of adult female mosquitoes. This study demonstrates a dual nutritional and hormonal control of 4E-BP and its role in mosquito egg development.-Roy, S. G., Raikhel, A. S. Nutritional and hormonal regulation of the TOR effector 4E-binding protein (4E-BP) in the mosquito Aedes aegypti. FASEB J. 26, 1334-1342 (2012). www.fasebj.org	[Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, 900 Univ Ave, Riverside, CA 92521 USA.	araikhel@ucr.edu			U.S. National Institutes of Health [R37 AI24716]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024716] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health grant R37 AI24716 (to A. S. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The nucleotide sequence of A. aegypti 4E-BP reported in this article has been submitted to the GenBank databank with the accession number FJ392868.	Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Hansen IA, 2007, INSECT BIOCHEM MOLEC, V37, P985, DOI 10.1016/j.ibmb.2007.05.008; Hansen IA, 2011, J BIOL CHEM, V286, P10803, DOI 10.1074/jbc.M110.179739; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kramer JM, 2008, GENOME, V51, P668, DOI 10.1139/G08-047; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; MADER S, 1995, MOL CELL BIOL, V15, P4990; Maestro JL, 2009, J BIOL CHEM, V284, P5506, DOI 10.1074/jbc.M807042200; Park JH, 2006, J BIOL CHEM, V281, P11167, DOI 10.1074/jbc.M601517200; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Raikhel Alexander S., 2005, P329; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Roy SG, 2011, INSECT BIOCHEM MOLEC, V41, P62, DOI 10.1016/j.ibmb.2010.10.001; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; SONDERGAARD L, 1995, MOL GEN GENET, V248, P25, DOI 10.1007/BF02456610; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005	34	31	33	2	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1334	1342		10.1096/fj.11-189969	http://dx.doi.org/10.1096/fj.11-189969			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22159149	Green Published			2022-12-25	WOS:000300949300035
J	Kang, H; Davis-Dusenbery, BN; Nguyen, PH; Lal, A; Lieberman, J; Van Aelst, L; Lagna, G; Hata, A				Kang, Hara; Davis-Dusenbery, Brandi N.; Nguyen, Peter H.; Lal, Ashish; Lieberman, Judy; Van Aelst, Linda; Lagna, Giorgio; Hata, Akiko			Bone Morphogenetic Protein 4 Promotes Vascular Smooth Muscle Contractility by Activating MicroRNA-21 (miR-21), which Down-regulates Expression of Family of Dedicator of Cytokinesis (DOCK) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; CANCER CELLS; TARGETS; PROLIFERATION; INVASION; IDENTIFICATION; RECOGNITION; MODULATION; SIGNATURE; MIGRATION	The bone morphogenetic protein 4 (BMP4) signaling pathway plays a critical role in the promotion and maintenance of the contractile phenotype in vascular smooth muscle cell (vSMC). Misexpression or inactivating mutations of the BMP receptor gene can lead to dedifferentiation of vSMC characterized by increased migration and proliferation that is linked to vascular proliferative disorders. Previously we demonstrated that vSMCs increase microRNA-21 (miR-21) biogenesis upon BMP4 treatment, which induces contractile gene expression by targeting programmed cell death 4 (PDCD4). To identify novel targets of miR-21 that are critical for induction of the contractile phenotype by BMP4, biotinylated miR-21 was expressed in vSMCs followed by an affinity purification of mRNAs associated with miR-21. Nearly all members of the dedicator of cytokinesis (DOCK) 180-related protein superfamily were identified as targets of miR-21. Down-regulation of DOCK4, -5, and -7 by miR-21 inhibited cell migration and promoted cytoskeletal organization by modulating an activity of small GTPase. Thus, this study uncovers a regulatory mechanism of the vSMC phenotype by the BMP4-miR-21 axis through DOCK family proteins.	[Kang, Hara; Lagna, Giorgio; Hata, Akiko] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Kang, Hara; Davis-Dusenbery, Brandi N.; Nguyen, Peter H.; Lagna, Giorgio; Hata, Akiko] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Lal, Ashish; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Lal, Ashish; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Lal, Ashish] NCI, Genet Branch, NIH, Bethesda, MD 20889 USA; [Van Aelst, Linda] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	University of California System; University of California San Francisco; Tufts Medical Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cold Spring Harbor Laboratory; Tufts University	Hata, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd, San Francisco, CA 94158 USA.	akiko.hata@ucsf.edu	Davis-Dusenbery, Brandi/N-2798-2013; Lieberman, Judy/A-2717-2015	Davis-Dusenbery, Brandi/0000-0001-7811-8613; 	National Institutes of Health [HD042149, HL093154, HL082854]; American Heart Association [0940095N]; LeDucq Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042149] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108317, R01HL093154, R01HL082854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); LeDucq Foundation(Leducq Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants HD042149, HL093154, and HL082854 (to A. H.). This work was also supported by American Heart Association Grant 0940095N and a LeDucq Foundation transatlantic network grant (to A. H.).	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Qi YX, 2010, J CELL BIOCHEM, V109, P906, DOI 10.1002/jcb.22465; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Silvestri Pasquale, 2009, Recent Pat Cardiovasc Drug Discov, V4, P109; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Slack Frank J, 2006, Future Oncol, V2, P73, DOI 10.2217/14796694.2.1.73; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	50	79	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3976	3986		10.1074/jbc.M111.303156	http://dx.doi.org/10.1074/jbc.M111.303156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158624	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000300410900032
J	Zoghbi, ME; Fuson, KL; Sutton, RB; Altenberg, GA				Zoghbi, Maria E.; Fuson, Kerry L.; Sutton, Roger B.; Altenberg, Guillermo A.			Kinetics of the Association/Dissociation Cycle of an ATP-binding Cassette Nucleotide-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER MSBA; CATALYTIC CYCLE; P-GLYCOPROTEIN; CRYSTAL-STRUCTURES; HYDROLYSIS CYCLE; ACTIVE-SITE; DIMER; MECHANISMS; CLASSIFICATION; FLUORESCENCE	Most ATP binding cassette (ABC) proteins are pumps that transport substrates across biological membranes using the energy of ATP hydrolysis. Functional ABC proteins have two nucleotide-binding domains (NBDs) that bind and hydrolyze ATP, but the molecular mechanism of nucleotide hydrolysis is unresolved. This is due in part to the limited kinetic information on NBD association and dissociation. Here, we show dimerization of a catalytically active NBD and follow in real time the association and dissociation of NBDs from the changes in fluorescence emission of a tryptophan strategically located at the center of the dimer interface. Spectroscopic and structural studies demonstrated that the tryptophan can be used as dimerization probe, and we showed that under hydrolysis conditions (millimolar MgATP), not only the dimer dissociation rate increases, but also the dimerization rate. Neither dimer formation or dissociation are clearly favored, and the end result is a dynamic equilibrium where the concentrations of monomer and dimer are very similar. We proposed that based on their variable rates of hydrolysis, the rate-limiting step of the hydrolysis cycle may differ among full-length ABC proteins.	[Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Altenberg, Guillermo/0000-0002-8932-740X; Zoghbi, Maria/0000-0002-4206-4673	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; National Institutes of Health National Center for Research Resources Biomedical Technology [P41RR001209]; Cancer Prevention and Research Institute of Texas [RP101073]; United States Department of Energy Office of Biological and Environmental Research; National Institute of General Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629, T32GM008280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Research Resources Biomedical Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cancer Prevention and Research Institute of Texas; United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants R01GM79629 and 3R01GM079629-03S1 and by National Institutes of Health National Center for Research Resources Biomedical Technology Program grant P41RR001209 (to the Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program). This work was also supported by Cancer Prevention and Research Institute of Texas grant RP101073 (to G. A. A.). The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the United States Department of Energy Office of Biological and Environmental Research and the National Institute of General Medical Sciences.	Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHEN RF, 1991, BIOCHEMISTRY-US, V30, P5184, DOI 10.1021/bi00235a011; Csanady L, 2010, J GEN PHYSIOL, V135, P395, DOI 10.1085/jgp.201010443; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kayser V, 2011, J FLUORESC, V21, P275, DOI 10.1007/s10895-010-0715-0; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Moody J. E., 2006, THESIS U TEXAS SW ME; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; van der Does C, 2006, J BIOL CHEM, V281, P5694, DOI 10.1074/jbc.M511730200; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Westfahl KM, 2008, BIOCHEMISTRY-US, V47, P13878, DOI 10.1021/bi801745u; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	39	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4157	4164		10.1074/jbc.M111.318378	http://dx.doi.org/10.1074/jbc.M111.318378			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158619	hybrid, Green Published			2022-12-25	WOS:000300410900049
J	Kim, SY; Shim, JH; Chun, E; Lee, KY				Kim, So Yong; Shim, Jea-Hyuck; Chun, Eunyoung; Lee, Ki-Young			Reciprocal Inhibition between the Transforming Growth Factor-beta-activated Kinase 1 (TAK1) and Apoptosis Signal-regulating Kinase 1 (ASK1) Mitogen-activated Protein Kinase Kinase Kinases and Its Suppression by TAK1-binding Protein 2 (TAB2), an Adapter Protein for TAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; PEROXIREDOXIN 6; MAP KINASES; CELL-DEATH; STRESS; PATHWAYS; TRANSDUCTION; RESPONSES; COMPLEX; INNATE	Mitogen-activated protein kinase kinase kinases (MAP3Ks) are activated by a wide spectrum of extracellular stimuli and are involved in various cellular events including proinflammatory and oxidative damage response through activations of two specific transcription factors, nuclear factor kappa B (NF-kappa B) and activator protein-1 (AP-1). Although members of the MAP3K family have both overlapping and distinct functions, the inter-regulatory mechanism of MAP3Ks remains largely unknown. In this study we demonstrated that transforming growth factor-beta-activated kinase 1 (TAK1)-TAK1-binding protein 1 (TAB1) complex negatively regulates ASK1-mediated signaling, and TAB2 reciprocally regulates TAK1-induced NF-kappa B and apoptosis signal-regulating kinase 1 (ASK1)-mediated AP-1 activations through the TAK1-TAB2 interaction and the interferences of TAK1-ASK1 interaction. TAK1 interacted with the N or C terminus of ASK1 through the C-terminal TAB2 binding domain of TAK1, with resultant inhibition of ASK1-induced AP-1 activation. Interestingly, the interaction between TAK1 and TAB2 significantly attenuated the ASK1-TAK1 interaction through the competitive interaction with ASK1 to TAK1 and resulted in the activations of TAK1-induced activations of NF-kappa B and AP-1. More interestingly, H2O2- and TNF-alpha-induced apoptosis in TAK1-deficient mouse embryo fibroblast cells were dramatically enhanced by overexpression of ASK1, whereas the apoptosis was markedly inhibited by the overexpression of TAK1. Overall, these results demonstrate that TAK1 and its adapter protein, TAB2, reciprocally regulate both TAK1- and ASK1-mediated signaling pathways to direct the activations of NF-kappa B and AP-1.	[Kim, So Yong; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Kim, So Yong; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Shim, Jea-Hyuck; Chun, Eunyoung] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Shim, Jea-Hyuck; Chun, Eunyoung] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Chun, E (corresponding author), 665 Huntington Ave,Bldg 1,Rm 904, Boston, MA 02115 USA.	echun@hsph.harvard.edu; thylee@skku.edu			Ministry of Health and Welfare, Republic of Korea [A100289]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A100289).	Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Hayakawa T, 2006, MICROBES INFECT, V8, P1098, DOI 10.1016/j.micinf.2005.12.001; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kim SY, 2011, CELL DEATH DIFFER, V18, P1573, DOI 10.1038/cdd.2011.21; Kim S. Y., 2011, IMMUNOL CEL IN PRESS; Kim SW, 2008, BLOOD, V111, P1644, DOI 10.1182/blood-2007-05-088591; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Kim SY, 2008, J BIOL CHEM, V283, P33563, DOI 10.1074/jbc.M806578200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matsuzawa A, 2005, ANTIOXID REDOX SIGN, V7, P472, DOI 10.1089/ars.2005.7.472; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	33	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3381	3391		10.1074/jbc.M111.317875	http://dx.doi.org/10.1074/jbc.M111.317875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167179	Green Published, hybrid			2022-12-25	WOS:000300295100043
J	Stoyanova, T; Roy, N; Bhattacharjee, S; Kopanja, D; Valli, T; Bagchi, S; Raychaudhuri, P				Stoyanova, Tanya; Roy, Nilotpal; Bhattacharjee, Shaumick; Kopanja, Dragana; Valli, Ted; Bagchi, Srilata; Raychaudhuri, Pradip			p21 Cooperates with DDB2 Protein in Suppression of Ultraviolet Ray-induced Skin Malignancies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED-DNA-BINDING; COMPLEMENTATION GROUP-E; BASAL-CELL CARCINOMAS; G(1) ARREST; P53; REPAIR; FOXM1; GENE; SITES; P21(WAF1/CIP1)	Exposure to ultraviolet rays (UV) in sunlight is the main cause of skin cancer. Here, we show that the p53-induced genes DDB2 and p21 are down-regulated in skin cancer, and in the mouse model they functionally cooperate to prevent UV-induced skin cancer. Our previous studies demonstrated an antagonistic role of DDB2 and p21 in nucleotide excision repair and apoptosis. Surprisingly, we find that the loss of p21 restores nucleotide excision repair and apoptosis in Ddb2(-/-) mice, but it does not protect from UV-mediated skin carcinogenesis. In contrast, Ddb2(-/-)p21(-/-) mice are significantly more susceptible to UV-induced skin cancer than the Ddb2(-/-) or the p21(-/-) mice. We provide evidence that p21 deletion in the Ddb2(-/-) background causes a strong increase in cell proliferation. The increased proliferation in the Ddb2(-/-)p21(-/-) background is related to a severe deficiency in UV-induced premature senescence. Also, the oncogenic pro-proliferation transcription factor FOXM1 is overexpressed in the p21(-/-) background. Our results show that the anti-proliferative and the pro-senescence pathways of DDB2 and p21 are critical protection mechanisms against skin malignancies.	[Bagchi, Srilata] Univ Illinois, Coll Dent, Ctr Canc, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Stoyanova, Tanya; Roy, Nilotpal; Bhattacharjee, Shaumick; Kopanja, Dragana; Raychaudhuri, Pradip] Univ Illinois, Ctr Canc, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Valli, Ted] VDx Pathol, Davis, CA 95616 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bagchi, S (corresponding author), Univ Illinois, Coll Dent, Ctr Canc, Ctr Mol Biol Oral Dis, 801 S Paulina Ave, Chicago, IL 60612 USA.	sbagchi@uic.edu; pradip@uic.edu			National Institutes of Health from NCI [CA77637, CA 156164]; University of Illinois, College of Medicine; NATIONAL CANCER INSTITUTE [R01CA077637, R01CA156164] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Illinois, College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77637 and CA 156164 from NCI.; Supported by a Dean's Scholar Fellowship from the University of Illinois, College of Medicine.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Bagchi S, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-3; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Chen YJ, 2009, J BIOL CHEM, V284, P30695, DOI 10.1074/jbc.M109.007997; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Itoh T, 2004, P NATL ACAD SCI USA, V101, P2052, DOI 10.1073/pnas.0306551101; Kim MY, 2002, J DERMATOL SCI, V29, P1, DOI 10.1016/S0923-1811(01)00170-0; Kulaksiz G, 2005, MOL CELL BIOL, V25, P9784, DOI 10.1128/MCB.25.22.9784-9792.2005; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maeda T, 2005, CARCINOGENESIS, V26, P1804, DOI 10.1093/carcin/bgi140; Nichols AF, 2000, J BIOL CHEM, V275, P21422, DOI 10.1074/jbc.M000960200; Oh KS, 2011, J INVEST DERMATOL, V131, P785, DOI 10.1038/jid.2010.352; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Roy N, 2010, MOL CELL BIOL, V30, P2681, DOI 10.1128/MCB.01480-09; SHEA CR, 1992, AM J PATHOL, V141, P25; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Stoyanova T, 2008, MOL CELL BIOL, V28, P177, DOI 10.1128/MCB.00880-07; Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Willenbring H, 2008, CANCER CELL, V14, P59, DOI 10.1016/j.ccr.2008.05.004; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Yoon T, 2005, ONCOGENE, V24, P469, DOI 10.1038/sj.onc.1208211	39	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3019	3028		10.1074/jbc.M111.295816	http://dx.doi.org/10.1074/jbc.M111.295816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167187	Green Published, hybrid			2022-12-25	WOS:000300295100009
J	Bellucci, A; Navarria, L; Falarti, E; Zaltieri, M; Bono, F; Collo, G; Grazia, M; Missale, C; Spano, P				Bellucci, Arianna; Navarria, Laura; Falarti, Elisa; Zaltieri, Michela; Bono, Federica; Collo, Ginetta; Grazia, Maria; Missale, Cristina; Spano, PierFranco			Redistribution of DAT/alpha-Synuclein Complexes Visualized by "In Situ" Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease	PLOS ONE			English	Article							DOPAMINE TRANSPORTER TRAFFICKING; TRUNCATED ALPHA-SYNUCLEIN; CELL-SURFACE EXPRESSION; LEWY BODIES; SYNTAXIN 1A; AGGREGATION; DEMENTIA; BRAIN; LOCALIZATION; BIOCHEMISTRY	Alpha-synuclein, the major component of Lewy bodies, is thought to play a central role in the onset of synaptic dysfunctions in Parkinson's disease (PD). In particular, a-synuclein may affect dopaminergic neuron function as it interacts with a key protein modulating dopamine (DA) content at the synapse: the DA transporter (DAT). Indeed, recent evidence from our "in vitro" studies showed that alpha-synuclein aggregation decreases the expression and membrane trafficking of the DAT as the DAT is retained into alpha-synuclein-immunopositive inclusions. This notwithstanding, "in vivo" studies on PD animal models investigating whether DAT distribution is altered by the pathological overexpression and aggregation of alpha-synuclein are missing. By using the proximity ligation assay, a technique which allows the "in situ" visualization of protein-protein interactions, we studied the occurrence of alterations in the distribution of DAT/alpha-synuclein complexes in the SYN120 transgenic mouse model, showing insoluble alpha-synuclein aggregates into dopaminergic neurons of the nigrostriatal system, reduced striatal DA levels and an altered distribution of synaptic proteins in the striatum. We found that DAT/alpha-synuclein complexes were markedly redistributed in the striatum and substantia nigra of SYN120 mice. These alterations were accompanied by a significant increase of DAT striatal levels in transgenic animals when compared to wild type littermates. Our data indicate that, in the early pathogenesis of PD, alpha-synuclein acts as a fine modulator of the dopaminergic synapse by regulating the subcellular distribution of key proteins such as the DAT.	[Bellucci, Arianna; Navarria, Laura; Falarti, Elisa; Zaltieri, Michela; Bono, Federica; Collo, Ginetta; Missale, Cristina; Spano, PierFranco] Univ Brescia, Div Pharmacol, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Bellucci, Arianna; Navarria, Laura; Falarti, Elisa; Zaltieri, Michela; Bono, Federica; Collo, Ginetta; Missale, Cristina; Spano, PierFranco] Univ Brescia, Natl Inst Neurosci Italy, Sch Med, Brescia, Italy; [Grazia, Maria] Univ Cambridge, Dept Clin Neurosci, Brain Repair Ctr, Cambridge, England; [Spano, PierFranco] Ist Ricovero & Cura Carattere Sci San Camillo, Venice, Italy	University of Brescia; University of Brescia; University of Cambridge; IRCCS Ospedale San Camillo	Bellucci, A (corresponding author), Univ Brescia, Div Pharmacol, Dept Biomed Sci & Biotechnol, Brescia, Italy.	bellucci@med.unibs.it	BELLUCCI, Arianna/K-2063-2016; SPANO, PIERFRANCO/J-9944-2016	BELLUCCI, Arianna/0000-0002-9581-1919; SPANO, PIERFRANCO/0000-0002-9906-0964; BONO, Federica/0000-0001-9716-5327; COLLO, Ginetta/0000-0003-1888-5049	Italian Ministry of Education, University and Scientific Research; Italian Ministry of Health, Neurodegenerativo; University of Brescia; Regione Lombardia, Italy NEDD [CUPH81J09002660007]; Parkinson&quot;s UK [G-0701] Funding Source: researchfish	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health, Neurodegenerativo; University of Brescia; Regione Lombardia, Italy NEDD; Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by grants from the Italian Ministry of Education, University and Scientific Research-PRIN 2006; by a grant from the Italian Ministry of Health, Neurodegenerativo 2005; by University of Brescia Research Fund EX 60% and by the Regione Lombardia, Italy NEDD Project (CUPH81J09002660007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso-Oramas D, 2010, NEUROBIOL DIS, V40, P518, DOI 10.1016/j.nbd.2010.07.012; Baba M, 1998, AM J PATHOL, V152, P879; Bellani Serena, 2010, Commun Integr Biol, V3, P106; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; Bellucci A, 2008, J NEUROCHEM, V106, P560, DOI 10.1111/j.1471-4159.2008.05406.x; Bellucci A, 2006, NEUROBIOL DIS, V23, P260, DOI 10.1016/j.nbd.2006.03.012; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Blokzijl A, 2010, J INTERN MED, V268, P232, DOI 10.1111/j.1365-2796.2010.02256.x; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Chadchankar H, 2011, BRAIN RES, V1382, P37, DOI 10.1016/j.brainres.2011.01.064; Chen R, 2010, FUTUR NEUROL, V5, P123, DOI 10.2217/FNL.09.76; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Hersch SM, 1997, J COMP NEUROL, V388, P211; Jellinger KA, 2005, J NEUROPATH EXP NEUR, V64, P554, DOI 10.1093/jnen/64.6.554; Jellinger KA, 2003, ACTA NEUROPATHOL, V106, P191, DOI 10.1007/s00401-003-0725-y; Kovacs GG, 2008, MOVEMENT DISORD, V23, P1608, DOI 10.1002/mds.22207; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Mori F, 2008, ACTA NEUROPATHOL, V115, P453, DOI 10.1007/s00401-007-0316-4; Muramatsu Y, 2003, J NEURAL TRANSM, V110, P1129, DOI 10.1007/s00702-003-0021-y; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Oaks AW, 2011, FEBS LETT, V585, P1001, DOI 10.1016/j.febslet.2011.03.009; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Roy S, 2007, J NEUROSCI, V27, P3131, DOI 10.1523/JNEUROSCI.4999-06.2007; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sousa VL, 2009, MOL BIOL CELL, V20, P3725, DOI 10.1091/mbc.E08-03-0302; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Swant J, 2011, J BIOL CHEM      OCT; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Wersinger C, 2004, NEUROSCI LETT, V358, P95, DOI 10.1016/j.neulet.2003.12.118; Wersinger C, 2003, MOL CELL NEUROSCI, V24, P91, DOI 10.1016/S1044-7431(03)00124-6; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	60	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27959	10.1371/journal.pone.0027959	http://dx.doi.org/10.1371/journal.pone.0027959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163275	gold, Green Published, Green Submitted			2022-12-25	WOS:000298161900010
J	Frieman, M; Basu, D; Matthews, K; Taylor, J; Jones, G; Pickles, R; Baric, R; Engel, DA				Frieman, Matthew; Basu, Dipanwita; Matthews, Krystal; Taylor, Justin; Jones, Grant; Pickles, Raymond; Baric, Ralph; Engel, Daniel A.			Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PAPAIN-LIKE PROTEASE; SYNDROME CORONAVIRUS; CILIATED CELLS; INFECTION; IDENTIFICATION; VIRUSES; SPREAD	Severe acute respiratory coronavirus (SARS-CoV) emerged in 2002, resulting in roughly 8000 cases worldwide and 10% mortality. The animal reservoirs for SARS-CoV precursors still exist and the likelihood of future outbreaks in the human population is high. The SARS-CoV papain-like protease (PLP) is an attractive target for pharmaceutical development because it is essential for virus replication and is conserved among human coronaviruses. A yeast-based assay was established for PLP activity that relies on the ability of PLP to induce a pronounced slow-growth phenotype when expressed in S. cerevisiae. Induction of the slow-growth phenotype was shown to take place over a 60-hour time course, providing the basis for conducting a screen for small molecules that restore growth by inhibiting the function of PLP. Five chemical suppressors of the slow-growth phenotype were identified from the 2000 member NIH Diversity Set library. One of these, NSC158362, potently inhibited SARS-CoV replication in cell culture without toxic effects on cells, and it specifically inhibited SARS-CoV replication but not influenza virus replication. The effect of NSC158362 on PLP protease, deubiquitinase and anti-interferon activities was investigated but the compound did not alter these activities. Another suppressor, NSC158011, demonstrated the ability to inhibit PLP protease activity in a cell-based assay. The identification of these inhibitors demonstrated a strong functional connection between the PLP-based yeast assay, the inhibitory compounds, and SARS-CoV biology. Furthermore the data with NSC158362 suggest a novel mechanism for inhibition of SARS-CoV replication that may involve an unknown activity of PLP, or alternatively a direct effect on a cellular target that modifies or bypasses PLP function in yeast and mammalian cells.	[Frieman, Matthew; Matthews, Krystal; Taylor, Justin; Jones, Grant] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Basu, Dipanwita; Engel, Daniel A.] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Pickles, Raymond] Univ N Carolina, Dept Microbiol & Immunol, Gene Therapy Ctr, Chapel Hill, NC USA; [Baric, Ralph] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA	University System of Maryland; University of Maryland Baltimore; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Frieman, M (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	dae2s@virginia.edu			Public Health Service [1R21NS063854, K22AI077797]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063854] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Public Health Service grant 1R21NS063854 to DAE and RSB and K22AI077797 to MBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Basu D, 2009, J VIROL, V83, P1881, DOI 10.1128/JVI.01805-08; Chan PKS, 2003, EMERG INFECT DIS, V9, P1453, DOI 10.3201/eid0911.030421; Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Cheung OY, 2004, HISTOPATHOLOGY, V45, P119, DOI 10.1111/j.1365-2559.2004.01926.x; Chong PY, 2004, ARCH PATHOL LAB MED, V128, P195; Daniel JA, 2006, GENETICS, V172, P709, DOI 10.1534/genetics.105.047662; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; GEE MH, 1990, J APPL PHYSIOL, V69, P822, DOI 10.1152/jappl.1990.69.3.822; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; Katz JM, 2000, BIOMED PHARMACOTHER, V54, P178, DOI 10.1016/S0753-3322(00)89024-1; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Sheng WH, 2005, J FORMOS MED ASSOC, V104, P715; Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005; Walkiewicz MP, 2011, J GEN VIROL, V92, P60, DOI 10.1099/vir.0.025015-0; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Ziebuhr J, 2004, CURR OPIN MICROBIOL, V7, P412, DOI 10.1016/j.mib.2004.06.007	22	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28479	10.1371/journal.pone.0028479	http://dx.doi.org/10.1371/journal.pone.0028479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164298	gold, Green Submitted, Green Published			2022-12-25	WOS:000298171400099
J	Miccio, A; Poletti, V; Tiboni, F; Rossi, C; Antonelli, A; Mavilio, F; Ferrari, G				Miccio, Annarita; Poletti, Valentina; Tiboni, Francesca; Rossi, Claudia; Antonelli, Antonella; Mavilio, Fulvio; Ferrari, Giuliana			The GATA1-HS2 Enhancer Allows Persistent and Position-Independent Expression of a beta-globin Transgene	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; HEMATOPOIETIC STEM-CELLS; CREB-BINDING PROTEIN; ACTIVE CHROMATIN-STRUCTURE; LENTIVIRAL VECTORS; IN-VIVO; RETROVIRAL INTEGRATION; TARGETED DELETION; THALASSEMIA MAJOR; GENE DELIVERY	Gene therapy of genetic diseases requires persistent and position-independent expression of a therapeutic transgene. Transcriptional enhancers binding chromatin-remodeling and modifying complexes may play a role in shielding transgenes from repressive chromatin effects. We tested the activity of the HS2 enhancer of the GATA1 gene in protecting the expression of a beta-globin minigene delivered by a lentiviral vector in hematopoietic stem/progenitor cells. Gene expression from proviruses carrying GATA1-HS2 in both LTRs was persistent and resistant to silencing at most integration sites in the in vivo progeny of human hematopoietic progenitors and murine long-term repopulating stem cells. The GATA1-HS2-modified vector allowed correction of murine beta-thalassemia at low copy number without inducing clonal selection of erythroblastic progenitors. Chromatin immunoprecipitation studies showed that GATA1 and the CBP acetyltransferase bind to GATA1-HS2, significantly increasing CBP-specific histone acetylations at the LTRs and beta-globin promoter. Recruitment of CBP by the LTRs thus establishes an open chromatin domain encompassing the entire provirus, and increases the therapeutic efficacy of beta-globin gene transfer by reducing expression variegation and epigenetic silencing.	[Miccio, Annarita; Tiboni, Francesca; Rossi, Claudia; Antonelli, Antonella; Ferrari, Giuliana] Ist Sci H San Raffaele, H San Raffaele Telethon Inst Gene Therapy HSR TIG, Milan, Italy; [Miccio, Annarita; Mavilio, Fulvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Poletti, Valentina; Mavilio, Fulvio] Ist Sci H San Raffaele, Gene Express Lab, Milan, Italy; [Ferrari, Giuliana] Univ Vita Salute San Raffaele, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Miccio, A (corresponding author), Ist Sci H San Raffaele, H San Raffaele Telethon Inst Gene Therapy HSR TIG, Milan, Italy.	giuliana.ferrari@hsr.it	Antonelli, Antonella/AAN-1856-2020; MAVILIO, Fulvio/J-6125-2013; Rossi, Claudia/AAO-4711-2020; Ferrari, Giuliana/AAB-5546-2019; Miccio, Annarita/H-9585-2017; Tiboni, Francesca/AAO-2772-2020; ANTONELLI, ANTONELLA/C-6238-2011; Poletti, Venerino/K-8821-2016	Ferrari, Giuliana/0000-0003-0790-3133; Miccio, Annarita/0000-0002-3409-9665; Antonelli, Antonella/0000-0003-1497-3586; Mavilio, Fulvio/0000-0003-0459-4320; Poletti, Venerino/0000-0002-8634-2284; Rossi, Claudia/0000-0002-3810-7247	Italian Telethon Foundation (Core Grant TIGET); Italian Ministry of University and Research; European Commission	Italian Telethon Foundation (Core Grant TIGET)(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Italian Telethon Foundation (Core Grant TIGET), the Italian Ministry of University and Research (PRIN 2008), and the European Commission (FP7, PERSIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Bose F, 2006, MOL CELL BIOL, V26, P3942, DOI 10.1128/MCB.26.10.3942-3954.2006; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cho Y, 2008, NUCLEIC ACIDS RES, V36, P4521, DOI 10.1093/nar/gkn368; CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; D'Apolito D, 2009, MOL THER, V17, P1434, DOI 10.1038/mt.2009.74; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Grande A, 1999, BLOOD, V93, P3276, DOI 10.1182/blood.V93.10.3276.410k08_3276_3285; Hanawa H, 2004, BLOOD, V104, P2281, DOI 10.1182/blood-2004-03-0863; Hino S, 2006, J MOL BIOL, V357, P18, DOI 10.1016/j.jmb.2005.12.057; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; Jawaid K, 2010, BLOOD CELL MOL DIS, V45, P140, DOI 10.1016/j.bcmd.2010.05.006; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Lotti F, 2002, J VIROL, V76, P3996, DOI 10.1128/JVI.76.8.3996-4007.2002; Lucarelli G, 2002, BLOOD REV, V16, P81, DOI 10.1054/blre.2002.0192; Lutzko C, 2003, J VIROL, V77, P7341, DOI 10.1128/JVI.77.13.7341-7351.2003; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Miccio A, 2008, P NATL ACAD SCI USA, V105, P10547, DOI 10.1073/pnas.0711666105; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Nielsen TT, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-13; Persons DA, 2003, BLOOD, V101, P2175, DOI 10.1182/blood-2002-07-2211; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Ramezani A, 2003, BLOOD, V101, P4717, DOI 10.1182/blood-2002-09-2991; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Roselli EA, 2010, EMBO MOL MED, V2, P315, DOI 10.1002/emmm.201000083; Sutherland HGE, 1997, MOL CELL BIOL, V17, P1607, DOI 10.1128/MCB.17.3.1607; Sutter NB, 2003, P NATL ACAD SCI USA, V100, P1105, DOI 10.1073/pnas.242732999; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Urbinati F, 2009, MOL THER, V17, P1527, DOI 10.1038/mt.2009.89; Walters MC, 1996, GENE DEV, V10, P185, DOI 10.1101/gad.10.2.185; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zhang F, 2010, MOL THER, V18, P1640, DOI 10.1038/mt.2010.132; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	51	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27955	10.1371/journal.pone.0027955	http://dx.doi.org/10.1371/journal.pone.0027955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164220	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400021
J	Scheich, C; Szabadka, Z; Vertessy, B; Putter, V; Grolmusz, V; Schade, M				Scheich, Christoph; Szabadka, Zoltan; Vertessy, Beata; Puetter, Vera; Grolmusz, Vince; Schade, Markus			Discovery of Novel MDR-Mycobacterium tuberculosis Inhibitor by New FRIGATE Computational Screen	PLOS ONE			English	Article							ANTIGEN 85C; DRUGS; DESIGN; BIOSYNTHESIS; ALGORITHM; MECHANISM; DOCKING; INDEXES; ENZYME	With 1.6 million casualties annually and 2 billion people being infected, tuberculosis is still one of the most pressing healthcare challenges. Here we report on the new computational docking algorithm FRIGATE which unites continuous local optimization techniques (conjugate gradient method) with an inherently discrete computational approach in forcefield computation, resulting in equal or better scoring accuracies than several benchmark docking programs. By utilizing FRIGATE for a virtual screen of the ZINC library against the Mycobacterium tuberculosis (Mtb) enzyme antigen 85C, we identified novel small molecule inhibitors of multiple drug-resistant Mtb, which bind in vitro to the catalytic site of antigen 85C.	[Scheich, Christoph; Puetter, Vera; Schade, Markus] Combinat Biopharm AG, Berlin, Germany; [Szabadka, Zoltan; Grolmusz, Vince] Eotvos Lorand Univ, Dept Comp Sci, Budapest, Hungary; [Vertessy, Beata] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary; [Szabadka, Zoltan] Uratim Ltd, Budapest, Hungary; [Vertessy, Beata] Univ Technol & Econ, Dept Appl Biotechnol, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Budapest University of Technology & Economics	Scheich, C (corresponding author), Evotec AG, Hamburg, Germany.	grolmusz@cs.elte.hu; markus.schade@astrazeneca.com	Vertessy, Beata G/H-6202-2012	Vertessy, Beata G./0000-0002-1288-2982; Schade, Markus/0000-0002-5538-5767; Grolmusz, Vince/0000-0001-9456-8876	European Union [012127]; Hungarian Scientific Research Fund [OTKA-A08 CK78646, OTKA NK-84008]; Howard Hughes Medical Institutes [55000342]; Alexander von Humboldt-Stiftung, Germany; New Hungary Development Plan [TAMOP-4.2.1/B-09/1/KMR-2010-0002, 0003, OMFB-00266/2010 REG-KM-09-1-2009-0050]	European Union(European Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Alexander von Humboldt-Stiftung, Germany(Alexander von Humboldt Foundation); New Hungary Development Plan	The authors are grateful for the financial support by the European Union FP6 grant scrIN-SILICO (Contract No. 012127), Hungarian Scientific Research Fund OTKA-A08 CK78646, OTKA NK-84008; Howard Hughes Medical Institutes #55000342, Alexander von Humboldt-Stiftung, Germany; New Hungary Development Plan (Project IDs: TAMOP-4.2.1/B-09/1/KMR-2010-0002, 0003); Baross program of the New Hungary Development Plan (Project ID: 3DSTRUCT, OMFB-00266/2010 REG-KM-09-1-2009-0050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cosconati S, 2008, J MED CHEM, V51, P6627, DOI 10.1021/jm800571m; Coulson CJ, 1994, MOL MECH DRUG ACTION, P40; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P327, DOI 10.2174/138945010790711941; Ginsberg AM, 2008, SEMIN RESP CRIT CARE, V29, P552, DOI 10.1055/s-0028-1085706; Gobec S, 2007, EUR J MED CHEM, V42, P54, DOI 10.1016/j.ejmech.2006.08.007; Hajduk PJ, 2006, J MED CHEM, V49, P6972, DOI 10.1021/jm060511h; Harth G, 2002, P NATL ACAD SCI USA, V99, P15614, DOI 10.1073/pnas.242612299; Hawkins G.D., 2003, AMSOL VERSION 7 0; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Kovac A, 2006, J ENZYM INHIB MED CH, V21, P391, DOI 10.1080/14756360600703214; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Paul N, 2002, PROTEINS, V47, P521, DOI 10.1002/prot.10119; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179, DOI 10.1128/JCM.37.10.3179-3186.1999; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Schade M, 2006, IDRUGS, V9, P110; Scheich C, 2010, J MED CHEM; Senderowitz H, 2009, CURR PHARM DESIGN, V15, P4049, DOI 10.2174/138161209789824821; Shandil RK, 2007, ANTIMICROB AGENTS CH, V51, P576, DOI 10.1128/AAC.00414-06; STEIHAUG T, 1983, SIAM J NUMER ANAL, V20, P626, DOI 10.1137/0720042; Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004; Szabadka Z, 2007, PREDICTING PROTEIN L; Talukdar A, 2010, BIOORGAN MED CHEM, V18, P3518, DOI 10.1016/j.bmc.2010.03.072; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Villoutreix BO, 2009, COMB CHEM HIGH T SCR, V12, P1000, DOI 10.2174/138620709789824682; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	37	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28428	10.1371/journal.pone.0028428	http://dx.doi.org/10.1371/journal.pone.0028428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164290	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400091
J	Ding, C; Vidanes, GM; Maguire, SL; Guida, A; Synnott, JM; Andes, DR; Butler, G				Ding, Chen; Vidanes, Genevieve M.; Maguire, Sarah L.; Guida, Alessandro; Synnott, John M.; Andes, David R.; Butler, Geraldine			Conserved and Divergent Roles of Bcr1 and CFEM Proteins in Candida parapsilosis and Candida albicans	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BIOFILM FORMATION; SACCHAROMYCES-CEREVISIAE; IRON-DEFICIENCY; MESSENGER-RNA; HYPOXIC RESPONSE; MICROARRAY DATA; EVOLUTION; OUTBREAK; METABOLISM	Candida parapsilosis is a pathogenic fungus that is major cause of hospital-acquired infection, predominantly due to growth as biofilms on indwelling medical devices. It is related to Candida albicans, which remains the most common cause of candidiasis disease in humans. The transcription factor Bcr1 is an important regulator of biofilm formation in vitro in both C. parapsilosis and C. albicans. We show here that C. parapsilosis Bcr1 is required for in vivo biofilm development in a rat catheter model, like C. albicans. By comparing the transcription profiles of a bcr1 deletion in both species we found that regulation of expression of the CFEM family is conserved. In C. albicans, three of the five CFEM cell wall proteins (Rbt5, Pga7 and Csa1) are associated with both biofilm formation and acquisition of iron from heme, which is an important virulence characteristic. In C. parapsilosis, the CFEM family has undergone an expansion to 7 members. Expression of three genes (CFEM2, CFEM3, and CFEM6) is dependent on Bcr1, and is induced in low iron conditions. All three are involved in the acquisition of iron from heme. However, deletion of the three CFEM genes has no effect on biofilm formation in C. parapsilosis. Our data suggest that the role of the CFEM family in iron acquisition is conserved between C. albicans and C. parapsilosis, but their role in biofilm formation is not.	[Ding, Chen; Vidanes, Genevieve M.; Maguire, Sarah L.; Synnott, John M.; Butler, Geraldine] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Guida, Alessandro] Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland; [Andes, David R.] Univ Wisconsin, Dept Microbiol & Immunol, Madison, WI USA	University College Dublin; University College Dublin; University of Wisconsin System; University of Wisconsin Madison	Ding, C (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	gbutler@ucd.ie	Andes, David/ABE-8033-2020; Ding, Chen/C-4113-2013; Guida, Alessandro/H-6930-2019	Ding, Chen/0000-0002-2296-7963; Guida, Alessandro/0000-0002-8733-4470; Andes, David/0000-0002-7927-9950; Maguire, Sarah/0000-0001-6654-3620; Butler, Geraldine/0000-0002-1770-5301	Science Foundation Ireland [08IN1B1865]; Health Research Board [RP/2008/4]; Irish Research Council for Science, Engineering and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073289] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Science Foundation Ireland (08IN1B1865), the Health Research Board (RP/2008/4) and by a studentship to AG from the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Barchiesi F, 2004, DIAGN MICR INFEC DIS, V49, P269, DOI 10.1016/j.diagmicrobio.2004.03.011; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Braun BR, 2000, GENETICS, V156, P31; Brillowska-Dabrowska A, 2009, SCAND J INFECT DIS, V41, P135, DOI 10.1080/00365540802585301; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Clark TA, 2004, J CLIN MICROBIOL, V42, P4468, DOI 10.1128/JCM.42.10.4468-4472.2004; DiazGranados CA, 2008, BRAZ J INFECT DIS, V12, P390, DOI 10.1590/S1413-86702008000500009; Ding C, 2007, EUKARYOT CELL, V6, P1310, DOI 10.1128/EC.00136-07; Dizbay M, 2008, BRAZ J INFECT DIS, V12, P395, DOI 10.1590/S1413-86702008000500010; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Hlynialuk C, 2008, MICROBIOL-SGM, V154, P2482, DOI 10.1099/mic.0.2008/019976-0; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Hoot SJ, 2008, MICROBIOL-SGM, V154, P2748, DOI 10.1099/mic.0.2008/017475-0; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Laffey SF, 2005, MICROBIOL-SGM, V151, P1073, DOI 10.1099/mic.0.27739-0; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lass-Florl C, 2009, MYCOSES, V52, P197, DOI 10.1111/j.1439-0507.2009.01691.x; Lattif AA, 2010, INT J MED MICROBIOL, V300, P265, DOI 10.1016/j.ijmm.2009.09.001; Limjindaporn T, 2003, MOL MICROBIOL, V50, P993, DOI 10.1046/j.1365-2958.2003.03747.x; Logue ME, 2005, EUKARYOT CELL, V4, P1009, DOI 10.1128/EC.4.6.1009-1017.2005; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Mean M, 2008, CRIT CARE, V12, DOI 10.1186/cc6212; Melo AS, 2011, MED MYCOL, V49, P253, DOI 10.3109/13693786.2010.530032; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Perez A, 2006, FEMS YEAST RES, V6, P1074, DOI 10.1111/j.1567-1364.2006.00131.x; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, DIAGN MICR INFEC DIS, V68, P278, DOI 10.1016/j.diagmicrobio.2010.06.015; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Rossignol T, 2009, EUKARYOT CELL, V8, P550, DOI 10.1128/EC.00350-08; Sai SX, 2011, EUKARYOT CELL, V10, P578, DOI 10.1128/EC.00276-10; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x; SILVA S, 2009, MED MYCOL, V20, P1, DOI DOI 10.1080/13693780802549594; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sorgo AG, 2010, YEAST, V27, P661, DOI 10.1002/yea.1775; Synnott JM, 2010, EUKARYOT CELL, V9, P1734, DOI 10.1128/EC.00159-10; Tavanti A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-203; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Yi S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001117; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142	69	65	366	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28151	10.1371/journal.pone.0028151	http://dx.doi.org/10.1371/journal.pone.0028151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145027	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168900010
J	Jung, HJ; Park, JY; Jeon, HS; Kwon, TH				Jung, Hyun Jun; Park, Ji-Young; Jeon, Hyo-Sung; Kwon, Tae-Hwan			Aquaporin-5: A Marker Protein for Proliferation and Migration of Human Breast Cancer Cells	PLOS ONE			English	Article							HUMAN BRAIN-TUMORS; LUNG-CANCER; WATER CHANNEL; COLORECTAL CARCINOGENESIS; ALKALINE-PHOSPHATASE; GENE-EXPRESSION; KNOCKOUT MICE; PATHWAY; TISSUE; LOCALIZATION	Aquaporin (AQP) is a family of transmembrane proteins for water transport. Recent studies revealed that AQPs are likely to play a role in tumor progression and invasion. We aimed to examine the potential role of AQP5 in the progression of human breast cancer cells. Expression of AQP5 mRNA and protein was seen in human breast cancer cell line (both MCF7 and MDA-MB-231) by RT-PCR and immunoblotting analysis. Immunoperoxidase labeling of AQP5 was observed at ductal epithelial cells of human breast tissues. In benign tumor, AQP5 labeling was mainly seen at the apical domains of ductal epithelial cells. In contrast, in invasive ductal carcinoma, prominent AQP5 labeling was associated with cancer cells, whereas some ducts were unlabeled and apical polarity of AQP5 in ducts was lost. Cell proliferation (BrdU incorporation assay) and migration of MCF7 cells were significantly attenuated by lentivirus-mediated AQP5-shRNA transduction. Hyperosmotic stress induced by sorbitol treatment (100 mM, 24 h) reduced AQP5 expression in MCF7 cells, which was also associated with a significant reduction in cell proliferation and migration. Taken together, prominent AQP5 expression in breast cancer cells with the loss of polarity of ductal epithelial cells was seen during the progression of breast carcinoma. shRNA-or hyperosmotic stress-induced reduction in AQP5 expression of MCF7 cells was associated with significantly reduced cell proliferation and migration. In conclusion, AQP5 overexpression is likely to play a role in cell growth and metastasis of human breast cancer and could be a novel target for anti-breast cancer treatment.	[Jung, Hyun Jun; Jeon, Hyo-Sung; Kwon, Tae-Hwan] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Sch Med, Taegu 702701, South Korea; [Park, Ji-Young] Kyungpook Natl Univ, Dept Pathol, Sch Med, Taegu 702701, South Korea	Kyungpook National University; Kyungpook National University	Jung, HJ (corresponding author), Kyungpook Natl Univ, Dept Biochem & Cell Biol, Sch Med, Taegu 702701, South Korea.	thkwon@knu.ac.kr	Kwon, Tae-Hwan/ABA-1981-2020	Jung, Hyun Jun/0000-0003-0519-5858	National Research Foundation [2010-0019393]; Converging Research Center [2010K001054]; Ministry of Education, Science and Technology (MEST), Korea; Ministry of Health and Welfare, Korea [A100617]; Health Fellowship Foundation	National Research Foundation; Converging Research Center; Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Health Fellowship Foundation	This study was supported by grants from the National Research Foundation (2010-0019393), the Converging Research Center Program (2010K001054) funded by the Ministry of Education, Science and Technology (MEST), Korea; the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Korea (A100617); and the Health Fellowship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Brennan K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/460607; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002594; Chen ZH, 2011, RESP PHYSIOL NEUROBI, V176, P110, DOI 10.1016/j.resp.2011.02.001; Coradini D, 2002, BRIT J CANCER, V87, P1105, DOI 10.1038/sj.bjc.6600556; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; HUI M, 1993, CELL TISSUE RES, V274, P429, DOI 10.1007/BF00314539; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Kang SK, 2008, AM J PATHOL, V173, P518, DOI 10.2353/ajpath.2008.071198; KATO M, 1992, BREAST CANCER RES TR, V23, P241, DOI 10.1007/BF01833521; Kermer V, 2010, NEUROSCI LETT, V485, P208, DOI 10.1016/j.neulet.2010.09.013; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Lee YJ, 2011, AM J PHYSIOL-RENAL, V301, pF883, DOI 10.1152/ajprenal.00117.2011; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mobasheri A, 2005, INT J ONCOL, V26, P1149; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Sugiyama Y, 2001, BBA-GENE STRUCT EXPR, V1522, P82, DOI 10.1016/S0167-4781(01)00320-7; Wang DW, 2011, J CLIN NEUROSCI, V18, P122, DOI 10.1016/j.jocn.2010.07.115; Warth A, 2007, APPL IMMUNOHISTO M M, V15, P193, DOI 10.1097/01.pai.0000213110.05108.e9; Watanabe T, 2009, J PHYSIOL SCI, V59, P113, DOI 10.1007/s12576-008-0017-3; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Yang JH, 2006, GYNECOL ONCOL, V100, P294, DOI 10.1016/j.ygyno.2005.08.054; Yong B, 2008, RESP PHYSIOL NEUROBI, V161, P111, DOI 10.1016/j.resp.2007.12.007; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	37	115	124	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28492	10.1371/journal.pone.0028492	http://dx.doi.org/10.1371/journal.pone.0028492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145049	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900032
J	Su, Y; Li, J; Witkiewicz, AK; Brennan, D; Neill, T; Talarico, J; Radice, GL				Su, Y.; Li, J.; Witkiewicz, A. K.; Brennan, D.; Neill, T.; Talarico, J.; Radice, G. L.			N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer	ONCOGENE			English	Article						cell adhesion; apoptosis; invasion; matrix metalloproteinase	CELL-MIGRATION; DUCTAL ADENOCARCINOMA; SIGNALING PATHWAY; HEDGEHOG; METASTASIS; GROWTH; INVASION; KI-RAS(G12V); ADHESION; MATRIX	Pancreatic ductal adenocarcinoma (PDA) is often detected at a late stage, hence the identification of new therapies that have potential to block tumor progression is critical for this lethal disease. N-cadherin upregulation has been observed in many cancers including PDA, however, a causal role for this cell adhesion receptor in disease progression has yet to be defined. The concomitant expression of oncogenic Kras(G12D) and mutant p53 (Trp53(R172H)) in the murine pancreas results in metastatic PDA that recapitulates the cognate features of human pancreatic cancer providing an excellent animal model to identify genes required for tumor progression. Here we determine the consequences of genetically manipulating N-cadherin expression in a mouse model of PDA. Remarkably, mice with reduced N-cadherin expression (that is, Ncad(-/+)) survived 25% longer (177 vs 142 days, P<0.05) than animals expressing two wild-type N-cadherin (Cdh2) alleles. The survival benefit is likely due to a cumulative effect of N-cadherin's role in different aspects of tumorigenesis including tumor-cell survival, growth, migration and invasion. Interestingly, reduced hedgehog signaling may contribute to the better prognosis for the Ncad(-/+) mice. Moreover, the matrix metalloproteinase MMP-7, associated with poor prognosis in PDA, was reduced in Ncad(-/+) tumors. Finally, Ncad(-/+) tumor cells exhibited decreased FGF-stimulated ERK1/2 activation consistent with N-cadherin's ability to promote FGFR signaling. These data support a critical role for N-cadherin in PDA and its potential prognostic value. Additionally, this study provides in vivo genetic evidence that the cell-surface protein N-cadherin represents a promising therapeutic target for the treatment of pancreatic cancer. Oncogene (2012) 31, 4484--4489; doi: 10.1038/onc.2011.574; published online 12 December 2011	[Su, Y.; Li, J.; Brennan, D.; Neill, T.; Talarico, J.; Radice, G. L.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA; [Witkiewicz, A. K.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Radice, GL (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Ctr Translat Med, Coll Bldg,Room 309,1025 Walnut St, Philadelphia, PA 19107 USA.	glenn.radice@jefferson.edu			Center for Molecular Studies in Digestive and Liver Disease [NIH P30DK050306]; University Research Foundation-University of Pennsylvania; NIH [R21 CA133609]; Pilot Research Award-Thomas Jefferson University; NATIONAL CANCER INSTITUTE [R21CA133609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	Center for Molecular Studies in Digestive and Liver Disease; University Research Foundation-University of Pennsylvania; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot Research Award-Thomas Jefferson University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr D Tuveson (Cancer Research UK, Cambridge) for the LSL-K-ras<SUP>G12D</SUP> and LSL-Trp53<SUP>R172H</SUP> mice and Dr A Lowy (UCSD) for the Pdx1/Cre mice. We are grateful to Han Du, Craig Riley, David Kurz, Leeanne Griffith and Andrew Ho for technical assistance. This work was supported by the Center for Molecular Studies in Digestive and Liver Disease (NIH P30DK050306) and University Research Foundation-University of Pennsylvania, NIH R21 CA133609, Pilot Research Award-Thomas Jefferson University (to GLR).	Agbunag C, 2004, CANCER RES, V64, P5659, DOI 10.1158/0008-5472.CAN-04-0807; Augustine CK, 2008, CANCER RES, V68, P3777, DOI 10.1158/0008-5472.CAN-07-5949; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Brembeck FH, 2003, CANCER RES, V63, P2005; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Crawford HC, 2002, J CLIN INVEST, V109, P1437, DOI 10.1172/JCI200215051; Deramaudt TB, 2006, MOL CELL BIOL, V26, P4185, DOI 10.1128/MCB.01055-05; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Karafin MS, 2010, INT J CLIN EXP PATHO, V3, P47; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Nomura S, 2008, BRIT J CANCER, V99, P305, DOI 10.1038/sj.bjc.6604473; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Shintani Y, 2008, INT J CANCER, V122, P71, DOI 10.1002/ijc.23027; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455	31	26	26	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	41					4484	4489		10.1038/onc.2011.574	http://dx.doi.org/10.1038/onc.2011.574			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	018YR	22158044	Green Accepted			2022-12-25	WOS:000309704500006
J	Pauwels, K; Williams, TL; Morris, KL; Jonckheere, W; Vandersteen, A; Kelly, G; Schymkowitz, J; Rousseau, F; Pastore, A; Serpell, LC; Broersen, K				Pauwels, Kris; Williams, Thomas L.; Morris, Kyle L.; Jonckheere, Wim; Vandersteen, Annelies; Kelly, Geoff; Schymkowitz, Joost; Rousseau, Frederic; Pastore, Annalisa; Serpell, Louise C.; Broersen, Kerensa			Structural Basis for Increased Toxicity of Pathological A beta(42):A beta(40) Ratios in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; X-RAY-DIFFRACTION; SYNAPTIC PLASTICITY; SOLVENT PROTECTION; IN-VIVO; FIBRILS; AGGREGATION; A-BETA-40; PEPTIDES; NMR	The beta-amyloid peptide (A beta) is directly related to neurotoxicity in Alzheimer disease (AD). The two most abundant alloforms of the peptide co-exist under normal physiological conditions in the brain in an A beta(42):A beta(40) ratio of similar to 1:9. This ratio is often shifted to a higher percentage of A beta(42) in brains of patients with familial AD and this has recently been shown to lead to increased synaptotoxicity. The molecular basis for this phenomenon is unclear. Although the aggregation characteristics of A beta(40) and A beta(42) individually are well established, little is known about the properties of mixtures. We have explored the biophysical and structural properties of physiologically relevant A beta(42): A beta(40) ratios by several techniques. We show that A beta(40) and A beta(42) directly interact as well as modify the behavior of the other. The structures of monomeric and fibrillar assemblies formed from A beta(40) and A beta(42) mixtures do not differ from those formed from either of these peptides alone. Instead, the co-assembly of A beta(40) and A beta(42) influences the aggregation kinetics by altering the pattern of oligomer formation as evidenced by a unique combination of solution nuclear magnetic resonance spectroscopy, high molecular weight mass spectrometry, and cross-seeding experiments. We relate these observations to the observed enhanced toxicity of relevant ratios of A beta(42):A beta(40) in synaptotoxicity assays and in AD patients.	[Pauwels, Kris; Kelly, Geoff; Pastore, Annalisa] Natl Inst Med Res, Med Res Council, Div Mol Struct, London NW7 1AA, England; [Williams, Thomas L.; Morris, Kyle L.; Serpell, Louise C.] Univ Sussex, Sch Life Sci, Falmer BN1 9QJ, E Sussex, England; [Jonckheere, Wim; Vandersteen, Annelies; Schymkowitz, Joost; Rousseau, Frederic; Broersen, Kerensa] VIB, SWITCH Lab, B-1050 Brussels, Belgium; [Jonckheere, Wim; Vandersteen, Annelies; Schymkowitz, Joost; Rousseau, Frederic; Broersen, Kerensa] Vrije Univ Brussel, B-1050 Brussels, Belgium	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Sussex; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Broersen, K (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.	k.broersen@utwente.nl	Schymkowitz, Joost/AAV-3680-2021; Rousseau, Frederic/J-9044-2016; Williams, Thomas L./M-1260-2013; Schymkowitz, Joost/K-7764-2016	Rousseau, Frederic/0000-0002-9189-7399; Williams, Thomas L./0000-0003-1710-3914; Pauwels, Kris/0000-0002-7341-0890; Serpell, Louise/0000-0001-9335-7751; Morris, Kyle L/0000-0002-1717-8134; Schymkowitz, Joost/0000-0003-2020-0168	Fund for Scientific Research Flanders; Federal Office for Scientific Affairs, Belgium IUAP [P6/43]; Alzheimer's Research UK; Research Foundation-Flanders (FWO); Stichting Alzheimer Onderzoek (SAO); European Molecular Biology Organization [ALTF 512-2008]; agency for Innovation by Science and Technology; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish; BBSRC [BB/E009042/1] Funding Source: UKRI; MRC [MC_U117533887, MC_U117584256] Funding Source: UKRI	Fund for Scientific Research Flanders(FWO); Federal Office for Scientific Affairs, Belgium IUAP; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Research Foundation-Flanders (FWO)(FWO); Stichting Alzheimer Onderzoek (SAO); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); agency for Innovation by Science and Technology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Fund for Scientific Research Flanders, the Federal Office for Scientific Affairs, Belgium IUAP P6/43, Alzheimer's Research UK, the Research Foundation-Flanders (FWO), Stichting Alzheimer Onderzoek (SAO), and the FWO Odysseus Program.; Recipient of a European Molecular Biology Organization long term postdoctoral fellowship (ALTF 512-2008).; Supported by an agency for Innovation by Science and Technology doctoral fellowship.	Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Frost D, 2003, EUR J BIOCHEM, V270, P654, DOI 10.1046/j.1432-1033.2003.03415.x; Hellstrom-Lindahl E, 2009, NEUROCHEM INT, V55, P243, DOI 10.1016/j.neuint.2009.03.007; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2007, J APPL CRYSTALLOGR, V40, P966, DOI 10.1107/S0021889807034681; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9; Mann DMA, 1996, ANN NEUROL, V40, P149, DOI 10.1002/ana.410400205; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Myszka DG, 1999, METHOD ENZYMOL, V309, P386; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Ryu J, 2008, ANAL CHEM, V80, P2400, DOI 10.1021/ac7019514; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200	43	174	177	0	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5650	5660		10.1074/jbc.M111.264473	http://dx.doi.org/10.1074/jbc.M111.264473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157754	hybrid, Green Published			2022-12-25	WOS:000300638000042
J	Xu, XP; Sarbeng, EB; Vorvis, C; Kumar, DP; Zhou, L; Liu, QL				Xu, Xinping; Sarbeng, Evans Boateng; Vorvis, Christina; Kumar, Divya Prasanna; Zhou, Lei; Liu, Qinglian			Unique Peptide Substrate Binding Properties of 110-kDa Heat-shock Protein (Hsp110) Determine Its Distinct Chaperone Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; MOLECULAR CHAPERONE; YEAST HSP110; HSP70 CHAPERONES; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; STRUCTURAL BASIS; DNAK CHAPERONE; ATPASE DOMAIN; SPECIFICITY	The molecular chaperone 70-kDa heat-shock proteins (Hsp70s) play essential roles in maintaining protein homeostasis. Hsp110, an Hsp70 homolog, is highly efficient in preventing protein aggregation but lacks the hallmark folding activity seen in Hsp70s. To understand the mechanistic differences between these two chaperones, we first characterized the distinct peptide substrate binding properties of Hsp110s. In contrast to Hsp70s, Hsp110s prefer aromatic residues in their substrates, and the substrate binding and release exhibit remarkably fast kinetics. Sequence and structure comparison revealed significant differences in the two peptide-binding loops: the length and properties are switched. When we swapped these two loops in an Hsp70, the peptide binding properties of this mutant Hsp70 were converted to Hsp110-like, and more impressively, it functionally behaved like an Hsp110. Thus, the peptide substrate binding properties implemented in the peptide-binding loops may determine the chaperone activity differences between Hsp70s and Hsp110s.	[Xu, Xinping; Sarbeng, Evans Boateng; Vorvis, Christina; Kumar, Divya Prasanna; Zhou, Lei; Liu, Qinglian] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Liu, QL (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	qliu3@vcu.edu	Xu, Xinping/AAA-1304-2020; Prasanna Kumar, Divya/P-2759-2019	Prasanna Kumar, Divya/0000-0001-5935-379X; XU, XINPING/0000-0002-9568-4171	Virginia Commonwealth University School of Medicine; Ellison Medical Foundation; American Heart Association	Virginia Commonwealth University School of Medicine; Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association)	This work was supported by startup funds from the Virginia Commonwealth University School of Medicine (to Q. L.), a New Scholar Award in Aging from the Ellison Medical Foundation (to Q. L.) and a grant-in-aid award from the American Heart Association (to Q. L.).	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Bogatyreva Natalya S., 2006, Journal of Bioinformatics and Computational Biology, V4, P597, DOI 10.1142/S0219720006002016; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Goeckeler JL, 2008, FEBS LETT, V582, P2393, DOI 10.1016/j.febslet.2008.05.047; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatayama T, 1998, BIOCHEM BIOPH RES CO, V248, P395, DOI 10.1006/bbrc.1998.8979; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Manjili MH, 2002, CANCER RES, V62, P1737; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2004, J BIOL CHEM, V279, P19600, DOI 10.1074/jbc.M400921200; MUKAI H, 1993, GENE, V132, P57; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Parkhurst MR, 1998, CANCER RES, V58, P4895; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rudiger S, 2000, J MOL BIOL, V304, P245, DOI 10.1006/jmbi.2000.4193; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1992, EUR J BIOCHEM, V208, P699, DOI 10.1111/j.1432-1033.1992.tb17237.x; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shi L, 1996, BIOCHEMISTRY-US, V35, P3297, DOI 10.1021/bi951984l; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; WANG TF, 1993, J BIOL CHEM, V268, P26049; Wang XY, 2010, J IMMUNOL, V184, P6309, DOI 10.4049/jimmunol.0903891; Wang XY, 2000, FEBS LETT, V465, P98, DOI 10.1016/S0014-5793(99)01733-0; Wang XY, 2005, INT J HYPERTHER, V21, P717, DOI 10.1080/02656730500226407; Wang XY, 2001, J IMMUNOL, V166, P490, DOI 10.4049/jimmunol.166.1.490; Wegele H, 2003, J CHROMATOGR B, V786, P109, DOI 10.1016/S1570-0232(02)00724-9; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	68	64	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5661	5672		10.1074/jbc.M111.275057	http://dx.doi.org/10.1074/jbc.M111.275057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157767	Green Published, hybrid			2022-12-25	WOS:000300638000043
J	Shichiri, M; Kono, N; Shimanaka, Y; Tanito, M; Rotzoll, DE; Yoshida, Y; Hagihara, Y; Tamai, H; Arai, H				Shichiri, Mototada; Kono, Nozomu; Shimanaka, Yuta; Tanito, Masaki; Rotzoll, Daisy E.; Yoshida, Yasukazu; Hagihara, Yoshihisa; Tamai, Hiroshi; Arai, Hiroyuki			A Novel Role for alpha-Tocopherol Transfer Protein (alpha-TTP) in Protecting against Chloroquine Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NIEMANN-PICK-DISEASE; VITAMIN-E-DEFICIENCY; CELLS; HYDROXYCHLOROQUINE; ATAXIA; LIVER; C1; HEPATOCYTES; SPHINGOSINE	Chloroquine (CQ) is a widely prescribed anti-malarial agent and is also prescribed to treat autoimmune diseases. Clinical treatment with CQ is often accompanied by serious side effects such as hepatitis and retinopathy. As a weak base, CQ accumulates in intracellular acidic organelles, raises the pH, and induces osmotic swelling and permeabilization of acidic organelles, which account for CQ-induced cytotoxicity. We reported previously that CQ treatment caused alpha-tocopherol transfer protein (alpha-TTP), a gene product of familial vitamin E deficiency, to change its location from the cytosol to the surface of acidic organelles. Here we show that alpha-TTP plays a novel role in protecting against CQ toxicity both in vitro and in vivo. In the presence of CQ, rat hepatoma McARH7777 cells, which do not express alpha-TTP endogenously, showed more severe cytotoxicity, such as larger vacuolation of acidic organelles and caspase activation, than alpha-TTP transfectant cells. Similarly, alpha-TTP knockout mice showed more severe CQ toxicity, such as hepatotoxicity and retinopathy, than wild-type mice. These effects were not ameliorated by vitamin E supplementation. In contrast to bafilomycin A1 treatment, which prevents CQ accumulation in cells by raising the pH of acidic organelles, alpha-TTP expression prevented CQ accumulation without affecting the pH of acidic organelles. Taken together, our data suggest that alpha-TTP protects against CQ toxicity by preventing CQ accumulation in acidic organelles through a mechanism distinct from vitamin E transport.	[Shichiri, Mototada; Kono, Nozomu; Shimanaka, Yuta; Arai, Hiroyuki] Univ Tokyo, Dept Hlth Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shichiri, Mototada; Yoshida, Yasukazu; Hagihara, Yoshihisa] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka 5638577, Japan; [Shichiri, Mototada; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan; [Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, Matsue, Shimane 6938501, Japan; [Rotzoll, Daisy E.] Heidelberg Univ, Div Neonatol, Dept Pediat, D-69120 Heidelberg, Germany	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Osaka Medical College; Shimane University; Ruprecht Karls University Heidelberg	Arai, H (corresponding author), Univ Tokyo, Dept Hlth Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp	Shimanaka, Yuta/AHA-3394-2022; YOSHIDA, YASUKAZU/H-8510-2016; KONO, nozomu/AAM-3178-2020; Shichiri, Mototada/L-9276-2018; HAGIHARA, Yoshihisa/K-4996-2016	Shimanaka, Yuta/0000-0002-2333-0091; YOSHIDA, YASUKAZU/0000-0001-6034-2502; Shichiri, Mototada/0000-0003-1108-7597; HAGIHARA, Yoshihisa/0000-0002-5980-1764	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research [23227004] Funding Source: KAKEN	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (to H. A.), the Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry (to H. A.), Grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and the Japanese Ministry of Health, Labor, and Welfare (to H. A.).	Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; CAMBIAGGI A, 1957, ARCH OPHTHALMOL-CHIC, V57, P451; CHEN HW, 1984, J BIOL CHEM, V259, P8156; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; EKPECHI OL, 1964, ARCH DERMATOL, V89, P631; Galvan VG, 2007, CLIN RHEUMATOL, V26, P971, DOI 10.1007/s10067-006-0218-1; GOLDIN E, 1992, BIOCHIM BIOPHYS ACTA, V1127, P303, DOI 10.1016/0005-2760(92)90236-O; Gong YP, 2006, J PHARMACOL EXP THER, V316, P242, DOI 10.1124/jpet.105.089482; Horiguchi M, 2003, GENES CELLS, V8, P789, DOI 10.1046/j.1365-2443.2003.00676.x; Hosomi A, 1998, NEUROSCI LETT, V256, P159, DOI 10.1016/S0304-3940(98)00785-X; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; LINSER PJ, 1984, DEV BRAIN RES, V13, P65, DOI 10.1016/0165-3806(84)90077-4; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; MAKIN AJ, 1994, GUT, V35, P569, DOI 10.1136/gut.35.4.569; Marmor MF, 2002, OPHTHALMOLOGY, V109, P1377, DOI 10.1016/S0161-6420(02)01168-5; Michihara A, 2005, BIOL PHARM BULL, V28, P947, DOI 10.1248/bpb.28.947; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; SATO Y, 1993, J BIOL CHEM, V268, P17705; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shichiri M, 2007, BRAIN RES, V1182, P106, DOI 10.1016/j.brainres.2007.08.084; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; VANES HHG, 1994, MOL BIOCHEM PARASIT, V68, P209, DOI 10.1016/0166-6851(94)90166-X; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; Wozniacka A, 2007, LUPUS, V16, P89, DOI 10.1177/0961203306075384; Yokota T, 1997, ANN NEUROL, V41, P826, DOI 10.1002/ana.410410621; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098	35	17	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2926	2934		10.1074/jbc.M111.321281	http://dx.doi.org/10.1074/jbc.M111.321281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147702	Green Published, hybrid			2022-12-25	WOS:000300292300064
J	Bhatia, HS; Agrawal, R; Sharma, S; Huo, YX; Ying, Z; Gomez-Pinilla, F				Bhatia, Harsharan Singh; Agrawal, Rahul; Sharma, Sandeep; Huo, Yi-Xin; Ying, Zhe; Gomez-Pinilla, Fernando			Omega-3 Fatty Acid Deficiency during Brain Maturation Reduces Neuronal and Behavioral Plasticity in Adulthood	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; NEUROPEPTIDE-Y; RAT-BRAIN; FATTY-ACIDS; ANXIETY; EXPRESSION; DEPRESSION; DEPRIVATION; DISORDERS; INCREASES	Omega-3-fatty acid DHA is a structural component of brain plasma membranes, thereby crucial for neuronal signaling; however, the brain is inefficient at synthesizing DHA. We have asked how levels of dietary n-3 fatty acids during brain growth would affect brain function and plasticity during adult life. Pregnant rats and their male offspring were fed an n-3 adequate diet or n-3 deficient diets for 15 weeks. Results showed that the n-3 deficiency increased parameters of anxiety-like behavior using open field and elevated plus maze tests in the male offspring. Behavioral changes were accompanied by a level reduction in the anxiolytic-related neuropeptide Y-1 receptor, and an increase in the anxiogenic-related glucocorticoid receptor in the cognitive related frontal cortex, hypothalamus and hippocampus. The n-3 deficiency reduced brain levels of docosahexaenoic acid (DHA) and increased the ratio n-6/ n-3 assessed by gas chromatography. The n-3 deficiency reduced the levels of BDNF and signaling through the BDNF receptor TrkB, in proportion to brain DHA levels, and reduced the activation of the BDNF-related signaling molecule CREB in selected brain regions. The n-3 deficiency also disrupted the insulin signaling pathways as evidenced by changes in insulin receptor (IR) and insulin receptor substrate (IRS). DHA deficiency during brain maturation reduces plasticity and compromises brain function in adulthood. Adequate levels of dietary DHA seem crucial for building long-term neuronal resilience for optimal brain performance and aiding in the battle against neurological disorders.	[Bhatia, Harsharan Singh; Agrawal, Rahul; Sharma, Sandeep; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, UCLA Brain Injury Res Ctr, Los Angeles, CA USA; [Huo, Yi-Xin] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bhatia, HS (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Sharma, Sandeep/AAU-7050-2021; Bhatia, Harsharan singh/AAR-4628-2021; Sharma, Sandeep/A-9248-2011; Agrawal, Rahul/F-6412-2015	Sharma, Sandeep/0000-0002-9680-7460; Sharma, Sandeep/0000-0002-9680-7460; Agrawal, Rahul/0000-0001-8128-3724; Bhatia, Harsharan Singh/0000-0001-9912-8263; huo, yixin/0000-0003-4644-999X	National Institutes of Health [NS50465, NS56413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS50465 and NS56413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bergami Matteo, 2009, Commun Integr Biol, V2, P14; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Branchi I, 2006, BEHAV BRAIN RES, V172, P299, DOI 10.1016/j.bbr.2006.05.019; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; CRAWFORD MA, 1976, LANCET, V1, P452; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Ernst C, 2011, BIOL PSYCHIAT, V69, P604, DOI 10.1016/j.biopsych.2010.10.008; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gomez-Pinilla F, 2010, NEUROSCIENCE, V168, P130, DOI 10.1016/j.neuroscience.2010.02.070; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Igarashi M, 2007, J LIPID RES, V48, P1150, DOI 10.1194/jlr.M600549-JLR200; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Koponen E, 2005, CELL MOL NEUROBIOL, V25, P973, DOI 10.1007/s10571-005-8468-z; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Moriguchi T, 2001, J LIPID RES, V42, P419; Nakajima M, 1998, PEPTIDES, V19, P359, DOI 10.1016/S0196-9781(97)00298-2; Nibuya M, 1996, J NEUROSCI, V16, P2365; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Pandey SC, 2003, TRENDS PHARMACOL SCI, V24, P456, DOI 10.1016/S0165-6147(03)00226-8; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; SINCLAIR AJ, 1975, LIPIDS, V10, P175, DOI 10.1007/BF02534156; Suganuma H, 2010, NEUROPATHOLOGY, V30, P597, DOI 10.1111/j.1440-1789.2010.01114.x; Vaynman S, 2006, NEUROSCIENCE, V139, P1221, DOI 10.1016/j.neuroscience.2006.01.062; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Zhang HB, 2003, PEPTIDES, V24, P1397, DOI 10.1016/j.peptides.2003.08.008	38	128	129	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28451	10.1371/journal.pone.0028451	http://dx.doi.org/10.1371/journal.pone.0028451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163304	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900041
J	Geng, J; Liang, D; Jiang, K; Zhang, P				Geng, Jie; Liang, Dan; Jiang, Ke; Zhang, Peng			Molecular Evolution of the Infrared Sensory Gene TRPA1 in Snakes and Implications for Functional Studies	PLOS ONE			English	Article							SELECTION; RECEPTOR; ANKYRIN; VISION	TRPA1 is a calcium ion channel protein recently identified as the infrared receptor in pit organ-containing snakes. Therefore, understanding the molecular evolution of TRPA1 may help to illuminate the origin of "heat vision" in snakes and reveal the molecular mechanism of infrared sensitivity for TRPA1. To this end, we sequenced the infrared sensory gene TRPA1 in 24 snake species, representing nine snake families and multiple non-snake outgroups. We found that TRPA1 is under strong positive selection in the pit-bearing snakes studied, but not in other non-pit snakes and non-snake vertebrates. As a comparison, TRPV1, a gene closely related to TRPA1, was found to be under strong purifying selection in all the species studied, with no difference in the strength of selection between pit-bearing snakes and non-pit snakes. This finding demonstrates that the adaptive evolution of TRPA1 specifically occurred within the pit-bearing snakes and may be related to the functional modification for detecting infrared radiation. In addition, by comparing the TRPA1 protein sequences, we identified 11 amino acid sites that were diverged in pit-bearing snakes but conserved in non-pit snakes and other vertebrates, 21 sites that were diverged only within pit-vipers but conserved in the remaining snakes. These specific amino acid substitutions may be potentially functional important for infrared sensing.	[Geng, Jie; Liang, Dan; Jiang, Ke; Zhang, Peng] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Geng, J (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	alarzhang@gmail.com	Zhang, Peng/F-9664-2013					Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; BULLOCK TH, 1956, J PHYSIOL-LONDON, V134, P47, DOI 10.1113/jphysiol.1956.sp005624; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Ebert J, 2007, THESIS RHEINISCHE F; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Grace MS, 2001, BEHAV BRAIN RES, V119, P23, DOI 10.1016/S0166-4328(00)00336-3; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nylander J, 2004, MR MODELTEST V2 PROG; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pride DT, 2000, SWAAP TOOL ANAL SUBS; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vidal Nicolas, 2009, P390; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Yokoyama S, 2011, MOL BIOL EVOL, V28, P45, DOI 10.1093/molbev/msq267; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812	36	15	16	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28644	10.1371/journal.pone.0028644	http://dx.doi.org/10.1371/journal.pone.0028644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163322	Green Submitted, gold, Green Published			2022-12-25	WOS:000298161900058
J	Kakishima, S; Yoshimura, J; Murata, H; Murata, J				Kakishima, Satoshi; Yoshimura, Jin; Murata, Hiroko; Murata, Jin			6-Year Periodicity and Variable Synchronicity in a Mass-Flowering Plant	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; SEED PRODUCTION; POLLINATION; VERSICOLOR; BEHAVIOR; CICADAS; BAMBOOS; TREES; LONG	Periodical organisms, such as bamboos and periodical cicadas, are very famous for their synchronous reproduction. In bamboos and other periodical plants, the synchronicity of mass-flowering and withering has been often reported indicating these species are monocarpic (semelparous) species. Therefore, synchronicity and periodicity are often suspected to be fairly tightly coupled traits in these periodical plants. We investigate the periodicity and synchronicity of Strobilanthes flexicaulis, and a closely related species S. tashiroi on Okinawa Island, Japan. The genus Strobilanthes is known for several periodical species. Based on 32-year observational data, we confirmed that S. flexicaulis is 6-year periodical mass-flowering monocarpic plant. All the flowering plants had died after flowering. In contrast, we found that S. tashiroi is a polycarpic perennial with no mass-flowering from three-year individual tracking. We also surveyed six local populations of S. flexicaulis and found variation in the synchronicity from four highly synchronized populations (> 98% of plants flowering in the mass year) to two less synchronized one with 11-47% of plants flowering before and after the mass year. This result might imply that synchrony may be selected for when periodicity is established in monocarpic species. We found the selective advantages for mass-flowering in pollinator activities and predator satiation. The current results suggest that the periodical S. flexicaulis might have evolved periodicity from a non-periodical close relative. The current report should become a key finding for understanding the evolution of periodical plants.	[Kakishima, Satoshi; Murata, Jin] Univ Tokyo, Grad Sch Sci, Bot Gardens, Bunkyo Ku, Tokyo 113, Japan; [Yoshimura, Jin] Shizuoka Univ, Dept Syst Engn, Hamamatsu, Shizuoka, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Chiba, Japan; [Murata, Hiroko] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 57301, Japan	University of Tokyo; Shizuoka University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Chiba University; Setsunan University	Kakishima, S (corresponding author), Univ Tokyo, Grad Sch Sci, Bot Gardens, Bunkyo Ku, Tokyo 113, Japan.	kakishima@ns.bg.s.u-tokyo.ac.jp		Kakishima, Satoshi/0000-0001-6000-3068	Japan Society for the Promotion of Science; Global COE (Integrative Life Science Based on the Study of Biosignaling Mechanisms); Ministry of Education, Culture, Sports, Science and Technology, Japan;  [20370032];  [22255004];  [22370010]; Grants-in-Aid for Scientific Research [21570100, 22370010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE (Integrative Life Science Based on the Study of Biosignaling Mechanisms); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research to J.M. (no. 20370032) and J.Y. (nos. 22255004 and 22370010), and Grant-in-Aid for JSPS Fellows to S. K. from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), and Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), The Ministry of Education, Culture, Sports, Science and Technology, Japan ( http://www.coe.s.u-tokyo.ac.jp/integr-life/english/index.html) to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. D., 1962, U MICHIGAN MUSEUM ZO, V121, P1; Burd M, 2006, ECOLOGY, V87, P2755, DOI 10.1890/0012-9658(2006)87[2755:APFRIM]2.0.CO;2; Daniel Thomas F., 2006, Proceedings of the California Academy of Sciences, V57, P1011; Forget PM, 1999, J TROP ECOL, V15, P61, DOI 10.1017/S026646749900067X; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Keeley JE, 1999, AM NAT, V154, P383, DOI 10.1086/303243; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 2001, ECOLOGY, V82, P117, DOI 10.1890/0012-9658(2001)082[0117:ETWPBO]2.0.CO;2; KITAJIMA K, 1989, ECOLOGY, V70, P1102, DOI 10.2307/1941379; Koenig WD, 2003, OIKOS, V102, P581, DOI 10.1034/j.1600-0706.2003.12272.x; Makita Akifumi, 1998, Plant Species Biology, V13, P85, DOI 10.1111/j.1442-1984.1998.tb00251.x; Read J, 2008, AM J BOT, V95, P558, DOI 10.3732/ajb.2007194; SILVERTOWN JW, 1980, BIOL J LINN SOC, V14, P235, DOI 10.1111/j.1095-8312.1980.tb00107.x; Soek DI, 2004, J JAP BOT, V79, P145; Tsvuura Z, 2011, ANN BOT-LONDON, V107, P379, DOI 10.1093/aob/mcq262; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; Wood J. R. I., 2003, Kew Bulletin, V58, P83, DOI 10.2307/4119357; Wood J. R. I., 1994, Edinburgh Journal of Botany, V51, P175; YAMAZAKI T, 1991, Journal of Japanese Botany, V66, P303; Yoshimura J, 1997, AM NAT, V149, P112, DOI 10.1086/285981	24	19	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28140	10.1371/journal.pone.0028140	http://dx.doi.org/10.1371/journal.pone.0028140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163279	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900014
J	Djadid, ND; Jazayeri, H; Raz, A; Favia, G; Ricci, I; Zakeri, S				Djadid, Navid Dinparast; Jazayeri, Hoda; Raz, Abbasali; Favia, Guido; Ricci, Ignacio; Zakeri, Sedigheh			Identification of the Midgut Microbiota of An. stephensi and An. maculipennis for Their Application as a Paratransgenic Tool against Malaria	PLOS ONE			English	Article							ANOPHELES-STEPHENSI; SPOROGONIC DEVELOPMENT; CULEX-QUINQUEFASCIATUS; SYMBIOTIC BACTERIA; MOSQUITO MIDGUT; GAMBIAE; CULICIDAE; DIPTERA; VECTOR	The midgut microbiota associated with Anopheles stephensi and Anopheles maculipennis (Diptera: Culicidae) was investigated for development of a paratransgenesis-based approach to control malaria transmission in Eastern Mediterranean Region (EMR). Here, we present the results of a polymerase chain reaction (PCR) and biochemical-based approaches to identify the female adult and larvae mosquitoe microbiota of these two major malaria vectors, originated from South Eastern and North of Iran. Plating the mosquito midgut contents from lab-reared and field-collected Anopheles spp. was used for microbiota isolation. The Gram-negative and Gram-positive bacterial colonies were identified by Gram staining and specific mediums. Selected colonies were identified by differential biochemical tests and 16S rRNA gene sequence analysis. A number of 10 An. stephensi and 32 An. maculipennis adult mosquitoes and 15 An. stephensi and 7 An. maculipennis larvae were analyzed and 13 sequences of 16S rRNA gene bacterial species were retrieved, that were categorized in 3 classes and 8 families. The majority of the identified bacteria were belonged to the gamma-proteobacteria class, including Pseudomonas sp. and Aeromonas sp. and the others were some closely related to those found in other vector mosquitoes, including Pantoea, Acinetobacter, Brevundimonas, Bacillus, Sphingomonas, Lysinibacillus and Rahnella. The 16S rRNA sequences in the current study aligned with the reference strains available in GenBank were used for construction of the phylogenetic tree that revealed the relatedness among the bacteria identified. The presented data strongly encourage further investigations, to verify the potential role of the detected bacteria for the malaria control in Iran and neighboring countries.	[Djadid, Navid Dinparast; Jazayeri, Hoda; Raz, Abbasali; Zakeri, Sedigheh] Pasteur Inst Iran, Biotechnol Res Ctr BRC, Malaria & Vector Res Grp MVRG, Tehran, Iran; [Favia, Guido; Ricci, Ignacio] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Camerino	Djadid, ND (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr BRC, Malaria & Vector Res Grp MVRG, Tehran, Iran.	navidmvrg@gmail.com	Jazayeri, Seyede Hoda/AAO-3652-2021; Djadid, Navid D/L-2910-2017; Raz, Abbasali/L-1319-2017; Zakeri, Sedigheh/L-1274-2017	Jazayeri, Seyede Hoda/0000-0002-9620-7684; Djadid, Navid D/0000-0002-2277-4504; Raz, Abbasali/0000-0002-7937-8350; Zakeri, Sedigheh/0000-0003-0933-0981; Favia, Guido/0000-0002-4420-8482	MOH, Iran; Pasteur Institute of Iran	MOH, Iran; Pasteur Institute of Iran	This work has been jointly funded by Deputy for Research, MOH, I.R. Iran and Pasteur Institute of Iran in the frame of "International Research Cooperation and Grant Scheme" dme.behdasht.gov.ir; www.pasteur.ac.ir. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144; Chao J., 1960, Journal of Insect Pathology, V2, P220; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; FERGUSON MJ, 1961, J INSECT PATHOL, V3, P112; Fouda M. A., 2001, Journal of the Egyptian Society of Parasitology, V31, P767; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; JADIN J, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P514; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Manson P., 1897, British Medical Journal, Vii, P1786; Pidiyar V, 2002, INT J SYST EVOL MICR, V52, P1723, DOI [10.1099/ijs.0.02019-0, 10.1099/00207713-52-5-1723]; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Ramirez JL, 2009, CURR MOL MED, V9, P116, DOI 10.2174/156652409787581600; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Ross R, 1897, Br Med J, V1, P251; SEITZ HM, 1987, ZBL BAKT-INT J MED M, V266, P155; SHAHGUDIAN E R, 1960, Acta Med Iran, V3, P38; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; Vasanthi V., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P312; Yoshida S, 2001, MOL BIOCHEM PARASIT, V113, P89, DOI 10.1016/S0166-6851(00)00387-X	29	79	80	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28484	10.1371/journal.pone.0028484	http://dx.doi.org/10.1371/journal.pone.0028484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163022	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500025
J	Wang, X; Li, GX; Ren, YD; Ren, XF				Wang, Xin; Li, Guangxing; Ren, Yudong; Ren, Xiaofeng			Phages Bearing Affinity Peptides to Bovine Rotavirus Differentiate the Virus from Other Viruses	PLOS ONE			English	Article							A ROTAVIRUS; DIARRHEA; VACCINE	The aim of this study was to identify potential ligands and develop a novel diagnostic test to pathogenic bovine rotavirus (BRV) using phage display technology. The viruses were used as an immobilized target followed by incubation with a 12-mer phage display random peptide library. After five rounds of biopanning, phages had a specific binding activity to BRV were isolated. DNA sequencing indicated that phage displayed peptides HVHPPLRPHSDK, HATNHLPTPHNR or YPTHHAHTTPVR were potential ligands to BRV. Using the specific peptide-expressing phages, we developed a phage-based ELISA to differentiate BRV from other viruses. Compared with quantitative real-time PCR (qPCR), the phage-mediated ELISA was more suitable for the capture of BRV and the detection limitation of this approach was 0.1 mu g/ml of samples. The high sensitivity, specificity and low cross-reactivity for the phage-based ELISA were confirmed in receiver operating characteristics (ROC) analysis.	[Wang, Xin; Li, Guangxing; Ren, Xiaofeng] NE Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Harbin, Peoples R China; [Ren, Yudong] NE Agr Univ, Coll Engn, Dept Comp, Harbin, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Wang, X (corresponding author), NE Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn	wang, xin/HGT-7291-2022	wang, xin/0000-0002-2968-3082	Natural Science Foundation of China [30972195, 31172295]; Heilongjiang Provincial University [1155-NCET-005, 2011TD001]; University of Ministry of Education of People's Republic of China [NCET-10-0144]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial University; University of Ministry of Education of People's Republic of China	The authors acknowledge National Natural Science Foundation of China (30972195; 31172295), funding supported by Program for New Century Excellent Talents in Heilongjiang Provincial University (1155-NCET-005), Research Team Program on Scientific and Technological Innovation in Heilongjiang Provincial University (2011TD001) and Program for New Century Excellent Talents in University of Ministry of Education of People's Republic of China (NCET-10-0144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHANASSIOUS R, 1994, CAN VET J, V35, P163; Estes MK, 2001, FIELDS VIROLOGY, V2, P1917; Ha TPM, 2009, J CLIN MICROBIOL, V47, P3329, DOI 10.1128/JCM.01583-08; Hayden MS, 1997, CURR OPIN IMMUNOL, V9, P201, DOI 10.1016/S0952-7915(97)80136-7; Kang SK, 2008, J BIOTECHNOL, V135, P210, DOI 10.1016/j.jbiotec.2008.01.021; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Knipe DM, 2001, FIELDS VIROLOGY, V2, P1747; Kwon HJ, 2010, BIOORGAN MED CHEM, V18, P7668, DOI 10.1016/j.bmc.2010.07.073; Latzka J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019383; Lee S, 2010, CLIN VACCINE IMMUNOL, V17, P1647, DOI 10.1128/CVI.00135-10; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Li X, 2010, CHINES J PREVENTIVE, V9, P664; Liu XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019848; MADKOUR AA, 1993, J PEDIATR GASTR NUTR, V17, P176, DOI 10.1097/00005176-199308000-00008; Maes RK, 2003, J CLIN MICROBIOL, V41, P290, DOI 10.1128/JCM.41.1.290-294.2003; Ren XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018669; Ren XF, 2011, VIROLOGY, V410, P299, DOI 10.1016/j.virol.2010.11.014; Ren XF, 2010, J CLIN MICROBIOL, V48, P1875, DOI 10.1128/JCM.01707-09; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; World Health Organization, 2008, WHOIVB0816; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023058	21	8	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28667	10.1371/journal.pone.0028667	http://dx.doi.org/10.1371/journal.pone.0028667			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163050	gold, Green Submitted, Green Published			2022-12-25	WOS:000298173500045
J	Yimer, G; Ueda, N; Habtewold, A; Amogne, W; Suda, A; Riedel, KD; Burhenne, J; Aderaye, G; Lindquist, L; Makonnen, E; Aklillu, E				Yimer, Getnet; Ueda, Nobuhisa; Habtewold, Abiy; Amogne, Wondwossen; Suda, Akira; Riedel, Klaus-Dieter; Burhenne, Juergen; Aderaye, Getachew; Lindquist, Lars; Makonnen, Eyasu; Aklillu, Eleni			Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INDUCED HEPATOTOXICITY; N-ACETYLTRANSFERASE-2 GENE; ANTITUBERCULOSIS THERAPY; RAPID ACETYLATORS; TUBERCULOSIS; POLYMORPHISM; CYP2B6; NAT2; INDIVIDUALS	Background: Implication of pharmacogenetic variations and efavirenz pharmacokinetics in concomitant efavirenz based antiviral therapy and anti-tubercular drug induced liver injury (DILI) has not been yet studied. We performed a prospective case-control association study to identify the incidence, pharmacogenetic, pharmacokinetic and biochemical predictors for anti-tubercular and antiretroviral drugs induced liver injury (DILI) in HIV and tuberculosis (TB) co-infected patients. Methods and Findings: Newly diagnosed treatment naive TB-HIV co-infected patients (n = 353) were enrolled to receive efavirenz based ART and rifampicin based anti-TB therapy, and assessed clinically and biochemically for DILI up to 56 weeks. Quantification of plasma efavirenz and 8-hydroxyefaviernz levels and genotyping for NAT2, CYP2B6, CYP3A5, ABCB1, UGT2B7 and SLCO1B1 genes were done. The incidence of DILI and identification of predictors was evaluated using survival analysis and the Cox Proportional Hazards Model. The incidence of DILI was 30.0%, or 14.5 per 1000 person-week, and that of severe was 18.4%, or 7.49 per 1000 person-week. A statistically significant association of DILI with being of the female sex (p = 0.001), higher plasma efavirenz level (p = 0.009), efavirenz/8-hydroxyefavirenz ratio (p = 0.036), baseline AST (p = 0.022), ALT (p = 0.014), lower hemoglobin (p = 0.008), and serum albumin (p = 0.007), NAT2 slow-acetylator genotype (p = 0.039) and ABCB1 3435TT genotype (p = 0.001). Conclusion: We report high incidence of anti-tubercular and antiretroviral DILI in Ethiopian patients. Between patient variability in systemic efavirenz exposure and pharmacogenetic variations in NAT2, CYP2B6 and ABCB1 genes determines susceptibility to DILI in TB-HIV co-infected patients. Close monitoring of plasma efavirenz level and liver enzymes during early therapy and/or genotyping practice in HIV clinics is recommended for early identification of patients at risk of DILI.	[Yimer, Getnet; Ueda, Nobuhisa; Habtewold, Abiy; Suda, Akira; Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden; [Yimer, Getnet; Habtewold, Abiy; Makonnen, Eyasu] Univ Addis Ababa, Dept Pharmacol, Fac Med, Addis Ababa, Ethiopia; [Amogne, Wondwossen; Aderaye, Getachew] Univ Addis Ababa, Dept Internal Med, Fac Med, Addis Ababa, Ethiopia; [Amogne, Wondwossen; Lindquist, Lars] Karolinska Inst, Div Infect Dis, Dept Med, Stockholm, Sweden; [Riedel, Klaus-Dieter; Burhenne, Juergen] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany	Karolinska Institutet; Addis Ababa University; Addis Ababa University; Karolinska Institutet; Ruprecht Karls University Heidelberg	Yimer, G (corresponding author), Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden.	Eleni.Aklillu@ki.se	Degu, Wondwossen Amogne/GON-3590-2022; Aklillu, Eleni/ABG-3461-2021; Burhenne, Jürgen/AAU-2769-2021; Yimer, Getnet/A-9436-2015	Burhenne, Jürgen/0000-0002-2190-1698; Makonnen, Eyasu/0000-0002-9259-5288; Yimer, Getnet/0000-0002-1469-837X; Aklillu, Eleni/0000-0002-9788-0790	EDCTP (European & Developing Countries Clinical Trials Partnership) [CG_TA.05.40204_005, CT.2005.32030.001]; SIDA/SAREC [HIV-2006-031, SWE 2007-270]	EDCTP (European & Developing Countries Clinical Trials Partnership); SIDA/SAREC	This study was supported by grants from EDCTP (European & Developing Countries Clinical Trials Partnership), CG_TA.05.40204_005, CT.2005.32030.001 and SIDA/SAREC HIV-2006-031, SWE 2007-270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha A, 2003, INT J MOL MED, V11, P125; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Apostolova N, 2011, HEPATOLOGY, V54, P1009, DOI 10.1002/hep.24459; Bae SK, 2011, XENOBIOTICA, V41, P437, DOI 10.3109/00498254.2011.551849; BENICHOU C, 1990, J HEPATOL, V11, P272; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Coffie PA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-188; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Cohen K, 2009, ANTIVIR THER, V14, P687; Daly AK, 2010, PHARMACOGENOMICS, V11, P607, DOI [10.2217/pgs.10.24, 10.2217/PGS.10.24]; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; di Iulio J, 2009, PHARMACOGENET GENOM, V19, P300, DOI 10.1097/FPC.0b013e328328d577; Diaz-Molina R, 2008, MOL MED REP, V1, P875, DOI 10.3892/mmr_00000044; Djordjevic N, 2011, J CLIN PHARMACOL, V51, P994, DOI 10.1177/0091270010377630; Donald PR, 2007, EUR J CLIN PHARMACOL, V63, P633, DOI 10.1007/s00228-007-0305-5; Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94; Faucette SR, 2004, DRUG METAB DISPOS, V32, P348, DOI 10.1124/dmd.32.3.348; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Haas DW, 2009, JAIDS-J ACQ IMM DEF, V50, P290, DOI 10.1097/QAI.0b013e318189a7df; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Habtewold A, 2011, J ANTIMICROB CHEMOTH, V66, P2350, DOI 10.1093/jac/dkr304; Higuchi N, 2007, WORLD J GASTROENTERO, V13, P6003, DOI 10.3748/wjg.13.6003; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kontorinis N, 2003, SEMIN LIVER DIS, V23, P173; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; MITCHELL JR, 1975, CLIN PHARMACOL THER, V18, P70; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Mutlib AE, 1999, DRUG METAB DISPOS, V27, P1319; Ngaimisi E, 2010, CLIN PHARMACOL THER, V88, P676, DOI 10.1038/clpt.2010.172; Niemi M, 2006, PHARMACOGENET GENOM, V16, P565, DOI 10.1097/01.fpc.0000215070.52212.0e; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Ramachandran G, 2009, ANTIMICROB AGENTS CH, V53, P863, DOI 10.1128/AAC.00899-08; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Ren Y, 2009, JAIDS-J ACQ IMM DEF, V50, P439, DOI 10.1097/QAI.0b013e31819c33a3; Rodriguez-Rosado R, 1998, AIDS, V12, P1256, DOI 10.1097/00002030-199810000-00025; Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720; Saitoh A, 2007, JAIDS-J ACQ IMM DEF, V45, P280; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Stohr W, 2008, ANTIVIR THER, V13, P675; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Vavricka SR, 2002, HEPATOLOGY, V36, P164, DOI 10.1053/jhep.2002.34133; Vidal F, 2010, AIDS REV, V12, P15; Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423; Walker UA, 2007, CURR OPIN HIV AIDS, V2, P293, DOI 10.1097/COH.0b013e328122dbaa; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; Wen X, 2002, EUR J CLIN PHARMACOL, V57, P799, DOI 10.1007/s00228-001-0396-3; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; YAMAMOTO T, 1986, HEPATOLOGY, V6, P295, DOI 10.1002/hep.1840060223; Yimer G, 2012, PHARMACOGENOMICS J, V12, P499, DOI 10.1038/tpj.2011.34; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	60	76	83	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27810	10.1371/journal.pone.0027810	http://dx.doi.org/10.1371/journal.pone.0027810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162992	gold, Green Published, Green Submitted			2022-12-25	WOS:000298173500006
J	Hench, J; Hench, IB; Pujol, C; Ipsen, S; Brodesser, S; Mourier, A; Tolnay, M; Frank, S; Trifunovic, A				Hench, Juergen; Hench, Ivana Bratic; Pujol, Claire; Ipsen, Sabine; Brodesser, Susanne; Mourier, Arnaud; Tolnay, Markus; Frank, Stephan; Trifunovic, Aleksandra			A Tissue-Specific Approach to the Analysis of Metabolic Changes in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; ENERGY-METABOLISM; OXIDATIVE STRESS; GENETICS; DEFICIENCY; PROTEINS; SCREEN; DEFECT; MODEL	The majority of metabolic principles are evolutionarily conserved from nematodes to humans. Caenorhabditis elegans has widely accelerated the discovery of new genes important to maintain organismic metabolic homeostasis. Various methods exist to assess the metabolic state in worms, yet they often require large animal numbers and tend to be performed as bulk analyses of whole worm homogenates, thereby largely precluding a detailed studies of metabolic changes in specific worm tissues. Here, we have adapted well-established histochemical methods for the use on C. elegans fresh frozen sections and demonstrate their validity for analyses of morphological and metabolic changes on tissue level in wild type and various mutant strains. We show how the worm presents on hematoxylin and eosin (H&E) stained sections and demonstrate their usefulness in monitoring and the identification of morphological abnormalities. In addition, we demonstrate how Oil-Red-O staining on frozen worm cross-sections permits quantification of lipid storage, avoiding the artifact-prone fixation and permeabilization procedures of traditional whole-mount protocols. We also adjusted standard enzymatic stains for respiratory chain subunits (NADH, SDH, and COX) to monitor metabolic states of various C. elegans tissues. In summary, the protocols presented here provide technical guidance to obtain robust, reproducible and quantifiable tissue-specific data on worm morphology as well as carbohydrate, lipid and mitochondrial energy metabolism that cannot be obtained through traditional biochemical bulk analyses of worm homogenates. Furthermore, analysis of worm cross-sections overcomes the common problem with quantification in three-dimensional whole-mount specimens.	[Hench, Juergen; Ipsen, Sabine; Tolnay, Markus; Frank, Stephan] Univ Basel Hosp, Dept Neuropathol, Inst Pathol, CH-4031 Basel, Switzerland; [Hench, Ivana Bratic; Trifunovic, Aleksandra] Karolinska Inst, Dept Lab Med, Div Metab Dis, Stockholm, Sweden; [Hench, Ivana Bratic; Pujol, Claire; Trifunovic, Aleksandra] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Brodesser, Susanne] CECAD, Lipid Core Facil, Cologne, Germany; [Brodesser, Susanne] Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Mourier, Arnaud] Max Planck Inst Biol Ageing, Cologne, Germany	University of Basel; Karolinska Institutet; University of Cologne; University of Cologne; University of Cologne; Max Planck Society	Hench, J (corresponding author), Univ Basel Hosp, Dept Neuropathol, Inst Pathol, CH-4031 Basel, Switzerland.	jurgen.hench@gmail.com	MOURIER, Arnaud/I-8117-2012; MOURIER, Arnaud/F-9657-2019	MOURIER, Arnaud/0000-0002-5413-611X; MOURIER, Arnaud/0000-0002-5413-611X	Swedish Research Council [K2006-03P-20237-01-4]; CECAD (Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases) Cologne; Jeanssons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); CECAD (Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases) Cologne; Jeanssons Foundation; Ake Wiberg Foundation	This study was supported by grants from Swedish Research Council (K2006-03P-20237-01-4), CECAD (Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases) Cologne, Jeanssons Foundation (http://www.jeanssonsstiftelser.se/stipendiater.html), Ake Wiberg Foundation (http://www.ake-wiberg.com/) to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bianchi L, CULTURE EMBRYONIC C; Braeckman BP, 2002, MECH AGEING DEV, V123, P1447, DOI 10.1016/S0047-6374(02)00085-4; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Bratic I, 2010, METHODS, V51, P437, DOI 10.1016/j.ymeth.2010.03.003; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2; Duerr JS, IMMUNOHISTOCHEMISTRY; Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007; Grad LI, 2004, HUM MOL GENET, V13, P303, DOI 10.1093/hmg/ddh027; Haun C, 1998, P NATL ACAD SCI USA, V95, P5072, DOI 10.1073/pnas.95.9.5072; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jung CW, 2002, J NEUROSCI METH, V114, P165, DOI 10.1016/S0165-0270(01)00524-6; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McGhee J. D, C ELEGANS INTESTINE; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Paepe BD, 2009, CURRENT PROTOCOLS HU; Pearse AG, 1972, HISTOCHEMISTRY THEOR, V3; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pulak Rock, 2006, V351, P275; Rasband W, IMAGEJ; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Senoo-Matsuda N, 2003, J BIOL CHEM, V278, P22031, DOI 10.1074/jbc.M211377200; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Sheehan D.C., 1987, THEORY PRACTICE HIST; Signorelli P, 2002, METHOD ENZYMOL, V345, P275; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stiernagle T, MAINTENANCE C ELEGAN; Suthammarak W, 2010, J BIOL CHEM, V285, P40724, DOI 10.1074/jbc.M110.159608; Van Voorhies WA, 2002, FREE RADICAL BIO MED, V33, P587; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; WormBase Gene Summary for lpd-3, WORMBASE GEN SUMM LP; Xie GF, 1995, GENET ANAL-BIOMOL E, V12, P95, DOI 10.1016/1050-3862(95)00112-3; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810	48	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28417	10.1371/journal.pone.0028417	http://dx.doi.org/10.1371/journal.pone.0028417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162770	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800036
J	Osundiji, MA; Godes, ML; Evans, ML; Danial, NN				Osundiji, Mayowa A.; Godes, Marina L.; Evans, Mark L.; Danial, Nika N.			BAD Modulates Counterregulatory Responses to Hypoglycemia and Protective Glucoprivic Feeding	PLOS ONE			English	Article							SENSITIVE K+ CHANNELS; VENTROMEDIAL HYPOTHALAMUS CONTRIBUTES; ALPHA-CELL FUNCTION; GLUCAGON-SECRETION; BLOOD-GLUCOSE; FOOD-INTAKE; RAT-BRAIN; ANTECEDENT HYPOGLYCEMIA; ENERGY HOMEOSTASIS; HORMONE RESPONSES	Hypoglycemia or glucoprivation triggers protective hormonal counterregulatory and feeding responses to aid the restoration of normoglycemia. Increasing evidence suggests pertinent roles for the brain in sensing glucoprivation and mediating counterregulation, however, the precise nature of the metabolic signals and molecular mediators linking central glucose sensing to effector functions are not fully understood. Here, we demonstrate that protective hormonal and feeding responses to hypoglycemia are regulated by BAD, a BCL-2 family protein with dual functions in apoptosis and metabolism. BAD-deficient mice display impaired glycemic and hormonal counterregulatory responses to systemic glucoprivation induced by 2-deoxy-D-glucose. BAD is also required for proper counterregulatory responses to insulin-induced hypoglycemia as evident from significantly higher glucose infusion rates and lower plasma epinephrine levels during hyperinsulinemic hypoglycemic clamps. Importantly, RNA interference-mediated acute knockdown of Bad in the brain provided independent genetic evidence for its relevance in central glucose sensing and proper neurohumoral responses to glucoprivation. Moreover, BAD deficiency is associated with impaired glucoprivic feeding, suggesting that its role in adaptive responses to hypoglycemia extends beyond hormonal responses to regulation of feeding behavior. Together, these data indicate a previously unappreciated role for BAD in the control of central glucose sensing.	[Osundiji, Mayowa A.; Godes, Marina L.; Danial, Nika N.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Danial, Nika N.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Evans, Mark L.] Univ Cambridge, Dept Med, Metab Res Labs, Cambridge CB2 2QQ, England; [Evans, Mark L.] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Cambridge; University of Cambridge	Osundiji, MA (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	nika_danial@dfci.harvard.edu		Evans, Mark/0000-0001-8122-8987; Osundiji, Mayowa/0000-0001-6658-3964	Juvenile Diabetes Research Foundation [3-2010-472]; Burroughs Wellcome Fund Career Award in Biomedical Sciences; United States National Institutes of Health [K01CA10659, R01DK078081]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078081] Funding Source: NIH RePORTER; Medical Research Council [G0600717B] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MAO was supported by a post-doctoral fellowship from the Juvenile Diabetes Research Foundation (3-2010-472). NND is a recipient of the Burroughs Wellcome Fund Career Award in Biomedical Sciences. This work was supported by United States National Institutes of Health grants K01CA10659 and R01DK078081 (NND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; BEVERLY JL, 1995, AM J PHYSIOL-REG I, V269, pR1174; Beverly JL, 2000, AM J PHYSIOL-REG I, V279, pR990, DOI 10.1152/ajpregu.2000.279.3.R990; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; BORG WP, 1994, J CLIN INVEST, V93, P1677, DOI 10.1172/JCI117150; BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; BRANN DW, 1995, NEUROENDOCRINOLOGY, V61, P213, DOI 10.1159/000126843; Bu LH, 2005, NEUROSCI LETT, V385, P153, DOI 10.1016/j.neulet.2005.05.040; Chan O, 2008, DIABETES, V57, P1363, DOI 10.2337/db07-1559; Chan O, 2011, DIABETES, V60, P1582, DOI 10.2337/db10-1579; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; DAGOGOJACK SE, 1993, J CLIN INVEST, V91, P819, DOI 10.1172/JCI116302; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2010, ADV EXP MED BIOL, V687, P1; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dunn-Meynell AA, 2009, J NEUROSCI, V29, P7015, DOI 10.1523/JNEUROSCI.0334-09.2009; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Evans ML, 2004, DIABETES, V53, P2542, DOI 10.2337/diabetes.53.10.2542; HEPBURN DA, 1993, DIABETIC MED, V10, P940, DOI 10.1111/j.1464-5491.1993.tb00010.x; Jacobson L, 2006, AM J PHYSIOL-ENDOC M, V290, pE678, DOI 10.1152/ajpendo.00383.2005; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Kang L, 2006, DIABETES, V55, P412, DOI 10.2337/diabetes.55.02.06.db05-1229; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Levin BE, 2008, DIABETES, V57, P1371, DOI 10.2337/db07-1755; Lynch RM, 2000, DIABETES, V49, P693, DOI 10.2337/diabetes.49.5.693; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; MAYER J, 1952, Bull New Engl Med Cent, V14, P43; McCrimmon RJ, 2006, J CLIN INVEST, V116, P1723, DOI 10.1172/JCI27775; McCrimmon RJ, 2005, DIABETES, V54, P3169, DOI 10.2337/diabetes.54.11.3169; McCrimmon RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1076, DOI 10.1152/ajpendo.00195.2002; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Mobbs CV, 2001, AM J PHYSIOL-ENDOC M, V281, pE649, DOI 10.1152/ajpendo.2001.281.4.E649; Molina PE, 2001, BRAIN RES, V899, P201, DOI 10.1016/S0006-8993(01)02236-3; Osundiji MA, 2011, CURR DIABETES REV, V7, P84, DOI 10.2174/157339911794940701; Osundiji MA, 2010, ENDOCRINOLOGY, V151, P1499, DOI 10.1210/en.2009-0989; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Ritter S, 2000, BRAIN RES, V856, P37, DOI 10.1016/S0006-8993(99)02327-6; Rogers IT, 1999, CONTEMP TOP LAB ANIM, V38, P25; Roncero I, 2000, J NEUROCHEM, V74, P1848, DOI 10.1046/j.1471-4159.2000.0741848.x; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Slucca M, 2010, DIABETES, V59, P128, DOI 10.2337/db09-1098; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; WALL JS, 1957, AM J PHYSIOL, V189, P43, DOI 10.1152/ajplegacy.1957.189.1.43; Watts AG, 2010, FRONT NEUROENDOCRIN, V31, P32, DOI 10.1016/j.yfrne.2009.10.006; Yang XJ, 2004, DIABETES, V53, P67, DOI 10.2337/diabetes.53.1.67; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou HR, 2004, DIABETES, V53, P1482, DOI 10.2337/diabetes.53.6.1482	59	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28016	10.1371/journal.pone.0028016	http://dx.doi.org/10.1371/journal.pone.0028016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162752	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800009
J	Gutierrez, RA; Sorn, S; Nicholls, JM; Buchy, P				Gutierrez, Ramona Alikiiteaga; Sorn, San; Nicholls, John M.; Buchy, Philippe			Eurasian Tree Sparrows, Risk for H5N1 Virus Spread and Human Contamination through Buddhist Ritual: An Experimental Approach	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; DOMESTIC DUCKS; WILD BIRDS; A H5N1; PATHOGENICITY; EVOLUTION; FEATHERS; SUSCEPTIBILITY; TRANSMISSION; INOCULATION	Background: The Highly Pathogenic Avian Influenza H5N1 virus has dramatically spread throughout Southeast Asia since its first detection in 1997. Merit Release Birds, such as the Eurasian Tree Sparrow, are believed to increase one's positive karma when kissed and released during Buddhist rituals. Since these birds are often in close contact with both poultry and humans, we investigated their potential role in the spread of H5N1 virus. Methodology/Principal Findings: Seven series of experiments were conducted in order to investigate the possible interactions between inoculated and exposed birds, including sparrow/sparrow, sparrow/chicken, duck/sparrow. Daily and post-mortem samples collected were tested for H5N1 virus by real-time RT-PCR and egg inoculation. When directly inoculated, Eurasian Tree Sparrows were highly susceptible to the H5N1 virus, with a fatality rate approaching 100% within 5 days post-inoculation. Although transmission of fatal infection between sparrows did not occur, seroconversion of the exposed birds was observed. Up to 100% chickens exposed to inoculated sparrows died of H5N1 infection, depending on the caging conditions of the birds, while a fatality rate of 50% was observed on sparrows exposed to infected ducks. Large quantities of H5N1 virus were detected in the sparrows, particularly in their feathers, from which infectious particles were recovered. Conclusions/Significance: Our study indicates that under experimental conditions, Eurasian Tree Sparrows are susceptible to H5N1 infection, either by direct inoculation or by contact with infected poultry. Their ability to transmit H5N1 infection to other birds is also demonstrated, suggesting that the sparrows may play a role in the dissemination of the virus. Finally, the presence of significant quantities of H5N1 virus on sparrows' feathers, including infectious particles, would suggest that Merit Release Birds represent a risk for human contamination in countries where avian influenza virus is circulating and where this religious ritual is practiced.	[Gutierrez, Ramona Alikiiteaga; Buchy, Philippe] Inst Pasteur Cambodia, Virol Unit, Phnom Penh, Cambodia; [Sorn, San] Minist Agr Forestry & Fisheries, Natl Vet Inst, Phnom Penh, Cambodia; [Nicholls, John M.] Univ Hong Kong, Dept Pathol, Pok Fu Lam, Hong Kong, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of Hong Kong	Gutierrez, RA (corresponding author), Inst Pasteur Cambodia, Virol Unit, Phnom Penh, Cambodia.	pbuchy@pasteur-kh.org	; Nicholls, John Malcolm/C-4375-2009	BUCHY, Philippe/0000-0003-1372-3008; Nicholls, John Malcolm/0000-0001-7217-7444	French Ministry of Research; Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services	This work was supported by the French Ministry of Research and by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Breithaupt A, 2011, VET PATHOL, V48, P924, DOI 10.1177/0300985810386467; Brooks-Moizer F, 2009, ECOL SOC, V14; Busquets N, 2010, J GEN VIROL, V91, P2307, DOI 10.1099/vir.0.021592-0; Central Intelligence Agency (Ed.), 2011, WORLD FACTB 2011; Edmunds K, 2011, ECOHEALTH, V8, P63, DOI 10.1007/s10393-011-0691-0; Forrest HL, 2010, J VIROL, V84, P3718, DOI 10.1128/JVI.02017-09; Fujimoto Y, 2010, AVIAN PATHOL, V39, P95, DOI 10.1080/03079451003599268; Gutierrez RA, 2009, VIRUSES-BASEL, V1, P335, DOI 10.3390/v1030335; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Kalthoff D, 2008, PLOS ONE, V4, DOI 10.1371/journal.pone.0006170; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; KIDA H, 1980, INFECT IMMUN, V30, P547; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kou Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Liu QF, 2010, VIRUS RES, V147, P25, DOI 10.1016/j.virusres.2009.09.014; Nemeth NM, 2010, AVIAN PATHOL, V39, P411, DOI 10.1080/03079457.2010.513043; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; OIE World Organisation for Animal Health, 2011, OUTBR HIGHL PATH AV; OIE World Organization for Animal Health, 2009, MAN DIAGN TESTS VACC; Perkins LEL, 2003, VET PATHOL, V40, P14, DOI 10.1354/vp.40-1-14; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Poetranto ED, 2011, MICROBIOL IMMUNOL, V55, P666, DOI 10.1111/j.1348-0421.2011.00361.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Swayne DE, 2008, AVIAN DIS, V52, P455, DOI 10.1637/8229-012508-Reg.1; United States Commission on International Religious Freedom (USCRIF), 2010, US COMM INT REL FREE; USGS National Wildlife Health Center, 2011, LIST SPEC AFF H5N1 A; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2007, REC LAB PROC DET AV; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P1671, DOI [10.3201/1410.080415, 10.3201/eid1410.080415]; Yamamoto Y, 2007, AVIAN DIS, V51, P744, DOI 10.1637/0005-2086(2007)51[744:PICDII]2.0.CO;2; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P149, DOI 10.3201/eid1401.071036; Yamamoto Y, 2007, AVIAN DIS, V51, P52, DOI 10.1637/0005-2086(2007)051[0052:SNEWMA]2.0.CO;2; Yamamoto Y, 2010, APPL ENVIRON MICROB, V76, P5496, DOI 10.1128/AEM.00563-10; Yamamoto Y, 2009, J VET MED SCI, V71, P1549, DOI 10.1292/jvms.001549	39	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28609	10.1371/journal.pone.0028609	http://dx.doi.org/10.1371/journal.pone.0028609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164310	Green Published, gold			2022-12-25	WOS:000298171400112
J	Tajima, A; Iwaizumi, M; Tseng-Rogenski, S; Cabrera, BL; Carethers, JM				Tajima, Akihiro; Iwaizumi, Moriya; Tseng-Rogenski, Stephanie; Cabrera, Betty L.; Carethers, John M.			Both hMutS alpha and hMutS beta DNA Mismatch Repair Complexes Participate in 5-Fluorouracil Cytotoxicity	PLOS ONE			English	Article							COLORECTAL-CANCER; MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; MISPAIR-BINDING; COLON-CANCER; MUTS-ALPHA; IN-VITRO; MSH3; MUTATIONS; MSH2-MSH6	Background: Patients with advanced microsatellite unstable colorectal cancers do not show a survival benefit from 5-fluorouracil (5-FU)-based chemotherapy. We and others have shown that the DNA mismatch repair (MMR) complex hMutS alpha binds 5-FU incorporated into DNA. Although hMutS beta is known to interact with interstrand crosslinks (ICLs) induced by drugs such as cisplatin and psoralen, it has not been demonstrated to interact with 5-FU incorporated into DNA. Our aim was to examine if hMutS beta plays a role in 5-FU recognition. Methods: We compared the normalized growth of 5-FU treated cells containing either or both mismatch repair complexes using MTT and clonogenic assays. We utilized oligonucleotides containing 5-FU and purified baculovirus-synthesized hMutS alpha and hMutS beta in electromobility shift assays (EMSA) and further analyzed binding using surface plasmon resonance. Results: MTT and clonogenic assays after 5-FU treatment demonstrated the most cytotoxicity in cells with both hMutS alpha and hMutS beta, intermediate cytotoxicity in cells with hMutSa alone, and the least cytotoxicity in cells with hMutS beta alone, hMutS beta binds 5-FU-modified DNA, but its relative binding is less than the binding of 5-FU-modified DNA by hMutS alpha. Conclusion: Cytotoxicity induced by 5-FU is dependent on intact DNA MMR, with relative cell death correlating directly with hMutS alpha and/or hMutS beta 5-FU binding ability (hMutS alpha>hMutS beta). The MMR complexes provide a hierarchical chemosensitivity for 5-FU cell death, and may have implications for treatment of patients with certain MMR-deficient tumors.	[Tajima, Akihiro; Iwaizumi, Moriya; Cabrera, Betty L.; Carethers, John M.] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Iwaizumi, Moriya; Tseng-Rogenski, Stephanie; Carethers, John M.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Carethers, John M.] Univ Calif San Diego, Moores Comprehens Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Tajima, A (corresponding author), Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA.	jcarethe@umich.edu	Tajima, Akihiro/AAK-8017-2020; Iwaizumi, Moriya/AAG-3173-2019; Tajima, Akihiro/AAF-4912-2020	Tajima, Akihiro/0000-0003-4008-5048; Iwaizumi, Moriya/0000-0002-2629-0830; 	California Department of Health Services [99-86873]; United States Public Health Service [R01-CA90231, DK067287]; NATIONAL CANCER INSTITUTE [R01CA090231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287] Funding Source: NIH RePORTER	California Department of Health Services; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the California Department of Health Services Cancer Research Program (#99-86873 to JC), and the United States Public Health Service (R01-CA90231 and DK067287 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 2000, GASTROENTEROLOGY, V118, pS115, DOI 10.1016/S0016-5085(00)70010-2; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fischer F, 2007, GASTROENTEROLOGY, V133, P1858, DOI 10.1053/j.gastro.2007.09.003; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Iwaizumi M, 2011, CANC BIOL T IN PRESS; Johnson RE, 1996, J BIOL CHEM, V271, P7285, DOI 10.1074/jbc.271.13.7285; Jover R, 2009, EUR J CANCER, V45, P365, DOI 10.1016/j.ejca.2008.07.016; Kuraguchi M, 2001, CANCER RES, V61, P7934; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Liu A, 2008, J CELL BIOCHEM, V105, P245, DOI 10.1002/jcb.21824; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Meyers M, 2005, J BIOL CHEM, V280, P5516, DOI 10.1074/jbc.M412105200; Meyers M, 2001, CANCER RES, V61, P5193; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Tajima A, 2004, GASTROENTEROLOGY, V127, P1678, DOI 10.1053/j.gastro.2004.10.001; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; Umar A, 1998, GENETICS, V148, P1637; Vasquez KM, 2010, ENVIRON MOL MUTAGEN, V51, P527, DOI 10.1002/em.20557; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002	30	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28117	10.1371/journal.pone.0028117	http://dx.doi.org/10.1371/journal.pone.0028117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164234	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400035
J	Burdge, GC; Hoile, SP; Uller, T; Thomas, NA; Gluckman, PD; Hanson, MA; Lillycrop, KA				Burdge, Graham C.; Hoile, Samuel P.; Uller, Tobias; Thomas, Nicola A.; Gluckman, Peter D.; Hanson, Mark A.; Lillycrop, Karen A.			Progressive, Transgenerational Changes in Offspring Phenotype and Epigenotype following Nutritional Transition	PLOS ONE			English	Article							PROTEIN-RESTRICTED DIET; DEVELOPMENTAL PLASTICITY; EPIGENETIC INHERITANCE; PREGNANT RATS; IN-UTERO; METHYLATION; EVOLUTION; HSP90; ACCOMMODATION; MECHANISMS	Induction of altered phenotypes during development in response to environmental input involves epigenetic changes. Phenotypic traits can be passed between generations by a variety of mechanisms, including direct transmission of epigenetic states or by induction of epigenetic marks de novo in each generation. To distinguish between these possibilities we measured epigenetic marks over four generations in rats exposed to a sustained environmental challenge. Dietary energy was increased by 25% at conception in F0 female rats and maintained at this level to generation F3. F0 dams showed higher pregnancy weight gain, but lower weight gain and food intake during lactation than F1 and F2 dams. On gestational day 8, fasting plasma glucose concentration was higher and beta-hydroxybutyrate lower in F0 and F1 dams than F2 dams. This was accompanied by decreased phosphoenolpyruvate carboxykinase (PEPCK) and increased PPAR alpha and carnitine palmitoyl transferase-1 mRNA expression. PEPCK mRNA expression was inversely related to the methylation of specific CpG dinucleotides in its promoter. DNA methyltransferase (Dnmt) 3a2, but not Dnmt1 or Dnmt3b, expression increased and methylation of its promoter decreased from F1 to F3 generations. These data suggest that the regulation of energy metabolism during pregnancy and lactation within a generation is influenced by the maternal phenotype in the preceding generation and the environment during the current pregnancy. The transgenerational effects on phenotype were associated with altered DNA methylation of specific genes in a manner consistent with induction de novo of epigenetic marks in each generation.	[Burdge, Graham C.; Hoile, Samuel P.; Thomas, Nicola A.; Hanson, Mark A.] Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Inst Dev Sci,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Gluckman, Peter D.] Univ Auckland, Liggins Inst & Natl Res, Ctr Growth & Dev, Auckland 1, New Zealand; [Lillycrop, Karen A.] Univ Southampton, Fac Nat & Environm Sci, Inst Dev Sci, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England	University of Southampton; University of Oxford; University of Auckland; University of Southampton	Burdge, GC (corresponding author), Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Inst Dev Sci,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England.	g.c.burdge@southampton.ac.uk	Hanson, Mark/AAE-8236-2019; Burdge, Graham/A-2370-2014	Hanson, Mark/0000-0002-6907-613X; Burdge, Graham/0000-0002-7665-2967; Lillycrop, Karen/0000-0001-7350-5489	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F013043/1]; British Heart Foundation [CH/02/01]; BBSRC [BB/F013043/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013043/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F013043/1) to GCB, KAL and MAH. MAH receives salary support from the British Heart Foundation (CH/02/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; Badyaev AV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-3; Badyaev Alexander V., 2005, P277, DOI 10.1016/B978-012088777-4/50015-6; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1125, DOI 10.1098/rstb.2008.0285; BEALE EG, 1985, J BIOL CHEM, V260, P748; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Burdge GC, 2008, BRIT J NUTR, V99, P540, DOI 10.1017/S0007114507815819; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Crews D, 2008, FRONT NEUROENDOCRIN, V29, P344, DOI 10.1016/j.yfrne.2008.01.003; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guerrero-Bosagna CM, 2009, SEMIN REPROD MED, V27, P403, DOI 10.1055/s-0029-1237428; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kimura M, 1984, NEUTRAL THEORY MOL E; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Maestripieri D., 2009, MATERNAL EFFECTS MAM; Pimm SL, 2009, CURR BIOL, V19, pR595, DOI 10.1016/j.cub.2009.05.055; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Ruden DM, 2003, SEMIN CELL DEV BIOL, V14, P301, DOI 10.1016/j.semcdb.2003.09.024; Ruden DM, 2005, HUM MOL GENET, V14, pR149, DOI 10.1093/hmg/ddi103; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2009, SEMIN CELL DEV BIOL, V20, P304, DOI 10.1016/j.semcdb.2008.11.013; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; West-Eberhard Mary Jane, 2003, pi; West-Eberhard MJ, 2005, J EXP ZOOL PART B, V304B, P610, DOI 10.1002/jez.b.21071; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535	40	82	83	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28282	10.1371/journal.pone.0028282	http://dx.doi.org/10.1371/journal.pone.0028282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140567	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000298168100060
J	Balogh, K; Asa, SL; Zheng, L; Cassol, C; Cheng, S; Ezzat, S				Balogh, K.; Asa, S. L.; Zheng, L.; Cassol, C.; Cheng, S.; Ezzat, S.			The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression	ONCOGENE			English	Article						Grb14; RET; thyroid cancer; cancer progression	TYROSINE KINASE; EXPRESSION; ENDOCRINE; ASSOCIATION; FAMILY; GROWTH; ROLES	The growth factor receptor-bound protein (Grb) 14 is an adaptor molecule of the Grb7/10/14 family with characteristic Between Plekstrin and SH2 (BPS) domains serving to avidly bind tyrosine kinases. Grb14 inhibits insulin receptor (IR) catalytic activity through interaction with the BPS domain and impedes peptide substrate binding. Members of this Grb family have also been shown to interact with other kinases through their SH2 domain. Here we examined the functional role of Grb14 in thyroid cancer using loss- and gain-of-function approaches. Stable knockdown of Grb14 in thyroid cancer cells facilitated IR signaling. In contrast, RET phosphorylation was diminished in concert with reduced activation of Akt and signal transducer and activator of transcription 3 (STAT3). Loss of Grb14 also resulted in diminished cell proliferation and invasion both in vitro and in mouse flank xenografts. In complementary studies, forced expression of Grb14 interrupted IR signaling but facilitated RET activation, STAT3 and Akt phosphorylation. Consistent with these findings Grb14 overexpression enhanced cell invasion and resulted in striking metastases in an orthotopic thyroid cancer mouse xenograft model. Primary human thyroid cancer microarrays revealed a positive correlation between Grb14 expression and invasive behavior. Our findings uncover a new role for Grb14 in finely tuning receptor signaling and modulating thyroid cancer progression. Oncogene (2012) 31, 4012-4021; doi:10.1038/onc.2011.569; published online 12 December 2011	[Balogh, K.; Zheng, L.; Cheng, S.; Ezzat, S.] Univ Hlth Network, Ontario Canc Inst, Dept Med, Toronto, ON M5G 2M9, Canada; [Asa, S. L.; Cassol, C.] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Hosp, Pathol & Endocrine Oncol Site Grp, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Ezzat, S (corresponding author), Univ Hlth Network, Ontario Canc Inst, Dept Med, 610 Univ Ave,8-327, Toronto, ON M5G 2M9, Canada.	shereen.ezzat@utoronto.ca		Cassol, Clarissa/0000-0001-7536-6806; Asa, Sylvia/0000-0001-8418-5054	Canadian Institutes of Health Research (CIHR) [MOP-86493]; Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank Kelvin So for his technical assistance. This work was supported by the Canadian Institutes of Health Research (CIHR)(Grant MOP-86493), the Princess Margaret Hospital Foundation and the Ontario Ministry of Health and Long Term Care (OMOHLTC).	Asa SL, 2001, MODERN PATHOL, V14, P246, DOI 10.1038/modpathol.3880293; AVANTAGGIATO V, 1994, CELL GROWTH DIFFER, V5, P305; Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; Bereziat V, 2002, J BIOL CHEM, V277, P4845, DOI 10.1074/jbc.M106574200; Briese J, 2010, ANTICANCER RES, V30, P1681; Buckwalter TLF, 2002, ONCOGENE, V21, P8166, DOI 10.1038/sj.onc.1205938; Cheng S, 2011, CLIN CANCER RES, V17, P2385, DOI 10.1158/1078-0432.CCR-10-2837; Cheng S, 2009, ENDOCR-RELAT CANCER, V16, P455, DOI 10.1677/ERC-09-0002; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Daly RJ, 1996, J BIOL CHEM, V271, P12502, DOI 10.1074/jbc.271.21.12502; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Engelmann D, 2009, ENDOCR-RELAT CANCER, V16, P211, DOI 10.1677/ERC-08-0158; Ezzat S, 2005, J CLIN INVEST, V115, P1021, DOI 10.1172/JCI22486; Ezzat S, 2002, J CLIN INVEST, V109, P69, DOI 10.1172/JCI200214036; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hwang JH, 2003, MOL ENDOCRINOL, V17, P1155, DOI 10.1210/me.2002-0401; Kasus-Jacobi A, 1998, J BIOL CHEM, V273, P26026, DOI 10.1074/jbc.273.40.26026; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Liu W, 2007, ONCOGENE, V26, P2747, DOI 10.1038/sj.onc.1210077; Marchini S, 2008, CLIN CANCER RES, V14, P7850, DOI 10.1158/1078-0432.CCR-08-0523; MARGOLIS B, 1994, PROG BIOPHYS MOL BIO, V62, P223, DOI 10.1016/0079-6107(94)90013-2; Nouaille S, 2006, EMBO REP, V7, P512, DOI 10.1038/sj.embor.7400668; O-Sullivan I, 2008, CANCER RES, V68, P2463, DOI 10.1158/0008-5472.CAN-07-5685; Pandey A, 1996, J BIOL CHEM, V271, P10607, DOI 10.1074/jbc.271.18.10607; PANDEY A, 1995, J BIOL CHEM, V270, P21461, DOI 10.1074/jbc.270.37.21461; Reilly JF, 2000, J BIOL CHEM, V275, P7771, DOI 10.1074/jbc.275.11.7771; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Wang YJ, 2010, CLIN CANCER RES, V16, P2529, DOI 10.1158/1078-0432.CCR-10-0018; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	30	11	12	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	36					4012	4021		10.1038/onc.2011.569	http://dx.doi.org/10.1038/onc.2011.569			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NQ	22158039	Bronze, Green Accepted			2022-12-25	WOS:000308688800002
J	Le, HT; Gautier, V; Kthiri, F; Malki, A; Messaoudi, N; Mihoub, M; Landoulsi, A; An, YJ; Cha, SS; Richarme, G				Hai-Tuong Le; Gautier, Valerie; Kthiri, Fatoum; Malki, Abderrahim; Messaoudi, Nadia; Mihoub, Mouadh; Landoulsi, Ahmed; An, Young Jun; Cha, Sun-Shin; Richarme, Gilbert			YajL, Prokaryotic Homolog of Parkinsonism-associated Protein DJ-1, Functions as a Covalent Chaperone for Thiol Proteome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HSP31; RESOLUTION CRYSTAL-STRUCTURE; DISULFIDE-ISOMERASE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; ENDOPLASMIC-RETICULUM; BACTERIAL HOMOLOG; MUTANT DEFICIENT; CELL-DEATH; THIOREDOXIN	YajL is the closest Escherichia coli homolog of the Parkinsonism-associated protein DJ-1, a multifunctional oxidative stress response protein whose biochemical function remains unclear. We recently reported the aggregation of proteins in a yajL mutant in an oxidative stress-dependent manner and that YajL exhibits chaperone activity. Here, we show that YajL displays covalent chaperone and weak protein oxidoreductase activities that are dependent on its exposed cysteine 106. It catalyzes reduced RNase oxidation and scrambled RNase isomerization and insulin reduction and forms mixed disulfides with many cellular proteins upon oxidative stress. The formation of mixed disulfides was detected by immunoblotting bacterial extracts with anti-YajL antibodies under nonreducing conditions. Disulfides were purified from bacterial extracts on a YajL affinity column, separated by nonreducing-reducing SDS-PAGE, and identified by mass spectrometry. Covalent YajL substrates included ribosomal proteins, aminoacyl-tRNA synthetases, chaperones, catalases, peroxidases, and other proteins containing cysteines essential for catalysis or FeS cluster binding, such as glyceraldehyde-3-phosphate dehydrogenase, aldehyde dehydrogenase, aconitase, and FeS cluster-containing subunits of respiratory chains. In addition, we show that DJ-1 also forms mixed disulfides with cytoplasmic proteins upon oxidative stress. These results shed light on the oxidative stress-dependent chaperone function of YajL and identify YajL substrates involved in translation, stress protection, protein solubilization, and metabolism. They reveal a crucial role for cysteine 106 and suggest that DJ-1 also functions as a covalent chaperone. These findings are consistent with several defects observed in yajL or DJ-1 mutants, including translational defects, protein aggregation, oxidative stress sensitivity, and metabolic deficiencies.	[Hai-Tuong Le; Gautier, Valerie; Kthiri, Fatoum; Malki, Abderrahim; Messaoudi, Nadia; Mihoub, Mouadh; Richarme, Gilbert] Univ Paris 07, Stress Mol Grp, Inst Jacques Monod, CNRS, F-75013 Paris, France; [An, Young Jun; Cha, Sun-Shin] Korea Ocean Res & Dev Inst, Marine Biotechnol Res Ctr, Ansan 426744, South Korea; [Malki, Abderrahim] Univ Hassan II Mohammedia, Fac Sci Ben MSik, Casablanca, Morocco; [Kthiri, Fatoum; Messaoudi, Nadia; Mihoub, Mouadh; Landoulsi, Ahmed] Fac Sci Bizerte, Lab Biochim & Biol Mol, UR 0902 03, Bizerte, Tunisia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Korea Institute of Ocean Science & Technology (KIOST); Hassan II University of Casablanca; Universite de Carthage	Richarme, G (corresponding author), Univ Paris 07, Stress Mol Grp, Inst Jacques Monod, CNRS, 15 Rue Helene Brion, F-75013 Paris, France.	richarme@paris7.jussieu.fr		Cha, Sun-Shin/0000-0002-0913-8706; Landoulsi, Ahmed/0000-0002-5101-7641	PHC-Utique [10G0803]; la Fondation de la Recherche Medicale; Marine and Extreme Genome Research Cente of Ministry of Land, Transport, and Maritime Affairs, South Korea	PHC-Utique; la Fondation de la Recherche Medicale; Marine and Extreme Genome Research Cente of Ministry of Land, Transport, and Maritime Affairs, South Korea	This work was supported by grants from the PHC-Utique (to N. M. and M. M.) (Grant 10G0803), la Fondation de la Recherche Medicale (to F. K.), and the Marine and Extreme Genome Research Center program of Ministry of Land, Transport, and Maritime Affairs, South Korea (to Y. J. A. and S. C.).	Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; CALHOUN MW, 1993, J BACTERIOL, V175, P3013, DOI 10.1128/JB.175.10.3013-3019.1993; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cortini M, 2010, DIABETES OBES METAB, V12, P39, DOI 10.1111/j.1463-1326.2010.01272.x; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DECROUYCHANEL A, 1995, J BIOL CHEM, V270, P22669, DOI 10.1074/jbc.270.39.22669; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hu WT, 2010, ANAL BIOCHEM, V398, P245, DOI 10.1016/j.ab.2009.11.002; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kthiri F, 2010, J BACTERIOL, V192, P6302, DOI 10.1128/JB.01077-10; Kthiri F, 2010, J BIOL CHEM, V285, P10328, DOI 10.1074/jbc.M109.077529; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Ramsey CP, 2010, HUM MOL GENET, V19, P1425, DOI 10.1093/hmg/ddq017; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Walker KW, 1997, J BIOL CHEM, V272, P8845; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	49	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5861	5870		10.1074/jbc.M111.299198	http://dx.doi.org/10.1074/jbc.M111.299198			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157000	hybrid, Green Published			2022-12-25	WOS:000300638000060
J	Maeno, Y; Li, Q; Park, K; Rask-Madsen, C; Gao, BB; Matsumoto, M; Liu, YJ; Wu, IH; White, MF; Feener, EP; King, GL				Maeno, Yasuhiro; Li, Qian; Park, Kyoungmin; Rask-Madsen, Christian; Gao, Benbo; Matsumoto, Motonobu; Liu, Yingjie; Wu, I-Hsien; White, Morris F.; Feener, Edward P.; King, George L.			Inhibition of Insulin Signaling in Endothelial Cells by Protein Kinase C-induced Phosphorylation of p85 Subunit of Phosphatidylinositol 3-Kinase (PI3K)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-1 TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; NITRIC-OXIDE; DIABETIC COMPLICATIONS; GENE-EXPRESSION; PAI-1 GENE; IN-VIVO; ACTIVATION; GROWTH; RESISTANCE	The regulation of endothelial function by insulin is consistently abnormal in insulin-resistant states and diabetes. Protein kinase C (PKC) activation has been reported to inhibit insulin signaling selectively in endothelial cells via the insulin receptor substrate/PI3K/Akt pathway to reduce the activation of endothelial nitric-oxide synthase (eNOS). In this study, it was observed that PKC activation differentially inhibited insulin receptor substrate 1/2 (IRS1/2) signaling of insulin's activation of PI3K/eNOS by decreasing only tyrosine phosphorylation of IRS2. In addition, PKC activation, by general activator and specifically by angiotensin II, increased the phosphorylation of p85/PI3K, which decreases its association with IRS1 and activation. Thr-86 of p85/PI3K was identified to be phosphorylated by PKC activation and confirmed to affect IRS1-mediated activation of Akt/eNOS by insulin and VEGF using a deletion mutant of the Thr-86 region of p85/PI3K. Thus, PKC and angiotensin-induced phosphorylation of Thr-86 of p85/PI3K may partially inhibit the activation of PI3K/eNOS by multiple cytokines and contribute to endothelial dysfunction in metabolic disorders.	[Maeno, Yasuhiro; Li, Qian; Park, Kyoungmin; Rask-Madsen, Christian; Gao, Benbo; Matsumoto, Motonobu; Liu, Yingjie; Wu, I-Hsien; Feener, Edward P.; King, George L.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Vasc Cell Biol, Boston, MA 02115 USA; [White, Morris F.] Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital	King, GL (corresponding author), Joslin Diabet Ctr, Sect Vasc Cell Biol & Complicat, Dianne Nunnally Hoppes Lab Diabet Complicat, 1 Joslin Pl, Boston, MA 02215 USA.	George.king@joslin.harvard.edu		Park, Kyoungmin/0000-0003-0772-1217; Rask-Madsen, Christian/0000-0002-8548-466X	National Institutes of Health from NIDDK [R01-DK53105]; National Institutes of Health from NIDDK (DERC) [P30-DK36836-21]; American Diabetes Association [1-08-RA-93]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R01DK053105, P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Institutes of Health from NIDDK (DERC); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK53105 from NIDDK and P30-DK36836-21 from NIDDK (DERC). This work was also supported by American Diabetes Association Grant 1-08-RA-93.	Abe H, 1998, J CLIN INVEST, V101, P1784, DOI 10.1172/JCI1594; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Geraldes P, 2008, J BIOL CHEM, V283, P34327, DOI 10.1074/jbc.M807036200; GOLDSTEIN RH, 1989, ENDOCRINOLOGY, V124, P964, DOI 10.1210/endo-124-2-964; Greene MW, 2004, BIOCHEM J, V378, P105, DOI 10.1042/BJ20031493; Grenett HE, 1998, ARTERIOSCL THROM VAS, V18, P1803, DOI 10.1161/01.ATV.18.11.1803; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Harja E, 2009, FASEB J, V23, P1081, DOI 10.1096/fj.08-120345; Jiang ZY, 2003, J BIOL CHEM, V278, P31964, DOI 10.1074/jbc.M303314200; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; Naruse K, 2006, DIABETES, V55, P691, DOI 10.2337/diabetes.55.03.06.db05-0771; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; Nordt TK, 1998, J MOL CELL CARDIOL, V30, P1535, DOI 10.1006/jmcc.1998.0719; OLIVER FJ, 1991, J BIOL CHEM, V266, P23251; Pillay TS, 1996, J CLIN INVEST, V97, P613, DOI 10.1172/JCI118457; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2000, J CLIN INVEST, V105, P1437, DOI 10.1172/JCI7656; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Waraich RS, 2008, J BIOL CHEM, V283, P11226, DOI 10.1074/jbc.M708588200; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	37	40	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4518	4530		10.1074/jbc.M111.286591	http://dx.doi.org/10.1074/jbc.M111.286591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158866	hybrid, Green Published			2022-12-25	WOS:000300608500015
J	King, SM; Patel-King, RS				King, Stephen M.; Patel-King, Ramila S.			Functional Architecture of the Outer Arm Dynein Conformational Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN 1; MOTOR DOMAIN; FLAGELLAR BEAT; HEAVY-CHAIN; MICROTUBULES; DYNAMICS; COMPLEX; LC1	Dynein light chain 1 (LC1/DNAL1) is one of the most highly conserved components of ciliary axonemal outer arm dyneins, and it associates with both a heavy chain motor unit and tubulin located within the A-tubule of the axonemal outer doublet microtubules. In a variety of model systems, lack of LC1 or expression of mutant forms leads to profound defects in ciliary motility, including the failure of the hydrodynamic coupling needed for ciliary metachronal synchrony, random stalling during the power/recovery stroke transition, an aberrant response to imposed viscous load, and in some cases partial failure of motor assembly. These phenotypes have led to the proposal that LC1 acts as part of a mechanical switch to control motor function in response to alterations in axonemal curvature. Here we have used NMR chemical shift mapping to define the regions perturbed by a series of mutations in the C-terminal domain that yield a range of phenotypic effects on motility. In addition, we have identified the subdomain of LC1 involved in binding microtubules and characterized the consequences of an Asn -> Ser alteration within the terminal leucine-rich repeat that in humans causes primary ciliary dyskinesia. Together, these data define a series of functional subdomains within LC1 and allow us to propose a structural model for the organization of the dynein heavy chain-LC1-microtubule ternary complex that is required for the coordinated activity of dynein motors in cilia.	[King, Stephen M.; Patel-King, Ramila S.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Connecticut	King, SM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	king@neuron.uchc.edu			National Institutes of Health [GM051293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM051293 (to S. M. K.).	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Benashski SE, 1999, BIOCHEMISTRY-US, V38, P7253, DOI 10.1021/bi990466y; Brokaw CJ, 2009, CELL MOTIL CYTOSKEL, V66, P425, DOI 10.1002/cm.20313; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Hayashibe K, 1997, CELL MOTIL CYTOSKEL, V37, P232, DOI 10.1002/(SICI)1097-0169(1997)37:3<232::AID-CM5>3.0.CO;2-8; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; KING SM, 1988, J CELL BIOL, V107, P1799, DOI 10.1083/jcb.107.5.1799; King SM, 2009, CHLAMYDOMONAS SOURCE, V3, P131; King SM, 2010, CYTOSKELETON, V67, P207, DOI 10.1002/cm.20445; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Lindemann CB, 2002, CELL MOTIL CYTOSKEL, V52, P242, DOI 10.1002/cm.10049; Lindemann CB, 2007, CELL MOTIL CYTOSKEL, V64, P580, DOI 10.1002/cm.20205; Liu ZM, 2008, EUKARYOT CELL, V7, P1136, DOI 10.1128/EC.00102-08; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Mosavi LK, 2003, PROTEIN ENG, V16, P739, DOI 10.1093/protein/gzg098; Movassagh T, 2010, NAT STRUCT MOL BIOL, V17, P761, DOI 10.1038/nsmb.1832; Narayan RD, 2010, FUNGAL GENET BIOL, V47, P663, DOI 10.1016/j.fgb.2010.04.008; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PFISTER KK, 1982, CELL MOTIL CYTOSKEL, V2, P525, DOI 10.1002/cm.970020604; PFISTER KK, 1984, J BIOL CHEM, V259, P2072; Ralston KS, 2011, EUKARYOT CELL, V10, P884, DOI 10.1128/EC.00298-10; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; Sakakibara H, 1998, J CELL SCI, V111, P1155; Sakato M, 2007, MOL BIOL CELL, V18, P3620, DOI 10.1091/mbc.e06-10-0917; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SUGINO K, 1982, NATURE, V295, P609, DOI 10.1038/295609a0; Ueno H, 2008, P NATL ACAD SCI USA, V105, P19702, DOI 10.1073/pnas.0808194105; Vyas J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp616; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Wu HW, 1999, J BIOMOL NMR, V13, P309, DOI 10.1023/A:1008340420295; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Wu HW, 2003, CELL MOTIL CYTOSKEL, V54, P267, DOI 10.1002/cm.10108; Wu HW, 2003, BIOCHEMISTRY-US, V42, P57, DOI 10.1021/bi026762j; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200	39	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3108	3122		10.1074/jbc.M111.286211	http://dx.doi.org/10.1074/jbc.M111.286211			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157010	Green Published, hybrid			2022-12-25	WOS:000300295100017
J	Singh, SK; Thirumalai, A; Hammond, DJ; Pangburn, MK; Mishra, VK; Johnson, DA; Rusinol, AE; Agrawal, A				Singh, Sanjay K.; Thirumalai, Avinash; Hammond, David J., Jr.; Pangburn, Michael K.; Mishra, Vinod K.; Johnson, David A.; Rusinol, Antonio E.; Agrawal, Alok			Exposing a Hidden Functional Site of C-reactive Protein by Site-directed Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; STREPTOCOCCUS-PNEUMONIAE INFECTION; E-DEFICIENT MICE; FACTOR-H; ACIDIC PH; ATHEROSCLEROSIS DEVELOPMENT; CONFORMATIONAL-CHANGES; COMPLEMENT ACTIVATION; MACULAR DEGENERATION; SINGLE INJECTION	C-reactive protein (CRP) is a cyclic pentameric protein whose major binding specificity, at physiological pH, is for substances bearing exposed phosphocholine moieties. Another pentameric form of CRP, which exists at acidic pH, displays binding activity for oxidized LDL (ox-LDL). The ox-LDL-binding site in CRP, which is hidden at physiological pH, is exposed by acidic pH-induced structural changes in pentameric CRP. The aim of this study was to expose the hidden ox-LDL-binding site of CRP by site-directed mutagenesis and to generate a CRP mutant that can bind to ox-LDL without the requirement of acidic pH. Mutation of Glu(42), an amino acid that participates in intersubunit interactions in the CRP pentamer and is buried, to Gln resulted in a CRP mutant (E42Q) that showed significant binding activity for ox-LDL at physiological pH. For maximal binding to ox-LDL, E42Q CRP required a pH much less acidic than that required by wild-type CRP. At any given pH, E42Q CRP was more efficient than wild-type CRP in binding to ox-LDL. Like wild-type CRP, E42Q CRP remained pentameric at acidic pH. Also, E42Q CRP was more efficient than wild-type CRP in binding to several other deposited, conformationally altered proteins. The E42Q CRP mutant provides a tool to investigate the functions of CRP in defined animal models of inflammatory diseases including atherosclerosis because wild-type CRP requires acidic pH to bind to deposited, conformationally altered proteins, including ox-LDL, and available animal models may not have sufficient acidosis or other possible modifiers of the pentameric structure of CRP at the sites of inflammation.	[Singh, Sanjay K.; Thirumalai, Avinash; Hammond, David J., Jr.; Agrawal, Alok] E Tennessee State Univ, Quillen Coll Med, Dept Pharmacol, Johnson City, TN 37614 USA; [Johnson, David A.; Rusinol, Antonio E.] E Tennessee State Univ, Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA; [Pangburn, Michael K.] Univ Texas Hlth Sci Ctr, Dept Biochem, Ctr Biomed Res, Tyler, TX 75708 USA; [Mishra, Vinod K.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA	East Tennessee State University; East Tennessee State University; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Alabama System; University of Alabama Birmingham	Agrawal, A (corresponding author), E Tennessee State Univ, Quillen Coll Med, Dept Pharmacol, POB 70577, Johnson City, TN 37614 USA.	agrawal@etsu.edu	Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512; Thirumalai, Avinash/0000-0002-7722-7479	National Institutes of Health [R01HL071233, R01DK35081, R15HL091770, 1R15HL091502]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071233, R15HL091770, R15HL091502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL071233 (to A. A.), R01DK35081 (to M. K. P.), R15HL091770 (to D. A. J.), and 1R15HL091502 (to A. R.).	AGRAWAL A, 1992, J BIOL CHEM, V267, P25352; Agrawal Alok, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P235; Agrawal Alok, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P231, DOI 10.2174/187153008786848321; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Brown AJ, 1997, J LIPID RES, V38, P1730; Carlucci F, 2010, ARTHRITIS RHEUM-US, V62, P245, DOI 10.1002/art.27232; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; DONG AC, 1994, J BIOL CHEM, V269, P6424; Gaitonde S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1814, DOI 10.1002/art.24316; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haka AS, 2009, MOL BIOL CELL, V20, P4932, DOI 10.1091/mbc.E09-07-0559; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayashi M, 2006, RESPIROLOGY, V11, P24, DOI 10.1111/j.1440-1843.2006.00780.x; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Jarva H, 1999, J IMMUNOL, V163, P3957; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; Kushner I, 2010, ARTHRIT CARE RES, V62, P442, DOI 10.1002/acr.20052; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; MIYAZAWA K, 1988, J IMMUNOL, V141, P570; MOLD C, 1984, J IMMUNOL, V133, P882; MULLENIX MC, 1994, MOL IMMUNOL, V31, P615, DOI 10.1016/0161-5890(94)90169-4; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Oorni K, 2006, CURR OPIN LIPIDOL, V17, P534; Ortiz MA, 2009, EXP BIOL MED, V234, P624, DOI 10.3181/0812-RM-347; PANGBURN MK, 1983, BIOCHEMISTRY-US, V22, P178, DOI 10.1021/bi00270a026; Reifenberg K, 2005, ARTERIOSCL THROM VAS, V25, P1641, DOI 10.1161/01.ATV.0000171983.95612.90; Rodriguez W, 2006, ARTHRITIS RHEUM-US, V54, P325, DOI 10.1002/art.21556; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Sheu BC, 2010, BIOSENS BIOELECTRON, V26, P822, DOI 10.1016/j.bios.2010.06.001; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Singh SK, 2008, J IMMUNOL, V180, P4316, DOI 10.4049/jimmunol.180.6.4316; Singh SK, 2009, CLIN CHIM ACTA, V409, P143, DOI 10.1016/j.cca.2009.08.013; Singh U, 2008, J LIPID RES, V49, P1015, DOI 10.1194/jlr.M700535-JLR200; Singh V, 2009, CURR VASC PHARMACOL, V7, P75, DOI 10.2174/157016109787354097; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Sneck M, 2005, J BIOL CHEM, V280, P37449, DOI 10.1074/jbc.M508565200; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Suresh MV, 2006, J IMMUNOL, V176, P4369, DOI 10.4049/jimmunol.176.7.4369; Szalai AJ, 2003, ARTHRITIS RHEUM-US, V48, P1602, DOI 10.1002/art.11026; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Taskinen S, 2002, BIOCHEM J, V367, P403, DOI 10.1042/BJ20020492; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Torzewski M, 2008, THROMB HAEMOSTASIS, V99, P196, DOI 10.1160/TH07-10-0595; Trion A, 2005, ARTERIOSCL THROM VAS, V25, P1635, DOI 10.1161/01.ATV.0000171992.36710.1e; van Tits L, 2005, ARTERIOSCL THROM VAS, V25, P717, DOI 10.1161/01.ATV.0000157979.51673.2c; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741	63	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3550	3558		10.1074/jbc.M111.310011	http://dx.doi.org/10.1074/jbc.M111.310011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158621	Green Published, hybrid			2022-12-25	WOS:000300295100059
J	Cowin, RM; Bui, N; Graham, D; Green, JR; Grueninger, S; Yuva-Paylor, LA; Syed, AU; Weiss, A; Paylor, R				Cowin, Randi-Michelle; Bui, Nghiem; Graham, Deanna; Green, Jennie R.; Grueninger, Stephan; Yuva-Paylor, Lisa A.; Syed, Arsalan U.; Weiss, Andreas; Paylor, Richard			Onset and Progression of Behavioral and Molecular Phenotypes in a Novel Congenic R6/2 Line Exhibiting Intergenerational CAG Repeat Stability	PLOS ONE			English	Article							HUNTINGTONS-DISEASE MUTATION; KNOCK-IN MICE; YAC128 MOUSE MODEL; TRANSGENIC MICE; TRINUCLEOTIDE REPEAT; MUTANT HUNTINGTIN; STRIATAL NEURONS; ABNORMALITIES; EXPANSION; INSTABILITY	In the present study we report on the use of speed congenics to generate a C57BL/6J congenic line of HD-model R6/2 mice carrying 110 CAG repeats, which uniquely exhibits minimal intergenerational instability. We also report the first identification of the R6/2 transgene insertion site. The relatively stable line of 110 CAG R6/2 mice was characterized for the onset of behavioral impairments in motor, cognitive and psychiatric-related phenotypes as well as the progression of disease-related impairments from 4 to 10 weeks of age. 110Q mice exhibited many of the phenotypes commonly associated with the R6/2 model including reduced activity and impairments in rotarod performance. The onset of many of the phenotypes occurred around 6 weeks and was progressive across age. In addition, some phenotypes were observed in mice as early as 4 weeks of age. The present study also reports the onset and progression of changes in several molecular phenotypes in the novel R6/2 mice and the association of these changes with behavioral symptom onset and progression. Data from TR-FRET suggest an association of mutant protein state changes (soluble versus aggregated) in disease onset and progression.	[Cowin, Randi-Michelle; Bui, Nghiem; Graham, Deanna; Green, Jennie R.; Yuva-Paylor, Lisa A.; Syed, Arsalan U.; Paylor, Richard] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Grueninger, Stephan; Weiss, Andreas] Neurosci Discovery, Novartis Inst BioMed Res, Basel, Switzerland; [Paylor, Richard] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Novartis; Baylor College of Medicine	Cowin, RM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	rpaylor@bcm.edu			Cure Huntington's Disease Initiative, Inc. (CHDI), USA; National Institutes of Health (NIH) [T32 GM08307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	Cure Huntington's Disease Initiative, Inc. (CHDI), USA; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was generously supported by Cure Huntington's Disease Initiative, Inc. (CHDI), USA (http://www.highqfoundation.org/). We would also like to acknowledge support from the National Institutes of Health (NIH) for training grant T32 GM08307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Brooks S., 2010, BRAIN RES B, DOI 10.106/j.brainresbull.2010.05.003; Brooks SP, 2011, BRAIN RES B; Carter RJ, 1999, J NEUROSCI, V19, P3248; Ciarnei A, 2008, NEUROBIOL LEARN MEM, V89, P533, DOI 10.1016/j.nlm.2007.10.009; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Graham RK, 2009, J NEUROSCI, V29, P2193, DOI 10.1523/JNEUROSCI.5473-08.2009; Hickey MA, 2005, NEUROBIOL DIS, V20, P1, DOI 10.1016/j.nbd.2005.01.024; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Klivenyi P, 2006, BEHAV BRAIN RES, V169, P137, DOI 10.1016/j.bbr.2006.01.003; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Kung VWS, 2007, NEUROSCIENCE, V146, P1571, DOI 10.1016/j.neuroscience.2007.03.036; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; LORENZINI CA, 1995, NEUROBIOL LEARN MEM, V63, P87, DOI 10.1006/nlme.1995.1008; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; MATHIS C, 1994, BEHAV GENET, V24, P171, DOI 10.1007/BF01067821; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, P1869; PRADOALCALA RA, 1985, PHARMACOL BIOCHEM BE, V22, P243, DOI 10.1016/0091-3057(85)90385-5; Savouret C, 2004, MOL CELL BIOL, V24, P629, DOI 10.1128/MCB.24.2.629-637.2004; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shelbourne PF, 1999, HUM MOL GENET, V8, P763, DOI 10.1093/hmg/8.5.763; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Wood NI, 2011, NEUROBIOL DIS, V42, P427, DOI 10.1016/j.nbd.2011.02.005	49	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28409	10.1371/journal.pone.0028409	http://dx.doi.org/10.1371/journal.pone.0028409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163300	Green Submitted, gold, Green Published			2022-12-25	WOS:000298161900037
J	Robillard, R; Prince, F; Filipini, D; Carrier, J				Robillard, Rebecca; Prince, Francois; Filipini, Daniel; Carrier, Julie			Aging Worsens the Effects of Sleep Deprivation on Postural Control	PLOS ONE			English	Article							ATTENTIONAL DEMANDS; ELDERLY POPULATION; QUIET STANCE; OLDER-PEOPLE; RISK-FACTORS; FALLS; COMMUNITY; BALANCE; PREDICTORS; ADULTS	Falls increase with age and cause significant injuries in the elderly. This study aimed to determine whether age modulates the interactions between sleep deprivation and postural control and to evaluate how attention influences these interactions in the elderly. Fifteen young (24 +/- 2.7 y.o.) and 15 older adults (64 +/- 3.2 y.o.) stood still on a force plate after a night of sleep and after total sleep deprivation. Center of pressure range and velocity were measured with eyes open and with eyes closed while participants performed an interference task, a control task, and no cognitive task. Sleep deprivation increased the antero-posterior range of center of pressure in both age groups and center of pressure speed in older participants only. In elderly participants, the destabilizing effects of sleep deprivation were more pronounced with eyes closed. The interference task did not alter postural control beyond the destabilization induced by sleep loss in older subjects. It was concluded that sleep loss has greater destabilizing effects on postural control in older than in younger participants, and may therefore increase the risk of falls in the elderly.	[Robillard, Rebecca; Filipini, Daniel; Carrier, Julie] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Prince, Francois] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Carrier, Julie] Univ Montreal, Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Robillard, Rebecca; Carrier, Julie] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Robillard, R (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada.	julie.carrier.1@umontreal.ca	Prince, Francois/AAA-6763-2022; Robillard, Rebecca/G-9045-2017	Carrier, Julie/0000-0001-5311-2370	Fonds de la recherche en sante du Quebec; Fonds quebecois de la recherche sur la nature et les technologies; Canadian Institutes of Health Research; Institut de recherche Robert-Sauve en sante et en securite du travail	Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institut de recherche Robert-Sauve en sante et en securite du travail	This work was supported by Fonds de la recherche en sante du Quebec (http://www.frsq.gouv.qc.ca), Fonds quebecois de la recherche sur la nature et les technologies (http://www.fqrnt.gouv.qc.ca), Canadian Institutes of Health Research (www.cihr-irsc.gc.ca), Institut de recherche Robert-Sauve en sante et en securite du travail (www.irsst.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiridis IG, 2003, NEUROSCI LETT, V350, P137, DOI 10.1016/S0304-3940(03)00878-4; Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Avidan AY, 2005, J AM GERIATR SOC, V53, P955, DOI 10.1111/j.1532-5415.2005.53304.x; Berger L, 2005, J MOTOR BEHAV, V37, P348, DOI 10.3200/JMBR.37.5.348-358; Blaszczyk JW, 2000, J BIOMECH, V33, P1243, DOI 10.1016/S0021-9290(00)00097-X; Brassington GS, 2000, J AM GERIATR SOC, V48, P1234, DOI 10.1111/j.1532-5415.2000.tb02596.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carrier J., 2003, SLEEP PHYSL INVESTIG, P297, DOI DOI 10.1007/978-1-4615-0217-3_24; Dault MC, 2001, GAIT POSTURE, V14, P248, DOI 10.1016/S0966-6362(01)00130-8; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; FERNIE GR, 1982, AGE AGEING, V11, P11, DOI 10.1093/ageing/11.1.11; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Gomez S, 2008, CLIN NEUROPHYSIOL, V119, P617, DOI 10.1016/j.clinph.2007.10.058; Hill EL, 2007, J GERONTOL A-BIOL, V62, P62, DOI 10.1093/gerona/62.1.62; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Lord SR, 2000, GERONTOLOGY, V46, P306, DOI 10.1159/000022182; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; Painter Jane A, 2009, J Allied Health, V38, P201; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; Robillard R, 2011, CLIN NEUROPHYSIOL; Schechtman KB, 1997, J PSYCHOSOM RES, V43, P513, DOI 10.1016/S0022-3999(97)00117-7; Schlesinger A, 1998, NEUROREPORT, V9, P49, DOI 10.1097/00001756-199801050-00010; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Stone KL, 2008, ARCH INTERN MED, V168, P1768, DOI 10.1001/archinte.168.16.1768; Thapa PB, 1996, J GERONTOL A-BIOL, V51, pM239, DOI 10.1093/gerona/51A.5.M239; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vuillerme N, 2000, NEUROSCI LETT, V291, P77, DOI 10.1016/S0304-3940(00)01374-4; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334	38	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28731	10.1371/journal.pone.0028731	http://dx.doi.org/10.1371/journal.pone.0028731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KK	22163330	Green Submitted, Green Published, gold			2022-12-25	WOS:000298161900066
J	Tavares, ES; Goncalves, P; Miyaki, CY; Baker, AJ				Tavares, Erika Sendra; Goncalves, Priscila; Miyaki, Cristina Yumi; Baker, Allan J.			DNA Barcode Detects High Genetic Structure within Neotropical Bird Species	PLOS ONE			English	Article							PATTERNS; DIVERSIFICATION; EVOLUTION; AVES; DIFFERENTIATION; PASSERIFORMES; BIOGEOGRAPHY; HYPOTHESIS; MIOCENE; MAMMALS	Background: Towards lower latitudes the number of recognized species is not only higher, but also phylogeographic subdivision within species is more pronounced. Moreover, new genetically isolated populations are often described in recent phylogenies of Neotropical birds suggesting that the number of species in the region is underestimated. Previous COI barcoding of Argentinean bird species showed more complex patterns of regional divergence in the Neotropical than in the North American avifauna. Methods and Findings: Here we analyzed 1,431 samples from 561 different species to extend the Neotropical bird barcode survey to lower latitudes, and detected even higher geographic structure within species than reported previously. About 93% (520) of the species were identified correctly from their DNA barcodes. The remaining 41 species were not monophyletic in their COI sequences because they shared barcode sequences with closely related species (N = 21) or contained very divergent clusters suggestive of putative new species embedded within the gene tree (N = 20). Deep intraspecific divergences overlapping with among-species differences were detected in 48 species, often with samples from large geographic areas and several including multiple subspecies. This strong population genetic structure often coincided with breaks between different ecoregions or areas of endemism. Conclusions: The taxonomic uncertainty associated with the high incidence of non-monophyletic species and discovery of putative species obscures studies of historical patterns of species diversification in the Neotropical region. We showed that COI barcodes are a valuable tool to indicate which taxa would benefit from more extensive taxonomic revisions with multilocus approaches. Moreover, our results support hypotheses that the megadiversity of birds in the region is associated with multiple geographic processes starting well before the Quaternary and extending to more recent geological periods.	[Tavares, Erika Sendra; Baker, Allan J.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Goncalves, Priscila; Miyaki, Cristina Yumi] Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias, Sao Paulo, Brazil; [Baker, Allan J.] Univ Toronto, Dept Zool, Toronto, ON, Canada	Royal Ontario Museum; Universidade de Sao Paulo; University of Toronto	Tavares, ES (corresponding author), Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada.	erika.tavares@utoronto.ca	Tavares, Erika/ABB-9701-2020; Miyaki, Cristina Y/J-2431-2015	Miyaki, Cristina Y/0000-0002-9708-9202	Canadian Barcode of Life Network, Genome Canada through the Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC); ROM Governors' Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq)	Canadian Barcode of Life Network, Genome Canada through the Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); ROM Governors' Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funding through the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, Natural Sciences and Engineering Research Council of Canada (NSERC), and other sponsors, the ROM Governors' Fund, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES) and Conselho Nacional de Pesquisa (CNPq). The funders of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Baker AJ, 2009, MOL ECOL RESOUR, V9, P257, DOI 10.1111/j.1755-0998.2009.02650.x; Bates JM, 1998, J BIOGEOGR, V25, P783, DOI 10.1046/j.1365-2699.1998.2540783.x; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Borges SH, 2007, REV BRAS ZOOL, V24, P919, DOI 10.1590/S0101-81752007000400008; Brumfield RT, 2007, EVOLUTION, V61, P346, DOI 10.1111/j.1558-5646.2007.00039.x; Bulgarella M, 2010, J AVIAN BIOL, V41, P186, DOI 10.1111/j.1600-048X.2009.04819.x; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Campagna L, 2010, MOL ECOL RESOUR, V10, P449, DOI 10.1111/j.1755-0998.2009.02799.x; Caranton-Ayala Diego, 2010, Ornitologia Colombiana, V9, P56; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; DEAN AD, 1995, BIOTECHNIQUES, V18, P980; do Amaral FSR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-10; Drummond AJ, 2010, GENEIOUS; Fitzpatrick JW, 2004, HDB BIRDS WORLD, V9, P170; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J., 1985, Ornithological Monographs, P113; Haffer J., 1974, Publications Nuttall Orn Club, VNo. 14, P1; Haffer Juergen, 1992, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V8, P217; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V112, P187, DOI 10.1016/0031-0182(94)90074-4; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Joseph L, 2004, MOL PHYLOGENET EVOL, V31, P139, DOI 10.1016/S1055-7903(03)00259-8; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Marks BD, 2002, MOL PHYLOGENET EVOL, V24, P153, DOI 10.1016/S1055-7903(02)00233-6; Marroig G, 1997, J COMP BIOL, V2, P103; Mckay BD, 2010, MOL PHYLOGENET EVOL, V54, P647, DOI 10.1016/j.ympev.2009.08.024; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Miller MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1133, DOI 10.1098/rspb.2008.0015; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; Nyari AS, 2007, MOL PHYLOGENET EVOL, V44, P154, DOI 10.1016/j.ympev.2007.02.020; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Pessoa RO, 2008, SISTEMATICA BIOGEOGR; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price T, 2008, SPECIATION BIRDS; R Core Team, 2021, R LANG ENV STAT COMP; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ribas CC, 2007, IBIS, V149, P564, DOI 10.1111/j.1474-919X.2007.00681.x; Ribas CC, 2004, MOL PHYLOGENET EVOL, V30, P663, DOI 10.1016/S1055-7903(03)00223-9; Rohde K, 1999, ECOGRAPHY, V22, P593, DOI 10.1111/j.1600-0587.1999.tb00509.x; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Sick H, 1967, ATL S BIOT AM ZOOL; Sigrist T, 2009, AVIS BRASILIS FIELD; Swofford DL., 2002, PAUP PHYL AN US PARS; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Vilaca Sibelle T., 2006, Revista Brasileira de Ornitologia, V14, P7; Yoo HS, 2006, MOL CELLS, V22, P323	60	54	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28543	10.1371/journal.pone.0028543	http://dx.doi.org/10.1371/journal.pone.0028543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163311	Green Submitted, Green Published, gold			2022-12-25	WOS:000298161900047
J	De Filippis, D; Esposito, G; Cirillo, C; Cipriano, M; De Winter, BY; Scuderi, C; Sarnelli, G; Cuomo, R; Steardo, L; De Man, JG; Iuvone, T				De Filippis, Daniele; Esposito, Giuseppe; Cirillo, Carla; Cipriano, Mariateresa; De Winter, Benedicte Y.; Scuderi, Caterina; Sarnelli, Giovanni; Cuomo, Rosario; Steardo, Luca; De Man, Joris G.; Iuvone, Teresa			Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; NITRIC-OXIDE PRODUCTION; CELLS; PROTEIN; GUT; PATHOGENESIS; EXPRESSION; MODEL	Enteric glial cells (EGC) actively mediate acute and chronic inflammation in the gut; EGC proliferate and release neurotrophins, growth factors, and pro-inflammatory cytokines which, in turn, may amplify the immune response, representing a very important link between the nervous and immune systems in the intestine. Cannabidiol (CBD) is an interesting compound because of its ability to control reactive gliosis in the CNS, without any unwanted psychotropic effects. Therefore the rationale of our study was to investigate the effect of CBD on intestinal biopsies from patients with ulcerative colitis (UC) and from intestinal segments of mice with LPS-induced intestinal inflammation. CBD markedly counteracted reactive enteric gliosis in LPS-mice trough the massive reduction of astroglial signalling neurotrophin S100B. Histological, biochemical and immunohistochemical data demonstrated that S100B decrease was associated with a considerable decrease in mast cell and macrophages in the intestine of LPS-treated mice after CBD treatment. Moreover the treatment of LPS-mice with CBD reduced TNF-alpha expression and the presence of cleaved caspase-3. Similar results were obtained in ex vivo cultured human derived colonic biopsies. In biopsies of UC patients, both during active inflammation and in remission stimulated with LPS+INF-gamma, an increased glial cell activation and intestinal damage were evidenced. CBD reduced the expression of S100B and iNOS proteins in the human biopsies confirming its well documented effect in septic mice. The activity of CBD is, at least partly, mediated via the selective PPAR-gamma receptor pathway. CBD targets enteric reactive gliosis, counteracts the inflammatory environment induced by LPS in mice and in human colonic cultures derived from UC patients. These actions lead to a reduction of intestinal damage mediated by PPARgamma receptor pathway. Our results therefore indicate that CBD indeed unravels a new therapeutic strategy to treat inflammatory bowel diseases.	[De Filippis, Daniele; Cipriano, Mariateresa; Iuvone, Teresa] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Esposito, Giuseppe; Scuderi, Caterina; Steardo, Luca] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol Erspamer 5, Rome, Italy; [Cirillo, Carla; Sarnelli, Giovanni; Cuomo, Rosario] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [De Winter, Benedicte Y.; De Man, Joris G.] Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium; [De Filippis, Daniele; Cipriano, Mariateresa; Iuvone, Teresa] Endocannabinoid Res Grp, Pozzuoli, Italy	University of Naples Federico II; Sapienza University Rome; University of Naples Federico II; University of Antwerp	De Filippis, D (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy.	iuvone@unina.it	Scuderi, Caterina/J-4189-2012; Esposito, Giuseppe/AAA-7949-2019; De Man, Joris/E-2980-2013; De Winter, Benedicte Y/G-2616-2011; Sarnelli, Giovanni/AAB-4050-2019; Cuomo, Rosario/C-3446-2011	Scuderi, Caterina/0000-0002-7314-1539; Esposito, Giuseppe/0000-0001-8080-8218; De Winter, Benedicte Y/0000-0003-0327-6304; Sarnelli, Giovanni/0000-0002-1467-1134; Cuomo, Rosario/0000-0003-0768-8381; Cirillo, Carla/0000-0002-8445-5955; Cipriano, Mariateresa/0000-0001-6644-7137; Steardo, Luca/0000-0003-3570-2195				Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Ben-Horin S, 2008, CURR OPIN PHARMACOL, V8, P490, DOI 10.1016/j.coph.2008.07.010; Borrelli F, 2009, J MOL MED, V87, P1111, DOI 10.1007/s00109-009-0512-x; Burns AJ, 2009, NEUROGASTROENT MOTIL, V21, P100, DOI 10.1111/j.1365-2982.2008.01255.x; Burzynski G, 2009, NEUROGASTROENT MOTIL, V21, P113, DOI 10.1111/j.1365-2982.2008.01256.x; Capasso R, 2008, BRIT J PHARMACOL, V154, P1001, DOI 10.1038/bjp.2008.177; Caprioli F, 2008, GUT, V57, P1674, DOI 10.1136/gut.2008.149286; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Cirillo C, 2009, NEUROGASTROENT MOTIL, V21, P1209, DOI 10.1111/j.1365-2982.2009.01346.x; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; De Backer O, 2009, J PHARMACOL EXP THER, V331, P496, DOI 10.1124/jpet.109.155135; De Filippis D, 2008, BRIT J PHARMACOL, V154, P1672, DOI 10.1038/bjp.2008.211; De Filippis D, 2008, J NEUROENDOCRINOL, V20, P20, DOI 10.1111/j.1365-2826.2008.01674.x; De Winter BY, 2005, NEUROGASTROENT MOTIL, V17, P251, DOI 10.1111/j.1365-2982.2004.00618.x; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Esposito G, 2007, GASTROENTEROLOGY, V133, P918, DOI 10.1053/j.gastro.2007.06.009; FERRI GL, 1982, NATURE, V297, P409, DOI 10.1038/297409a0; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Iuvone T, 2009, CNS NEUROSCI THER, V15, P65, DOI 10.1111/j.1755-5949.2008.00065.x; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; O'Sullivan SE, 2009, EUR J PHARMACOL, V612, P61, DOI 10.1016/j.ejphar.2009.03.010; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Qiao S, 2009, CLIN NEUROPATHOL, V28, P105; Ruhl A, 2004, NEUROGASTROENT MOTIL, V16, P44, DOI 10.1111/j.1743-3150.2004.00474.x; von Boyen GBT, 2006, J NEUROENDOCRINOL, V18, P820, DOI 10.1111/j.1365-2826.2006.01478.x; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	29	103	105	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28159	10.1371/journal.pone.0028159	http://dx.doi.org/10.1371/journal.pone.0028159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163000	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500011
J	Lai, DY; Li, HZ; Fan, SL; Song, MZ; Pang, CY; Wei, HL; Liu, JJ; Wu, D; Gong, WF; Yu, SX				Lai, Deyong; Li, Huaizhu; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Liu, Junjie; Wu, Dong; Gong, Wenfang; Yu, Shuxun			Generation of ESTs for Flowering Gene Discovery and SSR Marker Development in Upland Cotton	PLOS ONE			English	Article							MICROSATELLITE MARKERS; IDENTIFICATION; TRANSCRIPTOME; ACCUMULATION; POLYPLOIDY; INITIATION; EXPRESSION; RESOURCE; IDENTITY; ARBOREUM	Background: Upland cotton, Gossypium hirsutum L., is one of the world's most important economic crops. In the absence of the entire genomic sequence, a large number of expressed sequence tag (EST) resources of upland cotton have been generated and used in several studies. However, information about the flower development of this species is rare. Methodology/Principal Findings: To clarify the molecular mechanism of flower development in upland cotton, 22,915 high-quality ESTs were generated and assembled into 14,373 unique sequences consisting of 4,563 contigs and 9,810 singletons from a normalized and full-length cDNA library constructed from pooled RNA isolated from shoot apexes, squares, and flowers. Comparative analysis indicated that 5,352 unique sequences had no high-degree matches to the cotton public database. Functional annotation showed that several upland cotton homologs with flowering-related genes were identified in our library. The majority of these genes were specifically expressed in flowering-related tissues. Three GhSEP (G. hirsutum L. SEPALLATA) genes determining floral organ development were cloned, and quantitative real-time PCR (qRT-PCR) revealed that these genes were expressed preferentially in squares or flowers. Furthermore, 670 new putative microsatellites with flanking sequences sufficient for primer design were identified from the 645 unigenes. Twenty-five EST-simple sequence repeats were randomly selected for validation and transferability testing in 17 Gossypium species. Of these, 23 were identified as true-to-type simple sequence repeat loci and were highly transferable among Gossypium species. Conclusions/Significance: A high-quality, normalized, full-length cDNA library with a total of 14,373 unique ESTs was generated to provide sequence information for gene discovery and marker development related to upland cotton flower development. These EST resources form a valuable foundation for gene expression profiling analysis, functional analysis of newly discovered genes, genetic linkage, and quantitative trait loci analysis.	[Lai, Deyong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Lai, Deyong; Li, Huaizhu; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Liu, Junjie; Wu, Dong; Gong, Wenfang; Yu, Shuxun] Chinese Acad Agr Sci, Cotton Res Inst, Minist Agr, Key Lab Cotton Genet Improvement, Anyang, Henan, Peoples R China; [Li, Huaizhu] NW A&F Univ, Coll Agron, Yangling, Shanxi, Peoples R China; [Wei, Hengling] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Zhejiang University	Yu, SX (corresponding author), Chinese Acad Agr Sci, Cotton Res Inst, Minist Agr, Key Lab Cotton Genet Improvement, Anyang, Henan, Peoples R China.	yu@cricaas.com.cn	Li, Huaizhu/AAE-1585-2022; Li, Huaizhu/GWN-4445-2022	Li, Huaizhu/0000-0003-0212-822X; 	National Science and Technology Major Project of China [2008ZX08005-002]	National Science and Technology Major Project of China	This work was supported by the National Science and Technology Major Project of China (No. 2008ZX08005-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Ahmad S, 2008, PAK J BOT, V40, P1201; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Carre IA, 2001, J BIOL RHYTHM, V16, P415, DOI 10.1177/074873001129002006; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Guo WZ, 2006, THEOR APPL GENET, V112, P1573, DOI 10.1007/s00122-006-0261-y; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Jackson SD, 2009, NEW PHYTOL, V181, P517, DOI 10.1111/j.1469-8137.2008.02681.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung Sook, 2005, Functional & Integrative Genomics, V5, P136, DOI 10.1007/s10142-005-0139-0; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Lindqvist C, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-16; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmitz RJ, 2007, BBA-GENE STRUCT EXPR, V1769, P269, DOI 10.1016/j.bbaexp.2007.02.003; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Taliercio E, 2006, GENOME, V49, P306, DOI 10.1139/G05-115; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tomkins JP, 2001, MOL BREEDING, V8, P255, DOI 10.1023/A:1013798716098; Tzeng TY, 2003, PLANT PHYSIOL, V133, P1091, DOI 10.1104/pp.103.026997; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang C, 2006, THEOR APPL GENET, V112, P770, DOI 10.1007/s00122-005-0183-0; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zhang Hong-Bin, 2008, Int J Plant Genomics, V2008, P742304, DOI 10.1155/2008/742304; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	53	15	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28676	10.1371/journal.pone.0028676	http://dx.doi.org/10.1371/journal.pone.0028676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163052	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500046
J	Schmidt, AKD; Romer, H				Schmidt, Arne K. D.; Roemer, Heiner			Solutions to the Cocktail Party Problem in Insects: Selective Filters, Spatial Release from Masking and Gain Control in Tropical Crickets	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION; TETTIGONIA-VIRIDISSIMA; AUDITORY-SENSITIVITY; SOUND LOCALIZATION; EVERGREEN FOREST; AMBIENT NOISE; CA2+ DYNAMICS; URBAN NOISE; RECOGNITION; EVOLUTION	Background: Insects often communicate by sound in mixed species choruses; like humans and many vertebrates in crowded social environments they thus have to solve cocktail-party-like problems in order to ensure successful communication with conspecifics. This is even more a problem in species-rich environments like tropical rainforests, where background noise levels of up to 60 dB SPL have been measured. Principal Findings: Using neurophysiological methods we investigated the effect of natural background noise (masker) on signal detection thresholds in two tropical cricket species Paroecanthus podagrosus and Diatrypa sp., both in the laboratory and outdoors. We identified three 'bottom-up' mechanisms which contribute to an excellent neuronal representation of conspecific signals despite the masking background. First, the sharply tuned frequency selectivity of the receiver reduces the amount of masking energy around the species-specific calling song frequency. Laboratory experiments yielded an average signal-to-noise ratio (SNR) of 28 dB, when masker and signal were broadcast from the same side. Secondly, displacing the masker by 180 degrees from the signal improved SNRs by further 6 to 9 dB, a phenomenon known as spatial release from masking. Surprisingly, experiments carried out directly in the nocturnal rainforest yielded SNRs of about -23 dB compared with those in the laboratory with the same masker, where SNRs reached only -14.5 and -16 dB in both species. Finally, a neuronal gain control mechanism enhances the contrast between the responses to signals and the masker, by inhibition of neuronal activity in interstimulus intervals. Conclusions: Thus, conventional speaker playbacks in the lab apparently do not properly reconstruct the masking noise situation in a spatially realistic manner, since under real world conditions multiple sound sources are spatially distributed in space. Our results also indicate that without knowledge of the receiver properties and the spatial release mechanisms the detrimental effect of noise may be strongly overestimated.	[Schmidt, Arne K. D.; Roemer, Heiner] Karl Franzens Univ Graz, Dept Zool, Graz, Styria, Austria	University of Graz	Schmidt, AKD (corresponding author), Karl Franzens Univ Graz, Dept Zool, Graz, Styria, Austria.	arne.schmidt@uni-graz.at			Austrian Science Fund (FWF) [P20882-B09]; Austrian Science Fund (FWF) [P 20882] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF): Project Grant P20882-B09 to HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2006, EVOLUTION, V60, P1874; ARAK A, 1992, BEHAV ECOL SOCIOBIOL, V30, P365; Baden T, 2007, DEV NEUROBIOL, V67, P68, DOI 10.1002/dneu.20323; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2007, ANIM BEHAV, V74, P549, DOI 10.1016/j.anbehav.2006.12.012; Bermudez-Cuamatzin E, 2011, BIOL LETTERS, V7, P36, DOI 10.1098/rsbl.2010.0437; Bradbury Jack W., 1998, pi; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2006, BEHAV ECOL SOCIOBIOL, V60, P475, DOI 10.1007/s00265-006-0188-y; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Capranica Robert R., 1992, Seminars in the Neurosciences, V4, P401, DOI 10.1016/1044-5765(92)90048-7; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Dent ML, 1997, BEHAV NEUROSCI, V111, P590, DOI 10.1037/0735-7044.111.3.590; Diwakar S, 2007, J TROP ECOL, V23, P479, DOI 10.1017/S0266467407004208; Diwakar S, 2007, BIOACOUSTICS, V16, P113, DOI 10.1080/09524622.2007.9753571; Douglas SB, 2010, J FIELD ORNITHOL, V81, P115, DOI 10.1111/j.1557-9263.2010.00268.x; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; Ellinger Norbert, 2003, Bioacoustics, V13, P297; Faulkes Z, 2000, J NEUROPHYSIOL, V84, P1247, DOI 10.1152/jn.2000.84.3.1247; FORREST T G, 1991, Bioacoustics, V3, P93; Freyman RL, 2001, J ACOUST SOC AM, V109, P2112, DOI 10.1121/1.1354984; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gogala Matija, 1995, Malayan Nature Journal, V48, P297; GREENFIELD MD, 1988, ANIM BEHAV, V36, P684, DOI 10.1016/S0003-3472(88)80151-9; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; HORSEMAN G, 1994, J COMP PHYSIOL A, V175, P399, DOI 10.1007/BF00199248; Hulse SH, 2002, ADV STUD BEHAV, V31, P163, DOI 10.1016/S0065-3454(02)80008-0; Klump Georg M., 1996, P321; Kostarakos K, 2010, J COMP PHYSIOL A, V196, P669, DOI 10.1007/s00359-010-0557-x; Kostarakos K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003005; Lang Alexander B., 2005, P152, DOI 10.1017/CBO9780511610363.011; Langemann U, 1998, ANIM BEHAV, V56, P763, DOI 10.1006/anbe.1998.0879; Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824; Lin WY, 2001, J COMP PHYSIOL A, V187, P699, DOI 10.1007/s00359-001-0241-2; Michelsen A, 1998, SPR HDB AUD, V10, P18; Pollack G, 2000, CURR OPIN NEUROBIOL, V10, P763, DOI 10.1016/S0959-4388(00)00161-6; POLLACK GS, 1988, J NEUROSCI, V8, P2635; Pollack GS, 1998, SPR HDB AUD, V10, P139; POTASH LM, 1972, ANIM BEHAV, V20, P192, DOI 10.1016/S0003-3472(72)80191-X; Ratnam R, 1998, J NEUROPHYSIOL, V80, P2848, DOI 10.1152/jn.1998.80.6.2848; RHEINLAENDER J, 1986, J COMP PHYSIOL A, V158, P647, DOI 10.1007/BF00603821; ROMER H, 1992, BEHAV ECOL SOCIOBIOL, V29, P437, DOI 10.1007/BF00170174; Romer H, 2000, J COMP PHYSIOL A, V186, P181, DOI 10.1007/s003590050018; Romer H, 1998, J EXP BIOL, V201, P1023; ROMER H, 1989, J COMP PHYSIOL A, V164, P609, DOI 10.1007/BF00614503; Ronacher B, 2003, J COMP PHYSIOL A, V189, P419, DOI 10.1007/s00359-003-0417-z; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; SCHILDBERGER K, 1988, J COMP PHYSIOL A, V163, P621, DOI 10.1007/BF00603846; Schmidt AKD, 2011, J EXP BIOL, V214, P1754, DOI 10.1242/jeb.053819; Schul J, 1998, J COMP PHYSIOL A, V182, P687, DOI 10.1007/s003590050213; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; STABEL J, 1989, J COMP PHYSIOL A, V165, P165, DOI 10.1007/BF00619191; Stumpner A, 1998, J NEUROPHYSIOL, V79, P2408, DOI 10.1152/jn.1998.79.5.2408; Sueur J, 2002, BIOL J LINN SOC, V75, P379, DOI 10.1111/j.1095-8312.2002.tb02079.x; THIELE D, 1980, AUST J ECOL, V5, P275, DOI 10.1111/j.1442-9993.1980.tb01253.x; VONHELVERSEN D, 1984, J COMP PHYSIOL, V154, P837, DOI 10.1007/BF00610684; VONHELVERSEN D, 1995, J COMP PHYSIOL A, V177, P767, DOI 10.1007/BF00187635; Witte K, 2005, BEHAV ECOL, V16, P571, DOI 10.1093/beheco/ari032; YOST WA, 1991, HEARING RES, V56, P8, DOI 10.1016/0378-5955(91)90148-3	67	44	44	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28593	10.1371/journal.pone.0028593	http://dx.doi.org/10.1371/journal.pone.0028593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163041	gold, Green Submitted, Green Published			2022-12-25	WOS:000298173500039
J	Wani, NA; Nada, R; Kaur, J				Wani, Nissar Ahmad; Nada, Ritambhara; Kaur, Jyotdeep			Biochemical and Molecular Mechanisms of Folate Transport in Rat Pancreas; Interference with Ethanol Ingestion	PLOS ONE			English	Article							METHYL-GROUP METABOLISM; DNA METHYLATION; BRUSH-BORDER; GENE-EXPRESSION; DOWN-REGULATION; CELL BIOLOGY; ACINAR-CELLS; LIPID RAFTS; FOLIC-ACID; ALCOHOL	Folic acid is an essential nutrient that is required for one-carbon biosynthetic processes and for methylation of biomolecules. Deficiency of this micronutrient leads to disturbances in normal physiology of cell. Chronic alcoholism is well known to be associated with folate deficiency which is due, in part to folate malabsorption. The present study deals with the mechanistic insights of reduced folate absorption in pancreas during chronic alcoholism. Male Wistar rats were fed 1 g/kg body weight/day ethanol (20% solution) orally for 3 months and the mechanisms of alcohol associated reduced folate uptake was studied in pancreas. The folate transport system in the pancreatic plasma membrane (PPM) was found to be acidic pH dependent one. The transporters proton coupled folate transporter (PCFT) and reduced folate carrier (RFC) are involved in folate uptake across PPM. The folate transporters were found to be associated with lipid raft microdomain of the PPM. Ethanol ingestion decreased the folate transport by reducing the levels of folate transporter molecules in lipid rafts at the PPM. The decreased transport efficiency of the PPM was reflected as reduced folate levels in pancreas. The chronic ethanol ingestion led to decreased pancreatic folate uptake. The decreased levels of PCFT and RFC expression in rat PPM were due to decreased association of these proteins with lipid rafts (LR) at the PPM.	[Wani, Nissar Ahmad; Kaur, Jyotdeep] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India; [Nada, Ritambhara] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Wani, NA (corresponding author), Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India.	jyotdeep2001@yahoo.co.in	Wani, Nissar Ahmad/AAC-7210-2022	Wani, Nissar Ahmad/0000-0002-9248-9039; Nada, Ritambhra/0000-0002-8955-1428				Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Ashokkumar B, 2007, AM J CLIN NUTR, V86, P159, DOI 10.1093/ajcn/86.1.159; BALAGHI M, 1993, AM J CLIN NUTR, V58, P198, DOI 10.1093/ajcn/58.2.198; BALAGHI M, 1992, J NUTR, V122, P1391, DOI 10.1093/jn/122.7.1391; BALAGHI M, 1995, AM J CLIN NUTR, V61, P90, DOI 10.1093/ajcn/61.1.90; BECK IT, 1981, DIGEST DIS SCI, V26, P817, DOI 10.1007/BF01309614; Bielawski DM, 2002, ALCOHOL CLIN EXP RES, V26, P347, DOI 10.1097/00000374-200203000-00007; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Capdevila A, 1997, ARCH BIOCHEM BIOPHYS, V345, P47, DOI 10.1006/abbi.1997.0249; DELISLE RC, 1991, ANAL BIOCHEM, V192, P1, DOI 10.1016/0003-2697(91)90173-Q; Dev S, 2011, BRIT J NUTR, V105, P827, DOI 10.1017/S0007114510004538; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P106, DOI 10.1053/gast.2002.30302; Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399; Hamid A, 2007, J MEMBRANE BIOL, V220, P69, DOI 10.1007/s00232-007-9075-3; Hamid A, 2007, FEBS J, V274, P6317, DOI 10.1111/j.1742-4658.2007.06150.x; Hamid A, 2007, MOL CELL BIOCHEM, V304, P265, DOI 10.1007/s11010-007-9509-3; Hamid A, 2006, ALCOHOL, V38, P59, DOI 10.1016/j.alcohol.2006.01.004; Hamid A, 2009, IUBMB LIFE, V61, P236, DOI 10.1002/iub.153; Hamid A, 2009, J NUTR BIOCHEM, V20, P291, DOI 10.1016/j.jnutbio.2008.03.004; Hamid A, 2009, FEBS J, V276, P2175, DOI 10.1111/j.1742-4658.2009.06959.x; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; Kubisch CH, 2006, PANCREAS, V33, P68, DOI 10.1097/01.mpa.0000226878.81377.94; LAKSHMAIAH N, 1975, INT J VITAM NUTR RES, V45, P262; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; LIEBER CS, 1979, CANCER RES, V39, P2863; Longnecker DS, 2002, J NUTR, V132, p2373S, DOI 10.1093/jn/132.8.2373S; McCabe DC, 2005, NUTR REV, V63, P183, DOI [10.1301/nr.2005.Jun.183-195, 10.1111/j.1753-4887.2005.tb00136.x]; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; PERSSON J, 1991, SCAND J GASTROENTERO, V26, P3, DOI 10.3109/00365529108996478; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; QUIGLEY JP, 1969, BIOCHIM BIOPHYS ACTA, V173, P456, DOI 10.1016/0005-2736(69)90010-8; Said HM, 2010, AM J PHYSIOL-GASTR L, V298, pG985, DOI 10.1152/ajpgi.00068.2010; Said HM, 2004, ANNU REV PHYSIOL, V66, P419, DOI 10.1146/annurev.physiol.66.032102.144611; Said HM, 2000, AM J PHYSIOL-CELL PH, V279, pC1889, DOI 10.1152/ajpcell.2000.279.6.C1889; Schalinske KL, 2005, NUTR REV, V63, P387, DOI [10.1111/j.1753-4887.2005.tb00375.x, 10.1301/nr.2005.nov.387-391]; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stolzenberg-Solomon RZ, 1999, JNCI-J NATL CANCER I, V91, P535, DOI 10.1093/jnci/91.6.535; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V295, pC828, DOI 10.1152/ajpcell.00249.2008; Tamura T., 1990, FOLIC ACID METABOLIS, P121; THEVENOD F, 1989, J MEMBRANE BIOL, V107, P263, DOI 10.1007/BF01871941; Toskes P P, 1983, Dis Mon, V29, P1; Towbin H, 1992, Biotechnology, V24, P145; Wani NA, 2011, BR J NUTR, V1-9, DOI [10.1017/S0007114511003710, DOI 10.1017/S0007114511003710]; Wani NA, 2011, J CELL PHYSIOL, V226, P579, DOI 10.1002/jcp.22525; Wani NA, 2008, IUBMB LIFE, V60, P834, DOI 10.1002/iub.133; Werner J, 2002, AM J PHYSIOL-GASTR L, V283, pG65, DOI 10.1152/ajpgi.00419.2001; Werner J, 2001, SURGERY, V129, P736, DOI 10.1067/msy.2001.113891; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Zhang YQ, 1996, GASTROENTEROLOGY, V110, P478, DOI 10.1053/gast.1996.v110.pm8566595; Zhao RB, 2001, J BIOL CHEM, V276, P1114, DOI 10.1074/jbc.M007919200	60	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28599	10.1371/journal.pone.0028599	http://dx.doi.org/10.1371/journal.pone.0028599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163044	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500040
J	Wesener, T; Raupach, MJ; Decker, P				Wesener, Thomas; Raupach, Michael J.; Decker, Peter			Mountain Refugia Play a Role in Soil Arthropod Speciation on Madagascar: A Case Study of the Endemic Giant Fire-Millipede Genus Aphistogoniulus	PLOS ONE			English	Article							BIOGEOGRAPHY; EVOLUTION; COLONIZATION; BIODIVERSITY; SPIROBOLIDA; PHYLOGENY; DIPLOPODA; PATTERNS; REVISION; BREAKUP	To elucidate the speciation mechanisms prevalent within hotspots of biodiversity, and the evolutionary processes behind the rise of their species-rich and endemic biota, we investigated the phylogeny of the giant fire-millipede genus Aphistogoniulus Silvestri, 1897, a Malagasy endemic. This study is the first comprehensive (molecular and morphological) phylogenetic study focusing on millipede (class Diplopoda) speciation on Madagascar. The morphological analysis is based on 35 morphological characters and incorporates ten described as well as two newly described species (A. rubrodorsalis n. sp. and A. jeekeli n. sp.) of Aphistogoniulus. The molecular analysis is based on both mitochondrial (COI and 16S), and nuclear genes (complete 18S rDNA), together comprised of 3031 base pairs, which were successfully sequenced for 31 individual specimens and eight species of Aphistogoniulus. In addition to the null-model (speciation by distance), two diversification models, mountain refugia and ecotone shift, were discovered to play a role in the speciation of soil arthropods on Madagascar. Mountain refugia were important in the speciation of the A. cowani clade, with three species occurring in the Andringitra and Ranomafana Mountains in the southeast (A. cowani), the Ambohijanahary and Ambohitantely Mountains in the mid-west (A. sanguineus), and the Marojejy Mountain in the northeast (A. rubrodorsalis n. sp.). An ecotone shift from the eastern rainforest to the unique subarid spiny forest of Mahavelo was discovered in the A. vampyrus - A. aridus species-pair. In the monophyletic A. diabolicus clade, evidence for divergent evolution of sexual morphology was detected: species with greatly enlarged gonopods are sister-taxa to species with normal sized gonopods. Among the large-bodied Spirobolida genera of Madagascar, Colossobolus and Sanguinobolus were found to be close sister-genera to Aphistogoniulus. Forest destruction has caused forest corridors between populations to disappear, which might limit the possible resolution of biogeographic analyses on Madagascar.	[Wesener, Thomas] Zool Res Museum Alexander Koenig, Bonn, Germany; [Raupach, Michael J.] Deutsch Zentrum Marine Biodiversitatsforsch, AG Mol Taxonomie Mariner Organismen, Wilhelmshaven, Germany; [Decker, Peter] Senckenberg Museum Nat Kunde Gorlitz, Gorlitz, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Senckenberg Gesellschaft fur Naturforschung (SGN)	Wesener, T (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	thomas.wesener@rub.de	Decker, Peter/S-6574-2019; Raupach, Michael J./AAF-7566-2020; Raupach, Michael/G-7072-2012	Decker, Peter/0000-0003-0345-7738; Raupach, Michael J./0000-0001-8299-6697; 	German Science Foundation [DFG WA 530/37-1]; PEET from the National Science Foundation of the United States (NSF) [05-29715]; Field Museum's Pritzker Laboratory of Molecular Systematics and Evolution	German Science Foundation(German Research Foundation (DFG)); PEET from the National Science Foundation of the United States (NSF)(National Science Foundation (NSF)); Field Museum's Pritzker Laboratory of Molecular Systematics and Evolution	This study was supported by both a German Science Foundation (www.dfg.de) fund for the 'Biodiversity and Biogeography of the Diplopoda from Madagascar' DFG WA 530/37-1 and a PEET grant from the National Science Foundation (nsf.gov) of the United States (NSF Grant 05-29715) to Petra Sierwald, William Shear and Jason Bond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our highest regards to Steven M. Goodman (FMNH), Brian L. Fisher and Charles Griswold (both CAS) for their numerous millipede collection efforts on Madagascar. The loan of the CAS millipedes was arranged by Darrel Ubick and Anthea Carmichael. Betty Strack (FMNH) thankfully advised at the SEM during frequent sessions. Intern Ioulia Bespalova (Mount Holyoke College) provided SEM images of A. cowani. Kai Schutte and Arne Hartig provided colour photographs of living specimens. We also thank Yan Yu for his help using RASP. The three anonymous reviewers and the editor greatly improved the quality of an earlier version of this paper. The authors gratefully acknowledge support from Kevin Feldheim and his colleagues in the Field Museum's Pritzker Laboratory of Molecular Systematics and Evolution. Specimens of A. hova were thankfully provided by OdenwaldExoten. Peter Schwendinger and the Musee d'Histoire Naturelle, Geneve graciously hosted P. D. during a visit. Holly Wesener proof read the English text. Dr. S. Goodman corrected the Malagasy locality names.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; Bruhl CA, 1997, J BIOGEOGR, V24, P233, DOI 10.1046/j.1365-2699.1997.00073.x; Butler A. G., 1882, Annals of Natural History, V(5), P328; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emberton KC, 2001, BIOL J LINN SOC, V72, P567, DOI 10.1006/bijl.2000.0517; Fisher BL, 1997, J NAT HIST, V31, P269, DOI 10.1080/00222939700770141; Fuller S, 2005, J BIOGEOGR, V32, P2135, DOI 10.1111/j.1365-2699.2005.01354.x; Gamble T, 2008, J BIOGEOGR, V35, P88, DOI 10.1111/j.1365-2699.2007.01770.x; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; GASTON KJ, 1995, BIODIVERS CONSERV, V4, P119, DOI 10.1007/BF00137780; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 2008, INTRO FORETS SECHES, V1, P12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Huber BA, 2003, ZOOL J LINN SOC-LOND, V137, P261, DOI 10.1046/j.1096-3642.2003.00046.x; Jokat W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001802; Kohler F, 2010, BIOL J LINN SOC, V99, P867, DOI 10.1111/j.1095-8312.2009.01390.x; Maddison, 2019, MESQUITE MODULAR SYS; Moat J., 2007, ATLAS VEGETATION MAD; Monaghan MT, 2005, P ROY SOC B-BIOL SCI, V272, P1829, DOI 10.1098/rspb.2005.3139; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon K. C., 2002, WINCLADA VER 1 00 08; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silvestri F., 1897, ANN MUSEO CIVICO STO, V18, P644; Sota T, 2010, P ROY SOC B-BIOL SCI, V277, P689, DOI 10.1098/rspb.2009.1822; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Vences Miguel, 2002, Spixiana, V25, P79; Vences M, 2004, ITAL J ZOOL, V71, P217, DOI 10.1080/11250000409356639; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Wesener T, 2009, TROP ZOOL, V22, P71; Wesener T, 2010, MOL PHYL EVO, DOI [10.1016/j.physletb.2003.10.071, DOI 10.1016/J.PHYSLETB.2003.10.071]; Wesener T, 2008, INVERTEBR SYST, V22, P37, DOI 10.1071/IS07008; Wesener Thomas, 2005, Proceedings of the California Academy of Sciences, V56, P557; Wesener T, 2009, ZOOTAXA, P1; Wesener Thomas, 2009, International Journal of Myriapodology, V2, P15, DOI 10.1163/187525409X462403; Wesener T, 2009, CLADISTICS, V25, P545, DOI 10.1111/j.1096-0031.2009.00267.x; Wesener T, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.19.221; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Yeates DK, 2002, INVERTEBR SYST, V16, P605, DOI 10.1071/IT01032; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9; Yu Y., 2011, RASP RECONSTRUCT ANC	56	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28035	10.1371/journal.pone.0028035	http://dx.doi.org/10.1371/journal.pone.0028035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162998	Green Submitted, gold, Green Published			2022-12-25	WOS:000298173500009
J	Holzer, B; Bakshi, S; Bridgen, A; Baron, MD				Holzer, Barbara; Bakshi, Siddharth; Bridgen, Anne; Baron, Michael D.			Inhibition of Interferon Induction and Action by the Nairovirus Nairobi Sheep Disease Virus/Ganjam Virus	PLOS ONE			English	Article							CONGO-HEMORRHAGIC-FEVER; RESPIRATORY SYNDROME CORONAVIRUS; UBIQUITIN-LIKE PROTEIN; PAPAIN-LIKE PROTEASE; STRAND RNA VIRUSES; HUMAN MXA PROTEIN; GANJAM VIRUS; NEGATIVE REGULATION; ANTIVIRAL ACTIVITY; ISG15 CONJUGATION	The Nairoviruses are an important group of tick-borne viruses that includes pathogens of man (Crimean Congo hemorrhagic fever virus) and livestock animals (Dugbe virus, Nairobi sheep disease virus (NSDV)). NSDV is found in large parts of East Africa and the Indian subcontinent (where it is known as Ganjam virus). We have investigated the ability of NSDV to antagonise the induction and actions of interferon. Both pathogenic and apathogenic isolates could actively inhibit the induction of type 1 interferon, and also blocked the signalling pathways of both type 1 and type 2 interferons. Using transient expression of viral proteins or sections of viral proteins, these activities all mapped to the ovarian tumour-like protease domain (OTU) found in the viral RNA polymerase. Virus infection, or expression of this OTU domain in transfected cells, led to a great reduction in the incorporation of ubiquitin or ISG15 protein into host cell proteins. Point mutations in the OTU that inhibited the protease activity also prevented it from antagonising interferon induction and action. Interestingly, a mutation at a peripheral site, which had little apparent effect on the ability of the OTU to inhibit ubiquitination and ISG15ylation, removed the ability of the OTU to block the induction of type 1 and the action of type 2 interferons, but had a lesser effect on the ability to block type 1 interferon action, suggesting that targets other than ubiquitin and ISG15 may be involved in the actions of the viral OTU.	[Holzer, Barbara; Bakshi, Siddharth; Baron, Michael D.] Inst Anim Hlth, Pirbright, Surrey, England; [Bakshi, Siddharth; Bridgen, Anne] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Ulster University	Holzer, B (corresponding author), Inst Anim Hlth, Pirbright, Surrey, England.	michael.baron@iah.ac.uk		Bakshi, Siddharth/0000-0002-1179-8623; Holzer, Barbara/0000-0003-0203-0601	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F00740X/1, BB/F006764/1]; BBSRC [BB/F006764/2, BB/F00740X/1, BBS/E/I/00001433, BB/F006764/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F006764/1, BBS/E/I/00001433, BB/F006764/2, BB/F00740X/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) (grants BB/F00740X/1 and BB/F006764/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boxer EL, 2009, VIROLOGY, V385, P134, DOI 10.1016/j.virol.2008.11.022; Bridgen A, 2004, VIRUS RES, V99, P47, DOI 10.1016/j.virusres.2003.10.002; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; CHANG KC, 1990, ARCH VIROL, V110, P151, DOI 10.1007/BF01311285; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Courtois G, 2008, CELL MOL LIFE SCI, V65, P1123, DOI 10.1007/s00018-007-7465-4; DANDAWAT.CN, 1969, INDIAN J MED RES, V57, P975; DANDAWAT.CN, 1969, INDIAN J MED RES, V57, P799; DAUBNEY R., 1934, PARASITOLOGY, V26, P496, DOI 10.1017/S0031182000023817; DAUBNEY R., 1931, PARASITOLOGY, V23, P507, DOI 10.1017/S0031182000013895; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P259, DOI 10.1017/S0022172400025092; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P251, DOI 10.1017/S0022172400025080; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Frias-Staheli N, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P129; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Honig JE, 2004, VIROLOGY, V321, P29, DOI 10.1016/j.virol.2003.09.042; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; MONTGOMERY E., 1917, Journal of Comparative Pathology and Therapeutics, V30, P28; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; RAO CVRM, 1981, INDIAN J MED RES, V74, P319; Schmaljohn C. S., 2007, FIELDS VIROLOGY, P1743; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Takeuchi T, 2006, FEBS LETT, V580, P4521, DOI 10.1016/j.febslet.2006.07.032; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Versteeg GA, 2010, J VIROL, V84, P5423, DOI 10.1128/JVI.02395-09; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	64	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28594	10.1371/journal.pone.0028594	http://dx.doi.org/10.1371/journal.pone.0028594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163042	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800051
J	Huang, SH; Hainzl, T; Grundstrom, C; Forsman, C; Samuelsson, G; Sauer-Eriksson, AE				Huang, Shenghua; Hainzl, Tobias; Grundstrom, Christin; Forsman, Cecilia; Samuelsson, Goran; Sauer-Eriksson, A. Elisabeth			Structural Studies of beta-Carbonic Anhydrase from the Green Alga Coccomyxa: Inhibitor Complexes with Anions and Acetazolamide	PLOS ONE			English	Article							PH-DEPENDENT ACTIVITY; CRYSTAL-STRUCTURE; PISUM-SATIVUM; ACTIVE-SITE; CO2 HYDRATION; MOLECULAR-GRAPHICS; REFINED STRUCTURE; ESCHERICHIA-COLI; BINDING; ENZYME	The beta-class carbonic anhydrases (beta-CAs) are widely distributed among lower eukaryotes, prokaryotes, archaea, and plants. Like all CAs, the beta-enzymes catalyze an important physiological reaction, namely the interconversion between carbon dioxide and bicarbonate. In plants the enzyme plays an important role in carbon fixation and metabolism. To further explore the structure-function relationship of beta-CA, we have determined the crystal structures of the photoautotroph unicellular green alga Coccomyxa beta-CA in complex with five different inhibitors: acetazolamide, thiocyanate, azide, iodide, and phosphate ions. The tetrameric Coccomyxa beta-CA structure is similar to other beta-CAs but it has a 15 amino acid extension in the C-terminal end, which stabilizes the tetramer by strengthening the interface. Four of the five inhibitors bind in a manner similar to what is found in complexes with alpha-type CAs. Iodide ions, however, make contact to the zinc ion via a zinc-bound water molecule or hydroxide ion - a type of binding mode not previously observed in any CA. Binding of inhibitors to Coccomyxa beta-CA is mediated by side-chain movements of the conserved residue Tyr-88, extending the width of the active site cavity with 1.5-1.8 angstrom. Structural analysis and comparisons with other alpha- and beta-class members suggest a catalytic mechanism in which the movements of Tyr-88 are important for the CO2-HCO3- interconversion, whereas a structurally conserved water molecule that bridges residues Tyr-88 and Gln-38, seems important for proton transfer, linking water molecules from the zinc-bound water to His-92 and buffer molecules.	[Huang, Shenghua; Hainzl, Tobias; Grundstrom, Christin; Forsman, Cecilia; Sauer-Eriksson, A. Elisabeth] Umea Univ, Dept Chem, Umea, Sweden; [Samuelsson, Goran] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden	Umea University; Umea University	Huang, SH (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	elisabeth.sauer-eriksson@chem.umu.se	Samuelsson, Goran/E-1824-2015	Sauer-Eriksson, Elisabeth/0000-0003-0124-0199	Swedish Research Council; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation	This work is funded by the Swedish Research Council and Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI G, 1981, BIOCHIM BIOPHYS ACTA, V668, P16, DOI 10.1016/0005-2795(81)90144-6; ATKINS CA, 1972, PLANT PHYSIOL, V50, P214, DOI 10.1104/pp.50.2.214; ATKINS CA, 1972, PLANT PHYSIOL, V50, P218, DOI 10.1104/pp.50.2.218; Avvaru BS, 2010, BIOCHEMISTRY-US, V49, P249, DOI 10.1021/bi902007b; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bjorkbacka H, 1997, BIOCHEMISTRY-US, V36, P4287, DOI 10.1021/bi962825k; Bjorkbacka H, 1999, ARCH BIOCHEM BIOPHYS, V361, P17, DOI 10.1006/abbi.1998.0961; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAKRAVARTY S, 1994, J MOL BIOL, V243, P298, DOI 10.1006/jmbi.1994.1655; Covarrubias AS, 2006, J BIOL CHEM, V281, P4993, DOI 10.1074/jbc.M510756200; Covarrubias AS, 2005, J BIOL CHEM, V280, P18782, DOI 10.1074/jbc.M414348200; Cronk JD, 2006, BIOCHEMISTRY-US, V45, P4351, DOI 10.1021/bi052272q; Cronk JD, 2001, PROTEIN SCI, V10, P911, DOI 10.1110/ps.46301; Di Fiore A, 2009, PROTEINS, V74, P164, DOI 10.1002/prot.22144; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; ERIKSSON AE, 1988, PROTEINS, V4, P283, DOI 10.1002/prot.340040407; Ferry JG, 2010, BBA-PROTEINS PROTEOM, V1804, P374, DOI 10.1016/j.bbapap.2009.08.026; GUILLOTON MB, 1992, J BIOL CHEM, V267, P3731; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; HILTONEN T, 1995, PLANTA, V195, P345; Hiltonen T, 1998, PLANT PHYSIOL, V117, P1341, DOI 10.1104/pp.117.4.1341; Hoffmann KM, 2011, ARCH BIOCHEM BIOPHYS, V511, P80, DOI 10.1016/j.abb.2011.04.013; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang SH, 1998, J MOL BIOL, V283, P301, DOI 10.1006/jmbi.1998.2077; JOHANSSON IM, 1994, EUR J BIOCHEM, V224, P901, DOI 10.1111/j.1432-1033.1994.00901.x; JOHANSSON IM, 1993, EUR J BIOCHEM, V218, P439, DOI 10.1111/j.1432-1033.1993.tb18394.x; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KUMAR V, 1994, ACTA CRYSTALLOGR D, V50, P731, DOI 10.1107/S0907444994001873; Liljas A, 2000, EMBO REP, V1, P16, DOI 10.1093/embo-reports/kvd016; LILJAS A, 1972, NATURE-NEW BIOL, V235, P131, DOI 10.1038/newbio235131a0; LILJAS A, 1994, EUR J BIOCHEM, V219, P1, DOI 10.1111/j.1432-1033.1994.tb19909.x; Lindskog S, 2000, EXS, V90, P175; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Mitsuhashi S, 2000, J BIOL CHEM, V275, P5521, DOI 10.1074/jbc.275.8.5521; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pacchiano F, 2011, BIOORG MED CHEM LETT, V21, P102, DOI 10.1016/j.bmcl.2010.11.064; PALMQVIST K, 1995, PLANTA, V197, P352; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rowlett RS, 2010, BBA-PROTEINS PROTEOM, V1804, P362, DOI 10.1016/j.bbapap.2009.08.002; Rowlett RS, 2002, ARCH BIOCHEM BIOPHYS, V404, P197, DOI 10.1016/S0003-9861(02)00243-6; ROWLETT RS, 1994, BIOCHEMISTRY-US, V33, P13967, DOI 10.1021/bi00251a003; Sawaya MR, 2006, J BIOL CHEM, V281, P7546, DOI 10.1074/jbc.M510464200; Sippel KH, 2009, ACTA CRYSTALLOGR F, V65, P992, DOI 10.1107/S1744309109036665; Strop P, 2001, J BIOL CHEM, V276, P10299, DOI 10.1074/jbc.M009182200; Supuran CT, 2008, CURR PHARM DESIGN, V14, P641, DOI 10.2174/138161208783877947; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; TIBELL L, 1984, BIOCHIM BIOPHYS ACTA, V789, P302, DOI 10.1016/0167-4838(84)90186-9; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VIDGREN J, 1990, INT J BIOL MACROMOL, V12, P342, DOI 10.1016/0141-8130(90)90040-H; Whittington DA, 2004, J BIOL CHEM, V279, P7223, DOI 10.1074/jbc.M310809200	56	35	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28458	10.1371/journal.pone.0028458	http://dx.doi.org/10.1371/journal.pone.0028458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162771	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800038
J	Liu, B; Jiang, GF; Zhang, YF; Li, JL; Li, XJ; Yue, JS; Chen, F; Liu, HQ; Li, HJ; Zhu, SP; Wang, JJ; Ran, C				Liu, Bin; Jiang, Gaofei; Zhang, Yunfei; Li, Junli; Li, Xiaojiao; Yue, Jiansu; Chen, Fei; Liu, Haoqiang; Li, Hongjun; Zhu, Shiping; Wang, Jinjun; Ran, Chun			Analysis of Transcriptome Differences between Resistant and Susceptible Strains of the Citrus Red Mite Panonychus citri (Acari: Tetranychidae)	PLOS ONE			English	Article							COMMON SENSITIZING ALLERGEN; EUKARYOTIC TRANSCRIPTOME; HEXYTHIAZOX RESISTANCE; GENE-EXPRESSION; MCGREGOR; VECTOR; GENOME; TOOL	Background: The citrus red mite is a worldwide citrus pest and a common sensitizing allergen of asthma and rhinitis. It has developed strong resistance to many registered acaricides, However, the molecular mechanisms of resistance remain unknown. we therefore used next generation sequencing technology to investigate the global transcriptomes between resistant strains and susceptible strains. Results: We obtained 34,159, 30,466 and 32,217 unigenes by assembling the SS reads, RS reads and SS&RS reads respectively. There are total 17,581 annotated unigenes from SS&RS reads by BLAST searching databases of nr, the Clusters of Orthologous Groups (COGs) and Kyoto Encyclopedia of Genes and Genomes (KEGG) with an E-value <= 1e-5, in which 7,075 unigenes were annotated in the COG database, 12, 712 unigenes were found in the KEGG database and 3,812 unigenes were assigned to Gene ontology (GO). Moreover, 2,701 unigenes were judged to be the differentially expressed genes (DEGs) based on the uniquely mapped reads. There are 219 pathways in all annotated unigenes and 198 pathways in DEGs that mapped to the KEGG database. We identified 211 metabolism genes and target genes related to general insecticide resistance such as P450 and Cytochrome b, and further compared their differences between RS and SS. Meanwhile, we identified 105 and 194 genes related to growth and reproduction, respectively, based on the mode of action of Hexythiazox. After further analyses, we found variation in sequences but not in gene expression related to mite growth and reproduction between different strains. Conclusion: To our knowledge, this is the first comparative transcriptome study to discover candidate genes involved in phytophagous mite resistance. This study identified differential unigenes related to general pesticide resistance and organism growth and reproduction in P. citri. The assembled, annotated transcriptomes provide a valuable genomic resource for further understanding the molecular basis of resistance mechanisms.	[Liu, Bin; Li, Xiaojiao; Yue, Jiansu] Southwest Univ, Key Lab Hort Sci So Mountainous Reg, Coll Hort & Landscape Architecture, Minist Educ, Chongqing, Peoples R China; [Liu, Bin; Jiang, Gaofei; Zhang, Yunfei; Li, Junli; Li, Xiaojiao; Yue, Jiansu; Chen, Fei; Liu, Haoqiang; Li, Hongjun; Zhu, Shiping; Ran, Chun] Chinese Acad Agr Sci, Citrus Res Inst, Natl Engn Res Ctr Citrus, Chongqing, Peoples R China; [Chen, Fei; Wang, Jinjun] Southwest Univ, Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Southwest University - China	Liu, B (corresponding author), Southwest Univ, Key Lab Hort Sci So Mountainous Reg, Coll Hort & Landscape Architecture, Minist Educ, Chongqing, Peoples R China.	ranchun@sohu.com			Science and Technique Foundation of CQ (CSTC) [2010AC1018]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0976]	Science and Technique Foundation of CQ (CSTC); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Science and Technique Foundation of CQ (CSTC, 2010AC1018) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0976). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bolland H.R., 1998, WORLD CATALOGUE SPID; Campos FJ, 2002, EXP APPL ACAROL, V26, P243, DOI 10.1023/A:1021103209193; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen ZY, 2009, INT J ACAROL, V35, P33, DOI 10.1080/01647950802655293; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Faunes F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r15; Feng XP, 2002, J NEUROCHEM, V83, P870, DOI 10.1046/j.1471-4159.2002.01199.x; Furuhashi K., 1994, P KANSAI PLANT PROT, V41, P267; GOUGH N, 1990, CROP PROT, V9, P119, DOI 10.1016/0261-2194(90)90090-T; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; HOY MA, 1986, J ECON ENTOMOL, V79, P1377, DOI 10.1093/jee/79.5.1377; Hu JF, 2010, PEST MANAG SCI, V66, P1025, DOI 10.1002/ps.1978; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang HB, 2010, ARCH INSECT BIOCHEM, V74, P17, DOI 10.1002/arch.20358; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73, DOI 10.1080/00021369.1991.10870535; Kim YK, 1999, CLIN EXP ALLERGY, V29, P1102, DOI 10.1046/j.1365-2222.1999.00607.x; Kim YK, 1999, ANN ALLERG ASTHMA IM, V82, P223, DOI 10.1016/S1081-1206(10)62601-4; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Lee MH, 2000, ANN ALLERG ASTHMA IM, V85, P200, DOI 10.1016/S1081-1206(10)62467-2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Masui S., 1995, P KANTO TOSAN PLANT, V42, P245; Meng HS, 2000, AGROCHEMICALS, V39, P26; Morin S, 2002, INSECT BIOCHEM MOLEC, V32, P1781, DOI 10.1016/S0965-1748(02)00137-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nikou D, 2003, GENE, V318, P91, DOI 10.1016/S0378-1119(03)00763-7; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Ran Chun, 2008, Acta Phytophylacica Sinica, V35, P537; Ran C, 2009, INT J ACAROL, V35, P115, DOI 10.1080/01647950902917593; Van Leeuwen T, 2011, INSECT MOL BIOL, V20, P135, DOI 10.1111/j.1365-2583.2010.01040.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamamoto A, 1996, J PESTIC SCI, V21, P37; YAMAMOTO A, 1995, J PESTIC SCI, V20, P513; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang ZhiQiang, 2003, Mites of greenhouses: identification, biology and control, DOI 10.1079/9780851995908.0000; Zhou L, 2009, J MED ENTOMOL, V46, P321, DOI 10.1603/033.046.0217	47	58	63	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28516	10.1371/journal.pone.0028516	http://dx.doi.org/10.1371/journal.pone.0028516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162774	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800044
J	Marquez, B; Ameye, G; Vallet, CM; Tulkens, PM; Poirel, HA; Van Bambeke, F				Marquez, Beatrice; Ameye, Genevieve; Vallet, Coralie M.; Tulkens, Paul M.; Poirel, Helene A.; Van Bambeke, Francoise			Characterization of Abcc4 Gene Amplification in Stepwise-Selected Mouse J774 Macrophages Resistant to the Topoisomerase II Inhibitor Ciprofloxacin	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; IN-VITRO; EFFLUX TRANSPORTER; EPIGENETIC CHANGES; CELL-LINES; QUINOLONES; DNA; IDENTIFICATION; MRP4/ABCC4; MRP4	Exposure of J774 mouse macrophages to stepwise increasing concentrations of ciprofloxacin, an antibiotic inhibiting bacterial topoisomerases, selects for resistant cells that overexpress the efflux transporter Abcc4 (Marquez et al. [2009] Antimicrob. Agents Chemother. 53:2410-2416), encoded by the Abcc4 gene located on Chromosome 14qE4. In this study, we report the genomic alterations occurring along the selection process. Abcc4 expression progressively increased upon selection rounds, with exponential changes observed between cells exposed to 150 and 200 mu M of ciprofloxacin, accompanied by a commensurate decrease in ciprofloxacin accumulation. Molecular cytogenetics experiments showed that this overexpression is linked to Abcc4 gene overrepresentation, grading from a partial trisomy of Chr 14 at the first step of selection (cells exposed to 100 mu M ciprofloxacin), to low-level amplifications (around three copies) of Abcc4 locus on 1 or 2 Chr 14 (cells exposed to 150 mu M ciprofloxacin), followed by high-level amplification of Abcc4 as homogeneous staining region (hsr), inserted on 3 different derivative Chromosomes (cells exposed to 200 mu M ciprofloxacin). In revertant cells obtained after more than 60 passages of culture without drug, the Abcc4 hsr amplification was lost in approx. 70% of the population. These data suggest that exposing cells to sufficient concentrations of an antibiotic with low affinity for eukaryotic topoisomerases can cause major genomic alterations that may lead to the overexpression of the transporter responsible for its efflux. Gene amplification appears therefore as a mechanism of resistance that can be triggered by non-anticancer agents but contribute to cross-resistance, and is partially and slowly reversible.	[Marquez, Beatrice] Hosp Univ Virgen del Rocio, Grp Tumorigenesis Endocrina & Regulac Hormonal Ca, Inst Biomed Sevilla, Seville, Spain; [Marquez, Beatrice; Vallet, Coralie M.; Tulkens, Paul M.; Van Bambeke, Francoise] Catholic Univ Louvain, Louvain Drug Res Inst, Brussels, Belgium; [Ameye, Genevieve; Poirel, Helene A.] Catholic Univ Louvain, Clin Univ St Luc, Ctr Genet Humaine, Brussels, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Marquez, B (corresponding author), Hosp Univ Virgen del Rocio, Grp Tumorigenesis Endocrina & Regulac Hormonal Ca, Inst Biomed Sevilla, Seville, Spain.	francoise.vanbambeke@uclouvain.be	Van Bambeke, Françoise/H-5934-2019; IBIS, TUMORIGENESIS/P-3506-2015; Tulkens, Paul/B-2087-2015	Van Bambeke, Françoise/0000-0002-0052-7991; Tulkens, Paul/0000-0002-7121-3623	Fonds National belge de la Recherche Medicale [3.4.597.06, 3.4.583.08]; Belgian Fonds de la Recherche Scientifique [1.5.195.07, 1.5.137.10]; Belgian Federal Science Policy Office [P6/19]	Fonds National belge de la Recherche Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by the Fonds National belge de la Recherche Medicale (grants no. 3.4.597.06 and 3.4.583.08), the Belgian Fonds de la Recherche Scientifique (grants no. 1.5.195.07 and 1.5.137.10), and the Belgian Federal Science Policy Office (Research project P6/19 [research action P6]). C.M.V. is Boursier of the Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.), B.M. was successively post-doctoral fellow of the First post-doc program of the Belgian Region wallonne and of the Fonds speciaux de recherche de l'Universite catholique de Louvain, F.V.B. is Maitre de Recherches of the Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI S, 1995, MUTAGENESIS, V10, P343, DOI 10.1093/mutage/10.4.343; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ansari M, 2009, BLOOD, V114, P1383, DOI 10.1182/blood-2008-11-191098; Anupama M, 2010, ARCH TOXICOL, V84, P411, DOI 10.1007/s00204-009-0509-9; Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Belinsky MG, 2007, CANCER RES, V67, P262, DOI 10.1158/0008-5472.CAN-06-2680; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; Choi HK, 2007, ENDOCR-RELAT CANCER, V14, P293, DOI 10.1677/ERC-06-0016; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; ELSEA SH, 1992, J BIOL CHEM, V267, P13150; European Medicines Agency, 2009, WHIT PAP RES ENG ATM, P1; Fojo T, 2007, DRUG RESIST UPDATE, V10, P59, DOI 10.1016/j.drup.2007.02.002; Foroumadi A, 2009, BIOMED PHARMACOTHER, V63, P216, DOI 10.1016/j.biopha.2008.01.016; Gorla N, 1999, TOXICOL LETT, V104, P43, DOI 10.1016/S0378-4274(98)00230-6; Gottesman MM, 1998, METHOD ENZYMOL, V292, P248; Graux C, 2009, LEUKEMIA, V23, P125, DOI 10.1038/leu.2008.278; Haslam IS, 2011, DRUG METAB DISPOS; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Herbold BA, 2001, MUTAT RES-GEN TOX EN, V498, P193, DOI 10.1016/S1383-5718(01)00275-3; Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809; Itoh S, 2002, MUTAT RES-GEN TOX EN, V517, P113, DOI 10.1016/S1383-5718(02)00058-X; Itoh T, 2006, MUTAT RES-GEN TOX EN, V603, P135, DOI 10.1016/j.mrgentox.2005.11.003; Knutsen T, 1998, GENE CHROMOSOME CANC, V23, P44, DOI 10.1002/(SICI)1098-2264(199809)23:1<44::AID-GCC7>3.0.CO;2-6; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; LEE JJ, 1990, ANAL BIOCHEM, V189, P1, DOI 10.1016/0003-2697(90)90036-9; Lee W, 2008, EXP MOL MED, V40, P109, DOI 10.3858/emm.2008.40.1.109; LEPAGE P, 1993, MOL CELL BIOL, V13, P7380, DOI 10.1128/MCB.13.12.7380; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch A, 2003, MUTAGENESIS, V18, P345, DOI 10.1093/mutage/geg003; Marquez B, 2011, CURR DRUG TARGETS, V12, P600, DOI 10.2174/138945011795378504; Marquez B, 2009, ANTIMICROB AGENTS CH, V53, P2410, DOI 10.1128/AAC.01428-08; Michot JM, 2005, ANTIMICROB AGENTS CH, V49, P2429, DOI 10.1128/AAC.49.6.2429-2437.2005; Michot JM, 2006, ANTIMICROB AGENTS CH, V50, P1689, DOI 10.1128/AAC.50.5.1689-1695.2006; Michot JM, 2004, ANTIMICROB AGENTS CH, V48, P2673, DOI 10.1128/AAC.48.7.2673-2682.2004; Mickley LA, 1997, J CLIN INVEST, V99, P1947, DOI 10.1172/JCI119362; MITELMAN F, 1988, ANTIMICROB AGENTS CH, V32, P936, DOI 10.1128/AAC.32.6.936; Mottino AD, 2008, WORLD J GASTROENTERO, V14, P7068, DOI 10.3748/wjg.14.7068; MUKHERJEE A, 1993, MUTAT RES, V301, P87, DOI 10.1016/0165-7992(93)90029-U; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; Peng XX, 2008, LEUKEMIA RES, V32, P799, DOI 10.1016/j.leukres.2007.09.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajabalian S, 2007, J PHARM PHARM SCI, V10, P153; Rao VK, 2005, CANCER GENET CYTOGEN, V160, P126, DOI 10.1016/j.cancergencyto.2004.12.013; Rosen JE, 1996, TOXICOL APPL PHARM, V140, P254, DOI 10.1006/taap.1996.0220; Rund D, 1999, ADV EXP MED BIOL, V457, P71; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; SLOVAK ML, 1993, CANCER RES, V53, P3221; SLOVAK ML, 1988, LEUKEMIA, V2, P453; SNYDERMAN R, 1977, J IMMUNOL, V119, P2060; TULKENS PM, 1991, EUR J CLIN MICROBIOL, V10, P100, DOI 10.1007/BF01964420; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28368	10.1371/journal.pone.0028368	http://dx.doi.org/10.1371/journal.pone.0028368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162766	Green Submitted, gold, Green Published			2022-12-25	WOS:000298172800029
J	Staats, M; Cuenca, A; Richardson, JE; Vrielink-van Ginkel, R; Petersen, G; Seberg, O; Bakker, FT				Staats, Martijn; Cuenca, Argelia; Richardson, James E.; Vrielink-van Ginkel, Ria; Petersen, Gitte; Seberg, Ole; Bakker, Freek T.			DNA Damage in Plant Herbarium Tissue	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MISCODING LESIONS; ANCIENT; AMPLIFICATION; PRESERVATION; SPECIMENS; SEQUENCES; REVEALS; REPAIR; EXTRACTION	Dried plant herbarium specimens are potentially a valuable source of DNA. Efforts to obtain genetic information from this source are often hindered by an inability to obtain amplifiable DNA as herbarium DNA is typically highly degraded. DNA post-mortem damage may not only reduce the number of amplifiable template molecules, but may also lead to the generation of erroneous sequence information. A qualitative and quantitative assessment of DNA post-mortem damage is essential to determine the accuracy of molecular data from herbarium specimens. In this study we present an assessment of DNA damage as miscoding lesions in herbarium specimens using 454-sequencing of amplicons derived from plastid, mitochondrial, and nuclear DNA. In addition, we assess DNA degradation as a result of strand breaks and other types of polymerase non-bypassable damage by quantitative real-time PCR. Comparing four pairs of fresh and herbarium specimens of the same individuals we quantitatively assess post-mortem DNA damage, directly after specimen preparation, as well as after long-term herbarium storage. After specimen preparation we estimate the proportion of gene copy numbers of plastid, mitochondrial, and nuclear DNA to be 2.4-3.8% of fresh control DNA and 1.0-1.3% after long-term herbarium storage, indicating that nearly all DNA damage occurs on specimen preparation. In addition, there is no evidence of preferential degradation of organelle versus nuclear genomes. Increased levels of C -> T/G -> A transitions were observed in old herbarium plastid DNA, representing 21.8% of observed miscoding lesions. We interpret this type of post-mortem DNA damage-derived modification to have arisen from the hydrolytic deamination of cytosine during long-term herbarium storage. Our results suggest that reliable sequence data can be obtained from herbarium specimens.	[Staats, Martijn; Vrielink-van Ginkel, Ria; Bakker, Freek T.] Wageningen Univ, Biosyst Grp, Wageningen, Netherlands; [Cuenca, Argelia; Petersen, Gitte; Seberg, Ole] Univ Copenhagen, Lab Mol Syst, Nat Hist Museum Denmark, Copenhagen, Denmark; [Richardson, James E.] Royal Bot Garden Edinburgh, Trop Divers Sect, Edinburgh, Midlothian, Scotland; [Richardson, James E.] Univ Los Andes, Lab Botan & Sistemat, Bogota, Colombia	Wageningen University & Research; University of Copenhagen; Universidad de los Andes (Colombia)	Staats, M (corresponding author), Wageningen Univ, Biosyst Grp, Wageningen, Netherlands.	freek.bakker@wur.nl	Cuenca, Argelia/AAK-9053-2021; Petersen, Gitte/H-1903-2011; Seberg, Ole/A-5111-2013; Richardson, James-Edward/L-2768-2016	Cuenca, Argelia/0000-0001-8596-1086; Petersen, Gitte/0000-0002-2325-0059; Seberg, Ole/0000-0001-9675-4090; Richardson, James-Edward/0000-0001-9014-4865; Bakker, Freek T./0000-0003-0227-6687	European Community	European Community(European Commission)	This work was supported by SYNTHESYS2 made available by the European Community Research Infrastructure under FP7 [Synthesis of Systematic Resources', 226506-CP-CSA-Infra]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Blankenberg D., 2010, CURR PROTOC MOL BIOL, V19, P101; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Boesch P, 2011, BBA-MOL CELL RES, V1813, P186, DOI 10.1016/j.bbamcr.2010.10.002; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Drabkova L, 2002, PLANT MOL BIOL REP, V20, P161, DOI 10.1007/BF02799431; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hansen AJ, 2006, GENETICS, V173, P1175, DOI 10.1534/genetics.106.057349; HARRIS SA, 1993, PLANT SYST EVOL, V188, P57, DOI 10.1007/BF00937835; Heyn P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq572; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1990, MUTAT RES, V238, P305, DOI 10.1016/0165-1110(90)90022-4; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; McCabe PF, 1997, PLANT J, V12, P267, DOI 10.1046/j.1365-313X.1997.12020267.x; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1990, J BIOL CHEM, V265, P4718; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; PYLE MM, 1989, TAXON, V38, P576, DOI 10.2307/1222632; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Roldan-Arjona T, 2009, MUTAT RES-REV MUTAT, V681, P169, DOI 10.1016/j.mrrev.2008.07.003; Rowan BA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-3; SAVOLAINEN V, 1995, PLANT SYST EVOL, V197, P87, DOI 10.1007/BF00984634; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; Shapiro B, 2008, TRENDS BIOTECHNOL, V26, P285, DOI 10.1016/j.tibtech.2008.03.005; Smith DR, 2009, PLANT MOL BIOL, V71, P627, DOI 10.1007/s11103-009-9545-3; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Telle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003584; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306	44	125	138	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28448	10.1371/journal.pone.0028448	http://dx.doi.org/10.1371/journal.pone.0028448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163018	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800037
J	Zhai, QT; Landesman, MB; Robinson, H; Sundquist, WI; Hill, CP				Zhai, Qianting; Landesman, Michael B.; Robinson, Howard; Sundquist, Wesley I.; Hill, Christopher P.			Structure of the Bro1 Domain Protein BROX and Functional Analyses of the ALIX Bro1 Domain in HIV-1 Budding	PLOS ONE			English	Article							ESCRT MACHINERY; BINDING-PROTEIN; HD-PTP; ALIX/AIP1; IDENTIFICATION; RHOPHILIN-2; INTERACT; SCISSION; MIDBODY; TARGETS	Background: Bro1 domains are elongated, banana-shaped domains that were first identified in the yeast ESCRT pathway protein, Bro1p. Humans express three Bro1 domain-containing proteins: ALIX, BROX, and HD-PTP, which function in association with the ESCRT pathway to help mediate intraluminal vesicle formation at multivesicular bodies, the abscission stage of cytokinesis, and/or enveloped virus budding. Human Bro1 domains share the ability to bind the CHMP4 subset of ESCRT-III proteins, associate with the HIV-1 NCGag protein, and stimulate the budding of viral Gag proteins. The curved Bro1 domain structure has also been proposed to mediate membrane bending. To date, crystal structures have only been available for the related Bro1 domains from the Bro1p and ALIX proteins, and structures of additional family members should therefore aid in the identification of key structural and functional elements. Methodology/Principal Findings: We report the crystal structure of the human BROX protein, which comprises a single Bro1 domain. The Bro1 domains from BROX, Bro1p and ALIX adopt similar overall structures and share two common exposed hydrophobic surfaces. Surface 1 is located on the concave face and forms the CHMP4 binding site, whereas Surface 2 is located at the narrow end of the domain. The structures differ in that only ALIX has an extended loop that projects away from the convex face to expose the hydrophobic Phe105 side chain at its tip. Functional studies demonstrated that mutations in Surface 1, Surface 2, or Phe105 all impair the ability of ALIX to stimulate HIV-1 budding. Conclusions/Significance: Our studies reveal similarities in the overall folds and hydrophobic protein interaction sites of different Bro1 domains, and show that a unique extended loop contributes to the ability of ALIX to function in HIV-1 budding.	[Zhai, Qianting; Landesman, Michael B.; Sundquist, Wesley I.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Zhai, QT (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu	zhai, qianting/G-1301-2013		National Institutes of Health (NIH) [AI051174, P50 082545]; Office of Basic Energy Sciences at the United States Department of Energy; National Center for Research Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051174, R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Basic Energy Sciences at the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grants AI051174 (to WIS) and P50 082545 (CPH). Operations of the National Synchrotron Light Source (NSLS) are supported by the Office of Basic Energy Sciences at the United States Department of Energy and by the NIH. Data collection at the NSLS was funded by the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Caballe A, 2011, TRAFFIC; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Eekels JJM, 2011, ANTIVIR RES, V89, P43, DOI 10.1016/j.antiviral.2010.11.005; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ichioka F, 2008, FEBS J, V275, P682, DOI 10.1111/j.1742-4658.2007.06230.x; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mircescu H, 2002, EUR J BIOCHEM, V269, P6241, DOI 10.1046/j.1432-1033.2002.03343.x; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Peck JW, 2002, J BIOL CHEM, V277, P43924, DOI 10.1074/jbc.M203569200; Peck JW, 2004, BIOCHEM J, V377, P693, DOI 10.1042/bj20031347; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Popov S, 2008, J VIROL, V82, P1389, DOI 10.1128/JVI.01912-07; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Roberts-Galbraith RH, 2010, CELL CYCLE, V9, P4091, DOI 10.4161/cc.9.20.13587; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Schmidt MHH, 2005, J BIOL CHEM, V280, P3414, DOI 10.1074/jbc.M409839200; Sette P, 2011, STRUCTURE; Shnyrova AV, 2009, CURR BIOL, V19, pR772, DOI 10.1016/j.cub.2009.07.063; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Steuve S, 2006, EXP CELL RES, V312, P3981, DOI 10.1016/j.yexcr.2006.08.028; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P11, DOI 10.1107/S0907444993008224; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Toyooka S, 2000, BIOCHEM BIOPH RES CO, V278, P671, DOI 10.1006/bbrc.2000.3870; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhai QT, 2011, J VIROL, V85, P632, DOI 10.1128/JVI.01683-10	50	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27466	10.1371/journal.pone.0027466	http://dx.doi.org/10.1371/journal.pone.0027466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162750	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800005
J	Borriello, A; Caldarelli, I; Basile, MA; Bencivenga, D; Tramontano, A; Perrotta, S; Della Ragione, F; Oliva, A				Borriello, Adriana; Caldarelli, Ilaria; Basile, Maria Assunta; Bencivenga, Debora; Tramontano, Annunziata; Perrotta, Silverio; Della Ragione, Fulvio; Oliva, Adriana			The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; PATIENTS RECEIVING IMATINIB; GROWTH-FACTOR RECEPTOR; STEM-CELLS; PPAR-GAMMA; OSTEOBLAST DIFFERENTIATION; CHRONIC-PHASE; SRC KINASE; BONE; NILOTINIB	Background: The introduction of specific BCR-ABL inhibitors in chronic myelogenous leukemia therapy has entirely mutated the prognosis of this hematologic cancer from being a fatal disorder to becoming a chronic disease. Due to the probable long lasting treatment with tyrosine-kinase inhibitors (TKIs), the knowledge of their effects on normal cells is of pivotal importance. Design and Methods: We investigated the effects of dasatinib treatment on human bone marrow-derived mesenchymal stromal cells (MSCs). Results: Our findings demonstrate, for the first time, that dasatinib induces MSCs adipocytic differentiation. Particularly, when the TKI is added to the medium inducing osteogenic differentiation, a high MSCs percentage acquires adipocytic morphology and overexpresses adipocytic specific genes, including PPAR gamma, CEBP alpha, LPL and SREBP1c. Dasatinib also inhibits the activity of alkaline phosphatase, an osteogenic marker, and remarkably reduces matrix mineralization. The increase of PPAR gamma is also confirmed at protein level. The component of osteogenic medium required for dasatinib-induced adipogenesis is dexamethasone. Intriguingly, the increase of adipocytic markers is also observed in MSCs treated with dasatinib alone. The TKI effect is phenotype-specific, since fibroblasts do not undergo adipocytic differentiation or PPAR gamma increase. Conclusions: Our data demonstrate that dasatinib treatment affects bone marrow MSCs commitment and suggest that TKIs therapy might modify normal phenotypes with potential significant negative consequences.	[Borriello, Adriana; Caldarelli, Ilaria; Basile, Maria Assunta; Bencivenga, Debora; Tramontano, Annunziata; Della Ragione, Fulvio; Oliva, Adriana] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy; [Perrotta, Silverio] Univ Naples 2, Dept Pediat, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Borriello, A (corresponding author), Univ Naples 2, Dept Biochem & Biophys, Naples, Italy.	fulvio.dellaragione@unina2.it	Borriello, Adriana/K-3464-2018	Perrotta, Silverio/0000-0001-6149-6845; Della Ragione, Fulvio/0000-0002-0592-4283; BENCIVENGA, Debora/0000-0003-0977-5374; BORRIELLO, Adriana/0000-0002-9026-8048	Associazione Italiana per la Ricerca sul Cancro (AIRC); Progetti di Rilevante Interesse Nazionale (PRIN); Foreign Investment Review Board (FIRB)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Foreign Investment Review Board (FIRB)	This work was supported in part by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), Progetti di Rilevante Interesse Nazionale (PRIN), and the Foreign Investment Review Board (FIRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas R, 2011, CANC CHEMOTHER  0121; Aguilera Dolly G, 2009, Ther Clin Risk Manag, V5, P281; An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Blay JY, 2011, SEMIN ONCOL, V38, pS3, DOI 10.1053/j.seminoncol.2011.01.016; Borriello A, 2006, CANCER RES, V66, P4240, DOI 10.1158/0008-5472.CAN-05-2759; Borriello A, 2011, CARCINOGENESIS, V32, P10, DOI 10.1093/carcin/bgq211; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Dizdar O, 2008, BREAST CANCER RES TR, V107, P303, DOI 10.1007/s10549-007-9551-6; Donzelli E, 2011, J MOL CELL BIOL, V3, P123, DOI 10.1093/jmcb/mjq050; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; DRUKER J, 2006, J CLIN ONCOL, V24; Fernandez-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973; Fierro F, 2007, CELL PROLIFERAT, V40, P355, DOI 10.1111/j.1365-2184.2007.00438.x; Fitter S, 2008, BLOOD, V111, P2538, DOI 10.1182/blood-2007-07-104281; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Heijink DM, 2011, ONCOGENE, V30, P2026, DOI 10.1038/onc.2010.578; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Jonsson S, 2010, LEUKEMIA, V24, P1357, DOI 10.1038/leu.2010.84; Jonsson S, 2008, HAEMATOL-HEMATOL J, V93, P1101, DOI 10.3324/haematol.12373; Kantarjian HM, 2007, CLIN CANCER RES, V13, P1089, DOI 10.1158/1078-0432.CCR-06-2147; Konecny GE, 2009, BRIT J CANCER, V101, P1699, DOI 10.1038/sj.bjc.6605381; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; le Coutre P, 2008, BLOOD, V111, P1834, DOI 10.1182/blood-2007-04-083196; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Nagaraj NS, 2010, MOL CANCER THER, V9, P2322, DOI 10.1158/1535-7163.MCT-09-1212; O'Brien SG, 2003, SEMIN HEMATOL, V40, P26, DOI 10.1053/shem.2003.50058; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; O'Sullivan S, 2011, CALCIFIED TISSUE INT, V88, P16, DOI 10.1007/s00223-010-9429-1; O'Sullivan S, 2009, J CLIN ENDOCR METAB, V94, P1131, DOI 10.1210/jc.2008-2324; Oliva A, 2005, Int J Immunopathol Pharmacol, V18, P47; Osorio S, 2007, AM J HEMATOL, V82, P394, DOI 10.1002/ajh.20778; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puissant A, 2008, FASEB J, V22, P1894, DOI 10.1096/fj.07-101394; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; Radich JP, 2010, HEMATOL-AM SOC HEMAT, P122, DOI 10.1182/asheducation-2010.1.122; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Tibullo D, 2012, HEMATOL ONCOL, V30, P27, DOI 10.1002/hon.988; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Vallabhaneni S, 2010, BREAST CANC RES TREA; Wei GQ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-47; Weisberg E, 2006, BRIT J CANCER, V94, P1765, DOI 10.1038/sj.bjc.6603170; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yu EY, 2011, UROLOGY, V77, P1166, DOI 10.1016/j.urology.2011.01.006	59	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28555	10.1371/journal.pone.0028555	http://dx.doi.org/10.1371/journal.pone.0028555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164306	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400108
J	Lahrmann, B; Halama, N; Sinn, HP; Schirmacher, P; Jaeger, D; Grabe, N				Lahrmann, Bernd; Halama, Niels; Sinn, Hans-Peter; Schirmacher, Peter; Jaeger, Dirk; Grabe, Niels			Automatic Tumor-Stroma Separation in Fluorescence TMAs Enables the Quantitative High-Throughput Analysis of Multiple Cancer Biomarkers	PLOS ONE			English	Article							CELL-GRAPHS; TISSUE; CLASSIFICATION; TECHNOLOGY; EXPRESSION	The upcoming quantification and automation in biomarker based histological tumor evaluation will require computational methods capable of automatically identifying tumor areas and differentiating them from the stroma. As no single generally applicable tumor biomarker is available, pathology routinely uses morphological criteria as a spatial reference system. We here present and evaluate a method capable of performing the classification in immunofluorescence histological slides solely using a DAPI background stain. Due to the restriction to a single color channel this is inherently challenging. We formed cell graphs based on the topological distribution of the tissue cell nuclei and extracted the corresponding graph features. By using topological, morphological and intensity based features we could systematically quantify and compare the discrimination capability individual features contribute to the overall algorithm. We here show that when classifying fluorescence tissue slides in the DAPI channel, morphological and intensity based features clearly outpace topological ones which have been used exclusively in related previous approaches. We assembled the 15 best features to train a support vector machine based on Keratin stained tumor areas. On a test set of TMAs with 210 cores of triple negative breast cancers our classifier was able to distinguish between tumor and stroma tissue with a total overall accuracy of 88%. Our method yields first results on the discrimination capability of features groups which is essential for an automated tumor diagnostics. Also, it provides an objective spatial reference system for the multiplex analysis of biomarkers in fluorescence immunohistochemistry.	[Lahrmann, Bernd; Grabe, Niels] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Lahrmann, Bernd; Halama, Niels; Schirmacher, Peter; Grabe, Niels] BIOQUANT, Hamamatsu Tissue Imaging & Anal Ctr TIGA, Heidelberg, Germany; [Halama, Niels; Jaeger, Dirk] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Sinn, Hans-Peter; Schirmacher, Peter] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Lahrmann, B (corresponding author), Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany.	niels.grabe@bioquant.uni-heidelberg.de	Grabe, Niels/AAP-6493-2020; Grabe, Niels/I-6214-2016; Sinn, Hans-Peter/C-5661-2008	Sinn, Hans-Peter/0000-0003-2836-6699; Halama, Niels/0000-0003-0344-6027; Grabe, Niels/0000-0003-1732-3706	German Ministry for Research and Education (BMBF) [0315401B, 0315263]	German Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	Funding was provided by the German Ministry for Research and Education (BMBF) in their MEDSYS and FORSYS funding programs. Grant Numbers: 0315401B (MEDSYS), 0315263 (FORSYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral T, 2008, MED IMAGE UNDERSTAND, P999; Amaral T, 2008, I S BIOMED IMAGING, P999, DOI 10.1109/ISBI.2008.4541167; Beucher Serge, 1992, SCANNING MICROSCPY S, P299; Bilgin C, 2007, P ANN INT IEEE EMBS, P5311, DOI 10.1109/IEMBS.2007.4353540; Bilgin CC, 2010, DATA MINING KNOWLEDG; Bilgin CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012783; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chen Y-wei, 2006, FEATURE EXTRACTION F, V315; Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Demir C, 2005, BIOINFORMATICS, V21, P7, DOI 10.1093/bioinformatics/bti1100; Dolled-Filhart M, 2006, CLIN CANCER RES, V12, P6459, DOI 10.1158/1078-0432.CCR-06-1383; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fuchs TJ, 2008, LECT NOTES COMPUT SC, V5242, P1, DOI 10.1007/978-3-540-85990-1_1; Gunduz C, 2004, BIOINFORMATICS, V20, P145, DOI 10.1093/bioinformatics/bth933; Gunduz-Demir C, 2007, MATH BIOSCI, V209, P514, DOI 10.1016/j.mbs.2007.03.005; Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657; Karacali Bilge, 2007, BMC Med Imaging, V7, P2, DOI 10.1186/1471-2342-7-2; Lahrmann B, 2010, CYTOMETRY A; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PADFIELD D, 2006, P 1 WORKSH MICR IM A, P86; Simon R, 2004, EXPERT REV MOL MED, V5, P1; Simon R, 2005, METH MOLEC MED, V114, P257; Soille P., 1999, MORPHOLOGICAL IMAGE, P170; Tabesh A, 2009, MED IMAGING 2009 COM, V7260; Teverovskiy M, 2008, I S BIOMED IMAGING, P300, DOI 10.1109/ISBI.2008.4540992; Vonesch C, 2006, IEEE SIGNAL PROC MAG, V23, P20, DOI 10.1109/MSP.2006.1628875; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015818; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28048	10.1371/journal.pone.0028048	http://dx.doi.org/10.1371/journal.pone.0028048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164226	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400027
J	Olojo, RO; Ziman, AP; Hernandez-Ochoa, EO; Allen, PD; Schneider, MF; Ward, CW				Olojo, Rotimi O.; Ziman, Andrew P.; Hernandez-Ochoa, Erick O.; Allen, Paul D.; Schneider, Martin F.; Ward, Christopher W.			Mice Null for Calsequestrin 1 Exhibit Deficits in Functional Performance and Sarcoplasmic Reticulum Calcium Handling	PLOS ONE			English	Article							SKELETAL-MUSCLE FIBERS; AMINO-ACID-SEQUENCE; CA2+ RELEASE; TWITCH FIBERS; TRANSIENTS; ENTRY; STORE; EXPRESSION; TRANSPORT; DEPLETION	In skeletal muscle, the release of calcium (Ca2+) by ryanodine sensitive sarcoplasmic reticulum (SR) Ca2+ release channels (i.e., ryanodine receptors; RyR1s) is the primary determinant of contractile filament activation. Much attention has been focused on calsequestrin (CASQ1) and its role in SR Ca2+ buffering as well as its potential for modulating RyR1, the L-type Ca2+ channel (dihydropyridine receptor, DHPR) and other sarcolemmal channels through sensing luminal [Ca2+]. The genetic ablation of CASQ1 expression results in significant alterations in SR Ca2+ content and SR Ca2+ release especially during prolonged activation. While these findings predict a significant loss-of-function phenotype in vivo, little information on functional status of CASQ1 null mice is available. We examined fast muscle in vivo and in vitro and identified significant deficits in functional performance that indicate an inability to sustain contractile activation. In single CASQ1 null skeletal myofibers we demonstrate a decrease in voltage dependent RyR Ca2+ release with single action potentials and a collapse of the Ca2+ release with repetitive trains. Under voltage clamp, SR Ca2+ release flux and total SR Ca2+ release are significantly reduced in CASQ1 null myofibers. The decrease in peak Ca2+ release flux appears to be solely due to elimination of the slowly decaying component of SR Ca2+ release, whereas the rapidly decaying component of SR Ca2+ release is not altered in either amplitude or time course in CASQ1 null fibers. Finally, intra-SR [Ca2+] during ligand and voltage activation of RyR1 revealed a significant decrease in the SR[Ca2+] free in intact CASQ1 null fibers and a increase in the release and uptake kinetics consistent with a depletion of intra-SR Ca2+ buffering capacity. Taken together we have revealed that the genetic ablation of CASQ1 expression results in significant functional deficits consistent with a decrease in the slowly decaying component of SR Ca2+ release.	[Olojo, Rotimi O.; Hernandez-Ochoa, Erick O.; Schneider, Martin F.] Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA; [Ziman, Andrew P.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA; [Ward, Christopher W.] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital; University System of Maryland; University of Maryland Baltimore	Olojo, RO (corresponding author), Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA.	ward@son.umaryland.edu			National Institutes of Health [R01AR055099, T32ARAR007592, P01AR044750, F32AR057647, RC2 NR011968]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057647, P01AR052354, P01AR044750, R01AR055099, R37AR055099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [RC2NR011968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was funded by the National Institutes of Health (R01AR055099 and T32ARAR007592 to MFS, P01AR044750 to PDA, F32AR057647 to APZ and RC2 NR011968 to CWW. ROO was partially supported by T32ARAR007592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly W, 2006, AMYOTROPH LATERAL SC, V7, P112, DOI 10.1080/14660820500443000; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Brown LD, 2007, AM J PHYSIOL-CELL PH, V292, pC1156, DOI 10.1152/ajpcell.00397.2006; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1197; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Cho JH, 2000, J CELL SCI, V113, P3947; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; DAMIANI E, 1990, BIOCHEM BIOPH RES CO, V172, P1253, DOI 10.1016/0006-291X(90)91584-F; Delbono O, 2007, P NATL ACAD SCI USA, V104, P20108, DOI 10.1073/pnas.0707389104; DIRKSEN RT, 2009, J PHYSL; EDWARDS C, 1966, J PHYSIOL-LONDON, V186, P295, DOI 10.1113/jphysiol.1966.sp008035; FLIEGEL L, 1987, P NATL ACAD SCI USA, V84, P1167, DOI 10.1073/pnas.84.5.1167; Fryer MW, 1996, J PHYSIOL-LONDON, V493, P357, DOI 10.1113/jphysiol.1996.sp021388; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holtmann B, 2005, J NEUROSCI, V25, P1778, DOI 10.1523/JNEUROSCI.4249-04.2005; Hume JR, 2009, VASC PHARMACOL, V50, P89, DOI 10.1016/j.vph.2008.11.001; INESI G, 1989, J BIOL CHEM, V264, P5929; KLEIN MG, 1988, BIOPHYS J, V53, P971, DOI 10.1016/S0006-3495(88)83178-3; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Lan W, 2009, CELL CALCIUM, V45, P474, DOI 10.1016/j.ceca.2009.03.006; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; LEBERER E, 1986, BIOCHEM J, V239, P295, DOI 10.1042/bj2390295; LEBERER E, 1988, EUR J BIOCHEM, V174, P247, DOI 10.1111/j.1432-1033.1988.tb14090.x; Liu YW, 1997, AM J PHYSIOL-CELL PH, V272, pC1919, DOI 10.1152/ajpcell.1997.272.6.C1919; MAKINOSE M, 1965, BIOCHEM Z, V343, P360; Massett MP, STRAIN DEPENDENT DIF, pR1006; MENDEZ J, 1960, METABOLISM, V9, P184; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Olojo RO, 2011, BIOPHYS J, V100, P2367, DOI 10.1016/j.bpj.2011.04.012; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini Cecilia MQ, 2007, J PHYSL, DOI [10.1113/jphysiol, DOI 10.1113/JPHYSIOL]; PAPE PC, 1993, J GEN PHYSIOL, V102, P295, DOI 10.1085/jgp.102.2.295; Payne ET, 2006, MUSCLE NERVE, V33, P66, DOI 10.1002/mus.20436; Pizarro G, 2004, J GEN PHYSIOL, V124, P239, DOI 10.1085/jgp.200409071; Prosser BL, 2009, J PHYSIOL-LONDON, V587, P4523, DOI 10.1113/jphysiol.2009.177238; Prosser BL, 2009, J PHYSIOL-LONDON, V587, P4543, DOI 10.1113/jphysiol.2009.177246; Royer L, 2008, J PHYSIOL-LONDON, V586, P4609, DOI 10.1113/jphysiol.2008.157990; Royer L, 2010, J GEN PHYSIOL, V136, P325, DOI 10.1085/jgp.201010454; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; SCHNEIDER MF, 1987, J PHYSIOL-LONDON, V392, P167, DOI 10.1113/jphysiol.1987.sp016775; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; Shirokova N, 1996, J GEN PHYSIOL, V107, P1, DOI 10.1085/jgp.107.1.1; SIMON BJ, 1988, BIOPHYS J, V54, P1159, DOI 10.1016/S0006-3495(88)83050-9; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Treves S, 2009, J PHYSL; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Wang ZM, 1999, BIOPHYS J, V77, P2709, DOI 10.1016/S0006-3495(99)77104-3; WEBER A, 1971, J GEN PHYSIOL, V57, P50, DOI 10.1085/jgp.57.1.50; Williams JH, 1998, J APPL PHYSIOL, V85, P619, DOI 10.1152/jappl.1998.85.2.619; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050; Ziman AP, 2010, BIOPHYS J, V99, P2705, DOI 10.1016/j.bpj.2010.08.032	56	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27036	10.1371/journal.pone.0027036	http://dx.doi.org/10.1371/journal.pone.0027036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164205	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400005
J	Pereira, LA; Wong, MS; Lim, SM; Sides, A; Stanley, EG; Elefanty, AG				Pereira, Lloyd A.; Wong, Michael S.; Lim, Sue Mei; Sides, Alexandra; Stanley, Edouard G.; Elefanty, Andrew G.			Brachyury and Related Tbx Proteins Interact with the Mixl1 Homeodomain Protein and Negatively Regulate Mixl1 Transcriptional Activity	PLOS ONE			English	Article							T-BOX GENES; EMBRYONIC STEM-CELLS; PRIMITIVE STREAK; DIFFERENTIATING MOUSE; EXPRESSION ANALYSIS; ENDODERM FORMATION; VENTRAL MESODERM; XENOPUS; EOMESODERMIN; PATTERN	Mixl1 is a homeodomain transcription factor required for mesoderm and endoderm patterning during mammalian embryogenesis. Despite its crucial function in development, co-factors that modulate the activity of Mixl1 remain poorly defined. Here we report that Mixl1 interacts physically and functionally with the T-box protein Brachyury and related members of the T-box family of transcription factors. Transcriptional and protein analyses demonstrated overlapping expression of Mixl1 and Brachyury during embryonic stem cell differentiation. In vitro protein interaction studies showed that the Mixl1 with Brachyury associated via their DNA-binding domains and gel shift assays revealed that the Brachyury T-box domain bound to Mixl1-DNA complexes. Furthermore, luciferase reporter experiments indicated that association of Mixl1 with Brachyury and related T-box factors inhibited the transactivating potential of Mixl1 on the Gsc and Pdgfr alpha promoters. Our results indicate that the activity of Mixl1 can be modulated by protein-protein interactions and that T-box factors can function as negative regulators of Mixl1 activity.	[Pereira, Lloyd A.] Univ Melbourne, Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, Melbourne, Vic, Australia; [Pereira, Lloyd A.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Wong, Michael S.; Lim, Sue Mei; Sides, Alexandra; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Monash University	Pereira, LA (corresponding author), Univ Melbourne, Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, Melbourne, Vic, Australia.	ed.stanley@monash.edu; andrew.elefanty@monash.edu	Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008	Stanley, Ed G/0000-0002-6389-3665; Lim, Sue Mei/0000-0001-8287-5756; Elefanty, Andrew/0000-0001-6448-8314	Australian Stem Cell Centre; Juvenile Diabetes Research Foundation (JDRF); National Health and Medical Research Council (NHMRC) of Australia	Australian Stem Cell Centre; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Stem Cell Centre (www.stemcellcentre.com.au), the Juvenile Diabetes Research Foundation (JDRF)(www.jdrf.org) and the National Health and Medical Research Council (NHMRC) of Australia (www.nhmrc.gov.au). AGE and EGS are Senior Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Barnett LD, 2000, METH MOL B, V158, P65; BLUM M, 1994, GENOMICS, V21, P388, DOI 10.1006/geno.1994.1281; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Casey ES, 1999, DEVELOPMENT, V126, P4193; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Conlon FL, 2001, DEVELOPMENT, V128, P3749; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Hart AH, 2002, DEVELOPMENT, V129, P3597; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kikuchi Y, 2000, GENE DEV, V14, P1279; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kondow A, 2007, BIOCHEM BIOPH RES CO, V359, P959, DOI 10.1016/j.bbrc.2007.05.211; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Latinkic BV, 1999, DEVELOPMENT, V126, P1769; Leconte L, 2004, J BIOL CHEM, V279, P47272, DOI 10.1074/jbc.M406624200; Lemaire P, 1998, DEVELOPMENT, V125, P2371; LIM SM, 2009, STEM CELLS; Mead PE, 1996, NATURE, V382, P357, DOI 10.1038/382357a0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mohn D, 2003, DEV DYNAM, V226, P446, DOI 10.1002/dvdy.10263; Mossman AK, 2005, STEM CELLS DEV, V14, P656, DOI 10.1089/scd.2005.14.656; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; PEREIRA LA, 2011, STEM CELL RES; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; RASHBASS P, 1991, NATURE, V353, P348, DOI 10.1038/353348a0; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; ROSA FM, 1989, CELL, V57, P965, DOI 10.1016/0092-8674(89)90335-8; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Sahr K, 2002, GENE, V291, P135, DOI 10.1016/S0378-1119(02)00590-5; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; SZABO P, 1994, DEVELOPMENT, V120, P1651; Tada M, 1998, DEVELOPMENT, V125, P3997; Tam PPL, 2007, DEVELOPMENT, V134, P251, DOI 10.1242/dev.02724; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Willey S, 2006, BLOOD, V107, P3122, DOI 10.1182/blood-2005-10-4120; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; WILSON V, 1993, DEVELOPMENT, V117, P1321; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; WILSON V, 1995, DEVELOPMENT, V121, P877; Zhang HL, 2009, STEM CELLS, V27, P2884, DOI 10.1002/stem.203	63	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28394	10.1371/journal.pone.0028394	http://dx.doi.org/10.1371/journal.pone.0028394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164283	Green Published, gold			2022-12-25	WOS:000298171400084
J	Syed, K; Porollo, A; Lam, YW; Yadav, JS				Syed, Khajamohiddin; Porollo, Aleksey; Lam, Ying Wai; Yadav, Jagjit S.			A Fungal P450 (CYP5136A3) Capable of Oxidizing Polycyclic Aromatic Hydrocarbons and Endocrine Disrupting Alkylphenols: Role of Trp(129) and Leu(324)	PLOS ONE			English	Article							CYTOCHROME-P450 3A4; HETEROLOGOUS EXPRESSION; PYRENE DEGRADATION; ARENE OXIDES; BISPHENOL-A; METABOLISM; PHENANTHRENE; NONYLPHENOL; OXIDATION; BIOTRANSFORMATION	The model white rot fungus Phanerochaete chrysosporium, which is known for its versatile pollutant-biodegradation ability, possesses an extraordinarily large repertoire of P450 monooxygenases in its genome. However, the majority of these P450s have hitherto unknown function. Our initial studies using a genome-wide gene induction strategy revealed multiple P450s responsive to individual classes of xenobiotics. Here we report functional characterization of a cytochrome P450 monooxygenase, CYP5136A3 that showed common responsiveness and catalytic versatility towards endocrine-disrupting alkylphenols (APs) and mutagenic/carcinogenic polycyclic aromatic hydrocarbons (PAHs). Using recombinant CYP5136A3, we demonstrated its oxidation activity towards APs with varying alkyl side-chain length (C3-C9), in addition to PAHs (3-4 ring size). AP oxidation involves hydroxylation at the terminal carbon of the alkyl side-chain (v-oxidation). Structure-activity analysis based on a 3D model indicated a potential role of Trp(129) and Leu(324) in the oxidation mechanism of CYP5136A3. Replacing Trp(129) with Leu (W129L) and Phe (W129F) significantly diminished oxidation of both PAHs and APs. The W129L mutation caused greater reduction in phenanthrene oxidation (80%) as compared to W129F which caused greater reduction in pyrene oxidation (88%). Almost complete loss of oxidation of C3-C8 APs (83-90%) was observed for the W129L mutation as compared to W129F (28-41%). However, the two mutations showed a comparable loss (60-67%) in C9-AP oxidation. Replacement of Leu(324) with Gly (L324G) caused 42% and 54% decrease in oxidation activity towards phenanthrene and pyrene, respectively. This mutation also caused loss of activity towards C3-C8 APs (20-58%), and complete loss of activity toward nonylphenol (C9-AP). Collectively, the results suggest that Trp(129) and Leu(324) are critical in substrate recognition and/or regio-selective oxidation of PAHs and APs. To our knowledge, this is the first report on an AP-oxidizing P450 from fungi and on structure-activity relationship of a eukaryotic P450 for fused-ring PAHs (phenanthrene and pyrene) and AP substrates.	[Syed, Khajamohiddin; Porollo, Aleksey; Lam, Ying Wai; Yadav, Jagjit S.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Syed, K (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	Jagjit.Yadav@uc.edu	Syed, Khajamohiddin/L-8774-2013; Yadav, Jagjit S./AAN-8805-2020	Syed, Khajamohiddin/0000-0002-1497-3570; Yadav, Jagjit S./0000-0001-5036-3609; Porollo, Alexey/0000-0002-3202-5099	NIH's National Institute of Environmental Health Science (NIEHS) [R01ES10210, R01 ES015543]; Center for Environmental Genetics (CEG); NIEHS [P30-ES006096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES010210, R01ES015543] Funding Source: NIH RePORTER	NIH's National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Environmental Genetics (CEG); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the NIH's National Institute of Environmental Health Science (NIEHS) grants R01ES10210 and R01 ES015543 to JSY. This work was also supported in part by the Next Generation Biomedical Investigator Award to AP by the Center for Environmental Genetics (CEG), which is funded by NIEHS (P30-ES006096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezalel L, 1996, APPL ENVIRON MICROB, V62, P2554, DOI 10.1128/AEM.62.7.2554-2559.1996; BOYLAND E, 1964, BIOCHEM J, V90, P391, DOI 10.1042/bj0900391; BRUICE PY, 1976, J AM CHEM SOC, V98, P2965, DOI 10.1021/ja00426a048; Cabana H, 2007, CHEMOSPHERE, V67, P770, DOI 10.1016/j.chemosphere.2006.10.037; Capotorti G, 2004, BIODEGRADATION, V15, P79, DOI 10.1023/B:BIOD.0000015612.10481.e6; CERNIGLIA CE, 1989, APPL ENVIRON MICROB, V55, P2275, DOI 10.1128/AEM.55.9.2275-2279.1989; CERNIGLIA CE, 1986, CHEM-BIOL INTERACT, V57, P203, DOI 10.1016/0009-2797(86)90038-4; Cerniglia CE, 1997, J IND MICROBIOL BIOT, V19, P324, DOI 10.1038/sj.jim.2900459; CHATURAPIT S, 1978, BIOCHEM PHARMACOL, V27, P1865, DOI 10.1016/0006-2952(78)90034-5; Cirja M, 2006, ENVIRON SCI TECHNOL, V40, P6131, DOI 10.1021/es060668z; Coldham NG, 1998, DRUG METAB DISPOS, V26, P347; CORTI A, 1995, ENVIRON POLLUT, V90, P83, DOI 10.1016/0269-7491(94)00080-W; DALY JW, 1972, EXPERIENTIA, V28, P1129, DOI 10.1007/BF01946135; Deng P, 2010, CHEM RES TOXICOL, V23, P1617, DOI 10.1021/tx100223h; DeVore NM, 2008, DRUG METAB DISPOS, V36, P2582, DOI 10.1124/dmd.108.023770; Doddapaneni H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-92; Doddapaneni H, 2005, CURR MICROBIOL, V50, P292, DOI 10.1007/s00284-005-4480-2; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; GOTOH O, 1992, J BIOL CHEM, V267, P83; Guengerich FP, 1989, PRINCIPLES METHODS T, P777; Hammel KE, 1995, ENVIRON HEALTH PERSP, V103, P41, DOI 10.2307/3432477; Harford-Cross CF, 2000, PROTEIN ENG, V13, P121, DOI 10.1093/protein/13.2.121; He YA, 2003, ARCH BIOCHEM BIOPHYS, V409, P92, DOI 10.1016/S0003-9861(02)00484-8; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ieda T, 2005, ENVIRON SCI TECHNOL, V39, P7202, DOI 10.1021/es050568d; Iida Y, 2008, J MASS SPECTROM SOC, V56, P215; Jacob J, 1996, ENVIRON TOXICOL PHAR, V1, P1, DOI 10.1016/1382-6689(95)00003-8; JACOB J, 1982, TOXICOLOGY, V25, P333, DOI 10.1016/0300-483X(82)90111-1; JERINA DM, 1976, J AM CHEM SOC, V98, P5988, DOI 10.1021/ja00435a035; Johnston JB, 2011, ARCH BIOCHEM BIOPHYS, V507, P86, DOI 10.1016/j.abb.2010.08.011; Junghanns C, 2005, MICROBIOL-SGM, V151, P45, DOI 10.1099/mic.0.27431-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan KK, 2002, MOL PHARMACOL, V61, P495, DOI 10.1124/mol.61.3.495; Kim YD, 2004, ENVIRON RES, V94, P262, DOI 10.1016/S0013-9351(03)00134-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin C, 2009, APPL ENVIRON MICROB, V75, P4398, DOI 10.1128/AEM.00139-09; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Mestres J, 2005, PROTEINS, V58, P596, DOI 10.1002/prot.20354; Ning D, 2005, J BIOCHEM MOL BIOL, V38, P294; NORDQVIST M, 1981, MOL PHARMACOL, V19, P168; Ohe T, 2000, DRUG METAB DISPOS, V28, P110; OKAMOTO H, 1981, CANCER LETT, V11, P215, DOI 10.1016/0304-3835(81)90110-5; PASZCZYNSKI A, 1995, BIOTECHNOL PROGR, V11, P368, DOI 10.1021/bp00034a002; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Porollo A, 2010, NUCLEIC ACIDS RES, V38, pW662, DOI 10.1093/nar/gkq445; Rehmann K, 1998, CHEMOSPHERE, V36, P2977, DOI 10.1016/S0045-6535(97)10240-5; Rozalska S, 2010, J HAZARD MATER, V180, P323, DOI 10.1016/j.jhazmat.2010.04.034; Sack U, 1997, APPL ENVIRON MICROB, V63, P3919, DOI 10.1128/AEM.63.10.3919-3925.1997; Sack U, 1997, APPL ENVIRON MICROB, V63, P2906, DOI 10.1128/AEM.63.7.2906-2909.1997; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schober W, 2010, CHEM-BIOL INTERACT, V183, P57, DOI 10.1016/j.cbi.2009.09.008; Sharma VK, 2009, J ENVIRON SCI HEAL A, V44, P423, DOI 10.1080/10934520902719704; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; SHOU MS, 1994, CANCER LETT, V83, P305, DOI 10.1016/0304-3835(94)90334-4; SOLBAKKEN JE, 1981, COMP BIOCHEM PHYS C, V70, P21, DOI 10.1016/0306-4492(81)90073-3; Subramanian V, 2008, ENZYME MICROB TECH, V43, P205, DOI 10.1016/j.enzmictec.2007.09.001; Subramanian V, 2009, APPL ENVIRON MICROB, V75, P5570, DOI 10.1128/AEM.02942-08; SUTHERLAND JB, 1991, APPL ENVIRON MICROB, V57, P3310, DOI 10.1128/AEM.57.11.3310-3316.1991; Syed K, 2011, ARCH BIOCHEM BIOPHYS, V509, P26, DOI 10.1016/j.abb.2011.02.023; Syed K, 2010, BIOCHEM BIOPH RES CO, V399, P492, DOI 10.1016/j.bbrc.2010.07.094; Tezuka Y, 2007, J HEALTH SCI, V53, P552, DOI 10.1248/jhs.53.552; Thibaut R, 2002, AQUAT TOXICOL, V56, P177, DOI 10.1016/S0166-445X(01)00204-1; Vallini G, 2001, INT BIODETER BIODEGR, V47, P133, DOI 10.1016/S0964-8305(01)00040-3; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Wunder T, 1997, ARCH MICROBIOL, V167, P310, DOI 10.1007/s002030050449; Yadav JS, 2001, BIODEGRADATION, V12, P443, DOI 10.1023/A:1015056530264; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	71	47	49	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28286	10.1371/journal.pone.0028286	http://dx.doi.org/10.1371/journal.pone.0028286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164262	gold, Green Submitted, Green Published			2022-12-25	WOS:000298171400063
J	Datta, J; Smith, A; Lang, JC; Islam, M; Dutt, D; Teknos, TN; Pan, Q				Datta, J.; Smith, A.; Lang, J. C.; Islam, M.; Dutt, D.; Teknos, T. N.; Pan, Q.			microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase C epsilon	ONCOGENE			English	Article						head and neck cancer; protein kinase C; microRNA; miR-107	EXPRESSION; APOPTOSIS; INVASION	Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide with about 600 000 new cases diagnosed each year. Understanding the molecular pathways that lead to HNSCC is crucial to identify new targets for anti-cancer drug development. Protein kinase C epsilon (PKC epsilon) is elevated in HNSCC and regulates the activation of Akt, Stat3 and Rho GTPases. To date, the molecular mechanism of PKC epsilon dysregulation in HNSCC remains to be elucidated. In silico analysis identified three putative microRNA-107 (miR-107) binding sites in the 3'-untranslated region (UTR) of PKC epsilon. An inverse relationship was revealed between miR-107 and PKCe in HNSCC cell lines. Delivery of miR-107 reduced PKCe levels in SCC15, SCC25 and CAL27, three HNSCC cell lines with high PKC epsilon and low miR-107. The activity of a luciferase reporter construct containing the 3'-UTR of PKCe was downregulated by miR-107 and mutations in the three cognate miR-107 binding sites completely ablated the regulation by miR-107. Treatment with miR-107 significantly blocked cell proliferation, DNA replication, colony formation and invasion in SCC25 and CAL27 cells. Ectopic expression of miR-resistant PKCe was sufficient to partially rescue the loss-of-function phenotype in miR-107-overexpressing SCC25 cells. Tumor growth in nude mice was retarded by 93 +/- 7% in CAL27/miR-107 cells compared with CAL27/miR-control cells. Last, human primary HNSCC tumors with elevated PKCe had reduced miR-107 expression. Our results demonstrate that PKCe is directly regulated by miR-107 and, moreover, suggest that miR-107 may be a potential anti-cancer therapeutic for HNSCC. Oncogene (2012) 31, 4045-4053; doi:10.1038/onc.2011.565; published online 12 December 2011	[Datta, J.; Lang, J. C.; Islam, M.; Teknos, T. N.; Pan, Q.] Ohio State Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Datta, J.; Smith, A.; Lang, J. C.; Islam, M.; Dutt, D.; Teknos, T. N.; Pan, Q.] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA; [Datta, J.; Smith, A.; Lang, J. C.; Islam, M.; Dutt, D.; Teknos, T. N.; Pan, Q.] Ohio State Univ, Ctr Comprehens Canc, Richard J Solove Res Inst, Columbus, OH 43210 USA; [Dutt, D.] VIT Univ, Sch Biosci & Technol, Dept Biomed Genet, Vellore, Tamil Nadu, India	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Vellore Institute of Technology	Pan, Q (corresponding author), Ohio State Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, 442 Tzagournis Med Res,420 W 12th Ave, Columbus, OH 43210 USA.	Quintin.Pan@osumc.edu	Reever, Larson/H-9685-2019; Pan, Quintin/E-3808-2011	Reever, Larson/0000-0002-5692-4793; 	National Cancer Institute at the National Institutes of Health [R01CA135096]; American Cancer Society [RSG0821901]; Michelle Theado Memorial Grant; John Young Memorial Grant from the Joan Bisesi Fund for Head and Neck Oncology Research; Arthur G. James Cancer Hospital; Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA135096] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Michelle Theado Memorial Grant; John Young Memorial Grant from the Joan Bisesi Fund for Head and Neck Oncology Research; Arthur G. James Cancer Hospital; Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Cancer Institute at the National Institutes of Health (R01CA135096); American Cancer Society (RSG0821901); the Michelle Theado Memorial Grant and the John Young Memorial Grant from the Joan Bisesi Fund for Head and Neck Oncology Research and the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center.	Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Aziz MH, 2010, ONCOGENE, V29, P3100, DOI 10.1038/onc.2010.63; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cohen EEW, 2009, CANCER RES, V69, P65, DOI 10.1158/0008-5472.CAN-08-0377; Cohen EEW, 2006, CANCER RES, V66, P6296, DOI 10.1158/0008-5472.CAN-05-3139; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; de la Pena FA, 2011, J BIOL CHEM, V286, P20778, DOI 10.1074/jbc.M110.198069; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Feng L, 2012, MED ONCOL, V29, P856, DOI 10.1007/s12032-011-9823-1; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; LARAMORE GE, 1992, INT J RADIAT ONCOL, V23, P705, DOI 10.1016/0360-3016(92)90642-U; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li XH, 2011, J CELL MOL MED, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; MARTINEZGIMENO C, 1995, HEAD NECK-J SCI SPEC, V17, P516, DOI 10.1002/hed.2880170609; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107	29	61	67	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	36					4045	4053		10.1038/onc.2011.565	http://dx.doi.org/10.1038/onc.2011.565			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NQ	22158047	Green Accepted			2022-12-25	WOS:000308688800005
J	van der Deen, M; Akech, J; Lapointe, D; Gupta, S; Young, DW; Montecino, MA; Galindo, M; Lian, JB; Stein, JL; Stein, GS; van Wijnen, AJ				van der Deen, Margaretha; Akech, Jacqueline; Lapointe, David; Gupta, Sneha; Young, Daniel W.; Montecino, Martin A.; Galindo, Mario; Lian, Jane B.; Stein, Janet L.; Stein, Gary S.; van Wijnen, Andre J.			Genomic Promoter Occupancy of Runt-related Transcription Factor RUNX2 in Osteosarcoma Cells Identifies Genes Involved in Cell Adhesion and Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; CHROMATIN IMMUNOPRECIPITATION; METASTATIC TUMOR; CANCER-CELLS; EXPRESSION; BINDING; GROWTH; CBFA1; CYCLE; DNA	Runt-related transcription factors (RUNX1, RUNX2, and RUNX3) are key lineage-specific regulators of progenitor cell growth and differentiation but also function pathologically as cancer genes that contribute to tumorigenesis. RUNX2 attenuates growth and stimulates maturation of osteoblasts during bone formation but is also robustly expressed in a subset of osteosarcomas, as well as in metastatic breast and prostate tumors. To assess the biological function of RUNX2 in osteosarcoma cells, we examined human genomic promoter interactions for RUNX2 using chromatin immunoprecipitation (ChIP)-microarray analysis in SAOS-2 cells. Promoter binding of both RUNX2 and RNA polymerase II was compared with gene expression profiles of cells in which RUNX2 was depleted by RNA interference. Many RUNX2-bound loci (1550 of 2339 total) exhibit promoter occupancy by RNA polymerase II and contain the RUNX consensus motif 5'-((T/A/C) G(T/A/C) GG(T/G). Gene ontology analysis indicates that RUNX2 controls components of multiple signaling pathways (e. g. WNT, TGF beta, TNF alpha, and interleukins), as well as genes linked to cell motility and adhesion (e. g. the focal adhesion-related genes FAK/PTK2 and TLN1). Our results reveal that siRNA depletion of RUNX2, PTK2, or TLN1 diminishes motility of U2OS osteosarcoma cells. Thus, RUNX2 binding to diverse gene loci may support the biological properties of osteosarcoma cells.	[Lapointe, David] Univ Massachusetts, Sch Med, Informat Serv Dept, Worcester, MA 01655 USA; [Montecino, Martin A.] Univ Andres Bello, Fac Ciencias Biol, Ctr Invest Biomed, Santiago, Chile; [Montecino, Martin A.] Univ Andres Bello, Fac Med, Santiago, Chile; [Galindo, Mario] Univ Chile, Fac Med, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago, Chile; [Galindo, Mario] Univ Chile, Inst Immunol & Immunotherapy, Santiago, Chile; [van der Deen, Margaretha; Akech, Jacqueline; Gupta, Sneha; Young, Daniel W.; Lian, Jane B.; Stein, Janet L.; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Dept Cell Biol & Canc Ctr, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; Universidad Andres Bello; Universidad Andres Bello; Universidad de Chile; Universidad de Chile; University of Massachusetts System; University of Massachusetts Worcester	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	gary.stein@umassmed.edu; andre.vanwijnen@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946	National Institutes of Health [AR49069, CA082834, AR048818]; FONDAP [15090007]; NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR039588, P01AR048818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FONDAP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants AR49069, CA082834, and AR048818, as well as from contract grant sponsor FONDAP 15090007.	Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Blyth K, 2006, CANCER RES, V66, P2195, DOI 10.1158/0008-5472.CAN-05-3558; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Chuang LSH, 2010, ONCOGENE, V29, P2605, DOI 10.1038/onc.2010.88; Das K, 2009, EUR J CANCER, V45, P2239, DOI 10.1016/j.ejca.2009.06.021; Dowdy CR, 2010, HUM MOL GENET, V19, P1048, DOI 10.1093/hmg/ddp568; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Galindo M, 2007, J MOL HISTOL, V38, P501, DOI 10.1007/s10735-007-9143-0; Han MS, 2010, J CELL BIOCHEM, V110, P97, DOI 10.1002/jcb.22516; Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Jeong JH, 2010, MOL CELL BIOL, V30, P2365, DOI 10.1128/MCB.00672-09; Kilbey A, 2008, CELL CYCLE, V7, P2333; Kilbey A, 2007, CANCER RES, V67, P11263, DOI 10.1158/0008-5472.CAN-07-3016; Kilbey A, 2010, CANCER RES, V70, P5860, DOI 10.1158/0008-5472.CAN-10-0726; Kim HJ, 2006, J CELL PHYSIOL, V207, P114, DOI 10.1002/jcp.20552; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leong DT, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2762; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Martin JW, 2010, CYTOGENET GENOME RES, V128, P199, DOI 10.1159/000308353; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Niebuhr B, 2008, BLOOD CELL MOL DIS, V40, P211, DOI 10.1016/j.bcmd.2007.07.018; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ott CE, 2010, HUM MUTAT, V31, pE1587, DOI 10.1002/humu.21298; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pereira BP, 2009, J CELL PHYSIOL, V221, P778, DOI 10.1002/jcp.21921; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Pratap J, 2003, CANCER RES, V63, P5357; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Pratap J, 2011, BONE, V48, P30, DOI 10.1016/j.bone.2010.05.035; Pratap J, 2009, CANCER RES, V69, P6807, DOI 10.1158/0008-5472.CAN-09-1471; Pregizer S, 2007, J CELL BIOCHEM, V102, P1458, DOI 10.1002/jcb.21366; RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; San Martin IA, 2009, J CELL PHYSIOL, V221, P560, DOI 10.1002/jcp.21894; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; Stewart M, 1996, J GEN VIROL, V77, P443, DOI 10.1099/0022-1317-77-3-443; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Teplyuk NM, 2009, MOL ENDOCRINOL, V23, P849, DOI 10.1210/me.2008-0270; Teplyuk NM, 2009, J CELL BIOCHEM, V107, P144, DOI 10.1002/jcb.22108; Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P225, DOI 10.1007/s11033-006-9037-3; Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P1, DOI 10.1007/s11033-006-9001-2; Vaillant F, 2002, J IMMUNOL, V169, P2866, DOI 10.4049/jimmunol.169.6.2866; van der Deen M, 2010, J CELL BIOCHEM, V109, P828, DOI 10.1002/jcb.22463; van der Deen Margaretha, 2008, V455, P165, DOI 10.1007/978-1-59745-104-8_13; van der Meijden CMJ, 2002, CANCER RES, V62, P3233; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang CG, 2001, FRONT BIOSCI-LANDMRK, V6, pD610, DOI 10.2741/1wang1; Wang CQ, 2010, BLOOD CELL MOL DIS, V44, P275, DOI 10.1016/j.bcmd.2010.01.006; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104	79	63	64	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4503	4517		10.1074/jbc.M111.287771	http://dx.doi.org/10.1074/jbc.M111.287771			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158627	Green Published, hybrid			2022-12-25	WOS:000300608500014
J	Rowe, DD; Leonardo, CC; Recio, JA; Collier, LA; Willing, AE; Pennypacker, KR				Rowe, Derrick D.; Leonardo, Christopher C.; Recio, Jesus A.; Collier, Lisa A.; Willing, Alison E.; Pennypacker, Keith R.			Human Umbilical Cord Blood Cells Protect Oligodendrocytes from Brain Ischemia through Akt Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ARTERY OCCLUSION; NF-KAPPA-B; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; THERAPEUTIC IMPLICATIONS; NEURONAL SURVIVAL; OXIDATIVE STRESS; GROWTH-FACTOR; PEROXIREDOXIN; STROKE	Human umbilical cord blood (HUCB) cells protect the brain against ischemic injury, yet the mechanism of protection remains unclear. Using both in vitro and in vivo paradigms, this study examined the role of Akt signaling and peroxiredoxin 4 expression in human umbilical cord blood cell-mediated protection of oligodendrocytes from ischemic conditions. As previously reported, the addition of HUCB cells to oligodendrocyte cultures prior to oxygen glucose deprivation significantly enhanced oligodendrocyte survival. The presence of human umbilical cord blood cells also increased Akt phosphorylation and elevated peroxiredoxin 4 expression in oligodendrocytes. Blocking either Akt or peroxiredoxin 4 activity with Akt Inhibitor IV or a peroxiredoxin 4-neutralizing antibody, respectively, negated the protective effects of human umbilical cord blood cells. In vivo, systemic administration of human umbilical cord blood cells 48 h after middle cerebral artery occlusion increased Akt phosphorylation and peroxiredoxin 4 protein expression while reducing proteolytic cleavage of caspase 3 in oligodendrocytes residing in the ipsilateral external capsule. Moreover, human umbilical cord blood cells protected striatal white matter bundles from degeneration following middle cerebral artery occlusion. These results suggest that the soluble factors released from human umbilical cord blood cells converge on Akt to elevate peroxiredoxin 4 levels, and these effects contribute to oligodendrocyte survival.	[Rowe, Derrick D.; Recio, Jesus A.; Collier, Lisa A.; Pennypacker, Keith R.] Univ S Florida, Dept Mol Pharmacol & Physiol, Sch Basic Biomed Sci, Coll Med, Tampa, FL 33612 USA; [Leonardo, Christopher C.] Univ Florida, Dept Anesthesiol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Willing, Alison E.] Univ S Florida, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida	Pennypacker, KR (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Sch Basic Biomed Sci, Coll Med, Tampa, FL 33612 USA.	kpennypa@health.usf.edu	Willing, Alison/I-4946-2012; Pennypacker, Keith/I-5092-2012; Willing, Alison/AAP-7759-2021	Recio, Juan Angel/0000-0002-7320-3832	National Institutes of Health [1-R01-NS052839]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-R01-NS052839.	Brouns R, 2010, CLIN CHEM, V56, P451, DOI 10.1373/clinchem.2009.134122; Butler TL, 2002, BRAIN RES, V929, P252, DOI 10.1016/S0006-8993(01)03371-6; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chua SJ, 2010, SPINE, V35, P1520, DOI 10.1097/BRS.0b013e3181c3e963; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Hall AA, 2009, J NEUROSCI RES, V87, P333, DOI 10.1002/jnr.21857; Hall A, 2009, J MOL BIOL, V393, P867, DOI 10.1016/j.jmb.2009.08.040; Haridas V, 1998, J IMMUNOL, V161, P1; Ho JN, 2010, MOL CANCER THER, V9, P825, DOI 10.1158/1535-7163.MCT-09-0904; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hwang IK, 2010, FREE RADICAL BIO MED, V48, P1242, DOI 10.1016/j.freeradbiomed.2010.02.007; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kassed CA, 2002, EXP NEUROL, V176, P277, DOI 10.1006/exnr.2002.7967; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Lee SJ, 2003, BIOCHEM BIOPH RES CO, V312, P1196, DOI 10.1016/j.bbrc.2003.11.050; Lentzsch S, 2004, LEUKEMIA, V18, P1883, DOI 10.1038/sj.leu.2403486; Leonardo CC, 2010, J NEUROSCI RES, V88, P1213, DOI 10.1002/jnr.22306; Lyons SA, 1998, J CEREBR BLOOD F MET, V18, P521, DOI 10.1097/00004647-199805000-00007; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; NAKAHATA T, 1982, J CLIN INVEST, V70, P1324, DOI 10.1172/JCI110734; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nieda M, 1997, BRIT J HAEMATOL, V98, P775, DOI 10.1046/j.1365-2141.1997.2583074.x; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; Radyuk SN, 2010, BBA-GEN SUBJECTS, V1800, P1153, DOI 10.1016/j.bbagen.2010.06.010; Rowe DD, 2010, BRAIN RES, V1366, P172, DOI 10.1016/j.brainres.2010.09.078; Shibata M, 2002, BRAIN RES, V942, P1, DOI 10.1016/S0006-8993(02)02474-5; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Won H, 2012, ANTIOXID REDOX SIGN, V16, P245, DOI 10.1089/ars.2011.3952; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com	52	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4177	4187		10.1074/jbc.M111.296434	http://dx.doi.org/10.1074/jbc.M111.296434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158864	Green Published, hybrid			2022-12-25	WOS:000300410900051
J	Tardiff, DF; Tucci, ML; Caldwell, KA; Caldwell, GA; Lindquist, S				Tardiff, Daniel F.; Tucci, Michelle L.; Caldwell, Kim A.; Caldwell, Guy A.; Lindquist, Susan			Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, alpha-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; A-BETA; NEURODEGENERATIVE DISEASES; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; IRON CHELATION; AMYLOID-BETA; METAL-IONS	No current therapies target the underlying cellular pathologies of age-related neurodegenerative diseases. Model organisms provide a platform for discovering compounds that protect against the toxic, misfolded proteins that initiate these diseases. One such protein, TDP-43, is implicated in multiple neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. In yeast, TDP-43 expression is toxic, and genetic modifiers first discovered in yeast have proven to modulate TDP-43 toxicity in both neurons and humans. Here, we describe a phenotypic screen for small molecules that reverse TDP-43 toxicity in yeast. One group of hit compounds was 8-hydroxyquinolines (8-OHQ), a class of clinically relevant bioactive metal chelators related to clioquinol. Surprisingly, in otherwise wild-type yeast cells, different 8-OHQs had selectivity for rescuing the distinct toxicities caused by the expression of TDP-43, alpha-synuclein, or polyglutamine proteins. In fact, each 8-OHQ synergized with the other, clearly establishing that they function in different ways. Comparative growth and molecular analyses also revealed that 8-OHQs have distinct metal chelation and ionophore activities. The diverse bioactivity of 8-OHQs indicates that altering different aspects of metal homeostasis and/or metalloprotein activity elicits distinct protective mechanisms against several neurotoxic proteins. Indeed, phase II clinical trials of an 8-OHQ has produced encouraging results in modifying Alzheimer disease. Our unbiased identification of 8-OHQs in a yeast TDP-43 toxicity model suggests that tailoring 8-OHQ activity to a particular neurodegenerative disease may be a viable therapeutic strategy.	[Tardiff, Daniel F.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tardiff, Daniel F.; Lindquist, Susan] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Alabama System; University of Alabama Tuscaloosa; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Lindquist_admin@wi.mit.edu		Thompson, Michelle/0000-0001-8134-9017; Caldwell, Kim/0000-0003-1580-6122; Caldwell, Guy/0000-0002-8283-9090	National Institutes of Health [5 P50 NS038372]; Robert P. and Judith N. Goldberg Foundation (RJG); American Parkinson's Disease Association; Ruth L. Kirschstein National Research Service [NS614192]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert P. and Judith N. Goldberg Foundation (RJG); American Parkinson's Disease Association; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 P50 NS038372. This work was also supported by a grant from the Robert P. and Judith N. Goldberg Foundation (RJG) (to S. L.).; Funded first by a fellowship from the American Parkinson's Disease Association and subsequently by Ruth L. Kirschstein National Research Service Award Fellowship Grant NS614192.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Bishop GM, 2002, DEV NEUROSCI-BASEL, V24, P184, DOI 10.1159/000065696; Bonini NM, 2011, J MOL NEUROSCI, V45, P676, DOI 10.1007/s12031-011-9548-9; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; De Freitas J, 2003, BIOMETALS, V16, P185, DOI 10.1023/A:1020771000746; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kaur D, 2004, AGEING RES REV, V3, P327, DOI 10.1016/j.arr.2004.01.003; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Li CH, 2010, J ALZHEIMERS DIS, V21, P1249, DOI 10.3233/JAD-2010-100024; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wang Y, 2009, J BIOL CHEM, V284, P314, DOI 10.1074/jbc.M807579200; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Youdim MBH, 2004, J NEURAL TRANSM, V111, P1455, DOI 10.1007/s00702-004-0143-x	54	64	65	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4107	4120		10.1074/jbc.M111.308668	http://dx.doi.org/10.1074/jbc.M111.308668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147697	Green Published, hybrid			2022-12-25	WOS:000300410900044
J	Wixted, JHF; Rothstein, JL; Eisenlohr, LC				Wixted, Josephine H. F.; Rothstein, Jay L.; Eisenlohr, Laurence C.			Identification of Functionally Distinct TRAF Proinflammatory and Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (PI3K/MEK) Transforming Activities Emanating from RET/PTC Fusion Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PAPILLARY THYROID-CARCINOMA; RET TYROSINE KINASE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHRONIC LYMPHOCYTIC THYROIDITIS; COLONY-STIMULATING FACTORS; HASHIMOTOS-THYROIDITIS; GENE-EXPRESSION; HUMAN THYROCYTES; BRAF MUTATIONS	Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways. A distinction, however, is that RET/PTCs induce immunostimulatory programs, suggesting that, in the case of this tumor type, the additional pro-inflammatory pathway reduces aggressiveness. Here, we demonstrate that pro-inflammatory programs are selectively activated by TRAF2 and TRAF6 association with RET/PTC oncoproteins. Eliminating this mechanism reduces pro-inflammatory cytokine production without decreasing transformation efficiency. Conversely, ablating MEK/ERK or PI3K/AKT signaling eliminates transformation but not pro-inflammatory cytokine secretion. Functional uncoupling of the two pathways demonstrates that intrinsic pro-inflammatory pathways are not required for cellular transformation and suggests a need for further investigation into the role inflammation plays in thyroid tumor progression.	[Eisenlohr, Laurence C.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Immunol, Philadelphia, PA 19107 USA; [Wixted, Josephine H. F.] Thomas Jefferson Univ, Immunol & Microbial Pathogenesis Program, Philadelphia, PA 19107 USA; [Rothstein, Jay L.] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA	Jefferson University; Jefferson University; Amgen	Eisenlohr, LC (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Immunol, Rm 730,Bluemle Life Sci Bldg,233 S 10th St, Philadelphia, PA 19107 USA.	Laurence.Eisenlohr@jefferson.edu			National Institutes of Health [F31NS054444, R21A1063065, R01AI069192]; State of Pennsylvania [SAP 4100026302]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31NS054444 (to J .H. F. W.), R21A1063065 (to J. L. R. and L. C. E.), and R01AI069192 (to L. C. E.). This work was also supported by State of Pennsylvania Grant SAP 4100026302 (to J. L. R. and L. C. E.).	Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Alberti L, 1998, ONCOGENE, V17, P1079, DOI 10.1038/sj.onc.1202046; Antonaci A, 2009, ONCOL RES, V17, P495, DOI 10.3727/096504009789735431; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bongarzone I, 1997, GENOMICS, V42, P252, DOI 10.1006/geno.1997.4685; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bozec A, 2010, CURR MED CHEM, V17, P3449, DOI 10.2174/092986710792927804; Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790; Caudill CM, 2005, J CLIN ENDOCR METAB, V90, P2364, DOI 10.1210/jc.2004-1811; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; De Falco V, 2007, CANCER RES, V67, P381, DOI 10.1158/0008-5472.CAN-06-0981; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; FUGAZZOLA L, 1995, CANCER RES, V55, P5617; Gallel P, 2008, HUM PATHOL, V39, P994, DOI 10.1016/j.humpath.2007.11.015; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guarino V, 2010, MOL CELL ENDOCRINOL, V321, P94, DOI 10.1016/j.mce.2009.10.003; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898; Hanson JL, 2003, J BIOL CHEM, V278, P34910, DOI 10.1074/jbc.M304189200; Heuer M, 1996, THYROID, V6, P97, DOI 10.1089/thy.1996.6.97; Hildebrand JM, 2010, J EXP MED, V207, P2569, DOI 10.1084/jem.20100857; Hostager BS, 2007, IMMUNOL RES, V39, P105, DOI 10.1007/s12026-007-0082-3; Hwang ES, 2004, MOL ENDOCRINOL, V18, P2672, DOI 10.1210/me.2004-0168; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; ITO T, 1993, CANCER RES, V53, P2940; Kasai K, 1997, BIOCHEM BIOPH RES CO, V238, P191, DOI 10.1006/bbrc.1997.7244; Kasai K, 1996, FEBS LETT, V394, P137, DOI 10.1016/0014-5793(96)00935-0; Kawamoto Y, 2004, J BIOL CHEM, V279, P14213, DOI 10.1074/jbc.M312600200; Kebebew E, 2001, WORLD J SURG, V25, P632, DOI 10.1007/s002680020165; Kimura ET, 2003, CANCER RES, V63, P1454; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Knauf JA, 2003, ONCOGENE, V22, P4406, DOI 10.1038/sj.onc.1206602; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kuhne MR, 1997, J EXP MED, V186, P337, DOI 10.1084/jem.186.2.337; Lin CI, 2011, J CLIN ENDOCR METAB, V96, pE554, DOI 10.1210/jc.2010-1800; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Ludwig L, 2001, CANCER RES, V61, P4526; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Matsumura M, 1999, LIFE SCI, V65, pPL129, DOI 10.1016/S0024-3205(99)00368-9; Mechler C, 2001, BRIT J CANCER, V85, P1831, DOI 10.1054/bjoc.2001.2187; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Mesa C, 2006, CANCER RES, V66, P6521, DOI 10.1158/0008-5472.CAN-06-0739; Neely RJ, 2011, ONCOGENE, V30, P87, DOI 10.1038/onc.2010.396; Nikiforov YE, 2008, MODERN PATHOL, V21, pS37, DOI 10.1038/modpathol.2008.10; OTT RA, 1985, SURGERY, V98, P1202; Ouyang B, 2006, CLIN CANCER RES, V12, P1785, DOI 10.1158/1078-0432.CCR-05-1729; Powell DJ, 2003, J IMMUNOL, V170, P861, DOI 10.4049/jimmunol.170.2.861; Powell DJ, 2001, ONCOGENE, V20, P3235, DOI 10.1038/sj.onc.1204425; PREHN RT, 1972, SCIENCE, V176, P170, DOI 10.1126/science.176.4031.170; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Rabes HM, 1998, RECENT RES CANCER, V154, P248; Rhoden KJ, 2006, J CLIN ENDOCR METAB, V91, P2414, DOI 10.1210/jc.2006-0240; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Ruan DT, 2008, SURGERY, V144, P908, DOI 10.1016/j.surg.2008.07.028; Russell JP, 2004, J IMMUNOL, V172, P4059, DOI 10.4049/jimmunol.172.7.4059; Russell JP, 2003, ONCOGENE, V22, P4569, DOI 10.1038/sj.onc.1206759; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Salvatore D, 2001, CANCER RES, V61, P1426; SEGAL K, 1985, INT SURG, V70, P205; Shinohara S, 2004, ONCOGENE, V23, P7571, DOI 10.1038/sj.onc.1207964; Singh B, 1999, SURGERY, V126, P1070, DOI 10.1067/msy.2099.101431; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weetman AP, 2004, CLIN ENDOCRINOL, V61, P405, DOI 10.1111/j.1365-2265.2004.02085.x; Wirtschafter A, 1997, LARYNGOSCOPE, V107, P95, DOI 10.1097/00005537-199701000-00019; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; YIP I, 1995, J CLIN ENDOCR METAB, V80, P1664, DOI 10.1210/jc.80.5.1664; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	80	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3691	3703		10.1074/jbc.M111.322677	http://dx.doi.org/10.1074/jbc.M111.322677			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158616	Green Published, hybrid			2022-12-25	WOS:000300410900007
J	Morita, T; Mayanagi, T; Sobue, K				Morita, Tsuyoshi; Mayanagi, Taira; Sobue, Kenji			Caldesmon Regulates Axon Extension through Interaction with Myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE; ATPASE ACTIVITY; ACTIN-BINDING; GROWTH CONES; TROPOMYOSIN; GIZZARD; PROTEIN; INHIBITION; ARP2/3; SITES	To begin the process of forming neural circuits, new neurons first establish their polarity and extend their axon. Axon extension is guided and regulated by highly coordinated cytoskeletal dynamics. Here we demonstrate that in hippocampal neurons, the actin-binding protein caldesmon accumulates in distal axons, and its N-terminal interaction with myosin II enhances axon extension. In cortical neural progenitor cells, caldesmon knockdown suppresses axon extension and neuronal polarity. These results indicate that caldesmon is an important regulator of axon development.	[Mayanagi, Taira; Sobue, Kenji] Iwate Med Univ, Inst Biomed Sci, Dept Neurosci, Yahaba, Iwate 0283694, Japan; [Morita, Tsuyoshi; Mayanagi, Taira; Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci, Suita, Osaka 5650871, Japan	Iwate Medical University; Osaka University	Sobue, K (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Neurosci, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	ksobue@iwate-med.ac.jp			Japan Society for the Promotion of Science [20240038]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23110510]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 20240038 from the Japan Society for the Promotion of Science (to K. S.) and 23110510 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to K. S.).	Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Bridgman PC, 2009, RESULTS PROBL CELL D, V48, P91, DOI 10.1007/400_2009_10; Chantler P D, 2003, IEE Proc Nanobiotechnol, V150, P111, DOI 10.1049/ip-nbt:20031076; Fukumoto K, 2009, MOL PSYCHIATR, V14, P1119, DOI 10.1038/mp.2009.60; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; HAYASHI K, 1991, J BIOL CHEM, V266, P355; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; Hur EM, 2011, P NATL ACAD SCI USA, V108, P5057, DOI 10.1073/pnas.1011258108; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; KIRA M, 1995, J NEUROSCI RES, V40, P294, DOI 10.1002/jnr.490400303; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; Li Y, 2004, J CELL SCI, V117, P3593, DOI 10.1242/jcs.01216; Li YH, 2000, J BIOL CHEM, V275, P10989, DOI 10.1074/jbc.275.15.10989; Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; Morita T, 2007, J BIOL CHEM, V282, P8454, DOI 10.1074/jbc.M609983200; NGAI PK, 1984, J BIOL CHEM, V259, P3656; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1982, BIOMED RES-TOKYO, V3, P188, DOI 10.2220/biomedres.3.188; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; SOBUE K, 1985, BIOCHEM BIOPH RES CO, V132, P645, DOI 10.1016/0006-291X(85)91181-7; Sobue K, 2010, CELL ADHES MIGR, V4, P185, DOI 10.4161/cam.4.2.10886; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; TANAKA J, 1993, J CELL SCI, V104, P595; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; VELAZ L, 1990, J BIOL CHEM, V265, P2929; Wang Z, 1997, P NATL ACAD SCI USA, V94, P11899, DOI 10.1073/pnas.94.22.11899; WARREN KS, 1994, J CELL BIOL, V125, P359, DOI 10.1083/jcb.125.2.359; Yamashiro S, 2001, MOL BIOL CELL, V12, P239, DOI 10.1091/mbc.12.1.239	36	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3349	3356		10.1074/jbc.M111.295618	http://dx.doi.org/10.1074/jbc.M111.295618			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158623	Green Published, hybrid			2022-12-25	WOS:000300295100040
J	Mersman, DP; Du, HN; Fingerman, IM; South, PF; Briggs, SD				Mersman, Douglas P.; Du, Hai-Ning; Fingerman, Ian M.; South, Paul F.; Briggs, Scott D.			Charge-based Interaction Conserved within Histone H3 Lysine 4 (H3K4) Methyltransferase Complexes Is Needed for Protein Stability, Histone Methylation, and Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAGE LEUKEMIA PROTEIN-1; MLL1 CORE COMPLEX; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; MOLECULAR RECOGNITION; TRITHORAX FAMILY; SET1 COMPLEX; WDR5; TRIMETHYLATION; COMPASS	Histone H3 lysine 4 (H3K4) methyltransferases are conserved from yeast to humans, assemble in multisubunit complexes, and are needed to regulate gene expression. The yeast H3K4 methyltransferase complex, Set1 complex or complex of proteins associated with Set1 (COMPASS), consists of Set1 and conserved Set1-associated proteins: Swd1, Swd2, Swd3, Spp1, Bre2, Sdc1, and Shg1. The removal of the WD40 domain-containing subunits Swd1 and Swd3 leads to a loss of Set1 protein and consequently a complete loss of H3K4 methylation. However, until now, how these WD40 domain-containing proteins interact with Set1 and contribute to the stability of Set1 and H3K4 methylation has not been determined. In this study, we identified small basic and acidic patches that mediate protein interactions between the C terminus of Swd1 and the nSET domain of Set1. Absence of either the basic or acidic patches of Set1 and Swd1, respectively, disrupts the interaction between Set1 and Swd1, diminishes Set1 protein levels, and abolishes H3K4 methylation. Moreover, these basic and acidic patches are also important for cell growth, telomere silencing, and gene expression. We also show that the basic and acidic patches of Set1 and Swd1 are conserved in their human counterparts SET1A/B and RBBP5, respectively, and are needed for the protein interaction between SET1A and RBBP5. Therefore, this charge-based interaction is likely important for maintaining the protein stability of the human SET1A/B methyltransferase complexes so that proper H3K4 methylation, cell growth, and gene expression can also occur in mammals.	[Briggs, Scott D.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Briggs, SD (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ, W Lafayette, IN 47907 USA.	sdbriggs@purdue.edu	Du, Hai-Ning/AAI-2020-2021; South, Paul/AAG-2634-2020; South, Paul/H-2636-2017; du, hai-ning/AAE-5626-2022	Du, Hai-Ning/0000-0001-8062-5411; South, Paul/0000-0001-7885-7096; South, Paul/0000-0001-7885-7096; Briggs, Scott D/0000-0003-2852-3594	National Institutes of Health [GM74183]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM74183 to (to S. D. B.).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Avdic V, 2011, STRUCTURE, V19, P101, DOI 10.1016/j.str.2010.09.022; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Halbach A, 2009, EMBO J, V28, P2959, DOI 10.1038/emboj.2009.240; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Odho Z, 2010, J BIOL CHEM, V285, P32967, DOI 10.1074/jbc.M110.159921; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; South PF, 2010, J BIOL CHEM, V285, P595, DOI 10.1074/jbc.M109.042697; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	43	28	30	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2652	2665		10.1074/jbc.M111.280867	http://dx.doi.org/10.1074/jbc.M111.280867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147691	Green Published, hybrid			2022-12-25	WOS:000300292300038
J	Pan, M; Yuan, H; Brent, M; Ding, EC; Marmorstein, R				Pan, Min; Yuan, Hua; Brent, Michael; Ding, Emily Chen; Marmorstein, Ronen			SIRT1 Contains N- and C-terminal Regions That Potentiate Deacetylase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NAD(+)-DEPENDENT HISTONE DEACETYLASES; SMALL-MOLECULE ACTIVATORS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; PROTEIN SIR2; SIRTUINS; INHIBITORS; MECHANISM; GENE; LONGEVITY	SIRT1 is one of seven mammalian sirtuin (silent information regulator 2-related) proteins that harbor NAD(+)-dependent protein deacetylase activity and is implicated in multiple metabolic and age-associated pathways and disorders. The sirtuin proteins contain a central region of high sequence conservation that is required for catalytic activity, but more variable N- and C-terminal regions have been proposed to mediate protein specific activities. Here we show that the conserved catalytic core domain of SIRT1 has very low catalytic activity toward several known protein substrates, but that regions N- and C-terminal to the catalytic core potentiate catalytic efficiency by between 12- and 45-fold, with the N-terminal domain contributing predominantly to catalytic rate, relatively independent of the nature of the acetyl-lysine protein substrate, and the C-terminal domain contributing significantly to the K-m for NAD(+). We show that the N- and C-terminal regions stimulate SIRT1 deacetylase activity intramolecularly and that the C-terminal region stably associates with the catalytic core domain to form a SIRT1 holoenzyme. We also demonstrate that the C-terminal region of SIRT1 can influence the inhibitory activity of some sirtuin inhibitors that are known to function through the catalytic core domain. Together, these studies highlight the unique properties of the SIRT1 member of the sirtuin proteins and have implications for the development of SIRT1-specific regulatory molecules.	[Pan, Min; Yuan, Hua; Brent, Michael; Ding, Emily Chen; Marmorstein, Ronen] Univ Penn, Wistar Inst, Philadelphia, PA 19104 USA; [Pan, Min; Brent, Michael; Ding, Emily Chen; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org			National Institutes of Health [GM060293, CA107107, CA010815]; NATIONAL CANCER INSTITUTE [R01CA107107, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060293 and CA107107 (to R. M.) and CA010815 (to the Wistar Proteomics Core facility).	Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cen Y, 2010, BBA-PROTEINS PROTEOM, V1804, P1635, DOI 10.1016/j.bbapap.2009.11.010; Chakrabarty SP, 2008, MOL BIOCHEM PARASIT, V158, P139, DOI 10.1016/j.molbiopara.2007.12.003; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim E, 1999, ONCOGENE, V18, P7310, DOI 10.1038/sj.onc.1203139; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schmidt C, 2010, NAT BIOTECHNOL, V28, P185, DOI 10.1038/nbt0310-185; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Trapp J, 2007, CHEMMEDCHEM, V2, P1419, DOI 10.1002/cmdc.200700003; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Wilson JM, 2006, EMBO REP, V7, P1247, DOI 10.1038/sj.embor.7400829; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978	37	51	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2468	2476		10.1074/jbc.M111.285031	http://dx.doi.org/10.1074/jbc.M111.285031			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22157016	hybrid, Green Published			2022-12-25	WOS:000300292300021
J	Li, TG; Francl, JM; Boehme, S; Ochoa, A; Zhang, YC; Klaassen, CD; Erickson, SK; Chiang, JYL				Li, Tiangang; Francl, Jessica M.; Boehme, Shannon; Ochoa, Adrian; Zhang, Youcai; Klaassen, Curtis D.; Erickson, Sandra K.; Chiang, John Y. L.			Glucose and Insulin Induction of Bile Acid Synthesis MECHANISMS AND IMPLICATION IN DIABETES AND OBESITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; HUMAN HEPATOCYTES; HISTONE ACETYLATION; ENERGY-EXPENDITURE; DIURNAL-VARIATION; RECEPTOR LXR; EXPRESSION; TRANSCRIPTION; METABOLISM; LIVER	Bile acids facilitate postprandial absorption of nutrients. Bile acids also activate the farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5 and play a major role in regulating lipid, glucose, and energy metabolism. Transgenic expression of cholesterol 7 alpha-hydroxylase (CYP7A1) prevented high fat diet-induced diabetes and obesity in mice. In this study, we investigated the nutrient effects on bile acid synthesis. Refeeding of a chow diet to fasted mice increased CYP7A1 expression, bile acid pool size, and serum bile acids in wild type and humanized CYP7A1-transgenic mice. Chromatin immunoprecipitation assays showed that glucose increased histone acetylation and decreased histone methylation on the CYP7A1 gene promoter. Refeeding also induced CYP7A1 in fxr-deficient mice, indicating that FXR signaling did not play a role in postprandial regulation of bile acid synthesis. In streptozocin-induced type I diabetic mice and genetically obese type II diabetic ob/ob mice, hyperglycemia increased histone acetylation status on the CYP7A1 gene promoter, leading to elevated basal Cyp7a1 expression and an enlarged bile acid pool with altered bile acid composition. However, refeeding did not further increase CYP7A1 expression in diabetic mice. In summary, this study demonstrates that glucose and insulin are major postprandial factors that induce CYP7A1 gene expression and bile acid synthesis. Glucose induces CYP7A1 gene expression mainly by epigenetic mechanisms. In diabetic mice, CYP7A1 chromatin is hyperacetylated, and fasting to refeeding response is impaired and may exacerbate metabolic disorders in diabetes.	[Li, Tiangang; Francl, Jessica M.; Boehme, Shannon; Ochoa, Adrian; Chiang, John Y. L.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Zhang, Youcai; Klaassen, Curtis D.] Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Med Ctr, Kansas City, KS 66160 USA; [Erickson, Sandra K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; [Erickson, Sandra K.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	Northeast Ohio Medical University (NEOMED); University of Kansas; University of Kansas Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Chiang, JYL (corresponding author), NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA.	jchiang@neomed.edu	Zhang, Youcai/C-9085-2013; zhang, youcai/K-1303-2015; Ferrell, Jessica/AAI-6996-2021; Chiang, John Y. L./G-2658-2011	Ferrell, Jessica/0000-0003-3691-3330; Chiang, John Y. L./0000-0001-9360-7650	National Institutes of Health [R01DK-44442, R37DK-58379, DK-081461, ES-009649, DK-072187]; Veterans Affairs merit award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461, R37DK058379, R01DK072187, R01DK044442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK-44442 and R37DK-58379 (to J.Y.L.C.), DK-081461 and ES-009649 (to C. D. K.), and DK-072187 (to S. K. E.). This work was also supported by a Veterans Affairs merit award (to S. K. E.).	BENNION LJ, 1977, NEW ENGL J MED, V296, P1365, DOI 10.1056/NEJM197706162962401; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; CHIANG JYL, 1990, J BIOL CHEM, V265, P3889; CHIANG JYL, 1991, METHOD ENZYMOL, V206, P483; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Galman C, 2005, GASTROENTEROLOGY, V129, P1445, DOI 10.1053/j.gastro.2005.09.009; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; HEUMAN DM, 1989, J LIPID RES, V30, P719; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li TG, 2005, AM J PHYSIOL-GASTR L, V288, pG74, DOI 10.1152/ajpgi.00258.2004; Li TG, 2007, GASTROENTEROLOGY, V133, P1660, DOI 10.1053/j.gastro.2007.08.042; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li TG, 2011, HEPATOLOGY, V53, P996, DOI 10.1002/hep.24107; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Li TG, 2010, J LIPID RES, V51, P832, DOI 10.1194/jlr.M002782; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Song KH, 2006, HEPATOLOGY, V43, P117, DOI 10.1002/hep.20919; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; SUBBIAH MTR, 1984, BIOCHEM BIOPH RES CO, V124, P896, DOI 10.1016/0006-291X(84)91042-8; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683	40	145	150	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1861	1873		10.1074/jbc.M111.305789	http://dx.doi.org/10.1074/jbc.M111.305789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22144677	hybrid, Green Published			2022-12-25	WOS:000299321000027
J	Arumugasundaram, S; Ghosh, M; Veerasamy, S; Ramasamy, Y				Arumugasundaram, Shanmugapriya; Ghosh, Modhumita; Veerasamy, Sivakumar; Ramasamy, Yasodha			Species Discrimination, Population Structure and Linkage Disequilibrium in Eucalyptus camaldulensis and Eucalyptus tereticornis Using SSR Markers	PLOS ONE			English	Article							ASSOCIATION GENETICS; NUCLEOTIDE DIVERSITY; MICROSATELLITE; L.; SOFTWARE; LOCI; WOOD; MAP; POLYMORPHISMS; CONSTRUCTION	Eucalyptus camaldulensis and E. tereticornis are closely related species commonly cultivated for pulp wood in many tropical countries including India. Understanding the genetic structure and linkage disequilibrium (LD) existing in these species is essential for the improvement of industrially important traits. Our goal was to evaluate the use of simple sequence repeat (SSR) loci for species discrimination, population structure and LD analysis in these species. Investigations were carried out with the most common alleles in 93 accessions belonging to these two species using 62 SSR markers through cross amplification. The polymorphic information content (PIC) ranged from 0.44 to 0.93 and 0.36 to 0.93 in E. camaldulensis and E. tereticornis respectively. A clear delineation between the two species was evident based on the analysis of population structure and species-specific alleles. Significant genotypic LD was found in E. camaldulensis, wherein out of 135 significant pairs, 17 pairs showed r(2) >= 0.1. Similarly, in E. tereticornis, out of 136 significant pairs, 18 pairs showed r(2) >= 0.1. The extent of LD decayed rapidly showing the significance of association analyses in eucalypts with higher resolution markers. The availability of whole genome sequence for E. grandis and the synteny and co-linearity in the genome of eucalypts, will allow genome-wide genotyping using microsatellites or single nucleotide polymorphims.	[Arumugasundaram, Shanmugapriya; Ghosh, Modhumita; Ramasamy, Yasodha] Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, Coimbatore, Tamil Nadu, India; [Veerasamy, Sivakumar] Inst Forest Genet & Tree Breeding, Div Genet & Tree Breeding, Coimbatore, Tamil Nadu, India	Indian Council of Forestry Research & Education (ICFRE); Institute of Forest Genetics & Tree Breeding (IFGTB); Indian Council of Forestry Research & Education (ICFRE); Institute of Forest Genetics & Tree Breeding (IFGTB)	Arumugasundaram, S (corresponding author), Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, Coimbatore, Tamil Nadu, India.	yasodha@icfre.org						Agrama HA, 2002, SILVAE GENET, V51, P201; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Balasaravanan T, 2005, TREE PHYSIOL, V25, P1295, DOI 10.1093/treephys/25.10.1295; Barnaud A, 2006, THEOR APPL GENET, V112, P708, DOI 10.1007/s00122-005-0174-1; Barnaud A, 2010, HEREDITY, V104, P431, DOI 10.1038/hdy.2009.143; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brondani RPV, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-20; Brondani RPV, 2002, MOL GENET GENOMICS, V267, P338, DOI 10.1007/s00438-002-0665-6; Butcher PA, 2009, TREE GENET GENOMES, V5, P189, DOI 10.1007/s11295-008-0169-6; Chezhian P, 2010, NEW FOREST, V40, P85, DOI 10.1007/s11056-009-9184-1; Chu YG, 2009, GENETICA, V137, P141, DOI 10.1007/s10709-009-9371-1; da Silva JM, 2009, CONSERV GENET RESOUR, V1, P465, DOI 10.1007/s12686-009-9107-7; Doran J. C., 1993, Commonwealth Forestry Review, V72, P198; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Haussmann BIG, 2004, THEOR APPL GENET, V109, P1005, DOI 10.1007/s00122-004-1706-9; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Ingvarson PK, 2010, PLANT GENET GENOMICS, V8, P91, DOI 10.1007/978-1-4419-1541-2_5; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Kirst M, 2005, J HERED, V96, P161, DOI 10.1093/jhered/esi023; Kirsten H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2683; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; Kumar S, 2004, THEOR APPL GENET, V108, P292, DOI 10.1007/s00122-003-1352-7; Lewis P, 2001, GENETIC DATA ANAL GD; Li MH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-32; Li MH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-66; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Marques CM, 2002, THEOR APPL GENET, V105, P474, DOI 10.1007/s00122-002-0899-z; Marques CM, 1998, THEOR APPL GENET, V96, P727, DOI 10.1007/s001220050795; Marroni F, 2011, TREE GENET GENOMES, V7, P1011, DOI 10.1007/s11295-011-0391-5; McRae AF, 2002, GENETICS, V160, P1113; Olson MS, 2010, NEW PHYTOL, V186, P526, DOI 10.1111/j.1469-8137.2009.03174.x; Oraguzie NC, 2007, ASS MAPPING PLANTS; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Shepherd M, 2006, SILVAE GENET, V55, P228, DOI 10.1515/sg-2006-0030; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; Thamarus KA, 2002, THEOR APPL GENET, V104, P379, DOI 10.1007/s001220100717; Thavamanikumar S, 2011, AUST FORESTRY, V74, P23, DOI 10.1080/00049158.2011.10676342; Thumma BR, 2010, TREE GENET GENOMES, V6, P877, DOI 10.1007/s11295-010-0298-6; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; Varghese M, 2009, TREE GENET GENOMES, V5, P629, DOI 10.1007/s11295-009-0215-z; Varilo T, 2003, HUM MOL GENET, V12, P51, DOI 10.1093/hmg/ddg005; Verhaegen D., 1998, Forest Genetics, V5, P61; Weir BS., 1996, GENETIC DATA ANAL; Yasodha R, 2008, J GENET, V87, P21, DOI 10.1007/s12041-008-0003-9; Zapata C, 2001, ANN HUM GENET, V65, P395, DOI 10.1017/S0003480001008697	59	28	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28252	10.1371/journal.pone.0028252	http://dx.doi.org/10.1371/journal.pone.0028252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163287	gold, Green Published, Green Submitted			2022-12-25	WOS:000298161900022
J	Burrows, M; Borycz, JA; Shaw, SR; Elvin, CM; Meinertzhagen, IA				Burrows, Malcolm; Borycz, Jolanta A.; Shaw, Stephen R.; Elvin, Christopher M.; Meinertzhagen, Ian A.			Antibody Labelling of Resilin in Energy Stores for Jumping in Plant Sucking Insects	PLOS ONE			English	Article							RUBBER-LIKE PROTEIN; FROGHOPPER INSECTS; XENOPSYLLA-CHEOPIS; CUTICLE; MECHANISM; TIMBAL; CICADA; GENE; IDENTIFICATION; PERFORMANCE	The rubbery protein resilin appears to form an integral part of the energy storage structures that enable many insects to jump by using a catapult mechanism. In plant sucking bugs that jump (Hemiptera, Auchenorrhyncha), the energy generated by the slow contractions of huge thoracic jumping muscles is stored by bending composite bow-shaped parts of the internal thoracic skeleton. Sudden recoil of these bows powers the rapid and simultaneous movements of both hind legs that in turn propel a jump. Until now, identification of resilin at these storage sites has depended exclusively upon characteristics that may not be specific: its fluorescence when illuminated with specific wavelengths of ultraviolet (UV) light and extinction of that fluorescence at low pH. To consolidate identification we have labelled the cuticular structures involved with an antibody raised against a product of the Drosophila CG15920 gene. This encodes pro-resilin, the first exon of which was expressed in E. coli and used to raise the antibody. We show that in frozen sections from two species, the antibody labels precisely those parts of the metathoracic energy stores that fluoresce under UV illumination. The presence of resilin in these insects is thus now further supported by a molecular criterion that is immunohistochemically specific.	[Burrows, Malcolm] Univ Cambridge, Dept Zool, Cambridge, England; [Borycz, Jolanta A.; Shaw, Stephen R.; Meinertzhagen, Ian A.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [Elvin, Christopher M.] Commonwealth Sci & Ind Res Org, Div Livestock Ind, St Lucia, Qld, Australia	University of Cambridge; Dalhousie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Burrows, M (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	mb135@hermes.cam.ac.uk	elvin, chris/H-2333-2013	Meinertzhagen, Ian/0000-0002-6578-4526	CSIRO Australia; Natural Science and Engineering Council (Canada) [DIS0000065]	CSIRO Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Natural Science and Engineering Council (Canada)	This work was supported by: Emerging Science Grant (nanotechnology) from CSIRO Australia to C.M.E., Natural Science and Engineering Council (Canada) Discovery grant DIS0000065 to I.A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; ANDERSEN SO, 1963, BIOCHIM BIOPHYS ACTA, V69, P249, DOI 10.1016/0006-3002(63)91258-7; Andersen SO, 2002, ELASTOMERIC PROTEINS; ANDERSEN SVEND OLAV, 1964, ADVANCES INSECT PHYSIOL, V2, P1, DOI 10.1016/S0065-2806(08)60071-5; Andersen SO, 2011, INSECT BIOCHEM MOLEC, V41, P620, DOI 10.1016/j.ibmb.2011.03.015; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P541, DOI 10.1016/j.ibmb.2010.05.002; Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3; BENNETCLARK HC, 1967, J EXP BIOL, V47, P59; BennetClark HC, 1997, J EXP BIOL, V200, P1681; Burrows M, 2010, J EXP BIOL, V213, P469, DOI 10.1242/jeb.037861; Burrows M, 2006, J EXP BIOL, V209, P4607, DOI 10.1242/jeb.02539; Burrows M, 2009, J EXP BIOL, V212, P2844, DOI 10.1242/jeb.032326; Burrows M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-27; Burrows M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-41; ELLIOTT GF, 1965, J MOL BIOL, V13, P791, DOI 10.1016/S0022-2836(65)80144-9; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; EVANS MEG, 1972, J ZOOL, V167, P319; EVANS MEG, 1973, J ZOOL, V169, P181; Fonseca PJ, 1998, J EXP BIOL, V201, P717; JENSEN M, 1962, PHILOS T ROY SOC B, V245, P137, DOI 10.1098/rstb.1962.0008; Lyons RE, 2007, PROTEIN ENG DES SEL, V20, P25, DOI 10.1093/protein/gzl050; Lyons RE, 2011, INSECT BIOCHEM MOLEC, V41, P881, DOI 10.1016/j.ibmb.2011.08.002; Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454; Nairn KM, 2008, BIOPHYS J, V95, P3358, DOI 10.1529/biophysj.107.119107; Neff D, 2000, ARTHROPOD STRUCT DEV, V29, P75, DOI 10.1016/S1467-8039(00)00014-1; NEVILLE AC, 1976, J CELL SCI, V21, P73; NEVILLE AC, 1963, J INSECT PHYSIOL, V9, P265, DOI 10.1016/0022-1910(63)90103-3; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P499, DOI 10.1098/rstb.1975.0064; ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P457, DOI 10.1098/rstb.1975.0062; Sannasi A., 1969, Journal of the Georgia Entomological Society, V4, P31; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; WEISFOGH T, 1960, J EXP BIOL, V37, P889; Wong CCD, 2007, IN VIVO IN VITRO EXP; YOUNG D, 1995, J EXP BIOL, V198, P1001	37	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28456	10.1371/journal.pone.0028456	http://dx.doi.org/10.1371/journal.pone.0028456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163306	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900043
J	Gillece, JD; Schupp, JM; Balajee, SA; Harris, J; Pearson, T; Yan, YP; Keim, P; DeBess, E; Marsden-Haug, N; Wohrle, R; Engelthaler, DM; Lockhart, SR				Gillece, John D.; Schupp, James M.; Balajee, S. Arunmozhi; Harris, Julie; Pearson, Talima; Yan, Yongpan; Keim, Paul; DeBess, Emilio; Marsden-Haug, Nicola; Wohrle, Ron; Engelthaler, David M.; Lockhart, Shawn R.			Whole Genome Sequence Analysis of Cryptococcus gattii from the Pacific Northwest Reveals Unexpected Diversity	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; VANCOUVER-ISLAND; BRITISH-COLUMBIA; OUTBREAK; LINEAGES; SOFTWARE; GENOTYPE; STRAINS	A recent emergence of Cryptococcus gattii in the Pacific Northwest involves strains that fall into three primarily clonal molecular subtypes: VGIIa, VGIIb and VGIIc. Multilocus sequence typing (MLST) and variable number tandem repeat analysis appear to identify little diversity within these molecular subtypes. Given the apparent expansion of these subtypes into new geographic areas and their ability to cause disease in immunocompetent individuals, differentiation of isolates belonging to these subtypes could be very important from a public health perspective. We used whole genome sequence typing (WGST) to perform fine-scale phylogenetic analysis on 20 C. gattii isolates, 18 of which are from the VGII molecular type largely responsible for the Pacific Northwest emergence. Analysis both including and excluding (289,586 SNPs and 56,845 SNPs, respectively) molecular types VGI and VGIII isolates resulted in phylogenetic reconstructions consistent, for the most part, with MLST analysis but with far greater resolution among isolates. The WGST analysis presented here resulted in identification of over 100 SNPs among eight VGIIc isolates as well as unique genotypes for each of the VGIIa, VGIIb and VGIIc isolates. Similar levels of genetic diversity were found within each of the molecular subtype isolates, despite the fact that the VGIIb clade is thought to have emerged much earlier. The analysis presented here is the first multi-genome WGST study to focus on the C. gattii molecular subtypes involved in the Pacific Northwest emergence and describes the tools that will further our understanding of this emerging pathogen.	[Gillece, John D.; Schupp, James M.; Engelthaler, David M.] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ USA; [Balajee, S. Arunmozhi; Harris, Julie; Lockhart, Shawn R.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Pearson, Talima; Keim, Paul] No Arizona Univ, Ctr Microbial Genet & Gen, Flagstaff, AZ 86011 USA; [Yan, Yongpan] Van Andel Inst, Ctr Genet Epidemiol & Prevent, Grand Rapids, MI USA; [DeBess, Emilio] Oregon State Dept Human Serv, Portland, OR USA; [Marsden-Haug, Nicola; Wohrle, Ron] Washington State Dept Hlth, Shoreline, WA USA; [Wohrle, Ron] Washington Dept Hlth, Tumwater, WA USA	Translational Genomics Research Institute; Centers for Disease Control & Prevention - USA; Northern Arizona University; Van Andel Institute	Gillece, JD (corresponding author), Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ USA.	jschupp@tgen.org	Pearson, Talima/O-7840-2019	Pearson, Talima/0000-0003-3696-041X	Translational Genomics Research Institute; Centers for Disease Control and Prevention	Translational Genomics Research Institute; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All work was funded by the Translational Genomics Research Institute and the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CRYPT GATT SEQ PROJ; Baro T, 1998, J CLIN MICROBIOL, V36, P458; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Byrnes E.J., 2009, F1000 BIOL REP; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; D'Souza CA, 2011, MBIO, V2, DOI 10.1128/mBio.00342-10; dos Santos WRA, 2008, MEM I OSWALDO CRUZ, V103, P813, DOI 10.1590/S0074-02762008000800012; Engelthaler DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001347; Engelthaler DM, 2011, EMERG INFECT DIS, V17, P227, DOI 10.3201/eid1702.100620; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Hoang LMN, 2004, J MED MICROBIOL, V53, P935, DOI 10.1099/jmm.0.05427-0; Iqbal N, 2010, J CLIN MICROBIOL, V48, P539, DOI 10.1128/JCM.01505-09; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Ngamskulrungroj P, 2011, CLIN MICROBIOL INFEC, V17, P251, DOI 10.1111/j.1469-0691.2010.03222.x; Okamoto K, 2010, EMERG INFECT DIS, V16, P1155, DOI 10.3201/eid1607.100106; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Stephen C, 2002, CAN VET J, V43, P792; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	27	56	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28550	10.1371/journal.pone.0028550	http://dx.doi.org/10.1371/journal.pone.0028550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163313	Green Submitted, Green Published, gold			2022-12-25	WOS:000298161900049
J	Xia, LC; Cram, JA; Chen, T; Fuhrman, JA; Sun, FZ				Xia, Li C.; Cram, Jacob A.; Chen, Ting; Fuhrman, Jed A.; Sun, Fengzhu			Accurate Genome Relative Abundance Estimation Based on Shotgun Metagenomic Reads	PLOS ONE			English	Article							INTERPOLATED MARKOV-MODELS; HUMAN MICROBIOME PROJECT; GUT MICROBIOME; PHYLOGENETIC CLASSIFICATION; DNA-SEQUENCES; ONE-CELL; METABOLISM; ALGORITHM; FRAGMENTS; ALIGNMENT	Accurate estimation of microbial community composition based on metagenomic sequencing data is fundamental for subsequent metagenomics analysis. Prevalent estimation methods are mainly based on directly summarizing alignment results or its variants; often result in biased and/or unstable estimates. We have developed a unified probabilistic framework (named GRAMMy) by explicitly modeling read assignment ambiguities, genome size biases and read distributions along the genomes. Maximum likelihood method is employed to compute Genome Relative Abundance of microbial communities using the Mixture Model theory (GRAMMy). GRAMMy has been demonstrated to give estimates that are accurate and robust across both simulated and real read benchmark datasets. We applied GRAMMy to a collection of 34 metagenomic read sets from four metagenomics projects and identified 99 frequent species (minimally 0.5% abundant in at least 50% of the datasets) in the human gut samples. Our results show substantial improvements over previous studies, such as adjusting the over-estimated abundance for Bacteroides species for human gut samples, by providing a new reference-based strategy for metagenomic sample comparisons. GRAMMy can be used flexibly with many read assignment tools (mapping, alignment or composition-based) even with low-sensitivity mapping results from huge short-read datasets. It will be increasingly useful as an accurate and robust tool for abundance estimation with the growing size of read sets and the expanding database of reference genomes.	[Xia, Li C.; Chen, Ting; Sun, Fengzhu] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Chen, Ting; Sun, Fengzhu] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Beijing 100084, Peoples R China	University of Southern California; Tsinghua University	Xia, LC (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	fsun@usc.edu	Fuhrman, Jed A/C-6461-2013; Xia, Charlie/H-4755-2012; Xia, Li (Charlie)/AAD-8271-2020; Sun, Fengzhu/G-4373-2010; Cram, Jacob/AFK-2633-2022	Fuhrman, Jed A/0000-0002-2361-1985; Xia, Charlie/0000-0003-0868-1923; Xia, Li (Charlie)/0000-0003-0868-1923; Sun, Fengzhu/0000-0002-8552-043X; Cram, Jacob/0000-0001-9546-1130	National Science Foundation (NSF) [DMS1043075, OCE1136818]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research is partially supported by National Science Foundation (NSF) DMS1043075 and OCE1136818. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Beszteri B, 2010, ISME J, V4, P1075, DOI 10.1038/ismej.2010.29; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; Chen YH, 2009, BIOINFORMATICS, V25, P2514, DOI 10.1093/bioinformatics/btp486; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; ENGEMAN RM, 1994, ECOLOGY, V75, P1769, DOI 10.2307/1939636; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kelley DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-544; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Liu J.S., 2008, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-76371-2, DOI 10.1007/978-0-387-76371-2]; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rosen GL, 2009, CURR GENOMICS, V10, P493, DOI 10.2174/138920209789208255; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wu YW, 2011, J COMPUT BIOL, V18, P523, DOI 10.1089/cmb.2010.0245	40	73	77	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27992	10.1371/journal.pone.0027992	http://dx.doi.org/10.1371/journal.pone.0027992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162995	Green Submitted, Green Published, gold			2022-12-25	WOS:000298173500008
J	Clementi, N; De Marco, D; Mancini, N; Solforosi, L; Moreno, GJ; Gubareva, LV; Mishin, V; Di Pietro, A; Vicenzi, E; Siccardi, AG; Clementi, M; Burioni, R				Clementi, Nicola; De Marco, Donata; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Gubareva, Larisa V.; Mishin, Vasiliy; Di Pietro, Andrea; Vicenzi, Elisa; Siccardi, Antonio G.; Clementi, Massimo; Burioni, Roberto			A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	PLOS ONE			English	Article							H1N1 2009 VIRUS; A VIRUSES; SEASONAL INFLUENZA; B-CELLS; S-OIV; PROTECTION; OSELTAMIVIR; INFECTION; VACCINE; EPITOPE	The interest in broad-range anti-influenza A monoclonal antibodies (mAbs) has recently been strengthened by the identification of anti-hemagglutinin (HA) mAbs endowed with heterosubtypic neutralizing activity to be used in the design of "universal" prophylactic or therapeutic tools. However, the majority of the single mAbs described to date do not bind and neutralize viral isolates belonging to highly divergent subtypes clustering into the two different HA-based influenza phylogenetic groups: the group 1 including, among others, subtypes H1, H2, H5 and H9 and the group 2 including, among others, H3 subtype. Here, we describe a human mAb, named PN-SIA28, capable of binding and neutralizing all tested isolates belonging to phylogenetic group 1, including H1N1, H2N2, H5N1 and H9N2 subtypes and several isolates belonging to group 2, including H3N2 isolates from the first period of the 1968 pandemic. Therefore, PN-SIA28 is capable of neutralizing isolates belonging to subtypes responsible of all the reported pandemics, as well as other subtypes with pandemic potential. The region recognized by PN-SIA28 has been identified on the stem region of HA and includes residues highly conserved among the different influenza subtypes. A deep characterization of PN-SIA28 features may represent a useful help in the improvement of available anti-influenza therapeutic strategies and can provide new tools for the development of universal vaccinal strategies.	[Clementi, Nicola; De Marco, Donata; Mancini, Nicasio; Solforosi, Laura; Moreno, Guisella J.; Clementi, Massimo; Burioni, Roberto] Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy; [Gubareva, Larisa V.; Mishin, Vasiliy] Ctr Dis Control & Prevent, Virus Surveillance & Diag Branch, Influenza Div, NCIRD, Atlanta, GA USA; [Di Pietro, Andrea; Vicenzi, Elisa] Ist Sci San Raffaele, Viral Pathogens & Biosafety Unit, Div Immunol Trapianti & Malattie Infett, Milan, Italy; [Siccardi, Antonio G.] Univ Milan, Dipartimento Biol & Genet Sci Med, Milan, Italy	Vita-Salute San Raffaele University; Centers for Disease Control & Prevention - USA; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Clementi, N (corresponding author), Univ Vita Salute San Raffaele, Lab Microbiol & Virol, Milan, Italy.	burioni.roberto@hsr.it	Di Pietro, Andrea/X-6373-2018; Burioni, Roberto/F-2396-2012; Mancini, Nicasio/AAN-6203-2020; Clementi, Nicola/G-8545-2014; Vicenzi, Elisa/AAL-3980-2020; Clementi, Massimo/F-6646-2013	Di Pietro, Andrea/0000-0003-2497-3862; Clementi, Nicola/0000-0002-1822-9861; MANCINI, Nicasio/0000-0003-0637-0910; Vicenzi, Elisa/0000-0003-0051-3968; Clementi, Massimo/0000-0002-7461-5898				Ansaldi F, 2009, VACCINE, V27, P3345, DOI 10.1016/j.vaccine.2009.01.081; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Burioni R, 2010, VIROLOGY, V399, P144, DOI 10.1016/j.virol.2009.12.014; Burioni R, 2009, NEW MICROBIOL, V32, P319; Burioni R, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61853-5; Burioni R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003423; Burioni Roberto, 2008, J Hepatol, V49, P299, DOI 10.1016/j.jhep.2008.05.008; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Clementi M, 2007, DRUG DISCOV TODAY TH, V4, P267; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ramirez-Gonzalez JE, 2011, EMERG INFECT DIS, V17, P283, DOI 10.3201/eid1702.100897; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Keizer RJ, 2010, CLIN PHARMACOKINET, V49, P493, DOI 10.2165/11531280-000000000-00000; Kitching A, 2009, EUROSURVEILLANCE, V14, P2; Koudstaal W, 2009, J INFECT DIS, V200, P1870, DOI 10.1086/648378; LAMARRE A, 1995, J IMMUNOL, V154, P3975; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; MA JKC, 1990, INFECT IMMUN, V58, P3407, DOI 10.1128/IAI.58.10.3407-3414.1990; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2009, VACCINE, V27, P5043, DOI 10.1016/j.vaccine.2009.06.032; Morens DM, 2010, CLIN INFECT DIS, V51, P1442, DOI 10.1086/657429; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Xue Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-724; YODEN S, 1985, ARCH VIROL, V85, P209, DOI 10.1007/BF01314232; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004	41	48	63	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28001	10.1371/journal.pone.0028001	http://dx.doi.org/10.1371/journal.pone.0028001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162996	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800008
J	Esposito, G; Scuderi, C; Valenza, M; Togna, GI; Latina, V; De Filippis, D; Cipriano, M; Carratu, MR; Iuvone, T; Steardo, L				Esposito, Giuseppe; Scuderi, Caterina; Valenza, Marta; Togna, Giuseppina Ines; Latina, Valentina; De Filippis, Daniele; Cipriano, Mariateresa; Carratu, Maria Rosaria; Iuvone, Teresa; Steardo, Luca			Cannabidiol Reduces Ab- Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPAR gamma Involvement	PLOS ONE			English	Article							TAU-PROTEIN HYPERPHOSPHORYLATION; NITRIC-OXIDE SYNTHASE; MOTOR IMPAIRMENTS; NUCLEAR; MICE; THERAPEUTICS; INFLAMMATION; MECHANISMS; EXPRESSION; COMPONENT	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) has been reported to be involved in the etiology of pathological features of Alzheimer's disease (AD). Cannabidiol (CBD), a Cannabis derivative devoid of psychomimetic effects, has attracted much attention because of its promising neuroprotective properties in rat AD models, even though the mechanism responsible for such actions remains unknown. This study was aimed at exploring whether CBD effects could be subordinate to its activity at PPAR gamma, which has been recently indicated as its putative binding site. CBD actions on beta-amyloid-induced neurotoxicity in rat AD models, either in presence or absence of PPAR antagonists were investigated. Results showed that the blockade of PPAR gamma was able to significantly blunt CBD effects on reactive gliosis and subsequently on neuronal damage. Moreover, due to its interaction at PPAR gamma, CBD was observed to stimulate hippocampal neurogenesis. All these findings report the inescapable role of this receptor in mediating CBD actions, here reported.	[Esposito, Giuseppe; Scuderi, Caterina; Togna, Giuseppina Ines; Latina, Valentina; Steardo, Luca] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy; [Valenza, Marta; Carratu, Maria Rosaria] Univ Bari, Dept Pharmacol & Human Physiol, Bari, Italy; [De Filippis, Daniele; Cipriano, Mariateresa; Iuvone, Teresa] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy	Sapienza University Rome; Universita degli Studi di Bari Aldo Moro; University of Naples Federico II	Esposito, G (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy.	luca.steardo@uniroma1.it	Scuderi, Caterina/J-4189-2012; Valenza, Marta/HDN-9003-2022; Esposito, Giuseppe/AAA-7949-2019; LATINA, VALENTINA/ABF-6504-2020; Valenza, Marta/AAG-6163-2019	Scuderi, Caterina/0000-0002-7314-1539; Valenza, Marta/0000-0002-2326-3896; Esposito, Giuseppe/0000-0001-8080-8218; LATINA, VALENTINA/0000-0002-6057-6154; Valenza, Marta/0000-0002-2326-3896; Cipriano, Mariateresa/0000-0001-6644-7137; Carratu, Maria/0000-0002-9709-6533; Steardo, Luca/0000-0003-3570-2195	Italian Ministry of Education, University and Research (FIRB)	Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by the Italian Ministry of Education, University and Research (FIRB 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Avraham Y, 2011, BRIT J PHARMACOL, V162, P1650, DOI 10.1111/j.1476-5381.2010.01179.x; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bodles AM, 2005, NEUROBIOL AGING, V26, P9, DOI 10.1016/j.neurobiolaging.2004.02.022; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Castillo A, 2010, NEUROBIOL DIS, V37, P434, DOI 10.1016/j.nbd.2009.10.023; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; DIROSA M, 1990, BIOCHEM BIOPH RES CO, V172, P1246, DOI 10.1016/0006-291X(90)91583-E; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Esposito G, 2006, J MOL MED, V84, P253, DOI 10.1007/s00109-005-0025-1; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Esposito G, 2006, NEUROSCI LETT, V399, P91, DOI 10.1016/j.neulet.2006.01.047; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Ho Gilbert J., 2005, Current Drug Targets - Inflammation and Allergy, V4, P247, DOI 10.2174/1568010053586237; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Iuvone T, 2009, CNS NEUROSCI THER, V15, P65, DOI 10.1111/j.1755-5949.2008.00065.x; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kersten S, 2008, PPAR RES, V2008, DOI 10.1155/2008/132960; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Magen I, 2010, BRIT J PHARMACOL, V159, P950, DOI 10.1111/j.1476-5381.2009.00589.x; Magen I, 2009, J HEPATOL, V51, P528, DOI 10.1016/j.jhep.2009.04.021; Mayo W, 2005, NEUROBIOL AGING, V26, P103, DOI 10.1016/j.neurobiolaging.2004.03.013; Miglio G, 2009, NEUROSCI LETT, V454, P134, DOI 10.1016/j.neulet.2009.03.014; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; O'Banion, 1999, Expert Opin Investig Drugs, V8, P1521, DOI 10.1517/13543784.8.10.1521; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Prins ND, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt28; Scuderi C, 2009, PHYTOTHER RES, V23, P597, DOI 10.1002/ptr.2625; Vairano M, 2002, EUR J NEUROSCI, V16, P584, DOI 10.1046/j.1460-9568.2002.02125.x; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Wolf SA, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-12; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	41	228	231	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28668	10.1371/journal.pone.0028668	http://dx.doi.org/10.1371/journal.pone.0028668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163051	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800055
J	Hallstrom, BM; Schneider, A; Zoller, S; Janke, A				Hallstroem, Bjoern M.; Schneider, Adrian; Zoller, Stefan; Janke, Axel			A Genomic Approach to Examine the Complex Evolution of Laurasiatherian Mammals	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INTERORDINAL RELATIONSHIPS; MITOCHONDRIAL GENOME; LIKELIHOOD; HYBRIDIZATION; RESOLUTION; PATTERNS; ELEMENTS; HISTORY; SINES	Recent phylogenomic studies have failed to conclusively resolve certain branches of the placental mammalian tree, despite the evolutionary analysis of genomic data from 32 species. Previous analyses of single genes and retroposon insertion data yielded support for different phylogenetic scenarios for the most basal divergences. The results indicated that some mammalian divergences were best interpreted not as a single bifurcating tree, but as an evolutionary network. In these studies the relationships among some orders of the super-clade Laurasiatheria were poorly supported, albeit not studied in detail. Therefore, 4775 protein-coding genes (6,196,263 nucleotides) were collected and aligned in order to analyze the evolution of this clade. Additionally, over 200,000 introns were screened in silico, resulting in 32 phylogenetically informative long interspersed nuclear elements (LINE) insertion events. The present study shows that the genome evolution of Laurasiatheria may best be understood as an evolutionary network. Thus, contrary to the common expectation to resolve major evolutionary events as a bifurcating tree, genome analyses unveil complex speciation processes even in deep mammalian divergences. We exemplify this on a subset of 1159 suitable genes that have individual histories, most likely due to incomplete lineage sorting or introgression, processes that can make the genealogy of mammalian genomes complex. These unexpected results have major implications for the understanding of evolution in general, because the evolution of even some higher level taxa such as mammalian orders may sometimes not be interpreted as a simple bifurcating pattern.	[Hallstroem, Bjoern M.; Janke, Axel] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Hallstroem, Bjoern M.; Janke, Axel] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Schneider, Adrian] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Zoller, Stefan] ETH, Computat Biochem Res Grp, Zurich, Switzerland; [Janke, Axel] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Edinburgh; Swiss Federal Institutes of Technology Domain; ETH Zurich; Goethe University Frankfurt	Hallstrom, BM (corresponding author), Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany.	bjoern.hallstroem@senckenberg.de	Janke, Axel/M-2135-2013	Janke, Axel/0000-0002-9394-1904	Hesse's Ministry of Higher Education, Research, and the Arts	Hesse's Ministry of Higher Education, Research, and the Arts	The present study was funded by the research funding programme " LOEWE - Landes -Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Arnason U, 2000, J MOL EVOL, V50, P569, DOI 10.1007/s002390010060; Asher RJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-102; Bell MA, 2005, TRENDS ECOL EVOL, V20, P358, DOI 10.1016/j.tree.2005.04.021; Benton Michael J., 2009, P35; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Cantrell MA, 2001, GENETICS, V158, P769; Churakov G, 2009, GENOME RES, V19, P868, DOI 10.1101/gr.090647.108; Clifford P, 1994, J R STAT SOC B, V56, P35; Curnoe D, 2006, J EVOLUTION BIOL, V19, P59, DOI 10.1111/j.1420-9101.2005.00989.x; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ebersberger I, 2007, MOL BIOL EVOL, V24, P2266, DOI 10.1093/molbev/msm156; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Gray A.P., 1972, MAMMALIAN HYBRIDS CH; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kim TM, 2004, J KOREAN MED SCI, V19, P177, DOI 10.3346/jkms.2004.19.2.177; Kramerov DA, 2005, INT REV CYTOL, V247, P165, DOI 10.1016/S0074-7696(05)47004-7; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Kunin V, 2005, GENOME RES, V15, P954, DOI 10.1101/gr.3666505; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Montgelard C, 1997, MOL BIOL EVOL, V14, P550, DOI 10.1093/oxfordjournals.molbev.a025792; Mouchaty SK, 2000, MOL BIOL EVOL, V17, P60, DOI 10.1093/oxfordjournals.molbev.a026238; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Pumo DE, 1998, J MOL EVOL, V47, P709, DOI 10.1007/PL00006430; Pupko T, 2002, MOL BIOL EVOL, V19, P2294, DOI 10.1093/oxfordjournals.molbev.a004053; Rannala B, 2008, ANNU REV GENOM HUM G, V9, P217, DOI 10.1146/annurev.genom.9.081307.164407; Ray DA, 2006, SYSTEMATIC BIOL, V55, P928, DOI 10.1080/10635150600865419; Schneider A, 2009, MOL BIOL EVOL, V26, P1259, DOI 10.1093/molbev/msp034; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; van de Lagemaat LN, 2005, GENOME RES, V15, P1243, DOI 10.1101/gr.3910705; Waddell P J, 2001, Genome Inform, V12, P141; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu XF, 1996, MOL BIOL EVOL, V13, P1167, DOI 10.1093/oxfordjournals.molbev.a025681; Zoller S, 2010, J MOL EVOL, V70, P605, DOI 10.1007/s00239-010-9356-9	64	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28199	10.1371/journal.pone.0028199	http://dx.doi.org/10.1371/journal.pone.0028199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164244	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400045
J	Kosugi, M; Ahmad, R; Alam, M; Uchida, Y; Kufe, D				Kosugi, Michio; Ahmad, Rehan; Alam, Maroof; Uchida, Yasumitsu; Kufe, Donald			MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; TUMOR-GROWTH; CARCINOMA ANTIGEN; SURVIVAL RESPONSE; LUNG-CANCER; C-SRC; METABOLISM; PROTEIN; PHOSPHORYLATION; PROLIFERATION	Aerobic glycolysis in cancer cells is regulated by multiple effectors that include Akt and pyruvate kinase M2 (PKM2). Mucin 1 (MUC1) is a heterodimeric glycoprotein that is aberrantly overexpressed by human breast and other carcinomas. Here we show that transformation of rat fibroblasts by the oncogenic MUC1-C subunit is associated with Akt-mediated increases in glucose uptake and lactate production, consistent with the stimulation of glycolysis. The results also demonstrate that the MUC1-C cytoplasmic domain binds directly to PKM2 at the B-and C-domains. Interaction between the MUC1-C cytoplasmic domain Cys-3 and the PKM2 C-domain Cys-474 was found to stimulate PKM2 activity. Conversely, epidermal growth factor receptor (EGFR)-mediated phosphorylation of the MUC1-C cytoplasmic domain on Tyr-46 conferred binding to PKM2 Lys-433 and inhibited PKM2 activity. In human breast cancer cells, silencing MUC1-C was associated with decreases in glucose uptake and lactate production, confirming involvement of MUC1-C in the regulation of glycolysis. In addition, EGFR-mediated phosphorylation of MUC1-C in breast cancer cells was associated with decreases in PKM2 activity. These findings indicate that the MUC1-C subunit regulates glycolysis and that this response is conferred in part by PKM2. Thus, the overexpression of MUC1-C oncoprotein in diverse human carcinomas could be of importance to the Warburg effect of aerobic glycolysis.	[Kosugi, Michio; Ahmad, Rehan; Alam, Maroof; Uchida, Yasumitsu; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kosugi, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		National Cancer Institute [CA97098, CA42802, CA100707]; NATIONAL CANCER INSTITUTE [R01CA097098, P50CA100707, R01CA042802] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants CA97098, CA42802 and CA100707 awarded by the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Khodarev NN, 2009, CANCER RES, V69, P2833, DOI 10.1158/0008-5472.CAN-08-4513; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MacDermed DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-16; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 1997, J BIOENERG BIOMEMBR, V29, P315, DOI 10.1023/A:1022490512705; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Pitroda SP, 2009, P NATL ACAD SCI USA, V106, P5837, DOI 10.1073/pnas.0812029106; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300	33	39	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28234	10.1371/journal.pone.0028234	http://dx.doi.org/10.1371/journal.pone.0028234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140559	Green Submitted, gold, Green Published			2022-12-25	WOS:000298163400040
J	Nakamura, R; Nakamoto, C; Obama, H; Durward, E; Nakamoto, M				Nakamura, Ritsuko; Nakamoto, Chizu; Obama, Hiroya; Durward, Elaine; Nakamoto, Masaru			Structure-Function Analysis of Nel, a Thrombospondin-1-like Glycoprotein Involved in Neural Development and Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING DOMAIN; GROWTH-FACTOR; FAMILY PROTEIN; RECEPTOR; EXPRESSION; MICE; DEGRADATION; MITOGENESIS; TERMINUS; REPEATS	Nel (neural epidermal growth factor (EGF)-like molecule) is a multimeric, multimodular extracellular glycoprotein with heparin- binding activity and structural similarities to thrombospondin- 1. Nel is predominantly expressed in the nervous system and has been implicated in neuronal proliferation and differentiation, retinal axon guidance, synaptic functions, and spatial learning. The Nel protein contains an N-terminal thrombospondin- 1 (TSP-N) domain, five cysteine-rich domains, and six EGF-like domains. However, little is known about the functions of specific domains of the Nel protein. In this study, we have performed structure-function analysis of Nel, by using a series of expression constructs for different regions of the Nel protein. Our studies demonstrate that the TSP-N domain is responsible for homo-multimer formation of Nel and its heparin-binding activity. In vivo, Nel and related Nell1 are expressed in several regions of the mouse central nervous system with partly overlapping patterns. When they are expressed in the same cells in vitro, Nel and Nell1 can form hetero-multimers through the TSP-N domain, but they do not hetero-oligomerize with thrombospondin- 1. Whereas both the TSP-N domain and cysteinerich domains can bind to retinal axons in vivo, only the latter causes growth cone collapse in cultured retinal axons, suggesting that cysteine-rich domains interact with and activate an inhibitory axon guidance receptor. These results suggest that Nel interacts with a range of molecules through its different domains and exerts distinct functions.	[Nakamoto, Masaru] Univ Aberdeen, Sch Med Sci, Aberdeen Dev Biol Grp, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Obama, Hiroya] Cleveland Clin Fdn, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; [Obama, Hiroya] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	University of Aberdeen; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Nakamoto, M (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen Dev Biol Grp, Inst Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	m.nakamoto@abdn.ac.uk		Nakamoto, Masaru/0000-0001-9356-1189; Nakamoto, Chizu/0000-0002-6560-3545	Royal Society (UK); Biotechnology and Biological Sciences Research Council (UK); BBSRC [BB/G007632/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007632/1] Funding Source: researchfish	Royal Society (UK)(Royal Society of London); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Royal Society (UK) and the Biotechnology and Biological Sciences Research Council (UK) (to M. N.).	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510; Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006; Chen H, 1996, BIOCHEM J, V318, P959, DOI 10.1042/bj3180959; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; DAVIS C G, 1990, New Biologist, V2, P410; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; DIXIT VM, 1984, J BIOL CHEM, V259, P100; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; HALFTER W, 1993, J NEUROSCI, V13, P2863; Hwang EM, 2007, BIOCHEM BIOPH RES CO, V353, P805, DOI 10.1016/j.bbrc.2006.12.115; Jeong JK, 2008, MOL CELLS, V26, P186; Jiang YL, 2009, MOL CELL NEUROSCI, V41, P113, DOI 10.1016/j.mcn.2009.02.006; Kim DG, 2010, BIOCHEM BIOPH RES CO, V391, P529, DOI 10.1016/j.bbrc.2009.11.092; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; Matsuhashi S, 1996, DEV DYNAM, V207, P233; Matsuyama S, 2005, J PHARMACOL SCI, V98, P239, DOI 10.1254/jphs.FP0050211; Matsuyama S, 2004, NEUROREPORT, V15, P417, DOI 10.1097/00001756-200403010-00007; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Nelson Branden R., 2002, Gene Expression Patterns, V2, P7, DOI 10.1016/S0925-4773(02)00347-7; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; OROURKE KM, 1992, J BIOL CHEM, V267, P24921; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375	35	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3282	3291		10.1074/jbc.M111.281485	http://dx.doi.org/10.1074/jbc.M111.281485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157752	Green Published, hybrid			2022-12-25	WOS:000300295100034
J	Gogna, R; Madan, E; Kuppusamy, P; Pati, U				Gogna, Rajan; Madan, Esha; Kuppusamy, Periannan; Pati, Uttam			Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor Regression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; P53-DEPENDENT TRANSACTIVATION; CANCER-THERAPY; APOPTOSIS; RESTORATION; CONFORMATION; ACTIVATION; MUTATIONS; PATHWAYS; PATIENT	Mutant (Mt) p53 abrogates tumor suppression functions of wild-type (WT) p53 through mutant-specific, gain-of-function effects, and patients bearing Mt p53 are chemoresistant. The dominant negative effect of p53 mutants results from their aggregation propensity which causes co-aggregation of WT p53. We explored the mechanism of p53 inactivation in hypoxia and hypothesized whether WT p53 could rescue Mt p53 in hypoxic tumors. WT p53 exists in mutant conformation in hypoxic core of MCF-7 solid tumors, and its conformation is oxygen-dependent. Under simulated hypoxia in cells, WT p53 undergoes conformational change in acquiring mutant conformation. An in vivo chaperone assay shows that WT p53 functions as a molecular chaperone in rescuing conformational and structural p53 mutants in cancer cells both at the transcription and proteome levels. WT p53 chaperone therapy is further shown to cause significant regression of tumor xenografts through reconversion of the mutant phenotype to wild-type p53. The chaperone function of WT p53 is directly linked to the induction of apoptosis in both cancer cells and tumor xenografts. As oncogenic p53 mutants are linked to chemoresistance in hypoxic tumors, p53 chaperone therapy will introduce new dimensions to existing cancer therapeutics. We propose that in cancer cells, WT p53 chaperoning may either exist as a cellular event to potentially reverse the dominant negative effect of its oncogenic mutants or to stabilize yet unidentified factors.	[Gogna, Rajan; Madan, Esha; Pati, Uttam] Jawaharlal Nehru Univ, Sch Biotechnol, Transcript & Human Biol Lab, New Delhi 110067, India; [Kuppusamy, Periannan] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Jawaharlal Nehru University, New Delhi; University System of Ohio; Ohio State University	Pati, U (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, Transcript & Human Biol Lab, New Delhi 110067, India.	uttam@mail.jnu.ac.in	Pati, Uttam/L-9345-2019	GOGNA, RAJAN/0000-0001-7304-7692; MADAN, ESHA/0000-0002-4941-0612	Department of Biotechnology (India); University Grant Commission	Department of Biotechnology (India)(Department of Biotechnology (DBT) India); University Grant Commission(University Grants Commission, India)	This work was supported by grants from the Department of Biotechnology (India), and the University Grant Commission.	Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Bajgelman MC, 2006, PROSTATE, V66, P1455, DOI 10.1002/pros.20462; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Chandrachud U, 2009, TECHNOL CANCER RES T, V8, P445, DOI 10.1177/153303460900800606; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Hammond EM, 2006, CLIN CANCER RES, V12, P5007, DOI 10.1158/1078-0432.CCR-06-0613; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kim H, 2012, J MOL BIOL, V415, P843, DOI 10.1016/j.jmb.2011.12.001; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Kuppusamy P, 2002, CANCER RES, V62, P307; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Liu T, 2007, CELL DEATH DIFFER, V14, P411, DOI 10.1038/sj.cdd.4402022; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Sauter ER, 2002, CANCER GENE THER, V9, P807, DOI 10.1038/sj.cgt.7700492; Schnitzer SE, 2006, CELL DEATH DIFFER, V13, P1611, DOI 10.1038/sj.cdd.4401864; Senzer N, 2007, MOL CANCER THER, V6, P1478, DOI 10.1158/1535-7163.MCT-07-0125; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sharma AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007159; SOMERS KD, 1992, CANCER RES, V52, P5997; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Wang PL, 2001, ONCOGENE, V20, P2318, DOI 10.1038/sj.onc.1204316; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	36	28	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2907	2914		10.1074/jbc.M111.317354	http://dx.doi.org/10.1074/jbc.M111.317354			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147694	Green Published, hybrid			2022-12-25	WOS:000300292300062
J	Arranz, P; de Soto, NA; Madsen, PT; Brito, A; Bordes, F; Johnson, MP				Arranz, Patricia; Aguilar de Soto, Natacha; Madsen, Peter T.; Brito, Alberto; Bordes, Fernando; Johnson, Mark P.			Following a Foraging Fish-Finder: Diel Habitat Use of Blainville's Beaked Whales Revealed by Echolocation	PLOS ONE			English	Article							CUVIERS ZIPHIUS-CAVIROSTRIS; SOUTHERN ELEPHANT SEALS; DIVING BEHAVIOR; DEPTH; PREY; METABOLISM; MIGRATION; CETACEANS; PREDATOR; ECOLOGY	Simultaneous high resolution sampling of predator behavior and habitat characteristics is often difficult to achieve despite its importance in understanding the foraging decisions and habitat use of predators. Here we tap into the biosonar system of Blainville's beaked whales, Mesoplodon densirostris, using sound and orientation recording tags to uncover prey-finding cues available to echolocating predators in the deep-sea. Echolocation sounds indicate where whales search and encounter prey, as well as the altitude of whales above the sea-floor and the density of organisms around them, providing a link between foraging activity and the bio-physical environment. Tagged whales (n = 9) hunted exclusively at depth, investing most of their search time either in the lower part of the deep scattering layer (DSL) or near the sea-floor with little diel change. At least 43% (420/974) of recorded prey-capture attempts were performed within the benthic boundary layer despite a wide range of dive depths, and many dives included both meso-and bentho-pelagic foraging. Blainville's beaked whales only initiate searching when already deep in the descent and encounter prey suitable for capture within 2 min of the start of echolocation, suggesting that these whales are accessing prey in reliable vertical strata. Moreover, these prey resources are sufficiently dense to feed the animals in what is effectively four hours of hunting per day enabling a strategy in which long dives to exploit numerous deep-prey with low nutritional value require protracted recovery periods (average 1.5 h) between dives. This apparent searching efficiency maybe aided by inhabiting steep undersea slopes with access to both the DSL and the sea-floor over small spatial scales. Aggregations of prey in these biotopes are located using biosonar-derived landmarks and represent stable and abundant resources for Blainville's beaked whales in the otherwise food-limited deep-ocean.	[Arranz, Patricia; Aguilar de Soto, Natacha; Brito, Alberto] Univ La Laguna, Biodiversidad Ecol Marina & Conservac BIOECOMAC, Dept Anim Biol, Tenerife, Spain; [Aguilar de Soto, Natacha] Univ Auckland, Leigh Marine Lab, Leigh, New Zealand; [Madsen, Peter T.] Aarhus Univ, Sect Zoophysiol, Dept Biosci, Aarhus, Denmark; [Madsen, Peter T.; Johnson, Mark P.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Bordes, Fernando] Inst Ciencias Marinas, Gran Canaria, Spain; [Johnson, Mark P.] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews, Fife, Scotland	Universidad de la Laguna; University of Auckland; Aarhus University; Woods Hole Oceanographic Institution; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); University of St Andrews	Arranz, P (corresponding author), Univ La Laguna, Biodiversidad Ecol Marina & Conservac BIOECOMAC, Dept Anim Biol, Tenerife, Spain.	arranz@ull.es	Madsen, Peter T/K-5832-2013; De Soto, Natacha Aguilar/D-3002-2011; Arranz, Patricia/ABD-7328-2021	Madsen, Peter T/0000-0002-5208-5259; De Soto, Natacha Aguilar/0000-0001-9818-3527; Arranz, Patricia/0000-0001-8998-5149	Office of Naval Research; National Ocean Partnership Program (US); Canary Islands Government; Spanish Ministry of Environment; Spanish Ministry of Defense; Spanish Ministry of Science [CGL2009-13112]; 7th European Frame Program; Strategic Environmental Research Development Program; National Ocean Partnership Program; National Danish Science Foundation; Natural Environment Research Council [smru10001] Funding Source: researchfish	Office of Naval Research(Office of Naval Research); National Ocean Partnership Program (US); Canary Islands Government; Spanish Ministry of Environment(Spanish Government); Spanish Ministry of Defense; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 7th European Frame Program; Strategic Environmental Research Development Program; National Ocean Partnership Program; National Danish Science Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by the Office of Naval Research and the National Ocean Partnership Program (US), by a consortium consisting of the Canary Islands Government, the Spanish Ministry of Environment and the Spanish Ministry of Defense, and by the European environmental funding LIFE-INDEMARES program for the inventory and designation of the Natura 2000 network in marine areas of the Spanish territory, headed by Fundacion Biodiversidad, with additional support from the Cabildo Insular of El Hierro. PA is currently supported by the National Research Project: Cetacean, Oceanography and Biodiversity from La Palma and El Hierro (CGL2009-13112) of the Spanish Ministry of Science and NAS by a Marie Curie fellowship from the 7th European Frame Program. MJ was supported by grants from the Strategic Environmental Research Development Program and from the National Ocean Partnership Program. PTM was supported by frame grants from the National Danish Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL MV, 1990, PHILOS T R SOC A, V331, P15, DOI 10.1098/rsta.1990.0053; ARDITI R, 1988, AM NAT, V131, P837, DOI 10.1086/284825; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; BARHAM EG, 1966, SCIENCE, V151, P1399, DOI 10.1126/science.151.3716.1399; Barton ED, 1998, PROG OCEANOGR, V41, P455, DOI 10.1016/S0079-6611(98)00023-8; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2001, MAR ECOL PROG SER, V217, P1, DOI 10.3354/meps217001; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Butler PJ, 2001, NEWS PHYSIOL SCI, V16, P222; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; CHILDRESS JJ, 1973, DEEP-SEA RES, V20, P1093, DOI 10.1016/0011-7471(73)90023-5; Claridge DE, 2006, THESIS U ABERDEEN SC; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Costa Daniel P., 1999, P176; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Davis RW, 1998, MAR MAMMAL SCI, V14, P490, DOI 10.1111/j.1748-7692.1998.tb00738.x; De Robertis A, 2007, ICES J MAR SCI, V64, P1282, DOI 10.1093/icesjms/fsm112; Drazen JC, 2007, LIMNOL OCEANOGR, V52, P2306, DOI 10.4319/lo.2007.52.5.2306; Gee MJR, 2001, MAR GEOL, V177, P271, DOI 10.1016/S0025-3227(01)00153-0; Hazen EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019269; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; HOLLDOBLER B, 1980, SCIENCE, V210, P86, DOI 10.1126/science.210.4465.86; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; JOHNSON MW, 1948, J MAR RES, V7, P443; Jones BA, 2008, J ACOUST SOC AM, V123, P1753, DOI 10.1121/1.2828210; KANE TC, 1976, ECOLOGY, V57, P793, DOI 10.2307/1936192; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Malakoff D, 2002, SCIENCE, V298, P722, DOI 10.1126/science.298.5594.722; MARSHALL N. B., 1965, DEEP SEA RES OCEANOGR ABSTR, V12, P299, DOI 10.1016/0011-7471(65)90004-5; MAUCHLINE J, 1991, MAR ECOL PROG SER, V74, P109, DOI 10.3354/meps074109; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Salvanes A. G. V, 2001, ENCY OCEAN SCI, V3, P1711, DOI DOI 10.1006/RWOS.2001.0012; Seibel BA, 1997, BIOL BULL, V192, P262, DOI 10.2307/1542720; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Thompson D, 1998, J ZOOL, V246, P135, DOI 10.1111/j.1469-7998.1998.tb00142.x; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Waring GT, 2001, MAR MAMMAL SCI, V17, P703, DOI 10.1111/j.1748-7692.2001.tb01294.x; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883	55	75	77	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28353	10.1371/journal.pone.0028353	http://dx.doi.org/10.1371/journal.pone.0028353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163295	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900031
J	Huang, LN; Xue, JY; He, Y; Wang, J; Sun, CH; Feng, RN; Teng, JH; He, YH; Li, Y				Huang, Lina; Xue, Jingyi; He, Ying; Wang, Jian; Sun, Changhao; Feng, Rennan; Teng, Jianhua; He, Yonghan; Li, Ying			Dietary Calcium but Not Elemental Calcium from Supplements Is Associated with Body Composition and Obesity in Chinese Women	PLOS ONE			English	Article							INSULIN-RESISTANCE; DAIRY-PRODUCTS; WEIGHT-LOSS; FAT-CONTENT; VITAMIN-D; BONE LOSS; MASS; DIGESTIBILITY; CONSUMPTION; POPULATION	Objective: We assessed whether dietary calcium intake or calcium supplements associated with body composition and obesity in a Chinese population. Methods: A cross-sectional survey was performed in a population of 8940, aged 20 to 74 y. 8127 participants responded (90.9%). Height, weight, fat mass (FM), waist circumference (WC) and hip circumference were measured. Obesity definition: body mass index (BMI) >= 28 kg/m(2) (overall obesity); WC >= 85 cm for men or >= 80 cm for women (abdominal obesity I) and waist hip ratio (WHR) >= 0.90 for men or >= 0.85 for women (abdominal obesity %). The data on dietary calcium and calcium supplements were collected using food-frequency questionnaire and self-report questionnaire. Multivariate linear and multivariable logistic regressions were used to examine the associations between dietary calcium intake or calcium supplements and body composition and obesity. Principal Findings: The average dietary calcium intake of all subjects was 430 mg/d. After adjusting for potential confounding factors, among women only, negative associations were observed between habitual dietary calcium intake and four measures of body composition (beta, -0.086, P < 0.001 for BMI; beta, -0.072, P < 0.001 for WC; beta, -0.044, P < 0.05 for WHR; and beta, -0.058, P < 0.01 for FM, respectively) and both measures of abdominal obesity (Odds Ratio [OR] = 0.86, 95% Confidence Interval [CI], 0.80-0.93; P < 0.001, for abdominal obesity I; OR = 0.92, 95% CI, 0.86-0.99; P = 0.026, for abdominal obesity II). These associations were not observed among men (P > 0.05). Similarly, among both men and women, we did not observe significant associations between calcium supplements and any measures of body composition or abdominal obesity (P > 0.05). Conclusions: Dietary calcium from food rather than elemental calcium from calcium supplements has beneficial effects on the maintenance of body composition and preventing abdominal obesity in Chinese women.	[Huang, Lina; He, Ying; Sun, Changhao; Feng, Rennan; Teng, Jianhua; He, Yonghan; Li, Ying] Harbin Med Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China; [Xue, Jingyi] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 1, Harbin, Peoples R China; [Wang, Jian] Ctr Dis Control & Prevent Harbin, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Huang, LN (corresponding author), Harbin Med Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China.	liying_helen@163.com	He, Yonghan/P-7271-2014; SUN, CHANG/GXM-3680-2022	He, Yonghan/0000-0003-4409-4590; 	National Natural Science Foundation of China [81172649]; National High Technology Research and Development Program of China (863 program) [2010AA023002]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA023002, R00AA023002] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Natural Science Foundation of China (No. 81172649) and the National High Technology Research and Development Program of China (863 program) (No. 2010AA023002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SA, 2001, P NUTR SOC, V60, P283; Barr SI, 2003, J NUTR, V133, p245S; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; DENKE MA, 1993, J NUTR, V123, P1047; ELDERS PJM, 1994, J BONE MINER RES, V9, P963; Gunther CW, 2005, AM J CLIN NUTR, V81, P751, DOI 10.1093/ajcn/81.4.751; Heaney RP, 2001, MENOPAUSE, V8, P84, DOI 10.1097/00042192-200103000-00003; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Jacobsen R, 2005, INT J OBESITY, V29, P292, DOI 10.1038/sj.ijo.0802785; Jacqmain M, 2003, AM J CLIN NUTR, V77, P1448, DOI 10.1093/ajcn/77.6.1448; Jensen LB, 2001, J BONE MINER RES, V16, P141, DOI 10.1359/jbmr.2001.16.1.141; Kamycheva E, 2003, J NUTR, V133, P102, DOI 10.1093/jn/133.1.102; Lin YC, 2000, J AM COLL NUTR, V19, P754, DOI 10.1080/07315724.2000.10718075; Loos RJF, 2004, J NUTR, V134, P1772, DOI 10.1093/jn/134.7.1772; Lorenzen JK, 2006, AM J CLIN NUTR, V83, P18; Ma G, 2008, OBES REV, V9, P113, DOI 10.1111/j.1467-789X.2007.00451.x; MCCARRON DA, 1984, NUTR REV, V42, P223; Panel on Macronutrients. Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2005, DIET REF INT EN CARB; Papakonstantinou E, 2003, OBES RES, V11, P387, DOI 10.1038/oby.2003.52; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Reid IR, 2005, J CLIN ENDOCR METAB, V90, P3824, DOI 10.1210/jc.2004-2205; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Sampath V, 2008, OBESITY, V16, P2400, DOI 10.1038/oby.2008.380; Shahkhalili Y, 2001, AM J CLIN NUTR, V73, P246; Shapses SA, 2004, J CLIN ENDOCR METAB, V89, P632, DOI 10.1210/jc.2002-021136; Summerbell CD, 1998, BRIT MED J, V317, P1487, DOI 10.1136/bmj.317.7171.1487; Sun XC, 2004, J NUTR, V134, P3054, DOI 10.1093/jn/134.11.3054; Trowman R, 2006, BRIT J NUTR, V95, P1033, DOI 10.1079/BJN20051727; WELBERG JWM, 1994, ANN NUTR METAB, V38, P185, DOI 10.1159/000177810; Zemel MB, 2005, J AM COLL NUTR, V24, p537S, DOI 10.1080/07315724.2005.10719502; Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144; Zemel MB, 1998, MOL CELL BIOCHEM, V188, P129, DOI 10.1023/A:1006880708475; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2001, J AM COLL NUTR, V20, p428S, DOI 10.1080/07315724.2001.10719180; Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	36	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27703	10.1371/journal.pone.0027703	http://dx.doi.org/10.1371/journal.pone.0027703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163269	gold, Green Submitted, Green Published			2022-12-25	WOS:000298161900005
J	Mitchell, T; Armstrong, GL; Hu, DJ; Wasley, A; Painter, JA				Mitchell, Tarissa; Armstrong, Gregory L.; Hu, Dale J.; Wasley, Annemarie; Painter, John A.			The Increasing Burden of Imported Chronic Hepatitis B - United States, 1974-2008	PLOS ONE			English	Article							VIRUS-INFECTION; DISEASE BURDEN; VACCINATION; AGE	Background: Without intervention, up to 25% of individuals chronically infected with hepatitis B virus (HBV) die of late complications, including cirrhosis and liver cancer. The United States, which in 1991 implemented a strategy to eliminate HBV transmission through universal immunization, is a country of low prevalence. Approximately 3,000-5,000 U. S.-acquired cases of chronic hepatitis B have occurred annually since 2001. Many more chronically infected persons migrate to the United States yearly from countries of higher prevalence. Although early identification of chronic HBV infection can reduce the likelihood of transmission and late complications, immigrants are not routinely screened for HBV infection during or after immigration. Methods: To estimate the number of imported cases of chronic hepatitis B, we multiplied country-specific prevalence estimates by the yearly number of immigrants from each country during 1974-2008. Results: During 1974-2008, 27.9 million immigrants entered the U. S. Sixty-three percent were born in countries of intermediate or high chronic hepatitis B prevalence (range 2%-31%). On average, an estimated 53,800 chronic hepatitis B cases were imported to the U. S. yearly from 2004 through 2008. The Philippines, China, and Vietnam contributed the most imported cases (13.4%, 12.5%, and 11.0%, respectively). Imported cases increased from an estimated low of 105,750 during the period 1974-1977 to a high of 268,800 in 2004-2008. Conclusions: Imported chronic hepatitis B cases account for approximately 95% of new U. S. cases. Earlier case identification and management of infected immigrants would strengthen the U. S. strategy to eliminate HBV transmission, and could delay disease progression and prevent some deaths among new Americans.	[Mitchell, Tarissa; Painter, John A.] Ctr Dis Control & Prevent, Immigrant Refugee & Migrant Hlth Branch, Atlanta, GA 30333 USA; [Armstrong, Gregory L.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Hu, Dale J.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA; [Wasley, Annemarie] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA USA; [Mitchell, Tarissa] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Mitchell, T (corresponding author), Ctr Dis Control & Prevent, Immigrant Refugee & Migrant Hlth Branch, Atlanta, GA 30333 USA.	TMitchell1@cdc.gov						*CDC, 2009, HILTH INF INT TRAV 2; *CDC, 2010, MED EX IMM REF; *CDC, 2010, VACC REQ US IMM TECH; Center for Disease Control, 2009, STAT SURV; Coleman PJ, 1998, J INFECT DIS, V178, P954, DOI 10.1086/515696; *DHS, 2009, YB IMM STAT; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; Fontana RJ, 2008, AM J MED, V121, P22, DOI 10.1016/j.amjmed.2008.09.026; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Grytdal SP, 2009, J COMMUN HEALTH, V34, P173, DOI 10.1007/s10900-008-9141-5; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Khokhar A, 2008, AM J MED, V121, P33, DOI 10.1016/j.amjmed.2008.09.027; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Ma Grace X, 2007, J Immigr Minor Health, V9, P213, DOI 10.1007/s10903-006-9028-4; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; U.S. Census Bureau, 2010, STAT COUNTR QUICKF; *US CIT IMM SERV, 2007, GUID NEW IMM; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; *WHO, 2009, HEP B GLOB SIT	24	93	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27717	10.1371/journal.pone.0027717	http://dx.doi.org/10.1371/journal.pone.0027717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163270	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900006
J	Gonzalez-Jara, P; Moreno-Letelier, A; Fraile, A; Pinero, D; Garcia-Arenal, F				Gonzalez-Jara, Pablo; Moreno-Letelier, Alejandra; Fraile, Aurora; Pinero, Daniel; Garcia-Arenal, Fernando			Impact of Human Management on the Genetic Variation of Wild Pepper, Capsicum annuum var. glabriusculum	PLOS ONE			English	Article							IN-SITU CONSERVATION; POLASKIA-CHICHIPE CACTACEAE; POPULATION-STRUCTURE; TEHUACAN VALLEY; DOMESTICATED POPULATIONS; DIVERSITY; DIFFERENTIATION; SOLANACEAE; PLANTS; RESOURCES	Management of wild peppers in Mexico has occurred for a long time without clear phenotypic signs of domestication. However, pre-domestication management could have implications for the population's genetic richness. To test this hypothesis we analysed 27 wild (W), let standing (LS) and cultivated (C) populations, plus 7 samples from local markets (LM), with nine polymorphic microsatellite markers. Two hundred and fifty two alleles were identified, averaging 28 per locus. Allele number was higher in W, and 15 and 40% less in LS and C populations, respectively. Genetic variation had a significant population structure. In W populations, structure was associated with ecological and geographic areas according to isolation by distance. When LM and C populations where included in the analysis, differentiation was no longer apparent. Most LM were related to distant populations from Sierra Madre Oriental, which represents their probable origin. Historical demography shows a recent decline in all W populations. Thus, pre-domestication human management is associated with a significant reduction of genetic diversity and with a loss of differentiation suggesting movement among regions by man. Measures to conserve wild and managed populations should be implemented to maintain the source and the architecture of genetic variation in this important crop relative.	[Gonzalez-Jara, Pablo; Fraile, Aurora; Garcia-Arenal, Fernando] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, ETSI Agronomos, Pozuelo Del Alarcon, Madrid, Spain; [Moreno-Letelier, Alejandra; Pinero, Daniel] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City, DF, Mexico	Universidad Politecnica de Madrid; Universidad Nacional Autonoma de Mexico	Gonzalez-Jara, P (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, ETSI Agronomos, Campus Montegancedo, Pozuelo Del Alarcon, Madrid, Spain.	fernando.garciaarenal@upm.es	Moreno-Letelier, Alejandra/AAF-8400-2020; Fraile, Aurora/H-1532-2015; Garcia-Arenal, Fernando/H-1603-2015	Moreno-Letelier, Alejandra/0000-0001-7524-7639; FRAILE PEREZ, AURORA/0000-0002-2785-7931; GARCIA-ARENAL RODRIGUEZ, FERNANDO/0000-0002-5327-3200; Pinero, Daniel/0000-0002-2509-2445	Fundacion BBVA, Spain ("Impacto de los patogenos en la conservacion de especies amenazadas: aplicacion a las poblaciones silvestres de chiltepin en Mexico") [BIOCON05/101]; Juan de la Cierva-UPM; Instituto de Ecologia	Fundacion BBVA, Spain ("Impacto de los patogenos en la conservacion de especies amenazadas: aplicacion a las poblaciones silvestres de chiltepin en Mexico")(BBVA Foundation); Juan de la Cierva-UPM; Instituto de Ecologia	This work was funded in part by a grant form Fundacion BBVA, Spain ("Impacto de los patogenos en la conservacion de especies amenazadas: aplicacion a las poblaciones silvestres de chiltepin en Mexico", BIOCON05/101) to FG-A. PG-J was supported also by a Juan de la Cierva-UPM contract. Financial support from Instituto de Ecologia to DP is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Melendez A, 2009, AM J BOT, V96, P1190, DOI 10.3732/ajb.0800155; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2004, MSVARL 3 UPDATE; Blanckaert I, 2007, AGR ECOSYST ENVIRON, V119, P39, DOI 10.1016/j.agee.2006.06.015; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Carlo TA, 2009, ECOLOGY, V90, P3516, DOI 10.1890/08-1313.1; Carmona A, 2005, J ARID ENVIRON, V60, P115, DOI 10.1016/j.jaridenv.2004.03.007; Casas A, 1999, AM J BOT, V86, P522, DOI 10.2307/2656813; Casas A, 2001, ECON BOT, V55, P129, DOI 10.1007/BF02864551; Casas A, 2007, ANN BOT-LONDON, V100, P1101, DOI 10.1093/aob/mcm126; Colunga-GarciaMarin P, 1999, AM J BOT, V86, P115, DOI 10.2307/2656960; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; D'Arcy W. G., 1974, Baileya, V19, P93; Damania AB, 2008, AGRON J, V100, P9, DOI 10.2134/agronj2005.0239c; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2004, HEREDITY, V92, P204, DOI 10.1038/sj.hdy.6800397; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Falush D, 2003, GENETICS, V164, P1567; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Hernandez- -V erdugo S., 1999, B SOC BOT MEX, V64, P65, DOI DOI 10.17129/B0TSCI.1583; Hernandez-Verdugo S, 2001, PLANT SYST EVOL, V226, P129, DOI 10.1007/s006060170061; Hernandez-Verdugo S, 2001, PLANT ECOL, V155, P245, DOI 10.1023/A:1013234100003; Hernandez-Verdugo S, 2001, EUPHYTICA, V122, P31, DOI 10.1023/A:1012624830340; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Khoury C, 2010, GENET RESOUR CROP EV, V57, P625, DOI 10.1007/s10722-010-9534-z; LOAIZAFIGUEROA F, 1989, PLANT SYST EVOL, V165, P159, DOI 10.1007/BF00936000; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Martinez-Castillo J, 2008, GENET RESOUR CROP EV, V55, P1065, DOI 10.1007/s10722-008-9314-1; Maxted N, 2009, ESTABLISHMENT GLOBAL, V266; Maxted N., 2008, CROP WILD RELATIVES; Meilleur BA, 2004, BIODIVERS CONSERV, V13, P663, DOI 10.1023/B:BIOC.0000011719.03230.17; Miller A, 2005, P NATL ACAD SCI USA, V102, P12801, DOI 10.1073/pnas.0505447102; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; Nabhan G. P., 1990, Diversity, V6, P47; Nei M, 1987, MOL EVOLUTIONARY GEN; Otero-Arnaiz A, 2005, MOL ECOL, V14, P1603, DOI 10.1111/j.1365-294X.2005.02494.x; Otero-Arnaiz A, 2003, AM J BOT, V90, P593, DOI 10.3732/ajb.90.4.593; Oyama K, 2006, GENET RESOUR CROP EV, V53, P553, DOI 10.1007/s10722-004-2363-1; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez-Meraz M, 2002, P 16 INT PEPP C TAMP; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Rodriguez delBosque L. A., 2002, P 16 INT PEPP C TAMP; Smith CE., 1967, PREHISTORY TEHUACAN, P220; SONNANTE G, 1994, THEOR APPL GENET, V89, P629, DOI 10.1007/BF00222458; Storz JF, 2002, EVOLUTION, V56, P154; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tewksbury JJ, 1999, CONSERV BIOL, V13, P98, DOI 10.1046/j.1523-1739.1999.97399.x; Tewksbury JJ, 2008, ECOLOGY, V89, P107, DOI 10.1890/07-0445.1; Votava EJ, 2002, CONSERV GENET, V3, P123, DOI 10.1023/A:1015216504565; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zizumbo-Villarreal D, 2005, CROP SCI, V45, P1073, DOI 10.2135/cropsci2004.0340	65	37	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28715	10.1371/journal.pone.0028715	http://dx.doi.org/10.1371/journal.pone.0028715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163053	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500047
J	Scheffzuk, C; Kukushka, VI; Vyssotski, AL; Draguhn, A; Tort, ABL; Brankack, J				Scheffzuek, Claudia; Kukushka, Valeriy I.; Vyssotski, Alexei L.; Draguhn, Andreas; Tort, Adriano B. L.; Brankack, Jurij			Selective Coupling between Theta Phase and Neocortical Fast Gamma Oscillations during REM-Sleep in Mice	PLOS ONE			English	Article							MULTIITEM WORKING-MEMORY; SOURCE DENSITY ANALYSIS; FREELY MOVING RAT; CAT VISUAL-CORTEX; BEHAVING RAT; NEURONAL OSCILLATIONS; SLOW OSCILLATIONS; HUMAN HIPPOCAMPUS; FIELD POTENTIALS; FLYING PIGEONS	Background: The mammalian brain expresses a wide range of state-dependent network oscillations which vary in frequency and spatial extension. Such rhythms can entrain multiple neurons into coherent patterns of activity, consistent with a role in behaviour, cognition and memory formation. Recent evidence suggests that locally generated fast network oscillations can be systematically aligned to long-range slow oscillations. It is likely that such cross-frequency coupling supports specific tasks including behavioural choice and working memory. Principal Findings: We analyzed temporal coupling between high-frequency oscillations and EEG theta activity (4-12 Hz) in recordings from mouse parietal neocortex. Theta was exclusively present during active wakefulness and REM-sleep. Fast oscillations occurred in two separate frequency bands: gamma (40-100 Hz) and fast gamma (120-160 Hz). Theta, gamma and fast gamma were more prominent during active wakefulness as compared to REM-sleep. Coupling between theta and the two types of fast oscillations, however, was more pronounced during REM-sleep. This state-dependent cross-frequency coupling was particularly strong for theta-fast gamma interaction which increased 9-fold during REM as compared to active wakefulness. Theta-gamma coupling increased only by 1.5-fold. Significance: State-dependent cross-frequency-coupling provides a new functional characteristic of REM-sleep and establishes a unique property of neocortical fast gamma oscillations. Interactions between defined patterns of slow and fast network oscillations may serve selective functions in sleep-dependent information processing.	[Scheffzuek, Claudia; Draguhn, Andreas; Brankack, Jurij] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Kukushka, Valeriy I.] Dniepropetrovsk Natl Univ, Quantum Chromoplasma Lab, Dnepropetrovsk, Ukraine; [Vyssotski, Alexei L.] Univ Zurich ETH, Inst Neuroinformat, Zurich, Switzerland; [Tort, Adriano B. L.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Ruprecht Karls University Heidelberg; Ministry of Education & Science of Ukraine; Oles Honchar Dnipro National University; Universidade Federal do Rio Grande do Norte	Scheffzuk, C (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany.	jurij.brankack@physiologie.uni-heidelberg.de	Brankack, Jurij/L-8179-2017; Tort, Adriano/A-9945-2009	Tort, Adriano/0000-0002-9877-7816; Vyssotski, Alexei/0000-0002-9021-1471	Deutsche Forschungsgemeinschaft [SFB 636/B06]; Bernstein Center for Computational Neurosciences (BMBF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bernstein Center for Computational Neurosciences (BMBF)(Federal Ministry of Education & Research (BMBF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by the Deutsche Forschungsgemeinschaft (SFB 636/B06) and the Bernstein Center for Computational Neurosciences (BMBF). ABL Tort was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Axmacher N, 2009, CELL MOL LIFE SCI, V66, P2285, DOI 10.1007/s00018-009-0019-1; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BLAND BH, 1976, BRAIN RES, V118, P259, DOI 10.1016/0006-8993(76)90711-3; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; Brankack J, 2010, BRAIN RES, V1322, P59, DOI 10.1016/j.brainres.2010.01.069; Brankack J, 2009, PROG NEURO-PSYCHOPH, V33, P806, DOI 10.1016/j.pnpbp.2009.03.027; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cantero JL, 2003, J NEUROSCI, V23, P10897; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Eckhorn R, 2000, Neurol Neurochir Pol, V34, P27; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gaona CM, 2011, J NEUROSCI, V31, P2091, DOI 10.1523/JNEUROSCI.4722-10.2011; GERBRANDT LK, 1978, ELECTROEN CLIN NEURO, V45, P454, DOI 10.1016/0013-4694(78)90290-0; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Gujar N, 2011, CEREB CORTEX, V21, P115, DOI 10.1093/cercor/bhq064; [Institute of Laboratory Animal Research Commission on Life Sciences National Research Council], 1996, GUID CAR US LAB AN; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016905; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; MORGANE PJ, 1985, DEV BRAIN RES, V22, P211, DOI 10.1016/0165-3806(85)90172-5; Nishida M, 2004, NEUROSCI RES, V50, P331, DOI 10.1016/j.neures.2004.08.004; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scheffer-Teixeira R, 2012, CEREB CORTEX, V22, P2404, DOI 10.1093/cercor/bhr319; Silvestri AJ, 2005, PHYSIOL BEHAV, V84, P343, DOI 10.1016/j.physbeh.2004.11.011; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; SUZUKI SS, 1987, ELECTROEN CLIN NEURO, V67, P348, DOI 10.1016/0013-4694(87)90123-4; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0	72	81	84	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28489	10.1371/journal.pone.0028489	http://dx.doi.org/10.1371/journal.pone.0028489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163023	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000298172800040
J	Srikhanta, YN; Gorrell, RJ; Steen, JA; Gawthorne, JA; Kwok, T; Grimmond, SM; Robins-Browne, RM; Jennings, MP				Srikhanta, Yogitha N.; Gorrell, Rebecca J.; Steen, Jason A.; Gawthorne, Jayde A.; Kwok, Terry; Grimmond, Sean M.; Robins-Browne, Roy M.; Jennings, Michael P.			Phasevarion Mediated Epigenetic Gene Regulation in Helicobacter pylori	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEMS; III DNA RESTRICTION; GASTRIC-CANCER; HAEMOPHILUS-INFLUENZAE; FUNCTIONAL-ANALYSIS; FLAGELLIN GENES; PHASE VARIATION; MULTIPLE GENES; COLONIZATION; SEQUENCE	Many host-adapted bacterial pathogens contain DNA methyltransferases (mod genes) that are subject to phase-variable expression (high-frequency reversible ON/OFF switching of gene expression). In Haemophilus influenzae and pathogenic Neisseria, the random switching of the modA gene, associated with a phase-variable type III restriction modification (R-M) system, controls expression of a phase-variable regulon of genes (a "phasevarion''), via differential methylation of the genome in the modA ON and OFF states. Phase-variable type III R-M systems are also found in Helicobacter pylori, suggesting that phasevarions may also exist in this key human pathogen. Phylogenetic studies on the phase-variable type III modH gene revealed that there are 17 distinct alleles in H. pylori, which differ only in their DNA recognition domain. One of the most commonly found alleles was modH5 (16% of isolates). Microarray analysis comparing the wild-type P12modH5 ON strain to a P12 Delta modH5 mutant revealed that six genes were either up-or down-regulated, and some were virulence-associated. These included flaA, which encodes a flagella protein important in motility and hopG, an outer membrane protein essential for colonization and associated with gastric cancer. This study provides the first evidence of this epigenetic mechanism of gene expression in H. pylori. Characterisation of H. pylori modH phasevarions to define stable immunological targets will be essential for vaccine development and may also contribute to understanding H. pylori pathogenesis.	[Srikhanta, Yogitha N.; Gawthorne, Jayde A.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Srikhanta, Yogitha N.; Gorrell, Rebecca J.; Robins-Browne, Roy M.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Gorrell, Rebecca J.; Robins-Browne, Roy M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Gorrell, Rebecca J.; Kwok, Terry] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Steen, Jason A.; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Griffith University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University; University of Queensland	Srikhanta, YN (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	m.jennings@griffith.edu.au	Gorrell, Rebecca/H-5259-2019; Jennings, Michael P/G-4822-2013; Steen, Jason/A-6031-2010; Grimmond, Sean M/J-5304-2016; Robinsbrowne, Roy/ABF-8434-2020; Grimmond, Sean/K-3246-2019; Gorrell, Rebecca/J-1454-2012	Gorrell, Rebecca/0000-0003-0728-3325; Jennings, Michael P/0000-0002-1027-4684; Grimmond, Sean M/0000-0002-8102-7998; Robinsbrowne, Roy/0000-0001-9179-7884; Grimmond, Sean/0000-0002-8102-7998; Kwok, Terry/0000-0002-5905-3233; Steen, Jason/0000-0003-1351-5815; Srikhanta, Yogitha/0000-0002-7513-9969	Australian National Health and Medical Research Council (NHMRC); NHMRC [565526, 284214, 519704]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) Biomedical Research Fellowship to YNS, NHMRC Program Grant 565526 to MPJ, NHMRC Program Grant 284214 to MPJ and RRB, and NHMRC Project Grant 519704 to MPJ and SMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; BACHI B, 1979, J MOL BIOL, V128, P143, DOI 10.1016/0022-2836(79)90123-2; Bayliss CD, 2006, NUCLEIC ACIDS RES, V34, P4046, DOI 10.1093/nar/gkl568; Bernarde C, 2010, MOL CELL PROTEOMICS, V9, P2796, DOI 10.1074/mcp.M110.001065; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Bjorkholm BM, 2002, J BIOL CHEM, V277, P34191, DOI 10.1074/jbc.M203613200; Blaser MJ, 1997, J CLIN INVEST, V100, P759, DOI 10.1172/JCI119588; Bourniquel AA, 2002, BIOCHIMIE, V84, P1047, DOI 10.1016/S0300-9084(02)00020-2; BOYER HW, 1971, ANNU REV MICROBIOL, V25, P153, DOI 10.1146/annurev.mi.25.100171.001101; de Vries N, 2002, J BACTERIOL, V184, P6615, DOI 10.1128/JB.184.23.6615-6624.2002; Doig P, 1999, MICROBIOL MOL BIOL R, V63, P675, DOI 10.1128/MMBR.63.3.675-707.1999; Eaton KA, 1996, INFECT IMMUN, V64, P2445, DOI 10.1128/IAI.64.7.2445-2448.1996; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Fox KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/nar/gkm571; Fox KL, 2007, MOL MICROBIOL, V65, P1375, DOI 10.1111/j.1365-2958.2007.05873.x; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Giannakis M, 2008, P NATL ACAD SCI USA, V105, P4358, DOI 10.1073/pnas.0800668105; Gorrell RJ, 2005, FEMS IMMUNOL MED MIC, V44, P213, DOI 10.1016/j.femsim.2004.10.019; HUMBELIN M, 1988, J MOL BIOL, V200, P23, DOI 10.1016/0022-2836(88)90330-0; JOSENHANS C, 1995, J BACTERIOL, V177, P3010, DOI 10.1128/jb.177.11.3010-3020.1995; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; KOSTRZYNSKA M, 1991, J BACTERIOL, V173, P937, DOI 10.1128/jb.173.3.937-946.1991; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; Lin LF, 2001, P NATL ACAD SCI USA, V98, P2740, DOI 10.1073/pnas.051612298; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; Moss SF, 2003, CURR OPIN INFECT DIS, V16, P445, DOI 10.1097/00001432-200310000-00011; Moxon ER, 1997, NATURE, V387, P659, DOI 10.1038/42607; Peck B, 2001, MICROBES INFECT, V3, P171, DOI 10.1016/S1286-4579(01)01377-6; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Ryan KA, 2005, J BACTERIOL, V187, P5742, DOI 10.1128/JB.187.16.5742-5750.2005; Skoglund A, 2007, J BACTERIOL, V189, P8914, DOI 10.1128/JB.00108-07; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; SUERBAUM S, 1993, J BACTERIOL, V175, P3278, DOI 10.1128/jb.175.11.3278-3288.1993; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Vitkute J, 2001, J BACTERIOL, V183, P443, DOI 10.1128/JB.183.2.443-450.2001	42	78	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27569	10.1371/journal.pone.0027569	http://dx.doi.org/10.1371/journal.pone.0027569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162751	Green Published, gold			2022-12-25	WOS:000298172800006
J	Lu, ZK; Cheng, ZY; Zhao, YM; Volchenboum, SL				Lu, Zhike; Cheng, Zhongyi; Zhao, Yingming; Volchenboum, Samuel L.			Bioinformatic Analysis and Post-Translational Modification Crosstalk Prediction of Lysine Acetylation	PLOS ONE			English	Article							HISTONE H3; PHOSPHORYLATION SITES; SECONDARY STRUCTURE; PROTEIN; DOMAIN; P53; UBIQUITINATION; METHYLATION; DATABASE; IDENTIFICATION	Recent proteomics studies suggest high abundance and a much wider role for lysine acetylation (K-Ac) in cellular functions. Nevertheless, cross influence between K-Ac and other post-translational modifications (PTMs) has not been carefully examined. Here, we used a variety of bioinformatics tools to analyze several available K-Ac datasets. Using gene ontology databases, we demonstrate that K-Ac sites are found in all cellular compartments. KEGG analysis indicates that the K-Ac sites are found on proteins responsible for a diverse and wide array of vital cellular functions. Domain structure prediction shows that K-Ac sites are found throughout a wide variety of protein domains, including those in heat shock proteins and those involved in cell cycle functions and DNA repair. Secondary structure prediction proves that K-Ac sites are preferentially found in ordered structures such as alpha helices and beta sheets. Finally, by mutating K-Ac sites in silico and predicting the effect on nearby phosphorylation sites, we demonstrate that the majority of lysine acetylation sites have the potential to impact protein phosphorylation, methylation, and ubiquitination status. Our work validates earlier smaller-scale studies on the acetylome and demonstrates the importance of PTM crosstalk for regulation of cellular function.	[Lu, Zhike; Cheng, Zhongyi; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Volchenboum, Samuel L.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Volchenboum, Samuel L.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Lu, ZK (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	Yingming.Zhao@uchicago.edu; SLV@uchicago.edu			NIH [RR020839, CA126832]; St. Baldrick's Foundation; Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH grants to Y.Z. (RR020839 and CA126832) and by the St. Baldrick's Foundation (http://www.stbaldricks.org) and the Cancer Research Foundation (http://www.cancerresearchfdn.org) to SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JK, 2009, MOL ENDOCRINOL, V23, P1963, DOI 10.1210/me.2009-0188; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; BATRA PP, 1990, J PROTEIN CHEM, V9, P37, DOI 10.1007/BF01024982; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boutet Emmanuel, 2007, V406, P89; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mollapour M, 2010, CELL CYCLE GEORGETOW, V9; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ren J, 2010, MOL CELL PROTEOMICS, V9, P623, DOI 10.1074/mcp.M900273-MCP200; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wiwanitkit V, 2007, DIABETES TECHNOL THE, V9, P145, DOI 10.1089/dia.2006.0022; XU XB, 1995, BIOPOLYMERS, V35, P93, DOI 10.1002/bip.360350110; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	64	54	60	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28228	10.1371/journal.pone.0028228	http://dx.doi.org/10.1371/journal.pone.0028228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164248	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400049
J	Yamada, H; Yamamoto, MT				Yamada, Hirokazu; Yamamoto, Masa-Toshi			Association between Circadian Clock Genes and Diapause Incidence in Drosophila triauraria	PLOS ONE			English	Article							PHOTOPERIODIC TIME MEASUREMENT; MITE TETRANYCHUS-URTICAE; REPRODUCTIVE DIAPAUSE; INSECT PHOTOPERIODISM; GEOGRAPHIC-VARIATION; NATURAL-SELECTION; MOLECULAR-BASES; LIFE-SPAN; MELANOGASTER; INDUCTION	Diapause is an adaptive response triggered by seasonal photoperiodicity to overcome unfavorable seasons. The photoperiodic clock is a system that controls seasonal physiological processes, but our knowledge about its physiological mechanisms and genetic architecture remains incomplete. The circadian clock is another system that controls daily rhythmic physiological phenomena. It has been argued that there is a connection between the two clocks. To examine the genetic connection between them, we analyzed the associations of five circadian clock genes (period, timeless, Clock, cycle and cryptochrome) with the occurrence of diapause in Drosophila triauraria, which shows a robust reproductive diapause with clear photoperiodicity. Non-diapause strains found in low latitudes were compared in genetic crosses with the diapause strain, in which the diapause trait is clearly dominant. Single nucleotide polymorphism and deletion analyses of the five circadian clock genes in backcross progeny revealed that allelic differences in timeless and cryptochrome between the strains were additively associated with the differences in the incidence of diapause. This suggests that there is a molecular link between certain circadian clock genes and the occurrence of diapause.	[Yamada, Hirokazu; Yamamoto, Masa-Toshi] Kyoto Inst Technol, Drosophila Genet Resource Ctr, Kyoto 606, Japan	Kyoto Institute of Technology	Yamada, H (corresponding author), Kyoto Inst Technol, Drosophila Genet Resource Ctr, Kyoto 606, Japan.	yamamoto@kit.jp			Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the National Bio-Resource Project from the Ministry of Education, Science, Sports and Culture of Japan. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; Bock IR, 1972, U TEXAS PUBLS STUD G, V7, P7213; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Bradshaw WE, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-115; Bradshaw WE, 2010, J BIOL RHYTHM, V25, P155, DOI 10.1177/0748730410365656; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Danks HV, 2003, EUR J ENTOMOL, V100, P209, DOI 10.14411/eje.2003.036; Danks HV, 2005, J INSECT PHYSIOL, V51, P609, DOI 10.1016/j.jinsphys.2005.01.005; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Goto SG, 2009, J INSECT PHYSIOL, V55, P401, DOI 10.1016/j.jinsphys.2008.11.008; Goto SG, 2006, J INSECT PHYSIOL, V52, P1213, DOI 10.1016/j.jinsphys.2006.09.003; Han B, 2009, J INSECT PHYSIOL, V55, P415, DOI 10.1016/j.jinsphys.2009.01.005; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ikeno T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-116; KIMURA MT, 1990, J INSECT PHYSIOL, V36, P147, DOI 10.1016/0022-1910(90)90115-V; KIMURA MT, 1983, PHYSIOL ENTOMOL, V8, P181, DOI 10.1111/j.1365-3032.1983.tb00347.x; KIMURA MT, 1995, PHYSIOL ENTOMOL, V20, P253, DOI 10.1111/j.1365-3032.1995.tb00009.x; KIMURA MT, 1984, PHYSIOL ENTOMOL, V9, P425, DOI 10.1111/j.1365-3032.1984.tb00784.x; KIMURA Y, 1993, PHYSIOL ENTOMOL, V18, P240, DOI 10.1111/j.1365-3032.1993.tb00594.x; King R. C., 1970, OVARIAN DEV DROSOPHI; Kostal V, 2001, J INSECT PHYSIOL, V47, P1269, DOI 10.1016/S0022-1910(01)00113-5; Kostal V, 2011, J INSECT PHYSIOL, V57, P538, DOI 10.1016/j.jinsphys.2010.10.006; LEES AD, 1986, J INSECT PHYSIOL, V32, P79, DOI 10.1016/0022-1910(86)90160-5; Mathias D, 2005, J INSECT PHYSIOL, V51, P661, DOI 10.1016/j.jinsphys.2005.03.011; Merrow M, 2005, EMBO REP, V6, P930, DOI 10.1038/sj.embor.7400541; NANDA K. K., 1958, BOT GAZ, V120, P14, DOI 10.1086/335992; Nunes MV, 1999, J BIOL RHYTHM, V14, P84, DOI 10.1177/074873049901400202; Nunes MV, 1997, ENTOMOL EXP APPL, V84, P195, DOI 10.1023/A:1003023307605; NUNES MV, 1986, J INSECT PHYSIOL, V32, P1029, DOI 10.1016/0022-1910(86)90122-8; NUNES MV, 1982, J INSECT PHYSIOL, V28, P1041, DOI 10.1016/0022-1910(82)90011-7; Nunes MV, 1998, J THEOR BIOL, V194, P299, DOI 10.1006/jtbi.1998.0767; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pavelka J, 2003, EUR J ENTOMOL, V100, P255, DOI 10.14411/eje.2003.041; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Saunders DS, 2005, J INSECT PHYSIOL, V51, P599, DOI 10.1016/j.jinsphys.2004.12.002; Saunders DS, 2004, PHYSIOL ENTOMOL, V29, P1, DOI 10.1111/j.1365-3032.2004.0369.x; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; SAUNDERS DS, 1988, J COMP PHYSIOL A, V163, P365, DOI 10.1007/BF00604012; Saunders DS, 2002, INSECT CLOCKS; Schiesari L, 2011, FEBS LETT, V585, P1450, DOI 10.1016/j.febslet.2011.02.026; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schultz TF, 2003, SCIENCE, V301, P326, DOI 10.1126/science.1085935; Sheeba V, 2001, J INSECT PHYSIOL, V47, P1217, DOI 10.1016/S0022-1910(01)00107-X; Stehlik J, 2008, J BIOL RHYTHM, V23, P129, DOI 10.1177/0748730407313364; Suzuki L, 2001, J PHYCOL, V37, P933, DOI 10.1046/j.1529-8817.2001.01094.x; Syrova Z, 2003, CELL MOL LIFE SCI, V60, P2510, DOI 10.1007/s00018-003-3227-0; Takeda M, 1997, ANNU REV ENTOMOL, V42, P323, DOI 10.1146/annurev.ento.42.1.323; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tauber E, 2001, J BIOL RHYTHM, V16, P381, DOI 10.1177/074873001129002088; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; VEERMAN A, 1988, J INSECT PHYSIOL, V34, P1063, DOI 10.1016/0022-1910(88)90206-5; VEERMAN A, 1987, J COMP PHYSIOL A, V160, P421, DOI 10.1007/BF00615076; Veerman A, 2001, J INSECT PHYSIOL, V47, P1097, DOI 10.1016/S0022-1910(01)00106-8; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; WINFREE AT, 1970, J THEOR BIOL, V28, P327, DOI 10.1016/0022-5193(70)90075-5; Wittwer F, 2005, DEV CELL, V8, P817, DOI 10.1016/j.devcel.2005.04.002; YOSHIDA T, 1994, APPL ENTOMOL ZOOL, V29, P499, DOI 10.1303/aez.29.499; YOSHIDA T, 1993, J INSECT PHYSIOL, V39, P101, DOI 10.1016/0022-1910(93)90100-6; YOSHIDA T, 1993, J INSECT PHYSIOL, V39, P223, DOI 10.1016/0022-1910(93)90092-6	69	41	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27493	10.1371/journal.pone.0027493	http://dx.doi.org/10.1371/journal.pone.0027493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164210	Green Submitted, gold, Green Published			2022-12-25	WOS:000298171400010
J	Little, R; Muimo, R; Robson, L; Harris, K; Grabowski, PS				Little, Robert; Muimo, Richmond; Robson, Louise; Harris, Kate; Grabowski, Peter S.			The Transient Receptor Potential Ion Channel TRPV6 Is Expressed at Low Levels in Osteoblasts and Has Little Role in Osteoblast Calcium Uptake	PLOS ONE			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; CELL-LINE SAOS-2; CA2+ CHANNEL; BONE-CELLS; ABSORPTION; EPITHELIA; GENE; TRANSPORT; KIDNEY; ECAC2	Background: TRPV6 ion channels are key mediators of regulated transepithelial absorption of Ca(2+) within the small intestine. Trpv6(-/-) mice were reported to have lower bone density than wild-type littermates and significant disturbances in calcium homeostasis that suggested a role for TRPV6 in osteoblasts during bone formation and mineralization. TRPV6 and molecules related to transepithelial Ca2+ transport have been reported to be expressed at high levels in human and mouse osteoblasts. Results: Transmembrane ion currents in whole cell patch clamped SaOS-2 osteoblasts did not show sensitivity to ruthenium red, an inhibitor of TRPV5/6 ion channels, and (45)Ca uptake was not significantly affected by ruthenium red in either SaOS-2 (P = 0.77) or TE-85 (P = 0.69) osteoblastic cells. In contrast, ion currents and (45)Ca uptake were both significantly affected in a human bronchial epithelial cell line known to express TRPV6. TRPV6 was expressed at lower levels in osteoblastic cells than has been reported in some literature. In SaOS-2 TRPV6 mRNA was below the assay detection limit; in TE-85 TRPV6 mRNA was detected at 6.90 +/- 1.9 x 10(-5) relative to B2M. In contrast, TRPV6 was detected at 7.7 +/- 3.0 x 10(-2) and 2.38 +/- 0.28 x 10(-4) the level of B2M in human carcinoma-derived cell lines LNCaP and CaCO-2 respectively. In murine primary calvarial osteoblasts TRPV6 was detected at 3.80 +/- 0.24 x 10(-5) relative to GAPDH, in contrast with 4.3 +/- 1.5 x 10(-2) relative to GAPDH in murine duodenum. By immunohistochemistry, TRPV6 was expressed mainly in myleocytic cells of the murine bone marrow and was observed only at low levels in murine osteoblasts, osteocytes or growth plate cartilage. Conclusions: TRPV6 is expressed only at low levels in osteoblasts and plays little functional role in osteoblastic calcium uptake.	[Little, Robert; Grabowski, Peter S.] Univ Sheffield, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [Muimo, Richmond] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Robson, Louise; Harris, Kate] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Little, R (corresponding author), Univ Sheffield, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England.	p.grabowski@sheffield.ac.uk	Robson, Louise/Y-3794-2018; Grabowski, Peter S/G-2345-2010	Robson, Louise/0000-0003-2984-6520; Grabowski, Peter S/0000-0001-5924-1587; Little, Robert/0000-0003-1870-3241	Research into Ageing [305]	Research into Ageing	This work was funded by a PhD Studentship (Reference No. 305) from Research into Ageing (now Age UK; website url: http://www.ageuk.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed E, 2009, MOL MEMBR BIOL, V26, P146, DOI 10.1080/09687680802612721; BALMAIN N, 1989, HISTOCHEMISTRY, V92, P359, DOI 10.1007/BF00492492; Berdal A, 1996, J BONE MINER RES, V11, P768; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; BINDELS RJM, 1992, PFLUG ARCH EUR J PHY, V420, P566, DOI 10.1007/BF00374634; Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Faucheux C, 1998, BIOCHEM J, V333, P817, DOI 10.1042/bj3330817; FEHER JJ, 1992, AM J PHYSIOL, V262, pC517, DOI 10.1152/ajpcell.1992.262.2.C517; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2002, BBA-PROTEINS PROTEOM, V1600, P6, DOI 10.1016/S1570-9639(02)00438-7; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; Laketic-Ljubojevic I, 1999, BONE, V25, P631, DOI 10.1016/S8756-3282(99)00224-0; Lieben L, 2010, BONE, V47, P301, DOI 10.1016/j.bone.2010.04.595; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundquist P, 2000, CALCIFIED TISSUE INT, V67, P60, DOI 10.1007/s00223001098; Magyar CE, 2002, AM J PHYSIOL-RENAL, V283, pF29, DOI 10.1152/ajprenal.00252.2000; MCQUILLAN DJ, 1995, BONE, V16, P415; MESZAROS JG, 1993, J BONE MINER RES, V8, P1235; Moonga BS, 2002, AM J PHYSIOL-RENAL, V282, pF921, DOI 10.1152/ajprenal.00045.2000; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Peet NM, 1999, FASEB J, V13, P2179, DOI 10.1096/fasebj.13.15.2179; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; RODAN SB, 1987, CANCER RES, V47, P4961; Scutt A, 2003, METH MOLEC MED, V80, P29; Taparia S, 2006, EUR J NUTR, V45, P196, DOI 10.1007/s00394-005-0586-3; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Van der Eerden BCJ, 2012, J CELL PHYSIOL, V227, P1951, DOI 10.1002/jcp.22923; Weber K, 2001, BIOCHEM BIOPH RES CO, V289, P1287, DOI 10.1006/bbrc.2001.6121; Yellowley CE, 1998, CALCIFIED TISSUE INT, V62, P122, DOI 10.1007/s002239900405; YPEY DL, 1992, J BONE MINER RES, V7, pS377, DOI 10.1002/jbmr.5650071404; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	36	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28166	10.1371/journal.pone.0028166	http://dx.doi.org/10.1371/journal.pone.0028166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22163264	Green Accepted, Green Published, gold			2022-12-25	WOS:000298166300034
J	Starr, AE; Dufour, A; Maier, J; Overall, CM				Starr, Amanda E.; Dufour, Antoine; Maier, Josefine; Overall, Christopher M.			Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; CC-CHEMOKINE; IN-VIVO; BIOLOGICAL-ACTIVITY; RECEPTOR-BINDING; CD26/DIPEPTIDYL-PEPTIDASE IV; HEMOFILTRATE CC-CHEMOKINE-1; PROTEOLYTIC ACTIVATION; NEUTROPHIL CHEMOTAXIS; NH2-TERMINAL RESIDUES	Leukocyte migration and activation is orchestrated by chemokines, the cleavage of which modulates their activity and glycosaminoglycan binding and thus their roles in inflammation and immunity. Early research identified proteolysis as a means of both activating or inactivating CXC chemokines and inactivating CC chemokines. Recent evidence has shown activating cleavages of the monocyte chemoattractants CCL15 and CCL23 by incubation with synovial fluid, although the responsible proteases could not be identified. Herein we show that CCL15 is processed in human synovial fluid by matrix metalloproteinases (MMPs) and serine proteases. Furthermore, a family-wide investigation of MMP processing of all 14 monocyte-directed CC chemokines revealed that each is precisely cleaved by one or more MMPs. By MALDI-TOF-MS, 149 cleavage sites were sequenced including the first reported instance of CCL1, CCL16, and CCL17 proteolysis. Full-length CCL15-(1-92) and CCL23-(1-99) were cleaved within their unique 31 and 32-amino acid residue extended amino termini, respectively. Unlike other CCL chemokines that lose activity and become receptor antagonists upon MMP cleavage, the prominent MMP-processed products CCL15-(25-92, 28-92) and CCL23-(26-99) are stronger agonists in calcium flux and Transwell CC receptor transfectant and monocytic THP-1 migration assays. MMP processing of CCL16-(1-97) in its extended carboxyl terminus yields two products, CCL16-(8-77) and CCL16-(8-85), with both showing unexpected enhanced glycosaminoglycan binding. Hence, our study reveals for the first time that MMPs activate the long amino-terminal chemokines CCL15 and CCL23 to potent forms that have potential to increase monocyte recruitment during inflammation.	[Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Life Sci Inst 4 401, Vancouver, BC V6T 1Z3, Canada; [Starr, Amanda E.; Dufour, Antoine; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Dufour, Antoine; Maier, Josefine; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, Life Sci Inst 4 401, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Dufour, Antoine/AAB-7886-2019		Canadian Institutes; Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research Strategic Training [STP-53877]	Canadian Institutes(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research Strategic Training(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research grant, an Infrastructure Grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research), and by the British Columbia Proteomics Network.; Supported by the Natural Sciences and Engineering Research Council of Canada, the Michael Smith Foundation for Health Research, and Canadian Institutes of Health Research Strategic Training Program STP-53877.	Baysal C, 2001, PROTEINS, V43, P150, DOI 10.1002/1097-0134(20010501)43:2<150::AID-PROT1027>3.0.CO;2-M; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Cox JH, 2010, ARTHRITIS RHEUM-US, V62, P3645, DOI 10.1002/art.27757; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Escher SE, 1999, J PEPT RES, V54, P505, DOI 10.1034/j.1399-3011.1999.00125.x; Escher SE, 2004, J PEPT RES, V63, P36, DOI 10.1046/j.1399-3011.2004.00102.x; Forssmann U, 1997, FEBS LETT, V408, P211, DOI 10.1016/S0014-5793(97)00408-0; Forssmann U, 2001, J LEUKOCYTE BIOL, V70, P357; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Graham GJ, 1996, EMBO J, V15, P6506, DOI 10.1002/j.1460-2075.1996.tb01041.x; Howard OMZ, 2000, BLOOD, V96, P840, DOI 10.1182/blood.V96.3.840.015k32_840_845; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Keller UAD, 2010, CANCER RES, V70, P7562, DOI 10.1158/0008-5472.CAN-10-1584; Kim JK, 2005, J LEUKOCYTE BIOL, V78, P442, DOI 10.1189/jlb.0305161; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Laurence JS, 1998, BIOCHEMISTRY-US, V37, P9346, DOI 10.1021/bi980329l; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Laurence JS, 2001, BIOCHEMISTRY-US, V40, P4990, DOI 10.1021/bi002593w; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Macphee CH, 1998, J IMMUNOL, V161, P6273; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Miao ZH, 2007, J IMMUNOL, V178, P7395, DOI 10.4049/jimmunol.178.11.7395; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Murphy PM, 2000, PHARMACOL REV, V52, P145; Murphy PM, 2002, PHARMACOL REV, V54, P227, DOI 10.1124/pr.54.2.227; Noso N, 1998, EUR J BIOCHEM, V253, P114, DOI 10.1046/j.1432-1327.1998.2530114.x; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2004, BIOL CHEM, V385, P493, DOI 10.1515/BC.2004.058; Pardigol A, 1998, P NATL ACAD SCI USA, V95, P6308, DOI 10.1073/pnas.95.11.6308; Proost P, 2000, BLOOD, V96, P1674, DOI 10.1182/blood.V96.5.1674.h8001674a_1674_1680; Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8; Proost P, 1999, J BIOL CHEM, V274, P3988, DOI 10.1074/jbc.274.7.3988; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Richter R, 2005, J IMMUNOL, V175, P1599, DOI 10.4049/jimmunol.175.3.1599; Richter R, 2009, J IMMUNOL, V183, P1229, DOI 10.4049/jimmunol.0802145; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Stropes MP, 2009, J VIROL, V83, P10016, DOI 10.1128/JVI.00354-09; Struyf S, 1998, EUR J IMMUNOL, V28, P1262, DOI 10.1002/(SICI)1521-4141(199804)28:04<1262::AID-IMMU1262>3.0.CO;2-G; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Vakili J, 2001, J IMMUNOL, V167, P3406, DOI 10.4049/jimmunol.167.6.3406; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Weber M, 1996, J EXP MED, V183, P681, DOI 10.1084/jem.183.2.681; Wolf M, 2003, AM J PATHOL, V162, P1183, DOI 10.1016/S0002-9440(10)63914-4; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Wuyts A, 1999, J IMMUNOL, V163, P6155; Youn BS, 1997, J IMMUNOL, V159, P5201	66	50	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5848	5860		10.1074/jbc.M111.314609	http://dx.doi.org/10.1074/jbc.M111.314609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22147696	Green Published, hybrid			2022-12-25	WOS:000300638000059
J	Mayati, A; Levoin, N; Paris, H; N'Diaye, M; Courtois, A; Uriac, P; Lagadic-Gossmann, D; Fardel, O; Le Ferrec, E				Mayati, Abdullah; Levoin, Nicolas; Paris, Herve; N'Diaye, Monique; Courtois, Arnaud; Uriac, Philippe; Lagadic-Gossmann, Dominique; Fardel, Olivier; Le Ferrec, Eric			Induction of Intracellular Calcium Concentration by Environmental Benzo(a)pyrene Involves a beta 2-Adrenergic Receptor/Adenylyl Cyclase/Epac-1/Inositol 1,4,5-Trisphosphate Pathway in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BETA-ADRENERGIC-RECEPTOR; NITRIC-OXIDE SYNTHASE; CYCLIC-AMP; CONTAMINANT BENZO(A)PYRENE; DEPENDENT INDUCTION; HUMAN MACROPHAGES; PHOSPHOLIPASE-C; EPAC; ACTIVATION	Polycyclic aromatic hydrocarbons (PAHs) such as benzo-(a)pyrene (B(a)P) are widely distributed environmental contaminants, known as potent ligands of the aryl hydrocarbon receptor (AhR). These chemicals trigger an early and transient increase of intracellular calcium concentration ([Ca2+](i)), required for AhR-related effects of PAHs. The mechanisms involved in this calcium mobilization were investigated in the present study. We demonstrated that B(a)P-mediated [Ca2+](i) induction was prevented in endothelial HMEC-1 cells by counteracting beta 2-adrenoreceptor (beta 2ADR) activity using pharmacological antagonists, anti-beta 2ADR antibodies, or siRNA-mediated knockdown of beta 2ADR expression; by contrast, it was strongly potentiated by beta 2ADR overexpression in human kidney HEK293 cells. B(a)P was shown, moreover, to directly bind to beta 2ADR, as assessed by in vitro binding assays and molecular modeling. Pharmacological inhibition and/or siRNA-mediated silencing of various signaling actors acting downstream of beta 2ADR in a sequential manner, such as G protein, adenylyl cyclase, Epac-1 protein, and inositol 1,4,5-trisphosphate (IP3)/IP3 receptor, were next demonstrated to prevent B(a)P-induced calcium signal. Inhibition or knockdown of these signaling elements, as well as the use of chemical beta-blockers, were finally shown to counteract B(a)P-mediated induction of cytochrome P-450 1B1, a prototypical AhR target gene. Taken together, our results show that B(a)P binds directly to beta 2ADR and consequently utilizes beta 2ADR machinery to mobilize [Ca2+](i),through activation of a G protein/adenylyl cyclase/cAMP/Epac-1/IP3 pathway. This beta 2ADR-dependent signaling pathway activated by PAHs may likely be crucial for PAH-mediated up-regulation of AhR target genes, thus suggesting a contribution of beta 2ADR to the health-threatening effects of these environmental pollutants.	[Mayati, Abdullah; N'Diaye, Monique; Lagadic-Gossmann, Dominique; Fardel, Olivier; Le Ferrec, Eric] Univ Rennes 1, INSERM IRSET U1085, IFR140, F-35043 Rennes, France; [Levoin, Nicolas] Bioprojet Biotech, F-35762 St Gregoire, France; [Paris, Herve] INSERM, I2MR U858, F-31432 Toulouse 4, France; [Courtois, Arnaud] Univ Bordeaux 2, INSERM U1045, F-33076 Bordeaux, France; [Fardel, Olivier] Ctr Hosp Univ, Hop Pontchaillou, F-35033 Rennes, France; [Uriac, Philippe] CNRS 6226 Sci Chim Rennes, UMR, Equipe Prod Nat Synth & Chim Med 4, F-35033 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Rennes; Centre National de la Recherche Scientifique (CNRS)	Le Ferrec, E (corresponding author), Univ Rennes 1, Fac Pharm, EA SeRAIC IRSET 4427, IFR140, 2 Ave Pr L Bernard, F-35043 Rennes, France.	eric.leferrec@univ-rennes1.fr	LAGADIC-GOSSMANN, Dominique/I-5079-2015; Fardel, Olivier/J-8560-2015; Le FERREC, Eric/K-1374-2015; N'DIAYE, Monique MND/K-6209-2015	LAGADIC-GOSSMANN, Dominique/0000-0002-4888-236X; Le FERREC, Eric/0000-0002-2015-2779; N'DIAYE, Monique MND/0000-0001-8867-0778; levoin, nicolas/0000-0002-7731-736X; courtois, arnaud/0000-0002-0996-7133	French Ecology minister	French Ecology minister	This work was supported by the Programme National de Recherche sur les Perturbateurs Endocriniens from the French Ecology minister.	ATACK JR, 1993, J NEUROCHEM, V60, P652, DOI 10.1111/j.1471-4159.1993.tb03197.x; Aygun SF, 2005, INT J FOOD SCI NUTR, V56, P581, DOI 10.1080/09637480500465436; Aygun SF, 2005, J SEP SCI, V28, P2370, DOI 10.1002/jssc.200500132; Bader AN, 2005, CHEM RES TOXICOL, V18, P1405, DOI 10.1021/tx050056c; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bohm HJ, 1998, J COMPUT AID MOL DES, V12, P309, DOI 10.1023/A:1007999920146; BURCHIEL SW, 1992, TOXICOL APPL PHARM, V113, P126, DOI 10.1016/0041-008X(92)90016-L; CANGA L, 1993, MOL PHARMACOL, V44, P1142; CANGA L, 1988, P NATL ACAD SCI USA, V85, P905, DOI 10.1073/pnas.85.3.905; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COLLINS S, 1990, BIOCHEM SOC T, V18, P541, DOI 10.1042/bst0180541; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Factor P, 2011, AM J RESP CELL MOL, V45, P1045, DOI 10.1165/rcmb.2010-0499OC; Gao J, 2005, TOXICOL SCI, V87, P419, DOI 10.1093/toxsci/kfi265; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gong Z, 2006, TOXICOL LETT, V166, P229, DOI 10.1016/j.toxlet.2006.07.307; Han EH, 2009, TOXICOLOGY, V266, P38, DOI 10.1016/j.tox.2009.10.013; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Herm M, 2002, CHEM-EUR J, V8, P1485, DOI 10.1002/1521-3765(20020315)8:6<1485::AID-CHEM1485>3.0.CO;2-H; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Kang JJ, 1997, TOXICOL LETT, V93, P39, DOI 10.1016/S0378-4274(97)00072-6; Karpen JW, 2004, P W PHARMACOL SOC, P1; Kaszuba K, 2010, J PHYS CHEM B, V114, P8374, DOI 10.1021/jp909971f; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kobayashi D, 2009, TOXICOLOGY, V258, P25, DOI 10.1016/j.tox.2009.01.002; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Korashy HM, 2006, DRUG METAB REV, V38, P411, DOI 10.1080/03602530600632063; KRIEGER JA, 1994, TOXICOL APPL PHARM, V127, P268, DOI 10.1006/taap.1994.1161; LAUSTIOLA KE, 1988, CIRCULATION, V78, P1234, DOI 10.1161/01.CIR.78.5.1234; LAUSTIOLA KE, 1991, J CARDIOVASC PHARM, V17, P923, DOI 10.1097/00005344-199106000-00010; Le Ferrec E, 2002, J BIOL CHEM, V277, P24780, DOI 10.1074/jbc.M111319200; Lecureur V, 2005, FEBS LETT, V579, P1904, DOI 10.1016/j.febslet.2005.01.081; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Malcolm CS, 1996, J NEUROCHEM, V66, P2350; Mayati A, 2012, ENVIRON TOXICOL, V27, P556, DOI 10.1002/tox.20675; Monteiro P, 2008, MOL PHARMACOL, V73, P769, DOI 10.1124/mol.107.043125; N'Diaye M, 2006, J BIOL CHEM, V281, P19906, DOI 10.1074/jbc.M601192200; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Omori N, 2007, HUM EXP TOXICOL, V26, P811, DOI 10.1177/0960327107072394; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Rich TC, 2002, ANN BIOMED ENG, V30, P1088, DOI 10.1114/1.1511242; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rousseau G, 1997, EUR J PHARMACOL, V326, P75, DOI 10.1016/S0014-2999(97)00138-6; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Sinnokrot MO, 2004, J AM CHEM SOC, V126, P7690, DOI 10.1021/ja049434a; Sommer RJ, 2005, TOXICOL SCI, V83, P363, DOI 10.1093/toxsci/kfi041; Sparfel L, 2010, TOXICOL SCI, V114, P247, DOI 10.1093/toxsci/kfq007; van Grevenynghe J, 2006, BIOCHEM BIOPH RES CO, V341, P763, DOI 10.1016/j.bbrc.2006.01.028; Vogel CFA, 2004, J BIOL CHEM, V279, P8886, DOI 10.1074/jbc.M310190200; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xiao JJ, 2010, EXP BIOL MED, V235, P862, DOI 10.1258/ebm.2010.009362; Zhao MF, 1996, INT J IMMUNOPHARMACO, V18, P589, DOI 10.1016/S0192-0561(96)00063-X; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005; Zsila F, 2006, BBA-GEN SUBJECTS, V1760, P1248, DOI 10.1016/j.bbagen.2006.04.006	61	47	50	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4041	4052		10.1074/jbc.M111.319970	http://dx.doi.org/10.1074/jbc.M111.319970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167199	Green Published, hybrid			2022-12-25	WOS:000300410900038
J	O'Brien, XM; Heflin, KE; Lavigne, LM; Yu, KB; Kim, M; Salomon, AR; Reichner, JS				O'Brien, Xian M.; Heflin, Katie E.; Lavigne, Liz M.; Yu, Kebing; Kim, Minsoo; Salomon, Arthur R.; Reichner, Jonathan S.			Lectin Site Ligation of CR3 Induces Conformational Changes and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOMODULATOR PGG-GLUCAN; RISK SURGICAL PATIENTS; PROTEIN-KINASE-C; BETA-GLUCAN; INTEGRIN ALPHA(M)BETA(2); NEUTROPHIL CHEMOTAXIS; CANCER-IMMUNOTHERAPY; CELL-MIGRATION; HOST-DEFENSE; I-DOMAIN	Neutrophils provide an innate immune response to tissues infected with fungal pathogens such as Candida albicans. This response is tightly regulated in part through the interaction of integrins with extracellular matrix ligands that are distributed within infected tissues. The beta(2) integrin, CR3 (CD11b/CD18), is unique among integrins in containing a lectin-like domain that binds the fungal pathogen-associated molecular pattern beta S-glucan and serves as the dominant receptor for recognition of fungal pathogens by human granulocytes. beta-Glucan, when isolated in soluble form, has been shown to be a safe and effective immune potentiator when administered therapeutically. Currently a pharmaceutical grade preparation of beta-glucan is in several clinical trials with an anti-cancer indication. CR3 binding of extracellular matrix, carbohydrate, or both ligands simultaneously differentially regulates neutrophil function through a mechanism not clearly understood. Using FRET reporters, we interrogated the effects of soluble beta-glucan on intracellular and extracellular CR3 structure. Although the canonical CR3 ligand fibrinogen induced full activation, beta-glucan alone or in conjunction with fibrinogen stabilized an intermediate conformation with moderate headpiece extension and full cytoplasmic tail separation. A set of phosphopeptides differentially regulated by beta-glucan in a CR3-dependent manner were identified using functional proteomics and found to be enriched for signaling molecules and proteins involved in transcriptional regulation, mRNA processing, and alternative splicing. These data confirm that CR3 is a signaling pattern recognition receptor for beta-glucan and represent the first direct evidence of soluble beta-glucan binding and affecting a signaling-competent intermediate CR3 conformation on living cells.	[O'Brien, Xian M.; Heflin, Katie E.; Lavigne, Liz M.; Reichner, Jonathan S.] Brown Univ, Rhode Isl Hosp, Dept Surg, Div Surg Res, Providence, RI 02903 USA; [O'Brien, Xian M.; Heflin, Katie E.; Lavigne, Liz M.; Reichner, Jonathan S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA; [O'Brien, Xian M.; Heflin, Katie E.] Brown Univ, Grad Program Pathobiol, Providence, RI 02912 USA; [Yu, Kebing; Salomon, Arthur R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02914 USA; [Kim, Minsoo] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Rochester, NY 14642 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University; University of Rochester	O'Brien, XM (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Surg, Div Surg Res, 593 Eddy St, Providence, RI 02903 USA.	xianobrien@gmail.com	Yu, Kebing/D-4585-2014	Reichner, Jonathan/0000-0002-7349-6321	National Institutes of Health [GM-066194, AI-079582]; United States Department of Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066194, R56GM066194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Education(US Department of Education); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-066194 and AI-079582 (to J. S. R.). This work was also supported by Grant Assistance in Areas of National Need from the United States Department of Education (to X. M. O.) and allocations to the Department of Surgery by Rhode Island Hospital.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BABINEAU TJ, 1994, ANN SURG, V220, P601, DOI 10.1097/00000658-199411000-00002; BABINEAU TJ, 1994, ARCH SURG-CHICAGO, V129, P1204; Bernaciak TM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2341; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; CZOP JK, 1991, J EXP MED, V173, P1511, DOI 10.1084/jem.173.6.1511; Defilippi P, 1997, J BIOL CHEM, V272, P21726, DOI 10.1074/jbc.272.35.21726; Dellinger EP, 1999, ARCH SURG-CHICAGO, V134, P977, DOI 10.1001/archsurg.134.9.977; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Harler MB, 1999, J IMMUNOL, V162, P6792; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Khunkaewla P, 2008, MOL IMMUNOL, V45, P1703, DOI 10.1016/j.molimm.2007.09.032; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kougias P, 2001, INFECT IMMUN, V69, P3933, DOI 10.1128/IAI.69.6.3933-3938.2001; Lavigne LM, 2007, J IMMUNOL, V178, P7276, DOI 10.4049/jimmunol.178.11.7276; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; LeBlanc BW, 2006, J LEUKOCYTE BIOL, V79, P667, DOI 10.1189/jlb.0305150; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li B, 2006, J IMMUNOL, V177, P1661, DOI 10.4049/jimmunol.177.3.1661; Liu JJ, 2009, EXP MOL PATHOL, V86, P208, DOI 10.1016/j.yexmp.2009.01.006; Mori T, 1997, EUR J CLIN CHEM CLIN, V35, P553; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Osuchowski MF, 2007, J IMMUNOL, V179, P623, DOI 10.4049/jimmunol.179.1.623; PHAFF HJ, 1963, ANNU REV MICROBIOL, V17, P15, DOI 10.1146/annurev.mi.17.100163.000311; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Sanada T, 2008, J BIOL CHEM, V283, P33858, DOI 10.1074/jbc.M806923200; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Trucy M, 2006, CELL IMMUNOL, V244, P33, DOI 10.1016/j.cellimm.2007.02.002; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; Xia Y, 1999, J IMMUNOL, V162, P7285; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang L, 1999, BIOCHEMISTRY-US, V38, P8064, DOI 10.1021/bi990141h; Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014	48	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3337	3348		10.1074/jbc.M111.298307	http://dx.doi.org/10.1074/jbc.M111.298307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158618	Green Published, hybrid			2022-12-25	WOS:000300295100039
J	Saunier, EF; Vivar, OI; Rubenstein, A; Zhao, XY; Olshansky, M; Baggett, S; Staub, RE; Tagliaferri, M; Cohen, I; Speed, TP; Baxter, JD; Leitman, DC				Saunier, Elise F.; Vivar, Omar I.; Rubenstein, Andrea; Zhao, Xiaoyue; Olshansky, Moshe; Baggett, Scott; Staub, Richard E.; Tagliaferri, Mary; Cohen, Isaac; Speed, Terence P.; Baxter, John D.; Leitman, Dale C.			Estrogenic Plant Extracts Reverse Weight Gain and Fat Accumulation without Causing Mammary Gland or Uterine Proliferation	PLOS ONE			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; RECEPTOR-BETA; BODY-WEIGHT; REPLACEMENT THERAPY; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; PLUS PROGESTIN; BREAST-CANCER; OB/OB MICE; ALPHA	Long-term estrogen deficiency increases the risk of obesity, diabetes and metabolic syndrome in postmenopausal women. Menopausal hormone therapy containing estrogens might prevent these conditions, but its prolonged use increases the risk of breast cancer, as wells as endometrial cancer if used without progestins. Animal studies indicate that beneficial effects of estrogens in adipose tissue and adverse effects on mammary gland and uterus are mediated by estrogen receptor alpha (ER alpha). One strategy to improve the safety of estrogens to prevent/treat obesity, diabetes and metabolic syndrome is to develop estrogens that act as agonists in adipose tissue, but not in mammary gland and uterus. We considered plant extracts, which have been the source of many pharmaceuticals, as a source of tissue selective estrogens. Extracts from two plants, Glycyrrhiza uralensis (RG) and Pueraria montana var. lobata (RP) bound to ER alpha, activated ER alpha responsive reporters, and reversed weight gain and fat accumulation comparable to estradiol in ovariectomized obese mice maintained on a high fat diet. Unlike estradiol, RG and RP did not induce proliferative effects on mammary gland and uterus. Gene expression profiling demonstrated that RG and RP induced estradiol-like regulation of genes in abdominal fat, but not in mammary gland and uterus. The compounds in extracts from RG and RP might constitute a new class of tissue selective estrogens to reverse weight gain, fat accumulation and metabolic syndrome in postmenopausal women.	[Saunier, Elise F.; Rubenstein, Andrea; Zhao, Xiaoyue; Baggett, Scott; Staub, Richard E.; Tagliaferri, Mary; Cohen, Isaac] Bionovo Inc, Emeryville, CA 94608 USA; [Vivar, Omar I.; Leitman, Dale C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Olshansky, Moshe; Speed, Terence P.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Bioinformat, Parkville, Vic 3050, Australia; [Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Baxter, John D.] Methodist Hosp, Diabet Ctr & Canc Res Unit, Res Inst, Houston, TX 77030 USA	University of California System; University of California Berkeley; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of California System; University of California Berkeley; The Methodist Hospital System; The Methodist Hospital - Houston	Saunier, EF (corresponding author), Bionovo Inc, Emeryville, CA 94608 USA.	dale@leitmanlab.com		Olshansky, Moshe/0000-0003-2085-9851	National Institutes of Health/National Center for Complementary and Alternative Medicine [1R41AT005575]; Bionovo, Inc.; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R41AT005575] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); Bionovo, Inc.; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a grant (1R41AT005575) from the National Institutes of Health/National Center for Complementary and Alternative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; OIV and MO have nothing to declare. EFS, AR, SB, RES, MT and IC are employees of Bionovo, Inc. and are stock owners. JDB is a Director and owner of options of Bionovo. JDB and TPS are on the Scientific Advisory Board of Bionovo, Inc. JDB has stock ownership in Karo Bio, A.B., which has commercial interests in this area of research. DCL has received financial support for research from Bionovo, Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	An JP, 1999, P NATL ACAD SCI USA, V96, P15161, DOI 10.1073/pnas.96.26.15161; An JP, 2001, J BIOL CHEM, V276, P17808, DOI 10.1074/jbc.M100953200; BAILEY CJ, 1980, DIABETOLOGIA, V19, P475, DOI 10.1007/BF00281829; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Espeland MA, 1997, J CLIN ENDOCR METAB, V82, P1549, DOI 10.1210/jc.82.5.1549; Ettinger B, 2003, OBSTET GYNECOL, V102, P1225, DOI 10.1016/j.obstetgynecol.2003.08.007; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Gower BA, 2006, OBESITY, V14, P1046, DOI 10.1038/oby.2006.120; Grady D, 2009, MENOPAUSE, V16, P458, DOI 10.1097/gme.0b013e31818e64dd; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Jensen L, 2003, J BONE MINER RES, V18, P333, DOI 10.1359/jbmr.2003.18.2.333; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; KIAN TM, 2004, MOL BIOL CELL, V15, P1262; Leitman DC, 2010, CURR OPIN PHARMACOL, V10, P629, DOI 10.1016/j.coph.2010.09.009; Levy N, 2007, ENDOCRINOLOGY, V148, P3449, DOI 10.1210/en.2006-1632; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Lundholm L, 2008, J ENDOCRINOL, V199, P275, DOI [10.1677/JOE-08-0192, 10.1530/JOE-08-0192e]; Mahady GB, 2003, MENOPAUSE, V10, P65, DOI 10.1097/01.GME.0000029028.95924.F9; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Mattiasson I, 2002, HORM METAB RES, V34, P583, DOI 10.1055/s-2002-35420; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Minutolo F, 2011, MED RES REV, V31, P364, DOI 10.1002/med.20186; Misiti S, 1998, ENDOCRINOLOGY, V139, P2493, DOI 10.1210/en.139.5.2493; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Molenda HA, 2003, BIOL REPROD, V69, P1449, DOI 10.1095/biolreprod.103.019364; Mostafaie N, 2009, MOL CARCINOGEN, V48, P642, DOI 10.1002/mc.20510; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; PARUTHIYIL S, 2011, BREAST CANC RES TREA, V186, P4354; Paruthiyil S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006271; Roesch DM, 2006, PHYSIOL BEHAV, V87, P39, DOI 10.1016/j.physbeh.2005.08.035; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Saunier E, 2003, ENDOCRINOLOGY, V144, P2669, DOI 10.1210/en.2002-221038; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; YI ST, 2008, CLIN PRACTICE CHINES, V2; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	52	8	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28333	10.1371/journal.pone.0028333	http://dx.doi.org/10.1371/journal.pone.0028333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163294	Green Published, gold			2022-12-25	WOS:000298161900029
J	Bruce, CR; Smith, DA; Rodgers, D; Dantas, AD; MacCallum, DM; Morgan, BA; Quinn, J				Bruce, Catherine R.; Smith, Deborah A.; Rodgers, David; Dantas, Alessandra da Silva; MacCallum, Donna M.; Morgan, Brian A.; Quinn, Janet			Identification of a Novel Response Regulator, Crr1, That Is Required for Hydrogen Peroxide Resistance in Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; 2-COMPONENT HISTIDINE KINASE; OXIDATIVE STRESS-RESPONSE; CELL-WALL BIOSYNTHESIS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; HYPHAL DEVELOPMENT; GENE; PHOSPHORELAY	Candida albicans colonises numerous niches within humans and thus its success as a pathogen is dependent on its ability to adapt to diverse growth environments within the host. Two component signal transduction is a common mechanism by which bacteria respond to environmental stimuli and, although less common, two component-related pathways have also been characterised in fungi. Here we report the identification and characterisation of a novel two component response regulator protein in C. albicans which we have named CRR1 (Candida Response Regulator 1). Crr1 contains a receiver domain characteristic of response regulator proteins, including the conserved aspartate that receives phosphate from an upstream histidine kinase. Significantly, orthologues of CRR1 are present only in fungi belonging to the Candida CTG clade. Deletion of the C. albicans CRR1 gene, or mutation of the predicted phospho-aspartate, causes increased sensitivity of cells to the oxidising agent hydrogen peroxide. Crr1 is present in both the cytoplasm and nucleus, and this localisation is unaffected by oxidative stress or mutation of the predicted phospho-aspartate. Furthermore, unlike the Ssk1 response regulator, Crr1 is not required for the hydrogen peroxide-induced activation of the Hog1 stress-activated protein kinase pathway, or for the virulence of C. albicans in a mouse model of systemic disease. Taken together, our data suggest that Crr1, a novel response regulator restricted to the Candida CTG clade, regulates the response of C. albicans cells to hydrogen peroxide in a Hog1-independent manner that requires the function of the conserved phospho-aspartate.	[Bruce, Catherine R.; Smith, Deborah A.; Rodgers, David; Dantas, Alessandra da Silva; Morgan, Brian A.; Quinn, Janet] Newcastle Univ, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [MacCallum, Donna M.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland	Newcastle University - UK; University of Aberdeen	Bruce, CR (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	brian.morgan@ncl.ac.uk; janet.quinn@ncl.ac.uk	Quinn, Janet/AAR-9957-2021; MacCallum, Donna M./D-7897-2011; da Silva Dantas, Alessandra/B-9151-2015	MacCallum, Donna M./0000-0003-4833-0378; Quinn, Janet/0000-0002-8732-7676	Wellcome Trust [078779, 086048]; Nuffield Foundation [URB/BH081624]	Wellcome Trust(Wellcome TrustEuropean Commission); Nuffield Foundation	This work was supported by the Wellcome Trust (grant numbers 078779 and 086048, www.wellcome.ac.uk) and Nuffield Foundation (grant number URB/BH081624, www.nuffieldfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex LA, 1998, P NATL ACAD SCI USA, V95, P7069, DOI 10.1073/pnas.95.12.7069; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; Blackwell C, 2003, YEAST, V20, P1235, DOI 10.1002/yea.1036; Bonhomme J, 2011, MOL MICROBIOL, V80, P995, DOI 10.1111/j.1365-2958.2011.07626.x; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calera JA, 1999, YEAST, V15, P1243, DOI 10.1002/(SICI)1097-0061(19990915)15:12&lt;1243::AID-YEA449&gt;3.0.CO;2-5; Calera JA, 2000, YEAST, V16, P1053, DOI 10.1002/1097-0061(200008)16:11&lt;1053::AID-YEA598&gt;3.0.CO;2-H; Calera JA, 2000, INFECT IMMUN, V68, P518, DOI 10.1128/IAI.68.2.518-525.2000; Calera JA, 1998, YEAST, V14, P665, DOI 10.1002/(SICI)1097-0061(199805)14:7&lt;665::AID-YEA246&gt;3.0.CO;2-#; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Deveau A, 2010, EUKARYOT CELL, V9, P569, DOI 10.1128/EC.00321-09; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; FONZI WA, 1993, GENETICS, V134, P717; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Kruppa M, 2006, FEMS YEAST RES, V6, P149, DOI 10.1111/j.1567-1364.2006.00024.x; Kunze D, 2005, MICROBIOL-SGM, V151, P3381, DOI 10.1099/mic.0.28353-0; Li DM, 2004, MICROBIOL-SGM, V150, P3305, DOI 10.1099/mic.0.27237-0; Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; Menon V, 2006, MOL MICROBIOL, V62, P997, DOI 10.1111/j.1365-2958.2006.05438.x; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nagahashi S, 1998, MICROBIOL-UK, V144, P425, DOI 10.1099/00221287-144-2-425; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Nguyen AN, 2000, MOL BIOL CELL, V11, P1169, DOI 10.1091/mbc.11.4.1169; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Ohmiya R, 1999, J BIOCHEM, V125, P1061, DOI 10.1093/oxfordjournals.jbchem.a022387; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Quinn J, 2011, ANTIOXID REDOX SIGN, V15, P153, DOI 10.1089/ars.2010.3345; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Roman E, 2009, EUKARYOT CELL, V8, P1235, DOI 10.1128/EC.00081-09; SANTOS JL, 2001, SCI STKE, pRE1, DOI DOI 10.1126/J.STKE.2001.98.RE1; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Singh P, 2004, INFECT IMMUN, V72, P2390, DOI 10.1128/IAI.72.4.2390-2394.2004; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Srikantha T, 1998, MICROBIOL-SGM, V144, P2715, DOI 10.1099/00221287-144-10-2715; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989	52	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27979	10.1371/journal.pone.0027979	http://dx.doi.org/10.1371/journal.pone.0027979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164221	gold, Green Published			2022-12-25	WOS:000298171400022
J	Chai, RJ; Vukovic, J; Dunlop, S; Grounds, MD; Shavlakadze, T				Chai, Ruth Jinfen; Vukovic, Jana; Dunlop, Sarah; Grounds, Miranda D.; Shavlakadze, Thea			Striking Denervation of Neuromuscular Junctions without Lumbar Motoneuron Loss in Geriatric Mouse Muscle	PLOS ONE			English	Article							AGE-RELATED-CHANGES; SKELETAL-MUSCLE; MORPHOLOGICAL-CHANGES; NEURONAL POPULATIONS; TOTAL NUMBER; SPINAL-CORD; FIBER TYPES; SARCOPENIA; CELLS; REINNERVATION	Reasons for the progressive age-related loss of skeletal muscle mass and function, namely sarcopenia, are complex. Few studies describe sarcopenia in mice, although this species is the mammalian model of choice for genetic intervention and development of pharmaceutical interventions for muscle degeneration. One factor, important to sarcopenia-associated neuromuscular change, is myofibre denervation. Here we describe the morphology of the neuromuscular compartment in young (3 month) compared to geriatric (29 month) old female C57Bl/6J mice. There was no significant difference in the size or number of motoneuron cell bodies at the lumbar level (L1-L5) of the spinal cord at 3 and 29 months. However, in geriatric mice, there was a striking increase (by similar to 2.5 fold) in the percentage of fully denervated neuromuscular junctions (NMJs) and associated deterioration of Schwann cells in fast extensor digitorum longus (EDL), but not in slow soleus muscles. There were also distinct changes in myofibre composition of lower limb muscles (tibialis anterior (TA) and soleus) with a shift at 29 months to a faster phenotype in fast TA muscle and to a slower phenotype in slow soleus muscle. Overall, we demonstrate complex changes at the NMJ and muscle levels in geriatric mice that occur despite the maintenance of motoneuron cell bodies in the spinal cord. The challenge is to identify which components of the neuromuscular system are primarily responsible for the marked changes within the NMJ and muscle, in order to selectively target future interventions to reduce sarcopenia.	[Chai, Ruth Jinfen; Grounds, Miranda D.; Shavlakadze, Thea] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia; [Vukovic, Jana] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Dunlop, Sarah] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia	University of Western Australia; University of Queensland; University of Western Australia	Chai, RJ (corresponding author), Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia.	tea.shavlakadze@uwa.edu.au	Dunlop, Sarah A/G-9357-2013; Vukovic, Jana/B-4845-2013	Vukovic, Jana/0000-0002-3739-1688; Dunlop, Sarah/0000-0002-1306-3962; Grounds, Miranda/0000-0002-4530-9402; Chai, Ruth Jinfen/0000-0001-7597-6137	National Health and Medical Research Council of Australia [572654]; University of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Western Australia	This study was supported by funding from the National Health and Medical Research Council of Australia (grant ID 572654 to TS and MG), Research Collaboration Award from the University of Western Australia (MG, JV, TS) and the University of Western Australia Scholarships for International Research Fees and University International Stipend postgraduate scholarship to RJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; ANIANSSON A, 1986, MUSCLE NERVE, V9, P585, DOI 10.1002/mus.880090702; ARIZONO N, 1984, ACTA PATHOL JAPON, V34, P1243; Arthur PG, 2008, CURR OPIN CLIN NUTR, V11, P408, DOI 10.1097/MCO.0b013e328302f3fe; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; CACCIA MR, 1979, MUSCLE NERVE, V2, P202, DOI 10.1002/mus.880020308; Ciavarro GL, 2003, J NEUROSCI METH, V129, P61, DOI 10.1016/S0165-0270(03)00201-2; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COURTNEY J, 1981, J PHYSIOL-LONDON, V320, P435, DOI 10.1113/jphysiol.1981.sp013960; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dedkov EI, 2003, CELL TISSUE RES, V311, P401, DOI 10.1007/s00441-002-0686-9; Deschenes MR, 2010, EXP GERONTOL, V45, P389, DOI 10.1016/j.exger.2010.03.007; Edstrom E, 2007, PHYSIOL BEHAV, V92, P129, DOI 10.1016/j.physbeh.2007.05.040; FAHIM MA, 1982, J NEUROCYTOL, V11, P641, DOI 10.1007/BF01262429; FLOOD DG, 1988, NEUROBIOL AGING, V9, P453, DOI 10.1016/S0197-4580(88)80098-8; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; FUJISAWA K, 1976, EXP GERONTOL, V11, P43, DOI 10.1016/0531-5565(76)90010-3; Gadamski R, 2006, FOLIA NEUROPATHOL, V44, P154; GAMBINO DR, 1990, LARYNGOSCOPE, V100, P262; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; GRIMBY G, 1982, ACTA PHYSIOL SCAND, V115, P125, DOI 10.1111/j.1748-1716.1982.tb07054.x; GUTMANN E, 1966, NATURE, V209, P921, DOI 10.1038/209921b0; Jacob JM, 1998, MECH AGEING DEV, V106, P205, DOI 10.1016/S0047-6374(98)00117-1; Jang YC, 2011, EXP GERONTOL, V46, P193, DOI 10.1016/j.exger.2010.08.029; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kawabuchi M, 2001, ANAT RECORD, V264, P183, DOI 10.1002/ar.1159; Kawabuchi M, 1998, RESTOR NEUROL NEUROS, V13, P117; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P55, DOI 10.1111/j.1748-1716.1990.tb08975.x; KNOX CA, 1989, J NEUROPATH EXP NEUR, V48, P119, DOI 10.1097/00005072-198903000-00001; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; LUDATSCHER RM, 1985, EXP GERONTOL, V20, P81, DOI 10.1016/0531-5565(85)90043-9; Luff AR, 1998, ANN NY ACAD SCI, V854, P92, DOI 10.1111/j.1749-6632.1998.tb09895.x; Lynch GS, 2005, AGING INTERVENTIONS AND THERAPIES, P63, DOI 10.1142/9789812701329_0004; MacIntosh B.R., 2006, SKELETAL MUSCLE FORM; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; McLennan IS, 2002, INT J DEV BIOL, V46, P559; McMahon CD, 2011, SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND TREATMENTS, P393, DOI 10.1007/978-90-481-9713-2_17; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Naguib M, 2002, ANESTHESIOLOGY, V96, P202, DOI 10.1097/00000542-200201000-00035; O'Donnell KA, 1999, EXP NEUROL, V160, P300, DOI 10.1006/exnr.1999.7192; PARRY DJ, 1990, CAN J PHYSIOL PHARM, V68, P596, DOI 10.1139/y90-086; Rattan SIS, 2010, EXPT GERONTOLOGY, V31, P33; Rennie MJ, 2010, SCAND J MED SCI SPOR, V20, P5, DOI 10.1111/j.1600-0838.2009.00967.x; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; ROWE RWD, 1969, EXP GERONTOL, V4, P119, DOI 10.1016/0531-5565(69)90034-5; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Shavlakadze T, 2003, BIOL AGING MODULAT, V5, P139; Shavlakadze T, 2005, NEUROMUSCULAR DISORD, V15, P139, DOI 10.1016/j.nmd.2004.10.013; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Sheard PW, 2011, BIOGERONTOL IN PRESS; STANMORE A, 1978, J ANAT, V127, P101; Stephens B, 2006, J NEUROL SCI, V244, P41, DOI 10.1016/j.jns.2005.12.003; The Jackson Laboratory, 2011, WE DEF LIF HIST PHAS; Thornell LE, 2011, CURR OPIN CLIN NUTR, V14, P22, DOI 10.1097/MCO.0b013e3283412260; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Ulfhake B, 2000, MOL NEUROBIOL, V21, P109, DOI 10.1385/MN:21:3:109; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Wang ZM, 2005, J PHYSIOL-LONDON, V565, P757, DOI 10.1113/jphysiol.2005.087601; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WIGSTON DJ, 1992, J NEUROBIOL, V23, P61, DOI 10.1002/neu.480230107; WOKKE JHJ, 1990, J NEUROL SCI, V95, P291, DOI 10.1016/0022-510X(90)90076-Y	67	139	143	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28090	10.1371/journal.pone.0028090	http://dx.doi.org/10.1371/journal.pone.0028090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164231	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400032
J	Chung, E; Hsu, CL; Kondo, M				Chung, Eva; Hsu, Chia-Lin; Kondo, Motonari			Constitutive MAP Kinase Activation in Hematopoietic Stem Cells Induces a Myeloproliferative Disorder	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; BINDING PROTEIN-ALPHA; C-MYC; SIGNALING PATHWAYS; SOMATIC ACTIVATION; GENE-EXPRESSION; TRANSGENIC MICE; LINEAGE CHOICE; K-RAS; LEUKEMIA	Myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPNs) are a group of myeloid neoplasms in which abnormal activation of the Ras signaling pathway is commonly observed. The PI3K/Akt pathway is a known target of Ras; however, activation of the PI3K/Akt pathway has been shown to lead to neoplastic transformation of not only myeloid but also lymphoid cells, suggesting that pathways other than the PI3K/Akt pathway should play a central role in pathogenesis of Ras-mediated MDS/MPN. The MEK/ERK pathway is another downstream target of Ras, which is involved in regulation of cell survival and proliferation. However, the role of the MEK/ERK pathway in the pathogenesis of MDS/MPN remains unclear. Here, we show that introduction of a constitutively activated form of MEK into hematopoietic stem cells (HSCs) causes hematopoietic neoplasms that are limited to MDS/MPNs, despite the multipotent differentiation potential of HSCs. Active MEK-mediated MDS/MPNs are lethal, but are not considered a frank leukemia because it cannot be transplanted into naive animals. However, transplantation of MDS/MPNs co-expressing active MEK and an anti-apoptotic molecule, Bcl-2, results in T-cell acute lymphocytic leukemia (T-ALL), suggesting that longevity of cells may impact transplantability and alter disease phenotype. Our results clearly demonstrate the proto-oncogenic property of the MEK/ERK pathway in hematopoietic cells, which manifest in MDS/MPN development.	[Chung, Eva; Hsu, Chia-Lin; Kondo, Motonari] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA; [Kondo, Motonari] Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan	Duke University; Toho University	Chung, E (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA.	motonari.kondo@med.toho-u.ac.jp			Alex's Lemonade Stand Foundation; NIH [AI056123, CA098129]; Ministry of Education, Culture, Sports, Science and Technology-Japan; Grant of Strategic Research Foundation, Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE [R01CA098129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056123] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant of Strategic Research Foundation, Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Alex's Lemonade Stand Foundation; NIH grants AI056123 and CA098129; Grant of the strategic basis on research grounds for non-governmental schools at Heisei 20th from Ministry of Education, Culture, Sports, Science and Technology-Japan; and Grant of Strategic Research Foundation Grant-aided Project for Private schools at Heisei 23rd from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2011-2015. MK is a scholar of the Leukemia & Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; ANTONSON P, 1995, EUR J BIOCHEM, V232, P397, DOI 10.1111/j.1432-1033.1995.tb20824.x; Blalock WL, 2001, LEUKEMIA, V15, P794, DOI 10.1038/sj.leu.2402109; Blalock WL, 2000, ONCOGENE, V19, P526, DOI 10.1038/sj.onc.1203337; BOS JL, 1989, CANCER RES, V49, P4682; Braun BS, 2006, BLOOD, V108, P2041, DOI 10.1182/blood-2006-01-013490; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Hsu CL, 2007, BLOOD, V110, P1420, DOI 10.1182/blood-2007-02-071761; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Lai AY, 2007, P NATL ACAD SCI USA, V104, P6311, DOI 10.1073/pnas.0609608104; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Lyubynska N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001069; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Tefferi A, 2009, NAT REV CLIN ONCOL, V6, P627, DOI 10.1038/nrclinonc.2009.149; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Vardiman JW, 2010, CHEM-BIOL INTERACT, V184, P16, DOI 10.1016/j.cbi.2009.10.009; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang J, 2004, BLOOD, V104, P1679, DOI 10.1182/blood-2004-04-1362; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	54	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28350	10.1371/journal.pone.0028350	http://dx.doi.org/10.1371/journal.pone.0028350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164275	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400076
J	Hussack, G; Hirama, T; Ding, W; MacKenzie, R; Tanha, J				Hussack, Greg; Hirama, Tomoko; Ding, Wen; MacKenzie, Roger; Tanha, Jamshid			Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability	PLOS ONE			English	Article							MILK IMMUNOGLOBULIN CONCENTRATE; SITE-DIRECTED MUTAGENESIS; MONOCLONAL-ANTIBODIES; IN-VITRO; V-H; DISULFIDE BOND; III SECRETION; FRAGMENTS; PROTEINS; PHAGE	The extreme pH and protease-rich environment of the upper gastrointestinal tract is a major obstacle facing orally-administered protein therapeutics, including antibodies. Through protein engineering, several Clostridium difficile toxin A-specific heavy chain antibody variable domains (V(H)Hs) were expressed with an additional disulfide bond by introducing Ala/Gly54Cys and Ile78Cys mutations. Mutant antibodies were compared to their wild-type counterparts with respect to expression yield, non-aggregation status, affinity for toxin A, circular dichroism (CD) structural signatures, thermal stability, protease resistance, and toxin A-neutralizing capacity. The mutant V(H)Hs were found to be well expressed, although with lower yields compared to wild-type counterparts, were non-aggregating monomers, retained low nM affinity for toxin A, albeit the majority showed somewhat reduced affinity compared to wild-type counterparts, and were capable of in vitro toxin A neutralization in cell-based assays. Far-UV and near-UV CD spectroscopy consistently showed shifts in peak intensity and selective peak minima for wild-type and mutant VHH pairs; however, the overall CD profile remained very similar. A significant increase in the thermal unfolding midpoint temperature was observed for all mutants at both neutral and acidic pH. Digestion of the V(H)Hs with the major gastrointestinal proteases, at biologically relevant concentrations, revealed a significant increase in pepsin resistance for all mutants and an increase in chymotrypsin resistance for the majority of mutants. Mutant VHH trypsin resistance was similar to that of wild-type V(H)Hs, although the trypsin resistance of one VHH mutant was significantly reduced. Therefore, the introduction of a second disulfide bond in the hydrophobic core not only increases VHH thermal stability at neutral pH, as previously shown, but also represents a generic strategy to increase VHH stability at low pH and impart protease resistance, with only minor perturbations in target binding affinities. These are all desirable characteristics for the design of protein-based oral therapeutics.	[Hussack, Greg; Hirama, Tomoko; Ding, Wen; MacKenzie, Roger; Tanha, Jamshid] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Hussack, Greg; Tanha, Jamshid] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [MacKenzie, Roger; Tanha, Jamshid] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	National Research Council Canada; University of Ottawa; University of Guelph	Hussack, G (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	Jamshid.Tanha@nrc-cnrc.gc.ca			National Research Council Canada	National Research Council Canada	The work was supported by an internal fund from National Research Council Canada. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Arbabi-Ghahroudi M, 2010, METHODS MOL BIOL, V634, P309, DOI 10.1007/978-1-60761-652-8_22; Arbabi-Ghahroudi Mehdi, 2009, V525, P187, DOI 10.1007/978-1-59745-554-1_10; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Balan KK, 1996, AM J GASTROENTEROL, V91, P1400; Bebbington C, 2008, CURR OPIN BIOTECH, V19, P613, DOI 10.1016/j.copbio.2008.10.002; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chan PH, 2008, BIOCHEMISTRY-US, V47, P11041, DOI 10.1021/bi8005797; Christ D, 2007, PROTEIN ENG DES SEL, V20, P413, DOI 10.1093/protein/gzm037; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; DAVIDSON GP, 1989, LANCET, V2, P709, DOI 10.1016/S0140-6736(89)90771-X; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Famm K, 2006, PROTEIN ENG DES SEL, V19, P479, DOI 10.1093/protein/gzl032; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; FRENKEN LGJ, 1993, PROTEIN ENG, V6, P637, DOI 10.1093/protein/6.6.637; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Harmsen MM, 2005, VET MICROBIOL, V111, P89, DOI 10.1016/j.vetmic.2005.09.005; Hinkson PL, 2008, ANTIMICROB AGENTS CH, V52, P2190, DOI 10.1128/AAC.00041-08; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; Hudson DL, 2007, ANTIMICROB AGENTS CH, V51, P2631, DOI 10.1128/AAC.01492-06; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jermutus L, 2001, P NATL ACAD SCI USA, V98, P75, DOI 10.1073/pnas.011311398; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Kim DY, 2011, METHODS MOL IN PRESS; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; Kruger C, 2006, APPL MICROBIOL BIOT, V72, P732, DOI 10.1007/s00253-006-0347-0; Kurtz CB, 2001, ANTIMICROB AGENTS CH, V45, P2340, DOI 10.1128/AAC.45.8.2340-2347.2001; Li SH, 2009, MOL IMMUNOL, V46, P1718, DOI 10.1016/j.molimm.2009.02.007; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Lynch SV, 2008, CURR OPIN CRIT CARE, V14, P593, DOI 10.1097/MCC.0b013e32830f1dd5; Lyon GJ, 2002, BIOCHEMISTRY-US, V41, P10095, DOI 10.1021/bi026049u; Matsuura T, 2003, FEBS LETT, V539, P24, DOI 10.1016/S0014-5793(03)00178-9; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Panchal RG, 2004, NAT STRUCT MOL BIOL, V11, P67, DOI 10.1038/nsmb711; PETERSON JW, 1979, INFECT IMMUN, V24, P774, DOI 10.1128/IAI.24.3.774-779.1979; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; SCHMIDT P, 1989, J VET MED B, V36, P619, DOI 10.1111/j.1439-0450.1989.tb00653.x; Schneemann A, 2009, FUTURE MICROBIOL, V4, P35, DOI 10.2217/17460913.4.1.35; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Spinelli S, 2000, BIOCHEMISTRY-US, V39, P1217, DOI 10.1021/bi991830w; STROCKBINE NA, 1985, INFECT IMMUN, V50, P695, DOI 10.1128/IAI.50.3.695-700.1985; Svensson A, 2001, CHEMBIOCHEM, V2, P915, DOI 10.1002/1439-7633(20011203)2:12<915::AID-CBIC915>3.3.CO;2-D; TACKET CO, 1992, AM J TROP MED HYG, V47, P276, DOI 10.4269/ajtmh.1992.47.276; TACKET CO, 1988, NEW ENGL J MED, V318, P1240, DOI 10.1056/NEJM198805123181904; Thiagarajah JR, 2005, TRENDS PHARMACOL SCI, V26, P172, DOI 10.1016/j.tips.2005.02.003; TJELLSTROM B, 1993, LANCET, V341, P701, DOI 10.1016/0140-6736(93)90477-X; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025; Werle Martin, 2009, Recent Pat Drug Deliv Formul, V3, P94; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Wu SL, 2009, ANAL CHEM, V81, P112, DOI 10.1021/ac801560k; YOKOYAMA H, 1992, INFECT IMMUN, V60, P998, DOI 10.1128/IAI.60.3.998-1007.1992; Young NM, 1995, FEBS LETT, V377, P135, DOI 10.1016/0014-5793(95)01325-3	70	86	102	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28218	10.1371/journal.pone.0028218	http://dx.doi.org/10.1371/journal.pone.0028218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140551	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100052
J	Jalaguier, P; Turcotte, K; Danylo, A; Cantin, R; Tremblay, MJ				Jalaguier, Pascal; Turcotte, Karine; Danylo, Alexis; Cantin, Rejean; Tremblay, Michel J.			Efficient Production of HIV-1 Virus-Like Particles from a Mammalian Expression Vector Requires the N-Terminal Capsid Domain	PLOS ONE			English	Article							TYPE-1 GAG PRECURSOR; BACULOVIRUS-INFECTED CELLS; LATE ASSEMBLY DOMAIN; MEMBRANE-BINDING; PLASMA-MEMBRANE; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; VIRAL INFECTIVITY; RELEASE; REGION	It is now well accepted that the structural protein Pr55(Gag) is sufficient by itself to produce HIV-1 virus-like particles (VLPs). This polyprotein precursor contains different domains including matrix, capsid, SP1, nucleocapsid, SP2 and p6. In the present study, we wanted to determine by mutagenesis which region(s) is essential to the production of VLPs when Pr55(Gag) is inserted in a mammalian expression vector, which allows studying the protein of interest in the absence of other viral proteins. To do so, we first studied a minimal Pr55(Gag) sequence called Gag min that was used previously. We found that Gag min fails to produce VLPs when expressed in an expression vector instead of within a molecular clone. This failure occurs early in the cell at the assembly of viral proteins. We then generated a series of deletion and substitution mutants, and examined their ability to produce VLPs by combining biochemical and microscopic approaches. We demonstrate that the matrix region is not necessary, but that the efficiency of VLP production depends strongly on the presence of its basic region. Moreover, the presence of the N-terminal domain of capsid is required for VLP production when Gag is expressed alone. These findings, combined with previous observations indicating that HIV-1 Pr55(Gag)-derived VLPs act as potent stimulators of innate and acquired immunity, make the use of this strategy worth considering for vaccine development.	[Jalaguier, Pascal; Turcotte, Karine; Danylo, Alexis; Cantin, Rejean; Tremblay, Michel J.] Univ Quebec CHUL, Ctr Rech Infectiol, Ctr Hosp, Quebec City, PQ, Canada; [Tremblay, Michel J.] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; University of Quebec; Laval University	Jalaguier, P (corresponding author), Univ Quebec CHUL, Ctr Rech Infectiol, Ctr Hosp, Quebec City, PQ, Canada.	michel.j.tremblay@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR) [MOP-14438]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant to M.J.T. from the Canadian Institutes of Health Research (CIHR) (MOP-14438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2004, J GEN VIROL, V85, P2903, DOI 10.1099/vir.0.80137-0; Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Adamson CS, 2004, REV MED VIROL, V14, P107, DOI 10.1002/rmv.418; Ako-Adjei D, 2005, J VIROL, V79, P13463, DOI 10.1128/JVI.79.21.13463-13472.2005; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Borsetti A, 1998, J VIROL, V72, P9313, DOI 10.1128/JVI.72.11.9313-9317.1998; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; CHAZAL N, 1994, J VIROL, V68, P111, DOI 10.1128/JVI.68.1.111-122.1994; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Cimarelli A, 2002, CELL MOL LIFE SCI, V59, P1166, DOI 10.1007/s00018-002-8495-6; Crist RM, 2009, J VIROL, V83, P2216, DOI 10.1128/JVI.02031-08; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Deml L, 2005, MOL IMMUNOL, V42, P259, DOI 10.1016/j.molimm.2004.06.028; Doan LX, 2005, REV MED VIROL, V15, P75, DOI 10.1002/rmv.449; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Feng YX, 1996, P NATL ACAD SCI USA, V93, P7577, DOI 10.1073/pnas.93.15.7577; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Furumoto Hiroyuki, 2002, Journal of Medical Investigation, V49, P124; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Garland SM, 2010, DRUGS, V70, P1079, DOI 10.2165/10898580-000000000-00000; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; HANSEN M, 1990, J VIROL, V64, P5306, DOI 10.1128/JVI.64.11.5306-5316.1990; HONG SS, 1993, J VIROL, V67, P2787, DOI 10.1128/JVI.67.5.2787-2798.1993; JONES TA, 1990, J VIROL, V64, P2265, DOI 10.1128/JVI.64.5.2265-2279.1990; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Khorchid A, 2002, J VIROL, V76, P4131, DOI 10.1128/JVI.76.8.4131-4137.2002; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Kwak K, 2011, CURR OPIN IMMUNOL, V23, P244, DOI 10.1016/j.coi.2010.11.009; Liang C, 2003, J VIROL, V77, P1772, DOI 10.1128/JVI.77.3.1772-1783.2003; Liang C, 2002, J VIROL, V76, P11729, DOI 10.1128/JVI.76.22.11729-11737.2002; LODGE R, 1994, J VIROL, V68, P4857, DOI 10.1128/JVI.68.8.4857-4861.1994; Muriaux D, 1996, J BIOL CHEM, V271, P33686, DOI 10.1074/jbc.271.52.33686; Ono A, 2005, J VIROL, V79, P14131, DOI 10.1128/JVI.79.22.14131-14140.2005; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Ono A, 2010, VACCINE, V28, pB55, DOI 10.1016/j.vaccine.2009.10.021; Ono Akira, 2007, Virus (Nagoya), V57, P9; Ott DE, 2005, J VIROL, V79, P9038, DOI 10.1128/JVI.79.14.9038-9045.2005; Paliard X, 2000, AIDS RES HUM RETROV, V16, P273, DOI 10.1089/088922200309368; Petry H, 2003, CURR OPIN MOL THER, V5, P524; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; Sandefur S, 1998, J VIROL, V72, P2723, DOI 10.1128/JVI.72.4.2723-2732.1998; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Strack B, 2002, J VIROL, V76, P5472, DOI 10.1128/JVI.76.11.5472-5479.2002; TRONO D, 1989, CELL, V59, P113, DOI 10.1016/0092-8674(89)90874-X; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; WADA KN, 1990, NUCLEIC ACIDS RES, V18, P2367, DOI 10.1093/nar/18.suppl.2367; Wang CT, 1998, J VIROL, V72, P7950, DOI 10.1128/JVI.72.10.7950-7959.1998; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Young KR, 2006, METHODS, V40, P98, DOI 10.1016/j.ymeth.2006.05.024; YUAN X, 1993, J VIROL, V67, P6387, DOI 10.1128/JVI.67.11.6387-6394.1993; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	67	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28314	10.1371/journal.pone.0028314	http://dx.doi.org/10.1371/journal.pone.0028314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140574	gold, Green Published			2022-12-25	WOS:000298168100063
J	Zhu, JL; Jiang, ZM; Gao, F; Hu, XD; Zhou, L; Chen, JH; Luo, HJ; Sun, JH; Wu, S; Han, YH; Yin, GL; Chen, MS; Han, ZJ; Li, XX; Huang, Y; Zhang, WX; Zhou, FJ; Chen, T; Fa, PP; Wang, Y; Sun, L; Leng, HM; Sun, FH; Liu, YC; Ye, MZ; Yang, HM; Cai, ZM; Gui, YT; Zhang, XQ				Zhu, Jialou; Jiang, Zhimao; Gao, Fei; Hu, Xueda; Zhou, Liang; Chen, Jiahao; Luo, Huijuan; Sun, Jihua; Wu, Song; Han, Yonghua; Yin, Guangliang; Chen, Maoshan; Han, Zujing; Li, Xianxin; Huang, Yi; Zhang, Weixing; Zhou, Fangjian; Chen, Tong; Fa, Pingping; Wang, Yong; Sun, Liang; Leng, Huimin; Sun, Fenghao; Liu, Yuchen; Ye, Mingzhi; Yang, Huanming; Cai, Zhiming; Gui, Yaoting; Zhang, Xiuqing			A Systematic Analysis on DNA Methylation and the Expression of Both mRNA and microRNA in Bladder Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CERVICAL INTRAEPITHELIAL NEOPLASIA; PROMOTER HYPERMETHYLATION; SLIT2 GENE; GROWTH; GUIDANCE; TARGETS; LUNG; OVEREXPRESSION; INACTIVATION	Background: DNA methylation aberration and microRNA (miRNA) deregulation have been observed in many types of cancers. A systematic study of methylome and transcriptome in bladder urothelial carcinoma has never been reported. Methodology/Principal Findings: The DNA methylation was profiled by modified methylation-specific digital karyotyping (MMSDK) and the expression of mRNAs and miRNAs was analyzed by digital gene expression (DGE) sequencing in tumors and matched normal adjacent tissues obtained from 9 bladder urothelial carcinoma patients. We found that a set of significantly enriched pathways disrupted in bladder urothelial carcinoma primarily related to "neurogenesis" and "cell differentiation" by integrated analysis of -omics data. Furthermore, we identified an intriguing collection of cancer-related genes that were deregulated at the levels of DNA methylation and mRNA expression, and we validated several of these genes (HIC1, SLIT2, RASAL1, and KRT17) by Bisulfite Sequencing PCR and Reverse Transcription qPCR in a panel of 33 bladder cancer samples. Conclusions/Significance: We characterized the profiles between methylome and transcriptome in bladder urothelial carcinoma, identified a set of significantly enriched key pathways, and screened four aberrantly methylated and expressed genes. Conclusively, our findings shed light on a new avenue for basic bladder cancer research.	[Zhu, Jialou; Gao, Fei; Hu, Xueda; Chen, Jiahao; Luo, Huijuan; Sun, Jihua; Yin, Guangliang; Chen, Maoshan; Han, Zujing; Ye, Mingzhi; Yang, Huanming; Zhang, Xiuqing] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Zhu, Jialou] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Jiang, Zhimao; Zhou, Liang; Wu, Song; Han, Yonghua; Li, Xianxin; Huang, Yi; Fa, Pingping; Wang, Yong; Sun, Liang; Leng, Huimin; Sun, Fenghao; Liu, Yuchen; Cai, Zhiming; Gui, Yaoting] Peking Univ, Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China; [Hu, Xueda] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Hu, Xueda] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cai, Zhiming] Second Peoples Hosp Shenzhen, Dept Urol, Shenzhen, Peoples R China; [Zhang, Weixing] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou, Peoples R China; [Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Tong; Liu, Yuchen] Shenzhen Peoples Hosp, Dept Urol, Shenzhen, Peoples R China; [Sun, Fenghao] Shantou Univ, Coll Med, Shantou, Peoples R China	Beijing Genomics Institute (BGI); Wuhan University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Second People's Hospital of Shenzhen; Zhengzhou University; Sun Yat Sen University; Jinan University; Shantou University	Zhu, JL (corresponding author), Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China.	guiyaoting2007@yahoo.com.cn; zhangxq@genomics.org.cn	liu, yuchen/GYQ-6286-2022; gui, yaoting/GLT-3684-2022; Zhu, Jialou/Q-5218-2016	Zhu, Jialou/0000-0003-0630-4964; CHEN, MAOSHAN/0000-0002-3827-4969; Chen, Jiahao/0000-0001-7719-3216	National High Technology Research and Development Program of China (863 Program) [2009AA022707]; Promotion Program for Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A, CXB201005250016A]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Promotion Program for Shenzhen Key Laboratory, Shenzhen, China	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program, 2009AA022707 to XZ), the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A and CXB201005250016A to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Ayala de la Pena F, 2011, J BIOL CHEM; Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOS JL, 1989, CANCER RES, V49, P4682; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Carrilho C, 2004, HUM PATHOL, V35, P546, DOI 10.1016/j.humpath.2004.01.021; Catto JWF, 2005, J CLIN ONCOL, V23, P2903, DOI 10.1200/JCO.2005.03.163; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cullum R, 2011, RESPIROLOGY, V16, P210, DOI 10.1111/j.1440-1843.2010.01899.x; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Frateschi S, 2010, OPEN DERMATOLOGY J, P27, DOI DOI 10.2174/1874372201004010027; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Jarmalaite S, 2008, ONCOLOGY-BASEL, V75, P145, DOI 10.1159/000158665; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kekeeva TV, 2007, MOL BIOL+, V41, P70, DOI 10.1134/S0026893307010104; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lazaris AC, 2006, ANTICANCER RES, V26, P1535; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-223; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Maddox P, 1999, J CLIN PATHOL, V52, P41, DOI 10.1136/jcp.52.1.41; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Marsit CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012334; Melki JR, 1999, LEUKEMIA, V13, P877, DOI 10.1038/sj.leu.2401401; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Nasarre P, 2010, CELL ADHES MIGR, V4, P130, DOI 10.4161/cam.4.1.10882; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Natali PG, 1996, INT J CANCER, V69, P212, DOI 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9; Ohta M, 2009, GASTROENTEROLOGY, V136, P206, DOI 10.1053/j.gastro.2008.09.063; Oosterlinck W, 2002, EUR UROL, V41, P105, DOI 10.1016/S0302-2838(01)00026-4; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Regauer S, 2007, HISTOPATHOLOGY, V50, P629, DOI 10.1111/j.1365-2559.2007.02652.x; Reinert T, 2011, CLIN CANC RES; Seto M, 2011, INT J CANCER, V128, P1293, DOI 10.1002/ijc.25459; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sugimura T, 2000, MUTAT RES-REV MUTAT, V462, P235, DOI 10.1016/S1383-5742(00)00005-3; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Toyoshima T, 2008, J CANCER RES CLIN, V134, P515, DOI 10.1007/s00432-007-0308-8; Uchida Y, 2011, UROL ONCOL; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wallenius V, 2000, AM J PATHOL, V156, P821, DOI 10.1016/S0002-9440(10)64950-4; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu Y, 2009, BMB REP, V42, P344, DOI 10.5483/BMBRep.2009.42.6.344; Yamamura H, 2008, BIOCHEM BIOPH RES CO, V366, P489, DOI 10.1016/j.bbrc.2007.11.177; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yates DR, 2007, CLIN CANCER RES, V13, P2046, DOI 10.1158/1078-0432.CCR-06-2476; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	82	31	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28223	10.1371/journal.pone.0028223	http://dx.doi.org/10.1371/journal.pone.0028223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140553	Green Submitted, Green Published, gold			2022-12-25	WOS:000298168100053
J	Albertazzi, L; Brondi, M; Pavan, GM; Sato, SS; Signore, G; Storti, B; Ratto, GM; Beltram, F				Albertazzi, Lorenzo; Brondi, Marco; Pavan, Giovanni M.; Sato, Sebastian Sulis; Signore, Giovanni; Storti, Barbara; Ratto, Gian Michele; Beltram, Fabio			Dendrimer-Based Fluorescent Indicators: In Vitro and In Vivo Applications	PLOS ONE			English	Article							RESOLUTION; PROBES; OXYGEN; PH	Background: The development of fluorescent proteins and synthetic molecules whose fluorescence properties are controlled by the environment makes it possible to monitor physiological and pathological events in living systems with minimal perturbation. A large number of small organic dyes are available and routinely used to measure biologically relevant parameters. Unfortunately their application is hindered by a number of limitations stemming from the use of these small molecules in the biological environment. Principal Findings: We present a novel dendrimer-based architecture leading to multifunctional sensing elements that can overcome many of these problems. Applications in vitro, in living cells and in vivo are reported. In particular, we image for the first time extracellular pH in the brain in a mouse epilepsy model. Conclusion: We believe that the proposed architecture can represent a useful and novel tool in fluorescence imaging that can be widely applied in conjunction with a broad range of sensing dyes and experimental setups.	[Albertazzi, Lorenzo; Brondi, Marco; Sato, Sebastian Sulis; Storti, Barbara; Ratto, Gian Michele; Beltram, Fabio] Scuola Normale Super Pisa, Lab NEST, Pisa, Italy; [Albertazzi, Lorenzo; Brondi, Marco; Sato, Sebastian Sulis; Storti, Barbara; Ratto, Gian Michele; Beltram, Fabio] Ist Nanosci CNR, Pisa, Italy; [Albertazzi, Lorenzo; Brondi, Marco; Sato, Sebastian Sulis; Signore, Giovanni; Storti, Barbara; Beltram, Fabio] Ctr Nanotechnol Innovat, IIT NEST, Pisa, Italy; [Pavan, Giovanni M.] Univ Appl Sci So Switzerland SUPSI, Lab Appl Math & Phys LaMFI, Manno, Switzerland	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Istituto Italiano di Tecnologia - IIT	Albertazzi, L (corresponding author), Scuola Normale Super Pisa, Lab NEST, Pisa, Italy.	l.albertazzi@sns.it	Albertazzi, Lorenzo/E-8323-2013; Pavan, Giovanni/E-7474-2011; Ratto, Gian Michele/AAX-8514-2020; Beltram, Fabio/L-9486-2019; signore, giovanni/GOV-6118-2022; Bizzarri, Ranieri/ABH-8343-2020; Storti, Barbara/AAB-7791-2019; Signore, Giovanni/A-3526-2010; Ratto, Gian Michele/AAB-8719-2021; Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/H-1779-2011; Signore, Giovanni/J-8465-2019	Albertazzi, Lorenzo/0000-0002-6837-0812; Pavan, Giovanni/0000-0002-3473-8471; Beltram, Fabio/0000-0002-6081-436X; Storti, Barbara/0000-0002-2758-0426; Signore, Giovanni/0000-0002-0067-2240; Ratto, Gian Michele/0000-0001-9632-7769; Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672; Signore, Giovanni/0000-0002-0067-2240	Italian Ministry for University and Research (MiUR) [RBLA03ER38]	Italian Ministry for University and Research (MiUR)(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by the Italian Ministry for University and Research (MiUR) under the framework of FIRB project RBLA03ER38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertazzi L, 2010, J AM CHEM SOC, V132, P18158, DOI 10.1021/ja105689u; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Avoli Massimo, 2006, Epilepsy Curr, V6, P203, DOI 10.1111/j.1535-7511.2006.00146.x; Buccella D, 2011, J AM CHEM SOC, V133, P4101, DOI 10.1021/ja110907m; Case D.A., 2022, AMBER 2020; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; FENG ZC, 1990, AM J PHYSIOL, V258, pR205, DOI 10.1152/ajpregu.1990.258.1.R205; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Huppert TJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3210779; Karton-Lifshin N, 2011, J AM CHEM SOC, V133, P10960, DOI 10.1021/ja203145v; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lecoq J, 2011, NAT MED, V17, P893, DOI 10.1038/nm.2394; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; MEUWIS K, 1995, BIOPHYS J, V68, P2469, DOI 10.1016/S0006-3495(95)80428-5; Mizukami S, 2009, CHEMBIOCHEM, V10, P1465, DOI 10.1002/cbic.200900214; Painter RG, 2006, ANAL CHEM, V78, P3133, DOI 10.1021/ac0521706; Pavan GM, 2010, J PHYS CHEM B, V114, P5686, DOI 10.1021/jp911439q; Pavan GM, 2010, BIOMACROMOLECULES, V11, P721, DOI 10.1021/bm901298t; Pavan GM, 2010, J PHYS CHEM B, V114, P2667, DOI 10.1021/jp100271w; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Signore G, 2010, J AM CHEM SOC, V132, P1276, DOI 10.1021/ja9050444; SILVER RA, 1992, PFLUG ARCH EUR J PHY, V420, P595, DOI 10.1007/BF00374639; Szmacinski H, 1993, ANAL CHEM, V65, P168; Wangler C, 2008, CHEM-EUR J, V14, P8116, DOI 10.1002/chem.200800328; Wang XJ, 2010, ANALYST, V135, P1585, DOI 10.1039/b922751b; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	31	28	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28450	10.1371/journal.pone.0028450	http://dx.doi.org/10.1371/journal.pone.0028450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163303	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900040
J	Cunha, HA; Moraes, LC; Medeiros, BV; Lailson-Brito, J; da Silva, VMF; Sole-Cava, AM; Schrago, CG				Cunha, Haydee A.; Moraes, Lucas C.; Medeiros, Bruna V.; Lailson-Brito, Jose, Jr.; da Silva, Vera M. F.; Sole-Cava, Antonio M.; Schrago, Carlos G.			Phylogenetic Status and Timescale for the Diversification of Steno and Sotalia Dolphins	PLOS ONE			English	Article							CYTOCHROME-B; MOLECULAR PHYLOGENETICS; MULTILOCUS PHYLOGENY; BAYESIAN-INFERENCE; AMAZON RIVER; LIKELIHOOD; CETACEANS; EVOLUTION; RADIATION; WHALES	Molecular data have provided many insights into cetacean evolution but some unsettled issues still remain. We estimated the topology and timing of cetacean evolutionary relationships using Bayesian and maximum likelihood analyses of complete mitochondrial genomes. In order to clarify the phylogenetic placement of Sotalia and Steno within the Delphinidae, we sequenced three new delphinid mitogenomes. Our analyses support three delphinid clades: one joining Steno and Sotalia (supporting the revised subfamily Stenoninae); another placing Sousa within the Delphininae; and a third, the Globicephalinae, which includes Globicephala, Feresa, Pseudorca, Peponocephala and Grampus. We also conclude that Orcinus does not belong in the Globicephalinae, but Orcaella may be part of that subfamily. Divergence dates were estimated using the relaxed molecular clock calibrated with fossil data. We hypothesise that the timing of separation of the marine and Amazonian Sotalia species (2.3 Ma) coincided with the establishment of the modern Amazon River basin.	[Cunha, Haydee A.; Moraes, Lucas C.; Medeiros, Bruna V.; Sole-Cava, Antonio M.; Schrago, Carlos G.] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Rio De Janeiro, Brazil; [Cunha, Haydee A.; Lailson-Brito, Jose, Jr.] Univ Fed Rio de Janeiro, Lab Mamiferos Aquat & Bioindicadores, Fac Oceanografia, Rio De Janeiro, Brazil; [da Silva, Vera M. F.] Inst Nacl de Pesquisas da Amazonia, Lab Mamiferos Aquat, Manaus, Amazonas, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Institute Nacional de Pesquisas da Amazonia	Cunha, HA (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Rio De Janeiro, Brazil.	guerra@biologia.ufrj.br	Cunha, Haydée/I-5443-2013; Sole-Cava, Antonio M/G-4209-2011; Schrago, Carlos/E-4612-2012; Cunha, Haydee/O-1940-2017; Brito, Jose Lailson/B-3572-2013	Sole-Cava, Antonio M/0000-0003-0363-5821; Schrago, Carlos/0000-0001-6257-8906; Brito, Jose Lailson/0000-0001-8366-458X; Vieira de Medeiros, Bruna/0000-0002-8830-0053	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [103.136/2008, 110.838/2010, 110.028/2011, E26/100.209/2008]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308147/2009-0]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financially supported by grants 103.136/2008, 110.838/2010 and 110.028/2011 from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and 308147/2009-0 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to CS. HC is supported by a post-doctoral scholarship from FAPERJ (E26/100.209/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arnason U, 1996, MOL BIOL EVOL, V13, P407, DOI 10.1093/oxfordjournals.molbev.a025599; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; BARNES LG, 1985, MAR MAMMAL SCI, V1, P149, DOI 10.1111/j.1748-7692.1985.tb00003.x; BARNES LG, 1976, SYST ZOOL, V25, P321, DOI 10.2307/2412508; BERTA A, 2006, MARINE MAMMALS EVOLU; Bianucci Giovanni, 1996, Palaeontographia Italica, V83, P73; Caballero S, 2007, MAR MAMMAL SCI, V23, P358, DOI 10.1111/j.1748-7692.2007.00110.x; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Cozzuol Mario A., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P321; Cunha HA, 2010, WILDL PROT DESTR EXT, P261; Cunha HA, 2005, MAR BIOL, V148, P449, DOI 10.1007/s00227-005-0078-2; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Fordyce R.E., 2008, ENCY MARINE MAMMALS, P207; FORDYCE RE, 1994, ANNU REV EARTH PL SC, V22, P419, DOI 10.1146/annurev.ea.22.050194.002223; Fordyce RE, 2002, SM C PALEOB, P185; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Gatesy J, 1996, MOL BIOL EVOL, V13, P954, DOI 10.1093/oxfordjournals.molbev.a025663; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; GEISLER JH, 2003, J MAMM EVOL, V10, P106; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Geisler JH, 2009, NATURE, V458, pE1, DOI 10.1038/nature07776; GRAUR D, 1994, MOL BIOL EVOL, V11, P357; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harlin-Cognato AD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-87; Ho SYW, 2010, MITOCHONDR DNA, V21, P138, DOI 10.3109/19401736.2010.494727; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; May-Collado L, 2006, MOL PHYLOGENET EVOL, V38, P344, DOI 10.1016/j.ympev.2005.09.019; McGowen MR, 2011, MOL PHYLOGENET EVOL, V60, P345, DOI 10.1016/j.ympev.2011.05.003; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; Nikaido M, 2001, P NATL ACAD SCI USA, V98, P7384, DOI 10.1073/pnas.121139198; Perrin W.F., 1989, DOLPHINS PORPOISES W; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; Yan H, 2005, MOL PHYLOGENET EVOL, V37, P743, DOI 10.1016/j.ympev.2005.06.009; Yang XG, 2009, BIOLOGIA, V64, P811, DOI 10.2478/s11756-009-0121-8; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557	60	23	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28297	10.1371/journal.pone.0028297	http://dx.doi.org/10.1371/journal.pone.0028297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163290	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900025
J	Feig, JE; Shang, YT; Rotllan, N; Vengrenyuk, Y; Wu, CW; Shamir, R; Torra, IP; Fernandez-Hernando, C; Fisher, EA; Garabedian, MJ				Feig, Jonathan E.; Shang, Yueting; Rotllan, Noemi; Vengrenyuk, Yuliya; Wu, Chaowei; Shamir, Raanan; Torra, Ines Pineda; Fernandez-Hernando, Carlos; Fisher, Edward A.; Garabedian, Michael J.			Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in Macrophages	PLOS ONE			English	Article							MONOCYTE-DERIVED CELLS; CORONARY ATHEROSCLEROSIS; RAPID REGRESSION; APOLIPOPROTEIN-E; GENE-EXPRESSION; BONE-MARROW; MOUSE; PLAQUES; MICE; CHOLESTEROL	HMG-CoA reductase inhibitors (statins) decrease atherosclerosis by lowering low-density-lipoprotein cholesterol. Statins are also thought to have additional anti-atherogenic properties, yet defining these non-conventional modes of statin action remains incomplete. We have previously developed a novel mouse transplant model of atherosclerosis regression in which aortic segments from diseased donors are placed into normolipidemic recipients. With this model, we demonstrated the rapid loss of CD68+ cells (mainly macrophages) in plaques through the induction of a chemokine receptor CCR7-dependent emigration process. Because the human and mouse CCR7 promoter contain Sterol Response Elements (SREs), we hypothesized that Sterol Regulatory Element Binding Proteins (SREBPs) are involved in increasing CCR7 expression and through this mechanism, statins would promote CD68+ cell emigration from plaques. We examined whether statin activation of the SREBP pathway in vivo would induce CCR7 expression and promote macrophage emigration from plaques. We found that western diet-fed apoE(-/-) mice treated with either atorvastatin or rosuvastatin led to a substantial reduction in the CD68+ cell content in the plaques despite continued hyperlipidemia. We also observed a significant increase in CCR7 mRNA in CD68+ cells from both the atorvastatin and rosuvastatin treated mice associated with emigration of CD68+ cells from plaques. Importantly, CCR7(-/-)/apoE(-/-) double knockout mice failed to display a reduction in CD68+ cell content upon statin treatment. Statins also affected the recruitment of transcriptional regulatory proteins and the organization of the chromatin at the CCR7 promoter to increase the transcriptional activity. Statins promote the beneficial remodeling of plaques in diseased mouse arteries through the stimulation of the CCR7 emigration pathway in macrophages. Therefore, statins may exhibit some of their clinical benefits by not only retarding the progression of atherosclerosis, but also accelerating its regression.	[Feig, Jonathan E.; Shang, Yueting; Rotllan, Noemi; Vengrenyuk, Yuliya; Shamir, Raanan; Fernandez-Hernando, Carlos; Fisher, Edward A.] NYU, Sch Med, Dept Med, Div Cardiol,Marc & Ruti Bell Program Vasc Biol, New York, NY USA; [Wu, Chaowei; Torra, Ines Pineda; Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Feig, JE (corresponding author), NYU, Sch Med, Dept Med, Div Cardiol,Marc & Ruti Bell Program Vasc Biol, New York, NY USA.	edward.fisher@nyumc.org; michael.garabedian@nyumc.org	Rotllan, Noemi/P-1375-2014; Vila, Noemi Rotllan/AAQ-8050-2020; Fisher, Edward/ABE-7469-2020	Rotllan, Noemi/0000-0002-0587-8045; Vila, Noemi Rotllan/0000-0002-0587-8045; Pineda Torra, Ines/0000-0002-7349-2208; Fisher, Edward/0000-0001-9802-143X	National Institutes of Health [R01HL084312, P01HL098055, AG029748, T32HL098129]; Pfizer; Astra-Zeneca; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, T32HL098129, R01HL084312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG029748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Astra-Zeneca(AstraZeneca); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by the National Institutes of Health [R01HL084312 and P01HL098055, (EAF, MJG), pre-doctoral fellowship AG029748 (JEF), training grant T32HL098129 (YV)] and grants from Pfizer and Astra-Zeneca (EAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Chereshnev I, 2003, J SURG RES, V111, P171, DOI 10.1016/S0022-4804(03)00039-8; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Francavilla V, 2004, EUR J IMMUNOL, V34, P427, DOI 10.1002/eji.200324539; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, P1329, DOI 10.1161/01.ATV.0000139012.45265.e0; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Liao JK, 2005, CURR OPIN LIPIDOL, V16, P624, DOI 10.1097/01.mol.0000191913.16321.60; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Reis ED, 2001, J VASC SURG, V34, P541, DOI 10.1067/mva.2001.115963; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Tabibiazar R, 2005, ARTERIOSCL THROM VAS, V25, P302, DOI 10.1161/01.ATV.0000151372.86863.a5; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Trogan E, 2004, ARTERIOSCL THROM VAS, V24, P1714, DOI 10.1161/01.ATV.0000139313.69015.1c; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Trogan Eugene, 2005, Methods Mol Biol, V293, P221; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Williams KJ, 2008, NAT CLIN PRACT CARD, V5, P91, DOI 10.1038/ncpcardio1086; Williams KJ, 2007, CURR OPIN LIPIDOL, V18, P443, DOI 10.1097/MOL.0b013e32823bcb15; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	38	118	125	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28534	10.1371/journal.pone.0028534	http://dx.doi.org/10.1371/journal.pone.0028534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163030	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500030
J	Hovakimyan, M; Petersen, J; Maass, F; Reichard, M; Witt, M; Lukas, J; Stachs, O; Guthoff, R; Rolfs, A; Wree, A				Hovakimyan, Marine; Petersen, Jana; Maass, Fabian; Reichard, Maria; Witt, Martin; Lukas, Jan; Stachs, Oliver; Guthoff, Rudolf; Rolfs, Arndt; Wree, Andreas			Corneal Alterations during Combined Therapy with Cyclodextrin/Allopregnanolone and Miglustat in a Knock-Out Mouse Model of NPC1 Disease	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; C-DISEASE; PROTEIN; ACTIVATION; ADULT	Background: Niemann Pick disease type C1 is a neurodegenerative disease caused by mutations in the NPC1 gene, which result in accumulation of unesterified cholesterol and glycosphingolipids in the endosomal-lysosomal system as well as limiting membranes. We have previously shown the corneal involvement in NPC1 pathology in form of intracellular inclusions in epithelial cells and keratocytes. The purpose of the present study was to clarify if these inclusions regress during combined substrate reduction-and by-product therapy (SRT and BPT). Methodology/Principal Findings: Starting at postnatal day 7 (P7) and thereafter, NPC1 knock-out mice (NPC1(-/-)) and wild type controls (NPC1(+/+)) were injected with cyclodextrin/allopregnanolone weekly. Additionally, a daily miglustat injection started at P10 until P23. Starting at P23 the mice were fed powdered chow with daily addition of miglustat. The sham group was injected with 0.9% NaCl at P7, thereafter daily starting at P10 until P23, and fed powdered chow starting at P23. For corneal examination, in vivo confocal laser-scanning microscopy (CLSM) was performed one day before experiment was terminated. Excised corneas were harvested for lipid analysis (HPLC/MS) and electron microscopy. In vivo CLSM demonstrated a regression of hyperreflective inclusions in all treated NPC1(-/-) mice. The findings varied between individual mice, demonstrating a regression, ranging from complete absence to pronounced depositions. The reflectivity of inclusions, however, was significantly lower when compared to untreated and sham-injected NPC1(-/-) mice. These confocal findings were confirmed by lipid analysis and electron microscopy. Another important CLSM finding revealed a distinct increase of mature dendritic cell number in corneas of all treated mice (NPC1(-/-) and NPC1(+/+)), including sham-treated ones. Conclusions/Significance: The combined substrate reduction-and by-product therapy revealed beneficial effects on the cornea. In vivo CLSM is a non-invasive tool to monitor disease progression and treatment effects in NPC1 disorder.	[Hovakimyan, Marine; Reichard, Maria; Stachs, Oliver; Guthoff, Rudolf] Univ Rostock, Dept Ophthalmol, Rostock, Germany; [Hovakimyan, Marine; Petersen, Jana; Maass, Fabian; Witt, Martin; Wree, Andreas] Univ Rostock, Dept Anat, Rostock, Germany; [Lukas, Jan; Rolfs, Arndt] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Hovakimyan, M (corresponding author), Univ Rostock, Dept Ophthalmol, Rostock, Germany.	marine.hovakimyan@uni-rostock.de	Witt, Martin/AAU-7529-2020	Witt, Martin/0000-0002-4538-877X; Maass, Fabian/0000-0002-4077-2852	DFG (Deutsche Forschungsgemeinschaft) [Transregio 37]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was generously supported by the DFG (Deutsche Forschungsgemeinschaft) (Transregio 37, Micro- and Nanosystems in Medicine - Reconstruction of Biological Functions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LA, 2009, NEUROLOGY, V72, P1083, DOI 10.1212/01.wnl.0000345040.01917.9d; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Biswas J, 2008, CURR OPIN OPHTHALMOL, V19, P507, DOI 10.1097/ICU.0b013e32831215c3; BRADY RO, 1978, OPHTHALMOLOGY, V85, P1007; Chien YH, 2007, J INHERIT METAB DIS, V30, P826, DOI 10.1007/s10545-007-0630-y; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; ELLEDER M, 1985, ACTA NEUROPATHOL, V66, P325, DOI 10.1007/BF00690966; EMERY JM, 1972, AM J OPHTHALMOL, V74, P1144, DOI 10.1016/0002-9394(72)90736-2; Falke K, 2009, GRAEF ARCH CLIN EXP, V247, P523, DOI 10.1007/s00417-008-0962-9; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; HARZER K, 1978, ACTA NEUROCHIR, V43, P97; Herrmann WA, 2004, CORNEA, V23, P825, DOI 10.1097/01.ico.0000126331.84852.f6; HERS HG, 1965, GASTROENTEROLOGY, V48, P625; Hovakimyan M, 2011, CORNEA, V30, P796, DOI 10.1097/ICO.0b013e3182012a33; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; Lachmann RH, 2004, NEUROBIOL DIS, V16, P654, DOI 10.1016/j.nbd.2004.05.002; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Liscum L, 1998, CURR OPIN LIPIDOL, V9, P131, DOI 10.1097/00041433-199804000-00009; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maegawa GHB, 2009, MOL GENET METAB, V97, P284, DOI 10.1016/j.ymgme.2009.04.013; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; MORRIS MD, 1982, AM J PATHOL, V108, P140; Nunes A, 2011, NEUROBIOL DIS, V42, P349, DOI 10.1016/j.nbd.2011.01.028; PALMER M, 1985, ARCH OPHTHALMOL-CHIC, V103, P817, DOI 10.1001/archopht.1985.01050060077030; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Pineda M, 2009, MOL GENET METAB, V98, P243, DOI 10.1016/j.ymgme.2009.07.003; Poupetova H, 2010, J INHERIT METAB DIS, V33, P387, DOI 10.1007/s10545-010-9093-7; Sawamura N, 2001, J BIOL CHEM, V276, P10314, DOI 10.1074/jbc.M009733200; Strauss JF, 2002, STEROIDS, V67, P947, DOI 10.1016/S0039-128X(02)00042-9; SUZUKI K, 1995, ACTA NEUROPATHOL, V89, P227; Tavakoli M, 2011, CONTACT LENS ANTERIO, V34, P7, DOI 10.1016/j.clae.2010.08.007; Tavares R, 2009, CORNEA, V28, P938, DOI 10.1097/ICO.0b013e318199eb5b; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1988, CLIN GENET, V33, P331; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vanier MT, 1998, BRAIN PATHOL, V8, P163; Wraith JE, 2010, MOL GENET METAB, V99, P351, DOI 10.1016/j.ymgme.2009.12.006; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0; Zhang M, 2008, J NEUROCHEM, V107, P814, DOI 10.1111/j.1471-4159.2008.05657.x	42	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28418	10.1371/journal.pone.0028418	http://dx.doi.org/10.1371/journal.pone.0028418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163015	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500019
J	Vizlin-Hodzic, D; Runnberg, R; Ryme, J; Simonsson, S; Simonsson, T				Vizlin-Hodzic, Dzeneta; Runnberg, Rikard; Ryme, Jessica; Simonsson, Stina; Simonsson, Tomas			SAF-A Forms a Complex with BRG1 and Both Components Are Required for RNA Polymerase II Mediated Transcription	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR RIBONUCLEOPROTEIN U; PROTEIN HNRNP-U; ATTACHMENT FACTOR; BINDING-PROTEIN; SELF-RENEWAL; IN-VIVO; EXPRESSION; CHROMATIN; BROMODOMAIN	Background: Scaffold attachment factor A (SAF-A) participates in the regulation of gene expression by organizing chromatin into transcriptionally active domains and by interacting directly with RNA polymerase II. Methodology: Here we use co-localization, co-immunoprecipitation (co-IP) and in situ proximity ligation assay (PLA) to identify Brahma Related Gene 1 (BRG1), the ATP-driven motor of the human SWI-SNF chromatin remodeling complex, as another SAF-A interaction partner in mouse embryonic stem (mES) cells. We also employ RNA interference to investigate functional aspects of the SAF-A/BRG1 interaction. Principal Findings: We find that endogenous SAF-A protein interacts with endogenous BRG1 protein in mES cells, and that the interaction does not solely depend on the presence of mRNA. Moreover the interaction remains intact when cells are induced to differentiate. Functional analyses reveal that dual depletion of SAF-A and BRG1 abolishes global transcription by RNA polymerase II, while the nucleolar RNA polymerase I transcription machinery remains unaffected. Conclusions: We demonstrate that SAF-A interacts with BRG1 and that both components are required for RNA Polymerase II Mediated Transcription.	[Vizlin-Hodzic, Dzeneta; Runnberg, Rikard; Ryme, Jessica; Simonsson, Tomas] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Simonsson, Stina] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Inst Biomed, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Vizlin-Hodzic, D (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	Stina.simonsson@medkem.gu.se; tomas.simonsson@gu.se	Simonsson, Stina/R-2699-2016	Simonsson, Stina/0000-0001-9020-3714	Swedish Research Council; Swedish Cancer Society; Clas Groschinsky Memory Foundation; Ake Wiberg Foundation; Magnus Bergvall Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Clas Groschinsky Memory Foundation; Ake Wiberg Foundation; Magnus Bergvall Research Foundation	This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Clas Groschinsky Memory Foundation, the Ake Wiberg Foundation, and the Magnus Bergvall Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2005, BIOCHEMISTRY-US, V44, P6276, DOI 10.1021/bi050018s; Asp P, 2002, J CELL SCI, V115, P2735; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Eggert M, 1997, J BIOL CHEM, V272, P28471, DOI 10.1074/jbc.272.45.28471; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kawano S, 2010, J BIOL CHEM, V285, P26451, DOI 10.1074/jbc.M110.112979; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Levros LC, 2010, BBA-MOL CELL RES, V1803, P1062, DOI 10.1016/j.bbamcr.2010.04.011; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Luo L, 2009, J CELL SCI, V122, P3729, DOI 10.1242/jcs.052555; Malik KF, 1997, MOL BRAIN RES, V45, P99, DOI 10.1016/S0169-328X(96)00238-0; Martens JHA, 2002, MOL CELL BIOL, V22, P2598, DOI 10.1128/MCB.22.8.2598-2606.2002; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Roshon MJ, 2005, TRANSGENIC RES, V14, P179, DOI 10.1007/s11248-004-8147-8; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spraggon L, 2007, ONCOGENE, V26, P1484, DOI 10.1038/sj.onc.1209922; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28049	10.1371/journal.pone.0028049	http://dx.doi.org/10.1371/journal.pone.0028049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162999	gold, Green Published, Green Submitted			2022-12-25	WOS:000298173500010
J	Thayil, SM; Albini, TA; Nazari, H; Moshfeghi, AA; Parel, JMA; Rao, NA; Karakousis, PC				Thayil, Seema M.; Albini, Thomas A.; Nazari, Hossein; Moshfeghi, Andrew A.; Parel, Jean-Marie A.; Rao, Narsing A.; Karakousis, Petros C.			Local Ischemia and Increased Expression of Vascular Endothelial Growth Factor Following Ocular Dissemination of Mycobacterium tuberculosis	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROINFLAMMATORY CYTOKINES; INTRAOCULAR TUBERCULOSIS; PULMONARY TUBERCULOSIS; PLEURAL EFFUSIONS; DISEASE-ACTIVITY; AQUEOUS-HUMOR; GUINEA-PIGS; SERUM; ANGIOGENESIS	The pathogenesis of intraocular tuberculosis remains poorly understood partly due to the lack of adequate animal models that accurately simulate human disease. Using a recently developed model of ocular tuberculosis following aerosol infection of guinea pigs with Mycobacterium tuberculosis, we studied the microbiological, histological, and clinical features of intraocular tuberculosis infection. Viable tubercle bacilli were cultivated from all eyes by Day 56 after aerosol delivery of similar to 200 bacilli to guinea pig lungs. Choroidal tuberculous granulomas showed reduced oxygen tension, as evidenced by staining with the hypoxia-specific probe pimonidazole, and expression of vascular endothelial growth factor (VEGF) was detected in the retinal pigment epithelium (RPE) and photoreceptors. Fundoscopic examination of M. tuberculosis-infected guinea pig eyes revealed altered vascular architecture and chorioretinal hemorrhage by Day 56 after infection. This model may be useful in further elucidating the pathogenesis of ocular tuberculosis, as well as in developing tools for diagnosis and assessment of antituberculosis treatment responses in the eye.	[Thayil, Seema M.; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Albini, Thomas A.; Moshfeghi, Andrew A.; Parel, Jean-Marie A.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA; [Nazari, Hossein; Rao, Narsing A.] Univ So Calif, Doheny Eye Inst, Los Angeles, CA USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Bascom Palmer Eye Institute; University of Miami; Doheny Eye Institute; University of Southern California; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Thayil, SM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	petros@jhmi.edu	Karakousis, Petros Constantine/AAR-7899-2020	Albini, Thomas/0000-0003-2199-9047; Thayil, SEEMA/0000-0002-3111-6861	Bill & Melinda Gates foundation [42851]; National Institutes of Health (NIH) [K08AI064229, R01AI083125, R01HL106786, P30EY14801]; Florida Lions Eye Bank; Henri and Flore Lesieur Foundation; Morris Morgenstern Foundation; Palm Beach Community Trust Fund; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI064229, R01AI083125] Funding Source: NIH RePORTER	Bill & Melinda Gates foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Lions Eye Bank; Henri and Flore Lesieur Foundation; Morris Morgenstern Foundation; Palm Beach Community Trust Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by TB Accelerator grant #42851 from the Bill & Melinda Gates foundation and National Institutes of Health (NIH) grants K08AI064229, R01AI083125, and R01HL106786 to P.C.K. Development of the fundus camera was supported by NIH P30EY14801 (Center Grant), the Florida Lions Eye Bank, the Henri and Flore Lesieur Foundation (J.M.P.), the Morris Morgenstern Foundation (T.A.A.), an unrestricted grant from the Palm Beach Community Trust Fund (T.A.A.), and an unrestricted grant from Research to Prevent Blindness (T.A.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P1527, DOI 10.1128/AAC.01524-10; Ahmad Z, 2009, J INFECT DIS, V200, P1136, DOI 10.1086/605605; Alagappan VKT, 2005, CELL BIOCHEM BIOPHYS, V43, P119, DOI 10.1385/CBB:43:1:119; Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Araujo AP, 2010, EXP MOL PATHOL, V89, P327, DOI 10.1016/j.yexmp.2010.09.003; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; *CDC, 2007, REP TUB US 2006; Cekmen M, 2003, INT J DERMATOL, V42, P870, DOI 10.1046/j.1365-4362.2003.01688.x; Charalambous C, 2005, CANCER RES, V65, P10347, DOI 10.1158/0008-5472.CAN-05-0949; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chu SC, 2004, J ENDODONT, V30, P704, DOI 10.1097/01.DON.0000129962.65752.C6; Cutrufello NJ, 2010, OCUL IMMUNOL INFLAMM, V18, P281, DOI 10.3109/09273948.2010.489729; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Euro TB, 2008, SURV TUB EUR; Ferrara N, 2010, RETINAL PHARMACOTHER, P230; Fine HF, 2001, AM J OPHTHALMOL, V132, P794, DOI 10.1016/S0002-9394(01)01103-5; Gupta V, 2007, SURV OPHTHALMOL, V52, P561, DOI 10.1016/j.survophthal.2007.08.015; Hernandez VM, VET OPHTHAL IN PRESS; Husain N, 2008, J INFECTION, V56, P114, DOI 10.1016/j.jinf.2007.11.004; Klinkenberg LG, 2008, J INFECT DIS, V198, P275, DOI 10.1086/589515; Lim SC, 2000, J KOREAN MED SCI, V15, P279, DOI 10.3346/jkms.2000.15.3.279; Liu JN, 2010, CARDIOLOGY, V116, P37, DOI 10.1159/000313465; Machein MR, 1999, NEUROPATH APPL NEURO, V25, P104; Maruotti N, 2006, HISTOL HISTOPATHOL, V21, P557, DOI 10.14670/HH-21.557; Matsuyama W, 2002, IMMUNOLOGY, V106, P96, DOI 10.1046/j.1365-2567.2002.01395.x; Matsuyama W, 2001, J NEUROL SCI, V186, P75, DOI 10.1016/S0022-510X(01)00515-9; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; Mitsuyama H, 2006, CHEST, V129, P407, DOI 10.1378/chest.129.2.407; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Paroli MP, 2007, EUR J OPHTHALMOL, V17, P938, DOI 10.1177/112067210701700611; Rajappa M, 2010, ADV CLIN CHEM, V50, P103, DOI 10.1016/S0065-2423(10)50006-4; Raleigh JA, 1998, CANCER RES, V58, P3765; Rao NA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1162, DOI 10.1001/archophthalmol.2009.220; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; ROL P, 1995, OPT ENG, V34, P2070, DOI 10.1117/12.204800; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Seiscento M, 2010, INT J TUBERC LUNG D, V14, P1153; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tolnay E, 1998, VIRCHOWS ARCH, V432, P61, DOI 10.1007/s004280050135; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; van der Flier M, 2004, PEDIATR INFECT DIS J, V23, P608, DOI 10.1097/01.inf.0000131634.57368.45; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vinores SA, 1997, HISTOL HISTOPATHOL, V12, P99; Wiertz K, 2010, RETINA-J RET VIT DIS, V30, P1734, DOI 10.1097/IAE.0b013e3181dde70b; World Health Organization, 2008, GLOB TUB CONTR SURV; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Zhou WB, 2009, INT J TUBERC LUNG D, V13, P381	51	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28383	10.1371/journal.pone.0028383	http://dx.doi.org/10.1371/journal.pone.0028383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162767	gold, Green Submitted, Green Published			2022-12-25	WOS:000298172800032
J	Bhushan, S; Hossain, H; Lu, YN; Geisler, A; Tchatalbachev, S; Mikulski, Z; Schuler, G; Klug, J; Pilatz, A; Wagenlehner, F; Chakraborty, T; Meinhardt, A				Bhushan, Sudhanshu; Hossain, Hamid; Lu, Yongning; Geisler, Andreas; Tchatalbachev, Svetlin; Mikulski, Zbigniew; Schuler, Gerhard; Klug, Joerg; Pilatz, Adrian; Wagenlehner, Florian; Chakraborty, Trinad; Meinhardt, Andreas			Uropathogenic E. coli Induce Different Immune Response in Testicular and Peritoneal Macrophages: Implications for Testicular Immune Privilege	PLOS ONE			English	Article							LEYDIG-CELL STEROIDOGENESIS; ESCHERICHIA-COLI; MALE-INFERTILITY; SEMEN QUALITY; KAPPA-B; ACTIVATION; EXPRESSION; APOPTOSIS; NFAT; 25-HYDROXYCHOLESTEROL	Infertility affects one in seven couples and ascending bacterial infections of the male genitourinary tract by Escherichia coli are an important cause of male factor infertility. Thus understanding mechanisms by which immunocompetent cells such as testicular macrophages (TM) respond to infection and how bacterial pathogens manipulate defense pathways is of importance. Whole genome expression profiling of TM and peritoneal macrophages (PM) infected with uropathogenic E. coli (UPEC) revealed major differences in regulated genes. However, a multitude of genes implicated in calcium signaling pathways was a common feature which indicated a role of calcium-dependent nuclear factor of activated T cells (NFAT) signaling. UPEC-dependent NFAT activation was confirmed in both cultured TM and in TM in an in vivo UPEC infectious rat orchitis model. Elevated expression of NFATC2-regulated anti-inflammatory cytokines was found in TM (IL-4, IL-13) and PM (IL-3, IL-4, IL-13). NFATC2 is activated by rapid influx of calcium, an activity delineated to the pore forming toxin alpha-hemolysin by bacterial mutant analysis. Alpha-hemolysin suppressed IL-6 and TNF-alpha cytokine release from PM and caused differential activation of MAP kinase and AP-1 signaling pathways in TM and PM leading to reciprocal expression of key proinflammatory cytokines in PM (IL-1 alpha, IL-1 beta, IL-6 downregulated) and TM (IL-1 beta, IL-6 upregulated). In addition, unlike PM, LPS-treated TM were refractory to NF kappa B activation shown by the absence of degradation of I kappa B alpha and lack of pro-inflammatory cytokine secretion (IL-6, TNF-alpha). Taken together, these results suggest a mechanism to the conundrum by which TM initiate immune responses to bacteria, while maintaining testicular immune privilege with its ability to tolerate neo-autoantigens expressed on developing spermatogenic cells.	[Bhushan, Sudhanshu; Lu, Yongning; Mikulski, Zbigniew; Klug, Joerg; Meinhardt, Andreas] Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Giessen, Germany; [Hossain, Hamid; Geisler, Andreas; Tchatalbachev, Svetlin; Chakraborty, Trinad] Univ Giessen, Dept Med Microbiol, Giessen, Germany; [Schuler, Gerhard] Univ Giessen, Clin Obstet Gynecol & Androl Large & Small Anim, Giessen, Germany; [Pilatz, Adrian; Wagenlehner, Florian] Univ Giessen, Clin Urol Pediat Urol & Androl, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Bhushan, S (corresponding author), Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Giessen, Germany.	trinad.chakraborty@mikrobio.med.uni-giessen.de; andreas.meinhardt@anatomie.med.uni-giessen.de	卢, 永宁/A-4650-2013; Mikulski, Zbigniew/AAB-4447-2020	Mikulski, Zbigniew/0000-0002-1918-9216; Schuler, Gerhard/0000-0002-9412-3743	Deutsche Forschungsgemeinschaft [KFO 181, ME 1323/6-1, 6-2]; Excellence Cluster "Cardiopulmonary System"; National Genome Research Network (NGFN), Germany [NGFN IE-S08T03];  [IntGK 1062]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster "Cardiopulmonary System"(German Research Foundation (DFG)); National Genome Research Network (NGFN), Germany; 	This study was supported by a grant of the Deutsche Forschungsgemeinschaft (Clinical Research Unit KFO 181, ME 1323/6-1 and 6-2), Excellence Cluster "Cardiopulmonary System" and IntGK 1062 and the National Genome Research Network (NGFN), Germany (NGFN IE-S08T03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhushan S, 2008, J IMMUNOL, V180, P5537, DOI 10.4049/jimmunol.180.8.5537; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; EggertKruse W, 1995, HUM REPROD UPDATE, V1, P462, DOI 10.1093/humupd/1.5.462; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; HALES DB, 1992, ENDOCRINOLOGY, V131, P2165, DOI 10.1210/en.131.5.2165; Hayes R, 1996, J ANDROL, V17, P41; Hecker A, 2009, J LEUKOCYTE BIOL, V86, P13, DOI [10.1189/JLB.1107722, 10.1189/jlb.1107722]; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; Hoffmann B, 1999, ANIM REPROD SCI, V57, P89, DOI 10.1016/S0378-4320(99)00050-0; HUTSON JC, 1994, INT REV CYTOL, V149, P99, DOI 10.1016/S0074-7696(08)62087-2; Hutson JC, 2006, EXP BIOL MED, V231, P1; KERN S, 1995, BIOL REPROD, V53, P1407, DOI 10.1095/biolreprod53.6.1407; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Ludwig M, 2002, BJU INT, V90, P933, DOI 10.1046/j.1464-410X.2002.03029.x; Lukyanenko Y, 2002, BIOL REPROD, V67, P1435, DOI 10.1095/biolreprod.102.007575; Lukyanenko YO, 2001, BIOL REPROD, V64, P790, DOI 10.1095/biolreprod64.3.790; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Maresz K, 2008, J REPROD IMMUNOL, V78, P140, DOI 10.1016/j.jri.2008.01.001; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; MERINO G, 1995, ARCH ANDROLOGY, V35, P209, DOI 10.3109/01485019508987872; Moon DO, 2008, CANCER LETT, V264, P316, DOI 10.1016/j.canlet.2008.02.011; Nieschlag E., 2000, ANDROLOGY MALE REPRO; Park S, 2004, J CELL BIOCHEM, V91, P973, DOI 10.1002/jcb.10768; Schuppe HC, 2008, ANDROLOGIA, V40, P84, DOI 10.1111/j.1439-0272.2008.00837.x; Shen WH, 2002, BRAIN RES, V933, P23, DOI 10.1016/S0006-8993(02)02291-6; Shibata N, 2010, CIRC J, V74, P2045, DOI 10.1253/circj.CJ-10-0860; Soto SM, 2007, J UROLOGY, V177, P365, DOI 10.1016/j.juro.2006.08.081; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Weidner W, 1999, HUM REPROD UPDATE, V5, P421, DOI 10.1093/humupd/5.5.421; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; *WHO, 1987, INT J ANDROL S7; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Willen M, 1996, SCAND J UROL NEPHROL, V30, P387, DOI 10.3109/00365599609181315; Winnall WR, 2011, J LEUKOC BIOL; XIONG YT, 1993, ENDOCRINOLOGY, V132, P2438, DOI 10.1210/en.132.6.2438	40	58	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28452	10.1371/journal.pone.0028452	http://dx.doi.org/10.1371/journal.pone.0028452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164293	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400094
J	Gonzalez-del Pozo, M; Borrego, S; Barragan, I; Pieras, JI; Santoyo, J; Matamala, N; Naranjo, B; Dopazo, J; Antinolo, G				Gonzalez-del Pozo, Maria; Borrego, Salud; Barragan, Isabel; Pieras, Juan I.; Santoyo, Javier; Matamala, Nerea; Naranjo, Belen; Dopazo, Joaquin; Antinolo, Guillermo			Mutation Screening of Multiple Genes in Spanish Patients with Autosomal Recessive Retinitis Pigmentosa by Targeted Resequencing	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; EYS GENE; FAMILIES; ORTHOLOG; IDENTIFICATION; DYSTROPHIES; PHENOTYPES; PUPASUITE	Retinitis Pigmentosa (RP) is a heterogeneous group of inherited retinal dystrophies characterised ultimately by the loss of photoreceptor cells. RP is the leading cause of visual loss in individuals younger than 60 years, with a prevalence of about 1 in 4000. The molecular genetic diagnosis of autosomal recessive RP (arRP) is challenging due to the large genetic and clinical heterogeneity. Traditional methods for sequencing arRP genes are often laborious and not easily available and a screening technique that enables the rapid detection of the genetic cause would be very helpful in the clinical practice. The goal of this study was to develop and apply microarray-based resequencing technology capable of detecting both known and novel mutations on a single high-throughput platform. Hence, the coding regions and exon/intron boundaries of 16 arRP genes were resequenced using microarrays in 102 Spanish patients with clinical diagnosis of arRP. All the detected variations were confirmed by direct sequencing and potential pathogenicity was assessed by functional predictions and frequency in controls. For validation purposes 4 positive controls for variants consisting of previously identified changes were hybridized on the array. As a result of the screening, we detected 44 variants, of which 15 are very likely pathogenic detected in 14 arRP families (14%). Finally, the design of this array can easily be transformed in an equivalent diagnostic system based on targeted enrichment followed by next generation sequencing.	[Gonzalez-del Pozo, Maria; Borrego, Salud; Barragan, Isabel; Pieras, Juan I.; Matamala, Nerea; Naranjo, Belen; Antinolo, Guillermo] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla,Unidad Gest Clin Genet Reprod, Seville, Spain; [Gonzalez-del Pozo, Maria; Borrego, Salud; Barragan, Isabel; Pieras, Juan I.; Santoyo, Javier; Dopazo, Joaquin; Antinolo, Guillermo] CIBERER, Seville, Spain; [Santoyo, Javier; Matamala, Nerea; Dopazo, Joaquin; Antinolo, Guillermo] Andalusian Ctr Human Genom Sequencing, Med Genome Project, Seville, Spain; [Santoyo, Javier; Dopazo, Joaquin] Ctr Invest Principe Felipe, Dept Bioinformat & Genom, Valencia, Spain; [Dopazo, Joaquin] Funct Genom Node INB, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center	Gonzalez-del Pozo, M (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla,Unidad Gest Clin Genet Reprod, Seville, Spain.	jdopazo@cipf.es; guillermo.antinolo.sspa@juntadeandalucia.es	IBIS, GENETICA/P-3384-2015; Santoyo-Lopez, Javier/C-9714-2012; Borrego, Salud/M-6314-2015; Matamala, Nerea/AAA-5006-2020; Naranjo, Belen/E-2273-2019; Santoyo-Lopez, Javier/AHE-5002-2022; Barragan, Isabel/AAJ-6532-2020; Dopazo, Joaquin/A-9270-2014; González-del Pozo, María/N-1742-2015; IBIS, REPRODUCCION/P-3399-2015	Santoyo-Lopez, Javier/0000-0003-1988-5059; Naranjo, Belen/0000-0003-4586-3259; Santoyo-Lopez, Javier/0000-0003-1988-5059; Barragan, Isabel/0000-0002-8586-6502; Dopazo, Joaquin/0000-0003-3318-120X; González-del Pozo, María/0000-0003-4858-938X; Antinolo Gil, Guillermo/0000-0002-2113-074X; Matamala, Nerea/0000-0002-3082-2414	Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Instituto de Salud Carlos III (ISCIII) - Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria, Spain [PI081131]; Consejeria de Innovacion, Ciencia y Empresa [PI08-CTS-03687]; Junta de Andalucia, Spain; El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the ISCIII; Spanish Ministry of Science and Innovation [BIO2008-04212]; Generalitat Valenciana-Fondo Europeo de Desarrollo Regional (GVA-FEDER) [PROMETEO/2010/001]; Instituto Nacional de Bioinformatica (INB)	Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Instituto de Salud Carlos III (ISCIII) - Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria, Spain; Consejeria de Innovacion, Ciencia y Empresa; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the ISCIII; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana-Fondo Europeo de Desarrollo Regional (GVA-FEDER); Instituto Nacional de Bioinformatica (INB)	This study was funded by Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011 (PN de I+ D+ I 2008-2011), Instituto de Salud Carlos III (ISCIII) - Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PI081131), Spain; Consejeria de Innovacion, Ciencia y Empresa (PI08-CTS-03687), Junta de Andalucia, Spain; El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the ISCIII. This work is also partly supported by grants from projects BIO2008-04212 from the Spanish Ministry of Science and Innovation, PROMETEO/2010/001 from Generalitat Valenciana-Fondo Europeo de Desarrollo Regional (GVA-FEDER) and the Instituto Nacional de Bioinformatica (INB), which is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Abd El-Aziz MM, 2010, INVEST OPHTH VIS SCI, V51, P4266, DOI 10.1167/iovs.09-5109; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Audo I, 2010, HUM MUTAT, V31, pE1406, DOI 10.1002/humu.21249; Avila-Fernandez A, 2008, INVEST OPHTH VIS SCI, V49, P2709, DOI 10.1167/iovs.07-0865; Avila-Fernandez A, 2010, MOL VIS, V16, P2550; Bandah-Rozenfeld D, 2010, INVEST OPHTH VIS SCI, V51, P4387, DOI 10.1167/iovs.09-4732; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; Booij JC, 2011, OPHTHALMOLOGY, V118, P160, DOI 10.1016/j.ophtha.2010.04.022; Bruce CK, 2010, HUM MUTAT, V31, P858, DOI 10.1002/humu.21261; Clark GR, 2010, OPHTHALMOLOGY, V117, P2169, DOI 10.1016/j.ophtha.2010.02.029; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Karaman MW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni034; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Lebet T, 2008, GENET MED, V10, P575, DOI [10.1097/GIM.0b013e31818063bc, 10.1097GIM.0b013e31818063bc]; Littink KW, 2010, OPHTHALMOLOGY, V117, P2026, DOI 10.1016/j.ophtha.2010.01.040; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Lotery A J, 2001, Ophthalmic Genet, V22, P163, DOI 10.1076/opge.22.3.163.2222; Mandal MNA, 2005, INVEST OPHTH VIS SCI, V46, P3355, DOI 10.1167/iovs.05-0007; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Pieras JI, 2011, INVEST OPHTH VIS SCI, V52, P5625, DOI 10.1167/iovs.11-7292; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reumers J, 2008, NUCLEIC ACIDS RES, V36, pD825, DOI 10.1093/nar/gkm979; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; SOUIED E, 1994, HUM MOL GENET, V3, P1433, DOI 10.1093/hmg/3.8.1433; Splicing site Mutation by Berkeley Drosophila Genome Project (BDGP) website, SPLIC SIT MUT; STONE EM, 1993, INVEST OPHTH VIS SCI, V34, P1149; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; Walia S, 2008, ARCH OPHTHALMOL-CHIC, V126, P379, DOI 10.1001/archophthalmol.2007.72; Warrington JA, 2002, HUM MUTAT, V19, P402, DOI 10.1002/humu.10075; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717	38	24	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27894	10.1371/journal.pone.0027894	http://dx.doi.org/10.1371/journal.pone.0027894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164218	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400019
J	Hsu, WC; Okeke, E; Cheung, S; Keenan, H; Tsui, T; Cheng, K; King, GL				Hsu, William C.; Okeke, Eyiuche; Cheung, Sophia; Keenan, Hillary; Tsui, Tracy; Cheng, Kyle; King, George L.			A Cross-Sectional Characterization of Insulin Resistance by Phenotype and Insulin Clamp in East Asian Americans with Type 1 and Type 2 Diabetes	PLOS ONE			English	Article							ACID-BINDING PROTEIN; PREVALENCE; RETINOL-BINDING-PROTEIN-4; POPULATION	Objective: Classic features of type 1 and type 2 diabetes may not apply in Asian Americans, due to shared absence of common HLA DR-DQ genotype, low prevalence of positive anti-islet antibodies and low BMI in both types of diabetes. Our objective was to characterize diabetic phenotypes in Asian Americans by clamp and clinical features. Materials/Methods: This was a cross-sectional study conducted in a referral center. Thirty East young Asian American adult volunteers (27.6 +/- 5.5 years) with type 1, type 2 diabetes or controls underwent hyperinsulinemic euglycemic clamp to assess insulin resistance and DEXA to assess adiposity. Results: Gender, BMI, waist/hip ratio, leptin, LDL, anti-GAD, anti-IA2 antibodies and C-reactive protein were similar among three groups. Serum C-peptide, adiponectin, free fatty acid, HDL concentrations and truncal fat by DEXA, were different between diabetic groups. Glucose disposal rate by clamp was lowest in type 2 diabetes, followed by type 1 diabetes and controls (5.43 +/- 2.70, 7.62 +/- 2.59, 8.61 +/- 2.37 mg/min/kg, respectively, p = 0.001). Free fatty acid concentration universally plummeted during steady state of the clamp procedure regardless of diabetes types in all three groups. Adipocyte fatty acid binding protein in the entire cohort (r = -0.625, p = 0.04) and controls (r = -0.869, p = 0.046) correlated best with insulin resistance, independent of BMI. Conclusions: Type 2 diabetes in Asian Americans was associated with insulin resistance despite having low BMI as type 1 diabetes, suggesting a potential role for targeting insulin resistance apart from weight loss. Adipocyte fatty acid binding protein, strongly associated with insulin resistance, independent of adiposity in the young Asian American population, may potentially serve as a biomarker to identify at-risk individuals. Larger studies are needed to confirm this finding.	[Hsu, William C.; Okeke, Eyiuche; Cheung, Sophia; Tsui, Tracy; Cheng, Kyle; King, George L.] Joslin Diabet Ctr, Asian Amer Diabet Initiat, Boston, MA 02215 USA; [Keenan, Hillary; King, George L.] Joslin Diabet Ctr, Dianne Nunnally Hoppes Lab Diabet Complicat, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.	Hsu, WC (corresponding author), Joslin Diabet Ctr, Asian Amer Diabet Initiat, Boston, MA 02215 USA.	William.hsu@joslin.harvard.edu			Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; Joslin Diabetes Center; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; Joslin Diabetes Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was conducted with support provided by Joslin Diabetes Center's Asian American Diabetes Fund, an internal fund. This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chiu KC, 2000, DIABETES CARE, V23, P1353, DOI 10.2337/diacare.23.9.1353; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; FUJIMOTO WY, 1987, DIABETES, V36, P721, DOI 10.2337/diabetes.36.6.721; Goldberg RB, 2005, DIABETES CARE, V28, P2472; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; International Diabetes Federation, 2009, IDF DIAB ATL; Jia WP, 2007, J CLIN ENDOCR METAB, V92, P3224, DOI 10.1210/jc.2007-0209; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Maskarinec G, 2009, ETHNIC DIS, V19, P49; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Park Y, 2001, DIABETES-METAB RES, V17, P2, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR164>3.0.CO;2-M; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Raji A, 2004, J CLIN ENDOCR METAB, V89, P3965, DOI 10.1210/jc.2004-0087; Thorpe LE, 2009, DIABETES CARE, V32, P57, DOI 10.2337/dc08-0727; Todd AL, 2004, INTERN MED J, V34, P24, DOI 10.1111/j.1444-0903.2004.00482.x; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503	20	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28311	10.1371/journal.pone.0028311	http://dx.doi.org/10.1371/journal.pone.0028311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164267	Green Submitted, gold, Green Published			2022-12-25	WOS:000298171400068
J	Waldeisen, JR; Wang, T; Mitra, D; Lee, LP				Waldeisen, John R.; Wang, Tim; Mitra, Debkishore; Lee, Luke P.			A Real-Time PCR Antibiogram for Drug-Resistant Sepsis	PLOS ONE			English	Article							16S RDNA PCR; BACTERIAL PATHOGENS; BLOOD; IDENTIFICATION; BACTEREMIA; DIAGNOSIS; ASSAY	Current molecular diagnostic techniques for susceptibility testing of septicemia rely on genotyping for the presence of known resistance cassettes. This technique is intrinsically vulnerable due to the inability to detect newly emergent resistance genes. Traditional phenotypic susceptibility testing has always been a superior method to assay for resistance; however, relying on the multi-day growth period to determine which antimicrobial to administer jeopardizes patient survival. These factors have resulted in the widespread and deleterious use of broad-spectrum antimicrobials. The real-time PCR antibiogram, described herein, combines universal phenotypic susceptibility testing with the rapid diagnostic capabilities of PCR. We have developed a procedure that determines susceptibility by monitoring pathogenic load with the highly conserved 16S rRNA gene in blood samples exposed to different antimicrobial drugs. The optimized protocol removes heme and human background DNA from blood, which allows standard real-time PCR detection systems to be employed with high sensitivity (<100 CFU/mL). Three strains of E. coli, two of which were antimicrobial resistant, were spiked into whole blood and exposed to three different antibiotics. After real-time PCR-based determination of pathogenic load, a Delta C(t)<3.0 between untreated and treated samples was found to indicate antimicrobial resistance (P<0.01). Minimum inhibitory concentration was determined for susceptible bacteria and pan-bacterial detection was demonstrated with 3 Gram-negative and 2 Gram-positive bacteria. Species identification was performed via analysis of the hypervariable amplicons. In summary, we have developed a universal diagnostic phenotyping technique that assays for the susceptibility of drug-resistant septicemia with the speed of PCR. The real-time PCR antibiogram achieves detection, susceptibility testing, minimum inhibitory concentration determination, and identification in less than 24 hours.	[Waldeisen, John R.; Wang, Tim; Mitra, Debkishore; Lee, Luke P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Waldeisen, JR (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	lplee@berkeley.edu	Lee, Luke/AAN-6695-2021		Korea Institute for Advancement of Technology and Center for Nanostructured Materials Technology; National Science Foundation	Korea Institute for Advancement of Technology and Center for Nanostructured Materials Technology; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Korea Institute for Advancement of Technology and Center for Nanostructured Materials Technology. JRW acknowledges support from an National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avolio M, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181d49299; Bauer M, 2010, INT J MED MICROBIOL, V300, P411, DOI 10.1016/j.ijmm.2010.04.006; Blanc DS, 2011, J CLIN MICROBIOL, V49, P722, DOI 10.1128/JCM.01988-10; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Cleven BEE, 2006, J CLIN MICROBIOL, V44, P2389, DOI 10.1128/JCM.02291-05; Costa SF, 2008, SHOCK, V30, P23, DOI 10.1097/SHK.0b013e3181818990; Handschur M, 2009, COMP IMMUNOL MICROB, V32, P207, DOI 10.1016/j.cimid.2007.10.005; Kellogg JA, 2000, J CLIN MICROBIOL, V38, P2181; Lane DJ, 2004, NUCL ACID TECHNIQUES, p[16S/23S, 115]; Lindholm L, 2004, J CLIN MICROBIOL, V42, P5609, DOI 10.1128/JCM.42.12.5609-5613.2004; PHILLIPS SE, 1990, J CLIN MICROBIOL, V28, P1; Procop GW, 2007, CLIN INFECT DIS, V45, pS99, DOI 10.1086/519259; Reier-Nilsen T, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-5; Rolain JM, 2004, J ANTIMICROB CHEMOTH, V54, P538, DOI 10.1093/jac/dkh324; Sener S, 2011, J CLIN MICROBIOL, V49, P1124, DOI 10.1128/JCM.02104-10; Shopsin B, 2000, J CLIN MICROBIOL, V38, P3453, DOI 10.1128/JCM.38.9.3453-3456.2000; Stutz K, 2011, J CLIN MICROBIOL, V49, P638, DOI 10.1128/JCM.01148-10; Tissari P, 2010, LANCET, V375, P224, DOI 10.1016/S0140-6736(09)61569-5; Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0; von Lilienfeld-Toal M, 2009, J CLIN MICROBIOL, V47, P2405, DOI 10.1128/JCM.00491-09; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Walsh AL, 1995, CLIN INFECT DIS, V21, P1498, DOI 10.1093/clinids/21.6.1498; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yanagihara K, 2010, CRIT CARE, V14, DOI 10.1186/cc9234; Zhang SX, 2011, J CLIN MICROBIOL, V49, P704, DOI 10.1128/JCM.01622-10	25	34	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28528	10.1371/journal.pone.0028528	http://dx.doi.org/10.1371/journal.pone.0028528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164303	gold, Green Submitted, Green Published			2022-12-25	WOS:000298171400104
J	Spijkerman, E; de Castro, F; Gaedke, U				Spijkerman, Elly; de Castro, Francisco; Gaedke, Ursula			Independent Colimitation for Carbon Dioxide and Inorganic Phosphorus	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; FRESH-WATER ALGAE; CHLAMYDOMONAS-ACIDOPHILA; MARINE-PHYTOPLANKTON; MIXOTROPHIC GROWTH; LIMITATION; ACQUISITION; EVOLUTION; PHOSPHATE; NITROGEN	Simultaneous limitation of plant growth by two or more nutrients is increasingly acknowledged as a common phenomenon in nature, but its cellular mechanisms are far from understood. We investigated the uptake kinetics of CO(2) and phosphorus of the algae Chlamydomonas acidophila in response to growth at limiting conditions of CO(2) and phosphorus. In addition, we fitted the data to four different Monod-type models: one assuming Liebigs Law of the minimum, one assuming that the affinity for the uptake of one nutrient is not influenced by the supply of the other (independent colimitation) and two where the uptake affinity for one nutrient depends on the supply of the other (dependent colimitation). In addition we asked whether the physiological response under colimitation differs from that under single nutrient limitation. We found no negative correlation between the affinities for uptake of the two nutrients, thereby rejecting a dependent colimitation. Kinetic data were supported by a better model fit assuming independent uptake of colimiting nutrients than when assuming Liebigs Law of the minimum or a dependent colimitation. Results show that cell nutrient homeostasis regulated nutrient acquisition which resulted in a trade-off in the maximum uptake rates of CO(2) and phosphorus, possibly driven by space limitation on the cell membrane for porters for the different nutrients. Hence, the response to colimitation deviated from that to a single nutrient limitation. In conclusion, responses to single nutrient limitation cannot be extrapolated to situations where multiple nutrients are limiting, which calls for colimitation experiments and models to properly predict growth responses to a changing natural environment. These deviations from single nutrient limitation response under colimiting conditions and independent colimitation may also hold for other nutrients in algae and in higher plants.	[Spijkerman, Elly; de Castro, Francisco; Gaedke, Ursula] Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany	University of Potsdam	Spijkerman, E (corresponding author), Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany.	spijker@uni-potsdam.de	de Castro, Francisco/G-2213-2011	de Castro, Francisco/0000-0001-8834-3363	German research foundation (DFG) [SP695/2, GA401/12-1]	German research foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German research foundation (DFG, SP695/2 & GA401/12-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSNES DL, 1991, MAR ECOL PROG SER, V70, P65, DOI 10.3354/meps070065; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Beardall J, 2005, CAN J BOT, V83, P859, DOI 10.1139/B05-070; BEARDALL J, 1991, CAN J BOT, V69, P1146, DOI 10.1139/b91-147; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Bolker M. B., 2008, ECOLOGICAL MODELS DA; Buitenhuis ET, 2003, LIMNOL OCEANOGR, V48, P1575, DOI 10.4319/lo.2003.48.4.1575; Clark DR, 2000, P ROY SOC B-BIOL SCI, V267, P953, DOI 10.1098/rspb.2000.1096; Clegg MR, 2004, PLANT CELL ENVIRON, V27, P123, DOI 10.1111/j.1365-2478.2004.01138.x; Davidson EA, 2007, NATURE, V449, P1000, DOI 10.1038/4491000a; Dietrich P, 1998, PLANTA, V205, P277, DOI 10.1007/s004250050322; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Gerhart LM, 2010, NEW PHYTOL, V188, P674, DOI 10.1111/j.1469-8137.2010.03441.x; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Giordano M, 2001, J PLANT PHYSIOL, V158, P577, DOI 10.1078/0176-1617-00234; GROVER JP, 1989, LIMNOL OCEANOGR, V34, P341, DOI 10.4319/lo.1989.34.2.0341; Ibelings BW, 1998, LIMNOL OCEANOGR, V43, P408, DOI 10.4319/lo.1998.43.3.0408; Kilham SS, 1977, J GREAT LAKES RES, V31, P93; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kooijman SALM, 1998, BIOPHYS CHEM, V73, P179, DOI 10.1016/S0301-4622(98)00162-8; Kozlowska-Szerenos B, 2004, PLANT PHYSIOL BIOCH, V42, P403, DOI 10.1016/j.plaphy.2004.02.010; MEDVECZKY N, 1971, BIOCHIM BIOPHYS ACTA, V241, P494, DOI 10.1016/0005-2736(71)90048-4; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nagai T, 2006, AQUAT MICROB ECOL, V44, P231, DOI 10.3354/ame044231; Nichols HW., 1975, HDB PHYCOLOGICAL MET, P7; North RL, 2007, LIMNOL OCEANOGR, V52, P315, DOI 10.4319/lo.2007.52.1.0315; ONEILL RV, 1989, ECOL MODEL, V46, P147, DOI 10.1016/0304-3800(89)90015-X; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; Raven J A, 1980, Adv Microb Physiol, V21, P47; RAVEN JA, 1982, NEW PHYTOL, V92, P1, DOI 10.1111/j.1469-8137.1982.tb03358.x; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Raven JA, 2008, PHYSIOL PLANTARUM, V133, P4, DOI 10.1111/j.1399-3054.2007.01024.x; Rhee G-Y, 1980, ADV AQUATIC MICROB, P151; RHEE GY, 1973, J PHYCOL, V9, P495, DOI 10.1111/j.1529-8817.1973.tb04126.x; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; SANDWELL DT, 1987, GEOPHYS RES LETT, V14, P139, DOI 10.1029/GL014i002p00139; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schrader PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018753; Spijkerman E, 2005, CAN J BOT, V83, P872, DOI 10.1139/B05-073; Spijkerman E, 1996, EUR J PHYCOL, V31, P53, DOI 10.1080/09670269600651191; Spijkerman E, 1997, J PLANKTON RES, V19, P1899, DOI 10.1093/plankt/19.12.1899; Spijkerman E, 1998, FRESHWATER BIOL, V39, P503, DOI 10.1046/j.1365-2427.1998.00299.x; Spijkerman E, 2008, PHYSIOL PLANTARUM, V133, P41, DOI 10.1111/j.1399-3054.2008.01062.x; Spijkerman E, 2007, J EXP BOT, V58, P4195, DOI 10.1093/jxb/erm276; Spijkerman E, 2007, EUR J PHYCOL, V42, P327, DOI 10.1080/09670260701529596; Spijkerman E, 2011, PHOTOSYNTH RES, V109, P179, DOI 10.1007/s11120-010-9607-z; Spijkerman E, 2011, EXTREMOPHILES, V15, P597, DOI 10.1007/s00792-011-0390-3; Spijkerman E, 2010, J PHYCOL, V46, P658, DOI 10.1111/j.1529-8817.2010.00859.x; Spijkerman E, 2008, AQUAT MICROB ECOL, V53, P201, DOI 10.3354/ame01244; STUMM W, 1970, AQUATIC CHEM CHEM EQ; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747; Tittel J, 2005, PROTIST, V156, P63, DOI 10.1016/j.protis.2004.09.001; Turpin D.H., 1988, P316; van Hunnik E, 2002, PLANTA, V215, P763, DOI 10.1007/s00425-002-0817-2; Vance P, 2005, CAN J BOT, V83, P796, DOI 10.1139/B05-064; Wilson JB, 2007, AM NAT, V169, P700, DOI 10.1086/513113; Wolf-Gladrow D, 1997, MAR CHEM, V59, P17, DOI 10.1016/S0304-4203(97)00069-8; [No title captured]	62	21	22	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28219	10.1371/journal.pone.0028219	http://dx.doi.org/10.1371/journal.pone.0028219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145031	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168900014
J	Tallon-Baudry, C; Meyniel, F; Bourgeois-Gironde, S				Tallon-Baudry, Catherine; Meyniel, Florent; Bourgeois-Gironde, Sacha			Fast and Automatic Activation of an Abstract Representation of Money in the Human Ventral Visual Pathway	PLOS ONE			English	Article							HUMAN BRAIN; CORTEX; PERCEPTION; REWARD; EXPERIENCE; TASK	Money, when used as an incentive, activates the same neural circuits as rewards associated with physiological needs. However, unlike physiological rewards, monetary stimuli are cultural artifacts: how are monetary stimuli identified in the first place? How and when does the brain identify a valid coin, i.e. a disc of metal that is, by social agreement, endowed with monetary properties? We took advantage of the changes in the Euro area in 2002 to compare neural responses to valid coins (Euros, Australian Dollars) with neural responses to invalid coins that have lost all monetary properties (French Francs, Finnish Marks). We show in magneto-encephalographic recordings, that the ventral visual pathway automatically distinguishes between valid and invalid coins, within only similar to 150 ms. This automatic categorization operates as well on coins subjects were familiar with as on unfamiliar coins. No difference between neural responses to scrambled controls could be detected. These results could suggest the existence of a generic, all-purpose neural representation of money that is independent of experience. This finding is reminiscent of a central assumption in economics, money fungibility, or the fact that a unit of money is substitutable to another. From a neural point of view, our findings may indicate that the ventral visual pathway, a system previously thought to analyze visual features such as shape or color and to be influenced by daily experience, could also able to use conceptual attributes such as monetary validity to categorize familiar as well as unfamiliar visual objects. The symbolic abilities of the posterior fusiform region suggested here could constitute an efficient neural substrate to deal with culturally defined symbols, independently of experience, which probably fostered money's cultural emergence and success.	[Tallon-Baudry, Catherine; Meyniel, Florent] Univ Paris 06, CNRS, Ctr Rech,Inst Cerveau Moelle, INSERM, Paris, France; [Bourgeois-Gironde, Sacha] ENS, Inst Jean Nicod, F-75230 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Tallon-Baudry, C (corresponding author), Univ Paris 06, CNRS, Ctr Rech,Inst Cerveau Moelle, INSERM, Paris, France.	catherine.tallon-baudry@upmc.fr	Tallon-Baudry, Catherine/J-8637-2015	Tallon-Baudry, Catherine/0000-0001-8480-5831; Meyniel, Florent/0000-0002-6992-678X	Agence Nationale de la Recherche [ANR-07-BLAN-0025]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche, grant ANR-07-BLAN-0025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; Alter AL, 2008, PSYCHON B REV, V15, P985, DOI 10.3758/PBR.15.5.985; Barber HA, 2007, BRAIN RES REV, V53, P98, DOI 10.1016/j.brainresrev.2006.07.002; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Burgoyne CB, 2006, SCIENCE, V314, P1091, DOI 10.1126/science.1135429; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; de Saussure F., 1916, COURS LINGUISTIQUE G; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Delgado MR, 2006, SOC COGN AFFECT NEUR, V1, P250, DOI 10.1093/scan/nsl025; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; Lea SE, 1987, INDIVIDUAL EC; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Maurer B, 2006, ANNU REV ANTHROPOL, V35, P15, DOI 10.1146/annurev.anthro.35.081705.123127; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Schyns PG, 1998, BEHAV BRAIN SCI, V21, P1, DOI 10.1017/S0140525X98000107; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; SNELDERS HMJJ, 1992, J ECON PSYCHOL, V13, P71, DOI 10.1016/0167-4870(92)90053-A; Tadel F, COMPUTATION IN PRESS; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; ZELIZER VA, 1989, AM J SOCIOL, V95, P342, DOI 10.1086/229272	30	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28229	10.1371/journal.pone.0028229	http://dx.doi.org/10.1371/journal.pone.0028229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140556	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100054
J	Sidler, D; Brockmann, A; Mueller, J; Nachbur, U; Corazza, N; Renzulli, P; Hemphill, A; Brunner, T				Sidler, D.; Brockmann, A.; Mueller, J.; Nachbur, U.; Corazza, N.; Renzulli, P.; Hemphill, A.; Brunner, T.			Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel	ONCOGENE			English	Article						apoptosis; colon cancer; glutathione S-transferase; Bim; TRAIL; chemotherapy	N-TERMINAL KINASE; BAX-DEPENDENT APOPTOSIS; ETHACRYNIC-ACID; FLOW-CYTOMETRY; LIVER-DAMAGE; JNK; TRAIL; DEATH; PI; PHOSPHORYLATION	Glutathione-S-transferase of the Pi class (GSTP1) is frequently overexpressed in a variety of solid tumors and has been identified as a potential therapeutic target for cancer therapy. GSTP1 is a phase II detoxification enzyme and conjugates the tripeptide glutathione to endogenous metabolites and xenobiotics, thereby limiting the efficacy of antitumor chemotherapeutic treatments. In addition, GSTP1 regulates cellular stress responses and apoptosis by sequestering and inactivating c-Jun N-terminal kinase (JNK). Thiazolides are a novel class of antibiotics for the treatment of intestinal pathogens with no apparent side effects on the host cells and tissue. Here we show that thiazolides induce a GSTP1-dependent and glutathione-enhanced cell death in colorectal tumor cell lines. Downregulation of GSTP1 reduced the apoptotic activity of thiazolides, whereas overexpression enhanced it. Thiazolide treatment caused strong Jun kinase activation and Jun kinase-dependent apoptosis. As a critical downstream target of Jun kinase we identified the proapoptotic Bcl-2 homolog Bim. Thiazolides induced Bim expression and activation in a JNK-dependent manner. Downregulation of Bim in turn significantly blocked thiazolide-induced apoptosis. Whereas low concentrations of thiazolides failed to induce apoptosis directly, they potently sensitized colon cancer cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic drug-induced cell death. Although GSTP1 overexpression generally limits chemotherapy and thus antitumor treatment, our study identifies GSTP1 as Achilles' heel and thiazolides as novel interesting apoptosis sensitizer for the treatment of colorectal tumors. Oncogene (2012) 31, 4095-4106; doi:10.1038/onc.2011.575; published online 12 December 2011	[Brockmann, A.; Brunner, T.] Univ Konstanz, Dept Biol, Div Biochem Pharmacol, D-78457 Constance, Germany; [Mueller, J.; Hemphill, A.] Univ Bern, Inst Parasitol, Vetsuisse Fac, Bern, Switzerland; [Nachbur, U.] Walter & Eliza Hall Inst Med Res, Div Cell Signalling & Cell Death, Parkville, Vic, Australia; [Renzulli, P.] Cantonal Hosp, Dept Surg, Munsterlingen, Switzerland; [Sidler, D.; Corazza, N.; Brunner, T.] Univ Bern, Inst Pathol Expt Pathol, Bern, Switzerland	University of Konstanz; University of Bern; Walter & Eliza Hall Institute; University of Bern	Brunner, T (corresponding author), Univ Konstanz, Dept Biol, Div Biochem Pharmacol, Box 660, D-78457 Constance, Germany.	thomas.brunner@uni-konstanz.de	Sidler, Daniel/G-2447-2019; Renzulli, Pietro/GQH-9366-2022	Renzulli, Pietro/0000-0001-5557-5512; Hemphill, Andrew/0000-0002-0622-2128; Nachbur, Ueli/0000-0001-5968-2235	Swiss National Science Foundation; Oncosuisse; AFF grant from the University of Konstanz; Graduate School Chemical Biology of the University of Konstanz	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; AFF grant from the University of Konstanz; Graduate School Chemical Biology of the University of Konstanz	The authors thank the members of the Brunner and Corazza lab for their excellent technical help and scientific advice, Thomas Kaufmann from the Institute of Pharmacology, University of Berne for providing the antibodies, Philippe Bouillet from the Walter and Eliza Hall Institute, Melbourne, for the Bim promoter construct, Christian Leumann from the Department of Chemistry and Biochemistry, University of Bern for the synthesis of RM4819, and Vicky Hatzig and Thomas Herdegen, University of Kiel for expression plasmids. This work was supported by grants from the Swiss National Science Foundation, Oncosuisse and AFF grant from the University of Konstanz to Thomas Brunner. Daniel Sidler was supported by an MD-PhD fellowship from the Swiss National Science Foundation. Anette Brockmann was supported by a fellowship from the Graduate School Chemical Biology of the University of Konstanz.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Badmann A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.55; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen YR, 2000, INT J ONCOL, V16, P651; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Elsby R, 2003, J BIOL CHEM, V278, P22243, DOI 10.1074/jbc.M301211200; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Garrett CR, 2011, EXPERT OPIN BIOL TH, V11, P937, DOI 10.1517/14712598.2011.582464; Goto S, 1999, FREE RADICAL RES, V31, P549, DOI 10.1080/10715769900301121; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; Ishimoto TM, 2002, PHARMACOGENETICS, V12, P543, DOI 10.1097/00008571-200210000-00006; Jakob S, 2008, METHODS, V44, P255, DOI 10.1016/j.ymeth.2007.11.004; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kuo CT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-43; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Muller J, 2008, INT J CANCER, V123, P1797, DOI 10.1002/ijc.23755; Muller J, 2008, EXP PARASITOL, V118, P80, DOI 10.1016/j.exppara.2007.06.008; Mueller M, 2007, ENDOCRINOLOGY, V148, P1445, DOI 10.1210/en.2006-0591; Muller J, 2006, ANTIMICROB AGENTS CH, V50, P162, DOI 10.1128/AAC.50.1.162-170.2006; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; ODWYER PJ, 1991, CANCER RES, V51, P6059; Ozoren N, 2002, NEOPLASIA, V4, P551, DOI 10.1038/sj.neo.7900270; PETRINI M, 1993, BRIT J HAEMATOL, V85, P409, DOI 10.1111/j.1365-2141.1993.tb03187.x; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Ritchie KJ, 2009, P NATL ACAD SCI USA, V106, P20859, DOI 10.1073/pnas.0911351106; Ruzza P, 2009, ANTI-CANCER AGENT ME, V9, P763, DOI 10.2174/187152009789056895; Schneider-Jakob S, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.66; Steensma DP, 2010, HEMATOL ONCOL CLIN N, V24, P423, DOI 10.1016/j.hoc.2010.02.010; Strahl BD, 1997, ENDOCRINOLOGY, V138, P2621, DOI 10.1210/en.138.6.2621; Tew KD, 2005, EXPERT OPIN INV DRUG, V14, P1047, DOI 10.1517/13543784.14.8.1047; TEW KD, 1988, CANCER RES, V48, P3622; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Villafania A, 2000, ANN CLIN LAB SCI, V30, P57; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Webb C, 2006, VET IMMUNOL IMMUNOP, V112, P129, DOI 10.1016/j.vetimm.2006.02.009; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Yang SY, 2009, TRENDS MOL MED, V15, P225, DOI 10.1016/j.molmed.2009.03.003; Yin ZM, 2000, CANCER RES, V60, P4053; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	49	23	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	37					4095	4106		10.1038/onc.2011.575	http://dx.doi.org/10.1038/onc.2011.575			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NR	22158036	Green Submitted			2022-12-25	WOS:000308688900002
J	Hsu, TI; Wang, MC; Chen, SY; Yeh, YM; Su, WC; Chang, WC; Hung, JJ				Hsu, T-I; Wang, M-C; Chen, S-Y; Yeh, Y-M; Su, W-C; Chang, W-C; Hung, J-J			Sp1 expression regulates lung tumor progression	ONCOGENE			English	Article						Sp1; metastasis; E-cadherin	TRANSCRIPTION FACTOR SP1; FACTOR-I-RECEPTOR; E-CADHERIN; BETA-CATENIN; SPECIFICITY PROTEIN-1; GENE-EXPRESSION; DOWN-REGULATION; CELL-GROWTH; CANCER; METASTASIS	The role of specificity protein 1 (Sp1) in controlling gene expression in lung tumor development and metastasis is not well understood. In this study, we showed that the Sp1 level was highly increased and required for lung tumor growth in transgenic mice bearing Kras-induced lung tumors under the control of doxycycline. Furthermore, the Sp1 level was highly upregulated in lung adenocarcinoma cells with low invasiveness and in patients with stage I lung cancer. We also demonstrated that Sp1 was downregulated in lung adenocarcinoma cells with high invasiveness and in patients with stage IV lung adenocarcinoma. Moreover, Sp1 inversely regulated migration, invasion and metastasis of lung adenocarcinoma cells in vivo. In addition, a decrease in the Sp1 level in highly invasive lung adenocarcinoma cells resulted from instability of the Sp1 protein. Furthermore, overexpression of Sp1 in highly invasive lung adenocarcinoma cells increased expression of E-cadherin, a suppressor of metastasis, and attenuated the translocation of beta-catenin into the cellular nucleus that leads to tumor malignancy. Taken together, Sp1 level accumulated strongly in early stage and then declined in late stage, which is important for lung cancer cell proliferation and metastasis during tumorigenesis. Oncogene (2012) 31, 3973-3988; doi: 10.1038/onc.2011.568; published online 12 December 2011	[Hung, J-J] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Ctr Gene Regulat & Signal Transduct, Tainan 701, Taiwan; [Hsu, T-I; Chang, W-C; Hung, J-J] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; [Wang, M-C; Hung, J-J] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan; [Hsu, T-I; Chen, S-Y; Chang, W-C; Hung, J-J] Natl Cheng Kung Univ, Coll Biosci Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Yeh, Y-M; Su, W-C] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Internal Med, Tainan 701, Taiwan; [Chang, W-C] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Hung, JJ (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Ctr Gene Regulat & Signal Transduct, 1 Univ Rd, Tainan 701, Taiwan.	petehung@mail.ncku.edu.tw	Hsu, Tsung-I/AAK-9942-2020	Hsu, Tsung-I/0000-0002-7524-7740; Su, Wu-Chou/0000-0003-2953-4105	National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers; National Science Council, Taiwan [NSC 97-2320-B-006-016-MY3, NSC 97-2311-B-006-002-MY3]; Department of Health, Executive Yuan, Taiwan [DOH99-TD-B-111-002, DOH99-TD-B111-003]	National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan	This work was supported by the National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with Grants NSC 97-2320-B-006-016-MY3 and NSC 97-2311-B-006-002-MY3 obtained from the National Science Council, Taiwan. The clinical work in this study was supported by the Department of Health, Executive Yuan, Taiwan (Grants DOH99-TD-B-111-002 and DOH99-TD-B111-003).	Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; Bu YH, 2011, INT J CANCER, V128, P1836, DOI 10.1002/ijc.25524; Chang HC, 2004, CELL SIGNAL, V16, P675, DOI 10.1016/j.cellsig.2003.11.001; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chen JF, 2010, ANTICANCER RES, V30, P1113; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Clair SS, 2006, CELL CYCLE, V5, P709, DOI 10.4161/cc.5.7.2628; DeFino MC, 2010, BIOCHEM BIOPH RES CO, V393, P603, DOI 10.1016/j.bbrc.2010.02.026; Denlinger CE, 2010, J THORAC CARDIOV SUR, V140, P505, DOI 10.1016/j.jtcvs.2010.02.061; Duverger V, 2004, BRIT J CANCER, V90, P2025, DOI 10.1038/sj.bjc.6601824; Esteve PO, 2007, J BIOL CHEM, V282, P2615, DOI 10.1074/jbc.M606203200; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Hommura F, 2002, CANCER-AM CANCER SOC, V94, P752, DOI 10.1002/cncr.10213; Hung TL, 2003, CLIN CANCER RES, V9, P2605; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang YX, 2004, CLIN EXP METASTAS, V21, P755, DOI 10.1007/s10585-005-1198-2; Kumar AP, 1999, CANCER LETT, V137, P159, DOI 10.1016/S0304-3835(98)00351-6; Kwak HJ, 2006, MOL CANCER RES, V4, P209, DOI 10.1158/1541-7786.MCR-05-0140; Lee YC, 2011, AM J RESP CELL MOL, V45, P270, DOI 10.1165/rcmb.2010-0313OC; Leroy I, 2006, APOPTOSIS, V11, P113, DOI 10.1007/s10495-005-3089-z; Lin RK, 2007, ANTI-CANCER DRUG, V18, P1157, DOI 10.1097/CAD.0b013e3282a215e9; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Lou Z, 2005, CANCER RES, V65, P1007; Maor S, 2006, J ENDOCRINOL, V191, P605, DOI 10.1677/joe.1.07016; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Mitchell DC, 2007, ONCOGENE, V26, P1739, DOI 10.1038/sj.onc.1209963; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Remsing LL, 2003, BIOCHEMISTRY-US, V42, P8313, DOI 10.1021/bi034091z; Rivard N, 2009, FRONT BIOSCI-LANDMRK, V14, P510, DOI 10.2741/3259; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Su KH, 1999, J BIOL CHEM, V274, P15194, DOI 10.1074/jbc.274.21.15194; Sun XJ, 2009, CANCER RES, V69, P6445, DOI 10.1158/0008-5472.CAN-09-1001; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Zheng Y, 2009, CANCER RES, V69, P896, DOI 10.1158/0008-5472.CAN-08-2677	44	108	108	0	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	35					3973	3988		10.1038/onc.2011.568	http://dx.doi.org/10.1038/onc.2011.568			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	999VJ	22158040	Green Published, hybrid			2022-12-25	WOS:000308342800006
J	Van Ba, IAT; Marchal, S; Francois, F; Silhol, M; Lleres, C; Michel, B; Benyamin, Y; Verdier, JM; Trousse, F; Marcilhac, A				Van Ba, Isabelle Acquatella-Tran; Marchal, Stephane; Francois, Florence; Silhol, Michele; Lleres, Coline; Michel, Bernard; Benyamin, Yves; Verdier, Jean-Michel; Trousse, Francoise; Marcilhac, Anne			Regenerating Islet-derived 1 alpha (Reg-1 alpha) Protein Is New Neuronal Secreted Factor That Stimulates Neurite Outgrowth via Exostosin Tumor-like 3 (EXTL3) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC STONE PROTEIN; REG GENE FAMILY; THREAD PROTEIN; ALZHEIMERS-DISEASE; GROWTH-FACTOR; LITHOSTATHINE; EXPRESSION; DIFFERENTIATION; CELL	Regenerating islet-derived 1 alpha (Reg-1 alpha)/lithostathine, amember of a family of secreted proteins containing a C-type lectin domain, is expressed in various organs and plays a role in proliferation, differentiation, inflammation, and carcinogenesis of cells of the digestive system. We previously reported that Reg-1 alpha is overexpressed during the very early stages of Alzheimer disease, and Reg-1 alpha deposits were detected in the brain of patients with Alzheimer disease. However, the physiological function of Reg-1 alpha in neural cells remains unknown. Here, we show that Reg-1 alpha is expressed in neuronal cell lines (PC12 and Neuro-2a) and in rat primary hippocampal neurons (E17.5). Reg-1 alpha is mainly localized around the nucleus and at the membrane of cell bodies and neurites. Transient overexpression of Reg-1 alpha or addition of recombinant Reg-1 alpha significantly increases the number of cells with longer neurites by stimulating neurite outgrowth. These effects are abolished upon down-regulation of Reg-1 alpha by siRNA and following inhibition of secreted Reg-1 alpha by antibodies. Moreover, Reg-1 alpha colocalizes with exostosin tumor-like 3 (EXTL3), its putative receptor, at the membrane of these cells. Overexpression of EXTL3 increases the effect of recombinant Reg-1 alpha on neurite outgrowth, and Reg-1 alpha is not effective when EXTL3 overexpression is down-regulated by shRNA. Our findings indicate that Reg-1 alpha regulates neurite outgrowth and suggest that this effect is mediated by its receptor EXTL3.	[Van Ba, Isabelle Acquatella-Tran; Marchal, Stephane; Francois, Florence; Silhol, Michele; Lleres, Coline; Michel, Bernard; Verdier, Jean-Michel; Trousse, Francoise; Marcilhac, Anne] Univ Montpellier 2, INSERM, U710, F-34095 Montpellier 05, France; [Van Ba, Isabelle Acquatella-Tran; Marchal, Stephane; Francois, Florence; Silhol, Michele; Lleres, Coline; Michel, Bernard; Verdier, Jean-Michel; Trousse, Francoise; Marcilhac, Anne] EPHE, F-75007 Paris, France; [Michel, Bernard] Hop St Marguerite, Serv Neurol, F-13009 Marseille, France; [Benyamin, Yves] CNRS, UMR5539, F-34095 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS)	Marcilhac, A (corresponding author), Univ Montpellier 2, INSERM, U710, Pl E Bataillon,CC 105, F-34095 Montpellier 05, France.	marcilhac@univ-montp2.fr	MARCHAL, stéphane/M-4324-2017	MARCHAL, stéphane/0000-0002-1101-7890; , francoise/0000-0002-6354-3331; VERDIER, Jean-Michel/0000-0002-7252-1556	Groupe de Recherche sur la Maladie d'Alzheimer	Groupe de Recherche sur la Maladie d'Alzheimer	This work was supported by grants from Groupe de Recherche sur la Maladie d'Alzheimer.	Averill S, 2002, J NEUROSCI, V22, P7493; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bimmler D, 1997, J BIOL CHEM, V272, P3073, DOI 10.1074/jbc.272.5.3073; Cerini C, 1999, J BIOL CHEM, V274, P22266, DOI 10.1074/jbc.274.32.22266; DECARO A, 1979, BIOCHEM BIOPH RES CO, V87, P1176, DOI 10.1016/S0006-291X(79)80031-5; DELAMONTE SM, 1990, J CLIN INVEST, V86, P1004, DOI 10.1172/JCI114762; delaMonte SM, 1996, J NEUROL SCI, V138, P26, DOI 10.1016/0022-510X(95)00350-B; DEREGGI M, 1995, EUR J BIOCHEM, V230, P503; Duplan L, 2001, NEUROBIOL AGING, V22, P79, DOI 10.1016/S0197-4580(00)00182-2; Geider S, 1996, J BIOL CHEM, V271, P26302, DOI 10.1074/jbc.271.42.26302; Gregoire C, 2001, EMBO J, V20, P3313, DOI 10.1093/emboj/20.13.3313; Hashimoto M, 2003, NEUROCHEM RES, V28, P1743, DOI 10.1023/A:1026073324672; Iovanna JL, 2005, BBA-GEN SUBJECTS, V1723, P8, DOI 10.1016/j.bbagen.2005.01.002; Kinoshita Y, 2004, J GASTROENTEROL, V39, P507, DOI 10.1007/s00535-004-1354-5; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Laurine E, 2005, BBA-GENE STRUCT EXPR, V1727, P177, DOI 10.1016/j.bbaexp.2005.01.011; Laurine E, 2003, J BIOL CHEM, V278, P51770, DOI 10.1074/jbc.M306767200; Marchal S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.002; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Miyaoka Y, 2004, ONCOGENE, V23, P3572, DOI 10.1038/sj.onc.1207333; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Osman NMS, 2004, DEV BRAIN RES, V151, P111, DOI 10.1016/j.devbrainres.2004.04.008; Sanchez D, 2004, PANCREAS, V29, P14, DOI 10.1097/00006676-200407000-00050; Sanchez D, 2009, PANCREAS, V38, P572, DOI 10.1097/MPA.0b013e3181a1d9f9; WATANABE T, 1990, J BIOL CHEM, V265, P7432; Xu YY, 1995, J MOL NEUROSCI, V6, P91, DOI 10.1007/BF02736769; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635	27	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4726	4739		10.1074/jbc.M111.260349	http://dx.doi.org/10.1074/jbc.M111.260349			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158612	hybrid, Green Published			2022-12-25	WOS:000300608500034
J	Park, KJ; Lee, CH; Kim, A; Jeong, KJ; Kim, CH; Kim, YS				Park, Kyung-Jin; Lee, Chang-Han; Kim, Aeyung; Jeong, Ki Jun; Kim, Chul-Ho; Kim, Yong-Sung			Death Receptors 4 and 5 Activate Nox1 NADPH Oxidase through Riboflavin Kinase to Induce Reactive Oxygen Species-mediated Apoptotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSTAINED JNK ACTIVATION; TNF-RECEPTOR; INVOLVEMENT; GENERATION; CASPASE-8; ANTIBODY; PATHWAY; COUPLES; STRESS; FAMILY	Stimulation of the proapoptotic tumor necrosis factor (TNF)related apoptosis-inducing ligand (TRAIL) receptors, death receptors 4 (DR4) and 5 (DR5), conventionally induces caspase-dependent apoptosis in tumor cells. Here we report that stimulation of DR4 and/or DR5 by the agonistic protein KD548-Fc, an Fc-fused DR4/DR5 dual-specific Kringle domain variant, activates plasma membrane-associated Nox1 NADPH oxidase to generate superoxide anion and subsequently accumulates intracellular reactive oxygen species (ROS), leading to sustained c-Jun N-terminal kinase activation and eventual apoptotic cell death in human HeLa and Jurkat tumor cells. KD548-Fc treatment induces the formation of a DR4/DR5 signaling complex containing riboflavin kinase (RFK), Nox1, the Nox1 subunits (Rac1, Noxo1, and Noxa1), TNF receptor-associated death domain (TRADD), and TNF receptor-associated factor 2 (TRAF2). Depletion of RFK, but not the Nox1 subunits, TRADD and TRAF2, failed to recruit Nox1 and Rac1 to DR4 and DR5, demonstrating that RFK plays an essential role in linking DR4/DR5 with Nox1. Knockdown studies also reveal that RFK, TRADD, and TRAF2 play critical, intermediate, and negligible roles, respectively, in the KD548-Fc-mediated ROS accumulation and downstream signaling. Binding assays using recombinantly expressed proteins suggest that DR4/DR5 directly interact with cytosolic RFK through RFK-binding regions within the intracellular death domains, and TRADD stabilizes the DR4/DR5-RFK complex. Our results suggest that DR4 and DR5 have a capability to activate Nox1 by recruiting RFK, resulting in ROS-mediated apoptotic cell death in tumor cells.	[Park, Kyung-Jin; Lee, Chang-Han; Kim, Aeyung; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Jeong, Ki Jun] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea; [Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 443749, South Korea	Ajou University; Korea Advanced Institute of Science & Technology (KAIST); Ajou University	Kim, YS (corresponding author), Ajou Univ, Dept Mol Sci & Technol, San 5, Suwon 443749, South Korea.	kimys@ajou.ac.kr	Lee, Chang-Han/AAG-9178-2019; JEONG, KI JUN/C-1704-2011	Lee, Chang-Han/0000-0002-7156-4423; Kim, Yong-Sung/0000-0003-2673-1509	Ministry for Health, Welfare Family Affairs [A101800]; National Research Foundation of MEST [2009-0093653, 2011-0022978]; Gyeonggi Provincial Government, Republic of Korea	Ministry for Health, Welfare Family Affairs; National Research Foundation of MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Gyeonggi Provincial Government, Republic of Korea	This work was supported by grants from the Korean Health Technology R&D Project (A101800) from the Ministry for Health, Welfare & Family Affairs, the Converging Research Center Program (2009-0093653) and the Priority Research Center Program (2011-0022978) from the National Research Foundation of MEST, and the "GRRC" Project of the Gyeonggi Provincial Government, Republic of Korea.	AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Cao XM, 2011, FASEB J, V25, P1353, DOI 10.1096/fj.10-170480; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen CF, 2009, CELL RES, V19, P984, DOI 10.1038/cr.2009.60; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; Kieser A, 2008, BIOL CHEM, V389, P1261, DOI 10.1515/BC.2008.144; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lee CH, 2011, J MOL BIOL, V411, P201, DOI 10.1016/j.jmb.2011.05.040; Lee CH, 2010, P NATL ACAD SCI USA, V107, P9567, DOI 10.1073/pnas.1001541107; Lee MW, 2002, CANCER LETT, V182, P75; Morgan MJ, 2010, MOL CELLS, V30, P1, DOI 10.1007/s10059-010-0105-0; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Park HH, 2011, APOPTOSIS, V16, P209, DOI 10.1007/s10495-010-0571-z; Park KJ, 2007, CANCER RES, V67, P7327, DOI 10.1158/0008-5472.CAN-06-4766; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sung ES, 2010, APOPTOSIS, V15, P1256, DOI 10.1007/s10495-010-0521-9; Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206	29	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3313	3325		10.1074/jbc.M111.309021	http://dx.doi.org/10.1074/jbc.M111.309021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158615	Green Published, hybrid			2022-12-25	WOS:000300295100037
J	Yan, CG; Zhu, M; Staiger, J; Johnson, PF; Gao, HW				Yan, Chunguang; Zhu, Mei; Staiger, Jennifer; Johnson, Peter F.; Gao, Hongwei			C5a-regulated CCAAT/Enhancer-binding Proteins beta and delta Are Essential in Fc gamma Receptor-mediated Inflammatory Cytokine and Chemokine Production in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP-BETA; PROINFLAMMATORY CYTOKINES; KINASE ACTIVATION; IMMUNE-COMPLEXES; LUNG INJURY; GENE; EXPRESSION; INDUCTION; CELLS; C5A	CCAAT/enhancer-binding protein beta (C/EBP beta) and C/EBP delta are known to participate in the regulation of many genes associated with inflammation. However, little is known about the activation and function of C/EBP beta and -delta in inflammatory responses elicited by Fc gamma receptor (Fc gamma R) activation. Here we show that C/EBP beta and -delta activation are induced in IgG immune complex (IC)-treated macrophages. The increased expression of C/EBP beta and -delta occurred at both mRNA and protein levels. Furthermore, induction of C/EBP beta and -delta was mediated, to a large extent, by activating Fc gamma Rs. Using siRNA-mediated knockdown as well as macrophages deficient for C/EBP beta and/or -delta, we demonstrate that C/EBP beta and -delta play a critical role in the production of TNF-alpha, MIP-2, and MIP-1 alpha in IgG IC-stimulated macrophages. Moreover, both ERK1/2 and p38 MAPK are involved in C/EBP induction and TNF-alpha, MIP-2, and MIP-1 alpha production induced by IgGIC. We provide the evidence that C5a regulates IgGIC-induced inflammatory responses by enhancing ERK1/2 and p38 MAPK activities as well as C/EBP beta and -delta activities. Collectively, these data suggest that C/EBP beta and -delta are key regulators for Fc gamma R-mediated induction of cytokines and chemokines in macrophages. Furthermore, C/EBPs may play an important regulatory role in IC-associated inflammatory responses.	[Yan, Chunguang; Gao, Hongwei] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Sch Med, Boston, MA 02115 USA; [Zhu, Mei] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Staiger, Jennifer] Mt St Marys Univ, Dept Sci, Sch Nat Sci & Math, Emmitsburg, MD 21727 USA; [Johnson, Peter F.] NCI, Lab Canc Prevent, Ctr Canc Res, NIH, Frederick, MD 21702 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gao, HW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol,Sch Med, 20 Shattuck St, Boston, MA 02115 USA.	hgao@zeus.bwh.harvard.edu	Yan, Chunguang/ABE-5021-2021; Johnson, Peter/A-1940-2012	Johnson, Peter/0000-0002-4145-4725	National Institutes of Health (NIH) [5R01HL092905-04, 3R01HL092905-02S1]; NIH, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010328] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092905] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants 5R01HL092905-04 and 3R01HL092905-02S1 (to H. G.) and the Intramural Research Program of the NIH, NCI, Center for Cancer Research.	Adelmant G, 1998, J BIOL CHEM, V273, P15574, DOI 10.1074/jbc.273.25.15574; Akagi T, 2008, BRIT J CANCER, V99, P781, DOI 10.1038/sj.bjc.6604544; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ALAM T, 1992, J BIOL CHEM, V267, P5021; Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Arnett Brenda, 2003, Mol Cancer, V2, P21, DOI 10.1186/1476-4598-2-21; Bayon Y, 1997, J IMMUNOL, V159, P887; Bianchi G, 2007, ANN NY ACAD SCI, V1095, P209, DOI 10.1196/annals.1397.025; Bless NM, 1999, AM J PHYSIOL-LUNG C, V276, pL57, DOI 10.1152/ajplung.1999.276.1.L57; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; DAVATELIS G, 1988, J EXP MED, V167, P1939, DOI 10.1084/jem.167.6.1939; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Fernandez N, 2002, J IMMUNOL, V169, P3321, DOI 10.4049/jimmunol.169.6.3321; Gao HW, 2006, ANNU REV PATHOL-MECH, V1, P215, DOI 10.1146/annurev.pathol.1.110304.100155; Garcia-Garcia E, 2001, J LEUKOCYTE BIOL, V70, P649; Gerbitz A, 2005, TRANSPLANTATION, V79, P536, DOI 10.1097/01.TP.0000151763.16800.B0; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Hillyard DZ, 2004, ATHEROSCLEROSIS, V172, P219, DOI 10.1016/j.atherosclerosis.2003.11.004; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Konrad S, 2007, J BIOL CHEM, V282, P37906, DOI 10.1074/jbc.M707937200; Konrad S, 2008, J BIOL CHEM, V283, P33296, DOI 10.1074/jbc.M804617200; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Masumoto M, 1999, J IMMUNOL, V163, P5039; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Sanchez-Mejorada G, 1998, J BIOL CHEM, V273, P27610, DOI 10.1074/jbc.273.42.27610; Schmal H, 1998, J IMMUNOL, V161, P3685; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Song XY, 2004, J LEUKOCYTE BIOL, V75, P1147, DOI 10.1189/jlb.0403128; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Trotta R, 1996, J EXP MED, V184, P1027, DOI 10.1084/jem.184.3.1027; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Walpen S, 2001, FASEB J, V15, P571; WIDMER U, 1993, J IMMUNOL, V150, P4996; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; ZHANG Y, 1993, MOL CELL BIOL, V13, P3831, DOI 10.1128/MCB.13.6.3831	53	33	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3217	3230		10.1074/jbc.M111.280834	http://dx.doi.org/10.1074/jbc.M111.280834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22147692	Green Published, hybrid			2022-12-25	WOS:000300295100027
J	Dockter, C; Muller, AH; Dietz, C; Volkov, A; Polyhach, Y; Jeschke, G; Paulsen, H				Dockter, Christoph; Mueller, Andre H.; Dietz, Carsten; Volkov, Aleksei; Polyhach, Yevhen; Jeschke, Gunnar; Paulsen, Harald			Rigid Core and Flexible Terminus STRUCTURE OF SOLUBILIZED LIGHT-HARVESTING CHLOROPHYLL a/b COMPLEX (LHCII) MEASURED BY EPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; PROTEIN; PHOSPHORYLATION; CRYSTALS; SITE; PHOTOSYNTHESIS; RECONSTITUTION; SPINACH; DOMAIN	The structure of the major light-harvesting chlorophyll a/b complex ( LHCII) was analyzed by pulsed EPR measurements and compared with the crystal structure. Site-specific spin labeling of the recombinant protein allowed the measurement of distance distributions over several intra-and intermolecular distances in monomeric and trimeric LHCII, yielding information on the protein structure and its local flexibility. A spin label rotamer library based on a molecular dynamics simulation was used to take the local mobility of spin labels into account. The core of LHCII in solution adopts a structure very similar or identical to the one seen in crystallized LHCII trimers with little motional freedom as indicated by narrow distance distributions along and between alpha helices. However, distances comprising the lumenal loop domain show broader distance distributions, indicating some mobility of this loop structure. Positions in the hydrophilic N-terminal domain, upstream of the first trans-membrane alpha helix, exhibit more and more mobility the closer they are to the N terminus. The nine amino acids at the very N terminus that have not been resolved in any of the crystal structure analyses give rise to very broad and possibly bimodal distance distributions, which may represent two families of preferred conformations.	[Dockter, Christoph; Mueller, Andre H.; Dietz, Carsten; Paulsen, Harald] Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, D-55099 Mainz, Germany; [Volkov, Aleksei] Max Planck Inst Polymer Res, D-55021 Mainz, Germany; [Polyhach, Yevhen; Jeschke, Gunnar] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	Johannes Gutenberg University of Mainz; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Paulsen, H (corresponding author), Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, Mullerweg 6, D-55099 Mainz, Germany.	paulsen@uni-mainz.de	Paulsen, Harald/D-3742-2011	Jeschke, Gunnar/0000-0001-6853-8585	Deutsche Forschungsgemeinschaft [SFB 625, TP B10, Pa 324/9-1]; Swiss National Science Foundation [200020-103550/1]; Max Planck Graduate Center, Johannes Gutenberg-Universitat Mainz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Graduate Center, Johannes Gutenberg-Universitat Mainz	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB 625, TP B10 (to G. J. and H. P.), and Pa 324/9-1 (to H. P.) and Swiss National Science Foundation Grant 200020-103550/1 (to G. J.).; Supported by the Max Planck Graduate Center, Johannes Gutenberg-Universitat Mainz.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; CASHMORE AR, 1984, P NATL ACAD SCI-BIOL, V81, P2960, DOI 10.1073/pnas.81.10.2960; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Dockter C, 2009, P NATL ACAD SCI USA, V106, P18485, DOI 10.1073/pnas.0906462106; Hilger D, 2009, BIOPHYS J, V96, P217, DOI 10.1016/j.bpj.2008.09.030; Hobe S, 2000, EUR J BIOCHEM, V267, P616, DOI 10.1046/j.1432-1327.2000.01060.x; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2005, J BIOL CHEM, V280, P18623, DOI 10.1074/jbc.M501171200; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2009, PHYS CHEM CHEM PHYS, V11, P6580, DOI 10.1039/b905724b; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Kavalenka AA, 2009, BIOPHYS J, V96, P3620, DOI 10.1016/j.bpj.2009.01.038; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; KUHLBRANDT W, 1987, J MOL BIOL, V194, P757, DOI 10.1016/0022-2836(87)90255-5; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Nilsson A, 1997, J BIOL CHEM, V272, P18350, DOI 10.1074/jbc.272.29.18350; NUSSBERGER S, 1993, J MOL BIOL, V234, P347, DOI 10.1006/jmbi.1993.1591; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Pesaresi P, 2010, PLANT SIGNAL BEHAV, V5, P21, DOI 10.4161/psb.5.1.10198; PETER GF, 1991, J BIOL CHEM, V266, P16745; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P878, DOI 10.1016/j.bbabio.2011.05.009; ROTH M, 1989, NATURE, V340, P659, DOI 10.1038/340659a0; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruhle W, 2011, METHODS MOL BIOL, V684, P113, DOI [10.1007/978.1.60761.925.3_11, 10.1007/978-1-60761-925-3_11]; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tikkanen M, 2011, TRENDS PLANT SCI, V16, P126, DOI 10.1016/j.tplants.2010.11.006; Volkov A, 2009, BIOPHYS J, V96, P1124, DOI 10.1016/j.bpj.2008.09.047; Zer H, 1999, P NATL ACAD SCI USA, V96, P8277, DOI 10.1073/pnas.96.14.8277	41	31	31	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2915	2925		10.1074/jbc.M111.307728	http://dx.doi.org/10.1074/jbc.M111.307728			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147706	Green Published, hybrid			2022-12-25	WOS:000300292300063
J	van Meegen, MA; Terheggen-Lagro, SWJ; van der Ent, CK; Beekman, JM				van Meegen, Marit A.; Terheggen-Lagro, Suzanne W. J.; van der Ent, Cornelis K.; Beekman, Jeffrey M.			CFTR Expression Analysis in Human Nasal Epithelial Cells by Flow Cytometry	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; WILD-TYPE; RESPIRATORY EPITHELIA; DELTA-F508 CFTR; AIRWAY CELLS; IDENTIFICATION; LOCALIZATION; PROTEASOME; PROTEIN	Rationale: Unbiased approaches that study aberrant protein expression in primary airway epithelial cells at single cell level may profoundly improve diagnosis and understanding of airway diseases. We here present a flow cytometric procedure to study CFTR expression in human primary nasal epithelial cells from patients with Cystic Fibrosis (CF). Our novel approach may be important in monitoring of therapeutic responses, and better understanding of CF disease at the molecular level. Objectives: Validation of a panel of CFTR-directed monoclonal antibodies for flow cytometry and CFTR expression analysis in nasal epithelial cells from healthy controls and CF patients. Methods: We analyzed CFTR expression in primary nasal epithelial cells at single cell level using flow cytometry. Nasal cells were stained for pan-Cytokeratin, E cadherin, and CD45 (to discriminate epithelial cells and leukocytes) in combination with intracellular staining of CFTR. Healthy individuals and CF patients were compared. Measurements and Main Results: We observed various cellular populations present in nasal brushings that expressed CFTR protein at different levels. Our data indicated that CF patients homozygous for F508del express varying levels of CFTR protein in nasal epithelial cells, although at a lower level than healthy controls. Conclusion: CFTR protein is expressed in CF patients harboring F508del mutations but at lower levels than in healthy controls. Multicolor flow cytometry of nasal cells is a relatively simple procedure to analyze the composition of cellular subpopulations and protein expression at single cell level.	[van Meegen, Marit A.; Terheggen-Lagro, Suzanne W. J.; van der Ent, Cornelis K.; Beekman, Jeffrey M.] Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands; [van Meegen, Marit A.; Beekman, Jeffrey M.] Univ Med Ctr Utrecht, Ctr Mol & Cellular Intervent, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Meegen, MA (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands.	J.Beekman@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014	Beekman, Jeffrey M/0000-0003-4886-3756; Van der Ent, Cornelis/0000-0002-2501-4121	Wilhelmina Childrens Hospital (WKZ) Foundation, The Netherlands	Wilhelmina Childrens Hospital (WKZ) Foundation, The Netherlands	This work was supported by the Wilhelmina Childrens Hospital (WKZ) Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman JM, 2009, BLOOD, V114, P3917, DOI 10.1182/blood-2009-03-208850; Beekman JM, 2004, J BIOL CHEM, V279, P33875, DOI 10.1074/jbc.M401018200; Borthwick LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023226; Carvalho-Oliveira I, 2004, J HISTOCHEM CYTOCHEM, V52, P193, DOI 10.1177/002215540405200207; Clancy JP, 2007, AM J RESP CELL MOL, V37, P57, DOI 10.1165/rcmb.2006-0173OC; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dormer RL, 2001, PFLUG ARCH EUR J PHY, V443, pS117; DUPUIT F, 1995, J CLIN INVEST, V96, P1601, DOI 10.1172/JCI118199; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Harris Ceinwen M, 2004, J Cyst Fibros, V3 Suppl 2, P43, DOI 10.1016/j.jcf.2004.05.009; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Moreau-Marquis S, 2008, AM J PHYSIOL-LUNG C, V295, pL25, DOI 10.1152/ajplung.00391.2007; Nicolis E, 1999, GENE THER MOL BIOL, V4, P221; Penque D, 2000, LAB INVEST, V80, P857, DOI 10.1038/labinvest.3780090; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27658	10.1371/journal.pone.0027658	http://dx.doi.org/10.1371/journal.pone.0027658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163268	gold, Green Published, Green Submitted			2022-12-25	WOS:000298161900004
J	Burioni, R; Scalco, R; Casartelli, M				Burioni, Raffaella; Scalco, Riccardo; Casartelli, Mario			Rohlin Distance and the Evolution of Influenza A Virus: Weak Attractors and Precursors	PLOS ONE			English	Article							GENETIC EVOLUTION; NETWORK; H3N2	The evolution of the hemagglutinin amino acids sequences of Influenza A virus is studied by a method based on an informational metrics, originally introduced by Rohlin for partitions in abstract probability spaces. This metrics does not require any previous functional or syntactic knowledge about the sequences and it is sensitive to the correlated variations in the characters disposition. Its efficiency is improved by algorithmic tools, designed to enhance the detection of the novelty and to reduce the noise of useless mutations. We focus on the USA data from 1993/94 to 2010/2011 for A/H3N2 and on USA data from 2006/07 to 2010/2011 for A/H1N1. We show that the clusterization of the distance matrix gives strong evidence to a structure of domains in the sequence space, acting as weak attractors for the evolution, in very good agreement with the epidemiological history of the virus. The structure proves very robust with respect to the variations of the clusterization parameters, and extremely coherent when restricting the observation window. The results suggest an efficient strategy in the vaccine forecast, based on the presence of "precursors" (or "buds") populating the most recent attractor.	[Burioni, Raffaella; Casartelli, Mario] Univ Parma, Dipartimento Fis, I-43100 Parma, Italy; [Burioni, Raffaella; Casartelli, Mario] Univ Parma, Inst Nazl Si Fis Nucl INFN, I-43100 Parma, Italy; [Scalco, Riccardo] Univ Zurich, Dept Biochem, Zurich, Switzerland	University of Parma; University of Parma; University of Zurich	Burioni, R (corresponding author), Univ Parma, Dipartimento Fis, Viale Sci, I-43100 Parma, Italy.	raffaella.burioni@fis.unipr.it	Burioni, Raffaella/C-6780-2017		MIUR FIRB [RBFR08EKEV]; Instituto Nazionale di Fisca Nucleare (INF)	MIUR FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Instituto Nazionale di Fisca Nucleare (INF)	This work was partially supported by the MIUR FIRB grant RBFR08EKEV and by the Instituto Nazionale di Fisca Nucleare (INF) project "Biological applications of theoretical physics methods". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliari E, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/09/P09002; Arnold V.I., 1967, PROBLEMES ERGODIQUES; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baxevanis A.D., 2005, BIOINFORMATICS PRACT; Butte A J, 2000, Pac Symp Biocomput, P418; Casartelli M, 2004, J PHYS A-MATH GEN, V37, P11731, DOI 10.1088/0305-4470/37/49/001; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hampson A, 2002, INUENZA; Hastie T., 2009, UNSUPERVISED LEARNIN; He JK, 2010, PROTEIN ENG DES SEL, V23, P935, DOI 10.1093/protein/gzq078; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Hoft DF, 2004, NEW ENGL J MED, V351, P2550, DOI 10.1056/NEJMcibr043708; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Khinchin AI., 1957, MATH FDN INFORM THEO; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Martin N.F.G., 1981, MATH THEORY ENTROPY; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Ouyang Zhengqing, 2004, J Bioinform Comput Biol, V2, P353, DOI 10.1142/S0219720004000624; Pevzner P. A., 2000, COMPUTATIONAL MOL BI; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rao Suyog, 2005, Genome Inform, V16, P3; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sun J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228107; Waterman M.S., 1995, INTRO COMPUTATIONAL; Wolf Y, 2010, PLOS CURR, V3; Xia Z, 2009, BIOINFORMATICS, V25, P2309, DOI 10.1093/bioinformatics/btp423	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27924	10.1371/journal.pone.0027924	http://dx.doi.org/10.1371/journal.pone.0027924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162994	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500007
J	Schlick, SN; Wood, CD; Gunnell, A; Webb, HM; Khasnis, S; Schepers, A; West, MJ				Schlick, Sandra N.; Wood, C. David; Gunnell, Andrea; Webb, Helen M.; Khasnis, Sarika; Schepers, Aloys; West, Michelle J.			Upregulation of the Cell-Cycle Regulator RGC-32 in Epstein-Barr Virus-Immortalized Cells	PLOS ONE			English	Article							NUCLEAR ANTIGEN 3C; B-CELLS; C-MYC; KINASE-ACTIVITY; GENE; ACTIVATION; EXPRESSION; PROTEIN; RNA; PROGRESSION	Epstein-Barr virus (EBV) is implicated in the pathogenesis of multiple human tumours of lymphoid and epithelial origin. The virus infects and immortalizes B cells establishing a persistent latent infection characterized by varying patterns of EBV latent gene expression (latency 0, I, II and III). The CDK1 activator, Response Gene to Complement-32 (RGC-32, C13ORF15), is overexpressed in colon, breast and ovarian cancer tissues and we have detected selective high-level RGC-32 protein expression in EBV-immortalized latency III cells. Significantly, we show that overexpression of RGC-32 in B cells is sufficient to disrupt G2 cell-cycle arrest consistent with activation of CDK1, implicating RGC-32 in the EBV transformation process. Surprisingly, RGC-32 mRNA is expressed at high levels in latency I Burkitt's lymphoma (BL) cells and in some EBV-negative BL cell-lines, although RGC-32 protein expression is not detectable. We show that RGC-32 mRNA expression is elevated in latency I cells due to transcriptional activation by high levels of the differentially expressed RUNX1c transcription factor. We found that proteosomal degradation or blocked cytoplasmic export of the RGC-32 message were not responsible for the lack of RGC-32 protein expression in latency I cells. Significantly, analysis of the ribosomal association of the RGC-32 mRNA in latency I and latency III cells revealed that RGC-32 transcripts were associated with multiple ribosomes in both cell-types implicating post-initiation translational repression mechanisms in the block to RGC-32 protein production in latency I cells. In summary, our results are the first to demonstrate RGC-32 protein upregulation in cells transformed by a human tumour virus and to identify post-initiation translational mechanisms as an expression control point for this key cell-cycle regulator.	[Schlick, Sandra N.; Wood, C. David; Gunnell, Andrea; Webb, Helen M.; Khasnis, Sarika; Schepers, Aloys; West, Michelle J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sussex	Schlick, SN (corresponding author), Res Ctr Borstel, Borstel, Germany.	M.J.West@sussex.ac.uk		Schepers, Aloys/0000-0002-5442-5608; Gunnell, Andrea/0000-0001-5162-5391; West, Michelle/0000-0002-9497-9365	Wellcome Trust [076990, 088140]; Royal Society; University of Sussex	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); University of Sussex	This work was supported by grants from the Wellcome Trust (076990 and 088140) and the Royal Society and by a PhD studentship from the University of Sussex to SNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Babcock GJ, 2000, P NATL ACAD SCI USA, V97, P12250, DOI 10.1073/pnas.200366597; Badea T, 2002, J BIOL CHEM, V277, P502, DOI 10.1074/jbc.M109354200; Badea TC, 1998, J BIOL CHEM, V273, P26977, DOI 10.1074/jbc.273.41.26977; Bajaj BG, 2008, J VIROL, V82, P4082, DOI 10.1128/JVI.02500-07; Bark-Jones SJ, 2006, ONCOGENE, V25, P1775, DOI 10.1038/sj.onc.1209205; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Brady G, 2009, J VIROL, V83, P6909, DOI 10.1128/JVI.00216-09; Bredel M, 2006, J CLIN ONCOL, V24, P274, DOI 10.1200/JCO.2005.02.9405; Cameron JE, 2008, VIROLOGY, V382, P257, DOI 10.1016/j.virol.2008.09.018; Cannell EJ, 1998, FEBS LETT, V439, P297, DOI 10.1016/S0014-5793(98)01391-X; Cheng AY, 2008, CELL CYCLE, V7, P3037, DOI 10.4161/cc.7.19.6736; Choudhuri T, 2007, J VIROL, V81, P6718, DOI 10.1128/JVI.00053-07; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Fosbrink M, 2005, EXP MOL PATHOL, V78, P116, DOI 10.1016/j.yexmp.2004.11.001; Fosbrink M, 2009, EXP MOL PATHOL, V86, P87, DOI 10.1016/j.yexmp.2008.12.005; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Gastwirt RF, 2007, CELL CYCLE, V6, P1188, DOI 10.4161/cc.6.10.4252; GREGORY CD, 1991, NATURE, V349, P612, DOI 10.1038/349612a0; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hertle ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000506; Hochberg D, 2004, P NATL ACAD SCI USA, V101, P239, DOI 10.1073/pnas.2237267100; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jo M, 2006, MOL ENDOCRINOL, V20, P2156, DOI 10.1210/me.2005-0512; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim DS, 2011, CANCER-AM CANCER SOC, V117, P590, DOI 10.1002/cncr.25451; KING W, 1980, J VIROL, V36, P506, DOI 10.1128/JVI.36.2.506-518.1980; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Knight JS, 2005, MOL CELL BIOL, V25, P1749, DOI 10.1128/MCB.25.5.1749-1763.2005; Knight JS, 2004, J VIROL, V78, P12857, DOI 10.1128/JVI.78.23.12857-12867.2004; Knight JS, 2004, J VIROL, V78, P1981, DOI 10.1128/JVI.78.4.1981-1991.2004; Krauer KG, 2004, ONCOGENE, V23, P1342, DOI 10.1038/sj.onc.1207253; Lau YFC, 2003, CYTOGENET GENOME RES, V101, P250, DOI 10.1159/000074345; Lau YFC, 1999, AM J HUM GENET, V64, P921, DOI 10.1086/302353; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; Maruo S, 2006, P NATL ACAD SCI USA, V103, P19500, DOI 10.1073/pnas.0604919104; Maruo S, 2011, P NATL ACAD SCI USA, V108, P1919, DOI 10.1073/pnas.1019599108; MENEZES J, 1975, BIOMEDICINE, V22, P276; O'Nions J, 2003, ONCOGENE, V22, P7181, DOI 10.1038/sj.onc.1206838; O'Nions J, 2006, J VIROL, V80, P12408, DOI 10.1128/JVI.01363-06; Oram SW, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-154; Park ES, 2008, ENDOCRINOLOGY, V149, P3025, DOI 10.1210/en.2007-1129; Parker GA, 1996, ONCOGENE, V13, P2541; Parker GA, 2000, ONCOGENE, V19, P700, DOI 10.1038/sj.onc.1203327; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; Porter LA, 2002, J CELL BIOL, V157, P357, DOI 10.1083/jcb.200109045; Ritzi M, 2003, J CELL SCI, V116, P3971, DOI 10.1242/jcs.00708; Saha A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001275; Saha A, 2011, J VIROL, V85, P2079, DOI 10.1128/JVI.02279-10; Saha A, 2009, J VIROL, V83, P4652, DOI 10.1128/JVI.02408-08; Saigusa K, 2007, ONCOGENE, V26, P1110, DOI 10.1038/sj.onc.1210148; SINCLAIR AJ, 1994, EMBO J, V13, P3321, DOI 10.1002/j.1460-2075.1994.tb06634.x; Skalska L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000951; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Spender LC, 2002, J VIROL, V76, P4919, DOI 10.1128/JVI.76.10.4919-4927.2002; Topisirovic I, 2002, MOL CELL BIOL, V22, P6183, DOI 10.1128/MCB.22.17.6183-6198.2002; Vlaicu SI, 2008, ARCH IMMUNOL THER EX, V56, P115, DOI 10.1007/s00005-008-0016-3; Vlaicu SI, 2010, EXP MOL PATHOL, V88, P67, DOI 10.1016/j.yexmp.2009.10.010; Wade M, 2000, MOL CELL BIOL, V20, P1344, DOI 10.1128/MCB.20.4.1344-1360.2000; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; West MJ, 2004, J VIROL, V78, P9431, DOI 10.1128/JVI.78.17.9431-9445.2004; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; West MJ, 1995, ONCOGENE, V11, P2515; White RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013979; Wotton S, 2008, ONCOGENE, V27, P5856, DOI 10.1038/onc.2008.195; Yi FM, 2009, VIROLOGY, V388, P236, DOI 10.1016/j.virol.2009.03.027; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	77	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28638	10.1371/journal.pone.0028638	http://dx.doi.org/10.1371/journal.pone.0028638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163048	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000298173500044
J	Gilbert, DF; Erdmann, G; Zhang, X; Fritzsche, A; Demir, K; Jaedicke, A; Muehlenberg, K; Wanker, EE; Boutros, M				Gilbert, Daniel F.; Erdmann, Gerrit; Zhang, Xian; Fritzsche, Anja; Demir, Kubilay; Jaedicke, Andreas; Muehlenberg, Katja; Wanker, Erich E.; Boutros, Michael			A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening	PLOS ONE			English	Article							HUNTINGTONS-DISEASE MUTATION; SYNTHETIC LETHALITY; MUTANT HUNTINGTIN; CANCER; DYSFUNCTION; INHIBITORS; TOXICITY; NUCLEUS; PATHWAY	Cell-based high-throughput RNAi screening has become a powerful research tool in addressing a variety of biological questions. In RNAi screening, one of the most commonly applied assay system is measuring the fitness of cells that is usually quantified using fluorescence, luminescence and absorption-based readouts. These methods, typically implemented and scaled to large-scale screening format, however often only yield limited information on the cell fitness phenotype due to evaluation of a single and indirect physiological indicator. To address this problem, we have established a cell fitness multiplexing assay which combines a biochemical approach and two fluorescence-based assaying methods. We applied this assay in a large-scale RNAi screening experiment with siRNA pools targeting the human kinome in different modified HEK293 cell lines. Subsequent analysis of ranked fitness phenotypes assessed by the different assaying methods revealed average phenotype intersections of 50.7 +/- 2.3%-58.7 +/- 14.4% when two indicators were combined and 40-48% when a third indicator was taken into account. From these observations we conclude that combination of multiple fitness measures may decrease false-positive rates and increases confidence for hit selection. Our robust experimental and analytical method improves the classical approach in terms of time, data comprehensiveness and cost.	[Gilbert, Daniel F.; Erdmann, Gerrit; Zhang, Xian; Fritzsche, Anja; Demir, Kubilay; Jaedicke, Andreas; Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; [Gilbert, Daniel F.; Erdmann, Gerrit; Zhang, Xian; Fritzsche, Anja; Demir, Kubilay; Jaedicke, Andreas; Boutros, Michael] Heidelberg Univ, Dept Cell & Mol Biol, Heidelberg, Germany; [Muehlenberg, Katja; Wanker, Erich E.] Max Delbrueck Ctr Mol Med MDC, Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Gilbert, DF (corresponding author), German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany.	daniel.gilbert@mbt.uni-erlangen.de	Boutros, Michael/C-3566-2008; Gilbert, Daniel F./F-8714-2011	Boutros, Michael/0000-0002-9458-817X; Erdmann, Gerrit/0000-0002-4183-3995; /0000-0003-4431-4741; Wanker, Erich/0000-0001-8072-1630	Nationales Genomforschungsnetz Plus (BMBF) [01GS08173]	Nationales Genomforschungsnetz Plus (BMBF)	This project was funded by the Nationales Genomforschungsnetz Plus (BMBF, Grant No. 01GS08173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BRAUTBOUCHER F, 1995, J IMMUNOL METHODS, V178, P41, DOI 10.1016/0022-1759(94)00239-S; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Caviston JP, 2011, MOL BIOL CELL, V22, P478, DOI 10.1091/mbc.E10-03-0233; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiang MC, 2011, BBA-MOL BASIS DIS, V1812, P1111, DOI 10.1016/j.bbadis.2011.05.006; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; da Silveira MG, 2002, APPL ENVIRON MICROB, V68, P6087, DOI 10.1128/AEM.68.12.6087-6093.2002; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; Einav Y, 2003, MOL CANCER THER, V2, P1121; Falschlehner C, 2010, BIOTECHNOL J, V5, P368, DOI 10.1002/biot.200900277; Giacomello M, 2011, BIOFACTORS, V37, P206, DOI 10.1002/biof.162; Godin JD, 2010, EMBO J, V29, P2433, DOI 10.1038/emboj.2010.117; Iglehart JD, 2009, NEW ENGL J MED, V361, P189, DOI 10.1056/NEJMe0903044; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karachitos Andonis, 2010, Postepy Biochem, V56, P174; King MA, 2008, J NEUROSCI, V28, P14401, DOI 10.1523/JNEUROSCI.4751-08.2008; LARSSON R, 1989, ANTICANCER RES, V9, P1111; Licchesi JD, 2010, ONCOGENE; Marcora E, 2010, HUM MOL GENET, V19, P4373, DOI 10.1093/hmg/ddq358; Martin-Aparicio E, 2002, EUR J NEUROSCI, V16, P355, DOI 10.1046/j.1460-9568.2002.02075.x; Mollapour M, 2010, CELL CYCLE, V9; Nguyen AV, 2010, INT J MOL MED, V26, P121, DOI 10.3892/ijmm_00000443; Pelz O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-185; Perrin V, 2009, EXP NEUROL, V215, P191, DOI 10.1016/j.expneurol.2008.10.008; Ross BM, 1998, J NEUROCHEM, V70, P786; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Steffan JS, 2010, CELL CYCLE, V9, P3401, DOI [10.4161/cc.9.17.12718, 10.4161/cc.9.17.12671]; Titus S, 2010, PROBE REPORTS NIH MO; Tomashevski A, 2001, J ALZHEIMERS DIS, V3, P195; Willingham AT, 2004, ONCOGENE, V23, P8392, DOI 10.1038/sj.onc.1208217; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x	36	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28338	10.1371/journal.pone.0028338	http://dx.doi.org/10.1371/journal.pone.0028338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162763	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800026
J	Zou, HD; Zhang, X; Xu, X; Liu, HY; Bai, L; Xu, X				Zou, Haidong; Zhang, Xi; Xu, Xun; Liu, Haiyun; Bai, Lin; Xu, Xian			Vision-Related Quality of Life and Self-Rated Satisfaction Outcomes of Rhegmatogenous Retinal Detachment Surgery: 3-Year Prospective Study	PLOS ONE			English	Article							VITREORETINAL SURGERY; VISUAL FUNCTION; QUESTIONNAIRE; RECOVERY	Background: Subjective functional outcomes measurements, such as vision health-related quality of life (VRQoL) and self-rated satisfaction measures can provide helpful multidimensional vision health information that is more comprehensive than traditional objective measures, such as best corrected visual acuity (BCVA). The purpose of this study is to demonstrate 3-year longitudinal postoperative VRQoL and self-rated satisfaction changes after rhegmatogenous retinal detachment (RRD) surgery. Methodology/Principal Findings: A prospective case series report was conducted in 92 RRD patients who underwent surgery during January 2004 through December 2006. Preoperative, 3-month, 1-year and 3-year postoperative patient VRQoL and self-rated satisfaction were assessed by face-to-face interviews. The importance of objective variables for predicting three dependent variables: CLVQOL composite scores change, 3-year postoperative CVLQOL composite score and self-rated satisfaction degree scores were calculated by stepwise multivariate linear or logistic regression analysis methods. Results: The total CLVQOL composite scores change ranged between -48 and 90 (mean +/- standard deviation: 19.48 +/- 31.34), including positive changes in 62 patients. The self-rated satisfaction degree scores ultimately improved in 86 patients as compared with preoperative degrees. Statistically significant increases occurred only in the composite scores of subscale mobility and self-rated satisfaction degrees in the first 3 months, while the composite scores of the remaining subscales, and the total CLVQOL, BCVA in the RRD eye and weighted average BCVA, increased steadily throughout the first postoperative year. A better 3-year postoperative weighted average BCVA was associated with all of the 3 dependent outcome variables. Conclusions: VRQoL of RRD patients improved substantially after surgery and they were satisfied with their postoperative vision. The BCVA, VRQoL and self-rated satisfactory degree scores recovered in different patterns, and supplemented each other in the RRD surgery outcomes evaluated. Surgeons are advised to pay closer attention to binocular vision in RRD patients, and make efforts to explain the results of surgery.	[Zou, Haidong; Zhang, Xi; Xu, Xun; Liu, Haiyun; Bai, Lin; Xu, Xian] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China.	zouhaidong@hotmail.com		Zou, Haidong/0000-0002-6831-7560	Shanghai Health Bureau; Hong Kong K.C. Wong Education foundation	Shanghai Health Bureau; Hong Kong K.C. Wong Education foundation	Supported by a grant from Shanghai Health Bureau and a grant from Hong Kong K.C. Wong Education foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; HOLLADAY JT, 1991, AM J OPHTHALMOL, V111, P372, DOI 10.1016/S0002-9394(14)72328-1; Kusaka S, 1998, JPN J OPHTHALMOL, V42, P218, DOI 10.1016/S0021-5155(97)00136-6; Liu F, 2006, OPHTHALMOLOGICA, V220, P174, DOI 10.1159/000091761; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; Ranta P, 2002, OPHTHALMOLOGY, V109, P1432, DOI 10.1016/S0161-6420(02)01111-9; Ross W H, 2000, Curr Opin Ophthalmol, V11, P191, DOI 10.1097/00055735-200006000-00007; Scott IU, 1998, OPHTHALMOLOGY, V105, P795, DOI 10.1016/S0161-6420(98)95017-5; Scott IU, 1997, OPHTHALMOLOGY, V104, P1041, DOI 10.1016/S0161-6420(97)30189-4; SULLIVAN PM, 1993, EYE, V7, P433, DOI 10.1038/eye.1993.86; Wolffsohn JS, 2000, AM J OPHTHALMOL, V130, P793, DOI 10.1016/S0002-9394(00)00610-3; Zou H, 2005, QUAL LIFE RES, V14, P1633, DOI 10.1007/s11136-004-0026-5; Zou HD, 2008, OPHTHAL EPIDEMIOL, V15, P212, DOI 10.1080/09286580701843804	14	17	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28597	10.1371/journal.pone.0028597	http://dx.doi.org/10.1371/journal.pone.0028597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162779	Green Published, gold, Green Submitted			2022-12-25	WOS:000298172800052
J	Bartova, E; Sustackova, G; Stixova, L; Kozubek, S; Legartova, S; Foltankova, V				Bartova, Eva; Sustackova, Gabriela; Stixova, Lenka; Kozubek, Stanislav; Legartova, Sona; Foltankova, Veronika			Recruitment of Oct4 Protein to UV-Damaged Chromatin in Embryonic Stem Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE; ES CELLS; HETEROCHROMATIN PROTEIN-1; GENE-EXPRESSION; POU DOMAIN; DIFFERENTIATION; REPAIR; NANOG	Background Oct4 is a specific marker of embryonic stem cell (ESC) pluripotency. However, little is known regarding how Oct4 responds to DNA damage. Here, we investigated whether Oct4 recognizes damaged chromatin in mouse ESCs stably expressing GFP-Oct4. These experiments should contribute to the knowledge of how ESC genomic integrity is maintained, which is crucial for potential application of human ESCs in regenerative medicine. Methodology/Principal Findings: We used time-lapse confocal microscopy, microirradiation by UV laser (355 nm), induction of DNA lesions by specific agents, and GFP technology to study the Oct4 response to DNA damage. We found that Oct4 accumulates in UV-damaged regions immediately after irradiation in an adenosine triphosphate-dependent manner. Intriguingly, this event was not accompanied by pronounced Nanog and c-MYC recruitment to the UV-damaged sites. The accumulation of Oct4 to UV-damaged chromatin occurred simultaneously with H3K9 deacetylation and H2AX phosphorylation (gamma H2AX). Moreover, we observed an ESC-specific nuclear distribution of gamma H2AX after interference to cellular processes, including histone acetylation, transcription, and cell metabolism. Inhibition of histone deacetylases mostly prevented pronounced Oct4 accumulation at UV-irradiated chromatin. Conclusions/Significance: Our studies demonstrate pluripotency-specific events that accompany DNA damage responses. Here, we discuss how ESCs might respond to DNA damage caused by genotoxic injury that might lead to unwanted genomic instability.	[Bartova, Eva; Sustackova, Gabriela; Stixova, Lenka; Kozubek, Stanislav; Legartova, Sona; Foltankova, Veronika] Acad Sci Czech Republ, Inst Biophys, Dept Mol Cytol & Cytometry, CS-61265 Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Bartova, E (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Mol Cytol & Cytometry, Kralovopolska 135, CS-61265 Brno, Czech Republic.	bartova@ibp.cz	Stixová, Lenka/H-1909-2014; Bartova, Eva/H-1945-2014; Kozubek, Stanislav/H-1953-2014; Kozubek, Stanislav/N-2490-2013	Bartova, Eva/0000-0003-1299-0470; Kozubek, Stanislav/0000-0003-3016-2687	Ministry of Education Youth and Sports of the Czech Republic [LC535, LC06027, ME 919]; Academy of Sciences of the Czech Republic [AVOZ50040702, AVOZ50040507]; Grant Agency of the Czech Republic [P302/10/1022]; European Union [TD09/05]; Maria Curie project [PIRSES-GA-2010-269156]	Ministry of Education Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Union(European Commission); Maria Curie project	This work was supported by the Ministry of Education Youth and Sports of the Czech Republic; the research projects LC535, LC06027, and ME 919. The Academy of Sciences of the Czech Republic supported this work by projects AVOZ50040702 and AVOZ50040507 and the Grant Agency of the Czech Republic by grant no. P302/10/1022. The work was also supported by European Union project COST TD09/05 and corresponding national COST-CZ project LC11020. This study was partly supported by Maria Curie project PIRSES-GA-2010-269156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Banath JP, 2009, EXP CELL RES, V315, P1505, DOI 10.1016/j.yexcr.2008.12.007; Bartova E, 2000, LEUKEMIA RES, V24, P233, DOI 10.1016/S0145-2126(99)00174-5; Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x; Bartova E, 2011, J MOL BIOL, V405, P679, DOI 10.1016/j.jmb.2010.11.001; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; de Waard H, 2008, DNA REPAIR, V7, P1659, DOI 10.1016/j.dnarep.2008.06.009; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Giglia-Mari G, 2010, DNA DAMAGE RESPONSE, P361; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Jiang JM, 2008, CELL STEM CELL, V3, P127, DOI 10.1016/j.stem.2008.07.011; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Kruhlak MJ, 2006, CELL CYCLE, V5, P1910, DOI 10.4161/cc.5.17.3169; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; RAMANATHAN B, 1986, CARCINOGENESIS, V7, P1087, DOI 10.1093/carcin/7.7.1087; Reim G, 2004, DEV CELL, V6, P91, DOI 10.1016/S1534-5807(03)00396-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Stixova L, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-5; Sustackova G, 2011, J CELL PHYSL; Sustackova G., 2011, STEM CELLS DEV; Suzuki K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq226; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613	50	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27281	10.1371/journal.pone.0027281	http://dx.doi.org/10.1371/journal.pone.0027281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164208	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400008
J	Correia, C; Grayson, WL; Park, M; Hutton, D; Zhou, B; Guo, XE; Niklason, L; Sousa, RA; Reis, RL; Vunjak-Novakovic, G				Correia, Cristina; Grayson, Warren L.; Park, Miri; Hutton, Daphne; Zhou, Bin; Guo, X. Edward; Niklason, Laura; Sousa, Rui A.; Reis, Rui L.; Vunjak-Novakovic, Gordana			In Vitro Model of Vascularized Bone: Synergizing Vascular Development and Osteogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERED BONE; ENDOTHELIAL-CELLS; OSTEOBLAST DIFFERENTIATION; MATURE OSTEOBLASTS; HOST VASCULATURE; BLOOD-VESSELS; ANGIOGENESIS; COMMUNICATION; ANASTOMOSIS	Tissue engineering provides unique opportunities for regenerating diseased or damaged tissues using cells obtained from tissue biopsies. Tissue engineered grafts can also be used as high fidelity models to probe cellular and molecular interactions underlying developmental processes. In this study, we co-cultured human umbilical vein endothelial cells (HUVECs) and human mesenchymal stem cells (MSCs) under various environmental conditions to elicit synergistic interactions leading to the colocalized development of capillary-like and bone-like tissues. Cells were encapsulated at the 1:1 ratio in fibrin gel to screen compositions of endothelial growth medium (EGM) and osteogenic medium (OM). It was determined that, to form both tissues, co-cultures should first be supplied with EGM followed by a 1:1 cocktail of the two media types containing bone morphogenetic protein-2. Subsequent studies of HUVECs and MSCs cultured in decellularized, trabecular bone scaffolds for 6 weeks assessed the effects on tissue construct of both temporal variations in growth-factor availability and addition of fresh cells. The resulting grafts were implanted subcutaneously into nude mice to determine the phenotype stability and functionality of engineered vessels. Two important findings resulted from these studies: (i) vascular development needs to be induced prior to osteogenesis, and (ii) the addition of additional hMSCs at the osteogenic induction stage improves both tissue outcomes, as shown by increased bone volume fraction, osteoid deposition, close proximity of bone proteins to vascular networks, and anastomosis of vascular networks with the host vasculature. Interestingly, these observations compare well with what has been described for native development. We propose that our cultivation system can mimic various aspects of endothelial cell -osteogenic precursor interactions in vivo, and could find utility as a model for studies of heterotypic cellular interactions that couple blood vessel formation with osteogenesis.	[Correia, Cristina; Grayson, Warren L.; Park, Miri; Zhou, Bin; Guo, X. Edward; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Grayson, Warren L.; Hutton, Daphne] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Niklason, Laura] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Correia, Cristina; Sousa, Rui A.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal	Columbia University; Johns Hopkins University; Yale University; Universidade do Minho	Correia, C (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	gv2131@columbia.edu	Reis, Rui L./A-8938-2008; vunjak-novakovic, gordana/J-9279-2012	Reis, Rui L./0000-0002-4295-6129; Sousa, Rui/0000-0003-0362-7418; Correia, Cristina/0000-0002-4979-3254; Vunjak-Novakovic, Gordana/0000-0002-9382-1574; UMinho, 3B's Research Group/0000-0002-5195-3456	National Institutes of Health [DE161525, EB02520]; Orthopaedic Research Society (ORS); Fundacao para a Ciencia e a Tecnologia of Portugal; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Orthopaedic Research Society (ORS); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding support of this work was provided by the National Institutes of Health (DE161525 and EB02520 to GVN), the Orthopaedic Research Society (ORS) Career Development Award (to WLG), and the Fundacao para a Ciencia e a Tecnologia of Portugal (PhD grant to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058; Bidarra SJ, 2011, STEM CELL RES, V7, P186, DOI 10.1016/j.scr.2011.05.006; Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521; Clarkin CE, 2008, EXP CELL RES, V314, P3152, DOI 10.1016/j.yexcr.2008.07.027; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Grayson WL, 2010, OSTEOARTHR CARTILAGE, V18, P714, DOI 10.1016/j.joca.2010.01.008; Grayson WL, 2008, TISSUE ENG PT A, V14, P1809, DOI 10.1089/ten.tea.2007.0255; Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024; Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106; Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; Ingber DE, 2007, DEVELOPMENT, V134, P2541, DOI 10.1242/dev.003707; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Klein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020540; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Koob S, 2010, BRIT J SURG, V97, pS55; Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI [10.1089/ten.tea.2010.0338, 10.1089/ten.TEA.2010.0338]; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu XWS, 2006, J BONE MINER RES, V21, P1608, DOI 10.1359/JBMR.060716; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meury T, 2006, J CELL BIOCHEM, V98, P992, DOI 10.1002/jcb.20818; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685; Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107; Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057; Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142; VILLANUEVA JE, 1990, J BONE MINER RES, V5, P733; Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Zhang FJ, 2009, J BONE MINER RES, V24, P1224, DOI [10.1359/JBMR.090204, 10.1359/jbmr.090204]	41	94	99	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28352	10.1371/journal.pone.0028352	http://dx.doi.org/10.1371/journal.pone.0028352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164277	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400078
J	Wardman, JH; Berezniuk, I; Di, S; Tasker, JG; Fricker, LD				Wardman, Jonathan H.; Berezniuk, Iryna; Di, Shi; Tasker, Jeffrey G.; Fricker, Lloyd D.			ProSAAS-Derived Peptides are Colocalized with Neuropeptide Y and Function as Neuropeptides in the Regulation of Food Intake	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NEUROENDOCRINE POLYPEPTIDE 7B2; PROHORMONE CONVERTASE PC2; MOUSE-BRAIN; MASS-SPECTROMETRY; GENE-EXPRESSION; ARCUATE NUCLEUS; NEURONS; RAT; NPY	ProSAAS is the precursor of a number of peptides that have been proposed to function as neuropeptides. Because proSAAS mRNA is highly expressed in the arcuate nucleus of the hypothalamus, we examined the cellular localization of several proSAAS-derived peptides in the mouse hypothalamus and found that they generally colocalized with neuropeptide Y (NPY), but not a-melanocyte stimulating hormone. However, unlike proNPY mRNA, which is upregulated by food deprivation in the mediobasal hypothalamus, neither proSAAS mRNA nor proSAAS-derived peptides were significantly altered by 1-2 days of food deprivation in wild-type mice. Furthermore, while proSAAS mRNA levels in the mediobasal hypothalamus were significantly lower in Cpe(fat/fat) mice as compared to wild-type littermates, proNPY mRNA levels in the mediobasal hypothalamus and in other subregions of the hypothalamus were not significantly different between wild-type and Cpe(fat/fat) mice. Intracerebroventricular injections of antibodies to two proSAAS-derived peptides (big LEN and PEN) significantly reduced food intake in fasted mice, while injections of antibodies to two other proSAAS-derived peptides (little LEN and little SAAS) did not. Whole-cell patch clamp recordings of parvocellular neurons in the hypothalamic paraventricular nucleus, a target of arcuate NPY projections, showed that big LEN produced a rapid and reversible inhibition of synaptic glutamate release that was spike independent and abolished by blocking postsynaptic G protein activity, suggesting the involvement of a postsynaptic G protein-coupled receptor and the release of a retrograde synaptic messenger. Taken together with previous studies, these findings support a role for proSAAS-derived peptides such as big LEN as neuropeptides regulating food intake.	[Wardman, Jonathan H.; Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY 10333 USA; [Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA; [Di, Shi; Tasker, Jeffrey G.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Tasker, Jeffrey G.] Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA	Yeshiva University; Yeshiva University; Tulane University; Tulane University	Wardman, JH (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY 10333 USA.	lloyd.fricker@einstein.yu.edu	Tasker, Jeffrey/J-4879-2014	Tasker, Jeffrey/0000-0003-1977-4199	National Institutes of Health [DA-04494, MH066958]; FAPESP; INCT Bioanalitica; CNPq; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT Bioanalitica; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported primarily by National Institutes of Health grants DA-04494 (to LDF) and MH066958 (to JGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Mass spectrometry was performed in the Dalton Mass Spectrometry Laboratory at the Institute of Chemistry, University of Campinas, Brazil, directed by Prof. Fabio Gozzo and supported by FAPESP, INCT Bioanalitica and CNPq. Thanks to Leandro Castro and Dr. Emer Ferro for assistance with the mass spectrometry. Thanks to Dr. Clemence Blouet and Dr. Gary Schwartz for the gift of the NPY-GFP mice and advice on qRTPCR and immunohistochemistry. Thanks to Dr. Iris Lindberg for the gift of an antiserum to little LEN.	Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Atkins N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012612; Berezniuk I, 2011, RECEPT SER, P93, DOI 10.1007/978-1-60761-993-2_5; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, J BIOL CHEM, V280, P4451, DOI 10.1074/jbc.M411178200; Che FY, 2002, ANAL CHEM, V74, P3190, DOI 10.1021/ac015681a; DAVIES L, 1994, AM J PHYSIOL, V266, pR1687, DOI 10.1152/ajpregu.1994.266.5.R1687; DICKERSON IM, 1990, J BIOL CHEM, V265, P2462; EIPPER BA, 1986, TRENDS NEUROSCI, V9, P463, DOI 10.1016/0166-2236(86)90149-9; Feng Y, 2001, NEUROSCIENCE, V105, P469, DOI 10.1016/S0306-4522(01)00200-7; Feng Yun, 2002, Brain Res Gene Expr Patterns, V1, P135; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Fricker LD, 1999, TRENDS BIOCHEM SCI, V24, P390, DOI 10.1016/S0968-0004(99)01448-6; FRICKER LD, 1998, HDB PROTEOLYTIC ENZY, P1341; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; HSI KL, 1982, FEBS LETT, V147, P261, DOI 10.1016/0014-5793(82)81055-7; Legradi G, 1998, ENDOCRINOLOGY, V139, P3262, DOI 10.1210/en.139.7.3262; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lindberg I., 1991, PEPTIDE BIOSYNTHESIS; Luque RM, 2007, ENDOCRINOLOGY, V148, P300, DOI 10.1210/en.2006-0592; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; MAINS RE, 1990, FRONT NEUROENDOCRIN, V11, P52; MARTENS GJM, 1994, P NATL ACAD SCI USA, V91, P5784, DOI 10.1073/pnas.91.13.5784; Mercer JG, 1996, PHYSIOL BEHAV, V60, P121, DOI 10.1016/0031-9384(95)02255-4; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Morgan DJ, 2010, J NEUROCHEM; Mzhavia N, 2002, BIOCHEM J, V361, P67, DOI 10.1042/0264-6021:3610067; Mzhavia N, 2001, J BIOL CHEM, V276, P6207, DOI 10.1074/jbc.M009067200; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; PAEZ X, 1991, PEPTIDES, V12, P609, DOI 10.1016/0196-9781(91)90109-3; PAEZ XM, 1991, PHARMACOL BIOCHEM BE, V38, P379, DOI 10.1016/0091-3057(91)90295-D; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Qian YM, 2000, J BIOL CHEM, V275, P23596, DOI 10.1074/jbc.M001583200; Sayah M, 2001, J NEUROCHEM, V76, P1833, DOI 10.1046/j.1471-4159.2001.00165.x; SCHWARTZ MW, 1993, BRAIN RES BULL, V31, P361, DOI 10.1016/0361-9230(93)90228-4; Seidah NG, 1998, HDB PROTEOLYTIC ENZY; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; TASKER JG, 1991, J PHYSIOL-LONDON, V434, P271, DOI 10.1113/jphysiol.1991.sp018469; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; VANHORSSEN AM, 1995, J BIOL CHEM, V270, P14292; Wardman JH, QUANTITATIV IN PRESS; Wardman JH, 2010, J NEUROCHEM, V114, P215, DOI 10.1111/j.1471-4159.2010.06760.x; Wei SW, 2004, J ENDOCRINOL, V180, P357, DOI 10.1677/joe.0.1800357; Yokosuka M, 1999, ENDOCRINOLOGY, V140, P4494, DOI 10.1210/en.140.10.4494; Zhang X, 2010, J NEUROCHEM, V112, P1168, DOI 10.1111/j.1471-4159.2009.06530.x; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	49	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28152	10.1371/journal.pone.0028152	http://dx.doi.org/10.1371/journal.pone.0028152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164236	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400037
J	Sharma, A; Bode, B; Wenger, RH; Lehmann, K; Sartori, AA; Moch, H; Knuth, A; von Boehmer, L; van den Broek, M				Sharma, Anu; Bode, Beata; Wenger, Roland H.; Lehmann, Kuno; Sartori, Alessandro A.; Moch, Holger; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries			gamma-Radiation Promotes Immunological Recognition of Cancer Cells through Increased Expression of Cancer-Testis Antigens In Vitro and In Vivo	PLOS ONE			English	Article							CD8(+) T-CELLS; DNA-DAMAGE RESPONSE; GENE-EXPRESSION; TUMOR; IMMUNOTHERAPY; MELANOMA; THERAPY; ATM; RADIOTHERAPY; INDIVIDUALS	Background: gamma-radiation is an effective treatment for cancer. There is evidence that radiotherapy supports tumor-specific immunity. It was described that irradiation induces de novo protein synthesis and enhances antigen presentation, we therefore investigated whether gamma-radiation results in increased expression of cancer-testis (CT) antigens and MHC-I, thus allowing efficient immunological control. This is relevant because the expression of CT-antigens and MHC-I on tumor cells is often heterogeneous. We found that the changes induced by gamma-radiation promote the immunological recognition of the tumor, which is illustrated by the increased infiltration by lymphocytes after radiotherapy. Methods/Findings: We compared the expression of CT-antigens and MHC-I in various cancer cell lines and fresh biopsies before and after in vitro irradiation (20 Gy). Furthermore, we compared paired biopsies that were taken before and after radiotherapy from sarcoma patients. To investigate whether the changed expression of CT-antigens and MHC-I is specific for gamma-radiation or is part of a generalized stress response, we analyzed the effect of hypoxia, hyperthermia and genotoxic stress on the expression of CT-antigens and MHC-I. In vitro irradiation of cancer cell lines and of fresh tumor biopsies induced a higher or de novo expression of different CT-antigens and a higher expression of MHC-I in a time-and dose-dependent fashion. Importantly, we show that irradiation of cancer cells enhances their recognition by tumor-specific CD8+ T cells. The analysis of paired biopsies taken from a cohort of sarcoma patients before and after radiotherapy confirmed our findings and, in addition showed that irradiation resulted in higher infiltration by lymphocytes. Other forms of stress did not have an impact on the expression of CT-antigens or MHC-I. Conclusions: Our findings suggest that gamma-radiation promotes the immunological recognition of the tumor. We therefore propose that combining radiotherapy with treatments that support tumor specific immunity may result in increased therapeutic efficacy.	[Sharma, Anu; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland; [Bode, Beata; Moch, Holger] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Wenger, Roland H.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Lehmann, Kuno] Univ Zurich Hosp, Dept Visceral Surg, CH-8091 Zurich, Switzerland; [Sartori, Alessandro A.] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich	Sharma, A (corresponding author), Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland.	maries@van-den-broek.ch	van den Broek, Maries/L-6532-2019; Sartori, Alessandro/AAK-7840-2021; Lehmann, Kuno/M-8504-2016; Wenger, Roland H./B-7953-2009; knuth, alexander/H-2608-2014	Sartori, Alessandro/0000-0003-2770-0333; Lehmann, Kuno/0000-0002-6177-9543; Wenger, Roland H./0000-0001-7592-4839; knuth, alexander/0000-0002-9318-2784; SHARMA, ANU/0000-0002-5934-994X	Ludwig Institute for Cancer Research/Cancer Research Institute (Cancer Antigen Discovery Collaborative); Cancer Research Institute; Hanne Liebermann Foundation; Hartmann Muller Foundation; Terry Fox Foundation; Ellinger Foundation; Med Alumini University of Zurich; Vontobel-Foundation; Swiss National Science Foundation (SNSF)	Ludwig Institute for Cancer Research/Cancer Research Institute (Cancer Antigen Discovery Collaborative); Cancer Research Institute; Hanne Liebermann Foundation; Hartmann Muller Foundation; Terry Fox Foundation; Ellinger Foundation; Med Alumini University of Zurich; Vontobel-Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by the Ludwig Institute for Cancer Research/Cancer Research Institute (Cancer Antigen Discovery Collaborative), Atlantic Philanthropies, the Cancer Research Institute, the Hanne Liebermann Foundation, the Hartmann Muller Foundation, the Terry Fox Foundation and the Ellinger Foundation, Med Alumini University of Zurich (www.alumuni.uzh.ch). Alessandro A. Sartori is supported by the Vontobel-Foundation and by an Ambizione fellowship from the Swiss National Science Foundation (SNSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BYERS VS, 1975, J CLIN INVEST, V55, P500, DOI 10.1172/JCI107956; Chiriva-Internati M, 2006, IN VITRO CELL DEV-AN, V42, P89; Coral S, 2002, CLIN CANCER RES, V8, P2690; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; HAUSER SH, 1993, CANCER RES, V53, P1952; Horig H, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S146239940000168X; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jang ER, 2010, EXP MOL MED, V42, P195, DOI 10.3858/emm.2010.42.3.020; Karanikas V, 2009, J BUON, V14, pS153; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Mairs Robert J., 2007, Dose-Response, V5, P204, DOI 10.2203/dose-response.07-002.Mairs; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; NORTH RJ, 1984, CANCER IMMUNOL IMMUN, V16, P175; Pandey R, 2005, INT J RADIAT BIOL, V81, P801, DOI 10.1080/09553000500531886; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Parmigiani RB, 2006, P NATL ACAD SCI USA, V103, P18066, DOI 10.1073/pnas.0608853103; PENN I, 1988, ANNU REV MED, V39, P63, DOI 10.1146/annurev.me.39.020188.000431; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schulz TF, 2009, INT J CANCER, V125, P1755, DOI 10.1002/ijc.24741; Shiao SL, 2010, J MAMMARY GLAND BIOL, V15, P411, DOI 10.1007/s10911-010-9194-9; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Suni MA, 2005, CURR OPIN IMMUNOL, V17, P434, DOI 10.1016/j.coi.2005.05.002; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; van der Bruggen P, 2007, J IMMUNOL, V178, P2617; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229	38	94	100	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28217	10.1371/journal.pone.0028217	http://dx.doi.org/10.1371/journal.pone.0028217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140550	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000298166300039
J	Tominaga, W; Matsubayashi, J; Furuya, M; Matsuhashi, M; Mima, T; Fukuyama, H; Mitani, A				Tominaga, Wataru; Matsubayashi, Jun; Furuya, Makiko; Matsuhashi, Masao; Mima, Tatsuya; Fukuyama, Hidenao; Mitani, Akira			Asymmetric Activation of the Primary Motor Cortex during Observation of a Mirror Reflection of a Hand	PLOS ONE			English	Article							PAIN SYNDROME TYPE-1; PHANTOM LIMB PAIN; VISUAL FEEDBACK; 20-HZ ACTIVITY; THERAPY; STROKE; REHABILITATION; HEMIPARESIS; IMAGERY; RHYTHMS	Mirror therapy is an effective technique for pain relief and motor function recovery. It has been demonstrated that magnetic 20-Hz activity is induced in the primary motor cortex (M1) after median nerve stimulation and that the amount of the stimulus-induced 20-Hz activity is decreased when the M1 is activated. In the present study, we investigated how the image or the mirror reflection of a hand holding a pencil modulates the stimulus-induced 20-Hz activity in the M1. Neuromagnetic brain activity was recorded from 13 healthy right-handed subjects while they were either viewing directly their hand holding a pencil or viewing a mirror reflection of their hand holding a pencil. The 20-Hz activity in the left or the right M1 was examined after the right or the left median nerve stimulation, respectively, and the suppression of the stimulus-induced 20-Hz in the M1 by viewing directly one hand holding a pencil or by viewing the mirror image of the hand holding a pencil was assumed to indicate the activation of the M1. The results indicated that the M1 innervating the dominant hand was suppressed either by viewing directly the dominant hand holding a pencil or by viewing the mirror image of the non-dominant hand holding a pencil. On the other hand, the M1 innervating the non-dominant hand was activated by viewing the mirror image of the dominant hand holding a pencil, but was not activated by viewing directly the non-dominant hand holding a pencil. The M1 innervating either the dominant or the non-dominant hand, however, was not activated by viewing the hand on the side ipsilateral to the M1 examined or the mirror image of the hand on the side contralateral to the M1 exaimined. Such activation of the M1 might induce some therapeutic effects of mirror therapy.	[Tominaga, Wataru; Matsubayashi, Jun; Furuya, Makiko; Mitani, Akira] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Lab Neurorehabil, Kyoto, Japan; [Matsuhashi, Masao; Mima, Tatsuya; Fukuyama, Hidenao] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University	Tominaga, W (corresponding author), Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Lab Neurorehabil, Kyoto, Japan.	amitani@hs.med.kyoto-u.ac.jp	Fukuyama, Hidenao/AAI-7118-2020	Mima, Tatsuya/0000-0001-7787-4855; Matsubayashi, Jun/0000-0003-4104-6833	Japan Society for the Promotion of Science [22300187, 21613003, 21700288, 21700529]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is partly supported by Grants-in-Aid for Scientific Research (B) 22300187 (to A.M.) and (C) 21613003 (to T.M.), and for Young Scientists (B) 21700288 (to M.M.) and (B) 21700529 (to J.M.) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altschuler EL, 1999, LANCET, V353, P2035, DOI 10.1016/S0140-6736(99)00920-4; Cacchio A, 2009, NEW ENGL J MED, V361, P634, DOI 10.1056/NEJMc0902799; Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Garry MI, 2005, EXP BRAIN RES, V163, P118, DOI 10.1007/s00221-005-2226-9; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Ichikawa A, 2007, NEUROSCI RES, V58, P285, DOI 10.1016/j.neures.2007.03.012; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Mercier C, 2009, NEUROREHAB NEURAL RE, V23, P587, DOI 10.1177/1545968308328717; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Ro T, 2004, J COGNITIVE NEUROSCI, V16, P24, DOI 10.1162/089892904322755520; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Stevens JA, 2003, ARCH PHYS MED REHAB, V84, P1090, DOI 10.1016/S0003-9993(03)00042-X; Tominaga W, 2009, NEUROIMAGE, V46, P500, DOI 10.1016/j.neuroimage.2009.02.021; Touzalin-Chretien P, 2008, J NEUROPHYSIOL, V100, P19, DOI 10.1152/jn.90260.2008; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162	21	15	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28226	10.1371/journal.pone.0028226	http://dx.doi.org/10.1371/journal.pone.0028226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140555	gold, Green Published, Green Submitted			2022-12-25	WOS:000298166300041
J	Khanal, P; Yun, HJ; Lim, SC; Ahn, SG; Yoon, HE; Kang, KW; Hong, R; Choi, HS				Khanal, P.; Yun, H. J.; Lim, S. C.; Ahn, S. G.; Yoon, H. E.; Kang, K. W.; Hong, R.; Choi, H. S.			Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells	ONCOGENE			English	Article						Pin1; CDK10; ubiquitination; Raf-1; tamoxifen resistance	ESTROGEN-RECEPTOR; GROWTH-FACTOR; INDEPENDENT GROWTH; THERAPEUTIC TARGET; ENDOCRINE THERAPY; ALPHA EXPRESSION; RAF-1 KINASE; PHOSPHORYLATION; PATHWAY; IDENTIFICATION	Endocrine therapies that inhibit estrogen receptor (ER)-alpha signaling are the most common and effective treatment for ER-a-positive breast cancer. However, the use of these agents is limited by the frequent development of resistance. The aim of this study was to elucidate the mechanisms by which downregulation of CDK10 expression confers resistance to tamoxifen in breast cancer. Here, we show that peptidyl-prolyl isomerase Pin1 downregulates CDK10 protein as a result of its interaction with and ubiquitination of CDK10, thereby affecting CDK10-dependent Raf-1 phosphorylation (S338). Pin1(-/-) mouse embryonic fibroblasts (MEFs) show higher CDK10 expression than Pin1(+/+) MEFs, whereas CDK10 protein was downregulated in the rescued Pin1(-/-) MEFs after reexpression of Pin1. Pin1 silencing in SKBR-3 and MCF7 cells increased the CDK10 expression. In human tamoxifen-resistant breast cancer and tamoxifen-resistant MCF7 cells, immunohistochemical staining and immunoblotting analysis shows an inverse correlation between the expression of CDK10 and the degree of tamoxifen resistance. There was also a positive correlation between the high level of P-Raf-1 (Ser338) and Pin1 in human tamoxifen-resistant breast cancer and tamoxifen-resistant MCF7 (TAMR-MCF7) cells. Importantly, 4-OH tamoxifen (4-OHT), when used in combination with overexpressed CDK10 or Raf-1 inhibitor, increased cleaved PARP and DNA fragmentation to inhibit cologenic growth of MCF7 cells and Tamoxifen-resistant MCF7 cells, respectively. On the basis of these findings, we suggest that the Pin1-mediated CDK10 ubiquitination is a major regulator of tamoxifen-resistant breast cancer cell growth and survival. Oncogene (2012) 31, 3845-3856; doi:10.1038/onc.2011.548; published online 12 December 2011	[Khanal, P.; Yun, H. J.; Kang, K. W.; Choi, H. S.] Chosun Univ, Coll Pharm, Project Team BK21, Kwangju 501759, South Korea; [Lim, S. C.; Hong, R.] Chosun Univ, Sch Med, Dept Pathol, Kwangju 501759, South Korea; [Ahn, S. G.; Yoon, H. E.] Chosun Univ, Sch Dent, Dept Pathol, Kwangju 501759, South Korea	Chosun University; Chosun University; Chosun University	Choi, HS (corresponding author), Chosun Univ, Coll Pharm, Project Team BK21, Kwangju 501759, South Korea.	chs@chosun.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2009-0073468, 2010-0009728]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2009-0073468 and 2010-0009728).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; BRAMBILLA R, 1994, ONCOGENE, V9, P3037; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; ElAshry D, 1997, ONCOGENE, V15, P423, DOI 10.1038/sj.onc.1201198; Finn G, 2008, CURR CANCER DRUG TAR, V8, P223, DOI 10.2174/156800908784293622; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Heller G, 2009, ANTICANCER RES, V29, P3939; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Lee M, 2003, CANCER LETT, V193, P57, DOI 10.1016/S0304-3835(02)00722-X; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; LI S, 1995, CANCER RES, V55, P3992; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; McGlynn LM, 2009, CLIN CANCER RES, V15, P1487, DOI 10.1158/1078-0432.CCR-07-4967; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Namgoong GM, 2010, J BIOL CHEM, V285, P23829, DOI 10.1074/jbc.M109.092874; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Trowbridge JM, 1997, P NATL ACAD SCI USA, V94, P10132, DOI 10.1073/pnas.94.19.10132; Valabrega G, 2011, BREAST CANCER RES TR, V130, P29, DOI 10.1007/s10549-010-1281-5; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Yoshiji H, 2004, HEPATOLOGY, V39, P1517, DOI 10.1002/hep.20218; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	39	34	36	6	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	34					3845	3856		10.1038/onc.2011.548	http://dx.doi.org/10.1038/onc.2011.548			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IV	22158035	Bronze			2022-12-25	WOS:000307925000002
J	Chiang, CY; Veckman, V; Limmer, K; David, M				Chiang, Chih-Yuan; Veckman, Ville; Limmer, Kirsten; David, Michael			Phospholipase C gamma-2 and Intracellular Calcium Are Required for Lipopolysaccharide-induced Toll-like Receptor 4 (TLR4) Endocytosis and Interferon Regulatory Factor 3 (IRF3) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA PRODUCTION; TOLL-LIKE-RECEPTOR-4; INNATE; MICE; MUTATIONS; DYNAMICS; CA2+; CELL; SYK	Toll-like receptor 4 (TLR4) is unique among the TLRs in its use of multiple adaptor proteins leading to activation of both the interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-kappa B) pathways. Previous work has demonstrated that TLR4 initiates NF-kappa B activation from the plasma membrane, but that subsequent TLR4 translocation to the endosomes is required for IRF3 activation. Here we have characterized several components of the signaling pathway that governs TLR4 translocation and subsequent IRF3 activation. We find that phospholipase C gamma 2 (PLC gamma 2) accounts for LPS-induced inositol 1,4,5-trisphosphate (IP3) production and subsequent calcium (Ca2+) release. Blockage of PLC gamma 2 function by inhibitors or knockdown of PLC gamma 2 expression by siRNAs in RAW 264.7 macrophages lead to reduced IRF3, but enhanced NF-kappa B activation. In addition, bone marrow-derived macrophages from PLC gamma 2-deficient mice showed impaired IRF3 phosphorylation and expression of IRF3-regulated genes after LPS stimulation. Using cell fractionation, we show that PLC gamma 2-IP3-Ca2+ signaling cascade is required for TLR4 endocytosis following LPS stimulation. In conclusion, our results describe a novel role of the PLC gamma 2-IP3-Ca2+ cascade in the LPS-induced innate immune response pathway where release of intracellular Ca2+ mediates TLR4 trafficking and subsequent activation of IRF3.	[Chiang, Chih-Yuan; Veckman, Ville; Limmer, Kirsten; David, Michael] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	David, M (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr,Bonner Hall 3138, La Jolla, CA 92093 USA.	midavid@ucsd.edu			National Institutes of Health [R01 AI 047182]; Academy of Finland; Sigrid Juselius Foundation; Finnish Cultural Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI 047182 (to M. D.) and grants from the Academy of Finland, Sigrid Juselius Foundation, and Finnish Cultural Foundation (to V. V.).	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Chiang E, 2006, J IMMUNOL, V176, P5720, DOI 10.4049/jimmunol.176.10.5720; Cremasco V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008909; Dang O, 2004, SHOCK, V21, P470, DOI 10.1097/00024382-200405000-00012; Dearden-Badet MT, 2005, CELL SIGNAL, V17, P1560, DOI 10.1016/j.cellsig.2005.03.018; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hagen E, 1999, J LIPID RES, V40, P309; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Jin SW, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/36192; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Watanabe N, 1996, J BIOCHEM-TOKYO, V120, P1190; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	27	83	87	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3704	3709		10.1074/jbc.C111.328559	http://dx.doi.org/10.1074/jbc.C111.328559			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158869	Green Published, hybrid			2022-12-25	WOS:000300410900008
J	Acosta-Martin, AE; Panchaud, A; Chwastyniak, M; Dupont, A; Juthier, F; Gautier, C; Jude, B; Amouyel, P; Goodlett, DR; Pinet, F				Acosta-Martin, Adelina E.; Panchaud, Alexandre; Chwastyniak, Maggy; Dupont, Annabelle; Juthier, Francis; Gautier, Corinne; Jude, Brigitte; Amouyel, Philippe; Goodlett, David R.; Pinet, Florence			Quantitative Mass Spectrometry Analysis Using PAcIFIC for the Identification of Plasma Diagnostic Biomarkers for Abdominal Aortic Aneurysm	PLOS ONE			English	Article							SHOTGUN PROTEOMICS; OXIDATIVE STRESS; RISK-FACTORS; PROTEIN; INHIBITOR; PATHOGENESIS; INFLAMMATION; PROJECT; HEALTH; MODEL	Background: Abdominal aortic aneurysm (AAA) is characterized by increased aortic vessel wall diameter (>1.5 times normal) and loss of parallelism. This disease is responsible for 1-4% mortality occurring on rupture in males older than 65 years. Due to its asymptomatic nature, proteomic techniques were used to search for diagnostic biomarkers that might allow surgical intervention under nonlife threatening conditions. Methodology/Principal Findings: Pooled human plasma samples of 17 AAA and 17 control patients were depleted of the most abundant proteins and compared using a data-independent shotgun proteomic strategy, Precursor Acquisition Independent From Ion Count (PAcIFIC), combined with spectral counting and isobaric tandem mass tags. Both quantitative methods collectively identified 80 proteins as statistically differentially abundant between AAA and control patients. Among differentially abundant proteins, a subgroup of 19 was selected according to Gene Ontology classification and implication in AAA for verification by Western blot (WB) in the same 34 individual plasma samples that comprised the pools. From the 19 proteins, 12 were detected by WB. Five of them were verified to be differentially up-regulated in individual plasma of AAA patients: adiponectin, extracellular superoxide dismutase, protein AMBP, kallistatin and carboxypeptidase B2. Conclusions/Significance: Plasma depletion of high abundance proteins combined with quantitative PAcIFIC analysis offered an efficient and sensitive tool for the screening of new potential biomarkers of AAA. However, WB analysis to verify the 19 PAcIFIC identified proteins of interest proved inconclusive save for five proteins. We discuss these five in terms of their potential relevance as biological markers for use in AAA screening of population at risk.	[Acosta-Martin, Adelina E.; Chwastyniak, Maggy; Amouyel, Philippe; Pinet, Florence] INSERM, U744, F-59045 Lille, France; [Acosta-Martin, Adelina E.; Chwastyniak, Maggy; Dupont, Annabelle; Juthier, Francis; Jude, Brigitte; Amouyel, Philippe; Pinet, Florence] Univ Lille Nord France, USDL, Lille, France; [Acosta-Martin, Adelina E.; Chwastyniak, Maggy; Amouyel, Philippe; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Panchaud, Alexandre; Goodlett, David R.] Univ Washington, Seattle, WA 98195 USA; [Juthier, Francis; Gautier, Corinne; Jude, Brigitte; Amouyel, Philippe; Pinet, Florence] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Washington; University of Washington Seattle; Universite de Lille - ISITE; CHU Lille	Acosta-Martin, AE (corresponding author), INSERM, U744, F-59045 Lille, France.	florence.pinet@pasteur-lille.fr	dupont, annabelle/K-5890-2013; Pinet, Florence/F-2892-2013	Pinet, Florence/0000-0002-5471-1487; Amouyel, Philippe/0000-0001-9088-234X; Acosta Martin, Adelina E/0000-0002-4047-5487; Juthier, Francis/0000-0002-5072-9073	European Fighting Aneurysmal Disease [Health-F2-2008-200647]; "Societe Francaise d'Hypertension Arterielle'' fellowship; SERVIER; Swiss National Science Foundation [PBLAA-119623]	European Fighting Aneurysmal Disease; "Societe Francaise d'Hypertension Arterielle'' fellowship; SERVIER(Servier); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a European Fighting Aneurysmal Disease grant (Health-F2-2008-200647). A.E. Acosta-Martin is a recipient of "Societe Francaise d'Hypertension Arterielle'' and SERVIER fellowships. A. Panchaud is a recipient of a Swiss National Science Foundation Grant (PBLAA-119623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P172, DOI 10.1016/S0167-4838(00)00157-6; Alcorn HG, 1996, ARTERIOSCL THROM VAS, V16, P963, DOI 10.1161/01.ATV.16.8.963; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P995, DOI 10.1074/mcp.M800446-MCP200; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Blackburn K, 2010, J PROTEOME RES, V9, P3621, DOI 10.1021/pr100144z; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chao J, 2001, BIOL CHEM, V382, P15, DOI 10.1515/BC.2001.003; DAVON L, 2008, ANAL CHEM, V80, P2921; Dejouvencel T, 2010, ARTERIOSCL THROM VAS, V30, P269, DOI 10.1161/ATVBAHA.109.198309; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; Dupont A, 2010, AM J CARDIOL, V105, P1545, DOI 10.1016/j.amjcard.2010.01.011; Fortin T, 2009, ANAL CHEM, V81, P9343, DOI 10.1021/ac901447h; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Giron P, 2011, J PROTEOME RES, V10, P249, DOI 10.1021/pr100535f; Golledge J, 2007, CIRCULATION, V116, P2275, DOI 10.1161/CIRCULATIONAHA.107.717926; Golledge J, 2008, CIRCULATION, V118, P2382, DOI 10.1161/CIRCULATIONAHA.108.802074; Haab BB, 2005, PROTEOMICS, V5, P3278, DOI 10.1002/pmic.200401276; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P543, DOI 10.1038/nrcardio.2009.102; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; Kaschina E, 2004, PHYSIOL GENOMICS, V19, P41, DOI 10.1152/physiolgenomics.00035.2004; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lamblin N, 2010, J PROTEOME RES, V9, P3720, DOI 10.1021/pr100250s; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martinez-Pinna R, 2011, ARTERIOSCL THROM VAS, V31, P935, DOI 10.1161/ATVBAHA.110.214429; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nordon IM, 2010, VASCULAR, V18, P264, DOI 10.2310/6670.2010.00046; Panchaud A, 2011, ANAL CHEM, V83, P2250, DOI 10.1021/ac103079q; Panchaud A, 2009, ANAL CHEM, V81, P6481, DOI 10.1021/ac900888s; Ramos H, 2008, BIOINFORMATICS, V24, P2110, DOI 10.1093/bioinformatics/btn363; Righetti PG, 2006, PROTEOMICS, V6, P3980, DOI 10.1002/pmic.200500904; Scherl A, 2008, ANAL CHEM, V80, P1182, DOI 10.1021/ac701680f; Thompson MM, 2000, BRIT MED J, V320, P1193, DOI 10.1136/bmj.320.7243.1193; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Urbonavicius S, 2009, J VASC SURG, V49, P455, DOI 10.1016/j.jvs.2008.08.097; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	43	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28698	10.1371/journal.pone.0028698	http://dx.doi.org/10.1371/journal.pone.0028698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163325	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900061
J	Chang, FM; Lemmon, C; Lietha, D; Eck, M; Romer, L				Chang, Fumin; Lemmon, Christopher; Lietha, Daniel; Eck, Michael; Romer, Lewis			Tyrosine Phosphorylation of Rac1: A Role in Regulation of Cell Spreading	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SRC FAMILY KINASES; IN-VIVO; DEPENDENT REGULATION; STRUCTURAL BASIS; RHO GTPASES; PROTEIN; ACTIVATION; DYNAMICS; FAK	Rac1 influences a multiplicity of vital cellular-and tissue-level control functions, making it an important candidate for targeted therapeutics. The activity of the Rho family member Cdc42 has been shown to be modulated by tyrosine phosphorylation at position 64. We therefore investigated consequences of the point mutations Y64F and Y64D in Rac1. Both mutations altered cell spreading from baseline in the settings of wild type, constitutively active, or dominant negative Rac1 expression, and were accompanied by differences in Rac1 targeting to focal adhesions. Rac1-Y64F displayed increased GTP-binding, increased association with beta PIX, and reduced binding with RhoGDI as compared with wild type Rac1. Rac1-Y64D had less binding to PAK than Rac1-WT or Rac1-64F. In vitro assays demonstrated that Y64 in Rac1 is a target for FAK and Src. Taken together, these data suggest a mechanism for the regulation of Rac1 activity by non-receptor tyrosine kinases, with consequences for membrane extension.	[Chang, Fumin; Romer, Lewis] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Lemmon, Christopher] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lietha, Daniel] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Eck, Michael] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Eck, Michael] Dana Farber Canc Inst, Boston, MA 02115 USA; [Romer, Lewis] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Romer, Lewis] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Romer, Lewis] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Romer, Lewis] Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Baltimore, MD 21205 USA	Johns Hopkins University; Duke University; Centro Nacional de Investigaciones Oncologicas (CNIO); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chang, FM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	lromer@jhmi.edu	Lemmon, Christopher/GPP-1470-2022; Lietha, Daniel/AAD-1952-2022; Lietha, Daniel/L-8041-2014	Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486; Lemmon, Christopher/0000-0002-9049-6366	National Institutes of Health [AI061042, HL088203]; National Science Foundation [MCB-0923661]; Department of Defense [BC06911]; Maryland Stem Cell Research Fund [MSCRFE-0043-00]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K18HL088203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI061042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to L.R. from the National Institutes of Health (AI061042 and HL088203), the National Science Foundation (MCB-0923661), the Department of Defense (BC06911), and MSCRFE-0043-00 from the Maryland Stem Cell Research Fund. None of these funding sources had any role in conducting the research or preparing the manuscript.	Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Choi JH, 2007, CELL SIGNAL, V19, P1784, DOI 10.1016/j.cellsig.2007.04.002; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fuss H, 2007, J COMPUT BIOL, V14, P1185, DOI 10.1089/cmb.2007.0095; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Grunicke HH, 2009, CRIT REV EUKAR GENE, V19, P139, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.40; HART MJ, 1990, J BIOL CHEM, V265, P5990; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Li SF, 2008, ADV CANCER RES, V101, P45, DOI 10.1016/S0065-230X(08)00403-X; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; MOODIE SA, 1995, ONCOGENE, V11, P447; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nikolova E, 2007, BIOCHEM BIOPH RES CO, V359, P834, DOI 10.1016/j.bbrc.2007.05.214; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roepstorff K, 2008, J BIOL CHEM, V283, P7983, DOI 10.1074/jbc.M708281200; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	46	43	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28587	10.1371/journal.pone.0028587	http://dx.doi.org/10.1371/journal.pone.0028587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163037	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500036
J	Dangaj, D; Abbott, KL; Mookerjee, A; Zhao, AZ; Kirby, PS; Sandaltzopoulos, R; Powell, DJ; Lamaziere, A; Siegel, DL; Wolf, C; Scholler, N				Dangaj, Denarda; Abbott, Karen L.; Mookerjee, Ananda; Zhao, Aizhi; Kirby, Pamela S.; Sandaltzopoulos, Raphael; Powell, Daniel J., Jr.; Lamaziere, Antonin; Siegel, Don L.; Wolf, Claude; Scholler, Nathalie			Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant Antibody	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; SEPTICUM ALPHA-TOXIN; CARBOHYDRATE-RECOGNITION DOMAIN; GENE-EXPRESSION ANALYSIS; DENDRITIC CELLS; IMMUNE-RESPONSES; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY; PROSTATE-CANCER; DOWN-REGULATION	Tumor-infiltrating macrophages respond to microenvironmental signals by developing a tumor-associated phenotype characterized by high expression of mannose receptor (MR, CD206). Antibody cross-linking of CD206 triggers anergy in dendritic cells and CD206 engagement by tumoral mucins activates an immune suppressive phenotype in tumor-associated macrophages (TAMs). Many tumor antigens are heavily glycosylated, such as tumoral mucins, and/or attached to tumor cells by mannose residue-containing glycolipids (GPI anchors), as for example mesothelin and the family of carcinoembryonic antigen (CEA). However, the binding to mannose receptor of soluble tumor antigen GPI anchors via mannose residues has not been systematically studied. To address this question, we analyzed the binding of tumor-released mesothelin to ascites-infiltrating macrophages from ovarian cancer patients. We also modeled functional interactions between macrophages and soluble mesothelin using an in vitro system of co-culture in transwells of healthy donor macrophages with human ovarian cancer cell lines. We found that soluble mesothelin bound to human macrophages and that the binding depended on the presence of GPI anchor and of mannose receptor. We next challenged the system with antibodies directed against the mannose receptor domain 4 (CDR4-MR). We isolated three novel anti-CDR4-MR human recombinant antibodies (scFv) using a yeast-display library of human scFv. Anti-CDR4-MR scFv #G11 could block mesothelin binding to macrophages and prevent tumor-induced phenotype polarization of CD206(low) macrophages towards TAMs. Our findings indicate that tumor-released mesothelin is linked to GPI anchor, engages macrophage mannose receptor, and contributes to macrophage polarization towards TAMs. We propose that compounds able to block tumor antigen GPI anchor/CD206 interactions, such as our novel anti-CRD4-MR scFv, could prevent tumor-induced TAM polarization and have therapeutic potential against ovarian cancer, through polarization control of tumor-infiltrating innate immune cells.	[Dangaj, Denarda; Mookerjee, Ananda; Zhao, Aizhi; Powell, Daniel J., Jr.; Scholler, Nathalie] Univ Penn, Dept Obstet & Gynecol, Penn Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Dangaj, Denarda; Sandaltzopoulos, Raphael] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Abbott, Karen L.; Kirby, Pamela S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Powell, Daniel J., Jr.; Siegel, Don L.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lamaziere, Antonin; Wolf, Claude] Univ Paris 06, Sch Med St Antoine, Dept Biochem, Paris, France	University of Pennsylvania; Democritus University of Thrace; University System of Georgia; University of Georgia; University of Pennsylvania; UDICE-French Research Universities; Sorbonne Universite	Dangaj, D (corresponding author), Univ Penn, Dept Obstet & Gynecol, Penn Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA.	naths@mail.med.upenn.edu	Lamaziere, Antonin/AAH-2285-2022; Lamaziere, Antonin/AFM-0000-2022; Scholler, Nathalie/O-9003-2014		ovarian SPORE; University of Pennsylvania (National Institutes of Health/National Cancer Institute (NIH/NCI)) [P50 CA83638]; American Cancer Society [IRG-78-002-29]; Department of Defense [BC075534]; National Heart, Lung, and Blood Institute [P50-HL81012]; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081012] Funding Source: NIH RePORTER	ovarian SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pennsylvania (National Institutes of Health/National Cancer Institute (NIH/NCI)); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Career Development Award (N.S.) from the ovarian SPORE grant to Fox Chase Cancer Center and University of Pennsylvania (National Institutes of Health/National Cancer Institute (NIH/NCI) P50 CA83638), in part by the grant #IRG-78-002-29 from the American Cancer Society (Pilot Project, N.S.), by the Breast Cancer Concept Award from Department of Defense (BC075534) (K. L. A.) and by the National Heart, Lung, and Blood Institute (P50-HL81012) (D. L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Belisle JA, 2007, IMMUNOLOGY, V122, P418, DOI 10.1111/j.1365-2567.2007.02660.x; Bergan L, 2007, CANCER LETT, V255, P263, DOI 10.1016/j.canlet.2007.04.012; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Bones J, 2011, J PROTEOME RES, V10, P1246, DOI 10.1021/pr101036b; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Butikofer P, 2001, FASEB J, V15, P545, DOI 10.1096/fj.00-0415hyp; Chan C H F, 2007, Curr Oncol, V14, P70; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Cheng WF, 2009, BRIT J CANCER, V100, P1144, DOI 10.1038/sj.bjc.6604964; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; EZEKOWITZ RAB, 1982, ADV EXP MED BIOL, V155, P401; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Feldhaus Michael, 2004, Methods Mol Biol, V263, P311; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Foged C, 2004, VACCINE, V22, P1903, DOI 10.1016/j.vaccine.2003.11.008; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Gubbels JAA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-11; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HARRIS N, 1992, BLOOD, V80, P2363; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; Hellstrom I, 2006, CANCER EPIDEM BIOMAR, V15, P1014, DOI 10.1158/1055-9965.EPI-05-0334; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Kusumoto T, 2010, ONCOL REP, V23, P917, DOI 10.3892/or_00000715; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; LENNARTZ MR, 1987, BIOCHEM J, V245, P705, DOI 10.1042/bj2450705; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Linehan SA, 2001, EUR J IMMUNOL, V31, P1857, DOI 10.1002/1521-4141(200106)31:6<1857::AID-IMMU1857>3.0.CO;2-D; MacRae JI, 2005, GLYCOBIOLOGY, V15, P131, DOI 10.1093/glycob/cwh149; MAGNUSSON S, 1993, BIOCHEM J, V291, P749, DOI 10.1042/bj2910749; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez-Pomares L, 2001, IMMUNOBIOLOGY, V204, P527, DOI 10.1078/0171-2985-00089; Martinez-Pomares Luisa, 2009, V531, P103, DOI 10.1007/978-1-59745-396-7_8; Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984; Melton-Witt JA, 2006, BIOCHEMISTRY-US, V45, P14347, DOI 10.1021/bi061334p; MIOTTI S, 1992, INT J CANCER, V51, P499, DOI 10.1002/ijc.2910510326; MULLIN NP, 1994, J BIOL CHEM, V269, P28405; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Orntoft TF, 1999, ELECTROPHORESIS, V20, P362, DOI 10.1002/(SICI)1522-2683(19990201)20:2<362::AID-ELPS362>3.3.CO;2-M; Patankar MS, 2005, GYNECOL ONCOL, V99, P704, DOI 10.1016/j.ygyno.2005.07.030; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qiu YH, 2008, J PROTEOME RES, V7, P1693, DOI 10.1021/pr700706s; QUINN PJ, 2009, METH MOL B, V579, P127, DOI DOI 10.1007/978-1-60761-322-0_7; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Rooney IA, 1996, J CLIN INVEST, V97, P1675, DOI 10.1172/JCI118594; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sasaroli D, 2009, BIOMARK MED, V3, P275, DOI 10.2217/BMM.09.21; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Scholler N, 2006, J IMMUNOL METHODS, V317, P132, DOI 10.1016/j.jim.2006.10.003; Scholler N, 2007, CANCER LETT, V247, P130, DOI 10.1016/j.canlet.2006.03.029; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Semmes OJ, 2006, J CELL BIOCHEM, V98, P496, DOI 10.1002/jcb.20855; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Singh V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016097; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang CK, 2007, IMMUNOLOGY, V120, P325, DOI 10.1111/j.1365-2567.2006.02506.x; Tanyi JL, 2010, ONCOL REV, V4, P43, DOI 10.1007/s12156-010-0035-2; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tiede A, 1999, BIOL CHEM, V380, P503, DOI 10.1515/BC.1999.066; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Xaplanteri P, 2009, EUR J IMMUNOL, V39, P730, DOI 10.1002/eji.200838872; Zacks MA, 2006, MOL MEMBR BIOL, V23, P209, DOI 10.1080/09687860600601494; Zhang JM, 2004, INFECT IMMUN, V72, P3147, DOI 10.1128/IAI.72.6.3147-3160.2004; Zhao AZ, 2011, J IMMUNOL METHODS, V363, P221, DOI 10.1016/j.jim.2010.09.001	102	25	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28386	10.1371/journal.pone.0028386	http://dx.doi.org/10.1371/journal.pone.0028386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163010	Green Submitted, Green Published, gold			2022-12-25	WOS:000298173500015
J	Lockwood, S; Krishnamoorthy, B; Ye, P				Lockwood, Svetlana; Krishnamoorthy, Bala; Ye, Ping			Neighborhood Properties Are Important Determinants of Temperature Sensitive Mutations	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; AMINO-ACID SUBSTITUTIONS; PROTEIN-STRUCTURE; BACTERIOPHAGE-T4 LYSOZYME; SATURATION MUTAGENESIS; SOLVENT ACCESSIBILITY; BINDING SITES; PREDICTION; MUTANTS; SEQUENCE	Temperature-sensitive (TS) mutants are powerful tools to study gene function in vivo. These mutants exhibit wild-type activity at permissive temperatures and reduced activity at restrictive temperatures. Although random mutagenesis can be used to generate TS mutants, the procedure is laborious and unfeasible in multicellular organisms. Further, the underlying molecular mechanisms of the TS phenotype are poorly understood. To elucidate TS mechanisms, we used a machine learning method-logistic regression-to investigate a large number of sequence and structure features. We developed and tested 133 features, describing properties of either the mutation site or the mutation site neighborhood. We defined three types of neighborhood using sequence distance, Euclidean distance, and topological distance. We discovered that neighborhood features outperformed mutation site features in predicting TS mutations. The most predictive features suggest that TS mutations tend to occur at buried and rigid residues, and are located at conserved protein domains. The environment of a buried residue often determines the overall structural stability of a protein, thus may lead to reversible activity change upon temperature switch. We developed TS prediction models based on logistic regression and the Lasso regularized procedure. Through a ten-fold cross-validation, we obtained the area under the curve of 0.91 for the model using both sequence and structure features. Testing on independent datasets suggested that the model predicted TS mutations with a 50% precision. In summary, our study elucidated the molecular basis of TS mutants and suggested the importance of neighborhood properties in determining TS mutations. We further developed models to predict TS mutations derived from single amino acid substitutions. In this way, TS mutants can be efficiently obtained through experimentally introducing the predicted mutations.	[Lockwood, Svetlana; Ye, Ping] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Lockwood, Svetlana] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Krishnamoorthy, Bala] Washington State Univ, Dept Math, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Lockwood, S (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	pye@wsu.edu	Krishnamoorthy, Bala/GVR-7967-2022	Lockwood, Svetlana/0000-0002-9401-239X	Washington State University; NSF [EF 0531870]	Washington State University; NSF(National Science Foundation (NSF))	This work was supported by a Washington State University start-up grant to PY, and the NSF Grant EF 0531870 to SL, BK, and PY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aita T, 2010, COMPUT BIOL CHEM, V34, P53, DOI 10.1016/j.compbiolchem.2009.10.005; ALBER T, 1987, BIOCHEMISTRY-US, V26, P3754, DOI 10.1021/bi00387a002; [Anonymous], 2002, LEARNING KERNELS; Bajaj K, 2008, BIOCHEMISTRY-US, V47, P12964, DOI 10.1021/bi8014345; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Cai ZH, 2004, HUM MUTAT, V24, P178, DOI 10.1002/humu.20063; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Dobson RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-217; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Huang ZW, 2008, NAT METHODS, V5, P167, DOI 10.1038/NMETH.1173; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karchin R, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P397; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Krishnamoorthy B, 2003, BIOINFORMATICS, V19, P1540, DOI 10.1093/bioinformatics/btg186; Krishnan VG, 2003, BIOINFORMATICS, V19, P2199, DOI 10.1093/bioinformatics/btg297; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; MANCHESTER M, 1994, J BIOL CHEM, V269, P7689; Masso M, 2007, BIOINFORMATICS, V23, P3155, DOI 10.1093/bioinformatics/btm509; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Poultney CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023947; Preparata F.P., 1985, COMPUTATIONAL GEOMET; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Razak ZRA, 2004, MOL CELL BIOL, V24, P5967, DOI 10.1128/MCB.24.13.5967-5977.2004; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shiraishi K, 2004, J BIOL CHEM, V279, P348, DOI 10.1074/jbc.M310815200; SIMCHEN G, 1978, ANNU REV GENET, V12, P161, DOI 10.1146/annurev.ge.12.120178.001113; Singh RK, 1996, J COMPUT BIOL, V3, P213, DOI 10.1089/cmb.1996.3.213; Stuart AC, 2002, BIOINFORMATICS, V18, P200, DOI 10.1093/bioinformatics/18.1.200; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Varadarajan R, 1996, P NATL ACAD SCI USA, V93, P13908, DOI 10.1073/pnas.93.24.13908; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Ye ZQ, 2007, BIOINFORMATICS, V23, P1444, DOI 10.1093/bioinformatics/btm119; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	56	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28507	10.1371/journal.pone.0028507	http://dx.doi.org/10.1371/journal.pone.0028507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164302	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400103
J	Hawkins, JB; Jones, MT; Plassmann, PE; Thorley-Lawson, DA				Hawkins, Jared B.; Jones, Mark T.; Plassmann, Paul E.; Thorley-Lawson, David A.			Chemotaxis in Densely Populated Tissue Determines Germinal Center Anatomy and Cell Motility: A New Paradigm for the Development of Complex Tissues	PLOS ONE			English	Article							AFFINITY MATURATION; IMMUNE-RESPONSE; LYMPHOCYTE; MIGRATION; SELECTION; DYNAMICS; SYSTEM; ORGANIZATION; MICROSCOPY; PHENOTYPE	Germinal centers (GCs) are complex dynamic structures that form within lymph nodes as an essential process in the humoral immune response. They represent a paradigm for studying the regulation of cell movement in the development of complex anatomical structures. We have developed a simulation of a modified cyclic re-entry model of GC dynamics which successfully employs chemotaxis to recapitulate the anatomy of the primary follicle and the development of a mature GC, including correctly structured mantle, dark and light zones. We then show that correct single cell movement dynamics (including persistent random walk and inter-zonal crossing) arise from this simulation as purely emergent properties. The major insight of our study is that chemotaxis can only achieve this when constrained by the known biological properties that cells are incompressible, exist in a densely packed environment, and must therefore compete for space. It is this interplay of chemotaxis and competition for limited space that generates all the complex and biologically accurate behaviors described here. Thus, from a single simple mechanism that is well documented in the biological literature, we can explain both higher level structure and single cell movement behaviors. To our knowledge this is the first GC model that is able to recapitulate both correctly detailed anatomy and single cell movement. This mechanism may have wide application for modeling other biological systems where cells undergo complex patterns of movement to produce defined anatomical structures with sharp tissue boundaries.	[Hawkins, Jared B.; Thorley-Lawson, David A.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; [Jones, Mark T.; Plassmann, Paul E.] Virginia Tech, Bradley Dept Elect & Comp Engn, Blacksburg, VA USA	Tufts University; Virginia Polytechnic Institute & State University	Hawkins, JB (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.	david.thorley-lawson@tufts.edu		Hawkins, Jared/0000-0002-6352-1618	Public Health Service [R01 CA65883, R01 AI18757, RO1 AI062989]; National Science Foundation [CCF-0728901]; NATIONAL CANCER INSTITUTE [R01CA065883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062989, R01AI018757] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R01 CA65883, R01 AI18757 and RO1 AI062989 to DT-L and partially supported by National Science Foundation grant CCF-0728901 to MJ/PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Berg HC, 1983, RANDOM WALKS BIOL, P142; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; El Shikh ME, 2006, EUR J IMMUNOL, V36, P2715, DOI 10.1002/eji.200636122; Figge MT, 2008, J EXP MED, V205, P3019, DOI 10.1084/jem.20081160; GERISCH G, 1981, J CELL SCI, V52, P1; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; MACLENNAN ICM, 1990, CURR TOP MICROBIOL, V159, P37; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oprea M, 1997, J IMMUNOL, V158, P5155; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012; ZIGMOND SH, 1978, J CELL BIOL, V77, P269, DOI 10.1083/jcb.77.2.269; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e27650	10.1371/journal.pone.0027650	http://dx.doi.org/10.1371/journal.pone.0027650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145018	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900001
J	Peletskaya, E; Andrake, M; Gustchina, A; Merkel, G; Alexandratos, J; Zhou, DW; Bojja, RS; Satoh, T; Potapov, M; Kogon, A; Potapov, V; Wlodawer, A; Skalka, AM				Peletskaya, Elena; Andrake, Mark; Gustchina, Alla; Merkel, George; Alexandratos, Jerry; Zhou, Dongwen; Bojja, Ravi S.; Satoh, Tadashi; Potapov, Mikhail; Kogon, Alex; Potapov, Viktor; Wlodawer, Alexander; Skalka, Anna Marie			Localization of ASV Integrase-DNA Contacts by Site-Directed Crosslinking and their Structural Analysis	PLOS ONE			English	Article							SARCOMA-VIRUS INTEGRASE; TYPE-1 REVERSE-TRANSCRIPTASE; HIV-1 INTEGRASE; VIRAL-DNA; RETROVIRAL INTEGRATION; FINGERS SUBDOMAIN; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; BINDING; PROTEIN	Background: We applied crosslinking techniques as a first step in preparation of stable avian sarcoma virus (ASV) integrase (IN)-DNA complexes for crystallographic investigations. These results were then compared with the crystal structures of the prototype foamy virus (PFV) intasome and with published data for other retroviral IN proteins. Methodology/Results: Photoaffinity crosslinking and site-directed chemical crosslinking were used to localize the sites of contacts with DNA substrates on the surface of ASV IN. Sulfhydryl groups of cysteines engineered into ASV IN and amino-modified nucleotides in DNA substrates were used for attachment of photocrosslinkers. Analysis of photocrosslinking data revealed several specific DNA-protein contacts. To confirm contact sites, thiol-modified nucleotides were introduced into oligo-DNA substrates at suggested points of contact and chemically crosslinked to the cysteines via formation of disulfide bridges. Cysteines incorporated in positions 124 and 146 in the ASV IN core domain were shown to interact directly with host and viral portions of the Y-mer DNA substrate, respectively. Crosslinking of an R244C ASV IN derivative identified contacts at positions 11 and 12 on both strands of viral DNA. The most efficient disulfide crosslinking was observed for complexes of the ASV IN E157C and D64C derivatives with linear viral DNA substrate carrying a thiol-modified scissile phosphate. Conclusion: Analysis of our crosslinking results as well as published results of retroviral IN protein from other laboratories shows good agreement with the structure of PFV IN and derived ASV, HIV, and MuLV models for the core domain, but only partial agreement for the N- and C-terminal domains. These differences might be explained by structural variations and evolutionary selection for residues at alternate positions to perform analogous functions, and by methodological differences: i.e., a static picture of a particular assembly from crystallography vs. a variety of interactions that might occur during formation of functional IN complexes in solution.	[Peletskaya, Elena; Kogon, Alex] Biolinx LLC, Alburgh, VT USA; [Andrake, Mark; Merkel, George; Bojja, Ravi S.; Skalka, Anna Marie] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; [Gustchina, Alla; Alexandratos, Jerry; Zhou, Dongwen; Satoh, Tadashi; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Potapov, Mikhail; Potapov, Viktor] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Peletskaya, E (corresponding author), Biolinx LLC, Alburgh, VT USA.	wlodawer@nih.gov	Zhou, Dongwen/O-1889-2019; Satoh, Tadashi/M-5157-2017	Satoh, Tadashi/0000-0002-4493-4978	National Institutes of Health (NIH) [AI064098, AI40385, CA71515, CA06927]; Civilian Research and Development Foundation [RUXO-2713-MO-06]; Commonwealth of Pennsylvania; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010348, R01CA071515, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385, R21AI064098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Civilian Research and Development Foundation; Commonwealth of Pennsylvania; NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (NIH) grants AI064098 (EP), AI40385, CA71515, CA06927 (AS), by the Civilian Research and Development Foundation grant RUXO-2713-MO-06 (VP and AK), by an appropriation from the Commonwealth of Pennsylvania, and by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Mawsawi LQ, 2011, CHEMMEDCHEM, V6, P228, DOI 10.1002/cmdc.201000443; Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Asante-Appiah E, 1998, J BIOL CHEM, V273, P35078, DOI 10.1074/jbc.273.52.35078; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dirac AMG, 2001, EUR J BIOCHEM, V268, P743, DOI 10.1046/j.1432-1327.2001.01932.x; Dolan J, 2009, J MOL BIOL, V385, P568, DOI 10.1016/j.jmb.2008.10.083; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ERLANSON DA, 1993, J AM CHEM SOC, V115, P12583, DOI 10.1021/ja00079a047; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Harper AL, 2001, J VIROL, V75, P7756, DOI 10.1128/JVI.75.16.7756-7762.2001; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Hobaika Z, 2009, NUCLEIC ACIDS RES, V37, P7691, DOI 10.1093/nar/gkp824; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Katz RA, 2001, J BIOL CHEM, V276, P34213, DOI 10.1074/jbc.M104632200; Katz RA, 2011, J BIOL CHEM IN PRESS; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Kulinski J, 2000, BIOTECHNIQUES, V29, P44, DOI 10.2144/00291bm07; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Lubkowski J, 1998, J BIOL CHEM, V273, P32685, DOI 10.1074/jbc.273.49.32685; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Mazumder A, 1997, MOL PHARMACOL, V51, P567, DOI 10.1124/mol.51.4.567; Merkel G, 2009, METHODS, V47, P243, DOI 10.1016/j.ymeth.2008.10.024; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; MORELAND RB, 1982, ANAL BIOCHEM, V121, P321, DOI 10.1016/0003-2697(82)90487-0; Nowal MG, 2009, VIROLOGY, V389, P141, DOI 10.1016/j.virol.2009.04.014; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Oleykowski CA, 1999, BIOCHEMISTRY-US, V38, P2200, DOI 10.1021/bi982318y; Peletskaya EN, 2004, J VIROL, V78, P3387, DOI 10.1128/JVI.78.7.3387-3397.2004; Peletskaya EN, 2001, J VIROL, V75, P9435, DOI 10.1128/JVI.75.19.9435-9445.2001; Pommier Y, 1997, ANTIVIR CHEM CHEMOTH, V8, P463, DOI 10.1177/095632029700800601; Powderly WG, 2010, J ANTIMICROB CHEMOTH, V65, P2485, DOI 10.1093/jac/dkq350; Prada N, 2010, EXPERT OPIN INV DRUG, V19, P1087, DOI 10.1517/13543784.2010.501078; Renisio JG, 2005, NUCLEIC ACIDS RES, V33, P1970, DOI 10.1093/nar/gki346; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; Vera J, 2008, BIOL RES, V41, P69, DOI [10.4067/S0716-97602008000100009, /S0716-97602008000100009]; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Yang B, 2000, BIOCHEMISTRY-US, V39, P3533, DOI 10.1021/bi992376z; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200	55	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e27751	10.1371/journal.pone.0027751	http://dx.doi.org/10.1371/journal.pone.0027751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145019	Green Submitted, gold, Green Published			2022-12-25	WOS:000298168900002
J	Wojtovich, AP; Sherman, TA; Nadtochiy, SM; Urciuoli, WR; Brookes, PS; Nehrke, K				Wojtovich, Andrew P.; Sherman, Teresa A.; Nadtochiy, Sergiy M.; Urciuoli, William R.; Brookes, Paul S.; Nehrke, Keith			SLO-2 Is Cytoprotective and Contributes to Mitochondrial Potassium Transport	PLOS ONE			English	Article							K-ATP CHANNEL; VOLATILE ANESTHETICS; LARGE-CONDUCTANCE; NEUROTRANSMITTER RELEASE; BK CHANNELS; SODIUM; PROTEIN; SLACK; INHIBITION; ACTIVATION	Mitochondrial potassium channels are important mediators of cell protection against stress. The mitochondrial large-conductance "big" K+ channel (mBK) mediates the evolutionarily-conserved process of anesthetic preconditioning (APC), wherein exposure to volatile anesthetics initiates protection against ischemic injury. Despite the role of the mBK in cardioprotection, the molecular identity of the channel remains unknown. We investigated the attributes of the mBK using C. elegans and mouse genetic models coupled with measurements of mitochondrial K+ transport and APC. The canonical Ca2+-activated BK (or "maxi-K") channel SLO1 was dispensable for both mitochondrial K+ transport and APC in both organisms. Instead, we found that the related but physiologically-distinct K+ channel SLO2 was required, and that SLO2-dependent mitochondrial K+ transport was triggered directly by volatile anesthetics. In addition, a SLO2 channel activator mimicked the protective effects of volatile anesthetics. These findings suggest that SLO2 contributes to protection from hypoxic injury by increasing the permeability of the mitochondrial inner membrane to K+.	[Wojtovich, Andrew P.; Sherman, Teresa A.; Nehrke, Keith] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Nadtochiy, Sergiy M.; Urciuoli, William R.; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Brookes, Paul S.; Nehrke, Keith] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Wojtovich, AP (corresponding author), Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.	Keith_Nehrke@urmc.rochester.edu		Wojtovich, Andrew/0000-0002-7725-5349; Nehrke, Keith/0000-0001-9697-726X; Brookes, Paul/0000-0002-8639-8413	American Heart Association [11POST7290028]; US National Institutes of Health [HL071158, GM087483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087483] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an American Heart Association, Founder Affiliate Postdoctoral Fellowship award 11POST7290028 (to APW), and by US National Institutes of Health grants HL071158 (to PSB), GM087483 (to PSB & KWN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Cancherini DV, 2007, CARDIOVASC RES, V73, P720, DOI 10.1016/j.cardiores.2006.11.035; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; Cohen MV, 2007, CIRCULATION, V115, P1895, DOI 10.1161/CIRCULATIONAHA.106.675710; Costa ADT, 2009, J BIOENERG BIOMEMBR, V41, P123, DOI 10.1007/s10863-009-9213-y; De Hert SG, 2005, ANESTH ANALG, V100, P1584, DOI 10.1213/01.ANE.0000153483.61170.0C; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Facundo HTF, 2006, BBA-MOL BASIS DIS, V1762, P202, DOI 10.1016/j.bbadis.2005.06.003; Garlid KD, 2001, IUBMB LIFE, V52, P153, DOI 10.1080/15216540152845948; Hausenloy DJ, 2007, BASIC RES CARDIOL, V102, P445, DOI 10.1007/s00395-007-0656-1; Hawasli AH, 2004, GENETICS, V168, P831, DOI 10.1534/genetics.104.030502; Imlach WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008698; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Jia BS, 2008, ANESTHESIOLOGY, V108, P426, DOI 10.1097/ALN.0b013e318164d013; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Hai-lan, 2008, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V28, P28; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nadtochiy SM, 2009, J MOL CELL CARDIOL, V46, P960, DOI 10.1016/j.yjmcc.2009.01.012; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; PIKE MM, 1990, AM J PHYSIOL, V259, pH1767, DOI 10.1152/ajpheart.1990.259.6.H1767; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Riess ML, 2004, AM J PHYSIOL-HEART C, V286, pH1603, DOI 10.1152/ajpheart.00963.2003; Ruffin VA, 2008, NEUROSCIENCE, V151, P410, DOI 10.1016/j.neuroscience.2007.10.031; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Wojtovich AP, 2008, BIOCHEM BIOPH RES CO, V376, P625, DOI 10.1016/j.bbrc.2008.09.043; Wojtovich AP, 2010, ACTA BIOCHIM POL, V57, P431; Wojtovich AP, 2010, CIRC RES, V106, P1190, DOI 10.1161/CIRCRESAHA.109.215400; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yang B, 2006, NEUROPHARMACOLOGY, V51, P896, DOI 10.1016/j.neuropharm.2006.06.003; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107; Zhou Y, 2010, J GEN PHYSIOL, V135, P481, DOI 10.1085/jgp.201010403	48	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28287	10.1371/journal.pone.0028287	http://dx.doi.org/10.1371/journal.pone.0028287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145034	Green Submitted, Green Published, gold			2022-12-25	WOS:000298168900017
J	Fenyk, S; Campillo, AD; Pohl, E; Hussey, PJ; Cann, MJ				Fenyk, Stepan; Campillo, Alba de San Eustaquio; Pohl, Ehmke; Hussey, Patrick J.; Cann, Martin J.			A Nucleotide Phosphatase Activity in the Nucleotide Binding Domain of an Orphan Resistance Protein from Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NB-ARC DOMAIN; GENE-PRODUCTS; CELL-DEATH; EXCHANGE; APOPTOSOME; ARABIDOPSIS; HYDROLYSIS; DEFENSE; APAF-1; I-2	Plant resistance proteins (R-proteins) are key components of the plant immune system activated in response to a plethora of different pathogens. R-proteins are P-loop NTPase superfamily members, and current models describe their main function as ATPases in defense signaling pathways. Here we show that a subset of R-proteins have evolved a new function to combat pathogen infection. This subset of R-proteins possesses a nucleotide phosphatase activity in the nucleotide-binding domain. Related R-proteins that fall in the same phylogenetic clade all show the same nucleotide phosphatase activity indicating a conserved function within at least a subset of R-proteins. R-protein nucleotide phosphatases catalyze the production of nucleoside from nucleotide with the nucleotide monophosphate as the preferred substrate. Mutation of conserved catalytic residues substantially reduced activity consistent with the biochemistry of P-loop NTPases. Kinetic analysis, analytical gel filtration, and chemical cross-linking demonstrated that the nucleotide-binding domain was active as a multimer. Nuclear magnetic resonance and nucleotide analogues identified the terminal phosphate bond as the target of a reaction that utilized a metal-mediated nucleophilic attack by water on the phosphoester. In conclusion, we have identified a group of R-proteins with a unique function. This biochemical activity appears to have co-evolved with plants in signaling pathways designed to resist pathogen attack.	[Fenyk, Stepan; Campillo, Alba de San Eustaquio; Pohl, Ehmke; Hussey, Patrick J.; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Fenyk, Stepan; Campillo, Alba de San Eustaquio; Pohl, Ehmke; Hussey, Patrick J.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, Durham DH1 3LE, England; [Pohl, Ehmke] Univ Durham, Dept Chem, Durham DH1 3LE, England	Durham University; Durham University; Durham University	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Pohl, Ehmke/I-2408-2012; Cann, Martin/G-2864-2012	Pohl, Ehmke/0000-0002-9949-4471; Cann, Martin/0000-0001-6305-8769; Hussey, Patrick/0000-0002-7349-8722	Leverhulme Trust [F/00128/AU]; BBSRC [BB/I011994/1]; Biotechnology and Biological Sciences Research Council [BB/I011994/1, 1220464] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Leverhulme Trust Grant F/00128/AU and BBSRC Grant BB/I011994/1 (to M. J. C.).	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; COHN M, 1978, P NATL ACAD SCI USA, V75, P200, DOI 10.1073/pnas.75.1.200; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar N., 2006, CURR PROTOC BIOINFOR, V15, P5; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang K, 2008, PLANT SIGNAL BEHAV, V3, P389, DOI 10.4161/psb.3.6.5401; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Moutinho A, 2001, P NATL ACAD SCI USA, V98, P10481, DOI 10.1073/pnas.171104598; Pillai MA, 2002, THEOR APPL GENET, V105, P34, DOI 10.1007/s00122-001-0833-9; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; VANETTEN RL, 1978, P NATL ACAD SCI USA, V75, P4784	25	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4023	4032		10.1074/jbc.M111.314450	http://dx.doi.org/10.1074/jbc.M111.314450			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157756	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000300410900036
J	Ferrero, M; Ferragud, J; Orlando, L; Valero, L; del Pino, MS; Farras, R; de Mora, JF				Ferrero, Macarena; Ferragud, Juan; Orlando, Leonardo; Valero, Luz; Sanchez del Pino, Manuel; Farras, Rosa; Font de Mora, Jaime			Phosphorylation of AIB1 at Mitosis Is Regulated by CDK1/CYCLIN B	PLOS ONE			English	Article							NUCLEAR RECEPTOR COACTIVATOR; PROTEIN PHOSPHATASE 1; CDK1 ACTIVITY; MITOTIC EXIT; AURORA-A; ACTIVATION; DEPHOSPHORYLATION; KINASE	Background: Although the AIB1 oncogene has an important role during the early phase of the cell cycle as a coactivator of E2F1, little is known about its function during mitosis. Methodology/Principal Findings: Mitotic cells isolated by nocodazole treatment as well as by shake-off revealed a post-translational modification occurring in AIB1 specifically during mitosis. This modification was sensitive to the treatment with phosphatase, suggesting its modification by phosphorylation. Using specific inhibitors and in vitro kinase assays we demonstrate that AIB1 is phosphorylated on Ser728 and Ser867 by Cdk1/cyclin B at the onset of mitosis and remains phosphorylated until exit from M phase. Differences in the sensitivity to phosphatase inhibitors suggest that PP1 mediates dephosphorylation of AIB1 at the end of mitosis. The phosphorylation of AIB1 during mitosis was not associated with ubiquitylation or degradation, as confirmed by western blotting and flow cytometry analysis. In addition, luciferase reporter assays showed that this phosphorylation did not alter the transcriptional properties of AIB1. Importantly, fluorescence microscopy and sub-cellular fractionation showed that AIB1 phosphorylation correlated with the exclusion from the condensed chromatin, thus preventing access to the promoters of AIB1-dependent genes. Phospho-specific antibodies developed against Ser728 further demonstrated the presence of phosphorylated AIB1 only in mitotic cells where it was localized preferentially in the periphery of the cell. Conclusions: Collectively, our results describe a new mechanism for the regulation of AIB1 during mitosis, whereby phosphorylation of AIB1 by Cdk1 correlates with the subcellular redistribution of AIB1 from a chromatin-associated state in interphase to a more peripheral localization during mitosis. At the exit of mitosis, AIB1 is dephosphorylated, presumably by PP1. This exclusion from chromatin during mitosis may represent a mechanism for governing the transcriptional activity of AIB1.	[Ferrero, Macarena; Ferragud, Juan; Orlando, Leonardo; Font de Mora, Jaime] CIPF, Lab Cellular & Mol Biol, Valencia, Spain; [Valero, Luz; Sanchez del Pino, Manuel] CIPF, Lab Prote, Valencia, Spain; [Farras, Rosa] CIPF, Lab Cyt, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; Prince Felipe Research Center	Ferrero, M (corresponding author), CIPF, Lab Cellular & Mol Biol, Valencia, Spain.	jfont@cipf.es	del Pino, Manuel/Q-6254-2019; del Pino, Manuel M. Sánchez/I-3977-2015; de Mora, Jaime Font/AAK-7591-2021; Farràs, Rosa/B-5180-2014; de Mora, Jaime Font/H-6304-2015	del Pino, Manuel/0000-0001-6048-0657; del Pino, Manuel M. Sánchez/0000-0001-9696-7600; de Mora, Jaime Font/0000-0002-6816-2095; Farràs, Rosa/0000-0003-4931-1494; de Mora, Jaime Font/0000-0002-6816-2095; Ferrero Gimeno, Macarena/0000-0001-9470-9800	Spanish Ministry of Science and Innovation [SAF2009-08334]; Conselleria d'Educacio, Generalitat Valenciana	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria d'Educacio, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This work was supported by SAF2009-08334 grant from the Spanish Ministry of Science and Innovation. Ferrero was supported by a pre-doctoral fellowship from Conselleria d'Educacio, Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avivar A, 2006, FEBS LETT, V580, P5222, DOI 10.1016/j.febslet.2006.08.057; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Ferrero M, 2008, CANCER RES, V68, P5450, DOI 10.1158/0008-5472.CAN-07-6433; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Horiguchi K, 2006, J BIOCHEM, V140, P409, DOI 10.1093/jb/mvj167; Kajiro M, 2009, NAT CELL BIOL; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lahusen T, 2007, CANCER RES, V67, P7256, DOI 10.1158/0008-5472.CAN-07-1013; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Li SS, 2007, CELL SIGNAL, V19, P1101, DOI 10.1016/j.cellsig.2007.02.002; Louie MC, 2006, MOL CELL BIOL, V26, P3810, DOI 10.1128/MCB.26.10.3810-3823.2006; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lu YY, 1996, BIOCHEM J, V317, P321, DOI 10.1042/bj3170321; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Macurek L, 2009, CANCER RES, V69, P4555, DOI 10.1158/0008-5472.CAN-09-0142; Mani A, 2006, CANCER RES, V66, P8680, DOI 10.1158/0008-5472.CAN-06-0557; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Planas-Silva MD, 2001, CANCER RES, V61, P3858; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28602	10.1371/journal.pone.0028602	http://dx.doi.org/10.1371/journal.pone.0028602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163316	gold, Green Published, Green Submitted			2022-12-25	WOS:000298161900052
J	Birch, AH; Arcand, SL; Oros, KK; Rahimi, K; Watters, AK; Provencher, D; Greenwood, CM; Mes-Masson, AM; Tonin, PN				Birch, Ashley H.; Arcand, Suzanna L.; Oros, Kathleen K.; Rahimi, Kurosh; Watters, A. Kevin; Provencher, Diane; Greenwood, Celia M.; Mes-Masson, Anne-Marie; Tonin, Patricia N.			Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours	PLOS ONE			English	Article							BORDERLINE TUMORS; GENETIC ALTERATIONS; TYROSINE KINASE; PRIMARY CULTURES; TP53 MUTATIONS; CANCER; HETEROZYGOSITY; HYBRIDIZATION; HOMOZYGOSITY; METHYLATION	Ovarian carcinomas exhibit extensive heterogeneity, and their etiology remains unknown. Histological and genetic evidence has led to the proposal that low grade ovarian serous carcinomas (LGOSC) have a different etiology than high grade carcinomas (HGOSC), arising from serous tumours of low malignant potential (LMP). Common regions of chromosome (chr) 3 loss have been observed in all types of serous ovarian tumours, including benign, suggesting that these regions contain genes important in the development of all ovarian serous carcinomas. A high-density genome-wide genotyping bead array technology, which assayed >600,000 markers, was applied to a panel of serous benign and LMP tumours and a small set of LGOSC, to characterize somatic events associated with the most indolent forms of ovarian disease. The genomic patterns inferred were related to TP53, KRAS and BRAF mutations. An increasing frequency of genomic anomalies was observed with pathology of disease: 3/22 (13.6%) benign cases, 40/53 (75.5%) LMP cases and 10/11 (90.9%) LGOSC cases. Low frequencies of chr3 anomalies occurred in all tumour types. Runs of homozygosity were most commonly observed on chr3, with the 3p12-p11 candidate tumour suppressor region the most frequently homozygous region in the genome. An LMP harboured a homozygous deletion on chr6 which created a GOPC-ROS1 fusion gene, previously reported as oncogenic in other cancer types. Somatic TP53, KRAS and BRAF mutations were not observed in benign tumours. KRAS-mutation positive LMP cases displayed significantly more chromosomal aberrations than BRAF-mutation positive or KRAS and BRAF mutation negative cases. Gain of 12p, which harbours the KRAS gene, was particularly evident. A pathology review reclassified all TP53-mutation positive LGOSC cases, some of which acquired a HGOSC status. Taken together, our results support the view that LGOSC could arise from serous benign and LMP tumours, but does not exclude the possibility that HGOSC may derive from LMP tumours.	[Birch, Ashley H.; Tonin, Patricia N.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Arcand, Suzanna L.; Tonin, Patricia N.] McGill Univ Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Oros, Kathleen K.; Greenwood, Celia M.] McGill Univ, Jewish Gen Hosp, Div Clin Epidemiol, Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada; [Oros, Kathleen K.; Greenwood, Celia M.] McGill Univ, Jewish Gen Hosp, Lady Davis Res Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Rahimi, Kurosh] Ctr Hosp Univ Montreal CHUM, Dept Pathol, Montreal, PQ, Canada; [Watters, A. Kevin] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Watters, A. Kevin] McGill Univ Hlth Ctr MUHC, Montreal, PQ, Canada; [Provencher, Diane; Mes-Masson, Anne-Marie] Ctr Rech Ctr Hosp Univ Montreal CRCHUM, Inst Canc Montreal, Montreal, PQ, Canada; [Provencher, Diane] Univ Montreal, Div Gynecol Oncol, Montreal, PQ, Canada; [Greenwood, Celia M.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Greenwood, Celia M.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Tonin, Patricia N.] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; McGill University	Birch, AH (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	patricia.tonin@mcgill.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Greenwood, Celia/0000-0002-2427-5696	Fonds de la recherche du Quebec - Sante (FRQS); Canadian Institute of Health Research (CIHR); Ovarian Cancer Canada	Fonds de la recherche du Quebec - Sante (FRQS); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ovarian Cancer Canada	We thank Manon de Ladurantaye for her helpful expertise. Research was conducted at The Research Institute of the McGill University Health Centre which receives support from the Fonds de la recherche du Quebec - Sante (FRQS). Clinical specimens were provided by the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the FRQS affiliated with the Canadian Tumour Repository Network (CRTNet).; A.H.B. is a recipient of the Frederick Banting and Charles Best Canada Graduate Scholarships from the Canadian Institute of Health Research (CIHR). This research was supported by grants from the CIHR to P.N.T., D. P. and A.-M. M.-M., and from Ovarian Cancer Canada to P.N.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Angeloni D, 2006, GENE CHROMOSOME CANC, V45, P676, DOI 10.1002/gcc.20332; Arcand SL, 2008, BREAST CANCER RES TR, V108, P399, DOI 10.1007/s10549-007-9608-6; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernardini M, 2004, BIOMED PHARMACOTHER, V58, P17, DOI 10.1016/j.biopha.2003.11.002; Birch AH, 2008, MOL CARCINOGEN, V47, P56, DOI 10.1002/mc.20361; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Charest A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/pnas.242741799; Charest A, 2006, CANCER RES, V66, P7473, DOI 10.1158/0008-5472.CAN-06-1193; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Choi YL, 2006, VIRCHOWS ARCH, V448, P331, DOI 10.1007/s00428-005-0091-3; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cody NAL, 2007, ONCOGENE, V26, P618, DOI 10.1038/sj.onc.1209821; Cody NAL, 2009, MOL CARCINOGEN, V48, P1077, DOI 10.1002/mc.20535; Crispens MA, 2002, OBSTET GYNECOL, V99, P3, DOI 10.1016/S0029-7844(01)01649-0; DENICTOLIS M, 1992, CANCER, V70, P152, DOI 10.1002/1097-0142(19920701)70:1<152::AID-CNCR2820700125>3.0.CO;2-6; Fullwood P, 1999, CANCER RES, V59, P4662; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, MOL ONCOL, V3, P157, DOI 10.1016/j.molonc.2008.12.005; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hauptmann S, 2002, HUM PATHOL, V33, P632, DOI 10.1053/hupa.2002.124913; Helou K, 2006, CANCER GENET CYTOGEN, V170, P1, DOI 10.1016/j.cancergencyto.2006.04.010; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu J, 2002, CANCER GENET CYTOGEN, V139, P18, DOI 10.1016/S0165-4608(02)00603-9; Imura M, 2006, CANCER LETT, V241, P213, DOI 10.1016/j.canlet.2005.10.010; IWABUCHI H, 1995, CANCER RES, V55, P6172; Katsaros D, 2004, GYNECOL ONCOL, V94, P685, DOI 10.1016/j.ygyno.2004.06.018; Kiechle M, 2001, CANCER, V91, P534, DOI 10.1002/1097-0142(20010201)91:3<534::AID-CNCR1031>3.3.CO;2-K; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li A J, 2001, Curr Oncol Rep, V3, P27, DOI 10.1007/s11912-001-0039-y; Lounis H, 1998, ONCOGENE, V17, P2359, DOI 10.1038/sj.onc.1202152; LOUNIS H, 1994, EXP CELL RES, V215, P303, DOI 10.1006/excr.1994.1346; Manderson EN, 2009, INT J GYNECOL CANCER, V19, P513, DOI 10.1111/IGC.0b013e3181a3cd38; Manderson EN, 2002, MOL CARCINOGEN, V34, P78, DOI 10.1002/mc.10051; McCluskey LL, 1999, GYNECOL ONCOL, V72, P87, DOI 10.1006/gyno.1998.5235; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mertens F, 1997, CANCER RES, V57, P2765; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Murphy MA, 2010, INT J CANC      1207; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Osterberg L, 2006, CANCER GENET CYTOGEN, V167, P103, DOI 10.1016/j.cancergencyto.2006.01.009; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Ouellet V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-152; PEJOVIC T, 1991, INT J CANCER, V47, P358, DOI 10.1002/ijc.2910470308; Pejovic T, 1996, CANCER GENET CYTOGEN, V92, P95, DOI 10.1016/S0165-4608(96)00169-0; Presneau N, 2005, MOL CARCINOGEN, V43, P141, DOI 10.1002/mc.20096; Presneau N, 2003, ONCOGENE, V22, P1568, DOI 10.1038/sj.onc.1206219; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roy WJ, 1997, ONCOGENE, V15, P2031, DOI 10.1038/sj.onc.1201372; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Sasaki H, 2011, J THORAC ONCOL, V6, P15, DOI 10.1097/JTO.0b013e31820594f0; Schmeler KM, 2008, GYNECOL ONCOL, V108, P510, DOI 10.1016/j.ygyno.2007.11.013; SCHULTZ DC, 1995, CANCER RES, V55, P2150; Schuyer M, 1999, EUR J OBSTET GYN R B, V82, P147, DOI 10.1016/S0301-2115(98)00217-6; Shepherd R, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar018; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Staebler A, 2002, HUM PATHOL, V33, P47, DOI 10.1053/hupa.2002.30212; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Tang W, 2009, COLD SPRING HARB PRO; Thomas NA, 2003, INT J CANCER, V105, P499, DOI 10.1002/ijc.11107; Trimble CL, 2002, GYNECOL ONCOL, V86, P34, DOI 10.1006/gyno.2002.6711; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Wang S, 2009, GENET EPIDEMIOL, V33, P172, DOI 10.1002/gepi.20344; Wolf NG, 1999, GENE CHROMOSOME CANC, V25, P307, DOI 10.1002/(SICI)1098-2264(199908)25:4<307::AID-GCC1>3.0.CO;2-1; YANGFENG TL, 1991, INT J CANCER, V48, P678, DOI 10.1002/ijc.2910480508; Zhang GL, 2002, INT J GYNECOL CANCER, V12, P198	78	72	91	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28250	10.1371/journal.pone.0028250	http://dx.doi.org/10.1371/journal.pone.0028250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163003	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500012
J	Ding, F; Zarlenga, DS; Ren, YD; Li, GX; Luan, J; Ren, XF				Ding, Fan; Zarlenga, Dante S.; Ren, Yudong; Li, Guangxing; Luan, Jin; Ren, Xiaofeng			Use of the D-R Model to Define Trends in the Emergence of Ceftazidime-Resistant Escherichia coli in China	PLOS ONE			English	Article							INFECTION	Objective: To assess the efficacy of the D-R model for defining trends in the appearance of Ceftazidime-resistant Escherichia coli. Methods: Actual data related to the manifestation of Ceftazidime-resistant E. coli spanning years 1996-2009 were collected from the China National Knowledge Internet. These data originated from 430 publications encompassing 1004 citations of resistance. The GM(1,1) and the novel D-R models were used to fit current data and from this, predict trends in the appearance of the drug-resistant phenotype. The results were evaluated by Relative Standard Error (RSE), Mean Absolute Deviation (MAD) and Mean Absolute Error (MAE). Results: Results from the D-R model showed a rapid increase in the appearance of Ceftazidime-resistant E. coli in this region of the world. These results were considered accurate based upon the minor values calculated for RSE, MAD and MAE, and were equivalent to or better than those generated by the GM(1,1) model. Conclusion: The D-R model which was originally created to define trends in the transmission of swine viral diseases can be adapted to evaluating trends in the appearance of Ceftazidime-resistant E. coli. Using only a limited amount of data to initiate the study, our predictions closely mirrored the changes in drug resistance rates which showed a steady increase through 2005, a decrease between 2005 and 2008, and a dramatic inflection point and abrupt increase beginning in 2008. This is consistent with a resistance profile where changes in drug intervention temporarily delayed the upward trend in the appearance of the resistant phenotype; however, resistance quickly resumed its upward momentum in 2008 and this change was better predicted using the D-R model. Additional work is needed to determine if this pattern of "increase-control-increase" is indicative of Ceftazidime-resistant E. coli or can be generally ascribed to bacteria acquiring resistance to drugs in the absence of alternative intervention.	[Ding, Fan; Li, Guangxing; Ren, Xiaofeng] NE Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Zarlenga, Dante S.] ARS, Anim Parasit Dis Lab, Beltsville, MD USA; [Ren, Yudong] NE Agr Univ, Coll Engn, Dept Comp, Harbin, Peoples R China; [Luan, Jin] Chinas Armed Police Force Ctr Dis Control, Beijing, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Ding, F (corresponding author), Chinese Armed Police Forest Force Command, Dept Hlth, Beijing, Peoples R China.	rxfemail@yahoo.com.cn			Heilongjiang Provincial University [1155-NCET-005]; Ministry of Education of the People's Republic of China	Heilongjiang Provincial University; Ministry of Education of the People's Republic of China(Ministry of Education, China)	The work of XR is funded by the Program for New Century Excellent Talents at the Heilongjiang Provincial University (1155-NCET-005), and the New Century Excellent Talents program from the Ministry of Education of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publishe, or preparation of the manuscript.	BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; CDC Division of Bacterial and Mycotic Diseases, 2009, ESCH COL O157 H7; DENG JL, 1982, SYST CONTROL LETT, V1, P288, DOI 10.1016/S0167-6911(82)80025-X; Ding F, 2011, INFECT GENET EVOL, V11, P222, DOI 10.1016/j.meegid.2010.09.015; Hudault S, 2001, GUT, V49, P47, DOI 10.1136/gut.49.1.47; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Vogt RL, 2005, PUBLIC HEALTH REP, V120, P174, DOI 10.1177/003335490512000211; XIONG HJ, 2005, GREY CONTROL; Yu PH, 2005, TIME SERIES ANAL	10	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e27295	10.1371/journal.pone.0027295	http://dx.doi.org/10.1371/journal.pone.0027295			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22162989	Green Published, gold, Green Submitted			2022-12-25	WOS:000298173500003
J	Monk, AC; Siddall, NA; Fraser, B; McLaughlin, EA; Hime, GR				Monk, Adrian C.; Siddall, Nicole A.; Fraser, Barbara; McLaughlin, Eileen A.; Hime, Gary R.			Differential Roles of HOW in Male and Female Drosophila Germline Differentiation	PLOS ONE			English	Article							CELL SELF-RENEWAL; BAG-OF-MARBLES; RNA-BINDING PROTEIN; EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; ASYMMETRIC DIVISION; 2 ISOFORMS; TESTIS; OVARY; GENE	The adult gonads in both male and female Drosophila melanogaster produce gametes that originate from a regenerative pool of germline stem cells (GSCs). The differentiation programme that produces gametes must be co-ordinated with GSC maintenance and proliferation in order to regulate tissue regeneration. The HOW RNA-binding protein has been shown to maintain mitotic progression of male GSCs and their daughters by maintenance of Cyclin B expression as well as suppressing accumulation of the differentiation factor Bam. Loss of HOW function in the male germline results in loss of GSCs due to a delay in G2 and subsequent apoptosis. Here we show that female how mutant GSCs do not have any cell cycle defects although HOW continues to bind bam mRNA and suppress Bam expression. The role of HOW in suppressing germ cell Bam expression appears to be conserved between sexes, leading to different cellular outcomes in how mutants due to the different functions of Bam. In addition the role in maintaining Cyclin B expression has not been conserved so female how GSCs differentiate rather than arrest.	[Monk, Adrian C.; Siddall, Nicole A.; Hime, Gary R.] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia; [Fraser, Barbara; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Melbourne; University of Newcastle	Monk, AC (corresponding author), Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia.	n.siddall@unimelb.edu.au	McLaughlin, Eileen A/G-7620-2013; McLaughlin, Eileen/AAF-5588-2021; Hime, Gary/B-7162-2015	Hime, Gary/0000-0003-4732-3184; McLaughlin, Eileen/0000-0002-5837-3876; Fraser, Barbara/0000-0002-8270-2860	Australian Research Council Centre of Excellence in Biotechnology and Development; National Health and Medical Research Council [509158]	Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Australian Research Council Centre of Excellence in Biotechnology and Development and the National Health and Medical Research Council project grant #509158 supported this work (www.arc.gov.au, www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Cox DN, 2000, DEVELOPMENT, V127, P503; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Forbes A, 1998, DEVELOPMENT, V125, P679; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gonczy P, 1997, DEVELOPMENT, V124, P4361; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Israeli D, 2007, DEVELOPMENT, V134, P2107, DOI 10.1242/dev.001594; Jacobs HW, 2002, CURR BIOL, V12, P1435, DOI 10.1016/S0960-9822(02)01074-6; Jiang XY, 2008, DEV CELL, V14, P494, DOI 10.1016/j.devcel.2008.02.018; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, DEV BIOL, V319, P548, DOI 10.1016/j.ydbio.2008.05.292; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Lin HF, 1997, DEVELOPMENT, V124, P2463; Maines JZ, 2007, DEVELOPMENT, V134, P1471, DOI 10.1242/dev.02810; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Monk AC, 2010, CELL STEM CELL, V6, P348, DOI 10.1016/j.stem.2010.02.016; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Prout M, 1997, GENETICS, V146, P275; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wang Z, 2005, CURR BIOL, V15, P328, DOI 10.1016/j.cub.2005.02.016; WHITFIELD WGF, 1989, NATURE, V338, P337, DOI 10.1038/338337a0; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	46	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28508	10.1371/journal.pone.0028508	http://dx.doi.org/10.1371/journal.pone.0028508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163028	Green Published, gold			2022-12-25	WOS:000298173500028
J	Schurch, AC; Kremer, K; Hendriks, ACA; Freyee, B; McEvoy, CRE; van Crevel, R; Boeree, MJ; van Helden, P; Warren, RM; Siezen, RJ; van Soolingen, D				Schurch, Anita C.; Kremer, Kristin; Hendriks, Amber C. A.; Freyee, Benthe; McEvoy, Christopher R. E.; van Crevel, Reinout; Boeree, Martin J.; van Helden, Paul; Warren, Robin M.; Siezen, Roland J.; van Soolingen, Dick			SNP/RD Typing of Mycobacterium tuberculosis Beijing Strains Reveals Local and Worldwide Disseminated Clonal Complexes	PLOS ONE			English	Article							GENOMIC DELETIONS; NUCLEOTIDE POLYMORPHISMS; DISCRIMINATORY POWER; POPULATION-STRUCTURE; DIVERSITY; EVOLUTION; GENOTYPE; PHYLOGEOGRAPHY; LINEAGE; FAMILY	The Beijing strain is one of the most successful genotypes of Mycobacterium tuberculosis worldwide and appears to be highly homogenous according to existing genotyping methods. To type Beijing strains reliably we developed a robust typing scheme using single nucleotide polymorphisms (SNPs) and regions of difference (RDs) derived from whole-genome sequencing data of eight Beijing strains. SNP/RD typing of 259 M. tuberculosis isolates originating from 45 countries worldwide discriminated 27 clonal complexes within the Beijing genotype family. A total of 16 Beijing clonal complexes contained more than one isolate of known origin, of which two clonal complexes were strongly associated with South African origin. The remaining 14 clonal complexes encompassed isolates from different countries. Even highly resolved clonal complexes comprised isolates from distinct geographical sites. Our results suggest that Beijing strains spread globally on multiple occasions and that the tuberculosis epidemic caused by the Beijing genotype is at least partially driven by modern migration patterns. The SNPs and RDs presented in this study will facilitate future molecular epidemiological and phylogenetic studies on Beijing strains.	[Schurch, Anita C.; Kremer, Kristin; Hendriks, Amber C. A.; Freyee, Benthe; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, TB Reference Lab, Ctr Infect Dis Control, Bilthoven, Netherlands; [Schurch, Anita C.; Siezen, Roland J.] Radboud Univ Nijmegen Med Ctr NCMLS, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [McEvoy, Christopher R. E.; van Helden, Paul; Warren, Robin M.] Univ Stellenbosch, Dept Sci & Technol, Natl Res Fdn Ctr Excellence Biomed TB Res, Med Res Council Ctr Mol & Cellular Biol, Cape Town, South Africa; [McEvoy, Christopher R. E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [van Crevel, Reinout] Radboud Univ Nijmegen Med Ctr, Dept Med, Nijmegen, Netherlands; [Boeree, Martin J.; van Soolingen, Dick] Radboud Univ Nijmegen Med Ctr Univ Lung Ctr Dekke, Dept Pulm Dis, Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; National Research Foundation - South Africa; Stellenbosch University; University of Melbourne; Radboud University Nijmegen; Radboud University Nijmegen	Schurch, AC (corresponding author), Natl Inst Publ Hlth & Environm RIVM, TB Reference Lab, Ctr Infect Dis Control, CIb-LIS,Pb 22, Bilthoven, Netherlands.	dick.van.soolingen@rivm.nl	van Crevel, reinout/A-6636-2010; Boeree, Martin J./G-6132-2010; Siezen, Roland J/P-5745-2015	van Crevel, reinout/0000-0002-6233-6410; Schurch, Anita/0000-0003-1894-7545; Warren, Robin/0000-0001-5741-7358	RIVM [S/3230136/01/GA]; EU [LSHP-CT-2007-037919]	RIVM; EU(European Commission)	This study was supported by the Strategical Research (SOR) fund of the RIVM (S/3230136/01/GA) and the EU-funded TBadapt project (LSHP-CT-2007-037919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Alland D, 2003, J BACTERIOL, V185, P3392, DOI 10.1128/JB.185.11.3392-3399.2003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P69; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P168, DOI 10.1016/S0966-842X(02)02318-1; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cubillos-Ruiz Andres, 2008, BMC Res Notes, V1, P110, DOI 10.1186/1756-0500-1-110; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Fournier PE, 2007, LANCET INFECT DIS, V7, P711, DOI 10.1016/S1473-3099(07)70260-8; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutacker MM, 2002, GENETICS, V162, P1533; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Jurinke C, 2001, Methods Mol Biol, V170, P103; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuroda M, 2010, J CLIN MICROBIOL, V48, P2821, DOI 10.1128/JCM.00137-10; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2008, INFECT GENET EVOL, V8, P777, DOI 10.1016/j.meegid.2008.07.003; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; PLIKAYTIS BB, 1994, J CLIN MICROBIOL, V32, P1542, DOI 10.1128/JCM.32.6.1542-1546.1994; Qi WH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000580; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751; Schurch AC, 2011, INFECT GENET EVOL, V49, P1318; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Stavrum R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001973; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; van Helden PD, 2002, TRENDS MICROBIOL, V10, P167, DOI 10.1016/S0966-842X(02)02317-X; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; van Soolingen D, 2007, TUBERCULOSIS, V1; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08	66	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28365	10.1371/journal.pone.0028365	http://dx.doi.org/10.1371/journal.pone.0028365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162765	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800028
J	Gu, Q; Sood, N				Gu, Qian; Sood, Neeraj			Do People Taking Flu Vaccines Need Them the Most?	PLOS ONE			English	Article							INFLUENZA VACCINATION RATES; PNEUMOCOCCAL VACCINATION; RACIAL/ETHNIC DISPARITIES; MEDICARE BENEFICIARIES; IMMUNIZATION; OLDER; US; ADULTS; BARRIERS; DETERMINANTS	Background A well targeted flu vaccine strategy can ensure that vaccines go to those who are at the highest risk of getting infected if unvaccinated. However, prior research has not explicitly examined the association between the risk of flu infection and vaccination rates. Purpose: This study examines the relationship between the risk of flu infection and the probability of getting vaccinated. Methods: Nationally representative data from the US and multivariate regression models were used to estimate what individual characteristics are associated with (1) the risk of flu infection when unvaccinated and (2) flu vaccination rates. These results were used to estimate the correlation between the probability of infection and the probability of getting vaccinated. Separate analyses were performed for the general population and the high priority population that is at increased risk of flu related complications. Results: We find that the high priority population was more likely to get vaccinated compared to the general population. However, within both the high priority and general populations the risk of flu infection when unvaccinated was negatively correlated with vaccination rates (r = -0.067, p<0.01). This negative association between the risk of infection when unvaccinated and the probability of vaccination was stronger for the high priority population (r = -0.361, p<0.01). Conclusions: There is a poor match between those who get flu vaccines and those who have a high risk of flu infection within both the high priority and general populations. Targeting vaccination to people with low socioeconomic status, people who are engaged in unhealthy behaviors, working people, and families with kids will likely improve effectiveness of flu vaccine policy.	[Gu, Qian] KNG Hlth Consulting, Rockville, MD USA; [Sood, Neeraj] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	University of Southern California	Gu, Q (corresponding author), KNG Hlth Consulting, Rockville, MD USA.	nsood@usc.edu		Sood, Neeraj/0000-0001-9805-213X				BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Blanton L., 2007, Morbidity and Mortality Weekly Report, V56, P789; Blue Carolyn L, 2002, AAOHN J, V50, P227; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bonito AJ, 2004, AM J PREV MED, V27, P153, DOI 10.1016/j.amepre.2004.04.004; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Chen JY, 2005, AM J PREV MED, V29, P388, DOI 10.1016/j.amepre.2005.08.006; Chi RC, 2004, AM J MED SCI, V327, P113, DOI 10.1097/00000441-200403000-00001; Clark SJ, 2009, AM J INFECT CONTROL, V37, P551, DOI 10.1016/j.ajic.2009.02.012; COUCH RB, 1971, J INFECT DIS, V124, P473, DOI 10.1093/infdis/124.5.473; CUMMINGS KM, 1979, MED CARE, V17, P639, DOI 10.1097/00005650-197906000-00008; Ding H., 2010, Morbidity and Mortality Weekly Report, V59, P477; DUCLOS P, 1993, CAN J PUBLIC HEALTH, V84, P311; Egede LE, 2003, AM J PUBLIC HEALTH, V93, P2074, DOI 10.2105/AJPH.93.12.2074; Enserink M, 2004, SCIENCE, V306, P385, DOI 10.1126/science.306.5695.385; Ettner SL, 2010, SOC SCI MED, V71, P134, DOI 10.1016/j.socscimed.2010.03.029; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Glasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012777; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 2005, PEDIATRICS, V116, pE868, DOI 10.1542/peds.2005-1301; Kwong JC, 2009, CLIN INFECT DIS, V49, P750, DOI 10.1086/605087; Lees KA, 2005, AM J PREV MED, V29, P404, DOI 10.1016/j.amepre.2005.08.009; Li Y, 2010, AM J PUBLIC HEALTH, V100, pS256, DOI 10.2105/AJPH.2009.173468; Li Z, 2010, VACCINE, V28, P3462, DOI 10.1016/j.vaccine.2010.02.068; Lindley MC, 2006, AM J PREV MED, V31, P281, DOI 10.1016/j.amepre.2006.06.025; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Logan JL, 2009, J NATL MED ASSOC, V101, P161, DOI 10.1016/S0027-9684(15)30830-0; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Lu PJ, 2009, AM J PREV MED, V37, P109, DOI 10.1016/j.amepre.2009.03.021; Lu PJ, 2005, ARCH INTERN MED, V165, P1849, DOI 10.1001/archinte.165.16.1849; Marin MG, 2002, PREV MED, V34, P235, DOI 10.1006/pmed.2001.0983; Mark TL, 1996, AM J PUBLIC HEALTH, V86, P1545, DOI 10.2105/AJPH.86.11.1545; McNeil Jr DG, 2009, NY TIMES        1104; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Moore BS, 2009, AAOHN J, V57, P475, DOI 10.3928/08910162-20091027-02; Nichol KL, 1996, J GEN INTERN MED, V11, P673, DOI 10.1007/BF02600158; Nowalk MP, 2004, J AM GERIATR SOC, V52, P25, DOI 10.1111/j.1532-5415.2004.52006.x; O'Malley AS, 2006, AM J PREV MED, V31, P150, DOI 10.1016/j.amepre.2006.03.021; O'Reilly FW, 2005, OCCUP MED-OXFORD, V55, P474, DOI 10.1093/occmed/kqi099; Ostbye T, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-41; Pearson WS, 2009, PREV MED, V48, P180, DOI 10.1016/j.ypmed.2008.11.001; Rangel MC, 2005, J GEN INTERN MED, V20, P426, DOI 10.1111/j.1525-1497.2005.0097.x; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Santibanez TA, 2002, J AM GERIATR SOC, V50, P1711, DOI 10.1046/j.1532-5415.2002.50466.x; Santibanez TA, 2010, AM J HEALTH BEHAV, V34, P77; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Singleton JA, 2005, AM J PREV MED, V29, P412, DOI 10.1016/j.amepre.2005.08.012; Straits-Troster KA, 2006, AM J PREV MED, V31, P375, DOI 10.1016/j.amepre.2006.07.018; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; vanEssen GA, 1997, AGE AGEING, V26, P275; Winston CA, 2006, J AM GERIATR SOC, V54, P303, DOI 10.1111/j.1532-5415.2005.00585.x; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4; Zimmerman RK, 2003, AM J MED, V114, P31, DOI 10.1016/S0002-9343(02)01421-3	63	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e26347	10.1371/journal.pone.0026347	http://dx.doi.org/10.1371/journal.pone.0026347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863NO	22164202	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400002
J	Han, WD; Sun, J; Feng, LF; Wang, KF; Li, D; Pan, Q; Chen, Y; Jin, W; Wang, X; Pan, HM; Jin, HC				Han, Weidong; Sun, Jie; Feng, Lifeng; Wang, KaiFeng; Li, Da; Pan, Qin; Chen, Yan; Jin, Wei; Wang, Xian; Pan, Hongming; Jin, Hongchuan			Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells	PLOS ONE			English	Article							COLON-CANCER CELLS; SIGNALING PATHWAYS; DRUG-RESISTANCE; JNK ACTIVATION; DEPENDENT ERK; DEATH; INDUCTION; PROTEIN; THERAPY	Anthracycline daunorubicin (DNR) is one of the major antitumor agents widely used in the treatment of myeloid leukemia. Unfortunately, the clinical efficacy of DNR was limited because of its cytotoxity at high dosage. As a novel cytoprotective mechanism for tumor cell to survive under unfavorable conditions, autophagy has been proposed to play a role in drug resistance of tumor cells. Whether DNR can activate to impair the sensitivity of cancer cells remains unknown. Here, we first report that DNR can induce a high level of autophagy, which was associated with the activation of extracellular signal-regulated kinase 1/2 (ERK1/2). Moreover, cell death induced by DNR was greatly enhanced after autophagy inhibition by the pharmacological inhibitor chloroquine (CQ) and siRNAs targeting Atg5 and Atg7, the most important components for the formation of autophagosome. In conclusion, we found that DNR can induce cytoprotective autophagy by activation of ERK in myeloid leukemia cells. Autophagy inhibition thus represents a promising approach to improve the efficacy of DNR in the treatment of patients with myeloid leukemia.	[Han, Weidong; Wang, KaiFeng; Li, Da; Pan, Qin; Chen, Yan; Jin, Wei; Wang, Xian; Pan, Hongming] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jie; Feng, Lifeng; Jin, Hongchuan] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Biomed Res Ctr,Canc Biol Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Pan, HM (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	panhongming@medmail.com.cn; jinhc@zju.edu.cn	Jin, Hongchuan/C-3686-2009	Wang, Xian/0000-0003-0041-7589; Jin, Hongchuan/0000-0002-6697-3097	National Natural Science Foundation of China [30901740]; China National Ministry of Education [20090101120124]; Zhejiang Natural Sciences Foundation [Y2090166]; Science Technology Department of Zhejiang Province [2010c33168]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Ministry of Education; Zhejiang Natural Sciences Foundation(Natural Science Foundation of Zhejiang Province); Science Technology Department of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No.:30901740), China National Ministry of Education Grant (No.: 20090101120124), Zhejiang Natural Sciences Foundation Grant (No.: Y2090166) and Research Projects of Science Technology Department of Zhejiang Province (No.: 2010c33168) to WH and the Fundamental Research Funds for the Central Universities to HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; BOOSER DJ, 1994, DRUGS, V47, P223, DOI 10.2165/00003495-199447020-00002; Chen SY, 2011, AUTOPHAGY, V7, P217, DOI 10.4161/auto.7.2.14212; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Cui Q, 2007, BIOL PHARM BULL, V30, P859, DOI 10.1248/bpb.30.859; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Ellington AA, 2006, CARCINOGENESIS, V27, P298, DOI 10.1093/carcin/bgi214; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Han W., 2011, PLOS ONE, V6; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Laurent G, 2001, BLOOD, V98, P913, DOI 10.1182/blood.V98.4.913; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; MARAL RJ, 1981, CANCER TREAT REP, V65, P9; MCCULLOCH EA, 1983, BLOOD, V62, P1; Moretti E, 2009, CURR OPIN ONCOL, V21, P507, DOI 10.1097/CCO.0b013e328331a501; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Ohtake S, 2011, BLOOD, V117, P2358, DOI 10.1182/blood-2010-03-273243; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	30	91	97	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28491	10.1371/journal.pone.0028491	http://dx.doi.org/10.1371/journal.pone.0028491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164300	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400101
J	Marino, IAM; Pujolar, JM; Zane, L				Marino, Ilaria A. M.; Pujolar, Jose Martin; Zane, Lorenzo			Reconciling Deep Calibration and Demographic History: Bayesian Inference of Post Glacial Colonization Patterns in Carcinus aestuarii (Nardo, 1847) and C. maenas (Linnaeus, 1758)	PLOS ONE			English	Article							POPULATION-STRUCTURE; TIME DEPENDENCY; MITOCHONDRIAL PHYLOGEOGRAPHY; MEDITERRANEAN SEA; GENETIC-STRUCTURE; MOLECULAR-RATES; ICE-SHEET; DIVERGENCE; EVOLUTION; MODEL	A precise inference of past demographic histories including dating of demographic events using Bayesian methods can only be achieved with the use of appropriate molecular rates and evolutionary models. Using a set of 596 mitochondrial cytochrome c oxidase I (COI) sequences of two sister species of European green crabs of the genus Carcinus (C. maenas and C. aestuarii), our study shows how chronologies of past evolutionary events change significantly with the application of revised molecular rates that incorporate biogeographic events for calibration and appropriate demographic priors. A clear signal of demographic expansion was found for both species, dated between 10,000 and 20,000 years ago, which places the expansions events in a time frame following the Last Glacial Maximum (LGM). In the case of C. aestuarii, a population expansion was only inferred for the Adriatic-Ionian, suggestive of a colonization event following the flooding of the Adriatic Sea (18,000 years ago). For C. maenas, the demographic expansion inferred for the continental populations of West and North Europe might result from a northward recolonization from a southern refugium when the ice sheet retreated after the LGM. Collectively, our results highlight the importance of using adequate calibrations and demographic priors in order to avoid considerable overestimates of evolutionary time scales.	[Marino, Ilaria A. M.; Pujolar, Jose Martin; Zane, Lorenzo] Univ Padua, Dept Biol, Padua, Italy	University of Padua	Marino, IAM (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	lorenzo.zane@unipd.it	Zane, Lorenzo/G-6249-2010	Zane, Lorenzo/0000-0002-6963-2132; pujolar, marti/0000-0002-5037-8840	CORILA (Consortium for Coordination of Research Activities Concerning the Venice Lagoon System); University of Padova	CORILA (Consortium for Coordination of Research Activities Concerning the Venice Lagoon System); University of Padova	This work was supported by a CORILA (Consortium for Coordination of Research Activities Concerning the Venice Lagoon System) grant to LZ and a PhD Fellowship in "Biologia Evoluzionistica'' from the University of Padova to IAMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi L, 2005, MAR ECOL PROG SER, V297, P233, DOI 10.3354/meps297233; Ayala FJ, 1997, P NATL ACAD SCI USA, V94, P7776, DOI 10.1073/pnas.94.15.7776; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Behrens Yamada S, 2001, GLOBAL INVADER EUROP; Borrero-Perez GH, 2011, MOL ECOL, V20, P1964, DOI 10.1111/j.1365-294X.2011.05068.x; Brown J, 1999, ESTUAR COAST SHELF S, V48, P343, DOI 10.1006/ecss.1999.0426; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Bulnheim HP, 1996, INT REV GES HYDROBIO, V81, P611, DOI 10.1002/iroh.19960810417; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Congiu L, 2002, MAR ECOL PROG SER, V229, P279, DOI 10.3354/meps229279; Darling JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017828; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Dawson AG, 1992, ICE AGE EARTH LATE Q; Debes PV, 2008, MOL ECOL, V17, P3873, DOI 10.1111/j.1365-294X.2008.03872.x; Debruyne R, 2009, SYST BIOL, V58, P348, DOI 10.1093/sysbio/syp028; DEMEUSY NOELLE, 1958, ARCH ZOOL EXPTL ET GEN, V95, P253; Domingues CP, 2010, MAR ECOL PROG SER, V410, P111, DOI 10.3354/meps08610; Dov Por Francis, 2010, P13; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foss A, 1998, J FISH BIOL, V53, P901, DOI 10.1111/j.1095-8649.1998.tb01845.x; Fu YX, 1997, GENETICS, V147, P915; Geller JB, 1997, MOL ECOL, V6, P901, DOI 10.1046/j.1365-294X.1997.00256.x; Gysels ES, 2004, MOL ECOL, V13, P403, DOI 10.1046/j.1365-294X.2003.02087.x; HASEGAWA M, 1989, JPN J GENET, V64, P243, DOI 10.1266/jjg.64.243; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoarau G, 2004, J SEA RES, V51, P183, DOI 10.1016/j.seares.2003.12.002; Hofreiter M, 2004, CURR BIOL, V14, P40, DOI 10.1016/j.cub.2003.12.035; Howell N, 2008, HEREDITY, V101, P107, DOI 10.1038/hdy.2008.52; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Huelsenbeck JP, 2000, GENETICS, V154, P1879; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lecomte F, 2004, MOL ECOL, V13, P2169, DOI 10.1111/j.1365-294X.2004.02229.x; Lepage T, 2006, MATH BIOSCI, V199, P216, DOI 10.1016/j.mbs.2005.11.002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Maltagliati F, 2010, BIOL J LINN SOC, V100, P910, DOI 10.1111/j.1095-8312.2010.01482.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; Mona S, 2007, MOL PHYLOGENET EVOL, V45, P757, DOI 10.1016/j.ympev.2007.05.025; Navascues M, 2009, MOL ECOL, V18, P4390, DOI 10.1111/j.1365-294X.2009.04333.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Pampoulie C, 2008, BIOL J LINN SOC, V94, P315, DOI 10.1111/j.1095-8312.2008.00995.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Por FD, 2006, MARE NOSTRUM NEOGENE; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pujolar JM, 2010, MOL PHYLOGENET EVOL, V57, P942, DOI 10.1016/j.ympev.2010.08.002; Ramakrishnan U, 2009, MOL ECOL, V18, P4341, DOI 10.1111/j.1365-294X.2009.04334.x; Rambaut A, 2007, TRACER VERSION 1 5 M; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; RICE A L, 1975, Bulletin of the British Museum (Natural History) Zoology, V28, P101; Ritten RJ, 1986, SCIENCE, V231, P1393; Rogl F, 1999, GEOL CARPATH, V50, P339; Rogl F., 1983, ANN NATURH MUS WIEN, V85, P135; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Shaw PW, 1999, HEREDITY, V83, P490, DOI 10.1038/sj.hdy.6885860; Siegert MJ, 2004, QUATERNARY SCI REV, V23, P1273, DOI 10.1016/j.quascirev.2003.12.010; Susnik S, 2007, MOL PHYLOGENET EVOL, V44, P63, DOI 10.1016/j.ympev.2006.08.021; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THIEDE J, 1978, NATURE, V276, P680, DOI 10.1038/276680a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Vliet-Lanoe B, 2007, CR GEOSCI, V339, P1, DOI 10.1016/j.crte.2006.12.001; Villacorta C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-7; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Zane L, 2006, MOL ECOL, V15, P4499, DOI 10.1111/j.1365-294X.2006.03105.x; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	94	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28567	10.1371/journal.pone.0028567	http://dx.doi.org/10.1371/journal.pone.0028567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164307	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400109
J	Marko, K; Kohidi, T; Hadinger, N; Jelitai, M; Mezo, G; Madarasz, E				Marko, Karoly; Kohidi, Timea; Hadinger, Nora; Jelitai, Marta; Mezo, Gabor; Madarasz, Emilia			Isolation of Radial Glia-Like Neural Stem Cells from Fetal and Adult Mouse Forebrain via Selective Adhesion to a Novel Adhesive Peptide-Conjugate	PLOS ONE			English	Article							CEREBRAL-CORTEX; IN-VITRO; SUBVENTRICULAR ZONE; PROGENITOR CELLS; NERVOUS-SYSTEM; OLFACTORY-BULB; DIFFERENTIATION; INTEGRINS; ASTROCYTES; GROWTH	Preferential adhesion of neural stem cells to surfaces covered with a novel synthetic adhesive polypeptide (AK-cyclo[RGDfC]) provided a unique, rapid procedure for isolating radial glia-like cells from both fetal and adult rodent brain. Radial glia-like (RGl) neural stem/progenitor cells grew readily on the peptide-covered surfaces under serum-free culture conditions in the presence of EGF as the only growth factor supplement. Proliferating cells derived either from fetal (E 14.5) forebrain or from different regions of the adult brain maintained several radial glia-specific features including nestin, RC2 immunoreactivity and Pax6, Sox2, Blbp, Glast gene expression. Proliferating RGl cells were obtained also from non-neurogenic zones including the parenchyma of the adult cerebral cortex and dorsal midbrain. Continuous proliferation allowed isolating one-cell derived clones of radial glia-like cells. All clones generated neurons, astrocytes and oligodendrocytes under appropriate inducing conditions. Electrophysiological characterization indicated that passive conductance with large delayed rectifying potassium current might be a uniform feature of non-induced radial glia-like cells. Upon induction, all clones gave rise to GABAergic neurons. Significant differences were found, however, among the clones in the generation of glutamatergic and cathecolamine-synthesizing neurons and in the production of oligodendrocytes.	[Marko, Karoly; Kohidi, Timea; Hadinger, Nora; Jelitai, Marta; Madarasz, Emilia] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Mezo, Gabor] Eotvos Lorand Univ, Hungarian Acad Sci, Res Grp Peptide Chem, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand University; Hungarian Academy of Sciences	Marko, K (corresponding author), Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary.	marko@koki.hu			National Office for Research and Technology (NKTH); Hungarian Scientific Research Fund [OTKA 68940, K-68939]; Hungarian Academy of Sciences	National Office for Research and Technology (NKTH)(National Office for Research and Technology); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The study was supported by the National Office for Research and Technology (NKTH) NTP grant "Bio-Surf'', the grants of Hungarian Scientific Research Fund (OTKA 68940 and K-68939) and by the "Janos Bolyai'' scholarship of the Hungarian Academy of Sciences to J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Aplin AE, 1998, PHARMACOL REV, V50, P197; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Bithell A, 2008, STEM CELLS, V26, P1565, DOI 10.1634/stemcells.2007-0832; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256; Carstea BV, 2007, CLONING STEM CELLS, V9, P247, DOI 10.1089/clo.2006.0055; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; ffrench-Constant C, 2004, TRENDS CELL BIOL, V14, P678, DOI 10.1016/j.tcb.2004.10.005; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Goodman SL, 2002, J MED CHEM, V45, P1045, DOI 10.1021/jm0102598; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gubert F, 2009, BRAIN RES, V1258, P43, DOI 10.1016/j.brainres.2008.12.021; Hadinger N, 2009, INT J DEV NEUROSCI, V27, P365, DOI 10.1016/j.ijdevneu.2009.02.004; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; HUDECZ F, 1995, ANTI-CANCER DRUG, V6, P171, DOI 10.1097/00001813-199504000-00001; Jelitai M, 2007, J NEUROSCI RES, V85, P1606, DOI 10.1002/jnr.21282; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marko K, 2008, BIOCONJUGATE CHEM, V19, P1757, DOI 10.1021/bc8000134; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nelson AD, 2008, STEM CELLS, V26, P348, DOI 10.1634/stemcells.2007-0299; Nolte C, 2001, GLIA, V33, P72; Onorati M, 2010, CELL MOL LIFE SCI; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schlett K, 1997, J NEUROSCI RES, V47, P405; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Tarnok K, 2002, EUR J CELL BIOL, V81, P403, DOI 10.1078/0171-9335-00262; Varga BV, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-89; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x	45	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28538	10.1371/journal.pone.0028538	http://dx.doi.org/10.1371/journal.pone.0028538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22163310	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400105
J	Park, JB; Kim, BK; Kwon, YW; Muller, DN; Lee, HC; Youn, SW; Choi, YE; Lee, SW; Yang, HM; Cho, HJ; Park, KW; Kim, HS				Park, Jun-Bean; Kim, Baek-Kyung; Kwon, Yoo-Wook; Muller, Dominik N.; Lee, Hyun-Chae; Youn, Seock-Won; Choi, Young-Eun; Lee, Sae-Won; Yang, Han-Mo; Cho, Hyun-Jai; Park, Kyung Woo; Kim, Hyo-Soo			Peroxisome Proliferator-Activated Receptor-Gamma Agonists Suppress Tissue Factor Overexpression in Rat Balloon Injury Model with Paclitaxel Infusion	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ISCHEMIA-REPERFUSION INJURY; FACTOR PATHWAY INHIBITOR; HUMAN ENDOTHELIAL-CELLS; DRUG-ELUTING STENTS; FACTOR EXPRESSION; NEOINTIMAL HYPERPLASIA; PPAR-GAMMA; ROSIGLITAZONE; MECHANISM	The role and underlying mechanisms of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, on myocardial infarction are poorly understood. We investigated the effects of this PPAR-gamma agonist on the expression of tissue factor (TF), a primary molecule for thrombosis, and elucidated its underlying mechanisms. The PPAR-gamma agonist inhibited TF expression in response to TNF-alpha in human umbilical vein endothelial cells, human monocytic leukemia cell line, and human umbilical arterial smooth muscle cells. The overexpression of TF was mediated by increased phosphorylation of mitogen-activated protein kinase (MAPK), which was blocked by the PPAR-gamma agonist. The effective MAPK differed depending on each cell type. Luciferase and ChIP assays showed that transcription factor, activator protein-1 (AP-1), was a pivotal target of the PPAR-gamma agonist to lower TF transcription. Intriguingly, two main drugs for drug-eluting stent, paclitaxel or rapamycin, significantly exaggerated thrombin-induced TF expression, which was also effectively blocked by the PPAR-gamma agonist in all cell types. This PPAR-gamma agonist did not impair TF pathway inhibitor (TFPI) in three cell types. In rat balloon injury model (Sprague-Dawley rats, n = 10/group) with continuous paclitaxel infusion, the PPAR-gamma agonist attenuated TF expression by 70 +/- 5% (n = 4; P,<0.0001) in injured vasculature. Taken together, rosiglitazone reduced TF expression in three critical cell types involved in vascular thrombus formation via MAPK and AP-1 inhibitions. Also, this PPAR-gamma agonist reversed the paclitaxel-induced aggravation of TF expression, which suggests a possibility that the benefits might outweigh its risks in a group of patients with paclitaxel-eluting stent implanted.	[Park, Jun-Bean; Yang, Han-Mo; Cho, Hyun-Jai; Park, Kyung Woo; Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Baek-Kyung; Kwon, Yoo-Wook; Lee, Hyun-Chae; Youn, Seock-Won; Choi, Young-Eun; Lee, Sae-Won; Cho, Hyun-Jai; Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Natl Res Lab Stem Cell Niche, Seoul, South Korea; [Kwon, Yoo-Wook; Lee, Sae-Won; Cho, Hyun-Jai; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Seoul 110744, South Korea; [Muller, Dominik N.] Max Delbruck Ctr, Berlin, Germany; [Muller, Dominik N.] Expt & Clin Res Ctr, Berlin, Germany	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Park, JB (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	hyosoo@snu.ac.kr	Park, Kyung Woo/AAX-3046-2020; Park, Jun-Bean/AAN-3026-2021	Park, Jun-Bean/0000-0003-4053-8713; Muller, Dominik N/0000-0003-3650-5644; Youn, Seock-Won/0000-0003-3275-2170	National Research Foundation; Korea government (MEST) [2010-0020257]; Ministry of Health & Welfare, Republic of Korea [A100476]	National Research Foundation; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the National Research Foundation grant funded by the Korea government (MEST) [grant number: 2010-0020257, URL: http://www.mest.go.kr/]; and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [grant number: A100476, URL:http://mw.go.kr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Bavendiek U, 2002, J BIOL CHEM, V277, P25032, DOI 10.1074/jbc.M204003200; BIERHAUS A, 1995, J BIOL CHEM, V270, P26419, DOI 10.1074/jbc.270.44.26419; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; Calkin AC, 2005, ARTERIOSCL THROM VAS, V25, P1903, DOI 10.1161/01.ATV.0000177813.99577.6b; Camera M, 1999, ARTERIOSCL THROM VAS, V19, P531, DOI 10.1161/01.ATV.19.3.531; Caplice NM, 1998, CIRC RES, V83, P1264, DOI 10.1161/01.RES.83.12.1264; Chen M, 2007, HYPERTENS RES, V30, P971, DOI 10.1291/hypres.30.971; Coyle AT, 2006, BIOCHEM PHARMACOL, V71, P1308, DOI 10.1016/j.bcp.2006.01.011; Farb A, 2001, CIRCULATION, V104, P473, DOI 10.1161/hc3001.092037; He MX, 2006, THROMB RES, V117, P579, DOI 10.1016/j.thromres.2005.04.033; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lee CS, 2009, ARTERIOSCL THROM VAS, V29, P472, DOI 10.1161/ATVBAHA.108.176230; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Liu HR, 2009, CARDIOVASC RES, V81, P344, DOI 10.1093/cvr/cvn308; Llorente-Cortes V, 2004, CIRCULATION, V110, P452, DOI 10.1161/01.CIR.0000136032.40666.3D; Lloyd S, 2002, CHEM-BIOL INTERACT, V142, P57, DOI 10.1016/S0009-2797(02)00054-6; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Lupu C, 1997, ARTERIOSCL THROM VAS, V17, P2964, DOI 10.1161/01.ATV.17.11.2964; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; Muller DN, 2000, AM J PATHOL, V157, P111, DOI 10.1016/S0002-9440(10)64523-3; Napoleone E, 1997, BLOOD, V89, P541, DOI 10.1182/blood.V89.2.541; NEMERSON Y, 1988, BLOOD, V71, P1; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Paget MB, 2011, DIABETES OBES METAB, V13, P662, DOI 10.1111/j.1463-1326.2011.01392.x; Park KW, 2003, ARTERIOSCL THROM VAS, V23, P1364, DOI 10.1161/01.ATV.0000081633.53390.B4; Parulkar AA, 2001, ANN INTERN MED, V134, P61, DOI 10.7326/0003-4819-134-1-200101020-00014; Pickavance LC, 1999, BRIT J PHARMACOL, V128, P1570, DOI 10.1038/sj.bjp.0702932; Pucci A, 2011, ATHEROSCLEROSIS, V218, P479, DOI 10.1016/j.atherosclerosis.2011.06.009; Schecter AD, 1997, J CLIN INVEST, V100, P2276, DOI 10.1172/JCI119765; SOLLOTT SJ, 1995, J CLIN INVEST, V95, P1869, DOI 10.1172/JCI117867; Stahli BE, 2006, CIRC RES, V99, P149, DOI 10.1161/01.RES.0000233379.92010.fd; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Steffel J, 2005, CIRCULATION, V112, P2002, DOI 10.1161/CIRCULATIONAHA.105.569129; Steffel J, 2005, CIRCULATION, V112, P341, DOI 10.1161/CIRCULATIONAHA.105.553735; Thornton SR, 1997, EUR J PHARMACOL, V340, P161, DOI 10.1016/S0014-2999(97)01434-9; Watt J, 2008, CLIN SCI, V114, P265, DOI 10.1042/CS20070207; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Yuan L, 2003, ACTA PHARMACOL SIN, V24, P429	46	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28327	10.1371/journal.pone.0028327	http://dx.doi.org/10.1371/journal.pone.0028327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140576	Green Published, gold, Green Accepted			2022-12-25	WOS:000298166300048
J	Tran, DT; Zhang, LP; Zhang, Y; Tian, E; Earl, LA; Ten Hagen, KG				Tran, Duy T.; Zhang, Liping; Zhang, Ying; Tian, E.; Earl, Lesley A.; Ten Hagen, Kelly G.			Multiple Members of the UDP-GalNAc: Polypeptide N-Acetylgalactosaminyltransferase Family Are Essential for Viability in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION; TRANSGENIC RNAI; CELL-ADHESION; GERM-LINE; PROTEIN; EXPRESSION; MELANOGASTER; MUTATIONS; SECRETION; GLYCANS	Mucin-type O-glycosylation represents a major form of post-translational modification that is conserved across most eukaryotic species. This type of glycosylation is initiated by a family of enzymes (GalNAc-Ts in mammals and PGANTs in Drosophila) whose members are expressed in distinct spatial and temporal patterns during development. Previous work from our group demonstrated that one member of this family is essential for viability and another member modulates extracellular matrix composition and integrin-mediated cell adhesion during development. To investigate whether other members of this family are essential, we employed RNA interference (RNAi) to each gene in vivo. Using this approach, we identified 4 additional pgant genes that are required for viability. Ubiquitous RNAi to pgant4, pgant5, pgant7, or the putative glycosyltransferase CG30463 resulted in lethality. Tissue-specific RNAi was also used to define the specific organ systems and tissues in which each essential family member is required. Interestingly, each essential pgant had a unique complement of tissues in which it was required. Additionally, certain tissues (mesoderm, digestive system, and tracheal system) required more than one pgant, suggesting unique functions for specific enzymes in these tissues. Expanding upon our RNAi results, we found that conventional mutations in pgant5 resulted in lethality and specific defects in specialized cells of the digestive tract, resulting in loss of proper digestive system acidification. In summary, our results highlight essential roles for O-glycosylation and specific members of the pgant family in many aspects of development and organogenesis.	[Tran, Duy T.; Zhang, Liping; Tian, E.; Earl, Lesley A.; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Unit, NIH, Bethesda, MD 20892 USA; [Zhang, Ying] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Virginia	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov			National Institutes of Health of the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER	National Institutes of Health of the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDCR.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dubreuil RR, 2004, INT J BIOCHEM CELL B, V36, P745, DOI 10.1016/j.biocel.2003.07.004; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Ichikawa S, 2007, J CLIN ENDOCR METAB, V92, P1943, DOI 10.1210/jc.2006-1825; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; Kramer KL, 2010, SEMIN CELL DEV BIOL, V21, P631, DOI 10.1016/j.semcdb.2010.06.002; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Nakamura N, 2010, SEMIN CELL DEV BIOL, V21, P622, DOI 10.1016/j.semcdb.2010.03.010; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schachter H, 2010, SEMIN CELL DEV BIOL, V21, P609, DOI 10.1016/j.semcdb.2010.02.010; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zacharogianni M, 2011, EMBO J, V30, P3684, DOI 10.1038/emboj.2011.253; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	48	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5243	5252		10.1074/jbc.M111.306159	http://dx.doi.org/10.1074/jbc.M111.306159			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157008	hybrid, Green Published			2022-12-25	WOS:000300638000007
J	Michailidou, Z; Turban, S; Miller, E; Zou, XT; Schrader, J; Ratcliffe, PJ; Hadoke, PWF; Walker, BR; Iredale, JP; Morton, NM; Seckl, JR				Michailidou, Zoi; Turban, Sophie; Miller, Eileen; Zou, Xiantong; Schrader, Joerg; Ratcliffe, Peter J.; Hadoke, Patrick W. F.; Walker, Brian R.; Iredale, John P.; Morton, Nicholas M.; Seckl, Jonathan R.			Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11 beta-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED VISCERAL OBESITY; INDUCIBLE FACTOR 1-ALPHA; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; TISSUE HYPOXIA; INFLAMMATION; INSULIN; CELLS; HIF-1-ALPHA; PATHWAY	In obesity, rapidly expanding adipose tissue becomes hypoxic, precipitating inflammation, fibrosis, and insulin resistance. Compensatory angiogenesis may prevent these events. Mice lacking the intracellular glucocorticoid-amplifying enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta HSD1(-/-)) have "healthier" adipose tissue distribution and resist metabolic disease with diet-induced obesity. Here we show that adipose tissues of 11 beta HSD1(-/-) mice exhibit attenuated hypoxia, induction of hypoxia-inducible factor (HIF-1 alpha) activation of the TGF beta/Smad3/alpha-smooth muscle actin (alpha-SMA) signaling pathway, and fibrogenesis despite similar fat accretion with diet-induced obesity. Moreover, augmented 11 beta HSD1(-/-) adipose tissue angiogenesis is associated with enhanced peroxisome proliferator-activated receptor gamma (PPAR gamma)-inducible expression of the potent angiogenic factors VEGF-A, apelin, and angiopoietin-like protein 4. Improved adipose angiogenesis and reduced fibrosis provide a novel mechanism whereby suppression of intracellular glucocorticoid regeneration promotes safer fat expansion with weight gain.	[Michailidou, Zoi; Schrader, Joerg; Iredale, John P.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; [Turban, Sophie; Miller, Eileen; Zou, Xiantong; Hadoke, Patrick W. F.; Walker, Brian R.; Morton, Nicholas M.; Seckl, Jonathan R.] Univ Edinburgh, Queens Med Res Inst, Univ British Heart Fdn BHF, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Ratcliffe, Peter J.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England	University of Edinburgh; University of Edinburgh; University of Oxford	Michailidou, Z (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	v1zmicha@staffmail.ed.ac.uk	Morton, NICHOLAS/ABF-3774-2020; Seckl, Jonathan R/C-3555-2013	Ratcliffe, Peter/0000-0002-2853-806X; Iredale, John/0000-0003-2174-5127; Miller, Eileen/0000-0003-1566-8217	British Heart Foundation Centre of Research Excellence; Henry Wellcome Postdoctoral Fellowship; Wellcome Trust [079660/z/06/z]; European Community [201608]; British Heart Foundation [RG/11/4/28734] Funding Source: researchfish	British Heart Foundation Centre of Research Excellence(British Heart Foundation); Henry Wellcome Postdoctoral Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); British Heart Foundation(British Heart Foundation)	We acknowledge the support of the British Heart Foundation Centre of Research Excellence. We are grateful to the Centre for Inflammation Research Histology staff for excellent technical support and Sheila Macpherson in the MRC-Centre for Reproductive Biology (CRB) for expertise and generous help on CD31 immunohistochemistry.; This work was supported by a Henry Wellcome Postdoctoral Fellowship (to Z. M.), a Wellcome Trust Programme Grant (to J. R. S.), and a grant from the European Community 7th Framework Programme (FP7/2007-2013) under Grant Agreement 201608, entitled Targeting Obesity-driven Inflammation (TOBI). B. R. W., J. R. S., and N. M. M. are inventors on relevant patents owned by the University of Edinburgh. B. R. W. and J. R. S. have consulted on 11 beta HSD1 inhibitors for a number of pharmaceutical companies.; Supported by a Wellcome Trust Career Development Fellowship (079660/z/06/z).	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Copple BL, 2010, HEPATOL RES, V40, P530, DOI 10.1111/j.1872-034X.2010.00635.x; Eickelberg O, 2001, FEBS LETT, V506, P11, DOI 10.1016/S0014-5793(01)02875-7; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feldser D, 1999, CANCER RES, V59, P3915; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Kodama T, 2003, J BIOL CHEM, V278, P33384, DOI 10.1074/jbc.M302581200; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Leonard MO, 2005, J IMMUNOL, V174, P2250, DOI 10.4049/jimmunol.174.4.2250; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McSweeney SJ, 2010, CARDIOVASC RES, V88, P159, DOI 10.1093/cvr/cvq149; Michailidou Z, 2007, OBESITY, V15, P1155, DOI 10.1038/oby.2007.618; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Nauck M, 1998, EUR J PHARMACOL, V341, P309, DOI 10.1016/S0014-2999(97)01464-7; Ndubuizu OI, 2010, BRAIN RES, V1366, P101, DOI 10.1016/j.brainres.2010.09.064; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Peixoto RADS, 2008, ENDOCRINOLOGY, V149, P1861, DOI 10.1210/en.2007-1028; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Shimba S, 2004, J BIOL CHEM, V279, P40946, DOI 10.1074/jbc.M400840200; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Stockmann C, 2010, P NATL ACAD SCI USA, V107, P4329, DOI 10.1073/pnas.0912766107; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Villaret A, 2010, DIABETES, V59, P2755, DOI 10.2337/db10-0398; Wamil M, 2011, DIABETES, V60, P1158, DOI 10.2337/db10-0830; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE333, DOI 10.1152/ajpendo.90760.2008; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4	38	61	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4188	4197		10.1074/jbc.M111.259325	http://dx.doi.org/10.1074/jbc.M111.259325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158867	hybrid, Green Published			2022-12-25	WOS:000300410900052
J	Kosmider, B; Messier, EM; Chu, HW; Mason, RJ				Kosmider, Beata; Messier, Elise M.; Chu, Hong Wei; Mason, Robert J.			Human Alveolar Epithelial Cell Injury Induced by Cigarette Smoke	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN LUNG FIBROBLASTS; OXIDATIVE STRESS; N-ACETYLCYSTEINE; INDUCED EMPHYSEMA; HEME OXYGENASE-1; IN-VITRO; CIS-PT(II) COMPLEX; INDUCED APOPTOSIS; TOBACCO-SMOKE	Background: Cigarette smoke (CS) is a highly complex mixture and many of its components are known carcinogens, mutagens, and other toxic substances. CS induces oxidative stress and cell death, and this cell toxicity plays a key role in the pathogenesis of several pulmonary diseases. Methodology/Principal Findings: We studied the effect of cigarette smoke extract (CSE) in human alveolar epithelial type I-like (ATI-like) cells. These are isolated type II cells that are differentiating toward the type I cell phenotype in vitro and have lost many type II cell markers and express type I cell markers. ATI-like cells were more sensitive to CSE than alveolar type II cells, which maintained their differentiated phenotype in vitro. We observed disruption of mitochondrial membrane potential, apoptosis and necrosis that were detected by double staining with acridine orange and ethidium bromide or Hoechst 33342 and propidium iodide and TUNEL assay after treatment with CSE. We also detected caspase 3 and caspase 7 activities and lipid peroxidation. CSE induced nuclear translocation of Nrf2 and increased expression of Nrf2, HO-1, Hsp70 and Fra1. Moreover, we found that Nrf2 knockdown sensitized ATI-like cells to CSE and Nrf2 overexpression provided protection against CSE-induced cell death. We also observed that two antioxidant compounds N-acetylcysteine and trolox protected ATI-like cells against injury by CSE. Conclusions: Our study indicates that Nrf2 activation is a major factor in cellular defense of the human alveolar epithelium against CSE-induced toxicity and oxidative stress. Therefore, antioxidant agents that modulate Nrf2 would be expected to restore antioxidant and detoxifying enzymes and to prevent CS-related lung injury and perhaps lessen the development of emphysema.	[Kosmider, Beata; Messier, Elise M.; Chu, Hong Wei; Mason, Robert J.] Natl Jewish Hlth, Dept Med, Denver, CO USA	National Jewish Health	Kosmider, B (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	KosmiderB@NJHealth.org		Messier, Elise/0000-0003-3554-9282	Flight Attendant Medical Research Institute; National Heart, Lung and Blood Institute of the National Institutes of Health [HL029891]; ExxonMobil Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029891, R37HL029891] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ExxonMobil Foundation(Exxon Mobil Corporation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Young Clinical Scientist Award from the Flight Attendant Medical Research Institute (B.K.), National Heart, Lung and Blood Institute of the National Institutes of Health (HL029891 to R.J.M.) and by ExxonMobil Foundation (R.J.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baqir M, 2008, RESP MED, V102, P1604, DOI 10.1016/j.rmed.2008.05.002; Bernhard David, 2004, Journal of Pharmacological and Toxicological Methods, V50, P45, DOI 10.1016/j.vascn.2004.01.003; Bhalla DK, 2009, J TOXICOL ENV HEAL B, V12, P45, DOI 10.1080/10937400802545094; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Boutten A, 2011, TRENDS MOL IN PRESS; Cai S, 2009, RESPIROLOGY, V14, P354, DOI 10.1111/j.1440-1843.2009.01511.x; Cawood TJ, 2007, J CLIN ENDOCR METAB, V92, P59, DOI 10.1210/jc.2006-1824; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chirino YI, 2010, TOXICOL LETT, V193, P209, DOI 10.1016/j.toxlet.2010.01.009; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; Demiralay R, 2007, HUM EXP TOXICOL, V26, P595, DOI 10.1177/0960327106070079551; Dobbs LG, 2007, RESP PHYSIOL NEUROBI, V159, P283, DOI 10.1016/j.resp.2007.06.011; Donnelly LE, 2001, AM J RESP CELL MOL, V24, P295, DOI 10.1165/ajrcmb.24.3.4001; Ferguson HE, 2009, AM J PHYSIOL-LUNG C, V297, pL912, DOI 10.1152/ajplung.00148.2009; Galicia-Moreno M, 2008, BASIC CLIN PHARMACOL, V103, P476, DOI 10.1111/j.1742-7843.2008.00324.x; Gebel S, 2010, TOXICOL SCI, V115, P238, DOI 10.1093/toxsci/kfq039; Ginzberg HH, 2004, AM J PHYSIOL-GASTR L, V287, pG286, DOI 10.1152/ajpgi.00350.2003; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Hogan AE, 2011, CLIN IMMUNOL, V140, P229, DOI 10.1016/j.clim.2011.01.011; Hogg JC, 2002, THORAX, V57, P830, DOI 10.1136/thorax.57.9.830; Hoshino Y, 2001, AM J PHYSIOL-LUNG C, V281, pL509, DOI 10.1152/ajplung.2001.281.2.L509; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ishii T, 2001, AM J PHYSIOL-LUNG C, V280, pL1189, DOI 10.1152/ajplung.2001.280.6.L1189; Ji L, 2010, INHAL TOXICOL, V22, P535, DOI 10.3109/08958370903525183; Johnson MD, 2009, CANCER EPIDEM BIOMAR, V18, P3263, DOI 10.1158/1055-9965.EPI-09-0965; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kosmider B, 2006, MUTAT RES-GEN TOX EN, V604, P28, DOI 10.1016/j.mrgentox.2005.12.006; Kosmider B, 2004, MUTAT RES-GEN TOX EN, V558, P169, DOI 10.1016/j.mrgentox.2003.12.004; Kosmider B, 2010, FREE RADICAL BIO MED, V48, P1513, DOI 10.1016/j.freeradbiomed.2010.02.032; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Luo XP, 1999, FREE RADICAL BIO MED, V26, P1357, DOI 10.1016/S0891-5849(98)00334-7; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Morley N, 2003, J PHOTOCH PHOTOBIO B, V72, P55, DOI 10.1016/j.jphotobiol.2003.06.004; Nakajima Y, 2008, BRAIN RES, V1226, P226, DOI 10.1016/j.brainres.2008.06.026; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Sadowska AM, 2006, RESPIROLOGY, V11, P741, DOI 10.1111/j.1440-1843.2006.00943.x; Serviddio G, 2011, CURR PHARM IN PRESS; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Stav D, 2009, CHEST, V136, P381, DOI 10.1378/chest.09-0421; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Thaikoottathil JV, 2009, EUR RESPIR J, V33, P835, DOI 10.1183/09031936.00080708; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, pL1211, DOI 10.1152/ajplung.00291.2006; Vayssier-Taussat M, 2001, AM J PHYSIOL-HEART C, V280, pH1293, DOI 10.1152/ajpheart.2001.280.3.H1293; Vercelino R, 2008, BASIC CLIN PHARMACOL, V102, P370, DOI 10.1111/j.1742-7843.2007.00181.x; Villeneuve NF, 2009, CELL CYCLE, V8, P3255, DOI 10.4161/cc.8.20.9565; Walters DM, 2008, ANTIOXID REDOX SIGN, V10, P321, DOI 10.1089/ars.2007.1901; Wang J, 2011, AM J RESP C IN PRESS; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com	58	90	96	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e26059	10.1371/journal.pone.0026059	http://dx.doi.org/10.1371/journal.pone.0026059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163265	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900001
J	Zhao, KN; Masci, PP; Lavin, MF				Zhao, Kong-Nan; Masci, Paul P.; Lavin, Martin F.			Disruption of Spectrin-Like Cytoskeleton in Differentiating Keratinocytes by PKC delta Activation Is Associated with Phosphorylated Adducin	PLOS ONE			English	Article							PROTEIN-KINASE-C; HUMAN EPIDERMAL-KERATINOCYTES; CULTURED HUMAN KERATINOCYTES; TERMINAL DIFFERENTIATION; IN-VIVO; HEREDITARY SPHEROCYTOSIS; INVOLUCRIN EXPRESSION; CELL-DIFFERENTIATION; MOUSE KERATINOCYTES; PLATELET ACTIVATION	Spectrin is a central component of the cytoskeletal protein network in a variety of erythroid and non-erythroid cells. In keratinocytes, this protein has been shown to be pericytoplasmic and plasma membrane associated, but its characteristics and function have not been established in these cells. Here we demonstrate that spectrin increases dramatically in amount and is assembled into the cytoskeleton during differentiation in mouse and human keratinocytes. The spectrin-like cytoskeleton was predominantly organized in the granular and cornified layers of the epidermis and disrupted by actin filament inhibitors, but not by anti-mitotic drugs. When the cytoskeleton was disrupted PKC delta was activated by phosphorylation on Thr505. Specific inhibition of PKC delta((Thr505)) activation with rottlerin prevented disruption of the spectrin-like cytoskeleton and the associated morphological changes that accompany differentiation. Rottlerin also inhibited specific phosphorylation of the PKC delta substrate adducin, a cytoskeletal protein. Furthermore, knock-down of endogenous adducin affected not only expression of adducin, but also spectrin and PKC delta, and severely disrupted organization of the spectrin-like cytoskeleton and cytoskeletal distribution of both adducin and PKC delta. These results demonstrate that organization of a spectrin-like cytoskeleton is associated with keratinocytes differentiation, and disruption of this cytoskeleton is mediated by either PKC delta((Thr505)) phosphorylation associated with phosphorylated adducin or due to reduction of endogenous adducin, which normally connects and stabilizes the spectrin-actin complex.	[Zhao, Kong-Nan; Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Masci, Paul P.] Univ Queensland, Princess Alexandra Hosp, Ctr Integrat Clin & Mol Med, Sch Med, Brisbane, Qld, Australia; [Zhao, Kong-Nan; Lavin, Martin F.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute	Zhao, KN (corresponding author), Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.	k.zhao@uq.edu.au	Lavin, Martin F/F-5961-2014	Lavin, Martin F/0000-0002-5940-4769	National Health and Medical Research Council of Australia [301256]; Cancer Council of Queensland [401623, 511210]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland)	This work was funded by a National Health and Medical Research Council of Australia Industry Research Fellowship (301256 to KNZ) and grants from Cancer Council of Queensland (401623 and 511210 to KNZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Aho S, 2000, J CELL BIOL, V148, P1165, DOI 10.1083/jcb.148.6.1165; Banan A, 2004, AM J PHYSIOL-CELL PH, V287, pC218, DOI 10.1152/ajpcell.00575.2003; Barkalow KL, 2003, J CELL BIOL, V161, P557, DOI 10.1083/jcb.200211122; Baumann O, 1998, CELL MOTIL CYTOSKEL, V41, P74, DOI 10.1002/(SICI)1097-0169(1998)41:1<74::AID-CM7>3.0.CO;2-F; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; De Matteis MA, 2000, J CELL SCI, V113, P2331; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Fan Y, 2009, NEUROSCI BULL, V25, P187, DOI 10.1007/s12264-009-0416-3; Fang NX, 2007, VIROLOGY, V365, P187, DOI 10.1016/j.virol.2007.03.038; FOWLER VM, 1992, J CELL BIOL, V119, P1559, DOI 10.1083/jcb.119.6.1559; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; George A, 2010, BLOOD CELL MOL DIS, V45, P41, DOI 10.1016/j.bcmd.2010.02.006; Gilligan DM, 2002, BLOOD, V99, P2418, DOI 10.1182/blood.V99.7.2418; GOODMAN SR, 1981, P NATL ACAD SCI-BIOL, V78, P7570, DOI 10.1073/pnas.78.12.7570; GRANGER BL, 1985, NATURE, V313, P238, DOI 10.1038/313238a0; GREGORIO CC, 1994, J CELL BIOL, V125, P345, DOI 10.1083/jcb.125.2.345; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hassoun H, 1995, J CLIN INVEST, V96, P2623, DOI 10.1172/JCI118327; HILLER G, 1977, NATURE, V266, P181, DOI 10.1038/266181a0; Hoben GM, 2008, CELL TISSUE RES, V334, P469, DOI 10.1007/s00441-008-0705-6; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Johansen C, 2000, J INVEST DERMATOL, V114, P1174, DOI 10.1046/j.1523-1747.2000.00003.x; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; KAISER HW, 1993, J INVEST DERMATOL, V101, P783, DOI 10.1111/1523-1747.ep12371695; KARINIEMI AL, 1984, J CUTAN PATHOL, V11, P541, DOI 10.1111/j.1600-0560.1984.tb00416.x; KARINIEMI AL, 1984, BRIT J DERMATOL, V111, P139, DOI 10.1111/j.1365-2133.1984.tb04036.x; Khurana RN, 2003, EXP EYE RES, V76, P39, DOI 10.1016/S0014-4835(02)00255-5; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lee YS, 1997, MOL CARCINOGEN, V18, P44, DOI 10.1002/(SICI)1098-2744(199701)18:1<44::AID-MC6>3.0.CO;2-R; LEWIS L, 1987, DIFFERENTIATION, V36, P228, DOI 10.1111/j.1432-0436.1987.tb00197.x; Li B, 2008, DIFFERENTIATION, V76, P1068, DOI 10.1111/j.1432-0436.2008.00300.x; Li XL, 1996, J BIOL CHEM, V271, P15695, DOI 10.1074/jbc.271.26.15695; Liedtke CM, 2003, AM J PHYSIOL-CELL PH, V284, pC487, DOI 10.1152/ajpcell.00357.2002; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MANGEAT PH, 1984, J CELL BIOL, V98, P1363, DOI 10.1083/jcb.98.4.1363; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; PAINTER RG, 1975, P NATL ACAD SCI USA, V72, P1359, DOI 10.1073/pnas.72.4.1359; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Perrotta S, 2001, LEUKEMIA, V15, P440, DOI 10.1038/sj.leu.2402047; PETERS LL, 1992, P NATL ACAD SCI USA, V89, P5749, DOI 10.1073/pnas.89.13.5749; Pinder JC, 2000, NATURE, V406, P253, DOI 10.1038/35018679; PINES J, 1990, New Biologist, V2, P389; REPASKY EA, 1982, CELL, V29, P821, DOI 10.1016/0092-8674(82)90444-5; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Rutberg SE, 1996, ONCOGENE, V13, P167; SATO S, 1986, J BIOCHEM-TOKYO, V100, P643, DOI 10.1093/oxfordjournals.jbchem.a121756; SHIMIZU T, 1995, HISTOCHEM CELL BIOL, V103, P363, DOI 10.1007/BF01457811; Sihag RK, 1998, J NEUROCHEM, V71, P2220; Sikorski AF, 2000, BRAIN RES, V852, P161, DOI 10.1016/S0006-8993(99)02253-2; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Stanwell C, 1996, J INVEST DERMATOL, V106, P482, DOI 10.1111/1523-1747.ep12343690; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Tamaru S, 2005, BIOCHEM BIOPH RES CO, V332, P347, DOI 10.1016/j.bbrc.2005.04.127; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Tuominen H, 1996, BRIT J DERMATOL, V135, P576, DOI 10.1046/j.1365-2133.1996.d01-1043.x; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Zhao KN, 2005, MOL CELL BIOL, V25, P8643, DOI 10.1128/MCB.25.19.8643-8655.2005; Zhu L, 2008, J INVEST DERMATOL, V128, P833, DOI 10.1038/sj.jid.5701103	77	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28267	10.1371/journal.pone.0028267	http://dx.doi.org/10.1371/journal.pone.0028267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163289	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900024
J	Ilany, A; Barocas, A; Koren, L; Kam, M; Geffen, E				Ilany, Amiyaal; Barocas, Adi; Koren, Lee; Kam, Michael; Geffen, Eli			Do Singing Rock Hyraxes Exploit Conspecific Calls to Gain Attention?	PLOS ONE			English	Article							SPLENDID FAIRY-WREN; TESTOSTERONE LEVELS; COMMUNICATION; SIGNAL; SELECTION; SCREAMS; DANGER; FROG	Signal detection theory predicts that signals directed at distant or busy receivers in noisy backgrounds will begin with an alert component, in order to draw attention. Instead of an alert component, however, animals could get the same effect by using an external stimulus. Here we combined observations of free-living rock hyraxes (Procavia capensis) with playback experiments to elucidate the circumstances under which males begin singing. We show that males sing following hyrax pup screams, which elicit a strong response from hyraxes within hearing distance, which are potential receivers. We hypothesize that singers enhance their singing display by exploiting the rarely emitted pup screams. To our knowledge, our findings are the first indication that animals may enhance signal reception by exploiting conspecifics' signals and the differential attention to these signals. We suggest that the utilization of external stimuli by signalers may be widespread, as an adaptive strategy for communication in complex environments.	[Ilany, Amiyaal; Barocas, Adi; Koren, Lee; Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Barocas, Adi] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Barocas, Adi] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Koren, Lee] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Kam, Michael] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Wyler Dept Dryland Agr, IL-84105 Beer Sheva, Israel	Tel Aviv University; University of Wyoming; University of Wyoming; University of Calgary; Ben Gurion University	Ilany, A (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	amiyaal@gmail.com	Kam, Michael/Q-8764-2019	Kam, Michael/0000-0002-1062-7654; Ilany, Amiyaal/0000-0001-8089-569X	Israel Sciences Foundation [577/99, 488/05, 461/09]	Israel Sciences Foundation(Israel Science Foundation)	The Israel Sciences Foundation funded the study (grants 577/99, 488/05, 461/09; url: www.isf.org.il/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumstein DT, 2008, ANIM BEHAV, V76, P1055, DOI 10.1016/j.anbehav.2008.06.002; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; FOURIE PB, 1977, Z TIERPSYCHOL, V44, P194; Greig EI, 2010, BEHAV ECOL, V21, P1360, DOI 10.1093/beheco/arq155; Greig EI, 2009, ANIM BEHAV, V78, P45, DOI 10.1016/j.anbehav.2009.02.030; HOECK HN, 1982, Z TIERPSYCHOL, V59, P265; Koren L, 2006, HORM BEHAV, V49, P470, DOI 10.1016/j.yhbeh.2005.10.004; Koren L, 2000, HYRAX SOCIALIZATION; Koren L, 2008, HORM BEHAV, V54, P212, DOI 10.1016/j.yhbeh.2008.02.020; Koren L, 2011, BEHAV ECOL SOCIOBIOL, V65, P675, DOI 10.1007/s00265-010-1069-y; Koren L, 2009, BEHAV ECOL SOCIOBIOL, V63, P581, DOI 10.1007/s00265-008-0693-2; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; NEAVES WB, 1973, BIOL REPROD, V8, P451, DOI 10.1093/biolreprod/8.4.451; Ord TJ, 2008, P NATL ACAD SCI USA, V105, P18830, DOI 10.1073/pnas.0807657105; Peters RA, 2008, BIOL LETTERS, V4, P2, DOI 10.1098/rsbl.2007.0422; Reby D, 2012, ANIM COGN, V15, P265, DOI 10.1007/s10071-011-0451-0; RICHARDS DG, 1981, BEHAVIOUR, V76, P223, DOI 10.1163/156853981X00095; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zelano B, 2001, ETHOLOGY, V107, P201, DOI 10.1046/j.1439-0310.2001.00645.x	23	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28612	10.1371/journal.pone.0028612	http://dx.doi.org/10.1371/journal.pone.0028612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163045	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500041
J	Kim, YJ; Park, SJ; Choi, EY; Kim, S; Kwak, HJ; Yoo, BC; Yoo, H; Lee, SH; Kim, D; Park, JB; Kim, JH				Kim, Youn-Jae; Park, Se-Jeong; Choi, Eun Young; Kim, Sol; Kwak, Hee Jin; Yoo, Byong Chul; Yoo, Heon; Lee, Seung-Hoon; Kim, Daesoo; Park, Jong Bae; Kim, Jong Heon			PTEN Modulates miR-21 Processing via RNA-Regulatory Protein RNH1	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; MICRORNA BIOGENESIS; MESSENGER-RNA; NUCLEAR PTEN; HNRNP A1; COMPLEX; PHOSPHATASE; EXPRESSION; SUBSET; LIN28	Aberrant miR-21 expression is closely associated with cell proliferation, anti-apoptosis, migration, invasion, and metastasis in various cancers. However, the regulatory mechanism of miR-21 biogenesis is largely unknown. Here, we demonstrated that the tumor suppressor PTEN negatively regulates the expression of oncogenic miR-21 at the post-transcriptional level. Moreover, our results suggest that PTEN plays such a role through the indirect interaction with the Drosha complex. To elucidate how PTEN regulates pri- to pre-miR-21 processing, we attempted to find PTEN-interacting proteins and identified an RNA-regulatory protein, RNH1. Using the sensor to monitor pri-miR-21 processing, we demonstrated that RNH1 is necessary and sufficient for pri-miR-21 processing. Moreover, our results propose that the nuclear localization of RNH1 is important for this function. Further analysis showed that RNH1 directly interacts with the Drosha complex and that PTEN blocks this interaction. Taken together, these results suggest that the PTEN-mediated miR-21 regulation is achieved by inhibiting the interaction between the Drosha complex and RNH1, revealing previously unidentified role of PTEN in the oncogenic miR-21 biogenesis.	[Kim, Youn-Jae; Kim, Daesoo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Se-Jeong; Kim, Sol; Kim, Jong Heon] Natl Canc Ctr, Res Inst, Carcinogenesis Branch, Ilsan, South Korea; [Kim, Youn-Jae; Choi, Eun Young; Kwak, Hee Jin; Yoo, Heon; Lee, Seung-Hoon; Park, Jong Bae] Natl Canc Ctr, Res Inst, Specif Organs Canc Branch, Ilsan, South Korea; [Yoo, Byong Chul] Natl Canc Ctr, Res Inst, Colorectal Canc Branch, Ilsan, South Korea	Korea Advanced Institute of Science & Technology (KAIST); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, YJ (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jbp@ncc.re.kr; jhkim@ncc.re.kr	Kim, Daesoo/C-1625-2011	Kim, Daesoo/0000-0001-9915-1463; Yoo, Heon/0000-0001-6186-3262	National Cancer Center [1110110, 1010171, 1010172, 1110120]; National Research Foundation [2011-0024692]	National Cancer Center; National Research Foundation	JHK was supported by the National Cancer Center Grant (1110110) and the National Research Foundation Grant (2011-0024692). JBP was supported by the National Cancer Center Grants (1010171, 1010172, and 1110120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Furia A, 2011, FEBS LETT, V585, P613, DOI 10.1016/j.febslet.2011.01.034; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim S, 2009, FEBS J, V276, P2165, DOI 10.1111/j.1742-4658.2009.06935.x; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Pflieger D, 2011, PROTEOMICS, V11, P1824, DOI 10.1002/pmic.201000635; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Teplova M, 2011, NAT STRUCT MOL BIOL, V18, P990, DOI 10.1038/nsmb.2094; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Volkel P, 2010, BIOCHEM SOC T, V38, P883, DOI 10.1042/BST0380883; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388	53	23	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28308	10.1371/journal.pone.0028308	http://dx.doi.org/10.1371/journal.pone.0028308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162762	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800024
J	Yu, LL; Lu, W; Wei, YN				Yu, Linliang; Lu, Wei; Wei, Yinan			AcrB Trimer Stability and Efflux Activity, Insight from Mutagenesis Studies	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; PUMP ACRB; LIMITED PROTEOLYSIS; ROTATING MECHANISM; CRYSTAL-STRUCTURE; DISULFIDE BONDS; PROTEIN; PROLINE; COMPLEX	The multidrug transporter AcrB in Escherichia coli exists and functions as a homo-trimer. The assembly process of obligate membrane protein oligomers, including AcrB, remains poorly understood. In a previous study, we have shown that individual AcrB subunit is capable of folding independently, suggesting that trimerization of AcrB follows a three-stage pathway in which monomers first fold, and then assemble. Here we destabilized the AcrB trimer through mutating a single Pro (P223) in the protruding loop of AcrB, which drastically reduced the protein activity. We replaced P223 separately with five residues, including Ala, Val, Tyr, Asn, and Gly, and found that AcrB(P223G) was the least active. Detailed characterization of AcrB(P223G) revealed that the protein existed as a well-folded monomer after purification, but formed a trimer in vivo. The function of the mutant could be partly restored through strengthening the stability of the trimer using an inter-subunit disulfide bond. Our results also suggested that the protruding loop is well structured during AcrB assembly with P223 served as a "wedge'' close to the tip to stabilize the AcrB trimer structure. When this wedge is disrupted, the stability of the trimer is reduced, accompanied by a decrease of drug efflux activity.	[Yu, Linliang; Lu, Wei; Wei, Yinan] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky	Yu, LL (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	yinan.wei@uky.edu			Oak Ridge Associated Universities (ORAU) Ralph E. Powe Junior Faculty Enhancement Award	Oak Ridge Associated Universities (ORAU) Ralph E. Powe Junior Faculty Enhancement Award	Yinan Wei thanks the Oak Ridge Associated Universities (ORAU) Ralph E. Powe Junior Faculty Enhancement Award for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Bantscheff M, 1999, BIOCHEMISTRY-US, V38, P11012, DOI 10.1021/bi990781k; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Daley DO, 2008, CURR OPIN STRUC BIOL, V18, P420, DOI 10.1016/j.sbi.2008.04.006; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gunasekaran K, 1998, J MOL BIOL, V275, P917, DOI 10.1006/jmbi.1997.1505; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lu W, 2011, PROTEIN PEP IN PRESS; Lu W, 2011, J MOL BIOL, V411, P264, DOI 10.1016/j.jmb.2011.05.042; Michelle A., 2011, BIOCHEMISTRY-US, V49, P9181; Middlemiss JK, 2004, J BACTERIOL, V186, P1258, DOI 10.1128/JB.186.5.1258-1269.2004; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Pavlicek J, 2008, J BIOL CHEM, V283, P14552, DOI 10.1074/jbc.M800593200; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Schulz R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000806; Seeger MA, 2008, CURR DRUG TARGETS, V9, P729, DOI 10.2174/138945008785747789; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Suh JY, 1999, EUR J BIOCHEM, V266, P665, DOI 10.1046/j.1432-1327.1999.00917.x; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Takatsuka Y, 2009, J BACTERIOL, V191, P1729, DOI 10.1128/JB.01441-08; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Wallace BA, 2009, BIOCHIM BIOPHYS ACTA, V1788, P1279; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	46	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28390	10.1371/journal.pone.0028390	http://dx.doi.org/10.1371/journal.pone.0028390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163011	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800033
J	Kouznetsova, A; Benavente, R; Pastink, A; Hoog, C				Kouznetsova, Anna; Benavente, Ricardo; Pastink, Albert; Hoog, Christer			Meiosis in Mice without a Synaptonemal Complex	PLOS ONE			English	Article							CHROMOSOME SYNAPSIS; MEIOTIC CHROMOSOMES; CAENORHABDITIS-ELEGANS; DNA RECOMBINATION; MAMMALIAN MEIOSIS; STRAND-EXCHANGE; AXIAL ELEMENTS; CROSSING-OVER; MOUSE MEIOSIS; PROTEIN ZYP1	The synaptonemal complex (SC) promotes fusion of the homologous chromosomes (synapsis) and crossover recombination events during meiosis. The SC displays an extensive structural conservation between species; however, a few organisms lack SC and execute meiotic process in a SC-independent manner. To clarify the SC function in mammals, we have generated a mutant mouse strain (Sycp1(-/-) Sycp3(-/-), here called SC-null) in which all known SC proteins have been displaced from meiotic chromosomes. While transmission electron microscopy failed to identify any remnants of the SC in SC-null spermatocytes, neither formation of the cohesion axes nor attachment of the chromosomes to the nuclear membrane was perturbed. Furthermore, the meiotic chromosomes in SC-null meiocytes achieved pre-synaptic pairing, underwent early homologous recombination events and sustained a residual crossover formation. In contrast, in SC-null meiocytes synapsis and MLH1-MLH3-dependent crossovers maturation were abolished, whereas the structural integrity of chromosomes was drastically impaired. The variable consequences that SC inactivation has on the meiotic process in different organisms, together with the absence of SC in some unrelated species, imply that the SC could have originated independently in different taxonomic groups.	[Kouznetsova, Anna; Hoog, Christer] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Benavente, Ricardo] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany; [Pastink, Albert] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands	Karolinska Institutet; University of Wurzburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kouznetsova, A (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Anna.Kouznetsova@ki.se	Kouznetsova, Anna/AAF-2312-2019; Benavente, Ricardo/GNW-2855-2022	Kouznetsova, Anna/0000-0001-9059-4567; 	Swedish Cancer Society; Swedish Research Council, Torsten; Ragnar Soderbergs Stiftelser; Karolinska Institutet; DFG [Be1168/7-1]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council, Torsten(Swedish Research Council); Ragnar Soderbergs Stiftelser; Karolinska Institutet(Karolinska Institutet); DFG(German Research Foundation (DFG))	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, Torsten and Ragnar Soderbergs Stiftelser and Karolinska Institutet. R.B. was supported by grant Be1168/7-1 (Priority Program 1384 "Mechanisms of genome haploidization'', DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister LA, 2004, CYTOGENET GENOME RES, V107, P191, DOI 10.1159/000080597; Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Bolcun-Filas E, 2007, J CELL BIOL, V176, P741, DOI 10.1083/jcb.200610027; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Chicheportiche A, 2007, J CELL SCI, V120, P1733, DOI 10.1242/jcs.004945; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Costa Y, 2005, J CELL SCI, V118, P2755, DOI 10.1242/jcs.02402; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; de Boer E, 2006, CHROMOSOMA, V115, P220, DOI 10.1007/s00412-006-0057-5; de Boer E, 2007, J CELL SCI, V120, P731, DOI 10.1242/jcs.003186; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; DIETRICH AJJ, 1983, CHROMOSOMA, V88, P377, DOI 10.1007/BF00285860; Fukuda T, 2010, EXP CELL RES, V316, P158, DOI 10.1016/j.yexcr.2009.08.007; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Hamer G, 2008, THERIOGENOLOGY, V69, P333, DOI 10.1016/j.theriogenology.2007.09.029; Hamer G, 2006, J CELL SCI, V119, P4025, DOI 10.1242/jcs.03182; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Higgins JD, 2005, GENE DEV, V19, P2488, DOI 10.1101/gad.354705; Khetani RS, 2007, J CELL SCI, V120, P3123, DOI 10.1242/jcs.009977; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kouznetsova A, 2005, J CELL SCI, V118, P2271, DOI 10.1242/jcs.02362; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; Li XCL, 2011, GENETICS, V189, P71, DOI 10.1534/genetics.111.130674; Liebe B, 2004, MOL BIOL CELL, V15, P827, DOI 10.1091/mbc.E03-07-0524; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Loidl J, 2006, CHROMOSOMA, V115, P260, DOI 10.1007/s00412-006-0047-7; Loidl J, 2004, J CELL SCI, V117, P5791, DOI 10.1242/jcs.01504; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Manheim EA, 2003, CURR BIOL, V13, P276, DOI 10.1016/S0960-9822(03)00050-2; Mehrotra S, 2006, PLOS GENET, V2, P1883, DOI 10.1371/journal.pgen.0020200; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Osman K, 2006, CHROMOSOMA, V115, P212, DOI 10.1007/s00412-005-0042-4; Page SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000194; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Revenkova E, 2006, CHROMOSOMA, V115, P235, DOI 10.1007/s00412-006-0060-x; Schild-Prufert K, 2011, GENETICS, V189, P411, DOI 10.1534/genetics.111.132431; Schramm S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002088; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; Wang H, 2006, J CELL BIOL, V173, P485, DOI 10.1083/jcb.200512077; Wang KJ, 2011, MOL BIOL CELL, V22, P12, DOI 10.1091/mbc.E10-08-0667; Webber HA, 2004, J CELL BIOL, V164, P819, DOI 10.1083/jcb.200310077; Wilkins AS, 2009, GENETICS, V181, P3, DOI 10.1534/genetics.108.099762; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Yang F., 2009, V5, P69, DOI 10.1159/000166620; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	59	41	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28255	10.1371/journal.pone.0028255	http://dx.doi.org/10.1371/journal.pone.0028255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164254	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400055
J	Lucentini, L; Puletti, ME; Ricciolini, C; Gigliarelli, L; Fontaneto, D; Lanfaloni, L; Bilo, F; Natali, M; Panara, F				Lucentini, Livia; Puletti, Maria Elena; Ricciolini, Claudia; Gigliarelli, Lilia; Fontaneto, Diego; Lanfaloni, Luisa; Bilo, Fabiana; Natali, Mauro; Panara, Fausto			Molecular and Phenotypic Evidence of a New Species of Genus Esox (Esocidae, Esociformes, Actinopterygii): The Southern Pike, Esox flaviae	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; AFLP(TM) MARKERS; DNA; POLYMORPHISM; EVOLUTION; CONSERVATION; PHYLOGENIES; INVASIONS; TAXONOMY; CLADES	We address the taxonomic position of the southern European individuals of pike, performing a series of tests and comparisons from morphology, DNA taxonomy and population genetics parameters, in order to support the hypothesis that two species of pike, and not only one, exist in Europe. A strong relationship emerged between a northern genotype supported by COI, Cytb, AFLP and specific fragments, and a phenotype with round spot skin colour pattern and a large number of scales in the lateral line, clearly separated from a southern genotype with other skin colour pattern and a low number of scales in the lateral line. DNA taxonomy, based on a coalescent approach (GMYC) from phylogenetic reconstructions on COI and Cytb together with AFLP admixture analysis, supported the existence of two independently evolving entities. Such differences are not simply due to geographic distances, as northern European samples are more similar to Canadian and Chinese samples than the southern Europe ones. Thus, given that the differences between the two groups of European pike are significant at the phenotypic, genotypic and geographical levels, we propose the identification of two pike species: the already known northern pike (Esox lucius) and the southern pike (E. flaviae n. sp.). The correct identification of these two lineages as independent species should give rise to a ban on the introduction of northern pikes in southern Europe for recreational fishing, due to potential problems of hybridisation.	[Lucentini, Livia; Puletti, Maria Elena; Ricciolini, Claudia; Gigliarelli, Lilia; Lanfaloni, Luisa; Panara, Fausto] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Bilo, Fabiana] Veneto Agr Viale Univ, Legnaro, Italy; [Natali, Mauro] Prov Perugia, Perugia, Italy	University of Perugia	Lucentini, L (corresponding author), Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy.	livia@unipg.it	lucentini, livia/E-6187-2014; lucentini, livia/AAW-7479-2020; Fontaneto, Diego/B-9710-2008	lucentini, livia/0000-0001-5051-610X; lucentini, livia/0000-0001-5051-610X; Fontaneto, Diego/0000-0002-5770-0353; Ricciolini, Claudia/0000-0001-5956-313X	Natural Environment Research Council [NE/G013179/1] Funding Source: researchfish; NERC [NE/G013179/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ajmone-Marsan P, 1997, ANIM GENET, V28, P418, DOI 10.1111/j.1365-2052.1997.00204.x; Alfei L, 1996, J FISH BIOL, V48, P1051, DOI 10.1111/j.1095-8649.1996.tb01803.x; Amorosi A, 2003, J GEOL, V111, P39, DOI 10.1086/344577; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Barreto FS, 2008, EVOLUTION, V62, P226, DOI 10.1111/j.1558-5646.2007.00285.x; Bensch S, 2002, MOL ECOL, V11, P2359, DOI 10.1046/j.1365-294X.2002.01629.x; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Crawley M.J., 2007, R BOOK; David L, 2001, MOL GENET GENOMICS, V266, P353, DOI 10.1007/s004380100569; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Economidis PS, 2000, FISHERIES MANAG ECOL, V7, P239, DOI 10.1046/j.1365-2400.2000.00197.x; Epifanio J, 2000, REV FISH BIOL FISHER, V10, P245, DOI 10.1023/A:1016729132297; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FICKLING NJ, 1982, FISH MANAGE, V13, P79; Fitzhugh TW, 2004, BIOSCIENCE, V54, P741, DOI 10.1641/0006-3568(2004)054[0741:QUTGCA]2.0.CO;2; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Grande Terry, 2004, Copeia, V2004, P743, DOI 10.1643/CG-04-007R1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kottelat M, 2007, HDB EUROPEAN FRESHWA; Kyle CJ, 2007, FORENSIC SCI INT, V166, P68, DOI 10.1016/j.forsciint.2006.03.025; Larsen PF, 2005, HEREDITY, V95, P136, DOI 10.1038/sj.hdy.6800671; Launey S, 2006, J FISH BIOL, V68, P193, DOI 10.1111/j.0022-1112.2006.001059.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; LINNAEUS C, 1758, SYSTEMA NATURAE; Logan JA, 1999, ENVIRON ENTOMOL, V28, P143, DOI 10.1093/ee/28.2.143; Lorenzoni M, 2002, FISH RES, V59, P239, DOI 10.1016/S0165-7836(02)00013-9; Lucentini L., 2010, Journal of Water Resource and Protection, V2, P167; Lucentini L, 2009, FISH RES, V96, P139, DOI 10.1016/j.fishres.2008.10.007; Lucentini L, 2009, ENDANGERED SPECIES N; Lucentini L, 2006, CONSERV GENET, V7, P1009, DOI 10.1007/s10592-006-9137-6; Lucentini L, 2006, FISH RES, V80, P251, DOI 10.1016/j.fishres.2006.04.002; Lucentini L, 2011, HYDROBIOLOGIA, V673, P215, DOI 10.1007/s10750-011-0778-1; Ma GC, 2006, ZOOL SCR, V35, P341, DOI 10.1111/j.1463-6409.2006.00232.x; MELOTTO S, 1990, J FISH BIOL, V37, P687, DOI 10.1111/j.1095-8649.1990.tb02533.x; Meraner A, 2010, CONSERV GENET, V11, P985, DOI 10.1007/s10592-009-9942-9; Oksanen J, 2010, R PACKAGE VERSION 1; Orti G, 1996, MOL BIOL EVOL, V13, P556, DOI 10.1093/oxfordjournals.molbev.a025616; Papa R, 2005, J ANIM BREED GENET, V122, P62, DOI 10.1111/j.1439-0388.2004.00476.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Raat A. J. P., 1988, FAO FISHERIES SYNOPS, V2, P178; Rex M, 2007, GENOME, V50, P90, DOI 10.1139/G06-141; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Susnik S, 2007, MOL PHYLOGENET EVOL, V44, P63, DOI 10.1016/j.ympev.2006.08.021; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Welcomme RL., 1988, INT INTRO INLAND AQU; Zaragueta-Bagils R, 2002, CR BIOL, V325, P1191, DOI 10.1016/S1631-0691(02)01535-4; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661	65	31	32	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e25218	10.1371/journal.pone.0025218	http://dx.doi.org/10.1371/journal.pone.0025218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164201	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400001
J	Tang, J; Chen, X; Tu, WF; Guo, YB; Zhao, ZL; Xue, Q; Lin, CS; Xiao, JF; Sun, XG; Tao, T; Gu, MN; Liu, YT				Tang, Jing; Chen, Xi; Tu, Weifeng; Guo, Yuanbo; Zhao, Zhenlong; Xue, Qiong; Lin, Chunshui; Xiao, Jinfang; Sun, Xuegang; Tao, Tao; Gu, Miaoning; Liu, Youtan			Propofol Inhibits the Activation of p38 through Up-Regulating the Expression of Annexin A1 to Exert Its Anti-Inflammation Effect	PLOS ONE			English	Article							ACUTE LUNG INJURY; NITRIC-OXIDE; LIPOCORTIN 1; ENDOTOXIN; GLUCOCORTICOIDS; DEXAMETHASONE; SUPEROXIDE; MECHANISMS; MEMBRANE; RELEASE	Inflammatory response is a kind of nonspecific immune response, with the central link of vascular response, which is mainly manifested by changes in neutrophils and vascular endothelial cells. In recent years, the in vivo and in vitro role of intravenous anesthetic propofol in inhibiting inflammatory response has been attracting more and more attention, but the anti- inflammatory mechanisms of propofol for mononuclear cells still remain undefined. In this study, proteomics analysis was applied to investigate protein expression profile changes in serum mononuclear cells following intervention of rats with endotoxemia using propofol. After two-dimensional electrophoresis and mass spectrometric identification, it has been found that the protein Annexin A1 was up-regulated in the propofol intervention group. Annexin A1 is a glucocorticoiddependent anti-inflammatory protein. After detection using ELISA and Western blot assays, it has also been found that propofol can not only promote the expression of Annexin A1, but also inhibit the phosphorylation level of p38 and release of inflammatory factors (IL-1 beta, IL-6 and TNF-alpha) in rats with endotoxemia. In order to further determine the role of upregulated expression of Annexin A1 in anti-inflammation of propofol, this gene was silenced in vitro in human THP-1 cells, to detect the phosphorylation status of p38 and release of inflammatory factors. The results show that Annexin A1 can negatively regulate phosphorylation of p38 and release of IL-1 beta, IL-6 and TNF-alpha in THP-1 cells following propofol intervention and lipopolysaccharide (LPS) stimulation. Our results clearly indicate that propofol can up-regulate Annexin A1 to inhibit the phosphorylation level of p38 and release of IL-1 beta, IL-6 and TNF-alpha, so as to inhibit inflammatory response. Therefore, it can be speculated that Annexin A1 might be the key signaling protein in the in vivo and in vitro antiinflammatory mechanisms of propofol.	[Tang, Jing; Guo, Yuanbo; Zhao, Zhenlong; Xue, Qiong; Lin, Chunshui; Xiao, Jinfang; Tao, Tao; Gu, Miaoning] So Med Univ, Nanfang Hosp, Dept Anesthesia, Guangzhou, Guangdong, Peoples R China; [Chen, Xi; Tu, Weifeng] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Anesthesia, Guangzhou, Guangdong, Peoples R China; [Sun, Xuegang] So Med Univ, Sch Tradit Chinese Med, State Adm Tradit Chinese Med, Key Lab Mol Biol, Guangzhou, Guangdong, Peoples R China; [Liu, Youtan] Univ Hong Kong, Shenzhen Hosp, Dept Anesthesia, Shenzhen, Peoples R China	Southern Medical University - China; Southern Theater Command General Hospital; Southern Medical University - China; University of Hong Kong	Tang, J (corresponding author), So Med Univ, Nanfang Hosp, Dept Anesthesia, Guangzhou, Guangdong, Peoples R China.	taotao@126.com; gumiaoning@126.com; Youtanliuhao@163.com	Tao, Tao/S-6992-2016	Tao, Tao/0000-0002-6348-719X	National Natural Science Foundation of China [30872431]; Nanfang Hospital [2009A001, 2010C013]; Medical Scientific Research Foundation of Guangdong Province [B2011202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanfang Hospital; Medical Scientific Research Foundation of Guangdong Province	This work was supported by the National Natural Science Foundation of China (30872431), President Fund of Nanfang Hospital (2009A001), President Fund of Nanfang Hospital (2010C013), and Medical Scientific Research Foundation of Guangdong Province (B2011202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BarrientosVega R, 1997, CRIT CARE MED, V25, P33, DOI 10.1097/00003246-199701000-00009; Brunkhorst FM, 2009, INTERNIST, V50, P810, DOI 10.1007/s00108-008-2287-5; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Chen RM, 2005, ANN NY ACAD SCI, V1042, P262, DOI 10.1196/annals.1338.030; CROXTALL JD, 1992, P NATL ACAD SCI USA, V89, P3571, DOI 10.1073/pnas.89.8.3571; Diakonova M, 1997, J CELL SCI, V110, P1199; Ferlazzo V, 2003, INT IMMUNOPHARMACOL, V3, P1363, DOI 10.1016/S1567-5769(03)00133-4; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Gao J, 2004, BRIT J ANAESTH, V92, P277, DOI 10.1093/bja/aeh050; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hsing CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017598; Hsu BG, 2005, CLIN EXP PHARMACOL P, V32, P24, DOI 10.1111/j.1440-1681.2005.04155.x; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; LYNN WA, 1995, J INFECTION, V30, P207, DOI 10.1016/S0163-4453(95)90670-3; Mathy-Hartert M, 2000, ANAESTHESIA, V55, P1066, DOI 10.1046/j.1365-2044.2000.01606.x; MOLLOY RG, 1993, BRIT J SURG, V80, P289, DOI 10.1002/bjs.1800800308; Perretti M, 2000, CELL BIOL INT, V24, P163, DOI 10.1006/cbir.1999.0468; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Philip JG, 1997, NEUROREPORT, V8, P1871, DOI 10.1097/00001756-199705260-00016; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Renshaw D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012771; SEBEL PS, 1989, ANESTHESIOLOGY, V71, P260, DOI 10.1097/00000542-198908000-00015; STOUT RD, 1993, CURR OPIN IMMUNOL, V5, P398, DOI 10.1016/0952-7915(93)90059-2; Tabbutt S, 2001, CRIT CARE MED, V29, pS231, DOI 10.1097/00003246-200110001-00005; Takao Y, 2005, ANESTH ANALG, V100, P810, DOI 10.1213/01.ANE.0000144775.19385.8C; Takemoto Y, 2003, J ANESTH, V19, P40; Traverso V, 1998, J CELL SCI, V111, P1405; Tsao CM, 2003, EUR J PHARMACOL, V477, P183, DOI 10.1016/j.ejphar.2003.08.005; VIOLETTE SM, 1990, J CELL PHYSIOL, V142, P70, DOI 10.1002/jcp.1041420110; WEST MA, 1995, SURGERY, V118, P220, DOI 10.1016/S0039-6060(05)80327-7; WEST MA, 1994, J TRAUMA, V37, P82, DOI 10.1097/00005373-199407000-00015; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yang YH, 2006, J IMMUNOL, V177, P8148, DOI 10.4049/jimmunol.177.11.8148	37	37	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27890	10.1371/journal.pone.0027890	http://dx.doi.org/10.1371/journal.pone.0027890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164217	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400018
J	Li, YL; Hoxha, V; Lama, C; Dinh, BH; Vo, CN; Dauwalder, B				Li, Yuanli; Hoxha, Valbona; Lama, Chamala; Dinh, Bich Hien; Vo, Christina N.; Dauwalder, Brigitte			The hector G-Protein Coupled Receptor Is Required in a Subset of fruitless Neurons for Male Courtship Behavior	PLOS ONE			English	Article							DROSOPHILA TAKEOUT GENE; CENTRAL-NERVOUS-SYSTEM; SEXUAL-BEHAVIOR; NEURAL CIRCUITRY; MUSHROOM BODIES; DOUBLESEX GENE; EXPRESSION; DIFFERENTIATION; NEUROPEPTIDES; MELANOGASTER	Male courtship behavior in Drosophila melanogaster is controlled by two main regulators, fruitless (fru) and doublesex (dsx). Their sex-specific expression in brain neurons has been characterized in detail, but little is known about the downstream targets of the sex-specific FRU and DSX proteins and how they specify the function of these neurons. While sexual dimorphism in the number and connections of fru and dsx expressing neurons has been observed, a majority of the neurons that express the two regulators are present in both sexes. This poses the question which molecules define the sex-specific function of these neurons. Signaling molecules are likely to play a significant role. We have identified a predicted G-protein coupled receptor (GPCR), CG4395, that is required for male courtship behavior. The courtship defect in the mutants can be rescued by expression of the wildtype protein in fru neurons of adult males. The GPCR is expressed in a subset of fru-positive antennal glomeruli that have previously been shown to be essential for male courtship. Expression of 4395-RNAi in GH146 projection neurons lowers courtship. This suggests that signaling through the CG4395 GPCR in this subset of fru neurons is critical for male courtship behavior.	[Li, Yuanli; Hoxha, Valbona; Lama, Chamala; Dinh, Bich Hien; Vo, Christina N.; Dauwalder, Brigitte] Univ Houston, Dept Biol & Biochem, Houston, TX 77002 USA	University of Houston System; University of Houston	Li, YL (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77002 USA.	bdauwalder@uh.edu		Hoxha, Valbona/0000-0002-7515-4288	GEAR grant; University of Houston; National Science Foundation [IOS 0919697]; Division Of Integrative Organismal Systems [0919697] Funding Source: National Science Foundation	GEAR grant; University of Houston; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was funded by GEAR grant, University of Houston, National Science Foundation Grant IOS 0919697, http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2004, DEVELOPMENT, V131, P2007, DOI 10.1242/dev.01077; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Dauwalder B, 2008, CURR GENOMICS, V9, P517, DOI 10.2174/138920208786847980; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Diegelmann S, 2008, FLY, V2, P236, DOI 10.4161/fly.6817; Dornan AJ, 2005, GENESIS, V42, P236, DOI 10.1002/gene.20143; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Kido A, 2002, J NEUROBIOL, V52, P302, DOI 10.1002/neu.10100; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lee G, 2002, J NEUROGENET, V16, P229, DOI 10.1080/01677060216292; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lutz TA, 2010, FORUM NUTR, V63, P64, DOI 10.1159/000264394; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Skoulakis EMC, 2006, CELL MOL LIFE SCI, V63, P975, DOI 10.1007/s00018-006-6023-9; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; TAYLOR BJ, 1989, J NEUROGENET, V5, P173, DOI 10.3109/01677068909066207; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	49	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28269	10.1371/journal.pone.0028269	http://dx.doi.org/10.1371/journal.pone.0028269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140564	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100058
J	Marini, NJ; Hoffmann, TJ; Lammer, EJ; Hardin, J; Lazaruk, K; Stein, JB; Gilbert, DA; Wright, C; Lipzen, A; Pennacchio, LA; Carmichael, SL; Witte, JS; Shaw, GM; Rine, J				Marini, Nicholas J.; Hoffmann, Thomas J.; Lammer, Edward J.; Hardin, Jill; Lazaruk, Katherine; Stein, Jason B.; Gilbert, Dennis A.; Wright, Crystal; Lipzen, Anna; Pennacchio, Len A.; Carmichael, Suzan L.; Witte, John S.; Shaw, Gary M.; Rine, Jasper			A Genetic Signature of Spina Bifida Risk from Pathway-Informed Comprehensive Gene-Variant Analysis	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; ONE-CARBON METABOLISM; ISOLATED CLEFT-LIP; FOLIC-ACID; FOLATE METABOLISM; METHYLENETETRAHYDROFOLATE REDUCTASE; MATHEMATICAL-MODEL; DNA METHYLATION; DIETARY-FOLATE; MOUSE MUTANTS	Despite compelling epidemiological evidence that folic acid supplements reduce the frequency of neural tube defects (NTDs) in newborns, common variant association studies with folate metabolism genes have failed to explain the majority of NTD risk. The contribution of rare alleles as well as genetic interactions within the folate pathway have not been extensively studied in the context of NTDs. Thus, we sequenced the exons in 31 folate-related genes in a 480-member NTD case-control population to identify the full spectrum of allelic variation and determine whether rare alleles or obvious genetic interactions within this pathway affect NTD risk. We constructed a pathway model, predetermined independent of the data, which grouped genes into coherent sets reflecting the distinct metabolic compartments in the folate/one-carbon pathway (purine synthesis, pyrimidine synthesis, and homocysteine recycling to methionine). By integrating multiple variants based on these groupings, we uncovered two provocative, complex genetic risk signatures. Interestingly, these signatures differed by race/ethnicity: a Hispanic risk profile pointed to alterations in purine biosynthesis, whereas that in non-Hispanic whites implicated homocysteine metabolism. In contrast, parallel analyses that focused on individual alleles, or individual genes, as the units by which to assign risk revealed no compelling associations. These results suggest that the ability to layer pathway relationships onto clinical variant data can be uniquely informative for identifying genetic risk as well as for generating mechanistic hypotheses. Furthermore, the identification of ethnic-specific risk signatures for spina bifida resonated with epidemiological data suggesting that the underlying pathogenesis may differ between Hispanic and non-Hispanic groups.	[Marini, Nicholas J.; Rine, Jasper] Univ Calif Berkeley, Dept Mol & Cellular Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Hoffmann, Thomas J.; Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hoffmann, Thomas J.; Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Lammer, Edward J.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Hardin, Jill; Lazaruk, Katherine; Stein, Jason B.; Gilbert, Dennis A.] VitaPath Genet Inc, Foster City, CA USA; [Wright, Crystal; Lipzen, Anna; Pennacchio, Len A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Carmichael, Suzan L.; Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Stanford University	Marini, NJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	nmarini@berkeley.edu; jrine@berkeley.edu		Lipzen, Anna/0000-0003-2293-9329; Pennacchio, Len/0000-0002-8748-3732; Shaw, Gary/0000-0001-7438-4914	National Institutes of Health [R01 GM072859, RC1 DE020640, R25 CA112355]; Department of Energy, University of California [DE-AC02-05CH11231];  [R01 NS05249]; NATIONAL CANCER INSTITUTE [R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, University of California(United States Department of Energy (DOE)University of California System); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R01 GM072859 and RC1 DE020640 from the National Institutes of Health (NJM, SLC, EJL, GMS, JR). Partial support for SLC, EJL, and GMS was also provided by R01 NS05249. TJH was supported by National Institutes of Health Training Grant (R25 CA112355). Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy contract DE-AC02-05CH11231, University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman LA, 2003, BIRTH DEFECTS RES A, V67, P421, DOI 10.1002/bdra.10040; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Amorim MR, 2007, AM J MED GENET A, V143A, P1726, DOI 10.1002/ajmg.a.31812; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Au KS, 2010, DEV DISABIL RES REV, V16, P6, DOI 10.1002/ddrr.93; Beaudin Anna E., 2007, Birth Defects Research, V81, P183, DOI 10.1002/bdrc.20100; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Carmichael SL, 2003, MED HYPOTHESES, V60, P351, DOI 10.1016/S0306-9877(02)00402-4; Carroll N, 2009, HUM GENET, V125, P247, DOI 10.1007/s00439-008-0616-3; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Christensen KE, 2009, HUM MUTAT, V30, P212, DOI 10.1002/humu.20830; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Croen L A, 1991, Paediatr Perinat Epidemiol, V5, P423, DOI 10.1111/j.1365-3016.1991.tb00728.x; De Marco P, 2006, J HUM GENET, V51, P98, DOI 10.1007/s10038-005-0329-6; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Dunlevy LPE, 2006, BIRTH DEFECTS RES A, V76, P544, DOI 10.1002/bdra.20286; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Franke B, 2009, BIRTH DEFECTS RES A, V85, P216, DOI 10.1002/bdra.20556; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; HARRIS JA, 1995, ENVIRON HEALTH PERSP, V103, P163, DOI 10.2307/3432368; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Harris MJ, 2009, BIRTH DEFECTS RES A, V85, P331, DOI 10.1002/bdra.20552; Hendricks KA, 1999, AM J EPIDEMIOL, V149, P1119; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Hernandez-Diaz S, 2001, AM J EPIDEMIOL, V153, P961, DOI 10.1093/aje/153.10.961; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marini NJ, 2008, P NATL ACAD SCI USA, V105, P8055, DOI 10.1073/pnas.0802813105; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; NEUMANN PE, 1994, NAT GENET, V6, P357, DOI 10.1038/ng0494-357; Niihout HF, 2008, VITAM HORM, V79, P45, DOI 10.1016/S0083-6729(08)00402-0; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Parle-McDermott A, 2006, EUR J HUM GENET, V14, P768, DOI 10.1038/sj.ejhg.5201603; Parle-McDermott A, 2009, HUM MUTAT, V30, P1650, DOI 10.1002/humu.21109; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Reed MC, 2004, J THEOR BIOL, V226, P33, DOI 10.1016/j.jtbi.2003.08.001; Ross ME, 2010, WIRES SYST BIOL MED, V2, P471, DOI 10.1002/wsbm.72; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Shelnutt KP, 2004, J NUTR BIOCHEM, V15, P554, DOI 10.1016/j.jnutbio.2004.04.003; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; Suarez L, 2000, AM J EPIDEMIOL, V152, P1017, DOI 10.1093/aje/152.11.1017; Ulrich CM, 2008, CANCER EPIDEM BIOMAR, V17, P1822, DOI 10.1158/1055-9965.EPI-07-2937; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Zamar D, 2007, J STAT SOFTW, V21, P1; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	62	21	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28408	10.1371/journal.pone.0028408	http://dx.doi.org/10.1371/journal.pone.0028408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140583	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100069
J	Geiger, JA; Carvalho, L; Campos, I; Santos, AC; Jacinto, A				Geiger, Jennifer A.; Carvalho, Lara; Campos, Isabel; Santos, Ana Catarina; Jacinto, Antonio			Hole-in-One Mutant Phenotypes Link EGFR/ERK Signaling to Epithelial Tissue Repair in Drosophila	PLOS ONE			English	Article							MAP KINASE; EGF-RECEPTOR; GRAINY-HEAD; PATHWAY; SCREEN; GENES; GYF; INTERACTS; DYNAMICS; HOMOLOG	Background: Epithelia act as physical barriers protecting living organisms and their organs from the surrounding environment. Simple epithelial tissues have the capacity to efficiently repair wounds through a resealing mechanism. The known molecular mechanisms underlying this process appear to be conserved in both vertebrates and invertebrates, namely the involvement of the transcription factors Grainy head (Grh) and Fos. In Drosophila, Grh and Fos lead to the activation of wound response genes required for epithelial repair. ERK is upstream of this pathway and known to be one of the first kinases to be activated upon wounding. However, it is still unclear how ERK activation contributes to a proper wound response and which molecular mechanisms regulate its activation. Methodology/Principal Findings: In a previous screen, we isolated mutants with defects in wound healing. Here, we describe the role of one of these genes, hole-in-one (holn1), in the wound healing process. Holn1 is a GYF domain containing protein that we found to be required for the activation of several Grh and Fos regulated wound response genes at the wound site. We also provide evidence suggesting that Holn1 may be involved in the Ras/ERK signaling pathway, by acting downstream of ERK. Finally, we show that wound healing requires the function of EGFR and ERK signaling. Conclusions/Significance: Based on these data, we conclude that holn1 is a novel gene required for a proper wound healing response. We further propose and discuss a model whereby Holn1 acts downstream of EGFR and ERK signaling in the Grh/Fos mediated wound closure pathway.	[Geiger, Jennifer A.; Carvalho, Lara; Campos, Isabel; Santos, Ana Catarina; Jacinto, Antonio] Univ Lisbon, Tissue Morphogenesis & Repair Unit, Inst Mol Med, Fac Med, Lisbon, Portugal	Universidade de Lisboa	Geiger, JA (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	ajacinto@fm.ul.pt	Jacinto, Antonio/F-5729-2013; Carvalho, Lara/C-9721-2019; carvalho, lara/P-5102-2019; CAMPOS, ISABEL SOARES/ABE-4545-2020	Jacinto, Antonio/0000-0002-4193-6089; Carvalho, Lara/0000-0001-6350-3279; carvalho, lara/0000-0001-6350-3279; CAMPOS, ISABEL SOARES/0000-0002-2396-3163; Campos, Isabel/0000-0002-1541-8552	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU/OBD/65872/2006, SFRH/BD/21895/2005, SFRH/BPD/62896/2009, SFRH/BPD/17729/2004, SFRH/BPD/24976/2005]; European Research Fund [ERC-208631-RESEAL]; Marie Curie/FP7; Marie Curie Intra-European Fellowship	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Fund; Marie Curie/FP7; Marie Curie Intra-European Fellowship(European Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) PTDC/SAU/OBD/65872/2006, European Research Fund, ERC-208631-RESEAL, and Marie Curie/FP7. JAG was supported by a FCT fellowship, SFRH/BD/21895/2005, LC by a FCT fellowship, SFRH/BPD/62896/2009, and by Marie Curie Intra-European Fellowship, IC by a FCT fellowship, SFRH/BPD/17729/2004, and ACS by a FCT fellowship, SFRH/BPD/24976/2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Campos I, 2010, GENETICS, V184, P129, DOI 10.1534/genetics.109.110288; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; CLIFFORD R, 1994, GENETICS, V137, P531; Culi J, 2001, DEVELOPMENT, V128, P299; Dieckgraefe BK, 1997, BIOCHEM BIOPH RES CO, V233, P389, DOI 10.1006/bbrc.1997.6469; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Freund C, 2002, EMBO J, V21, P5985, DOI 10.1093/emboj/cdf602; Gabay L, 1997, DEVELOPMENT, V124, P3535; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Garcia-Fernandez B, 2009, INT J DEV BIOL, V53, P1549, DOI 10.1387/ijdb.072308bg; Heinze M, 2007, INT IMMUNOL, V19, P1313, DOI 10.1093/intimm/dxm100; Karim FD, 1996, GENETICS, V143, P315; Kim M, 2010, P NATL ACAD SCI US; Kofler M, 2005, J BIOL CHEM, V280, P33397, DOI 10.1074/jbc.M503989200; Kofler M, 2004, J BIOL CHEM, V279, P28292, DOI 10.1074/jbc.M402008200; Kofler MM, 2006, FEBS J, V273, P245, DOI 10.1111/j.1742-4658.2005.05078.x; Laggerbauer B, 2005, RNA, V11, P598, DOI 10.1261/rna.2300805; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Liaw GJ, 1995, GENE DEV, V9, P3163, DOI 10.1101/gad.9.24.3163; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Nishizawa K, 1998, P NATL ACAD SCI USA, V95, P14897, DOI 10.1073/pnas.95.25.14897; Pearson JC, 2009, P NATL ACAD SCI USA, V106, P2224, DOI 10.1073/pnas.0810219106; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; Wang SQ, 2009, NAT CELL BIOL, V11, P890, DOI 10.1038/ncb1898; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Wright TRF, 1996, J HERED, V87, P175, DOI 10.1093/oxfordjournals.jhered.a022983	41	18	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28349	10.1371/journal.pone.0028349	http://dx.doi.org/10.1371/journal.pone.0028349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140578	gold, Green Submitted, Green Published			2022-12-25	WOS:000298166300049
J	Liu, YC; Dos Santos, PC; Zhu, X; Orlando, R; Dean, DR; Soll, D; Yuan, J				Liu, Yuchen; Dos Santos, Patricia C.; Zhu, Xiang; Orlando, Ron; Dean, Dennis R.; Soell, Dieter; Yuan, Jing			Catalytic Mechanism of Sep-tRNA:Cys-tRNA Synthase SULFUR TRANSFER IS MEDIATED BY DISULFIDE AND PERSULFIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON METHANOCOCCUS-MARIPALUDIS; DEPENDENT CYSTEINE BIOSYNTHESIS; ESCHERICHIA-COLI; CYS-TRNA(CYS) FORMATION; SELENOCYSTEINE; 4-THIOURIDINE; PROTEINS; RESIDUES; REVEALS; COMPLEX	Sep-tRNA: Cys-tRNA synthase (SepCysS) catalyzes the sulfhydrylation of tRNA-boundO-phosphoserine (Sep) to form cysteinyl-tRNA(Cys) (Cys-tRNA(Cys)) in methanogens that lack the canonical cysteinyl-tRNA synthetase (CysRS). A crystal structure of the Archaeoglobus fulgidus SepCysS apoenzyme provides information on the binding of the pyridoxal phosphate cofactor as well as on amino acid residues that may be involved in substrate binding. However, the mechanism of sulfur transfer to form cysteine was not known. Using an in vivo Escherichia coli complementation assay, we showed that all three highly conserved Cys residues in SepCysS (Cys(64), Cys(67), and Cys(272) in the Methanocaldococcus jannaschii enzyme) are essential for the sulfhydrylation reaction in vivo. Biochemical and mass spectrometric analysis demonstrated that Cys(64) and Cys(67) form a disulfide linkage and carry a sulfane sulfur in a portion of the enzyme. These results suggest that a persulfide group (containing a sulfane sulfur) is the proximal sulfur donor for cysteine biosynthesis. The presence of Cys(272) increased the amount of sulfane sulfur in SepCysS by 3-fold, suggesting that this Cys residue facilitates the generation of the persulfide group. Based upon these findings, we propose for SepCysS a sulfur relay mechanism that recruits both disulfide and persulfide intermediates.	[Liu, Yuchen; Soell, Dieter; Yuan, Jing] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Dos Santos, Patricia C.] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Zhu, Xiang; Orlando, Ron] Univ Georgia, Dept Chem, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Dean, Dennis R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24060 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Wake Forest University; University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; yuanj@msn.com	Yuan, Jing/ABB-3977-2021	Yuan, Jing/0000-0003-1219-3316; Dos Santos, Patricia/0000-0002-3364-0931; Liu, Yuchen/0000-0003-0842-5882	National Institutes of Health [P41-RR-018502]; Department of Energy Office of Basic Energy Sciences [DE-FG02-98ER20311]; NIGMS/National Institutes of Health [GM22854]; National Science Foundation [MCB-071770]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854, R37GM022854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P41-RR-018502 (to R. O.). This work was also supported by Department of Energy Office of Basic Energy Sciences Grant DE-FG02-98ER20311 and NIGMS/National Institutes of Health Grant GM22854 (to D. S.) and National Science Foundation Grant MCB-071770 (to D. R. D.).	Ambrogelly A, 2004, CELL MOL LIFE SCI, V61, P2437, DOI 10.1007/s00018-004-4194-9; CAVALLINI D, 1970, EUR J BIOCHEM, V14, P169, DOI 10.1111/j.1432-1033.1970.tb00275.x; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200; Helgadottir S, 2012, FEBS LETT, V586, P60, DOI 10.1016/j.febslet.2011.11.024; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; JOHNSON R. J., 1970, Methods in Enzymology, V18A, P433, DOI 10.1016/0076-6879(71)18345-0; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Lacourciere GM, 2002, P NATL ACAD SCI USA, V99, P9150, DOI 10.1073/pnas.142291199; Li T, 1999, FEBS LETT, V462, P302, DOI 10.1016/S0014-5793(99)01550-1; Liu YC, 2010, J BIOL CHEM, V285, P31923, DOI 10.1074/jbc.M110.152447; MCFARLAN SC, 1992, J BIOL CHEM, V267, P10561; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mueller EG, 2001, J BIOL CHEM, V276, P33588, DOI 10.1074/jbc.M104067200; NEWTON GL, 1985, J BACTERIOL, V161, P438, DOI 10.1128/JB.161.1.438-441.1985; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V24, P324, DOI 10.1016/0006-3002(57)90201-9; Stathopoulos C, 2001, P NATL ACAD SCI USA, V98, P14292, DOI 10.1073/pnas.201540498; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Yuan J, 2010, FEBS LETT, V584, P2857, DOI 10.1016/j.febslet.2010.05.028	32	14	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5426	5433		10.1074/jbc.M111.313700	http://dx.doi.org/10.1074/jbc.M111.313700			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22167197	Green Published, hybrid			2022-12-25	WOS:000300638000023
J	Giguere, PM; Laroche, G; Oestreich, EA; Siderovski, DP				Giguere, Patrick M.; Laroche, Genevieve; Oestreich, Emily A.; Siderovski, David P.			G-protein Signaling Modulator-3 Regulates Heterotrimeric G-protein Dynamics through Dual Association with G beta and G alpha(i) Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISSOCIATION INHIBITOR ACTIVITY; NUCLEOTIDE EXCHANGE FACTOR; GOLOCO MOTIF; GAMMA-SUBUNITS; MOLECULAR CHAPERONE; COUPLED RECEPTORS; THP-1 CELLS; ACTIVATION; IDENTIFICATION; DIFFERENTIATION	Regulation of the assembly and function of G-protein heterotrimers (G alpha center dot GDP/G beta gamma) is a complex process involving the participation of many accessory proteins. One of these regulators, GPSM3, is a member of a family of proteins containing one or more copies of a small regulatory motif known as the GoLoco (or GPR) motif. Although GPSM3 is known to bind G alpha(i)center dot GDP subunits via its GoLoco motifs, here we report that GPSM3 also interacts with the G beta subunits G beta 1 to G beta 4, independent of G gamma or G alpha center dot GDP subunit interactions. Bimolecular fluorescence complementation studies suggest that the G beta-GPSM3 complex is formed at, and transits through, the Golgi apparatus and also exists as a soluble complex in the cytoplasm. GPSM3 and G beta co-localize endogenously in THP-1 cells at the plasma membrane and in a juxtanuclear compartment. We provide evidence that GPSM3 increases G beta stability until formation of the G beta gamma dimer, including association of the G beta-GPSM3 complex with phosducin-like protein PhLP and T-complex protein 1 subunit eta (CCT7), two known chaperones of neosynthesized G beta subunits. The G beta interaction site within GPSM3 was mapped to a leucinerich region proximal to the N-terminal side of its first GoLoco motif. Both G beta and G alpha(i)center dot GDP binding events are required for GPSM3 activity in inhibiting phospholipase-C beta activation. GPSM3 is also shown in THP-1 cells to be important for Akt activation, a known G beta gamma-dependent pathway. Discovery of a G beta/GPSM3 interaction, independent of G alpha center dot GDP and G gamma involvement, adds to the combinatorial complexity of the role of GPSM3 in heterotrimeric G-protein regulation.	[Giguere, Patrick M.; Laroche, Genevieve; Oestreich, Emily A.; Siderovski, David P.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Siderovski, DP (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	dsiderov@med.unc.edu	Siderovski, David Peter/AAA-9603-2019; , PEP-MX Core/AGV-4051-2022	Siderovski, David Peter/0000-0002-0688-8210; 	National Institutes of Health from NIGMS [GM082892]; NIAMS [F32 AR057644]; Heart and Stroke Foundation of Canada; Fond de la Recherche en Sante Quebec; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fond de la Recherche en Sante Quebec; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM082892 from NIGMS (to D. P. S.) and F32 AR057644 from NIAMS (Postdoctoral Fellowship to E. A. O.). This work was also supported by post-doctoral fellowships from the Heart and Stroke Foundation of Canada and Fond de la Recherche en Sante Quebec (to P. M. G. and G. L., respectively).	Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Saliba RS, 2002, J CELL SCI, V115, P2907; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Wang JT, 2009, J BIOL CHEM, V284, P16906, DOI 10.1074/jbc.M109.006585; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Westwick JK, 2006, METHOD ENZYMOL, V407, P388, DOI 10.1016/S0076-6879(05)07032-1; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Zhao PS, 2010, J BIOL CHEM, V285, P9008, DOI 10.1074/jbc.M109.057174	50	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4863	4874		10.1074/jbc.M111.311712	http://dx.doi.org/10.1074/jbc.M111.311712			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22167191	Green Published, hybrid			2022-12-25	WOS:000300608500047
J	Hallows, WC; Yu, W; Denu, JM				Hallows, William C.; Yu, Wei; Denu, John M.			Regulation of Glycolytic Enzyme Phosphoglycerate Mutase-1 by Sirt1 Protein-mediated Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; HEPATIC GLUCONEOGENESIS; CALORIE RESTRICTION; SIRTUINS; PROMOTES; GLUCOSE; METABOLISM; SUBSTRATE	Emerging proteomic evidence suggests that acetylation of metabolic enzymes is a prevalent post-translational modification. In a few recent reports, acetylation down-regulated activity of specific enzymes in fatty acid oxidation, urea cycle, electron transport, and anti-oxidant pathways. Here, we reveal that the glycolytic enzyme phosphoglycerate mutase-1 (PGAM1) is negatively regulated by Sirt1, a member of the NAD(+)-dependent protein deacetylases. Acetylated PGAM1 displays enhanced activity, although Sirt1-mediated deacetylation reduces activity. Acetylation sites mapped to the C-terminal "cap," a region previously known to affect catalytic efficiency. Overexpression of a constitutively active variant (acetylated mimic) of PGAM1 stimulated flux through glycolysis. Under glucose restriction, Sirt1 levels dramatically increased, leading to PGAM1 deacetylation and attenuated activity. Previously, Sirt1 has been implicated in the adaptation from glucose to fat burning. This study (i) demonstrates that protein acetylation can stimulate metabolic enzymes, (ii) provides biochemical evidence that glycolysis is modulated by reversible acetylation, and (iii) demonstrates that PGAM1 deacetylation and activity are directly controlled by Sirt1.	[Yu, Wei; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Hallows, William C.; Yu, Wei; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, 330 N Orchard St, Madison, WI 53715 USA.	jmdenu@wisc.edu	YU, WEI/G-4128-2013; YU, WEI/C-3822-2012	YU, WEI/0000-0001-9898-4607	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM059785] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Caton PW, 2011, J ENDOCRINOL, V208, P273, DOI 10.1530/JOE-10-0190; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Engel M, 2004, J BIOL CHEM, V279, P35803, DOI 10.1074/jbc.M402768200; Evans MJ, 2007, MOL BIOSYST, V3, P495, DOI 10.1039/b705113a; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Fothergill-Gilmore L. A., 1989, ADV ENZYMOLOGY RELAT, V62, P227; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Imai SI, 2009, CURR OPIN CLIN NUTR, V12, P350, DOI 10.1097/MCO.0b013e32832c932d; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Kan Y, 2008, FEBS LETT, V582, P2417, DOI 10.1016/j.febslet.2008.06.005; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shalom-Barak T, 2002, J BIOL CHEM, V277, P40659, DOI 10.1074/jbc.M206650200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; SOLANKI K, 1980, BIOCHEM J, V192, P377, DOI 10.1042/bj1920377; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Walter RA, 1999, BIOCHEM J, V337, P89, DOI 10.1042/0264-6021:3370089; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; WINN SI, 1981, PHILOS T ROY SOC B, V293, P121, DOI 10.1098/rstb.1981.0066; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	44	127	138	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3850	3858		10.1074/jbc.M111.317404	http://dx.doi.org/10.1074/jbc.M111.317404			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157007	Green Published, hybrid			2022-12-25	WOS:000300410900022
J	Hamza, A; Baetz, K				Hamza, Akil; Baetz, Kristin			Iron-responsive Transcription Factor Aft1 Interacts with Kinetochore Protein Iml3 and Promotes Pericentromeric Cohesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; BUDDING YEAST; SISTER CHROMATIDS; DNA-REPLICATION; INTERACTION MAP; MEIOSIS-I; RSC	The Saccharomyces cerevisiae iron-responsive transcription factor, Aft1, has a well established role in regulating iron homeostasis through the transcriptional induction of iron-regulon genes. However, recent studies have implicated Aft1 in other cellular processes independent of iron regulation such as chromosome stability. In addition, chromosome spreads and two-hybrid data suggest that Aft1 interacts with and co-localizes with kinetochore proteins; however, the cellular implications of this have not been established. Here, we demonstrate that Aft1 associates with the kinetochore complex through Iml3. Furthermore, like Iml3, Aft1 is required for the increased association of cohesin with pericentric chromatin, which is required to resist microtubule tension, and aft1 Delta cells display chromosome segregation defects in meiosis. Our work defines a new role for Aft1 in chromosome stability and transmission.	[Hamza, Akil; Baetz, Kristin] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baetz, K (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Roger Guindon Hall,Rm 4510B,451 Smyth Ave, Ottawa, ON K1H 8M5, Canada.	kbaetz@uottawa.ca	Baetz, Kristin/E-6859-2013	Hamza, Akil/0000-0002-3613-8744	Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada Discovery grant (to K. B.).; Supported by a Canadian Institute of Health Research Master's Award.	Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Berthelet S, 2010, GENETICS, V185, P1111, DOI 10.1534/genetics.110.117531; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Choy JS, 2011, GENETICS, V189, P11, DOI 10.1534/genetics.111.130781; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; Fernius J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000629; Ghosh SK, 2004, CURR GENET, V46, P82, DOI 10.1007/s00294-004-0516-6; Gkikopoulos T, 2011, EMBO J, V30, P1919, DOI 10.1038/emboj.2011.112; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lambert JP, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.104; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ng TM, 2009, MOL BIOL CELL, V20, P3818, DOI 10.1091/mbc.E09-04-0330; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Ogiwara H, 2007, CELL CYCLE, V6, P1090, DOI 10.4161/cc.6.9.4130; Oum JH, 2011, MOL CELL BIOL, V31, P3924, DOI 10.1128/MCB.01269-10; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; SIKORSKI RS, 1989, GENETICS, V122, P19; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; SORA S, 1982, GENETICS, V101, P17; Stephens AD, 2011, J CELL BIOL, V193, P1167, DOI 10.1083/jcb.201103138; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	52	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4139	4147		10.1074/jbc.M111.319319	http://dx.doi.org/10.1074/jbc.M111.319319			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157760	hybrid, Green Published			2022-12-25	WOS:000300410900047
J	Miller, TW; Wang, EA; Gould, S; Stein, EV; Kaur, S; Lim, L; Amarnath, S; Fowler, DH; Roberts, DD				Miller, Thomas W.; Wang, Evelyn A.; Gould, Serge; Stein, Erica V.; Kaur, Sukhbir; Lim, Langston; Amarnath, Shoba; Fowler, Daniel H.; Roberts, David D.			Hydrogen Sulfide Is an Endogenous Potentiator of T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE-GAMMA-LYASE; ANIMATION-LIKE STATE; ACTIN POLYMERIZATION; MYOCARDIAL-ISCHEMIA; COLONIC SULFIDE; LYMPHOCYTE; MICE; GLUTATHIONE; INHIBITION	H2S is an endogenous signaling molecule that may act via protein sulfhydrylation to regulate various physiological functions. H2S is also a byproduct of dietary sulfate metabolism by gut bacteria. Inflammatory bowel diseases such as ulcerative colitis are associated with an increase in the colonization of the intestine by sulfate reducing bacteria along with an increase in H2S production. Consistent with its increased production, H2S is implicated as a mediator of ulcerative colitis both in its genesis or maintenance. As T cells are well established mediators of inflammatory bowel disease, we investigated the effect of H2S exposure on T cell activation. Using primary mouse T lymphocytes (CD3+), OT-II CD4+ T cells, and the human Jurkat T cell line, we show that physiological levels of H2S potentiate TCR-induced activation. Nanomolar levels of H2S (50-500 nM) enhance T cell activation assessed by CD69 expression, interleukin-2 expression, and CD25 levels. Exposure of T cells to H2S dose-dependently enhances TCR-stimulated proliferation with a maximum at 300 nM (30% increase, p < 0.01). Furthermore, activation increases the capacity of T cells to make H2S via increased expression of cystathionine gamma-lyase and cystathionine beta-synthase. Disrupting this response by silencing these H2S producing enzymes impairs T cell activation, and proliferation and can be rescued by the addition of 300 nM H2S. Thus, H2S represents a novel autocrine immunomodulatory molecule in T cells.	[Miller, Thomas W.; Wang, Evelyn A.; Gould, Serge; Stein, Erica V.; Kaur, Sukhbir; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lim, Langston] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Amarnath, Shoba; Fowler, Daniel H.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10,Rm 2A33,10 Ctr Dr,MSC1500, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Miller, Thomas W/G-1215-2011; amarnath, shoba/AAP-4391-2020; Roberts, David D./A-9699-2008; Kaur, Sukhbir/ADW-6023-2022	Miller, Thomas W/0000-0001-8645-2785; Roberts, David D./0000-0002-2481-2981; Kaur, Sukhbir/0000-0003-0513-6225; Stein, Erica/0000-0001-8778-8846	National Institutes of Health of the National Cancer Institute, Center for Cancer Research [1ZIA SC 009174]; NATIONAL CANCER INSTITUTE [ZIASC009174, ZIASC010288] Funding Source: NIH RePORTER	National Institutes of Health of the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the National Cancer Institute, Center for Cancer Research (Grant 1ZIA SC 009174).	Abe K, 1996, J NEUROSCI, V16, P1066; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Barathi S, 2007, INDIAN J BIOCHEM BIO, V44, P179; Baratt A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003861; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; BRODIE AE, 1982, EUR J BIOCHEM, V123, P159, DOI 10.1111/j.1432-1033.1982.tb06512.x; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; Cunha TM, 2008, EUR J PHARMACOL, V590, P127, DOI 10.1016/j.ejphar.2008.05.048; CUTHBERT JA, 1983, J CELL PHYSIOL, V116, P127, DOI 10.1002/jcp.1041160202; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fu ZF, 2008, LIFE SCI, V82, P1196, DOI 10.1016/j.lfs.2008.04.005; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Garg SK, 2011, ANTIOXID REDOX SIGN, V15, P39, DOI 10.1089/ars.2010.3496; Garlie NK, 1999, J IMMUNOTHER, V22, P336, DOI 10.1097/00002371-199907000-00007; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x; GMUNDER H, 1990, CELL IMMUNOL, V129, P32, DOI 10.1016/0008-8749(90)90184-S; Griesbeck C, 2002, BIOCHEMISTRY-US, V41, P11552, DOI 10.1021/bi026032b; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; IWATA S, 1994, J IMMUNOL, V152, P5633; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; KAMATANI N, 1982, INT ARCH ALLER A IMM, V68, P84, DOI 10.1159/000233071; Kanazawa K, 1996, CANCER-AM CANCER SOC, V77, P1701, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1701::AID-CNCR42>3.3.CO;2-E; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Levine J, 1998, AM J GASTROENTEROL, V93, P83, DOI 10.1111/j.1572-0241.1998.083_c.x; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Medani M, 2011, INFLAMM BOWEL DIS, V17, P1620, DOI 10.1002/ibd.21528; Mirandola P, 2007, J CELL PHYSIOL, V213, P826, DOI 10.1002/jcp.21151; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; NOELLE RJ, 1980, CELL IMMUNOL, V50, P416, DOI 10.1016/0008-8749(80)90295-6; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; PARSEY MV, 1993, J IMMUNOL, V151, P1881; Pitcher MCL, 1996, GUT, V39, P1, DOI 10.1136/gut.39.1.1; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Sivarajah A, 2006, SHOCK, V26, P154, DOI 10.1097/01.shk.0000225722.56681.64; Sivarajah A, 2009, SHOCK, V31, P267, DOI 10.1097/SHK.0b013e318180ff89; Smith JL, 2003, J BIOL CHEM, V278, P41034, DOI 10.1074/jbc.M305615200; STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Taniguchi E, 2009, TOXICOLOGY, V264, P96, DOI 10.1016/j.tox.2009.07.018; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wang MJ, 2010, CLIN EXP PHARMACOL P, V37, P764, DOI 10.1111/j.1440-1681.2010.05371.x; Wilson K, 2008, DIGEST DIS SCI, V53, P277, DOI 10.1007/s10620-007-9854-9; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yong QC, 2008, AM J PHYSIOL-HEART C, V295, pH1330, DOI 10.1152/ajpheart.00244.2008; Yong R, 2001, COMP BIOCHEM PHYS B, V129, P129, DOI 10.1016/S1096-4959(01)00309-8; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2007, AM J PHYSIOL-LUNG C, V292, pL960, DOI 10.1152/ajplung.00388.2006; Zhu XY, 2010, CELL MOL LIFE SCI, V67, P1119, DOI 10.1007/s00018-009-0250-9	67	86	90	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4211	4221		10.1074/jbc.M111.307819	http://dx.doi.org/10.1074/jbc.M111.307819			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167178	Green Published, hybrid			2022-12-25	WOS:000300410900054
J	Fu, R; Jinnah, HA				Fu, Rong; Jinnah, H. A.			Genotype-Phenotype Correlations in Lesch-Nyhan Disease MOVING BEYOND THE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; SINGLE NUCLEOTIDE SUBSTITUTION; KELLEY-SEEGMILLER-SYNDROME; VITRO AMPLIFIED CDNA; HPRT DEFICIENCY; MOLECULAR-BASIS; TRANSFERASE DEFICIENCY; PLASMODIUM-FALCIPARUM; ARGENTINE PATIENTS; MISSENSE MUTATION	Lesch-Nyhan disease and its attenuated variants are caused by mutations in the HPRT1 gene, which encodes the purine recycling enzyme hypoxanthine-guanine phosphoribosyltransferase. The mutations are heterogeneous, with more than 400 different mutations already documented. Prior efforts to correlate variations in the clinical phenotype with different mutations have suggested that milder phenotypes typically are associated with mutants that permit some residual enzyme function, whereas the most severe phenotype is associated with null mutants. However, multiple exceptions to this concept have been reported. In the current studies 44 HPRT1 mutations associated with a wide spectrum of clinical phenotypes were reconstructed by site-directed mutagenesis, the mutant enzymes were expressed in vitro and purified, and their kinetic properties were examined toward their substrates hypoxanthine, guanine, and phosphoribosylpyrophosphate. The results provide strong evidence for a correlation between disease severity and residual catalytic activity of the enzyme (k(cat)) toward each of its substrates as well as several mechanisms that result in exceptions to this correlation. There was no correlation between disease severity and the affinity of the enzyme for its substrates (K-m). These studies provide a valuable model for understanding general principles of genotype-phenotype correlations in human disease, as the mechanisms involved are applicable to many other disorders.	[Jinnah, H. A.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Jinnah, HA (corresponding author), Emory Univ, Dept Neurol, Woodruff Mem Res Bldg,Suite 6300, Atlanta, GA 30322 USA.	hjinnah@emory.edu			National Institutes of Health [HD R01 053312, DK R24 082840]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053312] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HD R01 053312 and DK R24 082840.	Bertelli M, 2004, J INHERIT METAB DIS, V27, P767, DOI 10.1023/B:BOLI.0000045799.78633.23; BOUWENSROMBOUTS AGM, 1993, HUM GENET, V91, P451, DOI 10.1007/BF00217770; BOYD M, 1993, HUM MUTAT, V2, P127, DOI 10.1002/humu.1380020212; BURGEMEISTER R, 1994, ADV EXP MED BIOL, V370, P331; Chang SJ, 1999, J RHEUMATOL, V26, P1802; CHOI Y, 1993, PEDIATR NEPHROL, V7, P739, DOI 10.1007/BF01213340; Cossu A, 2002, Clin Exp Rheumatol, V20, P851; Craig SP, 2000, J BIOL CHEM, V275, P20231, DOI 10.1074/jbc.R000002200; Curto R, 1998, BIOCHEM J, V329, P477, DOI 10.1042/bj3290477; DAVIDSON BL, 1989, J CLIN INVEST, V84, P342, DOI 10.1172/JCI114160; DAVIDSON BL, 1991, AM J HUM GENET, V48, P951; de Gemmis P, 2010, MUTAT RES-FUND MOL M, V692, P1, DOI 10.1016/j.mrfmmm.2010.07.003; Deutsch SI, 2005, CLIN NEUROPHARMACOL, V28, P28, DOI 10.1097/01.wnf.0000152043.36198.25; Duan JX, 2004, HUM MUTAT, V23, P599, DOI 10.1002/humu.20047; Dussol B, 2004, J INHERIT METAB DIS, V27, P543, DOI 10.1023/B:BOLI.0000037399.72152.a9; Ea HK, 2009, ARTHRITIS RHEUM-US, V60, P2201, DOI 10.1002/art.24617; Fairbanks L D, 1986, Adv Exp Med Biol, V195 Pt A, P101; FAIRBANKS LD, 1987, J INHERIT METAB DIS, V10, P174, DOI 10.1007/BF01800045; FUJIMORI S, 1994, ADV EXP MED BIOL, V370, P679; FUJIMORI S, 1991, ADV EXP MED BIOL, V309, P101; FUJIMORI S, 1992, HUM GENET, V90, P385; GIACOMELLO A, 1978, J BIOL CHEM, V253, P6038; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; GORDON RB, 1990, J INHERIT METAB DIS, V13, P692, DOI 10.1007/BF01799570; Hersh J H, 1986, Pediatr Neurol, V2, P302, DOI 10.1016/0887-8994(86)90025-1; HidalgoLaos RI, 1997, PEDIATR NEPHROL, V11, P645, DOI 10.1007/s004670050357; HOLLAND MJC, 1976, J CLIN INVEST, V57, P1600, DOI 10.1172/JCI108430; Jinnah H, 2001, METABOLIC MOL BASES, P2537; Jinnah HA, 2010, BRAIN, V133, P671, DOI 10.1093/brain/awq013; Jinnah HA, 2006, BRAIN, V129, P1201, DOI 10.1093/brain/awl056; Jinnah HA, 2004, NUCLEOS NUCLEOT NUCL, V23, P1153, DOI 10.1081/NCN-200027400; Jinnah HA, 2000, MUTAT RES-REV MUTAT, V463, P309, DOI 10.1016/S1383-5742(00)00052-1; JOLLY DJ, 1983, P NATL ACAD SCI-BIOL, V80, P477, DOI 10.1073/pnas.80.2.477; Jurecka A, 2008, J INHERIT METAB DIS, V31, pS447, DOI 10.1007/s10545-008-1013-8; Keebaugh AC, 2007, GENOMICS, V89, P134, DOI 10.1016/j.ygeno.2006.07.003; Keough DT, 1999, MOL BIOCHEM PARASIT, V98, P29, DOI 10.1016/S0166-6851(98)00139-X; KEOUGH DT, 1988, J INHERIT METAB DIS, V11, P229, DOI 10.1007/BF01800364; Kim Ki Joong, 1997, Journal of Korean Medical Science, V12, P332; KIM SH, 1986, NUCLEIC ACIDS RES, V14, P3103, DOI 10.1093/nar/14.7.3103; Larovere LE, 2007, NUCLEOS NUCLEOT NUCL, V26, P255, DOI 10.1080/15257770701257269; Larovere LE, 2004, MOL GENET METAB, V81, P352, DOI 10.1016/j.ymgme.2004.01.013; Lee W J, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V56, P359; LIGHTFOOT T, 1994, HUM MOL GENET, V3, P1377, DOI 10.1093/hmg/3.8.1377; Mak BS, 2000, PEDIATR NEUROL, V23, P332, DOI 10.1016/S0887-8994(00)00199-5; Melton D W, 1987, Oxf Surv Eukaryot Genes, V4, P34; OLSEN AS, 1977, BIOCHEMISTRY-US, V16, P2501, DOI 10.1021/bi00630a029; PAGE T, 1989, ADV EXP MED BIOL, V253, P129; PAGE T, 1981, J INHERIT METAB DIS, V4, P203, DOI 10.1007/BF02263652; PATEL PI, 1986, MOL CELL BIOL, V6, P393, DOI 10.1128/MCB.6.2.393; Popowska Ewa, 1998, Journal of Applied Genetics, V39, P103; Puig JG, 2001, MEDICINE, V80, P102, DOI 10.1097/00005792-200103000-00003; RIJKSEN G, 1981, HUM GENET, V57, P39, DOI 10.1007/BF00271165; Sampat R, 2011, HUM GENET, V129, P71, DOI 10.1007/s00439-010-0901-9; SCULLEY DG, 1992, HUM GENET, V90, P195; SCULLEY DG, 1991, HUM GENET, V87, P688; Sebesta I, 2008, NUCLEOS NUCLEOT NUCL, V27, P648, DOI 10.1080/15257770802143863; Sege-Peterson Karin, 1992, Human Molecular Genetics, V1, P427, DOI 10.1093/hmg/1.6.427; Shi WX, 1999, NAT STRUCT BIOL, V6, P588; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; Srivastava T, 2002, AM J MED GENET, V108, P219, DOI 10.1002/ajmg.10217; STOUT JT, 1985, ANNU REV GENET, V19, P127, DOI 10.1146/annurev.genet.19.1.127; Subbayya INS, 2000, BIOCHEM BIOPH RES CO, V272, P596, DOI 10.1006/bbrc.2000.2816; TARLE SA, 1991, GENOMICS, V10, P499, DOI 10.1016/0888-7543(91)90341-B; TOHYAMA J, 1994, HUM GENET, V93, P175; Torres RJ, 2000, HUM MUTAT, V15, P383, DOI 10.1002/(SICI)1098-1004(200004)15:4<383::AID-HUMU17>3.0.CO;2-2; Willers I, 1999, J INHERIT METAB DIS, V22, P845, DOI 10.1023/A:1005522527689; WILSON JM, 1983, NEW ENGL J MED, V309, P900; WILSON JM, 1986, J CLIN INVEST, V77, P188, DOI 10.1172/JCI112275; Wu CH, 2007, J RHEUMATOL, V34, P794; Xu YM, 1997, BIOCHEMISTRY-US, V36, P3700, DOI 10.1021/bi9616007; Yamada Y, 2004, NUCLEOS NUCLEOT NUCL, V23, P1169, DOI 10.1081/NCN-200027439; YAMADA Y, 1992, HUM GENET, V90, P379; YAMADA Y, 1991, ADV EXP MED BIOL, V309, P121; Yamada Y, 2008, NUCLEOS NUCLEOT NUCL, V27, P570, DOI 10.1080/15257770802135869	75	30	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2997	3008		10.1074/jbc.M111.317701	http://dx.doi.org/10.1074/jbc.M111.317701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157001	Green Published, hybrid			2022-12-25	WOS:000300295100007
J	Fuchs, SM; Kizer, KO; Braberg, H; Krogan, NJ; Strahl, BD				Fuchs, Stephen M.; Kizer, Kelby O.; Braberg, Hannes; Krogan, Nevan J.; Strahl, Brian D.			RNA Polymerase II Carboxyl-terminal Domain Phosphorylation Regulates Protein Stability of the Set2 Methyltransferase and Histone H3 Di- and Trimethylation at Lysine 36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ELONGATION; CRYPTIC TRANSCRIPTION; DEACETYLASE COMPLEX; SET2/RPD3S PATHWAY; GENETIC-ANALYSIS; BINDING MODULES; GENOME-WIDE; CTD CODE; YEAST	Methylation of lysine 36 on histone H3 (H3K36) is catalyzed by the Set2 methyltransferase and is linked to transcriptional regulation. Previous studies have shown that trimethylation of H3K36 by Set2 is directed through its association with the phosphorylated repeats of the RNA polymerase C-terminal domain (RNAPII CTD). Here, we show that disruption of this interaction through the use of yeast mutants defective in CTD phosphorylation at serine 2 results in a destabilization of Set2 protein levels and H3K36 methylation. Consistent with this, we find that Set2 has a short half-life and is co-regulated, with RNAPII CTD phosphorylation levels, during logarithmic growth in yeast. To probe the functional consequence of uncoupling Set2-RNAPII regulation, we expressed a truncated and more stable form of Set2 that is capable of dimethylation but not trimethylation in vivo. Results of high throughput synthetic genetic analyses show that this Set2 variant has distinct genetics from either SET2 or set2 Delta and is synthetically sick or lethal with a number of transcription elongation mutants. Collectively, these results provide molecular insight into the regulation of Set2 protein levels that influence H3K36 methylation states.	[Fuchs, Stephen M.; Kizer, Kelby O.; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Fuchs, Stephen M.; Strahl, Brian D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Braberg, Hannes; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco	Strahl, BD (corresponding author), 120 Mason Farm Rd,Suite 3010, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Fuchs, Stephen/I-7251-2012; Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259; Fuchs, Stephen/0000-0001-7261-9214	National Institutes of Health [R01GM68088]; National Research Service [F32 GM80896]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448, F32GM080896, R01GM068088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM68088 (to B. D. S.). This work was also supported by National Research Service Award Postdoctoral Fellowship F32 GM80896 (to S. M. F.).	Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Burke D., 2000, METHODS YEAST GENETI, P174; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Fuchs SM, 2009, BBA-GENE REGUL MECH, V1789, P26, DOI 10.1016/j.bbagrm.2008.07.008; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Lickwar CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004886; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Pal B, 2007, MOL BIOL CELL, V18, P426, DOI 10.1091/mbc.E06-04-0304; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; WEST ML, 1995, GENETICS, V140, P1223; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	53	38	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3249	3256		10.1074/jbc.M111.273953	http://dx.doi.org/10.1074/jbc.M111.273953			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157004	hybrid, Green Published			2022-12-25	WOS:000300295100030
J	Lugassy, J; Zaffryar-Eilot, S; Soueid, S; Mordoviz, A; Smith, V; Kessler, O; Neufeld, G				Lugassy, Jennie; Zaffryar-Eilot, Shelly; Soueid, Sharon; Mordoviz, Amit; Smith, Victoria; Kessler, Ofra; Neufeld, Gera			The Enzymatic Activity of Lysyl Oxidas-like-2 (LOXL2) Is Not Required for LOXL2-induced Inhibition of Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR PROGRESSION; OXIDASE; EXPRESSION; ADHESION; CARCINOMAS; MODULATION; PROTEIN; DOMAIN; CELLS; ASSAY	Lysyl oxidase-like-2 (LOXL2) induces tumor progression and fibrosis. It also inhibits the differentiation of keratinocytes promoting development of squamous cell carcinomas. Stimulation of HaCaT skin keratinocytes with exogenous LOXL2 or overexpression of LOXL2 in these cells inhibits their differentiation as manifested by inhibition of calcium or vitamin D-induced involucrin expression. The inhibition was abrogated by the LOXL2 function-blocking monoclonal antibody AB0023 as well as by an anti-LOXL2 polyclonal antibody. Surprisingly, a point-mutated form of LOXL2 (LOXL2(Y689F)) lacking enzymatic activity, as well as a LOXL2 deletion mutant lacking the entire catalytic domain, also inhibited calcium or vitamin D-induced up-regulation of involucrin expression, suggesting that the enzymatic activity of LOXL2 is not required for this activity. This conclusion was supported by experiments that showed that beta-aminoproprionitrile, an irreversible competitive inhibitor of the enzymatic activity of all lysyl oxidases, is unable to abolish the LOXL2-induced inhibition of HaCaT cell differentiation. The activity of LOXL2(Y689F) required the presence of the fourth scavenger receptor-cysteine-rich (SRCR) domain of LOXL2, which is also the binding target of AB0023. Epitope-tagged LOXL2(Y689F) was internalized at 37 degrees C by HaCaT cells. The internalization was inhibited by AB0023 and by competition with unlabeled LOXL2, suggesting that these cells may express a LOXL2 receptor. Our results suggest that agents that inhibit the enzymatic activity of LOXL2 may not suffice to inhibit completely the effects of LOXL2 on complex processes that involve altered states of cellular differentiation.	[Smith, Victoria] Gilead Sci Inc, Foster City, CA 94404 USA; [Lugassy, Jennie; Zaffryar-Eilot, Shelly; Soueid, Sharon; Mordoviz, Amit; Kessler, Ofra; Neufeld, Gera] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Bruce Rappaport Fac Med, Rappaport Res Inst Med Sci, IL-31096 Haifa, Israel	Gilead Sciences; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Neufeld, G (corresponding author), Israel Inst Technol, Canc Res & Vasc Biol Ctr, Bruce Rappaport Fac Med Technion, POB 9679,1 Efron St, IL-31096 Haifa, Israel.	gera@tx.technion.ac.il	Neufeld, Gera/F-1524-2019		Arresto Biosciences Inc.; Israel Cancer Research Fund; Rappaport Family Institute for Research in the Medical Sciences of Technion	Arresto Biosciences Inc.; Israel Cancer Research Fund; Rappaport Family Institute for Research in the Medical Sciences of Technion	This work was supported by a research grant from Arresto Biosciences Inc., by a grant from the Israel Cancer Research Fund (to G. N.), and by a grant from the Rappaport Family Institute for Research in the Medical Sciences of Technion. Gilead Sciences is clinically testing a drug targeting LOXL2, which is based upon my patents (G. N.). However, Gilead Sciences does not fund research in my laboratory, nor am I or any of the other authors on their payroll except for V. S., who is a Gilead Sciences employee.	Akiri G, 2003, CANCER RES, V63, P1657; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bowen MA, 1996, J BIOL CHEM, V271, P17390, DOI 10.1074/jbc.271.29.17390; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fujimoto E, 2009, J DERMATOL SCI, V55, P91, DOI 10.1016/j.jdermsci.2009.03.010; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hussain MM, 2001, FRONT BIOSCI, V6, pD417, DOI 10.2741/Hussain1; Jiang YJ, 2008, J INVEST DERMATOL, V128, P104, DOI 10.1038/sj.jid.5700944; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Kikuchi A, 2007, J BIOCHEM, V141, P443, DOI 10.1093/jb/mvm061; Le Provost GS, 2010, EXP DERMATOL, V19, P1080, DOI 10.1111/j.1600-0625.2010.01135.x; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2009, HISTOL HISTOPATHOL, V24, P651, DOI 10.14670/HH-24.651; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Ohman T, 1999, AM J RESP CELL MOL, V21, P119, DOI 10.1165/ajrcmb.21.1.3521; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Saito H, 1997, J BIOL CHEM, V272, P8157, DOI 10.1074/jbc.272.13.8157; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; TANG SS, 1983, J BIOL CHEM, V258, P4331; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078	34	38	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3541	3549		10.1074/jbc.M111.261016	http://dx.doi.org/10.1074/jbc.M111.261016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157764	Green Published, hybrid			2022-12-25	WOS:000300295100058
J	Mulligan, C; Leech, AP; Kelly, DJ; Thomas, GH				Mulligan, Christopher; Leech, Andrew P.; Kelly, David J.; Thomas, Gavin H.			The Membrane Proteins SiaQ and SiaM Form an Essential Stoichiometric Complex in the Sialic Acid Tripartite ATP-independent Periplasmic (TRAP) Transporter SiaPQM (VC1777-1779) from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACYTOPLASMIC-SOLUTE-RECEPTOR; HAEMOPHILUS-INFLUENZAE; ESCHERICHIA-COLI; RHODOBACTER-CAPSULATUS; CRYSTAL-STRUCTURES; VIRULENCE FACTOR; BINDING; BACTERIA; EVOLUTION; FAMILY	Tripartite ATP-independent periplasmic (TRAP) transporters are widespread in bacteria but poorly characterized. They contain three subunits, a small membrane protein, a large membrane protein, and a substrate-binding protein (SBP). Although the function of the SBP is well established, the membrane components have only been studied in detail for the sialic acid TRAP transporter SiaPQM from Haemophilus influenzae, where the membrane proteins are genetically fused. Herein, we report the first in vitro characterization of a truly tripartite TRAP transporter, the SiaPQM system (VC1777-1779) from the human pathogen Vibrio cholerae. The active reconstituted transporter catalyzes unidirectional Na+-dependent sialic acid uptake having similar biochemical features to the orthologous system in H. influenzae. However, using this tripartite transporter, we demonstrate the tight association of the small, SiaQ, and large, SiaM, membrane proteins that form a 1:1 complex. Using reconstituted proteoliposomes containing particular combinations of the three subunits, we demonstrate biochemically that all three subunits are likely to be essential to form a functional TRAP transporter.	[Mulligan, Christopher; Thomas, Gavin H.] Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England; [Leech, Andrew P.] Univ York, Dept Biol, Technol Facil, York YO10 5YW, N Yorkshire, England; [Kelly, David J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of York - UK; University of York - UK; University of Sheffield	Thomas, GH (corresponding author), Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England.	gavin.thomas@york.ac.uk	Thomas, Gavin H/E-5753-2011	Thomas, Gavin H/0000-0002-9763-1313; Mulligan, Christopher/0000-0001-5157-4651	Biotechnology and Biological Sciences Research Council [BB/F014759/1]; BBSRC [BB/F014759/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F014759/1 (to G. H. T.).	Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; BARON C, 1975, BIOCHIM BIOPHYS ACTA, V382, P276, DOI 10.1016/0005-2736(75)90270-9; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; Forward JA, 1997, J BACTERIOL, V179, P5482, DOI 10.1128/jb.179.17.5482-5493.1997; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Jenkins GA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-48; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jermyn WS, 2005, MICROBIOL-SGM, V151, P311, DOI 10.1099/mic.0.27621-0; Jermyn WS, 2002, MICROBIOL-SGM, V148, P3681, DOI 10.1099/00221287-148-11-3681; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3691, DOI 10.1021/bi00584a009; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; MARTINEZ J, 1995, J BACTERIOL, V177, P6005, DOI 10.1128/jb.177.20.6005-6010.1995; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Mulligan C, 2007, J MOL MICROB BIOTECH, V12, P218, DOI 10.1159/000099643; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Mulligan C, 2009, P NATL ACAD SCI USA, V106, P1778, DOI 10.1073/pnas.0809979106; Nielsen AT, 2006, PLOS PATHOG, V2, P933, DOI 10.1371/journal.ppat.0020109; POOLMAN B, 1993, BIOCHIM BIOPHYS ACTA, V1183, P5, DOI 10.1016/0005-2728(93)90003-X; Rabus R, 1999, MICROBIOL-SGM, V145, P3431, DOI 10.1099/00221287-145-12-3431; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Rucktooa P, 2007, J MOL BIOL, V370, P93, DOI 10.1016/j.jmb.2007.04.047; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Severi E, 2010, FEMS MICROBIOL LETT, V304, P47, DOI 10.1111/j.1574-6968.2009.01881.x; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Urbani A, 2005, ANAL BIOCHEM, V336, P117, DOI 10.1016/j.ab.2004.09.040; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Ward A, 1999, BIOCHEM SOC T, V27, P893, DOI 10.1042/bst0270893; Wyborn NR, 2001, FEMS MICROBIOL LETT, V194, P13, DOI 10.1111/j.1574-6968.2001.tb09439.x	36	28	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3598	3608		10.1074/jbc.M111.281030	http://dx.doi.org/10.1074/jbc.M111.281030			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167185	hybrid, Green Published			2022-12-25	WOS:000300295100064
J	Kou, RQ; Shiroto, T; Sartoretto, JL; Michel, T				Kou, Ruqin; Shiroto, Takashi; Sartoretto, Juliano L.; Michel, Thomas			Suppression of G alpha(s) Synthesis by Simvastatin Treatment of Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; EPITHELIAL-CELLS; PHOSPHORYLATION; PROTEIN; TRANSLATION; ACTIVATION; INITIATION; RAPAMYCIN; SYSTEM; 4E-BP1	These studies explore the effects of statins on cyclic AMP-modulated signaling pathways in vascular endothelial cells. We previously observed (Kou, R., Sartoretto, J., and Michel, T. (2009) J. Biol. Chem. 284, 14734-14743) that simvastatin treatment of endothelial cells leads to a marked decrease in PKA-modulated phosphorylation of the protein VASP. Here we show that long-term treatment of mice with simvastatin attenuates the vasorelaxation response to the beta-adrenergic agonist isoproterenol, without affecting endothelin-induced vasoconstriction or carbachol-induced vasorelaxation. We found that statin treatment of endothelial cells dose-dependently inhibits PKA activation as assessed by analyses of serine 157 VASP phosphorylation as well as Epac-mediated Rap1 activation. These effects of simvastatin are completely reversed by mevalonate and by geranylgeranyl pyrophosphate, implicating geranylgeranylation as a critical determinant of the stain response. We used biochemical approaches as well as fluorescence resonance energy transfer (FRET) methods with a cAMP biosensor to show that simvastatin treatment of endothelial cells markedly inhibits cAMP accumulation in response to epinephrine. Importantly, simvastatin treatment significantly decreases G alpha(s) abundance, without affecting other G alpha subunits. Simvastatin treatment does not influence G alpha(s) protein stability, and paradoxically increases the abundance of G alpha(s) mRNA. Finally, we found that simvastatin treatment inhibits G alpha(s) translation mediated by Akt/mTOR/eIF4/4EBP. Taken together, these findings establish a novel mechanism by which simvastatin modulates beta-adrenergic signaling in vascular wall, and may have implications for cardiovascular therapeutics.	[Kou, Ruqin; Shiroto, Takashi; Sartoretto, Juliano L.; Michel, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	thomas_michel@harvard.edu		sartoretto, juliano/0000-0002-0355-5541	National Institutes of Health [GM36259, HL46457, HL48743]; Japan Heart Foundation; Uehara Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R01HL046457, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Heart Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM36259, HL46457, and HL48743 (to T. M.), and by funding from the Japan Heart Foundation and the Uehara Memorial Foundation (to T. S.).	Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bhandari BK, 2001, KIDNEY INT, V59, P866; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Lilja JJ, 1998, CLIN PHARMACOL THER, V64, P477, DOI 10.1016/S0009-9236(98)90130-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Moens AL, 2010, J MOL CELL CARDIOL, V48, P1088, DOI 10.1016/j.yjmcc.2010.02.011; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Namiecinska M, 2006, PHARMACOL REP, V58, P884; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Schmechel A, 2009, CARDIOVASC RES, V82, P100, DOI 10.1093/cvr/cvp005; Senthil D, 2001, BIOCHEM J, V360, P87, DOI 10.1042/0264-6021:3600087; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430	22	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2643	2651		10.1074/jbc.M111.303594	http://dx.doi.org/10.1074/jbc.M111.303594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22144680	Green Published, hybrid			2022-12-25	WOS:000300292300037
J	Chauvenet, ALM; Durant, SM; Hilborn, R; Pettorelli, N				Chauvenet, Alienor L. M.; Durant, Sarah M.; Hilborn, Ray; Pettorelli, Nathalie			Unintended Consequences of Conservation Actions: Managing Disease in Complex Ecosystems	PLOS ONE			English	Article							DOGS LYCAON-PICTUS; LONG-TERM; REPRODUCTIVE SUCCESS; SERENGETI; VACCINATION; CHEETAHS; PREY; DYNAMICS; PATTERNS; MANAGEMENT	Infectious diseases are increasingly recognised to be a major threat to biodiversity. Disease management tools such as control of animal movements and vaccination can be used to mitigate the impact and spread of diseases in targeted species. They can reduce the risk of epidemics and in turn the risks of population decline and extinction. However, all species are embedded in communities and interactions between species can be complex, hence increasing the chance of survival of one species can have repercussions on the whole community structure. In this study, we use an example from the Serengeti ecosystem in Tanzania to explore how a vaccination campaign against Canine Distemper Virus (CDV) targeted at conserving the African lion (Panthera leo), could affect the viability of a coexisting threatened species, the cheetah (Acinonyx jubatus). Assuming that CDV plays a role in lion regulation, our results suggest that a vaccination programme, if successful, risks destabilising the simple two-species system considered, as simulations show that vaccination interventions could almost double the probability of extinction of an isolated cheetah population over the next 60 years. This work uses a simple example to illustrate how predictive modelling can be a useful tool in examining the consequence of vaccination interventions on non-target species. It also highlights the importance of carefully considering linkages between human-intervention, species viability and community structure when planning species-based conservation actions.	[Chauvenet, Alienor L. M.; Durant, Sarah M.; Pettorelli, Nathalie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Chauvenet, Alienor L. M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England; [Durant, Sarah M.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Durant, Sarah M.] Wildlife Conservat Soc, Bronx, NY USA; [Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Zoological Society of London; Imperial College London; Wildlife Conservation Society; University of Washington; University of Washington Seattle	Chauvenet, ALM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	Nathalie.Pettorelli@ioz.ac.uk	Chauvenet, Alienor/A-7952-2011; Hilborn, Ray W/D-6332-2013; Durant, Sarah M/AAB-9659-2019; Pettorelli, Nathalie/AAW-8438-2021; Chauvenet, Alienor/L-9135-2015	Chauvenet, Alienor/0000-0002-3743-7375; Durant, Sarah M/0000-0003-0724-0878; Chauvenet, Alienor/0000-0002-3743-7375	Howard G. Buffett Foundation; Wildlife Conservation Society; Frankfurt Zoological Society (FZS); National Geographic Society; Leverhulme Trust; Royal Society UK; Times Christmas Appeal; Messerli Foundation; People's Trust for Endangered Species	Howard G. Buffett Foundation; Wildlife Conservation Society; Frankfurt Zoological Society (FZS); National Geographic Society(National Geographic Society); Leverhulme Trust(Leverhulme Trust); Royal Society UK(Royal Society of London); Times Christmas Appeal; Messerli Foundation; People's Trust for Endangered Species	The authors gratefully acknowledge the many organisations that have funded the project, principally The Howard G. Buffett Foundation, Wildlife Conservation Society, Frankfurt Zoological Society (FZS), National Geographic Society, Leverhulme Trust, Royal Society UK, Times Christmas Appeal 1998, Messerli Foundation and People's Trust for Endangered Species. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, MILLENNIUM ECOSYSTEM; Begon M., 1996, ECOLOGY; Benkman Craig W., 1993, American Birds, V47, P225; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Brauer F., 2000, MATH MODELS POPULATI; Breed Andrew C., 2009, P215, DOI 10.1007/978-4-431-77134-0_11; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Cabezas S, 2006, J WILDLIFE MANAGE, V70, P1125, DOI 10.2193/0022-541X(2006)70[1125:VSABCI]2.0.CO;2; Caro T., 1994, CHEETAHS SERENGETI P; CARO TM, 1987, BEHAV ECOL SOCIOBIOL, V20, P351, DOI 10.1007/BF00300681; Cleaveland S, 2009, ANIM CONSERV, V12, P187, DOI 10.1111/j.1469-1795.2009.00276.x; Cleaveland S, 1997, ORYX, V31, P13; Cleaveland S, 2008, MULTIPLE ROLE INFECT, P209; Cleaveland S, 2011, PROJECT LIFE LION SY; Cleaveland S, 2007, CONSERV BIOL, V21, P612, DOI 10.1111/j.1523-1739.2007.00701.x; Clutton-Brock T. H., 1988, REPROD SUCCESS; Cooper AB, 2007, ANIM BEHAV, V73, P651, DOI 10.1016/j.anbehav.2006.06.013; Craft ME, 2011, J R SOC INTERFACE, V8, P776, DOI 10.1098/rsif.2010.0511; DEVOS V, 1996, SALISBURY MED B S, V87, P116; Durant SM, 2007, CONSERV BIOL, V21, P602, DOI 10.1111/j.1523-1739.2007.00702.x; Durant Sarah M., 2010, P373; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; GASCOYNE SC, 1993, J WILDLIFE DIS, V29, P396, DOI 10.7589/0090-3558-29.3.396; Goodall J, 1971, SHADOW MAN; Guiserix M, 2007, J R SOC INTERFACE, V4, P1127, DOI 10.1098/rsif.2007.0235; Guldemond R, 2008, J WILDLIFE MANAGE, V72, P892, DOI 10.2193/2007-072; Hanby JP, 1995, SERENGETI; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; HASTINGS BE, 1991, PROCEEDINGS : AMERICAN ASSOCIATION OF ZOO VETERINARIANS - ANNUAL MEETING 1991, P198; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; JESSUP D, 1992, P 2 INT GAM RANCH S, P429; Kelly MJ, 2000, CONSERV BIOL, V14, P786, DOI 10.1046/j.1523-1739.2000.98329.x; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Landres PB, 1999, ECOL APPL, V9, P1179, DOI 10.2307/2641389; Laurenson M. Karen, 1995, P385; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; LAURENSON MK, 1992, RES EXPLOR, V8, P64; LEVER C., 2001, CANE TOAD HIST ECOLO; Mbaiwa J.E., 2006, INT J WILDERNESS, V12, P41; Munson L, 2004, J WILDLIFE DIS, V40, P23, DOI 10.7589/0090-3558-40.1.23; Ogutu JO, 2002, AFR J ECOL, V40, P120, DOI 10.1046/j.1365-2028.2002.00343.x; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Pettorelli N, 2007, J ANIM ECOL, V76, P908, DOI 10.1111/j.1365-2656.2007.01266.x; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Possingham HP, 2002, NATURE AUSTR, V27, P84; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Roelke Melody E., 1992, American Association of Zoo Veterinarians Annual Proceedings, V1992, P38; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Scheel D, 1995, SERENGETI; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; SINCLAIR ARE, 1995, SERENGETI, V2; Williams ES, 1996, J WILDLIFE DIS, V32, P417, DOI 10.7589/0090-3558-32.3.417; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2007, J MAMMAL, V88, P181, DOI 10.1644/05-MAMM-A-405R1.1	61	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28671	10.1371/journal.pone.0028671	http://dx.doi.org/10.1371/journal.pone.0028671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163323	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900059
J	Delva, W; Richter, M; De Koker, P; Chersich, M; Temmerman, M				Delva, Wim; Richter, Marlise; De Koker, Petra; Chersich, Matthew; Temmerman, Marleen			Sex Work during the 2010 FIFA World Cup: Results from a Three-Wave Cross-Sectional Survey	PLOS ONE			English	Article							SOUTH-AFRICA; CONFIDENCE	Background: In the months leading up to the 2010 FIFA World Cup in South Africa, international media postulated that at least 40,000 foreign sex workers would enter South Africa, and that an increased HIV incidence would follow. To strengthen the evidence base of future HIV prevention and sexual health programmes during international sporting events, we monitored the supply and demand of female sex work in the weeks before, during and after the 2010 FIFA World Cup. Methodology/Principal Findings: We conducted three telephonic surveys of female sex workers advertising online and in local newspapers, in the last week of May, June and July 2010. The overall response rate was 73.4% (718/978). The number of sex workers advertising online was 5.9% higher during the World Cup than before. The client turnover rate did not change significantly during (adjusted rate ratio [aRR] = 1.05; 95% CI: 0.90-1.23) or after (aRR = 1.06; 95% CI: 0.91-1.24) the World Cup. The fraction of non-South African sex workers declined during (adjusted odds ratio [aOR] = 0.50; 95% CI: 0.32-0.79) and after (aOR = 0.56; 95% CI: 0.37-0.86) the World Cup. Relatively more clients were foreign during the World Cup among sex workers advertising in the newspapers (aOR = 2.74; 95% CI: 1.37-5.48) but not among those advertising online (aOR = 1.06; 95% CI: 0.60-1.90). Self-reported condom use was high (99.0%) at baseline, and did not change during (aOR = 1.07; 95% CI: 0.16-7.30) or after (aOR = 1.13; 95% CI: 0.16-8.10) the Word Cup. Conclusions/Significance: Our findings do not provide evidence for mass-immigration of foreign sex workers advertising online and in local newspapers, nor a spike in sex work or risk of HIV transmission in this subpopulation of sex workers during the World Cup. Public health programmes focusing on sex work and HIV prevention during international sporting events should be based on evidence, not media-driven sensationalism that further heightens discrimination against sex workers and increases their vulnerability.	[Delva, Wim] S African Ctr Epidemiol Modelling & Anal SACEMA, Stellenbosch, South Africa; [Delva, Wim; Richter, Marlise; De Koker, Petra; Chersich, Matthew; Temmerman, Marleen] Univ Ghent, Int Ctr Reproduct Hlth ICRH, B-9000 Ghent, Belgium; [Richter, Marlise] Univ Witwatersrand, African Ctr Migrat & Soc, Johannesburg, South Africa; [Chersich, Matthew] Univ Witwatersrand, Ctr Hlth Policy, Johannesburg, South Africa	Ghent University; University of Witwatersrand; University of Witwatersrand	Delva, W (corresponding author), S African Ctr Epidemiol Modelling & Anal SACEMA, Stellenbosch, South Africa.	Wim.Delva@ugent.be	Delva, Wim/E-9950-2012	Delva, Wim/0000-0001-8054-1904; chersich, matthew/0000-0002-4320-9168	United Nations Population Fund (UNFPA)	United Nations Population Fund (UNFPA)	This study was funded by the United Nations Population Fund (UNFPA). UNFPA had full access to the study protocol and participated in the review process of the manuscript submitted for publication. The UNFPA approved the study design proposed by the consortium of researchers who conducted the study, but were not involved in the data analysis, nor in writing up the first draft of the manuscript. The UNFPA made the following suggestions on the first draft: 1. Improve the description of the context and rationale of the survey. 2. To make sure that no claims about an increase or decrease of human trafficking could be wrongly inferred from the manuscript, since the survey did not explicitly collect data to investigate the incidence of human trafficking. These decisions had been independently reached by the research consortium and hence, the revised draft took them into account. The revised draft was approved by UNFPA without further suggestions. The choice to submit the manuscript to PLoS Medicine, and thereafter to PLoS One was made by the researchers, independently of UNFPA.	[Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 2010, WORLD CUP 2010 40000; Battersby M, 2010, INSIDE S AFRICAS BRO; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; DEAN AG, 1991, AM J PREV MED, V7, P178, DOI 10.1016/S0749-3797(18)30936-X; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Johnson L, 2007, SAMJ S AFR MED J, V97, P658; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009, 2009, AIDS EP UPD DEC 2009; Loewenberg S, 2006, LANCET, V368, P105, DOI 10.1016/S0140-6736(06)68984-8; Minister of Police, 2010, 172010 MIN POL; R Development Core Team, 2005, R LANG ENV STAT COMP; Richter M, 2010, SEX WORK 2010 SOCCER; Richter M, 2010, SAMJ S AFR MED J, V100, P222, DOI 10.7196/SAMJ.4117; Richter ML, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-1; Ridge S, 2009, KILLER WORLD CUPENGL; [SAPA IOL], 2010, THOUS PROST WORLD CU; Shaw Marc T M, 2007, Travel Med Infect Dis, V5, P365, DOI 10.1016/j.tmaid.2007.09.003; Smith Derek R, 2008, Travel Med Infect Dis, V6, P161, DOI 10.1016/j.tmaid.2008.01.010; Smith DR, 2008, TRAVEL MED INFECT DI, V6; The German Delegation to Multidisciplinary Group on Organised Crime/Article 36 Committee, 2007, EXP REP HUM TRAFF PU; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; UNFPA Sex Worker Education & Advocacy Taskforce Sisonke Sex Worker Movement, 2011, MAYB IT WILL BE BETT	22	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28363	10.1371/journal.pone.0028363	http://dx.doi.org/10.1371/journal.pone.0028363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163298	Green Published, gold			2022-12-25	WOS:000298161900034
J	Li, JQ; Tang, KL; Wang, J; Li, QY; Xu, HT; Yang, HF; Tan, LW; Liu, KJ; Zhang, SX				Li, Jin-qing; Tang, Kang-lai; Wang, Jian; Li, Qi-yu; Xu, Hao-tong; Yang, Hui-feng; Tan, Li-wen; Liu, Kai-jun; Zhang, Shao-xiang			MRI Findings for Frozen Shoulder Evaluation: Is the Thickness of the Coracohumeral Ligament a Valuable Diagnostic Tool?	PLOS ONE			English	Article							ADHESIVE CAPSULITIS; ROTATOR INTERVAL; ARTHROGRAPHY; CONTRACTURE; PATHOLOGY	Background: Recent studies have demonstrated that the coracohumeral ligament (CHL) is shortened and thickened in a frozen shoulder. We analyzed the rate in CHL visualization between patients with frozen shoulder and normal volunteers using Magnetic Resonance Imaging (MRI) to determine the CHL thickness in the patients with a frozen shoulder. Methods and Findings: There were 72 shoulder joints in 72 patients (50 femles and 22 males with a mean age of 53.5 years) with clinical evidence and MR imaging evidence of frozen shoulder. These were prospectively analyzed to identify and measure the maximum thickness of the CHL. The control group, which included 120 shoulder joints in 60 normal volunteer individuals (30 females and 30 males with a mean age of 50.5 years) was also referred for MR imaging. A chi-square test was used to analyze the data of the rate of CHL visualization between the patients with frozen shoulder and the control group. A two-way ANOVA was used to analyze the mean maximal thickness of CHL. The CHL was visualized in 110 out of 120 shoulders in the control group (91.7%), and in 57 out of 72 shoulders for the frozen shoulder group (79.2%), there was significant difference, using a chi-square test (P<0.05). The CHL was not visualized in 10 out of 120 shoulders in the control group (8.3%), and 15 out of 72 shoulders in the frozen shoulder group (20.8%), there was a significant difference (P<0.05). The CHL thickness (3.99 +/- 1.68 mm) in the patients with frozen shoulder was significantly greater than that thickness (3.08 +/- 1.32 mm) in the control group, using a two-way ANOVA (P<0.001). The CHL thickness (3.52 +/- 1.52 mm, n = 97) in the female shoulders was no significantly greater than that thickness (3.22 +/- 1.49 mm, n = 70) in the male shoulders, using a two-way ANOVA (P>0.05). Conclusions: MR Imaging is a satisfactory method for CHL depiction, and a thickened CHL is highly suggestive of frozen shoulder.	[Li, Jin-qing; Li, Qi-yu; Xu, Hao-tong; Tan, Li-wen; Liu, Kai-jun; Zhang, Shao-xiang] Third Mil Med Univ, Coll Basic Med Sci, Dept Anat, Chongqing, Peoples R China; [Tang, Kang-lai; Yang, Hui-feng] Third Mil Med Univ, Southwest Hosp, Dept Orthopaed Surg, Chongqing, Peoples R China; [Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, JQ (corresponding author), 324 Hosp PLA, Dept Radiol, Chongqing, Peoples R China.	zhangsx1021@yahoo.com		Xu, Hao-tong/0000-0003-0352-1795; Xu, Haotong/0000-0001-6416-9970	National Science Foundation of China [60871099]; Study on Key Science and Technology Program of Chongqing [2009AB5196]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Study on Key Science and Technology Program of Chongqing	This research received funding from a National Science Foundation of China (No. 60871099; http://www.nsfc.gov.cn/) and a Study on Key Science and Technology Program of Chongqing (No. 2009AB5196; http://www.ctin.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUNKER TD, 1995, J BONE JOINT SURG BR, V77, P677, DOI 10.1302/0301-620X.77B5.7559688; Carrillon Y, 1999, REV RHUM, V66, P201; Chung CB, 2000, J COMPUT ASSIST TOMO, V24, P738, DOI 10.1097/00004728-200009000-00014; Codman E., 1934, RUPTURE SUPRASPINATU; Connell D, 2002, EUR RADIOL, V12, P2100, DOI 10.1007/s00330-002-1349-7; Hand GCR, 2007, J BONE JOINT SURG BR, V89B, P928, DOI 10.1302/0301-620X.89B7.19097; Homsi C, 2006, SKELETAL RADIOL, V35, P673, DOI 10.1007/s00256-006-0136-y; Krief OP, 2005, AM J ROENTGENOL, V184, P1490, DOI 10.2214/ajr.184.5.01841490; Magee T, 2009, AM J ROENTGENOL, V192, P86, DOI 10.2214/AJR.08.1097; Matsen FA, 1993, SHOULDER BALANCE MOB; Mengiardi B, 2004, RADIOLOGY, V233, P486, DOI 10.1148/radiol.2332031219; NEER CS, 1992, CLIN ORTHOP RELAT R, P182; NEVIASER JS, 1945, J BONE JOINT SURG, V27, P211; Omari A, 2001, J SHOULDER ELB SURG, V10, P353, DOI 10.1067/mse.2001.115986; OZAKI J, 1989, J BONE JOINT SURG AM, V71A, P1511, DOI 10.2106/00004623-198971100-00009; Sano H, 2010, J SHOULDER ELB SURG, V19, P262, DOI 10.1016/j.jse.2009.05.010; Tamai K, 1997, J SHOULDER ELB SURG, V6, P534, DOI 10.1016/S1058-2746(97)90086-0; Zuckerman JD, 1994, J SHOULDER ELB SURG, V3, pS72	18	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28704	10.1371/journal.pone.0028704	http://dx.doi.org/10.1371/journal.pone.0028704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163326	gold, Green Published, Green Submitted			2022-12-25	WOS:000298161900062
J	Urushihara, H; Doi, Y; Arai, M; Matsunaga, T; Fujii, Y; Iino, N; Kawamura, T; Kawakami, K				Urushihara, Hisashi; Doi, Yuko; Arai, Masaru; Matsunaga, Toshiyuki; Fujii, Yosuke; Iino, Naoko; Kawamura, Takashi; Kawakami, Koji			Oseltamivir Prescription and Regulatory Actions Vis-a-Vis Abnormal Behavior Risk in Japan: Drug Utilization Study Using a Nationwide Pharmacy Database	PLOS ONE			English	Article							NEUROPSYCHIATRIC ADVERSE EVENTS; INFLUENZA; MEDICATIONS	Background: In March 2007, a regulatory advisory was issued in Japan to restrict oseltamivir use in children aged 10-19 years because of safety concerns over abnormal behavior. The effectiveness and validity of regulatory risk minimization actions remain to be reviewed, despite their significant public health implications. To assess the impact of the regulatory actions on prescribing practices and safety reporting. Methodoloy/Prinicpal Findings: In this retrospective review of a nationwide pharmacy database, we analyzed 100,344 dispensation records for oseltamivir and zanamivir for the period from November 2006 to March 2009. The time trend in dispensations for these antiviral agents was presented before and after the regulatory actions, contrasted with intensity of media coverage and the numbers of spontaneous adverse reaction reports with regard to antivirals. The 2007 regulatory actions, together with its intense media coverage, reduced oseltamivir dispensation in targeted patients in fiscal year 2008 to 20.4% of that in fiscal year 2006, although influenza activities were comparable between these fiscal years. In contrast, zanamivir dispensation increased approximately nine-fold across all age groups. The number of abnormal behavior reports associated with oseltamivir in children aged 10-19 years decreased from fiscal year 2006 to 2008 (24 to 9 cases); this decline was offset by the increased number of reports of abnormal behavior in children under age 10 (12 to 28 cases). The number of reports associated with zanamivir increased in proportion to increased dispensation of this drug (11 to 114 cases). Conclusions/Significance: The 2007 actions effectively reduced oseltamivir prescriptions and the number of reports of abnormal behavior in the targeted group. The observed increase in abnormal behavior reports in oseltamivir patients under age 10 and in zanamivir patients suggests that these patient groups may also be at risk, calling into question the validity of the current discrimination by age and agent (Abstract translation is available in Japanese: Appendix S1).	[Urushihara, Hisashi; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan; [Doi, Yuko; Fujii, Yosuke] Ain Pharmaciez Inc, Tokyo, Japan; [Arai, Masaru; Matsunaga, Toshiyuki] Kraft Inc, Tokyo, Japan; [Iino, Naoko] Res Inst Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Tokyo, Japan; [Kawamura, Takashi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Prevent Serv, Kyoto, Japan	Kyoto University; Kraft Heinz; Kyoto University	Urushihara, H (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan.	kawakami.koji.4e@kyoto-u.ac.jp	Kawakami, Koji/GZA-6582-2022	Kawakami, Koji/0000-0002-7477-4071; Urushihara, Hisashi/0000-0001-6913-9930	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health Labor and Welfare for Medicines; Medical Devices Regulatory Science Multidisciplinary Research Project [H21-Iyaku-Ippan-020]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labor and Welfare for Medicines; Medical Devices Regulatory Science Multidisciplinary Research Project	HU was supported by the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology, and by a grant from the Ministry of Health Labor and Welfare for Medicines and Medical Devices Regulatory Science Multidisciplinary Research Project (Grant Number H21-Iyaku-Ippan-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MED DICT REG ACT; Blumentals William A, 2007, MedGenMed, V9, P23; Center for Drug Evaluation and Research, 2005, PED SAF UPD TAM PED; Chugai Pharmaceutical Co. Ltd., 2010, TAM PACK INS; Chugai Pharmaceutical Co Ltd., 2009, 15 CHUG PHARM CO LTD; Fujita T, 2011, JPN J PHARMACOEPIDEM, V15, P73; G-Search Limited, 2010, G SEARCH DAT; GlaxoSmithKline KK, 2009, REL PACK INS; Infectious Disease Surveillance Center, 2010, SENT SURV; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2009, LANCET, V374, P1312, DOI 10.1016/S0140-6736(09)61804-3; Matheson NJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002744.pub2; Medicines and Healthcare Products Regulatory Agency, 2010, SUSP ADV DRUG REACT; Moore N, 2003, PHARMACOEPIDEM DR S, V12, P271, DOI 10.1002/pds.848; MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Nakamura K, 2010, CLIN INFECT DIS, V50, pE47, DOI 10.1086/651166; National Statistics Center, 2008, PAT SURV PORT SIT OF; Nikkei Medical, 2010, VAL CLIN FEAT INH ZA; Pariente A, 2007, DRUG SAFETY, V30, P891, DOI 10.2165/00002018-200730100-00007; Pharmaceuticals and Medical Devices Agency, 2007, REG ABN BEH TAM INT; Pharmaceuticals and Medical Devices Agency, 2010, INF SERV WEBS PHARM; Reaserch Division Health Insurance Bureau, 2010, TRENDS PRESCR HEALTH; Satoh K, 2007, BIOL PHARM BULL, V30, P1816, DOI 10.1248/bpb.30.1816; Smith JR, 2009, INT J CLIN PRACT, V63, P596, DOI 10.1111/j.1742-1241.2009.02010.x; Subcommittee on Safety Measurement Committee of Safety of Drugs the Pharmaceutical Affairs and Food Sanitation Council, 2009, MIN 1 FISC 2009 SUBC; The Federation of Pharmaceutical Manufacturers' Associations of Japan, 2008, DRUG SAF UPD 166; The Federation of Pharmaceutical Manufacturers' Associations of Japan, 2004, DRUG SAF UPD 129; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; Weatherby LB, 2001, PHARMACOEPIDEM DR S, V10, P211, DOI 10.1002/pds.592; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Yokota S, 2006, RES REPORT RES GROUP; Yorifuji T, 2009, EPIDEMIOLOGY, V20, P619, DOI 10.1097/EDE.0b013e3181a3d3f6; Yoshida M, 2009, JPN J INFECT DIS, V62, P233	34	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28483	10.1371/journal.pone.0028483	http://dx.doi.org/10.1371/journal.pone.0028483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163021	gold, Green Submitted, Green Published			2022-12-25	WOS:000298173500024
J	Cheung, CYY; Tso, AWK; Cheung, BMY; Xu, AM; Fong, CHY; Ong, KL; Law, LSC; Wat, NMS; Janus, ED; Sham, PC; Lam, KSL				Cheung, Chloe Y. Y.; Tso, Annette W. K.; Cheung, Bernard M. Y.; Xu, Aimin; Fong, Carol H. Y.; Ong, K. L.; Law, Lawrence S. C.; Wat, Nelson M. S.; Janus, Edward D.; Sham, Pak C.; Lam, Karen S. L.			The KCNJ11 E23K Polymorphism and Progression of Glycaemia in Southern Chinese: A Long-Term Prospective Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LARGE-SCALE ASSOCIATION; DIABETES-MELLITUS; INSULIN-RESISTANCE; KIR6.2 KCNJ11; SUR1 ABCC8; TYPE-2; POPULATION; RISK; GENE	Context: The KCNJ11 E23K variant is associated with type 2 diabetes mellitus (T2DM) in cross-sectional studies, but conflicting findings have been reported from prospective studies. Objective: This study aimed to evaluate whether the E23K variant could predict glycaemic progression in a Southern Chinese population. Methods/Principal Findings: We performed a long-term prospective study on 1912 subjects from the Hong Kong Cardiovascular Risk Factors Prevalence Study (CRISPS). The KCNJ11 E23K variant was associated with the progression to prediabetes after a median interval of 12 years on multinomial logistic regression analysis, even after adjustment for traditional risk factors (OR 1.29, P(age, sex, BMI and fasting plasma glucose [ FPG] adjusted) = 0.02). Based on Cox proportional hazard regression analysis, the E23K variant also predicted incident prediabetes (HR 1.18, P(age, sex, BMI and FPG adjusted) = 0.021). However, E23K was not associated with the progression to T2DM in either multinomial or Cox regression analysis, and the association of E23K with glycaemic progression to either prediabetes or T2DM was significant only in unadjusted Cox regression analysis (P = 0.039). In a meta-analysis of eight prospective studies including our own, involving 15680 subjects, the E23K variant was associated with incident T2DM (fixed effect: OR 1.10, P = 4 x 10(-3); random effect: OR 1.11, P = 0.035). Conclusions: Our study has provided supporting evidence for the role of the E23K variant in glycaemic progression in Chinese, with its effect being more evident in the early stage of T2DM, as the subjects progressed from normal glucose tolerance to prediabetes.	[Cheung, Chloe Y. Y.; Tso, Annette W. K.; Cheung, Bernard M. Y.; Xu, Aimin; Fong, Carol H. Y.; Ong, K. L.; Law, Lawrence S. C.; Wat, Nelson M. S.; Lam, Karen S. L.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [Tso, Annette W. K.; Xu, Aimin; Lam, Karen S. L.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Pokfulam, Hong Kong, Peoples R China; [Janus, Edward D.] Univ Melbourne, Western Hosp, Dept Med, Footscray, Vic, Australia; [Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, Genome Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Melbourne; Western Hospital; University of Hong Kong	Cheung, CYY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	pcsham@hku.hk; ksllam@hku.hk	Janus, Edward/AAU-8652-2020; Xu, Aimin/D-3291-2013; Ong, Kwok Leung/B-9018-2009; /E-9829-2010	Xu, Aimin/0000-0002-0668-033X; Ong, Kwok Leung/0000-0001-7229-7614; /0000-0001-9106-7363; Cheung, Chloe Yu Yan/0000-0002-7884-5295; Law, Lawrence Siu-Chun/0000-0002-0429-2632	University of Hong Kong	University of Hong Kong(University of Hong Kong)	This study was financially supported by the CRCG seeding fund for basic research from the University of Hong Kong to Karen SL Lam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bennett K, 2010, REV ENDOCR METAB DIS, V11, P157, DOI 10.1007/s11154-010-9144-2; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Chistiakov DA, 2009, ACTA DIABETOL, V46, P43, DOI 10.1007/s00592-008-0056-5; Doi Y, 2007, DIABETES, V56, P2829, DOI 10.2337/db06-1709; Fischer A, 2008, DIABETES CARE, V31, P87, DOI 10.2337/dc07-1157; Florez JC, 2007, DIABETES, V56, P531, DOI 10.2337/db06-0966; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Janus ED, 1997, CLIN EXP PHARMACOL P, V24, P987, DOI 10.1111/j.1440-1681.1997.tb02736.x; Koo BK, 2007, DIABETIC MED, V24, P178, DOI 10.1111/j.1464-5491.2006.02050.x; Laukkanen O, 2004, J CLIN ENDOCR METAB, V89, P6286, DOI 10.1210/jc.2004-1204; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Qi L, 2007, DIABETIC MED, V24, P1187, DOI 10.1111/j.1464-5491.2007.02255.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou DZ, 2009, J HUM GENET, V54, P433, DOI 10.1038/jhg.2009.54	26	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28598	10.1371/journal.pone.0028598	http://dx.doi.org/10.1371/journal.pone.0028598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163043	Green Published, gold			2022-12-25	WOS:000298172800053
J	Chien, S; Ono, F; Watanabe, K				Chien, Sung-en; Ono, Fuminori; Watanabe, Katsumi			Mislocalization of Visual Stimuli: Independent Effects of Static and Dynamic Attention	PLOS ONE			English	Article							SPACE; COMPRESSION; POSITION; SHIFTS; MEMORY	Shifts of visual attention cause systematic distortions of the perceived locations of visual objects around the focus of attention. In the attention repulsion effect, the perceived location of a visual target is shifted away from an attention-attracting cue when the cue is presented before the target. Recently it has been found that, if the visual cue is presented after the target, the perceived location of the target shifts toward the location of the following cue. One unanswered question is whether a single mechanism underlies both attentional repulsion and attraction effects. We presented participants with two disks at diagonal locations as visual cues and two vertical lines as targets. Participants were asked to perform a forced-choice task to judge targets' positions. The present study examined whether the magnitude of the repulsion effect and the attraction effect would differ (Experiment 1), whether the two effects would interact (Experiment 2), and whether the location or the dynamic shift of attentional focus would determine the distortions effects (Experiment 3). The results showed that the effect size of the attraction effect was slightly larger than the repulsion effect and the preceding and following cues have independent influences on the perceived positions. The repulsion effect was caused by the location of attnetion and the attraction effect was due to the dynamic shift of attentional focus, suggesting that the underlying mechanisms for the retrospective attraction effect might be different from those for the repulsion effect.	[Chien, Sung-en; Ono, Fuminori; Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol Cognit Sci, Tokyo, Japan; [Watanabe, Katsumi] Japan Sci & Technol Agcy, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Chien, S (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol Cognit Sci, Tokyo, Japan.	chiensungen@gmail.com		Watanabe, Katsumi/0000-0003-1282-9994	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology [21730587, 21300301]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology's Grants-in-Aid for Scientific Research (21730587, 21300301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott SR, 2006, VISION RES, V46, P1553, DOI 10.1016/j.visres.2005.11.020; Eagleman DM, 2007, J VISION, V7, DOI 10.1167/7.4.3; Hamker FH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040031; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hubbard TL, 2000, PSYCHOL RES-PSYCH FO, V64, P41, DOI 10.1007/s004260000029; Kerzel D, 2002, VISION RES, V42, P159, DOI 10.1016/S0042-6989(01)00274-7; Kosovicheva AA, 2010, J VISION, V10, DOI 10.1167/10.12.33; Ono F, 2011, PSYCHOL SCI, V22, P472, DOI 10.1177/0956797611403319; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pratt J, 2008, ACTA PSYCHOL, V127, P137, DOI 10.1016/j.actpsy.2007.03.003; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Sheth BR, 2001, VISION RES, V41, P329, DOI 10.1016/S0042-6989(00)00230-3; Shim WM, 2004, VISION RES, V44, P2393, DOI 10.1016/j.visres.2004.05.003; Suzuki S, 1997, J EXP PSYCHOL HUMAN, V23, P443, DOI 10.1037/0096-1523.23.2.443; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Yamada Y, 2008, PSYCHOL RES-PSYCH FO, V72, P273, DOI 10.1007/s00426-007-0109-3; Yamada Y, 2011, J VISION, V11, DOI 10.1167/11.6.6; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Zirnsak M, 2010, VISION RES, V50, P1328, DOI 10.1016/j.visres.2010.02.002	19	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28371	10.1371/journal.pone.0028371	http://dx.doi.org/10.1371/journal.pone.0028371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163009	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800031
J	Kuo, CY; Huang, YC; Huang, CG; Tsao, KC; Lin, TY				Kuo, Chen-Yen; Huang, Yhu-Chering; Huang, Chung-Guei; Tsao, Kuo-Chien; Lin, Tzou-Yien			Symptomatic Predictors for 2009 Influenza A Virus (H1N1) Infection with an Emphasis for Patients with a Negative Rapid Diagnostic Test	PLOS ONE			English	Article							NEW-YORK-CITY; UNITED-STATES; ANTIVIRAL TREATMENT; CASE-DEFINITION; PREGNANT-WOMEN; PERFORMANCE; CHILDREN; OUTCOMES; WORKING	Background: The clinical diagnosis of influenza is difficult because it shares nonspecific symptoms with a variety of diseases. Emergency departments and clinics were overwhelmed by a surge of anxious patients during the 2009 influenza A virus (H1N1) outbreak. Our objective was to identify symptomatic predictors of influenza virus infection for patients with a negative rapid diagnostic test. Methodology/Principal Findings: We conducted a retrospective review of 805 patients who presented at Chang Gung Memorial Hospital, from August 1, 2009, to September 30, 2009. Respiratory specimens from these patients were subjected to rapid influenza tests and reverse-transcription polymerase chain reactions. In total, 36% of 308 children and 23% of 497 adults were positive for 2009 influenza A virus (H1N1) infection by polymerase chain reaction or virus culture. For pediatric patients, sore throat and influenza-like illness significantly increased the odds of having 2009 influenza A virus (H1N1) infection, by more than 3-fold (95% confidence interval (CI): 1.9-7.3) and 7-fold (95% CI: 4.00-14.2), respectively. For adult patients, cough and constitutional symptoms increased the odds of having 2009 influenza A virus (H1N1) by greater than 5-fold (95% CI: 3.1-10.2) and 3-fold (95% CI: 2.1-6.7), respectively. The negative likelihood ratio of the combination of fever and cough was 0.096 (95% CI: 0.01-0.69) for children with negative results of rapid influenza diagnostic tests. Conclusion/Significance: In influenza epidemic settings, clinicians should be aware that rapid influenza diagnostic tests are relatively insensitive for the diagnosis of influenza virus infection. For patients with negative rapid influenza diagnostic tests, those lacking fever and cough have a low probability of influenza virus infection. The management strategy should be made individually and depend on the severity of illness.	[Kuo, Chen-Yen; Huang, Yhu-Chering; Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan; [Kuo, Chen-Yen] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Huang, Chung-Guei; Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Kuo, CY (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan.	ychuang@cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG 470132]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by a grant from Chang Gung Memorial Hospital (CMRPG 470132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MED LETT DRUGS THER, V41, P121; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P826; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Covalciuc KA, 1999, J CLIN MICROBIOL, V37, P3971, DOI 10.1128/JCM.37.12.3971-3974.1999; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Lee N, 2007, ANTIVIR THER, V12, P501; LEONARDI GP, 1994, J CLIN MICROBIOL, V32, P70, DOI 10.1128/JCM.32.1.70-74.1994; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nichol KL, 2001, ARCH INTERN MED, V161, P749, DOI 10.1001/archinte.161.5.749; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Storch GA, 2003, CURR OPIN PEDIATR, V15, P77, DOI 10.1097/00008480-200302000-00013; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; *WHO, 2009, WHO GUID CDC PROT RE, DOI DOI 10.1016/S1386-6532(03)00122-7; 2009, MMWR MORB MORTAL WKL, V58, P470; 2009, MORB MORTAL WKLY REP, V58, P453	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28102	10.1371/journal.pone.0028102	http://dx.doi.org/10.1371/journal.pone.0028102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164233	Green Submitted, gold, Green Published			2022-12-25	WOS:000298171400034
J	Terrile, M; Bryan, K; Vaughan, L; Hallsworth, A; Webber, H; Chesler, L; Stallings, RL				Terrile, Marta; Bryan, Kenneth; Vaughan, Lynsey; Hallsworth, Albert; Webber, Hannah; Chesler, Louis; Stallings, Raymond L.			miRNA Expression Profiling of the Murine TH-MYCN Neuroblastoma Model Reveals Similarities with Human Tumors and Identifies Novel Candidate MiRNAs	PLOS ONE			English	Article							TRANSCRIPTIONAL TARGET; CHROMOSOMAL IMBALANCES; MALIGNANT PROGRESSION; MICRORNA EXPRESSION; TRANSGENIC MODEL; DOWN-REGULATION; RETINOIC ACID; CELL LINES; P53; SUPPRESSOR	Background: MicroRNAs are small molecules which regulate gene expression post-transcriptionally and aberrant expression of several miRNAs is associated with neuroblastoma, a childhood cancer arising from precursor cells of the sympathetic nervous system. Amplification of the MYCN transcription factor characterizes the most clinically aggressive subtype of this disease, and although alteration of p53 signaling is not commonly found in primary tumors, deregulation of proteins involved in this pathway frequently arise in recurrent disease after pharmacological treatment. TH-MYCN is a well-characterized transgenic model of MYCN-driven neuroblastoma which recapitulates many clinicopathologic features of the human disease. Here, we evaluate the dysregulation of miRNAs in tumors from TH-MYCN mice that are either wild-type (TH-MYCN) or deficient (TH-MYCN/p53ER(TAM)) for the p53 tumor suppressor gene. Principal Findings: We analyzed the expression of 591 miRNAs in control (adrenal) and neuroblastoma tumor tissues derived from either TH-MYCN or TH-MYCN/p53ER(TAM) mice, respectively wild-type or deficient in p53. Comparing miRNA expression in tumor and control samples, we identified 159 differentially expressed miRNAs. Using data previously obtained from human neuroblastoma samples, we performed a comparison of miRNA expression between murine and human tumors to assess the concordance between murine and human expression data. Notably, the miR-17-5p-92 oncogenic polycistronic cluster, which is over-expressed in human MYCN amplified tumors, was over-expressed in mouse tumors. Moreover, analyzing miRNAs expression in a mouse model (TH-MYCN/p53ER(TAM)) possessing a transgenic p53 allele that drives the expression of an inactive protein, we identified miR-125b-3p and miR-676 as directly or indirectly regulated by the level of functional p53. Significance: Our study represents the first miRNA profiling of an important mouse model of neuroblastoma. Similarities and differences in miRNAs expression between human and murine neuroblastoma were identified, providing important insight into the efficacy of this mouse model for assessing miRNA involvement in neuroblastoma and their potential effectiveness as therapeutic targets.	[Terrile, Marta; Bryan, Kenneth; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Terrile, Marta; Bryan, Kenneth; Stallings, Raymond L.] Our Ladys Childrens Hosp, Ireland & Natl Childrens Res Ctr, Dublin, Ireland; [Vaughan, Lynsey; Hallsworth, Albert; Webber, Hannah; Chesler, Louis] Inst Canc Res, Div Canc Therapeut, Sutton, Surrey, England	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of London; Institute of Cancer Research - UK	Terrile, M (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	rstallings@rcsi.ie	Stallings, Raymond/A-7213-2008; Xie, Huangming/B-2260-2012	Chesler, Louis/0000-0001-7842-2068; Bryan, Kenneth/0000-0002-9550-8354	Science Foundation Ireland [07/IN.1/B1776]; Children's Medical and Research Foundation; Neuroblastoma Society [NES003X]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; Neuroblastoma Society	This work was supported in part by Science Foundation Ireland (07/IN.1/B1776), Children's Medical and Research Foundation, and The Neuroblastoma Society, grant NES003X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Das S, 2010, CANCER RES, V70, P7874, DOI 10.1158/0008-5472.CAN-10-1534; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; Foley NH, 2011, CELL DEATH DIFFER, V18, P1089, DOI 10.1038/cdd.2010.172; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Gueta K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-20; Hackett CS, 2003, CANCER RES, V63, P5266; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Murphy DM, 2011, MOL CARCINOGEN, V50, P403, DOI 10.1002/mc.20722; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Slack A, 2005, CANCER LETT, V228, P21, DOI 10.1016/j.canlet.2005.01.050; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Stallings RL, 2007, TRENDS GENET, V23, P278, DOI 10.1016/j.tig.2007.03.009; Stallings RL, 2011, SEMIN CANCER BIOL, V21, P283, DOI 10.1016/j.semcancer.2011.07.001; Stallings RL, 2010, EXPERT OPIN THER TAR, V14, P951, DOI 10.1517/14728222.2010.510136; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	51	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28356	10.1371/journal.pone.0028356	http://dx.doi.org/10.1371/journal.pone.0028356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164278	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400079
J	Uceyler, N; Topuzoglu, T; Schiesser, P; Hahnenkamp, S; Sommer, C				Ueceyler, Nurcan; Topuzoglu, Tengue; Schiesser, Peter; Hahnenkamp, Saskia; Sommer, Claudia			IL-4 Deficiency Is Associated with Mechanical Hypersensitivity in Mice	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; PROINFLAMMATORY CYTOKINE EXPRESSION; PERIPHERAL NEUROPATHIC PAIN; MU-OPIOID RECEPTORS; MOUSE SCIATIC-NERVE; DIFFERENTIAL EXPRESSION; UP-REGULATION; INTERLEUKIN-4; INFLAMMATION; HYPERALGESIA	Interleukin-4 (IL-4) is an anti-inflammatory and analgesic cytokine that induces opioid receptor transcription. We investigated IL-4 knockout (ko) mice to characterize their pain behavior before and after chronic constriction injury (CCI) of the sciatic nerve as a model for neuropathic pain. We investigated opioid responsivity and measured cytokine and opioid receptor gene expression in the peripheral and central nervous system (PNS, CNS) of IL-4 ko mice in comparison with wildtype (wt) mice. Naive IL-4 ko mice displayed tactile allodynia (wt: 0.45 g; ko: 0.18 g; p<0.001), while responses to heat and cold stimuli and to muscle pressure were not different. No compensatory changes in the gene expression of tumor necrosis factor-alpha (TNF), IL-1 beta, IL-10, and IL-13 were found in the PNS and CNS of naive IL-4 ko mice. However, IL-1 beta gene expression was stronger in the sciatic nerve of IL-4 ko mice (p<0.001) 28 days after CCI and only IL-4 ko mice had elevated IL-10 gene expression (p = 0.014). Remarkably, CCI induced TNF (p<0.01), IL-1 beta (p<0.05), IL-10 (p<0.05), and IL-13 (p<0.001) gene expression exclusively in the ipsilateral spinal cord of IL-4 ko mice. The compensatory overexpression of the anti-inflammatory and analgesic cytokines IL-10 and IL-13 in the spinal cord of IL-4 ko mice may explain the lack of genotype differences for pain behavior after CCI. Additionally, CCI induced gene expression of mu, kappa, and delta opioid receptors in the contralateral cortex and thalamus of IL-4 ko mice, paralleled by fast onset of morphine analgesia, but not in wt mice. We conclude that a lack of IL-4 leads to mechanical sensitivity; the compensatory hyperexpression of analgesic cytokines and opioid receptors after CCI, in turn, protects IL-4 ko mice from enhanced pain behavior after nerve lesion.	[Ueceyler, Nurcan; Topuzoglu, Tengue; Schiesser, Peter; Hahnenkamp, Saskia; Sommer, Claudia] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany	University of Wurzburg	Uceyler, N (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	ueceyler_n@klinik.uni-wuerzburg.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002; Uceyler, Nurcan/0000-0001-6973-6428	University of Wurzburg; Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS); German Research Foundation (DFG)	University of Wurzburg; Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS); German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by research funds of the University of Wurzburg, and by the Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS). Additional funds provided by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Borner C, 2004, J NEUROCHEM, V91, P1493, DOI 10.1111/j.1471-4159.2004.02846.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cunha FQ, 1999, BRIT J PHARMACOL, V126, P45, DOI 10.1038/sj.bjp.0702266; Gabay E, 2011, EUR J PAIN, V15, P242, DOI 10.1016/j.ejpain.2010.07.012; Gendron L, 2006, J NEUROSCI, V26, P953, DOI 10.1523/JNEUROSCI.3598-05.2006; Hao SL, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-6; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Honore P, 2006, BEHAV BRAIN RES, V167, P355, DOI 10.1016/j.bbr.2005.09.024; Hoot MR, 2011, BRAIN RES, V1406, P1, DOI 10.1016/j.brainres.2011.06.023; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Karam MC, 2011, J NEUROIMMUNOL, V234, P49, DOI 10.1016/j.jneuroim.2011.02.003; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kraus J, 2001, J BIOL CHEM, V276, P43901, DOI 10.1074/jbc.M107543200; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lee HL, 2004, NEUROREPORT, V15, P2807; Leger T, 2011, J NEUROIMMUNOL, V234, P19, DOI 10.1016/j.jneuroim.2011.01.005; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; Martin G, 2008, EXP PHYSIOL, V93, P908, DOI 10.1113/expphysiol.2008.042432; MCCANN FV, 1991, CELL SIGNAL, V3, P483, DOI 10.1016/0898-6568(91)90078-9; Milligan ED, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-9; Niikura K, 2010, TRENDS PHARMACOL SCI, V31, P299, DOI 10.1016/j.tips.2010.04.003; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Puehler W, 2006, NEUROSCIENCE, V141, P989, DOI 10.1016/j.neuroscience.2006.03.078; Saadoun D, 2005, ARTHRITIS RHEUM-US, V52, P2917, DOI 10.1002/art.21270; Sommer C, 1998, BRAIN RES, V784, P154, DOI 10.1016/S0006-8993(97)01327-9; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Tu HL, 2003, J NEUROIMMUNOL, V139, P145, DOI 10.1016/S0165-5728(03)00126-7; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Uceyler N, 2008, NEUROSCI LETT, V437, P194, DOI 10.1016/j.neulet.2008.03.050; Uceyler N, 2008, NEUROSCI LETT, V436, P259, DOI 10.1016/j.neulet.2008.03.037; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; Uceyler N, 2006, ARTHRITIS RHEUM-US, V54, P2656, DOI 10.1002/art.22026; Uceyler N, 2010, EXP NEUROL, V222, P153, DOI 10.1016/j.expneurol.2009.12.026; Vale ML, 2003, J PHARMACOL EXP THER, V304, P102, DOI 10.1124/jpet.102.038703; Vidal EL, 1998, IMMUNOPHARMACOLOGY, V38, P261, DOI 10.1016/S0162-3109(97)00085-4; Vogel C, 2006, J PERIPHER NERV SYST, V11, P294, DOI 10.1111/j.1529-8027.2006.00101.x; Xu XJ, 1997, CYTOKINE, V9, P1028, DOI 10.1006/cyto.1997.0243	42	40	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28205	10.1371/journal.pone.0028205	http://dx.doi.org/10.1371/journal.pone.0028205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164245	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400046
J	Wang, YP; Wang, XY; Tang, HB; Tan, X; Ficklin, SP; Feltus, FA; Paterson, AH				Wang, Yupeng; Wang, Xiyin; Tang, Haibao; Tan, Xu; Ficklin, Stephen P.; Feltus, F. Alex; Paterson, Andrew H.			Modes of Gene Duplication Contribute Differently to Genetic Novelty and Redundancy, but Show Parallels across Divergent Angiosperms	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; ARABIDOPSIS-THALIANA; EXPRESSION DIVERSITY; CONCERTED EVOLUTION; DNA METHYLATION; YEAST; CONSERVATION; ACTIVATION; FAMILIES; DIVERSIFICATION	Background: Both single gene and whole genome duplications (WGD) have recurred in angiosperm evolution. However, the evolutionary effects of different modes of gene duplication, especially regarding their contributions to genetic novelty or redundancy, have been inadequately explored. Results: In Arabidopsis thaliana and Oryza sativa (rice), species that deeply sample botanical diversity and for which expression data are available from a wide range of tissues and physiological conditions, we have compared expression divergence between genes duplicated by six different mechanisms (WGD, tandem, proximal, DNA based transposed, retrotransposed and dispersed), and between positional orthologs. Both neo-functionalization and genetic redundancy appear to contribute to retention of duplicate genes. Genes resulting from WGD and tandem duplications diverge slowest in both coding sequences and gene expression, and contribute most to genetic redundancy, while other duplication modes contribute more to evolutionary novelty. WGD duplicates may more frequently be retained due to dosage amplification, while inferred transposon mediated gene duplications tend to reduce gene expression levels. The extent of expression divergence between duplicates is discernibly related to duplication modes, different WGD events, amino acid divergence, and putatively neutral divergence (time), but the contribution of each factor is heterogeneous among duplication modes. Gene loss may retard inter-species expression divergence. Members of different gene families may have non-random patterns of origin that are similar in Arabidopsis and rice, suggesting the action of pan-taxon principles of molecular evolution. Conclusion: Gene duplication modes differ in contribution to genetic novelty and redundancy, but show some parallels in taxa separated by hundreds of millions of years of evolution.	[Wang, Yupeng; Wang, Xiyin; Tang, Haibao; Tan, Xu; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wang, Yupeng; Paterson, Andrew H.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Wang, Xiyin] Hebei United Univ, Coll Life Sci, Tangshan, Hebei, Peoples R China; [Tang, Haibao; Tan, Xu; Paterson, Andrew H.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Feltus, F. Alex] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Paterson, Andrew H.] Univ Georgia, Dept Crop & Soil Sci, Athens, GA 30602 USA; [Paterson, Andrew H.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; North China University of Science & Technology; University System of Georgia; University of Georgia; Clemson University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wang, YP (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@plantbio.uga.edu	Tang, Haibao/A-6715-2011; Ficklin, Stephen/L-4324-2019; Wang, Yupeng/B-7986-2009	Tang, Haibao/0000-0002-3460-8570; Ficklin, Stephen/0000-0001-9138-6292; Wang, Yupeng/0000-0002-3002-8069; Feltus, Frank/0000-0002-2123-6114	National Science Foundation (NSF) [DBI 0849896, MCB 0821096, MCB 1021718]; University of Georgia Research Computing Center; Office of the Vice President for Research; Office of the Chief Information Officer; Direct For Biological Sciences [0849896, 0821096] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Georgia Research Computing Center; Office of the Vice President for Research; Office of the Chief Information Officer; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AHP appreciates funding from the National Science Foundation (NSF: DBI 0849896, MCB 0821096, MCB 1021718). This study was supported in part by resources and technical expertise from the University of Georgia Research Computing Center, a partnership between the Office of the Vice President for Research and the Office of the Chief Information Officer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Briggs GC, 2006, TRENDS PLANT SCI, V11, P492, DOI 10.1016/j.tplants.2006.08.005; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Cusack BP, 2007, MOL BIOL EVOL, V24, P679, DOI 10.1093/molbev/msl199; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Dutilh BE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-10; Elbez Y, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-136; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Essien K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003122; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Force A, 1999, GENETICS, V151, P1531; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Jukes TH, 1969, EVOLUTION PROTEIN MO; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kafri R, 2008, P NATL ACAD SCI USA, V105, P1243, DOI 10.1073/pnas.0711043105; Kashkush K, 2002, GENETICS, V160, P1651; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Li Z, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S8; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mizutani M, 1998, PLANT MOL BIOL, V37, P39, DOI 10.1023/A:1005921406884; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson David R., 2009, Human Genomics, V4, P59; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Ohno S., 1970, EVOLUTION GENE DUPLI; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Paterson AH, 2010, ANNU REV PLANT BIOL, V61, P349, DOI 10.1146/annurev-arplant-042809-112235; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Rodin SN, 2003, J MOL EVOL, V56, P718, DOI 10.1007/s00239-002-2446-6; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Stebbins G L, 1982, Prog Clin Biol Res, V96, P21; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Veitia RA, 2003, J THEOR BIOL, V220, P19, DOI 10.1006/jtbi.2003.3105; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; Wang XY, 2007, GENETICS, V177, P1753, DOI 10.1534/genetics.107.073197; Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622; Wang XY, 2009, GENOME RES, V19, P1026, DOI 10.1101/gr.087288.108; Wang YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013239; Wang YP, 2009, EVOL BIOINFORM, V5, P81; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Woodhouse MR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000949; Xu WY, 2001, GENE, V272, P61, DOI 10.1016/S0378-1119(01)00516-9; Zhang GJ, 2008, CURR OPIN GENET DEV, V18, P387, DOI 10.1016/j.gde.2008.07.009; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	93	85	89	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28150	10.1371/journal.pone.0028150	http://dx.doi.org/10.1371/journal.pone.0028150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164235	gold, Green Submitted, Green Published			2022-12-25	WOS:000298171400036
J	Lee, M; Choy, WC; Abid, MR				Lee, Monica; Choy, Wing C.; Abid, Md. Ruhul			Direct Sensing of Endothelial Oxidants by Vascular Endothelial Growth Factor Receptor-2 and c-Src	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-TYROSINE PHOSPHATASES; TGF-BETA RECEPTOR; NADPH OXIDASE; ANGIOTENSIN-II; REVERSIBLE OXIDATION; SIGNALING PATHWAYS; CRITICAL COMPONENT; NAD(P)H OXIDASE; KINASE-ACTIVITY	Background: ADPH oxidase-derived reactive oxygen species (ROS) play important roles in redox homeostasis and signal transduction in endothelial cells (ECs). We previously demonstrated that c-Src plays a key role in VEGF-induced, ROS-dependent selective activation of PI3K-Akt but not PLC gamma-1-ERK1/2 signaling pathways. The aim of the present study was to understand how VEGFR-2-c-Src signaling axis 'senses' NADPH oxidase-derived ROS levels and couples VEGF activation of c-Src to the redox state of ECs. Methodology/Principal Findings: Using biotinylated probe that detects oxidation of cysteine thiol (cys-OH) in intracellular proteins, we demonstrate that VEGF induced oxidative modification in c-Src and VEGFR-2, and that reduction in ROS levels using siRNA against p47(phox) subunit of Rac1-dependent NADPH oxidase inhibited this phenomenon. Co-immunoprecipitation studies using human coronary artery ECs (HCAEC) showed that VEGF-induced ROS-dependent interaction between VEGFR-2 and c-Src correlated with their thiol oxidation status. Immunofluorescence studies using antibodies against internalized VEGFR-2 and c-Src demonstrated that VEGF-induced subcellular co-localization of these tyrosine kinases were also dependent on NADPH oxidsase-derived ROS. Conclusion/Significance: These results demonstrate that VEGF induces cysteine oxidation in VEGFR-2 and c-Src in an NADPH oxidase-derived ROS-dependent manner, suggesting that VEGFR-2 and c-Src can 'sense' redox levels in ECs. The data also suggest that thiol oxidation status of VEGFR-2 and c-Src correlates with their ability to physically interact with each other and c-Src activation. Taken together, these findings suggest that prior to activating downstream c-Src-PI3K-Akt signaling pathway, VEGFR-2-c-Src axis requires an NADPH oxidase-derived ROS threshold in ECs.	[Lee, Monica; Choy, Wing C.; Abid, Md. Ruhul] Brown Univ, Rhode Isl Hosp, Div Cardiothorac Surg, Cardiovasc Res Ctr,Warren Alpert Med Sch, Providence, RI 02903 USA; [Lee, Monica] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA; [Choy, Wing C.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Harvard University; Beth Israel Deaconess Medical Center	Lee, M (corresponding author), Brown Univ, Rhode Isl Hosp, Div Cardiothorac Surg, Cardiovasc Res Ctr,Warren Alpert Med Sch, Providence, RI 02903 USA.	Ruhul_Abid@brown.edu			American Heart Association [SDG 0453284N];  [10GRNT3640011]	American Heart Association(American Heart Association); 	This work was supported by the American Heart Association grants SDG 0453284N and Grant-in-Aid 10GRNT3640011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2007, J BIOL CHEM, V282, P35373, DOI 10.1074/jbc.M702175200; Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; BAAS AS, 1995, CIRC RES, V77, P29, DOI 10.1161/01.RES.77.1.29; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Chou MT, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-32; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Ehrlich M, 2001, J CELL SCI, V114, P1777; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Feng J, 2010, ARTERIOSCL THROM VAS, V30, P1703, DOI 10.1161/ATVBAHA.110.209726; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Fichtlscherer S, 2004, CIRCULATION, V109, P178, DOI 10.1161/01.CIR.0000105763.51286.7F; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Marumo T, 1997, CIRCULATION, V96, P2361; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Oo ML, 2003, ONCOGENE, V22, P1411, DOI 10.1038/sj.onc.1206286; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Patterson C, 1999, J BIOL CHEM, V274, P19814, DOI 10.1074/jbc.274.28.19814; Pu MY, 1996, ONCOGENE, V13, P2615; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Veikkola T, 2000, CANCER RES, V60, P203; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488	40	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28454	10.1371/journal.pone.0028454	http://dx.doi.org/10.1371/journal.pone.0028454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145046	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900029
J	Mahajan, M; Ahuja, PS; Yadav, SK				Mahajan, Monika; Ahuja, Paramvir Singh; Yadav, Sudesh Kumar			Post-Transcriptional Silencing of Flavonol Synthase mRNA in Tobacco Leads to Fruits with Arrested Seed Set	PLOS ONE			English	Article							ROOT-NODULE FORMATION; CHALCONE SYNTHASE; AUXIN TRANSPORT; MALE-FERTILITY; TUBE GROWTH; BIOSYNTHESIS; ARABIDOPSIS; ANTHOCYANIN; GERMINATION; GENES	Flavonoids are synthesized by phenylpropanoid pathway. They are known to participate in large number of physiological and biochemical processes in plants. Parthenocarpy and male sterility has earlier been reported by silencing chalcone synthase (CHS) encoding gene. Silencing of CHS has blocked the synthesis of most of useful flavonoids including flavan-3-ols and flavonols. Also, these studies could not identify whether parthenocarpy/male sterility were due to lack of flavan-3-ols or flavonols or both. Flavonol synthase (FLS) is an important enzyme of flavonoid pathway that catalyzes the formation of flavonols. In this article, we propose a novel strategy towards the generation of seedless or less-seeded fruits by downregulation of flavonol biosynthesis in tobacco (Nicotiana tabacum cv Xanthi) through post-transcriptional gene silencing (PTGS) of FLS encoding mRNA. The FLS silenced lines were observed for 20-80% reduction in FLS encoding gene expression and 25-93% reduction in flavonol (quercetin) content. Interestingly, these FLS silenced tobacco lines also showed reduction in their anthocyanidins content. While the content of flavan-3-ols (catechin, epi-catechin and epigallocatechin) was found to be increased in FLS silenced lines. The delayed flowering in FLS silenced lines could be due to decrease in level of indole acetic acid (IAA) at apical region of their shoots. Furthermore, the pollen germination was hampered and pollens were unable to produce functional pollen tube in FLS silenced tobacco lines. Pods of FLS silenced lines contained significantly less number of seeds. The in vitro and in vivo studies where 1 mu M quercetin was supplied to germination media, documented the restoration of normal pollen germination and pollen tube growth. This finding identified the role of flavonols particularly quercetin in pollen germination as well as in the regulation of plant fertility. Results also suggest a novel approach towards generation of seedless/less-seeded fruits via PTGS of FLS encoding gene in plants.	[Mahajan, Monika; Ahuja, Paramvir Singh; Yadav, Sudesh Kumar] CSIR, Inst Himalayan Bioresource Technol, Council Sci & Ind Res, Plant Metab Engn Lab,Biotechnol Div, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Mahajan, M (corresponding author), CSIR, Inst Himalayan Bioresource Technol, Council Sci & Ind Res, Plant Metab Engn Lab,Biotechnol Div, Palampur, Himachal Prades, India.	sudeshkumar@ihbt.res.in		Mahajan, Monika/0000-0003-1061-579X	Council of Scientific and Industrial Research under NMITLI [TLP-0003]; Council of Scientific and Industrial Research	Council of Scientific and Industrial Research under NMITLI; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from Council of Scientific and Industrial Research under NMITLI (TLP-0003) research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are thankful to Mr. Robin Joshi and Mr. Digvijay Singh for their help in HPLC analysis and sequencing respectively. MM is thankful to Council of Scientific and Industrial Research for providing research fellowship as SRF.	Boase MR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-107; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Burbulis IE, 1996, PLANT CELL, V8, P1013, DOI 10.1105/tpc.8.6.1013; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Davies KM, 2003, EUPHYTICA, V131, P259, DOI 10.1023/A:1024018729349; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Fan LM, 2001, J EXP BOT, V52, P1603, DOI 10.1093/jexbot/52.361.1603; Feng XL, 2006, PLANT MOL BIOL, V61, P215, DOI 10.1007/s11103-006-0005-z; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Grebe M, 2004, BIOESSAYS, V26, P719, DOI 10.1002/bies.20065; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; KUBASEK WL, 1992, PLANT CELL, V4, P1229, DOI 10.1105/tpc.4.10.1229; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Lu QM, 2008, RAPID COMMUN MASS SP, V22, P2565, DOI 10.1002/rcm.3642; Mathesius U, 1998, PLANT J, V14, P23, DOI 10.1046/j.1365-313X.1998.00090.x; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakatsuka T, 2007, PLANT CELL REP, V26, P1951, DOI 10.1007/s00299-007-0401-0; Napoli CA, 1999, PLANT PHYSIOL, V120, P615, DOI 10.1104/pp.120.2.615; Nielsen K, 2002, MOL BREEDING, V9, P217, DOI 10.1023/A:1020320809654; POLLAK PE, 1993, PLANT PHYSIOL, V102, P925, DOI 10.1104/pp.102.3.925; RABINO I, 1986, PLANT PHYSIOL, V81, P922, DOI 10.1104/pp.81.3.922; Rubery P. H., 1990, Plant growth substances 1988., P428; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sharma V, 2005, J FOOD COMPOS ANAL, V18, P583, DOI 10.1016/j.jfca.2004.02.015; Singh K, 2004, ANAL BIOCHEM, V335, P330, DOI 10.1016/j.ab.2004.08.030; Subramanian S, 2005, PLANT PHYSIOL, V137, P1345, DOI 10.1104/pp.104.057257; TAYLOR LP, 1992, J HERED, V83, P11, DOI 10.1093/oxfordjournals.jhered.a111149; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; VANDERMEER IM, 1992, PLANT CELL, V4, P253, DOI 10.1105/tpc.4.3.253; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Wiermann R, 1979, REGULATION SECONDARY, P231; Wu JZ, 2008, J EXP BOT, V59, P2529, DOI 10.1093/jxb/ern119; Xu P, 1997, PLANTA, V202, P257, DOI 10.1007/s004250050127; YLSTRA B, 1992, PLANT PHYSIOL, V100, P902, DOI 10.1104/pp.100.2.902; Ylstra B, 1996, PLANT MOL BIOL, V32, P1155, DOI 10.1007/BF00041399	39	46	57	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28315	10.1371/journal.pone.0028315	http://dx.doi.org/10.1371/journal.pone.0028315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145036	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900019
J	Sharma, SS; Ma, L; Bagui, TK; Forinash, KD; Pledger, WJ				Sharma, S. S.; Ma, L.; Bagui, T. K.; Forinash, K. D.; Pledger, W. J.			A p27(Kip1) mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation	ONCOGENE			English	Article						p27(Kip1); cyclin F; micronuclei; centrosome amplification	CYCLIN-DEPENDENT-KINASE; CELL-CYCLE; MITOTIC CATASTROPHE; LACKING P27(KIP1); MICE LACKING; P27; DEGRADATION; PHOSPHORYLATION; TRANSCRIPTION; DUPLICATION	Mitotic catastrophe occurs when cells enter mitosis with damaged DNA or excess centrosomes. Cells overexpressing the centrosome protein CP110 or depleted of cyclin F, which targets CP110 for destruction, have more than two centrosomes and undergo mitotic catastrophe. Our studies show centrosome reduplication and mitotic catastrophe in osteosarcoma cells inducibly expressing a p27(Kip1) mutant (termed p27K) that binds cyclins but not cyclin-dependent kinases (CDKs). p27K inhibited cell proliferation but not CDK activity or cell cycle progression. It did not induce apoptosis; however, cells expressing p27K had more than two centrosomes and, indicative of mitotic catastrophe, irregularly shaped nuclei or multiple micronuclei. p27K interacted with cyclin F in vivo (as did endogenous p27(Kip1)) and displaced cyclin F from CP110. Depletion of CP110 rescued p27K-expressing cells from centrosome reduplication and mitotic catastrophe. Collectively, our data show that p27(Kip1) can perturb mitosis and suggest that it does so by sequestering cyclin F, which prevents its interaction with and the subsequent degradation of CP110, ultimately resulting in centrosome reduplication, mitotic catastrophe and abrogation of cell proliferation. Oncogene (2012) 31, 3989 3998; doi: 10.1038/onc.2011.550; published online 12 December 2011	[Pledger, W. J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Gonzmart Res Lab,Sarcoma Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Pledger, WJ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	jack.pledger@moffitt.org			Team Science Grant [09KT-03-23121]; Cortner Couch Chair; Amandalee Weiss Foundation; V Foundation; Bankhead-Coley Post-doctoral Grant [IBD08-34209]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Team Science Grant; Cortner Couch Chair; Amandalee Weiss Foundation; V Foundation; Bankhead-Coley Post-doctoral Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sources of Support: Team Science Grant no. 09KT-03-23121, the Cortner Couch Chair, the Amandalee Weiss Foundation and the V Foundation (WJP), and Bankhead-Coley Post-doctoral Grant no. IBD08-34209 (SSS).	Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Bagui TK, 2009, CELL CYCLE, V8, P115, DOI 10.4161/cc.8.1.7527; Bagui TK, 2000, MOL CELL BIOL, V20, P8748, DOI 10.1128/MCB.20.23.8748-8757.2000; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Caruso R, 2011, ULTRASTRUCT PATHOL, V35, P66, DOI 10.3109/01913123.2010.543753; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dodson H, 2007, CELL CYCLE, V6, P364, DOI 10.4161/cc.6.3.3834; Duensing A, 2006, ONCOGENE, V25, P2943, DOI 10.1038/sj.onc.1209310; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Khattar E, 2010, J BIOL CHEM, V285, P4554, DOI 10.1074/jbc.M109.029280; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Korzeniewski N, 2010, MOL BIOL CELL, V21, P3942, DOI 10.1091/mbc.E09-12-1049; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nallamshetty S, 2005, FEBS LETT, V579, P6529, DOI 10.1016/j.febslet.2005.10.028; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Singhal S, 2003, CANCER BIOL THER, V2, P291, DOI 10.4161/cbt.2.3.399; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	58	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	35					3989	3998		10.1038/onc.2011.550	http://dx.doi.org/10.1038/onc.2011.550			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	999VJ	22158041	Green Published, hybrid			2022-12-25	WOS:000308342800007
J	Gentil, BJ; Minotti, S; Beange, M; Baloh, RH; Julien, JP; Durham, HD				Gentil, Benoit J.; Minotti, Sandra; Beange, Madeleine; Baloh, Robert H.; Julien, Jean-Pierre; Durham, Heather D.			Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease	FASEB JOURNAL			English	Article						NFL; axonal trafficking; neuropathy; fusion	CU/ZN-SUPEROXIDE-DISMUTASE; DOMINANT OPTIC ATROPHY; AXONAL-TRANSPORT; INTERMEDIATE-FILAMENTS; HIPPOCAMPAL-NEURONS; MITOFUSIN 2; MUTATIONS; COMPLEMENTATION; NETWORK; MODEL	Intermediate filaments serve important structural roles, but other cellular functions are increasingly recognized. This study demonstrated normal function of the low-molecular-weight neurofilament protein (NFL) in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease (CMT) due to mutations in the Nefl gene. In motor neurons of spinal cord cultured from Nefl-knockout mice, mitochondrial length and the rate of fusion were decreased concomitant with increased motility. These parameters were normalized after expression of NFLwt on the Nefl(-/-) background, but not by overexpression of the profusion protein, mitofusin 2 (MFN2). The effects of CMT-causing NFL mutants bore similarities to and differences from Nefl knockout. In the early phase of toxicity before disruption of the neurofilament network, NFLQ333P and NFLP8R integrated into neurofilaments and had effects on mitochondria similar to those with Nefl knockout. The reduction of fusion rate by NFLQ333P was partly due to interference with the function of the profusion protein MFN2, which is mutated in CMT2A, functionally linking these forms of CMT. In the later phase of toxicity, mitochondria essentially stopped moving in neurons expressing NFL mutants, probably a consequence of cytoskeletal disruption. Overall, the data point to important functions of neurofilaments in mitochondrial dynamics as well as primary involvement in CMT2E/1F.-Gentil, B. J. Minotti, S., Beange, M., Baloh, R. H., Julien, J.-P., Durham, H. D. Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease. FASEB J. 26, 1194-1203 (2012). www.fasebj.org	[Gentil, Benoit J.; Minotti, Sandra; Beange, Madeleine; Durham, Heather D.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Gentil, Benoit J.; Minotti, Sandra; Beange, Madeleine; Durham, Heather D.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Baloh, Robert H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Baloh, Robert H.] Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO USA; [Julien, Jean-Pierre] Univ Laval, Ctr Rech, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada	McGill University; McGill University; Washington University (WUSTL); Washington University (WUSTL); Laval University	Gentil, BJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St,Room 649, Montreal, PQ H3A 2B4, Canada.	benoit.gentil@mcgill.ca; heather.durham@mcgill.ca	GENTIL, Benoit/B-9459-2012	GENTIL, Benoit/0000-0003-2022-1890	Canadian Institutes of Health Research [86725]; Muscular Dystrophy Association USA [MDA93897]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association USA(Muscular Dystrophy Association)	The authors thank Dr. Celine Amiez for assistance with statistical analyses, Dr. Claire Brown (McGill University Imaging Center) for valuable comments on confocal imaging, Dr. Heidi McBride (McGill University) for pcDNA-pOCT-EGFP, and Dr. R. Youle (U.S. National Institutes of Health, Bethesda, MD, USA) for pcDNA3-PA-OCT-EGFP. This work was supported by the Canadian Institutes of Health Research (grant 86725 to H. D. D.) and the Muscular Dystrophy Association USA (grant MDA93897 to H. D. D.). The authors declare no conflicts of interest.	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Bearer EL, 1999, J NEUROCYTOL, V28, P85, DOI 10.1023/A:1007025421849; Brownlees J, 2002, HUM MOL GENET, V11, P2837, DOI 10.1093/hmg/11.23.2837; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Carter J, 1998, J BIOL CHEM, V273, P5101, DOI 10.1074/jbc.273.9.5101; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kumemura H, 2008, BIOCHEM BIOPH RES CO, V367, P33, DOI 10.1016/j.bbrc.2007.12.116; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; Mironov SL, 2006, SYNAPSE, V59, P403, DOI 10.1002/syn.20256; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Pathak D., J NEUROSCI, V30, P8984; Perez-Olle R, 2002, J CELL SCI, V115, P4937, DOI 10.1242/jcs.00148; Perez-Olle R, 2004, HUM MOL GENET, V13, P2207, DOI 10.1093/hmg/ddh236; Perrot R, 2009, FASEB J, V23, P3213, DOI 10.1096/fj.09-129585; Rao MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017087; Rintoul GL, 2010, BBA-MOL BASIS DIS, V1802, P143, DOI 10.1016/j.bbadis.2009.09.005; Roy J, 1998, J NEUROSCI, V18, P9673; Shen HL, 2011, HUM MOL GENET, V20, P2535, DOI 10.1093/hmg/ddr152; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; Wagner OI, 2003, J NEUROSCI, V23, P9046; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	44	44	45	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1194	1203		10.1096/fj.11-196345	http://dx.doi.org/10.1096/fj.11-196345			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22155564				2022-12-25	WOS:000300949300022
J	Singh, KK; Shukla, PC; Quan, A; Desjardins, JF; Lovren, F; Pan, Y; Garg, V; Gosal, S; Garg, A; Szmitko, PE; Schneider, MD; Parker, TG; Stanford, WL; Leong-Poi, H; Teoh, H; Al-Omran, M; Verma, S				Singh, Krishna K.; Shukla, Praphulla C.; Quan, Adrian; Desjardins, Jean-Francois; Lovren, Fina; Pan, Yi; Garg, Vinay; Gosal, Sumandeep; Garg, Ankit; Szmitko, Paul E.; Schneider, Michael D.; Parker, Thomas G.; Stanford, William L.; Leong-Poi, Howard; Teoh, Hwee; Al-Omran, Mohammed; Verma, Subodh			BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER SUSCEPTIBILITY; DOUBLE-STRAND BREAKS; DNA-DAMAGE; MYOCARDIAL-INFARCTION; TRANSGENIC MICE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; CRE-RECOMBINASE; IN-VIVO; CARDIOTOXICITY	The tumor suppressor breast cancer susceptibility gene 2 (BRCA2) plays an important role in the repair of DNA damage, and loss of BRCA2 predisposes carriers to breast and ovarian cancers. Doxorubicin (DOX) remains the cornerstone of chemotherapy in such individuals. However, it is often associated with cardiac failure, which once manifests carries a poor prognosis. Because BRCA2 regulates genome-wide stability and facilitates DNA damage repair, we hypothesized that loss of BRCA2 may increase susceptibility to DOX-induced cardiac failure. To this aim, we generated cardiomyocyte-specific BRCA2 knock-out (CM-BRCA2(-/-)) mice using the Cre-loxP technology and evaluated their basal and post-DOX treatment phenotypes. Although CM-BRCA2(-/-) mice exhibited no basal cardiac phenotype, DOX treatment resulted in markedly greater cardiac dysfunction and mortality in CM-BRCA2(-/-) mice compared with control mice. Apoptosis in left ventricular (LV) sections from CM-BRCA2(-/-) mice compared with that in corresponding sections from wild-type (WT) littermate controls was also significantly enhanced after DOX treatment. Microscopic examination of LV sections from DOX-treated CM-BRCA2(-/-) mice revealed a greater number of DNA double-stranded breaks and the absence of RAD51 focus formation, an essential marker of double-stranded break repair. The levels of p53 and the p53-related proapoptotic proteins p53-up-regulated modulator of apoptosis (PUMA) and Bax were significantly increased in samples from CM-BRCA2(-/-) mice. This corresponded with increased Bax to Bcl-2 ratios and elevated cytochrome c release in the LV sections of DOX-treated CM-BRCA2(-/-) mice. Taken together, these data suggest a critical and previously unrecognized role of BRCA2 as a gatekeeper of DOX-induced cardiomyocyte apoptosis and susceptibility to overt cardiac failure. Pharmacogenomic studies evaluating cardiac function in BRCA2 mutation carriers treated with doxorubicin are encouraged.	[Singh, Krishna K.; Shukla, Praphulla C.; Quan, Adrian; Lovren, Fina; Pan, Yi; Gosal, Sumandeep; Teoh, Hwee; Verma, Subodh] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada; [Desjardins, Jean-Francois; Parker, Thomas G.; Leong-Poi, Howard] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Singh, Krishna K.; Shukla, Praphulla C.; Quan, Adrian; Desjardins, Jean-Francois; Lovren, Fina; Pan, Yi; Gosal, Sumandeep; Parker, Thomas G.; Leong-Poi, Howard; Teoh, Hwee; Al-Omran, Mohammed; Verma, Subodh] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Szmitko, Paul E.; Parker, Thomas G.; Leong-Poi, Howard] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Verma, Subodh] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Garg, Vinay; Garg, Ankit] Queens Univ, Kingston, ON K7L 3N6, Canada; [Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, British Heart Fdn Ctr Res Excellence, London SW7 2AZ, England; [Stanford, William L.] Univ Ottawa, Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Stanford, William L.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L6, Canada; [Al-Omran, Mohammed] King Saud Univ, Coll Med, Div Vasc Surg, Riyadh 11472, Saudi Arabia; [Al-Omran, Mohammed] King Saud Univ, Peripheral Vasc Dis Res Chair, Riyadh 11472, Saudi Arabia	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Queens University - Canada; Imperial College London; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; King Saud University; King Saud University	Verma, S (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiac Surg, Suite 8-003,Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	subodh.verma@sympatico.ca	Shukla, Praphulla Chandra/GSO-1633-2022; Pan, Yi/AAJ-2341-2021; Teoh, Hwee/F-2498-2018	Shukla, Praphulla Chandra/0000-0001-9031-1547; Teoh, Hwee/0000-0003-1036-4767; Quan, Adrian/0000-0001-8008-028X; Stanford, William/0000-0002-5813-8016; Schneider, Michael/0000-0001-9645-1938	Canadian Institutes for Health Research [93704, PPP99487]; Heart and Stroke Foundation of Canada/Pfizer; AstraZeneca; Physicians' Services Inc. Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada/Pfizer; AstraZeneca(AstraZeneca); Physicians' Services Inc. Foundation	This work was supported in part by Canadian Institutes for Health Research Grants 93704 and PPP99487 (to S.V.).; Recipient of a Heart and Stroke Foundation of Canada/Pfizer research fellowship.; Recipient of an AstraZeneca research fellowship.; Recipient of a Physicians' Services Inc. Foundation resident research grant.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Arola OJ, 2000, CANCER RES, V60, P1789; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bordeleau L, 2011, CANCER-AM CANCER SOC, V117, P1812, DOI 10.1002/cncr.25595; Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; Di Padova M, 2003, J BIOL CHEM, V278, P36496, DOI 10.1074/jbc.M306694200; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Hakem R, 1998, J MAMMARY GLAND BIOL, V3, P431, DOI 10.1023/A:1018792200700; Henderson I C, 1979, N Engl J Med, V300, P1393; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Kennedy RD, 2004, JNCI-J NATL CANCER I, V96, P1659, DOI 10.1093/jnci/djh312; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kondo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019659; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Lu HM, 2005, MOL CELL BIOL, V25, P1949, DOI 10.1128/MCB.25.5.1949-1957.2005; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mai PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004812; McAllister KA, 1997, CANCER RES, V57, P3121; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Misao J, 1996, CIRCULATION, V94, P1506, DOI 10.1161/01.CIR.94.7.1506; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teoh H, 2013, GENE THER, V20, P51, DOI 10.1038/gt.2011.214; Tsutsui H, 2001, CIRCULATION, V104, P2883, DOI 10.1161/hc4901.101347; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Yuan SSF, 1999, CANCER RES, V59, P3547	52	31	33	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6604	6614		10.1074/jbc.M111.292664	http://dx.doi.org/10.1074/jbc.M111.292664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22157755	Green Published, hybrid			2022-12-25	WOS:000300791800048
J	Yue, CY; Soboloff, J; Gamero, AM				Yue, Chanyu; Soboloff, Jonathan; Gamero, Ana M.			Control of Type I Interferon-induced Cell Death by Orai1-mediated Calcium Entry in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CRAC CHANNEL; LYMPHOCYTE-ACTIVATION; PLASMA-MEMBRANE; CA2+ SENSOR; APOPTOSIS; RECEPTOR; STORE; INHIBITION; SIGNALS	Store-operated Ca2+ entry (SOCE) is an essential process in T cell activation. SOCE is controlled by the Ca2+ release-activated Ca2+ (CRAC) channel encoded by the gene Orai1 that is expressed on the plasma membrane and activated by STIM1 when ER Ca2+ stores are depleted. Our earlier work showed that a somatic T-cell line Jurkat mutant H123 bearing a defect in Ca2+ signaling was susceptible to the apoptotic effects of type I interferons (IFN-alpha/beta). The nature of the mutation and whether this mutation was linked to IFN-alpha/beta apoptotic susceptibility was unknown. Here we show that H123 cells lacked Orai1 and exhibit reduced STIM1 protein. Reconstitution of both Orai1 and STIM1 in H123 cells rescued SOCE in response to thapsigargin and ionomycin and abrogated IFN-alpha/beta-induced apoptosis. Reciprocally, overexpression of the dominant negative Orai1-E106A in either parental Jurkat cells or an unrelated human T cell line (CEM391) inhibited SOCE and led to sensitization to IFN-alpha/beta-induced apoptosis. Furthermore, we showed that the Ca2+ response pathway antagonized the IFN-alpha/beta-induced transcriptional responses; in the absence of SOCE, this negative regulatory effect was lost. However, the inhibitory effect of Ca2+ on type IIFN-induced gene transcription was diminished by pharmacological inhibition of NF-kappa B in cells with intact SOCE. Our findings reveal an unexpected and novel regulatory crosstalk mechanism between type I IFNs and storeoperated Ca2+ signaling pathways mediated at least in part by NF-kappa B activity with significant clinical implications to both viral and tumor immunology.	[Yue, Chanyu; Soboloff, Jonathan; Gamero, Ana M.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Soboloff, J (corresponding author), 3400 N Broad St,Kresge Hall, Philadelphia, PA 19140 USA.	soboloff@temple.edu; gameroa@temple.edu	Yue, Chanyu/H-1792-2015; Soboloff, Jonathan/I-6995-2012	Soboloff, Jonathan/0000-0001-5192-1297	NCI, National Institutes of Health [R01CA140499, K22CA095326]; American Heart Association; Pennsylvania Dept. of Health; NATIONAL CANCER INSTITUTE [R01CA140499, K22CA095326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097335] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); Pennsylvania Dept. of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants R01CA140499 and K22CA095326 (to A. M. G.) from the NCI, National Institutes of Health, the American Heart Association (to J. S.), and the Pennsylvania Dept. of Health (to J. S. and A. M. G.).	Abraham RT, 2000, IMMUNOL RES, V22, P95, DOI 10.1385/IR:22:2-3:95; Belka C, 2003, ONCOGENE, V22, P176, DOI 10.1038/sj.onc.1206103; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Chang JW, 2006, NEPHRON EXP NEPHROL, V103, pE156, DOI 10.1159/000092906; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Dellis O, 2002, J BIOL CHEM, V277, P6044, DOI 10.1074/jbc.M111831200; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Dondi E, 2003, J IMMUNOL, V170, P749, DOI 10.4049/jimmunol.170.2.749; Erickson S, 1999, CELL GROWTH DIFFER, V10, P575; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gamero AM, 2006, CELL SIGNAL, V18, P1299, DOI 10.1016/j.cellsig.2005.10.008; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li SY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P101, DOI 10.1134/S000629791001013X; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rodriguez B, 2006, AIDS, V20, P1379, DOI 10.1097/01.aids.0000233571.51899.ab; Roifman CM, 2010, J ALLERGY CLIN IMMUN, V126, P1226, DOI 10.1016/j.jaci.2010.07.029; Soboloff J, 2002, J BIOL CHEM, V277, P13812, DOI 10.1074/jbc.M112129200; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yang CH, 2001, J BIOL CHEM, V276, P13756, DOI 10.1074/jbc.M011006200; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	46	18	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3207	3216		10.1074/jbc.M111.269068	http://dx.doi.org/10.1074/jbc.M111.269068			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22144678	Green Published, hybrid			2022-12-25	WOS:000300295100026
J	Fukushiro, M; Takeuchi, T; Takeuchi, Y; Hur, SP; Sugama, N; Takemura, A; Kubo, Y; Okano, K; Okano, T				Fukushiro, Masato; Takeuchi, Takahiro; Takeuchi, Yuki; Hur, Sung-Pyo; Sugama, Nozomi; Takemura, Akihiro; Kubo, Yoko; Okano, Keiko; Okano, Toshiyuki			Lunar Phase-Dependent Expression of Cryptochrome and a Photoperiodic Mechanism for Lunar Phase-Recognition in a Reef Fish, Goldlined Spinefoot	PLOS ONE			English	Article							MOLECULAR EVOLUTION; LIGHT; PHOTORECEPTOR; GENE; SYNCHRONIZATION; RABBITFISH; MATURATION; RHODOPSIN; GUTTATUS; CLOCK	Lunar cycle-associated physiology has been found in a wide variety of organisms. Recent study has revealed that mRNA levels of Cryptochrome (Cry), one of the circadian clock genes, were significantly higher on a full moon night than on a new moon night in coral, implying the involvement of a photoreception system in the lunar-synchronized spawning. To better establish the generalities surrounding such a mechanism and explore the underlying molecular mechanism, we focused on the relationship between lunar phase, Cry gene expression, and the spawning behavior in a lunar-synchronized spawner, the goldlined spinefoot (Siganus guttatus), and we identified two kinds of Cry genes in this animal. Their mRNA levels showed lunar cycle-dependent expression in the medial part of the brain (mesencephalon and diencephalon) peaking at the first quarter moon. Since this lunar phase coincided with the reproductive phase of the goldlined spinefoot, Cry gene expression was considered a state variable in the lunar phase recognition system. Based on the expression profiles of SgCrys together with the moonlight's pattern of timing and duration during its nightly lunar cycle, we have further speculated on a model of lunar phase recognition for reproductive control in the goldlined spinefoot, which integrates both moonlight and circadian signals in a manner similar to photoperiodic response.	[Fukushiro, Masato; Takeuchi, Takahiro; Kubo, Yoko; Okano, Keiko; Okano, Toshiyuki] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan; [Takeuchi, Yuki; Hur, Sung-Pyo; Sugama, Nozomi; Takemura, Akihiro] Univ Ryukyus, Dept Chem Biol & Marine Sci, Fac Sci, Nishihara, Okinawa 90301, Japan; [Okano, Toshiyuki] Japan Sci & Technol Agcy, Tokyo, Japan	Waseda University; University of the Ryukyus; Japan Science & Technology Agency (JST)	Fukushiro, M (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan.	okano@waseda.jp	Takeuchi, Yuki/B-2643-2018; TAKEUCHI, Tsutomu/I-7071-2014	Takeuchi, Yuki/0000-0002-8480-5206; TAKEUCHI, Tsutomu/0000-0001-8416-7673; Takemura, Akihiro/0000-0002-5024-4930; Okano, Toshiyuki/0000-0001-6740-6265	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for the Promotion of Science (JSPS) of Japan; Grants-in-Aid for Scientific Research [22657042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japanese Society for the Promotion of Science (JSPS) of Japan awarded to A.T. and T.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AMANO M, 1995, GEN COMP ENDOCR, V99, P22, DOI 10.1006/gcen.1995.1080; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Choi S, 2010, ZOOL SCI, V27, P24, DOI 10.2108/zsj.27.24; COLIN PL, 1987, B MAR SCI, V40, P220; Domeier ML, 1997, B MAR SCI, V60, P698; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Foley LE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1364; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Harahap AP, 2001, FISHERIES SCI, V67, P888, DOI 10.1046/j.1444-2906.2001.00337.x; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hoque MM, 1999, J FISH BIOL, V55, P1213, DOI 10.1111/j.1095-8649.1999.tb02071.x; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Kaiser TS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-49; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Kubo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009273; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Meseguer C, 2008, CHRONOBIOL INT, V25, P666, DOI 10.1080/07420520802380018; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; NEUMANN D, 1976, BIOL RHYTHMS MARINE, P115; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; Ozturk N, 2009, BIOCHEMISTRY-US, V48, P8585, DOI 10.1021/bi901043s; Rahman MS, 2003, J FISH BIOL, V62, P495, DOI 10.1046/j.1095-8649.2003.00036.x; Rahman MS, 2000, COMP BIOCHEM PHYS B, V127, P113, DOI 10.1016/S0305-0491(00)00240-6; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Sugama N, 2008, J PINEAL RES, V45, P133, DOI 10.1111/j.1600-079X.2008.00566.x; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Takemura A, 2004, J EXP ZOOL PART A, V301A, P844, DOI 10.1002/jez.a.105; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Vize PD, 2005, GULF MEXICO SCI, V23, P107, DOI DOI 10.18785/G0MS.2301.08; Wada Y, 1998, FEBS LETT, V424, P53, DOI 10.1016/S0014-5793(98)00138-0; Yasuo S, 2004, ENDOCRINOLOGY, V145, P1612, DOI 10.1210/en.2003-1285; Yoshimura T, 2006, COMP BIOCHEM PHYS A, V144, P345, DOI 10.1016/j.cbpa.2005.09.009	44	29	29	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28643	10.1371/journal.pone.0028643	http://dx.doi.org/10.1371/journal.pone.0028643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163321	Green Published, gold, Green Submitted			2022-12-25	WOS:000298161900057
J	Lim, TP; Lee, W; Tan, TY; Sasikala, S; Teo, J; Hsu, LY; Tan, TT; Syahidah, N; Kwa, AL				Lim, Tze-Peng; Lee, Winnie; Tan, Thean-Yen; Sasikala, Suranthran; Teo, Jocelyn; Hsu, Li-Yang; Tan, Thuan-Tong; Syahidah, Nur; Kwa, Andrea L.			Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; EXTENDED-SPECTRUM VARIANT; METALLO-BETA-LACTAMASES; INFECTIONS; MECHANISMS; PNEUMONIA; PHARMACOKINETICS; HOSPITALS; SINGAPORE; COLISTIN	Objective: Extreme drug-resistant Pseudomonas aeruginosa (XDR-PA) with decreased susceptibility to polymyxin B (PB) has emerged in Singapore, causing infections in immunocompromised hosts. Combination therapy may be the only viable therapeutic option until new antibiotics become available. The objective of this study is to assess the in vitro activity of various antibiotics against local XDR-PA isolates. Methods: PA isolates from all public hospitals in Singapore were systematically collected between 2006 and 2007. MICs were determined according to CLSI guidelines. All XDR-PA isolates identified were genotyped using a PCR-based method. Time-kill studies (TKS) were performed with approximately 10(5) CFU/ml at baseline using clinically achievable unbound concentrations of amikacin (A), levofloxacin (L), meropenem (M), rifampicin (R) and PB alone and in combination. Bactericidal activity (primary endpoint) was defined as a >= 3 log(10) CFU/ml decrease in the colony count from the initial inoculum at 24 hours. Results: 22 clinical XDR-PA isolates with PB MIC 2-16 mu g/ml were collected. From clonal typing, 5 clonal groups were identified and nine isolates exhibited clonal diversity. In TKS, meropenem plus PB, amikacin plus meropenem, amikacin plus rifampicin, amikacin plus PB exhibited bactericidal activity in 8/22, 3/22, 1/22 and 6/22 isolates at 24 hours respectively. Against the remaining ten isolates where none of the dual-drug combination achieved bactericidal activity against, only the triple-antibiotic combinations of ARP and AMP achieved bactericidal activity against 7/10 and 6/10 isolates respectively. Conclusion: Bactericidal activity with sustained killing effect of >= 99.9% is critical for eradicating XDR-PA infections, especially in immunocompromised hosts. These findings underscore the difficulty of developing combination therapeutic options against XDR-PA, demonstrating that at least 3 antibiotics are required in combination and that efficacy is strain dependant.	[Lim, Tze-Peng; Lee, Winnie; Sasikala, Suranthran; Teo, Jocelyn; Syahidah, Nur; Kwa, Andrea L.] Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore; [Tan, Thean-Yen] Changi Gen Hosp, Dept Lab Med, Singapore, Singapore; [Tan, Thuan-Tong] Singapore Gen Hosp, Dept Infect Dis, Singapore 0316, Singapore; [Lim, Tze-Peng; Hsu, Li-Yang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Div Infect Dis, Singapore 117595, Singapore	Singapore General Hospital; Changi General Hospital; Singapore General Hospital; National University of Singapore	Lim, TP (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore.	andrea.kwa.l.h@sgh.com.sg		Teo, Jocelyn Qi-Min/0000-0003-2508-3941; Tan, Thean Yen/0000-0003-4358-1098; Hsu, Li Yang/0000-0002-0396-066X	SingHealth Foundation (Singapore); Janssen-Cilag; Pfizer.Inc; Merck Sharp & Dohme (I.A.) Corp	SingHealth Foundation (Singapore); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer.Inc(Pfizer); Merck Sharp & Dohme (I.A.) Corp(Merck & Company)	This study was supported in part by research grants from the SingHealth Foundation (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; T-YT and L-YH have received funding for research from, and have been an invited as speakers for Wyeth Pharmaceuticals and Pfizer. ALK, WL and T-PL have received funding for research from Janssen-Cilag, Pfizer.Inc & Merck Sharp & Dohme (I.A.) Corp. None of these companies provided any funding for this particular study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bergen PJ, 2011, ANTIMICROB AGENTS CH, V55, P5134, DOI 10.1128/AAC.05028-11; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE, V29; DANEL F, 1995, ANTIMICROB AGENTS CH, V39, P1881, DOI 10.1128/AAC.39.8.1881; Dawson SL, 2002, J MICROBIOL METH, V50, P9, DOI 10.1016/S0167-7012(02)00003-9; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Furtado GHC, 2007, INT J ANTIMICROB AG, V30, P315, DOI 10.1016/j.ijantimicag.2007.05.017; Giamarellou H, 2010, INT J ANTIMICROB AG, V36, pS50, DOI 10.1016/j.ijantimicag.2010.11.014; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Hsu LY, 2010, ANTIMICROB AGENTS CH, V54, P1173, DOI 10.1128/AAC.01076-09; Jaruratanasirikul S, 2005, ANTIMICROB AGENTS CH, V49, P1337, DOI 10.1128/AAC.49.4.1337-1339.2005; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; Koh TH, 2004, J CLIN MICROBIOL, V42, P5378, DOI 10.1128/JCM.42.11.5378-5380.2004; KUNIN CM, 1973, ANN NY ACAD SCI, V226, P214, DOI 10.1111/j.1749-6632.1973.tb20483.x; Kwa A, 2007, EXPERT REV ANTI-INFE, V5, P811, DOI 10.1586/14787210.5.5.811; Kwa AL, 2008, ANN ACAD MED SINGAP, V37, P870; Kwa ALH, 2008, DIAGN MICR INFEC DIS, V60, P163, DOI 10.1016/j.diagmicrobio.2007.08.008; LETENDRE ED, 1988, J ANTIMICROB CHEMOTH, V22, P557, DOI 10.1093/jac/22.4.557; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2007, INT J ANTIMICROB AG, V29, pS1, DOI 10.1016/S0924-8579(07)00158-6; Magiorakos AP, 2011, CLIN MICROBIOL INFEC; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024; Navon-Venezia S, 2005, CURR OPIN INFECT DIS, V18, P306, DOI 10.1097/01.qco.0000171920.44809.f0; Ostronoff M, 2006, INT J INFECT DIS, V10, P339, DOI 10.1016/j.ijid.2005.06.003; Ouderkirk JP, 2003, ANTIMICROB AGENTS CH, V47, P2659, DOI 10.1128/AAC.47.8.2659-2662.2003; Pereira GH, 2007, DIAGN MICR INFEC DIS, V58, P235, DOI 10.1016/j.diagmicrobio.2007.01.008; Pitout JDD, 2005, J CLIN MICROBIOL, V43, P3129, DOI 10.1128/JCM.43.7.3129-3135.2005; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P447, DOI 10.1128/AAC.45.2.447-453.2001; Sobieszczyk ME, 2004, J ANTIMICROB CHEMOTH, V54, P566, DOI 10.1093/jac/dkh369; Tan TY, 2008, ANN ACAD MED SINGAP, V37, P819; Tan TT, 2010, 20 EUR C CLIN MICR I; Tod M, 1998, ANTIMICROB AGENTS CH, V42, P849, DOI 10.1128/AAC.42.4.849; Zavascki AP, 2008, CLIN INFECT DIS, V47, P1298, DOI 10.1086/592577	35	44	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28177	10.1371/journal.pone.0028177	http://dx.doi.org/10.1371/journal.pone.0028177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162759	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800018
J	Martin, NA; Patrick, SKM; Estrada, TE; Frisk, HA; Rogan, DT; Dvorak, B; Halpern, MD				Martin, Nina A.; Patrick, Sarah K. Mount; Estrada, Teresa E.; Frisk, Harrison A.; Rogan, Daniel T.; Dvorak, Bohuslav; Halpern, Melissa D.			Active Transport of Bile Acids Decreases Mucin 2 in Neonatal Ileum: Implications for Development of Necrotizing Enterocolitis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; COLON-CANCER CELLS; RAT MODEL; DEOXYCHOLIC-ACID; SMALL-INTESTINE; EPITHELIAL-CELLS; UP-REGULATION; EXPRESSION; SALTS; OVEREXPRESSION	Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency of premature infants, but its etiology remains unclear. We have previously shown that mucin 2 (Muc2) positive goblet cells are significantly decreased in NEC. We have also shown that ileal bile acids (BAs) are significantly increased during the development of this disease. Because BAs can affect mucins, we hypothesized that elevated ileal BAs contribute to decreased Muc2 in experimental NEC. The role of Muc2 in NEC was evaluated in Winnie +/+ mice, a strain that produces aberrant Muc2. Muc2 and trefoil factor 3 (Tff3) were assessed in neonatal rats subjected to the NEC protocol when bile acids were removed, and in ileal explants from newborn and older rats cultured with and without BAs. Further, the role of active transport of BAs was determined using neonatal rats given the apical sodium dependent bile acid transporter (Asbt) inhibitor SC-435 and in neonatal Asbt knockout mice subjected to the NEC protocol. Mice with aberrant Muc2 had significantly greater incidence and severity of NEC. Using both in vivo and ex vivo techniques, we determined that BAs decrease Muc2 positive cells in neonatal but not older ileum. However, Tff3 positive cells are not decreased by BAs. In addition, active transport of BAs is required for BAs to decrease Muc2 in immature ileum. These data show that functional Muc2 plays a critical role in the prevention of NEC and BAs can potentiate the decreased Muc2 in disease development. Further, BAs have a more profound effect on Muc2 in immature versus older ileum, which may explain at least in part why NEC occurs almost exclusively in premature infants.	[Martin, Nina A.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; Univ Arizona, Steele Childrens Res Ctr, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Martin, NA (corresponding author), Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA.	mhalpern@peds.arizona.edu		Rogan, Daniel/0000-0003-0313-2204	Arizona Biomedical Research Committee; Eunice Kennedy Shriver National Institute of Child Health and Human Development [RO1 HD-54485]; Howard Hughes Medical Institute HHMI [52005889]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054485] Funding Source: NIH RePORTER	Arizona Biomedical Research Committee; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Arizona Biomedical Research Committee and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development grant RO1 HD-54485 (to M.D. Halpern) and the Howard Hughes Medical Institute HHMI 52005889 (to the University of Arizona Undergraduate Biology Program, which partially supports N.A. Martin and D.T. Rogan). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bernstein H, 2006, INFLAMM BOWEL DIS, V12, P278, DOI 10.1097/01.MIB.0000209789.14114.63; CAPLAN MS, 1993, PEDIATR PATHOL, V13, P357, DOI 10.3109/15513819309048223; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; COLEMAN R, 1980, Biochemical Society Transactions, V8, P126; COLEMAN R, 1987, BIOCHEM SOC T, V15, P68; CRAVEN PA, 1986, CANCER RES, V46, P5754; CRAVEN PA, 1988, GASTROENTEROLOGY, V95, P676, DOI 10.1016/S0016-5085(88)80014-3; De Plaen IG, 2007, PEDIATR RES, V61, P716, DOI 10.1203/pdr.0b013e3180534219; Dvorak B, 2003, PEDIATR RES, V53, P426, DOI 10.1203/01.PDR.0000050657.56817.E0; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Dvorak B, 1998, FEBS LETT, V435, P119, DOI 10.1016/S0014-5793(98)01050-3; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Halpern MD, 2006, GASTROENTEROLOGY, V130, P359, DOI 10.1053/j.gastro.2005.10.023; Halpern MD, 2003, AM J PHYSIOL-GASTR L, V284, pG695, DOI 10.1152/ajpgi.00353.2002; Halpern MD, 2003, J PEDIATR GASTR NUTR, V36, P126, DOI 10.1097/00005176-200301000-00024; Halpern MD, 2002, PEDIATR RES, V51, P733, DOI 10.1023/01.PDR.0000017480.64723.56; Halpern MD, 2008, SEMIN PERINATOL, V32, P114, DOI 10.1053/j.semperi.2008.01.005; Halpern MD, 2008, AM J PHYSIOL-GASTR L, V294, pG20, DOI 10.1152/ajpgi.00168.2007; Halpern MD, 2010, AM J PHYSIOL-GASTR L, V299, pG623, DOI 10.1152/ajpgi.00242.2010; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hu YC, 2007, ARCH SURG-CHICAGO, V142, P540, DOI 10.1001/archsurg.142.6.540; ISRAEL EJ, 1994, ACTA PAEDIATR, V83, P27, DOI 10.1111/j.1651-2227.1994.tb13238.x; Jackson GDF, 2000, INFECT IMMUN, V68, P4714, DOI 10.1128/IAI.68.8.4714-4719.2000; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kim YD, 2002, MOL PHARMACOL, V62, P1112, DOI 10.1124/mol.62.5.1112; Klinkspoor JH, 1998, BIOCHEM J, V332, P257, DOI 10.1042/bj3320257; Klinkspoor JH, 1999, GLYCOBIOLOGY, V9, P13, DOI 10.1093/glycob/9.1.13; Lee HY, 2010, INT J ONCOL, V36, P941, DOI 10.3892/ijo_00000573; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; McElroy SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG656, DOI 10.1152/ajpgi.00550.2010; Milovic V, 2002, EUR J CLIN INVEST, V32, P29, DOI 10.1046/j.0014-2972.2001.00938.x; Muhlbauer M, 2004, AM J PHYSIOL-GASTR L, V286, pG1000, DOI 10.1152/ajpgi.00338.2003; Neu J, 1996, PEDIATR CLIN N AM, V43, P409, DOI 10.1016/S0031-3955(05)70413-2; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Podolsky Daniel K., 2000, Journal of Gastroenterology, V35, P69; Schanler RJ, 1999, CLIN PERINATOL, V26, P379, DOI 10.1016/S0095-5108(18)30058-7; Shekels LL, 1996, INT J BIOCHEM CELL B, V28, P193, DOI 10.1016/1357-2725(95)00125-5; Shneider BL, 1997, PEDIATR RES, V42, P189, DOI 10.1203/00006450-199708000-00010; SHUB MD, 1983, BIOCHEM J, V215, P405, DOI 10.1042/bj2150405; Song SM, 2005, CANCER-AM CANCER SOC, V103, P1606, DOI 10.1002/cncr.21015; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; THOMPSON JF, 1994, GASTROENTEROLOGY, V107, P1278, DOI 10.1016/0016-5085(94)90528-2; Walker WA, 2002, J PEDIATR GASTR NUTR, V34, pS33, DOI 10.1097/00005176-200205001-00009; Wiedmann TS, 2004, LIPIDS, V39, P51, DOI 10.1007/s11745-004-1201-y; Wu JT, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-333; Yajima M, 2007, BIOSCI BIOTECH BIOCH, V71, P2420, DOI 10.1271/bbb.70121; Zhong SP, 2001, AM J PHYSIOL-REG I, V280, pR376, DOI 10.1152/ajpregu.2001.280.2.R376	50	39	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e27191	10.1371/journal.pone.0027191	http://dx.doi.org/10.1371/journal.pone.0027191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162748	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800003
J	Singhal, A; Mathys, V; Kiass, M; Creusy, C; Delaire, B; Aliouat, E; Dartois, V; Kaplan, G; Bifani, P				Singhal, Amit; Mathys, Vanessa; Kiass, Mehdi; Creusy, Colette; Delaire, Baptiste; Aliouat, El Moukhtar; Dartois, Veronique; Kaplan, Gilla; Bifani, Pablo			BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model	PLOS ONE			English	Article							HELPER-CELL-DIFFERENTIATION; CALMETTE-GUERIN VACCINATION; IMMUNE-RESPONSE; MICE; EXPRESSION; STRAINS; CORRELATE; LUNG; METAANALYSIS; ACTIVATION	Our understanding of the correlation of Mycobacterium bovis Bacille Calmette-Guerin (BCG)-mediated immune responses and protection against Mycobacterium tuberculosis (Mtb) infection is still limited. We have recently characterized a Wistar rat model of experimental tuberculosis (TB). In the present study, we evaluated the efficacy of BCG vaccination in this model. Upon Mtb challenge, BCG vaccinated rats controlled growth of the bacilli earlier than unvaccinated rats. Histopathology analysis of infected lungs demonstrated a reduced number of granulomatous lesions and lower parenchymal inflammation in vaccinated animals. Vaccine-mediated protection correlated with the rapid accumulation of antigen specific CD4(+) and CD8(+) T cells in the infected lungs. Immunohistochemistry further revealed higher number of CD8(+) cells in the pulmonary granulomas of vaccinated animals. Evaluation of pulmonary immune responses in vaccinated and Mtb infected rats by real time PCR at day 15 post-challenge showed reduced expression of genes responsible for negative regulation of Th1 immune responses. Thus, early protection observed in BCG vaccinated rats correlated with a similarly timed shift of immunity towards the Th1 type response. Our data support the importance of (i) the Th1-Th2 balance in the control of mycobacterial infection and (ii) the value of the Wistar rats in understanding the biology of TB.	[Singhal, Amit; Bifani, Pablo] Novartis Inst Trop Dis, Singapore, Singapore; [Mathys, Vanessa; Kiass, Mehdi] Sci Inst Publ Hlth, Brussels, Belgium; [Creusy, Colette; Delaire, Baptiste] Univ Catholique Lille, Hop St Vincent, Inst Catholique Lillois, Grp Hosp, Lille, France; [Aliouat, El Moukhtar] Univ Lille Nord France, Dept Parasitol, Fac Biol & Pharmaceut Sci, Lille, France; [Dartois, Veronique; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA; [Singhal, Amit] ASTAR, Singapore Immunol Network, Singapore, Singapore	Novartis; Universite Catholique de Lille; Universite de Lille - ISITE; Universite de Lille; Rutgers State University New Brunswick; Rutgers State University Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Singhal, A (corresponding author), Novartis Inst Trop Dis, Singapore, Singapore.	Amit_Singhal@immunol.a-star.edu.sg; pablo.bifani@novartis.com	Aliouat, El Moukhtar/D-2859-2018	Aliouat, El Moukhtar/0000-0003-2905-7126; Bifani, Pablo/0000-0001-9651-6439; Singhal, Amit/0000-0003-3913-8798	Bill and Melinda Gates Foundation [42758]; Novartis Institute for Tropical Diseases, Singapore	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novartis Institute for Tropical Diseases, Singapore	The work has been supported primarily by the Bill and Melinda Gates Foundation Accelerator Grant (#42758). The rest of the project has been funded internally by the Novartis Institute for Tropical Diseases, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; da Fonseca DM, 2009, INFECT IMMUN, V77, P5311, DOI 10.1128/IAI.00580-09; Ellner JJ, 2000, CLIN INFECT DIS, V30, pS279, DOI 10.1086/313874; Eriksen J, 2010, THORAX, V65, P1067, DOI 10.1136/thx.2010.140186; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Goter-Robinson C, 2006, VACCINE, V24, P3522, DOI 10.1016/j.vaccine.2006.02.005; Grover A, 2009, INFECT IMMUN, V77, P4837, DOI 10.1128/IAI.00704-09; Gupta UD, 2009, INDIAN J MED RES, V129, P11; Hamoudi RA, 2010, LEUKEMIA, V24, P1487, DOI 10.1038/leu.2010.118; Hernandez-Pando R, 2004, EUR J IMMUNOL, V34, P174, DOI 10.1002/eji.200324253; Huang HY, 2010, J CLIN MICROBIOL, V48, P4474, DOI 10.1128/JCM.00930-10; Jeevan A, 2003, INFECT IMMUN, V71, P354, DOI 10.1128/IAI.71.1.354-364.2003; Jeevan A, 2011, TUBERCULOSIS, V91, P47, DOI 10.1016/j.tube.2010.11.006; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kamath AB, 2004, J EXP MED, V200, P1479, DOI 10.1084/jem.20041690; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kobayashi T, 2006, NAT IMMUNOL, V7, P123, DOI 10.1038/ni0206-123; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; McMurray David N., 1994, P135; Mendez A, 2011, TUBERCULOSIS, V91, P140, DOI 10.1016/j.tube.2010.12.008; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rook GAW, 2007, CURR MOL MED, V7, P327; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Singhal A, 2010, COLOR ATLAS COMP PAT, P157; Singhal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018632; Ting LM, 1999, J IMMUNOL, V163, P3898; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Tsenova L, 2007, VACCINE, V25, P5126, DOI 10.1016/j.vaccine.2006.11.024; Walker V, 2006, ARCH DIS CHILD, V91, P789, DOI 10.1136/adc.2006.098459; Wassie L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001522; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	49	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28082	10.1371/journal.pone.0028082	http://dx.doi.org/10.1371/journal.pone.0028082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162757	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800015
J	Chu, VC; Bhattacharya, S; Nomoto, A; Lin, JH; Zaidi, SK; Oberley, TD; Weinman, SA; Azhar, S; Huang, TT				Chu, Victor C.; Bhattacharya, Sayanti; Nomoto, Ann; Lin, Jiahui; Zaidi, Syed Kashif; Oberley, Terry D.; Weinman, Steven A.; Azhar, Salman; Huang, Ting-Ting			Persistent Expression of Hepatitis C Virus Non-Structural Proteins Leads to Increased Autophagy and Mitochondrial Injury in Human Hepatoma Cells	PLOS ONE			English	Article							CORE PROTEIN; OXIDATIVE STRESS; MICROVILLAR LOCALIZATION; SUPEROXIDE-DISMUTASE; SCAVENGER RECEPTOR; ER STRESS; CLASS-B; REPLICATION; NS5A; MACHINERY	HCV infection is a major cause of chronic liver disease and liver cancer in the United States. To address the pathogenesis caused by HCV infection, recent studies have focused on the direct cytopathic effects of individual HCV proteins, with the objective of identifying their specific roles in the overall pathogenesis. However, this approach precludes examination of the possible interactions between different HCV proteins and organelles. To obtain a better understanding of the various cytopathic effects of and cellular responses to HCV proteins, we used human hepatoma cells constitutively replicating HCV RNA encoding either the full-length polyprotein or the non-structural proteins, or cells constitutively expressing the structural protein core, to model the state of persistent HCV infection and examined the combination of various HCV proteins in cellular pathogenesis. Increased reactive oxygen species (ROS) generation in the mitochondria, mitochondrial injury and degeneration, and increased lipid accumulation were common among all HCV protein-expressing cells regardless of whether they expressed the structural or non-structural proteins. Expression of the non-structural proteins also led to increased oxidative stress in the cytosol, membrane blebbing in the endoplasmic reticulum, and accumulation of autophagocytic vacuoles. Alterations of cellular redox state, on the other hand, significantly changed the level of autophagy, suggesting a direct link between oxidative stress and HCV-mediated activation of autophagy. With the widespread cytopathic effects, cells with the full-length HCV polyprotein showed a modest antioxidant response and exhibited a significant increase in population doubling time and a concomitant decrease in cyclin D1. In contrast, cells expressing the non-structural proteins were able to launch a vigorous antioxidant response with up-regulation of antioxidant enzymes. The population doubling time and cyclin D1 level were also comparable to that of control cells. Finally, the cytopathic effects of core protein appeared to focus on the mitochondria without remarkable disturbances in the cytosol.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Nomoto, Ann; Zaidi, Syed Kashif; Azhar, Salman; Huang, Ting-Ting] VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA USA; [Oberley, Terry D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA; [Oberley, Terry D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Kansas; University of Kansas Medical Center	Chu, VC (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	tthuang@stanford.edu	Zaidi, Syed Kashif M/A-6160-2013; Zaidi, Syed Kashif/AAA-3924-2022	Zaidi, Syed Kashif M/0000-0003-2391-414X; Zaidi, Syed Kashif/0000-0003-2391-414X	National Institutes of Health [AA012863, HL33881, CA122499]; Stanford Digestive Disease Center; NATIONAL CANCER INSTITUTE [R01CA122499] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL033881, R01HL033881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Digestive Disease Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by funding from National Institutes of Health grant AA012863 to SW, HL33881 to SA, and CA122499 to T-TH, and from Stanford Digestive Disease Center to T-TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MY, 2005, J MED VIROL, V76, P489, DOI 10.1002/jmv.20388; Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Baumert TF, 1999, GASTROENTEROLOGY, V117, P1397, DOI 10.1016/S0016-5085(99)70290-8; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; BERRYMAN MA, 1990, J HISTOCHEM CYTOCHEM, V38, P159, DOI 10.1177/38.2.1688894; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Georgel P, 2010, TRENDS MOL MED, V16, P277, DOI 10.1016/j.molmed.2010.04.003; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Katsarou K, 2010, CELL MOL LIFE SCI, V67, P2491, DOI 10.1007/s00018-010-0351-5; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Lundin M, 2006, J GEN VIROL, V87, P3263, DOI 10.1099/vir.0.82211-0; Mahmood S, 2004, ANTIOXID REDOX SIGN, V6, P19, DOI 10.1089/152308604771978318; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nishina S, 2010, LIVER INT, V30, P683, DOI 10.1111/j.1478-3231.2010.02210.x; O'Donnell V, VIROLOGY, V142-150; Oberley TD, 2002, AM J PATHOL, V160, P403, DOI 10.1016/S0002-9440(10)64857-2; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Otani K, 2005, GASTROENTEROLOGY, V128, P96, DOI 10.1053/j.gastro.2004.10.045; Paradis V, 1997, J CLIN PATHOL, V50, P401, DOI 10.1136/jcp.50.5.401; Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Qadri I, 2004, BIOCHEM J, V378, P919, DOI 10.1042/BJ20031587; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; Reaven E, 1998, ENDOCRINOLOGY, V139, P2847, DOI 10.1210/en.139.6.2847; Reaven E, 2000, J LIPID RES, V41, P343; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Seronello S, 2007, FREE RADICAL BIO MED, V43, P869, DOI 10.1016/j.freeradbiomed.2007.05.036; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Siu L, 2009, SEMIN LIVER DIS, V29, P188, DOI 10.1055/s-0029-1214374; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Thoren F, 2004, J LEUKOCYTE BIOL, V76, P1180, DOI 10.1189/jlb.0704387; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tsutsumi T, 2002, VIROLOGY, V304, P415, DOI 10.1006/viro.2002.1702; Wang T, 2010, J VIRAL HEPATITIS, V17, P784, DOI 10.1111/j.1365-2893.2009.01238.x; Wang T, J VIRAL HEPAT, V17, P784; Wang T, 2006, J GASTROEN HEPATOL, V21, pS34, DOI 10.1111/j.1440-1746.2006.04591.x; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yi MK, 2002, VIROLOGY, V304, P197, DOI 10.1006/viro.2002.1652	58	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28551	10.1371/journal.pone.0028551	http://dx.doi.org/10.1371/journal.pone.0028551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164304	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400106
J	Ioannidis, JPA; Manzoli, L; De Vito, C; D'Addario, M; Villari, P				Ioannidis, John P. A.; Manzoli, Lamberto; De Vito, Corrado; D'Addario, Maddalena; Villari, Paolo			Publication Delay of Randomized Trials on 2009 Influenza A (H1N1) Vaccination	PLOS ONE			English	Article							CLINICAL-RESEARCH; REPORTING BIAS; IMMUNOGENICITY; COHORT	Background: Randomized evidence for vaccine immunogenicity and safety is urgently needed in the setting of pandemics with new emerging infectious agents. We carried out an observational survey to evaluate how many randomized controlled trials testing 2009 H1N1 vaccines were published among those registered, and what was the time lag from their start to publication and from their completion to publication. Methods: PubMed, EMBASE and 9 clinical trial registries were searched for eligible randomized controlled trials. The units of the analysis were single randomized trials on any individual receiving influenza vaccines in any setting. Results: 73 eligible trials were identified that had been registered in 2009-2010. By June 30, 2011 only 21 (29%) of these trials had been published, representing 38% of the randomized sample size (19905 of 52765). Trials starting later were published less rapidly (hazard ratio 0.42 per month; 95% Confidence Interval: 0.27 to 0.64; p<0.001). Similarly, trials completed later were published less rapidly (hazard ratio 0.43 per month; 95% CI: 0.27 to 0.67; p<0.001). Randomized controlled trials were completed promptly (median, 5 months from start to completion), but only a minority were subsequently published. Conclusions: Most registered randomized trials on vaccines for the H1N1 pandemic are not published in the peer-reviewed literature.	[Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Manzoli, Lamberto] Univ G DAnnunzio Chieti, Sect Hyg Epidemiol Pharmacol & Legal Med, Chieti, Italy; [De Vito, Corrado; D'Addario, Maddalena; Villari, Paolo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy	Stanford University; Stanford University; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome	Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	lmanzoli@post.harvard.edu	Ioannidis, John P. A./G-9836-2011; Manzoli, Lamberto/K-1895-2018	Manzoli, Lamberto/0000-0002-8129-9344; villari, paolo/0000-0002-3139-0668; DE VITO, CORRADO/0000-0002-7846-672X				[Anonymous], PLOS CURRENTS INFLUE; [Anonymous], 2010, PLOS MED, V7; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; European Medicines Agency, 2011, MED AUTH PAND; European Medicines Agency, 2009, EMEA6082592009; European Medicines Agency, 2011, EUR PUBL HLTH ASS RE; Food and Drug Administration, 2010, INFL A H1N1 2009 MON; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jackson LA, 2011, J INFECT DIS, V204, P854, DOI 10.1093/infdis/jir440; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Leung GM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000346; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; Lopez-Macias C, 2011, VACCINE, V29, P7826, DOI 10.1016/j.vaccine.2011.07.099; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Xing WJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000272; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	28	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28346	10.1371/journal.pone.0028346	http://dx.doi.org/10.1371/journal.pone.0028346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164274	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400075
J	Jia, X; He, WZ; Murchie, AIH; Chen, DR				Jia, Xu; He, Weizhi; Murchie, Alastair I. H.; Chen, Dongrong			The Global Transcriptional Response of Fission Yeast to Hydrogen Sulfide	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; NITRIC-OXIDE; RAT; PROLIFERATION; APOPTOSIS; H2S; ANGIOGENESIS; ACTIVATION	Background: Hydrogen sulfide (H(2)S) is a newly identified member of the small family of gasotransmitters that are endogenous gaseous signaling molecules that have a fundamental role in human biology and disease. Although it is a relatively recent discovery and the mechanism of H(2)S activity is not completely understood, it is known to be involved in a number of cellular processes; H(2)S can affect ion channels, transcription factors and protein kinases in mammals. Methodology/Principal Findings: In this paper, we have used fission yeast as a model organism to study the global gene expression profile in response to H(2)S by microarray. We initially measured the genome-wide transcriptional response of fission yeast to H(2)S. Through the functional classification of genes whose expression profile changed in response to H(2)S, we found that H(2)S mainly influences genes that encode putative or known stress proteins, membrane transporters, cell cycle/meiotic proteins, transcription factors and respiration protein in the mitochondrion. Our analysis showed that there was a significant overlap between the genes affected by H(2)S and the stress response. We identified that the target genes of the MAPK pathway respond to H(2)S; we also identified that a number of transporters respond to H(2)S, these include sugar/carbohydrate transporters, ion transporters, and amino acid transporters. We found many mitochondrial genes to be down regulated upon H(2)S treatment and that H(2)S can reduce mitochondrial oxygen consumption. Conclusion/Significance: This study identifies potential molecular targets of the signaling molecule H(2)S in fission yeast and provides clues about the identity of homologues human proteins and will further the understanding of the cellular role of H(2)S in human diseases.	[Jia, Xu; He, Weizhi; Murchie, Alastair I. H.; Chen, Dongrong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Jia, Xu; Murchie, Alastair I. H.; Chen, Dongrong] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Jia, X (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.	aihm@fudan.edu.cn; drchen@fudan.edu.cn	He, Weizhi/GQQ-5629-2022	He, Weizhi/0000-0002-8061-4947	National Key 973 grant [2010CB912602]; Natural Science Foundation [30970061, 31070666]; City of Shanghai Key project [09DJ1400601]; National Key Project 985	National Key 973 grant(National Basic Research Program of China); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); City of Shanghai Key project; National Key Project 985	This work was supported by National Key 973 grant (2010CB912602), Natural Science Foundation grant 30970061 to DC, 31070666 to AM, City of Shanghai Key project grant (09DJ1400601) and National Key Project 985. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Budde MW, 2010, MOL BIOL CELL, V21, P212, DOI 10.1091/mbc.E09-03-0199; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Du JB, 2004, HEART VESSELS, V19, P75, DOI 10.1007/s00380-003-0743-7; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eshaghi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011620; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong SO, 2006, BIOCHEM BIOPH RES CO, V345, P938, DOI 10.1016/j.bbrc.2006.05.002; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MORENO S, 1990, NATURE, V344, P549, DOI 10.1038/344549a0; Osipov RM, 2010, INTERACT CARDIOV TH, V10, P506, DOI 10.1510/icvts.2009.219535; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sivarajah A, 2006, SHOCK, V26, P154, DOI 10.1097/01.shk.0000225722.56681.64; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; Wang MJ, 2010, ANTIOXID REDOX SIGN, V12, P1065, DOI 10.1089/ars.2009.2945; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang Guang-Dong, 2007, Shengli Xuebao, V59, P133; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	36	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28275	10.1371/journal.pone.0028275	http://dx.doi.org/10.1371/journal.pone.0028275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164259	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400060
J	Aung, KM; Boldbaatar, D; Umemiya-Shirafuji, R; Liao, M; Xuan, XN; Suzuki, H; Galay, RL; Tanaka, T; Fujisaki, K				Aung, Kyaw Min; Boldbaatar, Damdinsuren; Umemiya-Shirafuji, Rika; Liao, Min; Xuan Xuenan; Suzuki, Hiroshi; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo			Scavenger Receptor Mediates Systemic RNA Interference in Ticks	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; HAEMAPHYSALIS-LONGICORNIS; HARD TICK; PROTECTIVE ANTIGENS; OOCYTE DEVELOPMENT; GENE; IDENTIFICATION	RNA interference is an efficient method to silence gene and protein expressions. Here, the class B scavenger receptor CD36 (SRB) mediated the uptake of exogenous dsRNAs in the induction of the RNAi responses in ticks. Unfed female Haemaphysalis longicornis ticks were injected with a single or a combination of H. longicornis SRB (HlSRB) dsRNA, vitellogenin-1 (HlVg-1) dsRNA, and vitellogenin receptor (HlVgR) dsRNA. We found that specific and systemic silencing of the HlSRB, HlVg-1, and HlVgR genes was achieved in ticks injected with a single dsRNA of HlSRB, HlVg-1, and HlVgR. In ticks injected first with HlVg-1 or HlVgR dsRNA followed 96 hours later with HlSRB dsRNA (HlVg-1/HlSRB or HlVgR/HlSRB), gene silencing of HlSRB was achieved in addition to first knockdown in HlVg-1 or HlVgR, and prominent phenotypic changes were observed in engorgement, mortality, and hatchability, indicating that a systemic and specific double knockdown of target genes had been simultaneously attained in these ticks. However, in ticks injected with HlSRB dsRNA followed 96 hours later with HlVg-1 or HlVgR dsRNAs, silencing of HlSRB was achieved, but no subsequent knockdown in HlVgR or HlVg-1 was observed. The Westernblot and immunohistochemical examinations revealed that the endogenous HlSRB protein was fully abolished in midguts of ticks injected with HlSRB/HlVg-1 dsRNAs but HlVg-1 was normally expressed in midguts, suggesting that HlVg-1 dsRNA-mediated RNAi was fully inhibited by the first knockdown of HlSRB. Similarly, the abolished localization of HlSRB protein was recognized in ovaries of ticks injected with HlSRB/HlVgR, while normal localization of HlVgR was observed in ovaries, suggesting that the failure to knock-down HlVgR could be attributed to the first knockdown of HlSRB. In summary, we demonstrated for the first time that SRB may not only mediate the effective knock-down of gene expression by RNAi but also play essential roles for systemic RNAi of ticks.	[Aung, Kyaw Min; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo] Yamaguchi Univ, Dept Pathol & Prevent Vet Sci, United Grad Sch Vet Sci, Yamaguchi, Japan; [Aung, Kyaw Min; Boldbaatar, Damdinsuren; Umemiya-Shirafuji, Rika; Liao, Min; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo] Kagoshima Univ, Fac Agr, Lab Emerging Infect Dis, Dept Frontier Vet Med, Kagoshima 890, Japan; [Xuan Xuenan; Suzuki, Hiroshi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan	Yamaguchi University; Kagoshima University; Obihiro University of Agriculture & Veterinary Medicine	Aung, KM (corresponding author), Yamaguchi Univ, Dept Pathol & Prevent Vet Sci, United Grad Sch Vet Sci, Yamaguchi, Japan.	tick@ms.kagoshima-u.ac.jp	Galay, Remil/AAN-4392-2021; Umemiya-Shirafuji, Rika/AFT-5139-2022	Galay, Remil/0000-0001-9749-8308; Umemiya-Shirafuji, Rika/0000-0001-7641-5526; Damdinsuren, Boldbaatar/0000-0002-0541-3766	Japan Society for the Promotion of Science (JSPS); National Researh Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine [23-joint-4]; Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Researh Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine; Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (JSPS) and a Cooperative Research Grant (23-joint-4) of the National Researh Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine. The first author (Kyaw Min Aung) is supported by the Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology) scholarship for PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung KM, 2011, PARASITOL RES, V108, P273, DOI 10.1007/s00436-010-2053-1; Boldbaatar D, 2006, INSECT BIOCHEM MOLEC, V36, P25, DOI 10.1016/j.ibmb.2005.10.003; Boldbaatar D, 2008, BIOCHEM CELL BIOL, V86, P331, DOI [10.1139/O08-071, 10.1139/o08-071]; Boldbaatar D, 2010, J INSECT PHYSIOL, V56, P1587, DOI 10.1016/j.jinsphys.2010.05.019; De la Fuente J, 2006, BIOCHEM BIOPH RES CO, V344, P332, DOI 10.1016/j.bbrc.2006.03.109; de la Fuente J, 2005, PARASITOL RES, V96, P137, DOI 10.1007/s00436-005-1351-5; de la Fuente J, 2007, TRENDS PARASITOL, V23, P427, DOI 10.1016/j.pt.2007.07.002; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; Gong HY, 2009, INSECT BIOCHEM MOLEC, V39, P372, DOI 10.1016/j.ibmb.2009.03.002; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Liao M, 2008, INSECT BIOCHEM MOLEC, V38, P285, DOI 10.1016/j.ibmb.2007.11.006; Miyoshi T, 2004, J VET MED SCI, V66, P1471, DOI 10.1292/jvms.66.1471; Nijhof AM, 2007, INT J PARASITOL, V37, P653, DOI 10.1016/j.ijpara.2006.11.005; Peter RJ, 2005, VET PARASITOL, V132, P205, DOI 10.1016/j.vetpar.2005.07.004; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007	20	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28407	10.1371/journal.pone.0028407	http://dx.doi.org/10.1371/journal.pone.0028407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145043	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900026
J	Langner, R; Eickhoff, SB; Steinborn, MB				Langner, Robert; Eickhoff, Simon B.; Steinborn, Michael B.			Mental Fatigue Modulates Dynamic Adaptation to Perceptual Demand in Speeded Detection	PLOS ONE			English	Article							SIMPLE REACTION-TIME; STIMULUS-INTENSITY; COGNITIVE CONTROL; SENSITIVITY DECREMENT; SUSTAINED ATTENTION; SIGNAL INTENSITY; MONITORING TASK; VIGILANCE TASK; INFORMATION; PERFORMANCE	When stimulus intensity in simple reaction-time tasks randomly varies across trials, detection speed usually improves after a low-intensity trial. With auditory stimuli, this improvement was often found to be asymmetric, being greater on current low-intensity trials. Our study investigated (1) whether asymmetric sequential intensity adaptation also occurs with visual stimuli; (2) whether these adjustments reflect decision-criterion shifts or, rather, a modulation of perceptual sensitivity; and (3) how sequential intensity adaptation and its underlying mechanisms are affected by mental fatigue induced through prolonged performance. In a continuous speeded detection task with randomly alternating high- and low-intensity visual stimuli, the reaction-time benefit after low-intensity trials was greater on subsequent low- than high-intensity trials. This asymmetry, however, only developed with time on task (TOT). Signal-detection analyses showed that the decision criterion transiently became more liberal after a low- intensity trial, whereas observer sensitivity increased when the preceding and current stimulus were of equal intensity. TOT-induced mental fatigue only affected sensitivity, which dropped more on low-than on high- intensity trials. This differential fatigue-related sensitivity decrease selectively enhanced the impact of criterion down-shifts on low- intensity trials, revealing how the interplay of two perceptual mechanisms and their modulation by fatigue combine to produce the observed overall pattern of asymmetric performance adjustments to varying visual intensity in continuous speeded detection. Our results have implications for similar patterns of sequential demand adaptation in other cognitive domains as well as for real-world prolonged detection performance.	[Langner, Robert; Eickhoff, Simon B.] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Langner, Robert] Rhein Westfal TH Aachen, Sch Med, Neuropsychol Sect, Dept Neurol, Aachen, Germany; [Langner, Robert; Eickhoff, Simon B.] Res Ctr Julich, Inst Neurosci & Med INM 2, Julich, Germany; [Eickhoff, Simon B.] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany; [Steinborn, Michael B.] Univ Tubingen, Inst Psychol, Tubingen, Germany	RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen	Langner, R (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	robert.langner@rwth-aachen.de	Eickhoff, Simon B./K-2061-2013	Eickhoff, Simon B./0000-0001-6363-2759; Langner, Robert/0000-0002-3237-001X	Human Brain Project [R01-MH074457-01A1]; Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); Deutsche Forschungsgemeinschaft [IRTG 1328]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER	Human Brain Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	SBE was supported by the Human Brain Project (R01-MH074457-01A1), the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model), and the Deutsche Forschungsgemeinschaft (IRTG 1328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMEISTER AA, 1967, PSYCHOL REC, V17, P503, DOI 10.1007/BF03393724; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Davies DR, 1982, PSYCHOL VIGILANCE; Dreisbach G, 2011, PSYCHOL RES-PSYCH FO, V75, P376, DOI 10.1007/s00426-010-0319-y; Drummond SPA, 2005, SLEEP, V28, P1059; Dukas R, 2001, BEHAV ECOL, V12, P192, DOI 10.1093/beheco/12.2.192; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Fischer R, 2008, J EXP PSYCHOL LEARN, V34, P712, DOI 10.1037/0278-7393.34.3.712; GENDRON RP, 1986, ANIM BEHAV, V34, P898, DOI 10.1016/S0003-3472(86)80076-8; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRICE GR, 1968, PSYCHOL REV, V75, P359, DOI 10.1037/h0026287; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; HENRIKSEN K, 1971, J EXP PSYCHOL, V90, P287, DOI 10.1037/h0031551; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jaskowski P, 2006, INT J PSYCHOPHYSIOL, V61, P98, DOI 10.1016/j.ijpsycho.2005.07.010; Jha AP, 2010, J EXP PSYCHOL LEARN, V36, P1036, DOI 10.1037/a0019337; JOHN ID, 1967, AUST J PSYCHOL, V19, P35, DOI 10.1080/00049536708255559; KELLAS G, 1969, J COMP PHYSIOL PSYCH, V68, P303, DOI 10.1037/h0027610; KOHFELD DL, 1969, J EXP PSYCHOL, V82, P88, DOI 10.1037/h0028033; KOHFELD DL, 1969, AM J PSYCHOL, V82, P104, DOI 10.2307/1420611; Langner R, 2012, HUM BRAIN MAPP, V33, P398, DOI 10.1002/hbm.21220; Langner R, 2010, PSYCHOL RES-PSYCH FO, V74, P499, DOI 10.1007/s00426-010-0275-6; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; LISPER HO, 1973, J EXP PSYCHOL, V98, P316, DOI 10.1037/h0034360; Los SA, 1996, ACTA PSYCHOL, V94, P145, DOI 10.1016/0001-6918(95)00050-X; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; McNicol D., 1972, PRIMER SIGNAL DETECT; Miller J, 2003, COGNITIVE PSYCHOL, V46, P101, DOI 10.1016/S0010-0285(02)00517-0; Montagna B, 2009, VISION RES, V49, P735, DOI 10.1016/j.visres.2009.02.001; MURRAY HG, 1970, J EXP PSYCHOL, V84, P383, DOI 10.1037/h0029284; Murray HG, 1965, PSYCHON SCI, V3, P439; NICKERSON RA, 1969, J EXP PSYCHOL, V79, P452, DOI 10.1037/h0026889; NICKERSON RS, 1967, ACTA PSYCHOL, V27, P23, DOI 10.1016/0001-6918(67)90041-8; NIEMI P, 1982, ACTA PSYCHOL, V50, P73, DOI 10.1016/0001-6918(82)90052-X; NIEMI P, 1981, PERCEPT MOTOR SKILL, V53, P615, DOI 10.2466/pms.1981.53.2.615; NISSEN MJ, 1977, PERCEPT PSYCHOPHYS, V22, P338, DOI 10.3758/BF03199699; NUECHTERLEIN KH, 1983, SCIENCE, V220, P327, DOI 10.1126/science.6836276; PARASURAMAN R, 1976, J EXP PSYCHOL HUMAN, V2, P578, DOI 10.1037/0096-1523.2.4.578; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rolike B, 2007, PSYCHON B REV, V14, P522, DOI 10.3758/BF03194101; SANDERS AF, 1982, ACTA PSYCHOL, V51, P41, DOI 10.1016/0001-6918(82)90018-X; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; SEE JE, 1995, PSYCHOL BULL, V117, P230, DOI 10.1037/0033-2909.117.2.230; SHIU LP, 1995, VISION RES, V35, P337, DOI 10.1016/0042-6989(94)00148-F; Smit AS, 2004, ACTA PSYCHOL, V115, P35, DOI 10.1016/j.actpsy.2003.11.001; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TANNER WP, 1954, PSYCHOL REV, V61, P401, DOI 10.1037/h0058700; Temple JG, 2000, HUM FACTORS, V42, P183, DOI 10.1518/001872000779656480; Willer B, 1993, KURZFRAGEBOGEN AKTUE; WILLIGES RC, 1969, J EXP PSYCHOL, V81, P61, DOI 10.1037/h0027432; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Woodworth R.S., 1938, EXP PSYCHOL	59	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28399	10.1371/journal.pone.0028399	http://dx.doi.org/10.1371/journal.pone.0028399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MQ	22145041	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900024
J	Alberti, C; Pinciroli, P; Valeri, B; Ferri, R; Ditto, A; Umezawa, K; Sensi, M; Canevari, S; Tomassetti, A				Alberti, C.; Pinciroli, P.; Valeri, B.; Ferri, R.; Ditto, A.; Umezawa, K.; Sensi, M.; Canevari, S.; Tomassetti, A.			Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer	ONCOGENE			English	Article						epithelial ovarian cancer; EGFR; IL-6; PAI-1; NFkB	GROWTH-FACTOR-RECEPTOR; KAPPA-B; BREAST-CANCER; PLASMINOGEN-ACTIVATOR; CELLS; TUMOR; EXPRESSION; OVEREXPRESSION; MACROPHAGES; PROGRESSION	The epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, is expressed in up to 70% of epithelial ovarian cancers (EOCs), where it correlates with poor prognosis. The majority of EOCs are diagnosed at an advanced stage, and at least 50% present malignant ascites. High levels of IL-6 have been found in the ascites of EOC patients and correlate with shorter survival. Herein, we investigated the signaling cascade led by EGFR activation in EOC and assessed whether EGFR activation could induce an EOC microenvironment characterized by pro-inflammatory molecules. In vitro analysis of EOC cell lines revealed that ligand-stimulated EGFR activated NFkB-dependent transcription and induced secretion of IL-6 and plasminogen activator inhibitor (PAI-1). IL-6/PAI-1 expression and secretion were strongly inhibited by the tyrosine kinase inhibitor AG1478 and EGFR silencing. A significant reduction of EGF-stimulated IL-6/PAI-1 secretion was also obtained with the NFkB inhibitor dehydroxymethylepoxyquinomicin. Of 23 primary EOC tumors from advanced-stage patients with malignant ascites at surgery, 12 co-expressed membrane EGFR, IL-6 and PAI-1 by immunohistochemistry; both IL-6 and PAI-1 were present in 83% of the corresponding ascites. Analysis of a publicly available gene-expression data set from 204 EOCs confirmed a significant correlation between IL-6 and PAI-1 expression, and patients with the highest IL-6 and PAI-1 co-expression showed a significantly shorter progression-free survival time (P = 0.028). This suggests that EGFR/NFkB/IL-6-PAI-1 may have a significant impact on the therapy of a particular subset of EOC, and that IL-6/PAI-1 co-expression may be a novel prognostic marker. Oncogene (2012) 31, 4139-4149; doi:10.1038/onc.2011.572; published online 12 December 2011	[Canevari, S.; Tomassetti, A.] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Unit Mol Therapies, Milan, Italy; [Valeri, B.] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy; [Ditto, A.] Fdn IRCCS Ist Nazl Tumori, Dept Gynecol Oncol, Milan, Italy; [Umezawa, K.] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Tokyo 108, Japan; [Sensi, M.] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Unit Human Tumor Immunobiol, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Keio University; Fondazione IRCCS Istituto Nazionale Tumori Milan	Canevari, S (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Unit Mol Therapies, Milan, Italy.	silvana.canevari@istitutotumori.mi.it; antonella.tomassetti@istitutotumori.mi.it	Ditto, Antonino/H-2219-2017; Ferri, Raffaele/B-5439-2013; Tomassetti, Antonella/G-7906-2015; Valeri, Barbara/C-1986-2017; Sensi, Marialuisa/K-5631-2014	Ditto, Antonino/0000-0002-5684-8225; Ferri, Raffaele/0000-0001-6937-3065; Tomassetti, Antonella/0000-0001-6772-9937; Valeri, Barbara/0000-0001-9143-7280; Sensi, Marialuisa/0000-0002-7643-0248	Italian Association for Cancer Research [IG4608]; Italian Ministry of Health	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	We thank the gynecologic clinical staff and the biorepository personnel at the Fondazione IRCCS Istituto Nazionale dei Tumori, whose activity made this study possible; we thank Dr. Patrick Moore for English editing of the manuscript. Financial Support: Italian Association for Cancer Research (IG4608 to SC) and Italian Ministry of Health (Grant Alleanza contro il Cancro, ACC and Progetto Oncologico di Medicina Molecolare: i Tumori Femminili to SC).	Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berchuck A, 2009, CLIN CANCER RES, V15, P2448, DOI 10.1158/1078-0432.CCR-08-2430; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Braun AH, 2005, CLIN CANCER RES, V11, P4639, DOI 10.1158/1078-0432.CCR-05-0973; Carey MS, 2010, CLIN CANCER RES, V16, P2852, DOI 10.1158/1078-0432.CCR-09-2502; Castellano G, 2006, CANCER RES, V66, P10709, DOI 10.1158/0008-5472.CAN-06-1327; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; Degl'Innocenti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012701; Guo YQ, 2010, CLIN CANCER RES, V16, P5759, DOI 10.1158/1078-0432.CCR-10-1095; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hartman ZC, 2011, CANCER RES, V71, P4380, DOI 10.1158/0008-5472.CAN-11-0308; Hudson LG, 2009, CANCER TREAT RES, V149, P203, DOI 10.1007/978-0-387-98094-2_10; Jiang T, 2011, CANCER RES, V71, P2183, DOI 10.1158/0008-5472.CAN-10-3626; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kryczek I, 2000, BRIT J CANCER, V82, P621; Leissner P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-216; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Penson RT, 2000, INT J GYNECOL CANCER, V10, P33, DOI 10.1046/j.1525-1438.2000.00003.x; Sheng Q, 2011, BRIT J CANCER, V104, P1241, DOI 10.1038/bjc.2011.62; Siwak DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/568938; Sternlicht MD, 2006, CANCER EPIDEM BIOMAR, V15, P2107, DOI 10.1158/1055-9965.EPI-06-0351; Tomassetti A, 2008, NEOPLASIA, V10, P1481, DOI 10.1593/neo.81004; TOSI E, 1995, INT J CANCER, V62, P643, DOI 10.1002/ijc.2910620525; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Umezawa K, 2006, CANCER SCI, V97, P990, DOI 10.1111/j.1349-7006.2006.00285.x; Van Laere SJ, 2007, BRIT J CANCER, V97, P659, DOI 10.1038/sj.bjc.6603906; Yamamoto M, 2008, J MED CHEM, V51, P5780, DOI 10.1021/jm8006245	35	84	87	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	37					4139	4149		10.1038/onc.2011.572	http://dx.doi.org/10.1038/onc.2011.572			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NR	22158046	hybrid			2022-12-25	WOS:000308688900006
J	Sasi, SP; Yan, X; Enderling, H; Park, D; Gilbert, HY; Curry, C; Coleman, C; Hlatky, L; Qin, G; Kishore, R; Goukassian, DA				Sasi, S. P.; Yan, X.; Enderling, H.; Park, D.; Gilbert, H-Y; Curry, C.; Coleman, C.; Hlatky, L.; Qin, G.; Kishore, R.; Goukassian, D. A.			Breaking the 'harmony' of TNF-alpha signaling for cancer treatment	ONCOGENE			English	Article						TNF-alpha; TNFR2/p75; cancer; angiogenesis; EPC; microenvironment	TUMOR-NECROSIS-FACTOR; ENDOTHELIAL PROGENITOR CELLS; ANGIOGENIC SWITCH; FACTOR-RECEPTOR; GROWTH-FACTOR; KAPPA-B; IN-VIVO; NEOVASCULARIZATION; ACTIVATION; APOPTOSIS	Tumor necrosis factor-alpha (TNF-alpha) binds to two distinct receptors, TNFR1/p55 and TNFR2/p75. TNF-alpha is implicated in the processes of tumor growth, survival, differentiation, invasion, metastases, secretion of cytokines and pro-angiogenic factors. We have shown that TNFR2/p75 signaling promotes ischemia-induced angiogenesis via modulation of several angiogenic growth factors. We hypothesized that TNFR2/p75 may promote tumor growth and angiogenesis. Growth of mouse Lewis lung carcinoma (LLC1) and/or mouse melanoma B16 cell was evaluated in wild type (WT), p75 knockout (KO) and double p55KO/p75KO mouse tumor xenograft models. Compared with WT and p55KO/p75KO mice, growth of tumors in p75KO mice was significantly decreased (twofold) in both LLC and B16 tumors. Tumor growth inhibition was correlated with decreases in vascular endothelial growth factor (VEGF) expression and capillary density, as well as bone marrow-derived endothelial progenitor cells incorporation into the functional capillary network, and an increase in apoptotic cells in LLC xenografts. Gene array analysis of tumor tissues showed a decrease in gene expression in pathways that promote tumor angiogenesis and cell survival. Blocking p75 by short-hairpin RNA in cultured LLCs led to increases in TNF-mediated apoptosis, as well as decreases in the constitutive and TNF-mediated expression of angiogenic growth factors (VEGF, HGF, PLGF), and SDF-1 alpha receptor CXCR4. In summary, p75 is essential for tumor angiogenesis and survival in highly vascularized murine lung tumor xenografts. Blocking p75 expression may lead to tumor regression. This may represent new and effective therapy against lung neoplasms and potentially tumors of other origin. Oncogene (2012) 31, 4117-4127; doi:10.1038/onc.2011.567; published online 12 December 2011	[Goukassian, D. A.] Tufts Univ, Sch Med, Ctr Canc Syst Biol, Brighton, MA 02135 USA; [Sasi, S. P.; Yan, X.; Park, D.; Gilbert, H-Y; Curry, C.; Coleman, C.; Goukassian, D. A.] Steward St Elizabeths Med Ctr, Cardiovasc Res Ctr, Brighton, MA USA; [Qin, G.; Kishore, R.] Northwestern Univ, Chicago, IL 60611 USA	Tufts University; St. Elizabeth's Medical Center; Northwestern University	Goukassian, DA (corresponding author), Tufts Univ, Sch Med, Ctr Canc Syst Biol, 736 Cambridge St,CBR 307, Brighton, MA 02135 USA.	david.goukassian@tufts.edu	Enderling, Heiko/AAA-2423-2021	Enderling, Heiko/0000-0002-9696-6410; Goukassian, David/0000-0001-5270-5270; Park, Daniel/0000-0001-5191-1371	NIH [HL091983]; NIH/NIA [5R21AG026777-02]; AHA SDG Award; NASA [NNX11AD22G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG026777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHA SDG Award; NASA(National Aeronautics & Space Administration (NASA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Marcy Silver and Sharon Kunder for their valuable technical support. This work was supported in part by grants from the NIH HL091983 (to RK), NIH/NIA 5R21AG026777-02, the AHA SDG Award and the NASA NNX11AD22G (all three to DAG).	Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Barbara JAJ, 1996, IMMUNOL CELL BIOL, V74, P434, DOI 10.1038/icb.1996.73; Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417; Coleman C, 2010, J ONCOL, V2010, DOI 10.1155/2010/928628; De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x; Eisenthal Avi, 2003, Sarcoma, V7, P57, DOI 10.1080/13577140310001607275; ELBAZ O, 1994, LEUKEMIA LYMPHOMA, V12, P191, DOI 10.3109/10428199409059589; FAJARDO LF, 1992, AM J PATHOL, V140, P539; Fiers W., 1995, Journal of Inflammation, V47, P67; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; GOILLOT E, 1992, CANCER RES, V52, P3194; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Gupta S, 2003, MECH AGEING DEV, V124, P503, DOI 10.1016/S0047-6374(03)00028-9; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hohenberger P, 2003, ANN SURG ONCOL, V10, P562, DOI 10.1245/ASO.2003.10.005; JACOBSEN SEW, 1994, STEM CELLS, V12, P111; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; Kohno K, 1998, CLIN IMMUNOL IMMUNOP, V86, P11, DOI 10.1006/clin.1997.4475; KOMORI A, 1993, CANCER RES, V53, P1982; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; Liu RY, 1998, CANCER RES, V58, P2217; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Montesano R, 2005, J CELL SCI, V118, P3487, DOI 10.1242/jcs.02467; Mukhopadhyay A, 2001, J BIOL CHEM, V276, P31906, DOI 10.1074/jbc.M105252200; Park CC, 2001, J IMMUNOL, V167, P1644, DOI 10.4049/jimmunol.167.3.1644; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Rafii S, 2008, SCIENCE, V319, P163, DOI 10.1126/science.1153615; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Santarelli JG, 2006, NEUROSURGERY, V59, P374, DOI 10.1227/01.NEU.0000222658.66878.CC; SATO N, 1987, J NATL CANCER I, V79, P1383; Sethi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5094, DOI 10.2741/3066; SLOWIK MR, 1993, AM J PATHOL, V143, P1724; Suganuma M, 1999, CANCER RES, V59, P4516; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; WONG GHW, 1994, J IMMUNOL, V152, P1751; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200	47	45	48	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	37					4117	4127		10.1038/onc.2011.567	http://dx.doi.org/10.1038/onc.2011.567			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NR	22158049	Green Accepted, hybrid			2022-12-25	WOS:000308688900004
J	Lubbe, SJ; Pittman, AM; Olver, B; Lloyd, A; Vijayakrishnan, J; Naranjo, S; Dobbins, S; Broderick, P; Gomez-Skarmeta, JL; Houlston, RS				Lubbe, S. J.; Pittman, A. M.; Olver, B.; Lloyd, A.; Vijayakrishnan, J.; Naranjo, S.; Dobbins, S.; Broderick, P.; Gomez-Skarmeta, J. L.; Houlston, R. S.			The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4	ONCOGENE			English	Article						bone morphogenetic protein-4; colorectal cancer; cis-regulatory	GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENE-EXPRESSION; CHROMOSOMAL INSTABILITY; GEL-ELECTROPHORESIS; RISK; COMMON; 8Q24; SCAN; PREDISPOSITION	Common genetic variation at human 14q22.2 tagged by rs4444235 is significantly associated with colorectal cancer (CRC) risk. Re-sequencing was used to comprehensively annotate the 17kb region of strong linkage disequilibrium encompassing rs4444235. Through bioinformatic analyses using H3K4Me1, H3K4Me3, and DNase-I hypersensitivity chromatin signatures and evolutionary conservation we identified seven candidate disease-causing single-nucleotide polymorphisms mapping to six regions within the 17-kb region predicted to have regulatory potential. Reporter gene studies of these regions demonstrated that the element to which rs4444235 maps acts as an allele-specific transcriptional enhancer. Allele-specific expression studies in CRC cell lines heterozygous for rs4444235 showed significantly increased expression of bone morphogenetic protein-4 (BMP4) associated with the risk allele (P<0.001). These data provide evidence for a functional basis for the non-coding risk variant rs4444235 at 14q22.2 and emphasizes the importance of genetic variation in the BMP pathway genes as determinants of CRC risk. Oncogene (2012) 31, 3777-3784; doi:10.1038/onc.2011.564; published online 12 December 2011	[Lubbe, S. J.; Pittman, A. M.; Olver, B.; Lloyd, A.; Vijayakrishnan, J.; Dobbins, S.; Broderick, P.; Houlston, R. S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Naranjo, S.; Gomez-Skarmeta, J. L.] CSIC UPO, Ctr Andaluz Biol Desarrollo, Seville, Spain	University of London; Institute of Cancer Research - UK; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	Richard.houlston@icr.ac.uk	Naranjo, Silvia/P-9845-2016; Pittman, Alan/AAP-2534-2020; Pittman, Alan M/D-6231-2012; Gomez-Skarmeta, Jose Luis/B-5268-2014; Lubbe, Steven/L-8261-2013	Naranjo, Silvia/0000-0002-4529-3332; Pittman, Alan/0000-0002-8112-2987; Pittman, Alan M/0000-0002-8112-2987; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Lubbe, Steven/0000-0002-7103-6671; Houlston, Richard/0000-0002-5268-0242; Broderick, Peter/0000-0002-8348-5829; Vijayakrishnan, Jayaram/0000-0002-8284-2249	National Health Service (NHS); Bobby Moore Fund; Spanish Ministry of Education and Science [BFU2010-14839, CSD2007-00008]; Junta de Andalucia [CVI-3488]; PhD studentship from Cancer Research UK; European Union Seventh Framework Programme (FP7) [258236]	National Health Service (NHS); Bobby Moore Fund; Spanish Ministry of Education and Science(Spanish Government); Junta de Andalucia(Junta de Andalucia); PhD studentship from Cancer Research UK; European Union Seventh Framework Programme (FP7)	We acknowledge the National Health Service (NHS) funding to the National Institute for Health Research (NIHR) Biomedical Research Centre. Finally, we are grateful to all patients and individuals for participation. Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund) provided principal funding for the study. JLG-S acknowledges grants from the Spanish Ministry of Education and Science (BFU2010-14839 and CSD2007-00008) and Junta de Andalucia (CVI-3488). SJL is in receipt of a PhD studentship from Cancer Research UK. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/207-2013) under grant no. 258236, FP7 collaborative project SYSCOL.	Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Deng HY, 2007, EXP CELL RES, V313, P1033, DOI 10.1016/j.yexcr.2006.12.020; Eisen T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-244; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; Gomez-Skarmeta JL, 2006, DEV DYNAM, V235, P870, DOI 10.1002/dvdy.20659; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Kawi K, 2002, GENE CHROMOSOME CANC, V34, P1, DOI 10.1002/gcc.10003; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Lubbe SJ, 2009, J CLIN ONCOL, V27, P2238, DOI 10.1200/JCO.2008.20.3364; Milani L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1152; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Penegar S, 2007, BRIT J CANCER, V97, P1305, DOI 10.1038/sj.bjc.6603997; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Polakis P, 2000, GENE DEV, V14, P1837; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pregizer S, 2009, CYTOKINE GROWTH F R, V20, P509, DOI 10.1016/j.cytogfr.2009.10.011; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tsushimi T, 2001, CANCER GENET CYTOGEN, V126, P34, DOI 10.1016/S0165-4608(00)00391-5; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	36	31	31	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	33					3777	3784		10.1038/onc.2011.564	http://dx.doi.org/10.1038/onc.2011.564			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IU	22158048				2022-12-25	WOS:000307924900004
J	Chen, SH; Dallas, MR; Balzer, EM; Konstantopoulos, K				Chen, Shih-Hsun; Dallas, Matthew R.; Balzer, Eric M.; Konstantopoulos, Konstantinos			Mucin 16 is a functional selectin ligand on pancreatic cancer cells	FASEB JOURNAL			English	Article						MUC16; metastasis; shear stress	COLON-CARCINOMA CELLS; P-SELECTIN; TUMOR-CELLS; EXTRACELLULAR SUPERSTRUCTURE; CARCINOEMBRYONIC ANTIGEN; VASCULAR INTERACTIONS; VARIANT ISOFORMS; CA-125 GENE; ADHESION; METASTASIS	Selectins promote metastasis by mediating specific interactions between selectin ligands on tumor cells and selectin-expressing host cells in the microvasculature. Using affinity chromatography in conjunction with tandem mass spectrometry and bioinformatics tools, we identified mucin 16 (MUC16) as a novel selectin ligand expressed by metastatic pancreatic cancer cells. While up-regulated in many pancreatic cancers, the biological function of sialofucosylated MUC16 has yet to be fully elucidated. To address this, we employed blot rolling and cell-free flow-based adhesion assays using MUC16 immunopurified from pancreatic cancer cells and found that it efficiently binds E-and L-but not P-selectin. The selectin-binding determinants are sialofucosylated structures displayed on O- and N-linked glycans. Silencing MUC16 expression by RNAi markedly reduces pancreatic cancer cell binding to E-and L-selectin under flow. These findings provide a novel integrated perspective on the enhanced metastatic potential associated with MUC16 overexpression and the role of selectins in metastasis.-Chen, S.-H., Dallas, M. R., Balzer, E. M., Konstantopoulos, K. Mucin 16 is a functional selectin ligand on pancreatic cancer cells. FASEB J. 26, 1349-1359 (2012). www.fasebj.org	[Chen, Shih-Hsun; Dallas, Matthew R.; Balzer, Eric M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Dallas, Matthew R.; Balzer, Eric M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Dallas, Matthew R.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Canc Nanotechnol Training Ctr, Baltimore, MD 21218 USA; [Balzer, Eric M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	konstant@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		U.S. National Cancer Institute [U54-CA143868, RO1-CA101135]; NATIONAL CANCER INSTITUTE [R01CA101135, U54CA143868, T32CA130840] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Drs. Robert Cole and Tatiana Boronina, who performed the peptide analysis and protein identification in the Mass Spectrometry and Proteomics Facility at Johns Hopkins School of Medicine with support from the Institute for Cell Engineering. The authors also thank Dr. Anirban Maitra (Department of Pathology, Johns Hopkins School of Medicine) for the generous gift of the Pa03C pancreatic carcinoma cell line. This work was supported by grants from the U.S. National Cancer Institute (awards U54-CA143868 and RO1-CA101135).	Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Belisle J. A., MOL CANC, V9, P118; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; Brodt P, 1997, INT J CANCER, V71, P612, DOI 10.1002/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D; Burdick MM, 2004, AM J PHYSIOL-CELL PH, V287, pC539, DOI 10.1152/ajpcell.00450.2003; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Burdick MM, 2001, IEEE ENG MED BIOL, V20, P86, DOI 10.1109/51.932731; CAPSTICK V, 1991, International Journal of Biological Markers, V6, P129; Fuhlbrigge RC, 2002, J IMMUNOL, V168, P5645, DOI 10.4049/jimmunol.168.11.5645; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gadducci A, 2004, BIOMED PHARMACOTHER, V58, P24, DOI 10.1016/j.biopha.2003.11.003; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Haridas D., PLOS ONE, V6; Hayashi N, 2004, PATHOBIOLOGY, V71, P26, DOI 10.1159/000072959; Ho S B, 1991, Semin Cancer Biol, V2, P389; Hosono J, 1998, J SURG ONCOL, V67, P77, DOI 10.1002/(SICI)1096-9098(199802)67:2<77::AID-JSO2>3.0.CO;2-I; Jadhav S, 2002, AM J PHYSIOL-CELL PH, V283, pC1133, DOI 10.1152/ajpcell.00104.2002; Jadhav S, 2001, J IMMUNOL, V167, P5986, DOI 10.4049/jimmunol.167.10.5986; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Kishimoto T, 1996, INT J CANCER, V69, P290, DOI 10.1002/(SICI)1097-0215(19960822)69:4<290::AID-IJC9>3.0.CO;2-S; Konstantopoulos K, 1997, J CLIN INVEST, V100, pS19; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Laubli H, 2006, CANCER RES, V66, P1536, DOI 10.1158/0008-5472.CAN-05-3121; MANNORI G, 1995, CANCER RES, V55, P4425; Mannori G, 1997, AM J PATHOL, V151, P233; MATSUOKA Y, 1990, CANCER, V65, P506, DOI 10.1002/1097-0142(19900201)65:3<506::AID-CNCR2820650322>3.0.CO;2-0; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; McCarty OJT, 2002, BIOPHYS J, V83, P836, DOI 10.1016/S0006-3495(02)75212-0; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Park Hee-Ug, 2003, Pancreas, V26, pe48, DOI 10.1097/00006676-200304000-00022; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; SATOMURA Y, 1991, PANCREAS, V6, P448, DOI 10.1097/00006676-199107000-00012; SAWADA T, 1994, INT J CANCER, V57, P901, DOI 10.1002/ijc.2910570621; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; Takahashi S, 2001, PATHOBIOLOGY, V69, P127, DOI 10.1159/000048767; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; Thomas SN, 2009, AM J PHYSIOL-CELL PH, V296, pC505, DOI 10.1152/ajpcell.00472.2008; Varki A, 1997, J CLIN INVEST, V100, pS31; Wirtz D., NAT REV CANC, V11, P512; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; Zeimet AG, 1998, TUMOR BIOL, V19, P275, DOI 10.1159/000030018	50	49	50	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1349	1359		10.1096/fj.11-195669	http://dx.doi.org/10.1096/fj.11-195669			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22159147	Green Published			2022-12-25	WOS:000300949300037
J	Piacente, F; Marin, M; Molinaro, A; De Castro, C; Seltzer, V; Salis, A; Damonte, G; Bernardi, C; Claverie, JM; Abergel, C; Tonetti, M				Piacente, Francesco; Marin, Margherita; Molinaro, Antonio; De Castro, Cristina; Seltzer, Virginie; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Claverie, Jean-Michel; Abergel, Chantal; Tonetti, Michela			Giant DNA Virus Mimivirus Encodes Pathway for Biosynthesis of Unusual Sugar 4-Amino-4,6-dideoxy-D-glucose (Viosamine)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHIGELLA-DYSENTERIAE TYPE-7; FRANCISELLA-TULARENSIS; PHYLOGENETIC ANALYSIS; ESCHERICHIA-COLI; GENOME; RHAMNOSE; PROTEIN; ENZYME; GLYCOSYLTRANSFERASE; EXOPOLYSACCHARIDES	Mimivirus is one the largest DNA virus identified so far, infecting several Acanthamoeba species. Analysis of its genome revealed the presence of a nine-gene cluster containing genes potentially involved in glycan formation. All of these genes are co-expressed at late stages of infection, suggesting their role in the formation of the long fibers covering the viral surface. Among them, we identified the L136 gene as a pyridoxal phosphate-dependent sugar aminotransferase. This enzyme was shown to catalyze the formation of UDP-4-amino-4,6-dideoxy-D-glucose (UDP-viosamine) from UDP-4-keto-6-deoxy-D-glucose, a key compound involved also in the biosynthesis of L-rhamnose. This finding further supports the hypothesis that Mimivirus encodes a glycosylation system that is completely independent of the amoebal host. Viosamine, together with rhamnose, (N-acetyl) glucosamine, and glucose, was found as a major component of the viral glycans. Most of the sugars were associated with the fibers, confirming a capsular-like nature of the viral surface. Phylogenetic analysis clearly indicated that L136 was not a recent acquisition from bacteria through horizontal gene transfer, but it was acquired very early during evolution. Implications for the origin of the glycosylation machinery in giant DNA virus are also discussed.	[Seltzer, Virginie; Claverie, Jean-Michel; Abergel, Chantal] Aix Marseille Univ, CNRS UPR 2589, Inst Microbiol Mediterranee, FR-13288 Marseille, France; [Piacente, Francesco; Marin, Margherita; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Tonetti, Michela] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Piacente, Francesco; Marin, Margherita; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Tonetti, Michela] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Molinaro, Antonio; De Castro, Cristina] Univ Naples Federico II, Dept Organ Chem & Biochem, Naples, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Genoa; University of Genoa; University of Naples Federico II	Abergel, C (corresponding author), Aix Marseille Univ, CNRS UPR 2589, Inst Microbiol Mediterranee, Parc Sci Luminy,Case 934, FR-13288 Marseille, France.	Chantal.Abergel@igs.cnrs-mrs.fr; tonetti@unige.it	Tonetti, Michela/F-3039-2018; De Castro, Cristina/I-5899-2012; Piacente, Francesco/J-8295-2016; TONETTI, MICHELA/AAF-3404-2021; Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019; Bernardi, Cinzia/K-3416-2018; Molinaro, Antonio/J-1866-2012; Salis, Annalisa/R-9241-2018	De Castro, Cristina/0000-0002-5147-1756; Piacente, Francesco/0000-0001-5470-5987; TONETTI, MICHELA/0000-0002-8829-7173; Claverie, Jean-Michel/0000-0003-1424-0315; Bernardi, Cinzia/0000-0001-9342-5929; Abergel, Chantal/0000-0003-1875-4049; Molinaro, Antonio/0000-0002-3456-7369; Salis, Annalisa/0000-0002-3082-2908	CNRS, Agence Nationale de la Recherche [ANRBLAN08-0089]	CNRS, Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS, Agence Nationale de la Recherche, Grant ANRBLAN08-0089.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Burgie ES, 2007, BIOCHEMISTRY-US, V46, P8999, DOI 10.1021/bi700751d; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; Cook PD, 2008, BIOCHEMISTRY-US, V47, P10685, DOI 10.1021/bi801309q; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dong SL, 2010, J BACTERIOL, V192, P5053, DOI 10.1128/JB.00568-10; Drsata J, 2005, J PHARMACEUT BIOMED, V37, P1173, DOI 10.1016/j.jpba.2004.10.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Fruscione F, 2008, J BIOL CHEM, V283, P184, DOI 10.1074/jbc.M706614200; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Herasimenka Y, 2007, CARBOHYD RES, V342, P2404, DOI 10.1016/j.carres.2007.07.012; Hwang BY, 2004, CHEM BIOL, V11, P915, DOI 10.1016/j.chembiol.2004.04.015; Ivashina TV, 2010, J APPL MICROBIOL, V109, P731, DOI 10.1111/j.1365-2672.2010.04702.x; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; JANN B, 1967, EUR J BIOCHEM, V2, P26, DOI 10.1111/j.1432-1033.1967.tb00100.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KNIREL YA, 1988, CARBOHYD RES, V179, P51, DOI 10.1016/0008-6215(88)84109-0; Kondakova AN, 2011, CARBOHYD RES, V346, P1951, DOI 10.1016/j.carres.2011.05.019; Kubler-Kielb J., 2008, P NATL ACAD SCI USA, V105, P8709; Kuznetsov YG, 2010, VIROLOGY, V404, P127, DOI 10.1016/j.virol.2010.05.007; Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99; Leone S, 2007, MAR DRUGS, V5, P85, DOI 10.3390/md503085; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Luther KB, 2011, J BIOL CHEM, V286, P43701, DOI 10.1074/jbc.M111.309096; Manzi A., 2001, CURR PROTOC MOL BIOL, V17; Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107; Nazarenko EL, 2003, CARBOHYD RES, V338, P2449, DOI 10.1016/j.carres.2003.06.004; Pelletier N, 2009, FEMS MICROBIOL LETT, V297, P117, DOI 10.1111/j.1574-6968.2009.01675.x; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Poli A, 2010, MAR DRUGS, V8, P1779, DOI 10.3390/md8061779; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06; Sharon N, 2007, GLYCOBIOLOGY, V17, P1150, DOI 10.1093/glycob/cwm089; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Sun LW, 1999, VIROLOGY, V263, P376, DOI 10.1006/viro.1999.9958; Takeuchi K, 2007, J BACTERIOL, V189, P6945, DOI 10.1128/JB.00500-07; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Van Etten JL, 2010, BBA-GEN SUBJECTS, V1800, P152, DOI 10.1016/j.bbagen.2009.07.024; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Y, 2007, J BACTERIOL, V189, P8626, DOI 10.1128/JB.00777-07; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Zhang Y, 2007, STRUCTURE, V15, P1031, DOI 10.1016/j.str.2007.07.006	53	34	34	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3009	3018		10.1074/jbc.M111.314559	http://dx.doi.org/10.1074/jbc.M111.314559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157758	Green Published, hybrid			2022-12-25	WOS:000300295100008
J	Taylor, CB; Talib, MF; McCabe, C; Bu, LT; Adney, WS; Himmel, ME; Crowley, MF; Beckham, GT				Taylor, Courtney B.; Talib, M. Faiz; McCabe, Clare; Bu, Lintao; Adney, William S.; Himmel, Michael E.; Crowley, Michael F.; Beckham, Gregg T.			Computational Investigation of Glycosylation Effects on a Family 1 Carbohydrate-binding Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY CALCULATIONS; CELLULOSE-BINDING; CELLOBIOHYDROLASE-I; MOLECULAR-DYNAMICS; MICROCRYSTALLINE CELLULOSE; CRYSTAL-STRUCTURE; O-GLYCOSYLATION; AMINO-ACIDS; AFFINITY; DOMAIN	Carbohydrate-binding modules (CBMs) are ubiquitous components of glycoside hydrolases, which degrade polysaccharides in nature. CBMs target specific polysaccharides, and CBM binding affinity to cellulose is known to be proportional to cellulase activity, such that increasing binding affinity is an important component of performance improvement. To ascertain the impact of protein and glycan engineering on CBM binding, we use molecular simulation to quantify cellulose binding of a natively glycosylated Family 1 CBM. To validate our approach, we first examine aromatic-carbohydrate interactions on binding, and our predictions are consistent with previous experiments, showing that a tyrosine to tryptophan mutation yields a 2-fold improvement in binding affinity. We then demonstrate that enhanced binding of 3-6-fold over a nonglycosylated CBM is achieved by the addition of a single, native mannose or a mannose dimer, respectively, which has not been considered previously. Furthermore, we show that the addition of a single, artificial glycan on the anterior of the CBM, with the native, posterior glycans also present, can have a dramatic impact on binding affinity in our model, increasing it up to 140-fold relative to the nonglycosylated CBM. These results suggest new directions in protein engineering, in that modifying glycosylation patterns via heterologous expression, manipulation of culture conditions, or introduction of artificial glycosylation sites, can alter CBM binding affinity to carbohydrates and may thus be a general strategy to enhance cellulase performance. Our results also suggest that CBM binding studies should consider the effects of glycosylation on binding and function.	[Taylor, Courtney B.; Talib, M. Faiz; McCabe, Clare] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [McCabe, Clare] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Bu, Lintao; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Adney, William S.; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines	McCabe, C (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.	c.mccabe@vanderbilt.edu; Gregg.Beckham@nrel.gov	crowley, michael F/A-4852-2013; McCabe, Clare/I-8017-2012	crowley, michael F/0000-0001-5163-9398; McCabe, Clare/0000-0002-8552-9135	United States Department of Energy Office of the Biomass Program; National Institute for Computational Sciences Athena and Kraken clusters under National Science Foundation [MCB090159]; National Energy Research Scientific Computing Center; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]	United States Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); National Institute for Computational Sciences Athena and Kraken clusters under National Science Foundation; National Energy Research Scientific Computing Center; Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy Office of the Biomass Program. Computer time was provided by the Texas Advanced Computing Center Ranger cluster and the National Institute for Computational Sciences Athena and Kraken clusters under National Science Foundation Teragrid Grant MCB090159, and the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the United States Department of Energy under Contract No. DE-AC02-05CH11231.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2003, J MOL MICROB BIOTECH, V5, P29, DOI 10.1159/000068721; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2001, BIOCHEM J, V358, P423, DOI 10.1042/0264-6021:3580423; Boyce SE, 2009, J MOL BIOL, V394, P747, DOI 10.1016/j.jmb.2009.09.049; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chundawat S. P. S., 2011, ANNU REV CHEM BIOMOL, V2, P61; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frenkel D., 2000, UNDERSTANDING MOL SI; Fujitani H, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1999637; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Heinzelman P, 2009, J BIOL CHEM, V284, P26229, DOI 10.1074/jbc.C109.034058; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim TW, 2010, BIOTECHNOL BIOENG, V107, P601, DOI 10.1002/bit.22856; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lantz SE, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-20; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; LINDER M, 1995, FEBS LETT, V372, P96, DOI 10.1016/0014-5793(95)00961-8; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mobley DL, 2007, J MOL BIOL, V371, P1118, DOI 10.1016/j.jmb.2007.06.002; Mobley DL, 2007, J CHEM THEORY COMPUT, V3, P1231, DOI 10.1021/ct700032n; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Paliwal H, 2011, J CHEM THEORY COMPUT, V7, P4115, DOI 10.1021/ct2003995; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pohorille A, 2010, J PHYS CHEM B, V114, P10235, DOI 10.1021/jp102971x; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; Takashima S, 2007, FEBS LETT, V581, P5891, DOI 10.1016/j.febslet.2007.11.068; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhao X, 2008, CHEM PHYS LETT, V460, P284, DOI 10.1016/j.cplett.2008.05.060; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005; Zhou W, 2009, BIOTECHNOL BIOENG, V104, P275, DOI 10.1002/bit.22388	62	52	54	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3147	3155		10.1074/jbc.M111.270389	http://dx.doi.org/10.1074/jbc.M111.270389			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22147693	hybrid, Green Published			2022-12-25	WOS:000300295100020
J	Novosad, BD; Astley, RA; Callegan, MC				Novosad, Billy D.; Astley, Roger A.; Callegan, Michelle C.			Role of Toll-Like Receptor (TLR) 2 in Experimental Bacillus cereus Endophthalmitis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA KERATITIS; STAPHYLOCOCCUS-EPIDERMIDIS ENDOPHTHALMITIS; NECROSIS-FACTOR-ALPHA; LIPOTEICHOIC ACID; CROSS-TOLERANCE; BACTERIAL ENDOPHTHALMITIS; INNATE IMMUNITY; HUMAN SEPSIS; EXPRESSION; LIPOPOLYSACCHARIDE	Bacillus cereus causes a uniquely rapid and blinding intraocular infection, endophthalmitis. B. cereus replicates in the eye, synthesizes numerous toxins, and incites explosive intraocular inflammation. The mechanisms involved in the rapid and explosive intraocular immune response have not been addressed. Because Toll-like receptors (TLRs) are integral to the initial recognition of organisms during infection, we hypothesized that the uniquely explosive immune response observed during B. cereus endophthalmitis is directly influenced by the presence of TLR2, a known Gram-positive pathogen recognition receptor. To address this hypothesis, we compared the courses of experimental B. cereus endophthalmitis in wild type C57BL/6J mice to that of age-matched homozygous TLR2(-/-) mice. Output parameters included analysis of bacterial growth, inflammatory cell (PMN) infiltration, cytokine/chemokine kinetics, retinal function testing, and histology, with N >= 4 eyes/assay/time point/mouse strain. B. cereus grew at similar rates to 10(8) CFU/eye by 12 h, regardless of the mouse strain. Retinal function was preserved to a greater degree in infected TLR2(-/-) eyes compared to that of infected wild type eyes, but infected eyes of both mouse strains lost significant function. Retinal architecture was preserved in infected TLR2(-/-) eyes, with limited retinal and vitreal cellular infiltration compared to that of infected wild type eyes. Ocular myeloperoxidase activities corroborated these results. In general, TNF alpha, IFN gamma, IL6, and KC were detected in greater concentrations in infected wild type eyes than in infected TLR2(-/-) eyes. The absence of TLR2 resulted in decreased intraocular proinflammatory cytokine/chemokine levels and altered recruitment of inflammatory cells into the eye, resulting in less intraocular inflammation and preservation of retinal architecture, and a slightly greater degree of retinal function. These results demonstrate TLR2 is an important component of the initial ocular response to B. cereus endophthalmitis.	[Novosad, Billy D.; Callegan, Michelle C.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Astley, Roger A.; Callegan, Michelle C.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73190 USA; [Callegan, Michelle C.] Dean A McGee Eye Inst, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Novosad, BD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	michelle-callegan@ouhsc.edu		Astley, Roger/0000-0002-2243-119X	National Institutes of Health (NIH) [R01EY012985, P30EY12191]; NCRR [P20RR17703]; Dean A. McGee Eye Institute from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190, R01EY012985] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Dean A. McGee Eye Institute from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by National Institutes of Health (NIH) Grant R01EY012985 (to MCC, http://www.nih.gov/). The authors' research is also supported in part by NIH Grants P30EY12191 (NIH CORE grant to Robert E. Anderson, OUHSC), Research Resources Grant P20RR17703 (NCRR COBRE grant to Robert E. Anderson, OUHSC), and an unrestricted grant to the Dean A. McGee Eye Institute from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; BEECHER DJ, 1995, INFECT IMMUN, V63, P632, DOI 10.1128/IAI.63.2.632-639.1995; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Brozou CG, 2009, OPHTHALMIC RES, V41, P181, DOI 10.1159/000217721; Burrough ER, 2010, VET PATHOL IN PRESS; Callegan MC, 1999, INFECT IMMUN, V67, P3348, DOI 10.1128/IAI.67.7.3348-3356.1999; Callegan MC, 2005, INVEST OPHTH VIS SCI, V46, P3233, DOI 10.1167/iovs.05-0410; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Chui JJY, 2010, INVEST OPHTH VIS SCI, V51, P2558, DOI 10.1167/iovs.09-3923; DAVID DB, 1994, BRIT J OPHTHALMOL, V78, P577, DOI 10.1136/bjo.78.7.577; Hei ZQ, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/519589; Hosseini H, 2009, CURR EYE RES, V34, P145, DOI 10.1080/02713680802585938; Huang X, 2007, INVEST OPHTH VIS SCI, V48, P4626, DOI 10.1167/iovs.07-0316; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Hughes MA, 2005, INFECT IMMUN, V73, P7535, DOI 10.1128/IAI.73.11.7535-7540.2005; Ito Y, 2005, INT IMMUNOL, V17, P1597, DOI 10.1093/intimm/dxh341; Jacinto R, 2002, J IMMUNOL, V168, P6136, DOI 10.4049/jimmunol.168.12.6136; Jin X, 2010, EUR J CLIN MICROBIOL, V29, P231, DOI 10.1007/s10096-009-0844-z; Kim HG, 2008, J MICROBIOL BIOTECHN, V18, P1191; Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Li FL, 2010, AM J NEPHROL, V32, P179, DOI 10.1159/000317023; Matsumura Naoki, 2007, Kobe J Med Sci, V53, P219; Moyer AL, 2009, INVEST OPHTH VIS SCI, V50, P3783, DOI 10.1167/iovs.08-3051; Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Pimentel-Nunes P, 2010, LIVER INT, V30, P1003, DOI 10.1111/j.1478-3231.2010.02251.x; Ramadan RT, 2008, INVEST OPHTH VIS SCI, V49, P4482, DOI 10.1167/iovs.08-2085; Ramadan RT, 2006, CURR EYE RES, V31, P955, DOI 10.1080/02713680600976925; Schaaf B, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-12; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tu XK, 2010, NEUROCHEM RES, V35, P1147, DOI 10.1007/s11064-010-0167-6; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; Wang JP, 2010, APMIS, V118, P261, DOI 10.1111/j.1600-0463.2010.02586.x; Yuan X, 2009, INVEST OPHTH VIS SCI, V1, P2094	41	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28619	10.1371/journal.pone.0028619	http://dx.doi.org/10.1371/journal.pone.0028619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163046	gold, Green Submitted, Green Published			2022-12-25	WOS:000298173500042
J	Badgaiyan, RD; Wack, D				Badgaiyan, Rajendra D.; Wack, David			Evidence of Dopaminergic Processing of Executive Inhibition	PLOS ONE			English	Article							REFERENCE TISSUE MODEL; RESPONSE ANTICIPATION; PARKINSONS-DISEASE; CAUDATE-NUCLEUS; RELEASE; ATTENTION; CONFLICT; PET; TASK; CATECHOLAMINES	Inhibition of unwanted response is an important function of the executive system. Since the inhibitory system is impaired in patients with dysregulated dopamine system, we examined dopamine neurotransmission in the human brain during processing of a task of executive inhibition. The experiment used a recently developed dynamic molecular imaging technique to detect and map dopamine released during performance of a modified Eriksen's flanker task. In this study, young healthy volunteers received an intravenous injection of a dopamine receptor ligand (C-11-raclopride) after they were positioned in the PET camera. After the injection, volunteers performed the flanker task under Congruent and Incongruent conditions in a single scan session. They were required to inhibit competing options to select an appropriate response in the Incongruent but not in the Congruent condition. The PET data were dynamically acquired during the experiment and analyzed using two variants of the simplified reference region model. The analysis included estimation of a number of receptor kinetic parameters before and after initiation of the Incongruent condition. We found increase in the rate of ligand displacement (from receptor sites) and decrease in the ligand binding potential in the Incongruent condition, suggesting dopamine release during task performance. These changes were observed in small areas of the putamen and caudate bilaterally but were most significant on the dorsal aspect of the body of left caudate. The results provide evidence of dopaminergic processing of executive inhibition and demonstrate that neurochemical changes associated with cognitive processing can be detected and mapped in a single scan session using dynamic molecular imaging.	[Badgaiyan, Rajendra D.] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA; [Badgaiyan, Rajendra D.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Badgaiyan, Rajendra D.] Vet Affairs Med Ctr, Dept Psychiat, Buffalo, NY USA; [Wack, David] SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Badgaiyan, RD (corresponding author), SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA.	rbrb@buffalo.edu	Badgaiyan, Rajendra D/B-8183-2012		National Institutes of Health (NIH)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was partially funded by a National Institutes of Health (NIH) grant awarded to RDB. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; Badgaiyan RD, 2008, NEUROREPORT, V19, P409, DOI 10.1097/WNR.0b013e3282f6435f; Badgaiyan RD, 2007, NEUROIMAGE, V38, P549, DOI 10.1016/j.neuroimage.2007.07.052; Badgaiyan RD, 2011, CURR MED IMAGING, V7, P98; Badgaiyan RD, 2011, CURR MED IMAGING REV, V7, P96; Badgaiyan RD, 2010, NEUROREPORT, V21, P1172, DOI 10.1097/WNR.0b013e3283410955; Badgaiyan RD, 2009, NEUROIMAGE, V47, P2041, DOI 10.1016/j.neuroimage.2009.06.008; Badgaiyan RD, 2003, NEUROREPORT, V14, P1421, DOI 10.1097/00001756-200308060-00003; Barto A.G., 1995, MODELS INFORM PROCES; Boraud T, 2000, J NEUROPHYSIOL, V83, P1760, DOI 10.1152/jn.2000.83.3.1760; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; CASTELLANOS FX, 1994, AM J PSYCHIAT, V151, P1791; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; CLARK CR, 1987, NEUROSCI BIOBEHAV R, V11, P341, DOI 10.1016/S0149-7634(87)80006-4; CLARK CR, 1987, NEUROSCI BIOBEHAV R, V11, P353, DOI 10.1016/S0149-7634(87)80007-6; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lutcke H, 2009, J COGNITIVE NEUROSCI, V21, P2172, DOI 10.1162/jocn.2008.21165; Luk G, 2010, BRAIN COGNITION, V74, P347, DOI 10.1016/j.bandc.2010.09.004; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Monchi O, 2006, NEUROIMAGE, V33, P907, DOI 10.1016/j.neuroimage.2006.06.058; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Riley JD, 2011, EPILEPSY BEHAV, V21, P80, DOI 10.1016/j.yebeh.2011.03.013; Rosell A, 1999, NEUROSCI RES, V34, P257, DOI 10.1016/S0168-0102(99)00060-7; SARTER M, 1994, PSYCHOPHARMACOLOGY, V114, P539, DOI 10.1007/BF02244983; Sawamoto N, 2008, BRAIN, V131, P1294, DOI 10.1093/brain/awn054; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Vaidya CJ, 2005, AM J PSYCHIAT, V162, P1605, DOI 10.1176/appi.ajp.162.9.1605; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Waltz RA, 2006, MATH PROGRAM, V107, P391, DOI 10.1007/s10107-004-0560-5; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P145, DOI 10.1016/j.neuropsychologia.2008.08.001; Zhou Y, 2006, NEUROIMAGE, V33, P550, DOI 10.1016/j.neuroimage.2006.06.038	43	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28075	10.1371/journal.pone.0028075	http://dx.doi.org/10.1371/journal.pone.0028075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162756	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800014
J	Okorie, PN; McKenzie, FE; Ademowo, OG; Bockarie, M; Kelly-Hope, L				Okorie, Patricia Nkem; McKenzie, F. Ellis; Ademowo, Olusegun George; Bockarie, Moses; Kelly-Hope, Louise			Nigeria Anopheles Vector Database: An Overview of 100 Years' Research	PLOS ONE			English	Article							VILLAGE-SCALE TRIAL; POPULATION GENETIC-STRUCTURE; PYRETHROID INSECTICIDE RESISTANCE; RESIDUAL FUMIGANT INSECTICIDE; GAMBIAE-SENSU-STRICTO; CHAIN-REACTION ASSAY; MALARIA VECTORS; LYMPHATIC FILARIASIS; MOLECULAR-FORMS; CHROMOSOMAL FORMS	Anopheles mosquitoes are important vectors of malaria and lymphatic filariasis (LF), which are major public health diseases in Nigeria. Malaria is caused by infection with a protozoan parasite of the genus Plasmodium and LF by the parasitic worm Wuchereria bancrofti. Updating our knowledge of the Anopheles species is vital in planning and implementing evidence based vector control programs. To present a comprehensive report on the spatial distribution and composition of these vectors, all published data available were collated into a database. Details recorded for each source were the locality, latitude/longitude, time/period of study, species, abundance, sampling/collection methods, morphological and molecular species identification methods, insecticide resistance status, including evidence of the kdr allele, and P. falciparum sporozoite rate and W. bancrofti microfilaria prevalence. This collation resulted in a total of 110 publications, encompassing 484,747 Anopheles mosquitoes in 632 spatially unique descriptions at 142 georeferenced locations being identified across Nigeria from 1900 to 2010. Overall, the highest number of vector species reported included An. gambiae complex (65.2%), An. funestus complex (17.3%), An. gambiae s.s. (6.5%). An. arabiensis (5.0%) and An. funestus s.s. (2.5%), with the molecular forms An. gambiae M and S identified at 120 locations. A variety of sampling/collection and species identification methods were used with an increase in molecular techniques in recent decades. Insecticide resistance to pyrethroids and organochlorines was found in the main Anopheles species across 45 locations. Presence of P. falciparum and W. bancrofti varied between species with the highest sporozoite rates found in An. gambiae s.s, An. funestus s.s. and An. moucheti, and the highest microfilaria prevalence in An. gambiae s.l., An. arabiensis, and An. gambiae s.s. This comprehensive georeferenced database provides an essential baseline on Anopheles vectors and will be an important resource for malaria and LF vector control programmes in Nigeria.	[Okorie, Patricia Nkem; Ademowo, Olusegun George] Univ Ibadan, Inst Adv Med Res & Training, Coll Med, Ibadan, Nigeria; [McKenzie, F. Ellis] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Bockarie, Moses; Kelly-Hope, Louise] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	University of Ibadan; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Liverpool School of Tropical Medicine; University of Liverpool	Okorie, PN (corresponding author), Univ Ibadan, Inst Adv Med Res & Training, Coll Med, Ibadan, Nigeria.	triciaokoye@yahoo.com	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021	Kelly-Hope, Louise/0000-0002-3330-7629; Ademowo, Olusegun/0000-0003-4020-5134	MRC [G1001337] Funding Source: UKRI; Medical Research Council [G1001337] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adeleke M A, 2008, Tanzan J Health Res, V10, P103; Adeleke MA, 2010, J VECTOR DIS, V47, P33; Adeleke Monsuru Adebayo, 2008, Acta Entomologica Sinica, V51, P1289; Afolabi BM, 2006, MED PRIN PRACT, V15, P200, DOI 10.1159/000092182; Agi P. I., 2009, Journal of Applied Sciences and Environmental Management, V13, P15; Amusan A A S, 2005, Tanzan Health Res Bull, V7, P111; Amusan AAS, 2003, NIGERIAN J PARASITOL, V24, P167; Annett E, 1901, LIVERPOOL SCH TROP M, VIV, P69; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2007, ANVR Q NEWSLETTER, V2; [Anonymous], DIR CIT TOWNS WORLD; [Anonymous], 2006, ANVR NEWSLETTER, V1; Anosike JC, 2005, ANN AGR ENV MED, V12, P181; Anosike JC, 2007, ANN AGR ENV MED, V14, P31; Anyanwu IN, 2000, VET PARASITOL, V92, P319, DOI 10.1016/S0304-4017(00)00311-3; ARCHIBALD H. MUNRO, 1956, BULL WORLD HEALTH ORGAN, V15, P695; Armstrong JA, 1957, ANN TROP MED PARASIT, V52, P247; Awolola TS, 2009, T ROY SOC TROP MED H, V103, P1139, DOI 10.1016/j.trstmh.2008.08.021; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P181; Awolola TS, 2005, ACTA TROP, V95, P204, DOI 10.1016/j.actatropica.2005.06.002; Awolola TS, 2005, T ROY SOC TROP MED H, V99, P525, DOI 10.1016/j.trstmh.2004.12.003; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P75, DOI 10.1179/000349802125000538; Awolola TS, 2003, AFR ENTOMOL, V11, P227; Awolola TS, 2003, TROP MED INT HEALTH, V8, P420, DOI 10.1046/j.1365-3156.2003.01034.x; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P849, DOI 10.1179/000349802125002581; Awolola TS, 2007, MALARIA ENTOMOLOGICA, P50; Ayanda OI, 2009, J PARASITOL, V1, P005; BARZEEV M, 1965, B WORLD HEALTH ORGAN, V33, P583; BARZEEV M, 1965, B WORLD HEALTH ORGAN, V33, P461; Bayoh MN, 2001, MED VET ENTOMOL, V15, P267, DOI 10.1046/j.0269-283x.2001.00298.x; Bockarie MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1686; BOREHAM PFL, 1979, T ROY SOC TROP MED H, V73, P418, DOI 10.1016/0035-9203(79)90167-6; Brooke BD, 1999, J AM MOSQUITO CONTR, V15, P565; Bruce-Chwatt LJ, 1985, ESSENTIAL MALARIOLOG; Brunhes J, 1998, ANN SOC ENTOMOL FR, V34, P397; Chandler AC, 1955, INTRO PARASITOLOGY, P693; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M, 1975, 24 WHO, P16; DAVIDSON G, 1962, B WORLD HEALTH ORGAN, V27, P303; De Meillon B, 1931, S AFRICA INVEST MED, V28, P578; de MEILLON BOTHA, 1947, JOUR ENT SOC SO AFRICA, V10, P110; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; Dialynas E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000465; Djouaka RF, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-159; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Dodge JS, WHOMAL52065; Edwards FW, 1941, PUB I MED RES, V23, P28; ELLIOTT R, 1956, NATURE, V177, P532, DOI 10.1038/177532a0; ELLIOTT R, 1963, B WORLD HEALTH ORGAN, V28, P35; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; FMEN (Federal Ministry of Environment of Nigeria), 2001, NAT ACT PROGR COMB D; FMH (Federal Ministry of Health), 2008, STRAT PLAN 2009 2013; FOLL CV, 1965, B WORLD HEALTH ORGAN, V32, P531; FOLL CV, 1966, B WORLD HEALTH ORGAN, V34, P395; Fontaine RE, 1971, WHOVBC71284; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; Gillett J. D., 1972, COMMON AFRICAN MOSQU, P1; GILLIES M. T., 1968, The Anophelinae of Africa south of the Sahara (Ethiopian Zoogeographical Region).; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Gordon RM, 1978, ENTOMOLOGY STUDENTS; Govella N, 2010, AM J TROP MED HYG, V83, P596, DOI 10.4269/ajtmh.2010.09-0682; GRATZ NG, 1963, B WORLD HEALTH ORGAN, V29, P251; Greenwood BM, 2006, TRENDS PARASITOL, V22, P278, DOI 10.1016/j.pt.2006.05.005; Hackett BJ, 2000, INSECT MOL BIOL, V9, P369, DOI 10.1046/j.1365-2583.2000.00198.x; HANNEY P. W., 1960, BULL ENT RES, V51, P145, DOI 10.1017/S0007485300055024; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hopkins GHE, 1952, MOSQUITOES ETHIOPIAN, p[1, 100, 136, 194, 250, 305]; Iloeje N.P., 2001, NEW GEOGRAPHY NIGERI; IRAC (Insecticide Resistance Action Committee), 2011, PREV MAN INS RES VEC, P72; IRAC (Insecticide Resistance Action Committee), 2010, IMP INS RES MAN CONT; IRAC (Insecticide Resistance Action Committee), 2010, INCR UT IMP BIOM TEC; Ivoke N, 2009, ANI RES INT, V6, P1072; Johnson W. B., 1919, Bulletin of Entomological Research London, V9, DOI 10.1017/S0007485300038049; Katz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017166; Kelly-Hope LA, 2006, TROP MED INT HEALTH, V11, P129, DOI 10.1111/j.1365-3156.2005.01558.x; Kelly-Hope LA, 2005, T ROY SOC TROP MED H, V99, P751, DOI 10.1016/j.trstmh.2005.05.008; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Kengne P, 2007, MED VET ENTOMOL, V21, P177, DOI 10.1111/j.1365-2915.2007.00681.x; Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kristan M, 2003, MED VET ENTOMOL, V17, P326, DOI 10.1046/j.1365-2915.2003.00449.x; KUHLOW F, 1962, B WORLD HEALTH ORGAN, V26, P93; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lehmann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004549; Lenhart Audrey, 2007, Filaria J, V6, P14, DOI 10.1186/1475-2883-6-14; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lindsay SW, 2000, T ROY SOC TROP MED H, V94, P37, DOI 10.1016/S0035-9203(00)90431-0; Manga SB, 2008, NIG J PARASITOL, V29, P103; Manguin S, 2010, INFECT GENET EVOL, V10, P159, DOI 10.1016/j.meegid.2009.11.014; MELLANBY K., 1956, Bulletin of Entomological Research, V47, P125, DOI 10.1017/S0007485300046587; Michel AP, 2005, MOL ECOL, V14, P4235, DOI 10.1111/j.1365-294X.2005.02754.x; MOLINEAUX L, 1976, B WORLD HEALTH ORGAN, V54, P379; MOLINEAUX L, 1979, B WORLD HEALTH ORGAN, V57, P265; Molineaux L, 1980, WHO, V312, P53; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Ndams IS, 2006, SCI WORLD J, V1, P15; Ndo C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-161; NGA, 2008, NGA GEONET NAM SERV; Nigeria FY, 2010, 2011 MALARIA OPERATI; Njenga SM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-90; Noutcha MAE, 2010, J VECTOR DIS, V47, P51; Noutcha MAE, 2009, J VECTOR DIS, V46, P43; Obomanu FG, 2006, AFR J BIOTECHNOL, V5, P761; Oduola A. O., 2010, Journal of Rural and Tropical Public Health, V9, P114; Ogba OM, 2007, J MED LAB SCI, V16, P1; OGUNBA EO, 1971, ANN TROP MED PARASIT, V65, P399, DOI 10.1080/00034983.1971.11686769; Oguoma V., 2009, ANIM RES INT, DOI [10.4314/ari.v5i2.48748, DOI 10.4314/ARI.V5I2.48748]; Oguoma V. M., 2010, Reviews in Infection, V1, P192; Okara RM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-69; Okogun Godwin R. A., 2005, Journal of Vector Borne Diseases, V42, P1; Okwa OO, 2009, ANN AFR MED, V8, P1, DOI 10.4103/1596-3519.55756; Okwa OO., 2007, J CELL ANIMAL BIOL, V1, P19; Olayemi I, 2008, J HLTH ALLIED SCI, V7, P1; Olayemi IK, 2009, J VECTOR DIS, V46, P295; Onyabe DY, 2003, T ROY SOC TROP MED H, V97, P605, DOI 10.1016/S0035-9203(03)80045-7; Onyabe DY, 2001, MOL ECOL, V10, P2577, DOI 10.1046/j.0962-1083.2001.01387.x; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Oparaocha ET, 2010, J VECTOR DIS, V47, P45; Oyewole I.O., 2010, International Journal of Insect Science, V2, P51; Oyewole I. O., 2007, Journal of Vector Borne Diseases, V44, P56; Oyewole I. O., 2006, Journal of Vector Borne Diseases, V43, P173; Oyewole IO, 2005, BIOKEMISTRI, V17, P171; PANT CP, 1969, B WORLD HEALTH ORGAN, V41, P311; PANT CP, 1969, B WORLD HEALTH ORGAN, V41, P316; PANT CP, 1966, B WORLD HEALTH ORGAN, V35, P709; Pant CP, 1968, WHOVBC68104; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Pluess B, INDOOR RESIDUAL SPRA; Pombi M, 2008, BMC EVOL BIOL, V8, P309, DOI DOI 10.1186/1471-2148-8-309; RAMAKRISHNA V, 1957, NATURE, V179, P1140, DOI 10.1038/1791140b0; RAMSDALE CD, 1967, B WORLD HEALTH ORGAN, V36, P494; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; RBM Report, 2005, BUILD CAP MON EV ROL; Richards F O Jr, 2005, Filaria J, V4, P6, DOI 10.1186/1475-2883-4-6; Richards FO, 2005, ANN TROP MED PARASIT, V99, P155, DOI 10.1179/136485905X19838; RISHIKESH N, 1985, ACTA TROP, V42, P165; Rosen P, 1970, WHOVBC70192; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SELF LS, 1966, B WORLD HEALTH ORGAN, V34, P960; SERVICE M W, 1961, West Afr Med J, V10, P109; SERVICE M. W., 1964, Bulletin of Entomological Research, V55, P29, DOI 10.1017/S0007485300049257; SERVICE M. W., 1963, Bulletin of Entomological Research, V54, P601, DOI 10.1017/S000748530004904X; SERVICE MW, 1971, B WORLD HEALTH ORGAN, V45, P169; SERVICE MW, 1964, J TROP MED HYG, V67, P190; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; SERVICE MW, 1964, J TROP MED HYG, V67, P11; SERVICE MW, 1970, ANN TROP MED PARASIT, V64, P131, DOI 10.1080/00034983.1970.11686674; SERVICE MW, 1964, NATURE, V203, P209, DOI 10.1038/203209a0; Service MW, 1976, MOSQUITO BIOL FIELD; Service MW, 1980, GUIDE MEDICAL ENTOMO; Service MW, 1964, T R SOC TROP MED HYG, V58, P1; Service MW, 1964, P R ENT SOC LOND B, V33, P73; Shidrawi GR, 1972, WHOMAL72776; Sikulu M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-197; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Smart J, 1956, HDB IDENTIFICATION I; SMITH DMS, 1981, J TROP MED HYG, V84, P95; Sogoba N, 2007, GEOSPATIAL HEALTH, V1, P213, DOI 10.4081/gh.2007.269; Sogoba N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-205; Sow G.J., 2007, SCI WORLD J, V2, P5, DOI [10.4314/swj.v2i4.51753, DOI 10.4314/SWJ.V2I4.51753]; TAYLOR A. W., 1930, ANN TROP MED AND PARASITOL, V24, P425; THOMSON RCM, 1948, B ENTOMOL RES, V38, P527, DOI 10.1017/S0007485300023221; UDONSI JK, 1988, FOLIA PARASIT, V35, P147; WHITE GB, 1973, B ENTOMOL RES, V62, P613, DOI 10.1017/S0007485300005502; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, 2005, ATL INS RES MAL VECT; *WHO, 1957, B WORLD HEALTH ORGAN, V16, P874; WHO, 2010, PROGR REP 2000 2009; WHO, 2011, WEEKLY EPIDEMIOLOGIC, V86, P113; WRIGHT JW, 1969, B WORLD HEALTH ORGAN, V40, P67	175	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28347	10.1371/journal.pone.0028347	http://dx.doi.org/10.1371/journal.pone.0028347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162764	gold, Green Published, Green Accepted			2022-12-25	WOS:000298172800027
J	Gallagher, AM; Smeeth, L; Seabroke, S; Leufkens, HGM; van Staa, TP				Gallagher, Arlene M.; Smeeth, Liam; Seabroke, Suzie; Leufkens, Hubert G. M.; van Staa, Tjeerd P.			Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; ACUTE MYOCARDIAL-INFARCTION; RETROSPECTIVE COHORT; OLDER PATIENTS; ROSIGLITAZONE; PIOGLITAZONE; EVENTS; ASSOCIATION	Objective: To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events and mortality in patients using diabetes medication. Methods: The General Practice Research Database was used to identify inception cohorts of insulin and different oral antidiabetics. An analysis of bias and incidence of mortality, acute coronary syndrome, stroke and heart failure were analysed in GPRD, Hospital Episode Statistics and death certificates. Results: 206,940 patients were identified. The bias analysis showed that past thiazolidinedione users had a lower mortality risk compared to past metformin users. There were no differences between past users of rosiglitazone and pioglitazone (adjusted RR of 1.04; 95% CI 0.93-1.18). Current rosiglitazone users had an increased risk of death (adjusted RR 1.20; 95% CI 1.08-1.34) and of hospitalisation for heart failure (adjusted RR of 1.73; 95% CI 1.19-2.51) compared to current pioglitazone users. Risk of mortality was increased two-fold shortly after starting rosiglitazone. Excess risk of death over 3 years with rosiglitazone was 0.3 per 100 in those aged 50-64 years, 2.0 aged 65-74, 3.0 aged 75-84, and 7.0 aged 85+. The cause of death with rosiglitazone was more likely to be due to a disease of the circulatory system. Conclusions: Higher risks for death (overall and due to cardiovascular disease) and heart failure were found for rosiglitazone compared to pioglitazone. These excess risks were largest in patients aged 65 years or older. The European regulatory decision to suspend rosiglitazone is supported by this study.	[Gallagher, Arlene M.; van Staa, Tjeerd P.] Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database, London, England; [Gallagher, Arlene M.; Leufkens, Hubert G. M.; van Staa, Tjeerd P.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Smeeth, Liam] London Sch Hyg & Trop Med, London WC1, England; [Seabroke, Suzie] Med & Healthcare Prod Regulatory Agcy, Div Vigilance & Risk Management Med, London, England	The Medicines & Healthcare Products Regulatory Agency; Utrecht University; University of London; London School of Hygiene & Tropical Medicine; The Medicines & Healthcare Products Regulatory Agency	Gallagher, AM (corresponding author), Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database, London, England.	Tjeerd.vanstaa@GPRD.com	Swaibu, Ramadhani A/H-3164-2011; Smeeth, Liam/X-5862-2018	van Staa, Tjeerd/0000-0001-9363-742X; Smeeth, Liam/0000-0002-9168-6022	Division of Vigilance and Risk Management of the Medicines and Healthcare products Regulatory Agency (MHRA), UK; MHRA; Wellcome Trust; Medical Research Council; NIHR; Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU; GlaxoSmithKline; Novo Nordisk; Dutch Medicines Evaluation Board; Dutch Ministry of Health; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Division of Vigilance and Risk Management of the Medicines and Healthcare products Regulatory Agency (MHRA), UK; MHRA; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU(European Commission); GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Dutch Medicines Evaluation Board; Dutch Ministry of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Division of Vigilance and Risk Management of the Medicines and Healthcare products Regulatory Agency (MHRA), UK. GPRD is owned by the Secretary of State of the UK Department of Health and operates within the Medicines and Healthcare products Regulatory Agency (MHRA). The General Practice Research Database (GPRD) is owned by the UK Department of Health and operates within the Medicines and Healthcare products Regulatory Agency (MHRA). GPRD has received funding from the MHRA, Wellcome Trust, Medical Research Council, NIHR Health Technology Assessment programme, Innovative Medicine Initiative, UK Department of Health, Technology Strategy Board, Seventh Framework Programme EU, various universities, contract research organisations and pharmaceutical companies. The department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private-public funded Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay L, 2010, PHARMACOEPIDEM DR S, V19, P343, DOI 10.1002/pds.1883; Bilik D, 2010, PHARMACOEPIDEM DR S, V19, P715, DOI 10.1002/pds.1954; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; de Vries F, 2006, INT J EPIDEMIOL, V35, P1301, DOI 10.1093/ije/dyl147; Dore DD, 2009, PHARMACOTHERAPY, V29, P775, DOI 10.1592/phco.29.7.775; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormuth CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006080; Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Habib ZA, 2009, PHARMACOEPIDEM DR S, V18, P437, DOI 10.1002/pds.1722; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hsiao FY, 2009, DRUG SAFETY, V32, P675, DOI 10.2165/00002018-200932080-00006; Johannes CB, 2007, PHARMACOEPIDEM DR S, V16, P504, DOI 10.1002/pds.1356; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Karter AJ, 2005, DIABETIC MED, V22, P986, DOI 10.1111/j.1464-5491.2005.01704.x; Koro CE, 2008, PHARMACOEPIDEM DR S, V17, P989, DOI 10.1002/pds.1640; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Lash TL, APPL QUANTITATIVE BI; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; Masoudi FA, 2005, CIRCULATION, V111, P583, DOI 10.1161/01.CIR.0000154542.13412.B1; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nissen SE, 2010, ARCH INTERN MED 0628; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Parkinson J, 2007, PHARMACOVIGILANCE, P341, DOI DOI 10.1002/9780470059210.CH27; Rajagopalan R, 2004, CLIN THER, V26, P1400, DOI 10.1016/j.clinthera.2004.09.016; RAMLAUHANSEN H, 1983, ANN STAT, V11, P453, DOI 10.1214/aos/1176346152; Shaya Fadia T, 2009, P T, V34, P490; Stockl KM, 2009, PHARMACOEPIDEM DR S, V18, P166, DOI 10.1002/pds.1700; Tzoulaki I, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4731; van Staa TP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000194; Vanasse A, 2009, DIABETES VASC DIS RE, V6, P87, DOI 10.1177/1479164109336047; Walker AM, 2008, PHARMACOEPIDEM DR S, V17, P760, DOI 10.1002/pds.1598; Wertz DA, 2010, CIRC-CARDIOVASC QUAL, V3, P538, DOI 10.1161/CIRCOUTCOMES.109.911461; Winkelmayer WC, 2008, ARCH INTERN MED, V168, P2368, DOI 10.1001/archinte.168.21.2368; Ziyadeh N, 2009, CLIN THER, V31, P2665, DOI 10.1016/j.clinthera.2009.11.003	39	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28157	10.1371/journal.pone.0028157	http://dx.doi.org/10.1371/journal.pone.0028157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164237	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000298171400038
J	Ghimenti, S; Lomonaco, T; Onor, M; Murgia, L; Paolicchi, A; Fuoco, R; Ruocco, L; Pellegrini, G; Trivella, MG; Di Francesco, F				Ghimenti, Silvia; Lomonaco, Tommaso; Onor, Massimo; Murgia, Laura; Paolicchi, Aldo; Fuoco, Roger; Ruocco, Lucia; Pellegrini, Giovanni; Trivella, Maria Giovanna; Di Francesco, Fabio			Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy	PLOS ONE			English	Article							INTERNATIONAL NORMALIZED RATIO; LIQUID-CHROMATOGRAPHY; BLEEDING COMPLICATIONS; DOSE REQUIREMENT; SELF-MANAGEMENT; VITAMIN-K; SALIVA; CYP2C9; DRUG; PHARMACOKINETICS	Background: Patients on warfarin therapy undergo invasive and expensive checks for the coagulability of their blood. No information on coagulation levels is currently available between two controls. Methodology: A method was developed to determine warfarin in oral fluid by HPLC and fluorimetric detection. The chromatographic separation was performed at room temperature on a C-18 reversed-phase column, 65% PBS and 35% methanol mobile phase, flow rate 0.7 mL/min, injection volume 25 mu L, excitation wavelength 310 nm, emission wavelength 400 nm. Findings: The method was free from interference and matrix effect, linear in the range 0.2-100 ng/mL, with a detection limit of 0.2 ng/mL. Its coefficient of variation was,3% for intra-day measurements and,5% for inter-day measurements. The average concentration of warfarin in the oral fluid of 50 patients was 2.5 +/- 1.6 ng/mL (range 0.8-7.6 ng/mL). Dosage was not correlated to INR (r = 20.03, p = 0.85) but positively correlated to warfarin concentration in the oral fluid (r = 0.39, p = 0.006). The correlation between warfarin concentration and pH in the oral fluid (r = 0.37, p = 0.009) confirmed the importance of pH in regulating the drug transfer from blood. A correlation between warfarin concentration in the oral fluid and INR was only found in samples with pH values >= 7.2 (r = 0.84, p = 0.004). Conclusions: Warfarin diffuses from blood to oral fluid. The method allows to measure its concentration in this matrix and to analyze correlations with INR and other parameters.	[Ghimenti, Silvia; Lomonaco, Tommaso; Murgia, Laura; Fuoco, Roger; Di Francesco, Fabio] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy; [Onor, Massimo] CNR, Ist Chim Composti Organometall, I-56100 Pisa, Italy; [Paolicchi, Aldo] Univ Pisa, Dipartimento Patol Sperimentale BMIE, Sez Patol Gen & Clin, Pisa, Italy; [Ruocco, Lucia; Pellegrini, Giovanni] Azienda Osped Univ Pisana, Lab Anal Chim Clin, Pisa, Italy; [Trivella, Maria Giovanna] CNR, Ist Fisiol Clin, I-56100 Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Isituto di Chimica dei Composti Organometallici (ICCOM-CNR); University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Consiglio Nazionale delle Ricerche (CNR)	Ghimenti, S (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.	fdifra@dcci.unipi.it	Pellegrini, Giovanni/ABF-4802-2020; Onor, Massimo/A-4382-2012; Paolicchi, Aldo/K-3946-2018; Lomonaco, Tommaso/K-8276-2016; Di Francesco, Fabio/I-8756-2012	Pellegrini, Giovanni/0000-0003-3131-1605; Onor, Massimo/0000-0003-3023-1072; Paolicchi, Aldo/0000-0002-9940-8481; Lomonaco, Tommaso/0000-0002-1822-7399; Di Francesco, Fabio/0000-0002-9285-1595; RUOCCO, LUCIA/0000-0002-2637-2705; Trivella, Maria Giovanna/0000-0001-8702-2859	University of Pisa	University of Pisa	This research was supported by the University of Pisa funds for basic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; ANDERSON DR, 1993, ARCH INTERN MED, V153, P1441, DOI 10.1001/archinte.153.12.1441; [Anonymous], PHARM TIMES; Booth SL, 1999, NUTR REV, V57, P288; Corran P, 1999, WHO TECH REP SER, V889, P1; DANHOF M, 1978, CLIN PHARMACOKINET, V3, P39, DOI 10.2165/00003088-197803010-00003; Furuya H, 1995, PHARMACOGENETICS, V5, P389, DOI 10.1097/00008571-199512000-00008; Gage BF, 2000, AM J MED, V109, P481, DOI 10.1016/S0002-9343(00)00545-3; HAECKEL R, 1990, J INT FED CLIN CHEM, V2, P208; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; Hirsh J, 2003, J AM COLL CARDIOL, V41, P1633, DOI 10.1016/S0735-1097(03)00416-9; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Huang CR, 2008, CLIN CHIM ACTA, V393, P85, DOI 10.1016/j.cca.2008.03.008; IUPAC, 1978, SPECTROCHIM ACTA B, V33, P241; Jolliffe, 2002, PRINCIPAL COMPONENT; Katzung B.G, 2012, BASIC CLIN PHARMACOL; Kidwell DA, 1998, J CHROMATOGR B, V713, P111, DOI 10.1016/S0378-4347(97)00572-0; Lombardi R, 2003, THROMB RES, V111, P281, DOI 10.1016/j.thromres.2003.09.006; MATIN SB, 1974, CLIN PHARMACOL THER, V16, P1052; MUCKLOW JC, 1978, CLIN PHARMACOL THER, V24, P563; Paxton J W, 1979, Methods Find Exp Clin Pharmacol, V1, P11; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; SELLERS EM, 1970, CLIN PHARMACOL THER, V11, P524; Siebenhofer A, 2008, THROMB HAEMOSTASIS, V100, P1089, DOI 10.1160/TH08-06-0361; SORANO GG, 1993, HAEMOSTASIS, V23, P77; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; WHITE RH, 1989, ANN INTERN MED, V111, P730, DOI 10.7326/0003-4819-111-9-730; WONG YWJ, 1989, J CHROMATOGR, V469, P281, DOI 10.1016/S0021-9673(01)96463-5; YACOBI A, 1977, J PHARMACOKINET BIOP, V5, P123, DOI 10.1007/BF01066216	32	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28182	10.1371/journal.pone.0028182	http://dx.doi.org/10.1371/journal.pone.0028182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164240	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400041
J	Jafari, N; Broer, L; van Duijn, CM; Janssens, ACJW; Hintzen, RQ				Jafari, Naghmeh; Broer, Linda; van Duijn, Cornelia M.; Janssens, A. Cecile J. W.; Hintzen, Rogier Q.			Perspectives on the Use of Multiple Sclerosis Risk Genes for Prediction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DISEASES; REPLICATION; POPULATION; GENETICS; ALLELES; VARIANT	Objective: A recent collaborative genome-wide association study replicated a large number of susceptibility loci and identified novel loci. This increase in known multiple sclerosis (MS) risk genes raises questions about clinical applicability of genotyping. In an empirical set we assessed the predictive power of typing multiple genes. Next, in a modelling study we explored current and potential predictive performance of genetic MS risk models. Materials and Methods: Genotype data on 6 MS risk genes in 591 MS patients and 600 controls were used to investigate the predictive value of combining risk alleles. Next, the replicated and novel MS risk loci from the recent and largest international genome-wide association study were used to construct genetic risk models simulating a population of 100,000 individuals. Finally, we assessed the required numbers, frequencies, and ORs of risk SNPs for higher discriminative accuracy in the future. Results: Individuals with 10 to 12 risk alleles had a significantly increased risk compared to individuals with the average population risk for developing MS (OR 2.76 (95% CI 2.02-3.77)). In the simulation study we showed that the area under the receiver operating characteristic curve (AUC) for a risk score based on the 6 SNPs was 0.64. The AUC increases to 0.66 using the well replicated 24 SNPs and to 0.69 when including all replicated and novel SNPs (n = 53) in the risk model. An additional 20 SNPs with allele frequency 0.30 and ORs 1.1 would be needed to increase the AUC to a slightly higher level of 0.70, and at least 50 novel variants with allele frequency 0.30 and ORs 1.4 would be needed to obtain an AUC of 0.85. Conclusion: Although new MS risk SNPs emerge rapidly, the discriminatory ability in a clinical setting will be limited.	[Jafari, Naghmeh; Hintzen, Rogier Q.] Erasmus MC, ErasMS Ctr, Dept Neurol, Rotterdam, Netherlands; [Broer, Linda; van Duijn, Cornelia M.; Janssens, A. Cecile J. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Jafari, N (corresponding author), Erasmus MC, ErasMS Ctr, Dept Neurol, Rotterdam, Netherlands.	r.hintzen@erasmusmc.nl		Janssens, A Cecile/0000-0002-6153-4976; Broer, Linda/0000-0003-0011-123X; Van Duijn, Cornelia/0000-0002-2374-9204	Dutch MS Research Foundation, The Netherlands	Dutch MS Research Foundation, The Netherlands(Netherlands Government)	The ErasMS Center Rotterdam is financially supported by the Dutch MS Research Foundation, The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; D'Netto MJ, 2009, NEUROLOGY, V72, P1984, DOI 10.1212/WNL.0b013e3181a92c25; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Gourraud PA, 2011, ANN NEUROL, V69, P65, DOI 10.1002/ana.22323; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Hoppenbrouwers IA, 2009, J HUM GENET, V54, P676, DOI 10.1038/jhg.2009.96; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Kieseier BC, 2008, J NEUROL, V255, P15, DOI 10.1007/s00415-008-6004-z; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Pepe MS, 2010, CANCER EPIDEM BIOMAR, V19, P655, DOI 10.1158/1055-9965.EPI-09-0510; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramagopalan SV, 2009, NEUROEPIDEMIOLOGY, V32, P257, DOI 10.1159/000201564; Sackett D.L., 1985, CLIN EPIDEMIOLOGY BA; SADOVNICK AD, 1988, AM J MED GENET, V29, P533, DOI 10.1002/ajmg.1320290310; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2010, ANN NEUROL, V67, P3, DOI 10.1002/ana.21911; Simon KC, 2010, NEUROLOGY, V74, P1365, DOI 10.1212/WNL.0b013e3181dad57e; Sundstrom P, 2008, MULT SCLER J, V14, P1120, DOI 10.1177/1352458508092353; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; van Zitteren M, 2011, CANCER EPIDEM BIOMAR, V20, P9, DOI 10.1158/1055-9965.EPI-10-0329; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zeggini E, 2011, NAT GENET, V43, P287, DOI 10.1038/ng0411-287	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e26493	10.1371/journal.pone.0026493	http://dx.doi.org/10.1371/journal.pone.0026493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164203	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400003
J	Forsyth, CB; Shannon, KM; Kordower, JH; Voigt, RM; Shaikh, M; Jaglin, JA; Estes, JD; Dodiya, HB; Keshavarzian, A				Forsyth, Christopher B.; Shannon, Kathleen M.; Kordower, Jeffrey H.; Voigt, Robin M.; Shaikh, Maliha; Jaglin, Jean A.; Estes, Jacob D.; Dodiya, Hemraj B.; Keshavarzian, Ali			Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease	PLOS ONE			English	Article							LEWY BODIES; METAGENOMIC ANALYSIS; NERVOUS-SYSTEM; LPS; LIPOPOLYSACCHARIDE; GUT; NEURONS; BARRIER; PROTEIN; BRAIN	Parkinson's disease (PD) is the second most common neurodegenerative disorder of aging. The pathological hallmark of PD is neuronal inclusions termed Lewy bodies whose main component is alpha-synuclein protein. The finding of these Lewy bodies in the intestinal enteric nerves led to the hypothesis that the intestine might be an early site of PD disease in response to an environmental toxin or pathogen. One potential mechanism for environmental toxin(s) and proinflammatory luminal products to gain access to mucosal neuronal tissue and promote oxidative stress is compromised intestinal barrier integrity. However, the role of intestinal permeability in PD has never been tested. We hypothesized that PD subjects might exhibit increased intestinal permeability to proinflammatory bacterial products in the intestine. To test our hypothesis we evaluated intestinal permeability in subjects newly diagnosed with PD and compared their values to healthy subjects. In addition, we obtained intestinal biopsies from both groups and used immunohistochemistry to assess bacterial translocation, nitrotyrosine (oxidative stress), and alpha-synuclein. We also evaluated serum markers of endotoxin exposure including LPS binding protein (LBP). Our data show that our PD subjects exhibit significantly greater intestinal permeability (gut leakiness) than controls. In addition, this intestinal hyperpermeability significantly correlated with increased intestinal mucosa staining for E. coli bacteria, nitrotyrosine, and alpha-synuclein as well as serum LBP levels in PD subjects. These data represent not only the first demonstration of abnormal intestinal permeability in PD subjects but also the first correlation of increased intestinal permeability in PD with intestinal alpha-synuclein (the hallmark of PD), as well as staining for gram negative bacteria and tissue oxidative stress. Our study may thus shed new light on PD pathogenesis as well as provide a new method for earlier diagnosis of PD and suggests potential therapeutic targets in PD subjects.	[Forsyth, Christopher B.; Voigt, Robin M.; Shaikh, Maliha; Keshavarzian, Ali] Rush Univ, Med Ctr, Gastroenterol Sect, Dept Internal Med, Chicago, IL 60612 USA; [Shannon, Kathleen M.; Jaglin, Jean A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Kordower, Jeffrey H.; Dodiya, Hemraj B.] Rush Med Coll, Ctr Brain Repair, Chicago, IL 60612 USA; [Estes, Jacob D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA	Rush University; Rush University; Rush University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Forsyth, CB (corresponding author), Rush Univ, Med Ctr, Gastroenterol Sect, Dept Internal Med, Chicago, IL 60612 USA.	christopher_b_forsyth@rush.edu		Dodiya, Hemraj/0000-0002-0908-0014	Parkinson's Research Center from the Parkinson's Disease Foundation	Parkinson's Research Center from the Parkinson's Disease Foundation	Funding provided by a gift from Mr. and Mrs. Larry Field (to AK) and Parkinson's Research Center Grant from the Parkinson's Disease Foundation (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Cirillo C, 2009, NEUROGASTROENT MOTIL, V21, P1209, DOI 10.1111/j.1365-2982.2009.01346.x; Davies KN, 1996, POSTGRAD MED J, V72, P164, DOI 10.1136/pgmj.72.845.164; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Emanuele E, 2010, NEUROSCI LETT, V471, P162, DOI 10.1016/j.neulet.2010.01.033; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Farhadi A, 2003, J CHROMATOGR B, V784, P145, DOI 10.1016/S1570-0232(02)00787-0; Farhadi A, 2006, J CHROMATOGR B, V836, P63, DOI 10.1016/j.jchromb.2006.03.046; Gao HM, 2011, ENV HLTH PERSPECT; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Greene JG, 2009, EXP NEUROL, V218, P154, DOI 10.1016/j.expneurol.2009.04.023; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hobson P, 2010, J NEUROL NEUROSUR PS, V81, P1093, DOI 10.1136/jnnp.2009.198689; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; John LJ, 2011, EPITHELIAL BARRIERS; Keck S, 2011, J IMMUNOL, V186, P5478, DOI 10.4049/jimmunol.1000458; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; KUPSKY WJ, 1987, NEUROLOGY, V37, P1253, DOI 10.1212/WNL.37.7.1253; Lebouvier T, 2008, GUT, V57, P1741, DOI 10.1136/gut.2008.162503; Lebouvier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012728; Lebouvier T, 2009, EUR J NEUROSCI, V30, P735, DOI 10.1111/j.1460-9568.2009.06873.x; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; McOmber ME, 2010, J PEDIATR GASTR NUTR, V50, P269, DOI 10.1097/MPG.0b013e3181aa3aa9; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Minter RM, 2009, AM J PHYSIOL-GASTR L, V296, pG45, DOI 10.1152/ajpgi.00041.2008; Murakami M, 2009, J NEUROSCI RES, V87, P2095, DOI 10.1002/jnr.22036; Niehaus I, 2003, OCCUP ENVIRON MED, V60, P378, DOI 10.1136/oem.60.5.378; Ouchi Y, 2009, PARKINSONISM RELAT D, V15, pS200, DOI 10.1016/S1353-8020(09)70814-4; Phillips RJ, 2008, NEUROSCIENCE, V153, P733, DOI 10.1016/j.neuroscience.2008.02.074; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; QUALMAN SJ, 1984, GASTROENTEROLOGY, V87, P848; Savidge TC, 2007, LAB INVEST, V87, P731, DOI 10.1038/labinvest.3700600; Shannon K, 2011, MOVEMENT DI IN PRESS; Shannon K.M., 2011, MOV DISORD; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; WAKABAYASHI K, 1988, ACTA NEUROPATHOL, V76, P217, DOI 10.1007/BF00687767; WAKABAYASHI K, 1990, ACTA NEUROPATHOL, V79, P581, DOI 10.1007/BF00294234; Wang S, 2009, BRAIN RES, V1265, P196, DOI 10.1016/j.brainres.2009.02.022; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017	51	516	543	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28032	10.1371/journal.pone.0028032	http://dx.doi.org/10.1371/journal.pone.0028032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145021	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168900004
J	Partridge, BJ; Bell, SK; Lucke, JC; Yeates, S; Hall, WD				Partridge, Bradley J.; Bell, Stephanie K.; Lucke, Jayne C.; Yeates, Sarah; Hall, Wayne D.			Smart Drugs "As Common As Coffee": Media Hype about Neuroenhancement	PLOS ONE			English	Article							NEWS MEDIA; COVERAGE; STORIES; ABUSE	Background: The use of prescription drugs to improve cognitive functioning in normal persons -"neuroenhancement" - has gained recent attention from bioethicists and neuroscientists. Enthusiasts claim that the practice is widespread and increasing, and has many potential benefits; however recent evidence provides weak support for these claims. In this study we explored how the newsprint media portrays neuroenhancement. Aims: We conducted an empirical study of media reporting of neuroenhancement to explore: media portrayals of the prevalence of neuroenhancement; the types of evidence used by the media to support claims about its prevalence; and, the possible benefits and risks of neuroenhancement mentioned in these media articles. Methods: Using the Factiva database, we found 142 newspaper articles about the non-medical use prescription drugs for neuroenhancement for the period 2008-2010. We conducted a thematic content analysis of how articles portrayed the prevalence of neuroenhancement; what type of evidence they used in support; and, the potential benefits and risks/side-effects of neuroenhancement that were mentioned. Results: 87% of media articles mentioned the prevalence of neuroenhancement, and 94% portrayed it as common, increasing or both. 66% referred to the academic literature to support these claims and 44% either named an author or a journal. 95% of articles mentioned at least one possible benefit of using prescription drugs for neuroenhancement, but only 58% mentioned any risks/side effects. 15% questioned the evidence for efficacy of prescription drugs to produce benefits to users. Conclusions: News media articles mentioned the possible benefits of using drugs for neuroenhancement more than the potential risks/side effects, and the main source for media claims that neuroenhancement is common and increasingly widespread has been reports from the academic literature that provide weak support for this claim. We urge journalists and researchers to be cautious in their portrayal of the non-medical use of drugs for neuroenhancement.	[Partridge, Bradley J.; Bell, Stephanie K.; Lucke, Jayne C.; Yeates, Sarah; Hall, Wayne D.] Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia	University of Queensland	Partridge, BJ (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia.	b.partridge@uq.edu.au	Lucke, Jayne C/A-5538-2008; Yeates, Sarah/M-6569-2013; Hall, Wayne D/A-3283-2008	Lucke, Jayne C/0000-0002-2885-5292; Yeates, Sarah/0000-0001-6675-8154; Hall, Wayne D/0000-0003-1984-0096	ARC; Bayer Australia [LP100200349]; NHMRC [2010000604, 569738]	ARC(Australian Research Council); Bayer Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	JL has been awarded an ARC Linkage Grant, which involves some cash and in-kind support from Bayer Australia (LP100200349). BP has been awarded an NHMRC Training Fellowship (2010000604). WH has been awarded an NHMRC Australia Fellowship (569738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medical Sciences, 2008, BRAIN SCI ADD DRUGS; *AUSTR PRESS COUNC, 246II AUSTR PRESS CO; Babcock Q, 2000, J AM COLL HEALTH, V49, P143, DOI 10.1080/07448480009596296; BOOT BP, 2011, NEUROCASE, P1; *BRIT MED ASS, 2007, BOOST YOUR BRAINP ET; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; Cakic V, 2009, J MED ETHICS, V35, P611, DOI 10.1136/jme.2009.030882; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Chatterjee A, 2006, J MED ETHICS, V32, P110, DOI 10.1136/jme.2005.013599; Dasgupta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007758; Fins JJ, 2002, LANCET NEUROL, V1, P213, DOI 10.1016/S1474-4422(02)00099-6; Forlini C, 2009, NEUROETHICS-NETH, V2, P163, DOI 10.1007/s12152-009-9043-y; Forlini C, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-9; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Gonon F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014618; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hall WD, 2010, ADDICTION, V105, P2041, DOI 10.1111/j.1360-0443.2010.03211.x; Larriviere D, 2009, NEUROLOGY, V73, P1406, DOI 10.1212/WNL.0b013e3181beecfe; Lucke Jayne C., 2011, AJOB NEUROSCIENCE, V2, P38, DOI [10.1080/21507740.2011.611122, DOI 10.1080/21507740.2011.611122]; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Mohamed AD, 2012, INT J NEUROPSYCHOPH, V15, P559, DOI 10.1017/S146114571100037X; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Outram SM, 2010, J MED ETHICS, V36, P198, DOI 10.1136/jme.2009.034421; Racine E, 2005, NAT REV NEUROSCI, V6, P159, DOI 10.1038/nrn1609; Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Repantis D, 2010, PHARMACOL RES, V61, P473, DOI 10.1016/j.phrs.2010.02.009; Riesch H, 2011, HEALTH RISK SOC, V13, P47, DOI 10.1080/13698575.2010.540645; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; SMITH ME, 2011, PSYCHOL BULL, V137; Soothill K, 1997, SOCIOLOGY, V31, P591, DOI 10.1177/0038038597031003014; White BP, 2006, J AM COLL HEALTH, V54, P261, DOI 10.3200/JACH.54.5.261-268	33	117	119	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28416	10.1371/journal.pone.0028416	http://dx.doi.org/10.1371/journal.pone.0028416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140584	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168100070
J	Bonawitz, ND; Soltau, WL; Blatchley, MR; Powers, BL; Hurlock, AK; Seals, LA; Weng, JK; Stout, J; Chapple, C				Bonawitz, Nicholas D.; Soltau, Whitney L.; Blatchley, Michael R.; Powers, Brendan L.; Hurlock, Anna K.; Seals, Leslie A.; Weng, Jing-Ke; Stout, Jake; Chapple, Clint			REF4 and RFR1, Subunits of the Transcriptional Coregulatory Complex Mediator, Are Required for Phenylpropanoid Homeostasis in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGNIN BIOSYNTHESIS; THALIANA; ACTIVATION; GENETICS; LIGHT; EXPRESSION; MUTATIONS; REGULATOR; MUTANTS; DEFENSE	The plant phenylpropanoid pathway produces an array of metabolites that impact human health and the utility of feed and fiber crops. We previously characterized several Arabidopsis thaliana mutants with dominant mutations in REDUCED EPIDERMAL FLUORESCENCE 4 (REF4) that cause dwarfing and decreased accumulation of phenylpropanoids. In contrast, ref4 null plants are of normal stature and have no apparent defect in phenylpropanoid biosynthesis. Here we show that disruption of both REF4 and its paralog, REF4-RELATED 1 (RFR1), results in enhanced expression of multiple phenylpropanoid biosynthetic genes, as well as increased accumulation of numerous downstream products. We also show that the dominant ref4-3 mutant protein interferes with the ability of the PAP1/MYB75 transcription factor to induce the expression of PAL1 and drive anthocyanin accumulation. Consistent with our experimental results, both REF4 and RFR1 have been shown to physically associate with the conserved transcriptional coregulatory complex, Mediator, which transduces information from cis-acting DNA elements to RNA polymerase II at the core promoter. Taken together, our data provide critical genetic support for a functional role of REF4 and RFR1 in the Mediator complex, and for Mediator in the maintenance of phenylpropanoid homeostasis. Finally, we show that wild-type RFR1 substantially mitigates the phenotype of the dominant ref4-3 mutant, suggesting that REF4 and RFR1 may compete with one another for common binding partners or for occupancy in Mediator. Determining the functions of diverse Mediator subunits is essential to understand eukaryotic gene regulation, and to facilitate rational manipulation of plant metabolic pathways to better suit human needs.	[Bonawitz, Nicholas D.; Soltau, Whitney L.; Blatchley, Michael R.; Powers, Brendan L.; Hurlock, Anna K.; Seals, Leslie A.; Weng, Jing-Ke; Stout, Jake; Chapple, Clint] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chapple, C (corresponding author), 175 S Univ St, W Lafayette, IN 47907 USA.	chapple@purdue.edu	Weng, Jing-Ke/E-7343-2013; Weng, Jing-Ke/V-5934-2019; Ye, Mingli/G-4909-2012; Chapple, Clint CS/Q-5456-2017; Weng, Jing-Ke/A-6900-2015	Weng, Jing-Ke/0000-0003-1079-3668; Weng, Jing-Ke/0000-0003-3059-0075; Chapple, Clint CS/0000-0002-5195-562X; Weng, Jing-Ke/0000-0003-3059-0075; Dolan, Whitney/0000-0001-9069-9764; Stout, Jake/0000-0002-0193-9066	Division of Energy Biosciences, United States Department of Energy [DE-FG02-07ER15905]; Global Climate and Energy Program (GCEP); Life Sciences Research Foundation; Howard Hughes Medical Institute	Division of Energy Biosciences, United States Department of Energy(United States Department of Energy (DOE)); Global Climate and Energy Program (GCEP); Life Sciences Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Division of Energy Biosciences, United States Department of Energy Grant DE-FG02-07ER15905, the Global Climate and Energy Program (GCEP), a fellowship from the Life Sciences Research Foundation (to N. D. B.), and a summer research fellowship from the Howard Hughes Medical Institute (to M. R. B.).	Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; BellLelong DA, 1997, PLANT PHYSIOL, V113, P729, DOI 10.1104/pp.113.3.729; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boudet AM, 2003, TRENDS PLANT SCI, V8, P576, DOI 10.1016/j.tplants.2003.10.001; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Boyce JM, 2003, PLANT J, V34, P395, DOI 10.1046/j.1365-313X.2003.01734.x; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Derikvand MM, 2008, PLANTA, V227, P943, DOI 10.1007/s00425-007-0669-x; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; HAHLBROCK K, 1976, EUR J BIOCHEM, V61, P199, DOI 10.1111/j.1432-1033.1976.tb10012.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys JM, 2002, CURR OPIN PLANT BIOL, V5, P224, DOI 10.1016/S1369-5266(02)00257-1; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Kitts DD, 1999, MOL CELL BIOCHEM, V202, P91, DOI 10.1023/A:1007022329660; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Nakatsubo T, 2008, J BIOL CHEM, V283, P15550, DOI 10.1074/jbc.M801131200; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ro DK, 2004, J BIOL CHEM, V279, P2600, DOI 10.1074/jbc.M309951200; Rogers LA, 2005, J EXP BOT, V56, P1651, DOI 10.1093/jxb/eri162; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Ruegger M, 2001, GENETICS, V159, P1741; Stout J, 2008, GENETICS, V178, P2237, DOI 10.1534/genetics.107.083881; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Umezawa T, 2010, PHYTOCHEM REV, V9, P1, DOI 10.1007/s11101-009-9155-3; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001	46	86	91	2	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5434	5445		10.1074/jbc.M111.312298	http://dx.doi.org/10.1074/jbc.M111.312298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22167189	Green Published, hybrid			2022-12-25	WOS:000300638000024
J	Cracan, V; Banerjee, R				Cracan, Valentin; Banerjee, Ruma			Novel Coenzyme B-12-dependent Interconversion of Isovaleryl-CoA and Pivalyl-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHANOLAMINE AMMONIA-LYASE; TERT-BUTYL ETHER; STREPTOMYCES-CINNAMONENSIS; METHYLMALONIC ACIDURIA; LYSINE 5,6-AMINOMUTASE; GLYCEROL DEHYDRATASES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; FATTY-ACID; MUTASE	5'-Deoxyadenosylcobalamin (AdoCbl)-dependent isomerases catalyze carbon skeleton rearrangements using radical chemistry. We have recently characterized a fusion protein that comprises the two subunits of the AdoCbl-dependent isobutyryl-CoA mutase flanking a G-protein chaperone and named it isobutyryl-CoA mutase fused (IcmF). IcmF catalyzes the interconversion of isobutyryl-CoA and n-butyryl-CoA, whereas GTPase activity is associated with its G-protein domain. In this study, we report a novel activity associated with IcmF, i.e. the interconversion of isovaleryl-CoA and pivalyl-CoA. Kinetic characterization of IcmF yielded the following values: a Km for isovaleryl-CoA of 62 +/- 8 mu M and V-max of 0.021 +/- 0.004 mu mol min(-1) mg(-1) at 37 degrees C. Biochemical experiments show that an IcmF in which the base specificity loop motif NKXD is modified to NKXE catalyzes the hydrolysis of both GTP and ATP. IcmF is susceptible to rapid inactivation during turnover, and GTP conferred modest protection during utilization of isovaleryl-CoA as substrate. Interestingly, there was no protection from inactivation when either isobutyryl-CoA or n-butyryl-CoA was used as substrate. Detailed kinetic analysis indicated that inactivation is associated with loss of the 5'-deoxyadenosine moiety from the active site, precluding reformation of AdoCbl at the end of the turnover cycle. Under aerobic conditions, oxidation of the cob(II)alamin radical in the inactive enzyme results in accumulation of aquacobalamin. Because pivalic acid found in sludge can be used as a carbon source by some bacteria and isovaleryl-CoA is an intermediate in leucine catabolism, our discovery of a new isomerase activity associated with IcmF expands its metabolic potential.	[Cracan, Valentin; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, 3220B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Cracan, Valentin/0000-0002-3280-0593	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; BABIOR BM, 1974, J BIOL CHEM, V249, P1689; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Brigham CJ, 2010, J BACTERIOL, V192, P5454, DOI 10.1128/JB.00493-10; Chang CH, 2000, J BIOL CHEM, V275, P106, DOI 10.1074/jbc.275.1.106; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gruber K, 2011, CHEM SOC REV, V40, P4346, DOI 10.1039/c1cs15118e; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Kajiura H, 2007, FEBS J, V274, P5556, DOI 10.1111/j.1742-4658.2007.06074.x; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; Maiti N, 1999, J BIOL CHEM, V274, P32733, DOI 10.1074/jbc.274.46.32733; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Matsuoka H, 2007, J BIOL CHEM, V282, P5180, DOI 10.1074/jbc.M606831200; Mori K, 2004, J BACTERIOL, V186, P6845, DOI 10.1128/JB.186.20.6845-6854.2004; Muller RH, 2007, APPL ENVIRON MICROB, V73, P1783, DOI 10.1128/AEM.01899-06; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Pandit SB, 2003, PROTEINS, V52, P585, DOI 10.1002/prot.10420; Probian C, 2003, APPL ENVIRON MICROB, V69, P1866, DOI 10.1128/AEM.69.3.1866-1870.2003; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Reddick JJ, 2008, BIOTECHNOL LETT, V30, P1045, DOI 10.1007/s10529-008-9642-4; Rezanka T, 2011, ENVIRON MICROBIOL, V13, P1577, DOI 10.1111/j.1462-2920.2011.02465.x; Rohwerder T, 2008, VITAMIN B NEW RES, P81; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rohwerder T, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-13; Solano-Serena F, 2004, J APPL MICROBIOL, V97, P629, DOI 10.1111/j.1365-2672.2004.02344.x; Soundararajan M, 2007, BIOCHEM J, V401, P679, DOI 10.1042/BJ20060555; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tang KH, 2001, BIOCHEMISTRY-US, V40, P5190, DOI 10.1021/bi010157j; Toraya T, 2000, CELL MOL LIFE SCI, V57, P106, DOI 10.1007/s000180050502; Toraya T, 2008, J BIOCHEM, V144, P437, DOI 10.1093/jb/mvn086; Vrijbloed JW, 1999, J BACTERIOL, V181, P5600, DOI 10.1128/JB.181.18.5600-5605.1999; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; ZELDER O, 1994, EUR J BIOCHEM, V226, P577, DOI 10.1111/j.1432-1033.1994.tb20083.x; Zhang YX, 1999, MICROBIOL-SGM, V145, P2323, DOI 10.1099/00221287-145-9-2323	43	17	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3723	3732		10.1074/jbc.M111.320051	http://dx.doi.org/10.1074/jbc.M111.320051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167181	Green Published, hybrid			2022-12-25	WOS:000300410900010
J	Somyajit, K; Subramanya, S; Nagaraju, G				Somyajit, Kumar; Subramanya, Shreelakshmi; Nagaraju, Ganesh			Distinct Roles of FANCO/RAD51C Protein in DNA Damage Signaling and Repair IMPLICATIONS FOR FANCONI ANEMIA AND BREAST CANCER SUSCEPTIBILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; HOMOLOGOUS RECOMBINATION; MONOUBIQUITINATED FANCD2; REPLICATION FORKS; GENE CONVERSION; S-PHASE; BRCA1; RAD51C; PATHWAY; ACTIVATION	RAD51C, a RAD51 paralog, has been implicated in homologous recombination (HR), and germ line mutations in RAD51C are known to cause Fanconi anemia (FA)-like disorder and breast and ovarian cancers. The role of RAD51C in the FA pathway of DNA interstrand cross-link (ICL) repair and as a tumor suppressor is obscure. Here, we report that RAD51C deficiency leads to ICL sensitivity, chromatid-type errors, and G(2)/M accumulation, which are hallmarks of the FA phenotype. We find that RAD51C is dispensable for ICL unhooking and FANCD2 monoubiquitination but is essential for HR, confirming the downstream role of RAD51C in ICL repair. Furthermore, we demonstrate that RAD51C plays a vital role in the HR-mediated repair of DNA lesions associated with replication. Finally, we show that RAD51C participates in ICL and double strand break-induced DNA damage signaling and controls intra-S-phase checkpoint through CHK2 activation. Our analyses with pathological mutants of RAD51C that were identified in FA and breast and ovarian cancers reveal that RAD51C regulates HR and DNA damage signaling distinctly. Together, these results unravel the critical role of RAD51C in the FA pathway of ICL repair and as a tumor suppressor.	[Somyajit, Kumar; Subramanya, Shreelakshmi; Nagaraju, Ganesh] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nagaraju, G (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nganesh@biochem.iisc.ernet.in		Somyajit, Kumar/0000-0003-2496-7155	Indian Institute of Science; Department of Biotechnology; Council of Scientific and Industrial Research; Department of Science and Technology	Indian Institute of Science; Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	This work was supported in part by the Indian Institute of Science, Department of Biotechnology, Council of Scientific and Industrial Research, and Department of Science and Technology.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ali AM, 2009, MUTAT RES-FUND MOL M, V668, P20, DOI 10.1016/j.mrfmmm.2009.04.002; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Gildemeister OS, 2009, J BIOL CHEM, V284, P31945, DOI 10.1074/jbc.M109.024646; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nagaraju G, 2006, MOL CELL BIOL, V26, P8075, DOI 10.1128/MCB.01235-06; Nagaraju G, 2009, MOL CELL BIOL, V29, P4283, DOI 10.1128/MCB.01406-08; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; OLIVE PL, 1991, CANCER RES, V51, P4671; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Somyajit K, 2010, CARCINOGENESIS, V31, P2031, DOI 10.1093/carcin/bgq210; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001	66	57	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3366	3380		10.1074/jbc.M111.311241	http://dx.doi.org/10.1074/jbc.M111.311241			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167183	Green Published, hybrid			2022-12-25	WOS:000300295100042
J	Zimmermann, J; Goebel, R; De Martino, F; van de Moortele, PF; Feinberg, D; Adriany, G; Chaimow, D; Shmuel, A; Ugurbil, K; Yacoub, E				Zimmermann, Jan; Goebel, Rainer; De Martino, Federico; van de Moortele, Pierre-Francois; Feinberg, David; Adriany, Gregor; Chaimow, Denis; Shmuel, Amir; Ugurbil, Kamil; Yacoub, Essa			Mapping the Organization of Axis of Motion Selective Features in Human Area MT Using High-Field fMRI	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; OCULAR DOMINANCE COLUMNS; MULTIPLE VISUAL AREAS; FUNCTIONAL ARCHITECTURE; 7 TESLA; RECEPTIVE FIELDS; COMPLETE PATTERN; MACAQUE MONKEY; SIGNAL CHANGES; CEBUS-APELLA	Functional magnetic resonance imaging (fMRI) at high magnetic fields has made it possible to investigate the columnar organization of the human brain in vivo with high degrees of accuracy and sensitivity. Until now, these results have been limited to the organization principles of early visual cortex (V1). While the middle temporal area (MT) has been the first identified extra-striate visual area shown to exhibit a columnar organization in monkeys, evidence of MT's columnar response properties and topographic layout in humans has remained elusive. Research using various approaches suggests similar response properties as in monkeys but failed to provide direct evidence for direction or axis of motion selectivity in human area MT. By combining state of the art pulse sequence design, high spatial resolution in all three dimensions (0.8 mm isotropic), optimized coil design, ultrahigh field magnets (7 Tesla) and novel high resolution cortical grid sampling analysis tools, we provide the first direct evidence for large-scale axis of motion selective feature organization in human area MT closely matching predictions from topographic columnar-level simulations.	[Zimmermann, Jan; Goebel, Rainer; De Martino, Federico] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Zimmermann, Jan; Goebel, Rainer; De Martino, Federico] Maastricht Univ, M BIC, Maastricht, Netherlands; [Goebel, Rainer] Netherlands Inst Neurosci, Dept Neuroimaging & Neuromodeling, Amsterdam, Netherlands; [De Martino, Federico; van de Moortele, Pierre-Francois; Adriany, Gregor; Chaimow, Denis; Shmuel, Amir; Ugurbil, Kamil; Yacoub, Essa] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Feinberg, David] Adv MRI Technol, Sebastopol, CA USA; [Feinberg, David] Univ Calif Berkeley, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA; [Feinberg, David] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Chaimow, Denis] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Shmuel, Amir] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Maastricht University; Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Max Planck Society; McGill University	Zimmermann, J (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	r.goebel@maastrichtuniversity.nl; kamil@cmrr.umn.edu	Shmuel, Amir/G-8690-2013; De Martino, Federico/ABF-9850-2021; Van de Moortele, Pierre-François/H-5087-2011; De Martino, Federico/I-1817-2012; Adriany, Gregor/AAK-1323-2020; Chaimow, Denis/AAX-8518-2021; Adriany, Gregor/R-6656-2016; Yacoub, Essa/AAS-7757-2021; Ugurbil, Kamil/AAD-6058-2022	De Martino, Federico/0000-0002-0352-0648; Van de Moortele, Pierre-François/0000-0002-6941-5947; De Martino, Federico/0000-0002-0352-0648; Chaimow, Denis/0000-0003-4532-3084; Adriany, Gregor/0000-0002-6428-9005; Zimmermann, Jan/0000-0003-3345-6074; Goebel, Rainer/0000-0003-1780-2467	National Institutes of Health (NIH) [R01 EB000331, R44NS063537, P30 NS057091, P41 RR08079, S10 RR1395]; W. M. Keck Foundation; NSERC [RGPIN 375457-09]; NSF [DBI-9907842]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079, P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091, R44NS063537] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work supported in part by the National Institutes of Health (R01 EB000331, R44NS063537, P30 NS057091, P41 RR08079) the W. M. Keck Foundation, and NSERC (RGPIN 375457-09). The 7 T magnet purchase was funded in part by NSF DBI-9907842 and NIH S10 RR1395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Chaimow D, 2010, NEUROIMAGE; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Diogo ACM, 2003, J NEUROSCI, V23, P3881; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; FEINBERG DA, 1985, RADIOLOGY, V156, P743, DOI 10.1148/radiology.156.3.4023236; Feinberg DA, 2008, 7 TESL P INT SOC MAG, P2373; Geesaman BJ, 1997, CEREB CORTEX, V7, P749, DOI 10.1093/cercor/7.8.749; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Goerke U, 2007, MAGN RESON MED, V58, P754, DOI 10.1002/mrm.21369; Goodyear BG, 2001, HUM BRAIN MAPP, V14, P210, DOI 10.1002/hbm.1053; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Huk AC, 2002, J NEUROSCI, V22, P7195; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; OSHIO K, 1991, MAGNET RESON MED, V20, P344, DOI 10.1002/mrm.1910200219; Park J, 2005, P ISMRM 13 SCI M MIA, P31; QIAN N, 1994, J NEUROSCI, V14, P7367; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; ROSA MGP, 1988, EXP BRAIN RES, V72, P645; SAITO H, 1986, J NEUROSCI, V6, P145; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shmuel A, 2007, NEUROIMAGE, V35, P539, DOI 10.1016/j.neuroimage.2006.12.030; Shmuel A, 2010, NEUROIMAGE, V49, P1957, DOI 10.1016/j.neuroimage.2009.08.040; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Sun P, 2007, NAT NEUROSCI, V10, P1404, DOI 10.1038/nn1983; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka S, 2011, NEURAL NETWORKS OFFI; Taylor JG, 2000, NEUROIMAGE, V11, P257, DOI 10.1006/nimg.1999.0529; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ugurbil K, 2003, MAGN RESON IMAGING, V21, P1263, DOI 10.1016/j.mri.2003.08.027; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Van de Moortele P-F, 2005, P INT SOC MAGN RESON, V13, P2748; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WORGOTTER F, 1991, J NEUROPHYSIOL, V66, P444, DOI 10.1152/jn.1991.66.2.444; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yacoub E, 2007, NEUROIMAGE, V37, P1161, DOI 10.1016/j.neuroimage.2007.05.020; ZEKI S, 1991, J NEUROSCI, V11, P641	60	116	116	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28716	10.1371/journal.pone.0028716	http://dx.doi.org/10.1371/journal.pone.0028716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163328	gold, Green Published, Green Submitted			2022-12-25	WOS:000298161900064
J	Bates, ME; Buckman, JF; Vaschillo, EG; Fonoberov, VA; Fonoberova, M; Vaschillo, B; Mun, EY; Mezic, A; Mezic, I				Bates, Marsha E.; Buckman, Jennifer F.; Vaschillo, Evgeny G.; Fonoberov, Vladimir A.; Fonoberova, Maria; Vaschillo, Bronya; Mun, Eun-Young; Mezic, Adriana; Mezic, Igor			The Redistribution of Power: Neurocardiac Signaling, Alcohol and Gender	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BIOFEEDBACK; BAROREFLEX; DEPRESSION; AGE	Human adaptability involves interconnected biological and psychological control processes that determine how successful we are in meeting internal and environmental challenges. Heart rate variability (HRV), the variability in consecutive R-wave to R-wave intervals (RRI) of the electrocardiogram, captures synergy between the brain and cardiovascular control systems that modulate adaptive responding. Here we introduce a qualitatively new dimension of adaptive change in HRV quantified as a redistribution of spectral power by applying the Wasserstein distance with exponent 1 metric (W-1) to RRI spectral data. We further derived a new index, D, to specify the direction of spectral redistribution and clarify physiological interpretation. We examined gender differences in real time RRI spectral power response to alcohol, placebo and visual cue challenges. Adaptive changes were observed as changes in power of the various spectral frequency bands (i.e., standard frequency domain HRV indices) and, during both placebo and alcohol intoxication challenges, as changes in the structure (shape) of the RRI spectrum, with a redistribution towards lower frequency oscillations. The overall conclusions from the present study are that the RRI spectrum is capable of a fluid and highly flexible response, even when oscillations (and thus activity at the sinoatrial node) are pharmacologically suppressed, and that low frequency oscillations serve a crucial but less studied role in physical and mental health.	[Bates, Marsha E.; Buckman, Jennifer F.; Vaschillo, Evgeny G.; Vaschillo, Bronya; Mun, Eun-Young] Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA; [Fonoberov, Vladimir A.; Fonoberova, Maria; Mezic, Adriana; Mezic, Igor] AIMdyn Inc, Santa Barbara, CA USA; [Mezic, Igor] Univ Calif Santa Barbara, Ctr Control Dynam Syst & Computat, Santa Barbara, CA 93106 USA	Rutgers State University New Brunswick; University of California System; University of California Santa Barbara	Bates, ME (corresponding author), Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA.	mebates@rutgers.edu	Mun, Eun-Young/AAA-2811-2020; Bates, Marsha/AAD-6426-2020; Mezic, Igor/R-9659-2018	Mun, Eun-Young/0000-0002-1820-615X; Vaschillo, Bronya/0000-0002-1316-2434; Mezic, Igor/0000-0002-2873-9013; Buckman, Jennifer/0000-0002-1898-5499	National Institute on Alcohol Abuse and Alcoholism [HHSN275201000003C, R01 AA015248]; American Recovery and Reinvestment Act Administrative Supplement [R01 AA015248, K02 AA00325, K01 AA017473]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA017473, R01AA015248, K02AA000325] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Recovery and Reinvestment Act Administrative Supplement; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by the National Institute on Alcohol Abuse and Alcoholism through HHSN275201000003C, R01 AA015248, American Recovery and Reinvestment Act Administrative Supplement to R01 AA015248, K02 AA00325, and K01 AA017473. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud FM, 2010, AM J PHYSIOL-REG I, V298, pR1449, DOI 10.1152/ajpregu.00130.2010; Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1; Aljuri N, 2004, AM J PHYSIOL-HEART C, V287, pH2252, DOI 10.1152/ajpheart.00489.2003; Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; Benarroch EE, 2008, NEUROLOGY, V71, P1733, DOI 10.1212/01.wnl.0000335246.93495.92; Benarroch EE., 1997, CENTRAL AUTONOMIC NE; Camm AJ, 1996, CIRCULATION, V93, P1043; Evans JM, 2001, J APPL PHYSIOL, V91, P2611, DOI 10.1152/jappl.2001.91.6.2611; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Goldstein DS, 2001, AUTONOMIC NERVOUS SY; JENNINGS JR, 1992, PSYCHOPHYSIOLOGY, V29, P742, DOI 10.1111/j.1469-8986.1992.tb02052.x; Julien C, 2006, J APPL PHYSIOL, V101, P684, DOI 10.1152/japplphysiol.00562.2006; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kraemer S, 2000, BRIT MED J, V321, P1609, DOI 10.1136/bmj.321.7276.1609; Labiner DM, 2007, ACTA NEUROL SCAND, V115, P23, DOI 10.1111/j.1600-0404.2006.00732.x; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; Lehrer PM, 2004, CHEST, V126, P352, DOI 10.1378/chest.126.2.352; Lehrer PM, 2000, APPL PSYCHOPHYS BIOF, V25, P177, DOI 10.1023/A:1009554825745; Li ZB, 2009, INT J PSYCHOPHYSIOL, V73, P212, DOI 10.1016/j.ijpsycho.2009.03.002; LIAO DP, 1995, AM J CARDIOL, V76, P906, DOI 10.1016/S0002-9149(99)80260-4; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Mezic I, 2008, AUTOMATICA, V44, P3003, DOI 10.1016/j.automatica.2008.04.020; Muskulus M, 2011, PHYSICA D, V240, P45, DOI 10.1016/j.physd.2010.08.005; Ni K, 2009, INT J COMPUT VISION, V84, P97, DOI 10.1007/s11263-009-0234-0; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Romanowicz M, 2011, ALCOHOL CLIN EXP RES, V35, P1092, DOI 10.1111/j.1530-0277.2011.01442.x; Rossy LA, 1998, PSYCHOSOM MED, V60, P773, DOI 10.1097/00006842-199811000-00022; Schmidt H, 2005, CRIT CARE MED, V33, P1994, DOI 10.1097/01.CCM.0000178181.91250.99; Siegle G. J, 1994, BALANCED AFFECTIVE W; Soroko SI, 2010, NEUROPHYSIOLOGICAL P; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Tolkunov D, 2010, NEUROIMAGE, V50, P72, DOI 10.1016/j.neuroimage.2009.12.021; Udo T, 2009, PSYCHOL ADDICT BEHAV, V23, P196, DOI 10.1037/a0015015; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; Vaschillo EG, 2008, PSYCHOPHYSIOLOGY, V45, P847, DOI 10.1111/j.1469-8986.2008.00673.x; Vaschillo EG, 2011, COMM COM INF SC, V127, P224; Vasilevskii N. N., 1993, Fiziologiya Cheloveka, V19, P91; Yasumasu T, 2006, PSYCHOPHYSIOLOGY, V43, P41, DOI 10.1111/j.1469-8986.2006.00377.x	41	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28281	10.1371/journal.pone.0028281	http://dx.doi.org/10.1371/journal.pone.0028281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863NO	22164260	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400061
J	Bhat, N; Riley, BB				Bhat, Neha; Riley, Bruce B.			Integrin-alpha 5 Coordinates Assembly of Posterior Cranial Placodes in Zebrafish and Enhances Fgf-Dependent Regulation of Otic/Epibranchial Cells	PLOS ONE			English	Article							ERK MAP KINASE; SENSORY GANGLIA; EPIBRANCHIAL PLACODE; BIOLOGICAL-ACTIVITY; OLFACTORY PLACODES; OTIC PLACODE; INDUCTION; CHEMOKINE; SPECIFICATION; MIGRATION	Vertebrate sensory organs develop in part from cranial placodes, a series of ectodermal thickenings that coalesce from a common domain of preplacodal ectoderm. Mechanisms coordinating morphogenesis and differentiation of discrete placodes are still poorly understood. We have investigated whether placodal assembly in zebrafish requires Integrin-alpha 5 (itga5), an extracellular matrix receptor initially expressed throughout the preplacodal ectoderm. Morpholino knockdown of itga5 had no detectable effect on anterior placodes (pituitary, nasal and lens), but posterior placodes developed abnormally, resulting in disorganization of trigeminal and epibranchial ganglia and reduction of the otic vesicle. Cell motion analysis in GFP-transgenic embryos showed that cell migration in itga5 morphants was highly erratic and unfocused, impairing convergence and blocking successive recruitment of new cells into these placodes. Further studies revealed genetic interactions between itga5 and Fgf signaling. First, itga5 morphants showed changes in gene expression mimicking modest reduction in Fgf signaling. Second, itga5 morphants showed elevated apoptosis in the otic/epibranchial domain, which was rescued by misexpression of Fgf8. Third, knockdown of the Fgf effector erm had no effect by itself but strongly enhanced defects in itga5 morphants. Finally, proper regulation of itga5 requires dlx3b/4b and pax8, which are themselves regulated by Fgf. These findings support a model in which itga5 coordinates cell migration into posterior placodes and augments Fgf signaling required for patterning of these tissues and cell survival in otic/epibranchial placodes.	[Bhat, Neha; Riley, Bruce B.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Bhat, N (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	briley@mail.bio.tamu.edu			National Institutes of Health-National Institute of Deafness and other Communication Disorders (NIDCD) [R01-DC03806]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003806] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Deafness and other Communication Disorders (NIDCD); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	National Institutes of Health-National Institute of Deafness and other Communication Disorders (NIDCD), grant R01-DC03806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Bhattacharyya S, 2004, DEV BIOL, V271, P403, DOI 10.1016/j.ydbio.2004.04.010; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev.01516; Carballada R, 2001, DEVELOPMENT, V128, P35; Chodniewicz D, 2004, EXP CELL RES, V301, P31, DOI 10.1016/j.yexcr.2004.08.006; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Dutta S, 2005, DEVELOPMENT, V132, P1579, DOI 10.1242/dev.01723; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Glavic A, 2004, DEV BIOL, V272, P89, DOI 10.1016/j.ydbio.2004.04.020; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; James BP, 2007, MOL BIOL CELL, V18, P4190, DOI 10.1091/mbc.E06-07-0659; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kaji T, 2004, DEV BIOL, V276, P523, DOI 10.1016/j.ydbio.2004.09.020; Knaut H, 2005, NEURON, V47, P653, DOI 10.1016/j.neuron.2005.07.014; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kwon HJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001133; Lee SA, 2003, DEVELOPMENT, V130, P2669, DOI 10.1242/dev.00502; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Long QM, 2000, MECH DEVELOP, V97, P183, DOI 10.1016/S0925-4773(00)00408-1; Ma H, 2009, J CELL SCI, V122, P4303, DOI 10.1242/jcs.057646; Mackereth MD, 2005, DEVELOPMENT, V132, P371, DOI 10.1242/dev.01587; Maves L, 2002, DEVELOPMENT, V129, P3825; McCabe KL, 2009, DEV BIOL, V332, P189, DOI 10.1016/j.ydbio.2009.05.572; Millimaki BB, 2010, DEV BIOL, V338, P262, DOI 10.1016/j.ydbio.2009.12.011; Miyasaka N, 2007, DEVELOPMENT, V134, P2459, DOI 10.1242/dev.001958; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Mori S, J BIOL CHEM, V283, P18066, DOI 1074/jbc.M801213200; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Nikaido M, 2007, DEV DYNAM, V236, P564, DOI 10.1002/dvdy.21050; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Picker A, 2002, DEVELOPMENT, V129, P3227; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Riley BB, 2010, DEV DYNAM, V239, P828, DOI 10.1002/dvdy.22227; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Schlosser G, 2010, INT REV CEL MOL BIO, V283, P129, DOI 10.1016/S1937-6448(10)83004-7; Solomon KS, 2002, DEVELOPMENT, V129, P3127; Streit A, 2007, INT J DEV BIOL, V51, P447, DOI 10.1387/ijdb.072327as; Sun SK, 2007, DEV BIOL, V303, P675, DOI 10.1016/j.ydbio.2006.12.008; Tanghetti E, 2002, ONCOGENE, V21, P3889, DOI 10.1038/sj.onc.1205407; Toro S, 2007, SEMIN CELL DEV BIOL, V18, P534, DOI 10.1016/j.semcdb.2007.04.003; Trinh LA, 2004, DEV CELL, V6, P371; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	54	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27778	10.1371/journal.pone.0027778	http://dx.doi.org/10.1371/journal.pone.0027778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164214	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400014
J	Krammer, EM; Homble, F; Prevost, M				Krammer, Eva-Maria; Homble, Fabrice; Prevost, Martine			Concentration Dependent Ion Selectivity in VDAC: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; PORE-FORMING PROTEIN; ANION CHANNEL; BROWNIAN DYNAMICS; ESCHERICHIA-COLI; OMPF-PORIN; BIOLOGICAL CHANNEL; NEUROSPORA-CRASSA; ALPHA-HEMOLYSIN; PURIFICATION	The voltage-dependent anion channel (VDAC) forms the major pore in the outer mitochondrial membrane. Its high conducting open state features a moderate anion selectivity. There is some evidence indicating that the electrophysiological properties of VDAC vary with the salt concentration. Using a theoretical approach the molecular basis for this concentration dependence was investigated. Molecular dynamics simulations and continuum electrostatic calculations performed on the mouse VDAC1 isoform clearly demonstrate that the distribution of fixed charges in the channel creates an electric field, which determines the anion preference of VDAC at low salt concentration. Increasing the salt concentration in the bulk results in a higher concentration of ions in the VDAC wide pore. This event induces a large electrostatic screening of the charged residues promoting a less anion selective channel. Residues that are responsible for the electrostatic pattern of the channel were identified using the molecular dynamics trajectories. Some of these residues are found to be conserved suggesting that ion permeation between different VDAC species occurs through a common mechanism. This inference is buttressed by electrophysiological experiments performed on bean VDAC32 protein akin to mouse VDAC.	[Krammer, Eva-Maria; Homble, Fabrice; Prevost, Martine] Univ Libre Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles	Krammer, EM (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	mprevost@ulb.ac.be	Homble, Fabrice/AAH-3780-2020; Krammer, Eva-Maria/H-2543-2013	Homble, Fabrice/0000-0001-6031-136X; Krammer, Eva-Maria/0000-0002-4821-2550	Brussels region (Institut d'encouragement de la recherche scientifique et de l'innovation de Bruxelles); Brussels region (Fonds de la Recherche Scientifique )	Brussels region (Institut d'encouragement de la recherche scientifique et de l'innovation de Bruxelles); Brussels region (Fonds de la Recherche Scientifique )	The funders of this study are the Brussels region (BB2B post-doctoral fellowship of the Institut d'encouragement de la recherche scientifique et de l'innovation de Bruxelles (http://www.iwoib.irisnet.be/site/index9dd4.html? page_id=1681(= nl) and the Fonds de la Recherche Scientifique (http://www1.frs-fnrs.be/). FH is a Research Director and MP is a Senior Research Associate at the FRS-FNRS (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrecht H, 2000, PLANT PHYSIOL, V124, P1181, DOI 10.1104/pp.124.3.1181; Abrecht H, 2000, J BIOL CHEM, V275, P40992, DOI 10.1074/jbc.M006437200; Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; Al Bitar F, 2003, BBA-GENE STRUCT EXPR, V1625, P43, DOI 10.1016/S0167-4781(02)00590-0; Alcaraz A, 2004, BIOPHYS J, V87, P943, DOI 10.1529/biophysj.104/043414; Alcaraz A, 2009, BIOPHYS J, V96, P56, DOI [10.1016/j.bpj.2008.09.024, 10.1016/j.hpj.2008.09.024]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 1980, Ann N Y Acad Sci, V341, P552, DOI 10.1111/j.1749-6632.1980.tb47198.x; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Corry B, 2004, BBA-BIOMEMBRANES, V1663, P2, DOI 10.1016/j.bbamem.2004.02.006; CORTESE JD, 1991, J CELL BIOL, V113, P1331, DOI 10.1083/jcb.113.6.1331; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Degreve L, 1999, J CHEM PHYS, V111, P5150, DOI 10.1063/1.479783; DEPINTO V, 1987, BIOCHIM BIOPHYS ACTA, V894, P109, DOI 10.1016/0005-2728(87)90180-0; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; DEPINTO V, 1993, J BIOL CHEM, V268, P12977; Egwolf B, 2010, J PHYS CHEM B, V114, P2901, DOI 10.1021/jp906791b; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FREITAG H, 1982, EUR J BIOCHEM, V123, P629; Garcia-Gimenez E, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021912; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jogini V, 2005, J MOL BIOL, V354, P272, DOI 10.1016/j.jmb.2005.09.031; KARSHIKOFF A, 1994, J MOL BIOL, V240, P372, DOI 10.1006/jmbi.1994.1451; KOBAYASHI Y, 1985, EUR J BIOCHEM, V151, P231, DOI 10.1111/j.1432-1033.1985.tb09093.x; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794; Lee KI, 2011, BIOPHYS J, V100, P611, DOI 10.1016/j.bpj.2010.12.3708; Levine BG, 2011, J COMPUT PHYS, V230, P3556, DOI 10.1016/j.jcp.2011.01.048; Lopez ML, 2009, J PHYS CHEM B, V113, P8745, DOI 10.1021/jp902267g; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; LUDWIG O, 1988, EUR BIOPHYS J BIOPHY, V15, P269, DOI 10.1007/BF00256477; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; MARRINK SJ, 1994, J PHYS CHEM-US, V98, P4155, DOI 10.1021/j100066a040; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; PENG S, 1992, BIOPHYS J, V62, P123, DOI 10.1016/S0006-3495(92)81799-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinto D., 2004, STRUCTURE FUNCTION P, P309; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; Ramirez P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011910; Raschle T, 2009, J AM CHEM SOC, V131, P17777, DOI 10.1021/ja907918r; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; Rui HA, 2011, BIOPHYS J, V100, P602, DOI 10.1016/j.bpj.2010.12.3711; Schirmer T, 1999, J MOL BIOL, V294, P1159, DOI 10.1006/jmbi.1999.3326; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Shao L, 1996, BIOPHYS J, V71, P778, DOI 10.1016/S0006-3495(96)79277-9; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SMACK DP, 1985, PLANT PHYSIOL, V79, P1094, DOI 10.1104/pp.79.4.1094; Smeyers M., 2003, MEMBRANE SCI TECHNOL, P449; Summers WAT, 2010, BIOCHEM CELL BIOL, V88, P425, DOI [10.1139/O09-115, 10.1139/o09-115]; Tai K, 2009, EUR BIOPHYS J BIOPHY, V38, P347, DOI 10.1007/s00249-008-0377-x; Tateda C, 2011, J EXP BOT, V62, P4773, DOI 10.1093/jxb/err113; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROLL H, 1992, J BIOL CHEM, V267, P21072; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Wandrey M, 2004, PLANT PHYSIOL, V134, P182, DOI 10.1104/pp.103.031484; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31; ZAMBROWICZ EB, 1993, BIOPHYS J, V65, P1093, DOI 10.1016/S0006-3495(93)81148-2	83	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27994	10.1371/journal.pone.0027994	http://dx.doi.org/10.1371/journal.pone.0027994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164223	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400024
J	Sormani, R; Masclaux-Daubresse, C; Daniele-Vedele, F; Chardon, F				Sormani, Rodnay; Masclaux-Daubresse, Celine; Daniele-Vedele, Francoise; Chardon, Fabien			Transcriptional Regulation of Ribosome Components Are Determined by Stress According to Cellular Compartments in Arabidopsis thaliana	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN GENES; CHLOROPLAST PROTEOME; CYCLING CELLS; S SUBUNIT; IDENTIFICATION; TRANSLATION; GENOME; PLANTS; PREDICTION	Plants have to coordinate eukaryotic ribosomes (cytoribosomes) and prokaryotic ribosomes (plastoribosomes and mitoribosomes) production to balance cellular protein synthesis in response to environmental variations. We identified 429 genes encoding potential ribosomal proteins (RP) in Arabidopsis thaliana. Because cytoribosome proteins are encoded by small nuclear gene families, plastid RP by nuclear and plastid genes and mitochondrial RP by nuclear and mitochondrial genes, several transcriptional pathways were attempted to control ribosome amounts. Examining two independent genomic expression datasets, we found two groups of RP genes showing very different and specific expression patterns in response to environmental stress. The first group represents the nuclear genes coding for plastid RP whereas the second group is composed of a subset of cytoribosome genes coding for RP isoforms. By contrast, the other cytoribosome genes and mitochondrial RP genes show less constraint in their response to stress conditions. The two subsets of cytoribosome genes code for different RP isoforms. During stress, the response of the intensively regulated subset leads to dramatic variation in ribosome diversity. Most of RP genes have same promoter structure with two motifs at conserved positions. The stress-response of the nuclear genes coding plastid RP is related with the absence of an interstitial telomere motif known as telo box in their promoters. We proposed a model for the "ribosome code" that influences the ribosome biogenesis by three main transcriptional pathways. The first pathway controls the basal program of cytoribosome and mitoribosome biogenesis. The second pathway involves a subset of cytoRP genes that are co-regulated under stress condition. The third independent pathway is devoted to the control of plastoribosome biosynthesis by regulating both nuclear and plastid genes.	[Sormani, Rodnay; Masclaux-Daubresse, Celine; Daniele-Vedele, Francoise; Chardon, Fabien] AgroParisTech, INRA, UMR1318, Inst Jean Pierre Bourgin,Saclay Plant Sci, Versailles, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Sormani, R (corresponding author), AgroParisTech, INRA, UMR1318, Inst Jean Pierre Bourgin,Saclay Plant Sci, Versailles, France.	rodnay.sormani@versailles.inra.fr	Masclaux-Daubresse, Celine/ABG-3128-2020; Chardon, Fabien/G-4826-2013; Chardon, Fabien/J-1963-2019	Masclaux-Daubresse, Celine/0000-0003-0719-9350; Chardon, Fabien/0000-0001-7909-3884; Chardon, Fabien/0000-0001-7909-3884; sormani, rodnay/0000-0002-0939-8639	Agence Nationale de la Recherche (ANR) [Blanc06-3-135436]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was partly supported by a grant from Agence Nationale de la Recherche to RS (ANR Blanc06-3-135436). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Beligni MV, 2004, PLANT CELL, V16, P3357, DOI 10.1105/tpc.104.026708; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bonen L, 2006, MOL BIOL EVOL, V23, P701, DOI 10.1093/molbev/msj080; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chang IF, 2005, PLANT PHYSIOL, V137, P848, DOI 10.1104/pp.104.053637; Creff A, 2010, PLANT MOL BIOL, V73, P533, DOI 10.1007/s11103-010-9639-y; Degenhardt RF, 2008, PLANT PHYSIOL, V147, P128, DOI 10.1104/pp.107.111799; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Giavalisco P, 2005, PLANT MOL BIOL, V57, P577, DOI 10.1007/s11103-005-0699-3; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Herve C, 2009, PLANT PHYSIOL, V149, P1462, DOI 10.1104/pp.108.126136; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Imai A, 2008, PLANT J, V56, P881, DOI 10.1111/j.1365-313X.2008.03647.x; Kawaguchi R, 2005, NUCLEIC ACIDS RES, V33, P955, DOI 10.1093/nar/gki240; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; KOSUGI S, 1995, PLANT J, V7, P877, DOI 10.1046/j.1365-313X.1995.07060877.x; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; LENVIK TR, 1994, PLANT PHYSIOL, V105, P1027, DOI 10.1104/pp.105.3.1027; Matsuura H, 2010, BIOSCI BIOTECH BIOCH, V74, P2110, DOI 10.1271/bbb.100330; McIntosh KB, 2006, CAN J BOT, V84, P342, DOI 10.1139/B06-014; Mollier P, 2002, CURR GENET, V40, P405, DOI 10.1007/s00294-002-0271-5; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; REGAD F, 1995, MOL GEN GENET, V248, P703, DOI 10.1007/BF02191710; Richly E, 2003, EMBO REP, V4, P491, DOI 10.1038/sj.embor.embor828; Sclep G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-400; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sormani R, 2011, PLANT CELL PHYSIOL, V52, P436, DOI 10.1093/pcp/pcr001; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; THOMPSON MD, 1992, PLANT MOL BIOL, V18, P931, DOI 10.1007/BF00019207; Tremousaygue D, 2003, PLANT J, V33, P957, DOI 10.1046/j.1365-313X.2003.01682.x; Tremousaygue D, 1999, PLANT J, V20, P553, DOI 10.1046/j.1365-313X.1999.00627.x; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Welchen E, 2006, PLANT PHYSIOL, V141, P540, DOI 10.1104/pp.105.075366; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; WITTMANN HG, 1982, ANNU REV BIOCHEM, V51, P155, DOI 10.1146/annurev.bi.51.070182.001103; Yamaguchi K, 2000, J BIOL CHEM, V275, P28455, DOI 10.1074/jbc.M004350200; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200; Yamaguchi K, 2003, EUR J BIOCHEM, V270, P190, DOI 10.1046/j.1432-1033.2003.03359.x; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	51	58	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28070	10.1371/journal.pone.0028070	http://dx.doi.org/10.1371/journal.pone.0028070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164228	Green Published, gold, Green Submitted			2022-12-25	WOS:000298171400029
J	Srinivasakumar, N				Srinivasakumar, Narasimhachar			Rev-Free HIV-1 Gene Delivery System for Targeting Rev-RRE-Crm1 Nucleocytoplasmic RNA Transport Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EXPRESSION; EXPORT; REPLICATION; INHIBITION; ELEMENT; PROTEIN; CELLS; SAM68; LOCALIZATION	The use of RNA transport elements from different viruses can provide novel attributes to HIV-1-based gene delivery systems such as improved safety or Rev independence. We previously described an HIV-1 based gene delivery system that utilized the simian immunodeficiency virus Rev-response element (RRE) in place of the HIV-1 RRE. Despite the use of Rev for the production of vector stocks, we showed the utility of this system for delivery of Rev M10, a dominant-negative mutant of HIV-1 Rev, into T-cells. Here, we investigated the use of RNA transport elements from Mason-Pfizer monkey virus or MPMV for the creation of high-titered Rev-free HIV-1-based packaging systems. The HIV-1 gag/pol expression constructs containing one or more copies of MPMV constitutive RNA transport element (CTE) were used to package similarly modified gene-transfer vectors in the presence or absence of Rev. An inverse correlation between the number of CTE modules and Rev dependency was noted for vector stock production. While packaging systems containing multiple CTEs were resistant to exogenously expressed Rev M10, the titers of vectors encoding Rev M10 were nevertheless reduced in comparison to vectors encoding only green fluorescent protein (GFP). In contrast, a gene transfer vector encoding the Rev M10 transgene and containing both RNA transport elements exhibited almost no loss in titer in comparison to a corresponding vector encoding only GFP. The optimized Rev-independent gene delivery system was used for delivery of Rev M10 transgene into T-lymphocytes. Upon challenge in single round infection assays with HIV-1, the modified T-cells produced fewer virus particles than control cells expressing GFP. This Rev-free packaging system may prove useful for targeting the Rev-RRE-Crm1 nucleocytoplasmic RNA transport pathway for inhibiting HIV replication.	St Louis Univ, Dept Internal Med, Div Hematol Oncol, St Louis, MO 63103 USA	Saint Louis University	Srinivasakumar, N (corresponding author), St Louis Univ, Dept Internal Med, Div Hematol Oncol, St Louis, MO 63103 USA.	skumar15@slu.edu			United States National Institutes of Health [AI 054211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054211] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The manuscript was supported by funds from the United States National Institutes of Health (AI 054211) to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Coyle JH, 2003, MOL CELL BIOL, V23, P92, DOI 10.1128/MCB.23.1.92-103.2003; Cullen BR, 2005, NATURE, V433, P26, DOI 10.1038/433026a; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Ernst RK, 1997, RNA, V3, P210; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Hakata Y, 1998, J VIROL, V72, P6602, DOI 10.1128/JVI.72.8.6602-6607.1998; HAMMARSKJOLD ML, 1989, J VIROL, V63, P1959; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Helga-Maria C, 1999, J VIROL, V73, P4127, DOI 10.1128/JVI.73.5.4127-4135.1999; Jeang K T, 1991, AIDS, V5 Suppl 2, pS3, DOI 10.1097/00002030-199101001-00002; Jin L, 2003, GENE DEV, V17, P3075, DOI 10.1101/gad.1155703; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Lu XB, 2004, J VIROL, V78, P7079, DOI 10.1128/JVI.78.13.7079-7088.2004; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; Mautino MR, 2000, GENE THER, V7, P1421, DOI 10.1038/sj.gt.3301262; Mautino MR, 2000, HUM GENE THER, V11, P895, DOI 10.1089/10430340050015509; Mautino MR, 2001, J VIROL, V75, P3590, DOI 10.1128/JVI.75.8.3590-3599.2001; Mclaren M, 2004, RNA, V10, P1119, DOI 10.1261/rna.5263904; McLaren M, 2009, VIROLOGY, V385, P93, DOI 10.1016/j.virol.2008.10.049; Oh T, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-38; Reddy TR, 2000, ONCOGENE, V19, P3110, DOI 10.1038/sj.onc.1203637; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Srinivasakumar N, 1999, J VIROL, V73, P9589, DOI 10.1128/JVI.73.11.9589-9598.1999; Srinivasakumar N, 2000, J VIROL, V74, P6659, DOI 10.1128/JVI.74.14.6659-6668.2000; Srinivasakumar N, 2002, J VIROL, V76, P7334, DOI 10.1128/JVI.76.14.7334-7342.2002; Srinivasakumar N, 1997, J VIROL, V71, P5841, DOI 10.1128/JVI.71.8.5841-5848.1997; Srinivasakumar N, 2001, HIV 1 VECTOR SYSTEMS; Srinivasakumar N, 2002, PACKAGING CELL SYSTE, P275; Srinivasakumar Narasimhachar, 2008, AIDS Res Ther, V5, P11, DOI 10.1186/1742-6405-5-11; Ward AM, 2009, J VIROL, V83, P940, DOI 10.1128/JVI.01520-08; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zaboikin M, 2004, HUM GENE THER, V15, P383, DOI 10.1089/104303404322959533; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28462	10.1371/journal.pone.0028462	http://dx.doi.org/10.1371/journal.pone.0028462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164294	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400095
J	Yoon, SY; Kim, KT; Jo, SJ; Cho, AR; Jeon, SI; Choi, HD; Kim, KH; Park, GS; Pack, JK; Kwon, OS; Park, WY				Yoon, Sun-Young; Kim, Kyu-Tae; Jo, Seong Jin; Cho, A-Ri; Jeon, Soon-Ik; Choi, Hyung-Do; Kim, Kyu Han; Park, Gun-Sik; Pack, Jeong-Ki; Kwon, Oh Sang; Park, Woong-Yang			Induction of Hair Growth by Insulin-Like Growth Factor-1 in 1,763 MHz Radiofrequency-Irradiated Hair Follicle Cells	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; ACTIVATION; APOPTOSIS; STRESS; CANCER; PROLIFERATION; EXPRESSION; RADIATION; EXPOSURE; ABLATION	Radiofrequency (RF) radiation does not transfer high energy to break the covalent bonds of macromolecules, but these low energy stimuli might be sufficient to induce molecular responses in a specific manner. We monitored the effect of 1,763 MHz RF radiation on cultured human dermal papilla cells (hDPCs) by evaluating changes in the expression of cytokines related to hair growth. The expression of insulin-like growth factor-1 (IGF-1) mRNA in hDPCs was significantly induced upon RF radiation at the specific absorption rate of 10 W/kg, which resulted in increased expression of B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL-2) and cyclin D1 (CCND1) proteins and increased phosphorylation of MAPK1 protein. Exposure to 10 W/kg RF radiation 1 h per day for 7 days significantly enhanced hair shaft elongation in ex vivo hair organ cultures. In RF-exposed follicular matrix keratinocytes in the hair bulb, the expression of Ki-67 was increased, while the signal for terminal deoxynucleotidyl transferase dUTP nick end labeling was reduced. From these results, we suggest that 1,763 MHz RF exposure stimulates hair growth in vitro through the induction of IGF-1 in hDPCs.	[Yoon, Sun-Young; Jo, Seong Jin; Cho, A-Ri; Kim, Kyu Han; Kwon, Oh Sang] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Kyu-Tae; Park, Woong-Yang] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Gun-Sik] Seoul Natl Univ, Coll Nat Sci, Dept Phys & Astron, Seoul 151742, South Korea; [Jeon, Soon-Ik; Choi, Hyung-Do] Commun & Broadcasting Covergence Elect & Telecomm, Radio Technol Res Dept, Taejon, South Korea; [Pack, Jeong-Ki] Chungnam Natl Univ, Ctr Electromagnet Res, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chungnam National University	Yoon, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea.	oskwon@snu.ac.kr; wypark@snu.ac.kr	park, woongyang/D-5727-2012; Kim, Kyu Han/E-7814-2012; Park, Gunsik/A-1415-2014; Kwon, Ohsang/J-2733-2012	Kwon, Ohsang/0000-0003-0464-5124; Jo, Seong Jin/0000-0002-2501-7672	Korea Communications Commission, Korea [KCA-2011-11911-01108]; National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0001300]	Korea Communications Commission, Korea(Korea Communications Commission (KCC)); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Funding provided by Korea Communications Commission, Korea, under the Research & Development program supervised by the Korea Communications Agency (KCA; KCA-2011-11911-01108) and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0001300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Han JH, 2004, J DERMATOL SCI, V34, P91, DOI 10.1016/j.jdermsci.2004.01.002; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Huang TQ, 2008, INT J RADIAT BIOL, V84, P734, DOI 10.1080/09553000802317760; Huang TQ, 2008, INT J RADIAT BIOL, V84, P909, DOI 10.1080/09553000802460123; Hurbin A, 2005, J BIOL CHEM, V280, P19757, DOI 10.1074/jbc.M413516200; Hwang KA, 2011, INT J MOL MED; Inui S, 2011, J DERMATOL SCI, V61, P1, DOI 10.1016/j.jdermsci.2010.10.015; Jahoda C, 1984, INDUCTION HAIR GROWT; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Karinen A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-77; Lee JS, 2006, BIOELECTROMAGNETICS, V27, P578, DOI 10.1002/bem.20235; Lee JJ, 2008, BIOELECTROMAGNETICS, V29, P615, DOI 10.1002/bem.20427; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; MADDIN WS, 1990, INT J DERMATOL, V29, P446, DOI 10.1111/j.1365-4362.1990.tb03837.x; McAchran SE, 2005, UROLOGY, V66, P15, DOI 10.1016/j.urology.2005.06.127; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Meltz ML, 2003, BIOELECTROMAGNETICS, pS196, DOI 10.1002/bem.10176; MESSENGER AG, 1984, BRIT J DERMATOL, V110, P685, DOI 10.1111/j.1365-2133.1984.tb04705.x; Moulder JE, 1999, RADIAT RES, V151, P513, DOI 10.2307/3580028; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Otomo Susumu, 2002, Folia Pharmacologica Japonica, V119, P167, DOI 10.1254/fpj.119.167; Ozeki M, 2002, BIOMATERIALS, V23, P2367, DOI 10.1016/S0142-9612(01)00372-6; Ozguner F, 2004, TOXICOL IND HEALTH, V20, P133, DOI 10.1191/0748233704th207oa; Peus D, 1996, DERMATOL CLIN, V14, P559, DOI 10.1016/S0733-8635(05)70384-3; PHILPOTT MP, 1994, J INVEST DERMATOL, V102, P857, DOI 10.1111/1523-1747.ep12382494; PHILPOTT MP, 1990, J CELL SCI, V97, P463; RANDALL VA, 1991, ANN NY ACAD SCI, V642, P355; SCHERER WF, 1954, P SOC EXP BIOL MED, V87, P480; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Smith TM, 2008, J INVEST DERMATOL, V128, P1286, DOI 10.1038/sj.jid.5701155; Solbiati L, 1997, RADIOLOGY, V202, P195, DOI 10.1148/radiology.202.1.8988211; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tsuboi R., 1997, J INVEST DERMATOL, V4, P103; Vijayalaxmi, 2004, RADIAT RES, V162, P481, DOI 10.1667/RR3252; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao JA, 2011, J NUTR BIOCHEM, V22, P227, DOI 10.1016/j.jnutbio.2010.01.008	41	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28474	10.1371/journal.pone.0028474	http://dx.doi.org/10.1371/journal.pone.0028474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164296	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400097
J	Veljkovic, M; Dopsaj, V; Dopsaj, M; Branch, DR; Veljkovic, N; Sakarellos-Daitsiotis, MM; Veljkovic, V; Glisic, S; Colombatti, A				Veljkovic, Milena; Dopsaj, Violeta; Dopsaj, Milivoj; Branch, Donald R.; Veljkovic, Nevena; Sakarellos-Daitsiotis, Maria M.; Veljkovic, Veljko; Glisic, Sanja; Colombatti, Alfonso			Physical Activity and Natural Anti-VIP Antibodies: Potential Role in Breast and Prostate Cancer Therapy	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; HORMONE-RELEASING HORMONE; POLYPEPTIDE VIP; NEUROENDOCRINE DIFFERENTIATION; MOLECULAR-IDENTIFICATION; PLASMA-CONCENTRATIONS; RECEPTOR ANTAGONISTS; HUMAN AUTOANTIBODY; MUSCULAR EXERCISE; PROLONGED STRAIN	Background: There is convincing evidence from numerous clinical and epidemiological studies that physical activity can reduce the risk for breast and prostate cancer. The biological mechanisms underlying this phenomenon remain elusive. Herein we suggest a role for naturally produced antibodies reactive with the vasoactive intestinal peptide (VIP) in the suppression of breast and prostate cancer, which we believe could offer a possible molecular mechanism underlying control of these cancers by physical exercise. Methodology and Results: We found that sera from individuals having breast and prostate cancers have decreased titers of VIP natural antibodies as demonstrated by a lower reactivity against peptide NTM1, having similar informational and structural properties as VIP. In contrast, sera collected from elite athletes, exhibited titers of natural NTM1-reactive antibodies that are significantly increased, suggesting that physical activity boosts production of these antibodies. Significance: Presented results suggest that physical exercise stimulates production of natural anti-VIP antibodies and likely results in suppression of VIP. This, in turn, may play a protective role against breast and prostate cancers. Physical exercise should be further investigated as a potential tool in the treatment of these diseases.	[Veljkovic, Milena] Sveti Sava Hosp, Belgrade, Serbia; [Dopsaj, Violeta] Clin Ctr Serbia, Inst Med Biochem, Belgrade, Serbia; [Dopsaj, Milivoj] Univ Belgrade, Fac Sport & Phys Educ, Belgrade, Serbia; [Branch, Donald R.] Canadian Blood Serv, Toronto, ON, Canada; [Veljkovic, Nevena; Veljkovic, Veljko; Glisic, Sanja] Inst Nucl Sci VINCA, Ctr Multidisciplinary Res, Belgrade, Serbia; [Sakarellos-Daitsiotis, Maria M.] Univ Ioannina, Dept Chem, Sect Organ Chem & Biochem, GR-45110 Ioannina, Greece; [Colombatti, Alfonso] Ctr Riferimento Oncol CRO IRCCS, Div Oncol Sperimentale, Aviano, Italy	Clinical Centre of Serbia; University of Belgrade; Canadian Blood Services; University of Belgrade; University of Ioannina; IRCCS Aviano (CRO)	Veljkovic, M (corresponding author), Sveti Sava Hosp, Belgrade, Serbia.	vv@vinca.rs	Dopsaj, Milivoj/P-4237-2019; Glisic, Sanja/AAE-8590-2019	Glisic, Sanja/0000-0001-5691-1055; colombatti, alfonso/0000-0002-3676-2379; Dopsaj, Milivoj/0000-0001-7153-2993; Veljkovic, Nevena/0000-0001-6562-5800	Ministry of Science and Technological Development of the Republic of Serbia [173001]	Ministry of Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Science and Technological Development of the Republic of Serbia (Grant no. 173001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOMPA TO, 2005, PERIODIZATION TRAINI, pR9; Collado B, 2006, MOL CELL ENDOCRINOL, V249, P116, DOI 10.1016/j.mce.2006.02.004; Collado B, 2004, REGUL PEPTIDES, V119, P69, DOI 10.1016/j.regpep.2004.01.013; Collado B, 2007, PEPTIDES, V28, P1896, DOI 10.1016/j.peptides.2007.04.015; Dagar S, 2001, BREAST CANCER RES TR, V65, P49, DOI 10.1023/A:1006406617497; Djordjevic A, 2007, CURR HIV RES, V5, P443, DOI 10.2174/157016207781662470; Fernandez-Martinez AB, 2010, CANCER LETT, V299, P11, DOI 10.1016/j.canlet.2010.07.019; Fernandez-Martinez AB, 2009, PROSTATE, V69, P774, DOI 10.1002/pros.20930; FRIEDENREICH CM, 2010, PHYS ACTIVITY BREAST, V188, P125; FRISCH RE, 1987, INT J FERTIL, V32, P217; FRISCH RE, 1992, ADV EXP MED BIOL, V322, P29; GALBO H, 1979, ACTA PHYSIOL SCAND, V105, P374, DOI 10.1111/j.1748-1716.1979.tb06353.x; Garcia-Fernandez MO, 2005, GYNECOL ENDOCRINOL, V20, P327, DOI 10.1080/09513590500098240; GESPACH C, 1988, BIOCHEM BIOPH RES CO, V151, P939, DOI 10.1016/S0006-291X(88)80372-3; GESPACH C, 1988, CANCER RES, V48, P5079; Gkonos PJ, 1996, REGUL PEPTIDES, V65, P153, DOI 10.1016/0167-0115(96)00086-9; Gutierrez-Canas I, 2005, PROSTATE, V63, P44, DOI 10.1002/pros.20173; IBRAHIM EM, 2010, MED ONCOLOGY; Irwin ML, 2008, J CLIN ONCOL, V26, P3958, DOI 10.1200/JCO.2007.15.9822; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Leitzmann MF, 2011, RECENT RESULTS CANC, V186, P43, DOI 10.1007/978-3-642-04231-7_3; MACLAREN DP, 1995, CLIN SCI, V89, P137, DOI 10.1042/cs0890137; Madsen B, 2000, ANN NY ACAD SCI, V921, P33; McTiernan A, 2010, J CLIN ONCOL, V28, P4074, DOI 10.1200/JCO.2010.27.9752; MEI S, 1991, J BIOL CHEM, V266, P15571; Moody TW, 2007, PEPTIDES, V28, P1883, DOI 10.1016/j.peptides.2007.04.017; Moody TW, 2007, CURR PHARM DESIGN, V13, P1099, DOI 10.2174/138161207780619000; Moody TW, 2006, ANN NY ACAD SCI, V1070, P436, DOI 10.1196/annals.1317.058; Moody TW, 2003, PEPTIDES, V24, P163, DOI 10.1016/S0196-9781(02)00290-5; Moody TW, 2004, LIFE SCI, V74, P1345, DOI 10.1016/j.lfs.2003.07.043; Moody TW, 2002, LIFE SCI, V71, P1005, DOI 10.1016/S0024-3205(02)01741-1; Moody TW, 2001, BREAST CANCER RES TR, V68, P55, DOI 10.1023/A:1017994722130; Moody TW, 1998, ANN NY ACAD SCI, V865, P290, DOI 10.1111/j.1749-6632.1998.tb11189.x; Nagakawa O, 2005, ONCOL REP, V13, P1217; OEKTEDALEN O, 1983, REGUL PEPTIDES, V5, P235, DOI 10.1016/0167-0115(83)90254-9; OKTEDALEN O, 1983, SCAND J GASTROENTERO, V18, P1057, DOI 10.3109/00365528309181840; OKTEDALEN O, 1983, EUR J APPL PHYSIOL O, V52, P5, DOI 10.1007/BF00429017; OPSTAD PK, 1987, PEPTIDES, V8, P175, DOI 10.1016/0196-9781(87)90183-5; PAUL S, 1991, J BIOL CHEM, V266, P16128; PAUL S, 1985, BIOCHEM BIOPH RES CO, V130, P479, DOI 10.1016/0006-291X(85)90442-5; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; PAUL S, 1988, LIFE SCI, V43, P1079, DOI 10.1016/0024-3205(88)90203-2; PAUL S, 1990, J BIOL CHEM, V265, P11910; Plonowski A, 2002, INT J CANCER, V98, P624, DOI 10.1002/ijc.10221; Rekasi Z, 2001, PROSTATE, V48, P188, DOI 10.1002/pros.1097; Richman EL, 2011, CANC RES; Sotomayor S, 2007, INT J ONCOL, V31, P1223; Torti DC, 2004, SPORTS MED, V34, P363, DOI 10.2165/00007256-200434060-00003; VALDEHITA A, 2011, MOL CELLULAR ENDOCRI; Valdehita A, 2007, REGUL PEPTIDES, V144, P101, DOI 10.1016/j.regpep.2007.06.006; Valdehita A, 2010, PEPTIDES, V31, P2035, DOI 10.1016/j.peptides.2010.07.024; Valdehita A, 2009, MOL CELL ENDOCRINOL, V302, P41, DOI 10.1016/j.mce.2008.11.024; Veljkovic M, 2010, SCAND J MED SCI SPOR, V20, P469, DOI 10.1111/j.1600-0838.2009.00962.x; Veljkovic N, 2003, J PEPT RES, V62, P158, DOI 10.1034/j.1399-3011.2003.00081.x; Veljkovic V, 2004, INT REV IMMUNOL, V23, P383, DOI 10.1080/08830180490432749; VELJKOVIC V, 1993, BIOCHEM BIOPH RES CO, V196, P1019, DOI 10.1006/bbrc.1993.2353; VELJKOVIC V, 1992, BIOCHEM BIOPH RES CO, V189, P705, DOI 10.1016/0006-291X(92)92258-Y; WOIE L, 1986, GEN PHARMACOL, V17, P321, DOI 10.1016/0306-3623(86)90047-9; Wyshak G, 2000, BRIT J CANCER, V82, P726; Zia H, 1996, CANCER RES, V56, P3486	60	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28304	10.1371/journal.pone.0028304	http://dx.doi.org/10.1371/journal.pone.0028304			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140573	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100062
J	Gronholm, J; Kaustio, M; Myllymaki, H; Kallio, J; Saarikettu, J; Kronhamn, J; Valanne, S; Silvennoinen, O; Ramet, M				Gronholm, Juha; Kaustio, Meri; Myllymaki, Henna; Kallio, Jenni; Saarikettu, Juha; Kronhamn, Jesper; Valanne, Susanna; Silvennoinen, Olli; Ramet, Mika			Not4 enhances JAK/STAT pathway-dependent gene expression in Drosophila and in human cells	FASEB JOURNAL			English	Article						Ccr4-Not complex; cytokine signaling; Stat92E; stress response	TRANSCRIPTIONAL ACTIVATION; CCR4-NOT COMPLEX; PROTEIN; IDENTIFICATION; P300/CBP; STAT6; YEAST; COOPERATION; INDUCTION; REGULATOR	The JAK/STAT pathway is essential for organogenesis, innate immunity, and stress responses in Drosophila melanogaster. The JAK/STAT pathway and its associated regulators have been highly conserved in evolution from flies to humans. We have used a genome-wide RNAi screen in Drosophila S2 cells to identify regulators of the JAK/STAT pathway, and here we report the characterization of Not4 as a positive regulator of the JAK/STAT pathway. Overexpression of Not4 enhanced Stat92E-mediated gene responses in vitro and in vivo in Drosophila. Specifically, Not4 increased Stat92E-mediated reporter gene activation in S2 cells; and in flies, Not4 overexpression resulted in an 8-fold increase in Turandot M (TotM) and in a 4-fold increase in Turandot A (TotA) stress gene activation when compared to wild-type flies. Drosophila Not4 is structurally related to human CNOT4, which was found to regulate interferon-gamma- and interleukin-4-induced STAT-mediated gene responses in human HeLa cells. Not4 was found to coimmunoprecipitate with Stat92E but not to affect tyrosine phosphorylation of Stat92E in Drosophila cells. However, Not4 is required for binding of Stat92E to its DNA recognition sequence in the TotM gene promoter. In summary, Not4/CNOT4 is a novel positive regulator of the JAK/STAT pathway in Drosophila and in humans.-Gronholm, J., Kaustio, M., Myllymaki, H., Kallio, J., Saarikettu, J., Kronhamn, J., Valanne, S., Silvennoinen, O., Ramet, M. Not4 enhances JAK/STAT pathway-dependent gene expression in Drosophila and in human cells. FASEB J. 26, 1239-1250 (2012). www.fasebj.org	[Gronholm, Juha; Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Inst Biomed Technol, Lab Mol Immunol & Cytokine Receptor Signaling, FIN-33101 Tampere, Finland; [Kaustio, Meri; Myllymaki, Henna; Kallio, Jenni; Valanne, Susanna; Ramet, Mika] Univ Tampere, Inst Biomed Technol, Expt Immunol Lab, FIN-33101 Tampere, Finland; [Silvennoinen, Olli] Tampere Univ Hosp, Ctr Sci, Ctr Lab Med, Tampere, Finland; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Kronhamn, Jesper] Umea Univ, Dept Mol Biol, Umea, Sweden	Tampere University; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Umea University	Ramet, M (corresponding author), Tampere Univ, Inst Biomed Technol, FIN-33014 Tampere, Finland.	mika.ramet@uta.fi	Grönholm, Juha/Q-4078-2017; Valanne, Susanna/GZK-2381-2022	Grönholm, Juha/0000-0002-4190-0000; Valanne, Susanna/0000-0003-0898-8423; Myllymaki, Henna/0000-0002-6936-4879	Academy of Finland; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Pirkanmaa Hospital District; Centre of Laboratory Medicine of the Tampere University Hospital; Finnish Cancer Foundation; Maire Lisko Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation; Biocenter Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Pirkanmaa Hospital District; Centre of Laboratory Medicine of the Tampere University Hospital; Finnish Cancer Foundation; Maire Lisko Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Biocenter Finland	This research was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation (to M. R and O.S.); the Tampere Tuberculosis Foundation (to M. R., S. V., and O.S.); Competitive Research Funding of the Pirkanmaa Hospital District (to M. R. and S. V.); Competitive Research Funding and Centre of Laboratory Medicine of the Tampere University Hospital, the Finnish Cancer Foundation, and the Maire Lisko Foundation (to O.S.); the Emil Aaltonen Foundation (to M. R. and J.G.); and the Finnish Cultural Foundation (to J.G.). The fly work was done at the University of Tampere Drosophila Core Facility, funded by Biocenter Finland. PG-13-luc and p53 plasmid constructs were kind gifts from Dr. Marikki Laiho (Haartman Institute, University of Helsinki, Helsinki, Finland). The authors thank Leena Makinen, Paula Kosonen, and Merja Lehtinen for excellent technical assistance. All authors approved the final version of the text.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Aittomaki S, 2000, J IMMUNOL, V164, P5689, DOI 10.4049/jimmunol.164.11.5689; Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown S, 2003, DEVELOPMENT, V130, P3077, DOI 10.1242/dev.00535; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Gronholm J, 2010, J INNATE IMMUN, V2, P618, DOI 10.1159/000318676; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Henriksen MA, 2002, GENE DEV, V16, P2379, DOI 10.1101/gad.1020702; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kallio J, 2010, FASEB J, V24, P4467, DOI 10.1096/fj.10-162784; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9; Pesu M, 2000, BLOOD, V95, P494, DOI 10.1182/blood.V95.2.494; Pesu M, 2003, EUR J IMMUNOL, V33, P1727, DOI 10.1002/eji.200323680; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Singh SR, 2005, CELL RES, V15, P1, DOI 10.1038/sj.cr.7290255; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	52	21	22	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1239	1250		10.1096/fj.11-195875	http://dx.doi.org/10.1096/fj.11-195875			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22159038				2022-12-25	WOS:000300949300026
J	Han, WQ; Wu, BL; Li, L; Zhao, GH; Woodward, R; Pettit, N; Cai, L; Thon, V; Wang, PG				Han, Weiqing; Wu, Baolin; Li, Lei; Zhao, Guohui; Woodward, Robert; Pettit, Nicholas; Cai, Li; Thon, Vireak; Wang, Peng G.			Defining Function of Lipopolysaccharide O-antigen Ligase WaaL Using Chemoenzymatically Synthesized Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI O86-H2; RFB GENE-CLUSTER; OUTER-MEMBRANE; VIBRIO-CHOLERAE; BIOSYNTHESIS; CORE; EXPRESSION; CLONING; OVEREXPRESSION; ANTIBODIES	The WaaL-mediated ligation of O-antigen onto the core region of the lipid A-core block is an important step in the lipopolysaccharide (LPS) biosynthetic pathway. Although the LPS biosynthesis has been largely characterized, only a limited amount of in vitro biochemical evidence has been established for the ligation reaction. Such limitations have primarily resulted from the barriers in purifying WaaL homologues and obtaining chemically defined substrates. Accordingly, we describe herein a chemical biology approach that enabled the reconstitution of this ligation reaction. The O-antigen repeating unit (O-unit) of Escherichia coli O86 was first enzymatically assembled via sequential enzymatic glycosylation of a chemically synthesized GalNAc-pyrophosphate-undecaprenyl precursor. Subsequent expression of WaaL through use of a chaperone co-expression system then enabled the demonstration of the in vitro ligation between the synthesized donor (O-unit-pyrophosphate-undecaprenyl) and the isolated lipid A-core acceptor. The previously reported ATP and divalent metal cation dependence were not observed using this system. Further analyses of other donor substrates revealed that WaaL possesses a highly relaxed specificity toward both the lipid moiety and the glycan moiety of the donor. Lastly, three conserved amino acid residues identified by sequence alignment were found essential for the WaaL activity. Taken together, the present work represents an in vitro systematic investigation of the WaaL function using a chemical biology approach, providing a system that could facilitate the elucidation of the mechanism of WaaL-catalyzed ligation reaction.	[Han, Weiqing; Wu, Baolin; Zhao, Guohui; Thon, Vireak; Wang, Peng G.] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Li, Lei] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Li, Lei] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Woodward, Robert; Pettit, Nicholas] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Woodward, Robert; Pettit, Nicholas] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Cai, Li] Univ S Carolina Salkehatchie, Dept Chem, Walterboro, SC 29488 USA	University System of Georgia; Georgia State University; Nankai University; Nankai University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of South Carolina System; University of South Carolina Salkehatchie	Wang, PG (corresponding author), Georgia State Univ, Dept Chem, 787 Petit Sci Ctr,POB 4098, Atlanta, GA 30302 USA.	pwang11@gsu.edu	Cai, Li/A-2214-2012; Zhao, Guohui/K-8624-2012; Zhao, Guohui/J-6782-2012; Wu, Baolin/F-8387-2012; WANG, Peng/GSN-5263-2022	Cai, Li/0000-0002-6098-1168; 	National Institutes of Health [R01 GM085267]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM085267 (to P. G. W.).	Abeyrathne PD, 2007, MOL MICROBIOL, V65, P1345, DOI 10.1111/j.1365-2958.2007.05875.x; ALHENDY A, 1991, MICROB PATHOGENESIS, V10, P47, DOI 10.1016/0882-4010(91)90065-I; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; BASTIN DA, 1991, MOL MICROBIOL, V5, P2223, DOI 10.1111/j.1365-2958.1991.tb02152.x; Brockhausen I, 2008, GLYCOCONJUGATE J, V25, P663, DOI 10.1007/s10719-008-9127-7; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chung HS, 2011, P NATL ACAD SCI USA, V108, P510, DOI 10.1073/pnas.1016462108; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GOLDBERG JB, 1992, P NATL ACAD SCI USA, V89, P10716, DOI 10.1073/pnas.89.22.10716; Guo H, 2006, PROTEIN EXPRES PURIF, V48, P49, DOI 10.1016/j.pep.2006.01.015; Hug I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000819; Islam ST, 2011, J BIOL CHEM, V286, P20600, DOI 10.1074/jbc.C110.204651; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Li M, 2008, BIOCHEMISTRY-US, V47, P11590, DOI 10.1021/bi801067s; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Palusiak A, 2008, ARCH IMMUNOL THER EX, V56, P135, DOI 10.1007/s00005-008-0012-7; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruan X., 2011, GLYCOBIOLOG IN PRESS; Rush JS, 2010, J BIOL CHEM, V285, P1671, DOI 10.1074/jbc.M109.061630; Schild S, 2005, J BIOL CHEM, V280, P25936, DOI 10.1074/jbc.M501259200; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Valvano MA, 2008, MOL MICROBIOL, V67, P232, DOI 10.1111/j.1365-2958.2007.06052.x; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Yi W, 2006, BIOCHEM BIOPH RES CO, V344, P631, DOI 10.1016/j.bbrc.2006.03.181; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; YOKOTA S, 1992, J GEN MICROBIOL, V138, P289, DOI 10.1099/00221287-138-2-289	38	49	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5357	5365		10.1074/jbc.M111.308486	http://dx.doi.org/10.1074/jbc.M111.308486			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22158874	Green Published, hybrid			2022-12-25	WOS:000300638000017
J	Yang, FK; Hu, LY; Chen, C; Yu, JX; O'Connell, CB; Khodjakov, A; Pagano, M; Dai, W				Yang, Feikun; Hu, Liyan; Chen, Cheng; Yu, Jianxiu; O'Connell, Christopher B.; Khodjakov, Alexey; Pagano, Michele; Dai, Wei			BubR1 Is Modified by Sumoylation during Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-E; SPINDLE CHECKPOINT; CELL-CYCLE; KINETOCHORE; MICE; PHOSPHORYLATION; BINDING; MITOSIS; INSUFFICIENCY; DEGRADATION	BubR1 functions as a crucial component that monitors proper chromosome congression and mitotic timing during cell division. We investigated molecular regulation of BubR1 and found that BubR1 was modified by an unknown post-translation mechanism during the cell cycle, resulting in a significant mobility shift on denaturing gels. We termed it BubR1-M as the nature of modification was not characterized. Extended (> 24 h) treatment of HeLa cells with a microtubule disrupting agent including nocodazole and taxol or release of mitotic shake-off cells into fresh medium induced BubR1-M. BubR1-M was derived from neither phosphorylation nor acetylation. Ectopic expression coupled with pulling down analyses showed that BubR1-M was derived from SUMO modification. Mutation analysis revealed that lysine 250 was a crucial site for sumoylation. Significantly, compared with the wild-type control, ectopic expression of a sumoylation-deficient mutant of BubR1 induced chromosomal missegregation and mitotic delay. Combined, our study identifies a new type of post-translational modification that is essential for BubR1 function during mitosis.	[Yang, Feikun; Hu, Liyan; Dai, Wei] NYU, Sch Med, Langone Med Ctr, Dept Environm Med & Pharmacol, Tuxedo Pk, NY 10987 USA; [Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, Dept Pathol, New York, NY 10016 USA; [Chen, Cheng; Yu, Jianxiu] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [O'Connell, Christopher B.; Khodjakov, Alexey] Wadsworth Ctr, Albany, NY 12201 USA	New York University; NYU Langone Medical Center; Howard Hughes Medical Institute; New York University; Shanghai Jiao Tong University; Wadsworth Center	Dai, W (corresponding author), NYU, Sch Med, Langone Med Ctr, Dept Environm Med & Pharmacol, Tuxedo Pk, NY 10987 USA.	wei.dai@med.nyu.edu		Dai, Wei/0000-0003-0169-8327; pagano, michele/0000-0003-3210-2442	United States Public Service [CA090658, CA113349, R01-GM057587, R21-AG032560]; NATIONAL CANCER INSTITUTE [R01CA090658, R37CA076584, R01CA113349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587, R01GM059363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032560] Funding Source: NIH RePORTER	United States Public Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Service Awards (to W. D.) (CA090658 and CA113349) and (to M. P.) (R01-GM057587 and R21-AG032560).	Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Harris L, 2005, EXP CELL RES, V308, P85, DOI 10.1016/j.yexcr.2005.03.036; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Huang HM, 2009, CELL CYCLE, V8, P1164, DOI 10.4161/cc.8.8.8151; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Li WQ, 1999, CELL GROWTH DIFFER, V10, P769; Liu Xue-Song, 2010, Genes Cancer, V1, P26, DOI 10.1177/1947601909358184; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Wu HY, 2000, ONCOGENE, V19, P4557, DOI 10.1038/sj.onc.1203803; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhao H, 2009, CYTOM PART A, V75A, P510, DOI 10.1002/cyto.a.20727	33	25	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4875	4882		10.1074/jbc.M111.318261	http://dx.doi.org/10.1074/jbc.M111.318261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22167194	Green Published, hybrid			2022-12-25	WOS:000300608500048
J	Kodippili, GC; Spector, J; Hale, J; Giger, K; Hughes, MR; McNagny, KM; Birkenmeier, C; Peters, L; Ritchie, K; Low, PS				Kodippili, Gayani C.; Spector, Jeff; Hale, Jacob; Giger, Katie; Hughes, Michael R.; McNagny, Kelly M.; Birkenmeier, Connie; Peters, Luanne; Ritchie, Ken; Low, Philip S.			Analysis of the Mobilities of Band 3 Populations Associated with Ankyrin Protein and Junctional Complexes in Intact Murine Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL MEMBRANE; COMPENSATED HEMOLYTIC-ANEMIA; CYTOPLASMIC DOMAIN; LATERAL MOBILITY; HEREDITARY SPHEROCYTOSIS; ROTATIONAL DIFFUSION; GLYCOPHORIN-C; TARGETED DISRUPTION; CRYSTAL-STRUCTURE; BETA-ADDUCIN	Current models of the erythrocyte membrane depict three populations of band 3: (i) a population tethered to spectrin via ankyrin, (ii) a fraction attached to the spectrin-actin junctional complex via adducin, and (iii) a freely diffusing population. Because many studies of band 3 diffusion also distinguish three populations of the polypeptide, it has been speculated that the three populations envisioned in membrane models correspond to the three fractions observed in diffusion analyses. To test this hypothesis, we characterized band 3 diffusion by single-particle tracking in wild-type and ankyrin-and adducin-deficient erythrocytes. We report that similar to 40% of total band 3 in wild-type murine erythrocytes is attached to ankyrin, whereas similar to 33% is immobilized by adducin, and similar to 27% is not attached to any cytoskeletal anchor. Moredetailed analyses reveal that mobilities of individual ankyrin- and adducin-tethered band 3 molecules are heterogeneous, varying by nearly 2 orders of magnitude and that there is considerable overlap in diffusion coefficients for adducin and ankyrin-tethered populations. Taken together, the data suggest that although the ankyrin-and adducin-immobilized band 3 can be monitored separately, significant heterogeneity still exists within each population, suggesting that structural and compositional properties likely vary considerably within each band 3 complex.	[Spector, Jeff; Hale, Jacob; Ritchie, Ken] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Kodippili, Gayani C.; Giger, Katie; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Spector, Jeff] Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; [Hughes, Michael R.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Birkenmeier, Connie; Peters, Luanne] Jackson Lab, Bar Harbor, ME 04609 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institute of Standards & Technology (NIST) - USA; University of British Columbia; Jackson Laboratory	Ritchie, K (corresponding author), Purdue Univ, Dept Phys, 525 Northwest Ave, W Lafayette, IN 47909 USA.	kpritchie@purdue.edu; plow@purdue.edu	McNagny, Kelly/P-5239-2014; Hughes, Michael/N-6039-2015	McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070; Peters, Luanne/0000-0002-0784-0534; Low, Philip/0000-0001-9042-5528	National Institute of Health [GM24417-32]; National Science Foundation [0646633]; Canadian Institutes for Health Research [MOP-93580]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024417, R37GM024417] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health Grant GM24417-32 (to P. S. L.). This work was also supported by National Science Foundation Grant 0646633 (to K. R.) and Canadian Institutes for Health Research Grant MOP-93580 (to K. M. M.).	ALLOISIO N, 1993, BLOOD, V82, P1323, DOI 10.1182/blood.V82.4.1323.bloodjournal8241323; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BENNETT V, 1979, NATURE, V281, P597, DOI 10.1038/281597a0; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Birkenmeier Connie S, 2003, Hematol J, V4, P445, DOI 10.1038/sj.thj.6200307; Blackman SM, 1996, BIOPHYS J, V71, P194, DOI 10.1016/S0006-3495(96)79216-0; Blackman SM, 2001, BIOPHYS J, V81, P3363, DOI 10.1016/S0006-3495(01)75969-3; Bruce LJ, 1999, BBA-BIOMEMBRANES, V1416, P258, DOI 10.1016/S0005-2736(98)00231-4; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; Burton NM, 2011, BIOCHEM CELL BIOL, V89, P200, DOI [10.1139/o10-154, 10.1139/O10-154]; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; CORBETT JD, 1994, J CLIN INVEST, V94, P683, DOI 10.1172/JCI117385; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; GOLAN DE, 1980, P NATL ACAD SCI-BIOL, V77, P2537, DOI 10.1073/pnas.77.5.2537; GOLAN DE, 1984, BIOCHEMISTRY-US, V23, P332, DOI 10.1021/bi00297a024; HUGHES CA, 1995, J BIOL CHEM, V270, P18990, DOI 10.1074/jbc.270.32.18990; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; Kodippili GC, 2010, BRIT J HAEMATOL, V150, P592, DOI 10.1111/j.1365-2141.2010.08268.x; Kodippili GC, 2009, BLOOD, V113, P6237, DOI 10.1182/blood-2009-02-205450; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1979, NATURE, V281, P426, DOI 10.1038/281426a0; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; MATAYOSHI ED, 1991, BIOCHEMISTRY-US, V30, P3527, DOI 10.1021/bi00228a025; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mirchev R, 2001, BLOOD CELL MOL DIS, V27, P143, DOI 10.1006/bcmd.2000.0367; Mirchev R, 2011, BRIT J HAEMATOL, V155, P111, DOI 10.1111/j.1365-2141.2011.08805.x; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; NIGG EA, 1980, P NATL ACAD SCI-BIOL, V77, P4702, DOI 10.1073/pnas.77.8.4702; NIGG EA, 1979, BIOCHEMISTRY-US, V18, P3457, DOI 10.1021/bi00583a004; Paramore S, 2006, BIOPHYS J, V90, P92, DOI 10.1529/biophysj.105.066969; PETERS LL, 1992, BLOOD, V80, P2122; Peters LL, 2004, BLOOD, V103, P3233, DOI 10.1182/blood-2003-08-2813; PETERS LL, 1991, J CELL BIOL, V114, P1233, DOI 10.1083/jcb.114.6.1233; Peters LL, 1999, J CLIN INVEST, V103, P1527, DOI 10.1172/JCI5766; PETERS LL, 2001, HEMATOPOIESIS DEV AP, P582; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; Robledo RF, 2008, BLOOD, V112, P4298, DOI 10.1182/blood-2008-05-156000; Robledo RF, 2007, BLOOD, V110, p49A, DOI 10.1182/blood.V110.11.141.141; Salhany JM, 2001, BLOOD CELL MOL DIS, V27, P901, DOI 10.1006/bcmd.2001.0464; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Satchwell TJ, 2009, BLOOD CELL MOL DIS, V42, P201, DOI 10.1016/j.bcmd.2009.01.005; SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; SMITH DK, 1982, NATURE, V297, P424, DOI 10.1038/297424a0; Southgate CD, 1996, NAT GENET, V14, P227, DOI 10.1038/ng1096-227; THEVENIN BJM, 1990, J BIOL CHEM, V265, P16166; Tomishige M, 1998, J CELL BIOL, V142, P989, DOI 10.1083/jcb.142.4.989; Tomishige M, 1999, MOL BIOL CELL, V10, P2475, DOI 10.1091/mbc.10.8.2475; TSUJI A, 1986, BIOCHEMISTRY-US, V25, P6133, DOI 10.1021/bi00368a045; TSUJI A, 1988, BIOCHEMISTRY-US, V27, P7447, DOI 10.1021/bi00419a041; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966	61	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4129	4138		10.1074/jbc.M111.294439	http://dx.doi.org/10.1074/jbc.M111.294439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147703	Green Published, hybrid			2022-12-25	WOS:000300410900046
J	Koole, C; Wootten, D; Simms, J; Savage, EE; Miller, LJ; Christopoulos, A; Sexton, PM				Koole, Cassandra; Wootten, Denise; Simms, John; Savage, Emilia E.; Miller, Laurence J.; Christopoulos, Arthur; Sexton, Patrick M.			Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Differentially Regulates Orthosteric but Not Allosteric Agonist Binding and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LIGAND-BINDING; ACTIVATION; RESIDUES; ADRENOCEPTOR; ANTAGONIST; EXPRESSION; CONTRIBUTE; MUTATIONS; EXENDIN-4	The glucagon-like peptide-1 receptor (GLP-1R) is a prototypical family B G protein-coupled receptor that exhibits physiologically important pleiotropic coupling and ligand-dependent signal bias. In our accompanying article (Koole, C., Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., and Sexton, P. M. (2012) J. Biol. Chem. 287, 3642-3658), we demonstrate, through alanine-scanning mutagenesis, a key role for extracellular loop (ECL) 2 of the receptor in propagating activation transition mediated by GLP-1 peptides that occurs in a peptide-and pathway-dependent manner for cAMP formation, intracellular (Ca-i(2+)) mobilization, and phosphorylation of extracellular signal-regulated kinases 1 and 2 (pERK1/2). In this study, we examine the effect of ECL2 mutations on the binding and signaling of the peptide mimetics, exendin-4 and oxyntomodulin, as well as small molecule allosteric agonist 6,7-dichloro-2-methylsulfonyl-3-tert-butylaminoquinoxaline (compound 2). Lys-288, Cys296, Trp-297, and Asn-300 were globally important for peptide signaling and also had critical roles in governing signal bias of the receptor. Peptide-specific effects on relative efficacy and signal bias were most commonly observed for residues 301-305, although R299A mutation also caused significantly different effects for individual peptides. Met-303 was more important for exendin-4 and oxyntomodulin action than those of GLP-1 peptides. Globally, ECL2 mutation was more detrimental to exendin-4-mediated Ca-i(2+) release than GLP-1(7-36)-NH2, providing additional evidence for subtle differences in receptor activation by these two peptides. Unlike peptide activation of the GLP-1R, ECL2 mutations had only limited impact on compound 2 mediated cAMP and pERK responses, consistent with this ligand having a distinct mechanism for receptor activation. These data suggest a critical role of ECL2 of the GLP-1R in the activation transition of the receptor by peptide agonists.	[Koole, Cassandra; Wootten, Denise; Simms, John; Savage, Emilia E.; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Koole, Cassandra; Wootten, Denise; Simms, John; Savage, Emilia E.; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Monash University; Monash University; Mayo Clinic; Mayo Clinic Phoenix	Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	patrick.sexton@monash.edu	Christopoulos, Arthur/B-6207-2013; Wootten, Denise/ABD-5703-2021; Sexton, Patrick M/B-1319-2008	Christopoulos, Arthur/0000-0003-4442-3294; Wootten, Denise/0000-0003-4563-1642; Sexton, Patrick M/0000-0001-8902-2473; Simms, John/0000-0002-4675-0902	National Health and Medical Research Council of Australia [1002180, 519461]; National Health and Medical Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 1002180 and Program Grant 519461 and by a National Health and Medical Research Council Principal Research Fellowship (to P. M. S.) and a Senior Research Fellowship (to A. C.).	Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Al-Sabah S, 2004, PROTEIN PEPTIDE LETT, V11, P9, DOI 10.2174/0929866043478365; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Drucker DJ, 2010, NAT REV DRUG DISCOV, V9, P267, DOI 10.1038/nrd3148; FEHMANN HC, 1994, PEPTIDES, V15, P453, DOI 10.1016/0196-9781(94)90204-6; Furman B. L., 2010, TOXICON IN PRESS; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; Irwin N, 2010, EUR J PHARMACOL, V628, P268, DOI 10.1016/j.ejphar.2009.11.022; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kolterman OG, 2005, AM J HEALTH-SYST PH, V62, P173, DOI 10.1093/ajhp/62.2.173; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koole C, 2011, MOL PHARMACOL, V80, P486, DOI 10.1124/mol.111.072884; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Mann R, 2007, BIOCHEM SOC T, V35, P713, DOI 10.1042/BST0350713; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SCHMIDTLER J, 1994, AM J PHYSIOL, V267, pG423, DOI 10.1152/ajpgi.1994.267.3.G423; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086	38	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3659	3673		10.1074/jbc.M111.309369	http://dx.doi.org/10.1074/jbc.M111.309369			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147709	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000300410900005
J	Ono, S; Hane, M; Kitajima, K; Sato, C				Ono, Sayaka; Hane, Masaya; Kitajima, Ken; Sato, Chihiro			Novel Regulation of Fibroblast Growth Factor 2 (FGF2)-mediated Cell Growth by Polysialic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE NCAM-H; ADHESION MOLECULE; ADULT-RAT; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; POSSIBLE ROLES; DENTATE GYRUS; BINDING; EXPRESSION; COMPLEX	Polysialic acid (polySia) is a unique polysaccharide that modifies neural cell adhesion molecule (NCAM) spatiotemporally. Recently, we demonstrated that polySia functions as a reservoir for several neurotrophic factors and neurotransmitters. Here, we showed the direct interaction between polySia and fibroblast growth factor-2 (FGF2) by native-PAGE, gel filtration, and surface plasmon resonance. The minimum chain length of polySia required for the interaction with FGF2 was 17. Compared with heparan sulfate, a well known glycosaminoglycan capable of forming a complex with FGF2, polySia formed a larger complex with distinct properties in facilitating oligomerization of FGF2, as well as in binding to FGF receptors. In polySia-NCAM-expressing NIH-3T3 cells, which were established by transfecting cells with either of the plasmids for the expression of the polysialyltransferases ST8SiaII/STX and ST8SiaIV/PST that can polysialylate NCAM, FGF2-stimulated cell growth, but not cell survival, was inhibited. Taken together, these results suggest that polySia-NCAM might be involved in the regulation of FGF2-FGF receptor signaling through the direct binding of FGF2 in a manner distinct from heparan sulfate.	[Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Kitajima, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	kitajima@agr.nagoya-u.ac.jp; chi@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X	Ministry of Education, Science, Sports and Culture [20570107, 23570133]; Hayashi Foundation; CREST of Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23570133] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Foundation; CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (C) 20570107 and 23570133 from the Ministry of Education, Science, Sports and Culture, the Hayashi Foundation (to C. S.), and CREST of Japan Science and Technology Agency (to K. K.).	Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Francavilla C, 2007, J CELL SCI, V120, P4388, DOI 10.1242/jcs.010744; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Fukuda M, 1996, CANCER RES, V56, P2237; Fumagalli F, 2005, NEUROBIOL DIS, V20, P731, DOI 10.1016/j.nbd.2005.05.005; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Graham BM, 2010, NEUROPSYCHOPHARMACOL, V35, P1348, DOI 10.1038/npp.2010.3; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Jacobsen J, 2008, NEUROCHEM RES, V33, P2532, DOI 10.1007/s11064-008-9680-2; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; KERN WF, 1993, LEUKEMIA LYMPHOMA, V12, P1, DOI 10.3109/10428199309059565; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Minana R, 2000, J NEUROCHEM, V75, P954, DOI 10.1046/j.1471-4159.2000.0750954.x; Miyata S, 2006, GLYCOBIOLOGY, V16, P1229, DOI 10.1093/glycob/cwl036; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Murphy KJ, 2006, NEUROPSYCHOPHARMACOL, V31, P90, DOI 10.1038/sj.npp.1300810; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Perez JA, 2009, J NEUROSCI, V29, P6379, DOI 10.1523/JNEUROSCI.4829-08.2009; Rey-Gallardo A, 2010, GLYCOBIOLOGY, V20, P1139, DOI 10.1093/glycob/cwq078; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 1999, TRENDS GLYCOSCI GLYC, V11, P371, DOI 10.4052/tigg.11.371; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 2011, TRENDS GLYCOSCI GLYC, V23, P221, DOI 10.4052/tigg.23.221; Sato C, 2010, METHOD ENZYMOL, V478, P219, DOI 10.1016/S0076-6879(10)78010-1; Saxena K, 2010, J BIOL CHEM, V285, P26628, DOI 10.1074/jbc.M109.095109; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Tanaka F, 2000, CANCER RES, V60, P3072; TROY FA, 1996, BIOL SIALIC ACIDS, P95; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Turner CA, 2009, PHARMACOL BIOCHEM BE, V92, P100, DOI 10.1016/j.pbb.2008.10.018; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P3658, DOI 10.1073/pnas.96.7.3658	51	74	90	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3710	3722		10.1074/jbc.M111.276618	http://dx.doi.org/10.1074/jbc.M111.276618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158871	Green Published, hybrid			2022-12-25	WOS:000300410900009
J	Zhuang, XL; Northup, JK; Ray, K				Zhuang, Xiaolei; Northup, John K.; Ray, Kausik			Large Putative PEST-like Sequence Motif at the Carboxyl Tail of Human Calcium Receptor Directs Lysosomal Degradation and Regulates Cell Surface Receptor Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; AUTOSOMAL-DOMINANT HYPOCALCEMIA; SENSING RECEPTOR; HYPOCALCIURIC HYPERCALCEMIA; SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; CYTOPLASMIC TAIL; UBIQUITINATION; EXPRESSION; PHOSPHORYLATION	A deletion between amino acid residues Ser(895) and Val(1075) in the carboxyl terminus of the human calcium receptor (hCaR), which causes autosomal dominant hypocalcemia, showed enhanced signaling activity and increased cell surface expression in HEK293 cells (Lienhardt, A., Garabedian, M. G., Bai, M., Sinding, C., Zhang, Z., Lagarde, J. P., Boulesteix, J., Rigaud, M., Brown, E. M., and Kottler, M. L. (2000) J. Clin. Endocrinol. Metab. 85, 1695-1702). To identify the underlying mechanism(s) for these increases, we investigated the effects of carboxyl tail truncation and deletion in hCaR mutants using a combination of biochemical and cell imaging approaches to define motifs that participate in regulating cell surface numbers of this G protein-coupled receptor. Our data indicate a rapid constitutive receptor internalization of the cell surface hCaR, accumulating in early (Rab7 positive) and late endosomal (LAMP1 positive) sorting compartments, before targeting to lysosomes for degradation. Recycling of hCaR back to the cell surface was also evident. Truncation and deletion mapping defined a 51-amino acid sequence between residues 920 and 970 that is required for targeting to lysosomes and degradation but not for internalization or recycling of the receptor. No singular sequence motif was identified, instead the required sequence elements seem to distribute throughout this entire interval. This interval includes a high proportion of acidic and hydroxylated amino acid residues, suggesting a similarity to PEST-like degradation motif (PEST find score of +10) and several glutamine repeats. The results define a novel large PEST-like sequence that participates in the sorting of internalized hCaR routed to the lysosomal/degradation pathway that regulates cell surface receptor numbers.	[Zhuang, Xiaolei; Northup, John K.; Ray, Kausik] NIDCD, Lab Cellular Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Northup, JK (corresponding author), Lab Cellular Biol, 5 Res Court,Rm 2A11, Rockville, MD 20850 USA.	northupJK@nidcd.nih.gov; rayk@nidcd.nih.gov	Ray, Kausik/Z-2055-2019		National Institutes of Health of the NIDCD, National Institues of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000068] Funding Source: NIH RePORTER	National Institutes of Health of the NIDCD, National Institues of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDCD, National Institues of Health.	Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Cavanaugh A, 2010, J BIOL CHEM, V285, P19854, DOI 10.1074/jbc.M110.124792; Chang WH, 2001, J BIOL CHEM, V276, P44129, DOI 10.1074/jbc.M104834200; Chen WG, 2005, J BIOL CHEM, V280, P29277, DOI 10.1074/jbc.M505566200; El Hiani Y, 2009, ARCH BIOCHEM BIOPHYS, V486, P58, DOI 10.1016/j.abb.2009.03.010; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; Goswami A, 2006, BIOCHEM BIOPH RES CO, V342, P184, DOI 10.1016/j.bbrc.2006.01.136; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; Huang Y, 2006, J BIOL CHEM, V281, P11610, DOI 10.1074/jbc.M513552200; Huang Y, 2010, J BIOL CHEM, V285, P35919, DOI 10.1074/jbc.M110.147918; Jiang YF, 2002, J BIOL CHEM, V277, P50543, DOI 10.1074/jbc.M205798200; Lienhardt A, 2000, J CLIN ENDOCR METAB, V85, P1695, DOI 10.1210/jc.85.4.1695; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Nissen PH, 2007, J CLIN ENDOCR METAB, V92, P4373, DOI 10.1210/jc.2007-0322; Pi M, 2005, MOL ENDOCRINOL, V19, P1078, DOI 10.1210/me.2004-0450; Pidasheva S, 2004, HUM MUTAT, V24, P107, DOI 10.1002/humu.20067; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Scillitani A, 2004, J CLIN ENDOCR METAB, V89, P5634, DOI 10.1210/jc.2004-0129; Simonds WF, 2002, MEDICINE, V81, P1, DOI 10.1097/00005792-200201000-00001; Stepanchick A, 2010, CELL PHYSIOL BIOCHEM, V26, P363, DOI 10.1159/000320560; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhuang XL, 2010, ENDOCRINOLOGY, V151, P5114, DOI 10.1210/en.2010-0422; Zhuang XL, 2010, BIOCHEM BIOPH RES CO, V396, P874, DOI 10.1016/j.bbrc.2010.05.014	38	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4165	4176		10.1074/jbc.M111.271528	http://dx.doi.org/10.1074/jbc.M111.271528			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158862	hybrid, Green Published			2022-12-25	WOS:000300410900050
J	Okada, R; Nagaosa, K; Kuraishi, T; Nakayama, H; Yamamoto, N; Nakagawa, Y; Dohmae, N; Shiratsuchi, A; Nakanishi, Y				Okada, Ryo; Nagaosa, Kaz; Kuraishi, Takayuki; Nakayama, Hiroshi; Yamamoto, Naoko; Nakagawa, Yukiko; Dohmae, Naoshi; Shiratsuchi, Akiko; Nakanishi, Yoshinobu			Apoptosis-dependent Externalization and Involvement in Apoptotic Cell Clearance of DmCaBP1, an Endoplasmic Reticulum Protein of Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; DISULFIDE-ISOMERASE; C-ELEGANS; ENGULFMENT; PHAGOCYTOSIS; DEATH; CALRETICULIN; RECEPTOR; DRAPER; CED-1	To elucidate the actions of Draper, a receptor responsible for the phagocytic clearance of apoptotic cells in Drosophila, we isolated proteins that bind to the extracellular region of Draper using affinity chromatography. One of those proteins has been identified to be an uncharacterized protein called Drosophila melanogaster calcium-binding protein 1 (DmCaBP1). This protein containing the thioredoxin-like domain resided in the endoplasmic reticulum and seemed to be expressed ubiquitously throughout the development of Drosophila. DmCaBP1 was externalized without truncation after the induction of apoptosis somewhat prior to chromatin condensation and DNA cleavage in a manner dependent on the activity of caspases. A recombinant DmCaBP1 protein bound to both apoptotic cells and a hemocyte-derived cell line expressing Draper. Forced expression of DmCaBP1 at the cell surface made non-apoptotic cells susceptible to phagocytosis. Flies deficient in DmCaBP1 expression developed normally and showed Draper-mediated pruning of larval axons, but a defect in the phagocytosis of apoptotic cells in embryos was observed. Loss of Pretaporter, a previously identified ligand for Draper, did not cause a further decrease in the level of phagocytosis in DmCaBP1-lacking embryos. These results collectively suggest that the endoplasmic reticulum protein DmCaBP1 is externalized upon the induction of apoptosis and serves as a tethering molecule to connect apoptotic cells and phagocytes for effective phagocytosis to occur.	[Okada, Ryo; Nagaosa, Kaz; Kuraishi, Takayuki; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Nagaosa, Kaz; Yamamoto, Naoko; Nakagawa, Yukiko; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Nakayama, Hiroshi; Dohmae, Naoshi] RIKEN Adv Sci Inst, Biomol Characterizat Team, Wako, Saitama 3510198, Japan	Kanazawa University; Kanazawa University; RIKEN	Nakanishi, Y (corresponding author), Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	nakanaka@p.kanazawa-u.ac.jp	Nagaosa, Kaz/G-3857-2014; Dohmae, Naoshi/C-2040-2011; Nakanishi, Yoshinobu/D-4602-2014; Shiratsuchi, Akiko/D-8391-2015	Nagaosa, Kaz/0000-0002-1695-2562; Dohmae, Naoshi/0000-0002-5242-9410; Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409	Japan Society for the Promotion of Science [19370051, 22370049]; Grants-in-Aid for Scientific Research [22370049, 23890014] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 19370051 and 22370049 from the Japan Society for the Promotion of Science (to Y. N.).	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Choi JY, 2002, DEV COMP IMMUNOL, V26, P335, DOI 10.1016/S0145-305X(01)00081-7; Cornwell WD, 2001, J CELL BIOCHEM, V82, P22, DOI 10.1002/jcb.1144; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Franz S, 2007, CELL DEATH DIFFER, V14, P733, DOI 10.1038/sj.cdd.4402066; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Goto Y, 2011, J BIOL CHEM, V286, P21906, DOI 10.1074/jbc.M111.239111; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li YB, 1998, DEV GENET, V23, P104, DOI 10.1002/(SICI)1520-6408(1998)23:2<104::AID-DVG2>3.0.CO;2-A; Liao J, 2005, MED HYPOTHESES, V65, P23, DOI 10.1016/j.mehy.2005.01.028; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Na KS, 2007, MOL CELLS, V24, P261; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nakanishi Y, 2011, DEV GROWTH DIFFER, V53, P149, DOI 10.1111/j.1440-169X.2010.01224.x; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Rumpf S, 2011, DEVELOPMENT, V138, P1153, DOI 10.1242/dev.062703; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	36	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3138	3146		10.1074/jbc.M111.277921	http://dx.doi.org/10.1074/jbc.M111.277921			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158613	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000300295100019
J	Wang, G; Xiao, QZ; Luo, ZL; Ye, S; Xu, QB				Wang, Gang; Xiao, Qingzhong; Luo, Zhenling; Ye, Shu; Xu, Qingbo			Functional Impact of Heterogeneous Nuclear Ribonucleoprotein A2/B1 in Smooth Muscle Differentiation from Stem Cells and Embryonic Arteriogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CREST CELLS; HNRNP A2/B1; MESSENGER-RNA; CHICK-EMBRYO; GENE-EXPRESSION; IN-VITRO; PROTEINS; BINDING; ACTIVATION; HINDBRAIN	Heterogeneous nuclear ribonucleoproteins (hnRNPs) play various roles in transcriptional and post-transcriptional modulation of gene expression. However, it remains unclear if hnRNPs are associated with smooth muscle cell (SMC) differentiation from stem cells and embryonic arteriogenesis. In this study, mouse embryonic stem (ES) cells were cultivated on collagen IV-coated plates and smooth muscle differentiation medium. We found that hnRNPA2/B1 gene and protein expression was significantly up-regulated following 3-7 days of cell differentiation. hnRNPA2/B1 knockdown resulted in down-regulation of specific smooth muscle markers and transcription factors, whereas enforced expression of hnRNPA2/B1 enhanced the expression of these genes. Moreover, we demonstrated by using luciferase and chromatin immunoprecipitation assays that hnRNPA2/B1 could transcriptionally regulate SMC gene expression through direct binding to promoters of Sm alpha a and Sm22 alpha genes. We further demonstrated that chromobox protein homolog gene 3, a previously identified SMC differentiation regulatory nuclear protein, is required for hnRNPA2/B1-mediated SMC differentiation gene expression. Importantly, specifically designed Hnrnpa2/b1 morpholinos for in vivo knockdown could inhibit the migration and differentiation of neural crest cells into SMCs in chick embryos. This resulted in the maldevelopment of branchial arch arteries and increased embryo lethality at a later developmental stage. Our findings demonstrated that hnRNPA2/B1 plays a functional role in SMC differentiation from stem cells in vitro and embryonic branchial arch artery development. This indicates that hnRNPA2/B1 is a potential modulating target for deriving SMCs from stem cells and cardiovascular regenerative medicine.	[Wang, Gang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China; [Xiao, Qingzhong; Ye, Shu] Queen Mary Univ London, Ctr Clin Pharmacol, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Wang, Gang; Luo, Zhenling; Xu, Qingbo] Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr, London SE5 9NU, England	Xi'an Jiaotong University; University of London; Queen Mary University London; University of London; King's College London	Xu, QB (corresponding author), Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr, 125 Cold Harbour Lane, London SE5 9NU, England.	qingbo.xu@kcl.ac.uk	Ye, Shu/R-6384-2017	Ye, Shu/0000-0002-4126-4278	British Heart Foundation [FS/09/044/28007, PG/11/40/28891]; Oak Foundation; National Institute of Health Research; China Scholarship Council; King's College London; British Heart Foundation [RG/09/004/27647] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Oak Foundation; National Institute of Health Research(National Institute for Health Research (NIHR)); China Scholarship Council(China Scholarship Council); King's College London; British Heart Foundation(British Heart Foundation)	This work was supported in part by the British Heart Foundation and Oak Foundation. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit supported and funded by the National Institute of Health Research.; A K. C. Wong Scholar sponsored by China Scholarship Council and King's College London.; Recipient of British Heart Foundation Intermediate Basic Science Research Fellowship FS/09/044/28007 and the principal investigator of British Heart Foundation Project Grant PG/11/40/28891. To whom correspondence may be addressed: Centre for Clinical Pharmacology, William Harvey Research Institute, Barts, and the London School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London EC1M6BQ, United Kingdom. Tel.: 44-2078826027; Fax: 44-2078823408; E-mail:q.xiao@qmul.ac.uk.	BALL EE, 1991, NUCLEIC ACIDS RES, V19, P397, DOI 10.1093/nar/19.2.397; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P3063, DOI 10.1093/nar/gkg435; Chen H, 2003, P NATL ACAD SCI USA, V100, P6109, DOI 10.1073/pnas.1031395100; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; COBIANCHI F, 1988, J BIOL CHEM, V263, P1063; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; He YW, 2005, J CELL SCI, V118, P3173, DOI 10.1242/jcs.02448; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kamma H, 1999, EXP CELL RES, V246, P399, DOI 10.1006/excr.1998.4323; Kostadinov R, 2006, NUCLEIC ACIDS RES, V34, pD119, DOI 10.1093/nar/gkj073; Leverrier S, 2000, BIOL CHEM, V381, P1031, DOI 10.1515/BC.2000.127; Liang Y, 2011, J CELL BIOCHEM, V112, P1722, DOI 10.1002/jcb.23063; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; McGlincy NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-565; Mende M, 2008, MECH DEVELOP, V125, P947, DOI 10.1016/j.mod.2008.08.005; Moran-Jones K, 2005, NUCLEIC ACIDS RES, V33, P486, DOI 10.1093/nar/gki203; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sato M, 2001, DNA SEQUENCE, V12, P97, DOI 10.3109/10425170109047562; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tauler J, 2010, CANCER RES, V70, P7137, DOI 10.1158/0008-5472.CAN-10-0860; Thakur S, 2003, MOL CELL BIOL, V23, P3774, DOI 10.1128/MCB.23.11.3774-3787.2003; Trainor PA, 2002, DEVELOPMENT, V129, P433; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Vera J, 2006, ONCOGENE, V25, P260, DOI 10.1038/sj.onc.1209050; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wiegreffe C, 2007, DEV DYNAM, V236, P2578, DOI 10.1002/dvdy.21279; Xia H, 2005, J BIOL CHEM, V280, P13171, DOI 10.1074/jbc.M414120200; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2011, ARTERIOSCL THROM VAS, V31, P1842, DOI 10.1161/ATVBAHA.111.230110; Xiao QZ, 2010, THROMB HAEMOSTASIS, V104, P440, DOI 10.1160/TH09-11-0794; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Xu QB, 2008, CIRC RES, V102, P1011, DOI 10.1161/CIRCRESAHA.108.171488; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zhang L, 2010, J BIOL CHEM, V285, P38463, DOI 10.1074/jbc.M110.153999; Zhao S, 2008, MOL CELL NEUROSCI, V37, P69, DOI 10.1016/j.mcn.2007.08.015	49	29	29	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2896	2906		10.1074/jbc.M111.297028	http://dx.doi.org/10.1074/jbc.M111.297028			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22144681	Green Published, hybrid			2022-12-25	WOS:000300292300061
J	Davies, TW; Jenkins, SR; Kingham, R; Kenworthy, J; Hawkins, SJ; Hiddink, JG				Davies, Thomas W.; Jenkins, Stuart R.; Kingham, Rachel; Kenworthy, Joseph; Hawkins, Stephen J.; Hiddink, Jan G.			Dominance, Biomass and Extinction Resistance Determine the Consequences of Biodiversity Loss for Multiple Coastal Ecosystem Processes	PLOS ONE			English	Article							FUNCTIONAL CONSEQUENCES; GRASSLAND EXPERIMENT; EUROPEAN GRASSLANDS; PARTICLE RETENTION; MARINE ECOSYSTEMS; PLANT DIVERSITY; FILTRATION-RATE; SPECIES LOSS; COMMUNITIES; PRODUCTIVITY	Key ecosystem processes such as carbon and nutrient cycling could be deteriorating as a result of biodiversity loss. However, currently we lack the ability to predict the consequences of realistic species loss on ecosystem processes. The aim of this study was to test whether species contributions to community biomass can be used as surrogate measures of their contribution to ecosystem processes. These were gross community productivity in a salt marsh plant assemblage and an intertidal macroalgae assemblage; community clearance of microalgae in sessile suspension feeding invertebrate assemblage; and nutrient uptake in an intertidal macroalgae assemblage. We conducted a series of biodiversity manipulations that represented realistic species extinction sequences in each of the three contrasting assemblages. Species were removed in a subtractive fashion so that biomass was allowed to vary with each species removal, and key ecosystem processes were measured at each stage of community disassembly. The functional contribution of species was directly proportional to their contribution to community biomass in a 1:1 ratio, a relationship that was consistent across three contrasting marine ecosystems and three ecosystem processes. This suggests that the biomass contributed by a species to an assemblage can be used to approximately predict the proportional decline in an ecosystem process when that species is lost. Such predictions represent "worst case scenarios" because, over time, extinction resilient species can offset the loss of biomass associated with the extinction of competitors. We also modelled a "best case scenario" that accounts for compensatory responses by the extant species with the highest per capita contribution to ecosystem processes. These worst and best case scenarios could be used to predict the minimum and maximum species required to sustain threshold values of ecosystem processes in the future.	[Davies, Thomas W.; Jenkins, Stuart R.; Kingham, Rachel; Kenworthy, Joseph; Hawkins, Stephen J.; Hiddink, Jan G.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Davies, Thomas W.; Jenkins, Stuart R.; Hawkins, Stephen J.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England	Bangor University; Marine Biological Association United Kingdom	Davies, TW (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.	Thomas.Davies@exeter.ac.uk	Jenkins, Stuart R/D-2032-2010; Davies, Thomas W/H-8103-2013; Hiddink, Jan Geert/C-1238-2009	Jenkins, Stuart R/0000-0002-2299-6318; Davies, Thomas W/0000-0002-4673-9893; Hiddink, Jan Geert/0000-0001-7114-830X; Kenworthy, Joseph/0000-0001-8655-137X	NERC [G00226 CASE]; University of Plymouth, UK; Oceans 2025 programme	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Plymouth, UK; Oceans 2025 programme	This work was funded under a NERC PhD studentship G00226 CASE partnered by the Marine Biological Association of the United Kingdom (MBA). Additional funding for the CO2 flux apparatus was provided by Dr Richard Thompson, University of Plymouth, UK. The MBA were supported by NERC grant-in-aid and the Oceans 2025 programme (theme 4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; [Anonymous], 1975, COMMUNITIES ECOSYSTE; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Fox DL, 1937, BIOL BULL-US, V72, P417, DOI 10.2307/1537700; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Gross K, 2005, ECOL LETT, V8, P409, DOI 10.1111/j.1461-0248.2005.00733.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JORGENSEN CB, 1984, MAR ECOL PROG SER, V15, P283, DOI 10.3354/meps015283; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; Noel LMLJ, 2010, ESTUAR COAST SHELF S, V88, P153, DOI 10.1016/j.ecss.2010.03.005; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; RANDLOV A, 1979, MAR ECOL PROG SER, V1, P55, DOI 10.3354/meps001055; RIISGARD HU, 1988, MAR ECOL PROG SER, V45, P217, DOI 10.3354/meps045217; Ritz C, 2008, USE R, P1; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Sasaki T, 2011, DOMINANT SPECIES RAT, P1; Schmid Bernhard, 2009, P14; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Turon X, 1997, J EXP ZOOL, V278, P22, DOI 10.1002/(SICI)1097-010X(19970501)278:1<22::AID-JEZ3>3.0.CO;2-8; Ulbrich U, 1999, CLIM DYNAM, V15, P551, DOI 10.1007/s003820050299; van Hulzen JB, 2006, J VEG SCI, V17, P291, DOI 10.1111/j.1654-1103.2006.tb02448.x; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Zavaleta E, 2009, ANN NY ACAD SCI, V1162, P311, DOI 10.1111/j.1749-6632.2009.04448.x; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	50	24	24	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28362	10.1371/journal.pone.0028362	http://dx.doi.org/10.1371/journal.pone.0028362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163297	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000298161900033
J	Somaweera, R; Webb, JK; Shine, R				Somaweera, Ruchira; Webb, Jonathan K.; Shine, Richard			Determinants of Habitat Selection by Hatchling Australian Freshwater Crocodiles	PLOS ONE			English	Article							AMERICAN CROCODILE; CAIMAN-CROCODILUS; CROCODYLUS-NILOTICUS; PREDATION RISK; MOLECULAR ASSESSMENT; TROPICAL AUSTRALIA; NESTING ECOLOGY; FOREST HABITAT; SITE SELECTION; DIET	Animals almost always use habitats non-randomly, but the costs and benefits of using specific habitat types remain unknown for many types of organisms. In a large lake in northwestern Australia (Lake Argyle), most hatchling (<12-month-old) freshwater crocodiles (Crocodylus johnstoni) are found in floating vegetation mats or grassy banks rather than the more widely available open banks. Mean body sizes of young crocodiles did not differ among the three habitat types. We tested four potential explanations for non-random habitat selection: proximity to nesting sites, thermal conditions, food availability, and exposure to predation. The three alternative habitat types did not differ in proximity to nesting sites, or in thermal conditions. Habitats with higher food availability harboured more hatchlings, and feeding rates (obtained by stomach-flushing of recently-captured crocodiles) were highest in such areas. Predation risk may also differ among habitats: we were twice as likely to capture a crocodile after seeing it in open-bank sites than in the other two habitat types. Thus, habitat selection of hatchling crocodiles in this system may be driven both by prey availability and by predation risk.	[Somaweera, Ruchira; Webb, Jonathan K.; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Somaweera, R (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	ruchira.somaweera@gmail.com	Somaweera, Ruchira/G-7531-2014	Somaweera, Ruchira/0000-0002-7470-8736; Webb, Jonathan/0000-0003-4822-6829	Australian Research Council; University of Sydney	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	This project was funded by the Australian Research Council grant to Richard Shine (http://www.arc.gov.au/) and the Postgraduate research support scheme grant of University of Sydney to Ruchira Somaweera (http://sydney.edu.au/scholarships/research/prss.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1989, ETHOLOGY, V82, P116; Abramsky Z, 2002, BEHAV ECOL, V13, P497, DOI 10.1093/beheco/13.4.497; ALLSTEADT J, 1994, J HERPETOL, V28, P12, DOI 10.2307/1564674; Barr AD, 2002, 2202 CSIRO LAND WAT; Barr B.R., 1997, THESIS U MIAMI CORAL; Bishop JM, 2009, BIOL CONSERV, V142, P2335, DOI 10.1016/j.biocon.2009.05.016; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Byrom AE, 2002, J APPL ECOL, V39, P67, DOI 10.1046/j.1365-2664.2002.00689.x; Campos Z, 2006, HERPETOL J, V16, P123; CONNER RN, 1991, WILSON BULL, V103, P446; Cooper-Preston H., 1991, THESIS U NEW ENGLAND; Da Silveira R, 1997, J HERPETOL, V31, P514; Di Stefano J, 2009, AUSTRAL ECOL, V34, P143, DOI 10.1111/j.1442-9993.2008.01890.x; Downes S, 1998, ANIM BEHAV, V55, P1373, DOI 10.1006/anbe.1997.0704; Dreitz VJ, 2004, AUK, V121, P894, DOI 10.1642/0004-8038(2004)121[0894:EONDAW]2.0.CO;2; Endo H, 2002, ANAT HISTOL EMBRYOL, V31, P206, DOI 10.1046/j.1439-0264.2002.00396.x; Fujisaki I, 2007, J WILDLIFE MANAGE, V71, P2284, DOI 10.2193/2006-278; G. Webb Pty Ltd, 1989, RES CROC SURV LAK KU; Games I, 1990, THESIS U ZIMBABWE; GARRICK LD, 1977, NAT HIST, V86, P54; Glen AS, 2010, ECOL RES, V25, P311, DOI 10.1007/s11284-009-0653-y; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hekkala ER, 2010, CONSERV GENET, V11, P1435, DOI 10.1007/s10592-009-9970-5; How RA, 2009, J ZOOL, V278, P206, DOI 10.1111/j.1469-7998.2009.00569.x; Hultgren KM, 2010, BEHAV ECOL, V21, P329, DOI 10.1093/beheco/arp192; JOANEN T, 1989, AM ZOOL, V29, P987; King DI, 2006, J ZOOL, V269, P414, DOI 10.1111/j.1469-7998.2006.00158.x; KUSHLAN JA, 1989, J HERPETOL, V23, P7, DOI 10.2307/1564310; LANG JW, 1981, J THERM BIOL, V6, P73, DOI 10.1016/0306-4565(81)90056-5; Langkilde T, 2004, OECOLOGIA, V140, P684, DOI 10.1007/s00442-004-1640-1; Lecomte N, 2008, J ANIM ECOL, V77, P439, DOI 10.1111/j.1365-2656.2008.01354.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIND AJ, 1994, ANIM BEHAV, V48, P1261, DOI 10.1006/anbe.1994.1362; MAZZOTTI FJ, 1986, HERPETOLOGICA, V42, P191; MAZZOTTI FJ, 1989, B MAR SCI, V44, P220; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; OGDEN JC, 1978, J HERPETOL, V12, P183, DOI 10.2307/1563406; OUBOTER PE, 1988, J HERPETOL, V22, P283, DOI 10.2307/1564151; Peterson MS, 2003, REV FISH SCI, V11, P291, DOI 10.1080/10641260390255844; Platt SG, 2000, COPEIA, P869, DOI 10.1643/0045-8511(2000)000[0869:NEOTAC]2.0.CO;2; Platt SG, 2002, HERPETOL J, V12, P81; POWER ME, 1984, J ANIM ECOL, V53, P357, DOI 10.2307/4521; Reagan S.R., 2000, THESIS LOUISIANA STA; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; Russello MA, 2007, CONSERV GENET, V8, P777, DOI 10.1007/s10592-006-9225-7; Sadleir RW, 2008, J EVOLUTION BIOL, V21, P1578, DOI 10.1111/j.1420-9101.2008.01602.x; Somaweera R, 2011, ECOL RES, V26, P957, DOI 10.1007/s11284-011-0853-0; Somaweera R, 2011, WILDLIFE RES, V38, P380, DOI 10.1071/WR11026; STEFFE AS, 1989, MAR ECOL PROG SER, V55, P23, DOI 10.3354/meps055023; Temsiripong Y, 1999, THESIS U FLORIDA; Tucker AD, 1997, J HERPETOL, V31, P114, DOI 10.2307/1565339; Tucker AD, 1996, COPEIA, P978, DOI 10.2307/1447661; Wallace KM, 2008, J HERPETOL, V42, P361, DOI 10.1670/07-1071.1; Webb G., 1998, CROCODILES AUSTR; WEBB GJW, 1982, AUST J ZOOL, V30, P877, DOI 10.1071/ZO9820877; WMI Pty Ltd, 2009, RES SPOTL SURV CROC; WMI Pty Ltd, 2005, RES SPOTL SURV CROC	58	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28533	10.1371/journal.pone.0028533	http://dx.doi.org/10.1371/journal.pone.0028533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163308	Green Published, gold			2022-12-25	WOS:000298161900045
J	Yang, SL; Zhang, H; Mao, HM; Yan, DW; Lu, SX; Lian, LS; Zhao, GY; Yan, YL; Deng, WD; Shi, XW; Han, SX; Li, S; Wang, XJ; Gou, X				Yang, Shuli; Zhang, Hao; Mao, Huaming; Yan, Dawei; Lu, Shaoxiong; Lian, Linsheng; Zhao, Guiying; Yan, Yulin; Deng, Weidong; Shi, Xianwei; Han, Shuxin; Li, Shuai; Wang, Xiujuan; Gou, Xiao			The Local Origin of the Tibetan Pig and Additional Insights into the Origin of Asian Pigs	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ANCIENT DNA; SUS-SCROFA; WILD BOARS; MICROSATELLITE MARKERS; GENETIC-RELATIONSHIP; DOMESTIC PIGS; HIGH-ALTITUDE; BREEDS; POPULATIONS	Background: The domestic pig currently indigenous to the Tibetan highlands is supposed to have been introduced during a continuous period of colonization by the ancestors of modern Tibetans. However, there is no direct genetic evidence of either the local origin or exotic migration of the Tibetan pig. Methods and Findings: We analyzed mtDNA hypervariable segment I (HVI) variation of 218 individuals from seven Tibetan pig populations and 1,737 reported mtDNA sequences from domestic pigs and wild boars across Asia. The Bayesian consensus tree revealed a main haplogroup M and twelve minor haplogroups, which suggested a large number of small scale in situ domestication episodes. In particular, haplogroups D1 and D6 represented two highly divergent lineages in the Tibetan highlands and Island Southeastern Asia, respectively. Network analysis of haplogroup M further revealed one main subhaplogroup M1 and two minor subhaplogroups M2 and M3. Intriguingly, M2 was mainly distributed in Southeastern Asia, suggesting for a local origin. Similar with haplogroup D6, M3 was mainly restricted in Island Southeastern Asia. This pattern suggested that Island Southeastern Asia, but not Southeastern Asia, might be the center of domestication of the so-called Pacific clade (M3 and D6 here) described in previous studies. Diversity gradient analysis of major subhaplogroup M1 suggested three local origins in Southeastern Asia, the middle and downstream regions of the Yangtze River, and the Tibetan highlands, respectively. Conclusions: We identified two new origin centers for domestic pigs in the Tibetan highlands and in the Island Southeastern Asian region.	[Yang, Shuli; Mao, Huaming; Yan, Dawei; Lu, Shaoxiong; Lian, Linsheng; Zhao, Guiying; Yan, Yulin; Deng, Weidong; Shi, Xianwei; Han, Shuxin; Li, Shuai; Wang, Xiujuan; Gou, Xiao] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China; [Zhang, Hao] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Yunnan Agricultural University; China Agricultural University	Yang, SL (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China.	gouxiaosa@163.com		Zhang, Hao/0000-0001-9576-3059	National Natural Science Foundation of China [30760165, 31060301, 30860182]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (grant No. 30760165, 31060301 and 30860182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDELT HJ, 1995, GENETICS, V141, P743; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Fan B, 2002, ANIM GENET, V33, P422, DOI 10.1046/j.1365-2052.2002.00898.x; Fang M, 2005, ANIM GENET, V36, P7, DOI 10.1111/j.1365-2052.2004.01234.x; Giuffra E, 2000, GENETICS, V154, P1785; Groves Colin P., 1993, P107; Guo SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-73; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kim KI, 2002, ANIM GENET, V33, P19, DOI 10.1046/j.1365-2052.2002.00784.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, P NATL ACAD SCI US, V104, P15276; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Lum JK, 2006, P NATL ACAD SCI USA, V103, P17190, DOI 10.1073/pnas.0608220103; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; NIE M, 1993, MOL BIOL EVOL, V10, P927; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Qian Y., 1979, ORIGIN DOMESTICATED; Qian YP, 2000, HUM GENET, V106, P453, DOI 10.1007/s004390000259; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Tanaka K, 2008, ANIM SCI J, V79, P417, DOI 10.1111/j.1740-0929.2008.00546.x; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Ursing BM, 1998, J MOL EVOL, V47, P302, DOI 10.1007/PL00006388; Van Driem G., 2005, PEOPLING E ASIA PUTT, P81, DOI DOI 10.4324/9780203343685_CHAPTER_6; Watanabe T, 2001, J MOL EVOL, V52, P281, DOI 10.1007/s002390010156; Watanobe T, 2003, ZOOL SCI, V20, P1477, DOI 10.2108/zsj.20.1477; Watanobe T, 2002, J MOL EVOL, V55, P222, DOI 10.1007/s00239-002-2320-6; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245; Xu W, 2000, NONGYEKAOGU, V1, P248; Yang SL, 2003, GENET SEL EVOL, V35, P657, DOI 10.1051/gse:2003045; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	34	49	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28215	10.1371/journal.pone.0028215	http://dx.doi.org/10.1371/journal.pone.0028215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163285	gold, Green Submitted, Green Published			2022-12-25	WOS:000298161900020
J	Belevych, AE; Sansom, SE; Terentyeva, R; Ho, HT; Nishijima, Y; Martin, MM; Jindal, HK; Rochira, JA; Kunitomo, Y; Abdellatif, M; Carnes, CA; Elton, TS; Gyorke, S; Terentyev, D				Belevych, Andriy E.; Sansom, Sarah E.; Terentyeva, Radmila; Ho, Hsiang-Ting; Nishijima, Yoshinori; Martin, Mickey M.; Jindal, Hitesh K.; Rochira, Jennifer A.; Kunitomo, Yukiko; Abdellatif, Maha; Carnes, Cynthia A.; Elton, Terry S.; Gyoerke, Sandor; Terentyev, Dmitry			MicroRNA-1 and-133 Increase Arrhythmogenesis in Heart Failure by Dissociating Phosphatase Activity from RyR2 Complex	PLOS ONE			English	Article							RYANODINE RECEPTOR PHOSPHORYLATION; RETICULUM CA2+ LEAK; CARDIAC-HYPERTROPHY; MYOCARDIAL-INFARCTION; HUMAN CARDIOMYOPATHY; CALCIUM-RELEASE; DOWN-REGULATION; FAILING HEARTS; ARRHYTHMIAS; MODEL	In heart failure (HF), arrhythmogenic spontaneous sarcoplasmic reticulum (SR) Ca2+ release and afterdepolarizations in cardiac myocytes have been linked to abnormally high activity of ryanodine receptors (RyR2s) associated with enhanced phosphorylation of the channel. However, the specific molecular mechanisms underlying RyR2 hyperphosphorylation in HF remain poorly understood. The objective of the current study was to test the hypothesis that the enhanced expression of muscle-specific microRNAs (miRNAs) underlies the HF-related alterations in RyR2 phosphorylation in ventricular myocytes by targeting phosphatase activity localized to the RyR2. We studied hearts isolated from canines with chronic HF exhibiting increased left ventricular (LV) dimensions and decreased LV contractility. qRT-PCR revealed that the levels of miR-1 and miR-133, the most abundant muscle-specific miRNAs, were significantly increased in HF myocytes compared with controls (2- and 1.6-fold, respectively). Western blot analyses demonstrated that expression levels of the protein phosphatase 2A (PP2A) catalytic and regulatory subunits, which are putative targets of miR-133 and miR-1, were decreased in HF cells. PP2A catalytic subunit mRNAs were validated as targets of miR-133 by using luciferase reporter assays. Pharmacological inhibition of phosphatase activity increased the frequency of diastolic Ca2+ waves and afterdepolarizations in control myocytes. The decreased PP2A activity observed in HF was accompanied by enhanced Ca2+/calmodulin-dependent protein kinase (CaMKII)-mediated phosphorylation of RyR2 at sites Ser-2814 and Ser-2030 and increased frequency of diastolic Ca2+ waves and afterdepolarizations in HF myocytes compared with controls. In HF myocytes, CaMKII inhibitory peptide normalized the frequency of pro-arrhythmic spontaneous diastolic Ca2+ waves. These findings suggest that altered levels of major muscle-specific miRNAs contribute to abnormal RyR2 function in HF by depressing phosphatase activity localized to the channel, which in turn, leads to the excessive phosphorylation of RyR2s, abnormal Ca2+ cycling, and increased propensity to arrhythmogenesis.	[Belevych, Andriy E.; Sansom, Sarah E.; Ho, Hsiang-Ting; Nishijima, Yoshinori; Martin, Mickey M.; Carnes, Cynthia A.; Elton, Terry S.; Gyoerke, Sandor] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Nishijima, Yoshinori; Carnes, Cynthia A.; Elton, Terry S.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA; [Belevych, Andriy E.; Ho, Hsiang-Ting; Nishijima, Yoshinori; Carnes, Cynthia A.; Elton, Terry S.; Gyoerke, Sandor] Ohio State Univ, Coll Med, Dept Med, Div Cardiol, Columbus, OH 43210 USA; [Belevych, Andriy E.; Ho, Hsiang-Ting; Nishijima, Yoshinori; Carnes, Cynthia A.; Gyoerke, Sandor] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Terentyeva, Radmila; Jindal, Hitesh K.; Rochira, Jennifer A.; Kunitomo, Yukiko; Terentyev, Dmitry] Rhode Isl Hosp, Dept Med, Cardiovasc Res Ctr, Providence, RI 02903 USA; [Terentyeva, Radmila; Jindal, Hitesh K.; Rochira, Jennifer A.; Kunitomo, Yukiko; Terentyev, Dmitry] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Abdellatif, Maha] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Belevych, AE (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Dmitry_Terentyev@brown.edu	Terentyev, Dmitry/V-2037-2019; Carnes, Cynthia A/C-9540-2012	Carnes, Cynthia A/0000-0003-0420-6973; Kunitomo, Yukiko/0000-0001-5564-8902; , Yoshinori/0000-0002-5547-4508; Sansom, Sarah/0000-0002-1924-8941; Terentyev, Dmitry/0000-0002-9530-7384; Belevych, Andriy/0000-0002-1272-5784; Terentyeva, Radmila/0000-0002-0133-3515	American Heart Association; National Institutes of Health [HL074045, HL063043, HL089836, HL048848, HD058997, 5T32HL094300]; Foundation Jerome Lejeune Research	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Jerome Lejeune Research	This work was supported by the American Heart Association (to AEB and DT); National Institutes of Health grants (HL074045 and HL063043 to SG, HL089836 to CAC HL048848, and HD058997 to TSE and 5T32HL094300 to Rhode Island Hospital for funding for JAR) and Foundation Jerome Lejeune Research Grant to TSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belevych AE, 2011, CARDIOVASC RES; Blayney LM, 2009, PHARMACOL THERAPEUT, V123, P151, DOI 10.1016/j.pharmthera.2009.03.006; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bridge JHB, 2008, CIRC RES, V102, pE65, DOI 10.1161/CIRCRESAHA.108.176172; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Dubell WH, 2002, AM J PHYSIOL-HEART C, V282, pH38, DOI 10.1152/ajpheart.00536.2001; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Elton TS, 2011, LIFE SCI, V88, P373, DOI 10.1016/j.lfs.2010.11.022; George CH, 2007, CURR PHARM DESIGN, V13, P3195, DOI 10.2174/138161207782341259; George CH, 2008, CARDIOVASC RES, V77, P302, DOI 10.1093/cvr/cvm006; Girmatsion Z, 2009, HEART RHYTHM, V6, P1802, DOI 10.1016/j.hrthm.2009.08.035; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Huke S, 2008, BIOCHEM BIOPH RES CO, V376, P80, DOI 10.1016/j.bbrc.2008.08.084; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Martin M, 2010, BIOTECHNOL AGRON SOC, V14, P243; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mozaffarian D, 2007, CIRCULATION, V116, P392, DOI 10.1161/CIRCULATIONAHA.106.687103; Nishijima Y, 2005, J CARD FAIL, V11, P638, DOI 10.1016/j.cardfail.2005.05.006; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Strack S., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/398751; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Terentyev D, 2003, J PHYSIOL-LONDON, V552, P109, DOI 10.1113/jphysiol.2003.046367; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Topkara VK, 2011, CARDIOVASC DRUG THER, V25, P171, DOI 10.1007/s10557-011-6289-5; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Ye Y, 2010, PHYSL GENOMICS	47	115	124	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28324	10.1371/journal.pone.0028324	http://dx.doi.org/10.1371/journal.pone.0028324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163007	Green Published, Green Submitted, gold			2022-12-25	WOS:000298173500014
J	Botelho, FM; Bauer, CMT; Finch, D; Nikota, JK; Zavitz, CCJ; Kelly, A; Lambert, KN; Piper, S; Foster, ML; Goldring, JJP; Wedzicha, JA; Bassett, J; Bramson, J; Iwakura, Y; Sleeman, M; Kolbeck, R; Coyle, AJ; Humbles, AA; Stampfli, MR				Botelho, Fernando M.; Bauer, Carla M. T.; Finch, Donna; Nikota, Jake K.; Zavitz, Caleb C. J.; Kelly, Ashling; Lambert, Kristen N.; Piper, Sian; Foster, Martyn L.; Goldring, James J. P.; Wedzicha, Jadwiga A.; Bassett, Jennifer; Bramson, Jonathan; Iwakura, Yoichiro; Sleeman, Matthew; Kolbeck, Roland; Coyle, Anthony J.; Humbles, Alison A.; Staempfli, Martin R.			IL-1 alpha/IL-1R1 Expression in Chronic Obstructive Pulmonary Disease and Mechanistic Relevance to Smoke-Induced Neutrophilia in Mice	PLOS ONE			English	Article							CIGARETTE-SMOKE; LUNG INFLAMMATION; VIRUS; INFECTION; EMPHYSEMA; IL-1-BETA; RESPONSES	Background: Cigarette smoking is the main risk factor for the development of chronic obstructive pulmonary disease (COPD), a major cause of morbidity and mortality worldwide. Despite this, the cellular and molecular mechanisms that contribute to COPD pathogenesis are still poorly understood. Methodology and Principal Findings: The objective of this study was to assess IL-1 alpha and beta expression in COPD patients and to investigate their respective roles in perpetuating cigarette smoke-induced inflammation. Functional studies were pursued in smoke-exposed mice using gene-deficient animals, as well as blocking antibodies for IL-1 alpha and beta. Here, we demonstrate an underappreciated role for IL-1 alpha expression in COPD. While a strong correlation existed between IL-1 alpha and beta levels in patients during stable disease and periods of exacerbation, neutrophilic inflammation was shown to be IL-1 alpha-dependent, and IL-1 beta- and caspase-1-independent in a murine model of cigarette smoke exposure. As IL-1 alpha was predominantly expressed by hematopoietic cells in COPD patients and in mice exposed to cigarette smoke, studies pursued in bone marrow chimeric mice demonstrated that the crosstalk between IL-1 alpha+ hematopoietic cells and the IL-1R1+ epithelial cells regulates smoke-induced inflammation. IL-1 alpha/IL-1R1-dependent activation of the airway epithelium also led to exacerbated inflammatory responses in H1N1 influenza virus infected smoke-exposed mice, a previously reported model of COPD exacerbation. Conclusions and Significance: This study provides compelling evidence that IL-1 alpha is central to the initiation of smoke-induced neutrophilic inflammation and suggests that IL-1 alpha/IL-1R1 targeted therapies may be relevant for limiting inflammation and exacerbations in COPD.	[Botelho, Fernando M.; Zavitz, Caleb C. J.; Kelly, Ashling; Lambert, Kristen N.; Bassett, Jennifer; Bramson, Jonathan; Staempfli, Martin R.] McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada; [Bauer, Carla M. T.; Nikota, Jake K.; Bassett, Jennifer] McMaster Univ, Med Sci Grad Program, Hamilton, ON, Canada; [Finch, Donna; Piper, Sian; Sleeman, Matthew] MedImmune LTD, Cambridge, England; [Goldring, James J. P.; Wedzicha, Jadwiga A.] UCL, Acad Unit Resp Med, London, England; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Kolbeck, Roland; Coyle, Anthony J.; Humbles, Alison A.] MedImmune LLC, Gaithersburg, MD USA; [Staempfli, Martin R.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; AstraZeneca; Medimmune; University of London; University College London; University of Tokyo; AstraZeneca; Medimmune; McMaster University	Botelho, FM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada.	stampfli@mcmaster.ca	Iwakura, Yoichiro/E-5457-2011; Sleeman, Matthew A/E-6675-2016; Zavitz, Caleb CJ/D-4659-2009	Iwakura, Yoichiro/0000-0002-9934-5775; Zavitz, Caleb CJ/0000-0002-1097-041X; Bramson, Jonathan/0000-0003-2874-6886; Stampfli, Martin/0000-0003-4918-5889	CIHR; Ontario's Early Research Award program (ERA); MedImmune; AstraZeneca; Canadian Thoracic Society; Medical Research Council [G0800570] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10270] Funding Source: researchfish; MRC [G0800570] Funding Source: UKRI	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario's Early Research Award program (ERA); MedImmune(AstraZenecaMedimmune); AstraZeneca(AstraZeneca); Canadian Thoracic Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work described herein was funded in-part by the CIHR, Ontario's Early Research Award program (ERA), MedImmune and AstraZeneca; CMTB holds a Canadian Thoracic Society Studentship; MRS holds a Canadian Institutes for Health Research New Investigator Award. The funders (DF and AAH) participated in study design, as well as data collection and analysis.	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Botelho FM, 2009, AM J RESP CELL MOL B; Botelho FM, EUR RESP J, V38, P285; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Caschler GJ, 2008, AM J RESP CELL MOL, V38, P218, DOI 10.1165/rcmb.2007-0053OC; Castro P, 2004, EUR J PHARMACOL, V498, P279, DOI 10.1016/j.ejphar.2004.07.047; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Falk Jeremy A, 2008, Proc Am Thorac Soc, V5, P506, DOI 10.1513/pats.200707-096ET; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Holmes J, 2010, 10 FACTS TOBACCO EPI; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kuschner WG, 1996, EUR RESPIR J, V9, P1989, DOI 10.1183/09031936.96.09101989; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Patel RR, 2008, DRUGS, V68, P1511, DOI 10.2165/00003495-200868110-00004; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Robbins CS, 2006, AM J RESP CRIT CARE; Rock KL, ANN REV IMMUNOL, V28, P321; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schultz K, 2007, AM J PHYSIOL-HEART C, V292, pH2927, DOI 10.1152/ajpheart.00700.2006; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Yao Y, 2009, HUM GENOMICS PROTEOM, V2009, P1	36	113	116	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28457	10.1371/journal.pone.0028457	http://dx.doi.org/10.1371/journal.pone.0028457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163019	Green Submitted, Green Published, gold			2022-12-25	WOS:000298173500022
J	Woolston, BM; Schlagnhaufer, C; Wilkinson, J; Larsen, J; Shi, ZX; Mayer, KM; Walters, DS; Curtis, WR; Romaine, CP				Woolston, Benjamin M.; Schlagnhaufer, Carl; Wilkinson, Jack; Larsen, Jeffrey; Shi, Zhixin; Mayer, Kimberly M.; Walters, Donald S.; Curtis, Wayne R.; Romaine, C. Peter			Long-Distance Translocation of Protein during Morphogenesis of the Fruiting Body in the Filamentous Fungus, Agaricus bisporus	PLOS ONE			English	Article							2 LACCASE GENES; ASPERGILLUS-NIDULANS; BUTTON MUSHROOM; EXPRESSION; GROWTH; TISSUE; IDENTIFICATION; ORGANIZATION; CULTIVATION; AUTOLYSIS	Commercial cultivation of the mushroom fungus, Agaricus bisporus, utilizes a substrate consisting of a lower layer of compost and upper layer of peat. Typically, the two layers are seeded with individual mycelial inoculants representing a single genotype of A. bisporus. Studies aimed at examining the potential of this fungal species as a heterologous protein expression system have revealed unexpected contributions of the mycelial inoculants in the morphogenesis of the fruiting body. These contributions were elucidated using a dual-inoculant method whereby the two layers were differientially inoculated with transgenic beta-glucuronidase (GUS) and wild-type (WT) lines. Surprisingly, use of a transgenic GUS line in the lower substrate and a WT line in the upper substrate yielded fruiting bodies expressing GUS activity while lacking the GUS transgene. Results of PCR and RT-PCR analyses for the GUS transgene and RNA transcript, respectively, suggested translocation of the GUS protein from the transgenic mycelium colonizing the lower layer into the fruiting body that developed exclusively from WT mycelium colonizing the upper layer. Effective translocation of the GUS protein depended on the use of a transgenic line in the lower layer in which the GUS gene was controlled by a vegetative mycelium-active promoter (laccase 2 and beta-actin), rather than a fruiting body-active promoter (hydrophobin A). GUS-expressing fruiting bodies lacking the GUS gene had a bonafide WT genotype, confirmed by the absence of stably inherited GUS and hygromycin phosphotransferase selectable marker activities in their derived basidiospores and mycelial tissue cultures. Differientially inoculating the two substrate layers with individual lines carrying the GUS gene controlled by different tissue-preferred promoters resulted in up to similar to 3.5-fold increase in GUS activity over that obtained with a single inoculant. Our findings support the existence of a previously undescribed phenomenon of long-distance protein translocation in A. bisporus that has potential application in recombinant protein expression and biotechnological approaches for crop improvement.	[Woolston, Benjamin M.; Larsen, Jeffrey; Curtis, Wayne R.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Schlagnhaufer, Carl; Romaine, C. Peter] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; [Schlagnhaufer, Carl; Wilkinson, Jack; Shi, Zhixin; Mayer, Kimberly M.; Walters, Donald S.; Romaine, C. Peter] Agarigen Inc, Durham, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Woolston, BM (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	cpr2@psu.edu		/0000-0002-6570-2236; Curtis, Wayne/0000-0001-6976-0890	Defense Advanced Research Projects Agency (DARPA) [HR0011-07-9-0004]; Penn State JB Swayne Endowed Chair; Penn State Chemical Engineering Endowment Fund	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Penn State JB Swayne Endowed Chair; Penn State Chemical Engineering Endowment Fund	This work was funded by the Defense Advanced Research Projects Agency (DARPA) under contract no. HR0011-07-9-0004 to CPR and DSW, Penn State JB Swayne Endowed Chair to CPR, and a summer undergraduate research fellowship from the Penn State Chemical Engineering Endowment Fund to BMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broothaerts W, 2005, NATURE, V433, P629, DOI 10.1038/nature03309; Callis J, 1995, STRUCTURE EVOLUTION; Chang ST, 2005, ACTA EDULIS FUNGI S, P3; Chen X, 1999, APPL MICROBIOL BIOT, V52, P246, DOI 10.1007/s002530051516; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; Darrah PR, 2006, EUKARYOT CELL, V5, P1111, DOI 10.1128/EC.00026-06; Deacon JW, 2006, FUNGAL BIOL-UK; DeGroot PWJ, 1996, J MOL BIOL, V257, P1008, DOI 10.1006/jmbi.1996.0219; Emri T, 2008, APPL BIOCHEM BIOTECH, V151, P211, DOI 10.1007/s12010-008-8174-7; HAMMOND JBW, 1976, J GEN MICROBIOL, V93, P309, DOI 10.1099/00221287-93-2-309; Heaton LLM, 2010, P ROY SOC B-BIOL SCI, V277, P3265, DOI 10.1098/rspb.2010.0735; HOLTZ RB, 1971, J AGR FOOD CHEM, V19, P1272, DOI 10.1021/jf60178a052; Ibrahim AS, 2010, MOL MICROBIOL, V77, P587, DOI 10.1111/j.1365-2958.2010.07234.x; KERRIGAN RW, 1995, CAN J BOT, V73, pS973, DOI 10.1139/b95-347; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; MACCANNA C, 1972, MUSHROOM SCI, V8, P727; Meyer V, 2009, EUKARYOT CELL, V8, P1677, DOI 10.1128/EC.00050-09; Neveu B, 2007, APPL MICROBIOL BIOT, V74, P1300, DOI 10.1007/s00253-006-0786-7; O'Neill KA, 2008, BIOTECHNOL PROGR, V24, P372, DOI 10.1021/bp0703127; PERRY CR, 1993, J GEN MICROBIOL, V139, P1209, DOI 10.1099/00221287-139-6-1209; Pollack JK, 2009, FUNGAL GENET BIOL, V46, P1, DOI 10.1016/j.fgb.2008.10.010; Romaine C. Peter, 2006, V344, P453; ROMAINE CP, 1992, APPL ENVIRON MICROB, V58, P3060, DOI 10.1128/AEM.58.9.3060-3066.1992; Romaine CP, 2002, DSRNA GENETIC ELEMEN, P237, DOI [10.1201/9781420039122, DOI 10.1201/9781420039122]; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; Smith M, 1998, MICROBIOL-UK, V144, P1063, DOI 10.1099/00221287-144-4-1063; Steinberg G, 2007, TRENDS MICROBIOL, V15, P14, DOI 10.1016/j.tim.2006.11.007; Tlalka M, 2007, FUNGAL GENET BIOL, V44, P1085, DOI 10.1016/j.fgb.2007.02.013; van Peer AF, 2010, ENVIRON MICROBIOL, V12, P833, DOI 10.1111/j.1462-2920.2009.02122.x; White S, 2002, CRIT REV BIOTECHNOL, V22, P1, DOI 10.1080/07388550490465817; Wichers HJ, 2003, APPL MICROBIOL BIOT, V61, P336, DOI 10.1007/s00253-002-1194-2; Wuest P.J., 1982, PENN STATE HDB COMME; Xu J, 1997, J HERED, V88, P482, DOI 10.1093/oxfordjournals.jhered.a023141	34	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28412	10.1371/journal.pone.0028412	http://dx.doi.org/10.1371/journal.pone.0028412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163014	gold, Green Published, Green Submitted			2022-12-25	WOS:000298173500018
J	Brezillon, N; Brunelle, MN; Massinet, H; Giang, E; Lamant, C; DaSilva, L; Berissi, S; Belghiti, J; Hannoun, L; Puerstinger, G; Wimmer, E; Neyts, J; Hantz, O; Soussan, P; Morosan, S; Kremsdorf, D				Brezillon, Nicolas; Brunelle, Marie-Noelle; Massinet, Helene; Giang, Eric; Lamant, Celine; DaSilva, Lucie; Berissi, Sophie; Belghiti, Jacques; Hannoun, Laurent; Puerstinger, Gherard; Wimmer, Eva; Neyts, Johan; Hantz, Olivier; Soussan, Patrick; Morosan, Serban; Kremsdorf, Dina			Antiviral Activity of Bay 41-4109 on Hepatitis B Virus in Humanized Alb-uPA/SCID Mice	PLOS ONE			English	Article							UPA-SCID MOUSE; HUMAN LIVER; HBV; HEPATOCYTES; REPLICATION; MODEL; NUCLEOCAPSIDS; REPOPULATION; INHIBITION; PARTICLES	Current treatments for HBV chronic carriers using interferon alpha or nucleoside analogues are not effective in all patients and may induce the emergence of HBV resistant strains. Bay 41-4109, a member of the heteroaryldihydropyrimidine family, inhibits HBV replication by destabilizing capsid assembly. The aim of this study was to determine the antiviral effect of Bay 41-4109 in a mouse model with humanized liver and the spread of active HBV. Antiviral assays of Bay 41-4109 on HepG2.2.15 cells constitutively expressing HBV, displayed an IC(50) of about 202 nM with no cell toxicity. Alb-uPA/SCID mice were transplanted with human hepatocytes and infected with HBV. Ten days post-infection, the mice were treated with Bay 41-4109 for five days. During the 30 days of follow-up, the HBV load was evaluated by quantitative PCR. At the end of treatment, decreased HBV viremia of about 1 log(10) copies/ml was observed. By contrast, increased HBV viremia of about 0.5 log(10) copies/ml was measured in the control group. Five days after the end of treatment, a rebound of HBV viremia occurred in the treated group. Furthermore, 15 days after treatment discontinuation, a similar expression of the viral capsid was evidenced in liver biopsies. Our findings demonstrate that Bay 41-4109 displayed antiviral properties against HBV in humanized Alb-uPA/SCID mice and confirm the usefulness of Alb-uPA/SCID mice for the evaluation of pharmaceutical compounds. The administration of Bay 41-4109 may constitute a new strategy for the treatment of patients in escape from standard antiviral therapy.	[Brezillon, Nicolas; Brunelle, Marie-Noelle; Massinet, Helene; Giang, Eric; Lamant, Celine; DaSilva, Lucie; Berissi, Sophie; Soussan, Patrick; Kremsdorf, Dina] Natl Inst Hlth & Med Res, INSERM, U845, Paris, France; [Brezillon, Nicolas; Brunelle, Marie-Noelle; Massinet, Helene; Giang, Eric; Lamant, Celine; DaSilva, Lucie; Berissi, Sophie; Soussan, Patrick; Kremsdorf, Dina] Univ Paris 05, Fac Med Rene Descartes, CHU Necker, Paris, France; [Brezillon, Nicolas; Brunelle, Marie-Noelle; Massinet, Helene; Giang, Eric; Lamant, Celine; DaSilva, Lucie; Soussan, Patrick; Kremsdorf, Dina] Inst Pasteur, Dept Virol, Paris, France; [Belghiti, Jacques] Hop Beaujon, Dept Hepatobilary & Digest Surg, Clichy, France; [Hannoun, Laurent] Hop La Pitie Salpetriere, Dept Hepatobilary & Digest Surg, Paris, France; [Puerstinger, Gherard; Wimmer, Eva] Univ Innsbruck, Inst Pharm, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Neyts, Johan] Univ Louvain, Rega Inst Med Res, Louvain, Belgium; [Hantz, Olivier] Natl Inst Hlth & Med Res, INSERM, U871, Lyon, France; [Morosan, Serban] Univ Paris 06, Fac Med Pitie Salpetriere, Ctr Expt Fonct, Paris, France; [Morosan, Serban] Fac Med Vet, Iasi, Romania	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Innsbruck; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Brezillon, N (corresponding author), Natl Inst Hlth & Med Res, INSERM, U845, Paris, France.	dina.kremsdorf@inserm.fr	Neyts, Johan/U-8267-2017; soussan, patrick/O-9801-2017; Kremsdorf, Dina/O-9797-2017	Neyts, Johan/0000-0002-0033-7514; soussan, patrick/0000-0003-2706-7371; Hantz, Olivier/0000-0002-1170-6186	Medicen Paris Region (Conseil General de l'Essonne and Direction Generale des Entreprises); VIRGIL (European surveillance network for Vigilance against Viral Resistance); INSERM (Institut National pour la Sante Et de la Recherche Medicale); Bill and Melinda Gates Foundation; Medicen Paris Region (Direction Generale des Entreprises)	Medicen Paris Region (Conseil General de l'Essonne and Direction Generale des Entreprises); VIRGIL (European surveillance network for Vigilance against Viral Resistance); INSERM (Institut National pour la Sante Et de la Recherche Medicale); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medicen Paris Region (Direction Generale des Entreprises)	This work received financial support from Medicen Paris Region (Conseil General de l'Essonne and Direction Generale des Entreprises), VIRGIL (European surveillance network for Vigilance against Viral Resistance) and INSERM (Institut National pour la Sante Et de la Recherche Medicale). NB, HM, CL and LD received grant support from the Bill and Melinda Gates Foundation. M-NB and HM benefited from a grant from the Medicen Paris Region (Direction Generale des Entreprises). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Chemin I, 2009, CANCER LETT, V286, P52, DOI 10.1016/j.canlet.2008.12.003; Dandri M, 2005, J HEPATOL, V42, P54, DOI 10.1016/j.jhep.2004.09.021; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Dienstag JL, 2009, HEPATOLOGY, V49, pS112, DOI 10.1002/hep.22920; Feld JJ, 2007, ANTIVIR RES, V76, P168, DOI 10.1016/j.antiviral.2007.06.014; Hacker HJ, 2003, BIOCHEM PHARMACOL, V66, P2273, DOI 10.1016/j.bcp.2003.08.001; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lu XY, 2003, J VIROL, V77, P11933, DOI 10.1128/JVI.77.22.11933-11940.2003; Meuleman P, 2006, J VIROL, V80, P2797, DOI 10.1128/JVI.80.6.2797-2807.2006; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; Morosan S, 2006, J INFECT DIS, V193, P996, DOI 10.1086/500840; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shi C, 2007, TOXICOL LETT, V173, P161, DOI 10.1016/j.toxlet.2007.07.010; Soussan P, 2008, J INFECT DIS, V198, P218, DOI 10.1086/589623; Stolting J, 2000, DIHYDROPYRIMIDINES T; Stray SJ, 2006, NAT BIOTECHNOL, V24, P358, DOI 10.1038/nbt1187; Stray SJ, 2005, P NATL ACAD SCI USA, V102, P8138, DOI 10.1073/pnas.0409732102; Stray SJ, 2006, J MOL RECOGNIT, V19, P542, DOI 10.1002/jmr.801; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9; Xu CX, 2010, J VIROL, V84, P9332, DOI 10.1128/JVI.00918-10; Zlotnick A, 2002, J VIROL, V76, P4848, DOI 10.1128/JVI.76.10.4848-4854.2002; Zoulim F, 2008, J HEPATOL, V48, pS2, DOI 10.1016/j.jhep.2008.01.011	28	67	95	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e25096	10.1371/journal.pone.0025096	http://dx.doi.org/10.1371/journal.pone.0025096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162746	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800001
J	Verweyen, L; Klimpel, S; Palm, HW				Verweyen, Lisa; Klimpel, Sven; Palm, Harry W.			Molecular Phylogeny of the Acanthocephala (Class Palaeacanthocephala) with a Paraphyletic Assemblage of the Orders Polymorphida and Echinorhynchida	PLOS ONE			English	Article							CLASS POLYACANTHOCEPHALA; SEQUENCES; POSITION; ERECTION; NUCLEAR; MODEL	Acanthocephalans are attractive candidates as model organisms for studying the ecology and co-evolutionary history of parasitic life cycles in the marine ecosystem. Adding to earlier molecular analyses of this taxon, a total of 36 acanthocephalans belonging to the classes Archiacanthocephala (3 species), Eoacanthocephala (3 species), Palaeacanthocephala (29 species), Polyacanthocephala (1 species) and Rotifera as outgroup (3 species) were analyzed by using Bayesian Inference and Maximum Likelihood analyses of nuclear 18S rDNA sequence. This data set included three re-collected and six newly collected taxa, Bolbosoma vasculosum from Lepturacanthus savala, Filisoma rizalinum from Scatophagus argus, Rhadinorhynchus pristis from Gempylus serpens, R. lintoni from Selar crumenophthalmus, Serrasentis sagittifer from Johnius coitor, and Southwellina hispida from Epinephelus coioides, representing 5 new host and 3 new locality records. The resulting trees suggest a paraphyletic arrangement of the Echinorhynchida and Polymorphida inside the Palaeacanthocephala. This questions the placement of the genera Serrasentis and Gorgorhynchoides within the Echinorhynchida and not the Polymorphida, necessitating further insights into the systematic position of these taxa based on morphology.	[Verweyen, Lisa; Klimpel, Sven] Goethe Univ Frankfurt, Inst Ecol Evolut & Diver, SGN, Biodivers & Climate Res Ctr Bik F, Frankfurt, Germany; [Palm, Harry W.] Univ Rostock, Fac Agr & Environm Sci, Rostock, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Rostock	Verweyen, L (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Diver, SGN, Biodivers & Climate Res Ctr Bik F, Frankfurt, Germany.	sven.klimpel@senckenberg.de			BiK-F (LOEWE); German Research Council (DFG) [PA 664/4-2, 6-1]	BiK-F (LOEWE); German Research Council (DFG)(German Research Foundation (DFG))	The present study was financially supported by BiK-F (LOEWE) and by the German Research Council (DFG PA 664/4-2, 6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin O.M., 1985, P27; AMIN OM, 1994, J PARASITOL, V80, P768, DOI 10.2307/3283256; AMIN OM, 1987, J PARASITOL, V73, P1216, DOI 10.2307/3282307; [Anonymous], 2002, PAUP 4 0 PHYLOGENETI; Aznar FJ, 2006, J PARASITOL, V92, P548, DOI 10.1645/GE-715R.1; Bhattacharya S.B, 2007, HDB INDIAN ACANTHOCE, P1; BULLOCK W. L., 1969, Problems in systematics of parasites., P9; Garcia-Varela M, 2005, J PARASITOL, V91, P1401, DOI 10.1645/GE-523R.1; Garcia-Varela M, 2002, MOL PHYLOGENET EVOL, V23, P288, DOI 10.1016/S1055-7903(02)00020-9; Garcia-Varela M, 2008, J PARASITOL, V94, P959, DOI 10.1645/GE-1420.1; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/BF02338837; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Golvan Y. J., 1969, ZOOLOGIE A, VLVII, P1; Herlyn H, 2003, MOL PHYLOGENET EVOL, V26, P155, DOI 10.1016/S1055-7903(02)00309-3; Herlyn H, 2001, SYST PARASITOL, V50, P105, DOI 10.1023/A:1011925516086; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Mark Welch D, 2005, HYDROBIOLOGIA, V546, P47, DOI 10.1007/s10750-005-4100-y; Monks S, 2001, SYST PARASITOL, V48, P81, DOI 10.1023/A:1006400207434; Near TJ, 1998, MOL PHYLOGENET EVOL, V10, P287, DOI 10.1006/mpev.1998.0569; Petrochenko V.I., 1971, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Taraschewski H, 2005, MARINE PARASITOLOGY, P116; TELFORD MJ, 1993, MOL BIOL EVOL, V10, P660; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wayland MT, 2004, SYST PARASITOL, V58, P149, DOI 10.1023/B:SYPA.0000029419.07989.1a; Witek A., 2008, BMC EVOL BIOL, V345, P1; Yamaguti S, 1963, SYST HELMINTHUM, P1; YANG ZB, 1994, J MOL EVOL, V39, P105; Zrzavy J, 2003, ZOOL SCR, V32, P61, DOI 10.1046/j.1463-6409.2003.00104.x	36	60	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28285	10.1371/journal.pone.0028285	http://dx.doi.org/10.1371/journal.pone.0028285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163005	Green Submitted, Green Published, gold			2022-12-25	WOS:000298172800021
J	De Silva, TM; Brait, VH; Drummond, GR; Sobey, CG; Miller, AA				De Silva, T. Michael; Brait, Vanessa H.; Drummond, Grant R.; Sobey, Christopher G.; Miller, Alyson A.			Nox2 Oxidase Activity Accounts for the Oxidative Stress and Vasomotor Dysfunction in Mouse Cerebral Arteries following Ischemic Stroke	PLOS ONE			English	Article							NADPH-OXIDASE; SUPEROXIDE-PRODUCTION; SYSTEMIC ARTERIES; ANGIOTENSIN-II; MICE; REPERFUSION; RESPONSES; MECHANISMS; GENDER; HYPERCHOLESTEROLEMIA	Background and Purpose: Post-ischemic oxidative stress and vasomotor dysfunction in cerebral arteries may increase the likelihood of cognitive impairment and secondary stroke. However, the underlying mechanisms of post-stroke vascular abnormalities, as distinct from those causing primary brain injury, are poorly understood. We tested whether augmented superoxide-dependent dysfunction occurs in the mouse cerebral circulation following ischemia-reperfusion, and evaluated the role of Nox2 oxidase. Methods: Cerebral ischemia was induced in male C57Bl6/J wild-type (WT) and Nox2-deficient (Nox2(-/-)) mice by middle cerebral artery occlusion (MCAO; 0.5 h), followed by reperfusion (23.5 h). Superoxide production by MCA was measured by L-012-enhanced chemiluminescence. Nitric oxide (NO) function was assessed in cannulated and pressurized MCA via the vasoconstrictor response to N (R)-nitro-L-arginine methyl ester (L-NAME; 100 mu mol/L). Expression of Nox2, the nitration marker 3-nitrotyrosine, and leukocyte marker CD45 was assessed in cerebral arteries by Western blotting. Results: Following ischemia-reperfusion, superoxide production was markedly increased in the MCA of WT, but not Nox2(-/-) mice. In WT mice, L-NAME-induced constriction was reduced by similar to 50% in ischemic MCA, whereas ischemia-reperfusion had no effect on responses to L-NAME in vessels from Nox2(-/-) mice. In ischemic MCA from WT mice, expression of Nox2 and 3-nitrotyrosine were similar to 1.4-fold higher than in the contralateral MCA, or in ischemic or contralateral vessels from Nox2(-/-) mice. Vascular CD45 levels were unchanged by ischemia-reperfusion. Conclusions: Excessive superoxide production, impaired NO function and nitrosative stress occur in mouse cerebral arteries after ischemia-reperfusion. These abnormalities appear to be exclusively due to increased activity of vascular Nox2 oxidase.	[De Silva, T. Michael; Brait, Vanessa H.; Drummond, Grant R.; Sobey, Christopher G.; Miller, Alyson A.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia	Monash University	De Silva, TM (corresponding author), Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia.	Chris.Sobey@monash.edu		De Silva, Travice/0000-0001-6351-7304; Brait, Vanessa Helena/0000-0002-0911-355X; Drummond, Grant/0000-0001-8556-9738	National Health and Medical Research Council of Australia (NHMRC) [350477, 491133]; Australian Postgraduate Award; Monash Graduate Scholarship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Monash Graduate Scholarship(Monash University)	These studies were supported by grants from the National Health and Medical Research Council of Australia (NHMRC) (ID 350477 & 491133). TMD was the recipient of an Australian Postgraduate Award and VHB was the recipient of a Monash Graduate Scholarship. GRD and CGS are NHMRC Senior Research Fellows. AAM is a NHMRC Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Budzyn K, 2004, AM J PHYSIOL-REG I, V287, pR342, DOI 10.1152/ajpregu.00156.2004; Bullen ML, 2011, AM J PHYSIOL-HEART C, V301, pH1405, DOI 10.1152/ajpheart.00489.2011; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cipolla MJ, 2009, STROKE, V40, P1451, DOI 10.1161/STROKEAHA.108.535435; De Silva TM, 2009, STROKE, V40, P1091, DOI 10.1161/STROKEAHA.108.531707; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Girouard H, 2006, ARTERIOSCL THROM VAS, V26, P826, DOI 10.1161/01.ATV.0000205849.22807.6e; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Ishikawa M, 2004, CIRC RES, V94, P239, DOI 10.1161/01.RES.0000111524.05779.60; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jackman KA, 2009, BRAIN RES, V1286, P215, DOI 10.1016/j.brainres.2009.06.056; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kahles T, 2010, NEUROBIOL DIS, V40, P185, DOI 10.1016/j.nbd.2010.05.023; Kim GS, 2009, J NEUROSCI, V29, P14779, DOI 10.1523/JNEUROSCI.4161-09.2009; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; KONTOS CD, 1992, AM J PHYSIOL, V263, pH1234, DOI 10.1152/ajpheart.1992.263.4.H1234; Kunz A, 2007, J CEREBR BLOOD F MET, V27, P545, DOI 10.1038/sj.jcbfm.9600369; Marrelli SP, 1999, AM J PHYSIOL-HEART C, V276, pH33, DOI 10.1152/ajpheart.1999.276.1.H33; MAYHAN WG, 1988, AM J PHYSIOL, V255, pH879, DOI 10.1152/ajpheart.1988.255.4.H879; Miller AA, 2005, CIRC RES, V97, P1055, DOI 10.1161/01.RES.0000189301.10217.87; Miller AA, 2007, STROKE, V38, P2142, DOI 10.1161/STROKEAHA.106.477406; Miller AA, 2006, BRAIN RES, V1111, P111, DOI 10.1016/j.brainres.2006.06.082; Miller AA, 2006, PHARMACOL THERAPEUT, V111, P928, DOI 10.1016/j.pharmthera.2006.02.005; Miller AA, 2010, STROKE, V41, P784, DOI 10.1161/STROKEAHA.109.575365; Miller AA, 2009, AM J PHYSIOL-HEART C, V296, pH220, DOI 10.1152/ajpheart.00987.2008; Miyazaki T, 2011, STROKE, V42, P1097, DOI 10.1161/STROKEAHA.110.598359; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; PARK L, 2007, J CEREB BLOOD FLOW M, V11, P11; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Xie H, 2005, STROKE, V36, P1047, DOI 10.1161/01.STR.0000157664.34308.cc; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	41	65	65	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28393	10.1371/journal.pone.0028393	http://dx.doi.org/10.1371/journal.pone.0028393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164282	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000298171400083
J	Fang, YD; Xu, X; Dang, YM; Zhang, YM; Zhang, JP; Hu, JY; Zhang, Q; Dai, X; Teng, M; Zhang, DX; Huang, YS				Fang, Ya-dong; Xu, Xue; Dang, Yong-ming; Zhang, Yi-ming; Zhang, Jia-ping; Hu, Jiong-yu; Zhang, Qiong; Dai, Xia; Teng, Miao; Zhang, Dong-xia; Huang, Yue-sheng			MAP4 Mechanism that Stabilizes Mitochondrial Permeability Transition in Hypoxia: Microtubule Enhancement and DYNLT1 Interaction with VDAC1	PLOS ONE			English	Article							LIGHT-CHAIN TCTEX-1; CYTOCHROME-C; CELL-DEATH; PROTEIN; DYNEIN; PORE; DYSFUNCTION; DEPOLARIZATION; TRAFFICKING; REPERFUSION	Mitochondrial membrane permeability has received considerable attention recently because of its key role in apoptosis and necrosis induced by physiological events such as hypoxia. The manner in which mitochondria interact with other molecules to regulate mitochondrial permeability and cell destiny remains elusive. Previously we verified that hypoxia-induced phosphorylation of microtubule-associated protein 4 (MAP4) could lead to microtubules (MTs) disruption. In this study, we established the hypoxic (1% O-2) cell models of rat cardiomyocytes, H9c2 and HeLa cells to further test MAP4 function. We demonstrated that increase in the pool of MAP4 could promote the stabilization of MT networks by increasing the synthesis and polymerization of tubulin in hypoxia. Results showed MAP4 overexpression could enhance cell viability and ATP content under hypoxic conditions. Subsequently we employed a yeast two-hybrid system to tag a protein interacting with mitochondria, dynein light chain Tctex-type 1 (DYNLT1), by hVDAC1 bait. We confirmed that DYNLT1 had protein-protein interactions with voltage-dependent anion channel 1 (VDAC1) using co-immunoprecipitation; and immunofluorescence technique showed that DYNLT1 was closely associated with MTs and VDAC1. Furthermore, DYNLT1 interactions with MAP4 were explored using a knockdown technique. We thus propose two possible mechanisms triggered by MAP4: (1) stabilization of MT networks, (2) DYNLT1 modulation, which is connected with VDAC1, and inhibition of hypoxia-induced mitochondrial permeabilization.	[Fang, Ya-dong; Dang, Yong-ming; Zhang, Jia-ping; Hu, Jiong-yu; Zhang, Qiong; Teng, Miao; Zhang, Dong-xia; Huang, Yue-sheng] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Xu, Xue] 324 Hosp PLA, Chongqing, Peoples R China; [Zhang, Yi-ming] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing, Peoples R China; [Dai, Xia] Third Mil Med Univ, Southwest Hosp, Dept Plast & Cosmet Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Fang, YD (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	yshuang.tmmu@gmail.com			National Natural Science Foundation of China [81000833, 81071547, 30901563]; Key Project of China National Programs for Basic Research and Development ("973" Program in China) [2012CB518101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of China National Programs for Basic Research and Development ("973" Program in China)	This work was supported by National Natural Science Foundation of China (No. 81000833, 81071547 and 30901563), and partly by the Key Project of China National Programs for Basic Research and Development ("973" Program in China, 2012CB518101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Cao LC, 2004, KIDNEY INT, V66, P1890, DOI 10.1111/j.1523-1755.2004.00963.x; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cheng GM, 2002, AM J PHYSIOL-HEART C, V283, pH2379, DOI 10.1152/ajpheart.00410.2002; Cheng Tsung-Lin, 2007, V408, P223, DOI 10.1007/978-1-59745-547-3_13; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Feng PH, 2007, PLOS PATHOG, V3, P1849, DOI 10.1371/journal.ppat.0030174; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Krestinina OV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P421, DOI 10.1134/S0006297909040105; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li DD, 2005, EUR J NEUROSCI, V22, P1319, DOI 10.1111/j.1460-9568.2005.04335.x; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McNaughton L, 2010, J BIOL CHEM, V285, P15994, DOI 10.1074/jbc.M109.083535; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Nadano D, 2002, BIOCHEM J, V364, P669, DOI 10.1042/BJ20011836; Nagano F, 1998, J BIOL CHEM, V273, P30065, DOI 10.1074/jbc.273.46.30065; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Permana S, 2005, CELL STRUCT FUNCT, V29, P147, DOI 10.1247/csf.29.147; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Putnam AJ, 1998, J CELL SCI, V111, P3379; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Saeed U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002459; SATO H, 1993, CIRC RES, V72, P361, DOI 10.1161/01.RES.72.2.361; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2; Seko Y, 1997, BIOCHEM BIOPH RES CO, V239, P840, DOI 10.1006/bbrc.1997.7570; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Stavrovskaya IG, 2005, FREE RADICAL BIO MED, V38, P687, DOI 10.1016/j.freeradbiomed.2004.11.032; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Vandroux D, 2004, MOL CELL BIOCHEM, V258, P99, DOI 10.1023/B:MCBI.0000012840.67616.cc; Webster DR, 1997, J MOL CELL CARDIOL, V29, P1747, DOI 10.1006/jmcc.1997.0421; White RJ, 1996, J NEUROSCI, V16, P5688; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Zhdanov AV, 2011, CELL MOL LIFE SCI, V68, P903, DOI 10.1007/s00018-010-0502-8	47	19	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28052	10.1371/journal.pone.0028052	http://dx.doi.org/10.1371/journal.pone.0028052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164227	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400028
J	Gorny, MK; Sampson, J; Li, HG; Jiang, XQ; Totrov, M; Wang, XH; Williams, C; O'Neal, T; Volsky, B; Li, LZ; Cardozo, T; Nyambi, P; Zolla-Pazner, S; Kong, XP				Gorny, Miroslaw K.; Sampson, Jared; Li, Huiguang; Jiang, Xunqing; Totrov, Maxim; Wang, Xiao-Hong; Williams, Constance; O'Neal, Timothy; Volsky, Barbara; Li, Liuzhe; Cardozo, Timothy; Nyambi, Phillipe; Zolla-Pazner, Susan; Kong, Xiang-Peng			Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN IMMUNE-RESPONSE; B-CELL RESPONSES; CROSS-REACTIVITY; V3 DOMAIN; HYPERVARIABLE REGIONS; HUMAN CYTOMEGALOVIRUS; BINDING-SITE; NEUTRALIZATION; GP120	Preferential usage of immunoglobulin (Ig) genes that encode antibodies (Abs) against various pathogens is rarely observed and the nature of their dominance is unclear in the context of stochastic recombination of Ig genes. The hypothesis that restricted usage of Ig genes predetermines the antibody specificity was tested in this study of 18 human anti-V3 monoclonal Abs (mAbs) generated from unrelated individuals infected with various subtypes of HIV-1, all of which preferentially used pairing of the VH5-51 and VL lambda genes. Crystallographic analysis of five VH5-51/VL lambda-encoded Fabs complexed with various V3 peptides revealed a common three dimensional (3D) shape of the antigen-binding sites primarily determined by the four complementarity determining regions (CDR) for the heavy (H) and light (L) chains: specifically, the H1, H2, L1 and L2 domains. The CDR H3 domain did not contribute to the shape of the binding pocket, as it had different lengths, sequences and conformations for each mAb. The same shape of the binding site was further confirmed by the identical backbone conformation exhibited by V3 peptides in complex with Fabs which fully adapted to the binding pocket and the same key contact residues, mainly germline-encoded in the heavy and light chains of five Fabs. Finally, the VH5-51 anti-V3 mAbs recognized an epitope with an identical 3D structure which is mimicked by a single mimotope recognized by the majority of VH5-51-derived mAbs but not by other V3 mAbs. These data suggest that the identification of preferentially used Ig genes by neutralizing mAbs may define conserved epitopes in the diverse virus envelopes. This will be useful information for designing vaccine immunogen inducing cross-neutralizing Abs.	[Gorny, Miroslaw K.; Williams, Constance; O'Neal, Timothy; Volsky, Barbara; Li, Liuzhe; Nyambi, Phillipe; Zolla-Pazner, Susan] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Sampson, Jared; Li, Huiguang; Jiang, Xunqing; Kong, Xiang-Peng] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Totrov, Maxim] Molsoft LLC, La Jolla, CA USA; [Wang, Xiao-Hong; Nyambi, Phillipe; Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Cardozo, Timothy] NYU, Sch Med, Dept Pharmacol, New York, NY USA	New York University; New York University; New York University	Gorny, MK (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.	mirek.gorny@med.nyu.edu	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666; Kong, Xiang-Peng/0000-0001-5773-2681; totrov, maxim/0000-0001-8594-274X; Sampson, Jared/0000-0001-6441-1579; Gorny, Miroslaw/0000-0002-2714-8780	National Institutes of Health [AI77451, AI36085, HL59725]; New York University Center for AIDS Research [AI27742]; Bill and Melinda Gates Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036085, P30AI027742, R21AI077451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Center for AIDS Research; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the National Institutes of Health grants AI77451, AI36085 and HL59725, by the Immunology Core of the New York University Center for AIDS Research (grant AI27742), by research funds from Department of Veterans Affairs, and by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Chi SW, 2007, P NATL ACAD SCI USA, V104, P9230, DOI 10.1073/pnas.0701279104; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; Eda Y, 2006, J VIROL, V80, P5563, DOI 10.1128/JVI.02095-05; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Gorny M.K., 1994, CELL BIOL LAB HDB, P276; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 1997, J IMMUNOL, V159, P5114; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Lucas AH, 2003, CLIN IMMUNOL, V108, P119, DOI 10.1016/S1521-6616(03)00094-9; Mage M G, 1980, Methods Enzymol, V70, P142; McLean GR, 2005, J IMMUNOL, V174, P4768, DOI 10.4049/jimmunol.174.8.4768; OHLIN M, 1993, J VIROL, V67, P703, DOI 10.1128/JVI.67.2.703-710.1993; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Vagin A, 1998, ACTA CRYSTALLOGR D, V54, P400, DOI 10.1107/S0907444997014923; Weitkamp JH, 2003, J IMMUNOL, V171, P4680, DOI 10.4049/jimmunol.171.9.4680; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039	40	39	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27780	10.1371/journal.pone.0027780	http://dx.doi.org/10.1371/journal.pone.0027780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164215	Green Submitted, Green Published, gold			2022-12-25	WOS:000298171400015
J	Takemura, H; Samejima, K; Vogels, R; Sakagami, M; Okuda, J				Takemura, Hiromasa; Samejima, Kazuyuki; Vogels, Rufin; Sakagami, Masamichi; Okuda, Jiro			Stimulus-Dependent Adjustment of Reward Prediction Error in the Midbrain	PLOS ONE			English	Article							TEMPORAL DIFFERENCE MODELS; DOPAMINE RESPONSES; HUMAN BRAIN; DECISION; REPRESENTATION; SENSITIVITY; INFERENCE; NEURONS; HUMANS; CORTEX	Previous reports have described that neural activities in midbrain dopamine areas are sensitive to unexpected reward delivery and omission. These activities are correlated with reward prediction error in reinforcement learning models, the difference between predicted reward values and the obtained reward outcome. These findings suggest that the reward prediction error signal in the brain updates reward prediction through stimulus-reward experiences. It remains unknown, however, how sensory processing of reward-predicting stimuli contributes to the computation of reward prediction error. To elucidate this issue, we examined the relation between stimulus discriminability of the reward-predicting stimuli and the reward prediction error signal in the brain using functional magnetic resonance imaging (fMRI). Before main experiments, subjects learned an association between the orientation of a perceptually salient (high-contrast) Gabor patch and a juice reward. The subjects were then presented with lower-contrast Gabor patch stimuli to predict a reward. We calculated the correlation between fMRI signals and reward prediction error in two reinforcement learning models: a model including the modulation of reward prediction by stimulus discriminability and a model excluding this modulation. Results showed that fMRI signals in the midbrain are more highly correlated with reward prediction error in the model that includes stimulus discriminability than in the model that excludes stimulus discriminability. No regions showed higher correlation with the model that excludes stimulus discriminability. Moreover, results show that the difference in correlation between the two models was significant from the first session of the experiment, suggesting that the reward computation in the midbrain was modulated based on stimulus discriminability before learning a new contingency between perceptually ambiguous stimuli and a reward. These results suggest that the human reward system can incorporate the level of the stimulus discriminability flexibly into reward computations by modulating previously acquired reward values for a typical stimulus.	[Takemura, Hiromasa] Univ Tokyo, Dept Life Sci, Tokyo, Japan; [Samejima, Kazuyuki; Sakagami, Masamichi; Okuda, Jiro] Tamagawa Univ, Brain Sci Inst, Brain Sci Res Ctr, Machida, Tokyo, Japan; [Vogels, Rufin] Katholieke Univ Leuven, Sch Med, Lab Neuroen Psychofysiol, Louvain, Belgium; [Okuda, Jiro] Kyoto Sangyo Univ, Fac Comp Sci & Engn, Dept Intelligent Syst, Khoyama Ctr Neurosci, Kyoto 603, Japan	University of Tokyo; KU Leuven; Kyoto Sangyo University	Takemura, H (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	hiromasa@fechner.c.u-tokyo.ac.jp	Takemura, Hiromasa/AAD-6065-2019	Takemura, Hiromasa/0000-0002-2096-2384; Lauwereyns, Jan/0000-0003-0551-2550	Tamagawa University) of the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology, Japan [19330161]; Grants-in-Aid for Scientific Research [21120007, 23243077] Funding Source: KAKEN	Tamagawa University) of the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the 21st Century Center of Excellence (COE) program (Integrative Human Science Program, Tamagawa University) of the Japan Society for the Promotion of Science (JSPS) and Grants-in-Aid for Scientific Research (#19330161) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (J.O., M.S., K.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nomoto K, 2010, J NEUROSCI, V30, P10692, DOI 10.1523/JNEUROSCI.4828-09.2010; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Tanaka SC, 2006, NEURAL NETWORKS, V19, P1233, DOI 10.1016/j.neunet.2006.05.039; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28337	10.1371/journal.pone.0028337	http://dx.doi.org/10.1371/journal.pone.0028337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164273	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400074
J	Tatti, O; Arjama, M; Ranki, A; Weiss, SJ; Keski-Oja, J; Lehti, K				Tatti, Olga; Arjama, Mariliina; Ranki, Annamari; Weiss, Stephen J.; Keski-Oja, Jorma; Lehti, Kaisa			Membrane-Type-3 Matrix Metalloproteinase (MT3-MMP) Functions as a Matrix Composition-Dependent Effector of Melanoma Cell Invasion	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MALIGNANT-MELANOMA; TUMOR PROGRESSION; BREAST-CANCER; A ACTIVATION; EXPRESSION; MT1-MMP; TRANSITION; GROWTH; METASTASIS	In primary human melanoma, the membrane-type matrix metalloproteinase, MT3-MMP, is overexpressed in the most aggressive nodular-type tumors. Unlike MT1-MMP and MT2-MMP, which promote cell invasion through basement membranes and collagen type I-rich tissues, the function of MT3-MMP in tumor progression remains unclear. Here, we demonstrate that MT3-MMP inhibits MT1-MMP-driven melanoma cell invasion in three-dimensional collagen, while yielding an altered, yet MT1-MMP-dependent, form of expansive growth behavior that phenocopies the formation of nodular cell colonies. In melanoma cell lines originating from advanced primary or metastatic lesions, endogenous MT3-MMP expression was associated with limited collagen-invasive potential. In the cell lines with highest MT3-MMP expression relative to MT1-MMP, collagen-invasive activity was increased following stable MT3-MMP gene silencing. Consistently, MT3-MMP overexpression in cells derived from less advanced superficially spreading melanoma lesions, or in the MT3-MMP knockdown cells, reduced MT1-MMP-dependent collagen invasion. Rather than altering MT1-MMP transcription, MT3-MMP interacted with MT1-MMP in membrane complexes and reduced its cell surface expression. By contrast, as a potent fibrinolytic enzyme, MT3-MMP induced efficient invasion of the cells in fibrin, a provisional matrix component frequently found at tumor-host tissue interfaces and perivascular spaces of melanoma. Since MT3-MMP was significantly upregulated in biopsies of human melanoma metastases, these results identify MT3-MMP as a matrix-dependent modifier of the invasive tumor cell functions during melanoma progression.	[Tatti, Olga; Lehti, Kaisa] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland; [Tatti, Olga; Arjama, Mariliina; Keski-Oja, Jorma; Lehti, Kaisa] Univ Helsinki, Dept Pathol, Haartman Inst, Cent Hosp, Helsinki, Finland; [Tatti, Olga; Arjama, Mariliina; Keski-Oja, Jorma; Lehti, Kaisa] Univ Helsinki, Dept Virol, Haartman Inst, Cent Hosp, Helsinki, Finland; [Ranki, Annamari] Univ Helsinki, Cent Hosp, Dept Dermatol & Allergol, Skin & Allergy Hosp, Helsinki, Finland; [Weiss, Stephen J.] Univ Michigan, Div Mol Med & Genet, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Michigan System; University of Michigan	Tatti, O (corresponding author), Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland.	kaisa.lehti@helsinki.fi		Lehti, Kaisa/0000-0001-9110-8719; Bugaeva, Olga/0000-0002-7960-7950	Academy of Finland; University of Helsinki Foundations; Finnish Cancer Foundation; Finnish Cancer Institute; Sigrid Juselius Foundation; Helsinki Univ. Hospital; Magnus Ehrnrooth Foundation; Biocentrum Helsinki; Helsinki Biomedical Graduate School; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); University of Helsinki Foundations; Finnish Cancer Foundation; Finnish Cancer Institute; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Univ. Hospital; Magnus Ehrnrooth Foundation; Biocentrum Helsinki; Helsinki Biomedical Graduate School; Emil Aaltonen Foundation	This work was supported by the Academy of Finland (J.K.-O., K.L.), University of Helsinki Foundations (K.L., O.T.), Finnish Cancer Foundation (J.K.-O., K.L.), Finnish Cancer Institute (K.L.), Sigrid Juselius Foundation (J.K.-O., K.L.), Helsinki Univ. Hospital Fund (J.K.-O.), Magnus Ehrnrooth Foundation (K.L.), Biocentrum Helsinki (J.K.-O.), Helsinki Biomedical Graduate School (O.T., M.A.), and Emil Aaltonen Foundation (O.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Arai I, 2007, HEPATO-GASTROENTEROL, V54, P167; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Bardos H, 1996, BLOOD COAGUL FIBRIN, V7, P536; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; CASLEYS.J, 1961, Q J EXP PHYSIOL CMS, V46, P101, DOI 10.1113/expphysiol.1961.sp001502; COSTANTINI V, 1992, CANCER METAST REV, V11, P283, DOI 10.1007/BF01307183; Ferraro GB, 2011, J BIOL CHEM, V286, P31418, DOI 10.1074/jbc.M111.249169; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HERLYN M, 1985, CANCER RES, V45, P5670; Hofmann UB, 2000, J PATHOL, V191, P245; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Illman SA, 2006, J CELL SCI, V119, P3856, DOI 10.1242/jcs.03157; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jiang WG, 2006, INT J MOL MED, V17, P583; Kang TB, 2000, FASEB J, V14, P2559, DOI 10.1096/fj.00-0269com; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Llano E, 1999, CANCER RES, V59, P2570; Lowy AM, 2006, CANCER RES, V66, P4734, DOI 10.1158/0008-5472.CAN-05-4268; MacDougall JR, 1999, BRIT J CANCER, V80, P504, DOI 10.1038/sj.bjc.6690385; Masters JRW, 1998, HUMAN CELL CULTURE, VI; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Morris MJ, 2009, BIOCHEMISTRY-US, V48, P5313, DOI 10.1021/bi900498z; Moss NM, 2009, MOL CANCER RES, V7, P809, DOI 10.1158/1541-7786.MCR-08-0571; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohnishi Y, 2001, EUR J DERMATOL, V11, P420; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Pagenstecher A, 2001, J NEUROPATH EXP NEUR, V60, P598, DOI 10.1093/jnen/60.6.598; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2002, CANCER RES, V62, P6966; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Poetsch M, 2003, CELL MOL LIFE SCI, V60, P1923, DOI 10.1007/s00018-003-2324-4; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sugiyama N, 2010, CANCER RES, V70, P7851, DOI 10.1158/0008-5472.CAN-10-1223; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Tatti O, 2008, EXP CELL RES, V314, P2501, DOI 10.1016/j.yexcr.2008.05.018; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Uchibori M, 2006, INT J ONCOL, V28, P33; Vuoriluoto K, 2011, MATRIX BIOL, V30, P207, DOI 10.1016/j.matbio.2011.03.003; WOJTUKIEWICZ MZ, 1990, AM J CLIN PATHOL, V93, P516, DOI 10.1093/ajcp/93.4.516; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	58	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28325	10.1371/journal.pone.0028325	http://dx.doi.org/10.1371/journal.pone.0028325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164270	Green Submitted, gold, Green Published			2022-12-25	WOS:000298171400071
J	Tsibris, AMN; Pal, U; Schure, AL; Veazey, RS; Kunstman, KJ; Henrich, TJ; Klasse, PJ; Wolinsky, SM; Kuritzkes, DR; Moore, JP				Tsibris, Athe M. N.; Pal, Urboshi; Schure, Allison L.; Veazey, Ronald S.; Kunstman, Kevin J.; Henrich, Timothy J.; Klasse, P. J.; Wolinsky, Steven M.; Kuritzkes, Daniel R.; Moore, John P.			SHIV-162P3 Infection of Rhesus Macaques Given Maraviroc Gel Vaginally Does Not Involve Resistant Viruses	PLOS ONE			English	Article							R5 HIV-1 INFECTION; CCR5 INHIBITORS; SHIV CHALLENGE; IN-VIVO; TYPE-1; TRANSMISSION; PROGRESSION; CORECEPTOR; PROTECTION; ENVELOPE	Maraviroc (MVC) gels are effective at protecting rhesus macaques from vaginal SHIV transmission, but breakthrough infections can occur. To determine the effects of a vaginal MVC gel on infecting SHIV populations in a macaque model, we analyzed plasma samples from three rhesus macaques that received a MVC vaginal gel (day 0) but became infected after high-dose SHIV-162P3 vaginal challenge. Two infected macaques that received a placebo gel served as controls. The infecting SHIV-162P3 stock had an overall mean genetic distance of 0.294 +/- 0.027%; limited entropy changes were noted across the envelope (gp160). No envelope mutations were observed consistently in viruses isolated from infected macaques at days 14-21, the time of first detectable viremia, nor selected at later time points, days 42-70. No statistically significant differences in MVC susceptibilities were observed between the SHIV inoculum (50% inhibitory concentration [IC50] 1.87 nM) and virus isolated from the three MVC-treated macaques (MVC IC50 1.18 nM, 1.69 nM, and 1.53 nM, respectively). Highlighter plot analyses suggested that infection was established in each MVC-treated animal by one founder virus genotype. The expected Poisson distribution of pairwise Hamming Distance frequency counts was observed and a phylogenetic analysis did not identify infections with distinct lineages from the challenge stock. These data suggest that breakthrough infections most likely result from incomplete viral inhibition and not the selection of MVC-resistant variants.	[Tsibris, Athe M. N.; Schure, Allison L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tsibris, Athe M. N.; Henrich, Timothy J.; Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA USA; [Pal, Urboshi] Cornell Univ, Ithaca, NY USA; [Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Covington, LA USA; [Kunstman, Kevin J.; Wolinsky, Steven M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Henrich, Timothy J.; Kuritzkes, Daniel R.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Klasse, P. J.; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University; Tulane University; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Cornell University	Tsibris, AMN (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	atsibris@partners.org	Klasse, P.J./AEX-0142-2022; Wolinsky, Steven/B-2893-2012; Pal, Umapada/AAC-4930-2022	Klasse, P.J./0000-0001-8222-278X; Wolinsky, Steven/0000-0002-9625-6697	Harvard Clinical and Translational Science Center [UL1 RR025758]; Pfizer;  [K08 AI081547];  [R37 AI055357];  [U19 AI076982]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076982, K08AI081547, R37AI055357, T32AI007387] Funding Source: NIH RePORTER	Harvard Clinical and Translational Science Center; Pfizer(Pfizer); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AMNT was supported by K08 AI081547. TJH was supported by the KL2 Medical Research Investigator Training (MeRIT) program of Harvard Catalyst, The Harvard Clinical and Translational Science Center UL1 RR025758. This work was supported in part by R37 AI055357 (DRK) and U19 AI076982 (JPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AMNT has served as a consultant to Merck. DRK has served as a consultant to and has received honoraria and/or research grant support from Pfizer. All other authors report no conflicts. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Drummond A., 2011, GENEIOUS V5 4 6; Dudley DM, 2009, J VIROL, V83, P5067, DOI 10.1128/JVI.00055-09; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Forbes CJ, 2011, J CONTROL RELEASE; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Greenier JL, 2001, J VIROL, V75, P3753, DOI 10.1128/JVI.75.8.3753-3765.2001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Henrich TJ, 2010, JAIDS-J ACQ IMM DEF, V55, P420, DOI 10.1097/QAI.0b013e3181f25574; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Kuiken CL, 1996, AIDS, V10, P31, DOI 10.1097/00002030-199601000-00005; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Lin NH, 2010, J VIROL METHODS, V169, P39, DOI 10.1016/j.jviromet.2010.06.012; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Nedellec R, 2010, J VIROL, V84, P5842, DOI 10.1128/JVI.01907-09; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pirrone V, 2011, ANTIMICROB AGENTS CH, V55, P1831, DOI 10.1128/AAC.00976-10; Roche M, 2011, RETROVIROLO IN PRESS; Sagar M, 2004, J VIROL, V78, P7279, DOI 10.1128/JVI.78.13.7279-7283.2004; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tamura K, 2011, MOL BIOL EVOL; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Tsai L, 2007, VIROLOGY, V362, P207, DOI 10.1016/j.virol.2006.12.024; Tsibris AMN, 2008, J VIROL, V82, P8210, DOI 10.1128/JVI.00444-08; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; *UNAIDS, 2008, UNAIDS REP GLOB AIDS; Valley-Omar Z, 2011, CAPRISA 004 TNV MICR; Varela M, J VIROL; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; YANG ZB, 1994, J MOL EVOL, V39, P105; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	51	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28047	10.1371/journal.pone.0028047	http://dx.doi.org/10.1371/journal.pone.0028047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164225	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400026
J	Tu, YH; Ho, YH; Chuang, YC; Chen, PC; Chen, CS				Tu, Yu-Hsuan; Ho, Yu-Hsuan; Chuang, Ying-Chih; Chen, Po-Chung; Chen, Chien-Sheng			Identification of Lactoferricin B Intracellular Targets Using an Escherichia coli Proteome Chip	PLOS ONE			English	Article							D-LACTATE PRODUCTION; FLUORESCENCE POLARIZATION; RIBONUCLEOTIDE REDUCTASE; ANTIMICROBIAL PEPTIDES; BIOLOGICAL NETWORKS; GENE KNOCKOUT; MICROARRAYS; METABOLISM; INHIBITORS; CYTOSCAPE	Lactoferricin B (LfcinB) is a well-known antimicrobial peptide. Several studies have indicated that it can inhibit bacteria by affecting intracellular activities, but the intracellular targets of this antimicrobial peptide have not been identified. Therefore, we used E. coli proteome chips to identify the intracellular target proteins of LfcinB in a high-throughput manner. We probed LfcinB with E. coli proteome chips and further conducted normalization and Gene Ontology (GO) analyses. The results of the GO analyses showed that the identified proteins were associated with metabolic processes. Moreover, we validated the interactions between LfcinB and chip assay-identified proteins with fluorescence polarization (FP) assays. Sixteen proteins were identified, and an E. coli interaction database (EcID) analysis revealed that the majority of the proteins that interact with these 16 proteins affected the tricarboxylic acid (TCA) cycle. Knockout assays were conducted to further validate the FP assay results. These results showed that phosphoenolpyruvate carboxylase was a target of LfcinB, indicating that one of its mechanisms of action may be associated with pyruvate metabolism. Thus, we used pyruvate assays to conduct an in vivo validation of the relationship between LfcinB and pyruvate level in E. coli. These results showed that E. coli exposed to LfcinB had abnormal pyruvate amounts, indicating that LfcinB caused an accumulation of pyruvate. In conclusion, this study successfully revealed the intracellular targets of LfcinB using an E. coli proteome chip approach.	[Tu, Yu-Hsuan; Ho, Yu-Hsuan; Chen, Po-Chung; Chen, Chien-Sheng] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Chuang, Ying-Chih] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan	National Central University; National Taiwan Ocean University	Tu, YH (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	cchen103@gmail.com	Chen, Chien-Sheng/ACO-7414-2022		National Science Council, Taiwan [NSC97-2311-B-008-004-MY2, NSC98-2627-M-008-004]; Veterans General Hospitals and University System of Taiwan [VGHUST99-G4-1]; Cathy General Hospital [99CGH-NCU-A3]; Ministry of Education of Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Veterans General Hospitals and University System of Taiwan; Cathy General Hospital; Ministry of Education of Taiwan(Ministry of Education, Taiwan)	This work is supported mainly by National Science Council, Taiwan (NSC97-2311-B-008-004-MY2 and NSC98-2627-M-008-004) and partly by Veterans General Hospitals and University System of Taiwan (VGHUST99-G4-1), Cathy General Hospital (99CGH-NCU-A3) and the Ministry of Education of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2000, J BIOMOL SCREEN, V5, P63, DOI 10.1177/108705710000500202; Leon E, 2009, NUCLEIC ACIDS RES, V37, pD629, DOI 10.1093/nar/gkn853; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beranova-Giorgianni S, 2003, TRAC-TREND ANAL CHEM, V22, P273, DOI 10.1016/S0165-9936(03)00508-9; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Chandra H, 2011, EXPERT REV PROTEOMIC, V8, P61, DOI 10.1586/EPR.10.99; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Chen CS, 2009, MOL CELL PROTEOMICS, V8, P1765, DOI 10.1074/mcp.M800593-MCP200; Chen CS, 2006, BIOTECHNIQUES, V40, P423, DOI 10.2144/06404TE01; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cudic M, 2002, CURR DRUG TARGETS, V3, P101, DOI 10.2174/1389450024605445; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haukland HH, 2001, FEBS LETT, V508, P389, DOI 10.1016/S0014-5793(01)03100-3; Hwang PM, 1998, BIOCHEMISTRY-US, V37, P4288, DOI 10.1021/bi972323m; Jameson DM, 1999, METHODS, V19, P222, DOI 10.1006/meth.1999.0853; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Knight SMG, 2002, ANAL BIOCHEM, V300, P230, DOI 10.1006/abio.2001.5468; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lueking A, 2003, MOL CELL PROTEOMICS, V2, P1342, DOI 10.1074/mcp.T300001-MCP200; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Moerke NJ, FLUORESCENCE POLARIZ; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Parker GJ, 2000, J BIOMOL SCREEN, V5, P77, DOI 10.1177/108705710000500204; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Ulvatne H, 2004, FEMS MICROBIOL LETT, V237, P377, DOI 10.1016/j.femsle.2004.07.001; WEBB M, 1968, BIOCHEM J, V106, P375, DOI 10.1042/bj1060375; Yang LN, 2011, ACTA BIOCH BIOPH SIN, V43, P161, DOI 10.1093/abbs/gmq127; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu J, 2004, APPL MICROBIOL BIOT, V64, P367, DOI 10.1007/s00253-003-1499-9; Zhu JF, 2005, METAB ENG, V7, P104, DOI 10.1016/j.ymben.2004.10.004; Zhu XW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r110	37	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28197	10.1371/journal.pone.0028197	http://dx.doi.org/10.1371/journal.pone.0028197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164243	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400044
J	Xu, Y; Liu, Z; Sun, J; Pan, QR; Sun, FF; Yan, ZY; Hu, X				Xu, Yang; Liu, Zhen; Sun, Jie; Pan, Qiangrong; Sun, Feifei; Yan, Zhiyu; Hu, Xun			Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo	PLOS ONE			English	Article							MEDIATED MULTIDRUG-RESISTANCE; GLUTATHIONE ANTIOXIDANT STATUS; P-GLYCOPROTEIN; ANTITUMOR-ACTIVITY; CANCER-CELLS; RAT HEARTS; ANTHRACYCLINE; ADRIAMYCIN; TOXICITY; PROTECTS	Background: To mitigate the cardiotoxicity of anthracycline antibiotics without compromising their anticancer activities is still an issue to be solved. We previously demonstrated that schisandrin B (Sch B) could protect against doxorubicin (Dox)-induced acute cardiotoxicity via enhancing cardiomyocytic glutathione redox cycling that could attenuate oxidative stress generated from Dox. In this study, we attempted to prove if Sch B could also protect against Dox-induced chronic cardiotoxicity, a more clinically relevant issue, without compromising its anticancer activity. Methodology: Rat was given intragastrically either vehicle or Sch B (50 mg/kg) two hours prior to i.p. Dox (2.5 mg/kg) weekly over a 5-week period with a cumulative dose of Dox 12.5 mg/kg. At the 6th and 12th week after last dosing, rats were subjected to cardiac function measurement, and left ventricles were processed for histological and ultrastructural examination. Dox anticancer activity enhanced by Sch B was evaluated by growth inhibition of 4T1, a breast cancer cell line, and S180, a sarcoma cell line, in vitro and in vivo. Principal Findings: Pretreatment with Sch B significantly attenuated Dox-induced loss of cardiac function and damage of cardiomyocytic structure. Sch B substantially enhanced Dox cytotoxicities toward S180 in vitro and in vivo in mice, and increased Dox cytotoxcity against 4T1 in vitro. Although we did not observe this enhancement against the implanted 4T1 primary tumor, the spontaneous metastasis to lung was significantly reduced in combined treatment group than Dox alone group. Conclusion: Sch B is capable of protecting Dox-induced chronic cardiotoxicity and enhancing its anticancer activity. To the best of our knowledge, Sch B is the only molecule ever proved to function as a cardioprotective agent as well as a chemotherapeutic sensitizer, which is potentially applicable for cancer treatment.	[Xu, Yang; Liu, Zhen; Sun, Jie; Pan, Qiangrong; Sun, Feifei; Yan, Zhiyu; Hu, Xun] Natl Minist Educ, Key Lab Canc Prevent & Intervent, Inst Canc, Key Lab Mol Biol Med Sci, Hangzhou, Zhejiang, Peoples R China; [Xu, Yang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hematol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Xu, Y (corresponding author), Natl Minist Educ, Key Lab Canc Prevent & Intervent, Inst Canc, Key Lab Mol Biol Med Sci, Hangzhou, Zhejiang, Peoples R China.	huxun@zju.edu.cn		Liu, Zhen/0000-0002-8910-9664	Natural Sciences Foundation of China [30772544]; China National 863 project [2007AA02Z143]; National Ministry of Health, China [WKJ2006-2-011]; Bureau for Traditional Chinese Medicine, Zhejiang Province, China [2006Z013A, 2008CA055]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China National 863 project(National High Technology Research and Development Program of China); National Ministry of Health, China; Bureau for Traditional Chinese Medicine, Zhejiang Province, China	This study was supported by Natural Sciences Foundation of China grant 30772544, China National 863 project 2007AA02Z143, National Ministry of Health grant WKJ2006-2-011, China; Bureau for Traditional Chinese Medicine grants 2006Z013A, 2008CA055, Zhejiang Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen N, 2010, BIOL PHARM BULL, V33, P825, DOI 10.1248/bpb.33.825; Chiu PY, 2011, MOL CELL BIOCHEM, V350, P237, DOI 10.1007/s11010-010-0703-3; CUSACK BJ, 1988, CANCER CHEMOTH PHARM, V22, P294; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; Fogli S, 2004, FASEB J, V18, P664, DOI 10.1096/fj.03-0724rev; Fong WF, 2007, PLANTA MED, V73, P212, DOI 10.1055/s-2007-967120; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; GREENE RF, 1983, CANCER RES, V43, P3417; Hu X, 2004, China Patent, Patent No. 200410059603; Hu X, 2006, China patent: application number, Patent No. 200610111128; Hu X, 2006, China patent: application number, Patent No. 200610111123; Hu X, 2004, China Patent, Patent No. [Z1200410059607, 200410059607]; Huang M, 2008, CANCER CHEMOTH PHARM, V62, P1015, DOI 10.1007/s00280-008-0691-0; Ip SP, 1996, FREE RADICAL BIO MED, V21, P709, DOI 10.1016/0891-5849(96)00179-7; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Ko KM, 2002, MOL CELL BIOCHEM, V238, P181, DOI 10.1023/A:1019907316129; Ko KM, 2001, MOL CELL BIOCHEM, V220, P141, DOI 10.1023/A:1010979404447; Li L, 2006, BIOCHEM PHARMACOL, V71, P584, DOI 10.1016/j.bcp.2005.11.026; Li L, 2007, CLIN CANCER RES, V13, P6753, DOI 10.1158/1078-0432.CCR-07-1579; Li L, 2007, LIFE SCI, V80, P741, DOI 10.1016/j.lfs.2006.11.002; Li TM, 2000, CIRCULATION, V102, P2105, DOI 10.1161/01.CIR.102.17.2105; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; Pacher P, 2002, J PHARMACOL EXP THER, V300, P862, DOI 10.1124/jpet.300.3.862; Pan QR, 2006, CANCER CHEMOTH PHARM, V58, P99, DOI 10.1007/s00280-005-0133-1; Pan QR, 2005, BIOCHEM BIOPH RES CO, V335, P406, DOI 10.1016/j.bbrc.2005.07.097; Peng XY, 2005, MOL INTERV, V5, P163, DOI 10.1124/mi.5.3.6; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Sacco G, 2003, BRIT J PHARMACOL, V139, P641, DOI 10.1038/sj.bjp.0705270; SIVESKIILISKOVIC N, 1995, CIRCULATION, V91, P10, DOI 10.1161/01.CIR.91.1.10; SIVESKIILISKOVIC N, 1994, CIRCULATION, V89, P2829, DOI 10.1161/01.CIR.89.6.2829; Sun M, 2007, CANCER LETT, V246, P300, DOI 10.1016/j.canlet.2006.03.009; Varvaresou A, 2004, ANTICANCER RES, V24, P907; Wan CK, 2006, BIOCHEM PHARMACOL, V72, P824, DOI 10.1016/j.bcp.2006.06.036; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Yim TK, 1999, MOL CELL BIOCHEM, V196, P151, DOI 10.1023/A:1006927926495; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	40	37	39	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28335	10.1371/journal.pone.0028335	http://dx.doi.org/10.1371/journal.pone.0028335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164272	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400073
J	Fisher, CA; Bhattarai, EK; Osterstock, JB; Dowd, SE; Seabury, PM; Vikram, M; Whitlock, RH; Schukken, YH; Schnabel, RD; Taylor, JF; Womack, JE; Seabury, CM				Fisher, Colleen A.; Bhattarai, Eric K.; Osterstock, Jason B.; Dowd, Scot E.; Seabury, Paul M.; Vikram, Meenu; Whitlock, Robert H.; Schukken, Ynte H.; Schnabel, Robert D.; Taylor, Jeremy F.; Womack, James E.; Seabury, Christopher M.			Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies paratuberculosis Infection	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; PROTEIN DOMAIN ARCHITECTURES; TOLL-LIKE RECEPTORS; BALANCING SELECTION; HAPLOTYPE RECONSTRUCTION; SEQUENCE VARIABILITY; FREQUENCY ESTIMATION; PURIFYING SELECTION; STATISTICAL-METHOD; RECOGNITION	Members of the Toll-like receptor (TLR) gene family occupy key roles in the mammalian innate immune system by functioning as sentries for the detection of invading pathogens, thereafter provoking host innate immune responses. We utilized a custom next-generation sequencing approach and allele-specific genotyping assays to detect and validate 280 biallelic variants across all 10 bovine TLR genes, including 71 nonsynonymous single nucleotide polymorphisms (SNPs) and one putative nonsense SNP. Bayesian haplotype reconstructions and median joining networks revealed haplotype sharing between Bos taurus taurus and Bos taurus indicus breeds at every locus, and specialized beef and dairy breeds could not be differentiated despite an average polymorphism density of 1 marker/158 bp. Collectively, 160 tagSNPs and two tag insertion-deletion mutations (indels) were sufficient to predict 100% of the variation at 280 variable sites for both Bos subspecies and their hybrids, whereas 118 tagSNPs and 1 tagIndel predictively captured 100% of the variation at 235 variable sites for B. t. taurus. Polyphen and SIFT analyses of amino acid (AA) replacements encoded by bovine TLR SNPs indicated that up to 32% of the AA substitutions were expected to impact protein function. Classical and newly developed tests of diversity provide strong support for balancing selection operating on TLR3 and TLR8, and purifying selection acting on TLR10. An investigation of the persistence and continuity of linkage disequilibrium (r(2) >= 0.50) between adjacent variable sites also supported the presence of selection acting on TLR3 and TLR8. A case-control study employing validated variants from bovine TLR genes recognizing bacterial ligands revealed six SNPs potentially eliciting small effects on susceptibility to Mycobacterium avium spp paratuberculosis infection in dairy cattle. The results of this study will broadly impact domestic cattle research by providing the necessary foundation to explore several avenues of bovine translational genomics, and the potential for marker-assisted vaccination.	[Fisher, Colleen A.; Bhattarai, Eric K.; Vikram, Meenu; Womack, James E.; Seabury, Christopher M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Osterstock, Jason B.] Pfizer Anim Genet, Kalamazoo, MI USA; [Dowd, Scot E.] Med Biofilm Res Inst, Res & Testing Lab, Lubbock, TX USA; [Seabury, Paul M.] ElanTech Inc, Greenbelt, MD USA; [Whitlock, Robert H.] Univ Penn, Sch Vet Med, Dept Clin Studies, Kennett Sq, PA 19348 USA; [Schukken, Ynte H.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Schnabel, Robert D.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA	Texas A&M University System; Texas A&M University College Station; Pfizer; University of Pennsylvania; Cornell University; University of Missouri System; University of Missouri Columbia	Osterstock, JB (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	cseabury@cvm.tamu.edu	Schukken, Ynte/ABD-3352-2021; Schukken, Ynte H/C-3405-2008; Dowd, Scot E/M-5386-2017	Schukken, Ynte/0000-0002-8250-4194; Schukken, Ynte H/0000-0002-8250-4194; Dowd, Scot E/0000-0002-6296-1427; Schnabel, Robert/0000-0001-5018-7641	United States Department of Agriculture National Institute of Food and Agriculture [2009-35205-05058]; National Institute of Food and Agriculture [3951-TAMU-USDA-8710, 2010-590119]; Texas AgriLife Research; College of Veterinary Medicine, Texas AM University	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Texas AgriLife Research; College of Veterinary Medicine, Texas AM University	This project was supported by National Research Initiative Competitive Grant no. 2009-35205-05058 from the United States Department of Agriculture National Institute of Food and Agriculture to CMS. Likewise, research activities described herein were also supported by a National Institute of Food and Agriculture Johne's Disease Integrated Program Grant 3951-TAMU-USDA-8710 to JBO, CMS, and YHS, as well as a National Institute of Food and Agriculture Formula Animal Health Grant 2010-590119 to CMS and JBO. The authors also acknowledge support from Texas AgriLife Research and the College of Veterinary Medicine, Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhide MR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-21; Bovine HAPMAP Consortium, 2009, SCIENCE, V324, P529, DOI [10.1126/science.1167936, DOI 10.1126/SCIENCE.1167936]; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Cahn CM, 2005, MERCK VET MANUAL, P441; Cargill EJ, 2007, GENOMICS, V89, P745, DOI 10.1016/j.ygeno.2007.02.008; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fauquet C.M., 2005, VIRUS TAXONOMY DOUBL, P441, DOI [10.1016/B978-0-12-249951-7.50013-4, DOI 10.1016/B978-0-12-249951-7.50013-4]; Fu YX, 1997, GENETICS, V147, P915; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glass EJ, 2011, VET IMMUNOL IN PRESS; Govindaraj RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012713; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; Hiwatashi T, 2010, MOL BIOL EVOL, V27, P453, DOI 10.1093/molbev/msp262; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; Jann OC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-216; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kataria RS, 2011, IMMUNOGENETICS, V63, P115, DOI 10.1007/s00251-010-0484-6; Kuhn C, 2003, J DAIRY SCI, V86, P360, DOI 10.3168/jds.S0022-0302(03)73614-5; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li N, 2003, GENETICS, V165, P2213; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Merx Sabine, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9409; Mucha R, 2009, VET IMMUNOL IMMUNOP, V128, P381, DOI 10.1016/j.vetimm.2008.12.007; Mukhopadhyay S, 2004, IMMUNOLOGY, V112, P521, DOI 10.1111/j.1365-2567.2004.01941.x; Neibergs HL, 2010, MAMM GENOME, V21, P419, DOI 10.1007/s00335-010-9278-2; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Osier FHA, 2010, INFECT IMMUN, V78, P4625, DOI 10.1128/IAI.00576-10; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pinedo PJ, 2009, PREV VET MED, V91, P189, DOI 10.1016/j.prevetmed.2009.05.020; Pinedo PJ, 2009, MAMM GENOME, V20, P124, DOI 10.1007/s00335-008-9167-0; Plain KM, 2010, VET IMMUNOL IMMUNOP, V137, P142, DOI 10.1016/j.vetimm.2010.04.002; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pradhan AK, 2011, J CLIN MICROBIOL, V49, P893, DOI 10.1128/JCM.01107-10; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rosenthal Kenneth L, 2006, Can J Infect Dis Med Microbiol, V17, P307; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Ruiz-Larranaga O, 2011, J DAIRY SCI, V94, P3635, DOI 10.3168/jds.2010-3788; Seabury CM, 2008, GENOMICS, V92, P235, DOI 10.1016/j.ygeno.2008.06.005; Seabury CM, 2007, GENOMICS, V90, P502, DOI 10.1016/j.ygeno.2007.07.001; Seabury CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015811; Seabury CM, 2010, P NATL ACAD SCI USA, V107, P151, DOI 10.1073/pnas.0913006107; Shey MS, 2010, GENES IMMUN, V11, P561, DOI 10.1038/gene.2010.14; SIMONSEN KL, 1995, GENETICS, V141, P413; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Subramanian S, 2006, MOL BIOL EVOL, V23, P2283, DOI 10.1093/molbev/msl123; TAJIMA F, 1989, GENETICS, V123, P585; Tennessen JA, 2008, MOL BIOL EVOL, V25, P2669, DOI 10.1093/molbev/msn208; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vasselon T, 2002, INFECT IMMUN, V70, P1033, DOI 10.1128/IAI.70.3.1033-1041.2002; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; White SN, 2003, P NATL ACAD SCI USA, V100, P10364, DOI 10.1073/pnas.1333957100; Zanella R, 2011, ANIM GENET, V42, P28, DOI 10.1111/j.1365-2052.2010.02076.x	69	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27744	10.1371/journal.pone.0027744	http://dx.doi.org/10.1371/journal.pone.0027744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22164200	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168100017
J	Weber, T; Schonig, K; Tews, B; Bartsch, D				Weber, Tillmann; Schoenig, Kai; Tews, Bjoern; Bartsch, Dusan			Inducible Gene Manipulations in Brain Serotonergic Neurons of Transgenic Rats	PLOS ONE			English	Article							KNOCKOUT RATS; STEM-CELLS; MICE; MUTAGENESIS; GENERATION; SYSTEM; GLIA; TOOL	The serotonergic (5-HT) system has been implicated in various physiological processes and neuropsychiatric disorders, but in many aspects its role in normal and pathologic brain function is still unclear. One reason for this might be the lack of appropriate animal models which can address the complexity of physiological and pathophysiological 5-HT functioning. In this respect, rats offer many advantages over mice as they have been the animal of choice for sophisticated neurophysiological and behavioral studies. However, only recently technologies for the targeted and tissue specific modification of rat genes - a prerequisite for a detailed study of the 5-HT system - have been successfully developed. Here, we describe a rat transgenic system for inducible gene manipulations in 5-HT neurons. We generated a Cre driver line consisting of a tamoxifen-inducible CreERT2 recombinase under the control of mouse Tph2 regulatory sequences. Tissue-specific serotonergic Cre recombinase expression was detected in four transgenic TPH2-CreERT2 rat founder lines. For functional analysis of Cre-mediated recombination, we used a rat Cre reporter line (CAG-loxP.EGFP), in which EGFP is expressed after Cre-mediated removal of a loxP-flanked lacZ STOP cassette. We show an in-depth characterisation of this rat Cre reporter line and demonstrate its applicability for monitoring Cre-mediated recombination in all major neuronal subpopulations of the rat brain. Upon tamoxifen induction, double transgenic TPH2-CreERT2/CAG-loxP. EGFP rats show selective and efficient EGFP expression in 5-HT neurons. Without tamoxifen administration, EGFP is only expressed in few 5-HT neurons which confirms minimal background recombination. This 5-HT neuron specific CreERT2 line allows Cre-mediated, inducible gene deletion or gene overexpression in transgenic rats which provides new opportunities to decipher the complex functions of the mammalian serotonergic system.	[Weber, Tillmann; Schoenig, Kai; Bartsch, Dusan] Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany; [Weber, Tillmann] Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, D-6800 Mannheim, Germany; [Weber, Tillmann] Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Tews, Bjoern] Swiss Fed Inst Technol, Brain Res Inst, Zurich, Switzerland; [Bartsch, Dusan] Heidelberg Univ, Med Fac Mannheim, D-6800 Mannheim, Germany	Central Institute of Mental Health; Central Institute of Mental Health; Central Institute of Mental Health; ETH Zurich; Ruprecht Karls University Heidelberg	Weber, T (corresponding author), Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany.	dusan.bartsch@zi-mannheim.de			German Ministry for Education and Research (BMBF) [01GQ1003B]; National Bernstein Network for Computational Neuroscience [HEALTH-F2-2007-201714]; Deutsche Forschungsgemeinschaft [SFB 636]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Bernstein Network for Computational Neuroscience; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by grants from the German Ministry for Education and Research (BMBF, 01GQ1003B) National Bernstein Network for Computational Neuroscience (http://www.gesundheitsforschung-bmbf.de/en/2478.php#Heidelberg), HEALTH-F2-2007-201714 DEVANX (http://devanx.vitamib.com), and the Deutsche Forschungsgemeinschaft SFB 636 (http://www.sfb636.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Buchanan GF, 2010, P NATL ACAD SCI USA, V107, P16354, DOI 10.1073/pnas.1004587107; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hakamata Y, 2001, BIOCHEM BIOPH RES CO, V286, P779, DOI 10.1006/bbrc.2001.5452; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Homberg JR, 2007, NEUROSCIENCE, V146, P1662, DOI 10.1016/j.neuroscience.2007.03.030; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/NMETH.1461, 10.1038/nmeth.1461]; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Kim JC, 2009, NEURON, V63, P305, DOI 10.1016/j.neuron.2009.07.010; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Li MA, 2011, NAT BIOTECHNOL, V29, P39, DOI 10.1038/nbt.1749; Li T, 2011, NUCL ACIDS RES; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Michalkiewicz M, 2007, AM J PHYSIOL-HEART C, V293, pH881, DOI 10.1152/ajpheart.00060.2007; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rogers RD, 2011, NEUROPSYCHOPHARMACOL, V36, P114, DOI 10.1038/npp.2010.165; Sato Y, 2004, BIOCHEM BIOPH RES CO, V319, P1197, DOI 10.1016/j.bbrc.2004.04.204; Schonig K, 2011, TRANSGENIC RES, V20, P709, DOI 10.1007/s11248-010-9427-0; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weber T, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.024.2009; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; Zhao ZQ, 2007, P NATL ACAD SCI USA, V104, P14519, DOI 10.1073/pnas.0705740104; Zhao ZQ, 2007, J NEUROSCI, V27, P6045, DOI 10.1523/JNEUROSCI.1623-07.2007	46	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28283	10.1371/journal.pone.0028283	http://dx.doi.org/10.1371/journal.pone.0028283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140568	Green Published, gold, Green Submitted			2022-12-25	WOS:000298166300045
J	Tessema, M; Yingling, CM; Thomas, CL; Klinge, DM; Bernauer, AM; Liu, Y; Dacic, S; Siegfried, JM; Dahlberg, SE; Schiller, JH; Belinsky, SA				Tessema, M.; Yingling, C. M.; Thomas, C. L.; Klinge, D. M.; Bernauer, A. M.; Liu, Y.; Dacic, S.; Siegfried, J. M.; Dahlberg, S. E.; Schiller, J. H.; Belinsky, S. A.			SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15	ONCOGENE			English	Article						NSCLC; camptothecin; SULF-2; topotecan	ORAL TOPOTECAN; PHASE-II; PROMOTER METHYLATION; ANTITUMOR-ACTIVITY; EXPRESSION; GROWTH; EGFR; RESISTANCE; GENES; ADENOCARCINOMAS	The heparan sulfate 6-O-endosulfatase (SULF2) promotes growth and metastasis of solid tumors. We recently identified that cytosine methylation of the SULF2 promoter is associated with better survival of resected lung adenocarcinoma patients, and now also demonstrates a marginal improvement in survival of advanced non-small cell lung cancer (NSCLC) patients receiving standard chemotherapy (hazard ratio = 0.63, P = 0.07). Subsequent studies focused on investigating the effect of methylation on SULF2 expression and its genome-wide impact. The genes and pathways modulated by epigenetic inactivation of SULF2 and the effects on sensitivity to chemotherapy were characterized in vitro and in vivo. Silencing SULF2 through small interfering RNA or methylation primarily increased expression of interferon-inducible genes including ISG15, a marker for increased sensitivity to topoisomerase-1 inhibitors such as camptothecin (CPT). NSCLC cell lines with methylated SULF2 (SULF2M) express 60-fold higher ISG15 compared with SULF2 unmethylated (SULF2U) NSCLC cell lines and normal human bronchial epithelial cells. In vitro, SULF2M and high ISG15 (ISG15H)-expressing NSCLC cell lines were 134-fold more sensitive to CPT than SULF2U and low ISG15 (ISG15L)-expressing cell lines. Topotecan, a soluble analog of CPT and FDA-approved anticancer drug, dramatically arrested the growth of SULF2M-ISG15H, but not SULF2U-ISG15L lung tumors in nude mice (P<0.002). Similarly, high ISG15 expression that is comparable to the topotecan (TPT)-sensitive NSCLC cell lines was found in tumors from 25% of NSCLC patients compared with normal lung, indicating a potential to identify and target the most sensitive NSCLC subpopulation for personalized TPT therapy. Oncogene (2012) 31, 4107-4116; doi: 10.1038/onc.2011.577; published online 12 December 2011	[Tessema, M.; Yingling, C. M.; Thomas, C. L.; Klinge, D. M.; Bernauer, A. M.; Liu, Y.; Belinsky, S. A.] LRRI, Lovelace Resp Res Inst, Lung Canc Program, Albuquerque, NM 87108 USA; [Dacic, S.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Siegfried, J. M.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Dahlberg, S. E.] Dana Farber Canc Inst, Dept Biostat & Comput Biol, Boston, MA 02115 USA; [Schiller, J. H.] Univ Texas SW, Dept Internal Med, Dallas, TX USA	Lovelace Respiratory Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Belinsky, SA (corresponding author), LRRI, Lovelace Resp Res Inst, Lung Canc Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	sbelinsk@LRRI.org	Dahlberg, Suzanne/L-2622-2019	Dahlberg, Suzanne/0000-0001-5139-831X	NIH [R01 ES008801, CA089551, P50 CA090440]; NATIONAL CANCER INSTITUTE [U24CA114737, R01CA089551, P50CA090440, U10CA023318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by NIH grants R01 ES008801 and CA089551 to SAB, and P50 CA090440 to JMS.	Andersen JB, 2006, BRIT J CANCER, V94, P1465, DOI 10.1038/sj.bjc.6603099; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Duan ZF, 2004, MOL CANCER THER, V3, P833; Gonzalez EE, 2011, INVEST NEW DRUG, V29, P1459, DOI 10.1007/s10637-010-9442-2; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Johansson FK, 2005, ONCOGENE, V24, P3896, DOI 10.1038/sj.onc.1208553; Jones S, 2008, CLIN LUNG CANCER, V9, P154, DOI 10.3816/CLC.2008.n.023; Kalikaki A, 2008, BRIT J CANCER, V99, P923, DOI 10.1038/sj.bjc.6604629; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2010, HEPATOLOGY, V52, P1680, DOI 10.1002/hep.23848; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORTAT-JACOB H, 1991, J CLIN INVEST, V87, P878, DOI 10.1172/JCI115093; McGuire WP, 2000, J CLIN ONCOL, V18, P1062, DOI 10.1200/JCO.2000.18.5.1062; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; O'Brien M, 2007, ONCOLOGIST, V12, P1194, DOI 10.1634/theoncologist.12-10-1194; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ramlau R, 2006, J CLIN ONCOL, V24, P2800, DOI 10.1200/JCO.2005.03.6491; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Tessema M, 2009, CARCINOGENESIS, V30, P1132, DOI 10.1093/carcin/bgp114; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Weitz JJ, 2000, LUNG CANCER-J IASLC, V28, P157, DOI 10.1016/S0169-5002(99)00128-2; White SC, 2000, CLIN CANCER RES, V6, P868	34	37	40	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	37					4107	4116		10.1038/onc.2011.577	http://dx.doi.org/10.1038/onc.2011.577			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NR	22158045	Green Accepted			2022-12-25	WOS:000308688900003
J	Villagrasa, P; Diaz, VM; Vinas-Castells, R; Peiro, S; Del Valle-Perez, B; Dave, N; Rodriguez-Asiain, A; Casal, JI; Lizcano, JM; Dunach, M; de Herreros, AG				Villagrasa, P.; Diaz, V. M.; Vinas-Castells, R.; Peiro, S.; Del Valle-Perez, B.; Dave, N.; Rodriguez-Asiain, A.; Casal, J. I.; Lizcano, J. M.; Dunach, M.; Garcia de Herreros, A.			Akt2 interacts with Snail1 in the E-cadherin promoter	ONCOGENE			English	Article						Snail1; EMT; Akt; E-cadherin	PROTEIN-KINASE-B; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; NF-KAPPA-B; COLORECTAL-CANCER; HISTONE H3; GENE-EXPRESSION; DISTINCT ROLES; UP-REGULATION; ACTIVATION	Snail1 is a transcriptional factor essential for triggering epithelial-to-mesenchymal transition. Moreover, Snail1 promotes resistance to apoptosis, an effect associated to PTEN gene repression and Akt stimulation. In this article we demonstrate that Snail1 activates Akt at an additional level, as it directly binds to and activates this protein kinase. The interaction is observed in the nucleus and increases the intrinsic Akt activity. We determined that Akt2 is the isoform interacting with Snail1, an association that requires the pleckstrin homology domain in Akt2 and the C-terminal half in Snail1. Snail1 enhances the binding of Akt2 to the E-cadherin (CDH1) promoter and Akt2 interference prevents Snail1 repression of CDH1 gene. We also show that Snail1 binding increases Akt2 intrinsic activity on histone H3 and have identified Thr45 as a residue modified on this protein. Phosphorylation of Thr45 in histone H3 is sensitive to Snail1 and Akt2 cellular levels; moreover, Snail1 upregulates the binding of phosphoThr45 histone H3 to the CDH1 promoter. These results uncover an unexpected role of Akt2 in transcriptional control and point out to phosphorylation of Thr45 in histone H3 as a new epigenetic mark related to Snail1 and Akt2 action. Oncogene (2012) 31, 4022-4033; doi:10.1038/onc.2011.562; published online 12 December 2011	[Villagrasa, P.; Del Valle-Perez, B.; Dunach, M.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Med, Unitat Biofis CEB, E-08193 Bellaterra, Spain; [Villagrasa, P.; Diaz, V. M.; Vinas-Castells, R.; Peiro, S.; Dave, N.; Garcia de Herreros, A.] IMIM Hosp Mar, Programa Recerca Canc, Barcelona, Spain; [Diaz, V. M.; Garcia de Herreros, A.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Rodriguez-Asiain, A.; Lizcano, J. M.] Univ Autonoma Barcelona, Fac Med, Inst Neurociencia, Bellaterra, Spain; [Rodriguez-Asiain, A.; Lizcano, J. M.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Med, Bellaterra, Spain; [Casal, J. I.] Ctr Invest Biol CSIC, Madrid, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Dunach, M (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Med, Unitat Biofis CEB, E-08193 Bellaterra, Spain.	mireia.dunach@uab.cat; agarcia@imim.es	Díaz, Víctor Manuel/F-5013-2016; Viñas-Castells, Rosa/J-7722-2017; Casal, Ignacio/M-2312-2014; de Herreros, A Garcia/H-3104-2014; Lizcano, Jose M/E-6080-2010; Dunach, Mireia/E-3604-2015; lizcano, jose m/AAK-3577-2020	Díaz, Víctor Manuel/0000-0001-8561-7576; Viñas-Castells, Rosa/0000-0003-0610-4495; Casal, Ignacio/0000-0003-1085-2840; de Herreros, A Garcia/0000-0001-5270-0808; Lizcano, Jose M/0000-0002-3154-5383; Dunach, Mireia/0000-0001-9844-5603; lizcano, jose m/0000-0002-3154-5383; Villagrasa-Gonzalez, Patricia/0000-0002-8662-3641; Peiro, Sandra/0000-0001-9519-3877	Ministerio de Ciencia e Innovacion [BFU2006-03203, BFU2009-07578, SAF2006-00339, SAF2010-16089]; Fundacio La Marato de TV3; Instituto Carlos III-Fondos FEDER (RTICCC) [C03710, RD06/0020/0040]; Generalitat de Catalunya [2009SGR867]; predoctoral fellowship from the Ministerio de Ciencia y Tecnologia; predoctoral fellowship from the Instituto Carlos III	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio La Marato de TV3; Instituto Carlos III-Fondos FEDER (RTICCC); Generalitat de Catalunya(Generalitat de Catalunya); predoctoral fellowship from the Ministerio de Ciencia y Tecnologia; predoctoral fellowship from the Instituto Carlos III	We are grateful to Neus Ontiveros for technical help; Dr David Casagolda for assistance with confocal microscopy; and Drs Lionel Larue and Alberto Munoz for reagents. This study was supported by grants awarded by the Ministerio de Ciencia e Innovacion (BFU2006-03203 and BFU2009-07578 to MD and SAF2006-00339 and SAF2010-16089 to AGH) and Fundacio La Marato de TV3 (to AGH). The partial support from the Instituto Carlos III-Fondos FEDER (RTICCC, C03710, RD06/0020/0040) and the Generalitat de Catalunya (2009SGR867) is also appreciated. PV and RV-C were supported by predoctoral fellowships from the Ministerio de Ciencia y Tecnologia and Instituto Carlos III, respectively.	AHMED NN, 1993, ONCOGENE, V8, P1957; Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Arboleda MJ, 2003, CANCER RES, V63, P196; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bellacosa A, 2004, CANCER BIOL THER, V3, P268, DOI 10.4161/cbt.3.3.703; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gao HD, 2007, MOL CELL BIOCHEM, V305, P35, DOI 10.1007/s11010-007-9525-3; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Grille SJ, 2003, CANCER RES, V63, P2172; He ZW, 2003, J BIOL CHEM, V278, P10588, DOI 10.1074/jbc.M208581200; Herranz N, 2008, MOL CELL BIOL, V28, P3198; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jahn T, 2002, MOL CELL BIOL, V22, P979, DOI 10.1128/MCB.22.4.979-991.2002; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Jorda M, 2007, EXP CELL RES, V313, P2389, DOI 10.1016/j.yexcr.2007.04.001; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Lee SB, 2008, P NATL ACAD SCI USA, V105, P16584, DOI 10.1073/pnas.0807668105; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Raurell I, 2006, J BIOL CHEM, V281, P1401, DOI 10.1074/jbc.M508153200; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	50	23	24	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2012	31	36					4022	4033		10.1038/onc.2011.562	http://dx.doi.org/10.1038/onc.2011.562			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NQ	22158034				2022-12-25	WOS:000308688800003
J	Ejlerskov, P; Christensen, DP; Beyaie, D; Burritt, JB; Paclet, MH; Gorlach, A; Van Deurs, B; Vilhardt, F				Ejlerskov, Patrick; Christensen, Dan Ploug; Beyaie, David; Burritt, James B.; Paclet, Marie-Helene; Gorlach, Agnes; Van Deurs, Bo; Vilhardt, Frederik			NADPH Oxidase Is Internalized by Clathrin-coated Pits and Localizes to a Rab27A/B GTPase-regulated Secretory Compartment in Activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; INTRACELLULAR VESICLES; CYTOCHROME-B; EXOCYTOSIS; EFFECTOR; RECEPTOR; PROTEIN; ACTIN; NEUTROPHILS; PHAGOCYTES	Here, we report that activation of different types of tissue macrophages, including microglia, by lipopolysaccharide (LPS) or GM-CSF stimulation correlates with the quantitative redistribution of NADPH oxidase (cyt b(558)) from the plasma membrane to an intracellular stimulus-responsive storage compartment. Cryo-immunogold labeling of gp91(phox) and CeCl3 cytochemistry showed the presence of gp91phox and oxidant production in numerous small (< 100 nm) vesicles. Cell homogenization and sucrose gradient centrifugation in combination with transferrin-HRP/DAB ablation showed that more than half of cyt b(558) is present in fractions devoid of endosomal markers, which is supported by morphological evidence to show that the cyt b(558)-containing compartment is distinct from endosomes or biosynthetic organelles. Streptolysin-O-mediated guanosine 5'-3-O-(thio) triphosphate loading of Ra2 microglia caused exocytosis of a major complement of cyt b(558) under conditions where lysosomes or endosomes were not mobilized. We establish phagocytic particles and soluble mediators ATP, TNF alpha, and CD40L as physiological inducers of cyt b(558) exocytosis to the cell surface, and by shRNA knockdown, we identify Rab27A/B as positive or negative regulators of vesicular mobilization to the phagosome or the cell surface, respectively. Exocytosis was followed by clathrin-dependent internalization of cyt b(558), which could be blocked by a dominant negative mutant of the clathrincoated pit-associated protein Eps15. Re-internalized cyt b(558) did not reach lysosomes but associated with recycling endosomes and undefined vesicular elements. In conclusion, cyt b(558) depends on clathrin for internalization, and in activated macrophages NADPH oxidase occupies a Rab27A/B-regulated secretory compartment, which allows rapid agonist-induced redistribution of superoxide production in the cell.	[Ejlerskov, Patrick; Christensen, Dan Ploug; Beyaie, David; Van Deurs, Bo; Vilhardt, Frederik] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Burritt, James B.] Univ Wisconsin Stout, Dept Biol, Menomonie, WI 54751 USA; [Paclet, Marie-Helene] Univ Grenoble 1, CHU Grenoble, GREPI, TIMC IMAG,CNRS,UMR 5525, F-38041 Grenoble, France; [Gorlach, Agnes] Tech Univ Munich, German Heart Ctr, D-080636 Munich, Germany	University of Copenhagen; University of Wisconsin System; University of Wisconsin Stout; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); German Heart Centre Munich; Technical University of Munich	Vilhardt, F (corresponding author), Panum Inst, Dept Cellular & Mol Med, Bldg 18-4,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	vilhardt@sund.ku.dk	Vilhardt, Frederik/AAX-4766-2021; Gorlach, Agnes/B-3494-2013; Paclet, Marie-Hélène/AAS-5029-2020	Vilhardt, Frederik/0000-0001-8604-7165; Ejlerskov, Patrick/0000-0002-2514-3185	NOVO Nordisk Foundation [50-65074]; Aase and Ejnar Danielsens Foundation [105560]; Desiree and Niels Yde Foundation	NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Aase and Ejnar Danielsens Foundation; Desiree and Niels Yde Foundation	This work was supported by NOVO Nordisk Foundation Grant 50-65074, The Aase and Ejnar Danielsens Foundation Grant 105560, and The Desiree and Niels Yde Foundation (to F. V.).	Anderson KE, 2010, BLOOD, V116, P4978, DOI 10.1182/blood-2010-03-275602; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CALAFAT J, 1993, BLOOD, V81, P3122; Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Cocucci E, 2007, TRAFFIC, V8, P742, DOI 10.1111/j.1600-0854.2007.00566.x; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Inoue H, 1999, GLIA, V28, P265, DOI 10.1002/(SICI)1098-1136(199912)28:3<265::AID-GLIA10>3.0.CO;2-F; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; JOHANSSON A, 1995, CELL IMMUNOL, V161, P61, DOI 10.1006/cimm.1995.1009; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kobayashi T, 1999, HISTOCHEM J, V31, P181, DOI 10.1023/A:1003547121574; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; Roepstorff K, 2008, J BIOL CHEM, V283, P7983, DOI 10.1074/jbc.M708281200; Sawada M., 2007, [No title captured], Patent No. [JP3410738, 3410738]; Sawada M., 2007, U.S. Patent, Patent No. [6.673,6,5, 667365]; Sawada M., 2007, [No title captured], Patent No. [EP10/602,234, 10602234]; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Vutskits GV, 2006, BREAST CANCER RES TR, V99, P143, DOI 10.1007/s10549-006-9195-y; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09	61	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4835	4852		10.1074/jbc.M111.293696	http://dx.doi.org/10.1074/jbc.M111.293696			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22157766	Green Published, hybrid			2022-12-25	WOS:000300608500045
J	Migueleti, DLS; Smetana, JHC; Nunes, HF; Kobarg, J; Zanchin, NIT				Migueleti, Deivid L. S.; Smetana, Juliana H. C.; Nunes, Hugo F.; Kobarg, Joerg; Zanchin, Nilson I. T.			Identification and Characterization of an Alternatively Spliced Isoform of the Human Protein Phosphatase 2A alpha Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; ALPHA4 PROTEIN; 2A; PP2A; REGULATOR; DOCKING; HOLOENZYME; CLUSPRO; STABILITY	PP2A is the main serine/threonine-specific phosphatase in animal cells. The active phosphatase has been described as a holoenzyme consisting of a catalytic, a scaffolding, and a variable regulatory subunit, all encoded by multiple genes, allowing for the assembly of more than 70 different holoenzymes. The catalytic subunit can also interact with alpha 4, TIPRL (TIP41, TOR signaling pathway regulator-like), the methyl-transferase LCMT-1, and the methyl-esterase PME-1. Here, we report that the gene encoding the catalytic subunit PP2Ac alpha can generate two mRNA types, the standard mRNA and a shorter isoform, lacking exon 5, which we termed PP2Ac alpha 2. Higher levels of the PP2Ac alpha 2 mRNA, equivalent to the level of the longer PP2Ac alpha mRNA, were detected in peripheral blood mononuclear cells that were left to rest for 24 h. After this time, the peripheral blood mononuclear cells are still viable and the PP2Ac alpha 2 mRNA decreases soon after they are transferred to culture medium, showing that generation of the shorter isoform depends on the incubation conditions. FLAG-tagged PP2Ac alpha 2 expressed in HEK293 is catalytically inactive. It displays a specific interaction profile with enhanced binding to the alpha 4 regulatory subunit, but no binding to the scaffolding subunit and PME-1. Consistently, alpha 4 out-competes PME-1 and LCMT-1 for binding to both PP2Ac alpha isoforms in pulldown assays. Together with molecular modeling studies, this suggests that all three regulators share a common binding surface on the catalytic sub-unit. Our findings add important new insights into the complex mechanisms of PP2A regulation.	[Migueleti, Deivid L. S.; Smetana, Juliana H. C.; Kobarg, Joerg] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13084971 Campinas, SP, Brazil; [Migueleti, Deivid L. S.; Kobarg, Joerg] Univ Estadual Campinas, Inst Biol, BR-13083875 Campinas, SP, Brazil; [Nunes, Hugo F.; Zanchin, Nilson I. T.] Univ Estadual Campinas, Ctr Biol Mol Engn Genet, BR-13083875 Campinas, SP, Brazil; [Zanchin, Nilson I. T.] Fdn Inst Oswaldo Cruz, Inst Carlos Chagas, BR-81350010 Curitiba, Parana, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Fundacao Oswaldo Cruz	Kobarg, J (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Rua Giuseppe Maximo Scolfaro 10-000,CP 6192, BR-13084971 Campinas, SP, Brazil.	jorg.kobarg@lnbio.org.br; nilson.zanchin@pq.cnpq.br	Kobarg, Jörg/T-4736-2019; Smetana, Juliana/J-5354-2013; Freire, Hugo/AAD-2936-2019; Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Smetana, Juliana/D-8683-2012	Kobarg, Jörg/0000-0002-9419-0145; Smetana, Juliana/0000-0001-9827-7013; Freire, Hugo/0000-0003-0075-4526; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; 	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Laboratorio Nacional de Biociencias, Centro Nacional de Pesquisa em Energia e Materiais	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Laboratorio Nacional de Biociencias, Centro Nacional de Pesquisa em Energia e Materiais	This work was supported by Fundacao de Amparo a Pesquisa do Estado Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Laboratorio Nacional de Biociencias, Centro Nacional de Pesquisa em Energia e Materiais.	Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Lizotte DL, 2008, J CELL BIOCHEM, V103, P1309, DOI 10.1002/jcb.21514; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; McDonald WJ, 2010, J CELL BIOCHEM, V110, P1123, DOI 10.1002/jcb.22624; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Smetana JHC, 2007, FEBS J, V274, P5891, DOI 10.1111/j.1742-4658.2007.06112.x; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	33	8	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4853	4862		10.1074/jbc.M111.283341	http://dx.doi.org/10.1074/jbc.M111.283341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22167190	Green Published, hybrid			2022-12-25	WOS:000300608500046
J	Koole, C; Wootten, D; Simms, J; Miller, LJ; Christopoulos, A; Sexton, PM				Koole, Cassandra; Wootten, Denise; Simms, John; Miller, Laurence J.; Christopoulos, Arthur; Sexton, Patrick M.			Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Has a Critical Role in GLP-1 Peptide Binding and Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CORTICOTROPIN-RELEASING-FACTOR; PARATHYROID-HORMONE-RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTORS; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; LIGAND-BINDING; MOLECULAR RECOGNITION; DETERMINE SPECIFICITY; CRITICAL DETERMINANTS	The glucagon-like peptide-1 receptor (GLP-1R) is a therapeutically important family B G protein-coupled receptor (GPCR) that is pleiotropically coupled to multiple signaling effectors and, with actions including regulation of insulin biosynthesis and secretion, is one of the key targets in the management of type II diabetes mellitus. However, there is limited understanding of the role of the receptor core in orthosteric ligand binding and biological activity. To assess involvement of the extracellular loop (ECL) 2 in ligand-receptor interactions and receptor activation, we performed alanine scanning mutagenesis of loop residues and assessed the impact on receptor expression and GLP-1(1-36)-NH2 or GLP-1(7-36)-NH2 binding and activation of three physiologically relevant signaling pathways as follows: cAMP formation, intracellular Ca2+ (Ca-i(2+)) mobilization, and phosphorylation of extracellular signal-regulated kinases 1 and 2 (pERK1/2). Although antagonist peptide binding was unaltered, almost all mutations affected GLP-1 peptide agonist binding and/or coupling efficacy, indicating an important role in receptor activation. However, mutation of several residues displayed distinct pathway responses with respect to wild type receptor, including Arg-299 and Tyr-305, where mutation significantly enhanced both GLP-1(1-36)-NH2- and GLP-1(7-36)NH2-mediated signaling bias for pERK1/2. In addition, mutation of Cys-296, Trp-297, Asn-300, Asn-302, and Leu-307 significantly increased GLP-1(7-36)-N(H)2-mediated signaling bias toward pERK1/2. Of all mutants studied, only mutation of Trp-306 to alanine abolished all biological activity. These data suggest a critical role of ECL2 of the GLP-1R in the activation transition(s) of the receptor and the importance of this region in the determination of both GLP-1 peptide-and pathway-specific effects.	[Koole, Cassandra; Wootten, Denise; Simms, John; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Koole, Cassandra; Wootten, Denise; Simms, John; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Monash University; Monash University; Mayo Clinic; Mayo Clinic Phoenix	Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Patrick.Sexton@monash.edu	Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013; Wootten, Denise/ABD-5703-2021	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Wootten, Denise/0000-0003-4563-1642; Simms, John/0000-0002-4675-0902	National Health and Medical Research Council of Australia [1002180, 519461]; National Health and Medical Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by the National Health and Medical Research Council of Australia Project Grant 1002180 and Program Grant 519461 and by National Health and Medical Research Council Principal Research Fellowship (to P. M. S.) and a Senior Research Fellowship (to A. C.).	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Alla SA, 1996, J BIOL CHEM, V271, P1748, DOI 10.1074/jbc.271.3.1748; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BUGGY JJ, 1995, J BIOL CHEM, V270, P7474, DOI 10.1074/jbc.270.13.7474; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dong MQ, 2011, BIOCHEMISTRY-US, V50, P2983, DOI 10.1021/bi200133u; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Gelling RW, 1997, ENDOCRINOLOGY, V138, P2640, DOI 10.1210/en.138.6.2640; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; HJORTH SA, 1994, J BIOL CHEM, V269, P30121; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Koole C, 2011, MOL PHARMACOL, V80, P486, DOI 10.1124/mol.111.072884; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mann RJ, 2010, BRIT J PHARMACOL, V160, P1973, DOI 10.1111/j.1476-5381.2010.00834.x; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MOJSOV S, 1992, INT J PEPT PROT RES, V40, P333; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Nicole P, 2000, J BIOL CHEM, V275, P24003, DOI 10.1074/jbc.M002325200; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Werry TD, 2005, J NEUROCHEM, V93, P1603, DOI 10.1111/j.1471-4159.2005.03161.x; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321	80	69	69	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3642	3658		10.1074/jbc.M111.309328	http://dx.doi.org/10.1074/jbc.M111.309328			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147710	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000300410900004
J	Sevrioukova, IF; Poulos, TL				Sevrioukova, Irina F.; Poulos, Thomas L.			Structural and Mechanistic Insights into the Interaction of Cytochrome P4503A4 with Bromoergocryptine, a Type I Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING; 3A4; COOPERATIVITY; BROMOCRIPTINE; HYDROXYLATION; RECOGNITION; DISPOSITION; ACTIVATION; OXIDATION; ANIMALS	Cytochrome P4503A4 (CYP3A4), a major human drug-metabolizing enzyme, is responsible for the oxidation and clearance of the majority of administered drugs. One of the CYP3A4 substrates is bromoergocryptine (BEC), a dopamine receptor agonist prescribed for the inhibition of prolactin secretion and treatment of Parkinson disease, type 2 diabetes, and several other pathological conditions. Here we present a 2.15 angstrom crystal structure of the CYP3A4-BEC complex in which the drug, a type I heme ligand, is bound in a productive mode. The manner of BEC binding is consistent with the in vivo metabolite analysis and identifies the 8' and 9' carbons of the proline ring as the primary sites of oxidation. The crystal structure predicts the importance of Arg(212) and Thr(224) for binding of the tripeptide and lysergic moieties of BEC, respectively, which we confirmed experimentally. Our data support a three-step BEC binding model according to which the drug binds first at a peripheral site without perturbing the heme spectrum and then translocates into the active site cavity, where formation of a hydrogen bond between Thr(224) and the N1 atom of the lysergic moiety is followed by a slower conformational readjustment of the tripeptide group modulated by Arg(212).	[Sevrioukova, Irina F.; Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sevrioukova, IF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	sevrioui@uci.edu			National Institutes of Health [GM33688]; Gilead Sciences, Inc.; California Center for Antiviral Drug Discovery; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources (NCRR); National Institute of General Medical Sciences (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences, Inc.(Gilead Sciences); California Center for Antiviral Drug Discovery; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33688. This study was also supported by Gilead Sciences, Inc. and the California Center for Antiviral Drug Discovery.; Research was carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources (NCRR) Biomedical Technology Program and the National Institute of General Medical Sciences (NIGMS).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Das A, 2007, J AM CHEM SOC, V129, P13778, DOI 10.1021/ja074864x; Davydov DR, 2007, BIOCHEMISTRY-US, V46, P7852, DOI 10.1021/bi602400y; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernando H, 2006, BIOCHEMISTRY-US, V45, P4199, DOI 10.1021/bi052491b; Fishelovitch D, 2007, J AM CHEM SOC, V129, P1602, DOI 10.1021/ja066007j; Guengerich FP, 1998, DRUG METAB DISPOS, V26, P1175; Harlow GR, 1997, J BIOL CHEM, V272, P5396, DOI 10.1074/jbc.272.9.5396; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; He Y. A., 2009, 16 INT C CYT P450 OK, P91; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Hosea NA, 1998, ARCH BIOCHEM BIOPHYS, V353, P365, DOI 10.1006/abbi.1998.0659; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Mak PJ, 2011, J AM CHEM SOC, V133, P1357, DOI 10.1021/ja105869p; MAURER G, 1982, EUR J DRUG METAB PH, V7, P281, DOI 10.1007/BF03189631; MAURER G, 1983, EUR J DRUG METAB PH, V8, P51, DOI 10.1007/BF03189581; Nath A, 2007, J BIOL CHEM, V282, P28309, DOI 10.1074/jbc.M703568200; Niwa T, 2008, CURR DRUG METAB, V9, P453, DOI 10.2174/138920008784746364; PEYRONNEAU MA, 1994, EUR J BIOCHEM, V223, P947, DOI 10.1111/j.1432-1033.1994.tb19072.x; Renaud JP, 1996, BIOCHEM J, V319, P675, DOI 10.1042/bj3190675; Scott EE, 2005, TRENDS BIOCHEM SCI, V30, P5, DOI 10.1016/j.tibs.2004.11.004; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Szklarz GD, 1998, DRUG METAB DISPOS, V26, P1179; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Viner RL, 1995, BIOCHEM BIOPH RES CO, V217, P886, DOI 10.1006/bbrc.1995.2854; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Wrighton SA, 2000, DRUG METAB REV, V32, P339, DOI 10.1081/DMR-100102338; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	32	92	95	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3510	3517		10.1074/jbc.M111.317081	http://dx.doi.org/10.1074/jbc.M111.317081			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157006	Green Published, hybrid			2022-12-25	WOS:000300295100055
J	Forero-Medina, G; Terborgh, J; Socolar, SJ; Pimm, SL				Forero-Medina, German; Terborgh, John; Socolar, S. Jacob; Pimm, Stuart L.			Elevational Ranges of Birds on a Tropical Montane Gradient Lag behind Warming Temperatures	PLOS ONE			English	Article							CLIMATE-CHANGE; SHIFTS; DISTRIBUTIONS; IMPACT	Background: Species may respond to a warming climate by moving to higher latitudes or elevations. Shifts in geographic ranges are common responses in temperate regions. For the tropics, latitudinal temperature gradients are shallow; the only escape for species may be to move to higher elevations. There are few data to suggest that they do. Yet, the greatest loss of species from climate disruption may be for tropical montane species. Methodology/Principal Findings: We repeat a historical transect in Peru and find an average upward shift of 49 m for 55 bird species over a 41 year interval. This shift is significantly upward, but also significantly smaller than the 152 m one expects from warming in the region. To estimate the expected shift in elevation we first determined the magnitude of warming in the locality from historical data. Then we used the temperature lapse rate to infer the required shift in altitude to compensate for warming. The range shifts in elevation were similar across different trophic guilds. Conclusions: Endothermy may provide birds with some flexibility to temperature changes and allow them to move less than expected. Instead of being directly dependent on temperature, birds may be responding to gradual changes in the nature of the habitat or availability of food resources, and presence of competitors. If so, this has important implications for estimates of mountaintop extinctions from climate change.	[Forero-Medina, German; Terborgh, John; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Terborgh, John] Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA; [Socolar, S. Jacob] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	Duke University; Duke University; Swarthmore College	Forero-Medina, G (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	stuartpimm@me.com	Socolar, Jacob/U-9136-2019; pimm, stuart/ABF-1082-2020	Socolar, Jacob/0000-0002-9126-9093; 	German Federal Ministry of the Environment, Nature Conservation and Nuclear Safety; German cooperation; Peruvian ministry of the environment (MINAM); Peruvian National Service for Protected Areas; ECOSIRA; Fulbright-Colciencias-DNP grant; Graduate School at Duke University; Deutsche Gesellschaft fur Internationale Zusammenarbeit	German Federal Ministry of the Environment, Nature Conservation and Nuclear Safety; German cooperation; Peruvian ministry of the environment (MINAM); Peruvian National Service for Protected Areas; ECOSIRA; Fulbright-Colciencias-DNP grant; Graduate School at Duke University; Deutsche Gesellschaft fur Internationale Zusammenarbeit	Data collection was conducted during the Conserving Biodiversity in Peru's Tropical Forests While Fostering Climate Change Mitigation (BMU-GIZ) project, funded by the German Federal Ministry of the Environment, Nature Conservation and Nuclear Safety (BMU), executed by the German cooperation (GIZ), the Peruvian ministry of the environment (MINAM), & the Peruvian National Service for Protected Areas and ECOSIRA. G.F.M. is sponsored by a Fulbright-Colciencias-DNP grant and the Graduate School at Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was partially funded by Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Chambers LE, 2005, EMU, V105, P1, DOI 10.1071/MU04033; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; DIAMOND JM, 1970, P NATL ACAD SCI USA, V67, P529, DOI 10.1073/pnas.67.2.529; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; FEINSINGER P, 1978, AM ZOOL, V18, P779; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Larsen T.H., 2011, CLIMATE CHANGE BIODI; LOISELLE BA, 1992, BIOSCIENCE, V42, P838, DOI 10.2307/1312083; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2005, CLIMATE CHANGE BIODI; Peh KSH, 2007, CONDOR, V109, P437, DOI 10.1650/0010-5422(2007)109[437:PEOCCO]2.0.CO;2; Pimm SL, 2010, CONSERVATION BIOLOGY FOR ALL, P181; Pimm SL, 2009, CURR BIOL, V19, pR595, DOI 10.1016/j.cub.2009.05.055; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; TERBORGH J, 1985, ECOLOGY, V66, P1237, DOI 10.2307/1939177; TERBORGH J, 1975, ECOLOGY, V56, P562, DOI 10.2307/1935491; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335	40	99	105	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28535	10.1371/journal.pone.0028535	http://dx.doi.org/10.1371/journal.pone.0028535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163309	Green Published, Green Submitted, gold			2022-12-25	WOS:000298161900046
J	Fink, P; Pflitsch, C; Marin, K				Fink, Patrick; Pflitsch, Claudia; Marin, Kay			Dietary Essential Amino Acids Affect the Reproduction of the Keystone Herbivore Daphnia pulex	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PREDATOR-INDUCED DIAPAUSE; RESTING-EGG-PRODUCTION; FRESH-WATER; PHOSPHORUS LIMITATION; NUTRIENT LIMITATION; PENAEUS-MONODON; FOOD QUALITY; MAGNA; MARINE	Recent studies have indicated that nitrogen availability can be an important determinant of primary production in freshwater lakes and that herbivore growth can be limited by low dietary nitrogen availability. Furthermore, a lack of specific essential nitrogenous biochemicals (such as essential amino acids) might be another important constraint on the fitness of consumers. This might be of particular importance for cladoceran zooplankton, which can switch between two alternative reproductive strategies - the production of subitaneously developing and resting eggs. Here, we hypothesize that both the somatic growth and the type of reproduction of the aquatic keystone herbivore Daphnia is limited by the availability of specific essential amino acids in the diet. In laboratory experiments, we investigated this hypothesis by feeding a high quality phytoplankton organism (Cryptomonas) and a green alga of moderate nutritional quality (Chlamydomonas) to a clone of Daphnia pulex with and without the addition of essential amino acids. The somatic growth of D. pulex differed between the algae of different nutritional quality, but not dependent on the addition of dissolved amino acids. However, in reproduction experiments, where moderate crowding conditions at saturating food quantities were applied, addition of the essential amino acids arginine and histidine (but not lysine and threonine) increased the total number and the developmental stage of subitaneous eggs. While D. pulex did not produce resting eggs on Cryptomonas, relatively high numbers of resting eggs were released on Chlamydomonas. When arginine and histidine were added to the green algal diet, the production of resting eggs was effectively suppressed. This demonstrates the high, but previously overlooked importance of single essential amino acids for the reproductive strategy of the aquatic keystone herbivore Daphnia.	[Fink, Patrick; Pflitsch, Claudia] Univ Cologne, Cologne Bioctr, Dept Aquat Chem Ecol, D-50931 Cologne, Germany; [Marin, Kay] Univ Cologne, Inst Biochem, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Fink, P (corresponding author), Univ Cologne, Cologne Bioctr, Dept Aquat Chem Ecol, D-50931 Cologne, Germany.	fink@limno.net	Fink, Patrick/A-5901-2009	Fink, Patrick/0000-0002-5927-8977	University of Cologne; Deutsche Forschungsgemeinschaft [FI 1548/4-1]	University of Cologne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the University of Cologne (www.uni-koeln.de) and the Deutsche Forschungsgemeinschaft (www.dfg.de), Grant FI 1548/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusan G, 2007, LIMNOL OCEANOGR, V52, P1724, DOI 10.4319/lo.2007.52.4.1724; AHLGREN G, 1990, J PLANKTON RES, V12, P809, DOI 10.1093/plankt/12.4.809; AHLGREN G, 1992, J PHYCOL, V28, P37, DOI 10.1111/j.0022-3646.1992.00037.x; Alekseev V, 2001, NATURE, V414, P899, DOI 10.1038/414899a; Alekseev VR, 2007, DIAPAUSE AQUATIC INV; Anderson TR, 2004, ECOLOGY, V85, P1193, DOI 10.1890/02-0252; Arbaciauskas K, 2003, FUNCT ECOL, V17, P431, DOI 10.1046/j.1365-2435.2003.00748.x; Caceres CE, 1998, ECOLOGY, V79, P1699, DOI 10.2307/176789; CHEN HY, 1992, MAR BIOL, V114, P229, DOI 10.1007/BF00349523; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fink P, 2006, OIKOS, V115, P484, DOI 10.1111/j.2006.0030-1299.14951.x; Finn RN, 2010, AQUAC RES, V41, P684, DOI 10.1111/j.1365-2109.2009.02220.x; GARDNER WS, 1981, CAN J FISH AQUAT SCI, V38, P157, DOI 10.1139/f81-021; Guisande C, 1999, LIMNOL OCEANOGR, V44, P691, DOI 10.4319/lo.1999.44.3.0691; HARRISON K E, 1990, Journal of Shellfish Research, V9, P1; Innes DJ, 2000, P ROY SOC B-BIOL SCI, V267, P991, DOI 10.1098/rspb.2000.1101; INNES DJ, 1993, J EVOLUTION BIOL, V6, P559, DOI 10.1046/j.1420-9101.1993.6040559.x; JUTTNER F, 1983, J GEN MICROBIOL, V129, P407; Kamjunke N, 2008, LIMNOLOGICA, V38, P360, DOI 10.1016/j.limno.2008.05.002; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; Kleppel GS, 1998, LIMNOL OCEANOGR, V43, P1000, DOI 10.4319/lo.1998.43.5.1000; Koch U, 2009, OECOLOGIA, V159, P317, DOI 10.1007/s00442-008-1216-6; LaFont R, 2000, ECOTOXICOLOGY, V9, P41, DOI 10.1023/A:1008912127592; Lampert W., 2007, LIMNOECOLOGY ECOLOGY, V2; Lurling M, 2003, J PLANKTON RES, V25, P967, DOI 10.1093/plankt/25.8.967; Martin-Creuzburg D, 2008, LIMNOL OCEANOGR, V53, P456, DOI 10.4319/lo.2008.53.2.0456; Millamena OM, 1999, AQUACULTURE, V179, P169, DOI 10.1016/S0044-8486(99)00160-X; Minelli A, 2006, TRENDS ECOL EVOL, V21, P474, DOI 10.1016/j.tree.2006.06.017; Olmstead AW, 2001, J EXP ZOOL, V290, P148, DOI 10.1002/jez.1044; Paland S, 2005, EVOLUTION, V59, P800; Panov Vadim E., 2007, Monographiae Biologicae, V84, P187; Peters R.H., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P193; Prabhakar V, 2010, PLANT CELL, V22, P2594, DOI 10.1105/tpc.109.073171; REDFIELD AC, 1958, AM SCI, V46, P205; Ronnestad I, 1999, AQUACULTURE, V177, P201, DOI 10.1016/S0044-8486(99)00082-4; Ronnestad I, 2003, AQUACULTURE, V227, P147, DOI 10.1016/S0044-8486(03)00500-3; Rosa R, 2005, HYDROBIOLOGIA, V537, P207, DOI 10.1007/s10750-004-2841-7; Rosa R, 2005, COMP BIOCHEM PHYS B, V140, P241, DOI 10.1016/j.cbpc.2004.10.009; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Slusarczyk M, 1999, OECOLOGIA, V119, P159, DOI 10.1007/s004420050772; SLUSARCZYK M, 1995, ECOLOGY, V76, P1008, DOI 10.2307/1939364; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573; STROSS RG, 1965, SCIENCE, V150, P1462, DOI 10.1126/science.150.3702.1462; THRELKELD ST, 1979, LIMNOL OCEANOGR, V24, P601, DOI 10.4319/lo.1979.24.4.0601; Tonheim SK, 2000, AQUACULTURE, V190, P223, DOI 10.1016/S0044-8486(00)00402-6; von Elert E, 2003, P ROY SOC B-BIOL SCI, V270, P1209, DOI 10.1098/rspb.2003.2357; von Elert E, 2002, LIMNOL OCEANOGR, V47, P1764, DOI 10.4319/lo.2002.47.6.1764; Wacker A, 2001, ECOLOGY, V82, P2507, DOI 10.2307/2679932; Wojewodzic MW, 2011, FUNCT ECOL, V25, P1154, DOI 10.1111/j.1365-2435.2011.01864.x; Zaffagnini F., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P245	51	35	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28498	10.1371/journal.pone.0028498	http://dx.doi.org/10.1371/journal.pone.0028498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22163027	Green Published, gold			2022-12-25	WOS:000298172800042
J	Iriyama, A; Oba, M; Ishii, T; Nishiyama, N; Kataoka, K; Tamaki, Y; Yanagi, Y				Iriyama, Aya; Oba, Makoto; Ishii, Takehiko; Nishiyama, Nobuhiro; Kataoka, Kazunori; Tamaki, Yasuhiro; Yanagi, Yasuo			Gene Transfer Using Micellar Nanovectors Inhibits Choroidal Neovascularization In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; FACTOR RECEPTOR; POLYPLEX NANOMICELLES; RANIBIZUMAB; THERAPY; PEGAPTANIB; CELLS; RATS; SUPPRESSION	Purpose: Age-related macular degeneration caused by choroidal neovascularization (CNV) remains difficult to be treated despite the recent advent of several treatment options. In this study, we investigated the in vivo angiogenic control by intravenous injection of polyion complex (PIC) micelle encapsulating plasmid DNA (pDNA) using a mice CNV model. Methods: The transfection efficiency of the PIC micelle was investigated using the laser-induced CNV in eight-week-old male C57 BJ/6 mice. Firstly, each mouse received intravenous injection of micelle encapsulating pDNA of Yellow Fluorescent Protein (pYFP) on days 1,3 and 5. The expression of YFP was analyzed using fluorescein microscopy and western blotting analysis. In the next experiments, each mouse received intravenous injection of micelle encapsulating pDNA of soluble Fms-like tyrosine kinase-1 (psFlt-1) 1,3 and 5 days after the induction of CNV and the CNV lesion was analyzed by choroidal flatmounts on day 7. Results: Fluorescein microscopy and western blotting analysis revealed that the expression of YFP was confirmed in the CNV area after injection of the PIC micelle, but the expression was not detected neither in mice that received naked pDNA nor those without CNV. Furthermore, the CNV area in the mice that received intravenous injection of the psFlt-1-encapsulated PIC micelle was significantly reduced by 65% compared to that in control mice (p<0.01). Conclusions: Transfection of sFlt-1 with the PIC micelle by intravenous injection to mice CNV models showed significant inhibition of CNV. The current results revealed the significant potential of nonviral gene therapy for regulation of CNV using the PIC micelle encapsulating pDNA.	[Iriyama, Aya] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; [Iriyama, Aya; Tamaki, Yasuhiro; Yanagi, Yasuo] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan; [Oba, Makoto] Univ Tokyo, Dept Clin Vasc Regenerat, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Ishii, Takehiko; Kataoka, Kazunori] Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo, Japan; [Nishiyama, Nobuhiro; Kataoka, Kazunori] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Kataoka, Kazunori] Univ Tokyo, Dept Mat Engn, Grad Sch Engn, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Iriyama, A (corresponding author), Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan.	akagi-tky@umin.ac.jp	Kataoka, Kazunori/K-7108-2012; Yanagi, Yasuo/AAA-5441-2022; Nishiyama, Nobuhiro/F-1867-2014; Yanagi, Yasuo/AAF-2670-2020	Kataoka, Kazunori/0000-0002-8591-413X; Nishiyama, Nobuhiro/0000-0002-6886-9357; Oba, Makoto/0000-0002-3691-3608; Yanagi, Yasuo/0000-0002-0362-7285	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work is supported in part by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2006, OPHTHALMOLOGY, V113, P1508, DOI 10.1016/j.ophtha.2006.02.064; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Harada-Shiba M, 2009, MOL THER, V17, P1180, DOI 10.1038/mt.2009.63; Honda M, 2000, GENE THER, V7, P978, DOI 10.1038/sj.gt.3301203; Hoshida T, 2002, PANCREAS, V25, P111, DOI 10.1097/00006676-200208000-00001; Ideta R, 2004, FEBS LETT, V557, P21, DOI 10.1016/S0014-5793(03)01315-2; Ideta R, 2005, NANO LETT, V5, P2426, DOI 10.1021/nl051679d; Iriyama AUT, 2011, CORNEA; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; Iriyama A, 2007, BRIT J OPHTHALMOL, V91, P1230, DOI 10.1136/bjo.2007.117309; Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218; Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850, DOI 10.1016/j.ajo.2007.08.012; Kanayama N, 2006, CHEMMEDCHEM, V1, P439, DOI 10.1002/cmdc.200600008; Maclachlan TK, 2010, MOL THER; Mendrinos E, 2009, INVEST OPHTHALMOL VI; Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g; Murakami Y, 2010, HUM GENE THER, V21, P199, DOI 10.1089/hum.2009.102; Papadopoulou DN, 2009, OPHTHALMOLOGY, V116, P1755, DOI 10.1016/j.ophtha.2009.03.017; Rosenfeld Philip J, 2006, Ophthalmol Clin North Am, V19, P361; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sacu S, 2010, INVEST OPHTHALMOL VI; Schwesinger C, 2001, AM J PATHOL, V158, P1161, DOI 10.1016/S0002-9440(10)64063-1; Takahashi H, 2008, INVEST OPHTH VIS SCI, V49, P2143, DOI 10.1167/iovs.07-0523; Takahashi H, 2008, CURR EYE RES, V33, P1002, DOI 10.1080/02713680802492440; Takayama K, 2000, CANCER RES, V60, P2169; Takeda AL, 2007, BRIT J OPHTHALMOL, V91, P1177, DOI 10.1136/bjo.2007.118562; Tunon J, 2009, SURV OPHTHALMOL, V54, P339, DOI 10.1016/j.survophthal.2009.02.003; Wormald R., 2000, COCHRANE DB SYST REV; Yasukawa T, 1999, INVEST OPHTH VIS SCI, V40, P2690	34	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2011	6	12							e28560	10.1371/journal.pone.0028560	http://dx.doi.org/10.1371/journal.pone.0028560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NX	22162776	Green Published, Green Submitted, gold			2022-12-25	WOS:000298172800047
J	Ahmad, I; Lamprokostopoulou, A; Le Guyon, S; Streck, E; Barthel, M; Peters, V; Hardt, WD; Romling, U				Ahmad, Irfan; Lamprokostopoulou, Agaristi; Le Guyon, Soazig; Streck, Elena; Barthel, Melanie; Peters, Verena; Hardt, Wolf-Dieter; Romling, Ute			Complex c-di-GMP Signaling Networks Mediate Transition between Virulence Properties and Biofilm Formation in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							GGDEF DOMAIN PROTEINS; CYCLIC DIGUANYLATE; III SECRETION; PHOSPHODIESTERASES REVEALS; MULTICELLULAR BEHAVIOR; ALLOSTERIC CONTROL; RDAR MORPHOTYPE; ANIMAL-MODELS; IDENTIFICATION; CELLULOSE	Upon Salmonella enterica serovar Typhimurium infection of the gut, an early line of defense is the gastrointestinal epithelium which senses the pathogen and intrusion along the epithelial barrier is one of the first events towards disease. Recently, we showed that high intracellular amounts of the secondary messenger c-di-GMP in S. typhimurium inhibited invasion and abolished induction of a pro-inflammatory immune response in the colonic epithelial cell line HT-29 suggesting regulation of transition between biofilm formation and virulence by c-di-GMP in the intestine. Here we show that highly complex c-di-GMP signaling networks consisting of distinct groups of c-di-GMP synthesizing and degrading proteins modulate the virulence phenotypes invasion, IL-8 production and in vivo colonization in the streptomycin-treated mouse model implying a spatial and timely modulation of virulence properties in S. typhimurium by c-di-GMP signaling. Inhibition of the invasion and IL-8 induction phenotype by c-di-GMP (partially) requires the major biofilm activator CsgD and/or BcsA, the synthase for the extracellular matrix component cellulose. Inhibition of the invasion phenotype is associated with inhibition of secretion of the type three secretion system effector protein SipA, which requires c-di-GMP metabolizing proteins, but not their catalytic activity. Our findings show that c-di-GMP signaling is at least equally important in the regulation of Salmonella-host interaction as in the regulation of biofilm formation at ambient temperature.	[Ahmad, Irfan; Lamprokostopoulou, Agaristi; Le Guyon, Soazig; Streck, Elena; Peters, Verena; Romling, Ute] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Barthel, Melanie; Hardt, Wolf-Dieter] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Karolinska Institutet; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ahmad, I (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	Ute.Romling@ki.se	Lamprokostopoulou, Agaristi/ABE-4406-2021; Ahmad, Irfan/C-6523-2019	Lamprokostopoulou, Agaristi/0000-0002-6786-4407; Romling, Ute/0000-0003-3812-6621; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Le Guyon, Soazig/0000-0001-9447-9777	European Commission [MEST-CT-2004-008475]; Petrus and Augusta Hedlund Stiftelse and Vetenskapsradet [621-2004-3979]; Higher Education Commission in Pakistan	European Commission(European CommissionEuropean Commission Joint Research Centre); Petrus and Augusta Hedlund Stiftelse and Vetenskapsradet; Higher Education Commission in Pakistan(Higher Education Commission of Pakistan)	This work was supported by the European Commission under contract number MEST-CT-2004-008475, and the Petrus and Augusta Hedlund Stiftelse and Vetenskapsradet (621-2004-3979). Irfan Ahmad receives a scholarship from the Higher Education Commission in Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bobrov AG, 2011, MOL MICROBIOL, V79, P533, DOI 10.1111/j.1365-2958.2010.07470.x; BOYD JF, 1985, GUT, V26, P935, DOI 10.1136/gut.26.9.935; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Ehrbar K, 2002, INT J MED MICROBIOL, V291, P479; FINLAY BB, 1989, J CELL SCI, P99; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Geddes K, 2007, PLOS PATHOG, V3, P2017, DOI 10.1371/journal.ppat.0030196; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gerstel U, 2001, ENVIRON MICROBIOL, V3, P638, DOI 10.1046/j.1462-2920.2001.00235.x; Hanisch J, 2010, CELL MICROBIOL, V12, P84, DOI 10.1111/j.1462-5822.2009.01380.x; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Hornef MW, 2008, CURR OPIN INFECT DIS, V21, P304, DOI 10.1097/QCO.0b013e3282f88ba3; Hurley BP, 2003, TRENDS MICROBIOL, V11, P562, DOI 10.1016/j.tim.2003.10.002; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Kumagai Y, 2010, J BACTERIOL, V192, P4122, DOI 10.1128/JB.00132-10; Lamprokostopoulou A, 2010, ENVIRON MICROBIOL, V12, P40, DOI 10.1111/j.1462-2920.2009.02032.x; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Lim B, 2007, J BACTERIOL, V189, P717, DOI 10.1128/JB.00834-06; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Misselwitz B, 2011, INFECT IMMUN, V79, P330, DOI 10.1128/IAI.00581-10; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Ogasawara H, 2011, J BACTERIOL, V193, P2587, DOI 10.1128/JB.01468-10; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 2009, J BACTERIOL, V191, P4697, DOI 10.1128/JB.00651-09; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, VIRULENCE, V1, P404, DOI 10.4161/viru.1.5.12704; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Simm R, 2009, ANAL BIOCHEM, V386, P53, DOI 10.1016/j.ab.2008.12.013; Simm R, 2007, J BACTERIOL, V189, P3613, DOI 10.1128/JB.01719-06; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; Srikanth CV, 2010, SCIENCE, V330, P390, DOI 10.1126/science.1194598; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; White AP, 2008, INFECT IMMUN, V76, P1048, DOI 10.1128/IAI.01383-07; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zakikhany K, 2010, TYPHIMURIUM MOL MICR, V77, P771	66	66	68	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28351	10.1371/journal.pone.0028351	http://dx.doi.org/10.1371/journal.pone.0028351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164276	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400077
J	Buscariollo, DL; Breuer, GA; Wendler, CC; Rivkees, SA				Buscariollo, Daniela L.; Breuer, Gregory A.; Wendler, Christopher C.; Rivkees, Scott A.			Caffeine Acts via A1 Adenosine Receptors to Disrupt Embryonic Cardiac Function	PLOS ONE			English	Article							FETAL HEART-RATE; BLOOD-FLOW; IN-VIVO; SPONTANEOUS-ABORTION; DEVELOPING CHICK; A(1) RECEPTOR; MOUSE EMBRYOS; BIRTH-WEIGHT; LONG-TERM; HYPOXIA	Background: Evidence suggests that adenosine acts via cardiac A1 adenosine receptors (A1ARs) to protect embryos against hypoxia. During embryogenesis, A1ARs are the dominant regulator of heart rate, and A1AR activation reduces heart rate. Adenosine action is inhibited by caffeine, which is widely consumed during pregnancy. In this study, we tested the hypothesis that caffeine influences developing embryos by altering cardiac function. Methodology/Principal Findings: Effects of caffeine and adenosine receptor-selective antagonists on heart rate were studied in vitro using whole murine embryos at E9.5 and isolated hearts at E12.5. Embryos were examined in room air (21% O-2) or hypoxic (2% O-2) conditions. Hypoxia decreased heart rates of E9.5 embryos by 15.8% and in E12.5 isolated hearts by 27.1%. In room air, caffeine (200 mu M) had no effect on E9.5 heart rates; however, caffeine increased heart rates at E12.5 by 37.7%. Caffeine abolished hypoxia-mediated bradycardia at E9.5 and blunted hypoxia-mediated bradycardia at E12.5. Real-time PCR analysis of RNA from isolated E9.5 and E12.5 hearts showed that A1AR and A2aAR genes were expressed at both ages. Treatment with adenosine receptor-selective antagonists revealed that SCH-58261 (A2aAR-specific antagonist) had no affects on heart function, whereas DPCPX (A1AR-specific antagonist) had effects similar to caffeine treatment at E9.5 and E12.5. At E12.5, embryonic hearts lacking A1AR expression (A1AR-/-) had elevated heart rates compared to A1AR+/- littermates, A1AR-/- heart rates failed to decrease to levels comparable to those of controls. Caffeine did not significantly affect heart rates of A1AR-/- embryos. Conclusions/Significance: These data show that caffeine alters embryonic cardiac function and disrupts the normal cardiac response to hypoxia through blockade of A1AR action. Our results raise concern for caffeine exposure during embryogenesis, particularly in pregnancies with increased risk of embryonic hypoxia.	[Buscariollo, Daniela L.; Breuer, Gregory A.; Wendler, Christopher C.; Rivkees, Scott A.] Yale Univ, Sch Med, Dept Pediat, Sect Dev Endocrinol & Biol,Yale Child Hlth Res Ct, New Haven, CT 06510 USA	Yale University	Buscariollo, DL (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Dev Endocrinol & Biol,Yale Child Hlth Res Ct, New Haven, CT 06510 USA.	scott.rivkees@yale.edu		Breuer, Gregory/0000-0002-7830-3250	National Institutes of Health [R01HD058086-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grant R01HD058086-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PAW, 1986, J PHYSIOL-LONDON, V372, P557, DOI 10.1113/jphysiol.1986.sp016025; Bennet L, 2009, CLIN PERINATOL, V36, P655, DOI 10.1016/j.clp.2009.06.009; Browne ML, 2006, EPIDEMIOLOGY, V17, P324, DOI 10.1097/01.ede.0000208476.36988.44; CLARK EB, 1989, AM J PHYSIOL, V257, pH55, DOI 10.1152/ajpheart.1989.257.1.H55; Cnattingius S, 2003, FOOD CHEM TOXICOL, V41, P1202, DOI 10.1016/S0278-6915(03)00103-0; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; CUNEO B, 1991, AM J PHYSIOL, V260, pH1864, DOI 10.1152/ajpheart.1991.260.6.H1864; Cuneo B, 1993, AM J PHYSL HEART CIR, P264; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; DEVOE LD, 1993, AM J OBSTET GYNECOL, V168, P1105, DOI 10.1016/0002-9378(93)90353-K; Dunnigan A, 1987, PEDIAT RES, P22; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Franco D, 1997, ANAT REC, V248, P110; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Fredholm BB, 2011, METHYLXANTHINES PREG, P373; Furukawa S, 2007, J OBSTET GYNAECOL RE, V33, P114, DOI 10.1111/j.1447-0756.2007.00499.x; Ghatpande SK, 2008, BIRTH DEFECTS RES A, V82, P121, DOI 10.1002/bdra.20438; Gui YH, 1996, PEDIATR RES, V40, P633, DOI 10.1203/00006450-199610000-00020; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; HOFMAN PL, 1997, AM J PHYSIOL-REG I, V273, pR1374; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Huisman M, 1997, J REPROD MED, V42, P731; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KAUFMAN MH, 1998, ATLAS MOUSE DEV; Keller BB, 1996, CIRC RES, V79, P247, DOI 10.1161/01.RES.79.2.247; Kirby M. L., 2007, CARDIAC DEV; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; Koeppen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006784; Langley-Evans SC, 1998, NUTRITION, V14, P39, DOI 10.1016/S0899-9007(97)00391-2; LARROQUE B, 1993, AM J EPIDEMIOL, V137, P941, DOI 10.1093/oxfordjournals.aje.a116764; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Linden J, 2011, ADV PHARMACOL, V61, P95, DOI 10.1016/B978-0-12-385526-8.00004-7; MacLennan MJ, 1999, ULTRASOUND MED BIOL, V25, P361, DOI 10.1016/S0301-5629(98)00147-1; MCGOWAN J, 1987, AM J OBSTET GYNECOL, V157, P726, DOI 10.1016/S0002-9378(87)80038-8; MERCHIERS EH, 1991, AM J OBSTET GYNECOL, V165, P11, DOI 10.1016/0002-9378(91)90214-C; Miller CE, 2003, AM J PHYSIOL-HEART C, V285, pH1849, DOI 10.1152/ajpheart.00384.2002; MILLER RC, 1994, AM J PERINAT, V11, P132, DOI 10.1055/s-2007-994573; Miller SL, 2002, AM J OBSTET GYNECOL, V186, P261, DOI 10.1067/mob.2002.119629; Momoi N, 2008, AM J PHYSIOL-HEART C, V294, pH2248, DOI 10.1152/ajpheart.91469.2007; Mulder EJH, 2010, J PSYCHOPHARMACOL, V24, P1641, DOI 10.1177/0269881109106310; Ohta A, 2009, CURR OPIN PHARMACOL, V9, P501, DOI 10.1016/j.coph.2009.05.005; PAPPANO AJ, 1977, PHARMACOL REV, V29, P3; Patterson AJ, 2010, CURR MOL MED, V10, P653; Porter GA, 2001, AM J PHYSIOL-REG I, V281, pR401, DOI 10.1152/ajpregu.2001.281.2.R401; Poulsen SA, 1998, BIOORGAN MED CHEM, V6, P619, DOI 10.1016/S0968-0896(98)00038-8; RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0; RESCH BA, 1987, ZBL GYNAKOL, V109, P945; RESCH BA, 1985, ZBL GYNAKOL, V107, P1249; RIVKEES SA, 1995, DEV BRAIN RES, V89, P202, DOI 10.1016/0165-3806(95)00120-3; Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf; SALVADOR HS, 1989, AM J OBSTET GYNECOL, V160, P1043, DOI 10.1016/0002-9378(89)90157-9; Sedmera D, 2002, AM J PHYSIOL-REG I, V283, pR379, DOI 10.1152/ajpregu.00534.2001; Severi FM, 2000, FETAL DIAGN THER, V15, P8, DOI 10.1159/000020969; Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7; Tanaka N, 1997, AM J PHYSIOL-HEART C, V273, pH1368, DOI 10.1152/ajpheart.1997.273.3.H1368; Tobita K, 2005, ANAT REC PART A, V283A, P193, DOI 10.1002/ar.a.20133; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Wendler CC, 2006, DEV BIOL, V291, P264, DOI 10.1016/j.ydbio.2005.12.013; Wendler CC, 2007, P NATL ACAD SCI USA, V104, P9697, DOI 10.1073/pnas.0703557104; Wendler CC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-57; Wendler CC, 2009, FASEB J, V23, P1272, DOI 10.1096/fj.08-124941; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803; Xiang F, 2010, CLIN EXP PHARMACOL P, V37, P343, DOI 10.1111/j.1440-1681.2009.05300.x; Yang JN, 2009, J APPL PHYSIOL, V106, P631, DOI 10.1152/japplphysiol.90971.2008; Zhang LB, 2005, J SOC GYNECOL INVEST, V12, P2, DOI 10.1016/j.jsgi.2004.09.004	68	19	21	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28296	10.1371/journal.pone.0028296	http://dx.doi.org/10.1371/journal.pone.0028296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164264	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400065
J	Guerra, C; Morris, D; Sipin, A; Kung, S; Franklin, M; Gray, D; Tanzil, M; Guilford, F; Khasawneh, FT; Venketaraman, V				Guerra, Carlos; Morris, Devin; Sipin, Andrea; Kung, Steven; Franklin, Mesharee; Gray, Dennis; Tanzil, Michelle; Guilford, Frederick; Khasawneh, Fadi T.; Venketaraman, Vishwanath			Glutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GROWTH-FACTOR-BETA; PULMONARY TUBERCULOSIS; SEROPOSITIVE INDIVIDUALS; LYMPHOCYTES; ACTIVATION; NITROSOGLUTATHIONE; INTERLEUKIN-2; MODULATION; CHEMOKINES	Glutathione (GSH), a tripeptide antioxidant, is essential for cellular homeostasis and plays a vital role in diverse cellular functions. Individuals who are infected with Human immuno deficiency virus (HIV) are known to be susceptible to Mycobacterium tuberculosis (M. tb) infection. We report that by enhancing GSH levels, T-cells are able to inhibit the growth of M. tb inside macrophages. In addition, those GSH-replenished T cell cultures produced increased levels of Interleukin-2 (IL-2), Interleukin-12 (IL-12), and Interferon-gamma (IFN-gamma), cytokines, which are known to be crucial for the control of intracellular pathogens. Our study reveals that T lymphocytes that are derived from HIV infected individuals are deficient in GSH, and that this deficiency correlates with decreased levels of Th1 cytokines and enhanced growth of M. tb inside human macrophages.	[Guerra, Carlos; Gray, Dennis; Tanzil, Michelle; Venketaraman, Vishwanath] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA; [Morris, Devin; Franklin, Mesharee; Gray, Dennis; Tanzil, Michelle; Venketaraman, Vishwanath] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA; [Sipin, Andrea; Kung, Steven] Calif State Polytech Univ Pomona, Pomona, CA 91768 USA; [Guilford, Frederick] Your Energy Syst, Palo Alto, CA USA; [Khasawneh, Fadi T.] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences; California State University System; California State Polytechnic University Pomona; Western University of Health Sciences	Guerra, C (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA.	vvenketaraman@westernu.edu	Gray, Dennis/AAN-1041-2020; venketaraman, Vishwanath/AAW-6945-2020	Gray, Dennis/0000-0001-6692-5848; venketaraman, Vishwanath/0000-0002-2586-1160; Morris, Devin/0000-0002-4602-8987	Western University of Health Sciences; Potts Memorial Foundation	Western University of Health Sciences; Potts Memorial Foundation	The study was supported by start-up funds from Western University of Health Sciences and Potts Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P122; Bahia MS, 2010, CHEM BIOL DRUG DES, V75, P415, DOI 10.1111/j.1747-0285.2010.00950.x; Bautista AP, 2001, FREE RADICAL BIO MED, V31, P1527, DOI 10.1016/S0891-5849(01)00745-6; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; BUHL R, 1989, LANCET, V2, P1294; CLERICI M, 1993, J CLIN INVEST, V91, P759, DOI 10.1172/JCI116294; Dayaram YK, 2006, J BACTERIOL, V188, P1364, DOI 10.1128/JB.188.4.1364-1372.2006; Dobmeyer TS, 1997, FREE RADICAL BIO MED, V22, P775, DOI 10.1016/S0891-5849(96)00403-0; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; FAVIER A, 1994, CHEM-BIOL INTERACT, V91, P165, DOI 10.1016/0009-2797(94)90037-X; Fernandez-Ortega C, 2004, BIOCHEM BIOPH RES CO, V325, P1075, DOI 10.1016/j.bbrc.2004.10.142; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jaruga P, 2002, FREE RADICAL BIO MED, V32, P414, DOI 10.1016/S0891-5849(01)00821-8; Klein SA, 1997, AIDS, V11, P1111, DOI 10.1097/00002030-199709000-00005; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Millman AC, 2008, J INTERFERON CYTOKIN, V28, P1; Osakwe Chukwunomso E, 2010, Roum Arch Microbiol Immunol, V69, P24; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Staal FJT, 1998, EUR J CLIN INVEST, V28, P194; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Venketaraman V, 2005, INFECT IMMUN, V73, P1886, DOI 10.1128/IAI.73.3.1886-1889.2005; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; World Health Organization, 2009, GLOB TUB CONTR EP ST; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	34	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28378	10.1371/journal.pone.0028378	http://dx.doi.org/10.1371/journal.pone.0028378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164280	gold, Green Published, Green Submitted			2022-12-25	WOS:000298171400081
J	Hundahl, CA; Luuk, H; Ilmjarv, S; Falktoft, B; Raida, Z; Vikesaa, J; Friis-Hansen, L; Hay-Schmidt, A				Hundahl, Christian Ansgar; Luuk, Hendrik; Ilmjaerv, Sten; Falktoft, Birgitte; Raida, Zindy; Vikesaa, Jonas; Friis-Hansen, Lennart; Hay-Schmidt, Anders			Neuroglobin-Deficiency Exacerbates Hif1A and c-FOS Response, but Does Not Affect Neuronal Survival during Severe Hypoxia In Vivo	PLOS ONE			English	Article							GENE-EXPRESSION; PROTECTS NEURONS; MESSENGER-RNA; BRAIN; CYTOGLOBIN; BINDING; GLOBIN; OXYGEN; ADAPTATION; STRESS	Background: Neuroglobin (Ngb), a neuron-specific globin that binds oxygen in vitro, has been proposed to play a key role in neuronal survival following hypoxic and ischemic insults in the brain. Here we address whether Ngb is required for neuronal survival following acute and prolonged hypoxia in mice genetically Ngb-deficient (Ngb-null). Further, to evaluate whether the lack of Ngb has an effect on hypoxia-dependent gene regulation, we performed a transcriptome-wide analysis of differential gene expression using Affymetrix Mouse Gene 1.0 ST arrays. Differential expression was estimated by a novel data analysis approach, which applies non-parametric statistical inference directly to probe level measurements. Principal Findings: Ngb-null mice were born in expected ratios and were normal in overt appearance, home-cage behavior, reproduction and longevity. Ngb deficiency had no effect on the number of neurons, which stained positive for surrogate markers of endogenous Ngb-expressing neurons in the wild-type (wt) and Ngb-null mice after 48 hours hypoxia. However, an exacerbated hypoxia-dependent increase in the expression of c-FOS protein, an immediate early transcription factor reflecting neuronal activation, and increased expression of Hif1A mRNA were observed in Ngb-null mice. Large-scale gene expression analysis identified differential expression of the glycolytic pathway genes after acute hypoxia in Ngb-null mice, but not in the wts. Extensive hypoxia-dependent regulation of chromatin remodeling, mRNA processing and energy metabolism pathways was apparent in both genotypes. Significance: According to these results, it appears unlikely that the loss of Ngb affects neuronal viability during hypoxia in vivo. Instead, Ngb-deficiency appears to enhance the hypoxia-dependent response of Hif1A and c-FOS protein while also altering the transcriptional regulation of the glycolytic pathway. Bioinformatic analysis of differential gene expression yielded novel predictions suggesting that chromatin remodeling and mRNA metabolism are among the key regulatory mechanisms when adapting to prolonged hypoxia.	[Hundahl, Christian Ansgar; Luuk, Hendrik; Falktoft, Birgitte] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Luuk, Hendrik; Ilmjaerv, Sten] Univ Tartu, Dept Physiol, EE-50090 Tartu, Estonia; [Ilmjaerv, Sten] Quretec Ltd, Tartu, Estonia; [Raida, Zindy; Hay-Schmidt, Anders] Univ Copenhagen, Dept Neurosci & Pharmacol, Fac Hlth Sci, Copenhagen, Denmark; [Vikesaa, Jonas; Friis-Hansen, Lennart] Univ Copenhagen, Rigshosp, Dept Genom Med, DK-2100 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Tartu; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hundahl, CA (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Clin Biochem, Copenhagen, Denmark.	c.hundahl@gmail.com; hendrik.luuk@gmail.com; a.hay@sund.ku.dk	Luuk, Hendrik/AAI-7945-2021; Hundahl, Christian Ansgar/H-3938-2015	Friis-Hansen, Lennart/0000-0002-7222-0163; Luuk, Hendrik/0000-0001-6104-4021	Lundbeck Foundation; Novo Nordisk Foundation; King Christian the Xth Foundation; Simon Fougner Hartmanns Family Foundation; Fonden til Laegevidenskabens Fremme; Lundbeck Foundation [R77-2010-7108] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); King Christian the Xth Foundation; Simon Fougner Hartmanns Family Foundation; Fonden til Laegevidenskabens Fremme; Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Lundbeck Foundation, The Novo Nordisk Foundation, King Christian the Xth Foundation, Simon Fougner Hartmanns Family Foundation and Fonden til Laegevidenskabens Fremme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor TA, 2011, J BIOL CHEM, V286, P4718, DOI 10.1074/jbc.M110.115931; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Fordel E, 2004, BIOCHEM BIOPH RES CO, V319, P342, DOI 10.1016/j.bbrc.2004.05.010; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1317, DOI 10.1097/01.WCB.0000141558.40491.75; Horn EM, 2000, NEUROSCIENCE, V99, P711, DOI 10.1016/S0306-4522(00)00221-9; Hundahl C, 2005, NEUROPATH APPL NEURO, V31, P610, DOI 10.1111/j.1365-2990.2005.00657.x; Hundahl CA, 2010, J COMP NEUROL, V518, P1556, DOI 10.1002/cne.22290; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P183, DOI 10.1159/000135617; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P173, DOI 10.1159/000129698; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Johnson AB, 2007, MUTAT RES-FUND MOL M, V618, P149, DOI 10.1016/j.mrfmmm.2006.10.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Li Q, 2009, BIOCHIMIE, V91, P1307, DOI 10.1016/j.biochi.2009.07.001; Li RC, 2006, BRAIN RES, V1096, P173, DOI 10.1016/j.brainres.2006.04.063; Li RC, 2010, J CEREBR BLOOD F MET, V30, P1874, DOI 10.1038/jcbfm.2010.90; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Masuda K, 2009, J CELL MOL MED, V13, P2759, DOI 10.1111/j.1582-4934.2009.00842.x; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rodriguez-Enriquez S, 2010, INT J BIOCHEM CELL B, V42, P1744, DOI 10.1016/j.biocel.2010.07.010; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Teppema LJ, 1997, J COMP NEUROL, V388, P169, DOI 10.1002/(SICI)1096-9861(19971117)388:2<169::AID-CNE1>3.0.CO;2-#; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	54	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28160	10.1371/journal.pone.0028160	http://dx.doi.org/10.1371/journal.pone.0028160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164238	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400039
J	Kadota, M; White, EJ; Torisawa, S; Komeyama, K; Takagi, T				Kadota, Minoru; White, Eric J.; Torisawa, Shinsuke; Komeyama, Kazuyoshi; Takagi, Tsutomu			Employing Relative Entropy Techniques for Assessing Modifications in Animal Behavior	PLOS ONE			English	Article							TUNA THUNNUS-THYNNUS; PHYSIOLOGY	In order to make quantitative statements regarding behavior patterns in animals, it is important to establish whether new observations are statistically consistent with the animal's equilibrium behavior. For example, traumatic stress from the presence of a telemetry transmitter may modify the baseline behavior of an animal, which in turn can lead to a bias in results. From the perspective of information theory such a bias can be interpreted as the amount of information gained from a new measurement, relative to an existing equilibrium distribution. One important concept in information theory is the relative entropy, from which we develop a framework for quantifying time-dependent differences between new observations and equilibrium. We demonstrate the utility of the relative entropy by analyzing observed speed distributions of Pacific bluefin tuna, recorded within a 48-hour time span after capture and release. When the observed and equilibrium distributions are Gaussian, we show that the tuna's behavior is modified by traumatic stress, and that the resulting modification is dominated by the difference in central tendencies of the two distributions. Within a 95% confidence level, we find that the tuna's behavior is significantly altered for approximately 5 hours after release. Our analysis reveals a periodic fluctuation in speed corresponding to the moment just before sunrise on each day, a phenomenon related to the tuna's daily diving pattern that occurs in response to changes in ambient light.	[Kadota, Minoru; Torisawa, Shinsuke; Takagi, Tsutomu] Kinki Univ, Fac Agr, Dept Fisheries, Naka, Ibaraki, Japan; [White, Eric J.] Univ Cincinnati, Dept Phys, Cincinnati, OH 45221 USA; [Komeyama, Kazuyoshi] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan	Kindai University (Kinki University); University System of Ohio; University of Cincinnati; Kagoshima University	Kadota, M (corresponding author), Kinki Univ, Fac Agr, Dept Fisheries, Naka, Ibaraki, Japan.	kadota@cims.nyu.edu	Torisawa, Shinsuke/A-9704-2010; Takagi, Tsutomu/AAC-8250-2022	Torisawa, Shinsuke/0000-0002-5060-2128; 	Kinki University; International education and research center for aquaculture science of bluefin tuna and other cultured fish under the Global COE; Ministry of Education, Culture, Science, Sport and Technology, Japan [80399097]; Japan Society for the Promotion of Science [21880047]	Kinki University; International education and research center for aquaculture science of bluefin tuna and other cultured fish under the Global COE; Ministry of Education, Culture, Science, Sport and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was financially supported by a scientific research grant from Kinki University and the "International education and research center for aquaculture science of bluefin tuna and other cultured fish", under the Global COE Program; a Grant-in-Aid for Scientific Research (no. 80399097) from the Ministry of Education, Culture, Science, Sport and Technology, Japan; and a Grant-in-Aid for Research Activity Start-up (no. 21880047) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J. O., 2013, STAT DECISION THEORY; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; Cover TM, 1991, ELEMENTS INFORM THEO; Gardiner C. W., 1990, HDB STOCHASTIC METHO; Godfrey J, 2003, EFFECTS RADIO TRANSM, P83; Goldman S., 1953, INFORM THEORY; Hawkins P., 2004, MEM NATL I POLAR RES, V58, P58; James MC, 2006, CAN J ZOOL, V84, P754, DOI 10.1139/Z06-046; Kitagawa T, 2004, FISH OCEANOGR, V13, P161, DOI 10.1111/j.1365-2419.2004.00282.x; Kleeman R, 2002, J ATMOS SCI, V59, P2057, DOI 10.1175/1520-0469(2002)059<2057:MDPUUR>2.0.CO;2; Majda A., 2002, METH APPL ANAL, V9, P425, DOI DOI 10.4310/MAA.2002.V9.N3.A8; Masuma S, 2001, FISHERIES SCI, V67, P228, DOI 10.1046/j.1444-2906.2001.00244.x; National Research Council (US), 2003, OC NOIS MAR MAMM, DOI 10.17226/10564; Popper AN, 2003, MAR TECHNOL SOC J, V37, P35, DOI 10.4031/002533203787537050; Reza F M, 1961, INTRO INFORM THEORY; Sardeshmukh PD, 2000, J CLIMATE, V13, P4268, DOI 10.1175/1520-0442(2000)013<4268:COPAWE>2.0.CO;2; Shannon C., 1964, MATH THEORY COMMUNIC; Shannon C. E., 1948, BELL SYST TECH J, V27, P370; U.S. National Research Council, 2000, MAR MAMM LOW FREQ SO; U.S. National Research Council, 2005, MAR MAMM POP OC NOIS; U.S. National Research Council, 1994, LOW FREQ SOUND MAR M; Willis J, 2009, BEHAV ECOL SOCIOBIOL, V64, P57, DOI 10.1007/s00265-009-0818-2; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2	23	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28241	10.1371/journal.pone.0028241	http://dx.doi.org/10.1371/journal.pone.0028241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164249	Green Published, Green Submitted, gold			2022-12-25	WOS:000298171400050
J	Li, H; Sorenson, AL; Poczobutt, J; Amin, J; Joyal, T; Sullivan, T; Crossno, JT; Weiser-Evans, MCM; Nemenoff, RA				Li, Howard; Sorenson, Amber L.; Poczobutt, Joanna; Amin, Jay; Joyal, Teresa; Sullivan, Timothy; Crossno, Joseph T., Jr.; Weiser-Evans, Mary C. M.; Nemenoff, Raphael A.			Activation of PPAR gamma in Myeloid Cells Promotes Lung Cancer Progression and Metastasis	PLOS ONE			English	Article							RECEPTOR-GAMMA; GENE-EXPRESSION; COLON TUMORS; TARGET; THIAZOLIDINEDIONE; MACROPHAGES; SUPPRESSION; INHIBITION; APOPTOSIS; RAS	Activation of peroxisome proliferator-activated receptor-gamma (PPAR gamma) inhibits growth of cancer cells including non-small cell lung cancer (NSCLC). Clinically, use of thiazolidinediones, which are pharmacological activators of PPAR gamma is associated with a lower risk of developing lung cancer. However, the role of this pathway in lung cancer metastasis has not been examined well. The systemic effect of pioglitazone was examined in two models of lung cancer metastasis in immune-competent mice. In an orthotopic model, murine lung cancer cells implanted into the lungs of syngeneic mice metastasized to the liver and brain. As a second model, cancer cells injected subcutaneously metastasized to the lung. In both models systemic administration of pioglitazone increased the rate of metastasis. Examination of tissues from the orthotopic model demonstrated increased numbers of arginase I-positive macrophages in tumors from pioglitazone-treated animals. In co-culture experiments of cancer cells with bone marrow-derived macrophages, pioglitazone promoted arginase I expression in macrophages and this was dependent on the expression of PPAR gamma in the macrophages. To assess the contribution of PPAR gamma in macrophages to cancer progression, experiments were performed in bone marrow-transplanted animals receiving bone marrow from Lys-M-Cre+/PPAR gamma(flox/flox) mice, in which PPAR gamma is deleted specifically in myeloid cells (PPAR gamma-Mac(neg)), or control PPAR gamma(flox/flox) mice. In both models, mice receiving PPAR gamma-Mac(neg) bone marrow had a marked decrease in secondary tumors which was not significantly altered by treatment with pioglitazone. This was associated with decreased numbers of arginase I-positive cells in the lung. These data support a model in which activation of PPAR gamma may have opposing effects on tumor progression, with anti-tumorigenic effects on cancer cells, but pro-tumorigenic effects on cells of the microenvironment, specifically myeloid cells.	[Li, Howard; Crossno, Joseph T., Jr.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Sorenson, Amber L.; Poczobutt, Joanna; Amin, Jay; Joyal, Teresa; Weiser-Evans, Mary C. M.; Nemenoff, Raphael A.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Aurora, CO USA; [Sullivan, Timothy; Crossno, Joseph T., Jr.] Univ Colorado, Dept Med, Cardiovasc Pulm Res Lab, Aurora, CO USA; [Li, Howard; Crossno, Joseph T., Jr.] Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Li, H (corresponding author), Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Raphael.Nemenoff@ucdenver.edu	Li, Howard/AAM-3544-2021		NIH [CA103618, CA108610, CA58187]; SPORE on Lung Cancer; NATIONAL CANCER INSTITUTE [P50CA058187, R01CA108610, R01CA103618] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE on Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (CA103618, CA108610, and CA58187), as well as a Pilot Grant from the SPORE on Lung Cancer to Dr. Weiser-Evans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak SP, 2008, MOL IMMUNOL, V46, P258, DOI 10.1016/j.molimm.2008.08.266; Bonfield TL, 2008, J IMMUNOL, V181, P235, DOI 10.4049/jimmunol.181.1.235; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Budde K, 2003, BRIT J CLIN PHARMACO, V55, P368, DOI 10.1046/j.1365-2125.2003.01785.x; Choudhary R, 2010, NEOPLASIA, V12, P224, DOI 10.1593/neo.91638; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; FRANKS LM, 1976, CANCER RES, V36, P1049; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Govindarajan R, 2007, J CLIN ONCOL, V25, P1476, DOI 10.1200/JCO.2006.07.2777; Gupta RA, 2002, AM J PHYSIOL-GASTR L, V283, pG266, DOI 10.1152/ajpgi.00486.2001; Han SW, 2008, PPAR RES, V2008, DOI 10.1155/2008/254108; Heasley LE, 1997, J BIOL CHEM, V272, P14501, DOI 10.1074/jbc.272.23.14501; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li MY, 2010, AM J RESP CELL MOL, V43, P674, DOI 10.1165/rcmb.2009-0349OC; Li MY, 2006, J CELL PHYSIOL, V209, P428, DOI 10.1002/jcp.20738; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2007, BREAST, V16, pS27, DOI 10.1016/j.breast.2007.07.013; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Nemenoff RA, 2007, J THORAC ONCOL, V2, P989, DOI 10.1097/JTO.0b013e318158cf0a; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Oberlies J, 2009, J IMMUNOL, V182, P5259, DOI 10.4049/jimmunol.0803523; Pino MV, 2004, TOXICOL PATHOL, V32, P58, DOI 10.1080/01926230490261320; RICHES DWH, 1988, J IMMUNOL, V141, P180; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Sasaki H, 2002, LUNG CANCER-J IASLC, V36, P71, DOI 10.1016/S0169-5002(01)00449-4; SMITH GJ, 1984, CELL BIOL INT REP, V8, P161, DOI 10.1016/0309-1651(84)90083-3; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Wick M, 2002, MOL PHARMACOL, V62, P1207, DOI 10.1124/mol.62.5.1207; Zou W, 2007, CANCER BIOL THER, V6, P99, DOI 10.4161/cbt.6.1.3555	38	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2011	6	12							e28133	10.1371/journal.pone.0028133	http://dx.doi.org/10.1371/journal.pone.0028133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MQ	22145026	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168900009
J	Zhang, HY; Zhang, L; Gao, B; Fan, H; Jin, JB; Botella, MA; Jiang, LW; Lin, JX				Zhang, Haiyan; Zhang, Liang; Gao, Bin; Fan, Hai; Jin, Jingbo; Botella, Miguel A.; Jiang, Liwen; Lin, Jinxing			Golgi Apparatus-Localized Synaptotagmin 2 Is Required for Unconventional Secretion in Arabidopsis	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR-1; HYGROMYCIN-B INHIBITION; DYNAMIN-LIKE PROTEIN; BREFELDIN-A; SELECTABLE MARKER; PLASMA-MEMBRANE; PREVACUOLAR COMPARTMENTS; ACID-PHOSPHATASE; TRAFFICKING; ENDOCYTOSIS	Background: Most secretory proteins contain signal peptides that direct their sorting to the ER and secreted via the conventional ER/Golgi transport pathway, while some signal-peptide-lacking proteins have been shown to export through ER/Golgi independent secretory pathways. Hygromycin B is an aminoglycoside antibiotic produced by Streptomyces hygroscopicus that is active against both prokaryotic and eukaryotic cells. The hygromycin phosphotransferase (HYG(R)) can phosphorylate and inactivate the hygromycin B, and has been widely used as a positive selective marker in the construction of transgenic plants. However, the localization and trafficking of HYG(R) in plant cells remain unknown. Synaptotagmins (SYTs) are involved in controlling vesicle endocytosis and exocytosis as calcium sensors in animal cells, while their functions in plant cells are largely unclear. Methodology/Principal Findings: We found Arabidopsis synaptotagmin SYT2 was localized on the Golgi apparatus by immunofluorescence and immunogold labeling. Surprisingly, co-expression of SYT2 and HYG(R) caused hypersensitivity of the transgenic Arabidopsis plants to hygromycin B. HYG(R), which lacks a signal sequence, was present in the cytoplasm as well as in the extracellular space in HYG(R)-GFP transgenic Arabidopsis plants and its secretion is not sensitive to brefeldin A treatment, suggesting it is not secreted via the conventional secretory pathway. Furthermore, we found that HYG(R)-GFP was truncated at carboxyl terminus of HYG(R) shortly after its synthesis, and the cells deficient SYT2 failed to efficiently truncate HYGR-GFP, resulting in HYG(R)-GFP accumulated in prevacuoles/vacuoles, indicating that SYT2 was involved in HYG(R)-GFP trafficking and secretion. Conclusion/Significance: These findings reveal for the first time that SYT2 is localized on the Golgi apparatus and regulates HYG(R)-GFP secretion via the unconventional protein transport from the cytosol to the extracelluar matrix in plant cells.	[Zhang, Haiyan; Zhang, Liang; Gao, Bin; Jin, Jingbo; Lin, Jinxing] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China; [Zhang, Liang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Gao, Bin; Fan, Hai] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Botella, Miguel A.] Univ Malaga, Dept Biol Mol Bioquim, E-29071 Malaga, Spain; [Jiang, Liwen] Chinese Univ Hong Kong, Dept Biol, Shatin, Hong Kong, Peoples R China; [Jiang, Liwen] Chinese Univ Hong Kong, Mol Biotechnol Program, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong Normal University; Universidad de Malaga; Chinese University of Hong Kong; Chinese University of Hong Kong	Zhang, HY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China.	linjx@ibcas.ac.cn	JIANG, Liwen/S-6046-2018; Botella, Miguel Ángel/S-3676-2019; Botella, Miguel A/B-5734-2012; Zhang, Haitao/L-7612-2015	JIANG, Liwen/0000-0002-7829-1472; Botella, Miguel Ángel/0000-0002-8867-1831; Botella, Miguel A/0000-0002-8867-1831; Lin, Jinxing/0000-0001-9338-1356; Zhang, Haitao/0000-0003-4879-2951	National Natural Science Foundation of China [90817010, 30770123]; El Ministerio de Cienciae Innovacion [BIO2008-1709]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); El Ministerio de Cienciae Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The National Natural Science Foundation of China, (Granted No. 90817010 and 30770123)(http://www.nsfc.gov.cn/Portal0/default124.htm), and El Ministerio de Cienciae Innovacion (Grant BIO2008-1709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2010, PROTEOMICS, V10, P799, DOI 10.1002/pmic.200900514; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Cabral M, 2010, EUKARYOT CELL, V9, P1009, DOI 10.1128/EC.00337-09; Cheng FY, 2009, PLANTA, V230, P1093, DOI 10.1007/s00425-009-1006-3; Couchy I, 2003, J EXP BOT, V54, P2053, DOI 10.1093/jxb/erg230; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Fukuda M, 2004, J BIOL CHEM, V279, P52677, DOI 10.1074/jbc.M409241200; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Harlow E., 1988, ANTIBODIES LAB MANUA; Hu ZT, 2008, BIOCHEM BIOPH RES CO, V371, P781, DOI 10.1016/j.bbrc.2008.04.174; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kaneko TS, 1996, PLANT CELL REP, V15, P409, DOI 10.1007/BF00232065; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kotzer AM, 2004, J CELL SCI, V117, P6377, DOI 10.1242/jcs.01564; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Lu Y, 2007, J FOOD SCI, V72, pM228, DOI 10.1111/j.1750-3841.2007.00437.x; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; McGaha SM, 2007, ANTIMICROB AGENTS CH, V51, P591, DOI 10.1128/AAC.01116-06; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Neumann U, 2003, ANN BOT-LONDON, V92, P167, DOI 10.1093/aob/mcg134; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; ORCI L, 1991, CELL, V64, P1183; Ortiz JPA, 1996, PLANT CELL REP, V15, P877, DOI 10.1007/BF00231579; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PARDO JM, 1985, J GEN MICROBIOL, V131, P1289; Park JM, 1997, PLANT PHYSIOL, V115, P763, DOI 10.1104/pp.115.2.763; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Pfeffer SR, 2010, J CELL BIOL, V188, P451, DOI 10.1083/jcb.201001121; Pfeiffer W, 1996, PHYSIOL PLANTARUM, V98, P773, DOI 10.1111/j.1399-3054.1996.tb06684.x; PITTENGER RC, 1953, ANTIBIOT CHEMOTHER, V3, P1268; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Schapire AL, 2009, TRENDS PLANT SCI, V14, P645, DOI 10.1016/j.tplants.2009.09.004; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Tian LN, 2000, PLANT CELL REP, V19, P358, DOI 10.1007/s002990050740; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Wang JA, 2010, PLANT CELL, V22, P4009, DOI 10.1105/tpc.110.080697; Wang JQ, 2009, J EXP BOT, V60, P3075, DOI 10.1093/jxb/erp136; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	59	47	51	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e26477	10.1371/journal.pone.0026477	http://dx.doi.org/10.1371/journal.pone.0026477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140429	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163400001
J	Wei, GX; Zhang, YC; Jiang, TZ; Luo, J				Wei, Gaoxia; Zhang, Yuanchao; Jiang, Tianzi; Luo, Jing			Increased Cortical Thickness in Sports Experts: A Comparison of Diving Players with the Controls	PLOS ONE			English	Article							SPATIAL MEMORY DEFICITS; SURFACE-BASED ANALYSIS; GRAY-MATTER DENSITY; BRAIN; CORTEX; MEDITATION; PLASTICITY; NAVIGATION; INTERVENTION; HIPPOCAMPUS	Sports experts represent a population of people who have acquired expertise in sports training and competition. Recently, the number of studies on sports experts has increased; however, neuroanatomical changes following extensive training are not fully understood. In this study, we used cortical thickness measurement to investigate the brain anatomical characteristics of professional divers with extensive training experience. A comparison of the brain anatomical characteristics of the non-athlete group with those of the athlete group revealed three regions with significantly increased cortical thickness in the athlete group. These regions included the left superior temporal sulcus, the right orbitofrontal cortex and the right parahippocampal gyrus. Moreover, a significant positive correlation between the mean cortical thickness of the right parahippocampal gyrus and the training experience was detected, which might indicate the effect of extensive training on diving players' brain structure.	[Wei, Gaoxia; Luo, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Yuanchao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhang, Yuanchao; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Institute of Automation, CAS	Wei, GX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	jiangtz@nlpr.ia.ac.cn; luoj@psych.ac.cn	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X; Wei, Gao-Xia/0000-0002-6350-9096; Peng, Tao/0000-0001-5260-7128	Institute of Psychology [YOCX111S01]; National Basic Research Program of China [2010CB833904]; National Natural Science Foundation of China [30970890, 30770708]; National Hi-Tech Research and Development Program of China [2008AA022604]; Chinese Academy of Sciences [KSCX2-EW-J-8]	Institute of Psychology; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by Young Scientists Fund of Institute of Psychology (Grant NO.: YOCX111S01), National Basic Research Program of China (Grant NO.: 2010CB833904), National Natural Science Foundation of China (Grant NO.: 30970890 and 30770708), National Hi-Tech Research and Development Program of China (Grant NO.: 2008AA022604) and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant NO.: KSCX2-EW-J-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Barrash J, 2000, NEUROPSYCHOLOGIA, V38, P820, DOI 10.1016/S0028-3932(99)00131-1; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davids K., 2006, MOVEMENT SYSTEM VARI; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gaser C, 2003, J NEUROSCI, V23, P9240; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Jacini Wantuir F S, 2009, J Sci Med Sport, V12, P688, DOI 10.1016/j.jsams.2008.11.004; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Kim H, 2007, INT J DEV NEUROSCI, V25, P243, DOI 10.1016/j.ijdevneu.2007.03.003; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lay BS, 2002, HUM MOVEMENT SCI, V21, P807, DOI 10.1016/S0167-9457(02)00166-5; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Pagnoni G, 2007, NEUROBIOL AGING, V28, P1623, DOI 10.1016/j.neurobiolaging.2007.06.008; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Park IS, 2006, J KOREAN MED SCI, V21, P342, DOI 10.3346/jkms.2006.21.2.342; Park IS, 2010, HUMAN MOVEM IN PRESS; Ploner CJ, 2000, CEREB CORTEX, V10, P1211, DOI 10.1093/cercor/10.12.1211; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Starkes JL, 2003, ADV RES SPORT EXPERT, P371; Starkes JL, 2003, RECENT ADV RES SPORT, P49; Ste-Marie DM, 1999, APPL COGNITIVE PSYCH, V13, P269, DOI 10.1002/(SICI)1099-0720(199906)13:3<269::AID-ACP567>3.3.CO;2-P; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Wei GX, 2009, PROG NAT SCI-MATER, V19, P1397, DOI 10.1016/j.pnsc.2008.12.009; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x	55	60	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17112	10.1371/journal.pone.0017112	http://dx.doi.org/10.1371/journal.pone.0017112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	22164266	Green Published, gold, Green Submitted			2022-12-25	WOS:000287392700050
J	Santana, SE; Geipel, I; Dumont, ER; Kalka, MB; Kalko, EKV				Santana, Sharlene E.; Geipel, Inga; Dumont, Elizabeth R.; Kalka, Margareta B.; Kalko, Elisabeth K. V.			All You Can Eat: High Performance Capacity and Plasticity in the Common Big-Eared Bat, Micronycteris microtis (Chiroptera: Phyllostomidae)	PLOS ONE			English	Article							BITE FORCE; FOOD HARDNESS; DIET; ECHOLOCATION; INSECTIVORY; ASSEMBLAGE; EVOLUTION; BEHAVIOR; FOREST; SIZE	Ecological specialization and resource partitioning are expected to be particularly high in the species-rich communities of tropical vertebrates, yet many species have broader ecological niches than expected. In Neotropical ecosystems, Neotropical leaf-nosed bats (Phyllostomidae) are one of the most ecologically and functionally diverse vertebrate clades. Resource partitioning in phyllostomids might be achieved through differences in the ability to find and process food. We selected Micronycteris microtis, a very small (5-7 g) animalivorous phyllostomid, to explore whether broad resource use is associated with specific morphological, behavioral and performance traits within the phyllostomid radiation. We documented processing of natural prey and measured bite force in free-ranging M. microtis and other sympatric phyllostomids. We found that M. microtis had a remarkably broad diet for prey size and hardness. For the first time, we also report the consumption of vertebrates (lizards), which makes M. microtis the smallest carnivorous bat reported to date. Compared to other phyllostomids, M. microtis had the highest bite force for its size and cranial shape and high performance plasticity. Bite force and cranial shape appear to have evolved rapidly in the M. microtis lineage. High performance capacity and high efficiency in finding motionless prey might be key traits that allow M. microtis, and perhaps other species, to successfully co-exist with other gleaning bats.	[Santana, Sharlene E.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA; [Santana, Sharlene E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Geipel, Inga; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Kalka, Margareta B.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ulm University; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Berkeley; Smithsonian Institution; Smithsonian Tropical Research Institute	Santana, SE (corresponding author), Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA.	sesantana@ucla.edu	D, Betsy/ABD-1855-2020; Alfaro, Michael/Q-2113-2017	Eiting, Thomas/0000-0001-8544-0993; Geipel, Inga/0000-0003-3118-2460; Alfaro, Michael/0000-0002-8898-8230	University of Massachusetts; Institute of Experimental Ecology, University of Ulm; DAAD; NSF [IOB 0447616]; European Union	University of Massachusetts; Institute of Experimental Ecology, University of Ulm; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NSF(National Science Foundation (NSF)); European Union(European Commission)	S.E.S. was supported by University of Massachusetts Graduate School Fellowship and travel funds from the Institute of Experimental Ecology, University of Ulm; M.B.K. by a DAAD fellowship; E.R.D. by a NSF grant (IOB 0447616); and G.G. and E.K.V.K. by the European Union project ChiRoPing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Albrecht L, 2007, ACTA THERIOL, V52, P141, DOI 10.1007/BF03194209; Bumrungsri S, 2007, BIOTROPICA, V39, P241, DOI 10.1111/j.1744-7429.2006.00245.x; Dondini G, 2000, J ZOOL, V251, P233, DOI 10.1111/j.1469-7998.2000.tb00606.x; Dumont ER, 1999, J ZOOL, V248, P219, DOI 10.1017/S0952836999006093; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Evans AR, 2005, AUST J ZOOL, V53, P9, DOI 10.1071/ZO04018; FREEMAN PW, 1984, BIOL J LINN SOC, V21, P387, DOI 10.1111/j.1095-8312.1984.tb01601.x; FREEMAN PW, 1979, J MAMMAL, V60, P467, DOI 10.2307/1380088; Geipel I, 2007, PREY DETECTION NEOTR; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Giannini NP, 2005, ACTA CHIROPTEROL, V7, P131, DOI 10.3161/1733-5329(2005)7[131:TGSOAL]2.0.CO;2; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Herrel A, 2008, J EXP BIOL, V211, P86, DOI 10.1242/jeb.012211; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Kalko EKV, 2004, BAT ECHOLOCATION RES, P63; Kalko EKV, 2008, INTEGR COMP BIOL, V48, P60, DOI 10.1093/icb/icn030; Kalko Elisabeth K.V., 1998, P197; MCPEEK MA, 1995, AM NAT, V145, P686, DOI 10.1086/285763; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NORBERG UM, 1988, BIOL J LINN SOC, V33, P383, DOI 10.1111/j.1095-8312.1988.tb00451.x; Paradis E., 2006, APE ANAL PHYLOGENETI; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Santana SE, 2009, J EVOLUTION BIOL, V22, P2131, DOI 10.1111/j.1420-9101.2009.01827.x; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Santana SE, 2011, BIOL J LINN SOC, V102, P1, DOI 10.1111/j.1095-8312.2010.01551.x; Santana SE, 2010, FUNCT ECOL, V24, P776, DOI 10.1111/j.1365-2435.2010.01703.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SIMMONS N.B., 1998, B AM MUSEUM NATURAL, V237; SIMMONS NB, 2004, MAMMAL SPECIES WORLD, P2; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; TOFT CA, 1980, OECOLOGIA, V45, P131, DOI 10.1007/BF00346717; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; van de Sand M, 2004, OKOLOGIE VERHALTEN N; Wetterer AL, 2000, B AM MUS NAT HIST, P4, DOI 10.1206/0003-0090(2000)248<0001:POPBMC>2.0.CO;2; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	43	53	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28584	10.1371/journal.pone.0028584	http://dx.doi.org/10.1371/journal.pone.0028584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	21991371	gold, Green Published			2022-12-25	WOS:000298171400110
J	Zhang, PF; Dong, GH; Sun, BJ; Zhang, LW; Chen, X; Ma, NN; Yu, F; Guo, HM; Huang, H; Lee, YL; Tang, NJ; Chen, J				Zhang, Pengfei; Dong, Guanghui; Sun, Baijun; Zhang, Liwen; Chen, Xi; Ma, Nannan; Yu, Fei; Guo, Huimin; Huang, Hui; Lee, Yungling Leo; Tang, Naijun; Chen, Jie			Long-Term Exposure to Ambient Air Pollution and Mortality Due to Cardiovascular Disease and Cerebrovascular Disease in Shenyang, China	PLOS ONE			English	Article							PARTICULATE MATTER; HEALTH; WOMEN; ASSOCIATIONS; VARIABILITY; ADMISSIONS; DEPOSITION; COMPONENTS; PARTICLES; EDUCATION	Background: The relationship between ambient air pollution exposure and mortality of cardiovascular and cerebrovascular diseases in human is controversial, and there is little information about how exposures to ambient air pollution contribution to the mortality of cardiovascular and cerebrovascular diseases among Chinese. The aim of the present study was to examine whether exposure to ambient-air pollution increases the risk for cardiovascular and cerebrovascular disease. Methodology/Principal Findings: We conducted a retrospective cohort study among humans to examine the association between compound-air pollutants [particulate matter <10 mu m in aerodynamic diameter (PM10), sulfur dioxide (SO2) and nitrogen dioxide (NO2)] and mortality in Shenyang, China, using 12 years of data (1998-2009). Also, stratified analysis by sex, age, education, and income was conducted for cardiovascular and cerebrovascular mortality. The results showed that an increase of 10 mu g/m(3) in a year average concentration of PM10 corresponds to 55% increase in the risk of a death cardiovascular disease (hazard ratio [HR], 1.55; 95% confidence interval [CI], 1.51 to 1.60) and 49% increase in cerebrovascular disease (HR, 1.49; 95% CI, 1.45 to 1.53), respectively. The corresponding figures of adjusted HR (95% CI) for a 10 mu g/m(3) increase in NO2 was 2.46 (2.31 to 2.63) for cardiovascular mortality and 2.44 (2.27 to 2.62) for cerebrovascular mortality, respectively. The effects of air pollution were more evident in female that in male, and nonsmokers and residents with BMI < 18.5 were more vulnerable to outdoor air pollution. Conclusion/Significance: Long-term exposure to ambient air pollution is associated with the death of cardiovascular and cerebrovascular diseases among Chinese populations.	[Zhang, Pengfei; Dong, Guanghui; Ma, Nannan; Yu, Fei; Guo, Huimin; Huang, Hui] China Med Univ, Sch Publ Hlth, Dept Biostat, Shenyang, Peoples R China; [Dong, Guanghui; Chen, Jie] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang, Peoples R China; [Sun, Baijun] Shenyang Ctr Dis Control & Prevent, Shenyang, Peoples R China; [Zhang, Liwen; Chen, Xi; Tang, Naijun] Tianjin Med Univ, Dept Occupat Hlth, Coll Publ Hlth, Tianjin, Peoples R China; [Lee, Yungling Leo] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	China Medical University; China Medical University; Tianjin Medical University; National Taiwan University	Zhang, PF (corresponding author), China Med Univ, Sch Publ Hlth, Dept Biostat, Shenyang, Peoples R China.	chenjie@mail.cmu.edu.cn	Lee, Yungling/S-7011-2018; Dong, Guanghui/AAN-4630-2020	Lee, Yungling/0000-0002-2234-9479; Zhang, Liwen/0000-0002-5077-9732; Dong, Guang-Hui/0000-0002-2578-3369	Welfare Profession of China Environmental Protection Foundation [200709048]	Welfare Profession of China Environmental Protection Foundation	The funding for this study is supported by grants from the Special Scientific Research Fund of Welfare Profession of China Environmental Protection Foundation (200709048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Brauer Michael, 2010, Proc Am Thorac Soc, V7, P111, DOI 10.1513/pats.200908-093RM; Cakmak S, 2006, J OCCUP ENVIRON MED, V48, P89, DOI 10.1097/01.jom.0000184878.11956.4b; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; DOCKERY DW, 1992, ENVIRON RES, V59, P362, DOI 10.1016/S0013-9351(05)80042-8; Filleul L, 2005, OCCUP ENVIRON MED, V62, P453, DOI 10.1136/oem.2004.014746; Finkelstein MM, 2005, J EPIDEMIOL COMMUN H, V59, P481, DOI 10.1136/jech.2004.026203; Frampton MW, 2006, ENVIRON HEALTH PERSP, V114, P51, DOI 10.1289/ehp.7962; Franklin M, 2008, EPIDEMIOLOGY, V19, P680, DOI 10.1097/EDE.0b013e3181812bb7; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; Jerrett M, 2004, J EPIDEMIOL COMMUN H, V58, P31, DOI 10.1136/jech.58.1.31; Jousilahti P, 1996, LANCET, V348, P567, DOI 10.1016/S0140-6736(96)02374-4; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kim CS, 1998, J APPL PHYSIOL, V84, P1834, DOI 10.1152/jappl.1998.84.6.1834; Kim E, 2005, ENVIRON SCI TECHNOL, V39, P4172, DOI 10.1021/es049824x; Kim SB, 2008, J AIR WASTE MANAGE, V58, P965, DOI 10.3155/1047-3289.58.7.965; Kohlhaufl M, 1999, AM J RESP CRIT CARE, V159, P902, DOI 10.1164/ajrccm.159.3.9805036; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Lipfert FW, 2006, INHAL TOXICOL, V18, P645, DOI 10.1080/08958370600742946; Lippmann M, 2006, ENVIRON HEALTH PERSP, V114, P1662, DOI 10.1289/ehp.9150; Lippmann M, 2009, CRIT REV TOXICOL, V39, P865, DOI 10.3109/10408440903300080; Maheswaran R, 2005, STROKE, V36, P239, DOI 10.1161/01.STR.0000151363.71221.12; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Moolgavkar SH, 1996, EPIDEMIOLOGY, V7, P420, DOI 10.1097/00001648-199607000-00014; Nafstad P, 2004, ENVIRON HEALTH PERSP, V112, P610, DOI 10.1289/ehp.6684; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Pererz L, 2009, ENVIRON SCI TECHNOL, V43, P4707, DOI 10.1021/es8031488; POLGAR G, 1979, AM REV RESPIR DIS, V120, P625; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Ren DY, 2004, INT J COAL GEOL, V57, P187, DOI 10.1016/j.coal.2003.10.001; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Toren K, 2007, OCCUP ENVIRON MED, V64, P515, DOI 10.1136/oem.2006.029488; Townend JN, 2005, THORAX, V60, P441, DOI 10.1136/thx.2004.037903; Wong TW, 2002, OCCUP ENVIRON MED, V59, P30, DOI 10.1136/oem.59.1.30; Xu ZY, 2000, ARCH ENVIRON HEALTH, V55, P115, DOI 10.1080/00039890009603397; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; ZHAO DW, 1986, JAPCA J AIR WASTE MA, V36, P371, DOI 10.1080/00022470.1986.10466074	41	125	132	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20827	10.1371/journal.pone.0020827	http://dx.doi.org/10.1371/journal.pone.0020827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	22164211	Green Submitted, gold, Green Published			2022-12-25	WOS:000291612600030
J	He, S; Kato, K; Jiang, J; Wahl, DR; Mineishi, S; Fisher, EM; Murasko, DM; Glick, GD; Zhang, Y				He, Shan; Kato, Koji; Jiang, Jiu; Wahl, Daniel R.; Mineishi, Shin; Fisher, Erin M.; Murasko, Donna M.; Glick, Gary D.; Zhang, Yi			Characterization of the Metabolic Phenotype of Rapamycin-Treated CD8(+) T Cells with Augmented Ability to Generate Long-Lasting Memory Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; HUMAN CEREBRAL GLIOMA; DONOR TH2 CELLS; ENERGY-METABOLISM; MAMMALIAN TARGET; VIRAL-INFECTION; IN-VIVO; RESISTANT PROLIFERATION; PROTECTIVE IMMUNITY; DENDRITIC CELLS	Background: Cellular metabolism plays a critical role in regulating T cell responses and the development of memory T cells with long-term protections. However, the metabolic phenotype of antigen-activated T cells that are responsible for the generation of long-lived memory cells has not been characterized. Design and Methods: Using lymphocytic choriomeningitis virus (LCMV) peptide gp33-specific CD8(+) T cells derived from T cell receptor transgenic mice, we characterized the metabolic phenotype of proliferating T cells that were activated and expanded in vitro in the presence or absence of rapamycin, and determined the capability of these rapamycin-treated T cells to generate long-lived memory cells in vivo. Results: Antigen-activated CD8(+) T cells treated with rapamycin gave rise to 5-fold more long-lived memory T cells in vivo than untreated control T cells. In contrast to that control T cells only increased glycolysis, rapamycin-treated T cells upregulated both glycolysis and oxidative phosphorylation (OXPHOS). These rapamycin-treated T cells had greater ability than control T cells to survive withdrawal of either glucose or growth factors. Inhibition of OXPHOS by oligomycin significantly reduced the ability of rapamycin-treated T cells to survive growth factor withdrawal. This effect of OXPHOS inhibition was accompanied with mitochondrial hyperpolarization and elevation of reactive oxygen species that are known to be toxic to cells. Conclusions: Our findings indicate that these rapamycin-treated T cells may represent a unique cell model for identifying nutrients and signals critical to regulating metabolism in both effector and memory T cells, and for the development of new methods to improve the efficacy of adoptive T cell cancer therapy.	[He, Shan; Kato, Koji; Mineishi, Shin; Zhang, Yi] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Jiang, Jiu; Fisher, Erin M.; Murasko, Donna M.] Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; [Wahl, Daniel R.] Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Glick, Gary D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Drexel University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	He, S (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	yizha@med.umich.edu	He, Shan/C-4989-2015; Ma, Zhonghua/J-6972-2014	Yin, Yanni/0000-0002-0798-3420; Ma, Zhonghua/0000-0002-5426-0997	Damon Runyon-Rachleff Innovation Award; American Cancer Society; NIH [R01 CA102464, R01 AI47450]; National Institutes of Health through the University of Michigan [P30CA46592]; NATIONAL CANCER INSTITUTE [R01CA102464, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047450] Funding Source: NIH RePORTER	Damon Runyon-Rachleff Innovation Award; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the University of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Damon Runyon-Rachleff Innovation Award (YZ), American Cancer Society (YZ) and the NIH [R01 CA102464 (YZ) and R01 AI47450 (GDG)]. This research is supported in part by a grant from the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (P30CA46592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; BENKE PJ, 1991, BIOCHEM MED METAB B, V45, P28, DOI 10.1016/0885-4505(91)90005-6; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DWARAKANATH BS, 1991, INDIAN J BIOCHEM BIO, V28, P203; DWARKANATH BS, 1989, INT J RADIAT ONCOL, V17, P1033, DOI 10.1016/0360-3016(89)90152-1; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kuhnke A, 2003, ANN RHEUM DIS, V62, P133, DOI 10.1136/ard.62.2.133; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mariotti J, 2008, J IMMUNOL, V180, P89, DOI 10.4049/jimmunol.180.1.89; Masopust D, 2007, EUR J IMMUNOL, V37, pS103, DOI 10.1002/eji.200737584; Mehrotra S, 2009, ADV CANCER RES, V102, P197, DOI 10.1016/S0065-230X(09)02006-5; OROURKE AM, 1989, BIOCHIM BIOPHYS ACTA, V1010, P342, DOI 10.1016/0167-4889(89)90059-1; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; SARIBANSOHRABY S, 1983, CANCER RES, V43, P4662; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Slavik JM, 2004, J BIOL CHEM, V279, P910, DOI 10.1074/jbc.M209733200; Slavik JM, 2001, J IMMUNOL, V166, P3201, DOI 10.4049/jimmunol.166.5.3201; Sprent J, 2003, MICROBES INFECT, V5, P227, DOI 10.1016/S1286-4579(03)00015-7; Tejero-Taldo MI, 1999, J MOL CELL CARDIOL, V31, P1863, DOI 10.1006/jmcc.1999.1020; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Thoren FB, 2006, J IMMUNOL, V176, P7301, DOI 10.4049/jimmunol.176.12.7301; WAHL DR, LUPUS; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang Y, 2005, J IMMUNOL, V174, P3051, DOI 10.4049/jimmunol.174.5.3051; Zhang Y, 1998, BLOOD, V92, P118, DOI 10.1182/blood.V92.1.118.413a01_118_128; Zhang Y, 2004, BLOOD, V103, P3970, DOI 10.1182/blood-2003-09-3135; Zhang Y, 2002, J CLIN INVEST, V109, P1335, DOI 10.1172/JCI200214989; Zhao YX, 2008, METHOD ENZYMOL, V442, P439, DOI [10.1016/S0076-0879(08)01422-5, 10.1016/S0076-6879(08)01422-5]; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033	69	101	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20107	10.1371/journal.pone.0020107	http://dx.doi.org/10.1371/journal.pone.0020107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	22140571	gold, Green Submitted, Green Published			2022-12-25	WOS:000290657500043
J	Yu, XY; Chen, HM; Liang, JL; Lin, QX; Tan, HH; Fu, YH; Liu, XY; Shan, ZX; Li, XH; Yang, HZ; Yang, M; Li, YX; Lin, SG				Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Hua-Zhang; Yang, Min; Li, Yangxin; Lin, Shu-Guang			Hyperglycemic Myocardial Damage Is Mediated by Proinflammatory Cytokine: Macrophage Migration Inhibitory Factor	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; COUPLED RECEPTOR KINASES; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DEFICIENT MICE; ATHEROSCLEROSIS; MIF; INFLAMMATION; MECHANISMS; EXPRESSION	Background: Diabetes has been regarded as an inflammatory condition which is associated with left ventricular diastolic dysfunction (LVDD). The purpose of this study was to examine the expression levels of macrophage migration inhibitory factor (MIF) and G protein-coupled receptor kinase 2 (GRK2) in patients with early diabetic cardiomyopathy, and to investigate the mechanisms involved in MIF expression and GRK2 activation. Methods: 83 patients in the age range of 30-64 years with type 2 diabetes and 30 matched healthy men were recruited. Left ventricular diastolic function was evaluated by cardiac Doppler echocardiography. Plasma MIF levels were determined by ELISA. To confirm the clinical observation, we also studied MIF expression in prediabetic rats with impaired glucose tolerance (IGT) and relationship between MIF and GRK2 expression in H9C2 cardiomyoblasts exposed to high glucose. Results: Compared with healthy subjects, patients with diabetes have significantly increased levels of plasma MIF which was further increased in diabetic patients with Left ventricular diastolic dysfunction (LVDD). The increased plasma MIF levels in diabetic patients correlated with plasma glucose, glycosylated hemoglobin and urine albumin levels. We observed a significant number of TUNEL-positive cells in the myocardium of IGT-rats but not in the control rats. Moreover, we found higher MIF expression in the heart of IGT with cardiac dysfunction compared to that of the controls. In H9C2 cardiomyoblast cells, MIF and GRK2 expression was significantly increased in a glucose concentration-dependant manner. Furthermore, GRK2 expression was abolished by siRNA knockdown of MIF and by the inhibition of CXCR4 in H9C2 cells. Conclusions: Our findings indicate that hyperglycemia is a causal factor for increased levels of pro-inflammatory cytokine MIF which plays a role in the development of cardiomyopathy occurring in patients with type 2 diabetes. The elevated levels of MIF are associated with cardiac dysfunction in diabetic patients, and the MIF effects are mediated by GRK2.	[Yu, Xi-Yong; Chen, Hong-Mei; Liang, Jia-Liang; Lin, Qiu-Xiong; Tan, Hong-Hong; Fu, Yong-Heng; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Yang, Min; Lin, Shu-Guang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Cardiovasc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Hong-Mei; Yang, Hua-Zhang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Div Endocrinol, Guangzhou, Guangdong, Peoples R China; [Li, Yangxin] Texas Heart Inst, Houston, TX 77025 USA; [Li, Yangxin] Univ Texas Hlth Sci Ctr, Houston, TX USA	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston	Yu, XY (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Cardiovasc Inst, Med Res Ctr, Guangzhou, Guangdong, Peoples R China.	yuxycn@hotmail.com; yangxin_li@yahoo.com; yuxycn@163.com	LIANG, JIALIANG/L-5865-2015	LIANG, JIALIANG/0000-0001-8033-741X; Liang, Jialiang/0000-0002-1556-7195	National Natural Science Foundation of China [30772142, 81070103, 81070102, 30900610]; National Key Basic Research Program (NKBRP) of China [2006CB503806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program (NKBRP) of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30772142, 81070103, 81070102, 30900610) and the National Key Basic Research Program (NKBRP) of China (No. 2006CB503806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Bacha F, 2009, DIABETES CARE, V32, P100, DOI 10.2337/dc08-1030; Bartels ED, 2009, EUR J CLIN INVEST, V39, P190, DOI 10.1111/j.1365-2362.2009.02086.x; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; Dhanantwari P, 2008, BIOCHEM BIOPH RES CO, V371, P298, DOI 10.1016/j.bbrc.2008.04.070; Garner LB, 2003, AM J PHYSIOL-HEART C, V285, pH2500, DOI 10.1152/ajpheart.00432.2003; Grandi AM, 2006, AM J CARDIOL, V97, P71, DOI 10.1016/j.amjcard.2005.07.110; Hansen JL, 2006, TRENDS CARDIOVAS MED, V16, P169, DOI 10.1016/j.tcm.2006.03.004; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Liang JL, 2010, CLIN EXP PHARMACOL P, V37, P969, DOI 10.1111/j.1440-1681.2010.05420.x; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Schober A, 2004, CIRCULATION, V109, P380, DOI 10.1161/01.CIR.0000109201.72441.09; Suys BE, 2004, DIABETES CARE, V27, P1947, DOI 10.2337/diacare.27.8.1947; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Tevaearai HT, 2004, TRENDS CARDIOVAS MED, V14, P252, DOI 10.1016/j.tcm.2004.07.002; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Willis MS, 2005, AM J PHYSIOL-HEART C, V288, pH795, DOI 10.1152/ajpheart.00189.2004; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025; Yu XY, 2007, J INTERF CYTOK RES, V27, P103, DOI 10.1089/jir.2006.0054	32	81	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e16239	10.1371/journal.pone.0016239	http://dx.doi.org/10.1371/journal.pone.0016239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	22163012	Green Submitted, gold, Green Published			2022-12-25	WOS:000286661400038
J	Santana, SE; Dial, TO; Eiting, TP; Alfaro, ME				Santana, Sharlene E.; Dial, Thomas O.; Eiting, Thomas P.; Alfaro, Michael E.			Roosting Ecology and the Evolution of Pelage Markings in Bats	PLOS ONE			English	Article							FRUIT-EATING BATS; DISRUPTIVE COLORATION; SPERM COMPETITION; ECHOLOCATION; STRIPES; CRYPSIS; DISCRIMINATION; CHIROPTERA; CAMOUFLAGE; PATTERNS	Multiple lineages of bats have evolved striking facial and body pelage makings, including spots, stripes and countershading. Although researchers have hypothesized that these markings mainly evolved for crypsis, this idea has never been tested in a quantitative and comparative context. We present the first comparative study integrating data on roosting ecology (roost type and colony size) and pelage coloration patterns across bats, and explore the hypothesis that the evolution of bat pelage markings is associated with roosting ecologies that benefit from crypsis. We find that lineages that roost in the vegetation have evolved pelage markings, especially stripes and neck collars, which may function in crypsis through disruptive coloration and a type of countershading that might be unique to bats. We also demonstrate that lineages that live in larger colonies and are larger in size tend not to have pelage markings, possibly because of reduced predation pressures due to the predator dilution effect and a lower number of potential predators. Although social functions for pelage color patterns are also possible, our work provides strong support for the idea that roosting ecology has driven the evolution of pelage markings in bats.	[Santana, Sharlene E.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA; [Santana, Sharlene E.; Dial, Thomas O.; Alfaro, Michael E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Eiting, Thomas P.] Univ Massachusetts, Amherst, MA 01003 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Amherst	Santana, SE (corresponding author), Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA.	sesantana@ucla.edu	D, Betsy/ABD-1855-2020; Alfaro, Michael/Q-2113-2017	Eiting, Thomas/0000-0001-8544-0993; Geipel, Inga/0000-0003-3118-2460; Alfaro, Michael/0000-0002-8898-8230	Center for Society and Genetics; National Science Foundation [0918748]	Center for Society and Genetics; National Science Foundation(National Science Foundation (NSF))	Funding was provided by a Center for Society and Genetics (http://socgen.ucla.edu) Postdoctoral Fellowship to SES and National Science Foundation grant 0918748 to MEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham John D., 2005, P280; Baron G, 1996, COMP NEUROBIOLOGY CH; Bates P, 1998, BATS INDIAN SUBCONTI; Behrens RR, 2009, PHILOS T R SOC B, V364, P497, DOI 10.1098/rstb.2008.0250; Bonaccorso FJ, 1998, BATS PAPUA NEW GUINE; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Caro T, 2011, EVOL ECOL, V25, P1231, DOI 10.1007/s10682-011-9479-5; Caro T, 2010, BEHAV ECOL, V21, P78, DOI 10.1093/beheco/arp165; Caro Tim, 2005, pXIII; Clough D, 2009, INT J PRIMATOL, V30, P859, DOI 10.1007/s10764-009-9379-5; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Cott H.B., 1940, ADAPTIVE COLORATION; Csorba G., 2003, HORSESHOE BATS WORLD; Dechmann DKN, 2004, EVOL ECOL RES, V6, P1037; DEFANIS E, 1995, ANIM BEHAV, V49, P835; EDMUNDS M, 1994, BIOL J LINN SOC, V51, P447, DOI 10.1006/bijl.1994.1034; Edmunds M., 1974, DEFENCE ANIMALS; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Ewer RF, 1997, CARNIVORES; Fenton BM, 2008, KOEDOE AFRICAN PROTE, V35, P49; FENTON MB, 1994, ANIM BEHAV, V48, P9, DOI 10.1006/anbe.1994.1207; Frey JK, 2006, J MAMMAL, V87, P1175, DOI 10.1644/05-MAMM-A-374R2.1; Garnett Stephen, 1999, Australian Zoologist, V31, P38; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; GUSTIN MK, 1987, ANIM BEHAV, V35, P13, DOI 10.1016/S0003-3472(87)80205-1; Hodgkison R, 2003, J TROP ECOL, V19, P667, DOI 10.1017/S0266467403006060; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 1998, BEHAV ECOL SOCIOBIOL, V44, P169, DOI 10.1007/s002650050529; Hutson A, 2001, MICROCHIROPTERAN BAT; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kamilar JM, 2011, J ZOOL, V283, P227, DOI 10.1111/j.1469-7998.2010.00765.x; KILTIE RA, 1989, ANIM BEHAV, V38, P542, DOI 10.1016/S0003-3472(89)80048-X; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Kunz T.H., 1982, P1; Kunz TH, 2003, BAT ECOLOGY, P3; LANGEVIN P, 1990, Mammalian Species, P1, DOI 10.2307/3504110; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Majerus M, 1998, MELANISM EVOLUTION A; Marshall Justin, 2011, P186; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Nowak RM, 1994, WALKERS BATS WORLD; Ortolani A, 1999, BIOL J LINN SOC, V67, P433; Plumpton D.L., 1992, Mammalian Species, P1, DOI 10.2307/3504230; Poulton E.B., 1890, COLOURS ANIMALS THEI, DOI [10.1126/science.ns-16.407.286.a, DOI 10.1126/SCIENCE.NS-16.407.286.A]; Reid F., 2009, FIELD GUIDE MAMMALS, V2nd; Safi K, 2003, ANIM BEHAV, V65, P363, DOI 10.1006/anbe.2003.2067; Sandoval CP, 2008, BIOL J LINN SOC, V94, P1, DOI 10.1111/j.1095-8312.2007.00941.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SIMMONS NB, 2004, MAMMAL SPECIES WORLD, P2; Stankowich T, 2011, EVOLUTION, V65, P3090, DOI 10.1111/j.1558-5646.2011.01334.x; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stoner CJ, 2003, BEHAV ECOL, V14, P823, DOI 10.1093/beheco/arg072; TAYLOR PJ, 2000, BATS SO AFRICA; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Voigt CC, 1999, BEHAV ECOL SOCIOBIOL, V47, P29, DOI 10.1007/s002650050646; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648; von Helversen O, 2000, J COMP PHYSIOL A, V186, P143, DOI 10.1007/s003590050014; WICKLER W, 1976, Z TIERPSYCHOL, V40, P345; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x	68	53	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25845	10.1371/journal.pone.0025845	http://dx.doi.org/10.1371/journal.pone.0025845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991371	Green Submitted, Green Published, gold			2022-12-25	WOS:000295943000084
J	Zhang, LJ; Xi, J; Xu, GQ; Shu, H; Wang, XY; Li, P				Zhang, Linjun; Xi, Jie; Xu, Guoqing; Shu, Hua; Wang, Xiaoyi; Li, Ping			Cortical Dynamics of Acoustic and Phonological Processing in Speech Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TOP-DOWN INFLUENCES; HIERARCHICAL ORGANIZATION; INTELLIGIBLE SPEECH; MECHANISMS; PITCH; NEUROANATOMY; INFORMATION; MODULATION; NETWORKS	In speech perception, a functional hierarchy has been proposed by recent functional neuroimaging studies: Core auditory areas on the dorsal plane of superior temporal gyrus (STG) are sensitive to basic acoustic characteristics, whereas downstream regions, specifically the left superior temporal sulcus (STS) and middle temporal gyrus (MTG) ventral to Heschl's gyrus (HG) are responsive to abstract phonological features. What is unclear so far is the relationship between the dorsal and ventral processes, especially with regard to whether low-level acoustic processing is modulated by high-level phonological processing. To address the issue, we assessed sensitivity of core auditory and downstream regions to acoustic and phonological variations by using within-and across-category lexical tonal continua with equal physical intervals. We found that relative to within-category variation, across-category variation elicited stronger activation in the left middle MTG (mMTG), apparently reflecting the abstract phonological representations. At the same time, activation in the core auditory region decreased, resulting from the top-down influences of phonological processing. These results support a hierarchical organization of the ventral acoustic-phonological processing stream, which originates in the right HG/STG and projects to the left mMTG. Furthermore, our study provides direct evidence that low-level acoustic analysis is modulated by high-level phonological representations, revealing the cortical dynamics of acoustic and phonological processing in speech perception. Our findings confirm the existence of reciprocal progression projections in the auditory pathways and the roles of both feed-forward and feedback mechanisms in speech perception.	[Zhang, Linjun; Xi, Jie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Linjun] Beijing Language & Culture Univ, Coll Chinese Studies, Beijing, Peoples R China; [Xi, Jie] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Xu, Guoqing] Dalian Med Univ, Dept Psychol, Dalian, Peoples R China; [Wang, Xiaoyi] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Li, Ping] Penn State Univ, Ctr Language Sci, University Pk, PA 16802 USA	Beijing Normal University; Beijing Language & Culture University; Chinese Academy of Sciences; Institute of Psychology, CAS; Dalian Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, LJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn; pul8@psu.edu	; Speicher, Andreas/B-3134-2014	Lin, Jinxing/0000-0001-9338-1356; Speicher, Andreas/0000-0001-6608-3994; Li, Ping/0000-0002-3314-943X	Program for Changjiang Scholars and Innovative Research Team in University [IRT0710]; Natural Science Foundation of China [30870758]; Natural Science Foundation of Beijing [7092051]; Fund for Foreign Scholars in University Research and Teaching Programs [B07008]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Fund for Foreign Scholars in University Research and Teaching Programs	The research was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0710, http://www.cksp.edu.cn/index.php), by grants from the Natural Science Foundation of China (30870758, http://www.nsfc.gov.cn/Portal0/default124.htm), by grants from the Natural Science Foundation of Beijing (7092051, http://www.bjnsf.org/) to HS, and the Fund for Foreign Scholars in University Research and Teaching Programs (B07008, http://www.bjnsf.org/) to PL and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Joanisse MF, 2007, CEREB CORTEX, V17, P2084, DOI 10.1093/cercor/bhl124; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Liebenthal E, 2010, CEREB CORTEX, V20, P2958, DOI 10.1093/cercor/bhq045; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Schofield TM, 2009, P NATL ACAD SCI USA, V106, P11765, DOI 10.1073/pnas.0811402106; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Tervaniemi M, 2006, J NEUROSCI, V26, P8647, DOI 10.1523/JNEUROSCI.0995-06.2006; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922	36	344	349	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20963	10.1371/journal.pone.0020963	http://dx.doi.org/10.1371/journal.pone.0020963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	22022536	gold, Green Published, Green Submitted			2022-12-25	WOS:000291663300033
